PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Hirai, H; Kondo, N; Sasaki, R; Iwamuro, S; Masuno, K; Ohtsuka, R; Miura, H; Sakata, K				Hirai, Hiroshi; Kondo, Naoki; Sasaki, Ryohei; Iwamuro, Shinya; Masuno, Kanako; Ohtsuka, Rika; Miura, Hisayuki; Sakata, Kiyomi			Distance to retail stores and risk of being homebound among older adults in a city severely affected by the 2011 Great East Japan Earthquake	AGE AND AGEING			English	Article						older people; built environment; disaster; homebound; Japan	NEIGHBORHOOD ENVIRONMENT; DISABILITY; COMMUNITY; WALKING	Background: after the Great East Japan Earthquake in 2011, inactivity and the homebound status of older victims in affected areas have been a serious public health concern owing to the victims' prolonged existence as evacuees in mountainous areas. Objective: to evaluate the association between distances to retail stores and risks of being homebound. Design: secondary analysis of cross-sectional interview survey data with a geographical information analysis. Setting: Rikuzentakata, Iwate, a municipality seriously damaged by the 2011 earthquake and tsunami. Subjects: all Rikuzentakata residents aged 65 or older except for those living in temporary housing (n = 2,327). Methods: we calculated road distances between each residential address and retail stores, hawker sites and shopping bus stops, accounting for the extra load caused by walking on slopes. The prevalence ratio of being homebound adjusted for age, source of income and morbidity by road distance was estimated using Poisson regression with a generalised estimating equation. Results: those living at distances of 1,200 m or more were 1.78 (95% confidence intervals, 1.03-3.08) times more likely to be homebound (going out only every 4 or more days a week) among men and 1.85 (1.13-3.02) among women, compared with those residing in places <400 m from retail stores or shopping bus stops. The distances were reduced by new hawker and shopping bus services, but the improvements varied greatly across the districts. Conclusions: access to daily needs is essential to prevent homebound status. Post-disaster community diagnosis in terms of the built environment is important for strategic community restoration.	[Hirai, Hiroshi] Iwate Univ, Fac Engn, Dept Civil & Environm Engn, Morioka, Iwate 020, Japan; [Kondo, Naoki] Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Bunkyo Ku, Tokyo 1130033, Japan; [Sasaki, Ryohei] Iwate Med Univ, Iwate Tohoku Med Megabank Org, Yahaba, Iwate, Japan; [Iwamuro, Shinya] Hlth Promot Res Ctr, Tokyo, Japan; [Masuno, Kanako] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Ohtsuka, Rika; Miura, Hisayuki] Natl Ctr Geriatr & Gerontol, Dept Home Care Coordinators, Obu, Aichi, Japan; [Sakata, Kiyomi] Iwate Med Univ, Sch Med, Dept Hyg & Prevent Med, Morioka, Iwate 020, Japan	Kondo, N (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Bunkyo Ku, 7-3-1 Hongo Bldg 3, Tokyo 1130033, Japan.	naoki-kondo@umin.ac.jp			Ministry of Health, Labour, and Welfare, Japan [H25-iryou-shitei-003]	This work was supported by Ministry of Health, Labour, and Welfare, Japan (No. H25-iryou-shitei-003).	Cohen-Mansfield J, 2010, J AM GERIATR SOC, V58, P2358, DOI 10.1111/j.1532-5415.2010.03172.x; Webb E, 2012, J EPIDEMIOL COMMUN H, V66, P176, DOI 10.1136/jech.2011.133165; Hanibuchi T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-657; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Ishigaki A, 2013, TOHOKU J EXP MED, V229, P287, DOI 10.1620/tjem.229.287; Murayama H, 2012, ARCH GERONTOL GERIAT, V54, P67, DOI 10.1016/j.archger.2011.03.016; Inoue S, 2010, J EPIDEMIOL, V20, P277, DOI 10.2188/jea.JE20090120; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Duncan MJ, 2010, J URBAN HEALTH, V87, P782, DOI 10.1007/s11524-010-9488-7; [Anonymous], 2014, FUND GEOSP DAT; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; Leslie E, 2007, HEALTH PLACE, V13, P111, DOI 10.1016/j.healthplace.2005.11.001; BRANCH LG, 1988, AM J PUBLIC HEALTH, V78, P255, DOI 10.2105/AJPH.78.3.255; Cabinet Office of Japan, 2006, RES SURV SEN CIT ATT; Furuya Y, 2015, HEALTH PROMOT INT, V30, P505, DOI 10.1093/heapro/dat071; GILBERT GH, 1992, HEALTH SERV RES, V26, P787; Kondo N, 2009, J EPIDEMIOL COMMUN H, V63, P461, DOI 10.1136/jech.2008.078642; Kondo N, 2013, GERIATR MED, V52, P147; Moon JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023465; Satoh E, 2006, J ARCHITECTURAL PLAN, V610, P133; Shinkai S, 2003, GERIATR GERONTOL INT, V3, pS31, DOI 10.1111/j.1444-0594.2003.00094.x; Strobl R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-137	22	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0002-0729	1468-2834		AGE AGEING	Age Ageing	MAY	2015	44	3					478	484		10.1093/ageing/afu146		7	Geriatrics & Gerontology	Geriatrics & Gerontology	CJ6SE	WOS:000355623100023		
J	Akazawa, H; Fukuda, H				Akazawa, Housei; Fukuda, Hiroshi			Epitaxial ZnO/LiNbO3/ZnO stacked layer waveguide for application to thin-film Pockels sensors	AIP ADVANCES			English	Article							ELECTRON-CYCLOTRON-RESONANCE; PULSED-LASER DEPOSITION; AXIS-ORIENTED LINBO3; CHEMICAL-VAPOR-DEPOSITION; LITHIUM-NIOBATE; C-AXIS; OPTICAL-PROPERTIES; ZNO; GROWTH; TRANSPARENT	We produced slab waveguides consisting of a LiNbO3 (LN) core layer that was sandwiched with Al-doped ZnO cladding layers. The ZnO/LN/ZnO stacked layers were grown on sapphire C-planes by electron cyclotron resonance (ECR) plasma sputtering and were subjected to structural, electrical, and optical characterizations. X-ray diffraction confirmed that the ZnO and LN layers were epitaxial without containing misoriented crystallites. The presence of 60 degrees-rotational variants of ZnO and LN crystalline domains were identified from X-ray pole figures. Cross-sectional transmission electron microscopy images revealed a c-axis orientated columnar texture for LN crystals, which ensured operation as electro-optic sensors based on optical anisotropy along longitudinal and transversal directions. The interfacial roughness between the LN core and ZnO bottom layers as well as that between the ZnO top and the LN core layers was less than 20 nm, which agreed with surface images observed with atomic force microscopy. Outgrowth of triangular LN crystalline domains produced large roughness at the LN film surface. The RMS roughness of the LN film surface was twice that of the same structure grown on sapphire A-planes. Vertical optical transmittance of the stacked films was higher than 85% within the visible and infrared wavelength range. Following the approach adopted by Teng and Man [Appl. Phys. Lett. 56, 1734 (1990)], ac Pockels coefficients of r(33) = 24-28 pm/V were derived for c-axis oriented LN films grown on low-resistive Si substrates. Light propagation within a ZnO/LN/ZnO slab waveguide as well as within a ZnO single layer waveguide was confirmed. The birefringence of these waveguides was 0.11 for the former and 0.05 for the latter. (C) 2015 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 Unported License.	[Akazawa, Housei; Fukuda, Hiroshi] NTT Corp, NTT Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan	Akazawa, H (reprint author), NTT Corp, NTT Device Innovat Ctr, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	akazawa.housei@lab.ntt.co.jp	Akazawa, Housei/N-1441-2015				ADACHI H, 1983, APPL PHYS LETT, V42, P867, DOI 10.1063/1.93795; Akazawa H, 2006, VACUUM, V80, P704, DOI 10.1016/j.vacuum.2005.11.028; Akazawa H, 2004, J CRYST GROWTH, V270, P560, DOI 10.1016/j.jcrysgro.2004.07.044; Akazawa H, 2008, J VAC SCI TECHNOL A, V26, P281, DOI 10.1116/1.2841486; Akazawa H, 2009, J VAC SCI TECHNOL A, V27, P51, DOI 10.1116/1.3021365; Akazawa H, 2006, J APPL PHYS, V99, DOI 10.1063/1.2204817; Akazawa H, 2009, THIN SOLID FILMS, V518, P22, DOI 10.1016/j.tsf.2009.06.008; Akazawa H, 2004, J VAC SCI TECHNOL A, V22, P1793, DOI 10.1116/1.1764817; Akazawa H, 2010, J VAC SCI TECHNOL A, V28, P314, DOI 10.1116/1.3328053; TENG CC, 1990, APPL PHYS LETT, V56, P1734, DOI 10.1063/1.103107; Agura H, 2003, THIN SOLID FILMS, V445, P263, DOI 10.1016/S0040-6090(03)01158-1; Rabiei P, 2004, APPL PHYS LETT, V85, P4603, DOI 10.1063/1.1819527; Fons P, 2000, APPL PHYS LETT, V77, P1801, DOI 10.1063/1.1311603; Wong FJ, 2014, J VAC SCI TECHNOL A, V32, DOI 10.1116/1.4879695; Vigue F, 2001, APPL PHYS LETT, V79, P194, DOI 10.1063/1.1384907; Miyata T, 2004, J VAC SCI TECHNOL A, V22, P1711, DOI 10.1116/1.1759351; JIN ZC, 1988, J APPL PHYS, V64, P5117, DOI 10.1063/1.342419; Bayraktaroglu B, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2959071; Bornand V, 2002, INTEGR FERROELECTR, V43, P51, DOI [10.1080/1058458019004370.5, 10.1080/10584580190043705]; Chen M, 2001, J VAC SCI TECHNOL A, V19, P963, DOI 10.1116/1.1368836; Derouin TA, 1997, J MATER RES, V12, P1391, DOI 10.1557/JMR.1997.0189; FORK DK, 1995, MATER RES SOC SYMP P, V361, P155; Fork DK, 1995, P MRS, V392, P189; Gaeremynck Y, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3646103; Garzarella A, 2005, J APPL PHYS, V97, DOI 10.1063/1.1928313; GRIFFEL G, 1989, APPL PHYS LETT, V54, P1385, DOI 10.1063/1.101406; Gupta V, 2004, J MATER RES, V19, P2235, DOI [10.1557/JMR.2004.0322, 10.1557/jmr.2004.0322]; HEWIG GH, 1982, THIN SOLID FILMS, V88, P67, DOI 10.1016/0040-6090(82)90351-0; HIDAKA K, 1989, REV SCI INSTRUM, V60, P1252, DOI 10.1063/1.1140299; Hirano S, 2002, J CRYST GROWTH, V237, P2091, DOI 10.1016/S0022-0248(01)02262-X; HU JH, 1992, J APPL PHYS, V71, P880, DOI 10.1063/1.351309; Hu WS, 1996, OPT LETT, V21, P946, DOI 10.1364/OL.21.000946; HUANG CHJ, 1993, OPT LETT, V18, P811, DOI 10.1364/OL.18.000811; HUANG CHJ, 1995, INTEGR FERROELECTR, V6, P355, DOI 10.1080/10584589508019379; Igarashi Y., 1991, J APPL PHYS, V70, P3613; KINGSTON JJ, 1994, MATER RES SOC SYMP P, V341, P289; LEE SH, 1995, APPL PHYS LETT, V67, P43, DOI 10.1063/1.115486; Lee SY, 1998, J CRYST GROWTH, V186, P594, DOI 10.1016/S0022-0248(97)00593-9; MATSUNAGA H, 1990, J CRYST GROWTH, V99, P630, DOI 10.1016/0022-0248(90)90597-E; Minami T, 2000, J VAC SCI TECHNOL A, V18, P1584, DOI 10.1116/1.582389; MORICHERE D, 1989, OPT COMMUN, V74, P69, DOI 10.1016/0030-4018(89)90492-6; Nashimoto K, 1998, APPL PHYS LETT, V73, P303, DOI 10.1063/1.121816; NISHIDA T, 1995, JPN J APPL PHYS 1, V34, P5113, DOI 10.1143/JJAP.34.5113; NOMURA K, 1991, J APPL PHYS, V70, P3234, DOI 10.1063/1.349308; Rabiei P, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1906311; Rost T. A., 1992, J APPL PHYS, V72, P36; SCHWYN S, 1992, J APPL PHYS, V72, P1154, DOI 10.1063/1.351793; SHIMIZU M, 1993, JPN J APPL PHYS 1, V32, P4111, DOI 10.1143/JJAP.32.4111; Sung YM, 2003, REV SCI INSTRUM, V74, P1093, DOI 10.1063/1.1532838; Takahashi T, 1996, JPN J APPL PHYS 1, V35, P767, DOI 10.1143/JJAP.35.767; Takahashi T, 2001, SENSOR MATER, V13, P461; TAKIZAWA K, 1982, J OPT SOC AM, V72, P809, DOI 10.1364/JOSA.72.000809; Tan S, 1996, J APPL PHYS, V79, P3548, DOI 10.1063/1.361407; TURNER EH, 1966, APPL PHYS LETT, V8, P303, DOI 10.1063/1.1754449; UCHIKI H, 1988, J APPL PHYS, V64, P2625, DOI 10.1063/1.341654; Wang XC, 2004, MATER LETT, V58, P3597, DOI 10.1016/j.matlet.2004.06.059; Wang XC, 2007, J CRYST GROWTH, V306, P62, DOI 10.1016/j.jcrysgro.2007.05.016; WEIS RS, 1985, APPL PHYS A-MATER, V37, P191, DOI 10.1007/BF00614817; WERNBERG AA, 1993, APPL PHYS LETT, V62, P946, DOI 10.1063/1.108528; Yamada S, 2002, JPN J APPL PHYS 2, V41, pL275, DOI 10.1143/JJAP.41.L275; Ye ZZ, 2002, MATER LETT, V55, P265, DOI 10.1016/S0167-577X(01)00658-9	61	1	1	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	MAY	2015	5	5							057163	10.1063/1.4921981		13	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CJ5XV	WOS:000355568100083		
J	Fujiwara, R; Hemthavy, P; Takahashi, K; Saito, S				Fujiwara, Ryo; Hemthavy, Pasomphone; Takahashi, Kunio; Saito, Shigeki			Pulse voltage determination for electrostatic micro manipulation considering surface conductivity and adhesion of glass particle	AIP ADVANCES			English	Article							MICROMANIPULATION	A model with surface conductivity and adhesional force is proposed to investigate the mechanism for electrostatic micro manipulation of a dielectric object using a single probe. The manipulation system consists of three elements: a conductive probe as a manipulator, a conductive plate as a substrate, and a dielectric particle as the target object for manipulation. The particle can be successfully picked up/placed if a rectangular pulse voltage is applied between the probe and the plate. The reliability of the picking up/placing operation is improved by applying a pulse voltage that is determined by a theoretical model considering surface conductivity and adhesion. To verify the theoretical prediction, manipulation experiment is conducted using soda-lime glass particles with radii of 20 mu m and 40 mu m. (C) 2015 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 Unported License.	[Fujiwara, Ryo; Saito, Shigeki] Tokyo Inst Technol, Grad Sch Engn, Dept Mech & Aerosp Engn, Tokyo 1528550, Japan; [Hemthavy, Pasomphone; Takahashi, Kunio] Tokyo Inst Technol, Grad Sch Engn, Dept Int Dev Engn, Tokyo 1528550, Japan	Fujiwara, R (reprint author), Tokyo Inst Technol, Grad Sch Engn, Dept Mech & Aerosp Engn, I1-47,2-12-1 Meguro Ku O Okayama, Tokyo 1528550, Japan.	fujiwara.r.ab@m.titech.ac.jp; saitos@mep.titech.ac.jp					Warneke B, 2001, COMPUTER, V34, P44, DOI 10.1109/2.895117; Cai M, 2000, OPT LETT, V25, P1430, DOI 10.1364/OL.25.001430; Neild A, 2006, J MICROMECH MICROENG, V16, P1562, DOI 10.1088/0960-1317/16/8/017; Obata KJ, 2004, J FLUID MECH, V498, P113, DOI 10.1017/S0022112003006955; Altintas E, 2009, SENSOR ACTUAT A-PHYS, V154, P123, DOI 10.1016/j.sna.2009.05.022; Lambert P, 2006, J MICROMECH MICROENG, V16, P1267, DOI 10.1088/0960-1317/16/7/021; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Biganzoli F., 2005, ASS TASK PLANN NAN M, P36; Cagliani A, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/3/035009; Fearing R., 1995, IEEE RSJ INT C INT R, V2, P212; Feng JQ, 1997, J ELECTROSTAT, V40-1, P289, DOI 10.1016/S0304-3886(97)00052-1; Fuhr G., 1991, Proceedings. IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robots (Cat. No.91CH2957-9), DOI 10.1109/MEMSYS.1991.114807; Hays D. A., 2004, ELECTROSTATICS 2003, P77; Jeon CW, 2004, IEEE PHOTONIC TECH L, V16, P2421, DOI 10.1109/LPT.835626; Jiang L, 2011, J INSTRUM, V6, DOI 10.1088/1748-0221/6/10/P10014; Kasaya T, 1998, P SOC PHOTO-OPT INS, V3519, P181, DOI 10.1117/12.325738; Kawamoto H, 2006, J PHYS D APPL PHYS, V39, P1249, DOI 10.1088/0022-3727/39/6/036; Kawamoto H, 2009, J ELECTROSTAT, V67, P850, DOI 10.1016/j.elstat.2009.07.002; Kawamoto H, 2011, ADV POWDER TECHNOL, V22, P602, DOI 10.1016/j.apt.2010.09.001; Kishi T, 2012, AIP ADV, V2, DOI 10.1063/1.4769888; Konno T, 2005, SCI TECHNOL ADV MAT, V6, P939, DOI 10.1016/j.stam.2005.08.006; Lynch NA, 2008, J MICRONANOMECHATRON, V4, P73, DOI 10.1007/s12213-008-0008-8; Moesner FM, 1999, IEEE T IND APPL, V35, P530, DOI 10.1109/28.766997; Nakabayashi D, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/8/085003; Saito S, 2002, J APPL PHYS, V92, P5140, DOI 10.1063/1.1512313; Saito S., 2007, NAN 2007 IEEE NANO 2, P733; Saito S, 2003, APPL PHYS LETT, V83, P2076, DOI 10.1063/1.1609039; Saito S, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/10/107001; Sawai K, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/2/025022; Takahashi K, 2001, J APPL PHYS, V90, P432, DOI 10.1063/1.1379353; Tanikawa T., 1998, INT ROB SYST 1998 P, V2, P776; Yamashima A, 2009, J APPL PHYS, V106, DOI 10.1063/1.3260252	32	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	MAY	2015	5	5							057126	10.1063/1.4921090		12	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CJ5XV	WOS:000355568100046		
J	Niizeki, T; Kikkawa, T; Uchida, K; Oka, M; Suzuki, KZ; Yanagihara, H; Kita, E; Saitoh, E				Niizeki, Tomohiko; Kikkawa, Takashi; Uchida, Ken-ichi; Oka, Mineto; Suzuki, Kazuya Z.; Yanagihara, Hideto; Kita, Eiji; Saitoh, Eiji			Observation of longitudinal spin-Seebeck effect in cobalt-ferrite epitaxial thin films	AIP ADVANCES			English	Article							MAGNETIC-ANISOTROPY; INSULATOR	The longitudinal spin-Seebeck effect (LSSE) has been investigated in cobalt ferrite (CFO), an exceptionally hard magnetic spinel ferrite. A bilayer of a polycrystalline Pt and an epitaxially-strained CFO(110) exhibiting an in-plane uniaxial anisotropy was prepared by reactive rf sputtering technique. Thermally generated spin voltage in the CFO layer was measured via the inverse spin-Hall effect in the Pt layer. External-magnetic-field (H) dependence of the LSSE voltage (V-LSSE) in the Pt/CFO(110) sample with H parallel to [001] was found to exhibit a hysteresis loop with a high squareness ratio and high coercivity, while that with H parallel to [1 (1) over bar0] shows a nearly closed loop, reflecting the different anisotropies induced by the epitaxial strain. The magnitude of V-LSSE has a linear relationship with the temperature difference (Delta T), giving the relatively large V-LSSE/Delta T of about 3 mu V/K for CFO(110) which was kept even at zero external field. (C) 2015 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 Unported License.	[Niizeki, Tomohiko; Saitoh, Eiji] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Niizeki, Tomohiko; Kikkawa, Takashi; Uchida, Ken-ichi; Saitoh, Eiji] Japan Sci & Technol Agcy, ERATO, Spin Quantum Rectificat Project, Sendai, Miyagi 9808577, Japan; [Kikkawa, Takashi; Uchida, Ken-ichi; Saitoh, Eiji] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Uchida, Ken-ichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Oka, Mineto; Suzuki, Kazuya Z.; Yanagihara, Hideto; Kita, Eiji] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Saitoh, Eiji] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan	Niizeki, T (reprint author), Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.	t-niizeki@imr.tohoku.ac.jp; kuchida@imr.tohoku.ac.jp	Uchida, Ken-ichi/H-3098-2011; Saitoh, Eiji/C-1004-2011; Suzuki, Kazuya/P-6171-2014; Kikkawa, Takashi/P-9016-2015	Kikkawa, Takashi/0000-0002-7789-604X	JST; MEXT, Japan [26103005, 25707029, 25790039, 26600067, 24244051]; NEC Corporation	This work was supported by PRESTO "Phase Interfaces for Highly Efficient Energy Utilization", CREST "Creation of Nanosystems with Novel Functions through Process Integration", Japan Strategic International Cooperative Program ASPIMATT from JST, Grant-in-Aid for Scientific Research on Innovative Area, "Nano Spin Conversion Science" (26103005), Grant-in-Aid for Young Scientists (A) (25707029), Grant-in-Aid for Young Scientists (B) (25790039), Grant-in-Aid for Challenging Exploratory Research (26600067), Grant-in-Aid for Scientific Research (A) (24244051) from MEXT, Japan, and NEC Corporation.	Abe M, 2000, ELECTROCHIM ACTA, V45, P3337, DOI 10.1016/S0013-4686(00)00403-5; Siegel Gene, 2014, Sci Rep, V4, P4429, DOI 10.1038/srep04429; Uchida K, 2010, NAT MATER, V9, P894, DOI [10.1038/nmat2856, 10.1038/NMAT2856]; Uchida K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3507386; Ramos R, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4793486; Kirihara A, 2012, NAT MATER, V11, P686, DOI [10.1038/nmat3360, 10.1038/NMAT3360]; Kajiwara Y, 2010, NATURE, V464, P262, DOI 10.1038/nature08876; Lisfi A, 2007, PHYS REV B, V76, DOI [10.1103/PhysRevB.76.054405, 10.1103/PhysRevE.76.054405]; Uchida K, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/34/343202; SLONCZEWSKI JC, 1958, PHYS REV, V110, P1341, DOI 10.1103/PhysRev.110.1341; Uchida K, 2008, NATURE, V455, P778, DOI 10.1038/nature07321; Jaworski CM, 2010, NAT MATER, V9, P898, DOI [10.1038/nmat2860, 10.1038/NMAT2860]; Niizeki T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824761; Azevedo A, 2005, J APPL PHYS, V97, DOI 10.1063/1.1855251; Uchida K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3533397; Meier D, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.054421; Jaworski CM, 2012, NATURE, V487, P210, DOI 10.1038/nature11221; Adachi H, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3529944; Suzuki Y, 1996, APPL PHYS LETT, V68, P714, DOI 10.1063/1.116601; Valenzuela SO, 2006, NATURE, V442, P176, DOI 10.1038/nature04937; Bosu S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.224401; BOZORTH RM, 1955, PHYS REV, V99, P1788, DOI 10.1103/PhysRev.99.1788; Xiao J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214418; Kikkawa T, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.214403; Saitoh E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199473; Inoue J, 2013, IEEE T MAGN, V49, P3269, DOI 10.1109/TMAG.2013.2243703; Kikkawa T., 2015, ARXIV150305764; Li P, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4904479; Ren J, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.220406; Uchida K, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.104412; Yanagihara H, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2014.2327129; Yanagihara H, 2014, J APPL PHYS, V115, DOI 10.1063/1.4864048	32	2	2	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	MAY	2015	5	5							053603	10.1063/1.4916978		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CJ5XV	WOS:000355568100019		
J	Qiu, Z; Uruichi, M; Hou, D; Uchida, K; Yamamoto, HM; Saitoh, E				Qiu, Z.; Uruichi, M.; Hou, D.; Uchida, K.; Yamamoto, H. M.; Saitoh, E.			Spin-current injection and detection in kappa-(BEDT-TTF)(2)Cu[N(CN)(2)]Br	AIP ADVANCES			English	Article							ORGANIC SUPERCONDUCTOR; TRANSITION; TEMPERATURE; FILMS; POWER; NMR	Spin-current injection into an organic semiconductor kappa-(BEDT-TTF)(2)Cu[N(CN)(2)]Br film induced by the spin pumping from an yttrium iron garnet (YIG) film. When magnetization dynamics in the YIG film is excited by ferromagnetic or spin-wave resonance, a voltage signal was found to appear in the kappa-(BEDT-TTF)(2)Cu[N(CN)(2)]Br film. Magnetic-field-angle dependence measurements indicate that the voltage signal is governed by the inverse spin Hall effect in kappa-(BEDT-TTF)(2)Cu[N(CN)(2)]Br. We found that the voltage signal in the kappa-(BEDT-TTF)(2)Cu[N(CN)(2)]Br/YIG system is critically suppressed around 80 K, around which magnetic and/or glass transitions occur, implying that the efficiency of the spin-current injection is suppressed by fluctuations which critically enhanced near the transitions. (C) 2015 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 Unported License.	[Qiu, Z.; Hou, D.; Saitoh, E.] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Qiu, Z.; Hou, D.; Uchida, K.; Saitoh, E.] Japan Sci & Technol Agcy, ERATO, Spin Quantum Rectificat Project, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Uruichi, M.; Yamamoto, H. M.] Natl Inst Nat Sci, Inst Mol Sci, Res Ctr Integrat Mol Syst CIMoS, Okazaki, Aichi 4448585, Japan; [Uchida, K.; Saitoh, E.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Uchida, K.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Yamamoto, H. M.] RIKEN, Wako, Saitama 3510198, Japan; [Saitoh, E.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan	Qiu, Z (reprint author), Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.	qiuzy@imr.tohoku.ac.jp	Uchida, Ken-ichi/H-3098-2011; Saitoh, Eiji/C-1004-2011; Hou, Dazhi/O-2832-2015	Hou, Dazhi/0000-0002-1286-2965	PRESTO "Phase Interfaces for Highly Efficient Energy Utilization," Strategic International Cooperative Program ASPIMATT from JST, Japan [25707029, 26790038]; Scientific Research on Innovative Areas "Nano Spin Conversion Science" from MEXT, Japan [26600067, 24244051, 26103005]; NEC Corporation	This work was supported by PRESTO "Phase Interfaces for Highly Efficient Energy Utilization," Strategic International Cooperative Program ASPIMATT from JST, Japan, Grant-in-Aid for Young Scientists (A) (25707029), Grant-in-Aid for Young Scientists (B) (26790038), Grant-in-Aid for Challenging Exploratory Research (26600067), Grant-in-Aid for Scientific Research (A) (24244051), Grant-in-Aid for Scientific Research on Innovative Areas "Nano Spin Conversion Science" (26103005) from MEXT, Japan, and NEC Corporation.	Ando K, 2010, J APPL PHYS, V107, DOI 10.1063/1.3418441; Ando K, 2011, NAT MATER, V10, P655, DOI [10.1038/nmat3052, 10.1038/NMAT3052]; Wang ZH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3654148; Ando K, 2013, NAT MATER, V12, P622, DOI [10.1038/nmat3634, 10.1038/NMAT3634]; Limelette P, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.016401; Kagawa F, 2009, NAT PHYS, V5, P880, DOI 10.1038/NPHYS1428; Vignale G, 2010, J SUPERCOND NOV MAGN, V23, P3, DOI 10.1007/s10948-009-0547-9; Faltermeier D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165113; Kajiwara Y, 2010, NATURE, V464, P262, DOI 10.1038/nature08876; Rezende SM, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4773993; Kanoda K, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.051007; An T, 2013, NAT MATER, V12, P549, DOI [10.1038/nmat3628, 10.1038/NMAT3628]; Kagawa F, 2005, NATURE, V436, P534, DOI 10.1038/nature038O6; Watanabe S, 2014, NAT PHYS, V10, P308, DOI [10.1038/nphys2901, 10.1038/NPHYS2901]; Strack C, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.054511; Qiu Z, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3675463; Azevedo A, 2005, J APPL PHYS, V97, DOI 10.1063/1.1855251; Sandweg CW, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3528207; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323; WILLIAMS JM, 1990, INORG CHEM, V29, P3272, DOI 10.1021/ic00343a003; KINI AM, 1990, INORG CHEM, V29, P2555, DOI 10.1021/ic00339a004; Boudiar T, 2004, J MAGN MAGN MATER, V284, P77, DOI 10.1016/j.jmmm.2004.06.046; Saitoh E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199473; Fournier D, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.127002; Hahn C, 2014, EPL-EUROPHYS LETT, V108, DOI 10.1209/0295-5075/108/57005; Iguchi R, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.103004; Iguchil R, 2012, IEEE T MAGN, V48, P3051, DOI 10.1109/TMAG.2012.2202382; Kuwata Y, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.144505; LING SH, 1993, APPL PHYS LETT, V62, P1757, DOI 10.1063/1.109598; LOGVENOV GY, 1995, J PHYS SOC JPN, V64, P3622, DOI 10.1143/JPSJ.64.3622; Miyagawa K, 2004, CHEM REV, V104, P5635, DOI 10.1021/cr0306541; Muller J, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144521; Ohnuma Y, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.174417; Qiu Z, 2013, APPL PHYS LETT, V103, P3; Qiu Z, 2013, APPL PHYS LETT, V103, P4; Yamamoto HM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3379; Yefanov VS, 2003, PHYSICA C, V388, P589, DOI 10.1016/S0921-4534(02)02754-5; YU RC, 1991, PHYS REV B, V44, P6932, DOI 10.1103/PhysRevB.44.6932	38	1	1	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	MAY	2015	5	5							057167	10.1063/1.4922007		7	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CJ5XV	WOS:000355568100086		
J	Shimoi, N; Zhang, QW; Bahena-Garrido, S; Tanaka, Y				Shimoi, Norihiro; Zhang Qiwu; Bahena-Garrido, Sharon; Tanaka, Yasumitsu			Mechanochemical approaches to employ silicon as a lithium-ion battery anode	AIP ADVANCES			English	Article							CRYSTALLINE SILICON; SI; PERFORMANCE; LITHIATION; CU3SI; XPS	Silicon is essential as an active material in lithium-ion batteries because it provides both high-charge and optimal cycle characteristics. The authors attempted to realize a composite by a simple mechanochemical grinding approach of individual silicon (Si) particles and copper monoxide (CuO) particles to serve as an active material in the anode and optimize the charge-discharge characteristics of a lithium-ion battery. The composite with Si and CuO allowed for a homogenous dispersion with nano-scale Si grains, nano-scale copper-silicon alloy grains and silicon monoxide oxidized the oxide from CuO. The authors successfully achieved the synthesis of an active composite unites the structural features of an active material based on silicon composite as an anode in Li-ion battery with high capacity and cyclic reversible charge properties of 3256 mAh g(-1) after 200 cycles. (C) 2015 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 Unported License.	[Shimoi, Norihiro; Bahena-Garrido, Sharon; Tanaka, Yasumitsu] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Zhang Qiwu] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Shimoi, N (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-20 Aoba, Sendai, Miyagi 9808579, Japan.	shimoi@mail.kankyo.tohoku.ac.jp					Hu YS, 2008, ANGEW CHEM INT EDIT, V47, P1645, DOI 10.1002/anie.200704287; Ebner M, 2013, SCIENCE, V342, P716, DOI 10.1126/science.1241882; Magasinski A, 2010, NAT MATER, V9, P353, DOI [10.1038/nmat2725, 10.1038/NMAT2725]; Tanaka Y, 2003, J PHYS CHEM B, V107, P11091, DOI 10.1021/jp0376808; Zhao KJ, 2012, J ELECTROCHEM SOC, V159, pA238, DOI 10.1149/2.020203jes; Kovalenko I, 2011, SCIENCE, V334, P75, DOI 10.1126/science.1209150; Liu N, 2012, NANO LETT, V12, P3315, DOI 10.1021/nl3014814; Yang J, 2002, SOLID STATE IONICS, V152, P125, DOI 10.1016/S0167-2738(02)00362-4; Beyer MK, 2005, CHEM REV, V105, P2921, DOI 10.1021/cr030697h; Liu XH, 2012, ACS NANO, V6, P1522, DOI 10.1021/nn204476h; Holzapfel M, 2006, ELECTROCHIM ACTA, V52, P973, DOI 10.1016/j.electacta.2006.06.034; Szczech JR, 2011, ENERG ENVIRON SCI, V4, P56, DOI 10.1039/c0ee00281j; Netz A, 2003, J POWER SOURCES, V119, P95, DOI 10.1016/S0378-7753(03)00132-0; Hu LB, 2011, CHEM COMMUN, V47, P367, DOI 10.1039/c0cc02078h; McDowell MT, 2012, ADV MATER, V24, P6034, DOI 10.1002/adma.201202744; Hochgatterer NS, 2008, ELECTROCHEM SOLID ST, V11, pA76, DOI 10.1149/1.2888173; BANHOLZER WF, 1986, SURF SCI, V176, P125, DOI 10.1016/0039-6028(86)90167-6; Bernard F, 2000, MAT SCI ENG A-STRUCT, V284, P301, DOI 10.1016/S0921-5093(00)00749-8; Besenhard J., 1999, HDB BATTERY MAT; HUGGINS RA, 1989, J POWER SOURCES, V26, P109, DOI 10.1016/0378-7753(89)80020-5; Huixin Chen, 2011, Journal of Power Sources, V196, DOI 10.1016/j.jpowsour.2010.12.075; Jae Woo K., 2005, J POWER SOURCES, V147, P227; Obrovac MN, 2007, J ELECTROCHEM SOC, V154, pA103, DOI 10.1149/1.2402112; Parditka B, 2013, ACTA MATER, V61, P7173, DOI 10.1016/j.actamat.2013.08.021; Shengqi X., 1996, J MATER SCI, V15, P634, DOI 10.1007/BF00579274; Shimoi N, 2012, ELECTROCHIM ACTA, V80, P227, DOI 10.1016/j.electacta.2012.07.006; Sukeun Y., 2006, J POWER SOURCES, V161, P1319; Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9; Vijay A. S., 2011, J POWER SOURCES, V196, P393; Welham NJ, 1998, J ALLOY COMPD, V274, P303, DOI 10.1016/S0925-8388(98)00590-8; Wu H, 2012, NAT NANOTECHNOL, V7, P309, DOI [10.1038/nnano.2012.35, 10.1038/NNANO.2012.35]; Zhang QW, 2002, CHEM LETT, P1094, DOI 10.1246/cl.2002.1094	32	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	MAY	2015	5	5							057142	10.1063/1.4921563		8	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CJ5XV	WOS:000355568100062		
J	Suzuki, R; Kato, T; Tetsumoto, T; Tanabe, T				Suzuki, Ryo; Kato, Takumi; Tetsumoto, Tomohiro; Tanabe, Takasumi			Octagonal toroid microcavity for mechanically robust optical coupling	AIP ADVANCES			English	Article							FIBER TAPER; MODE; RESONATORS; CHIP	Light is usually coupled to a whispering gallery mode cavity using a tapered fiber. However, it is difficult to stabilize the optical coupling against mechanical vibration because it requires sub-mu m control of the gap distance between the fiber and cavity. In this study, we experimentally demonstrate mechanically robust coupling that we realize by allowing the tapered fiber to touch the sidewall of the cavity. By using an octagonal toroid microcavity, we prevent the cavity-waveguide system from over coupling and achieve critical coupling even when the fiber is in contact with the surface of the cavity. We show by numerical analysis that such a deformed microcavity is required if we need to control the coupling, since a circular cavity usually overcouples when the fiber contacts the surface. The fabricated octagonal silica toroid microcavity exhibits a quality factor of 2.2 x 10(4) when the tapered fiber touches a cavity with a diameter of 80 mu m. (C) 2015 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 Unported License.	[Suzuki, Ryo; Kato, Takumi; Tetsumoto, Tomohiro; Tanabe, Takasumi] Keio Univ, Fac Sci & Technol, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Suzuki, R (reprint author), Keio Univ, Fac Sci & Technol, Dept Elect & Elect Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.		Tanabe, Takasumi/B-4230-2009	Tanabe, Takasumi/0000-0001-5984-4265	Strategic Information and Communications R&D Promotion Program (SCOPE)	This work was supported by the Strategic Information and Communications R&D Promotion Program (SCOPE).	Jiang XF, 2012, ADV MATER, V24, pOP260, DOI 10.1002/adma.201201229; Cai M, 2000, PHYS REV LETT, V85, P74, DOI 10.1103/PhysRevLett.85.74; Kato T, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4752746; Del'Haye P, 2007, NATURE, V450, P1214, DOI 10.1038/nature06401; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Knight JC, 1997, OPT LETT, V22, P1129, DOI 10.1364/OL.22.001129; Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Yoshiki W, 2014, OPT EXPRESS, V22, P24332, DOI 10.1364/OE.22.024332; Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221; Little BE, 1997, J LIGHTWAVE TECHNOL, V15, P998, DOI 10.1109/50.588673; Kudo H, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.023807; Li C, 2006, IEEE J SEL TOP QUANT, V12, P1438, DOI 10.1109/JSTQE.2006.883150; Liu Y, 2005, OPT ENG, V44, DOI 10.1117/1.2012503; Zubel I, 2008, SURF SCI, V602, P1712, DOI 10.1016/j.susc.2008.03.010	14	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	MAY	2015	5	5							057127	10.1063/1.4921201		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CJ5XV	WOS:000355568100047		
J	Yin, Y; Sun, HB; Sang, LW; Chen, P; Zheng, YD; Dierre, B; Sumiya, M; Shi, Y; Sekiguchi, T				Yin, Yao; Sun, Huabin; Sang, Liwen; Chen, Peng; Zheng, Youdou; Dierre, Benjamin; Sumiya, Masatomo; Shi, Yi; Sekiguchi, Takashi			Influence of dislocations on indium diffusion in semi-polar InGaN/GaN heterostructures	AIP ADVANCES			English	Article							VAPOR-PHASE EPITAXY; SELECTIVE-AREA GROWTH; LATERAL OVERGROWTH; QUANTUM-WELLS; GAN; ALLOYS	The spatial distribution of indium composition in InGaN/GaN heterostructure is a critical topic for modulating the wavelength of light emitting diodes. In this letter, semi-polar InGaN/GaN heterostructure stripes were fabricated on patterned GaN/Sapphire substrates by epitaxial lateral overgrowth (ELO), and the spatial distribution of indium composition in the InGaN layer was characterized by using cathodoluminescence. It is found that the indium composition is mainly controlled by the diffusion behaviors of metal atoms (In and Ga) on the surface. The diffusivity of metal atoms decreases sharply as migrating to the region with a high density of dislocations and other defects, which influences the distribution of indium composition evidently. Our work is beneficial for the understanding of ELO process and the further development of InGaN/GaN heterostructure based devices. (C) 2015 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 Unported License.	[Yin, Yao; Sun, Huabin; Chen, Peng; Zheng, Youdou; Shi, Yi] Nanjing Univ, Natl Lab Microstruct, Nanjing 210093, Jiangsu, Peoples R China; [Yin, Yao; Sun, Huabin; Chen, Peng; Zheng, Youdou; Shi, Yi] Nanjing Univ, Sch Elect Sci & Engn, Nanjing 210093, Jiangsu, Peoples R China; [Yin, Yao; Sang, Liwen; Dierre, Benjamin; Sumiya, Masatomo; Sekiguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Zheng, Youdou; Shi, Yi] Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China	Yin, Y (reprint author), Nanjing Univ, Natl Lab Microstruct, Nanjing 210093, Jiangsu, Peoples R China.	yshi@nju.edu.cn; sekiguchi.takashi@nims.go.jp	sang, liwen/B-3497-2012		National Basic Research Program of China [2013CB932900, 2011CB922100]; NSFC [61205057, 61204050]; NSFJS [BK2011011, BK20130055]; China Scholarship Council	The authors acknowledge the financial support from the National Basic Research Program of China under Grant Nos. 2013CB932900 and 2011CB922100, NSFC under Grant Nos. 61205057 and 61204050, and NSFJS under Grant Nos. BK2011011 and BK20130055. Yao Yin also wants to thank China Scholarship Council for supporting her study in Japan.	Koester R, 2011, NANO LETT, V11, P4839, DOI 10.1021/nl202686n; Kapolnek D, 1997, APPL PHYS LETT, V71, P1204, DOI 10.1063/1.119626; Hiramatsu K, 1999, PHYS STATUS SOLIDI A, V176, P535, DOI 10.1002/(SICI)1521-396X(199911)176:1<535::AID-PSSA535>3.0.CO;2-I; Wu J, 2002, APPL PHYS LETT, V80, P4741, DOI 10.1063/1.1489481; Srinivasan S, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2067693; Srinivasan S, 2003, APPL PHYS LETT, V83, P5187, DOI 10.1063/1.1633029; Doppalapudi D, 1998, J APPL PHYS, V84, P1389, DOI 10.1063/1.368251; Nakamura S, 1996, APPL PHYS LETT, V69, P1568, DOI 10.1063/1.117032; Hiramatsu K, 2000, J CRYST GROWTH, V221, P316, DOI 10.1016/S0022-0248(00)00707-7; Yamamoto T, 2014, J CRYST GROWTH, V393, P108, DOI 10.1016/j.jcrysgro.2013.11.072; Fang H, 2008, J APPL PHYS, V103, DOI 10.1063/1.2829784; Greenspan JE, 2003, J CRYST GROWTH, V248, P405, DOI 10.1016/S0022-0248(02)01845-6; Kyaw Z, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4873395; Liua B. L., 2002, J CRYST GROWTH, V234, P637; Nam OH, 1998, J ELECTRON MATER, V27, P233, DOI 10.1007/s11664-998-0393-8; Park J, 1998, APPL PHYS LETT, V73, P333, DOI 10.1063/1.121825; Yamaguchi S, 2002, APPL PHYS LETT, V80, P802, DOI 10.1063/1.1446204	17	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	MAY	2015	5	5							057129	10.1063/1.4921207		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CJ5XV	WOS:000355568100049		
J	Kagitani, H; Hoshide, S; Kario, K				Kagitani, Hideaki; Hoshide, Satoshi; Kario, Kazuomi			Optimal Indicators of Home BP Variability in Perimenopausal Women and Associations With Albuminuria and Reproducibility: The J-HOT Home BP Study	AMERICAN JOURNAL OF HYPERTENSION			English	Article						blood pressure; hypertension; maximum home blood pressure; mean home blood pressure; middle-aged women; urinary albumin/creatinine ratio	BLOOD-PRESSURE VARIABILITY; TO-VISIT VARIABILITY; TARGET-ORGAN DAMAGE; PROGNOSTIC-SIGNIFICANCE; EPISODIC HYPERTENSION; CARDIOVASCULAR RISK; PROGRESSION; POPULATION; DISEASE; STROKE	BACKGROUND This study investigated the associations between various indicators of home blood pressure (BP) variability and albuminuria as well as the reproducibility of these indicators in perimenopausal women, who are likely to exhibit increased BP variability. METHODS As a measure of organ damage, urinary albumin/creatinine ratio (UACR) was examined at baseline in 151 women aged 40-59 years. Home BP was measured in duplicate in both morning and evening for 12 weeks using a home BP monitor. The following home BP variability indicators were calculated biweekly: mean, maximum, minimum, difference between maximum and minimum, average real variability (ARV), SD, and coefficient of variation. RESULTS In simple correlation, the ARV of systolic BP (SBP) (morning + evening and morning), maximum SBP (evening), and maximum diastolic BP (all time points) were most strongly correlated with UACR. In multivariate linear regression, the maximum, minimum, and ARV of SBP (morning) and both mean and maximum SBP (evening) were significantly associated with Box-Cox transformed UACR after adjustment for age, body mass index, and lifestyle. In particular, maximum SBP had the lowest P value among those BP indicators. Furthermore, maximum morning SBP tended to distinguish high-normal albuminuria (UACR >= 10 mg/g Cr) more clearly than mean morning SBP. The mean, maximum, and minimum values of home BP demonstrated the greatest reproducibility among all indicators. CONCLUSION Maximum home BP is associated with UACR and exhibits high reproducibility in perimenopausal women. These findings raise the hypothesis that maximum home SBP may be suitable to detect kidney damage.	[Kagitani, Hideaki; Hoshide, Satoshi; Kario, Kazuomi] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Kagitani, Hideaki] Terumo Co Ltd, Data Sci Sect, Dept Clin Dev, Tokyo, Japan	Kario, K (reprint author), Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan.	kkario@jichi.ac.jp			Terumo Corporation	This work was supported by Terumo Corporation.	Tatasciore A, 2007, HYPERTENSION, V50, P325, DOI 10.1161/HYPERTENSIONAHA.107.090084; Barnes JN, 2014, HYPERTENSION, V63, P303, DOI 10.1161/HYPERTENSIONAHA.113.02393; Carter JR, 2013, HYPERTENSION, V61, P395, DOI 10.1161/HYPERTENSIONAHA.112.202598; Tatasciore A, 2008, HYPERTENS RES, V31, P2137, DOI 10.1291/hypres.31.2137; Asayama K, 2013, HYPERTENSION, V61, P61, DOI 10.1161/HYPERTENSIONAHA.111.00138; Hata J, 2013, CIRCULATION, V128, P1325, DOI 10.1161/CIRCULATIONAHA.113.002717; Howard SC, 2009, CEREBROVASC DIS, V28, P331, DOI 10.1159/000229551; Schutte R, 2012, HYPERTENSION, V60, P1138, DOI 10.1161/HYPERTENSIONAHA.112.202143; Mena L, 2005, J HYPERTENS, V23, P505, DOI 10.1097/01.hjh.0000160205.81652.5a; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Parati G, 2012, CURR HYPERTENS REP, V14, P421, DOI 10.1007/s11906-012-0290-7; Yokota K, 2013, HYPERTENS RES, V36, P151, DOI 10.1038/hr.2012.145; Muntner P, 2011, J HYPERTENS, V29, P2332, DOI 10.1097/HJH.0b013e32834cf213; Muntner P, 2011, HYPERTENSION, V57, P160, DOI 10.1161/HYPERTENSIONAHA.110.162255; Ishikura K, 2012, CLIN EXP HYPERTENS, V34, P297, DOI 10.3109/10641963.2012.681087; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Mancia G, 2012, CIRCULATION, V126, P569, DOI 10.1161/CIRCULATIONAHA.112.107565; Dubey RK, 2001, AM J PHYSIOL-RENAL, V280, pF365; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Johansson JK, 2010, J HYPERTENS, V28, P1836, DOI 10.1097/HJH.0b013e32833b6c8a; Matsui Y, 2012, HYPERTENSION, V59, P1132, DOI 10.1161/HYPERTENSIONAHA.111.189217; Schillaci G, 2012, HYPERTENSION, V60, P369, DOI 10.1161/HYPERTENSIONAHA.112.197491; Matsui Y, 2011, HYPERTENSION, V57, P1087, DOI 10.1161/HYPERTENSIONAHA.111.171645; Pierdomenico SD, 2009, AM J HYPERTENS, V22, P842, DOI 10.1038/ajh.2009.103; Ciobanu Andrea O, 2013, Maedica (Buchar), V8, P129; Hart ECJ, 2014, PHYSIOLOGY, V29, P8, DOI 10.1152/physiol.00031.2013; Kagitani H, 2014, AM J HYPERTENS, V27, P503, DOI 10.1093/ajh/hpt125; Krakoff LR, 2012, CIRCULATION, V126, P525, DOI 10.1161/CIRCULATIONAHA.112.124750; Migneco A, 2008, EUR REV MED PHARMACO, V12, P89; Muntner P, 2013, BLOOD PRESS MONIT, V18, P232, DOI 10.1097/MBP.0b013e3283624b24; Muntner P, 2013, J CLIN HYPERTENS, V15, P112, DOI 10.1111/jch.12037; Noshad S, 2014, J HUM HYPERTENS, V28, P37, DOI 10.1038/jhh.2013.36; Ogihara T, 2009, HYPERTENS RES, V32, P3; Schillaci G, 2010, J HYPERTENS, V28, P660, DOI 10.1097/HJH.0b013e3283391950	35	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	MAY	2015	28	5					586	594		10.1093/ajh/hpu210		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ6SM	WOS:000355623900005		
J	Niiranen, TJ; Asayama, K; Thijs, L; Johansson, JK; Hara, A; Hozawa, A; Tsuji, I; Ohkubo, T; Jula, AM; Imai, Y; Staessen, JA				Niiranen, Teemu J.; Asayama, Kei; Thijs, Lutgarde; Johansson, Jouni K.; Hara, Azusa; Hozawa, Atsushi; Tsuji, Ichiro; Ohkubo, Takayoshi; Jula, Antti M.; Imai, Yutaka; Staessen, Jan A.		IDHOCO Investigators	Optimal Number of Days for Home Blood Pressure Measurement	AMERICAN JOURNAL OF HYPERTENSION			English	Article						blood pressure; cardiovascular diseases; home blood pressure monitoring; hypertension; meta-analysis; prognosis	CROSS-SECTIONAL ANALYSIS; WHITE-COAT HYPERTENSION; 10-YEAR FOLLOW-UP; INTERNATIONAL DATABASE; CARDIOVASCULAR RISK; MASKED HYPERTENSION; SELF-MEASUREMENT; FINN-HOME; OHASAMA; OFFICE	BACKGROUND Current guidelines make no outcome-based recommendations on the optimal measurement schedule for home blood pressure (BP). METHODS We enrolled 4,802 randomly recruited participants from three populations. The participants were classified by their (i) cross-classification according to office and home BP (normotension, masked hypertension, white-coat hypertension, and sustained hypertension) and (ii) home BP level (normal BP, high normal BP, grade 1 and 2 hypertension), while the number of home measurement days was increased from 1 to 7. The prognostic accuracy of home BP with an increasing number of home BP measurement days was also assessed by multivariable-adjusted Cox models. RESULTS Agreement in classification between consecutive measurement days indicated near perfect agreement (kappa >= 0.9) after the sixth measurement day for both office and home BP cross-classification (97.8% maintained classification, kappa = 0.97) and home BP level (93.6% maintained classification, kappa = 0.91). Over a follow-up of 8.3 years, 568 participants experienced a cardiovascular event, and the first home BP measurement alone predicted events significantly (P <= 0.003). The confidence intervals (CIs) were too wide and overlapping to show superiority of multiple measurement days over the first measurement day (hazard ratios per 10 mm Hg increase in systolic BP at initial day, 1.11 [CI 1.07-1.16]; that at 1-7 days, 1.18 [CI 1.12-1.24]). Masked hypertension, but not white-coat hypertension, was associated with increased cardiovascular risk, irrespective of the number of home measurement days. CONCLUSION Even a single home BP measurement is a potent predictor of cardiovascular events, whereas seven home measurement days may be needed to reliably diagnose hypertension.	[Niiranen, Teemu J.; Johansson, Jouni K.; Jula, Antti M.] Natl Inst Hlth & Welf, Populat Studies Unit, Dept Chron Dis Prevent, Turku, Finland; [Niiranen, Teemu J.] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland; [Asayama, Kei; Ohkubo, Takayoshi; Imai, Yutaka] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 980, Japan; [Asayama, Kei; Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Thijs, Lutgarde; Hara, Azusa; Staessen, Jan A.] Univ Leuven, KU Leuven Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Studies Coordinating Ctr, Leuven, Belgium; [Hozawa, Atsushi] Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Sendai, Miyagi 980, Japan; [Tsuji, Ichiro] Tohoku Univ, Dept Publ Hlth, Grad Sch Med, Sendai, Miyagi 980, Japan; [Staessen, Jan A.] Maastricht Univ, VitaK Res & Dev, NL-6200 MD Maastricht, Netherlands	Staessen, JA (reprint author), Univ Leuven, KU Leuven Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Studies Coordinating Ctr, Leuven, Belgium.	jan.staessen@med.kuleuven.be	Staessen, Jan/A-1065-2011	Staessen, Jan/0000-0002-3026-1637			Stergiou GS, 1998, J HYPERTENS, V16, P725, DOI 10.1097/00004872-199816060-00002; Pickering TG, 2008, HYPERTENSION, V52, P10, DOI 10.1161/HYPERTENSIONAHA.107.189010; Fukunaga H, 2008, J HYPERTENS, V26, P685, DOI 10.1097/HJH.0b013e3282f42285; Nakagawa H, 2010, J UROLOGY, V184, P1413, DOI 10.1016/j.juro.2010.05.093; Staessen JA, 2004, JAMA-J AM MED ASSOC, V291, P955, DOI 10.1001/jama.291.8.955; Niu K, 2008, HYPERTENS RES, V31, P409, DOI 10.1291/hypres.31.409; Mancia G, 2006, HYPERTENSION, V47, P846, DOI 10.1161/01.HYP.0000215363.69793.bb; Bobrie G, 2004, JAMA-J AM MED ASSOC, V291, P1342, DOI 10.1001/jama.291.11.1342; CHATELLIER G, 1995, HYPERTENSION, V25, P294; Ugajin T, 2005, ARCH INTERN MED, V165, P1541, DOI 10.1001/archinte.165.13.1541; Ohkubo T, 2005, J AM COLL CARDIOL, V46, P508, DOI 10.1016/j.jacc.2005.03.070; Niiranen TJ, 2013, HYPERTENSION, V61, P27, DOI 10.1161/HYPERTENSIONAHA.111.00100; Ohkubo T, 1998, J HYPERTENS, V16, P971, DOI 10.1097/00004872-199816070-00010; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Ohkubo T, 2004, J HYPERTENS, V22, P1099, DOI 10.1097/01.hjh.0000125406.50839.15; Stergiou GS, 2002, AM J HYPERTENS, V15, P101, DOI 10.1016/S0895-7061(01)02324-X; Niiranen TJ, 2010, HYPERTENSION, V55, P1346, DOI 10.1161/HYPERTENSIONAHA.109.149336; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Little P, 2002, BRIT MED J, V325, P258, DOI 10.1136/bmj.325.7358.258; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; Cacciolati C, 2012, AM J HYPERTENS, V25, P1279, DOI 10.1038/ajh.2012.121; Chatellier G, 1996, AM J HYPERTENS, V9, P644, DOI 10.1016/0895-7061(96)00018-0; Dunn G, 1989, DESIGN ANAL RELIABIL; Expert Committee on the Diagnosis Classification of Diabetes Mellitus, 2003, DIABETES CARE S1, V26, pS5; Kikuya M, 2012, AM J HYPERTENS, V25, P67, DOI 10.1038/ajh.2011.167; Niiranen TJ, 2012, HYPERTENS RES, V35, P1072, DOI 10.1038/hr.2012.97; Niiranen TJ, 2011, HYPERTENSION, V57, P1081, DOI 10.1161/HYPERTENSIONAHA.110.162123; Ostchega Y, 2013, AM J HYPERTENS, V26, P1086, DOI 10.1093/ajh/hpt054; Schettini C, 1999, HYPERTENSION, V34, P818; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; Stergiou GS, 2007, J HYPERTENS, V25, P1590, DOI 10.1097/HJH.0b013e3281ab6c69; Stergiou GS, 2010, J HUM HYPERTENS, V24, P158, DOI 10.1038/jhh.2009.54	33	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	MAY	2015	28	5					595	603		10.1093/ajh/hpu216		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ6SM	WOS:000355623900006		
J	Machida, R; Nakazawa, T; Furuta, N				Machida, Ryo; Nakazawa, Takashi; Furuta, Naoki			Temporal Changes of Fractionation Index Caused by Changes in the Large Size of Ablated Particles in Laser Ablation-Inductively Coupled Plasma Mass Spectrometry	ANALYTICAL SCIENCES			English	Article						Elemental fractionation; laser ablation; ICP-MS; NIST glass; fractionation index; large ablated particles; SEM; defocus	LA-ICP-MS; MATRIX-MATCHED CALIBRATION; NEAR-IR FEMTOSECOND; ND-YAG LASER; ELEMENTAL FRACTIONATION; EMISSION-SPECTROMETRY; 266 NM; NANOSECOND; BRASS; GLASS	To elucidate mechanisms of elemental fractionation that are observed in laser ablation-inductively coupled plasma mass spectrometry, the relative intensities of 34 elements, each normalized by a Ca internal standard, were measured every minute during a 10-min laser ablation of an NIST 610 glass standard. Temporal changes in the fractionation index (FI) were obtained by dividing the relative intensity of every minute by that of the first minute. The particles generated by laser ablation were collected on a filter every minute, and they were observed using scanning electron microscopy to investigate changes in the large size of particles. Large variations among the large size of particles were observed using single-site mode and under 1.0 mm defocus conditions. The 34 measured elements were classified into two groups, depending on their observed Fl variation. The Fl variation was rationalized by elemental behavior due to changes in the large size of ablated particles introduced into the ICP.	[Machida, Ryo; Nakazawa, Takashi; Furuta, Naoki] Chuo Univ, Fac Sci & Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1128551, Japan	Nakazawa, T (reprint author), Chuo Univ, Fac Sci & Engn, Dept Appl Chem, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	t-nakaz@kc.chuo-u.ac.jp; nfuruta@chem.chuo-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26410160, 26870595]	This research was supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan, through a Grant-in-Aid for Scientific Research (C) 26410160 and Young Scientists (B) 26870595. Part of this study was supported under a joint research project conducted at the Institute of Science and Engineering of Chuo University.	Longerich HP, 1996, FRESEN J ANAL CHEM, V355, P538; Ohata M, 2014, J ANAL ATOM SPECTROM, V29, P1345, DOI 10.1039/c4ja00030g; Gunther D, 1999, J ANAL ATOM SPECTROM, V14, P1369, DOI 10.1039/a901649j; Russo RE, 2013, ANAL CHEM, V85, P6162, DOI 10.1021/ac4005327; Jochum KP, 2007, J ANAL ATOM SPECTROM, V22, P112, DOI 10.1039/b609547j; Wang ZK, 2006, J AM SOC MASS SPECTR, V17, P641, DOI 10.1016/j.jasms.2006.01.005; Guillong M, 2002, J ANAL ATOM SPECTROM, V17, P831, DOI 10.1039/b202988j; Liu C, 2004, ANAL CHEM, V76, P379, DOI 10.1021/ac035040a; Hu ZC, 2008, J ANAL ATOM SPECTROM, V23, P1192, DOI 10.1039/b803934h; Souders AK, 2010, J ANAL ATOM SPECTROM, V25, P975, DOI 10.1039/c002729d; FRYER BJ, 1995, CAN MINERAL, V33, P303; Jeffries TE, 1998, J ANAL ATOM SPECTROM, V13, P935, DOI 10.1039/a801328d; Kroslakova I, 2007, J ANAL ATOM SPECTROM, V22, P51, DOI 10.1039/b606522h; Koch J, 2004, J ANAL ATOM SPECTROM, V19, P267, DOI 10.1039/b310512a; Guillong M, 2003, J ANAL ATOM SPECTROM, V18, P1224, DOI 10.1039/b305434a; Kuhn HR, 2004, ANAL BIOANAL CHEM, V378, P1069, DOI 10.1007/s00216-003-2346-7; Bian QZ, 2005, J ANAL ATOM SPECTROM, V20, P736, DOI 10.1039/b500632e; Claverie F, 2009, J ANAL ATOM SPECTROM, V24, P891, DOI 10.1039/b904134f; Fornarini L, 2006, ANAL BIOANAL CHEM, V385, P272, DOI 10.1007/s00216-006-0300-1; Luo Y. R., 2005, CRC HDB CHEM PHYS, P54; O'Connor CO., 2006, J ANAL ATOM SPECTROM, V21, P556, DOI 10.1039/b600916f; Ohata M, 2002, ANAL SCI, V18, P1105, DOI 10.2116/analsci.18.1105; Ohata M, 2004, ANAL SCI, V20, P701, DOI 10.2116/analsci.20.701; Rodushkin I, 2002, J ANAL ATOM SPECTROM, V17, P1223, DOI 10.1039/b205546e; Hiratat T, 2008, ANAL SCI, V24, P345, DOI 10.2116/analsci.24.345	25	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	MAY	2015	31	5					345	355				11	Chemistry, Analytical	Chemistry	CJ3CT	WOS:000355361700001		
J	Yamamoto, Y; Shirasaki, T; Yonetani, A; Imai, S				Yamamoto, Yuhei; Shirasaki, Toshihiro; Yonetani, Akira; Imai, Shoji			Study of the Roles of Chemical Modifiers in Determining Boron Using Graphite Furnace Atomic Absorption Spectrometry and Optimization of the Temperature Profile During Atomization	ANALYTICAL SCIENCES			English	Article						Boron; graphite furnace; atomic absorption spectrometry; chemical modifier		The measurement conditions for determining boron using graphite furnace-atomic absorption spectrometry (GF-AAS) were investigated. Differences in the boron absorbance profiles were found using three different commercially available GF-AAS instruments when the graphite atomizers in them were not tuned. The boron absorbances found with and without adjusting the graphite atomizers suggested that achieving an adequate absorbance for the determination of boron requires a sharp temperature profile that overshoots the target temperature during the atomization process. Chemical modifiers that could improve the boron absorbance without the need for using coating agents were tested. Calcium carbonate improved the boron absorbance but did not suppress variability in the peak height. Improvement of boron absorbance was comparatively less using iron nitrate or copper nitrate than using calcium carbonate, but variability in the peak height was clearly suppressed using iron nitrate or copper nitrate. The limit of detection was 0.0026 mg L-1 when iron nitrate was used. It appears that iron nitrate is a useful new chemical modifier for the quick and simple determination of boron using GF-AAS.	[Yamamoto, Yuhei; Imai, Shoji] Univ Tokushima, Grad Sch Integrated Arts & Sci, Tokushima 7708502, Japan; [Shirasaki, Toshihiro; Yonetani, Akira] Hitachi High Tech Sci Corp, Hitachinaka, Ibaraki 3120033, Japan	Yamamoto, Y (reprint author), Univ Tokushima, Grad Sch Integrated Arts & Sci, 1-1 Minamijosanjima Cho, Tokushima 7708502, Japan.	yamamoto.yuhei@tokushima-u.ac.jp			Faculty of Integrated Arts and Sciences, Tokushima University	We thank Mr. Furiki (Hitachi High-Technologies) for SEM observation. We are grateful to coworkers of the research group of analytic technique, Hitachi High-Technologies, for help to operate GF-AAS instruments. This research was supported by a Grant-in-Aid for scientific research from the Faculty of Integrated Arts and Sciences, Tokushima University.	[Anonymous], 1998, K0101 JIS; Burguera M, 2001, SPECTROCHIM ACTA B, V56, P1845, DOI 10.1016/S0584-8547(01)00340-8; GOYAL N, 1986, ANAL CHIM ACTA, V182, P225, DOI 10.1016/S0003-2670(00)82455-1; LUGUERA M, 1991, J ANAL ATOM SPECTROM, V6, P669, DOI 10.1039/ja9910600669; Matsusaki K., 1996, ANAL SCI, V12, P301; Matsusaki K, 1999, ANAL SCI, V15, P145, DOI 10.2116/analsci.15.145; Nowka R, 2000, SPECTROCHIM ACTA B, V55, P517, DOI 10.1016/S0584-8547(00)00187-7; Rohr U, 1999, SPECTROCHIM ACTA B, V54, P699, DOI 10.1016/S0584-8547(98)00254-7; Sah RN, 1997, PLANT SOIL, V193, P15, DOI 10.1023/A:1004251606504; VANDERGEUGTEN RP, 1981, FRESEN Z ANAL CHEM, V306, P13; WILTSHIRE GA, 1994, J ANAL ATOM SPECTROM, V9, P1255, DOI 10.1039/ja9940901255	11	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	MAY	2015	31	5					357	364				8	Chemistry, Analytical	Chemistry	CJ3CT	WOS:000355361700002		
J	Yokoyama, Y; Fujishima, T; Kurota, K				Yokoyama, Yukio; Fujishima, Takeru; Kurota, Kazuki			Fast and Efficient Separation and Determination of UV-absorbing Amino Acids, Nucleobases, and Creatinine Using a Carboxy-functionalized Cation-exchange Column	ANALYTICAL SCIENCES			English	Article						HPLC; carboxy-functionalized cation-exchange column; amino acids; nucleobases; phenylalanine/creatinine ratio; phenylketonuria	PERFORMANCE LIQUID-CHROMATOGRAPHY; POLYSTYRENE-DIVINYLBENZENE; URINARY CREATININE; CULTURED CORDYCEPS; MASS-SPECTROMETRY; CAPACITY; NUCLEOSIDES; BASES; RESIN; EXTRACTION	This paper presents a new HPLC technique for the determination of biogenic cations such as amino acids and nucleobases, using a weak-acid cation-exchange column. Fourteen analytes, five amino acids and seven bases in addition to creatinine and creatine, were separated in 12 min by means of a two-liquid gradient elution with UV detection. The newly released column packed with a carboxy-functionalized polymethacrylate resin could give excellent selectivity to the organic cations of interest, although such a column is in general suitable for the separation of inorganic common cations. The chromatographic intra-day repeatability was very good with RSDs less than 0.4%, and the quantitation precision based on peak area intensities was also good with RSDs less than 5% for all analytes. The linear calibration lines for quantitation ranged between 5 and 500 mu M on 20-mu L injections with R-2 more than 0.9990. Since the method could provide concentration data of urinary creatinine and some metabolites simultaneously, for example, the urinary phenylalanine/creatinine ratios for phenylketonuria of inborn errors of metabolism were simply determined through one chromatographic run. The ratios for patients were significantly higher than those for controls. We found that the new weak-acid cation-exchange column was suitable for the separation of organic cations as well as inorganic cations.	[Yokoyama, Yukio; Kurota, Kazuki] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Dept Analyt Chem, Yokohama, Kanagawa 2408501, Japan; [Fujishima, Takeru] Yokohama Natl Univ, Coll Engn Sci, Yokohama, Kanagawa 2408501, Japan	Yokoyama, Y (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Dept Analyt Chem, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	yokyuk@ynu.ac.jp			Mitsubishi Chemical Corp.	This work was partly supported by grants based on a joint research project with Mitsubishi Chemical Corp. We thank Mr. Ryuichi Sugimoto, Mr. Akihiro Shimura, and Miss Yuka Yoshidzumi of Mitsubishi Chemical Corp. for participating in helpful discussions and providing information for the analytical column.	Rigas PG, 2013, ANAL BIOANAL CHEM, V405, P7957, DOI 10.1007/s00216-013-7127-3; Li LS, 2004, TALANTA, V63, P433, DOI 10.1016/j.talanta.2003.11.016; Hou SJ, 2010, ANAL SCI, V26, P1111; Zhao HQ, 2011, J SEP SCI, V34, P2594, DOI 10.1002/jssc.201100421; Li SP, 2004, J CHROMATOGR A, V1036, P239, DOI 10.1016/j.chroma.2004.02.080; Yang FQ, 2007, TALANTA, V73, P269, DOI 10.1016/j.talanta.2007.03.034; Kaspar H, 2009, ANAL BIOANAL CHEM, V393, P445, DOI 10.1007/s00216-008-2421-1; Yokoyama Y, 2005, J CHROMATOGR B, V816, P333, DOI 10.1016/j.jchromb.2004.11.044; MOORE S, 1958, ANAL CHEM, V30, P1185, DOI 10.1021/ac60139a005; Chalmers R A, 1980, J Inherit Metab Dis, V3, P27, DOI 10.1007/BF02312520; Jaffe M, 1886, Z PHYSL CHEM, V10, P391; Klingenberg A, 1998, J CHROMATOGR A, V804, P63, DOI 10.1016/S0021-9673(98)00033-8; Liva L., 2008, J CHROMATOGR A, V1193, P104; Okabe T, 2010, ANAL SCI, V26, P449; Seubert A, 1997, J CHROMATOGR A, V782, P149, DOI 10.1016/S0021-9673(97)00488-3; Spackman D. H., 1958, ANAL CHEM, V30, P119; Szterk A, 2014, J LIQ CHROMATOGR R T, V37, P664, DOI 10.1080/10826076.2012.758136; Tamura H, 1998, REACT FUNCT POLYM, V38, P177, DOI 10.1016/S1381-5148(97)00164-8; Wenner D., 1981, ANNU REV BIOCHEM, V50, P911; Yokoyama Y, 1996, J CHROMATOGR A, V739, P333, DOI 10.1016/0021-9673(96)00214-2; Yokoyama Y, 2005, J CHROMATOGR A, V1085, P110, DOI 10.1016/j.chroma.2005.01.030; Yokoyama Y, 2004, ANAL SCI, V20, P1189, DOI 10.2116/analsci.20.1189; YOKOYAMA Y, 1991, J CHROMATOGR-BIOMED, V566, P19, DOI 10.1016/0378-4347(91)80107-N; Yokoyama Y., 1995, J MASS SPECTROM SOC, V43, P189; Yokoyama Y, 2002, ANAL SCI, V18, P59, DOI 10.2116/analsci.18.59; Yokoyama Y, 2013, TALANTA, V103, P245, DOI 10.1016/j.talanta.2012.10.039; Yokoyama Y, 2014, CHROMATOGRAPHIA, V77, P51, DOI 10.1007/s10337-013-2582-8	27	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	MAY	2015	31	5					371	376				6	Chemistry, Analytical	Chemistry	CJ3CT	WOS:000355361700004		
J	Giakisikli, G; Quezada, AA; Tanaka, J; Anthemidis, AN; Murakami, H; Teshima, N; Sakai, T				Giakisikli, Georgia; Quezada, Alejandro Ayala; Tanaka, Junpei; Anthemidis, Aristidis N.; Murakami, Hiroya; Teshima, Norio; Sakai, Tadao			Automatic On-line Solid-phase Extraction-Electrothermal Atomic Absorption Spectrometry Exploiting Sequential Injection Analysis for Trace Vanadium, Cadmium and Lead Determination in Human Urine Samples	ANALYTICAL SCIENCES			English	Article						Automation; sequential injection; solid phase extraction; metal determination; atomic spectrometry; chelating resin	PLASMA-MASS SPECTROMETRY; ACID CHELATING RESIN; RARE-EARTH-ELEMENTS; FIELD ICP-MS; LAB-ON-VALVE; NATURAL-WATERS; CARBON NANOTUBES; BIOLOGICAL SAMPLES; SORBENT MATERIAL; FRONT-END	A fully automated sequential injection column preconcentration method for the on-line determination of trace vanadium, cadmium and lead in urine samples was successfully developed, utilizing electrothermal atomic absorption spectrometry (ETAAS). Polyamino-polycarboxylic acid chelating resin (Nobias chelate PA-1) packed into a handmade minicolumn was used as a sorbent material. Effective on-line retention of chelate complexes of analytes was achieved at pH 6.0, while the highest elution effectiveness was observed with 1.0 mol L-1 HNO3 in the reverse phase. Several analytical parameters, like the sample acidity, concentration and volume of the eluent as well as the loading/elution flow rates, have been studied, regarding the efficiency of the method, providing appropriate conditions for the analysis of real samples. For a 4.5 mL sample volume, the sampling frequency was 27 h(-1). The detection limits were found to be 3.0, 0.06 and 2.0 ng L-1 for V(V), Cd(II) and Pb(II), respectively, with the relative standard deviations ranging between 1.9 - 3.7%. The accuracy of the proposed method was evaluated by analyzing a certified reference material (Seronorm (TM) trace elements urine) and spiked urine samples.	[Quezada, Alejandro Ayala; Tanaka, Junpei; Murakami, Hiroya; Teshima, Norio; Sakai, Tadao] Aichi Inst Technol, Dept Appl Chem, Toyota 4700392, Japan; [Giakisikli, Georgia; Anthemidis, Aristidis N.] Aristotle Univ Thessaloniki, Fac Sci, Dept Chem, Analyt Chem Lab, GR-54006 Thessaloniki, Greece	Teshima, N (reprint author), Aichi Inst Technol, Dept Appl Chem, 1247 Yachigusa, Toyota 4700392, Japan.	teshima@aitech.ac.jp			State Scholarships Foundation (IKY) in Greece; JSPS KAKENHI [26288072, 25860024]	Georgia Giakisikli acknowledges financial support from the State Scholarships Foundation (IKY) in Greece through the project "Scholarships IKY" from resources of the EP (European Program) "Education and Lifelong Learning", "European Social Fund of ESPA 2007 - 2013". This work was partly supported by JSPS KAKENHI Grant Nos. 26288072 (Grant-in-Aid for Scientific Research (B) for N. T.) and 25860024 (Grant-in-Aid for Young Scientists (B) for H. M.).	Ampan P, 2003, ANAL CHIM ACTA, V499, P167, DOI 10.1016/j.aca.2003.08.030; Wang BS, 2014, TALANTA, V128, P337, DOI 10.1016/j.talanta.2014.04.077; Das D, 2012, TRAC-TREND ANAL CHEM, V38, P163, DOI 10.1016/j.trac.2011.01.020; Anthemidis AN, 2002, J ANAL ATOM SPECTROM, V17, P1330, DOI 10.1039/b206073f; Anthemidis AN, 2011, MICROCHEM J, V98, P66, DOI 10.1016/j.microc.2010.11.007; Latorre CH, 2012, ANAL CHIM ACTA, V749, P16, DOI 10.1016/j.aca.2012.09.001; Sakamoto H, 2006, BUNSEKI KAGAKU, V55, P133, DOI 10.2116/bunsekikagaku.55.133; Biller DV, 2012, MAR CHEM, V130, P12, DOI 10.1016/j.marchem.2011.12.001; Barbosa AF, 2015, TALANTA, V131, P213, DOI 10.1016/j.talanta.2014.07.051; Conway TM, 2013, ANAL CHIM ACTA, V793, P44, DOI 10.1016/j.aca.2013.07.025; Anthemidis AN, 2009, APPL SPECTROSC REV, V44, P140, DOI 10.1080/05704920802352598; Alfven T, 2002, ENVIRON HEALTH PERSP, V110, P699; Takano S, 2013, ANAL CHIM ACTA, V784, P33, DOI 10.1016/j.aca.2013.04.032; Gao YH, 2002, ANALYST, V127, P1713, DOI 10.1039/b208341h; Suzuki Y, 2008, ANAL SCI, V24, P1049, DOI 10.2116/analsci.24.1049; Anthemidis AN, 2010, TALANTA, V81, P996, DOI 10.1016/j.talanta.2010.01.047; Miro M, 2013, ANAL CHIM ACTA, V782, P1, DOI 10.1016/j.aca.2013.03.019; Rousseau TCC, 2013, J ANAL ATOM SPECTROM, V28, P573, DOI 10.1039/c3ja30332b; Sohrin Y, 2008, ANAL CHEM, V80, P6267, DOI 10.1021/ac800500f; Hatje V, 2014, MAR CHEM, V160, P34, DOI 10.1016/j.marchem.2014.01.006; Anthemidis AN, 2012, ANAL LETT, V45, P1098, DOI 10.1080/00032719.2012.670792; Anthemidis AN, 2010, J ANAL ATOM SPECTROM, V25, P1717, DOI 10.1039/c0ja00002g; Butcher J. D., 2006, APPL SPECTROSC REV, V41, P15; Gialdsikli G., 2013, TALANTA, V110, P229; International Union of Pure and Applied Chemistry (IUPAC), 1998, COMPENDIUM ANAL NOME; Ma JX, 2014, J ANAL ATOM SPECTROM, V29, P2315, DOI 10.1039/c4ja00273c; Miller J. N., 2010, STAT CHEMOMETRICS AN, V6th, P297; Miro M, 2011, TRAC-TREND ANAL CHEM, V30, P153, DOI 10.1016/j.trac.2010.08.007; Persson PO, 2011, ANAL CHEM, V83, P1336, DOI 10.1021/ac102559k; Pyrzynska K, 2004, MICROCHIM ACTA, V147, P59, DOI 10.1007/s00604-004-0217-3; Queroue F, 2014, ANAL METHODS-UK, V6, P2837, DOI 10.1039/c3ay41312h; Ruzicka J., 1990, ANAL CHIM ACTA, V237, P239; Sakai T, 2008, ANAL SCI, V24, P855, DOI 10.2116/analsci.24.855; Tagami H., 2011, J RADIOANAL NUCL CHE, V287, P795; Takata H, 2011, TALANTA, V85, P1772, DOI 10.1016/j.talanta.2011.07.003; Takata H, 2009, ATOM SPECTROSC, V30, P10; Ueda M, 2010, ANAL SCI, V26, P597; Wang Y, 2012, ANAL CHIM ACTA, V713, P92, DOI 10.1016/j.aca.2011.11.022; Yamamoto K., 2007, B SOC SEA WATER SCI, V61, P260; Zhu YB, 2012, TALANTA, V90, P57, DOI 10.1016/j.talanta.2011.12.071	40	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	MAY	2015	31	5					383	389				7	Chemistry, Analytical	Chemistry	CJ3CT	WOS:000355361700006		
J	Zhou, XF; He, KY; Wang, Y; Zheng, HT; Suye, S				Zhou, Xinfei; He, Kunyun; Wang, Yu; Zheng, Haitao; Suye, Shin-ichiro			Amperometric Determination of Ascorbic Acid on an Au Electrode Modified by a Composite Film of Poly(3,4-ethylenedioxythiophene) and Superconductive Carbon Black	ANALYTICAL SCIENCES			English	Article						Ascorbic acid; poly(3,4-ethylenedioxythiophene); superconductive carbon black; cyclic voltammetry; chronoamperometry	URIC-ACID; ELECTROCHEMICAL DETECTION; PASTE ELECTRODE; SELECTIVE DETECTION; GOLD ELECTRODE; DOPAMINE; PEDOT; SENSOR; BIOSENSOR; NANOPARTICLES	A new composite film-modified electrode was prepared by the electropolymerisation of poly(3,4-ethylenedioxythiophene) (PEDOT) and superconductive carbon black (SCB) on a gold electrode. The PEDOT-SCB/Au electrode exhibited excellent ability towards the electrocatalytic oxidation of ascorbic acid, in terms of a 480 mV shift of the oxidation potential in the negative direction, and a dramatically enhanced oxidation current. Under the optimum conditions, the amperometric detection of ascorbic acid provided a wide linear detection range from 1.0 x 10(-7) to 8.0 x 10(-4) M, and a detection limit of 5.0 x 10(-8) M (S/N = 2) as well as good reproducibility and stability.	[Zhou, Xinfei; He, Kunyun; Wang, Yu; Zheng, Haitao] Tianjin Polytech Univ, Sch Environm & Chem Engn, Tianjin 300387, Peoples R China; [Suye, Shin-ichiro] Univ Fukui, Grad Sch Engn, Dept Appl Chem & Biotechnol, Fukui 9108507, Japan	Zheng, HT (reprint author), Tianjin Polytech Univ, Sch Environm & Chem Engn, Tianjin 300387, Peoples R China.	zhenght999@hotmail.com			Scientific Research Foundation for the Returned Overseas Chinese Scholars (ROCS), Ministry of Education, P. R. China; Natural Science Foundation of Tianjin, P. R. China [06YFJMJC15000]	The research was supported by the Scientific Research Foundation for the Returned Overseas Chinese Scholars (ROCS), Ministry of Education, P. R. China and Natural Science Foundation of Tianjin (No. 06YFJMJC15000), P. R. China.	Kutluay A, 2013, SENSOR ACTUAT B-CHEM, V185, P398, DOI 10.1016/j.snb.2013.05.025; Taouil AE, 2011, ULTRASON SONOCHEM, V18, P140, DOI 10.1016/j.ultsonch.2010.04.003; Ensafi AA, 2009, J ELECTROANAL CHEM, V633, P212, DOI 10.1016/j.jelechem.2009.06.001; Thangamuthu R, 2007, SENSOR ACTUAT B-CHEM, V120, P745, DOI 10.1016/j.snb.2006.03.048; Lin KC, 2010, BIOSENS BIOELECTRON, V26, P608, DOI 10.1016/j.bios.2010.07.019; Kocak CC, 2013, J ELECTROANAL CHEM, V694, P94, DOI 10.1016/j.jelechem.2013.02.006; Nien PC, 2009, SENSOR ACTUAT B-CHEM, V140, P58, DOI 10.1016/j.snb.2009.04.002; Zheng XY, 2013, SENSOR ACTUAT B-CHEM, V178, P359, DOI 10.1016/j.snb.2012.12.115; Radhakrishnan S, 2013, BIOSENS BIOELECTRON, V47, P133, DOI 10.1016/j.bios.2013.02.049; Wang XX, 2013, ANALYST, V138, P229, DOI 10.1039/c2an36112d; Dong YP, 2012, ELECTROCHIM ACTA, V74, P189, DOI 10.1016/j.electacta.2012.04.063; Zhang W, 2012, SENSOR ACTUAT B-CHEM, V166, P601, DOI 10.1016/j.snb.2012.03.018; Madrakian T, 2014, SENSOR ACTUAT B-CHEM, V193, P451, DOI 10.1016/j.snb.2013.11.117; Zhang R, 2009, SENSOR ACTUAT B-CHEM, V138, P174, DOI 10.1016/j.snb.2008.12.043; Wen YP, 2012, J ELECTROANAL CHEM, V674, P71, DOI 10.1016/j.jelechem.2012.03.021; Micic D, 2014, ELECTROCHIM ACTA, V120, P147, DOI 10.1016/j.electacta.2013.12.069; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Si WM, 2014, SENSOR ACTUAT B-CHEM, V193, P823, DOI 10.1016/j.snb.2013.12.052; Afkhami A, 2014, SENSOR ACTUAT B-CHEM, V196, P467, DOI 10.1016/j.snb.2014.01.115; Lin LQ, 2008, BIOELECTROCHEMISTRY, V73, P11, DOI 10.1016/j.bioelechem.2008.01.009; Zhang X, 2014, BIOSENS BIOELECTRON, V55, P446, DOI 10.1016/j.bios.2013.12.046; Weng CJ, 2013, ELECTROCHIM ACTA, V95, P162, DOI 10.1016/j.electacta.2013.01.150; Liu M, 2011, SENSOR ACTUAT B-CHEM, V159, P277, DOI 10.1016/j.snb.2011.07.005; Cai WH, 2014, SENSOR ACTUAT B-CHEM, V193, P492, DOI 10.1016/j.snb.2013.12.004; Liu Y, 2013, J ELECTROANAL CHEM, V709, P19, DOI 10.1016/j.jelechem.2013.09.027; Zhang X, 2013, BIOSENS BIOELECTRON, V44, P183, DOI 10.1016/j.bios.2013.01.020; Takmakov P, 2010, ANAL CHEM, V82, P2020, DOI 10.1021/ac902753x; Jirimali HD, 2013, CARBOHYD POLYM, V92, P641, DOI 10.1016/j.carbpol.2012.09.024; Raoof JB, 2001, J ELECTROANAL CHEM, V515, P45, DOI 10.1016/S0022-0728(01)00642-8; Giz MJ, 1999, J ELECTROANAL CHEM, V465, P72, DOI 10.1016/S0022-0728(99)00056-X; Atta NF, 2010, SENSOR ACTUAT B-CHEM, V145, P299, DOI 10.1016/j.snb.2009.12.014; Sekli-Belaidi F, 2010, J ELECTROANAL CHEM, V647, P159, DOI 10.1016/j.jelechem.2010.06.007; Atta NF, 1996, J ELECTROANAL CHEM, V408, P47, DOI 10.1016/0022-0728(95)04286-5; Balamurugan J, 2013, J MOL CATAL A-CHEM, V372, P13, DOI 10.1016/j.molcata.2013.02.001; Beitollahi H, 2013, CHINESE J CATAL, V34, P1098, DOI 10.1016/S1872-2067(12)60544-0; Bello A, 2007, SENSOR ACTUAT B-CHEM, V121, P430, DOI 10.1016/j.snb.2006.04.066; Chen YF, 2013, SENSOR ACTUAT B-CHEM, V188, P747, DOI 10.1016/j.snb.2013.07.075; He KY, 2014, SENSOR ACTUAT B-CHEM, V193, P212, DOI 10.1016/j.snb.2013.11.055; Kim SJ, 2014, SENSOR ACTUAT B-CHEM, V196, P480, DOI 10.1016/j.snb.2014.02.032; LEUBOLT R, 1993, J CHROMATOGR, V640, P271, DOI 10.1016/0021-9673(93)80190-J; Long CM, 2013, ENVIRON POLLUT, V181, P271, DOI 10.1016/j.envpol.2013.06.009; Mathiyarasu J, 2008, MATER LETT, V62, P571, DOI 10.1016/j.matlet.2007.06.004; Mazloum-Ardakani M, 2009, J APPL ELECTROCHEM, V39, P1117, DOI 10.1007/s10800-008-9769-y; Nicolleta M., 2004, ACTA CHIM SLOV, V51, P169; Oyama M, 2014, ANAL SCI, V30, P529; Swider K. E., 1999, LANGMUIR, V15, P3302, DOI 10.1021/la9803530; Takahashi K, 1999, ANAL SCI, V15, P181, DOI 10.2116/analsci.15.181; Vasantha VS, 2005, ELECTROCHIM ACTA, V51, P347, DOI 10.1016/j.electacta.2005.04.029; Xu GY, 2013, SENSOR ACTUAT B-CHEM, V188, P405, DOI 10.1016/j.snb.2013.07.038	49	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	MAY	2015	31	5					429	436				8	Chemistry, Analytical	Chemistry	CJ3CT	WOS:000355361700012		
J	Kawano, S; Hayakawa, Y; Hashi, Y; Lin, JM				Kawano, Shin-ichi; Hayakawa, Yoshihiro; Hashi, Yuki; Lin, Jin-Ming			Quantitative Analysis of Chloramphenicol in Royal Jelly by Column-switching LC-MS/MS Using a Pretreatment Column with a Higher-pressure Capability	ANALYTICAL SCIENCES			English	Article						Chloramphenicol; royal jelly; methylcellulose; restricted access media; on-line pretreatment; LC-MS/MS	TANDEM MASS-SPECTROMETRY; PERFORMANCE LIQUID-CHROMATOGRAPHY; DILUTION LINE; BEE PRODUCTS; HONEY; PLASMA; RESIDUES; EXTRACTION; SYSTEM; DRUGS	An on-line pretreatment liquid chromatography-tandem mass spectrometry (LC-MS/MS) system was developed for the analysis of chloramphenicol (CAP) in royal jelly. A novel methylcellulose-immobilized restricted access media column with a higher-pressure capability of 60 MPa (MC-ODS HP) was developed for the effective removal of proteins and other compounds in the sample matrix. CAP in a sample solution was extracted in 2 min by the column-switching LC-MS/MS system. The system provides a minimum sample pretreatment along with highly sensitive and reproducible analysis. As a result, the limit of quantitation of CAP was 10 pg/mL (= 0.1 mu g/kg royal jelly) and the linear dynamic range was between 10 and 10000 pg/mL (correlation coefficient greater than 0.999). The proposed method meets the requirements of regulations in EU (0.3 mu g/kg). The inter-day precision and accuracy of CAP at 100 pg/mL over 3 days were 4.5 and 95.4%, respectively. Compared with the conventional method with a pressure of below 25 MPa, the peak separation in the MRM chromatogram was improved by using smaller particles (1.6 mu m) for the analytical ODS column. The LC-MS/MS system with an MC-ODS HP expanded the applicability of the automated pretreatment.	[Kawano, Shin-ichi; Lin, Jin-Ming] Tsinghua Univ, Beijing Key Lab Microanalyt Methods & Instrumenta, Dept Chem, Beijing 100084, Peoples R China; [Kawano, Shin-ichi; Hashi, Yuki] Shimadzu China Co Ltd, Shimadzu Global COE Applicat & Tech Dev, Shanghai 200052, Peoples R China; [Hayakawa, Yoshihiro] Shimadzu Co Ltd, Global Applicat Dev Ctr, Nakagyo Ku, Kyoto 6048511, Japan	Kawano, S (reprint author), Tsinghua Univ, Beijing Key Lab Microanalyt Methods & Instrumenta, Dept Chem, Beijing 100084, Peoples R China.	kawashin@shimadzu.co.jp			National Natural Science Foundation of China [21227006, 81373373]; CERS-China Equipment and Education Resources System [CERS-1-75]	This work was supported by National Natural Science Foundation of China (Nos. 21227006 and 81373373), and CERS-China Equipment and Education Resources System (No. CERS-1-75).	Adams SJ, 2008, APIDOLOGIE, V39, P537, DOI 10.1051/apido:2008035; Alechaga E, 2012, ANALYST, V137, P2486, DOI 10.1039/c2an16052h; Jiang Y, 2006, J AOAC INT, V89, P1432; Lopez MI, 2008, J AGR FOOD CHEM, V56, P1553, DOI 10.1021/jf073236w; Bogdanov S, 2006, APIDOLOGIE, V37, P1, DOI 10.1051/apido:2005043; Reybroeck W, 2012, VET MICROBIOL, V158, P1, DOI 10.1016/j.vetmic.2012.01.012; Sheridan R, 2008, J AGR FOOD CHEM, V56, P3509, DOI 10.1021/jf800293m; Boyd B, 2007, J CHROMATOGR A, V1174, P63, DOI 10.1016/j.chroma.2007.08.072; Ortelli D, 2004, CHROMATOGRAPHIA, V59, P61, DOI [10.1365/s10337-004-0244-6, 10.1365/s10337-003-0132-5]; Liu M, 2006, J CHROMATOGR A, V1133, P142, DOI 10.1016/j.chroma.2006.08.009; Kaufmann A, 2005, RAPID COMMUN MASS SP, V19, P3694, DOI 10.1002/rcm.2240; Stoob K, 2005, J CHROMATOGR A, V1097, P138, DOI 10.1016/j.chroma.2005.08.030; Barreto F, 2012, FOOD ADDIT CONTAM A, V29, P550, DOI 10.1080/19440049.2011.641160; Viuda-Martos M, 2008, J FOOD SCI, V73, pR117, DOI 10.1111/j.1750-3841.2008.00966.x; Cho HY, 2006, J CHROMATOGR B, V835, P27, DOI 10.1016/j.jchromb.2006.02.058; Asakawa Y, 2007, J PHARMACEUT BIOMED, V43, P683, DOI 10.1016/j.jpba.2006.08.007; Cheng N., 2012, J FOOD SCI, V77, pT169; Hashi Y, 2008, CHROMATOGRAPHIA, V67, P773, DOI 10.1365/s10337-008-0530-9; Hashimoto H, 2004, J CHROMATOGR B, V803, P209, DOI 10.1016/j.jchromb.2003.12.029; Huang JF, 2006, J AGR FOOD CHEM, V54, P9279, DOI 10.1021/jf062246e; Igarashi K, 2004, J CHROMATOGR B, V806, P53, DOI 10.1016/j.jchromb.2004.02.024; Kawano S, 2015, CHINESE CHEM LETT, V26, P36, DOI 10.1016/j.cclet.2014.10.026; Kawano S, 2003, J CHROMATOGR B, V792, P49, DOI 10.1016/S1570-0232(03)00309-X; Liu M, 2008, J CHROMATOGR A, V1198, P87, DOI 10.1016/j.chroma.2008.05.021; Liu S, 2008, BIOMED CHROMATOGR, V22, P1442, DOI 10.1002/bmc.1079; Nakagawa S, 2013, BIOMED CHROMATOGR, V27, P551, DOI 10.1002/bmc.2822; Taka T, 2012, FOOD ADDIT CONTAM A, V29, P596, DOI 10.1080/19440049.2011.625047; Vivekanandan K, 2005, RAPID COMMUN MASS SP, V19, P3025, DOI 10.1002/rcm.2169; Yamamoto E, 2001, ANAL SCI, V17, P1155, DOI 10.2116/analsci.17.1155	29	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	MAY	2015	31	5					445	450				6	Chemistry, Analytical	Chemistry	CJ3CT	WOS:000355361700014		
J	Yoshino, H; Saito, Y; Kumamoto, Y; Taguchi, A; Verma, P; Kawata, S				Yoshino, Hikaru; Saito, Yuika; Kumamoto, Yasuaki; Taguchi, Atushi; Verma, Prabhat; Kawata, Satoshi			Temperature-dependent Photodegradation in UV-resonance Raman Spectroscopy	ANALYTICAL SCIENCES			English	Article						UV-resonance Raman spectroscopy; photodegradation; Arrhenius formula; photothermal effect	TRIPLET EXCITATION; BOND-DISSOCIATION; BACTERIOCHLOROPHYLL; DYNAMICS; SPECTRA; COORDINATION; PHOTODAMAGE; MACROCYCLE; ORDERS	Temperature-dependent photodegradation during UV-resonance Raman spectroscopy was investigated. Photodegradation was quantitatively probed by monitoring the temporal evolution of UV-resonance Raman spectra obtained from bacteriochlorophyll (BChl) showing, resonance effect at a 355-nm excitation wavelength. At 80 K, the molecular photodecomposition rate was 5-times lower than that at room temperature. The decomposition rates of BChl were analyzed by the Arrhenius formula, indicating that the mechanism of photodegradation includes a thermal process having an activation energy of 1.4 kJ/mol.	[Yoshino, Hikaru; Saito, Yuika; Taguchi, Atushi; Verma, Prabhat; Kawata, Satoshi] Osaka Univ, Dept Appl Phys, Suita, Osaka 5650871, Japan; [Kumamoto, Yasuaki] RIKEN, Near Field Nanophoton Res Team, Wako, Saitama 3510198, Japan	Saito, Y (reprint author), Osaka Univ, Dept Appl Phys, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	yuika@ap.eng.osaka-u.ac.jp					Sato A, 2007, P NATL ACAD SCI USA, V104, P9627, DOI 10.1073/pnas.0611560104; Chi ZH, 1998, BIOCHEMISTRY-US, V37, P2854, DOI 10.1021/bi971160z; Wu Q, 2001, ANAL CHEM, V73, P3432, DOI 10.1021/ac001268b; ASHER SA, 1988, ANNU REV PHYS CHEM, V39, P537; Wu Q, 2003, J PHYS CHEM A, V107, P8047, DOI 10.1021/jp027190f; Wright NT, 2003, J BIOMECH ENG-T ASME, V125, P300, DOI 10.1115/1.1553974; Lao KQ, 1996, P NATL ACAD SCI USA, V93, P5258, DOI 10.1073/pnas.93.11.5258; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Blanksby SJ, 2003, ACCOUNTS CHEM RES, V36, P255, DOI 10.1021/ar020230d; COTTON TM, 1980, J AM CHEM SOC, V102, P6399, DOI 10.1021/ja00541a002; DIERS JR, 1994, J PHYS CHEM-US, V98, P12884, DOI 10.1021/j100100a013; Ellervee A, 2008, CHEM PHYS LETT, V450, P386, DOI 10.1016/j.cplett.2007.11.021; Koyama Y, 1998, SPECTROCHIM ACTA A, V54, P1127, DOI 10.1016/S1386-1425(98)00064-X; Kumamoto Y, 2011, BIOMED OPT EXPRESS, V2, P927, DOI 10.1364/BOE.2.000927; Kumamoto Y, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.076001; Latosinska JN, 2008, CHEM PHYS LETT, V462, P284, DOI 10.1016/j.cplett.2008.07.035; Moran SD, 2013, BIOCHEMISTRY-US, V52, P6169, DOI 10.1021/bi4008353; NISHIZAWA E, 1990, CHEM PHYS LETT, V172, P317, DOI 10.1016/0009-2614(90)85411-5; PALANIAPPAN V, 1993, J AM CHEM SOC, V115, P12035, DOI 10.1021/ja00078a048; RODGERS KR, 1992, J AM CHEM SOC, V114, P3697, DOI 10.1021/ja00036a019; Tarcea N, 2007, SPECTROCHIM ACTA A, V68, P1029, DOI 10.1016/j.saa.2007.06.051	22	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	MAY	2015	31	5					451	454				4	Chemistry, Analytical	Chemistry	CJ3CT	WOS:000355361700015		
J	Takahashi, H; Yamauchi, T; Rajhi, I; Nishizawa, NK; Nakazono, M				Takahashi, Hirokazu; Yamauchi, Takaki; Rajhi, Imene; Nishizawa, Naoko K.; Nakazono, Mikio			Transcript profiles in cortical cells of maize primary root during ethylene-induced lysigenous aerenchyma formation under aerobic conditions	ANNALS OF BOTANY			English	Article						Lysigenous aerenchyma; maize; Zea mays; ethylene; waterlogging; laser microdissection; microarray; reactive oxygen species; ROS; programmed cell death; PCD; transcript profile; primary root; anaerobic stress	RADIAL OXYGEN LOSS; RICE ORYZA-SATIVA; ZEA-MAYS-L; ADVENTITIOUS ROOTS; PLANT EMBRYOGENESIS; FLOODING TOLERANCE; DEATH; HYPOXIA; GENES; WHEAT	Background and Aims Internal aeration is important for plants to survive during periods of waterlogging, and the ability to form aerenchyma contributes by creating a continuous gas space between the shoots and the roots. Roots of maize (Zea mays) react to prolonged waterlogging by forming aerenchyma in root cortical cells by programmed cell death (PCD) in response to ethylene. The aim of this study was to understand the molecular mechanisms of ethylene-induced aerenchyma formation by identifying genes that are either up-or downregulated by ethylene treatment in maize root cortical cells. Methods Three-day-old maize seedlings were treated with ethylene for several hours under aerobic conditions. Cortical cells were isolated from the primary roots using laser microdissection (LM), and transcript profiles with and without ethylene treatment were compared by microarray. In addition, the effect on ethylene-induced aerenchyma formation of diphenyleneiodonium (DPI), an inhibitor of NADPH oxidases, was examined in order to assess the involvement of reactive oxygen species (ROS). Key Results A total of 223 genes were identified whose transcript levels were significantly increased or decreased by ethylene treatment in root cortical cells under aerobic conditions. Subsequent tissue-specific quantitative reverse-transcription PCR analyses revealed that ethylene increased the transcript levels of genes related to ethylene signalling in all of the root tissues examined (stelar cells, cortical cells and outer cell layers), whereas it increased the transcript levels of genes related to cell wall modification and proteolysis specifically in the cortical cells. DPI treatment inhibited the ethylene-induced aerenchyma formation and suppressed expression of some cell wall modification-related genes. Conclusions Several genes related to cell wall modification and proteolysis are specifically up-or downregulated in cortical cells during lysigenous aerenchyma formation under aerobic conditions with ethylene treatment. The results suggest that ethylene is perceived in stelar cells, cortical cells and outer cell layers in the maize primary root, and that the cortical cell-specific PCD is controlled downstream of ethylene perception through subsequent gene expression, which is partly regulated by ROS, in the cortical cells.	[Takahashi, Hirokazu; Yamauchi, Takaki; Nakazono, Mikio] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Rajhi, Imene] Biotechnol Ctr Borj Cedria Sci & Technol Pk, Hammam Lif 2050, Tunisia; [Nishizawa, Naoko K.] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan	Nakazono, M (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	nakazono@agr.nagoya-u.ac.jp			Bio-oriented Technology Research Advancement Institution (Promotion of Basic Research Activities for Innovative Biosciences); Ministry of Agriculture, Forestry and Fisheries of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Drs A. Oyanagi, K. Kawaguchi, Y. Mano, F. Abe, M. Obara, T. Abiko, H. Mori and S. Nishiuchi for stimulating discussions, and Dr Y. Nagamura and Ms T, Motoyama for their support with the microarray experiments. This work was partly supported by a grant from the Bio-oriented Technology Research Advancement Institution (Promotion of Basic Research Activities for Innovative Biosciences), a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan, and grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Bouranis DL, 2006, ANN BOT-LONDON, V97, P695, DOI 10.1093/aob/mcl024; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; He CJ, 1996, PLANT PHYSIOL, V112, P463; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Malik AI, 2003, PLANT CELL ENVIRON, V26, P1713, DOI 10.1046/j.1365-3040.2003.01089.x; Takahashi H, 2010, J PLANT RES, V123, P807, DOI 10.1007/s10265-010-0319-4; Steffens B, 2009, PLANT CELL, V21, P184, DOI 10.1105/tpc.108.061887; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Suarez MF, 2004, CURR BIOL, V14, pR339, DOI 10.1016/j.cub.2004.04.019; Jackson MB, 1999, PLANT BIOLOGY, V1, P274, DOI 10.1055/s-2007-978516; Postma JA, 2011, PLANT PHYSIOL, V156, P1190, DOI 10.1104/pp.111.175489; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Shiono K, 2011, ANN BOT-LONDON, V107, P89, DOI 10.1093/aob/mcq221; Suzuki N, 2011, CURR OPIN PLANT BIOL, V14, P691, DOI 10.1016/j.pbi.2011.07.014; Rajhi I, 2011, NEW PHYTOL, V190, P351, DOI 10.1111/j.1469-8137.2010.03535.x; He CJ, 1996, PLANT PHYSIOL, V112, P1679; Schmid M, 1999, P NATL ACAD SCI USA, V96, P14159, DOI 10.1073/pnas.96.24.14159; Hadfield KA, 1998, PLANT PHYSIOL, V117, P337, DOI 10.1104/pp.117.2.337; Drew MC, 2000, TRENDS PLANT SCI, V5, P123, DOI 10.1016/S1360-1385(00)01570-3; Wu YJ, 2001, PLANT PHYSIOL, V126, P1471, DOI 10.1104/pp.126.4.1471; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; KNOWLES J, 1987, TRENDS BIOTECHNOL, V5, P255, DOI 10.1016/0167-7799(87)90102-8; McDonald MP, 2001, PLANT CELL ENVIRON, V24, P585, DOI 10.1046/j.0016-8025.2001.00707.x; Armstrong W, 1979, ADV BOT RES, V7, P236; ATWELL BJ, 1988, PHYSIOL PLANTARUM, V72, P15, DOI 10.1111/j.1399-3054.1988.tb06616.x; Bollhoner B, 2013, NEW PHYTOL, V200, P498, DOI 10.1111/nph.12387; Bouranis DL, 2003, PLANTA, V217, P382, DOI 10.1007/s00425-003-1007-6; Cardoso JA, 2014, AOB PLANTS, V6; Coetzer N, 2011, PLANT METHODS, V1, P31; Colmer TD, 2006, NEW PHYTOL, V170, P767, DOI 10.1111/j.1469-8137.2006.01725.x; Drew MC, 1979, PLANTA, V147, P83; Evans D., 2003, NEW PHYTOL, V161, P35, DOI DOI 10.1046/J.1469-8137.2003.00907.X; Gietl C, 2001, NATURWISSENSCHAFTEN, V88, P49, DOI 10.1007/s001140000203; Haque M. E., 2010, Plant Root, V4, P31, DOI 10.3117/plantroot.4.31; HE CJ, 1994, PLANT PHYSIOL, V105, P861; Jung JKH, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00186; JUSTIN SHFW, 1991, NEW PHYTOL, V118, P49, DOI 10.1111/j.1469-8137.1991.tb00564.x; KONINGS H, 1982, PHYSIOL PLANTARUM, V54, P119, DOI 10.1111/j.1399-3054.1982.tb06313.x; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; McPHERSON D. C., 1939, NEW PHYTOL, V38, P190, DOI 10.1111/j.1469-8137.1939.tb07098.x; Nishiuchi S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-2; Niture NK, 2008, BIOLOGIA, V63, P1; Parlanti S, 2011, ANN BOT-LONDON, V107, P1335, DOI 10.1093/aob/mcr086; Steffens B, 2011, NEW PHYTOL, V190, P369, DOI 10.1111/j.1469-8137.2010.03496.x; Takahashi H, 2014, PLANT CELL MONOGR, V21, P247, DOI 10.1007/978-3-7091-1254-0_13; TROUGHT MCT, 1980, J EXP BOT, V31, P1573, DOI 10.1093/jxb/31.6.1573; Visser EJW, 2004, PLANT SOIL, V254, P197, DOI DOI 10.1007/S11104-004-1650-0; Yamauchi Takaki, 2011, Plant Signal Behav, V6, P759; Yamauchi T, 2014, J EXP BOT, V65, P261, DOI 10.1093/jxb/ert371; York LM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00355	55	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7364	1095-8290		ANN BOT-LONDON	Ann. Bot.	MAY	2015	115	6					879	894		10.1093/aob/mcv018		16	Plant Sciences	Plant Sciences	CJ6SX	WOS:000355625000005		
J	Taneda, H; Watanabe-Taneda, A; Chhetry, R; Ikeda, H				Taneda, Haruhiko; Watanabe-Taneda, Ayako; Chhetry, Rita; Ikeda, Hiroshi			A theoretical approach to the relationship between wettability and surface microstructures of epidermal cells and structured cuticles of flower petals	ANNALS OF BOTANY			English	Article						Epidermis; cuticle structure; petal wettability; Wenzel wetting; Cassie-Baxter wetting; lotus effect; petal effect; alpine plant; water run-off; thermodynamic model	WATER; BEHAVIOR; CASSIE; WENZEL; WAX	Background and Aims The epidermal surface of a flower petal is composed of convex cells covered with a structured cuticle, and the roughness of the surface is related to the wettability of the petal. If the surface remains wet for an excessive amount of time the attractiveness of the petal to floral visitors may be impaired, and adhesion of pathogens may be promoted. However, it remains unclear how the epidermal cells and structured cuticle contribute to surface wettability of a petal. Methods By considering the additive effects of the epidermal cells and structured cuticle on petal wettability, a thermodynamic model was developed to predict the wetting mode and contact angle of a water droplet at a minimum free energy. Quantitative relationships between petal wettability and the geometries of the epidermal cells and the structured cuticle were then estimated. Measurements of contact angles and anatomical traits of petals were made on seven herbaceous species commonly found in alpine habitats in eastern Nepal, and the measured wettability values were compared with those predicted by the model using the measured geometries of the epidermal cells and structured cuticles. Key Results The model indicated that surface wettability depends on the height and interval between cuticular steps, and on a height-to-width ratio for epidermal cells if a thick hydrophobic cuticle layer covers the surface. For a petal epidermis consisting of lenticular cells, a repellent surface results when the cuticular step height is greater than 0.85 mu m and the height-to-width ratio of the epidermal cells is greater than 0.3. For an epidermis consisting of papillate cells, a height-to-width ratio of greater than 1.1 produces a repellent surface. In contrast, if the surface is covered with a thin cuticle layer, the petal is highly wettable (hydrophilic) irrespective of the roughness of the surface. These predictions were supported by the measurements of petal wettability made on flowers of alpine species. Conclusions The results indicate that surface roughness caused by epidermal cells and a structured cuticle produces a wide range of petal wettability, and that this can be successfully modelled using a thermodynamic approach.	[Taneda, Haruhiko; Watanabe-Taneda, Ayako] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Chhetry, Rita] Natl Herbarium & Plant Labs, Dept Plant Resources, Kathomandu, Nepal; [Ikeda, Hiroshi] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan	Taneda, H (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	taneda@bs.s.u-tokyo.ac.jp			Ministry of Education, Science, Sports, and Culture [23255005, 25923008]	We thank Dr I. Terashima for helpful discussions. This study was financially supported by the Ministry of Education, Science, Sports, and Culture (grant nos. 23255005 and 25923008).	Liu KS, 2010, CHEM SOC REV, V39, P3240, DOI 10.1039/b917112f; Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400; Bhushan B, 2010, LANGMUIR, V26, P8207, DOI 10.1021/la904585j; Marmur A, 2003, LANGMUIR, V19, P8343, DOI 10.1021/la0344682; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Gao LC, 2007, LANGMUIR, V23, P3762, DOI 10.1021/la062634a; Feng L, 2011, SOFT MATTER, V7, P2977, DOI 10.1039/c0sm01032d; Koch K, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/3/036005; Rosado BHP, 2013, ECOHYDROLOGY, V6, P150, DOI 10.1002/eco.1340; Yoshimitsu Z, 2002, LANGMUIR, V18, P5818, DOI 10.1021/la020088p; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; Argiropoulos A, 2012, WEED BIOL MANAG, V12, P47, DOI 10.1111/j.1445-6664.2012.00434.x; Argiropoulos A, 2013, PLANT BIOSYST, V147, P638, DOI 10.1080/11263504.2013.763863; Argiropoulos A, 2012, BOT STUD, V53, P479; WASER NM, 1983, NATURE, V302, P422, DOI 10.1038/302422a0; Bhushan B, 2010, PHILOS T R SOC A, V368, P4713, DOI 10.1098/rsta.2010.0203; Yang J, 2009, LANGMUIR, V25, P2567, DOI 10.1021/la803942h; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Marmur A, 2009, LANGMUIR, V25, P1277, DOI 10.1021/la802667b; Koch K, 2006, PLANTA, V223, P258, DOI 10.1007/s00425-005-0081-3; KEVAN PG, 1985, P NATL ACAD SCI USA, V82, P4750, DOI 10.1073/pnas.82.14.4750; Feng L, 2008, LANGMUIR, V24, P4114, DOI 10.1021/la703821h; Whitney HM, 2009, CURR BIOL, V19, P948, DOI 10.1016/j.cub.2009.04.051; Aral B, 2010, OECOLOGIA, V162, P1; de Gennes P, 2003, GOUTTES BULLES PERLE; HOLLOWAY P. J., 1970, Pesticide Science, V1, P156, DOI 10.1002/ps.2780010411; HOLLOWAY PJ, 1969, ANN APPL BIOL, V63, P145, DOI 10.1111/j.1744-7348.1969.tb05475.x; HUBER L, 1992, ANNU REV PHYTOPATHOL, V30, P553, DOI 10.1146/annurev.py.30.090192.003005; Korner C, 2003, ALPINE PLANT LIFE FU; Niklas K. J., 1992, PLANT BIOMECHANICS E; Shahraz A, 2012, LANGMUIR, V28, P14227, DOI 10.1021/la3026304; Vogelman TC, 1994, PHOTOMORPHOGENESIS P, V2nd; Whitney HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017576; Yeh KY, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/34/345303	34	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7364	1095-8290		ANN BOT-LONDON	Ann. Bot.	MAY	2015	115	6					923	937		10.1093/aob/mcv024		15	Plant Sciences	Plant Sciences	CJ6SX	WOS:000355625000008		
J	Tsujimoto, T; Yamamoto-Honda, R; Kajio, H; Kishimoto, M; Noto, H; Hachiya, R; Kimura, A; Kakei, M; Noda, M				Tsujimoto, Tetsuro; Yamamoto-Honda, Ritsuko; Kajio, Hiroshi; Kishimoto, Miyako; Noto, Hiroshi; Hachiya, Remi; Kimura, Akio; Kakei, Masafumi; Noda, Mitsuhiko			High risk of abnormal QT prolongation in the early morning in diabetic and non-diabetic patients with severe hypoglycemia	ANNALS OF MEDICINE			English	Article						Arrhythmia; diabetes; nocturnal hypoglycemia; QT prolongation; severe hypoglycemia	HEART-RATE CORRECTION; INTERVAL PROLONGATION; BED SYNDROME; CARDIAC REPOLARIZATION; NOCTURNAL HYPOGLYCEMIA; SPONTANEOUS EPISODES; ARRHYTHMIAS; MORTALITY; COHORT; DEAD	Background. Several studies have suggested that the occurrence of severe hypoglycemia during sleep may be more dangerous for cardiac arrhythmia than that in the day-time. Methods. We performed a retrospective study between January 2006 and March 2012 to assess electrocardiograms during severe hypoglycemia in patients with or without diabetes. Results. A total of 59,602 patients who visited the emergency room by ambulance were screened, and 287 patients with severe hypoglycemia were enrolled. The median blood glucose levels in patients with (DM, n = 192) and without diabetes (non-DM, n = 95) were 30 and 45 mg/dL, respectively. During severe hypoglycemia, the incidence of abnormal QT prolongation was significantly higher in the early morning (4-10 a.m.) than at other times (DM group, 74.3% versus 54.1%, P = 0.02; non-DM group, 78.3% versus 50.0%, P = 0.01). Multivariate logistic regression analysis identified the occurrence of severe hypoglycemia in the early morning as a strong factor for abnormal QT prolongation (DM group, odds ratio [OR] 2.80, 95% confidence interval [CI] 1.15-6.80, P = 0.02; non-DM group, OR 4.53, 95% CI 1.30-15.74, P = 0.01). Conclusions. The incidence of abnormal QT prolongation during severe hypoglycemia was significantly higher in the early morning than at all other times, independent of the cause of severe hypoglycemia.	[Tsujimoto, Tetsuro; Yamamoto-Honda, Ritsuko; Kajio, Hiroshi; Kishimoto, Miyako; Noto, Hiroshi; Hachiya, Remi] Natl Ctr Global Hlth & Med, Dept Diabet Endocrinol & Metab, Ctr Hosp, Tokyo, Japan; [Tsujimoto, Tetsuro; Kakei, Masafumi] Jichi Med Univ, Grad Sch Med, Div Gen Med, Shimotsuke, Japan; [Yamamoto-Honda, Ritsuko; Kishimoto, Miyako; Noto, Hiroshi; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Diabet Res Ctr, Tokyo, Japan; [Kimura, Akio] Natl Ctr Global Hlth & Med, Dept Emergency Med & Crit Care, Ctr Hosp, Tokyo, Japan; [Kakei, Masafumi] Jichi Med Univ, Dept Comprehens Med 1, Saitama Med Ctr, Sch Med, Saitama, Japan	Tsujimoto, T (reprint author), Natl Ctr Global Hlth & Med, Dept Diabet Endocrinol & Metab, Ctr Hosp, Tokyo, Japan.	ttsujimoto@hosp.ncgm.go.jp			JSPS KAKENHI [26860701]	This work was supported by JSPS KAKENHI [grant number 26860701].	ALEXOPOULOS D, 1988, AM J CARDIOL, V61, P482, DOI 10.1016/0002-9149(88)90318-9; Al-Khatib SM, 2003, JAMA-J AM MED ASSOC, V289, P2120, DOI 10.1001/jama.289.16.2120; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; Chow E, 2014, DIABETES, V63, P1738, DOI 10.2337/db13-0468; AHNVE S, 1985, AM HEART J, V109, P568, DOI 10.1016/0002-8703(85)90564-2; TATTERSALL RB, 1991, DIABETIC MED, V8, P49; Jones TW, 1998, NEW ENGL J MED, V338, P1657, DOI 10.1056/NEJM199806043382303; Ziegler D, 2008, DIABETES CARE, V31, P556, DOI 10.2337/dc07-1615; PANZA JA, 1991, NEW ENGL J MED, V325, P986, DOI 10.1056/NEJM199110033251402; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795; Tsujimoto T, 2014, DIABETES CARE, V37, P217, DOI 10.2337/dc13-0701; Watanabe J, 2012, J CLIN PSYCHOPHARM, V32, P18, DOI 10.1097/JCP.0b013e31823f6f21; Gill G, 2009, DIABETOLOGIA, V52, P42, DOI 10.1007/s00125-008-1177-7; Veglio M, 2000, DIABETES CARE, V23, P1381, DOI 10.2337/diacare.23.9.1381; BROWNE KF, 1983, AM J CARDIOL, V52, P55, DOI 10.1016/0002-9149(83)90068-1; Tanenberg RJ, 2010, ENDOCR PRACT, V16, P244, DOI 10.4158/EP09260.CR; Aso Y, 2006, METABOLISM, V55, P1014, DOI 10.1016/j.metabol.2006.03.011; BEXTON RS, 1986, BRIT HEART J, V55, P253; Bonds DE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b4909; Christensen TF, 2014, J DIABETES COMPLICAT, V28, P723, DOI 10.1016/j.jdiacomp.2014.03.007; Christensen TF, 2010, DIABETOLOGIA, V53, P2036, DOI 10.1007/s00125-010-1802-0; Giunti S, 2007, DIABETES CARE, V30, P2057, DOI 10.2337/dc07-0063; Gruden G, 2012, DIABETES CARE, V35, P125, DOI 10.2337/dc11-1739; Hnatkova K, 1999, PACE, V22, P1683, DOI 10.1111/j.1540-8159.1999.tb00390.x; Murphy NP, 2004, DIABETOLOGIA, V47, P1940, DOI 10.1007/s00125-004-1552-y; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; Reno CM, 2013, DIABETES, V62, P3570, DOI 10.2337/db13-0216; Robinson RTCE, 2003, DIABETES, V52, P1469, DOI 10.2337/diabetes.52.6.1469; THORDARSON H, 1995, DIABETIC MED, V12, P782; Tsujimoto T, 2014, ACTA DIABETOL; Veglio M, 2002, J INTERN MED, V251, P317, DOI 10.1046/j.1365-2796.2002.00955.x	32	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0785-3890	1365-2060		ANN MED	Ann. Med.	MAY	2015	47	3					238	244		10.3109/07853890.2015.1017528		7	Medicine, General & Internal	General & Internal Medicine	CJ5WD	WOS:000355562200007		
J	Ji, J; Zhang, YX; Wang, JS; Lin, JZ; Sun, L; Chen, X; Ito, K; Saito, Y				Ji, Jie; Zhang, Yanxuan; Wang, Jinshi; Lin, Jianzhen; Sun, Li; Chen, Xia; Ito, Katsura; Saito, Yutaka			Can the predatory mites Amblyseius swirskii and Amblyseius eharai reproduce by feeding solely upon conspecific or heterospecific eggs (Acari: Phytoseiidae)?	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Invasion risk; Intraguild predation; Cannibalism; Life history parameters; Competitive exclusion	BIOLOGICAL-CONTROL; INTRAGUILD PREDATION; TYPHLODROMIPS-SWIRSKII; PREDACEOUS MITES; PREDACIOUS MITES; SEX-RATIO; CANNIBALISM; TETRANYCHIDAE; POPULATIONS; PERSIMILIS	The phytoseiid mite, Amblyseius swirskii (Athias-Henriot) is an exotic biological control agent of mites and small insect pests in China. Amblyseius eharai (Amitai & Swirski), on the other hand, is a native predacious mite common throughout East and South-East Asia and considered to be an important natural enemy of Panonychus citri (McGregor). Understanding the ways introduced predators affect native ones is vital if we wish to use the former as biological control agents in the field. In order to evaluate the interactions between these two predacious mites, we observed their life histories when they cannibalized or fed upon intraguild prey under laboratory conditions. Both male and female A. eharai and A. swirskii could develop to adulthood by feeding upon both conspecific and heterospecific (IGP) eggs. However, A. swirskii females supplied with IGP eggs had shorter developmental durations, higher fecundity, and higher intrinsic rates of increase (r(m)) than those supplied with conspecific eggs. On the other hand, A. eharai females supplied with conspecific eggs had higher r(m) than those supplied with heterospecific eggs, suggesting that A. eharai females may prefer to prey upon conspecific immatures, even when A. swirskii immature stages are present. As a result, A. swirskii females may decrease A. eharai populations, when extra-guild prey species, such as spider mites, and pollen are scarce.	[Ji, Jie; Zhang, Yanxuan; Wang, Jinshi; Lin, Jianzhen; Sun, Li; Chen, Xia; Saito, Yutaka] Fujian Acad Agr Sci, Inst Plant Protect, Fuzhou 350013, Fujian, Peoples R China; [Ito, Katsura] Kochi Univ, Lab Insect Ecol, Fac Agr, Nankoku, Kochi 7838502, Japan	Saito, Y (reprint author), Fujian Acad Agr Sci, Inst Plant Protect, Fuzhou 350013, Fujian, Peoples R China.	yutsat@res.agr.hokudai.ac.jp			Science and Technology Innovation Team of Fujian Academy of Agricultural Sciences [CXTD-2-13-13]; China Recruitment Program of Global Experts (Foreign Experts) [WQ20123500080]; State Administration of Foreign Experts Affairs Key Project for Introduction of Foreign Expert [SZ2013003]; Ministry of Agriculture Special Fund for Scientific Research in the Public Interest [201103020]; 863 Program [2011AA10A201]	We thank A. R. Chittenden who kindly edited the English usage. We also thank F. P. Zhang, L. L. Zhao, J. T. Lin and J. Chen for their help. This study was partly supported by the Science and Technology Innovation Team of Fujian Academy of Agricultural Sciences (CXTD-2-13-13), China Recruitment Program of Global Experts (Foreign Experts) (WQ20123500080), State Administration of Foreign Experts Affairs Key Project for Introduction of Foreign Expert (SZ2013003), Ministry of Agriculture Special Fund for Scientific Research in the Public Interest (201103020) and the 863 Program (2011AA10A201).	Nomikou M, 2001, EXP APPL ACAROL, V25, P271, DOI 10.1023/A:1017976725685; CROFT BA, 1993, ENVIRON ENTOMOL, V22, P865; Lee HS, 2011, EXP APPL ACAROL, V53, P17, DOI 10.1007/s10493-010-9385-5; Brodeur J, 2000, ENTOMOL EXP APPL, V97, P93, DOI 10.1023/A:1004013232410; Montserrat M, 2006, ECOL ENTOMOL, V31, P430, DOI 10.1111/j.1365-2311.2006.00804.x; Ji J, 2007, EXP APPL ACAROL, V43, P171, DOI 10.1007/s10493-007-9114-x; Schausberger P, 2000, EXP APPL ACAROL, V24, P709, DOI 10.1023/A:1010747208519; Zannou ID, 2011, EXP APPL ACAROL, V53, P339, DOI 10.1007/s10493-010-9412-6; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Schausberger P, 2001, BIOL CONTROL, V20, P269, DOI 10.1006/bcon.2000.0908; Xiao YF, 2012, BIOL CONTROL, V63, P279, DOI 10.1016/j.biocontrol.2012.09.007; Buitenhuis R, 2010, B ENTOMOL RES, V100, P167, DOI 10.1017/S0007485309006944; Cao HG, 1998, ACTA AGR U JIANGXIEN, V20, P121; Chittenden AR, 2001, J ETHOL, V19, P55, DOI 10.1007/s101640170018; DUSO C, 1991, J APPL ENTOMOL, V112, P298; Gotoh T, 2014, EXP APPL ACAROL, V63, P205, DOI 10.1007/s10493-014-9769-z; Huang Y. B., 2012, J AGR FOR, V61, P37; Ji Jie, 2012, Shengwu Duoyangxing, V20, P24; Ji J, 2013, SYST APPL ACAROL-UK, V18, P321, DOI 10.11158/saa.18.4.2; Ji J, 2013, SYST APPL ACAROL-UK, V18, P123; Juan-Blasco M, 2012, FLA ENTOMOL, V95, P543; Mcmurtry JA, 2013, SYST APPL ACAROL-UK, V18, P297, DOI 10.11158/saa.18.4.1; Momen F. M., 2009, Acarina, V17, P223; Polis CA, 1981, ANNU REV ECOL SYST, V12, P225; SAITO Y, 1981, APPL ENTOMOL ZOOL, V16, P45; Schausberger P, 2001, ANIM BEHAV, V61, P459, DOI 10.1006/anbe.2000.1611; Schausberger P, 2003, EXP APPL ACAROL, V29, P173, DOI 10.1023/A:1025839206394; Schausberger P, 2005, BEHAV ECOL SOCIOBIOL, V58, P53, DOI 10.1007/s00265-004-0898-y; Toyoshima S, 1998, EXP APPL ACAROL, V22, P709, DOI 10.1023/A:1006093424452; Yang ZQ, 1986, ACTA AGR U JIANGXIEN, V8, P81; Zhang YX, 2015, EXP APPL ACAROL, V65, P29, DOI 10.1007/s10493-014-9847-2	31	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	MAY	2015	50	2					149	154		10.1007/s13355-014-0316-5		6	Entomology	Entomology	CJ5XM	WOS:000355566800001		
J	Ishihara, G; Kokusho, R; Shimada, T; Katsuma, S				Ishihara, Genki; Kokusho, Ryuhei; Shimada, Toru; Katsuma, Susumu			Functional analysis of antisense long non-coding RNAs transcribed from the Bombyx mori (Lepidoptera: Bombycidae) nucleopolyhedrovirus genome	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Baculovirus; Long non-coding RNA; Antisense transcript; Transcriptional regulation; BmNPV; Bombyx mori	NUCLEAR POLYHEDROSIS-VIRUS; GENE-EXPRESSION; BACULOVIRUS; PROTEIN; IDENTIFICATION; INFECTION; CELLS; HOST; APOPTOSIS; SEQUENCES	Although some viruses have been shown to encode long non-coding RNAs (lncRNAs), how they function during their infection cycles remains elusive. We previously found an unexpectedly large number of novel transcripts, including putative lncRNAs, which were expressed from the genome of the baculovirus Bombyx mori nucleopolyhedrovirus (BmNPV). To investigate the function of baculoviral antisense lncRNAs, we selected 15 BmNPV lncRNAs expressed from the baculovirus early or late promoter motif, and constructed the corresponding promoter knockout (PKO) viruses in which nucleotide substitutions were introduced at the transcription start sites of lncRNAs. We investigated the production of budded viruses (BVs) and occlusion bodies (OBs) in PKO virus-infected cultured cells and silkworm larvae. No defects in BV and OB production were observed for most of the PKO viruses, whereas KO122AS, in which an antisense lncRNA in the Bm122 locus was disrupted, produced fewer OBs than the wild-type or repair virus both in cultured cells and in silkworm larvae. Northern blot analysis revealed that loss of this antisense lncRNAs reduced the amounts of the corresponding sense mRNA. These results suggest that the lncRNA transcribed from the Bm122 locus might contribute to virus propagation by regulating viral gene expression. This is the first study to characterize the properties and functions of baculoviral lncRNAs.	[Ishihara, Genki; Kokusho, Ryuhei; Shimada, Toru; Katsuma, Susumu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan	Katsuma, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	katsuma@ss.ab.a.u-tokyo.ac.jp	Shimada, Toru/A-2033-2011	Shimada, Toru/0000-0002-5791-0000	JSPS KAKENHI [22380033, 25292196]; Japan Society for the Promotion of Science [253128]	We thank Munetaka Kawamoto for clerical assistance. This study was supported by JSPS KAKENHI grant numbers 22380033 and 25292196 to S.K. G.I. is a recipient of a fellowship from the Japan Society for the Promotion of Science (grant number 253128).	Cox JE, 2014, ANN REV VIROL, V1, P89, DOI 10.1146/annurev-virology-031413-085439; Singh J, 2010, VIROLOGY, V407, P120, DOI 10.1016/j.virol.2010.07.033; Ono C, 2012, VIRUS RES, V165, P197, DOI 10.1016/j.virusres.2012.02.016; Singh CP, 2014, INSECT BIOCHEM MOLEC, V49, P59, DOI 10.1016/j.ibmb.2014.03.008; Gomi S, 1999, J GEN VIROL, V80, P1323; Katsuma S, 2012, J VIROL, V86, P2545, DOI 10.1128/JVI.06308-11; Ishihara G, 2013, VIRUS RES, V174, P52, DOI 10.1016/j.virusres.2013.02.014; Kamita SG, 2005, P NATL ACAD SCI USA, V102, P2584, DOI 10.1073/pnas.0409457102; Chen YR, 2013, J VIROL, V87, P6391, DOI 10.1128/JVI.00194-13; OREILLY DR, 1989, SCIENCE, V245, P1110, DOI 10.1126/science.2505387; Nobiron I, 2003, J GEN VIROL, V84, P3029, DOI 10.1099/vir.0.19270-0; Singh CP, 2012, J VIROL, V86, P7867, DOI 10.1128/JVI.00064-12; BLISSARD GW, 1989, VIROLOGY, V168, P354, DOI 10.1016/0042-6822(89)90276-6; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Dickison VL, 2012, VIROLOGY, V431, P29, DOI 10.1016/j.virol.2012.05.002; Gomi S, 1997, VIROLOGY, V230, P35, DOI 10.1006/viro.1997.8457; HAWTIN RE, 1995, VIROLOGY, V212, P673, DOI 10.1006/viro.1995.1525; Iwanaga M, 2004, BIOCHEM BIOPH RES CO, V323, P599, DOI 10.1016/j.bbrc.2004.08.114; KAMITA SG, 1993, J VIROL, V67, P455; Katsuma S, 2011, J GEN VIROL, V92, P200, DOI 10.1099/vir.0.025908-0; MAEDA S, 1990, J GEN VIROL, V71, P1851, DOI 10.1099/0022-1317-71-8-1851; Maeda S, 1984, J SERICULT SCI JAPAN, V53, P547; OOI B, 1990, J VIROL, V64, P3126; PULLEN SS, 1995, J VIROL, V69, P3575; Rohrmann G.F., 2013, BACULOVIRUS MOL BIOL; SLACK JM, 1995, J GEN VIROL, V76, P1091, DOI 10.1099/0022-1317-76-5-1091; Smith I, 2007, J VIROL, V81, P7819, DOI 10.1128/JVI.00615-07; Xing K, 2005, VIRUS RES, V113, P64, DOI 10.1016/j.virusres.2005.04.016; Yang S, 1999, J VIROL, V73, P3404; Zhou CE, 1998, VIROLOGY, V240, P282, DOI 10.1006/viro.1997.8927; Zhu MX, 2013, J VIROL, V87, P13029, DOI 10.1128/JVI.02112-13	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	MAY	2015	50	2					155	167		10.1007/s13355-014-0317-4		13	Entomology	Entomology	CJ5XM	WOS:000355566800002		
J	Funayama, K				Funayama, Ken			Outbreaks of the two-spotted spider mite, Tetranychus urticae (Acari: Tetranychidae) are caused by broad-spectrum insecticide spraying in apple orchards	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Tetranychus urticae; Resurgence; Broad-spectrum insecticide; Apple orchard; Phytoseiid mite	PHYTOSEIID MITES; WOMERSLEYI; JAPAN	In this study I investigated whether the resurgence of Tetranychus urticae Koch in apple orchards in Akita Prefecture has occurred because of broad-spectrum insecticide spraying. Plots of two management types were established. Plot A was managed for conservation of phytoseiid mites by selective chemical spraying without mowing in both 2012 and 2013. Plot B was managed by not mowing in either year, with selective chemical spraying in 2012 and spraying of pyrethroids at two-week intervals from late May to early August in 2013. In 2012, there was no significant difference between numbers of T. urticae and phytoseiid mites [Typhlodromus vulgaris (Ehara), Neoseiulus womersleyi (Schicha), and Amblyseius tsugawai (Ehara)] in the two plots. In 2013, T. urticae was present in small numbers only in plot A and T. vulgaris and A. tsugawai were observed continuously, whereas in plot B phytoseiid mites were seldom observed and T. urticae numbers increased rapidly to a peak in mid-August. These findings clearly indicate that outbreaks of T. urticae are caused by broad-spectrum insecticide spraying in apple orchards.	Akita Fruit Tree Expt Stn, Yokote, Akita 0130102, Japan	Funayama, K (reprint author), Akita Fruit Tree Expt Stn, Yokote, Akita 0130102, Japan.	funayamak@pref.akita.lg.jp			Ministry of Agriculture, Forestry and Fisheries, Japan	I thank A. Oda, A. Sato, and K. Kagaya of the Akita Fruit Tree Experiment Station for their assistance with the field work. This research was financially supported by the Ministry of Agriculture, Forestry and Fisheries, Japan, through a research project entitled "Development of technologies for mitigation and adaptation to climate change in agriculture, forestry and fisheries".	Amano Hiroshi, 2004, Journal of the Acarological Society of Japan, V13, P65, DOI 10.2300/acari.13.65; Marko V, 2009, BIOL CONTROL, V48, P115, DOI 10.1016/j.biocontrol.2008.10.002; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Amalin DM, 2000, FLA ENTOMOL, V83, P254, DOI 10.2307/3496343; MCMURTRY JA, 1970, HILGARDIA, V40, P331; CROFT BA, 1990, CAN ENTOMOL, V122, P5; DUSO C, 1993, EXP APPL ACAROL, V17, P241, DOI 10.1007/BF02337274; Funayama K, 2010, ANN REPT PLANT PROT, V61, P236; Funayama K, 2010, JPN J APPL ENTOMOL Z, V54, P208, DOI 10.1303/jjaez.2010.208; Furuhashi K, 1990, JPN PESTIC INFO, V57, P91; Hamamura T, 2003, INFLUENCE AGR CHEM P; Hassan S. A., 1994, Bulletin OILB/SROP, V17, P1; Ishikawa T, 2011, AKINORI KIMURAS MIRA; Kawashima M, 2006, EXP APPL ACAROL, V39, P105, DOI 10.1007/s10493-006-9002-9; Kishimoto H, 2002, APPL ENTOMOL ZOOL, V37, P603, DOI 10.1303/aez.2002.603; Narita H, 1981, B AKITA FRUIT TREE E, V13, P33; Narita H., 1985, Annual Report of the Society of Plant Protection of North Japan, V36, P94; SAS Institute, 2008, JMP VERS 8 02; Sekita N, 1985, APPL ENTOMOL ZOOL, V21, P173; SSRI, 2012, EXC STAT 2012; Toyoshima S, 2008, APPL ENTOMOL ZOOL, V43, P443, DOI 10.1303/aez.2008.443; Toyoshima S, 2003, APPL ENTOMOL ZOOL, V38, P387, DOI 10.1303/aez.2003.387; Toyoshima S, 2013, PHYTOSEIID MITE PORT; Toyoshima Shingo, 2011, Journal of the Acarological Society of Japan, V20, P77, DOI 10.2300/acari.20.77; Uesugi R, 2002, J ECON ENTOMOL, V95, P1267, DOI 10.1603/0022-0493-95.6.1267	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	MAY	2015	50	2					169	174		10.1007/s13355-014-0318-3		6	Entomology	Entomology	CJ5XM	WOS:000355566800003		
J	Sobhy, IS; Mandour, NS; Sarhan, AA				Sobhy, Islam S.; Mandour, Nasser S.; Sarhan, Awad A.			Tomato treatment with chemical inducers reduces the performance of Spodoptera littoralis (Lepidoptera: Noctuidae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Chemical inducers; BTH; PDJ; Herbivore performance; Survival	SYSTEMIC ACQUIRED-RESISTANCE; BETA-AMINOBUTYRIC ACID; SALICYLIC-ACID; PLANT DEFENSE; CIS-JASMONE; LYCOPERSICON-ESCULENTUM; HERBIVOROUS INSECTS; CAMELLIA-SINENSIS; FOOD SECURITY; APHID	The evolving understanding of plant signaling pathways has promoted the possibility of using chemical inducers as an effective tactic for crop protection. In this study, under greenhouse conditions, we conducted a growth assay of Spodoptera littoralis (Boisduval) larvae on tomato plants treated with BTH (S-methyl benzo [1, 2, 3] thiadiazole 7 carbothioate) as a salicylic acid mimic, PDJ (propyl [1RS, 2RS]-[3-oxo-2-pentylcyclopentyl] acetate) as a jasmonic acid-mimic or both chemicals as a combined treatment. The larval body weight of S. littoralis was drastically reduced with each chemical compared to control plants, and there was a significant synergistic interaction. Overall, the total weight gain of surv/*-iving larvae fed on treated plants was distinctly tenfold less than for those fed on control plants. Moreover, incorporating the chemical inducers in artificial diets had no direct or toxic impact on the larval body weight of S. littoralis under laboratory conditions. Larval survival rates were significantly lower (35-40 %) on treated plants with either combined or independent inducers' treatments compared with control plants after 15-day feeding. In contrast, incorporating the chemical inducers in artificial diets had no direct effect on larval survival rates under laboratory conditions. The applied concentrations of BTH and PDJ had no detectable phytotoxicity to tomato plants. Our results demonstrate that BTH and PDJ can act synergistically when applied to tomato to reduce the performance of S. littoralis. These findings stress that the application of chemical inducers could provide an environment-friendly tactic to help manage insect pests and thereby play multiple roles in improving the overall plant resistance to herbivore pests.	[Sobhy, Islam S.; Mandour, Nasser S.; Sarhan, Awad A.] Suez Canal Univ, Dept Plant Protect, PSCBC, Fac Agr, Ismailia 41522, Egypt; [Sobhy, Islam S.] Okayama Univ, Inst Plant Sci & Resources, Plant Insect Interact Grp, Kurashiki, Okayama 7100046, Japan	Sobhy, IS (reprint author), Suez Canal Univ, Dept Plant Protect, PSCBC, Fac Agr, Ismailia 41522, Egypt.	is_sobhy@yahoo.com			Public Service Center for Biological Control (PSCBC), Faculty of Agriculture, Suez Canal University, Egypt	We greatly appreciate the useful comments and constructive remarks of Prof. Stuart Reitz (Oregon State University, USA) on the manuscript. We greatly thank Mohammed Abdel El-Hady and the graduate students (level 4) of the 2011-2012 academic year at the Department of Plant Protection, notably, Sara Mousa and Seham Mohammed, for their assistance in the experimental setup. This work was supported by the Public Service Center for Biological Control (PSCBC), Faculty of Agriculture, Suez Canal University, Egypt.	Schweiger R, 2014, PLANT CELL ENVIRON, V37, P1574, DOI 10.1111/pce.12257; Maeda T, 2012, EXP APPL ACAROL, V58, P247, DOI 10.1007/s10493-012-9577-2; Bruce TJA, 2003, PEST MANAG SCI, V59, P1031, DOI 10.1002/ps.730; Hegde M, 2012, PHYTOCHEMISTRY, V78, P81, DOI 10.1016/j.phytochem.2012.03.004; SHOREY HH, 1965, J ECON ENTOMOL, V58, P522; Sobhy IS, 2012, J CHEM ECOL, V38, P348, DOI 10.1007/s10886-012-0098-6; Yoshida K, 2010, JARQ-JPN AGR RES Q, V44, P391; Mandour NS, 2013, J APPL ENTOMOL, V137, P104, DOI 10.1111/j.1439-0418.2012.01721.x; Walters DR, 2013, J EXP BOT, V64, P1263, DOI 10.1093/jxb/ert026; Salzman RA, 2005, PLANT PHYSIOL, V138, P352, DOI 10.1104/pp.104.058206; Cooper WC, 2004, J CHEM ECOL, V30, P2527, DOI 10.1007/s10886-004-7948-9; Boughton AJ, 2006, ENTOMOL EXP APPL, V120, P175, DOI 10.1111/j.1570-7458.2006.00443.x; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; Gozzo F, 2013, J AGR FOOD CHEM, V61, P12473, DOI 10.1021/jf404156x; Bruce TJA, 2010, FOOD SECUR, V2, P133, DOI 10.1007/s12571-010-0061-8; ELDEFRAWI ME, 1964, J ECON ENTOMOL, V57, P591; Moraes MCB, 2008, PHYTOCHEMISTRY, V69, P9, DOI 10.1016/j.phytochem.2007.06.020; Smith JL, 2009, PEST MANAG SCI, V65, P497, DOI 10.1002/ps.1714; Hodge S, 2005, B ENTOMOL RES, V95, P449, DOI 10.1079/BER2005375; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Cao HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091768; Choh Y, 2004, APPL ENTOMOL ZOOL, V39, P311, DOI 10.1303/aez.2004.311; Erb M, 2011, PLANT CELL ENVIRON, V34, P1088, DOI 10.1111/j.1365-3040.2011.02307.x; Hodge S, 2006, ANN APPL BIOL, V148, P223, DOI 10.1111/j.1744-7348.2006.00061.x; Inbar M, 2001, ENTOMOL EXP APPL, V99, P65, DOI 10.1046/j.1570-7458.2001.00802.x; Koshiyama M., 2006, Regulation of Plant Growth & Development, V41, P24; Kutner M. H., 2005, APPL LINEAR STAT MOD; Leadbeater A, 2007, INDUCED RESISTANCE P, P229, DOI 10.1002/9780470995983.ch12; Pickett JA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0281; Plymale RC, 2007, J CHEM ECOL, V33, P1570, DOI 10.1007/s10886-007-9329-7; Sadek MM, 2010, BASIC APPL ECOL, V11, P135, DOI 10.1016/j.baae.2009.09.003; Sobhy IS, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0283; Sobhy IS, 2015, PEST MANAG SCI, V71, P686, DOI 10.1002/ps.3821; Stout MJ, 1998, OECOLOGIA, V113, P74; Thaler JS, 1996, J CHEM ECOL, V22, P1767, DOI 10.1007/BF02028503; Zhong YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085142; Tiwari S, 2013, B ENTOMOL RES, V103, P592, DOI 10.1017/S0007485313000229; Uefune M, 2014, J PLANT INTERACT, V9, P69, DOI 10.1080/17429145.2012.763146; Von Merey GE, 2013, FRONT PLANT SCI, V4, P1, DOI [10.3389/fpls.2013.00209, DOI 10.3389/FPLS.2013.00209]; Yoneya K, 2014, APPL ENTOMOL ZOOL, V49, P249, DOI 10.1007/s13355-013-0243-x	42	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	MAY	2015	50	2					175	182		10.1007/s13355-014-0319-2		8	Entomology	Entomology	CJ5XM	WOS:000355566800004		
J	Luo, ZX; Honda, H				Luo, Zhixin; Honda, Hiroshi			Olfactory and biophysical assessment of the oviposition stimulating potential of host and non-host plants for the yellow peach moth, Conogethes punctiferalis (Lepidoptera: Crambidae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Conogethes punctiferalis; Host plant preference; Oviposition; Olfactory responses; Plant structures	GUENEE LEPIDOPTERA; GRAPEVINE MOTH; BUSSEOLA-FUSCA; MANDUCA-SEXTA; FRUIT MOTH; BEHAVIOR; CUES; VOLATILES; RESPONSES; PYRALIDAE	Oviposition responses of gravid Conogethes punctiferalis (Guenee) females to various parts of 4 host and 14 non-host plants were assessed in laboratory cage tests, where females were not allowed to contact the materials tested. Normal responses were observed to typical host plants. Unexpectedly, the females showed normal oviposition responses to 13 species of non-host plant parts, even though some were underground parts. On the other hand, no or slight responses were observed to potato tubers and leaves. In choice tests between different parts of the same host plant, females always preferred young fruits. Females preferred young peach fruits to turnip taproots, but no preference was seen between codling and turnip, and they unexpectedly preferred Brussels sprout buds to codlings. However, when females were allowed to contact plant materials, they laid few eggs on the host and non-host leaves that attracted them in the olfaction stimulus assays. Egg distributions on codling and chestnut were concentrated at the stem cavity or calyx end and spiny involucre, respectively. These results indicate not only that oviposition was induced by plant olfactory stimuli, but also that various non-host plants potentially stimulate oviposition. Even in host plants, biophysical stimuli also restrict oviposition, suggesting that the real host range for oviposition may be narrower than that expected from laboratory assessments based on olfactory responses of female moths.	[Luo, Zhixin] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Honda, Hiroshi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Honda, H (reprint author), Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	honda.hiroshi.ew@u.tsukuba.ac.jp					Calatayud PA, 2008, ENTOMOL EXP APPL, V126, P233, DOI 10.1111/j.1570-7458.2007.00660.x; Tasin M, 2006, NATURWISSENSCHAFTEN, V93, P141, DOI 10.1007/s00114-005-0077-7; Bengtsson M, 2006, ENTOMOL EXP APPL, V118, P77, DOI 10.1111/j.1570-7458.2006.00359.x; Tasin M, 2011, CHEM SENSES, V36, P633, DOI 10.1093/chemse/bjr027; HONDA H, 1979, APPL ENTOMOL ZOOL, V14, P464; Myers CT, 2006, J ECON ENTOMOL, V99, P349; Goyret J, 2007, J EXP BIOL, V210, P1398, DOI 10.1242/jeb.02752; [Anonymous], 2006, MAJOR INSECT OTHER P, P354; Proffit M, 2011, J CHEM ECOL, V37, P565, DOI 10.1007/s10886-011-9961-0; JEFFRIES MJ, 1984, BIOL J LINN SOC, V23, P269, DOI 10.1111/j.1095-8312.1984.tb00145.x; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; RAMASWAMY SB, 1988, J INSECT PHYSIOL, V34, P235, DOI 10.1016/0022-1910(88)90054-6; Xiao W, 2012, J CHEM ECOL, V38, P1143, DOI 10.1007/s10886-012-0176-9; Anfora G, 2009, J CHEM ECOL, V35, P1054, DOI 10.1007/s10886-009-9686-5; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121; Baur R, 1998, PHYSIOL ENTOMOL, V23, P7, DOI 10.1046/j.1365-3032.1998.2310007.x; Bernays EA, 1994, HOST PLANT SELECTION, P97; Brevault T, 2009, ENTOMOL EXP APPL, V133, P165, DOI 10.1111/j.1570-7458.2009.00913.x; Brevault T, 2010, J CHEM ECOL, V36, P249, DOI 10.1007/s10886-010-9766-6; Calatayud PA, 2008, ENTOMOL EXP APPL, V129, P348, DOI 10.1111/j.1570-7458.2008.00787.x; Foster SP, 1997, ENTOMOL EXP APPL, V83, P147, DOI 10.1046/j.1570-7458.1997.00167.x; Galanihe LD, 1997, J CHEM ECOL, V23, P2639, DOI 10.1023/A:1022546506965; GUPTA P. D., 1960, ENT EXPTL ET APPL, V3, P241; Heinz CA, 2008, ENTOMOL EXP APPL, V128, P265, DOI 10.1111/j.1570-7458.2008.00717.x; HONDA H, 1984, JPN J APPL ENTOMOL Z, V28, P82; Inoue Hiroshi, 2006, Tinea, V19, P80; KANEKO J, 1978, APPL ENTOMOL ZOOL, V13, P131; Kimura T, 2002, THESIS U TSUKUBA TSU; Kondo A, 2008, JPN J APPL ENTOMOL Z, V50, P35; KONNO Y, 1982, APPL ENTOMOL ZOOL, V17, P207; Lakshminarayana M, 2005, INDIAN J PLANT PROT, V32, P216; Linn C, 2005, ENTOMOL EXP APPL, V114, P97, DOI 10.1111/j.1570-7458.2005.00222.x; Masante-Roca I, 2007, ENTOMOL EXP APPL, V122, P239, DOI 10.1111/j.1570-7458.2006.00510.x; Nava DE, 2005, ANN ENTOMOL SOC AM, V98, P409, DOI 10.1603/0013-8746(2005)098[0409:OBOSCL]2.0.CO;2; Plepys D, 2002, OIKOS, V99, P75, DOI 10.1034/j.1600-0706.2002.990108.x; Pontes WJT, 2010, PHYSIOL ENTOMOL, V35, P134, DOI 10.1111/j.1365-3032.2010.00720.x; R Development Core Team, 2010, R LANG ENV STAT COMP; Rojas JC, 2003, ENVIRON ENTOMOL, V32, P1386; Schoonhoven LM, 2005, INSECT PLANT BIOL, V2nd, P170; Schoonhoven LM, 2005, INSECT PLANT BIOL, V2nd, P157; Sekiguchi K, 1974, B IBARAKI HORT EXPT; Shinkaji N, 1969, B HORT RES STN JAP A, V8, P155; Spathe A, 2013, CHEM SENSES, V38, P147, DOI 10.1093/chemse/bjs089; TINGLE FC, 1991, J CHEM ECOL, V17, P1621, DOI 10.1007/BF00984693; Waterhouse DF, 1993, ACIAR MONOGR, V21, p[40, 49, 81]	45	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	MAY	2015	50	2					183	189		10.1007/s13355-014-0320-9		7	Entomology	Entomology	CJ5XM	WOS:000355566800005		
J	Omura, H; Yotsuzuka, S				Omura, Hisashi; Yotsuzuka, Shunsuke			Male-specific epicuticular compounds of the sulfur butterfly Colias erate poliographus (Lepidoptera: Pieridae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Colias erate poliographus; Adult butterfly; Epicuticular compounds; Male-specific compounds; Secretory organ	APHRODISIAC PHEROMONES; EURYTHEME BUTTERFLIES; MITOCHONDRIAL-DNA; SEX-PHEROMONE; PHYLOGENY	Adults of the sulfur butterfly Colias erate poliographus Motschulsky showed sexual dimorphism in their epicuticular composition, with octadecanal and hexyl myristate, palmitate, and stearate identified as male-specific compounds in 3-day-old adults. Since males of the closely related North American species Colias philodice Godart also have the 3 hexyl esters and utilize them as aphrodisiac pheromones toward conspecific females, these substances are likely to serve as pheromones for C. erate. These male-specific compounds were more abundant in wings, especially forewings, than in the body. Male wings lacked androconia but possessed characteristic intermembranous cells. These cells were present behind the base of the socket of ordinary scales and distributed from the basal to discal areas in the forewing costal region and hind wing inner-marginal region. The intermembranous cells were morphologically similar to the male-specific secretory organs of C. philodice and seemed to be the source of the male-specific compounds of C. erate. However, in the wing areas including these cells, the wing scales contained larger amounts of male-specific compounds than the wing membrane, suggesting that the male-specific compounds produced in the intermembranous cells were transferred to and disseminated from the wing scales.	[Omura, Hisashi] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Biofunct Sci & Technol, Higashihiroshima 7398528, Japan; [Yotsuzuka, Shunsuke] Hiroshima Univ, Fac Appl Biol Sci, Higashihiroshima 7398528, Japan	Omura, H (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Dept Biofunct Sci & Technol, Higashihiroshima 7398528, Japan.	homura@hiroshima-u.ac.jp					Andersson J, 2007, J EXP BIOL, V210, P964, DOI 10.1242/jeb.02726; Hall JPW, 2002, ZOOL J LINN SOC-LOND, V136, P171, DOI 10.1046/j.1096-3642.2002.00003.x; Shimizu N, 2012, J CHEM ECOL, V38, P23, DOI 10.1007/s10886-012-0063-4; Brunton CFA, 1998, HEREDITY, V80, P611; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Andersson J, 2003, J CHEM ECOL, V29, P1489, DOI 10.1023/A:1024277823101; Ginzel MD, 2006, J CHEM ECOL, V32, P435, DOI 10.1007/s10886-005-9010-y; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P19, DOI 10.1017/CBO9780511711909.003; BUCKNER JS, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P227; GRULA JW, 1980, J CHEM ECOL, V6, P241, DOI 10.1007/BF00987543; Guedot C, 2009, J CHEM ECOL, V35, P1437, DOI 10.1007/s10886-009-9725-2; JUAREZ P, 1993, COMP BIOCHEM PHYS B, V106, P667, DOI 10.1016/0305-0491(93)90147-W; Kristensen NP, 2003, HDB ZOOLOGIE, V2, P9; Miller L. D., 1969, J. Res. Lepid., V8, P37; Nieberding CM, 2012, ECOL LETT, V15, P414; Omura H, 2015, ENTOMOL SCI IN PRESS; Pollock DD, 1998, ANN ENTOMOL SOC AM, V91, P524; RUTOWSKI RL, 1980, J CHEM ECOL, V6, P13, DOI 10.1007/BF00987523; RUTOWSKI RL, 1977, J COMP PHYSIOL, V115, P75; Rutowski RL, 2007, BIOL J LINN SOC, V90, P349, DOI 10.1111/j.1095-8312.2007.00749.x; SAPPINGTON TW, 1990, J CHEM ECOL, V16, P2771, DOI 10.1007/BF00988085; SAPPINGTON TW, 1990, P NATL ACAD SCI USA, V87, P6132, DOI 10.1073/pnas.87.16.6132; Sielberglied RE, 1973, NATURE, V241, P406; Sielberglied RE, 1978, BEHAV ECOL SOCIOBIOL, V3, P203; Vetter R.S., 1978, Psyche (Cambridge), V85, P383, DOI 10.1155/1978/78397; VANEWRIGHT RI, 1993, PHILOS T ROY SOC B, V340, P197, DOI 10.1098/rstb.1993.0058; Warren B. C. S., 1961, Entomologisk Tidskrift Lund, V82, P121; Wheat CW, 2005, CAN J ZOOL, V83, P1614, DOI 10.1139/Z05-159; Wheat CW, 2008, MOL PHYLOGENET EVOL, V47, P893, DOI 10.1016/j.ympev.2008.03.013; Yildizhan S, 2009, CHEMBIOCHEM, V10, P1666, DOI 10.1002/cbic.200900183	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	MAY	2015	50	2					191	199		10.1007/s13355-015-0321-3		9	Entomology	Entomology	CJ5XM	WOS:000355566800006		
J	Ohta, I; Takeda, M				Ohta, Izumi; Takeda, Mitsuyoshi			Acute toxicities of 42 pesticides used for green peppers to an aphid parasitoid, Aphidius gifuensis (Hymenoptera: Braconidae), in adult and mummy stages	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Aphidius gifuensis; Pesticide; Acute toxicity; Adult; Mummy	IPM	Acute toxicities of 42 pesticides to adult stage Aphidius gifuensis Ashmead were studied in the laboratory. Adult parasitoids were brought into contact with pesticide residues on glass plates, and the resultant mortalities were measured. Abamectin, chlorfenapyr, emamectin benzoate, malathion, nitenpyram, permethrin and spinosad caused 100 % mortality against the parasitoids and were categorized as seriously harmful based on the IOBC/WPRS guideline. Chlotianidin, dinotefran, imidacloprid, lepimectin, pyridaben, thiamethoxam and tolfenpyrad also had harmful effects on A. gifuensis adults with mortalities ranging from 30 to 99 %. Sitobion akebiae (Shinji) aphids mummified by A. gifuensis were dipped into 14 pesticide solutions, and the emergence of A. gifuensis adults was observed. Abamectin, malathion, thiamethoxam and tolfenpyrad had harmful effects on mummy stage A. gifuensis with mortalities >30 %.	[Ohta, Izumi; Takeda, Mitsuyoshi] Natl Agr Res Org, NARO Inst Vegetable & Tea Sci, Tsu, Mie 5142392, Japan	Ohta, I (reprint author), Natl Agr Res Org, NARO Inst Vegetable & Tea Sci, 360 Kusawa, Tsu, Mie 5142392, Japan.	ohtaiz@affrc.go.jp			Scientific Technique Research Promotion Program for Agriculture, Forestry, Fisheries; Food Industry	We thank Dr. K. Kohno (NARO Institute of Vegetable Tea Science) for reviewing an early draft. This work was supported by the Scientific Technique Research Promotion Program for Agriculture, Forestry, Fisheries and the Food Industry (Development of mass reproduction techniques of Aphidius gifuensis and its application to control vegetable pest aphids).	Amano H, 2001, APPL ENTOMOL ZOOL, V36, P1, DOI 10.1303/aez.2001.1; Ohta I, 2010, APPL ENTOMOL ZOOL, V45, P233, DOI 10.1303/aez.2010.233; Longley M, 1999, INT J PEST MANAGE, V45, P139, DOI 10.1080/096708799227932; Abbott WS, 1925, J ECON ENTOMOL, V18, P265; BLUMEL S, 1999, DEV PLANT PATHOL, V14, P150; Croft BA, 1990, ARTHROPOD BIOL CONTR; HASSAN SA, 1987, J APPL ENTOMOL, V103, P92; Kim Jin-Ju, 2006, Korean Journal of Applied Entomology, V45, P217; Kobori Y, 2004, APPL ENTOMOL ZOOL, V39, P255, DOI 10.1303/aez.2004.255; Mead-Briggs M., 1992, Aspects of Applied Biology, V31, P179; Ohta I, 2014, TECHNICAL MANUAL BAN, P41; Takada H, 2000, BIOL APHIDS, P139	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	MAY	2015	50	2					207	212		10.1007/s13355-015-0323-1		6	Entomology	Entomology	CJ5XM	WOS:000355566800008		
J	Ido, A; Iwai, T; Ito, K; Ohta, T; Mizushige, T; Kishida, T; Miura, C; Miura, T				Ido, Atsushi; Iwai, Toshiharu; Ito, Katsutoshi; Ohta, Takashi; Mizushige, Takafumi; Kishida, Taro; Miura, Chiemi; Miura, Takeshi			Dietary effects of housefly (Musca domestica) (Diptera: Muscidae) pupae on the growth performance and the resistance against bacterial pathogen in red sea bream (Pagrus major) (Perciformes: Sparidae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Housefly (Musca domestica); Red sea bream (Pagrus major); Growth performance; Immunostimulation; Cholesterol reduction	METABOLIC RISK-FACTORS; SPARUS-AURATA L.; CARDIOVASCULAR-DISEASE; CHOLESTEROL ABSORPTION; ANTIFUNGAL PEPTIDE; FEEDING STIMULANTS; ATLANTIC SALMON; IMMUNE-RESPONSE; SOYBEAN-MEAL; EXTRACT	Insects are attracting increasing worldwide attention as living organisms that produce various useful substances. Although a wide variety of bioactive substances have been identified in insects, there has been little study of the dietary effects of insects that contain these useful substances. In our present study, we describe the dietary effects of housefly [Musca domestica (Linnaeus)] pupae in the red sea bream [Pagrus major (Temminck and Schlegel)]. The addition of low levels of housefly pupae to the diets of these fish caused significant increases in fork length and body weight and produced a marked improvement in feed conversion after 24 days of feeding. Furthermore, the results of 6-month feeding trials revealed that low dietary levels of housefly pupae promote growth performance in the red sea bream. We further found that dietary housefly pupae significantly enhance the peritoneal leukocyte phagocytic activity in the red sea bream and provides increased protection against a lethal challenge from a major pathogen in this species, Edwardsiella tarda (Ewing et al). We also show that housefly pupae dietary supplements do not negatively affect the health of rats [Rattus norvegicus (Berkenhout)]. Our current results indicate the great potential of insects as functional feed sources for farmed fish.	[Ido, Atsushi; Iwai, Toshiharu; Ohta, Takashi; Miura, Chiemi; Miura, Takeshi] Ehime Univ, South Ehime Fisheries Res Ctr, Ainan, Ehime 7984292, Japan; [Ito, Katsutoshi] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Hiroshima 7390452, Japan; [Mizushige, Takafumi] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Uji, Kyoto 6110011, Japan; [Kishida, Taro] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan	Miura, T (reprint author), Ehime Univ, South Ehime Fisheries Res Ctr, 1289-1 Funakoshi, Ainan, Ehime 7984292, Japan.	miutake@agr.ehime-u.ac.jp			A-step start-up venture program from the Japan Science and Technology Agency; Japan Society for the Promotion of Science	We thank Dr. Fritzie T. Celino, University of Washington, for her critical reading of the manuscript. We also thank Abies Co., Ltd., for producing the housefly pupae. This work was supported by an A-step start-up venture program from the Japan Science and Technology Agency and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Akiyama N, 2000, ANTICANCER RES, V20, P357; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Hirose Y, 2013, J NAT PROD, V76, P554, DOI 10.1021/np300713c; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; MAEDA S, 1985, NATURE, V315, P592, DOI 10.1038/315592a0; Esteban MA, 2001, FISH SHELLFISH IMMUN, V11, P303, DOI 10.1006/fsim.2000.0315; Kramer KJ, 1995, INSECT BIOCHEM MOLEC, V25, P1067, DOI 10.1016/0965-1748(95)00053-4; FUKE S, 1981, B JPN SOC SCI FISH, V47, P1631; Kasumyan AO, 2003, FISH FISH, V4, P289, DOI 10.1046/j.1467-2979.2003.00121.x; KELLERT SR, 1993, CONSERV BIOL, V7, P845, DOI 10.1046/j.1523-1739.1993.740845.x; Kris-Etherton PM, 1999, AM J CLIN NUTR, V70, P1009; Feng X, 2010, J ETHNOPHARMACOL, V130, P586, DOI 10.1016/j.jep.2010.05.044; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; St-Hilaire S, 2007, J WORLD AQUACULT SOC, V38, P59, DOI 10.1111/j.1749-7345.2006.00073.x; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Schuhmann B, 2003, ARCH INSECT BIOCHEM, V53, P125, DOI 10.1002/arch.10091; Swain P, 2008, FISH SHELLFISH IMMUN, V25, P191, DOI 10.1016/j.fsi.2008.04.009; Selvaraj V, 2006, VET IMMUNOL IMMUNOP, V114, P15, DOI 10.1016/j.vetimm.2006.06.011; Hou LX, 2007, J ETHNOPHARMACOL, V111, P227, DOI 10.1016/j.jep.2006.11.015; GOH Y, 1980, COMP BIOCHEM PHYS C, V66, P225, DOI 10.1016/0306-4492(80)90131-8; Baeverfjord G, 1996, J FISH DIS, V19, P375, DOI 10.1111/j.1365-2761.1996.tb00376.x; Hwangbo J, 2009, J ENVIRON BIOL, V30, P609; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Bricknell I, 2005, FISH SHELLFISH IMMUN, V19, P457, DOI 10.1016/j.fsi.2005.03.008; Chernysh S, 2002, P NATL ACAD SCI USA, V99, P12628, DOI 10.1073/pnas.192301899; Fu P, 2009, CELL MOL IMMUNOL, V6, P245, DOI 10.1038/cmi.2009.33; BARANYOVITS FLC, 1978, ENDEAVOUR, V2, P85, DOI 10.1016/0160-9327(78)90061-3; ELBOUSHY AR, 1991, BIORESOURCE TECHNOL, V38, P45, DOI 10.1016/0960-8524(91)90220-E; Esteban MA, 2000, FISH SHELLFISH IMMUN, V10, P543, DOI 10.1006/fsim.2000.0271; Furutani T, 2012, FISHERIES SCI, V78, P1075, DOI 10.1007/s12562-012-0537-x; Heek MV, 2009, BRIT J PHARMACOL, V134, P409; Hidaka I, 2000, AQUACULTURE, V181, P115, DOI 10.1016/S0044-8486(99)00221-5; Huis A. V., 2013, 171 FAO; IKEDA I, 1988, J LIPID RES, V29, P1573; Imamura M, 1999, ARCH INSECT BIOCHEM, V40, P88, DOI 10.1002/(SICI)1520-6327(1999)40:2<88::AID-ARCH3>3.0.CO;2-B; Kishida T, 2006, BIOSCI BIOTECH BIOCH, V70, P1547, DOI 10.1271/bbb.50008; KUSUDA R, 1988, NIPPON SUISAN GAKK, V54, P2065; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Mohanty B R, 2007, J Biosci, V32, P1331, DOI 10.1007/s12038-007-0143-8; Nicklas BJ, 2003, DIABETES CARE, V26, P1413, DOI 10.2337/diacare.26.5.1413; Ohta T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114823; Takeda M, 1984, NIPPON SUISAN GAKK, V59, P645; Téguia A., 2002, Tropicultura, V20, P187; Yang Ping, 2004, Journal of Insect Biotechnology and Sericology, V73, P7; ZACOUR AC, 1992, J NUTR SCI VITAMINOL, V38, P609	46	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	MAY	2015	50	2					213	221		10.1007/s13355-015-0325-z		9	Entomology	Entomology	CJ5XM	WOS:000355566800009		
J	Hosokawa, T; Koga, R; Tanaka, K; Moriyama, M; Anbutsu, H; Fukatsu, T				Hosokawa, Takahiro; Koga, Ryuichi; Tanaka, Kohjiro; Moriyama, Minoru; Anbutsu, Hisashi; Fukatsu, Takema			Nardonella endosymbionts of Japanese pest and non-pest weevils (Coleoptera: Curculionidae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Curculionidae; Nardonella; Bacteriome; Symbiosis; Coevolution	DRYOPHTHORIDAE WEEVILS; DIVERSITY; POPULATIONS; DIVERSIFICATION; REPLACEMENT; MANAGEMENT; SYMBIOSIS; PLANTS	Many weevils are known as notorious devastating agricultural pests and generally associated with symbiotic bacteria. Here, we investigated the following pest and non-pest weevils collected in Japan for their bacterial associates: the banana stem weevil Odoiporus longicollis (Olivier); the Asiatic palm weevil Rhabdoscelus lineaticollis (Heller); the red palm weevil Rhynchophorus ferrugineus (Olivier); the Japanese giant weevil Sipalinus gigas (Fabricius); the olive weevil Pimelocerus perforatus (Roelofs); the black hard weevil Pachyrhynchus infernalis Fairmaire; and the Yonaguni hard weevil Metapocyrtus yonagunianus Chujo. Bacterial 16S rRNA gene was amplified by a polymerase chain reaction (PCR) from all the weevils, and genotyping and sequencing of the PCR products revealed that Nardonella, an ancient weevil-associated endosymbiont lineage, is the dominant bacterial associate for them. Molecular phylogenetic analyses based on bacterial 16S rRNA and groEL gene sequences showed that the weevil endosymbionts are placed within the Nardonella clade in the gamma-Proteobacteria. The phylogenetic relationship of the Nardonella endosymbionts was concordant with the systematics of the weevil hosts, favoring the hypothesis of weevil-Nardonella co-speciation over evolutionary time. In situ hybridization visualized localization of the Nardonella endosymbionts in the larval bacteriome at the foregutmidgut junction in R. ferrugineus and S. gigas, and in the ovarial tips of adult females in O. longicollis. Our results highlight the general relevance of the Nardonella endosymbionts to the biology, control and management of these and other pest weevils.	[Hosokawa, Takahiro; Koga, Ryuichi; Tanaka, Kohjiro; Moriyama, Minoru; Anbutsu, Hisashi; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan; [Hosokawa, Takahiro] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan; [Tanaka, Kohjiro] Fuji Environm Serv Co Ltd, Shizuoka 4228046, Japan	Fukatsu, T (reprint author), Natl Inst Adv Ind Sci & Technol, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	t-fukatsu@aist.go.jp			Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); JSPS KAKENHI grant [22128007]; JSPS Fellowship for Young Scientists	We thank Toshihide Ichikawa, Aya Kobayashi, Tsuguo Kohama, Katsunori Nakamura, Takumi Uesato and Yousuke Usui for weevil samples, and Junko Makino and Wakana Kikuchi for technical and secretarial assistance. This study was supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) and by the JSPS KAKENHI grant (22128007) to T.F. The JSPS Fellowship for Young Scientists supported M.M.	Alonso-Zarazaga M.A., 1999, WORLD CATALOGUE FAMI; Aman Nobuhiko, 2000, Kyushu Byogaichu Kenkyukaiho, V46, P127; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Fukatsu T, 1999, MOL ECOL, V8, P1935, DOI 10.1046/j.1365-294x.1999.00795.x; McKenna DD, 2009, P NATL ACAD SCI USA, V106, P7083, DOI 10.1073/pnas.0810618106; Oberprieler RG, 2007, ZOOTAXA, P491; Faleiro J. R., 2006, International Journal of Tropical Insect Science, V26, P135, DOI 10.1079/IJT2006113; Fukatsu T, 1998, APPL ENVIRON MICROB, V64, P3599; Koga R, 2009, APPL ENTOMOL ZOOL, V44, P281, DOI 10.1303/aez.2009.281; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Oakeson KF, 2014, GENOME BIOL EVOL, V6, P76, DOI 10.1093/gbe/evt210; Conord C, 2008, MOL BIOL EVOL, V25, P859, DOI 10.1093/molbev/msn027; Toju H, 2011, MOL ECOL, V20, P853, DOI 10.1111/j.1365-294X.2010.04980.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Toju H, 2013, ISME J, V7, P1378, DOI 10.1038/ismej.2013.27; Buchner P, 1965, ENDOSYMBIOSIS ANIMAL; Gold Clifford S., 2002, Integrated Pest Management Reviews, V6, P79, DOI 10.1023/A:1023330900707; Heddi A, 2005, SYMBIOSIS, V39, P1; Hirsch J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S6; Hosokawa T, 2010, APPL ENTOMOL ZOOL, V45, P115, DOI 10.1303/aez.2010.115; ICHIKAWA T, 1987, JPN J APPL ENTOMOL Z, V31, P6; Kinjo Tsuneo, 1995, Proceedings of the Association for Plant Protection of Kyushu, V41, P81; Kohama T, 2002, B OKINAWA PREF MUS, V28, P55; Kuba H., 2000, PLANT PROT, V54, P483; Kuriwada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013101; Lefevre C, 2004, MOL BIOL EVOL, V21, P965, DOI 10.1093/molbev/msh063; Merville A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-28; Nardon P, 2002, SYMBIOSIS, V33, P227; Okada M., 2008, Journal of the Japanese Forest Society, V90, P306, DOI 10.4005/jjfs.90.306; Oshiro Y, 1991, OKINAWA AGR, V26, P19; OSTMARK HE, 1974, ANNU REV ENTOMOL, V19, P161, DOI 10.1146/annurev.en.19.010174.001113; Radcliffe E. B., 1998, Integrated Pest Management Reviews, V3, P225, DOI 10.1023/A:1009611219360; Rinke R, 2011, GENET MOL RES, V10, P2679, DOI 10.4238/2011.November.1.1; Smith JW, 1998, ANN ENTOMOL SOC AM, V91, P239; Toju H, 2010, APPL ENVIRON MICROB, V76, P275, DOI 10.1128/AEM.02154-09; Yasuda K., 1998, B OKINAWA AGR EXP ST, V21, P1	38	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	MAY	2015	50	2					223	229		10.1007/s13355-015-0326-y		7	Entomology	Entomology	CJ5XM	WOS:000355566800010		
J	Izumi, Y; Tian, RL; Sonoda, S; Imayoshi, Y; Iwabuchi, H; Miyashita, Y; Kanazaki, S; Tsumuki, H				Izumi, Yohei; Tian, Ruilin; Sonoda, Shoji; Imayoshi, Yuriko; Iwabuchi, Hisakatsu; Miyashita, Yuji; Kanazaki, Shuji; Tsumuki, Hisaaki			Analysis of peach fruit headspace volatiles and response by the fruit-piercing moth Oraesia excavata (Lepidoptera: Noctuidae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						'Hakutou' peach; Oraesia excavata; EAG; Ethyl acetate; Ethyl butanoate; Lactone	BUTLER LEPIDOPTERA; FIELD ATTRACTION; CODLING MOTH; APPLE; IDENTIFICATION	The fruit-piercing moth Oraesia excavata (Butler) only attacks ripe as opposed to immature peach fruits. The moth putatively uses volatile emissions from ripe peach fruits as a cue for food orientation. The volatiles emitted by 'Hakutou' peach (Prunus persica L.) fruit during maturation were analyzed by headspace solid-phase microextraction followed by gas chromatography and mass spectrometry. Although seven compounds increased remarkably during maturation, among them, only ethyl acetate and ethyl butanoate elicited electroantennographic responses. During a field-trap test, traps baited with both compounds captured moths, but significantly fewer moths were captured by the traps as compared to peach fruit. However, traps baited with a mixture of both compounds and lactones peculiar to ripe peach fruits captured more moths than did traps with ripe peach fruits only. The results of a seasonal survey using this mixture as an attractant suggest that seasonal forecasting of the fruit-piercing moth is possible.	[Izumi, Yohei; Tian, Ruilin; Sonoda, Shoji; Tsumuki, Hisaaki] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan; [Izumi, Yohei] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan; [Imayoshi, Yuriko; Iwabuchi, Hisakatsu] San Ei Gen FFI Inc, Osaka 5618588, Japan; [Miyashita, Yuji; Kanazaki, Shuji] Ehime Res Inst Agr Forestry & Fisheries, Fruit Tree Res Ctr, Matsuyama, Ehime 7910112, Japan	Izumi, Y (reprint author), Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan.	yohei@life.shimane-u.ac.jp			Ohara Foundation for Agricultural Research	This study was supported in part by a Grant-in-Aid for a Research Project utilizing Advanced Technologies in Agriculture, Forestry and Fisheries and by a grant from the Ohara Foundation for Agricultural Research.	WERKHOFF P, 1993, Z LEBENSM UNTERS FOR, V196, P307, DOI 10.1007/BF01197930; Hern A, 2001, PHYTOCHEMISTRY, V57, P409, DOI 10.1016/S0031-9422(01)00058-9; Fraser AM, 2003, J CHEM ECOL, V29, P1813, DOI 10.1023/A:1024898127549; HORVAT RJ, 1990, J AGR FOOD CHEM, V38, P234, DOI 10.1021/jf00091a051; Landolt PJ, 2008, ANN ENTOMOL SOC AM, V101, P675, DOI 10.1603/0013-8746(2008)101[675:FAOCML]2.0.CO;2; Natale D, 2004, J APPL ENTOMOL, V128, P22, DOI 10.1046/j.1439-0418.2003.00802.x; BERNREUTHER A, 1989, J CHROMATOGR, V481, P363, DOI 10.1016/S0021-9673(01)96780-9; Derail C, 1999, J AGR FOOD CHEM, V47, P4742, DOI 10.1021/jf990459g; Hern A, 2004, NATURWISSENSCHAFTEN, V91, P77, DOI 10.1007/s00114-003-0484-6; JENNINGS WG, 1964, J FOOD SCI, V29, P796, DOI 10.1111/j.1365-2621.1964.tb00450.x; Kohno M, 1962, RES CONTROL FRUIT PI, P81; MIYAZAKI A, 1972, Japanese Journal of Applied Entomology and Zoology, V16, P40; Muniappan R., 1995, Chemoecology, V5/6, P75; Nijssen L. M., 1963, VCF VOLATILE COMPOUN; NIST Mass Spec Data Center, 2011, NIST STANDARD REFERE, V69; Nomura K, 1962, RES CONTROL FRUIT PI, P19; Ogihara H, 1997, B EHIME FRUIT TREE E, P58; OHMASA Y, 1991, APPL ENTOMOL ZOOL, V26, P55; Omori H, 1962, RES CONTROL FRUIT PI, P65; PARK C G, 1988, Korean Journal of Applied Entomology, V27, P111; PIVNICK KA, 1994, J CHEM ECOL, V20, P1407, DOI 10.1007/BF02059870; Saito T, 1970, CONTROL INSECT BEHAV, P225; SPENCER MD, 1978, J AGR FOOD CHEM, V26, P725, DOI 10.1021/jf60217a052; Tian R, 2007, APPL ENTOMOL ZOOL, V42, P433, DOI 10.1303/aez.2007.433; Tian RL, 2008, APPL ENTOMOL ZOOL, V43, P265, DOI 10.1303/aez.2008.265; Uchida M, 1978, B TOTTORI TREE FRUIT, V8, P1; vanLoon JJA, 1996, ENTOMOL EXP APPL, V80, P7	27	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	MAY	2015	50	2					231	238		10.1007/s13355-015-0330-2		8	Entomology	Entomology	CJ5XM	WOS:000355566800011		
J	Tsurui, K; Ohishi, T; Kumano, N; Teruya, K; Toyosato, T; Shiromoto, K				Tsurui, Kaori; Ohishi, Tsuyoshi; Kumano, Norikuni; Teruya, Kiyohito; Toyosato, Tetsuya; Shiromoto, Keiko			Symptoms shown by late-stage larvae of the West Indian sweet potato weevil Euscepes postfasciatus (Coleoptera: Curculionidae) infected with Farinocystis sp (Neogregarinida: Lipotrophidae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Euscepes postfasciatus; Neogregarine Farinocystis sp.; Morphological symptoms; Body size; Sterile insect techniques (SIT)	FIELD-CAGE TESTS; MATTESIA GRANDIS; BOLL-WEEVIL; FEEDING STIMULANT; ARTIFICIAL DIET; BAIT PRINCIPLE; INSECTS; PARASITE; DISPORA	Pathogen outbreaks often represent a major issue when mass rearing target insects for biological control, even when applying sterile insect techniques (SIT). Here, we aimed to improve existing screening techniques used to detect a neogregarine Farinocystis sp. that infects the West Indian sweet potato weevil Euscepes postfasciatus Fairmaire (Coleoptera: Curculionidae) mass reared under the SIT program. Our results revealed that infected lateinstar larvae exhibited swelling symptoms, and that their body weight and head width significantly increased compared to uninfected larvae. The head width to body weight ratio differed between infected and uninfected larvae; yet, head width was highly correlated with body weight in both cases. Visual diagnosis based on the appearance of the late-instar larvae showed concordance of almost 90 % with the current diagnostic methods of optical microscopy and PCR. Thus, the swelling symptoms observed in late-instar larvae were directly noticeable. Therefore, visual diagnosis, based on larval appearance, represents a feasible, low-cost technique for the early detection of Farinocystis sp. infection of the West Indian sweet potato weevil.	[Tsurui, Kaori; Ohishi, Tsuyoshi; Kumano, Norikuni; Teruya, Kiyohito; Toyosato, Tetsuya; Shiromoto, Keiko] Okinawa Prefectural Plant Protect Ctr, Naha, Okinawa 9020072, Japan; [Tsurui, Kaori; Kumano, Norikuni; Toyosato, Tetsuya; Shiromoto, Keiko] Ryukyu Sankei Co Ltd, Tomigusuku, Okinawa 9010242, Japan; [Tsurui, Kaori; Kumano, Norikuni] Univ Ryukyus, Grad Sch Agr, Entomol Lab, Nishihara, Okinawa 9030213, Japan	Tsurui, K (reprint author), Okinawa Prefectural Plant Protect Ctr, 123 Maji, Naha, Okinawa 9020072, Japan.	tsuruikaori@gmail.com			JSPS KAKENHI [26450067]	We thank the staff of the Okinawa Prefectural Plant Protection Center and Ryukyu Sankei Co. Ltd. for their assistance with insect rearing and sampling. This work was partly supported by JSPS KAKENHI Grant Number 26450067 to N.K.	Altizer SM, 1999, J INVERTEBR PATHOL, V74, P76, DOI 10.1006/jipa.1999.4853; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459; Esperk T, 2007, J ECON ENTOMOL, V100, P627, DOI 10.1603/0022-0493(2007)100[627:IVINOL]2.0.CO;2; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; BURKHOLDER WE, 1964, J ECON ENTOMOL, V57, P818; COWLEY JM, 1989, J INVERTEBR PATHOL, V53, P159, DOI 10.1016/0022-2011(89)90003-7; GAST RT, 1966, J ECON ENTOMOL, V59, P793; James RR, 2012, INSECT PATHOLOGY, 2ND EDITION, P425, DOI 10.1016/B978-0-12-384984-7.00012-9; Jouvenaz D, 2007, J EUKARYOT MICROBIOL, V26, P354; Knipling EF, 1979, BASIC PRINCIPLES INS; Kuba H, 2003, P NIAES FFTC JOINT I, P273; Kumano N, 2014, JPN J APPL ENTOMOL Z, V58, P217, DOI 10.1303/jjaez.2014.217; Kumano N, 2010, J INVERTEBR PATHOL, V105, P298, DOI 10.1016/j.jip.2010.08.003; Lange CE, 2012, INSECT PATHOLOGY, 2ND EDITION, P367, DOI 10.1016/B978-0-12-384984-7.00010-5; MCLAUGHL.RE, 1967, J INVERTEBR PATHOL, V9, P70, DOI 10.1016/0022-2011(67)90045-6; MCLAUGHL.RE, 1968, J INVERTEBR PATHOL, V12, P168, DOI 10.1016/0022-2011(68)90173-0; MCLAUGHL.RE, 1966, J ECON ENTOMOL, V59, P909; MCLAUGHL.RE, 1965, J INVERTEBR PATHOL, V7, P464, DOI 10.1016/0022-2011(65)90123-0; Morita C., 2007, ENTOMOTECH, V31, P17; Morita C., 2009, ENTOMOTECH, V33, P27; Moriya S, 1997, B OKINAWA AGR EXP ST, V18, P19; Munster-Swendsen M, 2008, ECOL ENTOMOL, V16, P211; Nakamura T, 2011, JPN J APPL ENTOMOL Z, V55, P1, DOI 10.1303/jjaez.2011.1; Niimi H., 2011, ENTOMOTECH, V35, P9; Ohno Suguru, 2008, Japanese Journal of Entomology (New Series), V11, P169; Ohno S, 2006, NAT INSECTS, V41, P25; Okinawa Prefectural Government Department of Agriculture Forestry and Fisheries, 2014, ANN REP ER PROGR DES; R Core Team, 2013, R LANG ENV STAT COMP; RABINDRA RJ, 1981, J INVERTEBR PATHOL, V38, P345, DOI 10.1016/0022-2011(81)90100-2; Raman K.V., 1991, P263; Sherman M, 1954, HAWAII AGR EXPT STAT, V23, P1; Shimoji Y, 2003, J OKINAWA AGR, V67, P61; Sikorowski PP, 1984, B WEEVIL MASS REARIN; Sorensen JG, 2012, CROP PROT, V38, P87, DOI 10.1016/j.cropro.2012.03.023; Tanada Y., 1993, INSECT PATHOLOGY; Urasaki K, 2009, JPN J APPL ENTOMOL Z, V53, P1, DOI 10.1303/jjaez.2009.1; Valigurova A, 2006, EUR J PROTISTOL, V42, P313, DOI 10.1016/j.ejop.2006.07.007; Weiser J, 1953, VESTNIK CSL ZOOLOG S, V17, P199; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554; Yamagishi M., 2000, PLANT PROT, V54, P476; Yasuda Keiji, 1990, Proceedings of the Association for Plant Protection of Kyushu, V36, P123; Zuur A., 2009, MIXED EFFECTS MODELS	42	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	MAY	2015	50	2					245	254		10.1007/s13355-015-0329-8		10	Entomology	Entomology	CJ5XM	WOS:000355566800013		
J	Abe, N; Matsuzaki, M; Wada, K; Nakano, A; Sato, E; Hattori, G; Toyota, K				Abe, Naruhito; Matsuzaki, Masanori; Wada, Kentaro; Nakano, Akio; Sato, Erika; Hattori, Gen; Toyota, Koki			Influence of nematicide on the damage caused by Meloidogyne incognita (Tylenchida: Meloidogynidae) to sweet potato in sandy fields in northeastern Tokushima Prefecture	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Economic threshold; Meloidogyne incognita; Real-time PCR; Sandy fields; Sweet potato	REAL-TIME PCR; QUANTITATIVE DETECTION METHOD; HOST-PARASITE RELATIONSHIPS; PRATYLENCHUS-PENETRANS; SOIL COMPACTION; PATHOGENICITY; JUVENILES; JAVANICA; DENSITY; RADISH	Nematicides, especially 1,3-dichloropropene (D-D), are empirically used to control damage caused by the root-knot nematode Meloidogyne incognita (Kofoid and White) Chitwood in fields of sandy soils in northeast Tokushima, a major sweet potato (Ipomoea batatas (L.) Lam.) producing area. The objective of this study was to elucidate an economic threshold against the nematode damage. Relationship between the nematode density before nematicide use and the degree of nematode damage at harvest was evaluated in nematicide-treated and non-treated plots. There was a significant correlation between the pre-plant nematode densities and nematode damage in the nematicide non-treated plots. Marketable quality of sweet potato decreased in four out of 16 in the non-treated plots, while it did not decrease in all 11 nematicide non-treated plots in which the pre-plant nematode densities were less than 100 second-stage juveniles (J2) equivalent 20 g(-1) of soil, estimated using a real-time PCR method, suggesting that this density is an economic threshold for damage by root-knot nematodes to sweet potato. The present study demonstrates that nematicides can be avoided in fields containing root-knot nematodes at densities less than the economic threshold.	[Abe, Naruhito; Matsuzaki, Masanori; Wada, Kentaro; Nakano, Akio] Tokushima Agr Forestry & Fisheries Technol Suppor, Tokushima 7793233, Japan; [Sato, Erika] NARO Western Reg Agr Res Ctr, Ayabe, Kyoto 6230035, Japan; [Hattori, Gen] Designer Foods Co Ltd, Chikusa Ku, Nagoya, Aichi 4640858, Japan; [Toyota, Koki] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan	Sato, E (reprint author), NARO Western Reg Agr Res Ctr, 200 Ueno,Uenocho, Ayabe, Kyoto 6230035, Japan.	erikasato@affrc.go.jp			Agriculture Forestry and Fisheries [21008]	We thank farmers in Naruto city, Matsushige-cho, and Kawauchi-cho, Tokushima Prefecture for providing soil and sweet potato samples, and also Mr. T. Iwamoto, NARO Western Region Agriculture Research Center, and Mr. Y Shakutani, Ms. M Sadachi, Mr. S Kamada, Ms. S Maeda, Mr. K Gotoda and Ms. M Inoue, Tokushima Agriculture Forestry and Fisheries Technology Support Centre, for assistance in soil sampling. The work was supported by a research and development project for application in promoting a new policy of Agriculture Forestry and Fisheries (21008).	den Nijs L, 2013, NEMATOLOGY, V15, P143, DOI 10.1163/156854112X649954; Vovlas N, 2008, PLANT PATHOL, V57, P981, DOI 10.1111/j.1365-3059.2008.01843.x; McSorley R, 2004, APPL SOIL ECOL, V27, P55, DOI 10.1016/j.apsoil.2004.02.005; Oka Y, 2009, NEMATOLOGY, V11, P51, DOI 10.1163/156854108X398417; Vovlas N, 2005, PLANT PATHOL, V54, P657, DOI 10.1111/j.1365-3059.2005.01244.x; Di Vito M, 2004, PLANT PATHOL, V53, P508, DOI 10.1046/j.0032-0862.2004.01053.x; Goto Keita, 2009, Japanese Journal of Nematology, V39, P1; Gugino BK, 2006, J NEMATOL, V38, P483; HUANG SP, 1994, J NEMATOL, V26, P72; Ingham RE, 1994, METHODS SOIL ANAL 2, V5, P459; Kanaiso Y, 1998, TOKUSHIMA PREF AGR R, V34, P14; Koyama Y, 2013, NEMATOLOGY, V15, P851, DOI 10.1163/15685411-00002723; McSorley R, 2003, FLA ENTOMOL, V86, P138, DOI 10.1653/0015-4040(2003)086[0138:AONTEE]2.0.CO;2; Min YY, 2011, NEMATOLOGY, V13, P95, DOI 10.1163/138855410X504916; Pyrowolakis A, 2002, APPL SOIL ECOL, V19, P51, DOI 10.1016/S0929-1393(01)00170-6; Sano Z., 1988, Proceedings of the Association for Plant Protection of Kyushu, V34, P127; Sano Z., 2001, Japanese Journal of Nematology, V31, P37; Sato E, 2013, NEMATOLOGY, V15, P931, DOI 10.1163/15685411-00002731; Sato Erika, 2010, Nematological Research, V40, P1; Sato E, 2011, SOIL SCI PLANT NUTR, V57, P213, DOI 10.1080/00380768.2011.574233; Schomaker CH, 2006, PLANT NEMATOLOGY, P275, DOI 10.1079/9781845930561.0275; Suzui T, 1987, PLANT PROT, V41, P307; Toyota K, 2008, SOIL SCI PLANT NUTR, V54, P72, DOI 10.1111/j.1747-0765.2007.00212.x; Watanabe Takayoshi, 2013, Nematological Research, V43, P21; Yamada E, 1992, SENCHU KENKYU NO AYU, P297	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	MAY	2015	50	2					255	261		10.1007/s13355-015-0331-1		7	Entomology	Entomology	CJ5XM	WOS:000355566800014		
J	Nakamura, K; Takashima, K				Nakamura, Keiji; Takashima, Kazuki			Geographical variation in diapause development in eggs of Sympetrum frequens (Odonata: Libellulidae)	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						Sympetrum frequens; Egg diapause; Diapause development; Temperature; Geographical variation	TEMPERATURE; TERMINATION	Geographical differences causing variations in the egg period and the effects of environmental factors on diapause development were examined in Sympetum frequens (Selys), a univoltine species with an obligatory egg diapause for overwintering. Eggs were obtained from females collected from 11 localities in Japan and incubated under six different combinations of photoperiod and temperature. No clear geographical trends were found in the average egg period under any experimental treatment. Average hatch period (i.e., period from the date when 10 % of the eggs were hatched to the date when 90 % of the eggs were hatched) did not display any geographical trend at 25 and 20 degrees C. However, at 15 degrees C, a significant negative correlation was observed between the hatch period and the latitude of the collection site. Similarly, a significant correlation was also detected between the coefficient of variation in the egg period and the average annual temperature near the collection site, but only at 15 degrees C. Because each egg batch was divided into six groups which were then incubated under different experimental conditions, it was possible to discern that the rate of diapause development at 15 degrees C varies among eggs from southern populations. The large variations in the egg period in the southern populations at 15 degrees C were considered to be a risk-spreading strategy: a certain proportion of the eggs were able to maintain diapause until winter, even if the adults laid the eggs early in the season. These differences in the rate of diapause development within a population may be an adaptation to the unpredictable length of the summer-autumn period.	[Nakamura, Keiji; Takashima, Kazuki] Okayama Univ Sci, Fac Informat, Dept Biosphere Geosphere Syst Sci, Okayama 7000005, Japan	Nakamura, K (reprint author), Okayama Univ Sci, Fac Informat, Dept Biosphere Geosphere Syst Sci, Okayama 7000005, Japan.	nakamura@big.ous.ac.jp					Ando Y., 1983, Diapause and life cycle strategies in insects, P127; ANDREWARTHA HG, 1952, BIOL REV, V27, P50, DOI 10.1111/j.1469-185X.1952.tb01363.x; Hodek I, 2002, EUR J ENTOMOL, V99, P163; Hodek I, 1996, EUR J ENTOMOL, V93, P475; SCHOONEVELD H, 1977, J INSECT PHYSIOL, V23, P689, DOI 10.1016/0022-1910(77)90085-3; DINGLE H, 1990, OECOLOGIA, V84, P199; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Arai T, 2007, MYSTERY AKA TOMBO; Asahina S., 1984, Advances in Odonatology, V2, P1; Corbet P, 2004, DRAGONFLIES BEHAV EC; Corbet P. S., 1956, Proceedings of the Royal Entomological Society of London (A), V31, P45; Danilevsky AS, 1966, PHOTOPERIODISM SEASO; Danks HV, 1987, INSECT DORMANCY ECOL; Jinguji H, 2010, PADDY WATER ENVIRON, V8, P385, DOI 10.1007/s10333-010-0217-3; Lees AD, 1955, PHYSL DIAPAUSE ARTHR; Masaki S, 2002, EUR J ENTOMOL, V99, P143; SAWCHYN WW, 1973, CAN J ZOOL, V51, P1257, DOI 10.1139/z73-179; SCHALLER F, 1968, J INSECT PHYSIOL, V14, P1477, DOI 10.1016/0022-1910(68)90180-7; Sugimura M, 1999, DRAGONFLIES JAPANESE; Takashima K, 2014, INT J ODONATOL, V17, P81, DOI 10.1080/13887890.2014.907546; Tauber MJ, 1986, SEASONAL ADAPTATIONS; Ueda T, 1988, B ISHIKAWA AGR COLL, V18, P98; Ueda Tetsuyuki, 1993, Insectarium, V30, P292; Zar J. H., 2010, BIOSTATISTICAL ANAL	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	MAY	2015	50	2					263	270		10.1007/s13355-015-0332-0		8	Entomology	Entomology	CJ5XM	WOS:000355566800015		
J	Sugimoto, TN; Tsuchida, T				Sugimoto, T. N.; Tsuchida, T.			Simple electroporation device for gene functional analyses in insects	APPLIED ENTOMOLOGY AND ZOOLOGY			English	Article						In vivo electroporation; Somatic transformation; Bombyx mori; Ostrinia furnacalis; Ostrinia scapulalis		In vivo electroporation is a very powerful technology that enables both gain-of-function and loss-of-function analyses. However, the device required for the method is expensive. Here, we report a simple, inexpensive (under US$85), easily constructed, and one-piece electroporation device for gene functional analyses of insects. Using this simple electroporator, we successfully introduced exogenous fluorescence protein genes into three moth species. This simple low-cost electroporator will render gene function analyses accessible to many non-model insects, including pest species.	[Sugimoto, T. N.; Tsuchida, T.] Toyama Univ, Frontier Res Core Life Sci, Toyama, Toyama 9308555, Japan	Tsuchida, T (reprint author), Toyama Univ, Frontier Res Core Life Sci, 3190 Gofuku, Toyama, Toyama 9308555, Japan.	tsuchida@ctg.u-toyama.ac.jp			KAKENHI [22128007]; JSPS Research Fellowship for Young Scientists [13J10329]	We thank H. Fujiwara and H. Sezutsu for providing plasmids pPIG-A3GR and pHA3PIG, respectively; N. Konno for providing experimental equipment; Y. Ishikawa and T. Kayukawa for providing insect samples; M. Watanabe and K. Shinyashiki for technical assistance; and H. Matsuzawa, A. Fujiwara, M. Oida, A. Kurata, M. Takizawa and M. Wakabayashi for their helpful discussions. This work was supported by KAKENHI (grant number 22128007). T. S. was supported by a JSPS Research Fellowship for Young Scientists (grant number 13J10329).	Christiaens O, 2014, PEPTIDES, V53, P307, DOI 10.1016/j.peptides.2013.12.014; Futahashi R, 2011, INSECT BIOCHEM MOLEC, V41, P191, DOI 10.1016/j.ibmb.2010.12.003; Ando T, 2013, DEVELOPMENT, V140, P454, DOI 10.1242/dev.085241; Ma YW, 2014, FEBS J, V281, P3779, DOI 10.1111/febs.12935; Lassance JM, 2010, J CHEM ECOL, V36, P1155, DOI 10.1007/s10886-010-9856-5; Tamura T, 2000, NAT BIOTECHNOL, V18, P81; Ohde T, 2013, SCIENCE, V340, P495, DOI 10.1126/science.1234219; Golden K, 2007, J INSECT SCI, V7; Ishikawa Y, 1999, ENTOMOL EXP APPL, V91, P237, DOI 10.1046/j.1570-7458.1999.00489.x; Kayukawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008277; Kunieda T, 2004, BIOCHEM BIOPH RES CO, V318, P25, DOI 10.1016/j.bbrc.2004.03.178; Miyazaki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092875; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Watanabe T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2020	14	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0003-6862	1347-605X		APPL ENTOMOL ZOOL	Appl. Entomol. Zoolog.	MAY	2015	50	2					271	275		10.1007/s13355-014-0315-6		5	Entomology	Entomology	CJ5XM	WOS:000355566800016		
J	Uehara, Y; Kume, A; Chiwa, M; Honoki, H; Zhang, J; Watanabe, K				Uehara, Yoshitoshi; Kume, Atsushi; Chiwa, Masaaki; Honoki, Hideharu; Zhang, Jing; Watanabe, Koichi			Atmospheric deposition and interactions with Pinus pumila Regal canopy on Mount Tateyama in the Northern Japanese Alps	ARCTIC ANTARCTIC AND ALPINE RESEARCH			English	Article							TRANSPORTED AIR-POLLUTANTS; MT. TATEYAMA; ROCKY-MOUNTAINS; CHEMICAL-COMPOSITION; ECOSYSTEM RESPONSE; SEASONAL-VARIATION; PACIFIC-NORTHWEST; YAKUSHIMA ISLAND; DRY DEPOSITION; LONG-TERM	To estimate the impact of atmospheric deposition on alpine ecosystems, we evaluated the interactions between atmospheric deposition and the Pinus pumila canopy close to the summit of Mount Tateyama, central Japan. We analyzed the chemical characteristics of rain, fog, and throughfall under the canopy in the summertime for 5 years. The concentrations of inorganic nitrogen and sulfate in precipitation at the summit (2839 m a.s.l.) were lower than at the base (13 m a.s.l.), but the total amounts deposited tended to be larger, because the precipitation was greater at the summit and highly concentrated fog water was deposited on the pine canopy. Large fluctuations in the quality and quantity of deposition were due to interannual variations in the meteorological conditions. About 80% of NO3- N and NH4+-N (0.40 and 0.47 kg ha(-1) month(-1)) from rain and fog were retained in the P. pumila canopy, and contributions from fog were twice those from rain. Considerable amounts of K+, Mg2+, and Ca2+ ions (0.97, 0.13, and 0.13 kg ha(-1) month(-1)) were leached out from the canopy to the soil as throughfall. The leaching did not increase with rainfall, but increased as the duration of the fog and dew increased.	[Uehara, Yoshitoshi; Kume, Atsushi; Chiwa, Masaaki] Kyushu Univ, Fac Agr, Kyushu Univ Forest, Fukuoka 8112415, Japan; [Honoki, Hideharu] Toyama Sci Museum, Toyama 9398084, Japan; [Zhang, Jing] Toyama Univ, Fac Sci, Toyama 9308555, Japan; [Watanabe, Koichi] Toyama Prefectural Univ, Fac Engn, Toyama 9390398, Japan	Kume, A (reprint author), Kyushu Univ, Fac Agr, Kyushu Univ Forest, 394 Tsubakuro, Fukuoka 8112415, Japan.	glacier_foreland@yahoo.co.jp	Kume, Atsushi/G-3523-2011	Kume, Atsushi/0000-0002-0048-5680	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [18310022, 22310022, 23570030]; Global COE Program (Center of Excellence for Asian Conservation Ecology as a Basis of Human Nature Mutualism), MEXT, Japan	We thank Kazuma Aoki, Wataru Shimada, Hajime Iida, Kyoichi Otsuki, and Eisuke Niwa, and the members of the University of Toyama and the Tateyama Murodo Sanso for their support in this study. This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT; Nos. 18310022, 22310022, 23570030, 22310022) and Global COE Program (Center of Excellence for Asian Conservation Ecology as a Basis of Human Nature Mutualism), MEXT, Japan. Chubu Region Environmental Office, Toyama Prefecture and the Toyama District Forest Office granted admittance for research on Mount Tateyama.	Adriaenssens S, 2011, WATER AIR SOIL POLL, V219, P43, DOI 10.1007/s11270-010-0682-8; ANNEN K, 1995, NIPPON KAGAKU KAISHI, P916; Scherer HW, 2001, EUR J AGRON, V14, P81, DOI 10.1016/S1161-0301(00)00082-4; WALKER DA, 1993, BIOSCIENCE, V43, P287, DOI 10.2307/1312061; LOVETT GM, 1984, J APPL ECOL, V21, P1013, DOI 10.2307/2405064; KEENE WC, 1986, J GEOPHYS RES-ATMOS, V91, P6647, DOI 10.1029/JD091iD06p06647; Mladenov N, 2012, BIOGEOSCIENCES, V9, P3337, DOI 10.5194/bg-9-3337-2012; TUKEY HB, 1970, ANN REV PLANT PHYSIO, V21, P305, DOI 10.1146/annurev.pp.21.060170.001513; Kume A, 2009, ECOL RES, V24, P821, DOI 10.1007/s11284-008-0557-2; Fenn ME, 2013, FOREST ECOL MANAG, V302, P240, DOI 10.1016/j.foreco.2013.03.042; Bowman WD, 2006, ECOL APPL, V16, P1183, DOI 10.1890/1051-0761(2006)016[1183:NCLFAV]2.0.CO;2; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; Currie WS, 1999, CAN J FOREST RES, V29, P609, DOI 10.1139/cjfr-29-5-609; Osada K, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003544; Chiwa M, 2004, ENVIRON POLLUT, V127, P57, DOI 10.1016/S0269-7491(03)00259-8; OKITSU S, 1984, VEGETATIO, V58, P105, DOI 10.1007/BF00044934; Sase H, 2008, ENVIRON POLLUT, V152, P1, DOI 10.1016/j.envpol.2007.06.023; LOVETT GM, 1993, CAN J FOREST RES, V23, P1603, DOI 10.1139/x93-200; Watanabe K, 2010, WATER AIR SOIL POLL, V211, P379, DOI 10.1007/s11270-009-0307-2; Uehara Y, 2012, ARCT ANTARCT ALP RES, V44, P143, DOI 10.1657/1938-4246-44.1.143; Sparks JP, 2009, OECOLOGIA, V159, P1, DOI 10.1007/s00442-008-1188-6; Bowman WD, 2000, AMBIO, V29, P396, DOI 10.1639/0044-7447(2000)029[0396:BCOERT]2.0.CO;2; Burns DA, 2004, ENVIRON POLLUT, V127, P257, DOI 10.1016/S0269-7491(03)00264-1; Chiwa M, 2012, CAN J FOREST RES, V42, P1395, DOI [10.1139/X2012-091, 10.1139/x2012-091]; Chiwa M, 2003, ATMOS ENVIRON, V37, P327, DOI 10.1016/S1352-2310(02)00889-0; CRONAN CS, 1983, OECOLOGIA, V59, P216, DOI 10.1007/BF00378839; De Walle R. D., 1985, J ENVIRON QUAL, V14, P234; EANET, 2011, 2 PER REP STAT AC DE; Fillion N, 1998, ENVIRON INT, V24, P547, DOI 10.1016/S0160-4120(98)00048-8; FOWLER D, 1989, PHILOS T ROY SOC B, V324, P247, DOI 10.1098/rstb.1989.0047; HOLZMANN HP, 1988, OECOLOGIA, V76, P298, DOI 10.1007/BF00379967; Honoki H., 2010, B TOYAMA SCI MUSEUM, V33, P113; Honoki H., 2007, B GLACIOLOGICAL RES, V24, P23; Honoki H., 2009, B TOYAMA SCI MUSEUM, V32, P125; Honoki H., 2012, B TOYAMA SCI MUSEUM, V35, P119; Honoki H., 2012, B TOYAMA SCI MUSEUM, V36, P13; Honoki H., 2011, B TOYAMA SCI MUSEUM, V34, P151; Houle D, 1999, CAN J FOREST RES, V29, P1944; Ignatova N, 2000, ANN FOR SCI, V57, P113; KAJIMOTO T, 1992, ECOL RES, V7, P333, DOI 10.1007/BF02347100; KAJIMOTO T, 1994, ECOL RES, V9, P193, DOI 10.1007/BF02347495; Kido M, 2001, J GEOPHYS RES-ATMOS, V106, P17335, DOI 10.1029/2000JD900775; Klopatek JM, 2006, FOREST ECOL MANAG, V234, P344, DOI 10.1016/j.foreco.2006.07.019; Kume Atsushi, 2011, Japanese Journal of Ecology (Otsu), V61, P97; Kume A, 2010, ECOL RES, V25, P233, DOI 10.1007/s11284-009-0647-9; LOVETT GM, 1990, ATMOS ENVIRON A-GEN, V24, P2767, DOI 10.1016/0960-1686(90)90164-I; Marty C, 2012, ENVIRON POLLUT, V162, P354, DOI 10.1016/j.envpol.2011.12.007; Muramoto M., 2007, J JAPANESE ASS HYDRO, V37, P73; Okitsu S., 1983, J GRADUATE SCH ENV S, V6, P151; Okochi H., 1995, ENV SCI, V8, P305; OLSZYK DM, 1985, PLANT PHYSIOL, V79, P949, DOI 10.1104/pp.79.4.949; PARKER GG, 1983, ADV ECOL RES, V13, P57, DOI 10.1016/S0065-2504(08)60108-7; Rautio P, 2003, ENVIRON POLLUT, V122, P273, DOI 10.1016/S0269-7491(02)00289-0; Tomaszewski T, 2003, CAN J FOREST RES, V33, P2221, DOI 10.1139/X03-147; Ulrich B., 1983, Effects of accumulation of air pollutants in forest ecosystems, P33; Wada N, 2007, FAR E STUDIES, V6, P31; Watanabe K, 1999, J METEOROL SOC JPN, V77, P997; Watanabe K, 2011, ERDKUNDE, V65, P233, DOI 10.3112/erdkunde.2011.03.02; Wehren B, 2010, HANDB ENVIRON CHEM, V6, P17, DOI 10.1007/978-3-540-88275-6_2; YANAGIMACHI O, 1991, ARCTIC ALPINE RES, V23, P424, DOI 10.2307/1551684	60	0	0	INST ARCTIC ALPINE RES	BOULDER	UNIV COLORADO, BOULDER, CO 80309 USA	1523-0430	1938-4246		ARCT ANTARCT ALP RES	Arct. Antarct. Alp. Res.	MAY	2015	47	2					389	399		10.1657/AAAR0013-126		11	Environmental Sciences; Geography, Physical	Environmental Sciences & Ecology; Physical Geography	CJ6TS	WOS:000355627500019		
J	Kang, HN; Xu, M; Rodriguez, VP; Mefed, K; Hanada, K; Ahn, KS; Gangakhedkar, SJ; Pakzad, SR; Prawahju, EI; Lee, N; Phumiamorn, S; Nemec, M; Meng, SF; Knezevic, I				Kang, Hye-Na; Xu, Miao; Perez Rodriguez, Violeta; Mefed, Kirill; Hanada, Kentaro; Ahn, Kwang-Soo; Gangakhedkar, Shri Jayant; Pakzad, Saeed Reza; Prawahju, Elizabeth Ika; Lee, Naery; Phumiamorn, Supaporn; Nemec, Martin; Meng, Shufang; Knezevic, Ivana			Review of the current use and evaluation of cell substrates for producing biologicals in selected countries	BIOLOGICALS			English	Review						Survey; Cell substrates; Biological products; Implementation workshop; WHO		In 2010, the WHO guidance document for the evaluation of cell substrates for producing biologicals was replaced with updated recommendations and in May 2013 an implementation workshop on the new recommendations was held in Beijing, China. As part of this workshop, a survey of the use and evaluation of cell substrates for producing biologicals was undertaken and the information obtained was updated in June 2014. The purpose of survey was to capture the status of national requirements related to cell substrates in various countries with particular emphasis on whether or not the updated WHO recommendations had been, or were to be, incorporated into national requirements. This paper reports the outcome of the survey and is based on information provided by regulators in eleven countries. Since the publication of the updated WHO recommendations, several activities such as the implementation workshop and publications have been undertaken by the WHO. The aim of these activities, including the publication of this article, is to contribute to the implementation of WHO recommendations so as to reduce regulatory gaps between national requirements and globally agreed expectations. (C) 2015 Published by Elsevier Ltd on behalf of The International Alliance for Biological Standardization.	[Kang, Hye-Na; Knezevic, Ivana] WHO, Dept Essential Med & Hlth Prod, CH-1211 Geneva, Switzerland; [Xu, Miao; Meng, Shufang] Natl Inst Food & Drug Control, Inst Biol Product Control, Beijing, Peoples R China; [Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Ahn, Kwang-Soo; Lee, Naery] Minist Food & Drug Safety, Natl Inst Food & Drug Safety Evaluat, Seoul, South Korea; [Gangakhedkar, Shri Jayant] Cent Drugs Standard Control Org, Kolkata, India; [Pakzad, Saeed Reza] Food & Drug Control Labs & Res Ctr, Vaccine Potency Sect, Tehran, Iran; [Prawahju, Elizabeth Ika] Natl Agcy Drug & Food Control, Natl Qual Control Lab Drug & Food, Badan, Indonesia	Kang, HN (reprint author), WHO, Dept Essential Med & Hlth Prod, Ave Appia 20, CH-1211 Geneva, Switzerland.	kangh@who.int					[Anonymous], PREP QUAL INF DRUG S; [Anonymous], 2009, REP WHO STUD GROUP C; [Anonymous], 1985, POINTS CONS PROD TES; [Anonymous], 2014, 65 M WHO EXP COMM BI; ICH, 1997, INT C HARM TECHN REQ; ICH, 1995, INT C HARM TECHN REQ; ICH Q5A guideline, 1999, INT C HARM TECHN REQ; Petricciani J, 2014, BIOLOGICALS, V42, P223, DOI 10.1016/j.biologicals.2014.07.003; World Health Organization, 1998, WHO TECHN REP SER, V878; World Health Organization, 2013, WHO TECHN REP SER, V987	10	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1045-1056	1095-8320		BIOLOGICALS	Biologicals	MAY	2015	43	3					153	157		10.1016/j.biologicals.2015.01.004		5	Biochemical Research Methods; Biotechnology & Applied Microbiology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Pharmacology & Pharmacy	CJ3EU	WOS:000355367000001		
J	Sekine, S; Komuro, M; Sohka, T; Sato, T				Sekine, Shinya; Komuro, Masayasu; Sohka, Takayuki; Sato, Terry			Integrity testing of Planova (TM) BioEX virus removal filters used in the manufacture of biological products	BIOLOGICALS			English	Article						Planova (TM) BioEX virus filter; Air/water diffusion-based leakage test; Integrity testing; Forward/diffusive flow; Biologicals	NANOFILTRATION; MEMBRANES; ULTRAFILTRATION; SENSITIVITY	Confirmation of virus filter integrity is crucial for ensuring the safety of biological products. Two main types of virus filter defects may produce inconsistent and undesirable performance in virus removal: improper pore-size distribution across the membrane; and specific damage, such as tears, broken fibers, or pinholes. Two integrity tests are performed on each individual filter manufactured by Asahi Kasei Medical to ensure the absence of these defects prior to shipment. In this study, we verified that typical usage of Planova (TM) BioEX filters would not improperly shift the pore-size distribution. Damage occurring during shipment and use (e.g., broken fibers or pinholes) can be detected by end-users with sufficient sensitivity using air-water diffusion based leakage tests. We prepared and tested filters with model pinhole defects of various sizes to develop standard acceptance criteria for the leakage test relative to porcine parvovirus infectivity logarithmic reduction values (LRVs). Our results demonstrate that pinhole defects at or below a certain size for each effective filter surface area have no significant impact on the virus LRV. In conclusion the leakage test is sufficiently sensitive to serve as the sole end-user integrity test for Planova (TM) BioEX filters, facilitating their use in biopharmaceuticals manufacturing. (C) 2015 Asahi Kasei Medical CO., LTD. Published by Elsevier Ltd on behalf of The International Alliance for Biological Standardization. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).	[Sekine, Shinya] Asahi Kasei Med MT Corp, Bioproc Technol Dev Dept, Miyazaki 8820031, Japan; [Komuro, Masayasu] Asahi Kasei Med Co Ltd, Med Prod Dev Div, Med Mat Lab, Miyazaki 8820031, Japan; [Sohka, Takayuki; Sato, Terry] Asahi Kasei Med Co Ltd, Tech Mkt Dept, Bioproc Div, Chiyoda Ku, Tokyo 1018101, Japan	Sohka, T (reprint author), Asahi Kasei Med Co Ltd, Tech Mkt Dept, Bioproc Div, Chiyoda Ku, 1-105 Kanda Jinbocho, Tokyo 1018101, Japan.	souka.tb@om.asahi-kasei.co.jp					Lebleu N, 2010, J MEMBRANE SCI, V348, P56, DOI 10.1016/j.memsci.2009.10.045; Burnouf T, 2007, TRANSFUS MED REV, V21, P101, DOI 10.1016/j.tmrv.2006.11.001; Asatekin A, 2006, J MEMBRANE SCI, V285, P81, DOI 10.1016/j.memsci.2006.07.042; Khayet M, 2002, POLYMER, V43, P3879, DOI 10.1016/S0032-3861(02)00237-9; Burnouf T, 2003, HAEMOPHILIA, V9, P24, DOI 10.1046/j.1365-2516.2003.00701.x; Antony A, 2014, J MEMBRANE SCI, V454, P193, DOI 10.1016/j.memsci.2013.11.052; Badrot A, 2013, CONTRACT BIOMANUFACT; Bolton G, 2006, BIOPROCESS J, V5, P50; Dowd CJ, 2009, BIOTECHNOL BIOENG, V103, P574, DOI 10.1002/bit.22275; EMEA/CHMP/BWP, 2009, EMEACHMPBWP398498; EMEA/CPMP/BWP, 1996, EMEACPMPBWP26895; Fukada S, 2000, US patent, Patent No. [6065329, 9829184, W098/29184 A1]; Giglia S, 2008, J MEMBRANE SCI, V323, P60, DOI 10.1016/j.memsci.2008.06.017; Hamasaki N, 2010, US patent application publication, Patent No. [US2010/0096328 A1, 6065329]; Hamasaki N, 2008, Patent No. [W02008/111510 A1, 2014080676, WO2014/080676 A1]; Hongo-Hirasaki T, 2010, BIOTECHNOL PROGR, V26, P1080, DOI 10.1002/btpr.415; ICH Harmonised Tripartite Guideline, 1999, VIR SAF EV BIOT PROD; Jornitz MW, 2003, FILTRATION HDB INTEG; Korneyeva Marina, 2005, V308, P221; Kreil TR, 2006, TRANSFUSION, V46, P1143, DOI 10.1111/j.1537-2995.2006.00864.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Omar A, 2002, TRANSFUSION, V42, P1005, DOI 10.1046/j.1537-2995.2002.00145.x; Parenteral Drug Association (PDA), 2008, PDA J PHARM SCI TE S, V62; Perry R.H., 2007, PERRYS CHEM ENG HDB; Phillips MW, 1996, BIOLOGICALS, V24, P243, DOI 10.1006/biol.1996.0033; Remington KM, 2007, IBCS TRAINING ACAD C; Roberts PL, 2010, BIOLOGICALS, V38, P303, DOI 10.1016/j.biologicals.2009.12.006; United States Food and Drug Administration (FDA) Center for Biologics Evaluation and research (CBER), 1997, Docket No. 94D-0259, Patent No. [2008111510, W02008/111510 A1]; Velthove KJ, 2013, TRANSFUS MED REV, V27, P179, DOI 10.1016/j.tmrv.2013.05.002; World Health Organization, 2004, WHO TECHN REP SER, V924, P150; Yanagida K, 2014, Patent No. [WO2014/080676 A1, 20100096323, US2010/0096328 A1]; Zhang Qinglei, 2014, Membranes (Basel), V4, P81, DOI 10.3390/membranes4010081	32	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1045-1056	1095-8320		BIOLOGICALS	Biologicals	MAY	2015	43	3					186	194		10.1016/j.biologicals.2015.02.003		9	Biochemical Research Methods; Biotechnology & Applied Microbiology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Pharmacology & Pharmacy	CJ3EU	WOS:000355367000006		
J	Kitasato, L; Shimohama, T; Ikeda, Y; Namba, S; Hashikata, T; Kameda, R; Sato, N; Takeuchi, I; Yamaoka-Tojo, M; Tojo, T; Ako, J				Kitasato, Lisa; Shimohama, Takao; Ikeda, Yuki; Namba, Sayaka; Hashikata, Takehiro; Kameda, Ryo; Sato, Nobuhiro; Takeuchi, Ichiro; Yamaoka-Tojo, Minako; Tojo, Taiki; Ako, Junya			Clinical outcomes of chronic kidney disease patients treated with everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES)	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Everolimus-eluting stent; Paclitaxel-eluting stent; Chronic kidney disease	PERCUTANEOUS CORONARY INTERVENTION; RENAL-INSUFFICIENCY; HEMODIALYSIS-PATIENTS; STRUT THICKNESS; RISK FACTOR; IMPLANTATION; IMPACT; RESTENOSIS; REVASCULARIZATION; TRIAL	Background: The target lesion revascularization of paclitaxel-eluting stents (PES) has been reported to be lower than that of sirolimus-eluting stents in patients on hemodialysis (HD). However, the comparison of PES and second generation drug-eluting stents in CKD patients has not been fully investigated. We compared clinical outcomes of everolimus-eluting stents (EES) and PES in CKD patients. Methods: Hundred and forty seven CKD patients (eGFR < 60 mL min(-1) 1.73 m(-2)) treated with PES (n = 74, from May 2007 to December 2009) and EES (n = 73, from January 2010 to January 2013) were enrolled in the study. Major adverse cardiac events (MACEs) were defined as death, non-fatal myocardial infarction, and ischemia driven target lesion revascularization. Results: The incidence of 36-month MACE was significantly lower in EES, non-HD group compared to PES, non HD group (0% in EES group and 13.5% in PES group, respectively, P < 0.01). There was no significant difference in MACE between EES and PES in HD patients (5.4% in PES group and 5.5% in EES group, P = 0.98). In multivariate analysis, PES group and PES ISR were independent factors for worse incidence of MACE. Conclusions: In CKD patients, PES was associated with worse clinical outcomes in non-HD patients as compared with EES. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Kitasato, Lisa; Ikeda, Yuki; Namba, Sayaka; Hashikata, Takehiro; Ako, Junya] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa 2520373, Japan; [Yamaoka-Tojo, Minako] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Sagamihara, Kanagawa 2520373, Japan; [Shimohama, Takao; Kameda, Ryo; Sato, Nobuhiro; Takeuchi, Ichiro; Tojo, Taiki; Ako, Junya] Kitasato Univ, Sch Med, Dept Cardiovasc Med, Sagamihara, Kanagawa 2520373, Japan	Tojo, T (reprint author), Kitasato Univ, Sch Med Sci, Dept Cardiovasc Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	lisa@med.kitasato-u.ac.jp; takshimo@med.kitasato-u.ac.jp; y_ikeda@med.kitasato-u.ac.jp; sayakayasa@med.kitasato-u.ac.jp; t_hashikata@med.kitasato-u.ac.jp; rkameda@med.kitasato-u.ac.jp; hokkaidou_yamakosigun_@hotmail.com; itake@myad.jp; myamaoka@med.kitasato-u.ac.jp; ttojo@med.kitasato-u.ac.jp; jako@kitasato-u.ac.jp		Yamaoka-Tojo, Minako/0000-0003-3890-3777			Halkin A, 2005, AM HEART J, V150, P1163, DOI 10.1016/j.ahj.2005.01.032; Naidu SS, 2003, AM J CARDIOL, V92, P1160, DOI 10.1016/j.amjcard.2003.07.023; Dumaine R, 2004, AM J CARDIOL, V94, P1543, DOI 10.1016/j.amjcard.2004.08.035; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Nakazawa G, 2007, CATHETER CARDIO INTE, V69, P808, DOI 10.1002/ccd.21016; Smits PC, 2011, J AM COLL CARDIOL, V58, P11, DOI 10.1016/j.jacc.2011.02.023; Sakakibara T, 2012, CIRC J, V76, P351, DOI 10.1253/circj.CJ-11-0814; ELLIS SG, 1990, CIRCULATION, V82, P1193; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030; Mori S, 2009, CIRC J, V73, P1856; Hase H, 2001, NEPHROL DIAL TRANSPL, V16, P2372, DOI 10.1093/ndt/16.12.2372; Pache J, 2003, J AM COLL CARDIOL, V41, P1283, DOI 10.1016/S0735-1097(03)00119-0; Dangas GD, 2013, JACC-CARDIOVASC INTE, V6, P914, DOI 10.1016/j.jcin.2013.05.005; Otsuka Y, 2011, EUR HEART J, V32, P829, DOI 10.1093/eurheartj/ehq480; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; Best P.J., 2001, J AM COLL CARDIOL, V103, P2816; Briguori C, 2010, INT J CARDIOL, V142, P92, DOI 10.1016/j.ijcard.2008.11.138; Das Pranab, 2006, J Invasive Cardiol, V18, P405; Doostzadeh J, 2010, CORONARY ARTERY DIS, V21, P46, DOI 10.1097/MCA.0b013e328333f550; Foley R N, 1998, J Am Soc Nephrol, V9, pS16; Hassani Salah-Eddine, 2006, J Invasive Cardiol, V18, P273; Japanese Society of Dialysis Therapy, OV REG DIAL TREATM J; Jeong YH, 2009, INT J CARDIOL, V133, P247, DOI 10.1016/j.ijcard.2007.11.089; Jeong YH, 2008, INT J CARDIOL, V125, P36, DOI 10.1016/j.ijcard.2007.02.026; Jungers P, 1997, NEPHROL DIAL TRANSPL, V12, P2597, DOI 10.1093/ndt/12.12.2597; Lemos PA, 2005, AM J CARDIOL, V95, P167, DOI 10.1016/j.amjcard.2004.08.089; Lin JC, 2000, J BIOMAT SCI-POLYM E, V11, P701, DOI 10.1163/156856200743968; Luft FC, 2000, BASIC RES CARDIOL, V95, P72; Nickson CM, 2010, J BIOMATER APPL, V24, P437, DOI 10.1177/0885328208099338; Okada T, 2008, CIRC J, V72, P1430, DOI 10.1253/circj.CJ-08-0010; Rittersma SZH, 2004, AM J CARDIOL, V93, P477, DOI 10.1016/j.amjcard.2003.10.049; Rong S, 2014, CELL PHYSIOL BIOCHEM, V34, P2049, DOI 10.1159/000366400; Szczech LA, 2001, KIDNEY INT, V60, P292, DOI 10.1046/j.1523-1755.2001.00799.x; Tsai TT, 2011, J AM COLL CARDIOL, V58, P1859, DOI 10.1016/j.jacc.2011.06.056; Tsujita Hiroaki, 2013, Cardiovasc Interv Ther, V28, P9, DOI 10.1007/s12928-012-0103-6; Valenti R, 2011, AM J CARDIOL, V107, P1768, DOI 10.1016/j.amjcard.2011.01.063; Yazaki Y, 2011, J CARDIOL, V57, P61, DOI 10.1016/j.jjcc.2010.10.005; Zhang Q, 2008, CHINESE MED J-PEKING, V121, P2379	39	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	MAY	2015	72						6	10		10.1016/j.biopha.2015.03.002		5	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CJ7JF	WOS:000355670400002		
J	Hagiya, H				Hagiya, Hideharu			No blood culture examinations during off-hours?	BRAZILIAN JOURNAL OF INFECTIOUS DISEASES			English	Letter							IDENTIFICATION		[Hagiya, Hideharu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Okayama, Japan	Hagiya, H (reprint author), 2-5-1 Shikata Cho,Kitaku, Okayama 7008558, Japan.	e_dai_for_all@hotmail.com					Baron EJ, 2005, BLOOD CULTURES; Clinical and Laboratory Standards Institute, 2007, PRINC PROC BLOOD CUL; Hoyos-Mallecot Y, 2014, J MICROBIOL METH, V105, P98, DOI 10.1016/j.mimet.2014.07.016; Kobayashi Intetsu, 2004, Kansenshogaku Zasshi, V78, P959; Kothari A, 2014, CLIN INFECT DIS, V59, P272, DOI 10.1093/cid/ciu292	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1413-8670	1678-4391		BRAZ J INFECT DIS	Braz. J. Infect. Dis.	MAY-JUN	2015	19	3					330	331		10.1016/j.bjid.2015.01.002		2	Infectious Diseases	Infectious Diseases	CJ3JF	WOS:000355378500017		
J	Ido, A				Ido, Ayako			AN ESTIMATE OF HEMPEL DISTANCE FOR BRIDGE SPHERES	BULLETIN OF THE KOREAN MATHEMATICAL SOCIETY			English	Article						Heegaard splitting; bridge decomposition; distance	SURFACES; POSITION; BOUNDS	Tomova [8] gave an upper bound for the distance of a bridge surface for a knot with two different bridge positions in a 3-manifold. In this paper, we show that the result of Tomova [8, Theorem 10.3] can be improved in the case when there are two different bridge spheres for a link in S-3.	Aichi Univ Educ, Dept Math Educ, Kariya, Aichi 4488542, Japan	Ido, A (reprint author), Aichi Univ Educ, Dept Math Educ, 1 Hirosawa, Kariya, Aichi 4488542, Japan.	ayakoido@auecc.aichi-edu.ac.jp			Japan Society for the Promotion of Science (JSPS)	I would like to thank Professor Tsuyoshi Kobayashi for many helpful advices and comments. I would also like to thank Yeonhee Jang for her valuable advices and informations. I gratefully appreciate the financial support from Japan Society for the Promotion of Science (JSPS). Finally I would like to thank the referee for careful reading of the first version of the paper.	Hayashi C, 2001, PAC J MATH, V197, P301; Hempel J, 2001, TOPOLOGY, V40, P631, DOI 10.1016/S0040-9383(00)00033-1; Hartshorn K, 2002, PAC J MATH, V204, P61; Scharlemann M, 2006, GEOM TOPOL, V10, P593, DOI 10.2140/gt.2006.10.593; Bachman D, 2005, PAC J MATH, V219, P221; Jang Y, 2014, PAC J MATH, V267, P121, DOI 10.2140/pjm.2014.267.121; Johnson J, 2011, ALGEBR GEOM TOPOL, V11, P1987, DOI 10.2140/agt.2011.11.1987; Tomova M, 2007, ALGEBR GEOM TOPOL, V7, P957, DOI 10.2140/agt.2007.7.957	8	0	0	KOREAN MATHEMATICAL SOC	SEOUL	KOREA SCIENCE TECHNOLOGY CTR 202, 635-4 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1015-8634			B KOREAN MATH SOC	Bull. Korean. Math. Soc.	MAY	2015	52	3					735	740		10.4134/BKMS.2015.52.3.735		6	Mathematics	Mathematics	CJ8TO	WOS:000355776600004		
J	Park, J; Sekigawa, K; Shin, W				Park, JeongHyeong; Sekigawa, Kouei; Shin, Wonmin			A REMARK ON QUASI CONTACT METRIC MANIFOLDS	BULLETIN OF THE KOREAN MATHEMATICAL SOCIETY			English	Article						contact metric manifold; quasi contact metric manifold	RIEMANNIAN-MANIFOLDS	As a natural generalization of the contact metric manifolds, Kim, Park and Sekigawa discussed quasi contact metric manifolds based on the geometry of the corresponding quasi Kahler cones. In this paper, we show that a quasi contact metric manifold is a contact manifold.	[Park, JeongHyeong; Shin, Wonmin] Sungkyunkwan Univ, Dept Math, Suwon 440746, South Korea; [Sekigawa, Kouei] Niigata Univ, Fac Sci, Dept Math, Niigata 95021, Japan	Park, J (reprint author), Sungkyunkwan Univ, Dept Math, Suwon 440746, South Korea.	parkj@skku.edu; sekigawa@math.sc.niigata-u.ac.jp; jacarta1@skku.edu			National Research Foundation of Korea(NRF) - Ministry of Education [2014053413]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education(2014053413). The authors would like to their thanks to the referee for the helpful suggestions.	Blair D. E., 2002, PROGR MATH, V203; Dragomir S, 2014, J GEOM ANAL, V24, P1233, DOI 10.1007/s12220-012-9371-8; Gray A., 1976, TOHOKU MATH J, V28, P601, DOI 10.2748/tmj/1178240746; Gray A., 1980, ANN MAT PUR APPL, V123, P35, DOI 10.1007/BF01796539; Jin JE, 2012, BALK J GEOM APPL, V17, P54; Kim JH, 2014, BALK J GEOM APPL, V19, P94; Olszak Z., 1979, TOHOKU MATH J, V31, P247, DOI 10.2748/tmj/1178229842; Perrone D, 2014, J KOREAN MATH SOC, V51, P881, DOI 10.4134/JKMS.2014.51.5.881; Tashiro Y., 1963, TOHOKU MATH J, V15, P62, DOI 10.2748/tmj/1178243870; Tashiro Y., 1963, TOHOKU MATH J, V15, P167, DOI 10.2748/tmj/1178243843	10	0	0	KOREAN MATHEMATICAL SOC	SEOUL	KOREA SCIENCE TECHNOLOGY CTR 202, 635-4 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1015-8634			B KOREAN MATH SOC	Bull. Korean. Math. Soc.	MAY	2015	52	3					1027	1034		10.4134/BKMS.2015.52.3.1027		8	Mathematics	Mathematics	CJ8TO	WOS:000355776600028		
J	Ishihara, R; Hasegawa, K; Hosokawa, K; Maeda, M				Ishihara, Ryo; Hasegawa, Kazuki; Hosokawa, Kazuo; Maeda, Mizuo			Detection of Proteins and Nucleic Acids with Laminar Flow-Assisted Dendritic Amplification on Power-Free Microfluidic Chip	BUNSEKI KAGAKU			Japanese	Article						power-free microfluidic chip; laminar flow-assisted dendritic amplification; immunoassay; nucleic acid; PDMS	FREE MICROCHIP; CIRCULATING MICRORNAS; CANCER; DNA; IMMUNOASSAY; POLY(DIMETHYLSILOXANE); HYBRIDIZATION; BIOMARKER; STACKING; DEVICES	The detection of early signs of diseases is essential to maintain the quality of life of human beings. Some proteins and nucleic acids known as biomarkers have potential to be "signs". As novel detection method, point-of-care tests (POCT) are of growing importance in various clinical fields, such as routine health assessment, predicting of disease risk, and monitoring disease progression. POCT has several requirements, such as high sensitivity, small sample volume, short detection time, and portability of the device. In various detection methods, some microfluidic device seems to be one of the promising methods for POCT, because it meets the requirements of POCT, except for portability. In this paper, we introduce our two technologies to overcome these drawbacks toward POCT. One is a power-free microfluidic device, which is driven by degassed poly(dimethylsiloxane), and thus eliminating the need for external power sources for fluid pumping. The other is laminar flow-assisted dendritic amplification, which enables on to improve the sensitivity of the device. The combination of these two techniques allowed us to detect sub-picomolar levels of protein biomarkers and several tens of femtomolar levels of nucleic acid biomarker in 20 min The portability, rapidness, and high sensitivity of the device are ideal advantages for POCT.	[Ishihara, Ryo; Hasegawa, Kazuki; Hosokawa, Kazuo; Maeda, Mizuo] RIKEN, Bioengn Lab, Wako, Saitama 3510198, Japan	Ishihara, R (reprint author), RIKEN, Bioengn Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	k-hoso@riken.jp	Maeda, Mizuo/I-3498-2014				Ismagilov RF, 2000, APPL PHYS LETT, V76, P2376, DOI 10.1063/1.126351; Roberts WL, 2000, CLIN CHEM, V46, P461; Arata H, 2014, ANAL SCI, V30, P129; Duan RX, 2013, J AM CHEM SOC, V135, P4604, DOI 10.1021/ja311313b; Rusling JF, 2010, ANALYST, V135, P2496, DOI 10.1039/c0an00204f; Hosokawa K, 2007, ANAL CHEM, V79, P6000, DOI 10.1021/ac070659o; Merkel TC, 2000, J POLYM SCI POL PHYS, V38, P415, DOI 10.1002/(SICI)1099-0488(20000201)38:3<415::AID-POLB8>3.0.CO;2-Z; Hosokawa K, 2004, LAB CHIP, V4, P181, DOI 10.1039/b403930k; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Arata H, 2012, ANALYST, V137, P3234, DOI 10.1039/c2an16154k; Yamamoto Y, 2009, BIOMARKERS, V14, P529, DOI 10.3109/13547500903150771; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Ramnani P, 2013, ANAL CHEM, V85, P8061, DOI 10.1021/ac4018346; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Cai S, 2010, ANAL CHEM, V82, P7178, DOI 10.1021/ac101892t; Hosokawa K, 2006, LAB CHIP, V6, P236, DOI 10.1039/b513424b; PETERSHEIM M, 1983, BIOCHEMISTRY-US, V22, P256, DOI 10.1021/bi00271a004; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Yildiz UH, 2013, ANAL CHEM, V85, P820, DOI 10.1021/ac3034008; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Arata H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048329; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Diamandis E. P., 1996, IMMUNOASSAY; Hosokawa K, 2010, ANAL SCI, V26, P1053; Hosokawa K, 2009, LAB CHIP, V9, P464, DOI 10.1039/b810814e; Linder V, 2005, ANAL CHEM, V77, P64, DOI 10.1021/ac049071x; Lion L., 2004, CURR OPIN BIOTECH, V15, P31; Lucarelli F, 2006, LANGMUIR, V22, P4305, DOI 10.1021/la053187m; Okada H, 2011, ANAL SCI, V27, P237, DOI 10.2116/analsci.27.237; Seki M., 2009, PNAS, V106, P12085; Ueno T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090920	33	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	MAY	2015	64	5					319	328				10	Chemistry, Analytical	Chemistry	CJ3CS	WOS:000355361600001		
J	Nishiwaki, N; Kasama, T; Ishida, A; Tani, H; Baba, Y; Tokeshi, M				Nishiwaki, Nanako; Kasama, Toshihiro; Ishida, Akihiko; Tani, Hirofumi; Baba, Yoshinobu; Tokeshi, Manabu			Development of High-performance Immuno-pillar Devices: Improvement of Antibody-immobilized Solid Support	BUNSEKI KAGAKU			Japanese	Article						immunoassay; point-of-care testing; disease maker; microfluidic device; affinity beads	IMMUNOSORBENT-ASSAY; MICROCHIP	In order to realize ultra-early diagnosis of disease in practical applications, we have fabricated next-generation immuno-pillar devices with higher sensitivity. In the newly developed devices, capture antibodies were immobilized on affinity beads based on chemical bonding, while in the previous-generation ones, polystyrene beads were used for physical adsorption-based immobilization. To evaluate the sensitivity of the next-generation immuno-pillar device, we quantitatively analyzed C-reactive protein (CRP). The limit of detection was estimated to be 0.1 ng mL(-1) (total assay time, 23 mm), which was twoorders of magnitude lower than that obtained by using the previous-generation immuno-pillar device, and was low enough to perfoiin the CRP test. In addition, we investigated the storage stability of the immuno-pillar device, and confirmed that the device can retain its performance for over 9 months.	[Nishiwaki, Nanako] Hokkaido Univ, Grad Sch Chem Sci & Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Nishiwaki, Nanako; Kasama, Toshihiro; Baba, Yoshinobu; Tokeshi, Manabu] Knowledge Hub AICHI, Toyota, Aichi 4700356, Japan; [Kasama, Toshihiro; Baba, Yoshinobu] Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ishida, Akihiko; Tani, Hirofumi; Tokeshi, Manabu] Hokkaido Univ, Fac Engn, Div Biotechnol & Macromol Chem, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Baba, Yoshinobu; Tokeshi, Manabu] Nagoya Univ, Res Ctr Innovat Nanodevices 1, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Baba, Yoshinobu] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan	Nishiwaki, N (reprint author), Hokkaido Univ, Grad Sch Chem Sci & Engn, Kita Ku, Kita13 Nishi8, Sapporo, Hokkaido 0608628, Japan.	tokeshi@eng.hokudai.ac.jp					Sato K, 2001, ANAL CHEM, V73, P1213, DOI 10.1021/ac000991z; Kurita R, 2010, ANAL CHEM, V82, P1692, DOI 10.1021/ac902045y; Lin CC, 2010, JALA-J LAB AUTOM, V15, P253, DOI 10.1016/j.jala.2010.01.013; Jiang H, 2011, MICROFLUID NANOFLUID, V10, P941, DOI 10.1007/s10404-010-0718-9; Tachi T, 2011, ANAL BIOANAL CHEM, V401, P2301, DOI 10.1007/s00216-011-5304-9; Henares TG, 2008, ANAL CHIM ACTA, V611, P17, DOI 10.1016/j.aca.2008.01.064; Sato K, 2000, ANAL CHEM, V72, P1144, DOI 10.1021/ac991151r; Ohashi T, 2009, LAB CHIP, V9, P991, DOI 10.1039/b815475a; Ng AHC, 2010, ANAL BIOANAL CHEM, V397, P991, DOI 10.1007/s00216-010-3678-8; Han KN, 2013, ANNU REV ANAL CHEM, V6, P119, DOI 10.1146/annurev-anchem-062012-092616; Ikami M., 2010, LAB CHIP, V10, P335; Jun W., 2013, J MICROBIOL METH, V92, P323; Okada H, 2011, ANAL SCI, V27, P237, DOI 10.2116/analsci.27.237; Tachi T, 2009, LAB CHIP, V9, P966, DOI 10.1039/b813640h; Tachi T, 2009, ANAL SCI, V25, P149; U. S. Food and Drug Administration, REV CRIT ASS C REACT; Wild D., 2013, IMMUNOASSAY HDB	17	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	MAY	2015	64	5					329	335				7	Chemistry, Analytical	Chemistry	CJ3CS	WOS:000355361600002		
J	Higuchi, K; Ohkawara, Y				Higuchi, Kenya; Ohkawara, Yuzuru			Determination of Potassium, Magnesium and Calcium Ions in Lettuce by Ion Chromatography	BUNSEKI KAGAKU			Japanese	Article						lettuce; potassium; magnesium; calcium; ion chromatography		Using the same sample solution as the one adopted in the quantitative analysis of nitrate ion in lettuce, which we conducted by way of a prior verification of the analytical method stated herein, simultaneous determinations of potassium ion (K+), magnesium ion (Mg2+) and calcium ion (Ca2+) in lettuce were performed. The concentration of each of the said cations in the sample solution extracted from both leaf lettuce and head lettuce was determined by means of ion chromatography. As a result, the relative standard deviations of the quantitative values were all within five % for both leaf lettuce and head lettuce. Also, our adequacy evaluation of this analytical method (conducted in accordance with the "Guideline for the Adequacy Evaluation of Methods for Testing Metal Contents in Food" prescribed by the Ministry of Health, Labour and Welfare) found the trueness, repeatability and precision within the laboratory for each of the said cations to be: 108.6 %, 1.3 % and 12.6 % for K+; 96.2 %, 1.8 % and 8.5 % for Mg2+; and 104.0 %, 1.8 % and 5.7 % for Ca2+ respectively, attaining the pertinent target values indicated in the said guideline. Based on the above, we deem this analytical method to be effective for determining the concentrations of K+, Mg2+ and Ca2+ in lettuce.	[Higuchi, Kenya; Ohkawara, Yuzuru] Arisawa Mfg Co Ltd, Technol Dev Affairs Dept, Analyt Grp, Joetsu, Niigata 9438610, Japan	Higuchi, K (reprint author), Arisawa Mfg Co Ltd, Technol Dev Affairs Dept, Analyt Grp, 1 Nakadahara, Joetsu, Niigata 9438610, Japan.	bunseki@arisawa.co.jp						0	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	MAY	2015	64	5					337	340				4	Chemistry, Analytical	Chemistry	CJ3CS	WOS:000355361600003		
J	Fujisaki, W; Sawaki, Y; Yokoyama, T; Yamamoto, S; Maruyama, S				Fujisaki, Wataru; Sawaki, Yusuke; Yokoyama, Tetsuya; Yamamoto, Shinji; Maruyama, Shigenori			Constraints for the Causes of Mass Extinction at the Triassic-Jurassic Boundary Based on High Precision Platinum Group Element Analyses	BUNSEKI KAGAKU			Japanese	Article						T-J boundary; PGEs; isotope dilution; shale; CAMP	NEUTRON-ACTIVATION ANALYSIS; GEOLOGICAL-MATERIALS; BLOMIDON FORMATION; FUNDY BASIN; SPECTROMETRY; OSMIUM; IRIDIUM; IMPACT; PRECONCENTRATION; SEPARATION	The cause of mass extinctions during the Phanerozoic period has been a long standing problem in geology. The large magmatic activity (CAMP: Central Atlantic Magmatic Province) associated with the breakup of Pangaea or a bolide impact event would have led the mass extinction at the Triassic-Jurassic (T-J) boundary. However, the cause of the mass extinction is still controversial because of insufficient geological evidences. In this study, we conducted detailed geological survey of the Inuyama area where good exposure of deep-sea sediments across the T-J boundary is observed. We collected rock samples bed-by-bed to analyze the abundances of platinum group elements (PGEs) with a high spatial resolution. Twenty-eight samples were powdered and spiked with Ru-99, (105)pd, (OS)-O-190, Pt-194. The sample was digested by a 2 : 1 mixture of HNO3 and HCl in a sealed Carious tube at 240 degrees C for 48 hours. After chemical separation using an anion exchange resin, PGEs (except for Os) were measured by a quadrupole type inductively coupled plasma-mass spectrometry (ICP-MS). The PGEs concentrations were determined by the isotope dilution method. After solvent extraction with CCl4 and HBr, micro-distillation method was employed to purify Os. The Os isotopes were determined by Negative-Thermal Ionization Mass Spectrometry (N-TIMS). The relationship between Pd/Pt and Jr/Pt, as well as the PGE patterns, demonstrate that the high PGEs contents in shales can be explained by the incorporation of basaltic rocks supplied from CAMP. In addition, compared with fossil records, the highest PGE abundances (Os and Pd) are discovered from a shale just above the chert including the first appearance of Jurassic type radiolarian. These lines of evidence indicate that the CAMP volcanism would have contributed to the mass extinction at the T-J boundary.	[Fujisaki, Wataru; Sawaki, Yusuke; Yokoyama, Tetsuya] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Yamamoto, Shinji] Univ Tokyo, Dept Earth Sci & Astron, Meguro Ku, Tokyo 1538902, Japan; [Maruyama, Shigenori] Tokyo Inst Technol, ELSI, Meguro Ku, Tokyo 1528551, Japan	Fujisaki, W (reprint author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528551, Japan.	fujisaki.w.aa@m.titech.ac.jp					White RV, 2005, LITHOS, V79, P299, DOI 10.1016/j.lithos.2004.09.016; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; MATSUDA T, 1991, TECTONICS, V10, P475, DOI 10.1029/90TC02134; Onoue T, 2012, P NATL ACAD SCI USA, V109, P19134, DOI 10.1073/pnas.1209486109; VOLKENING J, 1991, INT J MASS SPECTROM, V105, P147, DOI 10.1016/0168-1176(91)80077-Z; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; HOFFMAN EL, 1978, ANAL CHIM ACTA, V102, P157, DOI 10.1016/S0003-2670(01)93469-5; ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Philipp H, 2001, J PETROL, V42, P407, DOI 10.1093/petrology/42.2.407; SHIREY SB, 1995, ANAL CHEM, V67, P2136, DOI 10.1021/ac00109a036; Cohen AS, 1996, ANAL CHIM ACTA, V332, P269, DOI 10.1016/0003-2670(96)00226-7; CREASER RA, 1991, GEOCHIM COSMOCHIM AC, V55, P397, DOI 10.1016/0016-7037(91)90427-7; Jarvis I, 1997, ANALYST, V122, P19, DOI 10.1039/a606169i; Brick J. L., 1997, GEOSTANDARD NEWSLETT, V21, P19; Carter ES, 2005, CAN J EARTH SCI, V42, P777, DOI 10.1139/E05-020; CROCKET JH, 1968, J RADIOANAL CHEM, V1, P487, DOI 10.1007/BF02518480; Ely JC, 2003, CHEM GEOL, V196, P235, DOI 10.1016/S0009-2541(02)00415-1; GANAPATHY R, 1980, SCIENCE, V209, P921, DOI 10.1126/science.209.4459.921; Hori Rie, 1992, Journal of Geosciences Osaka City University, V35, P53; Hori RS, 2007, PALAEOGEOGR PALAEOCL, V244, P391, DOI 10.1016/j.palaeo.2006.06.038; Hori R.S., 1993, ISL ARC, V3, P170, DOI DOI 10.1111/J.1440-1738.1993.TB00084.X; Ishikawa A, 2014, CHEM GEOL, V384, P27, DOI 10.1016/j.chemgeo.2014.06.013; NADKARNI RA, 1974, ANAL CHEM, V46, P232, DOI 10.1021/ac60338a027; Olsen PE, 2002, GEOL SOC AM SPEC PAP, V356, P505; Pearson P. G., 2000, CHEM GEOL, V165, P87; Peucker-Ehrenbrink B., 2001, GEOCHEM GEOPHY GEOSY, V2, P1525; Ravizza G, 1997, CHEM GEOL, V141, P251, DOI 10.1016/S0009-2541(97)00091-0; Tanner LH, 2008, EARTH PLANET SC LETT, V274, P103, DOI 10.1016/j.epsl.2008.07.013; Tanner LH, 2005, EARTH PLANET SC LETT, V240, P634, DOI 10.1016/j.epsl.2005.09.050; Wakita K., 1988, B GEOL SURV JPN, V39, P675; WALCZYK T, 1991, FRESEN J ANAL CHEM, V341, P537, DOI 10.1007/BF00328491; Xu L, 2007, CHEM GEOL, V246, P55, DOI 10.1016/j.chemgeo.2007.08.013	32	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	MAY	2015	64	5					341	348				8	Chemistry, Analytical	Chemistry	CJ3CS	WOS:000355361600004		
J	Ariga, H; Tanaka, M				Ariga, Hiroka; Tanaka, Miho			Elucidation of Reaction Mechanism for Complex Formation of Silicate and Metal Ions in ESI-MS	BUNSEKI KAGAKU			Japanese	Article						silicate ion; ESI-MS; stability; metal ions	SI-29 NMR-SPECTROSCOPY; MASS-SPECTROMETRY; CHLORIDE SOLUTION; POLYMERIZATION	Silicate and metal species with both positive and negative ions in solutions were examined by electrospray ionization mass spectrometry (ESI-MS). Comparing with detected species in chloride solutions of group-2 elements and transition metals (MCl2), and silicate solutions with MCl2, the reaction mechanism of the silicate and metal complexes through the ESI-MS was elucidated, and the information on their stability was obtained. In the positive ion, it was shown that in both MCl2 solutions and silicate solutions with MCl2 that bivalent transition metals (Mn, Fe, Co, Ni, Cu, Zn) were more easily hydrolyzed than group-2 elements (Mg, Ca, Sr, Ba). It was also confirmed that Ca2+ made the most stable complex with silicate ion among Mg2+, Ca2+, Sr2+ and Ba2+. Concerning the negative ion, Ca2+ and Na+ were found to make stable complexes with silicate. Furthermore, the stability of M2+ with silicate were examined by controlling the ionization conditions, such as the CDL temperature or the ESI probe voltage, for both positive and negative ions. The results showed that, the silicate complexes with Ca2+ and Na+ were identified by negative ions. These negative complexes are concluded to exist as they were as original species in the solutions. From these results, the stability between silicate and M2+ depends on their ionic size. Thus, Ca2+ and Na+ with silicate possess high stability.	[Ariga, Hiroka; Tanaka, Miho] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan	Ariga, H (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.	mihotnk@kaiyodai.ac.jp					Pelster SA, 2006, J AM CHEM SOC, V128, P4310, DOI 10.1021/ja057423r; Hook RJ, 1996, J NON-CRYST SOLIDS, V195, P1, DOI 10.1016/0022-3093(95)00508-0; Aerts A, 2010, CHEM-EUR J, V16, P2764, DOI 10.1002/chem.200901688; Urabe T, 2007, J MASS SPECTROM, V42, P591, DOI 10.1002/jms.1188; Eggers K, 2005, INT J MASS SPECTROM, V244, P72, DOI 10.1016/j.ijms.2005.05.001; Goudarzi N, 2013, APPL MAGN RESON, V44, P469, DOI 10.1007/s00723-012-0394-x; Haouas M, 2014, MICROPOR MESOPOR MAT, V198, P35, DOI 10.1016/j.micromeso.2014.07.011; Hiraoka K., 2010, J MASS SPECTROM, V58, P139; Oikawa T, 2011, J SOLUTION CHEM, V40, P1094, DOI 10.1007/s10953-011-9696-0; Samadi-Maybodi A., 2007, J SOLUTION CHEM, V37, P413; Simonsen ME, 2009, INT J MASS SPECTROM, V285, P78, DOI 10.1016/j.ijms.2009.04.010; Simonsen ME, 2009, J SOL-GEL SCI TECHN, V50, P372, DOI 10.1007/s10971-009-1907-4; Smith R. M., 1976, CRITICAL STABILITY C, P1; Tanaka M, 2000, ANAL CHIM ACTA, V411, P109, DOI 10.1016/S0003-2670(00)00730-3	14	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	MAY	2015	64	5					349	358				10	Chemistry, Analytical	Chemistry	CJ3CS	WOS:000355361600005		
J	Noda, H; Ogata, T; Manabe, N				Noda, Hiroyuki; Ogata, Tateaki; Manabe, Norio			Evaluation for Thermal-oxidation Degree of Poly(Butylene Terephthalate) Mold Parts Using a Fluorescence Imaging Method with a UV Light Excitation	BUNSEKI KAGAKU			Japanese	Article						PBT; MMB; thermal oxidation; fluorescence imaging	DEGRADATION; PBT	An evaluation of the thermal-oxidation degree of poly(butylene terephthalate) [PBT] mold parts at practical temperatures was made by applying a fluorescence imaging method with a UV light excitation. Methyl 4-methoxybutyrate (MMB), based on the reactive pyrolysis-GC/MS method, was used as an index of the thermal-oxidation degree. The fluorescence intensities of the PBT mold parts increased with the increase of the thermal aging times at 120 - 180 degrees C. The fluorescence intensities also increased with the increase of the amount of MMB. From the above results, it is suggested that this method can be used as a useful technique for evaluating the thermal-oxidation degree of PBT mold parts.	[Noda, Hiroyuki; Ogata, Tateaki] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan; [Manabe, Norio] Sumitomo Wiring Syst Co Ltd, Res & Evaluat Ctr, Suzuka Shi, Mie 5138631, Japan	Noda, H (reprint author), Yamagata Univ, Grad Sch Sci & Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	hironoda@yz.yamagata-u.ac.jp					MONTAUDO G, 1993, POLYM DEGRAD STABIL, V42, P13, DOI 10.1016/0141-3910(93)90021-A; [Anonymous], 1981, 746B UL; Dobkowski Z., 1997, J THERMAL ANAL CALOR, V48, P393; Giannoni S, 2003, J MATER RES, V18, P1342, DOI 10.1557/JMR.2003.0184; Kaufmann W., 1982, KUNSTS GERPLAST, V72, P11; Kellehfer P. G., 1979, TECH C SOC PLAST ENG, V37th, P527; Lebok F. J., 1987, WERKSTOFFTECHNIK, V18, P15; Lin H-F., 1992, SOC PLAST ENG ANN TE, V50th, P1558; Manabe N, 2000, POLYM DEGRAD STABIL, V69, P183, DOI 10.1016/S0141-3910(00)00059-8	9	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	MAY	2015	64	5					359	362				4	Chemistry, Analytical	Chemistry	CJ3CS	WOS:000355361600006		
J	Kaneko, T; Nojima, H; Suzuki, Y				Kaneko, Tsuyoshi; Nojima, Hiroka; Suzuki, Yusuke			Development and Applications of a Sampling Device Using Micro Coil for GC	BUNSEKI KAGAKU			Japanese	Article						micro coil; sampling device; gas chromatography; forensic science; vegetable oil	THERMALLY ASSISTED HYDROLYSIS; VEGETABLE-OILS; METHYLATION	A simple and rapid procedure was developed for the gas chromatographic analysis of vegetable oil involved in a crime. This procedure was performed using a syringe-type device. This device consists of a stainless-steel micro coil that is attached to a retractable plunger wire, which fits inside of a syringe needle housing. This device using a micro coil was called MCSD (Micro Coil Sampling Device), and was used as follows. In the first step, sampling was accomplished by dipping the end of the micro coil in a trace amount of oil, which was drawn into the micro coil by capillary action, and introducing it into the injection port of a gas chromatograph. Unsaponifiable constituents, such as sterols, could be detected by thermal desorption from the micro coil in the injection port. After thermal desorption, a GC/MS measurement of unsaponifiable constituents, a trimethylphenylammonium hydroxide solution was added to the remaining acylglycerols on a micro coil. Then, the micro coil was introduced into the injection port of the gas chromatograph to observe the fatty acid components by thermochemolysis with an esterification reagent. This procedure used MCSD could serve as a useful and powerful tool for forensic inspection of vegetable oil.	[Kaneko, Tsuyoshi; Nojima, Hiroka; Suzuki, Yusuke] Chiba Pref Police HQ, Forens Sci Lab, Chuo Ku, Chiba, Chiba 2600024, Japan	Kaneko, T (reprint author), Chiba Pref Police HQ, Forens Sci Lab, Chuo Ku, 1-71-1 Chuoko, Chiba, Chiba 2600024, Japan.	cat3666@k3.dion.ne.jp					Amphaisri K, 2011, J CHROMATOGR A, V1218, P972, DOI 10.1016/j.chroma.2010.12.065; Xu ZM, 1999, J AGR FOOD CHEM, V47, P2724, DOI 10.1021/jf981175j; Pitts SJ, 2003, J FORENSIC SCI, V48, P1293; Stauffer E, 2006, J FORENSIC SCI, V51, P1016, DOI 10.1111/j.1556-4029.2006.00220.x; Cert A, 2000, J CHROMATOGR A, V881, P131, DOI 10.1016/S0021-9673(00)00389-7; Challinor JM, 1996, J ANAL APPL PYROL, V37, P185, DOI 10.1016/0165-2370(96)00946-1; Hermosin B, 1999, J ANAL APPL PYROL, V49, P417, DOI 10.1016/S0165-2370(98)00111-9; Ishida Y, 1999, J ANAL APPL PYROL, V49, P267, DOI 10.1016/S0165-2370(98)00095-3; LLOYD JBF, 1973, J CHROMATOGR, V77, P228, DOI 10.1016/S0021-9673(00)93952-9; Mikuma T, 2010, FORENSIC SCI INT, V198, P79, DOI 10.1016/j.forsciint.2010.01.005	10	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	MAY	2015	64	5					363	369				7	Chemistry, Analytical	Chemistry	CJ3CS	WOS:000355361600007		
J	Yanase, K; Matsuzaki, M; Sawamura, D; Nakamura, K; Morioka, K; Nakai, I				Yanase, Kazuya; Matsuzaki, Mayumi; Sawamura, Daichi; Nakamura, Kazuyuki; Morioka, Kenji; Nakai, Izumi			Characterization of Ancient Japanese Glass Excavated from Aechaeological Sites of the Epi-Jomon Period in Hokkaido by XRF Analysis	BUNSEKI KAGAKU			Japanese	Article						portable X-ray fluorescence spectrometer; Hokkaido; ancient glass; Epi-Jomon period; non-destructive analysis		Ancient glass beads from the Epi-Jomon period, excavated from 7 archaeological sites in Hokkaido, were non-destructively analyzed by using a portable XRF spectrometer. The origin and distribution of the glass beads were analyzed based on their quantitative chemical compositions. The chemical compositions of glass beads from Hokkaido can be classified into two glass types based on their major components: i.e., potash silica glass type (K2O-SiO2) and soda lime silica glass (Na2O-CaO-SiO2). The heavy trace element compsitions of glass beads excavated from Hokkaido were basically similar to those excavated from the Kyushu region, Kanto region and Southeast Asia, as reported in our previous studies. From these results it has been found for the first time that glass beads exist with the same origin as those from Honshu distibuted in Hokkaido in Epi-Jomon period.	[Yanase, Kazuya; Matsuzaki, Mayumi; Sawamura, Daichi; Nakai, Izumi] Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan; [Nakamura, Kazuyuki] Hakodate Coll, Natl Inst Technol, Hakodate, Hokkaido 0428501, Japan; [Morioka, Kenji] Hist Museum Saru River, Biratori, Hokkaido 0550101, Japan	Yanase, K (reprint author), Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, 3-1 Kagurazaka, Tokyo 1628601, Japan.	inakai@rs.kagu.tus.ac.jp					Lankton JW, 2006, J GLASS STUD, V48, P121; SAYRE EV, 1961, SCIENCE, V133, P1824, DOI 10.1126/science.133.3467.1824; Nakai I., 2012, ANAL REPORT GLASS CO, P1; Nakai I., 2013, ANAL REPORT GLASS CO, P1; Sayre E. V., 1963, ADV GLASS TECHNOLOGY, V2, P263	5	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	MAY	2015	64	5					371	377				7	Chemistry, Analytical	Chemistry	CJ3CS	WOS:000355361600008		
J	Sugimura, N; Yatsu, T; Igarashi, Y; Shibue, T				Sugimura, Natsuhiko; Yatsu, Takahiro; Igarashi, Yoko; Shibue, Toshimichi			Alkoxysiloxane Oligomer as Reference of Density Functional Theory Calculation for Si-29-NMR Sol-Gel Chemistry	BUNSEKI KAGAKU			Japanese	Article						density functional theory; sol-gel chemistry; Si-29-NMR; gauge-including atom orbital method	NMR CHEMICAL-SHIFTS; SPIN COUPLING-CONSTANTS; DFT CALCULATIONS; SILANE	We tested a practical method for reducing the error in computed the Si-29-NMR chemical shifts of sol-gel chemistry. Alkoxysiloxane oligomer Si[OSiMe(OMe)(2)](4) was employed as a reference compound of a density functional theory calculation (DFT). Tha alkoxysiloxane oligomer Si[OSiMe(OMe)(2)](4) is a symmetric molecular structure, which has two chemical shift values (-50 ppm, -100 ppm) of an important range for sol-gel chemistry. These two reference points could reduce any systematic errors of a DFT calculation for Si-29-NMR. The alkoxysiloxane oligomer reference method had a smaller DFT basis set dependence than did the tetramethylsilane reference method, and provided better root-mean-square errors.	[Sugimura, Natsuhiko; Yatsu, Takahiro; Igarashi, Yoko; Shibue, Toshimichi] Waseda Univ, Mat Characterizat Cent Lab, Shinjuku Ku, Tokyo 1698555, Japan	Sugimura, N (reprint author), Waseda Univ, Mat Characterizat Cent Lab, Shinjuku Ku, 3-4-1 Ohkubo, Tokyo 1698555, Japan.	shib@waseda.jp					Ambati J, 2010, J PHYS CHEM A, V114, P5279, DOI 10.1021/jp911327a; Anafcheh M, 2012, PHYSICA E, V44, P2099, DOI 10.1016/j.physe.2012.06.023; GAUSS J, 1992, CHEM PHYS LETT, V191, P614, DOI 10.1016/0009-2614(92)85598-5; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Epping JD, 2010, J AM CHEM SOC, V132, P5443, DOI 10.1021/ja1004812; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; WOLINSKI K, 1990, J AM CHEM SOC, V112, P8251, DOI 10.1021/ja00179a005; Wakabayashi R, 2011, ANGEW CHEM INT EDIT, V50, P10708, DOI 10.1002/anie.201104948; Casanovas J, 2000, CHEM PHYS LETT, V326, P523, DOI 10.1016/S0009-2614(00)00818-6; Kuroda K, 2014, CHEM MATER, V26, P211, DOI 10.1021/cm4023387; Loy DA, 2000, CHEM MATER, V12, P3624, DOI 10.1021/cm000451i; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Sefzik TH, 2005, J PHYS CHEM A, V109, P1180, DOI 10.1021/jp0455780; Butler KT, 2012, J PHYS CHEM A, V116, P8786, DOI 10.1021/jp306119n; Cadars S, 2009, PHYS CHEM CHEM PHYS, V11, P1825, DOI 10.1039/b815361b; Casserly TB, 2005, J PHYS CHEM B, V109, P13605, DOI 10.1021/jp044385+; Chernyshev K A., 2013, RUSS J ORG CHEM+, V48, P1518; Corminboeuf C, 2002, CHEM PHYS LETT, V357, P1, DOI 10.1016/S0009-2614(02)00372-X; Du V. A., 2011, EUR J INORG CHEM, V2011, P3365; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Heine T, 2001, J PHYS CHEM A, V105, P620, DOI 10.1021/jp002495k; Poblador-Bahamonde AI, 2011, DALTON T, V40, P11321, DOI 10.1039/c1dt11135c; Rusakov YY, 2013, MAGN RESON CHEM, V51, P557, DOI 10.1002/mrc.3986; Selvaraj K, 2009, MICROPOR MESOPOR MAT, V122, P105, DOI 10.1016/j.micromeso.2009.02.022; Wakabayashi R, 2010, ANGEW CHEM INT EDIT, V49, P5273, DOI 10.1002/anie.201001640; Wakabayashi R, 2012, J ORGANOMET CHEM, V716, P26, DOI 10.1016/j.jorganchem.2012.05.033; Xue XY, 2000, SOLID STATE NUCL MAG, V16, P245, DOI 10.1016/S0926-2040(00)00075-8; Zhang C, 2014, PHYS CHEM CHEM PHYS, V16, P16642, DOI 10.1039/c4cp01736f	28	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	MAY	2015	64	5					379	383				5	Chemistry, Analytical	Chemistry	CJ3CS	WOS:000355361600009		
J	Ladislav, R; Ladislav, S; Akira, M; Mirko, S; Yoonseong, P; Dusan, Z				Ladislav, Roller; Ladislav, Simo; Akira, Mizoguchi; Mirko, Slovak; Yoonseong, Park; Dusan, Zitnan			Orcokinin-like immunoreactivity in central neurons innervating the salivary glands and hindgut of ixodid ticks	CELL AND TISSUE RESEARCH			English	Article						Neuropeptides; Orcokinin; Synganglion; Salivary gland; Hindgut; Tick	BLACK-LEGGED TICK; LONE STAR TICK; WATER-BALANCE; DERMACENTOR-VARIABILIS; MYOINHIBITORY PEPTIDE; ORCONECTES-LIMOSUS; RHODNIUS-PROLIXUS; SCAPULARIS; NEUROPEPTIDES; SIFAMIDE	Orcokinins are conserved neuropeptides within the Arthropoda but their cellular distribution and functions in ticks are unknown. We use an antibody against the highly conserved N-terminal (NFDEIDR) of mature orcokinin peptides to examine their distribution in six ixodid species: Amblyomma variegatum, Dermacentor reticulatus, Hyalomma anatolicum, Ixodes scapularis, Ixodes ricinus and Rhipicephalus appendiculatus. Numerous immunoreactive neurons (similar to 100) were detected in various regions of the synganglion (central nervous system) in all examined tick species. Immunoreactive projections of two prominent groups of efferent neurons in the post-oesophageal region were examined in detail: (1) neurons innervating the salivary glands; (2) neurons innervating the hindgut. Using matrix-assisted laser desorption/ ionisation-time-of-flight (MALDI-TOF), we detected orcokinin peaks in extracts of the synganglia and hindguts but not in the salivary glands of I. scapularis females. Our data provide further evidence of the presence of orcokinin in ixodid ticks and establish a morphological basis for functional studies of identified peptidergic neuronal networks.	[Ladislav, Roller; Mirko, Slovak; Dusan, Zitnan] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Ladislav, Simo; Yoonseong, Park] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Akira, Mizoguchi] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan	Dusan, Z (reprint author), Slovak Acad Sci, Inst Zool, Bratislava, Slovakia.	dusan.zitnan@savba.sk			Research and Development Operational Programme - European Regional Development Fund [ITMS: 26240220044]; National Institute of Health [R01AI090062]	This study was supported by the Research and Development Operational Programme funded by the European Regional Development Fund (ITMS: 26240220044); L.S. and Y.P. were supported by the National Institute of Health (grant no. R01AI090062).	SAUER JR, 1995, ANNU REV ENTOMOL, V40, P245, DOI 10.1146/annurev.en.40.010195.001333; Hofer S, 2005, J COMP NEUROL, V490, P57, DOI 10.1002/cne.20650; Dircksen H, 2000, J EXP BIOL, V203, P2807; Donohue KV, 2010, INSECT BIOCHEM MOLEC, V40, P79, DOI 10.1016/j.ibmb.2009.12.014; Hofer S, 2006, J EXP BIOL, V209, P2794, DOI 10.1242/jeb.02307; Christie AE, 2008, GEN COMP ENDOCR, V157, P174, DOI 10.1016/j.ygcen.2008.03.027; Brugge VAT, 2008, J EXP BIOL, V211, P382, DOI 10.1242/jeb.013771; Pascual N, 2004, INSECT BIOCHEM MOLEC, V34, P1141, DOI 10.1016/j.ibmb.2004.07.005; KAUFMAN WR, 1973, J EXP BIOL, V58, P523; Yasuda-Kamatani Y, 2000, GEN COMP ENDOCR, V118, P161, DOI 10.1006/gcen.1999.7453; STANGIER J, 1992, PEPTIDES, V13, P859, DOI 10.1016/0196-9781(92)90041-Z; Terhzaz S, 2007, BIOCHEM BIOPH RES CO, V352, P305, DOI 10.1016/j.bbrc.2006.11.030; Veenstra JA, 2014, CELL TISSUE RES, V357, P607, DOI 10.1007/s00441-014-1880-2; SAUER JR, 1971, J MED ENTOMOL, V8, P479; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Fu Q, 2005, J COMP NEUROL, V493, P607, DOI 10.1002/cne.20773; Li LJ, 2002, J COMP NEUROL, V444, P227, DOI 10.1002/cne.10139; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Neupert S, 2009, J PROTEOMICS, V72, P1040, DOI 10.1016/j.jprot.2009.06.007; Yamanaka N, 2011, J COMP NEUROL, V519, P238, DOI 10.1002/cne.22517; Balashov YS, 1983, ATLAS IXODID TICK UL; Bhatt G, 2014, PEPTIDES, V53, P148, DOI 10.1016/j.peptides.2013.04.009; Binnington KC, 1978, TISSUE CELL, V13, P475; COONS LB, 1994, INT J PARASITOL, V24, P551, DOI 10.1016/0020-7519(94)90147-3; Coons Lewis B., 1999, P267; Dyrlov JB, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Fawcett D.W., 1986, P22; Jasik K, 2004, EXP APPL ACAROL, V32, P219, DOI 10.1023/B:APPA.0000021805.51307.37; KAUFMAN WR, 1973, J EXP BIOL, V58, P537; KROLAK JM, 1982, J PARASITOL, V68, P61, DOI 10.2307/3281326; Lange AB, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00098; Persson MGS, 2001, J NEUROBIOL, V48, P19, DOI 10.1002/neu.1040; Remedio RN, 2013, PARASITOL RES, V112, P415, DOI 10.1007/s00436-012-3153-x; Richards OW, 1977, IMMS GEN TXB ENTOMOL, V1; Simo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016158; Simo L, 2013, INSECT BIOCHEM MOLEC, V43, P376, DOI 10.1016/j.ibmb.2013.01.002; Simo L., 2014, BIOL TICKS, V1, P309; Simo L, 2009, CELL TISSUE RES, V335, P639, DOI 10.1007/s00441-008-0731-4; Simo L, 2014, INT J PARASITOL, V44, P819, DOI 10.1016/j.ijpara.2014.06.007; Simo L, 2009, J COMP NEUROL, V517, P551, DOI 10.1002/cne.22182; Simo L, 2014, J COMP NEUROL, V522, P2038, DOI 10.1002/cne.23515; Slovak M, 2002, BIOLOGIA, V57, P261; Sonenshine DE, 1991, BIOL TICKS, V1; Steen NA, 2006, TOXICON, V47, P1, DOI 10.1016/j.toxicon.2005.09.010; TARNOWSKI BI, 1989, EXP APPL ACAROL, V6, P263, DOI 10.1007/BF01193300; Veenstra JA, 1997, J BIOL CHEM, V272, P10402; ZHU XX, 1995, EXP APPL ACAROL, V19, P1, DOI 10.1007/BF00051932	47	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	MAY	2015	360	2					209	222		10.1007/s00441-015-2121-z		14	Cell Biology	Cell Biology	CJ5XS	WOS:000355567700002		
J	Onouchi, S; Ichii, O; Otsuka-Kanazawa, S; Kon, Y				Onouchi, Sawa; Ichii, Osamu; Otsuka-Kanazawa, Saori; Kon, Yasuhiro			Asymmetric morphology of the cells comprising the inner and outer bending sides of the murine duodenojejunal flexure	CELL AND TISSUE RESEARCH			English	Article						Morphogenesis; Duodenojejunal flexure; Morphological asymmetry; Inner bending side; Outer bending side	NERVOUS-SYSTEM DEVELOPMENT; GUT; DIFFERENTIATION; DISEASE; MOUSE; MORPHOGENESIS; MECHANISMS; MIGRATION; GROWTH; HEART	The asymmetric shape of component cells determines the asymmetric features of developing organs. Here, we focused on the murine duodenojejunal flexure (DJF), which bends without affecting the mesentery, and analyzed the morphological asymmetries of the mucosal epithelium and gut wall cells between the inner and outer bending sides at embryonic days 10.75-11.75. In the mucosal epithelium, the cell shape and the expression of epithelial markers (Cdx2, Ecadherin) showed no differences between the two DJF sides. In contrast, the gut wall cells comprising the inner and outer sides of the DJF were elongated along the inner-outer axis and perpendicular to this axis, respectively. Furthermore, the gut wall cells in the outer side possessed cytoplasmic processes connecting cells via adherens junctions, but those in the inner side were attached via adherens junctions of juxtaposed cell bodies and were relatively more crowded. In immunohistochemistry experiments, there was no remarkable difference in the positive reactions of markers for mesenchyme (vimentin), smooth muscle cells (alpha SMA), endothelial cells (LYVE-1, CD34), and undifferentiated neurons (Sox10) between the DJF sides. Interestingly, Tuj1-positive cells, indicating differentiated neurons, were observed in the middle layer of the gut wall, and these cells were significantly more abundant and tended to be larger in the inner side than in the outer side of the DJF. In conclusion, we clarified the asymmetries of gut wall cell morphology and neural differentiation between the inner and outer sides of the DJF. These characteristics of the developing murine DJF indicate its asymmetric formation.	[Onouchi, Sawa; Ichii, Osamu; Otsuka-Kanazawa, Saori; Kon, Yasuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab,Kita Ku, Sapporo, Hokkaido 0600818, Japan	Kon, Y (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Anat Lab,Kita Ku, Kita 18,Nishi 9, Sapporo, Hokkaido 0600818, Japan.	y-kon@vetmed.hokudai.ac.jp			Hokkaido University Leading Graduate School Veterinary Science; JSPS KAKENHI [2566024603, 2600167304]	This work was supported by grant-in-aid for scientific research in academic year 2013 (for graduate students) from Hokkaido University Leading Graduate School Veterinary Science. This work was also supported by the JSPS KAKENHI (grant numbers 2566024603 and 2600167304).	Savin T, 2011, NATURE, V476, P57, DOI 10.1038/nature10277; Davis NM, 2008, DEV CELL, V15, P134, DOI 10.1016/j.devcel.2008.05.001; Kim KE, 2007, DEV DYNAM, V236, P2020, DOI 10.1002/dvdy.21200; Taber LA, 2006, INT J DEV BIOL, V50, P323, DOI 10.1387/ijdb.052045lt; Fu M, 2004, J CELL BIOL, V166, P673, DOI 10.1083/jcb.200401077; Vokes SA, 2004, DEVELOPMENT, V131, P4371, DOI 10.1242/dev.01304; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; Mackie AR, 2011, TEX HEART I J, V38, P474; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Eckes B, 2000, J CELL SCI, V113, P2455; Tondeleir D, 2009, CELL MOTIL CYTOSKEL, V66, P798, DOI 10.1002/cm.20350; Bondurand N, 2013, DEV BIOL, V382, P330, DOI 10.1016/j.ydbio.2013.04.024; Bondow BJ, 2012, DEV BIOL, V371, P1, DOI 10.1016/j.ydbio.2012.06.005; Kathiriya IS, 2000, AM J MED GENET, V97, P271, DOI 10.1002/1096-8628(200024)97:4<271::AID-AJMG1277>3.0.CO;2-O; Welsh IC, 2013, DEV CELL, V26, P629, DOI 10.1016/j.devcel.2013.07.019; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; Burn SF, 2009, BIOESSAYS, V31, P1026, DOI 10.1002/bies.200900056; Gutierrez-Mazariegos J, 2011, SEMIN CELL DEV BIOL, V22, P603, DOI 10.1016/j.semcdb.2011.06.001; Harrison C, 2013, NEUROGASTROENT MOTIL, V25, P554, DOI 10.1111/nmo.12142; Lake JI, 2013, AM J PHYSIOL-GASTR L, V305, pG1, DOI 10.1152/ajpgi.00452.2012; Liu JAJ, 2014, NEUROSIGNALS, V22, P1, DOI 10.1159/000356305; Makinena T, 2007, CELL MOL LIFE SCI, V64, P1915, DOI 10.1007/s00018-007-7040-z; Onouchi S, 2013, J ANAT, V223, P385, DOI 10.1111/joa.12093; Spence JR, 2011, DEV DYNAM, V240, P501, DOI 10.1002/dvdy.22540	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	MAY	2015	360	2					273	285		10.1007/s00441-014-2091-6		13	Cell Biology	Cell Biology	CJ5XS	WOS:000355567700007		
J	Seguchi, S; Yue, F; Asanuma, K; Sasaki, K				Seguchi, S.; Yue, F.; Asanuma, K.; Sasaki, K.			Experimental splenosis in the liver and lung spread through the vasculature	CELL AND TISSUE RESEARCH			English	Article						Splenosis; Intra-organ; Lung; Liver; Wistar rat model	SPLENIC WHITE PULP; INTRAHEPATIC SPLENOSIS; SPLENECTOMIZED RATS; TISSUE; REGENERATION; MIMICKING; SPLEEN; MICE; AUTOTRANSPLANTATION; IMPLANTATION	To demonstrate that intra-organ splenosis can engraft and develop after being distributed through the vasculature, tiny fragments of splenic tissues were injected into the inferior vena cava or the portal vein to induce intrapulmonary and intrahepatic splenosis in rats. After 1 month, splenic autograft structures in the lung and liver were assessed for structure by histology, for immunologic compartments by immunohistochemistry, for phagocytic function by carbon uptake and for vascular formation by Microfil (a silicon rubber compound) injection. Intrapulmonary and intrahepatic splenoses were indeed able to spread through the vasculature. The intrapulmonary splenic autografts were trapped and spread out in the interstitium, without forming a capsule. White pulp was markedly developed, showing lymphocyte aggregations that consisted in B cells surrounding the dilated vessel. Splenic sinuses were not definitively observed. Although macrophages were detected by immunohistochemistry, they showed no indication of having phagocytized carbon particles from the vessels, implying a closed circulation. In contrast, intrahepatic splenic autografts formed well-developed capsules, trabeculae and red pulp with splenic sinuses. Macrophages detected by immunohistochemistry were observed capturing carbon particles, which clearly revealed an open system circulation, as seen in normal rat spleen. The development of white pulp was poor and lymphocytes consisting in B cells aggregated in the peripheral margins. These results demonstrate that intra-organ splenosis can spread through the vasculature and that the morphologic and immunologic structures formed in these regenerated autografts are influenced by the organ vasculature and extracellular matrix wherein the tissue fragments settled.	[Seguchi, S.; Yue, F.; Asanuma, K.; Sasaki, K.] Shinshu Univ, Sch Med, Dept Histol & Embryol, Matsumoto, Nagano 3908621, Japan	Sasaki, K (reprint author), Shinshu Univ, Sch Med, Dept Histol & Embryol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	katsmd@shinshu-u.ac.jp					Rickert CH, 1998, AM J SURG PATHOL, V22, P894, DOI 10.1097/00000478-199807000-00011; Kwok CM, 2006, MED HYPOTHESES, V67, P1330, DOI 10.1016/j.mehy.2006.04.064; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Tanaka H, 1996, J ELECTRON MICROSC, V45, P407; IINUMA H, 1992, J SURG RES, V53, P109, DOI 10.1016/0022-4804(92)90021-Q; Nolte MA, 2002, IMMUNOLOGY, V106, P299, DOI 10.1046/j.1365-2567.2002.01443.x; BASILE RM, 1989, ARCH SURG-CHICAGO, V124, P1087; BERGMANN L, 1990, ARCH ORTHOP TRAUM SU, V109, P102, DOI 10.1007/BF00439388; Buebbinder JH, 1939, SURGERY, V6, P927; CORAZZA GR, 1984, BRIT MED J, V289, P861; Davidson LA, 1997, J CLIN PATHOL, V50, P532, DOI 10.1136/jcp.50.6.532; Fefrman I, 1991, J EMERGENCY MED, V9, P239; Gueders MM, 2006, EUR J PHARMACOL, V533, P133, DOI 10.1016/j.ejphar.2005.12.082; IINUMA H, 1989, J INFECT DIS, V160, P66; Jonson J, 1989, AM J ANAT, V185, P89; Kang Kyu Chul, 2011, J Gastric Cancer, V11, P64, DOI 10.5230/jgc.2011.11.1.64; Lee JB, 2002, SURG TODAY, V32, P180; Liu YH, 2012, INT J MED SCI, V9, P174, DOI 10.7150/ijms.3983; PABST R, 1980, CELL TISSUE RES, V209, P137; PABST R, 1985, J TRAUMA, V25, P326, DOI 10.1097/00005373-198504000-00008; Page JB, 2006, THESCIENTIFICWORLDJO, V6, P2442, DOI 10.1100/tsw.2006.380; PATEL J, 1982, SURGERY, V91, P638; Sandri GBL, 2014, LIVER INT, V34, P162, DOI 10.1111/liv.12250; Sarda R, 2001, DIAGN CYTOPATHOL, V24, P352, DOI 10.1002/dc.1076; Sasaki K, 1989, CLIN ANAT, V2, P175, DOI 10.1002/ca.980020307; SASAKI K, 1991, CELL TISSUE RES, V265, P503, DOI 10.1007/BF00340873; SASAKI K, 1990, ACTA ANAT, V139, P315; SASAKI K, 1990, APMIS, V98, P507; SIRINEK KR, 1984, SOUTHERN MED J, V77, P764, DOI 10.1097/00007611-198406000-00026; WALKER DC, 1994, MICROVASC RES, V48, P259, DOI 10.1006/mvre.1994.1054; YOSHIDA K, 1993, CELL TISSUE RES, V272, P1, DOI 10.1007/BF00323564; YOSHIMITSU K, 1993, ABDOM IMAGING, V18, P156; Zhao Ming, 2004, Chin J Traumatol, V7, P62	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	MAY	2015	360	2					287	296		10.1007/s00441-014-2097-0		10	Cell Biology	Cell Biology	CJ5XS	WOS:000355567700008		
J	Akisaka, T; Yoshida, A				Akisaka, Toshitaka; Yoshida, Atsushi			Visualization of structural organization of ventral membranes of sheared-open resorbing osteoclasts attached to apatite pellets	CELL AND TISSUE RESEARCH			English	Article						Resorbing osteoclasts; Membrane modification; Podosome; Actin polarity; Clathrin sheets	CLATHRIN-DEPENDENT ENDOCYTOSIS; CELL SUBSTRATUM ADHESIONS; ACTIN-FILAMENTS; RUFFLED BORDER; INTERFERENCE REFLECTION; CULTURED OSTEOCLASTS; RESORPTION CYCLE; SEALING ZONE; COATED PITS; PODOSOMES	Osteoclasts are highly polarized cells from both morphological and functional points of view. Using quick-freeze, rotary-replication methods combined with cell-shearing, we clarified the variability of cytoplasmic surface of the polarized membranes of osteoclasts seeded on apatite. As to the organization of actin filaments and clathrin sheets, we confirmed almost the same ventral membrane specializations of osteoclasts on apatite as seen on glass plates. The organized actin filaments and membrane-associated particles supported the ruffled border membranes. Inside the actin sealing zone, membrane specializations were not always occupied with the ruffled border but also with other types of membranes. Some osteoclasts formed an actin ring but lacked the ruffled border projections. We report a unique and distinctive membrane modification of apatite-attached osteoclasts, i.e., the presence of dense aggregates of membrane-associated particles and related structures not found in the osteoclasts seeded on glass plates. Actin filament polarity in the podosomes was determined by decoration with myosin S1. The actin filament polarity within podosome appears to be oriented predominantly with its barbed ends toward the core, whereas the interconnecting F-actin appears to be mixed oriented. Two different types of clathrin plaques displayed different distributions: clathrin-dependent endocytosis was observed in the ruffled border regions, whereas flat clathrin sheets were found in the leading edge of lamellipodia and near podosomes. The clathrin sheets adhered to the apatite surface tightly on the ventral membranes overlaying the resorption lacunae. All these membrane specializations as mentioned above may indicate the functional variability of osteoclasts seeded on apatite.	[Akisaka, Toshitaka; Yoshida, Atsushi] Osaka Univ, Grad Sch Dent, Dept Oral Anat & Neurobiol, Suita, Osaka 5650871, Japan	Akisaka, T (reprint author), Osaka Univ, Grad Sch Dent, Dept Oral Anat & Neurobiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	takisaka@dent.osaka-u.ac.jp; yoshida@dent.osaka-u.ac.jp					AGGELER J, 1982, J CELL BIOL, V94, P613, DOI 10.1083/jcb.94.3.613; AGGELER J, 1983, J CELL BIOL, V97, P1452, DOI 10.1083/jcb.97.5.1452; Akisaka T, 2003, J ELECTRON MICROSC, V52, P535, DOI 10.1093/jmicro/52.6.535; Akisaka T, 2001, J BONE MINER RES, V16, P1248, DOI 10.1359/jbmr.2001.16.7.1248; Akisaka T, 2006, J ELECTRON MICROSC, V55, P53, DOI 10.1093/jmicro/dfl012; Akisaka T, 1997, J ANAT, V190, P433, DOI 10.1046/j.1469-7580.1997.19030433.x; Akisaka T, 2008, CELL TISSUE RES, V331, P625, DOI 10.1007/s00441-007-0552-x; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; LAKKAKORPI PT, 1991, J BONE MINER RES, V6, P817; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Mulari MTK, 2003, TRAFFIC, V4, P113, DOI 10.1034/j.1600-0854.2003.40206.x; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; GAVAZZI I, 1989, J CELL SCI, V94, P85; ZAMBONINZALLONE A, 1988, J BONE MINER RES, V3, P517; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Akisaka T, 2011, J HISTOCHEM CYTOCHEM, V59, P630, DOI 10.1369/0022155411405334; VERSCHUEREN H, 1985, J CELL SCI, V75, P279; LARKIN JM, 1986, J CELL BIOL, V103, P2619, DOI 10.1083/jcb.103.6.2619; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Badowski C, 2008, MOL BIOL CELL, V19, P633, DOI 10.1091/mbc.E06-01-0088; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Babb SG, 1997, CELL MOTIL CYTOSKEL, V37, P308; Batchelder EM, 2010, MOL BIOL CELL, V21, P3070, DOI 10.1091/mbc.E09-12-1044; Chabadel A, 2007, MOL BIOL CELL, V18, P4899, DOI 10.1091/mbc.E07-04-0378; Collins A, 2011, CURR BIOL, V21, P1157; De Deyne PG, 1998, J CELL SCI, V111, P2729; Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037; Geblinger D, 2009, CHEMBIOCHEM, V10, P158, DOI 10.1002/cbic.200800549; Heuser JE, 1983, MOL BIOL, V160, P97; Lakkakorpi PT, 1996, MICROSC RES TECHNIQ, V33, P171, DOI 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W; Linder S, 2000, J CELL SCI, V113, P4165; Luxenburg C, 2006, EUR J CELL BIOL, V85, P203, DOI 10.1016/j.ejcb.2005.11.002; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; MAUPIN P, 1983, J CELL BIOL, V96, P51, DOI 10.1083/jcb.96.1.51; NERMUT MV, 1991, EXP CELL RES, V193, P382, DOI 10.1016/0014-4827(91)90111-7; NERMUT MV, 1986, EUR J CELL BIOL, V42, P35; NICOL A, 1987, EUR J CELL BIOL, V43, P348; ONO M, 1993, BIOL CELL, V77, P219, DOI 10.1016/S0248-4900(05)80191-1; Palokangas H, 1997, J CELL SCI, V110, P1767; PIERCE A, 1988, J SUBMICR CYTOL PATH, V20, P161; PUMPLIN DW, 1989, J CELL BIOL, V109, P739, DOI 10.1083/jcb.109.2.739; Pumplin DW, 1990, CELL MOTIL CYTOSKEL, V15, P123; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; SAMUELSSON SJ, 1993, J CELL BIOL, V122, P485, DOI 10.1083/jcb.122.2.485; Stenbeck G, 2004, J CELL SCI, V117, P827, DOI 10.1242/jcs.00935; Stenbeck G, 2000, J CELL SCI, V113, P1577; Svitkina TM, 1995, J STRUCT BIOL, V115, P290, DOI 10.1006/jsbi.1995.1054; Szewczyk KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060285; Traub LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000192; Traub LM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001037; Verkhovsky AB, 1997, J CELL SCI, V110, P1693	55	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	MAY	2015	360	2					347	362		10.1007/s00441-014-2085-4		16	Cell Biology	Cell Biology	CJ5XS	WOS:000355567700013		
J	Fukuda, H; Hidaka, T; Takagi-Akiba, M; Ichimura, K; Trejo, JAO; Sasaki, Y; Wang, J; Sakai, T; Asanuma, K; Tomino, Y				Fukuda, Hiromitsu; Hidaka, Teruo; Takagi-Akiba, Miyuki; Ichimura, Koichiro; Trejo, Juan Alejandro Oliva; Sasaki, Yu; Wang, Juan; Sakai, Tatsuo; Asanuma, Katsuhiko; Tomino, Yasuhiko			Podocin is translocated to cytoplasm in puromycin aminonucleoside nephrosis rats and in poor-prognosis patients with IgA nephropathy	CELL AND TISSUE RESEARCH			English	Article						Podocyte; Podocin; Synaptopodin; IgA nephropathy; Puromycin aminonucleoside nephrosis rats	FOOT PROCESS EFFACEMENT; SLIT DIAPHRAGM; GLOMERULAR PODOCYTES; PAN NEPHROSIS; NEPHRIN; ENDOCYTOSIS; INJURY; NPHS2; MICRODOMAINS; MUTATIONS	Podocytes serve as the final barrier to urinary protein loss through a highly specialized structure called a slit membrane and maintain foot process and glomerular basement membranes. Podocyte injury results in progressive glomerular damage and accelerates sclerotic changes, although the exact mechanism of podocyte injury is still obscure. We focus on the staining gap (podocin gap) defined as the staining difference between podocin and synaptopodin, which are normally located in the foot process. In puromycin aminonucleoside nephrosis rats, the podocin gap is significantly increased (p<0.05) and podocin is translocated to the cytoplasm on days 7 and 14 but not on day 28. Surprisingly, the gap is also significantly increased (p<0.05) in human kidney biopsy specimens of poor-prognosis IgA nephropathy patients. This suggests that the podocin gap could be a useful marker for classifying the prognosis of IgA nephropathy and indicating the translocation of podocin to the cytoplasm. Next, we find more evidence of podocin trafficking in podocytes where podocin merges with Rab5 in puromycin aminonucleoside nephrosis rats at day 14. In immunoelectron microscopy, the podocin positive area was significantly translocated from the foot process areas to the cytoplasm (p<0.05) on days 7 and 14 in puromycin aminonucleoside nephrosis rats. Interestingly, podocin is also translocated to the cytoplasm in poor-prognosis human IgA nephropathy. In this paper, we demonstrate that the translocation of podocin by endocytosis could be a key traffic event of critical podocyte injury and that the podocin gap could indicate the prognosis of IgA nephropathy.	[Fukuda, Hiromitsu; Hidaka, Teruo; Takagi-Akiba, Miyuki; Trejo, Juan Alejandro Oliva; Sasaki, Yu; Wang, Juan; Asanuma, Katsuhiko; Tomino, Yasuhiko] Juntendo Univ, Sch Med, Dept Internal Med, Div Nephrol,Bunkyo Ku, Tokyo 1138421, Japan; [Asanuma, Katsuhiko] Kyoto Univ, Grad Sch Med, TMK Project, Med Innovat Ctr,Lab Kidney Res, Kyoto, Japan; [Ichimura, Koichiro; Sakai, Tatsuo] Juntendo Univ, Sch Med, Dept Anat, Tokyo 113, Japan; [Wang, Juan] China Med Univ, Hosp 1, Dept Nephrol, Shenyang 110001, Peoples R China	Tomino, Y (reprint author), Juntendo Univ, Sch Med, Dept Internal Med, Div Nephrol,Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	yasu@juntendo.ac.jp			Research Institute for Diseases of Old Age;  [23591201];  [26670431];  [24790856];  [23790956]	We thank Ms. Terumi Shibata, Ms. Kaori Takahashi, Mr. Junichi Nakamoto and Mr. Mitsutaka Yoshida, of Juntendo University Graduate School of Medicine, Tokyo, Japan, for their excellent technical assistance. This work was supported by a research assistant grant from the Research Institute for Diseases of Old Age to J.A.O.T., by a Grant-in-Aid for Scientific Research (C): (23591201) and a Grant-in-Aid for Challenging Exploratory Research (26670431) to K.A., by a Grant-in-Aid for Young Scientists (B): (24790856) to M.A-T. and by a Grant-in-Aid for Young Scientists (B): (23790956) to T.H.	Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Boute N, 2000, NAT GENET, V24, P349; Lemley KV, 2002, KIDNEY INT, V61, P1475, DOI 10.1046/j.1523-1755.2002.00269.x; DIAMOND JR, 1986, KIDNEY INT, V29, P478, DOI 10.1038/ki.1986.24; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Roselli S, 2004, TRAFFIC, V5, P37, DOI 10.1046/j.1600-0854.2003.00148.x; Suzuki K, 2003, KIDNEY INT, V63, P2286, DOI 10.1046/j.1523-1755.63.6s.2.x; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Godel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057078; Hishiki T, 2001, KIDNEY BLOOD PRESS R, V24, P99, DOI 10.1159/000054214; Ichimura K, 2009, ARCH HISTOL CYTOL, V72, P165; Inokuchi S, 1996, KIDNEY INT, V50, P1278, DOI 10.1038/ki.1996.439; KIHARA I, 1995, PATHOL INT, V45, P625, DOI 10.1111/j.1440-1827.1995.tb03514.x; Kim YH, 2002, NEPHRON, V90, P471, DOI 10.1159/000054736; Kriz W, 2014, J AM SOC NE IN PRESS; Nosaka K, 1997, FREE RADICAL BIO MED, V22, P597; Rychlik I, 1999, ANN MED INTERNE, V150, P117; Seckin I, 2012, J BIOMED SCI, V16, P19; Shirato I, 1996, AM J PATHOL, V148, P1283; Shono A, 2007, J AM SOC NEPHROL, V18, P2525, DOI 10.1681/ASN.2006101084; Soda K, 2012, J CLIN INVEST, V122, P4401, DOI 10.1172/JCI65289; Soda K, 2013, CURR OPIN NEPHROL HY, V22, P432, DOI 10.1097/MNH.0b013e3283624820; Tanimoto M, 2004, METABOLISM, V53, P1473, DOI 10.1016/j.metabol.2004.06.016; Tomino Yasuhiko, 2003, Clin Exp Nephrol, V7, P93, DOI 10.1007/s10157-003-0232-4; Tossidou I, 2012, MOL CELL BIOL, V32, P1068, DOI 10.1128/MCB.06106-11; Tossidou I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010185; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	MAY	2015	360	2					391	400		10.1007/s00441-014-2100-9		10	Cell Biology	Cell Biology	CJ5XS	WOS:000355567700016		
J	Luft, V; Reinhard, J; Shibuya, M; Fischer, KD; Faissner, A				Luft, Veronika; Reinhard, Jacqueline; Shibuya, Masabumi; Fischer, Klaus D.; Faissner, Andreas			The guanine nucleotide exchange factor Vav3 regulates differentiation of progenitor cells in the developing mouse retina (vol 359, pg 423, 2015)	CELL AND TISSUE RESEARCH			English	Correction									[Luft, Veronika; Reinhard, Jacqueline; Faissner, Andreas] Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, D-44780 Bochum, Germany; [Luft, Veronika] IGSN, D-44780 Bochum, Germany; [Shibuya, Masabumi] Univ Tokyo, Inst Med Sci, Div Genet, Minato Ku, Tokyo 1088639, Japan; [Fischer, Klaus D.] Univ Magdeburg, Inst Biochem & Cell Biol, D-39120 Magdeburg, Germany	Faissner, A (reprint author), Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, NDEF 05-594,Univ Str 150, D-44780 Bochum, Germany.	Andreas.Faissner@ruhr-uni-bochum.de	Faissner, Andreas/A-5314-2008	Faissner, Andreas/0000-0002-2211-8259			Luft V, 2015, CELL TISSUE RES, V359, P423, DOI 10.1007/s00441-014-2050-2	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	MAY	2015	360	2					431	433		10.1007/s00441-015-2160-5		3	Cell Biology	Cell Biology	CJ5XS	WOS:000355567700020		
J	Zhang, GQ; Fu, GY; Zhou, X; Xu, CY				Zhang Guo-Qing; Fu Guang-Yu; Zhou Xin; Xu Chang-Yi			Retrieve post-seismic gravity changes induced by Sumatra earthquake (M(w)9. 3) based on the viscoelastic dislocation theory	CHINESE JOURNAL OF GEOPHYSICS-CHINESE EDITION			Chinese	Article						Spherical dislocation theory; GRACE; Sumatra earthquake (M(w)9. 3); Gravity changes; Viscosity	SPHERICAL EARTH; ANDAMAN EARTHQUAKE; POINT DISLOCATIONS; GRAVITATIONAL DEFORMATION; INTERNAL DISLOCATIONS; RELAXATION THEORY; 2004 DECEMBER; HALF-SPACE; MODEL; SURFACE	The GRACE (Gravity Recovery and Climate Experiment) mission has continually provided the data of temporal variability of the global gravity after its launch. Several coseismic gravity changes have been successfully retrieved by the GRACE mission. The visco-elastic dislocation theory is used to study the co- and post-seismic deformations. In this paper, we study the post-seismic gravity changes due to the 2004 Sumatra earthquake (M(w)9. 3) based on the visco-elastic spherical dislocation theory and the GRACE data, and then analyze the viscosity of the mantle and horizontal difference at this area. We adopt the RL05 data provided by UT/CSR (Center for Space Research, University of Texas), and the data spans from January 2003 to December 2014. We replaced the Earth's oblateness values (C-20) with those from Satellite Laser Ranging because of their poor accuracy. After the de-correlation filter using polynomials of degree 3 for coefficients with orders 6 or higher to alleviate longitudinal stripes and the Gaussian smoothing with averaging radius of 350 km to reduce short wavelength noises, we obtain the post-seismic gravity changes due to the 2004 Sumatra earthquake (M(w)9. 3) based on the difference method and time series of two points respectively located on the hanging side and the heading side. We adopt the visco-elastic spherical dislocation theory to validate the GRACE-derived result. We first use the integration of the finite fault models to solve the problem of large errors in the near-field computation using the visco-elastic spherical dislocation theory, and comparing the modified results with the results of elastic spherical dislocation theory. After that, we retrieve post-seismic gravity changes induced by the earthquake. The result shows that the peak of the gravity changes is from -8. 3 to 4. 6 mu Gal in the period of 2004-2005 based on the GRACE, which is consistent with the result derived by the elastic spherical dislocation theory in the spatial distribution and the magnitude. Based on the spatial distribution of the gravity changes and the analysis of time series, we find that the rate of the post-seismic gravity change at the heading side is 0. 55 mu Gal/yr and the rate is 0. 16 mu Gal/yr on the other side, which demonstrates that the viscosity of the two sides of the fault is different. The differences of coseismic vertical displacement and gravity changes based on the modified visco-elastic theory are respectively 0. 06% and 0. 1%, compared with those derived from the elastic spherical dislocation theory. We also analyze the Green functions of the vertical displacement and gravity changes at the source depth of 32 km in two different periods of 0 similar to 0. 7 years and 0 similar to 7 years, which demonstrate that we have successfully solved the problem of large errors in the near-field computation using the visco-elastic spherical dislocation theory. Based on the corrected method, we simulate the post-seismic gravity changes due to the 2004 Sumatra earthquake (M(w)9. 3), finding that only when the viscosity of the heading side is 1 x 10(18) Pa . s and the viscosity of the hanging side is 8 x 10(18) Pa . s, the simulating results are consistent with the GRACE-derived results in the spatial distribution and the magnitude. Based on the theory results, we find that the rate of the post-seismic gravity changes at the heading side is 0. 52 mu Gal/yr and the rate of the post-seismic gravity changes at the hanging side is 0. 12 mu Gal/yr. Comparing the observing results with the simulating results, it demonstrates that the viscosity of the mantle at the Sumatra region is laterally inhomogeneous. The viscosity at the left side (the heading side) of the fault is smaller than the one at the right side (the hanging side) of the fault, and the viscosity is respectively 1 x 10(18) Pa . s and 8 x 10(18) Pa . s.	[Zhang Guo-Qing; Fu Guang-Yu] CEA, Key Lab Earthquake Predict, Inst Earthquake Sci, Beijing 100036, Peoples R China; [Fu Guang-Yu; Zhou Xin; Xu Chang-Yi] Chinese Acad Sci, Key Lab Computat Geodynam, Grad Univ, Beijing 100049, Peoples R China; [Fu Guang-Yu] State Key Lab Geodesy & Earths Dynam, Wuhan 430077, Peoples R China; [Zhou Xin] Univ Tokyo, Earthquake Res Inst, Tokyo 1130032, Japan	Fu, GY (reprint author), CEA, Key Lab Earthquake Predict, Inst Earthquake Sci, Beijing 100036, Peoples R China.	zhangguo_qing_123@126.com; fugy@seis.ac.cn					POLLITZ FF, 1992, B SEISMOL SOC AM, V82, P422; Cambiotti G, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007848; de Viron O, 2008, GEOPHYS J INT, V174, P14, DOI 10.1111/j.1365-246X.2008.03807.x; Jonsson S, 2003, NATURE, V424, P179, DOI 10.1038/nature01776; Han SC, 2006, SCIENCE, V313, P658, DOI 10.1126/science.1128661; Zhou X, 2011, CHINESE J GEOPHYS-CH, V54, P1745, DOI 10.3969/j.issn.0001-5733.2011.07.007; Panet I, 2007, GEOPHYS J INT, V171, P177, DOI 10.1111/j.1365-246X.2007.03525.X; Pollitz FF, 2003, GEOPHYS J INT, V155, P57, DOI 10.1046/j.1365-246X.2003.01980.x; Swenson S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025285; RUNDLE JB, 1980, J GEOPHYS RES, V85, P5355, DOI 10.1029/JB085iB10p05355; Sun WK, 1996, J GEOPHYS RES-SOL EA, V101, P8561, DOI 10.1029/95JB03536; Broerse DBT, 2011, EARTH PLANET SC LETT, V305, P341, DOI 10.1016/j.epsl.2011.03.011; Zhou X, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008849; Wang L, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051104; Sun WK, 2009, GEOPHYS J INT, V177, P817, DOI 10.1111/j.1365-246X.2009.04113.x; STEKETEE JA, 1958, CAN J PHYS, V36, P192; Han SC, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005705; Wang RJ, 2003, COMPUT GEOSCI-UK, V29, P195, DOI 10.1016/S0098-3004(02)00111-5; de Linage C, 2009, GEOPHYS J INT, V176, P695, DOI 10.1111/j.1365-246X.2008.04025.x; Cadek O, 2003, GEOPHYS J INT, V152, P566, DOI 10.1046/j.1365-246X.2003.01859.x; Cambiotti G, 2013, J GEOPHYS RES-SOL EA, V118, P183, DOI 10.1029/2012JB009555; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; SABADINI R, 1995, GEOPHYS RES LETT, V22, P985, DOI 10.1029/95GL00819; Cannelli V, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005296; Chen JL, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2007GL030356, 10.1029/2007GL030356,]; Chen Y T, 1979, CHINESE J GEOPHYS, V22, P201; Chen Y T, 1975, CHINESE J GEOPHYS, V18, P164; Deng JS, 1998, SCIENCE, V282, P1689, DOI 10.1126/science.282.5394.1689; [付广裕 Fu Guangyu], 2012, [地震, Earthquake], V32, P73; Fu GY, 2010, GEOPHYS J INT, V183, P706, DOI 10.1111/j.1365-246X.2010.04757.x; Hao JL, 2012, CHINESE J GEOPHYS-CH, V55, P1682, DOI 10.6038/j.issn.0001-5733.2012.05.025; Hoechner A, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003450; Hoechner A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033133; Ju XL, 2013, CHINESE J GEOPHYS-CH, V56, P2918, DOI 10.6038/cjg20130906; MA XQ, 1994, GEOPHYS J INT, V118, P201, DOI 10.1111/j.1365-246X.1994.tb04684.x; Ogawa R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029340; Panet I, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002905; PIERSANTI A, 1995, GEOPHYS J INT, V120, P544, DOI 10.1111/j.1365-246X.1995.tb01838.x; Pollitz FF, 1996, GEOPHYS J INT, V125, P1, DOI 10.1111/j.1365-246X.1996.tb06530.x; RUNDLE JB, 1982, J GEOPHYS RES, V87, P7787, DOI 10.1029/JB087iB09p07787; Sheu SY, 2004, GEOPHYS J INT, V159, P1112, DOI 10.1111/j.1365-246X.2004.02437.x; Spada G, 2006, GEOPHYS J INT, V166, P309, DOI 10.1111/j.1365-246X.2006.02995.x; Sun W, 1998, GEOPHYS J INT, V132, P79, DOI 10.1046/j.1365-246x.1998.00400.x; SUN WK, 1993, GEOPHYS J INT, V114, P569, DOI 10.1111/j.1365-246X.1993.tb06988.x; Tanaka T, 2007, GEOPHYS J INT, V170, P1031, DOI [10.1111/j.1365-246X.2007.03486.x, DOI 10.1111/J.1365-246X.2007.03486.X]; Tanaka T, 2006, GEOPHYS J INT, V164, P273, DOI [10.1111/j.1365-246X.2005.02821.x, DOI 10.1111/J.1365-246X.2005.02821.X]; Tanaka Y, 2009, GEOPHYS J INT, V176, P715, DOI 10.1111/j.1365-246X.2008.04015.x; Wang H, 1999, GEOPHYS J INT, V137, P429, DOI 10.1046/j.1365-246X.1999.00797.x; Wang RJ, 2006, COMPUT GEOSCI-UK, V32, P527, DOI 10.1016/j.cageo.2005.08.006; Wang WX, 2011, SCI CHINA EARTH SCI, V54, P1257, DOI 10.1007/s11430-011-4217-y; [张国庆 Zhang Guoqing], 2015, [大地测量与地球动力学, Journal of Gecodesy and Geodynamics], V35, P303; Zhou X., 2012, THESIS U CHINESE ACA	52	1	1	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	0001-5733			CHINESE J GEOPHYS-CH	Chinese J. Geophys.-Chinese Ed.	MAY	2015	58	5					1654	1665		10.6038/cjg20150517		12	Geochemistry & Geophysics	Geochemistry & Geophysics	CJ6XZ	WOS:000355639800017		
J	Jiang, XH; Wang, YB; Furumura, T				Jiang Xiang-Hua; Wang Yan-Bin; Furumura, Takashi			Numerical simulation of lunar seismic coda caused by scattering in upper Moon crust	CHINESE JOURNAL OF GEOPHYSICS-CHINESE EDITION			Chinese	Article						Scattering; Lunar seismic coda; Numerical simulation; Computational seismology; Wave propagation	WAVE PROPAGATION; PSEUDOSPECTRAL METHOD; CRATER EJECTA; EARTH MODEL; SEISMOGRAMS; THICKNESS; GUIDE	The Apollo lunar seismic data generally exhibits a long and strong coda, which masks seismic phases other than initial P and S waves and causes difficulties in analyses of secondary waves. Recent numerical simulation of 2D global seismic wave propagation in a whole-Moon. model showed that lunar seismic coda couldn't be produced by a layered Moon model. A widely accepted explanation is that lunar seismic coda is resulted from scattering in a near-surface layer, which could be several to more than twenty kilometers thick. This study presents numerical simulations of scattering effects caused by small-scale heterogeneity in upper Moon crust in order to explain the coda. Wave equations in velocity-stress form are solved in a 2D cylindrical coordinate system. The spatial derivatives are calculated by a hybrid pseudospectral and finite difference method defined on staggered grid. The background layered model is based on recent published seismic velocity and attenuation models of the Moon. In order to simulate the heterogeneity of upper Moon crust, von-Karman auto correlation function is used to generate velocity fluctuations, superimposed on the background velocity. We firstly check the effectiveness of scattering in upper Moon crust to reproduce lunar seismic coda. Wavefields are calculated for an upper Moon crust model without scattering and one with scattering. Calculations are performed for a 71 km shallow moonquake and an 867 km deep moonquake. Comparison of the wavefield snapshots generated by the two models shows that wave energy can last a very long time in the upper Moon crust due to scattering in this layer. Comparison of waveforms shows that scattering in upper Moon crust can effectively produce long-duration coda. Comparison with Apollo seismograms shows that the duration and strength of coda caused by scattering in upper Moon crust can be well consistent with observations. The mechanism which produces lunar seismic coda is tentatively discussed. We propose that scattering, low attenuation and low velocity in the upper Moon crust may all contribute to the lunar seismic coda. Effects of fluctuant strength on synthetic coda are discussed. Different standard deviations of velocity fluctuations are set for upper Moon crust, 1%, 3%, 5%, 7% and 9%. For both shallow and deep moonquakes, wavefields are simulated for each model and the characteristic decay times of synthetic coda are calculated at four epicentral distances: 22 degrees, 45 degrees, 67.5 degrees and 90 degrees. The characteristic decay times firstly increase with standard deviation of velocity fluctuations and then decrease. The characteristic decay times reach the largest value where standard deviation equals to 3%. Finally, similarities between synthetics and Apollo lunar seismograms are measured via correlation coefficient in order to estimate the most realistic strength of velocity fluctuations. We propose that the standard deviation of velocity fluctuations should be between 3% and 5%, and it's likely close to 3%.	[Jiang Xiang-Hua; Wang Yan-Bin] Peking Univ, Sch Earth & Space Sci, Dept Geophys, Beijing 100871, Peoples R China; [Furumura, Takashi] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Wang, YB (reprint author), Peking Univ, Sch Earth & Space Sci, Dept Geophys, Beijing 100871, Peoples R China.	jxh22255@sina.com; ybwang@pku.edu.cn					Aki K, 1980, QUANTITATIVE SEISMOL, V2; Bulow RC, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002414; [Anonymous], 2005, J GEOPHYS RES-SOL EA; Furumura T, 2008, ADV GEOPHYS, V50, P195, DOI 10.1016/S0065-2687(08)00007-1; HERRMANN RB, 1979, B SEISMOL SOC AM, V69, P1; Wang YB, 2013, GEOPHYS J INT, V192, P1271, DOI 10.1093/gji/ggs094; NAKAMURA Y, 1977, J GEOPHYS-Z GEOPHYS, V43, P389; Garcia RF, 2011, PHYS EARTH PLANET IN, V188, P96, DOI 10.1016/j.pepi.2011.06.015; GOINS NR, 1981, J GEOPHYS RES, V86, P378, DOI 10.1029/JB086iB01p00378; Khan A, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002608; Kennett BLN, 2013, GEOPHYS J INT, V195, P1862, DOI 10.1093/gji/ggt344; Furumura T, 1998, GEOPHYS J INT, V135, P845, DOI 10.1046/j.1365-246X.1998.00682.x; Weber RC, 2011, SCIENCE, V331, P309, DOI 10.1126/science.1199375; FRANKEL A, 1986, J GEOPHYS RES-SOLID, V91, P6465, DOI 10.1029/JB091iB06p06465; LATHAM GV, 1970, SCIENCE, V167, P455, DOI 10.1126/science.167.3918.455; LEVANDER AR, 1988, GEOPHYSICS, V53, P1425, DOI 10.1190/1.1442422; Shearer PM, 2004, GEOPHYS J INT, V158, P1103, DOI 10.1111/j.1365-246X.2004.02378.x; Blanchette-Guertin JF, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE004042; Blanchette-Guertin J F, 2013, 44 LUN PLAN SCI C HO; Blanchette-Guertin J-F, 2012, 43 LUN PLAN SCI C LU; CERJAN C, 1985, GEOPHYSICS, V50, P705, DOI 10.1190/1.1441945; Dainty A. M., 1974, Moon, V9, DOI 10.1007/BF00565388; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Graves RW, 1996, B SEISMOL SOC AM, V86, P1091; HELMBERGER DV, 1988, B SEISMOL SOC AM, V78, P109; [姜明明 JIANG Ming-ming], 2010, [地球化学, Geochimica], V39, P15; Koyama J, 1980, LUNAR PLANET SCI, V11, P1855; Latham G., 1972, Moon, V4, DOI 10.1007/BF00562004; Lawrence J F, 2010, 41 LUN PLAN SCI C HO; Li DZ, 2014, GEOPHYS J INT, V197, P1166, DOI 10.1093/gji/ggu050; MCGETCHI.TR, 1973, EARTH PLANET SC LETT, V20, P226, DOI 10.1016/0012-821X(73)90162-3; Nakamura Y, 1978, LUNAR PLANET SCI, V9, P3589; Nakamura Y, 1979, LUNAR PLANET SCI, V10, P2299; Nakamura Y., 2005, J GEOPHYS RES, V110, pE0100, DOI [10.1029/204JE002332, DOI 10.1029/204JE002332]; Ouyang Z.-Y., 2005, INTRO LUNAR SCI; Sato H., 1998, SEISMIC WAVE PROPAGA; Shearer P M, 2007, TREATISE GEOPHYS, V1, P695; Thompson TW, 2009, GEOLOGY, V37, P655, DOI 10.1130/G25565A.1; Tromp J, 2007, TREATISE GEOPHYS, P191; Wang YB, 2001, GEOPHYS J INT, V145, P689, DOI 10.1046/j.1365-246x.2001.01413.x; Witte D C, 1990, COMPUTATIONAL ACOUST, V3, P148; [占伟 ZHAN Wei], 2007, [地球物理学进展, Progress in Geophysiscs], V22, P737	42	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	0001-5733			CHINESE J GEOPHYS-CH	Chinese J. Geophys.-Chinese Ed.	MAY	2015	58	5					1675	1691		10.6038/cjg20150519		17	Geochemistry & Geophysics	Geochemistry & Geophysics	CJ6XZ	WOS:000355639800019		
J	Harada, T; Tsuboi, I; Hirabayashi, Y; Kosaku, K; Naito, M; Hara, H; Inoue, T; Aizawa, S				Harada, Tomonori; Tsuboi, Isao; Hirabayashi, Yukio; Kosaku, Kazuhiro; Naito, Michiko; Hara, Hiroyuki; Inoue, Tohru; Aizawa, Shin			Decreased "ineffective erythropoiesis" preserves polycythemia in mice under long-term hypoxia	CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Erythropoiesis; Hypoxia; EPO; Apoptosis	DIFFERENTIATION; PROGENITORS; PROTEINS; RECEPTOR; BMP4	Hypoxia induces innumerable changes in humans and other animals, including an increase in peripheral red blood cells (polycythemia) caused by the activation of erythropoiesis mediated by increased erythropoietin (EPO) production. However, the elevation of EPO is limited and levels return to normal ranges under normoxia within 5-7 days of exposure to hypoxia, whereas polycythemia continues for as long as hypoxia persists. We investigated erythropoiesis in bone marrow and spleens from mouse models of long-term normobaric hypoxia (10 % O-2) to clarify the mechanism of prolonged polycythemia in chronic hypoxia. The numbers of erythroid colony-forming units (CFU-E) in the spleen remarkably increased along with elevated serum EPO levels indicating the activation of erythropoiesis during the first 7 days of hypoxia. After 14 days of hypoxia, the numbers of CFU-E returned to normoxic levels, whereas polycythemia persisted for >140 days. Flow cytometry revealed a prolonged increase in the numbers of TER119-positive cells (erythroid cells derived from pro-erythroblasts through mature erythrocyte stages), especially the TER119 (high) CD71 (high) population, in bone marrow. The numbers of annexin-V-positive cells among the TER119-positive cells particularly declined under chronic hypoxia, suggesting that the numbers of apoptotic cells decrease during erythroid cell maturation. Furthermore, RT-PCR analysis showed that the RNA expression of BMP-4 and stem cell factor that reduces apoptotic changes during erythroid cell proliferation and maturation was increased in bone marrow under hypoxia. These findings indicated that decreased apoptosis of erythroid cells during erythropoiesis contributes to polycythemia in mice during chronic exposure to long-term hypoxia.	[Harada, Tomonori; Tsuboi, Isao; Hirabayashi, Yukio; Kosaku, Kazuhiro; Naito, Michiko; Hara, Hiroyuki; Inoue, Tohru; Aizawa, Shin] Nihon Univ, Dept Funct Morphol, Sch Med, Itabashi Ku, Tokyo 1738610, Japan	Tsuboi, I (reprint author), Nihon Univ, Dept Funct Morphol, Sch Med, Itabashi Ku, 30-1 Ohyaguchi Kamicho, Tokyo 1738610, Japan.	tsuboi.isao@nihon-u.ac.jp			Ministry of Education, Culture, Sports and Science and Technology of Japan; Japan Society for the Promotion of Science	This study was supported by a grant-in-aid for Scientific Research (C) and grants-in-aid for Young Scientists (B) from the Ministry of Education, Culture, Sports and Science and Technology of Japan and the Japan Society for the Promotion of Science.	ALIPPI RM, 1983, EXP HEMATOL, V11, P122; ECKARDT KU, 1990, AM J PHYSIOL, V258, pF1432; Smith TG, 2008, BRIT J HAEMATOL, V141, P325, DOI 10.1111/j.1365-2141.2008.07029.x; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Ebert BL, 1999, BLOOD, V94, P1864; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Jelkmann W, 2004, INTERNAL MED, V43, P649, DOI 10.2169/internalmedicine.43.649; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Rogers HM, 2008, EXP HEMATOL, V36, P17, DOI 10.1016/j.exphem.2007.08.014; Mide SM, 2001, IN VIVO, V15, P125; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; Maekawa S, 2013, J EXP BIOL, V216, P901, DOI 10.1242/jeb.076760; BERGLUND B, 1992, SPORTS MED, V14, P289, DOI 10.2165/00007256-199214050-00002; Brandan Nora, 1997, Acta Physiologica Pharmacologica et Therapeutica Latinoamericana, V47, P125; Detmer K, 2002, CYTOKINE, V17, P36, DOI 10.1006/cyto.2001.0984; FRIED W, 1970, BLOOD-J HEMATOL, V36, P607; KAPA D, 1984, ACTA HAEMATOL-BASEL, V72, P295; Koulnis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021192; Koulnis M, 2011, J VIS EXP, V54, P1; Maguer-Satta Veronique, 2003, Experimental Cell Research, V282, P110, DOI 10.1016/S0014-4827(02)00013-7; Okamura H, 2013, J NIHON U MED ASS, V72, P266; Rhodes MM, 2005, BLOOD, V106, P1857, DOI 10.1182/blood-2004-11-4344; Tsuboi I, 2010, IMMUNOBIOLOGY, V215, P348, DOI 10.1016/j.imbio.2009.05.004; Vannucchi AM, 2001, BLOOD, V97, P3040, DOI 10.1182/blood.V97.10.3040; Wu DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011303	29	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1591-8890	1591-9528		CLIN EXP MED	Clin. Exper. Med.	MAY	2015	15	2					179	188		10.1007/s10238-014-0286-5		10	Medicine, Research & Experimental	Research & Experimental Medicine	CJ5XY	WOS:000355568600007		
J	Fernandez-Solis, C; Kuroda, Y; Zinchenko, A; Murata, S				Fernandez-Solis, Christian; Kuroda, Yasuhiro; Zinchenko, Anatoly; Murata, Shizuaki			Uptake of aromatic compounds by DNA: Toward the environmental application of DNA for cleaning water	COLLOIDS AND SURFACES B-BIOINTERFACES			English	Article						DNA binding; DNA hydrogel; Organic compounds; Aromatic compounds; Organic pollutants; Environmental cleaning	HEAVY-METAL IONS; CATIONIC SURFACTANT; AQUEOUS-SOLUTIONS; UV-IRRADIATION; NANOPARTICLES; REMOVAL; HYDROCARBONS; COMPACTION; COMPLEXATION; HYDROGEL	Hypothesis: Although the interaction of DNA with various types of intercalating chemicals, such as planar polycyclic aromatic compounds, has been extensively investigated over the past several decades, little is known about the relationship between the structure of a DNA binder and its affinity for DNA. The use of DNA as an adsorbent for environmental cleaning purposes requires information on its affinity for organic chemicals with different structures. Experiment: In the present study we investigated the binding of DNA to aromatic chemicals with various structures and charges by three methods: binding of organic chemicals to DNA followed by removal by precipitation with cationic nanoparticles (1) or a cationic surfactant (2), and absorption of organic chemicals by a DNA hydrogel (3). Findings: The results showed that, for most neutral organic chemicals, the hydrophobicity of the organic molecule is the main driving force for efficient binding to DNA. The double-helicity of DNA contributed to stronger binding to most of the compounds. The efficiency of the uptake of organic chemicals increased substantially when a hydrophobic cationic surfactant was used for DNA-complex condensation and removal. The potential environmental application of DNA as an adsorbent for the removal of aromatic organic pollutants from water is discussed. (C) 2015 Elsevier B.V. All rights reserved.	[Fernandez-Solis, Christian] Max Planck Inst Eisenforsch GmbH, D-40237 Dusseldorf, Germany; [Kuroda, Yasuhiro] Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Zinchenko, Anatoly; Murata, Shizuaki] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Zinchenko, A (reprint author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	zinchenko@urban.env.nagoya-u.ac.jp					Rudiuk S, 2008, LANGMUIR, V24, P8452, DOI 10.1021/la800751k; MELNIKOV SM, 1995, J AM CHEM SOC, V117, P2401, DOI 10.1021/ja00114a004; Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r; Lapworth DJ, 2012, ENVIRON POLLUT, V163, P287, DOI 10.1016/j.envpol.2011.12.034; Sergeyev VG, 1999, LANGMUIR, V15, P4434, DOI 10.1021/la981583h; Zinchenko A, 2014, ACS APPL MATER INTER, V6, P3226, DOI 10.1021/am5008886; AMIYA T, 1987, MACROMOLECULES, V20, P1162, DOI 10.1021/ma00171a050; BOYLAND E, 1964, BIOCHEM J, V92, pC4; Kamata H, 2011, COLLOID POLYM SCI, V289, P1329, DOI 10.1007/s00396-011-2453-5; LESKO SA, 1968, BIOCHEMISTRY-US, V7, P434, DOI 10.1021/bi00841a056; Liu XD, 2005, INT J BIOL MACROMOL, V35, P193, DOI 10.1016/j.ijbiomac.2005.01.008; Navarro RR, 2007, ENVIRON SCI TECHNOL, V41, P4240, DOI 10.1021/es0624523; PEZZUTO JM, 1980, P NATL ACAD SCI-BIOL, V77, P1427, DOI 10.1073/pnas.77.3.1427; Rudiuk S, 2011, PHOTOCHEM PHOTOBIOL, V87, P103, DOI 10.1111/j.1751-1097.2010.00831.x; Sakai H, 2009, COLLOID SURFACE A, V347, P210, DOI 10.1016/j.colsurfa.2009.04.031; Takenaka T, 2010, CHEM LETT, V39, P72, DOI 10.1246/cl.2010.72; Takenaka T, 2010, B CHEM SOC JPN, V83, P643, DOI 10.1246/bcsj.20090324; WOLFE A, 1987, BIOCHEMISTRY-US, V26, P6392, DOI 10.1021/bi00394a013; Yamada M, 2002, CHEM-EUR J, V8, P1407, DOI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L; Yamada M, 2002, B CHEM SOC JPN, V75, P1627, DOI 10.1246/bcsj.75.1627; Yamada M, 2001, BIOMATERIALS, V22, P3121, DOI 10.1016/S0142-9612(01)00061-8; Yang KG, 2005, DESALINATION, V175, P297, DOI 10.1016/j.desal.2004.08.046; Zinchenko AA, 2009, J HAZARD MATER, V168, P38, DOI 10.1016/j.jhazmat.2009.01.121; Zinchenko AA, 2007, J PHYS CHEM B, V111, P3019, DOI 10.1021/jp067926z	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-7765	1873-4367		COLLOID SURFACE B	Colloid Surf. B-Biointerfaces	MAY 1	2015	129						146	153		10.1016/j.colsurfb.2015.03.041		8	Biophysics; Chemistry, Physical; Materials Science, Biomaterials	Biophysics; Chemistry; Materials Science	CJ3AQ	WOS:000355356200020		
J	Kanda, M; Oya, H; Nomoto, S; Takami, H; Shimizu, D; Hashimoto, R; Sueoka, S; Kobayashi, D; Tanaka, C; Yamada, S; Fujii, T; Nakayama, G; Sugimoto, H; Koike, M; Fujiwara, M; Kodera, Y				Kanda, Mitsuro; Oya, Hisaharu; Nomoto, Shuji; Takami, Hideki; Shimizu, Dai; Hashimoto, Ryoji; Sueoka, Satoshi; Kobayashi, Daisuke; Tanaka, Chie; Yamada, Suguru; Fujii, Tsutomu; Nakayama, Goro; Sugimoto, Hiroyuki; Koike, Masahiko; Fujiwara, Michitaka; Kodera, Yasuhiro			Diversity of Clinical Implication of B-Cell Translocation Gene 1 Expression by Histopathologic and Anatomic Subtypes of Gastric Cancer	DIGESTIVE DISEASES AND SCIENCES			English	Article						B-cell translocation gene 1; Gastric cancer; Expression; Subtype	PROMOTER HYPERMETHYLATION; HEPATOCELLULAR-CARCINOMA; MOLECULAR PATHOLOGY; BTG1; LEUKEMIA; IDENTIFICATION; LOCALIZATION; PROGRESSION; STATISTICS; ACTIVATION	Background Genetic signatures may differ by histopathologic and anatomic subtypes of gastric cancer (GC). B-cell translocation gene 1 (BTG1) was identified as one of genes downregulated in GC tissues from our microarray data. Aims To evaluate the clinical implications of BTG1 expression in GC and the genetic diversity among GC subtypes. Methods BTG1 mRNA expression was analyzed in GC cell lines and 233 pairs of surgical specimens. The mutational and methylation status of BTG1 in GC cell lines was analyzed, and immunohistochemistry was conducted to determine the distribution of BTG1. The pattern and prognostic significance of BTG1 expression were correlated with the three proposed GC subtypes. Results BTG1 mRNA was downregulated in 82 % of GC cell lines and in 88 % of clinical GC tissues. Promoter hypermethylation events or sequence mutations were not detected in GC cell lines. The pattern of BTG1 expression as observed by immunohistochemistry was consistent with that of its mRNA. Downregulation of BTG1 mRNA in GCs was significantly associated with shorter disease-specific and recurrence-free survival. Multivariate analysis of disease-specific survival identified downregulation of BTG1 transcription as an independent prognostic factor. BTG1 mRNA expression was more strongly suppressed in proximal nondiffuse and diffuse GC compared with distal nondiffuse GC, and subgroup analysis revealed that BTG1 downregulation led to adverse prognosis, specifically in patients with proximal nondiffuse and diffuse GC. Conclusions Altered expression of BTG1 is a potential biomarker for carcinogenesis and progression of GC, particularly for proximal nondiffuse and diffuse GC.	[Kanda, Mitsuro; Oya, Hisaharu; Nomoto, Shuji; Takami, Hideki; Shimizu, Dai; Hashimoto, Ryoji; Sueoka, Satoshi; Kobayashi, Daisuke; Tanaka, Chie; Yamada, Suguru; Fujii, Tsutomu; Nakayama, Goro; Sugimoto, Hiroyuki; Koike, Masahiko; Fujiwara, Michitaka; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Showa Ku, Nagoya, Aichi 4668550, Japan	Kanda, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	m-kanda@med.nagoya-u.ac.jp					Kanda M, 2011, MOL CARCINOGEN, V50, P571, DOI 10.1002/mc.20735; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Kanda M, 2013, GUT, V62, P1024, DOI 10.1136/gutjnl-2012-302823; Lin LL, 2012, J PROTEOMICS, V75, P3081, DOI 10.1016/j.jprot.2012.03.046; Gonzalez CA, 2012, INT J CANCER, V130, P745, DOI 10.1002/ijc.26430; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Berthet C, 2002, GENES CELLS, V7, P29, DOI 10.1046/j.1356-9597.2001.00497.x; ROUAULT JP, 1992, EMBO J, V11, P1663; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Kanda M, 2009, INT J ONCOL, V35, P477, DOI 10.3892/ijo_00000359; Lee H, 2003, J IMMUNOL, V171, P5802; Shikata K, 2008, AM J EPIDEMIOL, V168, P1409, DOI 10.1093/aje/kwn276; Rodier A, 2001, ONCOGENE, V20, P2691, DOI 10.1038/sj.onc.1204398; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; Zhao Y, 2013, INT J MOL SCI, V14, P19670, DOI 10.3390/ijms141019670; Tramacere I, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mdr135; Steevens J, 2010, EUR J GASTROEN HEPAT, V22, P669, DOI 10.1097/MEG.0b013e32832ca091; Tafe LJ, 2011, ARCH PATHOL LAB MED, V135, P1460, DOI 10.5858/arpa.2010-0541-OA; Marrelli D, 2002, WORLD J SURG, V26, P1160, DOI 10.1007/s00268-002-6344-2; Yasui W, 2011, PATHOL RES PRACT, V207, P608, DOI 10.1016/j.prp.2011.09.006; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Kanda M, 2014, J SURG ONCOL, V110, P136, DOI 10.1002/jso.23614; Sakaguchi T, 1998, J AM COLL SURGEONS, V187, P352, DOI 10.1016/S1072-7515(98)00191-4; Hibino S, 2014, ONCOL REP, V31, P693, DOI 10.3892/or.2013.2901; Janjigian YY, 2013, J SURG ONCOL, V107, P237, DOI 10.1002/jso.23263; Jang BG, 2011, PATHOBIOLOGY, V78, P302, DOI 10.1159/000321703; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; van Galen JC, 2010, BLOOD, V115, P4810, DOI 10.1182/blood-2009-05-223081; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Cho JW, 2004, PROTEOMICS, V4, P3456, DOI 10.1002/pmic.200400968; GLOBOCAN, 2012, EST CANC INC MORT PR; Kanda M, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0066-9; Kanda M, 2012, GASTROENTEROLOGY, V142; Kanda M, 2013, CLIN GASTROENTEROL H, V11; Kanda M, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0088-3; Kanda M, 2015, GASTRIC CANCER, V18, P288, DOI 10.1007/s10120-014-0372-0; Kawamura-Tsuzuku J, 2004, ONCOGENE, V23, P6630, DOI 10.1038/sj.onc.1207890; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sobin LH, 2009, TNM CLASSIFICATION M; Waanders E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002533	40	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	MAY	2015	60	5					1256	1264		10.1007/s10620-014-3477-8		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ5YN	WOS:000355570200021		
J	Nakano, E; Masamune, A; Niihori, T; Kume, K; Hamada, S; Aoki, Y; Matsubara, Y; Shimosegawa, T				Nakano, Eriko; Masamune, Atsushi; Niihori, Tetsuya; Kume, Kiyoshi; Hamada, Shin; Aoki, Yoko; Matsubara, Yoichi; Shimosegawa, Tooru			Targeted Next-Generation Sequencing Effectively Analyzed the Cystic Fibrosis Transmembrane Conductance Regulator Gene in Pancreatitis	DIGESTIVE DISEASES AND SCIENCES			English	Article						Chloride channel; HaloPlex; In silico analysis; MiSeq; Target enrichment	CATIONIC TRYPSINOGEN GENE; SERINE-PROTEASE INHIBITOR; CFTR-RELATED DISORDERS; HEREDITARY PANCREATITIS; JAPANESE PATIENTS; CTRC VARIANTS; KAZAL TYPE-1; MUTATIONS; DIAGNOSIS; DISEASE	Background The cystic fibrosis transmembrane conductance regulator (CFTR) gene, responsible for the development of cystic fibrosis, is known as a pancreatitis susceptibility gene. Direct DNA sequencing of PCR-amplified CFTR gene segments is a first-line method to detect unknown mutations, but it is a tedious and labor-intensive endeavor given the large size of the gene (27 exons, 1,480 amino acids). Next-generation sequencing (NGS) is becoming standardized, reducing the cost of DNA sequencing, and enabling the generation of millions of reads per run. We here report a comprehensive analysis of CFTR variants in Japanese patients with chronic pancreatitis using NGS coupling with target capture. Methods Exon sequences of the CFTR gene from 193 patients with chronic pancreatitis (121 idiopathic, 46 alcoholic, 17 hereditary, and nine familial) were captured by HaloPlex target enrichment technology, followed by NGS. Results The sequencing data covered 91.6 % of the coding regions of the CFTR gene by >= 20 reads with a mean read depth of 449. We could identify 12 non-synonymous variants including three novel ones [c.A1231G (p.K411E), c.1753G>T (p.E585X) and c.2869delC (p.L957fs)] and seven synonymous variants including three novel ones in the exonic regions. The frequencies of the c.4056G>C (p.Q1352H) and the c.3468G>T (p.L1156F) variants were higher in patients with chronic pancreatitis than those in controls. Conclusions Target sequence capture combined with NGS is an effective method for the analysis of pancreatitis susceptibility genes.	[Nakano, Eriko; Masamune, Atsushi; Kume, Kiyoshi; Hamada, Shin; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Niihori, Tetsuya; Aoki, Yoko; Matsubara, Yoichi] Tohoku Univ, Grad Sch Med, Dept Med Genet, Sendai, Miyagi 9808574, Japan; [Matsubara, Yoichi] Natl Res Inst Child Hlth & Dev, Tokyo 1578535, Japan	Masamune, A (reprint author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	amasamune@med.tohoku.ac.jp			Pancreas Research Foundation of Japan; HIROMI Medical Research Foundation; Mother and Child Health Foundation; Smoking Research Foundation; Ministry of Health, Labour, and Welfare of Japan	The authors are grateful to Ms. Yoko Tateda for the excellent technical assistance. This work was supported in part by the Pancreas Research Foundation of Japan (to E. Nakano), the HIROMI Medical Research Foundation (to A. Masamune), the Mother and Child Health Foundation (to A. Masamune), the Smoking Research Foundation (to A. Masamune), and by the Ministry of Health, Labour, and Welfare of Japan.	Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Yamashiro Y, 1997, J PEDIATR GASTR NUTR, V24, P544, DOI 10.1097/00005176-199705000-00010; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Lee JH, 2003, HUM MOL GENET, V12, P2321, DOI 10.1093/hmg/ddg243; Howes N, 2004, CLIN GASTROENTEROL H, V2, P252, DOI 10.1053/S1542-3565(04)00013-8; STEER ML, 1995, NEW ENGL J MED, V332, P1482, DOI 10.1056/NEJM199506013322206; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001; Dequeker E, 2009, EUR J HUM GENET, V17, P51, DOI 10.1038/ejhg.2008.136; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Masamune A, 2013, GUT, V62, P653, DOI 10.1136/gutjnl-2012-303860; Witt H, 2013, NAT GENET, V45, P1216, DOI 10.1038/ng.2730; RIORDAN JR, 1989, SCIENCE, V245, P1066; Steiner B, 2011, HUM MUTAT, V32, P912, DOI 10.1002/humu.21511; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Schneider A, 2011, GASTROENTEROLOGY, V140, P162, DOI 10.1053/j.gastro.2010.10.045; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Etemad B, 2001, GASTROENTEROLOGY, V120, P682, DOI 10.1053/gast.2001.22586; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; Rosendahl J, 2013, GUT, V62, P582, DOI [10.1136/gutjnl-2011-300645, 10.1136/gutjnl-2012-303192]; Dorfman R, 2010, CLIN GENET, V77, P464, DOI 10.1111/j.1399-0004.2009.01351.x; Chen JM, 2009, ANNU REV GENOM HUM G, V10, P63, DOI 10.1146/annurev-genom-082908-150009; Do R, 2012, HUM MOL GENET, V21, pR1, DOI 10.1093/hmg/dds387; Audrezet MP, 2002, EUR J HUM GENET, V10, P100, DOI 10.1038/sj/ejhg/5200786; Berglund EC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-856; Bombieri C, 2011, J CYST FIBROS, V10, pS86, DOI 10.1016/S1569-1993(11)60014-3; Fujiki K, 2004, J Med Genet, V41, pe55, DOI 10.1136/jmg.2003.014456; Gilissen C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-228; Ko S, 2006, J PHYSIOL SCI, V56, pS71; Kume K, 2005, PANCREATOLOGY, V5, P354, DOI 10.1159/000086535; Masamune A, 2014, TOHOKU J EXP MED, V232, P69, DOI 10.1620/tjem.232.69; Masamune A, 2014, GUT, V63, P336; Metzker ML, 2009, NAT REV GENET, V11, P31, DOI [10.1038/nrg2626, DOI 10.1038/NRG2626]; Myllykangas S, 2010, BIOTECHNOL GENET ENG, V27, P135; Ngiam NSP, 2006, J CYST FIBROS, V5, P159, DOI 10.1016/j.jcf.2006.02.002; Nishimori I, 1999, GUT, V44, P259; Noone PG, 2001, GASTROENTEROLOGY, V121, P1310, DOI 10.1053/gast.2001.29673; Wang W, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003150; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C	42	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	MAY	2015	60	5					1297	1307		10.1007/s10620-014-3476-9		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ5YN	WOS:000355570200026		
J	Kamata, N; Oshitani, N; Watanabe, K; Watanabe, K; Hosomi, S; Noguchi, A; Yukawa, T; Yamagami, H; Shiba, M; Tanigawa, T; Watanabe, T; Tominaga, K; Fujiwara, Y; Arakawa, T				Kamata, Noriko; Oshitani, Nobuhide; Watanabe, Kenji; Watanabe, Kimihiko; Hosomi, Shuhei; Noguchi, Atsushi; Yukawa, Tomomi; Yamagami, Hirokazu; Shiba, Matsatsugu; Tanigawa, Tetsuya; Watanabe, Toshio; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo			Efficacy of Concomitant Elemental Diet Therapy in Scheduled Infliximab Therapy in Patients with Crohn's Disease to Prevent Loss of Response	DIGESTIVE DISEASES AND SCIENCES			English	Article						Crohn's disease; Infliximab; Loss of response; Elemental diet	INFLAMMATORY-BOWEL-DISEASE; MAINTENANCE THERAPY; ENTERAL NUTRITION; SERUM INFLIXIMAB; REMISSION; TRIAL; OUTCOMES; TERM; IBD	Background Loss of response (LOR) to infliximab (IFX) has become an important clinical issue for patients with Crohn's disease (CD). Elemental diet (ED) therapy has been established as a nutrition therapy for CD in Japan. ED therapy can reduce antigen exposure and is both efficacious and safe. Aim To evaluate the efficacy of concomitant ED therapy in maintaining regular IFX infusion in patients with CD. Methods We retrospectively studied 125 patients with luminal CD treated with scheduled IFX maintenance therapy with a regular dosage. Patients were classified into two groups: the ED group with intake >= 900 kcal/day and the non-ED group with intake <900 kcal/day. When clinical LOR was detected on the basis of disease activity, laboratory parameters, or endoscopic findings, the physician discontinued the infusion schedule of IFX. We investigated the efficacy of ED therapy for sustaining the scheduled IFX maintenance therapy. Results With the exception of ED intake, no significant differences were found in patient characteristics between the ED group and the non-ED group. The ED group was significantly superior to the non-ED group (p = 0.049) in sustaining scheduled IFX maintenance therapy. It is well known that ED therapy is more effective for small bowel lesions than colonic lesions in CD. When comparing ileitis and ileocolitis patients with CD, the ED group was significantly superior to the non-ED group (p = 0.015). Conclusions Concomitant ED therapy is effective in maintaining scheduled IFX maintenance therapy in patients with luminal CD in order to prevent LOR.	[Kamata, Noriko; Watanabe, Kenji; Hosomi, Shuhei; Noguchi, Atsushi; Yukawa, Tomomi; Yamagami, Hirokazu; Shiba, Matsatsugu; Tanigawa, Tetsuya; Watanabe, Toshio; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo] Osaka City Univ, Dept Gastroenterol, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan; [Oshitani, Nobuhide] Aizeznbashi Hosp, Dept Med, Social Welf Serv Corp, Ishii Mem Aizen En,Naniwa Ku, Osaka 5950029, Japan; [Watanabe, Kimihiko] Osaka City Gen Hosp, Dept Gastroenterol, Miyakojima Ku, Osaka 5340021, Japan	Kamata, N (reprint author), Osaka City Univ, Dept Gastroenterol, Grad Sch Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	nkamata@med.osaka-cu.ac.jp; n.oshitani@aizenen.or.jp; threedice3156@gmail.com; kenjiw@med.osaka-cu.ac.jp; m1265271@med.osaka-cu.ac.jp; noguchi@med.osaka-cu.ac.jp; m1384049@med.osaka-cu.ac.jp; yamagami@med.osaka-cu.ac.jp; shiba@med.osaka-cu.ac.jp; ttanigawa@med.osaka-cu.ac.jp; watanabet@med.osaka-cu.ac.jp; tomy@med.osaka-cu.ac.jp; yasu@med.osaka-cu.ac.jp; arakawat@med.osaka-cu.ac.jp					Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Gisbert JP, 2009, AM J GASTROENTEROL, V104, P760, DOI 10.1038/ajg.2008.88; Wilschanski M, 1996, GUT, V38, P543, DOI 10.1136/gut.38.4.543; Mackey AC, 2009, J PEDIATR GASTR NUTR, V48, P386; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2007.11.041; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; D'Haens GR, 2011, AM J GASTROENTEROL, V106, P199, DOI 10.1038/ajg.2010.392; Nanda KS, 2013, AM J GASTROENTEROL, V108, P40, DOI 10.1038/ajg.2012.363; Maser EA, 2006, CLIN GASTROENTEROL H, V4, P1248, DOI 10.1016/j.cgh.2006.06.025; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Schnitzler F, 2009, INFLAMM BOWEL DIS, V15, P1295, DOI 10.1002/ibd.20927; Bhatia JK, 2007, J CLIN GASTROENTEROL, V41, P677, DOI 10.1097/MCG.0b013e31802c2a23; Hirai F, 2013, DIGEST DIS SCI, V58, P1329, DOI 10.1007/s10620-012-2374-2; HIRAKAWA H, 1993, GASTROENTEROL JPN, V28, P379; Lochs H, 2007, INFLAMM BOWEL DIS, V13, P1581, DOI 10.1002/ibd.20271; MATSUEDA K, 1995, J GASTROENTEROL, V30, P91; Takagi S, 2006, ALIMENT PHARM THERAP, V24, P1333, DOI 10.1111/j.1365-2036.2006.03120.x; Tanaka T, 2006, J GASTROEN HEPATOL, V21, P1143, DOI 10.1111/j.1440-1746.2006.04317.x; Vande CN, 2013, AM J GASTROENTEROL, V108, P962, DOI DOI 10.1038/AJG.2013.12]; Verma S, 2000, DIGEST LIVER DIS, V32, P769, DOI 10.1016/S1590-8658(00)80353-9	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	MAY	2015	60	5					1382	1388		10.1007/s10620-014-3493-8		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ5YN	WOS:000355570200036		
J	Nakai, Y; Isayama, H; Takahara, N; Hamada, T; Mohri, D; Kogure, H; Matsubara, S; Yamamoto, N; Tada, M; Koike, K				Nakai, Yousuke; Isayama, Hiroyuki; Takahara, Naminatsu; Hamada, Tsuyoshi; Mohri, Dai; Kogure, Hirofumi; Matsubara, Saburo; Yamamoto, Natsuyo; Tada, Minoru; Koike, Kazuhiko			Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Duodenal Obstruction Without a Discrete Mass	DIGESTIVE DISEASES AND SCIENCES			English	Article						Duodenal obstruction; Endoscopic ultrasound; Fine-needle aspiration	GASTRIC OUTLET OBSTRUCTION; BIOPSY; DIAGNOSIS; EUS		[Nakai, Yousuke; Isayama, Hiroyuki; Takahara, Naminatsu; Hamada, Tsuyoshi; Mohri, Dai; Kogure, Hirofumi; Matsubara, Saburo; Yamamoto, Natsuyo; Tada, Minoru; Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan	Isayama, H (reprint author), Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	isayama-2im@h.u-tokyo.ac.jp					Adler DG, 2002, AM J GASTROENTEROL, V97, P72; Nguyen NQ, 2013, GASTROINTEST ENDOSC, V78, P868, DOI 10.1016/j.gie.2013.05.020; Iwashita T, 2013, GASTROINTEST ENDOSC, V77, P909, DOI 10.1016/j.gie.2013.01.001; VILMANN P, 1992, GASTROINTEST ENDOSC, V38, P172, DOI 10.1016/S0016-5107(92)70385-X; SHONE DN, 1995, AM J GASTROENTEROL, V90, P1769; CHANG KJ, 1994, AM J GASTROENTEROL, V89, P263; Feng JN, 2006, DIAGN CYTOPATHOL, V34, P177, DOI 10.1002/dc.20382; Thomas T, 2009, ENDOSCOPY, V41, P335, DOI 10.1055/s-0029-1214470; ZARGAR SA, 1991, GUT, V32, P745, DOI 10.1136/gut.32.7.745	9	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	MAY	2015	60	5					1502	1504		10.1007/s10620-014-3458-y		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CJ5YN	WOS:000355570200050		
J	Nagao, K; Kanda, J				Nagao, Kenichi; Kanda, Jun			Estimation of Damping Correction Factors Using Duration Defined by the Standard Deviation of Phase Difference	EARTHQUAKE SPECTRA			English	Article							EARTHQUAKE GROUND MOTIONS; SPECTRA	The damping correction factors (DCFs) to convert the 5% damping acceleration response spectra to those for other damping levels are computed for the records of 13 Japanese earthquakes. Their correlation with the standard deviation of phase difference (sigma) is also investigated in ten frequency bands. The sigma-DCF relations obtained are found to be very similar across the different types of earthquakes. Further, regression analysis suggests that for damping ratios of 1% and 2%, with the increase in sigma, the DCFs increase in low-frequency bands (up to 4-5 Hz), whereas they decrease in higher frequency bands. On the other hand, for damping ratios of more than 5%, with the increase in sigma, the DCFs decrease in low-frequency bands (up to 1 Hz), whereas the opposite tendency is observed in higher frequency ranges. This research also discusses the applicability of the sigma-DCF relations to design ground motion simulation.	[Nagao, Kenichi] Daiwa House Ind, Kita Ku, Osaka, Osaka, Japan; [Kanda, Jun] Nihon Univ, Dept Architecture, Chiyoda Ku, Tokyo, Japan	Nagao, K (reprint author), Daiwa House Ind, Kita Ku, Umeda 3-3-5, Osaka, Osaka, Japan.						Lin YY, 2003, J STRUCT ENG-ASCE, V129, P206, DOI 10.1061/(ASCE)0733-9445(2003)129:2(206); Bommer JJ, 2005, EARTHQ ENG STRUCT D, V34, P145, DOI 10.1002/eqe.414; Hatzigeorgiou GD, 2010, EARTHQ ENG STRUCT D, V39, P1239, DOI 10.1002/eqe.991; Berge-Thierry C, 2003, J EARTHQUAKE ENG, V7, P193, DOI 10.1142/S1363246903001061; Kempton JJ, 2006, EARTHQ SPECTRA, V22, P985, DOI 10.1193/1.2358175; Ashour S. A., 1987, THESIS U MICHIGAN; Bommer J. J., 1998, 983 ESEE IMP COLL LO; BOORE DM, 1983, B SEISMOL SOC AM, V73, P1865; Cameron WI, 2007, B SEISMOL SOC AM, V97, P934, DOI 10.1785/0120060034; WU JP, 1989, J STRUCT ENG-ASCE, V115, P1412; Iwasaki R., 1988, J ARCHITECTURAL I JA, V386, P16; Joyner W, 1993, 93509 US GEOL SURV; Nagao K., 2012, P 15 WORLD C EARTHQ; Nagao K., 2011, P JAP C STRUCT SAF R, V7, P24; Nagao K., 2012, THESIS U TOKYO; Newmark N.M., 1982, EARTHQUAKE SPECTRA D; Ohsaki Y., 1979, J EARTHQUAKE ENG STR, V7, P427; Papagiannopoulos GA, 2013, EARTHQ STRUCT, V4, P489, DOI 10.12989/eas.2013.4.5.489; Papoulis A, 1977, SIGNAL ANAL; Ramirez O. M., 2000, MCEER000010 U NEW YO; Rezaeian S., 2012, 2012102 PEER; Sato T., 2007, J JAPAN ASS EARTHQUA, V7, P1; Stafford P. J., 2008, J STRUCTURAL ENG ASC, V134, P206; Trifunac M. D., 1989, Soil Dynamics and Earthquake Engineering, V8, DOI 10.1016/S0267-7261(89)80008-9; Yamane T., 2002, J ARCHITECTURAL I JA, V553, P49	25	0	0	EARTHQUAKE ENGINEERING RESEARCH INST	OAKLAND	499 14TH ST, STE 320, OAKLAND, CA 94612-1934 USA	8755-2930	1944-8201		EARTHQ SPECTRA	Earthq. Spectra	MAY	2015	31	2					761	783		10.1193/103012EQS321M		23	Engineering, Civil; Engineering, Geological	Engineering	CJ6AS	WOS:000355576000007		
J	Suppasri, A; Charvet, I; Imai, K; Imamura, F				Suppasri, Anawat; Charvet, Ingrid; Imai, Kentaro; Imamura, Fumihiko			Fragility Curves Based on Data from the 2011 Tohoku-Oki Tsunami in Ishinomaki City, with Discussion of Parameters Influencing Building Damage	EARTHQUAKE SPECTRA			English	Article							INDIAN-OCEAN TSUNAMI; PTVA MODEL; VULNERABILITY; EARTHQUAKE; JAPAN; AREAS	The 63,605 damaged buildings from the 2011 Tohoku-oki tsunami in Ishinomaki were used to develop 52 fragility curves using linear regression. The data comprise the damage level and the measured inundation depth for each building. In agreement with previous studies, the present results indicate that reinforced concrete and steel buildings with three stories or more perform better under tsunami loading. Performance with respect to their intended function was found to depend mainly on structural material. Moreover, based on Japan's design code for earthquake-resistant buildings, buildings constructed after 1981 do not display a better performance compared to more recent constructions. Finally, the results show that for the same inundation depth, a higher damage probability exists along a ria coast due to higher flow velocities, confirmed by numerical simulation and survivor videos. These new findings are useful for building damage assessment, town reconstruction, and comparison of vulnerability functions in future studies.	[Suppasri, Anawat; Imai, Kentaro; Imamura, Fumihiko] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 9808579, Japan; [Charvet, Ingrid] UCL, Earthquake & People Interact Ctr, London WC1E 6BT, England	Suppasri, A (reprint author), Tohoku Univ, Int Res Inst Disaster Sci, 6-6-11 Aoba, Sendai, Miyagi 9808579, Japan.				Tokio Marine & Nichido Fire Insurance Co., Ltd., through the International Research Institute of Disaster Science (IRIDeS) at Tohoku University; Willis Research Network (WRN), under the Pan-Asian/Oceanian tsunami risk modeling and mapping project; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	The detailed building damage data used in this study were collected during the damage field survey of the 2011 Tohoku tsunami conducted by the Ministry of Land, Infrastructure, and Transport (MLIT) and were officially provided by Ishinomaki City. This research was partly funded by the Tokio Marine & Nichido Fire Insurance Co., Ltd., through the International Research Institute of Disaster Science (IRIDeS) at Tohoku University; the Willis Research Network (WRN), under the Pan-Asian/Oceanian tsunami risk modeling and mapping project; and the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The authors greatly appreciate questions and comments from reviewers that helped to improve the manuscript.	Suppasri A, 2013, NAT HAZARDS, V66, P319, DOI 10.1007/s11069-012-0487-8; Iuchi K, 2013, EARTHQ SPECTRA, V29, pS479, DOI 10.1193/1.4000119; Reese S, 2011, EARTH-SCI REV, V107, P156, DOI 10.1016/j.earscirev.2011.01.009; Leone F, 2011, APPL GEOGR, V31, P363, DOI 10.1016/j.apgeog.2010.07.009; Dominey-Howes D, 2007, NAT HAZARDS, V40, P113, DOI 10.1007/s11069-006-0007-9; Suppasri A, 2012, COAST ENG J, V54, DOI 10.1142/S0578563412500052; Suppasri A, 2012, COAST ENG J, V54, DOI 10.1142/S0578563412500088; Suppasri A, 2013, PURE APPL GEOPHYS, V170, P993, DOI 10.1007/s00024-012-0511-7; Reese S, 2007, NAT HAZARD EARTH SYS, V7, P573; Papathoma M, 2003, NAT HAZARD EARTH SYS, V3, P377; Suppasri A, 2011, NAT HAZARD EARTH SYS, V11, P173, DOI 10.5194/nhess-11-173-2011; Omira R, 2010, NAT HAZARDS, V54, P75, DOI 10.1007/s11069-009-9454-4; Dall'Osso F, 2009, NAT HAZARD EARTH SYS, V9, P1557; Mas E, 2012, NAT HAZARD EARTH SYS, V12, P2689, DOI 10.5194/nhess-12-2689-2012; Foytong P, 2013, EARTHQ SPECTRA, V29, pS161, DOI 10.1193/1.4000128; Koshimura S, 2009, COAST ENG J, V51, P243, DOI 10.1142/S0578563409002004; Architectural Institute of Japan (AIJ), 1992, STAND STRUCT CALC RE; Arikawa T., 2009, J DISASTER RES, V4, P377; Chatterjee S, 2006, REGRESSION ANAL EXAM; Chock F., 2013, EARTHQ SPECTRA, V29, pS99; Federal Emergency Management Agency (FEMA), 2008, P646 FEMA US DEP HOM; Foytong P., 2007, 12 KKCNN S CIV ENG J, pS8; Fritz HM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050686; Gardi A, 2011, NAT HAZARD EARTH SYS, V11, P883, DOI 10.5194/nhess-11-883-2011; Gokon H, 2014, NAT HAZARD EARTH SYS, V14, P3231, DOI 10.5194/nhess-14-3231-2014; Koshimura S, 2009, J DISASTER RES, V4, P479; Koshimura S., 2012, P 9 INT C URB EARTHQ; Koshimura S., 2009, P 7 INT WORKSH REM S; Koshimura S., 2012, J JSCE B2, V68, P336; Lukkunaprasit P, 2010, J EARTHQ TSUNAMI, V4, P105, DOI 10.1142/S1793431110000753; Maruyama Y, 2013, EARTHQ SPECTRA, V29, pS201, DOI 10.1193/1.4000123; Matsutomi H., 2010, P 3 INT FIELD S 10 1; Ministry of Land Infrastructure and Transportation (MLIT), 2012, SURV TSUN DAM COND; Murao O., 2010, P 7 INT C SUST BUILT; Narita Y., 2013, P CIV ENG C TOH BRAN, P11; National Police Agency, 2011, DAM COND 2011 EARTHQ; Nihei Y., 2012, J JSCE B2, V2, P276; Okada T., 2006, TSUNAMI LOADS STRUCT; Ruangrassamee A, 2006, EARTHQ SPECTRA, V22, P377; SHUTO N, 1993, ADV NAT TECHNOL HAZ, V1, P197; Suppasri A., 2012, P INT SESSIONS COAST, V3, P76; Suzuki S., 2005, P WATER ENG JSCE, V49, P439; The 2011 Tohoku Earthquake Tsunami Joint Survey Group, 2011, J JPN SOC CIV ENG B, V67, P63; Valencia N, 2011, NAT HAZARD EARTH SYS, V11, P2385; Yanagisawa H., 2012, J JAPAN SOC CIVIL B, V68, P1401; Yeh Harry, 2007, J DISASTER RES, V2, P531	46	1	1	EARTHQUAKE ENGINEERING RESEARCH INST	OAKLAND	499 14TH ST, STE 320, OAKLAND, CA 94612-1934 USA	8755-2930	1944-8201		EARTHQ SPECTRA	Earthq. Spectra	MAY	2015	31	2					841	868		10.1193/053013EQS138M		28	Engineering, Civil; Engineering, Geological	Engineering	CJ6AS	WOS:000355576000011		
J	Hatayama, K				Hatayama, Ken			Damage to Oil Storage Tanks from the 2011 M-w 9.0 Tohoku-Oki Tsunami	EARTHQUAKE SPECTRA			English	Article								The M-w 9.0 2011 Tohoku-oki tsunami damaged 418 oil storage tanks and moved 157 of them. Using data on the severity of damage and the maximum inundation depth of the tsunami, a fragility curve representing the damage to oil storage tank plumbing is presented in this paper: P(eta) = Phi((eta - 1.02)/0.574), where P is the damage rate, eta is the maximum inundation depth in meters, and Phi is the standard normal cumulative distribution function. The existing method of predicting the movement of tanks exposed to a tsunami is validated by comparing the predicted damage with actual damage data from the 2011 tsunami. The accuracy (hit rate) is 76%.	Natl Res Inst Fire & Disaster, Tokyo, Japan	Hatayama, K (reprint author), Natl Res Inst Fire & Disaster, Tokyo, Japan.						Chile Tsunami Joint Survey Group, 1960, PREL SURV REP CHIL E; Committee on the Alaska Earthquake Division of Earth Sciences National Research Council, 1972, GREAT AL EARTHQ 1964; Fire and Disaster Management Agency Japan (FDMA), 2013, 147 FDMA; Fire and Disaster Management Agency Japan (FDMA), 2009, REP COUNT TSUN IN HA; Fire and Disaster Management Agency Japan (FDMA), 1965, STUD FIR 1964 NIIG E; Fire and Disaster Management Agency Japan (FDMA), 2011, REP COUNT EARTHQ TSU; Fujii N., 2006, ANN J COASTAL ENG, V53, P271; Goto Y., 2005, SAFETY TOMORROW, V104, P61; Hydrographic Department Japan, 1948, HYDR B; Japan Meteorological Agency, 1969, 68 JAP MET AG; Kesennuma Motoyoshi Fire Department, 2012, GREAT E JAP EARTHQ R; Mori N., 2012, COAST ENG J, V54; National Research Institute of Fire and Disaster Japan (NRIFD), 2011, IN REP DAM DUE 2011; Omote S., 1946, B EARTHQ RES I TOKYO, V24, P31; Shuto N, 1987, 4 TOH U; Tsuji Y., 1984, MARINE SCI MONTHLY, V16, P527	16	0	0	EARTHQUAKE ENGINEERING RESEARCH INST	OAKLAND	499 14TH ST, STE 320, OAKLAND, CA 94612-1934 USA	8755-2930	1944-8201		EARTHQ SPECTRA	Earthq. Spectra	MAY	2015	31	2					1103	1124		10.1193/050713EQS120M		22	Engineering, Civil; Engineering, Geological	Engineering	CJ6AS	WOS:000355576000022		
J	Xu, F; Xiang, N; Higano, Y				Xu, Feng; Xiang, Nan; Higano, Yoshiro			COMPREHENSIVE EVALUATION OF ENVIRONMENTAL POLICIES FOR SUSTAINABLE DEVELOPMENT IN JIAXING CITY, CHINA	ENVIRONMENTAL ENGINEERING AND MANAGEMENT JOURNAL			English	Article						dynamic programming; environmental policy; optimization simulation; water environment		Recently, various environmental problems have been introduced with the rapid economic development and population growth in China. It is important to enforce optimal environmental policies to achieve economic development along with environmental improvements. In this study, we selected the city of Jiaxing for our research area due to its high water pollution and its fast economic growth, and we constructed a comprehensive environmental policy evaluation model to elucidate the optimal development proposals for local sustainable development. The optimization simulation model includes a water pollutant reduction model and a socioeconomic model; it can evaluate the feasibility and efficiency of the environmental policies based on the consideration of environmental preservation and economic development. Established using dynamic programming in LINGO, simulation results proved that a comprehensive environmental policy with biomass plant construction is the best choice to achieve the research targets. This study can provide information like specific policy initiatives to improve the trade-off between environment and economic in Jiaxing city, China.	[Xu, Feng] Beijing Univ Chem Technol, Sch Econ & Management, Beijing 100029, Peoples R China; [Xiang, Nan] Univ Chinese Acad Sci, Sch Management, Beijing 100190, Peoples R China; [Higano, Yoshiro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Xu, F (reprint author), Beijing Univ Chem Technol, Sch Econ & Management, Beijing 100029, Peoples R China.	xufeng_t@tsinghua.edu.cn					Beroggi G.E.G., 1999, DECISION MODELLING P; Brock W.A., 2003, BROOKINGS PAPERS EC, V1, P15; Frank D.G., 2006, BIOMASS ASSESSMENT H; Fu X.D., 2006, OPTIMIZATION MANAGEM; Fumiaki H., 2000, STUDIES REGIONAL SCI, V30, P47; Gunton TI, 2007, ENV J, V34, P1; Higano Yoshiro, 2009, International Journal of Environmental Technology and Management, V11, DOI 10.1504/IJETM.2009.027190; Iles A.T., 1996, ENV PLANNING LAW J, V13, P288; Japanese Energy Association, 2003, BIOM HDB; Jiaxing City Statistics, 2007, YB JIAXING CITY STAT; Jiaxing Government, 2007, WAT POLL GEN AM RED; Mizunoya T., 2007, STUDIES REGIONAL SCI, V36, P355; NAPA, 2000, TRANSF ENV PROT 21 C; Newnan D.G., 2002, ESSENTIALS ENG EC AN; OECD, 1997, EV EC INSTR ENV POL; SAEP, 2007, ENV REP JIAX CIT; SAEP, 2010, ENV REP JIAX CIT; Sami S, 2014, ENVIRON ENG MANAG J, V13, P2615; Song G.J., 2007, ENV POLLUTION CONTRO, V12, P157; Vikolainen V, 2013, ENVIRON ENG MANAG J, V12, P1637; Wang B, 2003, SYSTEMS ENG THEORY P, V3, P14; Xu F, 2013, ENVIRON ENG MANAG J, V12, P1897; Yan J.J., 2010, HUMAN ENV SYMBIOSIS, V17, P87; Young P, 1998, ENVIRON MODELL SOFTW, V13, P105, DOI 10.1016/S1364-8152(98)00011-5	24	0	0	GH ASACHI TECHNICAL UNIV IASI	IASI	71 MANGERON BLVD, IASI, 700050, ROMANIA	1582-9596	1843-3707		ENVIRON ENG MANAG J	Environ. Eng. Manag. J.	MAY	2015	14	5					1079	1088				10	Environmental Sciences	Environmental Sciences & Ecology	CJ9UD	WOS:000355847800013		
J	Lim, JH; Lee, CW; Kudo, I				Lim, Joon Hai; Lee, Choon Weng; Kudo, Isao			Temporal variation of phytoplankton growth and grazing loss in the west coast of Peninsular Malaysia	ENVIRONMENTAL MONITORING AND ASSESSMENT			English	Article						Phytoplankton growth rate; Grazing loss rate; Grazing pressure; Tropical waters; Straits of Malacca	MARINE-PHYTOPLANKTON; BACTERIAL ABUNDANCE; MICROZOOPLANKTON; ESTUARY; IMPACT; ZOOPLANKTON; VARIABILITY; ECOSYSTEMS; DYNAMICS; SYSTEMS	Phytoplankton growth (mu) and grazing loss (g) rates were measured monthly by the Landry-Hassett dilution method over a 2-year period at both estuarine (Klang) and coastal water (Port Dickson) systems along the Straits of Malacca. Chlorophyll a (Chl a) concentration ranged from 0.20 to 4.47 mu g L-1 at Klang except on two occasions when Chl a spiked above 10 mu g L-1. In contrast, Chl a concentrations were relatively stable at Port Dickson (0.14 to 2.76 mu g L-1). From the rate measurements, mu was higher (t=2.01, df=43, p<0.05) at Klang (0.30 to 2.26 day(-1)) than at Port Dickson (0.18 to 1.66 day(-1)), but g was not significantly different (p>0.80). g ranged from 0.30 to 1.50 and 0.21 to 1.51 day(-1) at Klang and Port Dickson, respectively. In this study, grazing loss was coupled to phytoplankton growth, and the ratio of g/mu or grazing pressure which estimates the proportion of primary production grazed was 50 % at Klang and lower than at Port Dickson (68 %; t=2.213, df=36, p<0.05). We found that the higher growth rates in a eutrophic system, i.e., Klang, were not matched by higher grazing loss, and this may have implications for the biogeochemical cycling in coastal waters.	[Lim, Joon Hai; Lee, Choon Weng] Univ Malaya, Microbial Ecol Lab, Inst Biol Sci, Kuala Lumpur 50603, Malaysia; [Lee, Choon Weng] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur 50603, Malaysia; [Kudo, Isao] Hokkaido Univ, Grad Sch Fisheries Sci, Sapporo, Hokkaido, Japan	Lee, CW (reprint author), Univ Malaya, Microbial Ecol Lab, Inst Biol Sci, Kuala Lumpur 50603, Malaysia.	lee@um.edu.my	Lee, Choon Weng/B-6934-2008	Lee, Choon Weng/0000-0001-9805-9980	University of Malaya [UM.C/625/1/HIR/050, RU006D-2014, PV060/2011B]; Ministry of Science, Technology and Innovation [04-01-03-SF0671]; Ministry of Education [IOES-2014D]	We are grateful to the University of Malaya for the grants (UM.C/625/1/HIR/050, RU006D-2014 and PV060/2011B) that supported this work. We also thank the Ministry of Science, Technology and Innovation for the eScience grant (04-01-03-SF0671) and the Ministry of Education for the HiCoE grant (IOES-2014D).	Schmoker C, 2013, J PLANKTON RES, V35, P691, DOI 10.1093/plankt/fbt023; CLOERN JE, 1985, HYDROBIOLOGIA, V129, P153, DOI 10.1007/BF00048693; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; LANDRY MR, 1984, MAR ECOL PROG SER, V16, P127, DOI 10.3354/meps016127; Liu HB, 2009, DEEP-SEA RES PT I, V56, P561, DOI 10.1016/j.dsr.2008.12.003; Lee CW, 2009, APPL ENVIRON MICROB, V75, P7594, DOI 10.1128/AEM.01227-09; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Alongi DM, 2003, MAR ENVIRON RES, V55, P313, DOI 10.1016/S0141-1136(02)00276-3; Stukel MR, 2011, LIMNOL OCEANOGR, V56, P1866, DOI 10.4319/lo.2011.56.5.1866; Calbet A, 2001, LIMNOL OCEANOGR, V46, P1824; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; Yoshiyama K, 2006, LIMNOL OCEANOGR, V51, P424; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; MANN KH, 1993, ICES J MAR SCI, V50, P105, DOI 10.1006/jmsc.1993.1013; Chen BZ, 2012, LIMNOL OCEANOGR, V57, P519, DOI 10.4319/lo.2012.57.2.0519; Kuipers BR, 1999, MAR ECOL PROG SER, V180, P93, DOI 10.3354/meps180093; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Cole JJ, 1999, ECOSYSTEMS, V2, P215, DOI 10.1007/s100219900069; Lee CW, 2008, MAR FRESHWATER RES, V59, P10, DOI 10.1071/MF07099; Pomeroy LR, 2001, AQUAT MICROB ECOL, V23, P187, DOI 10.3354/ame023187; Turner JT, 2002, AQUAT MICROB ECOL, V27, P57, DOI 10.3354/ame027057; Pomeroy LR, 2001, SCI MAR, V65, P31; Paterson HL, 2008, J PLANKTON RES, V30, P379, DOI 10.1093/plankt/fbn004; Modigh M, 2009, J PLANKTON RES, V31, P853, DOI 10.1093/plankt/fbp035; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bong CW, 2011, MAR FRESHWATER RES, V62, P414, DOI 10.1071/MF10213; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51; Grasshoff K., 1999, METHODS SEAWATER ANA; Gutierrez-Rodriguez A, 2009, MAR ECOL PROG SER, V383, P1, DOI 10.3354/meps08005; Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025; IPCC, 2007, CLIM CHANG PHYS SCI; Irwin AJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039883; KIRCHMAN D, 1984, MAR ECOL PROG SER, V19, P247, DOI 10.3354/meps019247; Landry MR, 2014, LIMNOL OCEANOGR, V59, P1095, DOI 10.4319/lo.2014.59.3.1095; Lee CW, 2012, B MAR SCI, V88, P1, DOI 10.5343/bms.2010.1075; Lee CW, 2013, ENVIRON MONIT ASSESS, V185, P9697, DOI 10.1007/s10661-013-3283-3; Ma Lu, 2014, Acta Ecologica Sinica, V34, P546; MOAL J, 1987, OCEANOL ACTA, V10, P339; Pagano M, 2006, ESTUAR COAST SHELF S, V67, P369, DOI 10.1016/j.ecss.2005.10.018; Parsons T.R, 1984, MANUAL CHEM BIOL MET; Welch P. S., 1948, LIMNOLOGICAL METHODS; York J. K., 2010, ESTUAR COAST, V34, P373; ZAR J. H., 1999, BIOSTATISTICAL ANAL	43	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6369	1573-2959		ENVIRON MONIT ASSESS	Environ. Monit. Assess.	MAY	2015	187	5							246	10.1007/s10661-015-4487-5		9	Environmental Sciences	Environmental Sciences & Ecology	CJ6LY	WOS:000355606500019		
J	Sun, WC; Ishidaira, H; Bastola, S; Yu, JS				Sun, Wenchao; Ishidaira, Hiroshi; Bastola, Satish; Yu, Jingshan			Estimating daily time series of streamflow using hydrological model calibrated based on satellite observations of river water surface width: Toward real world applications	ENVIRONMENTAL RESEARCH			English	Article						Hydrological model; Model calibration; Remote sensing; River water-surface width; GLUE	RAINFALL-RUNOFF MODELS; RADAR ALTIMETRY; BASIN; DISCHARGE; UNCERTAINTY; CLIMATE; FUTURE	Lacking observation data for calibration constrains applications of hydrological models to estimate daily time series of streamflow. Recent improvements in remote sensing enable detection of river water-surface width from satellite observations, making possible the tracking of streamflow from space. In this study, a method calibrating hydrological models using river width derived from remote sensing is demonstrated through application to the ungauged Irrawaddy Basin in Myanmar. Generalized likelihood uncertainty estimation (GLUE) is selected as a tool for automatic calibration and uncertainty analysis. Of 50,000 randomly generated parameter sets, 997 are identified as behavioral, based on comparing model simulation with satellite observations. The uncertainty band of streamflow simulation can span most of 10-year average monthly observed streamflow for moderate and high flow conditions. Nash-Sutcliffe efficiency is 95.7% for the simulated streamflow at the 50% quantile. These results indicate that application to the target basin is generally successful. Beyond evaluating the method in a basin lacking streamflow data, difficulties and possible solutions for applications in the real world are addressed to promote future use of the proposed method in more ungauged basins. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Sun, Wenchao; Yu, Jingshan] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Sun, Wenchao] JCGCS, Beijing 100875, Peoples R China; [Ishidaira, Hiroshi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008511, Japan; [Bastola, Satish] Georgia Inst Technol, Atlanta, GA 30332 USA	Sun, WC (reprint author), Beijing Normal Univ, Coll Water Sci, Xinjiekouwai St 19, Beijing 100875, Peoples R China.	sunny@bnu.edu.cn			National Natural Science Foundation of China [41201018, 91125015]; MEXT Japan [24560619]; National Key Technology R&D Program of China [2013BAB05B04]; Fundamental Research Funds for the Central Universities of China [251-105569GK]	This study was supported by the National Natural Science Foundation of China (Grant nos. 41201018 and 91125015), the Grant-in-Aid for Scientific Research (C), MEXT Japan (No. 24560619, PI: Hiroshi Ishidaira, University of Yamanashi), National Key Technology R&D Program of China (Grant no. 2013BAB05B04), and Fundamental Research Funds for the Central Universities of China (Grant no. 251-105569GK).	Abileah R., 2013, EUR GEOSC UN EGU GEN, V15; Abileah R, 2011, INT WATER TECHNOL J, V1, P63; Ahn C. H., 1994, J JAPANESE SOC PHOTO, V33, P12; Alsdorf DE, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000197; Bjerklie DM, 2005, J HYDROL, V309, P191, DOI 10.1016/j.jhydrol.2004.11.022; Biancamaria S, 2011, REMOTE SENS ENVIRON, V115, P373, DOI 10.1016/j.rse.2010.09.008; Michailovsky CI, 2013, WATER RESOUR RES, V49, P4807, DOI 10.1002/wrcr.20345; Hirabayashi Y, 2013, NAT CLIM CHANGE, V3, P816, DOI [10.1038/nclimate1911, 10.1038/NCLIMATE1911]; Sivapalan M, 2003, HYDROLOG SCI J, V48, P857, DOI 10.1623/hysj.48.6.857.51421; Domeneghetti A, 2014, REMOTE SENS ENVIRON, V149, P130, DOI 10.1016/j.rse.2014.04.007; Dingman SL, 2007, J HYDROL, V334, P17, DOI 10.1016/j.jhydrol.2006.09.021; SMITH LC, 1995, WATER RESOUR RES, V31, P1325, DOI 10.1029/95WR00145; Durand M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034150; Sun WC, 2010, HYDROL EARTH SYST SC, V14, P2011, DOI 10.5194/hess-14-2011-2010; Stephens EM, 2012, J HYDROL, V414, P162, DOI 10.1016/j.jhydrol.2011.10.040; BEVEN K, 1992, HYDROL PROCESS, V6, P279, DOI 10.1002/hyp.3360060305; Getirana ACV, 2010, J HYDROL, V387, P244, DOI 10.1016/j.jhydrol.2010.04.013; MOORE RJ, 1985, HYDROLOG SCI J, V30, P273, DOI 10.1080/02626668509490989; Finsen F, 2014, HYDROL RES, V45, P148, DOI 10.2166/nh.2013.191; Hirabayashi Y, 2008, HYDROLOG SCI J, V53, P754, DOI 10.1623/hysj.53.4.754; Sun WC, 2012, HYDROL PROCESS, V26, P3524, DOI 10.1002/hyp.8429; Viglione A, 2010, J HYDROL, V394, P198, DOI 10.1016/j.jhydrol.2010.05.047; Pardo-Pascual JE, 2012, REMOTE SENS ENVIRON, V123, P1, DOI 10.1016/j.rse.2012.02.024; Seibert J, 2009, HYDROL EARTH SYST SC, V13, P883; Gao YX, 2009, J HYDROL, V374, P136, DOI 10.1016/j.jhydrol.2009.06.009; Boyle D., 2001, THESIS U ARIZONA TUC; Chavoshian H., 2007, THESIS U YAMANASHI J; Chavoshian H., 2006, HYDROLOGICAL MODELIN, VAvailable at; Coe MT, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002543; Dingman S.L., 2005, ENCY HYDROLOGICAL SC; Fekete B. M., 2007, IAHS PUBL, V309, P129; Freer J., 1996, WATER RESOUR RES, V32, P2061; Kachin Environment Organization, 2008, DAMM IRR; Koren V., 2003, WATER SCI APPL, V6, P239; Leopold L. B., 1953, 252 US GEOL SURV; Li Q., 2009, ANN J HYDRAUL ENG JS, V53, P19; Masutomi Y, 2009, HYDROL PROCESS, V23, P572, DOI 10.1002/hyp.7186; Merz R, 2004, J HYDROL, V287, P95, DOI 10.1016/j.jhydrol.2003.09.028; Montanan A., 2013, HYDROL SCI J, V58; Montanari M, 2009, HYDROL EARTH SYST SC, V13, P367; Schumann G, 2009, REV GEOPHYS, V47, DOI 10.1029/2008RG000274; Shamir E, 2005, HYDROL PROCESS, V19, P2187, DOI 10.1002/hyp.5676; Smith LC, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006133; Sun W., 2010, ANN J HYDRAUL ENG JS, V54, P1; Sun W., 2009, ANN J HYDRAUL ENG JS, V53, P49; Usachev V.F, 1983, IAHS PUBL, V145, P475; World Conservation Monitoring Center, 1998, WCMC BIOD SER, V8; Yatagai A, 2009, SOLA, V5, P137, DOI 10.2151/sola.2009-035	48	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	MAY	2015	139				SI		36	45		10.1016/j.envres.2015.01.002		10	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CJ5ZW	WOS:000355573800006		
J	Ino, Y; Kubo, T; Tanaka, A; Liu, Y; Tanimoto, T; Kitabata, H; Shiono, Y; Shimamura, K; Orii, M; Komukai, K; Satogami, K; Matsuo, Y; Yamano, T; Yamaguchi, T; Hirata, K; Imanishi, T; Akasaka, T				Ino, Yasushi; Kubo, Takashi; Tanaka, Atsushi; Liu, Yong; Tanimoto, Takashi; Kitabata, Hironori; Shiono, Yasutsugu; Shimamura, Kunihiro; Orii, Makoto; Komukai, Kenichi; Satogami, Keisuke; Matsuo, Yoshiki; Yamano, Takashi; Yamaguchi, Tomoyuki; Hirata, Kumiko; Imanishi, Toshio; Akasaka, Takashi			Comparison of vascular response between everolimus-eluting stent and bare metal stent implantation in ST-segment elevation myocardial infarction assessed by optical coherence tomography	EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING			English	Article						Everolimus-eluting stent; ST-segment elevation myocardial infarction; Stent malapposition; Optical coherence tomography	PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED-TRIALS; FOLLOW-UP; TISSUE COVERAGE; THROMBOSIS; VS.; METAANALYSIS; ANGIOPLASTY	Aims The long-term safety of second-generation everolimus-eluting stents (EESs) in ST-segment elevation myocardial infarction (STEMI) remains unclear. The aim of this study was to evaluate the late vascular response after stent implantation in STEMI between EES and bare-metal stent (BMS) by using optical coherence tomography (OCT). Methods and results A prospective OCT examination was performed in 102 patients at 10 months after stent implantation for treatment of STEMI. A total of 1253 frames with 12 772 struts in 61 EESs and 776 frames with 8594 struts in 41 BMSs were analysed. There were no significant differences in the percentage of uncovered struts (2.1 +/- 2.8 vs. 1.7 +/- 2.7%, P = 0.422) and malapposed struts (0.7 +/- 1.3 vs. 0.6 +/- 1.2%, P = 0.756) between EES and BMS. The frequency of intra-stent thrombus was comparable between the two stents (13 vs. 10%, P = 0.758). The mean neointimal thickness was smaller in EES compared with BMS (104 +/- 39 vs. 388 +/- 148 mm, P < 0.001). In-segment binary restenosis and target lesion revascularization was less often seen in EES compared with BMS (3 vs. 17%, P = 0.028 and 2 vs. 12%, P = 0.037, respectively). Conclusion When compared with BMS, EES showed a lower rate of stent restenosis, similar frequency of neointimal coverage, stent malapposition, and intra-stent thrombus at 10 months after stent implantation in STEMI. Our results suggest the safety and effectiveness of EES in primary percutaneous coronary intervention for STEMI patients.	[Ino, Yasushi; Kubo, Takashi; Tanaka, Atsushi; Liu, Yong; Tanimoto, Takashi; Kitabata, Hironori; Shiono, Yasutsugu; Shimamura, Kunihiro; Orii, Makoto; Komukai, Kenichi; Satogami, Keisuke; Matsuo, Yoshiki; Yamano, Takashi; Yamaguchi, Tomoyuki; Hirata, Kumiko; Imanishi, Toshio; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418509, Japan	Kubo, T (reprint author), Wakayama Med Univ, Dept Cardiovasc Med, 811-1 Kimiidera, Wakayama 6418509, Japan.	takakubo@wakayama-med.ac.jp					De Luca G, 2008, INT J CARDIOL, V126, P37, DOI 10.1016/j.ijcard.2007.03.112; Stone GW, 2009, NEW ENGL J MED, V360, P1946, DOI 10.1056/NEJMoa0810116; Gonzalo N, 2009, JACC-CARDIOVASC INTE, V2, P445, DOI 10.1016/j.jcin.2009.01.012; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Gutierrez-Chico JL, 2011, EUR HEART J, V32, P2454, DOI 10.1093/eurheartj/ehr182; Hofma SH, 2012, J AM COLL CARDIOL, V60, P381, DOI 10.1016/j.jacc.2012.01.073; Kastrati A, 2007, EUR HEART J, V28, P2706, DOI 10.1093/eurheartj/ehm402; Kalesan B, 2012, EUR HEART J, V33, P977, DOI 10.1093/eurheartj/ehs036; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Jensen LO, 2008, CIRC-CARDIOVASC INTE, V1, P176, DOI 10.1161/CIRCINTERVENTIONS.108.794578; Lowe HC, 2011, JACC-CARDIOVASC INTE, V4, P1257, DOI 10.1016/j.jcin.2011.08.015; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Guagliumi G, 2011, CIRCULATION, V123, P274, DOI 10.1161/CIRCULATIONAHA.110.963181; Palmerini T, 2012, CIRC-CARDIOVASC INTE, V5, P357, DOI 10.1161/CIRCINTERVENTIONS.111.967083; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; Bangalore S, 2013, CIRC-CARDIOVASC INTE, V6, P378, DOI 10.1161/CIRCINTERVENTIONS.113.000415; Finn AV, 2008, JACC-CARDIOVASC IMAG, V1, P485, DOI 10.1016/j.jcmg.2008.04.007; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Kubo Takashi, 2010, Cardiovasc Interv Ther, V25, P2, DOI 10.1007/s12928-009-0006-3; Park J, 2013, EUR HEART J-CARD IMG, V14, P1181, DOI 10.1093/ehjci/jet088; Toledano Delgado FJ, 2013, CATHETER CARDIOVASC, DOI [10.1002/ccd.25235, DOI 10.1002/CCD.25235]	22	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2047-2404	2047-2412		EUR HEART J-CARD IMG	Eur. Heart J.-Cardiovasc. Imaging	MAY	2015	16	5					513	520		10.1093/ehjci/jeu227		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CJ9PE	WOS:000355833800013		
J	Dokuni, K; Matsumoto, K; Tanaka, H; Okita, Y; Hirata, K				Dokuni, Kumiko; Matsumoto, Kensuke; Tanaka, Hidekazu; Okita, Yutaka; Hirata, Ken-ichi			A case of non-infective endocarditis accompanied by multiple cerebral infarctions and severe mitral regurgitation as initial presentation of primary antiphospholipid syndrome	EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING			English	Editorial Material									[Dokuni, Kumiko; Matsumoto, Kensuke; Tanaka, Hidekazu; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan; [Okita, Yutaka] Kobe Univ, Grad Sch Med, Dept Surg, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan	Matsumoto, K (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kenmatsu@med.kobe-u.ac.jp						0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2047-2404	2047-2412		EUR HEART J-CARD IMG	Eur. Heart J.-Cardiovasc. Imaging	MAY	2015	16	5					572	572		10.1093/ehjci/jeu325		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CJ9PE	WOS:000355833800023		
J	Horiuchi, S; Winter, G				Horiuchi, Shohei; Winter, Gerhard			CMC determination of nonionic surfactants in protein formulations using ultrasonic resonance technology	EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS			English	Article						Protein formulation; Surfactant; Ultrasonic resonance technology; Critical micelle concentration; Surface tensiometry; Dynamic light scattering	HUMAN GROWTH-HORMONE; POLYSORBATE 20; SOLUTION BEHAVIOR; SELF-AGGREGATION; COMPRESSIBILITY; STABILITY; IMMUNOGENICITY; ERYTHROPOIETIN; STABILIZATION; ANTIBODIES	Biological products often contain surfactants as stabilizers in their formulations to avoid surface adsorption, interfacial denaturation and aggregation of the protein drug and thereby improve the overall pharmaceutical quality of the product. On the other hand, when the surfactant concentration exceeds the critical micelle concentration (CMC) in a protein formulation, protein-loaded micelles could be formed which could potentially be the cause of immunogenicity. Therefore, the actual CMC and the presence of micelles generally need to be confirmed for each protein formulation because the CMC is affected by the presence of protein and other formulation factors. In this study, the ultrasonic resonance technology (URT) was applied to determine CMC of surfactants in pharmaceutical protein solutions in comparison with surface tensiometry (TE) and dynamic light scattering (DLS). According to our results, the ultrasonic resonance technology can easily and precisely provide CMCs of surfactants in protein formulations while it is not working for protein-free formulations. This indicates that the signal we measure with ultrasonic velocity comes from complex micelles composed of surfactant and protein molecules. DLS did not provide reliable data for protein/surfactant systems. Interestingly, a protein formulation with arginine and polysorbate 20 behaved differently when studied with TE and URT allowing us to see that arginine is bound to protein and that the complex interacts with the surfactant. (C) 2015 Elsevier B.V. All rights reserved.	[Horiuchi, Shohei; Winter, Gerhard] Univ Munich, Dept Pharm Pharmaceut Technol & Biopharmaceut, Munich, Germany; [Horiuchi, Shohei] Takeda Pharmaceut Co Ltd, CMC Ctr, Pharmaceut Technol Res & Dev Labs, Osaka, Japan	Horiuchi, S (reprint author), Takeda Pharmaceut Co Ltd, CMC Ctr, Pharmaceut Technol Res & Dev Labs, Osaka, Japan.	shohei.horiuchi@takeda.com					Patapoff TW, 2009, PHARM DEV TECHNOL, V14, P659, DOI [10.1080/10837450902911929, 10.3109/10837450902911929]; Hoffmann C, 2009, EUR BIOPHYS J BIOPHY, V38, P557, DOI 10.1007/s00249-009-0404-6; Hermeling S, 2006, PHARM RES, V23, P641, DOI 10.1007/s11095-006-9573-5; Ruiz-Pena M, 2010, COLLOID SURFACE B, V75, P282, DOI 10.1016/j.colsurfb.2009.08.046; Shire SJ, 2009, CURR OPIN BIOTECH, V20, P708, DOI 10.1016/j.copbio.2009.10.006; Wang Q, 2006, J AGR FOOD CHEM, V54, P6501, DOI 10.1021/jf060895k; Arakawa T, 2000, J PHARM SCI, V89, P646, DOI 10.1002/(SICI)1520-6017(200005)89:5<646::AID-JPS10>3.3.CO;2-A; Lee S, 2008, BIOPHYS CHEM, V134, P185, DOI 10.1016/j.bpc.2008.02.009; Dixit N, 2013, PHARM RES-DORDR, V30, P1848, DOI 10.1007/s11095-013-1028-1; Chakraborty T, 2009, LANGMUIR, V25, P3062, DOI 10.1021/la803797x; Bam NB, 1998, J PHARM SCI, V87, P1554, DOI 10.1021/js980175v; Deechongkit S, 2009, J PHARM SCI-US, V98, P3200, DOI 10.1002/jps.21740; Chou DK, 2005, J PHARM SCI-US, V94, P1368, DOI 10.1002/jps.20365; NISHIKIDO N, 1982, B CHEM SOC JPN, V55, P3085, DOI 10.1246/bcsj.55.3085; Bam NB, 1996, BIOTECHNOL PROGR, V12, P801, DOI 10.1021/bp960068b; Singh SK, 2011, J PHARM SCI-US, V100, P354, DOI 10.1002/jps.22276; Garidel P, 2009, BIOPHYS CHEM, V143, P70, DOI 10.1016/j.bpc.2009.04.004; Mahler HC, 2009, J PHARM SCI-US, V98, P4525, DOI 10.1002/jps.21776; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Shek YL, 2013, BIOCHEMISTRY-US, V52, P672, DOI 10.1021/bi301554h; Fuchs S, 2010, J MICROENCAPSUL, V27, P242, DOI 10.3109/02652040903079534; Fukuda M., 2013, PHARM RES; GEKKO K, 1986, BIOCHEMISTRY-US, V25, P6563, DOI 10.1021/bi00369a034; Hermeling S, 2003, PHARM RES, V20, P1903, DOI 10.1023/B:PHAM.0000008034.61317.02; Huang YX, 2001, J COLLOID INTERF SCI, V236, P28, DOI 10.1006/jcis.2000.7278; Kamerzell TJ, 2008, J PHYS CHEM B, V112, P3240, DOI 10.1021/jp710061a; Malvern Instruments Ltd, 2006, MRK80901 MALV INSTR; Mathis K.B., 2010, THESIS LMU MUNCHEN M; Mehta SK, 2013, J COLLOID INTERF SCI, V393, P219, DOI 10.1016/j.jcis.2012.11.001; Mehta SK, 2012, COLLOID SURFACE A, V403, P103, DOI 10.1016/j.colsurfa.2012.03.062; Nino M.R.R., 1998, J AM OIL CHEM SOC, V75, P1241, DOI 10.1007/s11746-998-0169-6; Norisuye T, 2011, ULTRASONICS, V51, P215, DOI 10.1016/j.ultras.2010.08.005; Nyuta K, 2006, J COLLOID INTERF SCI, V301, P267, DOI 10.1016/j.jcis.2006.04.075; SARVAZYAN AP, 1982, ULTRASONICS, V20, P151, DOI 10.1016/0041-624X(82)90032-4; Sunada N, 2013, ACTA ODONTOL SCAND, V71, P137, DOI 10.3109/00016357.2011.654252; TAMURA Y, 1995, BIOCHEMISTRY-US, V34, P1878, DOI 10.1021/bi00006a008; Thakkar SV, 2012, J PHARM SCI-US, V101, P3062, DOI 10.1002/jps.23187; Uchiyama S, 2014, BBA-PROTEINS PROTEOM, V1844, P2041, DOI 10.1016/j.bbapap.2014.07.016; Villalobos AP, 2005, PHARM RES, V22, P1186, DOI 10.1007/s11095-005-5356-7	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0939-6411	1873-3441		EUR J PHARM BIOPHARM	Eur. J. Pharm. Biopharm.	MAY	2015	92						8	14		10.1016/j.ejpb.2015.02.005		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CJ3AG	WOS:000355355200002		
J	Aoki, H; Iwao, Y; Mizoguchi, M; Noguchi, S; Itai, S				Aoki, Hajime; Iwao, Yasunori; Mizoguchi, Midori; Noguchi, Shuji; Itai, Shigeru			Clarithromycin highly-loaded gastro-floating fine granules prepared by high-shear melt granulation can enhance the efficacy of Helicobacter pylori eradication	EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS			English	Article						Gastro-retentive drug delivery system; Floating granules; Clarithromycin; Helicobacter pylori eradication; High-shear melt granulation; Highly-drug loaded fine granules; Synchrotron X-ray computed tomography		In an effort to develop a new gastro-retentive drug delivery system (GRDDS) without a large amount of additives, 75% clarithromycin (CAM) loaded fine granules were prepared with three different hydrophobic binders by high-shear melt granulation and their properties were evaluated. Granules containing the higher hydrophobic binder showed sustained drug release and were able to float over 24 h. The synchrotron X-ray CT measurement indicated that both the high hydrophobicity of the binder and the void space inside the granules might be involved in their buoyancy. In an in vivo experiment, the floating granules more effectively eradicated Helicobacter pylori than a CAM suspension by remaining in the stomach for a longer period. In short, CAM highly-loaded gastro-floating fine granules can enhance the eradication efficiency of H. pylori compared with CAM alone. (C) 2015 Elsevier B.V. All rights reserved.	[Aoki, Hajime; Iwao, Yasunori; Mizoguchi, Midori; Noguchi, Shuji; Itai, Shigeru] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmaceut Engn, Shizuoka 4228526, Japan	Itai, S (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmaceut Engn, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	s-itai@u-shizuoka-ken.ac.jp					Rajinikanth PS, 2008, J CONTROL RELEASE, V125, P33, DOI 10.1016/j.jconrel.2007.07.011; Aoki H, 2015, INT J PHARMACEUT, V478, P530, DOI 10.1016/j.ijpharm.2014.11.058; Bardonnet PL, 2006, J CONTROL RELEASE, V111, P1, DOI 10.1016/j.jconrel.2005.10.031; Nagahara N, 1998, ANTIMICROB AGENTS CH, V42, P2492; Sriamornsak P, 2005, EUR J PHARM SCI, V24, P363, DOI 10.1016/j.ejps.2004.12.004; Carr RL, 1965, CHEM ENG, V72, P163; Hiramatsu Y., 1966, INT J ROCK MECH MIN, V3, P89, DOI DOI 10.1016/0148-9062(66)90002-7; Schiel JE, 2005, TALANTA, V65, P495, DOI 10.1016/j.talanta.2004.06.029; THOMSEN LJ, 1994, DRUG DEV IND PHARM, V20, P1179, DOI 10.3109/03639049409038360; Uesugi K., 2012, P SOC PHOTO-OPT INS, V8506, DOI DOI 10.1117/12.929575	10	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0939-6411	1873-3441		EUR J PHARM BIOPHARM	Eur. J. Pharm. Biopharm.	MAY	2015	92						22	27		10.1016/j.ejpb.2015.02.012		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CJ3AG	WOS:000355355200004		
J	Sato, H; Fujimori, M; Suzuki, H; Kadota, K; Shirakawa, Y; Onoue, S; Tozuka, Y				Sato, Hideyuki; Fujimori, Miki; Suzuki, Hiroki; Kadota, Kazunori; Shirakawa, Yoshiyuki; Onoue, Satomi; Tozuka, Yuichi			Absorption improvement of tranilast by forming highly soluble nano-size composite structures associated with alpha-glucosyl rutin via spray drying	EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS			English	Article						Tranilast; alpha-Glucosyl rutin; Nanostructure; Spray-drying; Oral bioavailability; Composite	AMORPHOUS SOLID DISPERSION; ANTHRANILIC ACID N-5'; CYCLOSPORINE-A; ORAL BIOAVAILABILITY; IMPROVED DISSOLUTION; INHALATION-THERAPY; IN-VITRO; DRUG; ENHANCEMENT; CLASSIFICATION	Tranilast (TL) composite particles with ct-glucosyl rutin (Rutin-G) were developed to improve the solubility and oral bioavailability of TL Composite formulation of TL/Rutin-G was prepared using the spray-drying method, and their physicochemical properties were evaluated with respect to the morphology, particle size distribution, solubility and crystallinity. The nanostructure formation of Rutin-G was characterized by dynamic light scattering and transmission electron microscopy when Rutin-G or TL/Rutin-G spray-dried particles (SDPs) were introduced into water. A pharmacokinetic study was also performed to assess the improvement of oral absorption in rats. TL/Rutin-G SDPs were spherical particles with a diameter of 5.5 mu m. Even in the acidic condition, the remarkable improvement in solubility of TL was achieved, as evidenced by a 32.2-fold increase in solubility compared with untreated TL. The median size of Rutin-G nanostructures in water was 2 nm, The formation of Rutin-G nanostructures and their drug inclusion properties may enhance the solubility and dissolution behavior of TL. A drastic increase was found in the exposure of TL in rats, with an increase in C-max and AUC values of 114- and 36.4-fold, respectively, compared with those of untreated TL These findings indicated that a TL formulation spraydried with Rutin-G could enhance its solubility and absorption and thus its therapeutic properties. (C) 2015 Elsevier B.V. All rights reserved.	[Sato, Hideyuki; Fujimori, Miki; Kadota, Kazunori; Tozuka, Yuichi] Osaka Univ Pharmaceut Sci, Takatsuki, Osaka 5691094, Japan; [Suzuki, Hiroki; Onoue, Satomi] Univ Shizuoka, Dept Pharmacokinet & Pharmacodynam, Sch Pharmaceut Sci, Shizuoka 4228526, Japan; [Shirakawa, Yoshiyuki] Doshisha Univ, Dept Chem Engn & Mat Sci, Kyotanabe, Japan	Tozuka, Y (reprint author), Osaka Univ Pharmaceut Sci, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan.	ytozuka@gly.oups.ac.jp			JSPS KAKENHI (Tokyo, Japan) [25504018]	This work was supported by the JSPS KAKENHI grant (No. 25504018) (Tokyo, Japan). We thank Toyo Sugar Refining Co., Ltd. for the kind gift of the transglycosylated compounds. Authors are grateful to Towa Pharmaceutical Co., Ltd., for kindly providing tranilast.	Tamai H, 1999, AM HEART J, V138, P968, DOI 10.1016/S0002-8703(99)70025-6; SUZAWA H, 1992, JPN J PHARMACOL, V60, P85, DOI 10.1254/jjp.60.85; Uchiyama H, 2010, EUR J PHARM BIOPHARM, V76, P238, DOI 10.1016/j.ejpb.2010.07.006; Pina MF, 2014, J PHARM SCI-US, V103, P1214, DOI 10.1002/jps.23894; Onoue S, 2009, J CONTROL RELEASE, V138, P16, DOI 10.1016/j.jconrel.2009.04.014; Sadekar S, 2013, INT J PHARMACEUT, V456, P175, DOI 10.1016/j.ijpharm.2013.07.071; Szuts A, 2011, INT J PHARMACEUT, V410, P107, DOI 10.1016/j.ijpharm.2011.03.033; AZUMA H, 1976, BRIT J PHARMACOL, V58, P483; Serajuddin ATM, 2007, ADV DRUG DELIVER REV, V59, P603, DOI 10.1016/j.addr.2007.05.010; Onoue S, 2014, EUR J PHARM SCI, V62, P16, DOI 10.1016/j.ejps.2014.05.006; Tozuka Y, 2011, EUR J PHARM BIOPHARM, V79, P559, DOI 10.1016/j.ejpb.2011.07.006; Paudel A, 2013, INT J PHARMACEUT, V453, P253, DOI 10.1016/j.ijpharm.2012.07.015; Lobenberg R, 2000, EUR J PHARM BIOPHARM, V50, P3, DOI 10.1016/S0939-6411(00)00091-6; KAWASHIMA Y, 1991, J PHARM SCI, V80, P472, DOI 10.1002/jps.2600800515; Ha ES, 2014, CHEM PHARM BULL, V62, P545; Zhang J, 2014, INT J PHARMACEUT, V465, P255, DOI 10.1016/j.ijpharm.2014.01.035; Uchiyama H, 2011, EUR J PHARM SCI, V43, P71, DOI 10.1016/j.ejps.2011.03.014; Tozuka Y, 2012, EUR J PHARM BIOPHARM, V82, P120, DOI 10.1016/j.ejpb.2012.05.005; AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; Jiang LF, 2014, APPL MICROBIOL BIOT, V98, P10187, DOI 10.1007/s00253-014-6065-0; Kawabata Y, 2010, EUR J PHARM SCI, V39, P256, DOI 10.1016/j.ejps.2009.12.009; KODA A, 1976, J ALLERGY CLIN IMMUN, V57, P396, DOI 10.1016/0091-6749(76)90054-3; Kulthe V V, 2014, Drug Res (Stuttg), V64, P493, DOI 10.1055/s-0033-1363249; Lakshmi K, 2013, Curr Drug Discov Technol, V10, P305; Liu Longxiao, 2007, AAPS PharmSciTech, V8, pE113, DOI 10.1208/pt0804113; Onoue S, 2010, INT J PHARMACEUT, V399, P94, DOI 10.1016/j.ijpharm.2010.08.007; Rachmawati H, 2013, AAPS PHARMSCITECH, V14, P1303, DOI 10.1208/s12249-013-0023-5; Sato H, 2013, INT J PHARMACEUT, V448, P282, DOI 10.1016/j.ijpharm.2013.03.026; SUZUKI Y, 1991, AGR BIOL CHEM TOKYO, V55, P181; Uchiyama H, 2011, INT J PHARMACEUT, V410, P114, DOI 10.1016/j.ijpharm.2011.03.017; Vogt FG, 2005, J PHARM SCI-US, V94, P651, DOI 10.1002/jps.20268; Whitney A.S.N.a.W.R., 1897, J AM CHEM SOC, V19, P930	32	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0939-6411	1873-3441		EUR J PHARM BIOPHARM	Eur. J. Pharm. Biopharm.	MAY	2015	92						49	55		10.1016/j.ejpb.2015.02.021		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CJ3AG	WOS:000355355200008		
J	Sakuma, S; Morimoto, N; Nishida, K; Murakami, T; Egawa, T; Endo, R; Kataoka, M; Yamashita, S; Miyata, K; Mohri, K; Ochiai, K; Hiwatari, K; Koike, S; Tobita, E; Uto, T; Baba, M				Sakuma, Shinji; Morimoto, Naoki; Nishida, Kazuhiro; Murakami, Tomofumi; Egawa, Tomomi; Endo, Rikito; Kataoka, Makoto; Yamashita, Shinji; Miyata, Kohei; Mohri, Kohta; Ochiai, Kyohei; Hiwatari, Ken-ichiro; Koike, Seiji; Tobita, Etsuo; Uto, Tomofumi; Baba, Masanori			Cross-reactivity of immunoglobulin A secreted on the nasal mucosa in mice nasally inoculated with inactivated H1N1 influenza A viruses in the presence of D-octaarginine-linked polymers	EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS			English	Article						Mucosal vaccination; Cross-reactivity; Secreted IgA; Cell-penetrating peptide; Oligoarginine; D-Octaarginine-linked polymer	CELL-PENETRATING PEPTIDES; ARGININE-RICH PEPTIDES; HEAT-LABILE TOXIN; B-SUBUNIT; INTRANASAL IMMUNIZATION; TRACE AMOUNT; VACCINE; INFECTION; PROTECTION; MECHANISMS	We evaluated cross-reactivity of immunoglobulin A(IgA) secreted on the nasal mucosa in mice that were nasally inoculated 4 times with a mixture of inactivated Hi NI influenza A viruses and poly(N-vinylacetamide-co-acrylic acid) (PNVA-co-AA) bearing D-octaarginine at 7-day intervals. Three viral strains (A/ Puerto Rico/8/34, A/New Caledonia/20/99 IVR116, and A/Solomon Islands/03/2006) and DW-octaarginine-linked polymers with different molecular weights were used as antigens and their carriers, respectively. Secretion of intranasal IgA was barely observed when the inactivated virus alone was administered. The polymer induced the production of intranasal IgA specific to the inoculated viruses, irrespective of the viral strain and molecular weight of the polymer. The respective antibodies cross-reacted to recombinant hemagglutinin proteins of not only the viral strain used for immunization but also other H1N1 strains, including A/Puerto Rico/8/34 strain whose hemagglutinin proteins are diverse from those of other strains. Mice with high reactivity of IgA to the inoculated viruses tended to acquire clear cross-reactivity to other viral strains. Notably, IgA induced by inactivated H1NI1 A/New Caledonia/20/99 IVR116 strain with the strongest immunogenicity between 3 antigens in the presence of the polymer cross-reacted to recombinant hemagglutinin proteins of the A/Brisbane/10/2007 and A/Viet Nam/1194/2004 strains, which are categorized into H3N2 and H5N1, respectively. Our polymer is a potential candidate for an efficient antigen carrier that induces mucosal IgA having cross-reactivity to antigenically drifted variants, irrespective of the subtype of viral strains. (C) 2015 Elsevier B.V. All rights reserved.	[Sakuma, Shinji; Morimoto, Naoki; Nishida, Kazuhiro; Murakami, Tomofumi; Egawa, Tomomi; Endo, Rikito; Kataoka, Makoto; Yamashita, Shinji; Miyata, Kohei; Mohri, Kohta] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 5730101, Japan; [Morimoto, Naoki; Miyata, Kohei; Ochiai, Kyohei; Hiwatari, Ken-ichiro; Koike, Seiji; Tobita, Etsuo] ADEKA Co, Life Sci Mat Lab, Arakawa Ku, Tokyo, Japan; [Uto, Tomofumi; Baba, Masanori] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	Sakuma, S (reprint author), Setsunan Univ, Fac Pharmaceut Sci, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.	sakuma@pharm.setsunan.ac.jp; m-baba@m2.kufm.kagoshima-u.ac.jp	Baba, Masanori/G-3867-2011		Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) Exploratory Research [AS242Z01497Q]; Japan Science and Technology Agency (JST) [AS2531303Q]	This work was financially supported in part by Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) Exploratory Research (Research No.: AS242Z01497Q) and Seeds Validation (Research No.: AS2531303Q) from Japan Science and Technology Agency (JST).	Sakuma S, 2010, J CONTROL RELEASE, V148, P187, DOI 10.1016/j.jconrel.2010.08.022; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Carter NJ, 2011, DRUGS, V71, P1591, DOI 10.2165/11206860-000000000-00000; Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l; Ichinohe T, 2007, MICROBES INFECT, V9, P1333, DOI 10.1016/j.micinf.2007.06.007; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Jones AT, 2007, J CELL MOL MED, V11, P670, DOI 10.1111/j.1582-4934.2007.00062.x; Nakase I, 2008, ADV DRUG DELIVER REV, V60, P598, DOI 10.1016/j.addr.2007.10.006; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.1440-1711.2004.01272.x; Uto T, 2007, J IMMUNOL, V178, P2979; Yuki Y, 2003, REV MED VIROL, V13, P293, DOI 10.1002/rmv.398; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; UNDERDOWN BJ, 1986, ANNU REV IMMUNOL, V4, P389, DOI 10.1146/annurev.immunol.4.1.389; Mizuno D, 2006, J IMMUNOL, V176, P1122; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Gluck R, 2000, J INFECT DIS, V181, P1129, DOI 10.1086/315337; Tamura SI, 2005, JPN J INFECT DIS, V58, P195; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Sakuma S, 2012, EUR J PHARM BIOPHARM, V81, P64, DOI 10.1016/j.ejpb.2012.01.008; Belshe RB, 2004, VIRUS RES, V103, P177, DOI 10.1016/j.virusres.2004.02.031; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Nichol KL, 2003, VACCINE, V21, P1769, DOI 10.1016/S0264-410X(03)00070-7; Greenbaum E, 2001, J MED VIROL, V65, P178, DOI 10.1002/jmv.2018.abs; Hashigucci K, 1996, VACCINE, V14, P113, DOI 10.1016/0264-410X(95)00174-Y; Ichinohe T, 2007, J INFECT DIS, V196, P1313, DOI 10.1086/521304; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; Mossad SB, 2003, CLEV CLIN J MED, V70, P801; Okamoto S, 2009, VACCINE, V27, P5896, DOI 10.1016/j.vaccine.2009.07.037; Sakuma S, 2012, MOL PHARMACEUT, V9, P2933, DOI 10.1021/mp300329r; TAMURA S, 1988, VACCINE, V6, P409, DOI 10.1016/0264-410X(88)90140-5; TAMURA S, 1994, VACCINE, V12, P419, DOI 10.1016/0264-410X(94)90118-X; TAMURA S, 1992, EUR J IMMUNOL, V22, P477, DOI 10.1002/eji.1830220228; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	35	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0939-6411	1873-3441		EUR J PHARM BIOPHARM	Eur. J. Pharm. Biopharm.	MAY	2015	92						56	64		10.1016/j.ejpb.2015.02.010		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CJ3AG	WOS:000355355200009		
J	Gaowa, A; Horibe, T; Kohno, M; Tabata, Y; Harada, H; Hiraoka, M; Kawakami, K				Gaowa, Arong; Horibe, Tomohisa; Kohno, Masayuki; Tabata, Yasuhiko; Harada, Hiroshi; Hiraoka, Masahiro; Kawakami, Koji			Enhancement of anti-tumor activity of hybrid peptide in conjugation with carboxymethyl dextran via disulfide linkers	EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS			English	Article						Hybrid peptide; Carboxymethyl dextran; Disulfide linkage; Drug delivery; Anti-tumor activity	INTRACELLULAR DRUG-DELIVERY; GELATIN NANOPARTICLES; POLY(ETHYLENE GLYCOL); POLYMERIC MICELLES; GLUTATHIONE LEVELS; BLOCK-COPOLYMERS; DNA DELIVERY; RELEASE; PHARMACOKINETICS; CAMPTOTHECIN	To improve the anti-tumor activity of EGFR2R-lytic hybrid peptide, we prepared peptide-modified dextran conjugates with the disulfide bonds between thiolated carboxymethyl dextran (CMD-Cys) and cysteine-conjugated peptide (EGFR2R-lytic-Cys). In vitro release studies showed that the peptide was released from the CMD-s-s-peptide conjugate in a concentration-dependent manner in the presence of glutathione (GSH, 2 mu M-2 mM). The CMD-s-s-peptide conjugate exhibited a similar cytotoxic activity with free peptide alone against human pancreatic cancer BxPC-3 cells in vitro. Furthermore, it was shown that the CMD-s-s-peptide conjugates were highly accumulated in tumor tissue in a mouse xenograft model using BxPC-3 cells, and the anti-tumor activity of the conjugate was more effective than that of the free peptide. In addition, the plasma concentrations of peptide were moderately increased and the elimination half-life of the peptide was prolonged after intravenous injection of CMD-s-s-peptide conjugates. These results demonstrated that the conjugate based on thiolated CMD polymer would be potentially useful carriers for the sustained release of the hybrid peptide in vivo. (C) 2015 Elsevier B.V. All rights reserved.	[Gaowa, Arong; Horibe, Tomohisa; Kohno, Masayuki; Kawakami, Koji] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto 6068501, Japan; [Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Field Tissue Engn, Dept Biomat, Kyoto 6068501, Japan; [Harada, Hiroshi; Hiraoka, Masahiro] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto 6068501, Japan	Kawakami, K (reprint author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Sakyo Ku, Kyoto 6068501, Japan.	kawakami.koji.4e@kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) - Japan [25860113, 23680089]	We thank Aya Torisawa, Mitsuko Tachi, and Yoshie Masuda (Department of Pharmacoepidemiology, Kyoto University) for their technical assistance in cell culturing and animal studies. This study was supported by Grants-in-Aid for Young Scientist (A) (Grant No. 23680089) and Young Scientist (B) (Grant No. 25860113) from the Japan Society for the Promotion of Science (JSPS) - Japan.	Abu Ajaj K, 2009, BIOCONJUGATE CHEM, V20, P390, DOI 10.1021/bc800429q; Zheng ZB, 2005, BIOCONJUGATE CHEM, V16, P598, DOI 10.1021/bc0499634; Bae Y, 2003, ANGEW CHEM INT EDIT, V42, P4640, DOI 10.1002/anie.200250653; CHIOU WL, 1978, J PHARMACOKINET BIOP, V6, P539, DOI 10.1007/BF01062108; Khorsand B, 2013, BIOMACROMOLECULES, V14, P2103, DOI 10.1021/bm4004805; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; Sugahara SI, 2008, BIOL PHARM BULL, V31, P223, DOI 10.1248/bpb.31.223; Kommareddy S, 2005, BIOCONJUGATE CHEM, V16, P1423, DOI 10.1021/bc050146t; Fan NC, 2012, ANGEW CHEM INT EDIT, V51, P8806, DOI 10.1002/anie.201203339; Thambi T, 2011, BIOCONJUGATE CHEM, V22, P1924, DOI [10.1021/bc2000963, 10.1021/bc2000969]; Kommareddy S, 2007, NANOMED-NANOTECHNOL, V3, P32, DOI 10.1016/j.nano.2006.11.005; Shahnaz G, 2010, J CONTROL RELEASE, V144, P32, DOI 10.1016/j.jconrel.2010.01.033; Hattori M, 2000, BIOCONJUGATE CHEM, V11, P84, DOI 10.1021/bc990096q; Harada M, 2011, CANCER SCI, V102, P192, DOI 10.1111/j.1349-7006.2010.01745.x; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Koo AN, 2008, CHEM COMMUN, P6570, DOI 10.1039/b815918a; Law B, 2009, BIOCONJUGATE CHEM, V20, P1683, DOI 10.1021/bc800500a; RUSSO A, 1986, CANCER RES, V46, P2845; Okuno S, 2000, CANCER RES, V60, P2988; Shamay Y, 2011, BIOMATERIALS, V32, P1377, DOI 10.1016/j.biomaterials.2010.10.029; Liu SQ, 2005, BIOMATERIALS, V26, P5064, DOI 10.1016/j.biomaterials.2005.01.030; Ishida O, 1999, INT J PHARM, V190, P49, DOI 10.1016/S0378-5173(99)00256-2; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x; Hong R, 2006, J AM CHEM SOC, V128, P1078, DOI 10.1021/ja056726; Bernkop-Schnurch A, 2000, J CONTROL RELEASE, V66, P39, DOI 10.1016/S0168-3659(99)00256-4; Fang F, 2009, ACS NANO, V3, P4080, DOI 10.1021/nn900785b; Gaowa A, 2014, J CONTROL RELEASE, V176, P1, DOI 10.1016/j.jconrel.2013.12.021; Kohno M, 2011, EUR J CANCER, V47, P773, DOI 10.1016/j.ejca.2010.10.021; Lee SD, 2002, DRUG DELIV, V9, P187, DOI 10.1080/15227950290097624; McIntosh DP, 1997, J PHARM SCI, V86, P1478, DOI 10.1021/js960282u; Navath RS, 2008, BIOCONJUGATE CHEM, V19, P2446, DOI 10.1021/bc800342d; Nikoo Mehdi, 2011, International Aquatic Research, V3, P135; ROSENBLU.WI, 1968, NATURE, V218, P591, DOI 10.1038/218591a0; Shahnaz G, 2012, J CONTROL RELEASE, V157, P375, DOI 10.1016/j.jconrel.2011.09.092; Tada N, 2011, BIOCHEM BIOPH RES CO, V407, P383, DOI 10.1016/j.bbrc.2011.03.030; YAMAOKA T, 1994, J PHARM SCI, V83, P601, DOI 10.1002/jps.2600830432	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0939-6411	1873-3441		EUR J PHARM BIOPHARM	Eur. J. Pharm. Biopharm.	MAY	2015	92						228	236		10.1016/j.ejpb.2015.03.015		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CJ3AG	WOS:000355355200026		
J	Kono, K; Kono, B				Kono, Kazuhito; Kono, Buhei			Observation of microwave superfluid phenomena of multiple phase magnetic fluid	EUROPEAN PHYSICAL JOURNAL-APPLIED PHYSICS			English	Article							SUPEREXCHANGE; SUPERCONDUCTIVITY; SEMICONDUCTORS; TURBULENCE; SYMMETRY	We observe superfluid phenomena by microwaves irradiation to multiple phase magnetic fluid in room temperature or room pressure. Ferromagnetism transformation of diamagnetic or paramagnetic particles in multiple phase magnetic fluid containing constant rate of ferromagnetic particles, diamagnetic or paramagnetic particles mixing organic polyphenol and irradiation of microwaves is, observed by superexchange interaction. Superfluid phenomena are observed by irradiation of microwaves to aforementioned multiple phase of magnetic fluid containing ferromagnetism transformed diamagnetic or paramagnetic particles with ferromagnetic particles. Mixing semiconductor pigments amplifying superfluid energy by photosensitivity is observed. Visible light LED selecting wavelength is irradiated to superfluid condition of aforementioned multiple phase magnetic fluid thus magnetic field and energy of superfluid is enhanced by light quantum amplification effect.	[Kono, Kazuhito; Kono, Buhei] Shozen Co Ltd, Kyoto 6040903, Japan; [Kono, Buhei] Kyoto Inst Technol, Kyoto 606, Japan	Kono, K (reprint author), Shozen Co Ltd, Kyoto 6040903, Japan.	qqdt545d@waltz.ocn.ne.jp					Chesler PM, 2013, SCIENCE, V341, P368, DOI 10.1126/science.1233529; Sato M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.020401; SPALEK J, 1986, PHYS REV B, V33, P3407, DOI 10.1103/PhysRevB.33.3407; Nambu Y, 2009, REV MOD PHYS, V81, P1015, DOI 10.1103/RevModPhys.81.1015; SPANHEL L, 1987, J AM CHEM SOC, V109, P5649, DOI 10.1021/ja00253a015; Demidov VE, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.047205; MOLLOW BR, 1967, PHYS REV, V160, P1076, DOI 10.1103/PhysRev.160.1076; Wilczek F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.160401; Yefsah T, 2013, NATURE, V499, P426, DOI 10.1038/nature12338; Yoon J, 2004, J AM CHEM SOC, V126, P12586, DOI 10.1021/ja046380w; Kloss T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.104308; Bloch I, 2008, SCIENCE, V319, P1202, DOI 10.1126/science.1152501; BROWN F, 1954, PHYS REV, V93, P381, DOI 10.1103/PhysRev.93.381; Dneprovskii V. S., 1991, Soviet Physics - JETP, V72; Evans JR, 1998, PHYS REV LETT, V81, P4624, DOI 10.1103/PhysRevLett.81.4624; Hummel R.E., 1997, HDB OPTICAL PROPERTI, P173; Hummel R.E., 1997, HDB OPTICAL PROPERTI, P145; Kittel Ch, 1996, INTRO SOLID STATE PH; Kono K., P 2012 2 GLOB C MICR, P342; Lagoudakis P.G., 2002, PHYS REV B, V65; Matusnaga Ryuske, 2014, SCIENCE, V345, P1145; RUCKENSTEIN AE, 1987, PHYS REV B, V36, P857, DOI 10.1103/PhysRevB.36.857; SALOMAA MM, 1985, PHYS REV B, V31, P203, DOI 10.1103/PhysRevB.31.203; SCHMIDT WW, 1982, PHYS REV B, V26, P3656, DOI 10.1103/PhysRevB.26.3656; Weick G, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.125405; Weick G, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.125441; Wilczek F., 2012, PHYS REV LETT, V109; Wilczek F, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.250402	28	0	0	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	1286-0042	1286-0050		EUR PHYS J-APPL PHYS	Eur. Phys. J.-Appl. Phys	MAY	2015	70	2							20903	10.1051/epjap/2015140400		17	Physics, Applied	Physics	CJ6PI	WOS:000355615400011		
J	Imura, T; Inoue, G; Nakazawa, T; Saito, W; Takaso, M				Imura, Takayuki; Inoue, Gen; Nakazawa, Toshiyuki; Saito, Wataru; Takaso, Masashi			Surgical treatment of an atlantoaxial fracture after a delayed diagnosis in a comatose patient	EUROPEAN SPINE JOURNAL			English	Article						Upper cervical injury; Delayed diagnosis; Comatose patient	CERVICAL-SPINE INJURIES; EASTERN ASSOCIATION; TRAUMA PATIENTS; MANAGEMENT; GUIDELINES; ETIOLOGY; SURGERY; AXIS; CT	Study design Case report. Objective To report a case of fractures of the right lateral atlantoaxial joint and C2 body diagnosed more than 5 months after injury. Summary of background data Misdiagnosis of an injury to the cervical spine has been reported frequently. For patients in whom cervical injury is suspected, the primary screening modality is axial CT from the occiput to T1 with sagittal and coronal reconstructions. The inadequacy of this radiological evaluation could delay diagnosis of fractures and lead to unnecessary surgical treatment of the cervical spine. Methods We report the case of a 74-year-old woman with an old, displaced combined fracture of the C1 and C2 right facet joint. In this case, CT of the brain was evaluated at the time of injury, but not CT of the cervical spine. As a consequence, diagnosis was delayed and surgical treatment was necessary. Results We performed posterior fusion surgery for C1 and C2. A pedicle screw was not inserted on both sides of C2, because of destruction of the insertional point on the right side and a high-riding VA on the left. Alternatively, a lamina screw and hook were used for C2, fixed with lateral mass screws on C1, with a bone graft harvested from the iliac crest. Conclusions To avoid unnecessary surgery, surgeons should recognize the possibility of cervical fractures that cannot be detected without CT, especially in patients who are comatose at injury. Atlantoaxial fixation with a hook and lamina screw in C2 is an option for old upper cervical fractures in cases where a pedicle screw cannot be inserted into C2.	[Imura, Takayuki; Inoue, Gen; Nakazawa, Toshiyuki; Saito, Wataru; Takaso, Masashi] Kitasato Univ, Sch Med, Dept Orthopaed Surg, Minami Ku, Sagamihara, Kanagawa 2520374, Japan	Inoue, G (reprint author), Kitasato Univ, Sch Med, Dept Orthopaed Surg, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	ginoue@kitasato-u.ac.jp					REID DC, 1987, J TRAUMA, V27, P980; Meyer D, 2012, NEUROSURG REV, V35, P255, DOI 10.1007/s10143-011-0358-x; Ryken TC, 2013, NEUROSURGERY, V72, P151, DOI 10.1227/NEU.0b013e318276ee55; DAVIS JW, 1993, J TRAUMA, V34, P342; Como JJ, 2009, J TRAUMA, V67, P651, DOI 10.1097/TA.0b013e3181ae583b; Platzer P, 2006, J TRAUMA, V61, P150, DOI 10.1097/01.ta.0000196673.58429.2a; Dorward IG, 2011, NEUROSURGERY, V68, P1491, DOI 10.1227/NEU.0b013e318212a4d7; Yamazaki M, 2012, SPINE, V37, pE1389, DOI 10.1097/BRS.0b013e31826a0c9f; ALKER GJ, 1975, RADIOLOGY, V114, P611; Blackmore CC, 1999, RADIOLOGY, V212, P117; Holmes JF, 2005, J TRAUMA, V58, P902, DOI 10.1097/01.TA.0000162138.36519.2A; Ghanta MK, 2002, AM SURGEON, V68, P563; Sarani B, 2007, J TRAUMA, V63, P637, DOI 10.1097/TA.0b013e31812eedb1; GERRELTS BD, 1991, J TRAUMA, V31, P1622, DOI 10.1097/00005373-199112000-00010; Daffner RH, 2001, AM J ROENTGENOL, V177, P677; LEE AS, 1994, J BONE JOINT SURG BR, V76B, P352; MACDONALD RL, 1990, J TRAUMA, V30, P392, DOI 10.1097/00005373-199030040-00004; O'Dowd JK, 2010, EUR SPINE J, V19, P18, DOI 10.1007/s00586-009-1118-2; ROTH BJ, 1994, ARCH SURG-CHICAGO, V129, P643	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	MAY	2015	24			4			S623	S627		10.1007/s00586-015-3907-0		5	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CJ6SN	WOS:000355624000031		
J	Matsumoto, T; Ando, M; Sasaki, S				Matsumoto, Takuji; Ando, Muneharu; Sasaki, Shunji			Effective treatment of delayed union of a lumbar vertebral fracture with daily administration of teriparatide in a patient with diffuse idiopathic skeletal hyperostosis	EUROPEAN SPINE JOURNAL			English	Article						Diffuse idiopathic skeletal hyperostosis; Lumbar spine; Vertebral fracture; Delayed union; Teriparatide	PARATHYROID-HORMONE 1-34; POSTMENOPAUSAL WOMEN; RISK REDUCTION; OSTEOPOROSIS; MECHANISMS; FEATURES	Introduction We herein describe a case of delayed union of a lumbar spine fracture in a 70-year-old patient with diffuse idiopathic skeletal hyperostosis (DISH). Clinical Course and Result Because he decided not to undergo surgical treatment, we provided conservative treatment with teriparatide (TPTD). Union was obtained in 2 months, and no adverse events were observed during treatment. Six months after starting the TPTD, further bone formation was observed and the lumbar instability had resolved. Conclusion This is the first report of successful use of TPTD to treat delayed union of a spine fracture in a patient with DISH without surgical intervention.	[Matsumoto, Takuji] Nokami Kosei Gen Hosp, Dept Orthoped Surg, Kimino, Wakayama 6401141, Japan; [Matsumoto, Takuji; Ando, Muneharu; Sasaki, Shunji] Wakayama Rosai Hosp, Dept Orthoped Surg, Wakayama, Japan	Matsumoto, T (reprint author), Nokami Kosei Gen Hosp, Dept Orthoped Surg, 198 Kobata, Kimino, Wakayama 6401141, Japan.	matsumoto_t@nokami-hospital.jp					Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Westerveld LA, 2009, EUR SPINE J, V18, P145, DOI 10.1007/s00586-008-0764-0; Lindsay R, 2004, ARCH INTERN MED, V164, P2024, DOI 10.1001/archinte.164.18.2024; RESNICK D, 1976, RADIOLOGY, V119, P559; Chintamaneni S, 2010, OSTEOPOROSIS INT, V21, P1059, DOI 10.1007/s00198-009-1061-4; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Jiang YB, 2003, J BONE MINER RES, V18, P1932, DOI 10.1359/jbmr.2003.18.11.1932; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Mader R, 2013, NAT REV RHEUMATOL, V9, P741, DOI 10.1038/nrrheum.2013.165; Rubery PT, 2010, J SPINAL DISORD TECH, V23, P151, DOI 10.1097/BSD.0b013e31819a8b7a; Fukuda F, 2014, BIOL THER; Gass M, 2006, AM J MED, V119, p3S, DOI 10.1016/j.amjmed.2005.12.017; Giannotti S, 2013, Eur J Orthop Surg Traumatol, V23 Suppl 2, pS291, DOI 10.1007/s00590-012-1143-4; Heaney Robert P, 2003, Clin Med Res, V1, P93; Iida Y, 2013, OPEN J ORTHOP, V3, P278; Lindsay R, 2007, J BONE MINER RES, V22, P495, DOI 10.1359/JBMR.070104; MAHONEY F I, 1965, Md State Med J, V14, P61; Mitani Yuichi, 2013, Arch Osteoporos, V8, P131, DOI 10.1007/s11657-013-0131-6; Ochi Kensuke, 2013, Arch Osteoporos, V8, P159, DOI 10.1007/s11657-013-0159-7; Prevrhal S, 2009, CURR MED RES OPIN, V25, P921, DOI 10.1185/03007990902790993 ; Su CH, 2013, J SPINAL DISORD TECH, V26, P200, DOI 10.1097/BSD.0b013e31823f6298; Tachiiri Hisakazu, 2014, Arch Osteoporos, V9, P179, DOI 10.1007/s11657-014-0179-y; Ulivieri Fabio Massimo, 2007, Aging Clin Exp Res, V19, P21	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	MAY	2015	24			4			S573	S576		10.1007/s00586-014-3733-9		4	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CJ6SN	WOS:000355624000021		
J	Ohnishi, Y; Iwatsuki, K; Taketsuna, S; Ninomiya, K; Yoshimine, T				Ohnishi, Yu-ichiro; Iwatsuki, Koichi; Taketsuna, Shigenori; Ninomiya, Koshi; Yoshimine, Toshiki			Retro-odontoid synovial cyst resected via an anterolateral approach without fusion	EUROPEAN SPINE JOURNAL			English	Article						C1-2; Synovial cyst; Anterolateral approach; Atlantoaxial instability	DEGENERATIVE ARTICULAR CYST; CRANIOCERVICAL JUNCTION; CONSERVATIVE TREATMENT; TRANSVERSE LIGAMENT; ATLANTOAXIAL JOINT; C1-2 ARTICULATION; DETERIORATION; SUBLUXATION; PATIENT; SPINE	Purpose Retro-odontoid synovial cysts are rare and attributable to degenerative changes in the atlantoaxial joints. An anterolateral approach facilitates access to lesions located anterior to the craniocervical junction without harming the atlantoaxial joints, and can also treat small lesions in the ventral mid-portion of the craniocervical junction without compression of spinal cord. Methods We present herein the case of a 70-year-old man with a retro-odontoid synovial cyst. A ventral midsection mass was present at the level of the atlantoaxial joint. The compressed anterior medulla led to neurological deficits. Slight atlantoaxial instability was radiologically present. An intradural cyst resection without fusion was performed via the anterolateral approach. The diagnosis of a synovial cyst was histologically confirmed. Results The patient was followed up for 3 years and exhibited improvements in the neurological deficits. There were no recurrence and postoperative deterioration of atlantoaxial instability. Conclusions The anterolateral approach for the retroodontoid synovial cyst had little effect on C1-2 instability and yielded neurological improvements.	[Ohnishi, Yu-ichiro; Iwatsuki, Koichi; Taketsuna, Shigenori; Ninomiya, Koshi; Yoshimine, Toshiki] Osaka Univ, Sch Med, Dept Neurosurg, Suita, Osaka 5650871, Japan	Ohnishi, Y (reprint author), Osaka Univ, Sch Med, Dept Neurosurg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ohnishi@nsurg.med.osaka-u.ac.jp			Funding Program for World-Leading Innovative R&D on Science and Technology	This study was supported by a Grant-in-Aid for Scientific Research (C) and the Funding Program for World-Leading Innovative R&D on Science and Technology.	Akiyama H, 1999, NEUROL MED-CHIR, V39, P539, DOI 10.2176/nmc.39.539; Salas E, 1999, J NEUROSURG, V90, P206, DOI 10.3171/spi.1999.90.2.0206; ONOFRIO BM, 1988, NEUROSURGERY, V22, P642; GEORGE B, 1995, SKULL BASE SURG, V5, P9, DOI 10.1055/s-2008-1058945; Birch BD, 1996, J NEUROSURG, V85, P810, DOI 10.3171/jns.1996.85.5.0810; Bruneau M, 2006, NEUROSURGERY, V58, P29, DOI 10.1227/01.NEU.0000193930.74183.42; Cecchi PC, 2008, SPINE J, V8, P687, DOI 10.1016/j.spinee.2007.01.006; Chang H, 2000, SPINE, V25, P741, DOI 10.1097/00007632-200003150-00016; CHOE W, 1993, PARAPLEGIA, V31, P803; Eustacchio S, 2003, ZBL NEUROCHIR, V64, P86; Fransen P, 1997, J NEUROSURG, V86, P1027, DOI 10.3171/jns.1997.86.6.1027; Lot G, 1997, NEUROSURGERY, V41, P813, DOI 10.1097/00006123-199710000-00010; GOFFIN J, 1992, NEUROSURGERY, V30, P914; Kirk HJ, 2009, J CLIN NEUROSCI, V16, P822, DOI 10.1016/j.jocn.2008.06.027; Lyons MK, 2011, TURK NEUROSURG, V21, P483, DOI [10.5137/1019-5149.JTN .4288-11.1, 10.5137/1019-5149.JTN.4288-11.1]; MILLER JD, 1989, SURG NEUROL, V31, P239, DOI 10.1016/0090-3019(89)90125-0; Okamoto K, 2004, J SPINAL DISORD TECH, V17, P535, DOI 10.1097/01.bsd.0000117546.88865.62; Passacantilli E, 2005, J NEUROSURG-SPINE, V3, P123, DOI 10.3171/spi.2005.3.2.0123; Puffer RC, 2013, WORLD NEUROSURG, V79, P773, DOI 10.1016/j.wneu.2012.03.035; Sagiuchi T, 2006, J NEUROSURG-SPINE, V5, P161, DOI 10.3171/spi.2006.5.2.161; Tobenas-Dujardin AC, 2004, NEUROCHIRURGIE, V50, P652, DOI 10.1016/S0028-3770(04)98457-3; Van Gompel JJ, 2011, J NEUROSURG-SPINE, V14, P437, DOI 10.3171/2010.12.SPINE10302; Velan O, 2008, CARDIOVASC INTER RAD, V31, P1219, DOI 10.1007/s00270-008-9347-z; WEYMANN CA, 1993, NEUROLOGY, V43, P2151; Zorzon M, 2001, J NEUROSURG, V95, P111, DOI 10.3171/spi.2001.95.1.0111	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	MAY	2015	24			4			S508	S513		10.1007/s00586-014-3578-2		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CJ6SN	WOS:000355624000008		
J	Takeshima, Y; Tanaka, Y; Hironaka, Y; Shida, Y; Nakase, H				Takeshima, Yasuhiro; Tanaka, Yoshitaka; Hironaka, Yasuo; Shida, Yoichi; Nakase, Hiroyuki			Visualization of vascular structure of spinal hemangioblastoma using intraoperative indocyanine green videoangiography and temporary feeder occlusion	EUROPEAN SPINE JOURNAL			English	Article						FLOW (R) 800; Hemangioblastoma; Indocyanine green videoangiography; Spinal lesion; Temporary arterial occlusion; Intraoperative assessment	CORD HEMANGIOBLASTOMA; OPERATIVE MANAGEMENT; SURGERY	Background and purpose To more safely resect pathological lesions during spinal vascular lesion surgery, it is most important to understand local abnormal hemodynamics in detail. New devices or techniques that make out intraoperative local hemodynamics have been awaited. To introduce a resourceful method, we present a case of spinal hemangioblastoma for which temporary arterial occlusion during near-infrared intraoperative indocyanine green (ICG) videoangiography gives useful assessment of the main and minor feeders easily. Methods A 36-year-old female suffered progressive paresthesia of both lower extremities for 12 months and gait disturbance for 2 weeks. A neurological examination revealed T10 myelopathy. Magnetic resonance imaging (MRI) of the thoracic spine showed an intramedullary tumor at the T8 level and severe spinal cord edema with a flow void in the extended dorsal spinal veins. Spinal angiography showed a hemangioblastoma at the T8 level, with two main feeders and minor feeders. Results She underwent total resection of the tumor by a posterior approach. During the intraoperative ICG videoangiography, temporary arterial occlusion of the two main feeders and FLOW (R) 800 analysis enabled clear understanding of the vasculature, especially of the two minor feeders. At the 9-month follow-up, her neurological manifestation was partially resolved, and post-operative MRI showed total removal of the tumor and disappearance of the spinal cord edema. Conclusions Temporary clipping of the main feeders during intraoperative ICG videoangiography is very useful for easily determining the minor feeding arteries, and helpful for maintaining normal perfusion of the spinal cord in spinal hemangioblastoma surgery. Furthermore, the FLOW 800 analysis, especially the false color-coded variation, increased our understanding of the hemodynamics.	[Takeshima, Yasuhiro; Tanaka, Yoshitaka; Hironaka, Yasuo; Shida, Yoichi; Nakase, Hiroyuki] Nara Med Univ, Sch Med, Dept Neurosurg, Kashihara, Nara 6348521, Japan	Takeshima, Y (reprint author), Nara Med Univ, Sch Med, Dept Neurosurg, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	takeshim@naramed-u.ac.jp					Raabe A, 2005, J NEUROSURG, V103, P982, DOI 10.3171/jns.2005.103.6.0982; Baleriaux DLF, 1999, EUR RADIOL, V9, P1252, DOI 10.1007/s003300050831; Killory BD, 2009, NEUROSURGERY, V65, P456, DOI 10.1227/01.NEU.0000346649.48114.3A; Miyoshi Y, 2011, CLIN NEUROL NEUROSUR, V113, P239, DOI 10.1016/j.clineuro.2010.10.014; Mandigo CE, 2009, NEUROSURGERY, V65, P1166, DOI 10.1227/01.NEU.0000359306.74674.C4; Benedetto N, 2013, BRIT J NEUROSURG, V27, P847, DOI 10.3109/02688697.2013.798863; Clark AJ, 2010, WORLD NEUROSURG, V74, P200, DOI 10.1016/j.wneu.2010.03.016; Hao SY, 2013, J CLIN NEUROSCI, V20, P1269, DOI 10.1016/j.jocn.2012.12.008; Hwang SW, 2010, NEUROSURGERY, V67, P300, DOI 10.1227/01.NEU.0000383876.72704.7B; Kamp Marcel A, 2012, Neurosurgery, V70, P65, DOI 10.1227/NEU.0b013e31822f7d7c; Kamp MA, 2012, NEUROSURGERY, V70, P73; Murakami T, 2011, NEUROSURGERY, V68, P245; Murakami Tomohiro, 2011, Neurosurgery, V68, P241, DOI 10.1227/NEU.0b013e318207b6b5; Oppenlander ME, 2010, WORLD NEUROSURG, V74, P116, DOI 10.1016/j.wneu.2010.04.018; Hanel RA, 2010, NEUROSURGERY, V66, P978, DOI 10.1227/01.NEU.0000368108.94233.22; Schubert GA, 2011, SPINE, V36, pE811, DOI 10.1097/BRS.0b013e3181fd6557	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	MAY	2015	24			4			S585	S589		10.1007/s00586-014-3755-3		5	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CJ6SN	WOS:000355624000024		
J	Hagiwara, N				Hagiwara, Nobuhisa			Untitled	HEART AND VESSELS			English	Editorial Material									Tokyo Womens Med Univ, Shinjuku Ku, Tokyo 1628666, Japan	Hagiwara, N (reprint author), Tokyo Womens Med Univ, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	handved@hij.twmu.ac.jp						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAY	2015	30	3					285	285		10.1007/s00380-015-0663-3		1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ6FT	WOS:000355590000001		
J	Fujita, D; Takahashi, M; Doi, K; Abe, M; Tazaki, J; Kiyosue, A; Myojo, M; Ando, J; Fujita, H; Noiri, E; Sugaya, T; Hirata, Y; Komuro, I				Fujita, Daishi; Takahashi, Masao; Doi, Kent; Abe, Mitsuru; Tazaki, Junichi; Kiyosue, Arihiro; Myojo, Masahiro; Ando, Jiro; Fujita, Hideo; Noiri, Eisei; Sugaya, Takeshi; Hirata, Yasunobu; Komuro, Issei			Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease	HEART AND VESSELS			English	Article						Urinary liver-type fatty acid-binding proteins (uL-FABP); Renal prognosis; Coronary angiography (CAG); Contrast-induced nephropathy (CIN)	ACUTE KIDNEY INJURY; CARDIAC-SURGERY; L-FABP; INDUCED NEPHROPATHY; BIOMARKERS; PROGRESSION; EXCRETION; CATHETERIZATION; COMBINATION; REFLECTS	Urinary liver-type fatty acid-binding proteins (uL-FABP) have recently been recognized as a useful biomarker for predicting contrast-induced nephropathy. Although accumulating studies have evaluated short-term outcomes, its prognostic value for long-term renal prognosis in patients undergoing coronary angiography (CAG) has not been fully examined. This study aimed to evaluate the predictive value of uL-FABP for long-term renal outcome in patients with ischemic heart disease (IHD). Consecutive 24 patients with impaired renal function (serum creatinine >1.2 mg/dL) who underwent CAG were enrolled. uL-FABP was measured before CAG, 24 and 48 h after CAG. The changes in estimated glomerular filtration rate (eGFR) throughout CAG and at 1 year later were compared with the uL-FABP levels. The patients with a greater decrease in eGFR 1 year later had higher uL-FABP levels at all points, but only the value at 48 h after CAG reached statistical significance (lower vs. higher decreased eGFR group, 4.61 +/- 3.87 vs. 17.71 +/- 12.96; P < 0.01). Measurement of uL-FABP at 48 h after CAG (48h-uL-FABP) showed better correlation with the change in eGFR (pre-CAG uL-FABP vs. 48h-uL-FABP: R = 0.27, P = 0.20 vs. R = 0.65, P < 0.01). Moreover, the high-pre and high-48h-uL-FABP group showed a significantly larger decrease in eGFR compared with the high-pre and low-48h-uL-FABP group (change in eGFR; 8.12 +/- 4.06 vs. 1.25 +/- 2.23 mL/min/1.73 m(2), P < 0.01), although the baseline eGFR levels were similar between these two groups. In this pilot study, measurement of uL-FABP levels at 48 h after CAG may be useful in detecting renal damage, and in predicting 1-year renal outcome in IHD patients undergoing CAG.	[Fujita, Daishi; Takahashi, Masao; Kiyosue, Arihiro; Myojo, Masahiro; Ando, Jiro; Fujita, Hideo; Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Doi, Kent; Noiri, Eisei] Univ Tokyo, Div Nephrol, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Abe, Mitsuru] Kyoto Med Ctr, Dept Cardiol, Kyoto, Japan; [Tazaki, Junichi] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Kyoto, Japan; [Sugaya, Takeshi] CMIC Co Ltd, Tokyo, Japan; [Hirata, Yasunobu] Tokyo Teishin Hosp, Tokyo, Japan	Takahashi, M (reprint author), Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	masaotakahashi-gi@umin.org					Abe M, 2013, HEART VESSELS, V28, P480, DOI 10.1007/s00380-012-0274-1; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Kamijo A, 2004, AM J PATHOL, V165, P1243, DOI 10.1016/S0002-9440(10)63384-6; Matsui K, 2012, CIRC J, V76, P213, DOI 10.1253/circj.CJ-11-0342; Liu S, 2013, BIOMARKERS, V18, P95, DOI 10.3109/1354750X.2012.740687; Katoh H, 2014, HEART VESSELS, V29, P191, DOI 10.1007/s00380-013-0347-9; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Malyszko J, 2009, RENAL FAILURE, V31, P910, DOI 10.3109/08860220903216113; Katagiri D, 2012, ANN THORAC SURG, V93, P577, DOI 10.1016/j.athoracsur.2011.10.048; Panduru NM, 2013, DIABETES CARE, V36, P2077, DOI 10.2337/dc12-1868; Nakamura T, 2006, AM J KIDNEY DIS, V47, P439, DOI 10.1053/j.ajkd.2005.11.006; Yokoyama T, 2009, AM J PATHOL, V174, P2096, DOI 10.2353/ajpath.2009.080780; Doi K, 2011, CRIT CARE MED, V39, P2464, DOI 10.1097/CCM.0b013e318225761a; Cho E, 2013, J KOREAN MED SCI, V28, P100, DOI 10.3346/jkms.2013.28.1.100; Chou KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054863; Ivanisevic I, 2013, PEDIATR NEPHROL, V28, P963, DOI 10.1007/s00467-013-2421-z; Kamijo-Ikemori A, 2006, CLIN CHIM ACTA, V374, P1, DOI 10.1016/j.cca.2006.05.038; Kamijo-Ikemori A, 2011, DIABETES CARE, V34, P691, DOI 10.2337/dc10-1392; Kato K, 2008, CIRC J, V72, P1499, DOI 10.1253/circj.CJ-07-1006; Manabe K, 2012, EUR J CLIN INVEST, V42, P557, DOI 10.1111/j.1365-2362.2011.02620.x; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Tsigou E, 2013, CRIT CARE RES PRACT, V2013; von Eynatten M, 2010, EUR J CLIN INVEST, V40, P95, DOI 10.1111/j.1365-2362.2009.02220.x	23	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAY	2015	30	3					296	303		10.1007/s00380-014-0484-9		8	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ6FT	WOS:000355590000003		
J	Nakayama, A; Morita, H; Hamamatsu, A; Miyata, T; Hoshina, K; Nagayama, M; Takanashi, S; Sumiyoshi, T; Komuro, I				Nakayama, Atsuko; Morita, Hiroyuki; Hamamatsu, Akihiko; Miyata, Tetsuro; Hoshina, Katsuyuki; Nagayama, Masatoshi; Takanashi, Shuichiro; Sumiyoshi, Tetsuya; Komuro, Issei			Coronary atherosclerotic lesions in patients with a ruptured abdominal aortic aneurysm	HEART AND VESSELS			English	Article						Abdominal aortic aneurysm; Rupture; Coronary artery; Left main trunk; Mortality	RISK-FACTORS; REPAIR; ARTERY	In this study, the coronary findings in 185 autopsy cases with a ruptured abdominal aortic aneurysm (AAA) from the Tokyo Medical Examiner's Office were examined and compared with those in 1,056 patients undergoing AAA repair at the University of Tokyo Hospital or Sakakibara Heart Institute (Tokyo, Japan). The number of cases with any significant coronary stenosis was significantly greater in the autopsy cases with a ruptured AAA than in the patients undergoing emergency repair of a ruptured AAA, suggesting that the low prevalence of CAD observed in patients undergoing emergency repair of a ruptured AAA was due to the survival bias before reaching hospital. In addition, we also found that significant coronary left main trunk stenosis was more frequent in CAD cases with a ruptured AAA than in those with an unruptured AAA, findings that suggest novel clinical implications. Large-scale prospective studies are warranted to confirm our findings and to clarify the pathophysiological relationship between coronary atherosclerosis and AAA status.	[Nakayama, Atsuko; Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Tokyo 1138655, Japan; [Morita, Hiroyuki] Univ Tokyo, Dept Translat Res Healthcare & Clin Sci, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Hamamatsu, Akihiko] Tokyo Med Examiners Off, Tokyo, Japan; [Miyata, Tetsuro; Hoshina, Katsuyuki] Univ Tokyo, Div Vasc Surg, Grad Sch Med, Tokyo 1138655, Japan; [Nagayama, Masatoshi; Takanashi, Shuichiro; Sumiyoshi, Tetsuya] Sakakibara Heart Inst, Tokyo, Japan	Morita, H (reprint author), Univ Tokyo, Dept Translat Res Healthcare & Clin Sci, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hmrt-tky@umin.net			Ministry of Health, Labour and Welfare, Japan	This research is supported by grants-in-aid from the Ministry of Health, Labour and Welfare, Japan (to HM and TM). The authors have no conflicts of interest to declare.	Nakayama A, 2014, HEART VESSELS, V29, P65, DOI 10.1007/s00380-012-0319-5; Bown MJ, 2002, BRIT J SURG, V89, P714, DOI 10.1046/j.1365-2168.2002.02122.x; Nakayama A, 2012, ATHEROSCLEROSIS, V222, P278, DOI 10.1016/j.atherosclerosis.2012.02.031; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; [Anonymous], 2006, CIRC J S4, V70, P1569; CHIDA K, 1994, CARDIOVASC PATHOL, V3, P1; Oishi Y, 2013, HEART VESSELS, V28, P222, DOI 10.1007/s00380-011-0229-y; Tomanek Robert J., 2005, Angiogenesis, V8, P273, DOI 10.1007/s10456-005-9014-9; TRASK N, 1984, J AM COLL CARDIOL, V3, P1145	9	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAY	2015	30	3					304	308		10.1007/s00380-014-0488-5		5	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ6FT	WOS:000355590000004		
J	Gunji, K; Takagi, A; Arai, K; Ashihara, K; Hagiwara, N				Gunji, Kazue; Takagi, Atsushi; Arai, Kotaro; Ashihara, Kyomi; Hagiwara, Nobuhisa			Temporal analysis of regional strain rate during adenosine triphosphate stress before and after percutaneous coronary interventions	HEART AND VESSELS			English	Article						Coronary artery disease; Speckle tracking; Echocardiography; Adenosine; Ischemia; Strain; Strain rate	VENTRICULAR DELAYED RELAXATION; ARTERY-DISEASE; MYOCARDIAL-FUNCTION; DOPPLER-ECHOCARDIOGRAPHY; ISCHEMIC-MYOCARDIUM; COLOR KINESIS; DOBUTAMINE; VALIDATION; DIAGNOSIS; INFUSION	Regional myocardial ischemia is thought to be characterized by diastolic dysfunction. We aimed to clarify whether temporal analysis of strain rate (SR) index derived from two-dimensional speckle-tracking echocardiography (2DTE) can assess the regional myocardial ischemia or not. Forty-two patients with significant coronary stenoses were referred for percutaneous coronary intervention (PCI). 2DTE was performed before and a day after PCI. Time from aortic valve closure to peak early diastolic longitudinal SR D(TAVC-E-SR) was measured both at baseline and during adenosine triphosphate (ATP) infusion. TAVC-E-SR was calculated as TAVC-E-SR during ATP infusion subtracted by TAVC-E-SR at baseline. In forty-five target ischemic regions, TAVC-E-SR at baseline was significantly longer than that of control regions (166 +/- 28 vs. 136 +/- 32 ms, P < 0.0001). TAVC-E-SR in target ischemic regions significantly prolonged during ATP stress to 221 +/- 37 ms (P < 0.0001), while it did not change in control regions. Immediately after PCI, TAVC-E-SR in target regions significantly decreased to 135 +/- 27 ms, P < 0.0001 without prolongation during ATP stress. Receiver operating characteristic curves demonstrated that DTAVC-E-SR could assess regional myocardial ischemia by a cutoff criterion of 14 ms with sensitivity of 93 % and specificity of 95 %. 2DTE-derived TAVC-E-SR significantly increased during ATP stress only in ischemic myocardium. This phenomenon disappeared immediately after PCI. Temporal analysis of TAVC-E-SR appeared to be useful to assess the regional myocardial ischemia.	[Gunji, Kazue; Takagi, Atsushi; Arai, Kotaro; Ashihara, Kyomi; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Shinjuku Ku, Tokyo 1628666, Japan	Takagi, A (reprint author), Tokyo Womens Med Univ, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	mtakagi@hij.twmu.ac.jp					Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Azevedo CF, 2004, EUR HEART J, V25, P1419, DOI 10.1016/j.ehj.2004.06.024; Ishii K, 2008, J AM SOC ECHOCARDIOG, V21, P309, DOI 10.1016/j.echo.2007.10.006; Ambrosio G, 1996, CIRCULATION, V94, P2455; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Pislaru C, 2002, J AM COLL CARDIOL, V40, P1487, DOI 10.1016/S0735-1097(02)02171-4; Urheim S, 2000, CIRCULATION, V102, P1158; Ishii K, 2009, J AM COLL CARDIOL, V53, P698, DOI 10.1016/j.jacc.2008.09.057; Pirat B, 2008, J AM COLL CARDIOL, V51, P651, DOI 10.1016/j.jacc.2007.10.029; Pislaru C, 2001, J AM COLL CARDIOL, V37, P1141, DOI 10.1016/S0735-1097(01)01113-5; Kusunose K, 2011, CIRC J, V75, P141, DOI 10.1253/circj.CJ-10-0551; Anthopoulos LP, 1996, J AM COLL CARDIOL, V28, P52, DOI 10.1016/0735-1097(96)00127-1; DjordjevicDikic AD, 1996, J AM COLL CARDIOL, V28, P1689; EDLUND A, 1991, CLIN PHYSIOL, V11, P477, DOI 10.1111/j.1475-097X.1991.tb00820.x; Flachskampf FA, 2000, HEART, V96, P1063; Hosaka M, 2010, CIRC J, V74, P1600, DOI 10.1253/circj.CJ-09-0972; Jamal F, 2001, J AM SOC ECHOCARDIOG, V14, P874, DOI 10.1067/mje.2001.112037; Marwick TH, 1997, EUR HEART J, V18, pD31; Miwa K, 2004, CIRC J, V68, P483, DOI 10.1253/circj.68.483; Picano E, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-30; Qu HY, 2007, INT J CARDIOVAS IMAG, V23, P725, DOI 10.1007/s10554-006-9183-7; REN JF, 1995, AM HEART J, V129, P696, DOI 10.1016/0002-8703(95)90318-6; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Takagi T, 2010, J CARDIOL, V55, P41, DOI 10.1016/j.jjcc.2009.08.001; Takagi T, 2006, J AM SOC ECHOCARDIOG, V19, P1001, DOI 10.1016/j.echo.2006.02.009; Tanaka H, 2006, J AM SOC ECHOCARDIOG, V19, P756, DOI 10.1016/j.echo.2006.01.008; Thambyrajah J, 2008, EUR J ECHOCARDIOGR, V9, P646, DOI 10.1093/ejechocard/jen035; WIJNS W, 1986, J AM COLL CARDIOL, V7, P455; Yip G, 2004, J AM COLL CARDIOL, V44, P1664, DOI 10.1016/j.jacc.2004.02.065	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAY	2015	30	3					309	317		10.1007/s00380-014-0491-x		9	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ6FT	WOS:000355590000005		
J	Miyata, M; Yoshihisa, A; Yamauchi, H; Owada, T; Sato, T; Suzuki, S; Sugimoto, K; Yamaki, T; Kunii, H; Nakazato, K; Suzuki, H; Saitoh, S; Takeishi, Y				Miyata, Makiko; Yoshihisa, Akiomi; Yamauchi, Hiroyuki; Owada, Takashi; Sato, Takamasa; Suzuki, Satoshi; Sugimoto, Koichi; Yamaki, Takayoshi; Kunii, Hiroyuki; Nakazato, Kazuhiko; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika			Impact of sleep-disordered breathing on myocardial damage and metabolism in patients with chronic heart failure	HEART AND VESSELS			English	Article						Chronic heart failure; Sleep-disordered breathing; Myocardium; Troponin T; Carnitine	L-CARNITINE; VENTRICULAR-ARRHYTHMIAS; DILATED CARDIOMYOPATHY; BLOOD-PRESSURE; TROPONIN-T; APNEA; DYSFUNCTION; MORTALITY; EXCRETION; RISK	Sleep-disordered breathing (SDB) has a critical association with mortality and morbidity of patients with chronic heart failure (CHF). Troponin T is a marker of ongoing myocardial damage and predicts adverse clinical outcomes in patients with CHF. Carnitine plays an important role in the utilization of fatty acids in the myocardium. It has been reported that myocardial carnitine levels decrease in the failing heart. We hypothesized that plasma troponin T and carnitine are increased due to the leakage from damaged cardiomyocytes or the alteration of myocardial metabolism in CHF patients with SDB. We examined the relation of plasma troponin T and carnitine levels with severity of SDB in CHF. We used portable sleep monitor and measured the apnea-hypopnea index (AHI), plasma levels of high-sensitive troponin T and carnitine in 131 CHF patients. These patients were divided into three groups based on AHI: group A (None-mild SDB AHI < 15/h, n = 45), group B (Moderate SDB 15 <= AHI < 30/h, n = 32) and group C (Severe SDB AHI >= 30/h, n = 54). Levels of high-sensitive troponin T and plasm total carnitine were significantly higher in group C than in groups A and B [high-sensitive troponin T; group A 0.009 (0.005-0.016), group B 0.012 (0.006-0.021), group C 0.021 (0.011-0.039) ng/ml, total carnitine; group A 61.0 +/- 15.1, group B 65.0 +/- 13.5, group C 73.3 +/- 17.5 mu mol/l, P < 0.01 vs. group A and P < 0.05 vs. group B, respectively]. Furthermore, in the multiple regression analysis, the independent factors to determine plasma levels of log (high-sensitive troponin T) were high-sensitive C-reactive protein and AHI, and the independent factors to determine plasma levels of carnitine were glomerular filtration rate and AHI. The present study suggests that SDB is associated with latent myocardial damage and alteration of myocardial carnitine metabolism in patients with CHF, presented by higher circulating troponin T and carnitine levels.	[Miyata, Makiko; Yoshihisa, Akiomi; Yamauchi, Hiroyuki; Owada, Takashi; Sato, Takamasa; Suzuki, Satoshi; Sugimoto, Koichi; Yamaki, Takayoshi; Kunii, Hiroyuki; Nakazato, Kazuhiko; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima 9601295, Japan; [Yoshihisa, Akiomi; Suzuki, Satoshi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Adv Cardiac Therapeut, Fukushima 9601295, Japan	Yoshihisa, A (reprint author), Fukushima Med Univ, Dept Cardiol & Hematol, 1 Hikarigaoka, Fukushima 9601295, Japan.	yoshihis@fmu.ac.jp			Japan Society for the Promotion of Science [25461061]	The authors acknowledge Yuko Niimura and Emiko Kaneda for their outstanding technical assistance, and Dr. Hajime Iwasa (Department of Public Health, Fukushima Medical University) for valuable advices on medical statistics. This study was supported in part by a Grant-in-Aid for Scientific Research (No. 25461061) from the Japan Society for the Promotion of Science.	Flemons WW, 2003, CHEST, V124, P1543, DOI 10.1378/chest.124.4.1543; Hannon TS, 2011, INT J PEDIATR OBES, V6, P157, DOI 10.3109/17477166.2010.482156; Omori Y, 2012, J HYPERTENS, V30, P1834, DOI 10.1097/HJH.0b013e3283569c5a; Moller DS, 2003, AM J HYPERTENS, V16, P274, DOI 10.1016/S0895-7061(02)03267-3; Zoccali C, 2002, J AM SOC NEPHROL, V13; Bitter T, 2011, EUR HEART J, V32, P61, DOI 10.1093/eurheartj/ehq327; Wang HQ, 2007, J AM COLL CARDIOL, V49, P1625, DOI 10.1016/j.jacc.2006.12.046; Masson S, 2012, CIRCULATION, V125, P280, DOI 10.1161/CIRCULATIONAHA.111.044149; Grube M, 2011, AM J PATHOL, V178, P2547, DOI 10.1016/j.ajpath.2011.02.020; Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Javaheri S, 2007, J AM COLL CARDIOL, V49, P2028, DOI 10.1016/j.jacc.2007.01.084; Yamada S, 2013, CIRC J, V77, P1466, DOI 10.1253/circj.CJ-12-0836; Nakagomi A, 2010, J CARD FAIL, V16, P562, DOI 10.1016/j.cardfail.2010.02.003; Kanbay A, 2012, INT UROL NEPHROL, V44, P535, DOI 10.1007/s11255-011-9927-8; Guven SF, 2012, SLEEP BREATH, V16, P217, DOI 10.1007/s11325-011-0492-2; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Serati AR, 2010, CARDIOLOGY, V116, P178, DOI 10.1159/000318810; Vescovo G, 2005, EUR J HEART FAIL, V7, P997, DOI 10.1016/j.ejheart.204.11.010; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Dursunoglu D, 2005, EUR RESPIR J, V26, P283, DOI 10.1183/09031936.05.00038804; Randby A, 2012, CHEST, V142, P639, DOI 10.1378/chest.11-1779; WABER LJ, 1982, J PEDIATR-US, V101, P700, DOI 10.1016/S0022-3476(82)80294-1; Pekala J, 2011, CURR DRUG METAB, V12, P667; Ather S, 2013, INT J CARDIOL, V166, P394, DOI 10.1016/j.ijcard.2011.10.113; Foley R N, 1998, J Am Soc Nephrol, V9, pS16; MASUMURA Y, 1990, JPN CIRC J, V54, P1471; MATSUI S, 1994, CLIN CARDIOL, V17, P301; Nakamura Y, 2013, CIRC J; Pauly DF, 2003, AM J KIDNEY DIS, V41, pS35, DOI 10.1016/S0272-6386(03)00115-X; REGITZ V, 1990, AM J CARDIOL, V65, P755, DOI 10.1016/0002-9149(90)91383-H; SKLAR AH, 1989, NEPHRON, V51, P35, DOI 10.1159/000185239; TRIPP ME, 1981, NEW ENGL J MED, V305, P385, DOI 10.1056/NEJM198108133050707	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAY	2015	30	3					318	324		10.1007/s00380-014-0479-6		7	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ6FT	WOS:000355590000006		
J	Kishima, H; Mine, T; Kodani, T; Masuyama, T				Kishima, Hideyuki; Mine, Takanao; Kodani, Takeshi; Masuyama, Tohru			Prediction of left atrial thrombi in patients with atrial tachyarrhythmias during warfarin administration: retrospective study in Hyogo College of Medicine	HEART AND VESSELS			English	Article						Transesophageal echocardiography; Left atrial thrombus; Atrial tachyarrhythmia; Warfarin	TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CATHETER ABLATION; THROMBOEMBOLIC RISK; FLOW VELOCITY; FIBRILLATION; STROKE; APPENDAGE; THERAPY; RECOMMENDATIONS; CARDIOMYOPATHY	Some patients experience a left atrial thrombus (LAT) in spite of taking warfarin. We aimed to clarify the characteristics of patients with LAT during warfarin administration and investigated whether the CHADS(2) or CHA(2)DS(2)-VASc scores are useful predictors of LAT. We studied 230 patients (169 males, age 65 +/- 10 years) who underwent transesophageal echocardiography (TEE) prior to cardioversion or catheter ablation of atrial tachyarrhythmias between 2008 and 2012. All patients were taking oral warfarin. LAT was detected in 19 patients (8.3 %) using TEE. LAT was significantly associated with the presence of hypertension (P = 0.0035), prior congestive heart failure (P < 0.0001), structural heart disease (P = 0.0012), persistent arrhythmias (P < 0.0001), the absence of SR during TEE (P = 0.0070), left ventricular ejection fraction (P < 0.0001), left atrial diameter (P = 0.0015), left ventricular dimension during end diastole (P = 0.0215), left ventricular hypertrophy (LVH; P < 0.0001), and the E/e' ratio (P = 0.0074). A multivariate analysis showed that LVH (P = 0.0065, OR 5.591, 95 % CI 1.618-19.316) and persistent arrhythmia (P = 0.0364, OR 12.121, 95 % CI 1.171-125.451) were independently associated with LAT. Moreover, the mean CHADS2 (2.3 +/- 0.9 vs. 1.4 +/- 1.2) and CHA(2)DS(2)-VASc scores (3.8 +/- 1.2 vs. 2.8 +/- 1.7) were higher in the patients with than without LAT. However, a multivariate analysis showed that the CHADS(2)/CHA(2)D(S)2-VASc scores did not associate with LAT. LVH and persistent arrhythmia may be useful for predicting LAT in patients with atrial tachyarrhythmias.	[Kishima, Hideyuki; Mine, Takanao; Kodani, Takeshi; Masuyama, Tohru] Hyogo Coll Med, Cardiovasc Div, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan	Kishima, H (reprint author), Hyogo Coll Med, Cardiovasc Div, Dept Internal Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	kishima@hyo-med.ac.jp					Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Cappato R, 2005, CIRCULATION, V111, P1100, DOI 10.1161/01.CIR.0000157153.30978.67; Okumura K, 2011, CIRC J, V75, P2087, DOI 10.1253/circj.CJ-11-0350; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Cha MJ, 2012, EUR J NEUROL, V19, P473, DOI 10.1111/j.1468-1331.2011.03547.x; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; [Anonymous], 2011, CIRC J, V75, P2357; Corrado G, 2001, EUR HEART J, V22, P1042, DOI 10.1053/euhj.2000.2427; Goldman ME, 1999, J AM SOC ECHOCARDIOG, V12, P1080, DOI 10.1016/S0894-7317(99)70105-7; FATKIN D, 1994, J AM COLL CARDIOL, V23, P961; Scherr D, 2009, J CARDIOVASC ELECTR, V20, P379, DOI 10.1111/j.1540-8167.2008.01336.x; MANNING WJ, 1995, ANN INTERN MED, V123, P817; [Anonymous], 2007, NEUROLOGY, V69, P546; Khasnis A, 2005, PACE, V28, P710, DOI 10.1111/j.1540-8159.2005.00143.x; Calkins H, 2007, HEART RHYTHM, V4, P816; Fatkin D, 1996, AM J CARDIOL, V77, P321, DOI 10.1016/S0002-9149(97)89406-4; Feng DL, 2009, CIRCULATION, V119, P2490, DOI 10.1161/CIRCULATIONAHA.108.785014; Fujiwara M, 2012, HEART VESSELS, V27, P428, DOI 10.1007/s00380-011-0199-0; Schmidt H, 2001, J AM COLL CARDIOL, V38, P778, DOI 10.1016/S0735-1097(01)01463-2; SHIGEMATSU Y, 1995, JPN CIRC J, V59, P329; Sugiura S, 2012, J INTERV CARD ELECTR, V34, P59, DOI 10.1007/s10840-011-9633-6; Yakar Tuluce Selcen, 2010, J Am Soc Echocardiogr, V23, P1207, DOI 10.1016/j.echo.2010.08.016; Yamashita E, 2010, CIRC J, V74, P1081, DOI 10.1253/circj.CJ-09-1002	23	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAY	2015	30	3					331	337		10.1007/s00380-014-0496-5		7	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ6FT	WOS:000355590000008		
J	Kawai, T; Ohishi, M; Onishi, M; Ito, N; Takeya, Y; Oguro, R; Takami, Y; Yamamoto, K; Rakugi, H				Kawai, Tatsuo; Ohishi, Mitsuru; Onishi, Miyuki; Ito, Norihisa; Takeya, Yasushi; Oguro, Ryosuke; Takami, Yoichi; Yamamoto, Koichi; Rakugi, Hiromi			Prognostic impact of regional arterial stiffness in hypertensive patients	HEART AND VESSELS			English	Article						Cardiovascular disease; Prognosis; Regional pulse wave velocity	PULSE-WAVE VELOCITY; CHRONIC KIDNEY-DISEASE; AORTIC STIFFNESS; BLOOD-PRESSURE; ALL-CAUSE; PREDICTOR; MORTALITY; RISK; INDEX; WOMEN	Many reports have shown that brachial-ankle pulse wave velocity (baPWV) and carotid-femoral PWV are prognostic factors for cardiovascular diseases. We evaluated heart-carotid PWV, heart-femoral PWV (hfPWV), and femoral-ankle PWV (faPWV) using carotid and femoral sensors. Our objectives were to reveal correlations among PWVs and to determine the clinical importance of the respective PWVs in predicting the cardiovascular events. This prospective cohort study included 338 patients with essential hypertension (mean age 61.3 +/- 0.7, mean follow-up period 6.5 +/- 0.1 years) whose regional PWVs were measured. Primary end points were stroke, cardiovascular diseases (CVD), and death. Kaplan-Meier analysis showed that subjects with higher faPWV and baPWV had a significantly higher incidence of stroke (p = 0.0288 and 0.0277, respectively), subjects with higher hfPWV had a significantly higher incidence of CVD (p = 0.0212), subjects with higher baPWV and hfPWV had a significantly higher incidence of stroke ? CVD (p = 0.0070 and 0.0463, respectively), and subjects with higher baPWV had a significantly higher mortality rate (p = 0.0367). Cox proportional hazard model revealed that baPWV was a significant risk factor for stroke ? CVD after adjustment for traditional risk factors (relative risk: 14.50, p = 0.0288). Higher baPWV may be a risk factor for stroke and CVD, but the prognostic impact of regional PWVs is still unclear in patients with hypertension.	[Kawai, Tatsuo; Ohishi, Mitsuru; Onishi, Miyuki; Ito, Norihisa; Takeya, Yasushi; Oguro, Ryosuke; Takami, Yoichi; Yamamoto, Koichi; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan	Ohishi, M (reprint author), Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, 2-2 Yamadaoka,B6, Suita, Osaka 5650871, Japan.	ohishi@geriat.med.osaka-u.ac.jp			Ministry of Education, Science, and Culture [16590684]; Japan Arteriosclerosis Prevention Fund	This study was funded by a Grant-in-Aid (no. 16590684) from the Ministry of Education, Science, and Culture and by a grant from the Japan Arteriosclerosis Prevention Fund.	Kimoto E, 2003, DIABETES, V52, P448; Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3; Kimoto E, 2006, J AM SOC NEPHROL, V17, P2245, DOI 10.1681/ASN.2005101038; Lewington S, 2002, LANCET, V360, P1903; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; Smulyan H, 2001, J AM COLL CARDIOL, V37, P1374, DOI 10.1016/S0735-1097(01)01166-4; Cortez-Cooper MY, 2003, AM J CARDIOL, V91, P1519, DOI 10.1016/S0002-9149(03)00416-8; Ito N, 2006, HYPERTENS RES, V29, P989, DOI 10.1291/hypres.29.989; Blacher J, 1999, HYPERTENSION, V33, P1111; Pannier B, 2005, HYPERTENSION, V45, P592, DOI 10.1161/01.HYP.0000159190.71253.c3; Smith A, 2005, J AM SOC NEPHROL, V16, P1069, DOI 10.1681/ASN.2004090769; Taniwaki H, 1999, DIABETES CARE, V22, P1851, DOI 10.2337/diacare.22.11.1851; Turin TC, 2010, HYPERTENS RES, V33, P922, DOI 10.1038/hr.2010.103; Takase H, 2011, AM J HYPERTENS, V24, P667, DOI 10.1038/ajh.2011.19; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Terai M, 2008, HYPERTENS RES, V31, P1135, DOI 10.1291/hypres.31.1135; Laurent S, 2001, HYPERTENSION, V37, P1236; Mahmud A, 2004, J RENIN-ANGIO-ALDO S, V5, P102, DOI 10.3317/jraas.2004.025; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Ohishi M, 2011, HYPERTENS RES, V34, P1209, DOI 10.1038/hr.2011.117; Mineoka Y, 2012, HEART VESSELS, V27, P160, DOI 10.1007/s00380-011-0138-0; Nakamura M, 2010, HYPERTENS RES, V33, P1018, DOI 10.1038/hr.2010.126; Rossi A, 2013, HEART VESSELS, V28, P606, DOI 10.1007/s00380-012-0295-9; Shige H, 2001, ATHEROSCLEROSIS, V155, P245, DOI 10.1016/S0021-9150(00)00558-X; Toyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041369	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAY	2015	30	3					338	346		10.1007/s00380-014-0485-8		9	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ6FT	WOS:000355590000009		
J	Ohnuma, T; Kimura, N; Sasabuchi, Y; Asaka, K; Shiotsuka, J; Komuro, T; Mouri, H; Lefor, AT; Adachi, H; Sanui, M				Ohnuma, Tetsu; Kimura, Naoyuki; Sasabuchi, Yusuke; Asaka, Kayo; Shiotsuka, Junji; Komuro, Tetsuya; Mouri, Hideyuki; Lefor, Alan T.; Adachi, Hideo; Sanui, Masamitsu			Lower heart rate in the early postoperative period does not correlate with long-term outcomes after repair of type A acute aortic dissection	HEART AND VESSELS			English	Article						Aortic dissection; Heart rate; Outcomes; Surgery	INTERNATIONAL REGISTRY; MARFANS-SYNDROME; MANAGEMENT; MORTALITY; BLOCKADE; SURGERY; IRAD	Little evidence exists regarding the need for a reduction in postoperative heart rate after repair of type A acute aortic dissection. This single-center retrospective study was conducted to determine if lower heart rate during the early postoperative phase is associated with improved long-term outcomes after surgery for patients with type A acute aortic dissection. We reviewed 434 patients who underwent aortic repair between 1990 and 2011. Based on the average heart rate on postoperative days 1, 3, 5, and 7, 434 patients were divided into four groups, less than 70, 70-79, 80-89, and greater than 90 beats per minute. The mean age was 63.3 +/- 12.1 years. During a median follow-up of 52 months (range 16-102), 10-year survival in all groups was 67 %, and the 10-year aortic event-free rate was 79 %. The probability of survival and being aortic event-free using Kaplan-Meier estimates reveal that there is no significant difference when stratified by heart rate. Cox proportional regression analysis for 10-year mortality shows that significant predictors of mortality are age [Hazard Ratio (HR) 1.04; 95 % confidence interval (CI) 1.07-1.06; p = 0.001] and perioperative stroke (HR 2.30; 95 % CI 1.18-4.50; p = 0.024). Neither stratified heart rate around the time of surgery nor beta-blocker use at the time of discharge was significant. There is no association between stratified heart rate in the perioperative period with long-term outcomes after repair of type A acute aortic dissection. These findings need clarification with further clinical trials.	[Ohnuma, Tetsu; Sasabuchi, Yusuke; Asaka, Kayo; Shiotsuka, Junji; Komuro, Tetsuya; Mouri, Hideyuki; Sanui, Masamitsu] Jichi Med Univ, Saitama Med Ctr, Dept Anesthesiol & Crit Care Med, Omiya Ku, Saitama, Saitama 3308503, Japan; [Kimura, Naoyuki; Adachi, Hideo] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Saitama, Saitama 3308503, Japan; [Lefor, Alan T.] Jichi Med Univ, Dept Surg, Shimotsuke, Japan	Ohnuma, T (reprint author), Jichi Med Univ, Saitama Med Ctr, Dept Anesthesiol & Crit Care Med, Omiya Ku, 1-847 Amanuma Cho, Saitama, Saitama 3308503, Japan.	tetsu.fe3@gmail.com		Lefor, Alan/0000-0001-6673-5630			Stevens LM, 2009, J THORAC CARDIOV SUR, V138, P1349, DOI 10.1016/j.jtcvs.2009.01.030; Estrera AL, 2006, CIRCULATION, V114, pI384, DOI 10.1161/CIRCULATIONAHA.105.001479; Evangelista A, 2012, CIRCULATION, V125, P3133, DOI 10.1161/CIRCULATIONAHA.111.090266; Zierer A, 2007, ANN THORAC SURG, V84, P479, DOI 10.1016/j.athoracsur.2007.03.084; WHEAT MW, 1965, J THORAC CARDIOV SUR, V50, P364; Tsai TT, 2005, CIRCULATION, V112, P3802, DOI 10.1161/CIRCULATIONAHA.105.534198; Modi A, 2011, INTERACT CARDIOV TH, V13, P386, DOI 10.1510/icvts.2011.266692; Mochizuki S, 2007, LANCET, V369, P1431, DOI 10.1016/S0140-6736(07)60669-2; Kodama K, 2008, CIRCULATION, V118, pS167, DOI 10.1161/CIRCULATIONAHA.107.755801; Fattouch K, 2009, ANN THORAC SURG, V88, P1244, DOI 10.1016/j.athoracsur.2009.06.055; Suzuki T, 2012, AM J CARDIOL, V109, P122, DOI 10.1016/j.amjcard.2011.08.012; AUSTEN WG, 1966, SURG CLIN N AM, V46, P573; Bekkers JA, 2013, EUR J CARDIO-THORAC, V43, P389, DOI 10.1093/ejcts/ezs342; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Dean JCS, 2002, HEART, V88, P97, DOI 10.1136/heart.88.1.97; Delsart P, 2014, HEART VESSELS, V29, P220, DOI 10.1007/s00380-013-0354-x; Gariboldi Vlad, 2007, Interact Cardiovasc Thorac Surg, V6, P47; Genoni M, 2001, EUR J CARDIO-THORAC, V19, P606, DOI 10.1016/S1010-7940(01)00662-5; Melby SJ, 2013, J CLIN HYPERTENS, V15, P63, DOI 10.1111/jch.12024; Sakakura K, 2009, AM J HYPERTENS, V22, P371, DOI 10.1038/ajh.2009.5; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; Taguchi E, 2014, HEART VESSELS, V29, P78, DOI 10.1007/s00380-013-0328-z; Tan MESH, 2005, ANN THORAC SURG, V80, P523, DOI 10.1016/j.athoracsur.2005.02.059; Tsai TT, 2006, CIRCULATION, V114, pI350, DOI 10.1161/CIRCULATIONAHA.105.000497; Yu HY, 2004, EUR J CARDIO-THORAC, V25, P683, DOI 10.1016/j.ejcts.2003.12.041	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAY	2015	30	3					355	361		10.1007/s00380-014-0486-7		7	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ6FT	WOS:000355590000011		
J	Maeda, Y; Suzuki, A; Ishii, J; Sekiguchi-Ueda, S; Shibata, M; Yoshino, Y; Asano, S; Hayakawa, N; Nakamura, K; Akiyama, Y; Kitagawa, F; Sakuishi, T; Fujita, T; Hashimoto, S; Ozaki, Y; Itoh, M				Maeda, Yoshiteru; Suzuki, Atsushi; Ishii, Junnichi; Sekiguchi-Ueda, Sahoko; Shibata, Megumi; Yoshino, Yasumasa; Asano, Shogo; Hayakawa, Nobuki; Nakamura, Kazuhiro; Akiyama, Yasukazu; Kitagawa, Fumihiko; Sakuishi, Toshiaki; Fujita, Takashi; Hashimoto, Shuji; Ozaki, Yukio; Itoh, Mitsuyasu			Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2	HEART AND VESSELS			English	Article						Urinary liver-type fatty acid-binding protein; Cardiovascular disease; Type-2 diabetes; Chronic kidney disease	CHRONIC HEART-FAILURE; RENAL-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; GENERAL-POPULATION; TROPONIN-T; NEPHROPATHY; MORTALITY; METAANALYSIS	Urinary liver-type fatty acid-binding protein (L-FABP) reflects the degree of stress in proximal tubules of the kidney. We examined the level of L-FABP in type-2 diabetes mellitus (T2DM) patients with chronic kidney disease (CKD) stage G1 and G2, and its relationship with cardiac markers and electrocardiographic (ECG) abnormalities. T2DM patients whose estimated glomerular filtration rate (eGFR) was >= 60 mL/min/1.73 m(2) were recruited [n = 276 (165 males), mean age 64 years]. The median level of urinary L-FABP was 6.6 mu g/gCr. Urinary L-FABP showed significant correlation with urinary albumin-to-creatinine ratio (ACR) (r = 0.51, p < 0.0001). Median (25th-75th percentile) eGFR was 82 (72-95) mL/min/1.73 m(2). We divided patients into four subgroups (group 1, L-FABP <= 8.4 mu g/gCr and ACR <= 30 mg/gCr; group 2, L-FABP <= 8.4 mu g/gCr and ACR >30 mg/gCr; group 3, L-FABP >8.4 mu g/gCr and ACR <= 30 mg/gCr; group 4, L-FABP >8.4 mu g/gCr and ACR >30 mg/gCr). Compared with group 1, group 4 was significantly higher in systolic blood pressure, and eGFR using standardized serum cystatin C, high-sensitivity troponin T, and N-terminal pro-brain natriuretic peptide (NT-proBNP). Group 4 had significantly higher level of NT-proBNP than group 3. Groups 2, 3 and 4 showed more ECG abnormalities than group 1. These findings suggest that simultaneous measurement of urinary L-FABP and ACR should be useful to assess cardiovascular damage reflecting on the elevation of cardiac markers and ECG abnormalities in T2DM with CKD G1 and G2.	[Maeda, Yoshiteru; Suzuki, Atsushi; Sekiguchi-Ueda, Sahoko; Shibata, Megumi; Yoshino, Yasumasa; Asano, Shogo; Itoh, Mitsuyasu] Fujita Hlth Univ, Div Endocrinol, Dept Internal Med, Toyoake, Aichi 4701192, Japan; [Ishii, Junnichi; Nakamura, Kazuhiro; Akiyama, Yasukazu; Kitagawa, Fumihiko; Sakuishi, Toshiaki; Fujita, Takashi] Fujita Hlth Univ Hosp, Joint Res Lab Clin Med, Toyoake, Aichi, Japan; [Hayakawa, Nobuki] Meijo Univ, Fac Pharm, Clin Pharmacotherapeut 1, Nagoya, Aichi 468, Japan; [Hashimoto, Shuji] Fujita Hlth Univ, Dept Hyg, Toyoake, Aichi 4701192, Japan; [Ozaki, Yukio] Fujita Hlth Univ, Dept Cardiol, Toyoake, Aichi 4701192, Japan	Suzuki, A (reprint author), Fujita Hlth Univ, Div Endocrinol, Dept Internal Med, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	aslapin@fujita-hu.ac.jp			JSPS KAKENHI [24590712]	We are indebted to Emiko Horii, Sayaka Nomura and Dr. Hiroyuki Naruse for technical assistance. This work was supported by JSPS KAKENHI (Grant Number 24590712).	Unsal A, 2012, EUR REV MED PHARMACO, V16, P878; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; VEERKAMP JH, 1991, BIOCHIM BIOPHYS ACTA, V1081, P1, DOI 10.1016/0005-2760(91)90244-C; Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Smathers RL, 2013, J LIPID RES, V54, P1335, DOI 10.1194/jlr.M034892; Katoh H, 2014, HEART VESSELS, V29, P191, DOI 10.1007/s00380-013-0347-9; Horio M, 2013, AM J KIDNEY DIS, V61, P197, DOI 10.1053/j.ajkd.2012.07.007; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Fukuda Y, 2009, INTERNAL MED, V48, P1731, DOI 10.2169/internalmedicine.48.2410; Thygesen K, 2010, EUR HEART J, V31, P2197, DOI 10.1093/eurheartj/ehq251; Tang SCW, 2012, NEPHROL DIAL TRANSPL, V27, P3049, DOI 10.1093/ndt/gfs260; Freda BJ, 2002, J AM COLL CARDIOL, V40, P2065, DOI 10.1016/S0735-1097(02)02608-6; Kamijo A, 2005, J LAB CLIN MED, V145, P125, DOI 10.1016/j.lab.2004.12.003; Araki S, 2013, DIABETES CARE, V36, P1248, DOI 10.2337/dc12-1298; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Saito T, 2013, HEART VESSELS, V28, P323, DOI 10.1007/s00380-012-0254-5; Kaneko H, 2014, HEART VESSELS, V29, P437, DOI 10.1007/s00380-013-0382-6; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Araki S, 2008, DIABETES RES CLIN PR, V82, pS54, DOI 10.1016/j.diabres.2008.09.031; ASANO S, 2012, DIABETOLOGY INT, V3, P29; Atsunori K, 2012, J DIABETES INVEST, V3, P39; Cohen-Bucay A, 2012, INT J NEPHROL, DOI [10.1155/2012/146987, DOI 10.1155/2012/146987]; El Nahas AM, 2005, LANCET, V365, P331; Hildebrandt P, 2008, AM J CARDIOL, V2101, P21; Hildebrandt P, 2009, DIS MARKERS, V26, P227, DOI 10.3233/DMA-2009-0632; Ishii J, 2003, CLIN CHEM, V49, P2020, DOI 10.1373/clinchem.2003.021311; Ishii J, 2002, AM J CARDIOL, V89, P691, DOI 10.1016/S0002-9149(01)02341-4; Kalansooriya A, 2007, BRIT J BIOMED SCI, V64, P153; Kamijo A, 2004, J LAB CLIN MED, V143, P23, DOI 10.1016/j.lab.2003.08.001; Kamijo A, 2006, MOL CELL BIOCHEM, V284, P175, DOI 10.1007/s11010-005-9047-9; Kamijo-Ikemori A, 2006, CLIN CHIM ACTA, V374, P1, DOI 10.1016/j.cca.2006.05.038; Kamijo-Ikemori A, 2011, DIABETES CARE, V34, P691, DOI 10.2337/dc10-1392; Matsumori R, 2012, J CARDIOL, V60, P168, DOI 10.1016/j.jjcc.2012.03.008; Taub Pam R, 2012, Expert Rev Cardiovasc Ther, V10, P657, DOI 10.1586/erc.12.26; von Eynatten M, 2010, EUR J CLIN INVEST, V40, P95, DOI 10.1111/j.1365-2362.2009.02220.x	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAY	2015	30	3					362	368		10.1007/s00380-014-0489-4		7	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ6FT	WOS:000355590000012		
J	Sakata, K; Namura, M; Takagi, T; Tama, N; Inoki, I; Terai, H; Horita, Y; Ikeda, M; Yamagishi, M				Sakata, Kenji; Namura, Masanobu; Takagi, Toshimitsu; Tama, Naoto; Inoki, Isao; Terai, Hidenobu; Horita, Yuki; Ikeda, Masatoshi; Yamagishi, Masakazu			Repeated occurrence of slow flow phenomenon during and late after sirolimus-eluting stent implantation	HEART AND VESSELS			English	Article						Optical coherence tomography; Intravascular ultrasound; Percutaneous coronary intervention (PCI); Slow flow phenomenon; Neoatherosclerosis	ACUTE CORONARY SYNDROME; INTRAVASCULAR ULTRASOUND; NO-REFLOW; IMPACT; NEOATHEROSCLEROSIS; HYPERSENSITIVITY; INTERVENTION	A 78-year-old man with unstable angina showed 90 % stenosis in the proximal left anterior descending artery. Pre-procedural intravascular ultrasound revealed ruptured plaque and attenuated plaque in the lesion. Under these conditions, two overlapping sirolimus-eluting stent (SES) implantation in this lesion resulted in slow flow which was recovered by intracoronary nitrates, nicorandil, and nitroprusside without further complications. When the patient showed up again 5 years later with recurrence of angina pectoris, angiography revealed a hazy ulcerated in-stent restenosis (ISR) at the site of the SES. Pre-procedural optical coherence tomography (OCT) imaging revealed multiple intimal ruptures, cavity formation behind the stent struts, a thin-cap fibroatheroma containing neointima surrounded by signal-poor, lipid-rich area in the proximal SES, suggesting the progression of neoatherosclerosis within SES. Importantly, there occurred slow flow again after balloon angioplasty for this lesion. We would suggest careful OCT examination is warranted to confirm development of neoatherosclerosis within the stent, and distal protection device should be considered to prevent slow flow phenomenon even in a patient with very late ISR.	[Sakata, Kenji; Yamagishi, Masakazu] Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, Kanazawa, Ishikawa 9208640, Japan; [Namura, Masanobu; Takagi, Toshimitsu; Tama, Naoto; Inoki, Isao; Terai, Hidenobu; Horita, Yuki; Ikeda, Masatoshi] Kanazawa Cardiovasc Hosp, Div Cardiol, Kanazawa, Ishikawa, Japan	Yamagishi, M (reprint author), Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	myamagi@med.kanazawa-u.ac.jp					Kang SJ, 2011, CIRCULATION, V123, P2954, DOI 10.1161/CIRCULATIONAHA.110.988436; Kotani J, 2002, CIRCULATION, V106, P1672, DOI 10.1161/01.CIR.0000030189.27175.4E; Otsuka Y, 2012, HEART VESSELS, V27, P110, DOI 10.1007/s00380-011-0145-1; Kusama I, 2007, J AM COLL CARDIOL, V50, P1230, DOI 10.1016/j.jacc.2007.07.004; Iijima R, 2006, AM J CARDIOL, V97, P29, DOI 10.1016/j.amjcard.2005.07.104; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Inoue K, 2010, CIRC J, V74, P2232, DOI 10.1253/circj.CJ-10-0722; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Sakata K, 2012, CIRC-CARDIOVASC INTE, V5, P763, DOI 10.1161/CIRCINTERVENTIONS.111.962878; Sakata K, 2012, HEART VESSELS, V27, P443, DOI 10.1007/s00380-011-0175-8; Tada H, 2012, INT J CARDIOL, V158, P235, DOI 10.1016/j.ijcard.2011.01.058	11	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAY	2015	30	3					406	409		10.1007/s00380-014-0477-8		4	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ6FT	WOS:000355590000017		
J	Kuroki, K; Tada, H; Kunugida, F; Sekiguchi, Y; Machino, T; Yamasaki, H; Igarashi, M; Aonuma, K				Kuroki, Kenji; Tada, Hiroshi; Kunugida, Fusanori; Sekiguchi, Yukio; Machino, Takeshi; Yamasaki, Hiro; Igarashi, Miyako; Aonuma, Kazutaka			Hybrid epicardial and endocardial ablation of a persistent atrial tachycardia arising from the marshall bundle: the importance of a detailed analysis of the local potentials	HEART AND VESSELS			English	Article						Atrial tachycardia; Vein of Marshall; Catheter ablation; Local potential; Atrial fibrillation	FIBRILLATION; LIGAMENT	Radiofrequency catheter ablation of an atrial tachycardia (AT) and atrial fibrillation (AF) was performed in a patient with a history of pulmonary vein isolation for paroxysmal AF. The AT exhibited a centrifugal pattern with the posterolateral LA as the earliest activation site. The AT was not terminated by ablation at the endocardial earliest site, but its cycle length was prolonged by ablation at an opposite site within the Vein of Marshall. Finally, the AT was terminated by an energy application at a site 7 mm posteroinferior to the initial earliest activation site. We analyzed the local potentials of each energy delivery site in detail.	[Kuroki, Kenji; Kunugida, Fusanori; Sekiguchi, Yukio; Machino, Takeshi; Yamasaki, Hiro; Igarashi, Miyako; Aonuma, Kazutaka] Univ Tsukuba, Inst Clin Med, Cardiovasc Div, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan; [Tada, Hiroshi] Univ Fukui, Dept Cardiovasc Med, Fac Med Sci, Eiheiji, Fukui 9101193, Japan	Tada, H (reprint author), Univ Fukui, Dept Cardiovasc Med, Fac Med Sci, 23-3 Matsuokashimoaizuki, Eiheiji, Fukui 9101193, Japan.	htada2003@yahoo.co.jp					Hioki M, 2012, HEART VESSELS, V27, P221, DOI 10.1007/s00380-011-0159-8; Hwang C, 2006, HEART RHYTHM, V3, P1505, DOI 10.1016/j.hrthm.2006.09.014; Knecht S, 2007, J CARDIOVASC ELECTR, V18, P1004, DOI 10.1111/j.1540-8167.2007.00835.x; Maeda S, 2012, HEART VESSELS, V27, P58, DOI 10.1007/s00380-011-0120-x; Pak HN, 2007, J CARDIOVASC ELECTR, V18, P917, DOI 10.1111/j.1540-8167.2007.00882.x; Polymeropoulos KP, 2002, CIRCULATION, V105, P2112, DOI 10.1161/01.CIR.0000016168.49833.CE	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAY	2015	30	3					416	419		10.1007/s00380-014-0498-3		4	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ6FT	WOS:000355590000019		
J	Date, K; Okada, S; Ezure, M; Takihara, H; Okonogi, S; Hasegawa, Y; Sato, Y; Kaneko, T				Date, Kazuma; Okada, Shuuichi; Ezure, Masahiko; Takihara, Hitomi; Okonogi, Shuuichi; Hasegawa, Yutaka; Sato, Yasushi; Kaneko, Tatsuo			Aortoiliac aneurysm with congenital right pelvic kidney	HEART AND VESSELS			English	Article						Abdominal aortic aneurysm; Congenital pelvic kidney; Renal ischemia	ABDOMINAL AORTIC-ANEURYSM; RENAL-TRANSPLANT PROTECTION; HORSESHOE KIDNEY; RARE ASSOCIATION; REPAIR; ANOMALIES; PERFUSION	The association of congenital pelvic kidney with abdominal aortoiliac aneurysm is an extremely rare clinical finding. Previous reports have described various methods of aneurysm repair with successful preservation of the function of pelvic kidney. However, to our knowledge, reconstruction of more than two renal arteries has not been established. We report a case of abdominal aortic aneurysm complicated by congenital right pelvic kidney in a 72-year-old man. Computed tomography (CT) revealed an abdominal aortic aneurysm with a maximum diameter of 54 mm and a right common iliac aneurysm of 45 mm. In addition, he had a congenital right pelvic kidney and CT angiography identified three right pelvic renal arteries. The upper artery originated from the bifurcation of the terminal aorta and the lower two originated from the right common iliac artery. Three-dimensional CT was helpful for the accurate planning of the operation. Open surgical repair of the aortoiliac aneurysm with a Dacron bifurcated graft replacement was decided and reimplantation of all three right pelvic kidney arteries to the right limb of the graft was also performed. For renal preservation, the right pelvic kidney arteries were perfused with cold Ringer's lactate using a rapid infusion pump and coronary perfusion cannula. The patient's postoperative course was uneventful, and worsening of renal function was not observed. The perfusion of renal arteries with cold Ringer's solution was thought to be a simple and appropriate procedure for renal protection.	[Date, Kazuma; Okada, Shuuichi; Ezure, Masahiko; Takihara, Hitomi; Okonogi, Shuuichi; Hasegawa, Yutaka; Sato, Yasushi; Kaneko, Tatsuo] Gunma Prefectural Cardiovasc Ctr, Dept Cardiovasc Surg, Maebashi, Gunma, Japan; [Date, Kazuma] Univ Tokyo, Dept Cardiothorac Surg, Bunkyo Ku, Tokyo 1138655, Japan	Date, K (reprint author), Univ Tokyo, Dept Cardiothorac Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	miracle5jp@yahoo.co.jp					Akashi H, 2012, JPN J CARDIOVASC SUR, V41, P266; Spear R, 2012, EUR J VASC ENDOVASC, V43, P398, DOI 10.1016/j.ejvs.2012.01.003; Nakayama A, 2014, HEART VESSELS, V29, P65, DOI 10.1007/s00380-012-0319-5; Glock Y, 1997, TEX HEART I J, V24, P131; SCHNEIDER JR, 1993, J VASC SURG, V17, P613; Faggioli GL, 2003, SURGERY, V133, P641, DOI 10.1067/msy.2003.156; HOLLIS HW, 1989, J VASC SURG, V9, P404, DOI 10.1067/mva.1989.vs0090404; BELCASTRO S, 1993, J CARDIOVASC SURG, V34, P83; Bui TD, 2007, ANN VASC SURG, V21, P143, DOI 10.1016/j.avsg.2007.01.004; CAMPBELL DA, 1981, SURGERY, V90, P559; Coney PM, 2008, J VASC SURG, V48, P727, DOI 10.1016/j.jvs.2008.03.034; Cook W A, 1977, Birth Defects Orig Artic Ser, V13, P327; DOMENECHMATEU JM, 1988, ANAT REC, V222, P408, DOI 10.1002/ar.1092220413; EZZET F, 1977, AM J SURG, V134, P196, DOI 10.1016/0002-9610(77)90342-7; Hanif MA, 2005, EUR J VASC ENDOVASC, V30, P531, DOI 10.1016/j.ejvs.2005.04.044; HANS SS, 1984, J CARDIOVASC SURG, V25, P176; Ilic NS, 2010, AM SURGEON, V76, P550; Jinnouchi K, 2012, JPN J VASC SURG, V21, P829; Kaplan DB, 1999, J VASC SURG, V30, P407, DOI 10.1016/S0741-5214(99)70067-4; LACOMBE M, 1986, ANN SURG, V203, P62, DOI 10.1097/00000658-198601000-00011; Makris Sotirios A, 2011, J Med Case Rep, V5, P92, DOI 10.1186/1752-1947-5-92; Mandolfino Tommaso, 2005, Chir Ital, V57, P361; Marone EM, 2008, J VASC SURG, V47, P638, DOI 10.1016/j.jvs.2007.09.017; MERKLIN R J, 1958, J Int Coll Surg, V29, P41; Morales JP, 2009, EUR J VASC ENDOVASC, V37, P557, DOI 10.1016/j.ejvs.2009.01.006; Murakami T, 2004, J CARDIOVASC SURG, V45, P501; NGUESSEN G, 1984, UROLOGY, V24, P219, DOI 10.1016/0090-4295(84)90346-7; OMARA CS, 1983, SURGERY, V94, P512; Rehrig S T Jr, 2001, Vasc Surg, V35, P463, DOI 10.1177/153857440103500607; Renzulli JF, 2003, VASC MED, V8, P197, DOI 10.1191/1358863x03vm495cr; Saruhara H, 2012, HEART VESSELS, V27, P166, DOI 10.1007/s00380-011-0135-3	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0910-8327	1615-2573		HEART VESSELS	Heart Vessels	MAY	2015	30	3					420	425		10.1007/s00380-014-0483-x		6	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ6FT	WOS:000355590000020		
J	Kobayashi, K; Chikazawa, Y; Ezaki, K				Kobayashi, Kazuhiro; Chikazawa, Yuuki; Ezaki, Kosuke			One-Pot Synthesis of 3-Alkoxy-2,3-dihydro-1H-isoindol-1-ones by the Reactions of 2-(Azidomethyl)benzoates with NaH	HELVETICA CHIMICA ACTA			English	Article						1H-Isoindol-1-ones; 3-alkoxy-2; 3-dihydro-; Isoindolinones; 3-alkoxy-; Benzoates; 2-(azidomethyl)-; Benzyl anion; Denitrogenation	DERIVATIVES; CYCLIZATION	A new and facile method for the general preparation of 3-alkoxy-2,3-dihydro-1H-isoindol-1-ones has been developed. Thus, the reaction of 2-(azidomethyl)benzoates with NaH affords, after workup with H2O, 3-alkoxy-2,3-dihydro-1H-isoindol-1-ones 2. 2-Substituted 3-alkoxy-2,3-dihydro-1H-isoindol-1-ones 4 can be obtained by adding alkyl halides prior to workup with H2O.	[Kobayashi, Kazuhiro; Chikazawa, Yuuki; Ezaki, Kosuke] Tottori Univ, Grad Sch Engn, Div Appl Chem, Dept Chem & Biotechnol, Tottori 6808552, Japan	Kobayashi, K (reprint author), Tottori Univ, Grad Sch Engn, Div Appl Chem, Dept Chem & Biotechnol, 4-101 Koyama Minami, Tottori 6808552, Japan.	kkoba@chem.tottori-u.ac.jp			JSPS KAKENHI [26410051]	This work was supported in part by JSPS KAKENHI Grant No. 26410051. We thank Mrs. Miyuki Tanmatsu at our university for recording mass spectra and performing combustion analyses.	Andersson H, 2008, BIOORGAN MED CHEM, V16, P6924, DOI 10.1016/j.bmc.2008.05.046; Xu K, 2013, CHEM-EUR J, V19, P3573, DOI 10.1002/chem.201202409; Cho CS, 1996, B KOR CHEM SOC, V17, P1095; Dennis J. M., 2013, SYNLETT, P2567; DUNET A, 1948, CR HEBD ACAD SCI, V226, P821; Hardcastle IR, 2005, BIOORG MED CHEM LETT, V15, P1515, DOI 10.1016/j.bmcl.2004.12.061; Jayawardena VC, 2013, AUST J CHEM, V66, P619, DOI 10.1071/CH12528; KREHER RP, 1986, CHEM ZTG, V110, P363; Lee HJ, 2008, BIOORG MED CHEM LETT, V18, P1628, DOI 10.1016/j.bmcl.2008.01.066; Love KR, 2001, J ORG CHEM, V66, P8165, DOI 10.1021/jo015987h; PUMMERER R, 1947, CHEM BER-RECL, V80, P242, DOI 10.1002/cber.19470800311; SATO R, 1988, B CHEM SOC JPN, V61, P2481, DOI 10.1246/bcsj.61.2481	12	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0018-019X	1522-2675		HELV CHIM ACTA	Helv. Chim. Acta	MAY	2015	98	5					604	610		10.1002/hlca.201500051		7	Chemistry, Multidisciplinary	Chemistry	CJ2SR	WOS:000355335300002		
J	Pertuit, D; Lotfabad, TB; Mitaine-Offer, AC; Miyamoto, T; Tanaka, C; Lacaille-Dubois, MA				Pertuit, David; Lotfabad, Tayebe Baghery; Mitaine-Offer, Anne-Claire; Miyamoto, Tomofumi; Tanaka, Chiaki; Lacaille-Dubois, Marie-Aleth			Two New Triterpene Saponins from Acanthophyllum laxiusculum	HELVETICA CHIMICA ACTA			English	Article						Acanthophyllum laxiusculum; Saponins; Triterpenes; Glycosides		Two new triterpene glycosides, 1 and 2, together with three known ones, were isolated from roots of Acanthophyllum laxiusculumSchiman-Czeika. The structures of the new compounds were established by extensive 1D- and 2D-NMR spectroscopic experiments and MS analyses as 23-O--D-galactopyranosylgypsogenic acid 28-O-{-D-glucopyranosyl-(12)-6-O-[4-carboxy-3-hydroxy-3-methyl-1-oxobutyl]--D-glucopyranosyl-(16)}-[-D-glucopyranosyl-(13)]--D-galactopyranosyl ester (1) and gypsogenic acid 28-O-{-D-glucopyranosyl-(12)-6-O-[4-carboxy-3-hydroxy-3-methyl-1-oxobutyl]--D-glucopyranosyl-(16)}-[-D-glucopyranosyl-(13)]--D-galactopyranosyl ester (2).	[Pertuit, David; Mitaine-Offer, Anne-Claire; Lacaille-Dubois, Marie-Aleth] Univ Bourgogne, UFR Pharm, EA 4267, FDE UFC Lab Pharmacognosie, FR-21079 Dijon, France; [Lotfabad, Tayebe Baghery] NIGEB, Tehran, Iran; [Miyamoto, Tomofumi; Tanaka, Chiaki] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan	Lacaille-Dubois, MA (reprint author), Univ Bourgogne, UFR Pharm, EA 4267, FDE UFC Lab Pharmacognosie, 7,Bd Jeanne Arc,BP 87900, FR-21079 Dijon, France.	m-a.lacaille-dubois@u-bourgogne.fr					Koike K, 1998, PHYTOCHEMISTRY, V47, P1343, DOI 10.1016/S0031-9422(97)00707-3; HARA S, 1987, CHEM PHARM BULL, V35, P501; Elbandy M, 2007, HELV CHIM ACTA, V90, P260, DOI 10.1002/hlca.200790029; Gaidi G, 2004, J NAT PROD, V67, P1114, DOI 10.1021/np040001v; Gaidi G, 2000, J NAT PROD, V63, P1497, DOI 10.1021/np000212+; Ghaffari SM, 2004, BIOLOGIA, V59, P53; Haddad M, 2004, HELV CHIM ACTA, V87, P73, DOI 10.1002/hlca.200490019; Luo Jian-Guang, 2008, Bioorg Med Chem, V16, P2912, DOI 10.1016/j.bmc.2007.12.053; Mihci-Gaidi Ghezala, 2010, Nat Prod Commun, V5, P1023; Mihci-Gaidi G, 2010, PLANTA MED, V76, P818, DOI 10.1055/s-0029-1240727; Pertuit D, 2014, PHYTOCHEMISTRY, V102, P182, DOI 10.1016/j.phytochem.2014.02.018; Timite G, 2010, MAGN RESON CHEM, V48, P370, DOI 10.1002/mrc.2577	12	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0018-019X	1522-2675		HELV CHIM ACTA	Helv. Chim. Acta	MAY	2015	98	5					611	617		10.1002/hlca.201400253		7	Chemistry, Multidisciplinary	Chemistry	CJ2SR	WOS:000355335300003		
J	Wu, YB; Liu, D; Liu, PY; Yang, XM; Liao, M; Lu, NN; Sauriol, F; Gu, YC; Shi, QW; Kiyota, H; Dong, M				Wu, Yi-Bing; Liu, Dan; Liu, Pei-Yu; Yang, Xue-Mei; Liao, Man; Lu, Nan-Nan; Sauriol, Francoise; Gu, Yu-Cheng; Shi, Qing-Wen; Kiyota, Hiromasa; Dong, Mei			New Limonoids from the Seeds of Xylocarpus granatum	HELVETICA CHIMICA ACTA			English	Article						Xylocarpus granatum; Limonoids	PHRAGMALIN; FRUIT	Three novel limonoids, 2,3-dideacetylxyloccensin S (1), 30-deacetylxyloccensin W (2), and 7-hydroxy-21-methoxy-3-oxo-24,25,26,27-tetranortirucalla-1,14-diene-23(21)-lactone (3), were isolated from the seeds of the Chinese mangrove, Xylocarpus granatum. The structures were elucidated on the basis of 1D- and 2D-NMR (including H-1- and C-13-NMR, DEPT, H-1,H-1-COSY, HSQC, HMBC, and NOESY) data and confirmed by HR-MS.	[Wu, Yi-Bing; Liu, Dan; Liu, Pei-Yu; Yang, Xue-Mei; Liao, Man; Lu, Nan-Nan; Shi, Qing-Wen] Hebei Med Univ, Hebei Key Lab Forens Med, Sch Pharmaceut Sci, Shijiazhuang 050017, Peoples R China; [Sauriol, Francoise] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada; [Gu, Yu-Cheng] Syngenta Jealotts Hill Int Res Ctr, Bracknell RG42 6EY, Berks, England; [Kiyota, Hiromasa] Okayama Univ, Grad Sch Environm & Life Sci, Kitaa Ku, Okayama 7008530, Japan; [Shi, Qing-Wen; Dong, Mei] Hebei Med Univ, Hebei Key Lab Forens Med, Shijiazhuang 050017, Peoples R China	Shi, QW (reprint author), Hebei Med Univ, Hebei Key Lab Forens Med, Sch Pharmaceut Sci, Shijiazhuang 050017, Peoples R China.	shiqingwen@hebmu.edu.cn; meidong@hebmu.edu.cn			National Natural Science Foundation of China [81072551, 81241101]; Scientific Research Foundation of Hebei Province [C2010000489]; Youth Foundation of Hebei Educational Committee and Technology Research Project [QN2014090]; Science and Technology Research Projects of Hebei Educational Committee [ZD2014107]; Key Projects of Science & Technology of Hebei Province [13272508]; Syngenta Ltd. [2011-Hebei Medical University-Syngenta-03]; Science & Technology of Administration of Traditional Chinese Medicine of Hebei Province [2014133]	We are grateful for financial supports from the National Natural Science Foundation of China (81072551, 81241101), the Scientific Research Foundation of Hebei Province (C2010000489), the Youth Foundation of Hebei Educational Committee and Technology Research Project (QN2014090), the Science and Technology Research Projects of Hebei Educational Committee (ZD2014107), and the Key Projects of Science & Technology of Hebei Province (13272508). We also wish to extend our sincere thanks, for the financial support, to Syngenta Ltd. (2011-Hebei Medical University-Syngenta-03) and Projects of Science & Technology of Administration of Traditional Chinese Medicine of Hebei Province (2014133).	Yin S, 2006, ORG LETT, V8, P4935, DOI 10.1021/ol062101t; Cui JX, 2007, J NAT PROD, V70, P772, DOI 10.1021/np060622j; Cui JX, 2005, PHYTOCHEMISTRY, V66, P2334, DOI 10.1016/j.phytochem.2005.06.020; Huo CH, 2010, TETRAHEDRON LETT, V51, P754, DOI 10.1016/j.tetlet.2009.11.123; MULHOLLAND DA, 1992, PHYTOCHEMISTRY, V31, P4163, DOI 10.1016/0031-9422(92)80434-G; NG AS, 1979, CAN J CHEM, V57, P3088, DOI 10.1139/v79-504; Shen LR, 2009, Z NATURFORSCH C, V64, P37; TAYLOR DAH, 1965, J CHEM SOC, P3495; Wu J, 2007, Z NATURFORSCH B, V62, P569; Wu J, 2006, BIOCHEM SYST ECOL, V34, P838, DOI 10.1016/j.bse.2006.05.016; Wu J, 2005, Z NATURFORSCH B, V60, P1291; Yin S, 2007, J NAT PROD, V70, P682, DOI 10.1021/np060632k	12	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0018-019X	1522-2675		HELV CHIM ACTA	Helv. Chim. Acta	MAY	2015	98	5					691	698		10.1002/hlca.201400290		8	Chemistry, Multidisciplinary	Chemistry	CJ2SR	WOS:000355335300014		
J	Devkota, HP; Joshi, KR; Watanabe, T; Yahara, S				Devkota, Hari Prasad; Joshi, Khem Raj; Watanabe, Takashi; Yahara, Shoji			Biflavonoids, Lignans, and Related Compounds from the Roots of Diplomorpha canescens	HELVETICA CHIMICA ACTA			English	Article						Diplomorpha canescens; Dihydrodaphnodorin B; 14-O-methyl-Daphnodorin J; 14-O-methyl-Biflavonoids; Lignans	DAPHNE-ODORA; WIKSTROEMIA-SIKOKIANA; PHENOLIC-COMPOUNDS; AERIAL PARTS; CONSTITUENTS; FLAVONOIDS; THYMELAEACEAE; PLANTS; CHINA	Two new biflavonoids, 14-O-methyldihydrodaphnodorin B (1) and 14-O-methyldaphnodorin J (2), along with 16 known compounds, i.e., dihydrodaphnodorin B (3), daphnodorin J (4), 3-epidihydrodaphnodorin B (5), daphnodorin B (6), neochamaejasmin B (7), sikokianin B (8), (-)-syringaresinol (9), (-)-syringaresinol 4-O--D-glucopyranoside (10), (+)-nortrachelogenin (11), (-)-lariciresinol (12), (-)-pinoresinol (13), syringin (14), syringinoside (15), daphnoretin (16), phorbol 13-acetate (17), and methyl paraben (18) were isolated from the roots of Diplomorpha canescens (Meisn.) C.A. Meyer. The structures were determined on the basis of spectroscopic data.	[Devkota, Hari Prasad; Joshi, Khem Raj] Kumamoto Univ, Program Leading Grad Sch, Hlth Life Sci Interdisciplinary & Glocal Oriented, Chuo Ku, Kumamoto 8620973, Japan; [Devkota, Hari Prasad; Joshi, Khem Raj; Yahara, Shoji] Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan; [Watanabe, Takashi] Kochi Univ Technol, Res Org Reg Alliances, Kochi 7820003, Japan	Devkota, HP (reprint author), Kumamoto Univ, Program Leading Grad Sch, Hlth Life Sci Interdisciplinary & Glocal Oriented, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	devkotah@kumamoto-u.ac.jp; yaharas1@gpo.kumamoto-u.ac.jp					Almahy H. A., 2006, International Journal of Tropical Medicine, V1, P58; YAHARA S, 1991, CHEM PHARM BULL, V39, P2024; CORDELL GA, 1984, J NAT PROD, V47, P84, DOI 10.1021/np50031a010; Leong YW, 1999, PHYTOCHEMISTRY, V50, P1237, DOI 10.1016/S0031-9422(98)00687-6; Xie LH, 2003, CHEM PHARM BULL, V51, P508, DOI 10.1248/cpb.51.508; MARSHALL GT, 1984, J AM OIL CHEM SOC, V61, P1220, DOI 10.1007/BF02636256; Taniguchi M, 1997, PHYTOCHEMISTRY, V45, P183, DOI 10.1016/S0031-9422(96)00800-X; BABA K, 1986, CHEM PHARM BULL, V34, P1540; Liang S, 2011, CHEM PHARM BULL, V59, P653, DOI 10.1248/cpb.59.653; BABA K, 1986, CHEM PHARM BULL, V34, P595; Devkota HP, 2010, CHEM PHARM BULL, V58, P859; Devkota HP, 2012, PHYTOCHEM LETT, V5, P284, DOI 10.1016/j.phytol.2012.02.002; Devkota HP, 2012, CHEM PHARM BULL, V60, P554; Devkota HP, 2013, CHEM PHARM BULL, V61, P242; KONISHI T, 1993, YAKUGAKU ZASSHI, V113, P670; Manandhar N. P., 2002, PLANTS PEOPLE NEPAL, P411; NIWA M, 1988, CHEM PHARM BULL, V36, P1158; NIWA M, 1986, CHEM PHARM BULL, V34, P3631; NIWA M, 1984, CHEM LETT, P539, DOI 10.1246/cl.1984.539; Taniguchi M, 1996, PHYTOCHEMISTRY, V42, P1447, DOI 10.1016/0031-9422(96)00136-7; Ullah N., 1999, CHEM PHARM BULL, V47, P1237; Watanabe T., 2013, HDB MED PLANTS NE S1, P242; WU DG, 1993, PHYTOTHER RES, V7, P194; Xiao P. G., 1993, PICTORIAL ENCY CHINE, V8, P91	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0018-019X	1522-2675		HELV CHIM ACTA	Helv. Chim. Acta	MAY	2015	98	5					704	709		10.1002/hlca.201400299		6	Chemistry, Multidisciplinary	Chemistry	CJ2SR	WOS:000355335300016		
J	Egi, M; Akai, S				Egi, Masahiro; Akai, Shuji			TRANSITION METAL-CATALYZED INTRAMOLECULAR CYCLIZATION OF PROPARGYL ALCOHOLS AND THEIR DERIVATIVES FOR THE SYNTHESIS OF HIGHLY SUBSTITUTED FIVE-MEMBERED OXYGEN HETEROCYCLES	HETEROCYCLES			English	Article						Propargyl Alcohol; Furan; Furanone; Transition Metal; Intramolecular Cyclization Reaction	POLYSUBSTITUTED FURANS; EFFICIENT SYNTHESIS; GOLD CATALYSIS; TETRASUBSTITUTED FURANS; EPOXYPROPARGYL ESTERS; CARBONYL-COMPOUNDS; DOMINO PROCESS; CYCLOISOMERIZATION; ACCESS; ALKYNYLOXIRANES	The transition metal-catalyzed intramolecular cyclization of propargyl alcohols and their derivatives has been widely utilized in the synthesis of five-membered oxygen heterocycles such as furans, hydrofurans, and furanones. Prerequisites for the efficient transformations into highly substituted target compounds include the regioselectivity of the cyclization step and the chemoselectivity of the transition metal-mediated activation of substrates. This review documents recent progress on the title reactions by categorizing the initial activation modes of substrates.	[Egi, Masahiro] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan; [Akai, Shuji] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Egi, M (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	egi@u-shizuoka-ken.ac.jp; akai@phs.osaka-u.ac.jp					Adrio J, 2007, J AM CHEM SOC, V129, P778, DOI 10.1021/ja0684186; Egi M, 2010, J ORG CHEM, V75, P2123, DOI 10.1021/jo100048j; Egi M, 2013, ORG LETT, V15, P4150, DOI 10.1021/ol401824v; Huang XL, 2012, ANGEW CHEM INT EDIT, V51, P8886, DOI 10.1002/anie.201203637; Spina R, 2013, CHEM-EUR J, V19, P3817, DOI 10.1002/chem.201203800; Shen HC, 2008, TETRAHEDRON, V64, P3885, DOI 10.1016/j.tet.2008.01.081; Gabriele B, 2012, J ORG CHEM, V77, P8657, DOI 10.1021/jo301628n; Egi M, 2011, ADV SYNTH CATAL, V353, P287, DOI 10.1002/adsc.201000753; Targowska-Duda KM, 2014, NEUROSCI LETT, V569, P126, DOI 10.1016/j.neulet.2014.03.067; Suhre MH, 2005, ORG LETT, V7, P3925, DOI 10.1021/ol0514101; Huang HW, 2012, TETRAHEDRON, V68, P3135, DOI 10.1016/j.tet.2011.12.033; Cao H, 2010, ADV SYNTH CATAL, V352, P143, DOI 10.1002/adsc.200900685; Cadierno V, 2009, CHEM REV, V109, P3512, DOI 10.1021/cr8005476; Aponick A, 2009, ORG LETT, V11, P4624, DOI 10.1021/ol901901m; Kirsch SF, 2006, ORG BIOMOL CHEM, V4, P2076, DOI 10.1039/b602596j; Zhang GZ, 2007, J AM CHEM SOC, V129, P11358, DOI 10.1021/ja074536x; Cao H, 2009, ORG LETT, V11, P1931, DOI 10.1021/ol900364y; Blanc A, 2009, J ORG CHEM, V74, P5342, DOI 10.1021/jo9008172; Zhang LM, 2005, J AM CHEM SOC, V127, P16804, DOI 10.1021/ja056419c; Aurrecoechea JM, 2008, J ORG CHEM, V73, P3650, DOI 10.1021/jo800211q; MCDONALD FE, 1994, J AM CHEM SOC, V116, P9363, DOI 10.1021/ja00099a077; Hashmi ASK, 2004, ADV SYNTH CATAL, V346, P432, DOI 10.1002/adsc.200303201; Xu ZG, 2013, CHEM COMMUN, V49, P6755, DOI 10.1039/c3cc43432j; Gandini A, 2009, J POLYM SCI POL CHEM, V47, P295, DOI 10.1002/pola.23130; Yoshida M, 2012, CHEM-EUR J, V18, P1604, DOI 10.1002/chem.201103246; Cui ZN, 2010, EUR J MED CHEM, V45, P5576, DOI 10.1016/j.ejmech.2010.09.007; Jiang HF, 2010, J ORG CHEM, V75, P5347, DOI 10.1021/jo100813w; Barluenga J, 2007, J AM CHEM SOC, V129, P7772, DOI 10.1021/ja072864r; Buzas A, 2006, ORG LETT, V8, P1957, DOI 10.1021/ol0606839; Wakimoto T, 2011, P NATL ACAD SCI USA, V108, P17533, DOI 10.1073/pnas.1110577108; Ding CH, 2011, CHEM REV, V111, P1914, DOI 10.1021/cr100284m; Hayes SJ, 2007, TETRAHEDRON LETT, V48, P7709, DOI 10.1016/j.tetiet.2007.08.102; Gulevich AV, 2013, CHEM REV, V113, P3084, DOI 10.1021/cr300333u; Egi M, 2009, ORG LETT, V11, P5002, DOI 10.1021/ol901942t; Lo CY, 2002, J ORG CHEM, V67, P3930, DOI 10.1021/jo020004h; Bartoli A, 2011, NAT PROD REP, V28, P763, DOI 10.1039/c0np00053a; Patil NT, 2008, CHEM REV, V108, P3395, DOI 10.1021/cr050041j; Kirsch SF, 2006, ANGEW CHEM INT EDIT, V45, P5878, DOI 10.1002/anie.200601836; Chang F, 2014, J AGR FOOD CHEM, V62, P476, DOI 10.1021/jf4045843; Ugurchieva TM, 2009, RUSS CHEM REV+, V78, P337, DOI 10.1070/RC2009v078n04ABEH003899; Egi M, 2011, ANGEW CHEM INT EDIT, V50, P12197, DOI 10.1002/anie.201106381; Hou XL, 1998, TETRAHEDRON, V54, P1955, DOI 10.1016/S0040-4020(97)10303-9; Egi M, 2008, ORG LETT, V10, P1867, DOI 10.1021/ol800596c; [Anonymous], 2011, SYNTHESIS; Barluenga J, 2008, J AM CHEM SOC, V130, P13528, DOI 10.1021/ja8058342; Aurrecoechea JM, 2001, J ORG CHEM, V66, P564, DOI 10.1021/jo0014257; Aurrecoechea JM, 2004, TETRAHEDRON, V60, P4139, DOI 10.1016/j.tet.2004.03.060; AURRECOECHEA JM, 1994, HETEROCYCLES, V37, P223; Bauer EB, 2012, SYNTHESIS-STUTTGART, V44, P1131, DOI 10.1055/s-0031-1290503; Biannic B, 2011, EUR J ORG CHEM, P6605, DOI 10.1002/ejoc.201100858; Binder JT, 2007, EUR J ORG CHEM, P1636, DOI 10.1002/ejoc.200601060; Blanc A, 2010, EUR J ORG CHEM, P1644, DOI 10.1002/ejoc.200901331; Blanc A, 2009, J ORG CHEM, V74, P4360, DOI 10.1021/jo900483m; Brown RCD, 2005, ANGEW CHEM INT EDIT, V44, P850, DOI 10.1002/anie.20046168; Carter NB, 2002, J CHEM SOC PERK T 1, P2324, DOI 10.1039/b007664n; Che J, 2014, MED CHEM RES, V23, P426, DOI 10.1007/s00044-013-0648-7; Cordonnier MC, 2008, ORG LETT, V10, P1569, DOI 10.1021/ol800219k; Egi M, 2012, J ORG CHEM, V77, P7092, DOI 10.1021/jo300889p; Fernandes JA, 2011, J POLYM SCI POL CHEM, V49, P3664, DOI 10.1002/pola.24791; Gabriele B, 2010, TETRAHEDRON LETT, V51, P1663, DOI 10.1016/j.tetlet.2010.01.054; Graening T., 2008, COMPREHENSIVE HETERO, V3, P497, DOI DOI 10.1016/B978-008044992-0.00307-2; Keay B. A., 2008, COMPREHENSIVE HETERO, VIII, P571, DOI DOI 10.1016/B978-008044992-0.00308-4; Marion N, 2007, ANGEW CHEM INT EDIT, V46, P2750, DOI 10.1002/anie.200604773; McDonald FE, 1996, J AM CHEM SOC, V118, P6648, DOI 10.1021/ja960581l; MCDONALD FE, 1993, J ORG CHEM, V58, P6952, DOI 10.1021/jo00077a006; Sakai M, 2002, TETRAHEDRON LETT, V43, P1705, DOI 10.1016/S0040-4039(02)00079-5; Schwier T, 2007, J AM CHEM SOC, V129, P9868, DOI 10.1021/ja072446m; Shu XZ, 2007, ADV SYNTH CATAL, V349, P2493, DOI 10.1002/adsc.200700319; Sromek AW, 2004, ANGEW CHEM INT EDIT, V43, P2280, DOI 10.1002/anie.200353535; WAKABAYASHI Y, 1985, TETRAHEDRON, V41, P3655, DOI 10.1016/S0040-4020(01)91384-5; Yada Y, 2008, ORGANOMETALLICS, V27, P3614, DOI 10.1021/om800298r; Yoshida M, 2009, SYNTHESIS-STUTTGART, P2454, DOI 10.1055/s-0029-1216867	72	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	MAY 1	2015	91	5					931	958		10.3987/REV-15-818		28	Chemistry, Organic	Chemistry	CJ7UU	WOS:000355706500001		
J	Katsuyama, M; Furuta, M; Kobayashi, K; Teruya, K; Makabe, H; Akaji, K; Hattori, Y				Katsuyama, Masatomo; Furuta, Masahiro; Kobayashi, Kazuya; Teruya, Kenta; Makabe, Hidefumi; Akaji, Kenichi; Hattori, Yasunao			DIVERGENT SYNTHESIS OF 2,6-DISUBSTITUTED PIPERIDINE ALKALOID, (+)-SPECTALINE BY PALLADIUM-CATALYZED CYCLIZATION	HETEROCYCLES			English	Article						Piperidine; Natural Product; Stereoselective Synthesis	CASSIA-SPECTABILIS; (-)-CASSINE; OXIDATION	Convergent synthesis of 2,6-disubstituted piperidine alkaloid, (+)-spectaline is described. Using substrate-controlled diastereo-selective Pd(II)-catalyzed cyclization, both cis-2,6- and trans-2,6-disubstituted piperidine backbones were constructed from adequately protected precursors with high selectivity. Synthesis of (+)-spectaline containing cis-2,6-disubstituents was accomplished by 10 step reactions with a 31% total yield.	[Katsuyama, Masatomo; Furuta, Masahiro; Kobayashi, Kazuya; Akaji, Kenichi; Hattori, Yasunao] Kyoto Pharmaceut Univ, Dept Med Chem, Yamashina Ku, Kyoto 6078412, Japan; [Teruya, Kenta] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Sakyo Ku, Kyoto 6060823, Japan; [Makabe, Hidefumi] Shinshu Univ, Grad Sch Agr Sci Funct Foods, Kami Ina, Nagano 3994598, Japan	Katsuyama, M (reprint author), Kyoto Pharmaceut Univ, Dept Med Chem, Yamashina Ku, Kyoto 6078412, Japan.	hattori@mb.kyoto-phu.ac.jp					Trost BM, 2005, J AM CHEM SOC, V127, P10028, DOI 10.1021/ja051578h; Grubbs RH, 1998, TETRAHEDRON, V54, P4413, DOI 10.1016/S0040-4020(97)10427-6; Valli M, 2012, QUIM NOVA, V35, P2278, DOI 10.1590/S0100-40422012001100036; Shibuya M, 2006, J AM CHEM SOC, V128, P8412, DOI 10.1021/ja0620336; Makabe H, 2003, ORG LETT, V5, P27, DOI 10.1021/ol0201916; Bolzani V. S., 1995, TETRAHEDRON, V51, P5919; Kamo T, 2003, HETEROCYCLES, V60, P1303; Kurogome Y, 2013, TETRAHEDRON, V69, P8349, DOI 10.1016/j.tet.2013.07.083; Lee YS, 2003, TETRAHEDRON-ASYMMETR, V14, P87, DOI 10.1016/S0957-4166(02)00794-2; Momose T, 1997, J CHEM SOC PERK T 1, P2005, DOI 10.1039/a608490g; MOMOSE T, 1993, TETRAHEDRON LETT, V34, P5785, DOI 10.1016/S0040-4039(00)73860-3; Shi Y, 1997, J ORG CHEM, V62, P5666, DOI 10.1021/jo9711347; Silva FD, 2011, FITOTERAPIA, V82, P255, DOI 10.1016/j.fitote.2010.10.007; Viegas C, 2004, J NAT PROD, V67, P908, DOI 10.1021/np0303963; Welter J., 1977, TETRAHEDRON LETT, V33, P977	15	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	MAY 1	2015	91	5					959	969		10.3987/COM-15-13172		11	Chemistry, Organic	Chemistry	CJ7UU	WOS:000355706500002		
J	Rao, KUM; Kimuro, T; Yamada, M; Kondo, Y; Hamada, F				Rao, Kunda Uma Maheswara; Kimuro, Takashi; Yamada, Manabu; Kondo, Yoshihiko; Hamada, Fumio			SYNTHESIS, X-RAY STRUCTURE AND METAL EXTRACTON ABILITIES OF NEW DIETHYL PHOSPHATE MODIFIED THIACALIX[4]ARENE	HETEROCYCLES			English	Article						Thiacalixarene Derivative; Crystal Structure; Metal Extraction Ability	AUTOMOTIVE CATALYST RESIDUE; INCLUSION BEHAVIOR; PLATINUM; PHOSPHORYLATION; THIACALIXARENES; CALIXARENE; COMPLEXES; ANALOGS; ESTERS; SULFUR	New lower rim modified phosphorylated thiacalix[4]arene (TC4A) derivatives such as TC4A-phosphate (2a) and de-t-Bu-TC4A-phosphate (2b) were synthesized. IR, H-1 & P-31-NMR and mass spectral and elemental analysis characterized the structures of the synthesized compounds. Single crystal X-ray diffraction measurement reveals that, both the compounds (2a & 2b) stabilized in pinched cone conformation. We also investigated the metal extraction ability of the newly synthesized compounds through solvent extraction technique and these compounds selectively extracted Pd (II) ions from automotive catalyst residue solution containing nine metals.	[Rao, Kunda Uma Maheswara] Akita Univ, Venture Business Lab, Akita 0108502, Japan; [Kimuro, Takashi; Hamada, Fumio] Akita Univ, Grad Sch Engn & Resource Sci, Dept Appl Chem Environm, Akita 0108502, Japan; [Yamada, Manabu] Akita Univ, Res Ctr Engn Sci, Grad Sch Engn & Resource Sci, Akita 0108502, Japan; [Kondo, Yoshihiko] Akita Univ, Grad Sch Engn & Resource Sci, Dept Life Sci, Akita 0108502, Japan	Rao, KUM (reprint author), Akita Univ, Venture Business Lab, 1-1 Tegatagakuen Machi, Akita 0108502, Japan.	hamada@gipc.akita-u.ac.jp					Karavan M, 2010, J INCL PHENOM MACRO, V66, P113, DOI 10.1007/s10847-009-9660-4; Murugavel R, 2008, CHEM REV, V108, P3549, DOI 10.1021/cr000119q; Morohashi N, 2006, CHEM REV, V106, P5291, DOI 10.1021/cr050565j; Kumar R, 2014, CHEM SOC REV, V43, P4824, DOI 10.1039/c4cs00068d; ENGEL R, 1977, CHEM REV, V77, P349, DOI 10.1021/cr60307a003; Yang CJ, 2009, ENERG POLICY, V37, P1805, DOI 10.1016/j.enpol.2009.01.019; Kumagai H, 1997, TETRAHEDRON LETT, V38, P3971, DOI 10.1016/S0040-4039(97)00792-2; Al-Saraierh H, 2005, J ORG CHEM, V70, P8273, DOI 10.1021/jo050488s; Fornalczyk A., 2012, MAT MANUF ENG, V55, P864; Gandhi MR, 2014, IND ENG CHEM RES, V53, P2559, DOI 10.1021/ie404161s; GOREN Z, 1990, J CHEM SOC PERK T 1, P1484, DOI 10.1039/p19900001484; Huang K, 2008, SPECTROSC SPECT ANAL, V28, P2038, DOI 10.3964/j.issn.1000-0593(2008)09-2038-06; Iki N, 2002, ORG LETT, V4, P509, DOI 10.1021/ol017053l; Iki N, 2001, J INCL PHENOM MACRO, V41, P99, DOI 10.1023/A:1014406709512; Itoh S., 2010, INT J SOC MAT ENG RE, V17, P211; Kalchenko VI, 1995, ZH OBSHCH KHIM+, V65, P1311; Katagiri H, 2003, DALTON T, P723, DOI 10.1039/b208317e; Kon N, 2003, ORG BIOMOL CHEM, V1, P751, DOI 10.1039/b210198j; Kondo Y., 2010, U. S. Patent, Patent No. [2011/0011215, 20110011215]; Kondo Y., 2014, INT J SOC MAT ENG RE, V20, P103; Kondo Y., 2010, U. S. Patent, Patent No. [2010/0129277 A1, 20100129277]; Kondo Y., 2011, U.S. Patent, Patent No. 8038969; Lhotak P, 2004, EUR J ORG CHEM, P1675, DOI 10.1002/ejoc.200300492; MARKOVSKII LN, 1990, ZH OBSHCH KHIM+, V60, P2811; MCMURRY JE, 1991, TETRAHEDRON LETT, V32, P5655, DOI 10.1016/S0040-4039(00)93521-4; Morohashi N, 2001, CHEM LETT, P66, DOI 10.1246/cl.2001.66; Naritav H., 2011, JMMIJ, V127, P175; Gandhi MR, 2015, HYDROMETALLURGY, V151, P133, DOI 10.1016/j.hydromet.2014.11.017; Sheldrick G.M., 1997, SHELXL 97 PROGRAM SO; Shibata J., 2002, J MMIJ, V118, P1; Sone T, 1997, TETRAHEDRON, V53, P10689, DOI 10.1016/S0040-4020(97)00700-X; Stoikov II, 2012, MENDELEEV COMMUN, V22, P21, DOI 10.1016/j.mencom.2012.01.007; Tanaka S, 2007, TETRAHEDRON LETT, V48, P5293, DOI 10.1016/j.tetlet.2007.05.150; TING YH, 1990, J CHEM SOC CHEM COMM, P1432, DOI 10.1039/c39900001432; Tollefson J, 2007, NATURE, V450, P334, DOI 10.1038/450334a; Ulzii M, 2014, HETEROCYCLES, V89, P2554, DOI 10.3987/COM-14-13083; Weber D, 2000, J CHEM SOC PERK T 2, P1741, DOI 10.1039/b000465k; Yamada M, 2014, SUPRAMOL CHEM, V26, P620, DOI 10.1080/10610278.2014.887202; Yamada Manabu, 2007, International Journal of the Society of Materials Engineering for Resources, V15; Yuan DQ, 2006, CRYST GROWTH DES, V6, P514, DOI 10.1021/cg050446x	40	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	MAY 1	2015	91	5					989	1000		10.3987/COM-15-13196		12	Chemistry, Organic	Chemistry	CJ7UU	WOS:000355706500004		
J	Suzuki, R; Sakagami, H; Shirataki, Y				Suzuki, Ryuichiro; Sakagami, Hiroshi; Shirataki, Yoshiaki			NEW ANTI-OXIDATIVE COMPOUNDS FROM RHINACANTHUS NASUTUS	HETEROCYCLES			English	Article						Rhinacanthus nasutus; Pyrrolidinone; Antioxidant	NECROSIS-FACTOR-ALPHA; MACROLEPIOTA-NEOMASTOIDEA; NITRIC-OXIDE; ALKALOIDS; CELLS	Two new antioxidative compounds were isolated from methanolic extract of root of the Rhinacanthus nasutus. These chemical structures were elucidated by analysis of 1D and 2D NMR spectra including MS. Antioxidant activities of these isolates were determined by DPPH radical scavenging activity test. As the results, antioxidant activities of these isolates were comparative to Trolox used as a positive control. These isolates showed little or no detectable cytotoxicity against both human cancerous and normal cells.	[Suzuki, Ryuichiro; Shirataki, Yoshiaki] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan; [Sakagami, Hiroshi] Meikai Univ, Sch Dent, Div Pharmacol, Sakado, Saitama 35002, Japan	Suzuki, R (reprint author), Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan.	shiratak@josai.ac.jp					Kantoh K, 2010, IN VIVO, V24, P843; Horii H, 2013, ANTICANCER RES, V33, P453; Ikeda S., 1997, FARUMASHIA, V33, P778; Kim KH, 2008, B KOREAN CHEM SOC, V29, P1591; Motohashi N, 2010, NUTR DIET RES PROG, P119; Nakamura A., 2004, TOKYO KASEI GAKUIN D, V44, P5; Ohta T, 1998, HETEROCYCLES, V47, P883; Punturee K, 2004, J ETHNOPHARMACOL, V95, P183, DOI 10.1016/j.jep.2004.06.019; Sadhu SK, 2003, CHEM PHARM BULL, V51, P595, DOI 10.1248/cpb.51.595; Siripong P., 2006, Journal of Traditional Medicines, V23, P166; Siripong P, 2009, BIOL PHARM BULL, V32, P1251, DOI 10.1248/bpb.32.1251; Siriwatanametanon N, 2010, J ETHNOPHARMACOL, V130, P196, DOI 10.1016/j.jep.2010.04.036; Tewtrakul S, 2009, PHYTOMEDICINE, V16, P581, DOI 10.1016/j.phymed.2008.12.022; Tewtrakul S, 2009, PHYTOMEDICINE, V16, P929, DOI 10.1016/j.phymed.2009.03.010; Wu TS, 1998, PHYTOCHEMISTRY, V49, P2001, DOI 10.1016/S0031-9422(98)00425-7	15	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0385-5414	1881-0942		HETEROCYCLES	Heterocycles	MAY 1	2015	91	5					1036	1041		10.3987/COM-15-13193		6	Chemistry, Organic	Chemistry	CJ7UU	WOS:000355706500009		
J	Kimura, R; Watanabe, C; Kawaguchi, A; Kim, YI; Park, SB; Maki, K; Ishida, H; Yamaguchi, T				Kimura, Ryosuke; Watanabe, Chiaki; Kawaguchi, Akira; Kim, Yong-Il; Park, Soo-Byung; Maki, Koutaro; Ishida, Hajime; Yamaguchi, Tetsutaro			Common polymorphisms in WNT10A affect tooth morphology as well as hair shape	HUMAN MOLECULAR GENETICS			English	Article							ONYCHO-DERMAL DYSPLASIA; MAJOR HUMAN-POPULATIONS; ECTODERMAL DYSPLASIA; POSITIVE SELECTION; ASIAN POPULATIONS; SIGNALING PATHWAY; MAMMALIAN TOOTH; SKIN APPENDAGE; DENTAL TRAITS; EDAR VARIANT	Hair and teeth are appendages of ectodermal origin, and there are common molecular backgrounds involved in their formation. To date, it has been revealed that a non-synonymous polymorphismin EDAR has effects on the morphological variation in both hair and teeth. Previous association studies have confirmed that single-nucleotide polymorphisms (SNPs) in/near THADA, FRAS1, WNT10A, NAF1 and FGFR2 are associated with hair morphology. In this study, we thus examined whether these SNPs are also associated with dental characteristics. We measured metric dental traits including crown size and also evaluated non-metric dental traits using plaster casts obtained from subjects (272 Japanese and 226 Koreans). DNA samples were prepared from the subjects and genotyped for the hair morphology-associated SNPs. We observed a significant association of crown size with an SNP in WNT10A (rs7349332), but not with SNPs in other genes. Therefore, we further examined four SNPs within and around WNT10A, among which rs10177996 had the strongest association with dental traits. World distribution of the derived allele in rs10177996, which is associated with larger teeth, showed that Eurasians have a higher allele frequency than Africans. Together with previous studies on hair morphology, this study demonstrated that common variations in WNT10A have pleiotropic effects on the morphology of ectodermal appendages.	[Kimura, Ryosuke; Watanabe, Chiaki; Kawaguchi, Akira; Ishida, Hajime] Univ Ryukyus, Grad Sch Med, Dept Human Biol & Anat, Nishihara, Okinawa 9030215, Japan; [Kim, Yong-Il; Park, Soo-Byung] Pusan Natl Univ, Dent Hosp, Dept Orthodont, Yangsan 626787, Kyeongsangnamdo, South Korea; [Maki, Koutaro; Yamaguchi, Tetsutaro] Showa Univ, Sch Dent, Dept Orthodont, Ota Ku, Tokyo 1458515, Japan	Kimura, R (reprint author), Univ Ryukyus, Grad Sch Med, Dept Human Biol & Anat, Uehara 207, Nishihara, Okinawa 9030215, Japan.	rkimura@med.u-ryukyu.ac.jp; tyamaguchi@dent.showa-u.ac.jp			KAKENHI from the Japan Society for the Promotion of Science [22687023, 22390393]	This work was supported by KAKENHI Grant-in-Aid for Young Scientists (A) (22687023 to R.K.) and Grant-in-Aid for Scientific Research (B) (22390393 to T.Y.) from the Japan Society for the Promotion of Science.	Mikkola ML, 2007, SEMIN CELL DEV BIOL, V18, P225, DOI 10.1016/j.semcdb.2007.01.007; Kirikoshi H, 2001, BIOCHEM BIOPH RES CO, V283, P798, DOI 10.1006/bbrc.2001.4855; Mikkola ML, 2006, J MAMMARY GLAND BIOL, V11, P187, DOI 10.1007/s10911-006-9029-x; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Kimura R, 2009, AM J HUM GENET, V85, P528, DOI 10.1016/j.ajhg.2009.09.006; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; Wang JW, 1996, ONCOGENE, V13, P1537; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Hayano S, 2012, J BIOL CHEM, V287, P12217, DOI 10.1074/jbc.M111.332924; Nawaz S, 2009, EUR J HUM GENET, V17, P1600, DOI 10.1038/ejhg.2009.81; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Fujimoto A, 2008, HUM GENET, V124, P179, DOI 10.1007/s00439-008-0537-1; Hanihara T, 2005, AM J PHYS ANTHROPOL, V128, P287, DOI 10.1002/ajpa.20080; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Song SJ, 2014, HUM GENET, V133, P117, DOI 10.1007/s00439-013-1360-x; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Wang XP, 2011, GENESIS, V49, P261, DOI 10.1002/dvg.20715; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Kantaputra P, 2014, AM J MED GENET A, V164, P1041, DOI 10.1002/ajmg.a.36388; Mostowska A, 2013, CLIN GENET, V84, P429, DOI 10.1111/cge.12061; Fujimoto A, 2009, J HUM GENET, V54, P461, DOI 10.1038/jhg.2009.61; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Mikkola ML, 2009, AM J MED GENET A, V149A, P2031, DOI 10.1002/ajmg.a.32855; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Arte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073705; Bohring A, 2009, AM J HUM GENET, V85, P97, DOI 10.1016/j.ajhg.2009.06.001; Ekuni D, 2011, EUR J ORTHODONT, V33, P558, DOI 10.1093/ejo/cjq121; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; EVANS R, 1987, EUR J ORTHODONT, V9, P314; FADHIL M, 1983, AM J MED GENET, V14, P335, DOI 10.1002/ajmg.1320140213; HANIHARA K, 1967, J DENT RES, V46, P923, DOI 10.1177/00220345670460055101; Hanihara K., 1968, P 8 INT C ANTHR ETHN, V1, P298; Hanihara T, 2008, AM J PHYS ANTHROPOL, V136, P169, DOI 10.1002/ajpa.20792; He HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080393; Jernvall J, 2000, Am J Phys Anthropol, VSuppl 31, P171; KELLY GM, 1993, DEV BIOL, V158, P113, DOI 10.1006/dbio.1993.1172; Kimura R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000286; Lee WC, 2012, J HUM GENET, V57, P654, DOI 10.1038/jhg.2012.90; Megarbane H, 2004, AM J MED GENET A, V129A, P193, DOI 10.1002/ajmg.a.30188; Park JH, 2012, J HUM GENET, V57, P508, DOI 10.1038/jhg.2012.60; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Scott G.R., 1997, ANTHR MODERN HUMAN T; Soh J, 2004, ANGLE ORTHOD, V74, P769; TURNER CG, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P13; TURNER CG, 1990, AM J PHYS ANTHROPOL, V82, P295, DOI 10.1002/ajpa.1330820308; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Yamashiro T, 2007, DIFFERENTIATION, V75, P452, DOI 10.1111/j.1432-0436.2006.00150.x; ZIRBEL GM, 1995, BRIT J DERMATOL, V133, P797	55	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	MAY 1	2015	24	9					2673	2680		10.1093/hmg/ddv014		8	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CJ2OX	WOS:000355325400021		
J	Takesue, H; Diamanti, E; Thew, R; Yuan, ZL				Takesue, Hiroki; Diamanti, Eleni; Thew, Rob; Yuan, Zhiliang			Introduction to the Issue on Quantum Communication and Cryptography	IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS			English	Editorial Material									[Takesue, Hiroki] NTT Corp, NTT Basic Res Labs, Yokohama, Kanagawa 2430198, Japan; [Diamanti, Eleni] Telecom ParisTech, Ctr Natl Rech Sci, F-75013 Paris, France; [Thew, Rob] Univ Geneva, Appl Phys Grp, CH-1211 Geneva, Switzerland; [Yuan, Zhiliang] Toshiba Res Europe Ltd, Cambridge Res Lab, Cambridge CB4 0GZ, England	Takesue, H (reprint author), NTT Corp, NTT Basic Res Labs, Yokohama, Kanagawa 2430198, Japan.	takesue.hiroki@lab.ntt.co.jp	Takesue, Hiroki/J-4514-2012					0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1077-260X	1558-4542		IEEE J SEL TOP QUANT	IEEE J. Sel. Top. Quantum Electron.	MAY-JUN	2015	21	3							0200402	10.1109/JSTQE.2015.2436231		2	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CK1VF	WOS:000355995100001		
J	Basin, D; Cremers, C; Miyazaki, K; Radomirovic, S; Watanabe, D				Basin, David; Cremers, Cas; Miyazaki, Kunihiko; Radomirovic, Sasa; Watanabe, Dai			Improving the Security of Cryptographic Protocol Standards	IEEE SECURITY & PRIVACY			English	Article						Computer security; Privacy; Protocols; Standards; Cryptography; Formal verification; formal methods; standards; network protocols; security; protocol verification	VERIFICATION		[Basin, David; Radomirovic, Sasa] Swiss Fed Inst Technol, Dept Comp Sci, Zurich, Switzerland; [Cremers, Cas] Univ Oxford, Dept Comp Sci, Oxford OX1 2JD, England; [Miyazaki, Kunihiko; Watanabe, Dai] Hitachi, Res & Dev Grp, Hitachinaka, Ibaraki, Japan	Basin, D (reprint author), Swiss Fed Inst Technol, Dept Comp Sci, Zurich, Switzerland.	basin@inf.ethz.ch; cas.cremers@cs.ox.ac.uk; kunihiko.miyazaki.zt@hitachi.com; sasa.radomirovic@inf.ethz.ch; dai.watanabe.td@hitachi.com					Aboba B., 2005, SUMMARY IEEE 802 16E; Andova S, 2008, INFORM COMPUT, V206, P425, DOI 10.1016/j.ic.2007.07.002; Schmidt B, 2012, P IEEE CSFW, P78, DOI 10.1109/CSF.2012.25; Meadows C, 1999, P IEEE S SECUR PRIV, P216, DOI 10.1109/SECPRI.1999.766916; [Anonymous], 2011, 29128 ISOIEC; DOLEV D, 1983, IEEE T INFORM THEORY, V29, P198, DOI 10.1109/TIT.1983.1056650; Cremers CJF, 2008, LECT NOTES COMPUT SC, V5123, P414; Blanchet B, 2001, P IEEE CSFW, P82, DOI 10.1109/CSFW.2001.930138; Basin D., 2005, INT J INF SECUR, V4, P181, DOI DOI 10.1007/S10207-004-0055-7]; Basin D, 2012, LECT NOTES COMPUT SC, V7215, P129, DOI 10.1007/978-3-642-28641-4_8; Johnston D, 2004, IEEE SECUR PRIV, V2, P40, DOI 10.1109/MSP.2004.20; Lowe G, 1997, P IEEE CSFW, P31, DOI 10.1109/CSFW.1997.596782; Matsuo S, 2010, LECT NOTES COMPUT SC, V6054, P182, DOI 10.1007/978-3-642-14992-4_16; Meadows C., 2004, Journal of Computer Security, V12; Meier Simon, 2013, Journal of Computer Security, V21, DOI 10.3233/JCS-2012-0455; Meier S, 2013, LECT NOTES COMPUT SC, V8044, P696; Xu S., 2006, P 3 INT S WIR COMM S, P185	17	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1540-7993	1558-4046		IEEE SECUR PRIV	IEEE Secur. Priv.	MAY-JUN	2015	13	3					24	31		10.1109/MSP.2013.162		8	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CK1XI	WOS:000356002100005		
J	Kozai, T				Kozai, Toyoki			Photoautotrophic (Sugar-free Medium) Micropropagation - Its Principle and Application	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL			English	Meeting Abstract									[Kozai, Toyoki] Japan Plant Factory Assoc, Kashiwa, Chiba 2770882, Japan		kozai@faculty.chiba-u.jp						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1071-2690	1543-706X		IN VITRO CELL DEV-AN	In Vitro Cell. Dev. Biol.-Anim.	MAY	2015	51			1		P-4	S14	S14				1	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CJ6HF	WOS:000355594000030		
J	Nakatao, H; Yamasaki, S; Akagi, E; Hamada, A; Ohtaka, M; Nishimura, K; Nakanishi, M; Toratani, S; Okamoto, T				Nakatao, Hirotaka; Yamasaki, Sachiko; Akagi, Eri; Hamada, Atsuko; Ohtaka, Manami; Nishimura, Ken; Nakanishi, Mahito; Toratani, Shigeaki; Okamoto, Tetsuji			Generation and Maintenance of Integration-free Human Induced Pluripotent Stem (hiPS) Cells from Peripheral Blood Mononuclear Cells in Serum- and Feeder-free Growth Factor Defined Medium.	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL			English	Meeting Abstract									[Nakatao, Hirotaka; Yamasaki, Sachiko; Akagi, Eri; Hamada, Atsuko; Toratani, Shigeaki; Okamoto, Tetsuji] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Div Frontier Med & Sci, Dept Mol Oral Med & Maxillofacial Surg, Hiroshima 730, Japan; [Ohtaka, Manami; Nakanishi, Mahito] Natl Inst Adv Ind Sci & Tech AIST, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki, Japan; [Nishimura, Ken] Univ Tsukuba, Grad Sch Comprehens Human Sci, Lab Gene Regulat, Tsukuba, Ibaraki 305, Japan		nakatao@hiroshima-u.ac.jp						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1071-2690	1543-706X		IN VITRO CELL DEV-AN	In Vitro Cell. Dev. Biol.-Anim.	MAY	2015	51			1		A-2000	S41	S41				1	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CJ6HF	WOS:000355594000096		
J	Sasamoto, H				Sasamoto, H.			A Novel Cell-based Bioassay for Allelopathy and Salt Tolerance Using Protoplasts	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL			English	Meeting Abstract									[Sasamoto, H.] Kanagawa Univ, Res Inst Integrated Sci, Hiratsuka, Kanagawa 2591293, Japan; [Sasamoto, H.] Yokohama Natl Univ, Yokohama, Kanagawa 2408501, Japan		sasamoto@ynu.ac.jp						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1071-2690	1543-706X		IN VITRO CELL DEV-AN	In Vitro Cell. Dev. Biol.-Anim.	MAY	2015	51			1		P-17	S18	S19				2	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CJ6HF	WOS:000355594000042		
J	Arito, H				Arito, Heihachiro			Risk assessment of hazardous substances revisited	INDUSTRIAL HEALTH			English	Editorial Material									Japan Ind Safety & Hlth Assoc, Occupat Hlth Res & Dev Ctr, Kanagawa, Japan	Arito, H (reprint author), Japan Ind Safety & Hlth Assoc, Occupat Hlth Res & Dev Ctr, Kanagawa, Japan.						Nagano K, 2011, J OCCUP HEALTH, V53, P175; Kumagai S, 2013, OCCUP ENVIRON MED, V70, P508, DOI 10.1136/oemed-2012-101246	2	1	1	NATL INST OCCUPATIONAL SAFETY & HEALTH, JAPAN	KAWASAKI KANAGAWA	21-1 NAGAO 6-CHOME TAMA-KU, KAWASAKI KANAGAWA, 214, JAPAN	0019-8366	1880-8026		IND HEALTH	Ind. Health	MAY	2015	53	3					193	195				3	Environmental Sciences; Public, Environmental & Occupational Health; Toxicology	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Toxicology	CK0GB	WOS:000355882600001		
J	Hoshi, T; Sugimoto, N				Hoshi, Toshiro; Sugimoto, Noboru			A consideration of the operation of automatic production machines	INDUSTRIAL HEALTH			English	Article						Safety; Safety control; Safety system; Industrial accident; Asymmetric on the time-axis		At worksites, various automatic production machines are in use to release workers from muscular labor or labor in the detrimental environment. On the other hand, a large number of industrial accidents have been caused by automatic production machines. In view of this, this paper considers the operation of automatic production machines from the viewpoint of accident prevention, and points out two types of machine operation - operation for which quick performance is required (operation that is not permitted to be delayed) - and operation for which composed performance is required (operation that is not permitted to be performed in haste). These operations are distinguished by operation buttons of suitable colors and shapes. This paper shows that these characteristics are evaluated as "asymmetric on the time-axis". Here, in order for workers to accept the risk of automatic production machines, it is preconditioned in general that harm should be sufficiently small or avoidance of harm is easy. In this connection, this paper shows the possibility of facilitating the acceptance of the risk of automatic production machines by enhancing the asymmetric on the time-axis.	[Hoshi, Toshiro] Nagaoka Univ Technol, Nagaoka, Niigata, Japan; [Sugimoto, Noboru] Meiji Univ, Tokyo 101, Japan	Hoshi, T (reprint author), Nagaoka Univ Technol, Nagaoka, Niigata, Japan.	houshi@meiji.ac.jp					[Anonymous], 2011, 38641 ISO 1; [Anonymous], 2006, ISO13850; [Anonymous], 2006, ISO138491 1; [Anonymous], 1999, GUIDE51 ISOIEC; [Anonymous], 2009, IEC602041 1; Furusawa N, PRACTICAL SAFETY ACT; Hoshi T, 2012, IND SAF HYG STUDY, V5, P3; Ministry of HealthLabour and Welfare, 2010, BAS SURV IND SAF HYG; Sugimoto N, 1988, COLLECTION ACAD PA C, V54, P2284; The Color Science Association of Japan, 2004, COLOR SCI, P118; The Japan Machinery Federation, 2012, IEC602041JISB99601 J; Yamanaka T, 1997, ELEMENTS CHROMATICS, V188; Yanagida K, 1983, HORROR 2 HOURS 18 MI, P64	13	0	0	NATL INST OCCUPATIONAL SAFETY & HEALTH, JAPAN	KAWASAKI KANAGAWA	21-1 NAGAO 6-CHOME TAMA-KU, KAWASAKI KANAGAWA, 214, JAPAN	0019-8366	1880-8026		IND HEALTH	Ind. Health	MAY	2015	53	3					236	244				9	Environmental Sciences; Public, Environmental & Occupational Health; Toxicology	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Toxicology	CK0GB	WOS:000355882600005		
J	Tamura, T; Suganuma, N; Hering, KG; Vehmas, T; Itoh, H; Akira, M; Takashima, Y; Hirano, H; Kusaka, Y				Tamura, Taro; Suganuma, Narufumi; Hering, Kurt G.; Vehmas, Tapio; Itoh, Harumi; Akira, Masanori; Takashima, Yoshihiro; Hirano, Harukazu; Kusaka, Yukinori			Relationships (I) of International Classification of High-resolution Computed Tomography for Occupational and Environmental Respiratory Diseases with the ILO International Classification of Radiographs of Pneumoconioses for parenchymal abnormalities	INDUSTRIAL HEALTH			English	Article						Conventional radiography; Environmental lung disease; High-resolution computed tomography; ILO classification; Occupational lung disease; Pneumoconiosis; Silicosis	COAL-WORKERS PNEUMOCONIOSIS; EXPOSED WORKERS; CT ASSESSMENT; LUNG-CANCER; ASBESTOS; RELIABILITY; DIAGNOSIS; SILICOSIS; PROGRAM; HRCT	The International Classification of High-resolution Computed Tomography (HRCT) for Occupational and Environmental Respiratory Diseases (ICOERD) has been developed for the screening, diagnosis, and epidemiological reporting of respiratory diseases caused by occupational hazards. This study aimed to establish a correlation between readings of HRCT (according to the ICOERD) and those of chest radiography (CXR) pneumoconiotic parenchymal opacities (according to the International Labor Organization Classification/International Classification of Radiographs of Pneumoconioses [ILO/ICRP]). Forty-six patients with and 28 controls without mineral dust exposure underwent posterior-anterior CXR and HRCT. We recorded all subjects' exposure and smoking history. Experts independently read CXRs (using ILO/ICRP). Experts independently assessed HRCT using the ICOERD parenchymal abnormalities grades for well-defined rounded opacities (RO), linear and/or irregular opacities (IR), and emphysema (EM). The correlation between the ICOERD summed grades and ILO/ICRP profusions was evaluated using Spearman's rank-order correlation. Twenty-three patients had small opacities on CXR. HRCT showed that 21 patients had RO; 20 patients, IR opacities; and 23 patients, EM. The correlation between ILO/ICRP profusions and the ICOERD grades was 0.844 for rounded opacities (p<0.01). ICOERD readings from HRCT scans correlated well with previously validated ILO/ICRP criteria. The ICOERD adequately detects pneumoconiotic micronodules and can be used for the interpretation of pneumoconiosis.	[Tamura, Taro; Kusaka, Yukinori] Univ Fukui, Sch Med, Dept Environm Hlth, Fukui, Japan; [Suganuma, Narufumi] Kochi Univ, Sch Med, Dept Environm Med, Kochi, Japan; [Hering, Kurt G.] Miners Hosp, Radiol Clin, Dept Diagnost Radiol Radiol & Nucl Med, Bochum, Germany; [Vehmas, Tapio] Finnish Inst Occupat Hlth, Dept Radiol, Helsinki, Finland; [Itoh, Harumi] Univ Fukui, Sch Med, Dept Radiol, Fukui, Japan; [Akira, Masanori] Natl Hosp, Org Kinki Chuo Chest, Med Ctr, Dept Radiol, Sakai, Osaka, Japan; [Takashima, Yoshihiro] Fukui Saiseikai Hosp, Dept Surg, Fukui, Japan; [Hirano, Harukazu] Koyo Seikyo Hosp, Fukui, Japan	Tamura, T (reprint author), Univ Fukui, Sch Med, Dept Environm Hlth, Fukui, Japan.	tarou@u-fulcui.ac.jp			Ministry of Education, Culture, Sports Science and Technology, Japan [13897004]	Grant sponsor: Ministry of Education, Culture, Sports Science and Technology, Japan; Grant number: Grant-in-Aid for Scientific Research (B) (2) 13897004.	AKIRA M, 1989, RADIOLOGY, V171, P117; Altman D. G., 1991, PRACTICAL STAT MED R, P403; HNIZDO E, 1993, AM J IND MED, V24, P427, DOI 10.1002/ajim.4700240408; BEGIN R, 1987, AM J ROENTGENOL, V148, P509; Das M, 2007, EUR RADIOL, V17, P1193, DOI 10.1007/s00330-006-0426-8; EGASHIRA K, 1991, Nippon Acta Radiologica, V51, P1210; International Labor Office, 2011, GUID US ILO INT CLAS; Japan Industrial Safety and Health Association (JISHA), 2007, SCI COMM REP DR FPD; Kusaka Y, 2005, INT CLASSIFICATION H; MCMILLAN GHG, 1982, BRIT J IND MED, V39, P60; Meijer E, 2011, OCCUP ENVIRON MED, V68, P542, DOI 10.1136/oem.2010.055616; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Ochsmann E, 2010, INT ARCH OCC ENV HEA, V83, P39, DOI 10.1007/s00420-009-0443-4; REMYJARDIN M, 1990, RADIOLOGY, V177, P363; Suganuma N, 2009, J OCCUP HEALTH, V51, P210; Suganuma N, 2006, INT ARCH OCC ENV HEA, V79, P472, DOI 10.1007/s00420-005-0067-2; Takashima Y, 2007, J OCCUP HEALTH, V49, P39, DOI 10.1539/joh.49.39; The National Institute for Occupational Safety and Health Centers for Disease Control and Prevention, USACHEST RADIOGRAPHY; Tossavainen Antti, 2000, Scandinavian Journal of Work Environment and Health, V26, P449; Henderson DW, 1997, SCAND J WORK ENV HEA, V23, P311; Vallyathan V, 1996, AM J RESP CRIT CARE, V154, P741; Vierikko T, 2010, INT ARCH OCC ENV HEA, V83, P47, DOI 10.1007/s00420-009-0462-1; Vierikko T, 2008, RESP MED, V102, P658, DOI 10.1016/j.rmed.2007.12.021; WAGNER GR, 1992, J OCCUP ENVIRON MED, V34, P879; World Health Organization, 2007, NEWSLETTER, V12, P1	25	0	0	NATL INST OCCUPATIONAL SAFETY & HEALTH, JAPAN	KAWASAKI KANAGAWA	21-1 NAGAO 6-CHOME TAMA-KU, KAWASAKI KANAGAWA, 214, JAPAN	0019-8366	1880-8026		IND HEALTH	Ind. Health	MAY	2015	53	3					260	270				11	Environmental Sciences; Public, Environmental & Occupational Health; Toxicology	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Toxicology	CK0GB	WOS:000355882600007		
J	Tamura, T; Suganuma, N; Hering, KG; Vehmas, T; Itoh, H; Akira, M; Takashima, Y; Hirano, H; Kusaka, Y				Tamura, Taro; Suganuma, Narufumi; Hering, Kurt G.; Vehmas, Tapio; Itoh, Harumi; Akira, Masanori; Takashima, Yoshihiro; Hirano, Harukazu; Kusaka, Yukinori			Relationships (II) of International Classification of High-resolution Computed Tomography for Occupational and Environmental Respiratory Diseases with ventilatory functions indices for parenchymal abnormalities	INDUSTRIAL HEALTH			English	Article						Environmental lung disease; High-resolution computed tomography; Emphysema; Occupational lung disease; Ventilatory function; Silicosis; Asbestosis; FEV1	OBSTRUCTIVE PULMONARY-DISEASE; CONSTRUCTION WORKERS; EXPOSED WORKERS; QUANTITATIVE CT; LUNG-FUNCTION; SILICOSIS; EMPHYSEMA; PNEUMOCONIOSES; RELIABILITY; SPIROMETRY	The International Classification of High-Resolution Computed Tomography (HRCT) for Occupational and Environmental Respiratory Diseases (ICOERD) is used to screen and diagnose respiratory illnesses. Using univariate and multivariate analysis, we investigated the relationship between subject characteristics and parenchymal abnormalities according to ICOERD, and the results of ventilatory function tests (VFT). Thirty-five patients with and 27 controls without mineral-dust exposure underwent VFT and HRCT. We recorded all subjects' occupational history for mineral dust exposure and smoking history. Experts independently assessed HRCT using the ICOERD parenchymal abnormalities (Items) grades for well-defined rounded opacities (RO), linear and/or irregular opacities (IR), and emphysema (EM). High-resolution computed tomography showed that 11 patients had RO; 15 patients, IR; and 19 patients, EM. According to the multiple regression model, age and height had significant associations with many indices ventilatory functions such as vital capacity, forced vital capacity, and forced expiratory volume in 1 s (FEV1). The EM summed grades on the upper, middle, and lower zones of the right and left lungs also had significant associations with FEV1 and the maximum mid-expiratory flow rate. The results suggest the ICOERD notation is adequate based on the good and significant multiple regression modeling of ventilatory function with the EM summed grades.	[Tamura, Taro; Kusaka, Yukinori] Univ Fukui, Sch Med, Dept Environm Hlth, Fukui, Japan; [Suganuma, Narufumi] Kochi Univ, Sch Med, Dept Environm Med, Kochi, Japan; [Hering, Kurt G.] Miners Hosp, Radiol Clin, Dept Diagnost Radiol Radiol & Nucl Med, Dortmund, Germany; [Vehmas, Tapio] Finnish Inst Occupat Hlth, Dept Radiol, Helsinki, Finland; [Itoh, Harumi] Univ Fukui, Sch Med, Dept Radiol, Fukui, Japan; [Akira, Masanori] Natl Hosp, Org Kinki Chuo Chest, Dept Radiol, Osaka, Japan; [Takashima, Yoshihiro] Fukui Saiseikai Hosp, Dept Surg, Fukui, Japan; [Hirano, Harukazu] Koyo Seikyo Hosp, Fukui, Japan	Tamura, T (reprint author), Univ Fukui, Sch Med, Dept Environm Hlth, Fukui, Japan.	tarou@u-fulcui.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [13897004]	The grant sponsor of this study was the Ministry of Education, Culture, Sports, Science and Technology, Japan. The grant number is Grant-in-Aid for Scientific Research (B) (2) 13897004.	Akira M, 2009, AM J ROENTGENOL, V192, P267, DOI 10.2214/AJR.07.3953; Akgun M, 2008, EUR RESPIR J, V32, P1295, DOI 10.1183/09031936.00093507; Park KJ, 1999, RADIOLOGY, V211, P541; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; BALDWIN ED, 1948, MEDICINE, V27, P243; BEGIN R, 1987, AM J ROENTGENOL, V148, P509; BERGIN CJ, 1986, AM J ROENTGENOL, V146, P477; Diaz AA, 2010, RESP MED, V104, P1145, DOI 10.1016/j.rmed.2010.02.023; Global initiative For Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Gupta PP, 2008, ANN THORAC MED, V3, P87, DOI 10.4103/1817-1737.39676; Huuskonen O, 2004, J OCCUP HEALTH, V46, P266, DOI 10.1539/joh.46.266; Japan Industrial Safety and Health Association, 1991, IND SAF HLTH LAW REL; Kusaka Y, 2005, INT CLASSIFICATION H; Meijer E, 2011, OCCUP ENVIRON MED, V68, P542, DOI 10.1136/oem.2010.055616; Ochsmann E, 2010, INT ARCH OCC ENV HEA, V83, P39, DOI 10.1007/s00420-009-0443-4; OKSA P, 1994, INT ARCH OCC ENV HEA, V65, P299, DOI 10.1007/BF00405693; Ooi GC, 2003, RADIOLOGY, V228, P816, DOI 10.1148/radiol.2283020557; Piirila P, 2009, CLIN PHYSIOL FUNCT I, V29, P1, DOI 10.1111/j.1475-097X.2008.00827.x; Piirila P, 2005, SCAND J WORK ENV HEA, V31, P44; Suganuma N, 2009, J OCCUP HEALTH, V51, P210; Suganuma N, 2006, INT ARCH OCC ENV HEA, V79, P472, DOI 10.1007/s00420-005-0067-2; Takashima Y, 2007, J OCCUP HEALTH, V49, P39, DOI 10.1539/joh.49.39; Tamura T, 2014, IND HLTH UNPUB; The Committee of Pulmonary Physiology Japanese Respiratory Society, 2004, GUID PULM FUNC TESTS; Vehmas T, 2012, INT ARCH OCC ENV HEA, V85, P207, DOI 10.1007/s00420-011-0654-3; Vierikko T, 2010, INT ARCH OCC ENV HEA, V83, P47, DOI 10.1007/s00420-009-0462-1	26	0	0	NATL INST OCCUPATIONAL SAFETY & HEALTH, JAPAN	KAWASAKI KANAGAWA	21-1 NAGAO 6-CHOME TAMA-KU, KAWASAKI KANAGAWA, 214, JAPAN	0019-8366	1880-8026		IND HEALTH	Ind. Health	MAY	2015	53	3					271	279				9	Environmental Sciences; Public, Environmental & Occupational Health; Toxicology	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Toxicology	CK0GB	WOS:000355882600008		
J	Murase, Y; Konnai, S; Yamada, S; Githaka, N; Isezaki, M; Ito, T; Takano, A; Ando, S; Kawabata, H; Murata, S; Ohashi, K				Murase, Yusuke; Konnai, Satoru; Yamada, Shinji; Githaka, Naftaly; Isezaki, Masayoshi; Ito, Takuya; Takano, Ai; Ando, Shuji; Kawabata, Hiroki; Murata, Siro; Ohashi, Kazuhko			An investigation of binding ability of Ixodes persulcatus Schulze Salp15 with Lyme disease spirochetes	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Ixodes persulcatus; Salp15; Borrelia burgdorferi; Borrelia garinii; Borrelia afzelii	TICK SALIVARY PROTEIN; BORRELIA-BURGDORFERI; IDENTIFICATION; TRANSMISSION; HOMOLOG; RICINUS; AGENT; IMMUNOSUPPRESSOR; VACCINES; IXODIDAE	Salp15, a 15-kDa tick salivary gland protein, has several suppressive modes of activity against host immunity and plays a critical role in the transmission of Lyme disease spirochetes in Ixodes scapularis and Ixodes ricinus, major vectors of Lyme disease in North America and Western Europe. Salp15 adheres to Borrelia burgdorferi and specifically interacts with its outer surface protein C (OspC), protecting the spirochete from antibody-mediated cytotoxicity and facilitating infection in the mice. Recently, we identified two Salp15 homologues, IperSalp15-1 and IperSalp15-2, in Ixodes persulcatus, a vector for Lyme disease in Japan. Here we describe the function of IperSalp15 in the transmission of Lyme borreliosis. To investigate the function of IperSalp15, recombinant IperSalp15-1 and IperSalp15-2 were prepared in bacterial and insect cells. Both were identified in the sera of tick-immunized hamsters, indicating that these are secretory proteins in exposed host animals. Solid-phase overlay and indirect fluorescence assays showed that IperSalp15 binds to OspC from B. burgdorferi, Borrelia garinii, and Borrelia afzelii. Importantly, this binding likely protected the spirochete from antibody-mediated cytotoxicity in vitro. In addition, IperSalp15 tended to facilitate infection in mice. Thus, further characterization of tick molecules, including IperSalp15, could lead to the development of new strategies to prevent the transmission of tick-borne diseases. (C) 2015 Elsevier Ltd. All rights reserved.	[Murase, Yusuke; Konnai, Satoru; Yamada, Shinji; Githaka, Naftaly; Isezaki, Masayoshi; Murata, Siro; Ohashi, Kazuhko] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido 0600818, Japan; [Ito, Takuya] Hokkaido Inst Publ Hlth, Sapporo, Hokkaido 0600819, Japan; [Takano, Ai] Yamaguchi Univ, Joint Fac Vet Med, Dept Vet Med, Yamaguchi, Japan; [Ando, Shuji; Kawabata, Hiroki] Natl Inst Infect Dis, Shinjuku Ku, Tokyo 1628640, Japan	Konnai, S (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido 0600818, Japan.	konnai@vetmed.hokudai.ac.jp			Japanese Ministry of Health, Labor and Welfare and Scientific Research; Japan Society for the Promotion of Science; Japan Society for the Promotion of Science (JSPS)	We are indebted to Toshiyuki Masuzawa, Chiba Institute of Science, for donating the anti-OspC antibody. We deeply thank Dr. Takeshi Yamasaki, Graduate School of Veterinary Medicine, Hokkaido University, for excellent technical support in the confocal microscope analysis. This work was supported by grants-in-aid for research on emerging and re-emerging infectious diseases from the Japanese Ministry of Health, Labor and Welfare and Scientific Research and the Japan Society for the Promotion of Science, and grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS).	Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; Mori A, 2010, INSECT MOL BIOL, V19, P359, DOI 10.1111/j.1365-2583.2010.00994.x; Juncadella IJ, 2007, FEMS IMMUNOL MED MIC, V49, P433, DOI 10.1111/j.1574-695X.2007.00223.x; Schuijt TJ, 2008, INFECT IMMUN, V76, P2888, DOI 10.1128/IAI.00232-08; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI 10.1172/JCI200421681; Konnai S, 2012, TICKS TICK-BORNE DIS, V3, P75, DOI 10.1016/j.ttbdis.2012.02.001; Hidano A, 2014, INSECT MOL BIOL, V23, P466, DOI 10.1111/imb.12101; Garg R, 2006, J IMMUNOL, V177, P6579; Stanek G, 2003, LANCET, V362, P1639, DOI 10.1016/S0140-6736(03)14798-8; De la Fuente J, 2006, PARASITE IMMUNOL, V28, P275, DOI 10.1111/j.1365-3024.2006.00828.x; Juncadella IJ, 2009, ADV EXP MED BIOL, V666, P121; Hovius JW, 2008, J INFECT DIS, V198, P1189, DOI 10.1086/591917; Dai JF, 2009, CELL HOST MICROBE, V6, P482, DOI 10.1016/j.chom.2009.10.006; Hojgaard A, 2009, J MED ENTOMOL, V46, P1458, DOI 10.1603/033.046.0631; NAKAO M, 1994, J MED ENTOMOL, V31, P467; Konnai S, 2008, JPN J VET RES, V55, P85; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; de la Fuente J, 2007, VET RES COMMUN, V31, P85, DOI 10.1007/s11259-007-0069-5; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Das S, 2001, J INFECT DIS, V184, P1056, DOI 10.1086/323351; Hovius JWR, 2007, VECTOR-BORNE ZOONOT, V7, P296, DOI 10.1089/vbz.2006.0624; Buckles EL, 2006, CLIN VACCINE IMMUNOL, V13, P1162, DOI 10.1128/CVI.00099-06; FUKUNAGA M, 1992, J GEN MICROBIOL, V138, P871; Hovius J. W., 2008, PLOS PATHOG, V4, P1; Hovius JWR, 2008, PLOS MED, V5, P202, DOI 10.1371/journal.pmed.0050043; Hovius JWR, 2007, TRENDS PARASITOL, V23, P434, DOI 10.1016/i.pt.2007.07.001; Juncadella IJ, 2008, BIOCHEM BIOPH RES CO, V367, P41, DOI 10.1016/j.bbrc.2007.12.104; Liu J, 2014, TICKS TICK-BORNE DIS, V5, P318, DOI 10.1016/j.ttbdis.2013.12.004; Murase Y, 2013, J VET MED SCI, V75, P215, DOI 10.1292/jvms.12-0211; Paveglio SA, 2007, J IMMUNOL, V178, P7064; Takano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104532; Wang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094131	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	MAY	2015	60						59	67		10.1016/j.ibmb.2015.01.010		9	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	CJ3BZ	WOS:000355359700008		
J	Sakisaka, K; Chadeka, EA; Nagi, S; Mwandembo, DS; Jimba, M				Sakisaka, Kayako; Chadeka, Evans Asena; Nagi, Sachiyo; Mwandembo, Dorcas Shambi; Jimba, Masamine			Introduction of a community water supply in rural western Kenya: impact on community wellbeing and child health	INTERNATIONAL HEALTH			English	Article						Childhood diarrhoea; Developing countries; Hygiene behaviour; Kenya; Water supply; Water treatment	SCHISTOSOMIASIS; COUNTRIES; DIARRHEA	This study aimed to examine water availability and community health before and after tube wells were introduced in a rural western Kenyan community. Differences in impact among income quintile groups were quantified, and users' perceptions of their water supply measured. We conducted a two-part pre- (2009) and post-intervention (2011), cross-sectional study using structured questionnaires for mothers. In total, 1391 (576 in 2009 and 815 in 2011) mothers participated. Well introduction changed the households' drinking-water source from river to ground water. The median distance to the water source was reduced by 40% (500 to 300 metres) and median collection time was reduced by 50% (30 to 15 minutes). Water consumption per household increased by approximately 20% (from 82.6 to 99.0 L) and drinking of untreated water decreased by approximately 10%. Regression analyses revealed mothers with higher monthly incomes had the highest satisfaction levels (beta=0.167, p < 0.001). Positive impacts were strongest among wealthier groups. The small-scale community water supply dramatically affected user hygiene behaviours and daily life. Water supply access improved from 'no access' to 'basic access'. Household connections to a water supply and hygiene education are important steps to enhance community health.	[Sakisaka, Kayako] Chuo Univ, Org Common Educ, Hachioji, Tokyo, Japan; [Sakisaka, Kayako] Chuo Univ, Fac Policy Studies, Hachioji, Tokyo, Japan; [Sakisaka, Kayako; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo 1138654, Japan; [Chadeka, Evans Asena] Nagasaki Univ, Kenya Res Stn, Nairobi, Kenya; [Nagi, Sachiyo] Nagasaki Univ, Grad Sch Biomed Sci Med, Nagasaki, Japan	Sakisaka, K (reprint author), Chuo Univ, Org Common Educ, Hachioji, Tokyo, Japan.	sakisaka@tamacc.chuo-u.ac.jp			Toyota Foundation [D08-R0331]; Japan Foundation for the Promotion of International Medical Research Cooperation	This study was supported by the Toyota Foundation [D08-R0331, 2009-2011] and a grant from the Japan Foundation for the Promotion of International Medical Research Cooperation in 2007.	Gaffga NH, 2007, AM J TROP MED HYG, V77, P705; [Anonymous], PROGR SAN DRINK WAT; Loharikar A, 2013, AM J TROP MED HYG, V88, P267, DOI 10.4269/ajtmh.2012.11-0375; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Sorenson SB, 2011, SOC SCI MED, V72, P1522, DOI 10.1016/j.socscimed.2011.03.010; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Haws RA, 2010, SOC SCI MED, V71, P1764, DOI 10.1016/j.socscimed.2010.03.051; Blum Annalise G., 2014, WATER, V6, P1873; Boisson S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001497; CDC, 2012, PAR SCHIST; CDC, 2006, SAF WAT SYST SWS HAS; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2010, KEN DEM HLTH SURV 20; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mengistie B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077887; Musuva RM, 2014, AM J TROP MED HYG, V90, P646, DOI 10.4269/ajtmh.13-0488; Odiere MR, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-278; Shikanga OT, 2009, AM J TROP MED HYG, V81, P108; UNICEF, STAT WORLD CHILDR 20; UNICEF, 2015, 5 MORT CURR STAT PRO; United Nations, MILL DEV GOALS REP 2; WHO, 2010, UNICEF JOINT MON PRO; WHO, 2012, KEN HLTH PROF; WHO, 2003, DOM WAT QUANT SERV L; WHO & UNICEF, PROGR SAN DRINK WAT; WHO. Water Sanitation Health, 2014, WAT SAN HLTH BURD DI; WHO. Water Sanitation Health. Fast Facts, 2013, WAT SAN HLTH FAST FA	26	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1876-3413	1876-3405		INT HEALTH	Int. Health	MAY	2015	7	3					204	211		10.1093/inthealth/ihv015		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CJ7JH	WOS:000355670600010		
J	Chin, K; Toue, S; Kawamata, Y; Watanabe, A; Miwa, T; Smriga, M; Sakai, R				Chin, Keigi; Toue, Sakino; Kawamata, Yasuko; Watanabe, Akiko; Miwa, Tadashi; Smriga, Miro; Sakai, Ryosei			A 4-Week Toxicity Study of Methionine in Male Rats	INTERNATIONAL JOURNAL OF TOXICOLOGY			English	Article						methionine; safety; NOAEL; LOAEL	EXCESS; PROTEIN; MICE	To examine 4-week toxicity of l-methionine (methionine), 5-week-old Fisher strain male rats were fed on diets containing 0, 0.1, 0.3, 0.9, 2.7 (w/w) of added methionine. Although no deaths were recorded, the highest dose of methionine (2.7% [w/w] of diet) reduced food intake and significantly suppressed growth rate. Growth suppression was characterized by an increase in hemolysis, splenic, and hepatic accumulation of hemosiderin, hemolytic anemia, and promotion of hematopoiesis. Other changes observed in the highest methionine intake group were a decrease in white blood cell count, thymus atrophy, and histological abnormalities in the adrenal gland and testis. Small, but significant, growth suppression, accompanied by some minor changes in plasma biochemical parameters, was also seen in rats fed on a test diet containing 0.9% (w/w) of additional methionine. Thus, no-observed-adverse-effect-level (NOAEL) and lowest-observed-adverse-effect level (LOAEL) of diet-added methionine were determined at 0.3% and 0.9% (w/w), corresponding to 236 and 705 mg/kg/d body weight, respectively. Since the basal diet contained protein-bound methionine at 0.5% (w/w), NOAEL and LOAEL of total dietary methionine were estimated at 0.8% and 1.4% (w/w) of diet.	[Chin, Keigi; Toue, Sakino; Kawamata, Yasuko; Watanabe, Akiko; Miwa, Tadashi; Sakai, Ryosei] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa 2108681, Japan; [Smriga, Miro] Ajinomoto Co Inc, Qual Assurance & External Sci Affairs Dept, Tokyo, Japan	Sakai, R (reprint author), Ajinomoto Co Inc, Inst Innovat, Kawasaki Ku, 1-1 Suzuki Cho, Kawasaki, Kanagawa 2108681, Japan.	ryosei_sakai@ajinomoto.com					Hardy MP, 2005, CELL TISSUE RES, V322, P147, DOI 10.1007/s00441-005-0006-2; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Zivkovic IP, 2005, J NEUROIMMUNOL, V160, P77, DOI 10.1016/j.jneuroim.2004.11.002; Kamata S, 2014, MOL NUTR FOOD RES, V58, P1309, DOI 10.1002/mnfr.201300758; CHANDRASHEKAR V, 1977, FERTIL STERIL, V28, P590; Dilger RN, 2007, POULTRY SCI, V86, P2367, DOI 10.3382/ps.2007-00203; GREEP RO, 1949, ANN NY ACAD SCI, V50, P596, DOI 10.1111/j.1749-6632.1949.tb39869.x; KLAVINS JV, 1963, ARCH PATHOL, V75, P661; KLAVINS JV, 1963, J NUTR, V79, P101; MENGEL CE, 1967, J NUTR, V92, P104; PIMSTONE B, 1976, CLIN ENDOCRINOL, V5, P79, DOI 10.1111/j.1365-2265.1976.tb03806.x; RUSSELL LE, 1983, J ANIM SCI, V56, P1115; Toue S, 2006, J NUTR, V136, p1716S	13	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1091-5818	1092-874X		INT J TOXICOL	Int. J. Toxicol.	MAY-JUN	2015	34	3					233	241		10.1177/1091581815583678		9	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CJ7QT	WOS:000355693600003		
J	Ito, H; Kumagai, T; Kimura, M; Koike, S; Shimizu, T				Ito, Haruyuki; Kumagai, Takako; Kimura, Midori; Koike, Shotaro; Shimizu, Takeshi			Dietary Intake in Body Mass Index Differences in Community-Based Japanese Patients with Schizophrenia	IRANIAN JOURNAL OF PUBLIC HEALTH			English	Article						Body mass index; Nutrition survey; Obesity; Schizophrenia	OBESITY; WEIGHT; SMOKING; PATTERN; PEOPLE; COHORT; ADULTS; FIBER	Background: Patients with schizophrenia reportedly have a high prevalence of obesity. One of the reasons is a poor choice of diet. The goal of this study was to clarify characteristics of the dietary intake across the strata of the body mass index (BMI) and to compare the general population and patients with schizophrenia in Japan. Methods: This is a cross-sectional study of 51 patients with schizophrenia residing in rural areas in 2011. Anthropometric indices (of height, weight, body mass index) were measured at the commencement of the survey. Intakes of energy, protein, fat, carbohydrate, calcium, phosphorus, vitamins, total fiber, and salt were noted through a 3-day dietary recording. The nutrient intake was estimated using Excel add-in software (Excel Eiyou-kun Ver. 6.0, Kenpakusha Co., Ltd.). Patients were divided into two groups: those with a BMI >= 25 kg/m(2) and with a BMI <25 kg/m(2), and the differences in their nutrition intake were analyzed. To compare these patients with the general population, the results of the National Health and Nutrition Survey, 2010 (NHNS) were used (the NHNS group). For statistical analysis, an unpaired t-test was performed with P<0.05. Results: Patients with a BMI >= 25 kg/m(2) had the higher intakes than those with a BMI <25 kg/m(2) of energy, fat and phosphorus and salt. Patients with schizophrenia showed higher intakes of energy, carbohydrate, fat, calcium, phosphorus and salt than the NHNS group. Conclusion: The characteristics of the dietary intake in patients with schizophrenia were suggested the food constitution that is likely to increase the body weight.	[Ito, Haruyuki; Kumagai, Takako; Koike, Shotaro; Shimizu, Takeshi] Aomori Univ Hlth & Welf, Dept Hlth Sci, Aomori, Japan; [Kimura, Midori] Hachinohe Gakuin Jr Coll, Dept Nursing, Aomori, Japan	Ito, H (reprint author), Aomori Univ Hlth & Welf, Dept Hlth Sci, Aomori, Japan.	h_ito@auhw.ac.jp					Amani R, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1171-244X-7-15; Marinou K, 2010, INT J CARDIOL, V138, P3, DOI 10.1016/j.ijcard.2009.03.135; Vancampfort D, 2012, PSYCHIAT RES, V200, P73, DOI 10.1016/j.psychres.2012.03.046; Suttajit S, 2013, NEUROPSYCH DIS TREAT, V9, P941, DOI 10.2147/NDT.S47450; McCreadie R, 1998, BRIT MED J, V317, P784; Sugawara N, 2010, SCHIZOPHR RES, V123, P244, DOI 10.1016/j.schres.2010.08.030; Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1053/S0002-8223(03)01086-1; Mitchell NS, 2011, PSYCHIAT CLIN N AM, V34, P717, DOI 10.1016/j.psc.2011.08.005; McCreadie RG, 2003, BRIT J PSYCHIAT, V183, P534, DOI 10.1192/bjp.183.6.534; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Bobes J, 2003, SCHIZOPHR RES, V62, P77, DOI 10.1016/S0920-9964(02)00431-0; Strassnig M, 2003, SCHIZOPHRENIA BULL, V29, P393; Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; Duvigneaud N, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-26; Fountoulakis KN, 2010, PSYCHIAT RES, V176, P13, DOI 10.1016/j.psychres.2008.11.018; Garaulet M, 2001, INT J OBESITY, V25, P243, DOI 10.1038/sj.ijo.0801476; Henderson David C, 2006, Ann Clin Psychiatry, V18, P99, DOI 10.1080/10401230600614538; Limosin F, 2008, ACTA PSYCHIAT SCAND, V118, P19, DOI 10.1111/j.1600-0447.2008.01208.x; Ministry of Health Labour and Welfare Japan, 2009, DIET REF INT JAP 201; Ministry of Health Labour and Welfare. Japan, 2012, NAT HLTH NUTR SURV J; Schulz M, 2005, J NUTR, V135, P1183; Teegarden D, 2003, J NUTR, V133, p249S; World Instant Noodles Association: WINA, 2014, NAT TRENDS INST NOOD	23	0	0	IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY	TEHRAN	SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN	2251-6085	2251-6093		IRAN J PUBLIC HEALTH	Iran J. Public Health	MAY	2015	44	5					639	645				7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CJ9SU	WOS:000355843800004		
J	Kukimoto, I; Muramatsu, M				Kukimoto, Iwao; Muramatsu, Masamichi			Genetic Variations of Human Papillomavirus Type 16: Implications for Cervical Carcinogenesis	JAPANESE JOURNAL OF INFECTIOUS DISEASES			English	Review							16 E6 VARIANTS; PERSISTENT INFECTIONS; MUTATIONAL PROCESSES; HUMAN CANCERS; RISK; DNA; CLASSIFICATION; POPULATION; APOBEC3; LESIONS	Human papillomaviruses (HPVs) are the causative agent of cervical cancer, and among approximately 15 high-risk genotypes, HPV16 accounts for more than half the cases of cervical cancer worldwide. Recent progress in determining HPV genomic sequences from clinical samples has revealed a wide variety in HPV16 genome sequences, and has allowed for comprehensive classification of intratype HPV16 variants. These consist of four variant lineages containing nucleotide variations in 1.0%-10.0% of the complete viral genome sequence. Epidemiological data suggest that the nonEuropean-Asian lineages of HPV16 entail a higher risk of progression to invasive cervical cancer than the European-Asian lineage. Deep sequencing analysis has recently demonstrated that HPV16 genome sequences are highly homogeneous in individual clinical specimens compared with those of RNA viruses. However, an extremely sensitive PCR method, differential DNA denaturation PCR, has detected hypermutations from C to T or G to A in the E2 gene and the long control region of the HPV16 genome, which suggests the involvement of cellular apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) proteins in this hypermutation. The quasispecies status of the HPV16 genome in the infected cervix may affect the development of cervical cancer and warrants further investigation.	[Kukimoto, Iwao] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo 2080011, Japan; [Muramatsu, Masamichi] Kanazawa Univ, Grad Sch Med Sci, Dept Mol Genet, Kanazawa, Ishikawa, Japan	Kukimoto, I (reprint author), Natl Inst Infect Dis, Pathogen Genom Ctr, 4-7-1 Gakuen, Tokyo 2080011, Japan.	ikuki@niid.go.jp					Andersson S, 2000, BRIT J CANCER, V83, P307, DOI 10.1054/bjoc.2000.1247; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Burk RD, 2003, CANCER RES, V63, P7215; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Wang Z, 2014, J VIROL, V88, P1308, DOI 10.1128/JVI.03091-13; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Xi LF, 2007, CANCER EPIDEM BIOMAR, V16, P4, DOI 10.1158/1055-9965.EPI-06-0670; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Rodriguez AC, 2008, J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Cornet I, 2013, BRIT J CANCER, V108, P240, DOI 10.1038/bjc.2012.508; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Burk RD, 2009, PUBLIC HEALTH GENOMI, V12, P281, DOI 10.1159/000214919; Sichero L, 2012, VIROLOGY, V432, P127, DOI 10.1016/j.virol.2012.06.011; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Rositch AF, 2013, INT J CANCER, V133, P1271, DOI 10.1002/ijc.27828; Gheit T, 2011, CANCER EPIDEM BIOMAR, V20, P1315, DOI 10.1158/1055-9965.EPI-10-1187; Lackey L, 2013, CELL CYCLE, V12, P762, DOI 10.4161/cc.23713; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Zehbe I, 2009, VIROLOGY, V383, P69, DOI 10.1016/j.virol.2008.09.036; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Berumen J, 2001, J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Van Doorslaer K, 2013, VIROLOGY, V445, P11, DOI [10.1016/j.virol.2013.05.012, 10.1016/j.viro1.2013.05.012]; Richard C, 2010, ONCOGENE, V29, P3435, DOI 10.1038/onc.2010.93; Zehbe I, 1998, LANCET, V352, P1441, DOI 10.1016/S0140-6736(05)61263-9; Hildesheim A, 2001, J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Cai HB, 2010, EJSO-EUR J SURG ONC, V36, P160, DOI 10.1016/j.ejso.2009.07.186; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Freitas LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100746; Geraets DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080382; Gottschling M, 2011, MOL BIOL EVOL, V28, P2101, DOI 10.1093/molbev/msr030; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; Jackson R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101540; Kukimoto I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080583; Matsumoto K, 2000, CANCER LETT, V156, P159, DOI 10.1016/S0304-3835(00)00457-2; Mussil B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073641; Ohba K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097787; Perez S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104678; Smith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021375; Steinau M, 2010, J GEN VIROL, V91, P2068, DOI 10.1099/vir.0.018663-0; Vieira VC, 2014, MBIO, V5; Warren CJ, 2015, J VIROL, V89, P688, DOI 10.1128/JVI.02383-14; Xi LF, 2010, J INFECT DIS, V202, P1667, DOI 10.1086/657083	53	0	0	NATL INST INFECTIOUS DISEASES	TOKYO	JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1, SHINJUKU-KU, TOKYO, 162-8640, JAPAN	1344-6304	1884-2836		JPN J INFECT DIS	Jpn. J. Infect. Dis.	MAY	2015	68	3					169	175		10.7883/yoken.JJID.2014.584		7	Infectious Diseases	Infectious Diseases	CJ8RE	WOS:000355770400001		
J	Goto, K; Kawamura, K; Arakawa, Y				Goto, Kensuke; Kawamura, Kumiko; Arakawa, Yoshichika			Contribution of QnrA, a Plasmid-Mediated Quinolone Resistance Peptide, to Survival of Escherichia coli Exposed to a Lethal Ciprofloxacin Concentration	JAPANESE JOURNAL OF INFECTIOUS DISEASES			English	Article							URINARY-TRACT-INFECTION; LEVEL FLUOROQUINOLONE RESISTANCE; MUTANT PREVENTION CONCENTRATIONS; EFFLUX PUMP; EMERGENCE; STRAINS; IMPACT; GENES; MODEL	We evaluated the effects of qnrA on survival of bacteria exposed to a lethal ciprofloxacin (CIP) concentration and development of quinolone resistance through the accumulation of amino acid substitutions in quinolone resistance-determining regions (QRDRs) of GyrA and ParC, targets of quinolones, in Escherichia coli. CIP-susceptible E. coli strains of different O-serotypes (O1, O6, O18, O25b, O74, and O78) were transformed by a recombinant plasmid harboring qnrA, and the parent strains and their transformants were subjected to killing curve assays and adaptation tests. In the killing curve assay at 2 x the minimum inhibitory concentration of CIP, the viable bacterial cell numbers of strains O1, O6, and O25b were maintained at 10(5)-10(8) CFU/mL after 24-h incubation, while the remaining strains showed a 105-fold reduction in viable cell numbers. In the adaptation test, a Ser83-Leu substitution in the QRDR of GyrA was identified earlier in the parent strains of O25b and O1 than in their transformants, suggesting that the acquisition of qnrA did not necessarily accelerate the rate of accumulation of amino acid substitutions in the QRDR. We confirmed that the presence of qnrA contributed to increased survival of the E. coli strains displaying certain O-serotypes. Further studies are necessary to evaluate the precise effects of qnrA on quinolone resistance acquisition by Enterobacteriaceae.	[Goto, Kensuke; Kawamura, Kumiko] Nagoya Univ, Dept Pathophysiol Lab Sci, Grad Sch Med, Nagoya, Aichi 4618673, Japan; [Arakawa, Yoshichika] Nagoya Univ, Dept Bacteriol, Grad Sch Med, Nagoya, Aichi 4668550, Japan	Kawamura, K (reprint author), Nagoya Univ, Dept Pathophysiol Lab Sci, Grad Sch Med, Higashi Ku, 1-1-20 Daikominami, Nagoya, Aichi 4618673, Japan.	kumiko@met.nagoya-u.ac.jp	Arakawa, Yoshichika/P-5997-2015		Japanese Ministry of Health, Labour, and Welfare [H21-Shinkou-Ippan-008, H24-Shinkou-Ippan-010]	This study was supported by grants from the Japanese Ministry of Health, Labour, and Welfare (H21-Shinkou-Ippan-008 and H24-Shinkou-Ippan-010). We are grateful to the department of Infection Control and Prevention, The University of Tokyo Hospital for providing E. coli E15.	Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Hansen LH, 2004, ANTIMICROB AGENTS CH, V48, P3332, DOI 10.1128/AAC.48.9.3332-3337.2004; Neuhauser MM, 2003, JAMA-J AM MED ASSOC, V289, P885, DOI 10.1001/jama.289.7.885; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Lau SH, 2008, J CLIN MICROBIOL, V46, P1076, DOI 10.1128/JCM.02065-07; Garau J, 1999, ANTIMICROB AGENTS CH, V43, P2736; Marcusson LL, 2005, J ANTIMICROB CHEMOTH, V55, P938, DOI 10.1093/jac/dki136; Briales A, 2011, ANTIMICROB AGENTS CH, V55, P1266, DOI 10.1128/AAC.00927-10; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Rice JC, 2006, AM J TRANSPLANT, V6, P2375, DOI 10.1111/j.1600-6143.2006.01471.x; Heisig P, 1996, ANTIMICROB AGENTS CH, V40, P879; Cesaro A, 2008, J ANTIMICROB CHEMOTH, V61, P1007, DOI 10.1093/jac/dkn077; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Allou N, 2009, ANTIMICROB AGENTS CH, V53, P4292, DOI 10.1128/AAC.01664-08; Hooper DC, 1999, DRUG RESIST UPDATE, V2, P38, DOI 10.1054/drup.1998.0068; Fonseca EL, 2013, J MED MICROBIOL, V62, P1628, DOI 10.1099/jmm.0.062661-0; Yamane K, 2007, ANTIMICROB AGENTS CH, V51, P3354, DOI 10.1128/AAC.00339-07; Chong YP, 2010, DIAGN MICR INFEC DIS, V67, P70, DOI 10.1016/j.diagmicrobio.2009.12.003; Clinical and Laboratory Standards Institute (CLSI), 2013, M100S23 CLSI; CLSI, 1999, M26A CLSI; Dominguez-Herrera J, 2013, J ANTIMICROB CHEMOTH, V68, P1609, DOI 10.1093/jac/dkt063; European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MICS; Jakobsen L, 2012, J ANTIMICROB CHEMOTH, V67, P2438, DOI 10.1093/jac/dks224; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80; Rodriguez-Martinez JM, 2007, ANTIMICROB AGENTS CH, V51, P2236, DOI 10.1128/AAC.01444-06; Rodriguez-Martinez JM, 2006, CLIN MICROBIOL INFEC, V12, P440, DOI 10.1111/j.1469-0691.2006.01389.x; Yu XL, 2004, J CLIN MICROBIOL, V42, P4083, DOI 10.1128/JCM.42.9.4083-4091.2004	28	1	1	NATL INST INFECTIOUS DISEASES	TOKYO	JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1, SHINJUKU-KU, TOKYO, 162-8640, JAPAN	1344-6304	1884-2836		JPN J INFECT DIS	Jpn. J. Infect. Dis.	MAY	2015	68	3					196	202		10.7883/yoken.JJID.2014.153		7	Infectious Diseases	Infectious Diseases	CJ8RE	WOS:000355770400006		
J	Okuma, K; Fukagawa, K; Tateyama, S; Kohma, T; Mochida, K; Hiyoshi, M; Takahama, Y; Hamaguchi, Y; Hirose, K; Buonocore, L; Rose, JK; Mizuochi, T; Hamaguchi, I				Okuma, Kazu; Fukagawa, Koji; Tateyama, Seiji; Kohma, Takuya; Mochida, Keiko; Hiyoshi, Masateru; Takahama, Youichi; Hamaguchi, Yukio; Hirose, Kunitaka; Buonocore, Linda; Rose, John K.; Mizuochi, Toshiaki; Hamaguchi, Isao			Development of an Infectious Surrogate Hepatitis C Virus Based on a Recombinant Vesicular Stomatitis Virus Expressing Hepatitis C Virus Envelope Glycoproteins and Green Fluorescent Protein	JAPANESE JOURNAL OF INFECTIOUS DISEASES			English	Article							ENDOPLASMIC-RETICULUM; CELL ENTRY; RECEPTOR; E2; LOCALIZATION; HCV; ANTIBODIES; BINDING; GENOME; SIGNAL	To develop surrogate viruses for hepatitis C virus (HCV), we previously produced recombinant vesicular stomatitis viruses (rVSVs) lacking glycoprotein G but instead expressing chimeric HCV El /E2 fused to G. These rVSVs were not infectious in HCV-susceptible hepatoma cells. In this study, to develop an infectious surrogate HCV based on an rVSV (vesicular stomatitis virus [VSV]/HCV), we generated a novel rVSV encoding the native E1/E2 (H77 strain) and green fluorescent protein (GFP) instead of G. Here, we showed that this VSV/HCV efficiently infected human hepatoma cells, including Huh7 human hepatoma cells, expressed GFP in these cells, and propagated, but did not do so in non-susceptible BHK-21 cells. The infectivity of VSV/HCV, measured as the number of foci of GFP-positive cells, was specifically reduced by the addition of chimpanzee anti-HCV serum, anti-E2 antibody, or anti-CD81 antibody to the cultures. When sera obtained from HCV-infected or uninfected patients were added, infection was selectively inhibited only by the sera of HCV-infected patients. These data together suggest that this infectious GFP-expressing VSV/HCV could be a useful tool for studying the mechanisms of HCV entry into cells and for assessing potential inhibitors of viral entry, including neutralizing antibodies.	[Okuma, Kazu; Fukagawa, Koji; Tateyama, Seiji; Kohma, Takuya; Hiyoshi, Masateru; Mizuochi, Toshiaki; Hamaguchi, Isao] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo 2080011, Japan; [Mochida, Keiko] Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect, Tokyo 2080011, Japan; [Fukagawa, Koji; Kohma, Takuya; Takahama, Youichi; Hamaguchi, Yukio] Sysmex Corp, Technol & Prod Dev Div, Diagnost Reagent Dev, Kobe, Hyogo 6510073, Japan; [Tateyama, Seiji; Hirose, Kunitaka] Micron Inc, Med Facil Support Dept, Tokyo 1000005, Japan; [Buonocore, Linda; Rose, John K.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Okuma, K (reprint author), Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, 4-7-1 Gakuen, Musashimurayama, Tokyo 2080011, Japan.	kokuma@niid.go.jp					Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Tani H, 2007, J VIROL, V81, P8601, DOI 10.1128/JVI.00608-07; Voisset C, 2006, J GEN VIROL, V87, P2577, DOI 10.1099/vir.0.81932-0; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Kanda T, 2006, J VIROL, V80, P4633, DOI 10.1128/JVI.80.9.4633-4639.2006; Buonocore L, 2002, J VIROL, V76, P6865, DOI 10.1128/JVI.76.14.6865-6872.2002; Major ME, 1999, J VIROL, V73, P3317; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Quinn ER, 2001, BLOOD, V98, P3745, DOI 10.1182/blood.V98.13.3745; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Cocquerel L, 1998, J VIROL, V72, P2183; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Schnell MJ, 1996, J VIROL, V70, P2318; Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Flint M, 1999, J VIROL, V73, P6782; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Dubuisson J, 2000, CURR TOP MICROBIOL, V242, P135; Flint M, 1999, J GEN VIROL, V80, P1943; Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712; Lyles DS, 2013, FIELDS VIROLOGY, V6th; Matsuura Y, 2001, VIROLOGY, V286, P263, DOI 10.1006/viro.2001.0971; Okuma K, 2003, J VIROL, V77, P8562, DOI 10.1128/JVI.77.15.8562-8569.2003; Schnell MJ, 1997, CELL, V90, P849, DOI 10.1016/S0092-8674(00)80350-5; Tsuruno C, 2011, HUM IMMUNOL, V72, P295, DOI 10.1016/j.humimm.2011.01.007	30	0	0	NATL INST INFECTIOUS DISEASES	TOKYO	JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1, SHINJUKU-KU, TOKYO, 162-8640, JAPAN	1344-6304	1884-2836		JPN J INFECT DIS	Jpn. J. Infect. Dis.	MAY	2015	68	3					203	208		10.7883/yoken.JJID.2014.328		6	Infectious Diseases	Infectious Diseases	CJ8RE	WOS:000355770400007		
J	Samosornsuk, W; Asakura, M; Yoshida, E; Taguchi, T; Eampokalap, B; Chaicumpa, W; Yamasaki, S				Samosornsuk, Worada; Asakura, Masahiro; Yoshida, Emi; Taguchi, Takashi; Eampokalap, Bunchuay; Chaicumpa, Wanpen; Yamasaki, Shinji			Isolation and Characterization of Campylobacter Strains from Diarrhea! Patients in Central and Suburban Bangkok, Thailand	JAPANESE JOURNAL OF INFECTIOUS DISEASES			English	Article							DISTENDING TOXIN CDT; MULTIPLEX PCR ASSAY; POLYMERASE-CHAIN-REACTION; SPECIES-LEVEL; JEJUNI; COLI; IDENTIFICATION; FETUS; SAMPLES; HUMANS	Campylobacter-induced diarrhea is increasingly recognized worldwide. However, little information is available regarding the Campylobacter strains associated with diarrheal patients in Thailand. In this study, we attempted to isolate Campylobacter strains from diarrheal patients in Thailand and to characterize the species using a cytolethal distending toxin (cdt) gene-based C. jejuni, C. coli, and C. fetus-specific multiplex PCR assay. Campylobacter species were also confirmed using 16S rRNA gene sequencing and hip gene detection. From 2,500 diarrheal stool specimens, 76 Campylobacter-like organisms were isolated and identified via conventional culture methods. Among these 76 organisms, 73 were identified as Campylobacter species (43 C. jejuni, 29 C. coli, and 1 C. fetus) via multiplex PCR, whereas 3 remained unidentified. Two Campylobacter-like organisms yielded 2 amplicons corresponding to cdt genes from C. jejuni and C. coli. Subsequently, C. jejuni and C. coli were re-isolated from each sample. The third isolate was identified as C. hyointestinalis via 16S rRNA gene sequencing. To our knowledge, this is the first report on the isolation of C. hyointestinalis from a diarrheal patient in Thailand. These data indicate that C. jejuni (58%) and C. coli (40%) are prevalent among diarrheal patients in Thailand.	[Samosornsuk, Worada; Asakura, Masahiro; Yoshida, Emi; Taguchi, Takashi; Chaicumpa, Wanpen; Yamasaki, Shinji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka 5988531, Japan; [Samosornsuk, Worada] Thammasat Univ, Fac Allied Hlth Sci, Pathum Thani, Thailand; [Eampokalap, Bunchuay] Bamrasnaradura Infect Dis Inst, Microbiol Lab, Nonthaburi, Thailand; [Chaicumpa, Wanpen] Mahidol Univ, Fac Med, Dept Parasitol, Bangkok 10700, Thailand	Yamasaki, S (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, 1L38,P2-58, Izumisano, Osaka 5988531, Japan.	shinji@vet.osakafu-u.ac.jp			JSPS; Ministry of Health, Labour and Welfare of Japan	We thank Dr. Rupak K. Bhadra, Indian Institute of Chemical Biology (IICB) for critically reading of the manuscript. This study was performed in partial fulfillment of the requirements of a Ph.D. thesis for W. Samosornsuk from Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Osaka, Japan. This work was supported in part by Grant-in-aid for Scientific Research from JSPS and for Scientific Research of US-Japan Cooperative Medical Science Program from the Ministry of Health, Labour and Welfare of Japan.	Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; Samosornsuk W, 2007, MICROBIOL IMMUNOL, V51, P909; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Asakura M, 2007, MICROB PATHOGENESIS, V42, P174, DOI 10.1016/j.micpath.2007.01.005; Asakura M, 2008, FEMS IMMUNOL MED MIC, V52, P260, DOI 10.1111/j.1574-695X.2007.00369.x; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191; Blaser MJ, 2008, CAMPYLOBACTER, 3RD EDITION, P99; Padungtod P, 2005, J FOOD PROTECT, V68, P2519; Linton D, 1997, J CLIN MICROBIOL, V35, P2568; Yamazaki-Matsune W, 2007, J MED MICROBIOL, V56, P1467, DOI 10.1099/jmm.0.47363-0; Hoshino K, 1998, FEMS IMMUNOL MED MIC, V20, P201, DOI 10.1111/j.1574-695X.1998.tb01128.x; Persson S, 2005, J MED MICROBIOL, V54, P1043, DOI 10.1099/jmm.0.46203-0; Prouzet-Mauleon V, 2006, EMERG INFECT DIS, V12, P307; Ribot EM, 2001, J CLIN MICROBIOL, V39, P1889, DOI 10.1128/JCM.39.5.1889-1894.2001; Yamasaki S, 2006, TOXIN REV, V25, P61, DOI 10.1080/15569540500320938; Friedman CR, 2000, CAMPYLOBACTER, VII, P121; Houng HSH, 2001, DIAGN MICR INFEC DIS, V40, P11, DOI 10.1016/S0732-8893(01)00251-6; Jacobs BC, 2008, CAMPYLOBACTER, 3RD EDITION, P245; Lastovica AJ, 2008, CAMPYLOBACTER, 3RD EDITION, P123; LIN Z, 1993, MICROBIOL IMMUNOL, V37, P451; Mak-im P, 2012, J MED TECH PHY THER, V24, P244; Nakari UM, 2008, EUR J CLIN MICROBIOL, V27, P513, DOI 10.1007/s10096-008-0467-9; On SLW, 2003, J CLIN MICROBIOL, V41, P330, DOI 10.1128/JCM.41.1.330-336.2003; PENNER J L, 1988, Clinical Microbiology Reviews, V1, P157; TOTTEN PA, 1987, J CLIN MICROBIOL, V25, P1747; Yokoyama K, 2006, JPN J FOOD MICROBIOL, V23, P109	27	2	2	NATL INST INFECTIOUS DISEASES	TOKYO	JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1, SHINJUKU-KU, TOKYO, 162-8640, JAPAN	1344-6304	1884-2836		JPN J INFECT DIS	Jpn. J. Infect. Dis.	MAY	2015	68	3					209	215		10.7883/yoken.JJID.2014.229		7	Infectious Diseases	Infectious Diseases	CJ8RE	WOS:000355770400008		
J	Kameyama, M; Yabata, J; Nomura, Y; Tominaga, K				Kameyama, Mitsuhiro; Yabata, Junko; Nomura, Yasuharu; Tominaga, Kiyoshi			Biochemical Features and Virulence Gene Profiles of Non-O157/O26 Enterohemorrhagic Escherichia coli Strains from Humans in the Yamaguchi Prefecture, Japan	JAPANESE JOURNAL OF INFECTIOUS DISEASES			English	Article							HEMOLYTIC-UREMIC SYNDROME; MOLECULAR CHARACTERIZATION; MULTIPLEX PCR; TOXINS; LOCUS; EAE; SEROGROUPS; PHENOTYPE; OUTBREAK; CHILDREN	The biochemical features and virulence gene profiles of 37 enterohemorrhagic Escherichia coli (EHEC) strains belonging to serogroups other than O157 and O26 (non-O157/O26 EHEC) were investigated. All strains were isolated from humans between 2002 and 2013 in the Yamaguchi Prefecture. Serogroup O111 strains were the most common, followed by O103, O121, and O145. Most strains (84%) were negative for sorbose fermentation, whereas only 1 and 2 were negative for sorbitol and rhamnose fermentation, respectively. Two strains lacked beta-D-glucuronidase activity. Shiga toxin (stx) subtyping revealed 6 genotypes:stx1a (n = 20), stx1a + stx2a (n = 8), stx2a (n = 4), stx2b (n = 3), stx2a + stx2c (n = 1), and stx2a + stx2d (n = 1). Polymerase chain reaction screening of other toxin and adherence genes showed that astA, subA, and cdtB were present in 5, 2, and 2 strains, respectively. The intimin gene eae was present in 30 strains (81%). Of the 7 eae-negative strains, saa and eibG were found in 3 and 2 strains, respectively; no adherence factors were detected in the remaining 2 strains. The antimicrobial susceptibility profiles of the strains to 12 drugs were examined and 11 strains (30%) showed resistance to 1 or more drugs. Our results revealed that non-O157/O26 EHEC strains exhibit various biochemical phenotypes and carry several toxins and adherence factor genes.	[Kameyama, Mitsuhiro; Yabata, Junko; Nomura, Yasuharu; Tominaga, Kiyoshi] Yamaguchi Prefectural Inst Publ Hlth & Environm, Dept Hlth Sci, Yamaguchi 7530821, Japan	Tominaga, K (reprint author), Yamaguchi Prefectural Inst Publ Hlth & Environm, Dept Hlth Sci, Yamaguchi 7530821, Japan.	k-tominaga@chosyudori.or.jp					Akiba Y, 2005, JPN J INFECT DIS, V58, P190; Bielaszewska M, 2004, INFECT IMMUN, V72, P1812, DOI 10.1128/IAI.72.3.1812-1816.2004; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Morabito S, 1998, J CLIN MICROBIOL, V36, P840; Paton AW, 2001, INFECT IMMUN, V69, P6999, DOI 10.1128/IAI.69.11.6999-7009.2001; Hinenoya A, 2009, MICROBIOL IMMUNOL, V53, P206, DOI 10.1111/j.1348-0421.2009.00116.x; Lu Y, 2006, INFECT IMMUN, V74, P5747, DOI 10.1128/IAI.00724-06; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Paton AW, 2002, J CLIN MICROBIOL, V40, P271, DOI 10.1128/JCM.40.1.271-274.2002; Paton AW, 2005, J CLIN MICROBIOL, V43, P2944, DOI 10.1128/JCM.43.6.2944-2947.2005; Paton AW, 1999, J CLIN MICROBIOL, V37, P3357; Clinical and Laboratory Standards Institute (CLSI), 2011, M100S21 CLSI; GUNZER F, 1992, J CLIN MICROBIOL, V30, P1807; Hiramatsu R, 2002, J CLIN MICROBIOL, V40, P922, DOI 10.1128/JCM.40.3.922-925.2002; Kameyama M, 2013, JPN J INFECT DIS, V66, P458; Kon M, 2005, J JPN ASS INFECT DIS, V79, P161; MARCH SB, 1986, J CLIN MICROBIOL, V23, P869; Narimatsu H, 2010, J CLIN MICROBIOL, V48, P4107, DOI 10.1128/JCM.00677-10; National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division Ministry of Health Labour and Welfare, 2013, INFECT AGENTS SURVEI, V34, p123'; Seto K, 2007, J VET MED SCI, V69, P1215, DOI 10.1292/jvms.69.1215; Tanaka H, 1999, J JPN CLIN MICROBIOL, V9, P48; THOMPSON JS, 1990, J CLIN MICROBIOL, V28, P2165; Wu YL, 2010, J VET MED SCI, V72, P589; Yamamoto T, 2000, FEBS LETT, V472, P22, DOI 10.1016/S0014-5793(00)01414-9; Yamasaki S, 1997, J TOXICOL-TOXIN REV, V16, P229	26	0	0	NATL INST INFECTIOUS DISEASES	TOKYO	JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1, SHINJUKU-KU, TOKYO, 162-8640, JAPAN	1344-6304	1884-2836		JPN J INFECT DIS	Jpn. J. Infect. Dis.	MAY	2015	68	3					216	220		10.7883/yoken.JJID.2014.303		5	Infectious Diseases	Infectious Diseases	CJ8RE	WOS:000355770400009		
J	Kwallah, AO; Inoue, S; Thairu-Muigai, AW; Kuttoh, N; Morita, K; Mwau, M				Kwallah, Allan Ole; Inoue, Shingo; Thairu-Muigai, Anne Wangari; Kuttoh, Nancy; Morita, Kouichi; Mwau, Matilu			Seroprevalence of Yellow Fever Virus in Selected Health Facilities in Western Kenya from 2010 to 2012	JAPANESE JOURNAL OF INFECTIOUS DISEASES			English	Article							1ST RECORDED OUTBREAK; JAPANESE ENCEPHALITIS; DENGUE; SUDAN; INFECTIONS; IDENTIFY	Yellow fever (YF), which is caused by a mosquito-borne virus, is an important viral hemorrhagic fever endemic in equatorial Africa and South America. Yellow fever virus (YFV) is the prototype of the family Flaviviridae and genus Flavivirus. The aim of this study was to determine the seroprevalence of YFV in selected health facilities in Western Kenya during the period 2010-2012. A total of 469 serum samples from febrile patients were tested for YFV antibodies using in-house IgM-capture ELISA, in-house indirect IgG ELISA, and 50% focus reduction neutralization test (FRNT50). The present study did not identify any IgM ELISA-positive cases, indicating absence of recent YFV infection in the area. Twenty-eight samples (6%) tested positive for YFV IgG, because of either YFV vaccination or past exposure to various flaviviruses including YFV. Five cases were confirmed by FRNT50; of these, 4 were either vaccination or natural infection during the YF outbreak in 1992-1993 or another period and 1 case was confirmed as a West Nile virus infection. Domestication and routine performance of arboviral differential diagnosis will help to address the phenomenon of pyrexia of unknown origin, contribute to arboviral research in developing countries, and enhance regular surveillance.	[Kwallah, Allan Ole; Thairu-Muigai, Anne Wangari] JKUAT, Inst Trop Med & Infect Dis ITROMID, Juja, Kenya; [Kwallah, Allan Ole; Kuttoh, Nancy; Mwau, Matilu] Kenya Med Res Inst KEMRI, CIPDCR, Busia, Kenya; [Kwallah, Allan Ole] Kenya Med Res Inst KEMRI, Prod Dept, Nairobi 5484000200, Kenya; [Inoue, Shingo; Morita, Kouichi] Nagasaki Univ, Inst Trop Med, Dept Virol, Nagasaki 852, Japan	Kwallah, AO (reprint author), Kenya Med Res Inst KEMRI, Prod Dept, Nairobi 5484000200, Kenya.	akwallah@gmail.com			Consortium for National Health Research (CNHR) [RLG-09/19-001]; JICA-JSPS Project; JICA-JST SATREPS; Science and Technology Research Partnership for Sustainable Development Project	This work was funded by the Consortium for National Health Research (CNHR) (RLG-09/19-001) through a research training fellowship to A. Kwallah. It was supported by JICA-JSPS Project and JICA-JST SATREPS; Science and Technology Research Partnership for Sustainable Development Project. The authors further acknowledge Dr Rosemary Sang, KEMRI, Center for Virus Research, for the positive control samples and Dr. James Kimotho for hosting the project at ICEMRI, Production Department.	IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; BUNDO K, 1985, J VIROL METHODS, V11, P15, DOI 10.1016/0166-0934(85)90120-X; Tun MMN, 2013, J MED VIROL, V85, P1258, DOI 10.1002/jmv.23577; McMullan LK, 2012, VIROLOGY, V422, P1, DOI 10.1016/j.virol.2011.08.024; Inoue S, 2010, VECTOR-BORNE ZOONOT, V10, P143, DOI 10.1089/vbz.2008.0153; BUNDO K, 1986, Tropical Medicine, V28, P101; Ellis BR, 2008, REV MED VIROL, V18, P331, DOI 10.1002/rmv.584; GOULD EA, 1989, J GEN VIROL, V70, P1889, DOI 10.1099/0022-1317-70-7-1889; Gould LH, 2008, T ROY SOC TROP MED H, V102, P1247, DOI 10.1016/j.trstmh.2008.04.014; Markoff L, 2013, NEW ENGL J MED, V368, P689, DOI 10.1056/NEJMp1300772; Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371; MONATH TP, 1984, AM J TROP MED HYG, V33, P151; Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0; Neidrig M, 1999, TROP MED INT HEALTH, V4, P867; OKELLO GBA, 1993, LANCET, V341, P489, DOI 10.1016/0140-6736(93)90237-B; Onyango CO, 2004, EMERG INFECT DIS, V10, P1668; Reiter P, 1998, AM J TROP MED HYG, V59, P650; Sanders EJ, 1998, AM J TROP MED HYG, V59, P644; Vainio J, 1998, YELLOW FEVER GLOBAL, P10; World Health Organisation (WHO), 2010, WKLY EPIDEMIOL REC, V85, P465; World Health Organization (WHO), 2013, WKLY EPIDEMIOL REC, V88, P285; World Health Organization (WHO), 2005, WKLY EPIDEMIOL REC, V80, P249	22	0	0	NATL INST INFECTIOUS DISEASES	TOKYO	JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1, SHINJUKU-KU, TOKYO, 162-8640, JAPAN	1344-6304	1884-2836		JPN J INFECT DIS	Jpn. J. Infect. Dis.	MAY	2015	68	3					230	234		10.7883/yoken.JJID.2014.288		5	Infectious Diseases	Infectious Diseases	CJ8RE	WOS:000355770400011		
J	Ohnishi, T; Furusawa, H; Oyama, R; Koike, S; Yoshinari, T; Kamata, Y; Sugita-Konishi, Y				Ohnishi, Takahiro; Furusawa, Hiroko; Oyama, Rie; Koike, Saki; Yoshinari, Tomoya; Kamata, Yoichi; Sugita-Konishi, Yoshiko			Molecular Epidemiological Analysis of Kudoa septempunctata by Random Amplified Polymorphic DNA Analysis	JAPANESE JOURNAL OF INFECTIOUS DISEASES			English	Article							PARALICHTHYS-OLIVACEUS; PRIMERS	Molecular epidemiological analysis of Kudoa septempunctata isolates from 34 olive flounders associated with foodborne disease outbreaks and from 6 reference samples was performed using random amplified polymorphic DNA (RAPD) analysis. The K. septempunctata isolates analyzed in this study were divided into 8 groups. Eight isolates obtained from the large Ehime Prefecture outbreak in Japan that had occurred on October 8, 2010, were further divided into 4 groups. Eight isolates obtained from Korean samples were divided into 3 groups. These groups included isolates that had been identified from the large Ehime Prefecture outbreak. These results indicated that the Korean isolates had similar genetic backgrounds to those involved in the Ehime Prefecture outbreak. Isolates associated with outbreaks with similar dates of onset tended to be classified in the same group, suggesting that the strains involved in these incidents were genetically related. These results demonstrated that RAPD analysis is a useful molecular epidemiological analysis method for K. septempunctata.	[Ohnishi, Takahiro; Furusawa, Hiroko; Oyama, Rie; Yoshinari, Tomoya] Natl Inst Hlth Sci, Tokyo 1588501, Japan; [Koike, Saki] Kyoritsu Womens Univ, Tokyo, Japan; [Kamata, Yoichi] Iwate Univ, Morioka, Iwate 020, Japan; [Sugita-Konishi, Yoshiko] Azabu Univ, Sagamihara, Kanagawa, Japan	Ohnishi, T (reprint author), Natl Inst Hlth Sci, Div Microbiol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	ohnisi@nihs.go.jp			Ministry of Education, Culture, Sports, Science, and Technology [24501026]	We thank the local governments in Japan and the National Research Institute of Aquaculture Fisheries Research Agency for kindly providing olive flounder samples. This study was supported by the Ministry of Education, Culture, Sports, Science, and Technology (Grant-in-Aid for Scientific Research (C) 24501026).	WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Kawai T, 2012, CLIN INFECT DIS, V54, P1046, DOI 10.1093/cid/cir1040; REITER RS, 1992, P NATL ACAD SCI USA, V89, P1477, DOI 10.1073/pnas.89.4.1477; Matsukane Y, 2010, PARASITOL RES, V107, P865, DOI 10.1007/s00436-010-1941-8; LYNCH M, 1990, MOL BIOL EVOL, V7, P478; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Kawai K, 2010, B HIROSHIMA U MUS, V2, P35; Nei M., 1987, BIOL EVOL, V4, P406; Ohnishi T, 2013, FOODBORNE PATHOG DIS, V10, P137, DOI 10.1089/fpd.2012.1294; ROY A, 1992, THEOR APPL GENET, V85, P173, DOI 10.1007/BF00222856; WELSH J, 1991, NUCLEIC ACIDS RES, V19, P5275	11	0	0	NATL INST INFECTIOUS DISEASES	TOKYO	JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1, SHINJUKU-KU, TOKYO, 162-8640, JAPAN	1344-6304	1884-2836		JPN J INFECT DIS	Jpn. J. Infect. Dis.	MAY	2015	68	3					235	238		10.7883/yoken.JJID.2014.190		4	Infectious Diseases	Infectious Diseases	CJ8RE	WOS:000355770400012		
J	Asoshima, N; Matsuda, M; Shigemura, K; Honda, M; Yoshida, H; Oda, T; Hiwaki, H				Asoshima, Nanami; Matsuda, Masanori; Shigemura, Kumiko; Honda, Mikiko; Yoshida, Hidehiro; Oda, Takahiro; Hiwaki, Hiroshi			Isolation of Escherichia albertii from Raw Chicken Liver in Fukuoka City, Japan	JAPANESE JOURNAL OF INFECTIOUS DISEASES			English	Article							OUTBREAK; GASTROENTERITIS; IDENTIFICATION		[Asoshima, Nanami; Shigemura, Kumiko; Honda, Mikiko] Fukuoka City Inst Hyg & Environm, Fukuoka 8100065, Japan; [Matsuda, Masanori] Fukuoka City Minami Hlth & Welf Ctr, Fukuoka 8150032, Japan; [Yoshida, Hidehiro] Fukuoka City Meat Inspect Stn, Fukuoka 8120055, Japan; [Oda, Takahiro] Nakamura Gakuen Univ, Coll Fac, Food & Nutr Div, Fukuoka 8140198, Japan; [Hiwaki, Hiroshi] Greenery City Dept, Housing & Urban Planning Bur, Fukuoka 8108620, Japan	Asoshima, N (reprint author), Fukuoka City Inst Hyg & Environm, Chuo Ku, 2-1-34 Jigyohama, Fukuoka 8100065, Japan.	asoshima.n01@city.fukuoka.lg.jp					Oaks JL, 2010, EMERG INFECT DIS, V16, P638, DOI 10.3201/eid1604.090695; Huys G, 2003, INT J SYST EVOL MICR, V53, P807, DOI 10.1099/ijs.0.02475-0; Murakami K, 2014, JPN J INFECT DIS, V67, P204; Konno T, 2012, JPN J INFECT DIS, V65, P203; ALBERT MJ, 1991, INFECT IMMUN, V59, P1507; Ooka T, 2013, EMERG INFECT DIS, V19, P144, DOI 10.3201/eid1901.120646; Hyma KE, 2005, J BACTERIOL, V187, P619, DOI 10.1128/JB.187.2.619-628.2005; Asoshima N, 2014, JPN J INFECT DIS, V67, P139, DOI 10.7883/yoken.67.139; Ooka T, 2012, EMERG INFECT DIS, V18, P488, DOI 10.3201/eid1803.111401; Baba A, 2006, JPN J INFECT DIS, V59, P59; Kobayashi K., 2002, J JPN ASS INFECT DIS, V76, P911; Toth I, 2003, J CLIN MICROBIOL, V41, P285	12	0	0	NATL INST INFECTIOUS DISEASES	TOKYO	JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1, SHINJUKU-KU, TOKYO, 162-8640, JAPAN	1344-6304	1884-2836		JPN J INFECT DIS	Jpn. J. Infect. Dis.	MAY	2015	68	3					248	250		10.7883/yoken.JJID.2014.530		3	Infectious Diseases	Infectious Diseases	CJ8RE	WOS:000355770400015		
J	Matsubara, K; Takegawa, H; Sakizono, K; Nomoto, R; Yamamoto, G; Osawa, R				Matsubara, Kousaku; Takegawa, Hiroshi; Sakizono, Kenji; Nomoto, Ryohei; Yamamoto, Go; Osawa, Ro			Transient Bacteremia Due to Streptococcus gallolyticus Subsp pasteurianus in a 3-Year-Old Infant	JAPANESE JOURNAL OF INFECTIOUS DISEASES			English	Article							BLOOD-STREAM INFECTIONS; NEONATAL MENINGITIS; BOVIS; RESISTANCE		[Matsubara, Kousaku] Nishi Kobe Med Ctr, Dept Pediat, Kobe, Hyogo 6512273, Japan; [Yamamoto, Go] Nishi Kobe Med Ctr, Dept Clin Lab, Kobe, Hyogo 6512273, Japan; [Nomoto, Ryohei] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo 6578501, Japan; [Osawa, Ro] Kobe Univ, Dept Bioresource Sci, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan; [Takegawa, Hiroshi; Sakizono, Kenji] Gen Hosp, Kobe City Med Ctr, Dept Clin Lab, Kobe, Hyogo 6500047, Japan	Matsubara, K (reprint author), Nishi Kobe Med Ctr, Dept Pediat, Nishi Ku, 5-7-1 Kojidai, Kobe, Hyogo 6512273, Japan.	kskmatsu@s4.dion.ne.jp					Lazarovitch T, 2013, INFECTION, V41, P329, DOI 10.1007/s15010-012-0314-x; Onoyama S, 2009, J MED MICROBIOL, V58, P1252, DOI 10.1099/jmm.0.006551-0; Takahashi Y, 2014, PEDIATR INT, V56, P282, DOI 10.1111/ped.12254; Schlegel L, 2003, INT J SYST EVOL MICR, V53, P631, DOI 10.1099/ijs.0.02361-0; Seifert H, 2009, CLIN INFECT DIS, V48, pS238, DOI 10.1086/598188; Shibata Y, 2014, MICROBIOL-SGM, V160, P113, DOI 10.1099/mic.0.071605-0; Floret N, 2010, INFECT CONT HOSP EP, V31, P194, DOI 10.1086/650380; Sheng WH, 2014, J INFECTION, V69, P145, DOI 10.1016/j.jinf.2014.03.010; Clinical and Laboratory Standards Institute (CLSI), 2011, M100521 CLSI; Gavin PJ, 2003, J CLIN MICROBIOL, V41, P3433, DOI 10.1128/JCM.41.7.3433-3435.2003; Khan A, 2009, J PAEDIATR CHILD H, V45, P474, DOI 10.1111/j.1440-1754.2009.01541.x; Klatte JM, 2012, J CLIN MICROBIOL, V50, P57, DOI 10.1128/JCM.05635-11; Lin IH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020519; Nagamatsu M, 2012, J INFECT CHEMOTHER, V18, P265, DOI 10.1007/s10156-011-0320-4; Punpanich Warunee, 2012, Journal of the Medical Association of Thailand, V95, P1606; Thatrimontrichai A, 2012, SE ASIAN J TROP MED, V43, P145; ZAIDI AKM, 1995, J PEDIATR-US, V127, P263, DOI 10.1016/S0022-3476(95)70305-5	17	0	0	NATL INST INFECTIOUS DISEASES	TOKYO	JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1, SHINJUKU-KU, TOKYO, 162-8640, JAPAN	1344-6304	1884-2836		JPN J INFECT DIS	Jpn. J. Infect. Dis.	MAY	2015	68	3					251	253		10.7883/yoken.JJID.2014.423		3	Infectious Diseases	Infectious Diseases	CJ8RE	WOS:000355770400016		
J	Shirato, K; Azumano, A; Nakao, T; Hagihara, D; Ishida, M; Tamai, K; Yamazaki, K; Kawase, M; Okamoto, Y; Kawakami, S; Okada, N; Fukushima, K; Nakajima, K; Matsuyama, S				Shirato, Kazuya; Azumano, Akinori; Nakao, Tatsuko; Hagihara, Daisuke; Ishida, Manabu; Tamai, Kanji; Yamazaki, Kouji; Kawase, Miyuki; Okamoto, Yoshiharu; Kawakami, Shigehisa; Okada, Naonori; Fukushima, Kazuko; Nakajima, Kensuke; Matsuyama, Shutoku			Middle East Respiratory Syndrome Coronavirus Infection Not Found in Camels in Japan	JAPANESE JOURNAL OF INFECTIOUS DISEASES			English	Article							SERINE-PROTEASE TMPRSS2; DROMEDARY CAMELS; MERS CORONAVIRUS; SAUDI-ARABIA; COV		[Shirato, Kazuya; Kawase, Miyuki; Matsuyama, Shutoku] Natl Inst Infect Dis, Dept Virol 3, Lab Acute Resp Viral Dis & Cytokines, Tokyo 2080011, Japan; [Azumano, Akinori] Zoorasia Yokohama Zool Gardens, Yokohama, Kanagawa 2410001, Japan; [Nakao, Tatsuko] Adventure World, Wakayama 6492201, Japan; [Hagihara, Daisuke] Himeji City Zoo, Himeji, Hyogo 6700012, Japan; [Ishida, Manabu] Kujukushima Zool & Bot Garden, Nagasaki 857231, Japan; [Tamai, Kanji] Hirakawa Zool Pk, Kagoshima 8910133, Japan; [Yamazaki, Kouji] Rakudaya, Tottori 6890105, Japan; [Okamoto, Yoshiharu] Tottori Univ, Sch Vet Med, Dept Vet Neurol & Oncol, Fac Agr, Tottori 6808553, Japan; [Kawakami, Shigehisa] Gunma Safari Pk, Gunma 3702321, Japan; [Okada, Naonori] Japanese Assoc Zoos & Aquariums, Tokyo 1108567, Japan; [Fukushima, Kazuko; Nakajima, Kensuke] Minist Hlth Labour & Welf, TB & Infect Dis Control Div, Hlth Serv Bur, Tokyo 1008916, Japan	Shirato, K (reprint author), Natl Inst Infect Dis, Dept Virol 3, Lab Acute Resp Viral Dis & Cytokines, Murayama Branch, 4-7-1 Gakuen, Musashimurayama, Tokyo 2080011, Japan.	shirato@nih.go.jp			Ministry of Health, Labor, and Welfare, Japan; Japan Agency for Medical Research and Development, AMED [15fk0108013h0101]	This work was supported by a grant-in-aid from Ministry of Health, Labor, and Welfare, Japan. This work was also supported by the Grant Number 15fk0108013h0101 from Japan Agency for Medical Research and Development, AMED. We thank all staff of Zoorasia Yokohama Zoological Gardens, Adventure World, Himeji City Zoo, Kujukushima Zoological and Botanical Garden, Hirakawa Zoological Park, Rakudaya, and Gunma Safari Park.	Alagaili AN, 2014, MBIO, V5, DOI DOI 10.1128/MBI0.00884-14; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Reusken CBEM, 2014, EMERG INFECT DIS, V20, P1370, DOI 10.3201/eid2008.140590; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Shirogane Y, 2008, J VIROL, V82, P8942, DOI 10.1128/JVI.00676-08; Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13; Adney DR, 2014, EMERG INFECT DIS, V20, P1999, DOI 10.3201/eid2012.141280; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Corman V.M., 2012, EURO SURVEILL, V17; Danielsson N, 2012, EUROSURVEILLANCE, V17, P9; Hemida MG, 2013, EUROSURVEILLANCE, V18, P21, DOI 10.2807/1560-7917.ES2013.18.50.20659; Hemida MG, 2014, EURO SURVEILL, V19; Kupferschmidt K, 2013, SCIENCE, V341, P702, DOI 10.1126/science.341.6147.702; Shirato K, 2012, VIRUS GENES, V44, P40, DOI 10.1007/s11262-011-0661-1; Shirato K, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-139; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12	17	1	1	NATL INST INFECTIOUS DISEASES	TOKYO	JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1, SHINJUKU-KU, TOKYO, 162-8640, JAPAN	1344-6304	1884-2836		JPN J INFECT DIS	Jpn. J. Infect. Dis.	MAY	2015	68	3					256	258		10.7883/yoken.JJID.2015.094		3	Infectious Diseases	Infectious Diseases	CJ8RE	WOS:000355770400018		
J	Obuchi, M; Yagi, S; Oguri, A; Takizawa, T; Kimura, H; Sata, T				Obuchi, Masatsugu; Yagi, Shin-ichi; Oguri, Ayako; Takizawa, Takenori; Kimura, Hirokazu; Sata, Tetsutaro			Outbreak of Human Bocavirus 1 Infection in Young Children in Toyama, Japan	JAPANESE JOURNAL OF INFECTIOUS DISEASES			English	Article							REAL-TIME PCR; RESPIRATORY-INFECTION; VIRUSES; INFLUENZA; SAMPLES		[Obuchi, Masatsugu; Takizawa, Takenori; Sata, Tetsutaro] Toyama Inst Hlth, Dept Virol, Kosugi, Toyama 9390363, Japan; [Yagi, Shin-ichi] Yagi Pediat Clin, Toyama 9300852, Japan; [Oguri, Ayako] Oguri Pediat Clin, Toyama 9330014, Japan; [Kimura, Hirokazu] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo 2080011, Japan	Obuchi, M (reprint author), Toyama Inst Hlth, Dept Virol, 17-1 Nakataikoyama, Kosugi, Toyama 9390363, Japan.	masatsugu.obuchi@pref.toyama.lg.jp			Ministry of Health, Labour and Welfare of Japan [H24-Shinko-Ippan-014]	This work was supported in part by a Grant-in-Aid for Research on Emerging and Re-emerging Infectious Diseases, Labour and Welfare Programs from the Ministry of Health, Labour and Welfare of Japan (H24-Shinko-Ippan-014).	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Endo R, 2007, J CLIN MICROBIOL, V45, P3218, DOI 10.1128/JCM.02140-06; Marcone DN, 2012, REV ARGENT MICROBIOL, V44, P259; Garcia-Garcia ML, 2008, PEDIATR INFECT DIS J, V27, P358, DOI 10.1097/INF.0b013e3181626d2a; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Calvo C, 2010, ACTA PAEDIATR, V99, P883, DOI 10.1111/j.1651-2227.2010.01714.x; Midulla F, 2010, ARCH DIS CHILD, V95, P35, DOI 10.1136/adc.2008.153361; Chieochansin T, 2007, VIRUS RES, V129, P54, DOI 10.1016/j.virusres.2007.04.022; Dunn JJ, 2014, CLIN LAB MED, V34, P409, DOI 10.1016/j.cll.2014.02.011; Huber I, 2011, EURO SURVEILL, V16; Katano H, 2011, J MED VIROL, V83, P322, DOI 10.1002/jmv.21962; Lu RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038638; SCHILDGEN M, 2008, CLIN MICROBIOL REV, V21, P291; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; Zhou LL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-424	15	0	0	NATL INST INFECTIOUS DISEASES	TOKYO	JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1, SHINJUKU-KU, TOKYO, 162-8640, JAPAN	1344-6304	1884-2836		JPN J INFECT DIS	Jpn. J. Infect. Dis.	MAY	2015	68	3					259	261		10.7883/yoken.JJID.2015.046		3	Infectious Diseases	Infectious Diseases	CJ8RE	WOS:000355770400019		
J	Shinoda, K; Taniguchi, H; Tsuda, T; Ishizawa, S; Taki, H; Tobe, K				Shinoda, Koichiro; Taniguchi, Hirokazu; Tsuda, Takeshi; Ishizawa, Shin; Taki, Hirofumi; Tobe, Kazuyuki			Pulmonary reversed halo sign as a presenting manifestation of rheumatoid arthritis	JOINT BONE SPINE			English	Editorial Material							HIGH-RESOLUTION CT		[Shinoda, Koichiro; Taki, Hirofumi; Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Toyama 9300194, Japan; [Taniguchi, Hirokazu; Tsuda, Takeshi; Ishizawa, Shin] Toyama Prefectual Cent Hosp, Toyama 9300975, Japan	Taki, H (reprint author), Toyama Univ, Dept Internal Med 1, 2630 Sugitani, Toyama 9300194, Japan.	htaki-tym@umin.ac.jp	Taki, Hirofumi/I-6284-2012				Kim SJ, 2003, AM J ROENTGENOL, V180, P1251; Marchiori E, 2012, CHEST, V141, P1260, DOI 10.1378/chest.11-1050	2	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	1297-319X	1778-7254		JOINT BONE SPINE	Joint Bone Spine	MAY	2015	82	3					207	207		10.1016/j.jbspin.2014.06.002		1	Rheumatology	Rheumatology	CJ8QC	WOS:000355767600017		
J	Mikami, OK; Sato, NJ; Ueda, K; Tanaka, KD				Mikami, Osamu K.; Sato, Nozomu J.; Ueda, Keisuke; Tanaka, Keita D.			Egg removal by cuckoos forces hosts to accept parasite eggs	JOURNAL OF AVIAN BIOLOGY			English	Article							BROWN-HEADED COWBIRDS; BROOD PARASITISM; CLUTCH SIZE; CUCULUS-CANORUS; SHINY COWBIRDS; REED WARBLERS; BEHAVIOR; RECOGNITION; EVOLUTION; MIMICRY	Many avian brood parasites remove one or more host eggs before laying their own eggs in the host nest. Various hypotheses have been proposed to explain the adaptive significance of this behaviour, but none of them provides an adequate explanation. Here we provide a new hypothesis for explaining why a parasite removes host eggs before laying its own. In this study, we attempted to answer this question by constructing a mathematical model that focused on the changes in host decision making according to reduced clutch size as a consequence of egg removal by parasites. We assume that a host selects one of the following two options to maximise the number of its own chicks: trying to eject a suspicious egg from the nest (trying-to-eject) or acceptance without trying to eject the egg (acceptance). The option selected depends on the number of eggs in the nest. Our model provides a new explanation for egg removal behaviour by showing that the host should select trying-to-eject if there is a large number of eggs in the nest but acceptance with a small number of eggs. This is because the relative payoff for a host that selects trying-to-eject decreases with the number of eggs in the nest. Therefore, parasites benefit by removing the host egg because this behaviour reduces the number of eggs in the nest, thereby increasing the probability of their own eggs being accepted. Thus, hosts have evolved egg ejection to combat brood parasites, but it may also have facilitated the evolution of egg removal by parasites. This hypothesis may also apply to brood parasitic species that do not eject host chicks. In addition, this hypothesis may explain other parasitic behaviours, such as egg damaging and egg puncturing, which lead to reductions in the host clutch size.	[Mikami, Osamu K.] Iwate Med Univ, Dept Biol, Yahaba, Iwate 0283694, Japan; [Sato, Nozomu J.; Ueda, Keisuke; Tanaka, Keita D.] Rikkyo Univ, Dept Life Sci, Toshima 1718501, Japan; [Sato, Nozomu J.] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland	Mikami, OK (reprint author), Hokkaido Univ, Dept Int & Reg Studies, 1-2 Hachiman Cho, Hakodate, Hokkaido 0408567, Japan.	osamu.k.mikami@gmail.com			JSPS KAKENHI [24770028, 23255004]; JSPS [24-4578]; Polish National Science Center [NCN 2012/05/E/NZ8/02694]	We thank K. Mikami for reading the manuscript and providing many helpful comments. We would like to thank the editor T. Alerstam, and the referee O. Kruger for their suggestions that improved the readability of this paper. This research was supported by JSPS KAKENHI grant numbers 24770028 to KOT, 23255004 to KU, and JSPS Research Fellowships grant number 24-4578 to NJS, and was partly supported by the Polish National Science Center grant number NCN 2012/05/E/NZ8/02694.	Thomson DL, 1998, BIOL REV, V73, P293, DOI 10.1017/S0006323198005180; Fiorini VD, 2006, BEHAV ECOL SOCIOBIOL, V60, P379, DOI 10.1007/s00265-006-0175-3; DUCKWORTH JW, 1991, IBIS, V133, P68, DOI 10.1111/j.1474-919X.1991.tb04812.x; BROWN CR, 1984, SCIENCE, V224, P518, DOI 10.1126/science.224.4648.518; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; KEMAL RE, 1988, ANIM BEHAV, V36, P175, DOI 10.1016/S0003-3472(88)80261-6; Tokue K, 2010, IBIS, V152, P835; LOMBARDO MP, 1989, BEHAV ECOL SOCIOBIOL, V24, P217, DOI 10.1007/BF00295201; Antonov A, 2010, J EVOLUTION BIOL, V23, P1170, DOI 10.1111/j.1420-9101.2010.01982.x; Langmore NE, 2011, P ROY SOC B-BIOL SCI, V278, P2455, DOI 10.1098/rspb.2010.2391; Welbergen JA, 2011, BEHAV ECOL, V22, P574, DOI 10.1093/beheco/arr008; Shizuka D, 2010, NATURE, V463, P223, DOI 10.1038/nature08655; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Forsman JT, 2012, BIOL LETTERS, V8, P341, DOI 10.1098/rsbl.2011.0970; Verboven N, 2002, ANIM BEHAV, V63, P951, DOI 10.1006/anbe.2001.1971; HAYWOOD S, 1993, Q REV BIOL, V68, P33, DOI 10.1086/417910; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; Sato NJ, 2010, BIOL LETTERS, V6, P67, DOI 10.1098/rsbl.2009.0540; Bennett A. F., 2002, EVOLUTIONARY ECOLOGY; Bourgeon S., 2005, POLAR BIOL, V29, P358; BROOKER LC, 1990, J THEOR BIOL, V146, P123, DOI 10.1016/S0022-5193(05)80048-7; Davies NB, 2000, CUCKOOS COWBIRDS OTH; GASTON AJ, 1976, J ANIM ECOL, V45, P331, DOI 10.2307/3878; Grim T, 2005, BIOL J LINN SOC, V84, P69, DOI 10.1111/j.1095-8312.2005.00414.x; Kruger O, 2011, P ROY SOC B-BIOL SCI, V278, P2777, DOI 10.1098/rspb.2010.2629; Lahti DC, 2005, P NATL ACAD SCI USA, V102, P18057, DOI 10.1073/pnas.0508930102; Langmore N. E., 2003, NATURE, V422, P3; Lyon BE, 1997, ANIM BEHAV, V54, P927, DOI 10.1006/anbe.1997.0476; LYON BE, 1993, BEHAV ECOL SOCIOBIOL, V33, P87; Massoni V, 1999, P ROY SOC B-BIOL SCI, V266, P1871; Master D. G., 1997, AUK, V114, P212; MOKSNES A, 1989, BEHAV ECOL SOCIOBIOL, V24, P25, DOI 10.1007/BF00300114; Peer BD, 2000, ECOLOGY AND MANAGEMENT OF COWBIRDS AND THEIR HOSTS, P187; Peer BD, 2006, AUK, V123, P16, DOI 10.1642/0004-8038(2006)123[0016:EDAERB]2.0.CO;2; Peer BD, 1999, STUD AVIAN BIOL, P235; ROTHSTEIN SI, 1986, ANIM BEHAV, V34, P1109, DOI 10.1016/S0003-3472(86)80170-1; Sato NJ, 2010, ORNITHOL SCI, V9, P115, DOI 10.2326/osj.9.115; SCOTT DM, 1992, CONDOR, V94, P579, DOI 10.2307/1369242; SEALY SG, 1992, CONDOR, V94, P40, DOI 10.2307/1368794; Soler Juan Jose, 2000, Etologia, V8, P9; SOLER M, 1990, ORNIS SCAND, V21, P212, DOI 10.2307/3676781; Soler M, 2000, BEHAV ECOL, V11, P495, DOI 10.1093/beheco/11.5.495; Stokke BG, 2002, EVOLUTION, V56, P199; Wood DR, 1997, CONDOR, V99, P851, DOI 10.2307/1370134	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0908-8857	1600-048X		J AVIAN BIOL	J. Avian Biol.	MAY	2015	46	3					275	282		10.1111/jav.00410		8	Ornithology	Zoology	CJ6RX	WOS:000355622400006		
J	Shimokawa, H; Satoh, K				Shimokawa, Hiroaki; Satoh, Kimio			Light and Dark of Reactive Oxygen Species for Vascular Function: 2014 ASVB (Asian Society of Vascular Biology)	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY			English	Article						reactive oxygen species; Rho-kinase; vascular homeostasis; vascular diseases	SMOOTH-MUSCLE-CELLS; INDUCED PULMONARY-HYPERTENSION; CORONARY-ARTERY SPASM; LONG-TERM INHIBITION; RHO-ASSOCIATED KINASE; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION; PIGS IN-VIVO; CYCLOPHILIN-A; ANGIOTENSIN-II; VASOSPASTIC ANGINA	Vascular-derived hydrogen peroxide (H2O2) serves as an important signaling molecule in the cardiovascular system and contributes to vascular homeostasis. H2O2 is a second messenger, transducing the oxidative signal into biological responses through posttranslational protein modification. The balance between oxidant and antioxidant systems regulates intracellular redox status, and their imbalance causes oxidative or reductive stress, leading to cellular damage in cardiovascular systems. Excessive H2O2 deteriorates vascular functions and promotes vascular disease through multiple pathways. The RhoA/Rho-kinase pathway plays an important role in various fimdamental cellular functions, including production of excessive reactive oxygen species, leading to the development of cardiovascular diseases. Rho-kinase (ROCK1 and ROCK2) belongs to the family of serine/threonine kinases and is an important downstream effector of the small GTP-binding protein RhoA. Rho-kinase plays a crucial role in the pathogenesis of vasospasm, arteriosclerosis, ischemia/reperfusion injury, hypertension, pulmonary hypertension, stroke, and heart failure. Thus, Rho-kinase inhibitors may be useful for the treatment of cardiovascular diseases in humans. In this review, we will briefly discuss the roles of vascular-derived H2O2 and review the recent progress in the translational research on the therapeutic importance of the Rho-kinase pathway in cardiovascular medicine.	[Shimokawa, Hiroaki; Satoh, Kimio] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan	Shimokawa, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	shimo@cardio.med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [21790698, 23659408, 24390193]; Ministry of Health, Labour, and Welfare, Tokyo, Japan [10102895]	Supported in part by the Grant-in-Aid for Tohoku University Global COE for Conquest of Signal Transduction Diseases with Network Medicine, the Grants-in-Aid for Scientific Research 21790698, 23659408, and 24390193 from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan, and the Grants-in-Aid for Scientific Research (10102895) from the Ministry of Health, Labour, and Welfare, Tokyo, Japan.	Abe K, 2006, J CARDIOVASC PHARM, V48, P280, DOI 10.1097/01.fjc.0000248244.64430.4a; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Satoh K, 2010, ANTIOXID REDOX SIGN, V12, P675, DOI 10.1089/ars.2009.2875; Shimokawa H, 2013, CIRC RES, V113, P1040, DOI 10.1161/CIRCRESAHA.113.302049; Higashi M, 2003, CIRC RES, V93, P767, DOI 10.1161/01.RES.0000096650.91688.28; Shimokawa H, 1999, J MOL CELL CARDIOL, V31, P23, DOI 10.1006/jmcc.1998.0841; Yang Y, 2008, RHEUMATOLOGY, V47, P1299, DOI 10.1093/rheumatology/ken225; Tanaka S, 2013, ARTERIOSCL THROM VAS, V33, P1591, DOI 10.1161/ATVBAHA.112.300922; Katsumata N, 1997, CIRCULATION, V96, P4357; Shimokawa H, 1999, CARDIOVASC RES, V43, P1029, DOI 10.1016/S0008-6363(99)00144-3; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Do E Z, 2009, CIRC J, V73, P1731; Jin ZG, 2004, ARTERIOSCL THROM VAS, V24, P1186, DOI 10.1161/01.ATV.0000130664.51010.28; Fleming I, 2001, CIRC RES, V88, P44; FELETOU M, 1988, BRIT J PHARMACOL, V93, P515; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Yang D, 2002, BRIT J PHARMACOL, V136, P104, DOI 10.1038/sj.bjp.0704669; Abe K, 2004, CIRC RES, V94, P385, DOI 10.1161/01.RES.0000111804.34509.94; Jin ZG, 2000, CIRC RES, V87, P789; Shimokawa H, 1996, J CLIN INVEST, V97, P769, DOI 10.1172/JCI118476; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Kim H, 2005, CLIN IMMUNOL, V116, P217, DOI 10.1016/j.clim.2005.05.004; Nigro P, 2011, J EXP MED, V208, P53, DOI 10.1084/jem.20101174; Shao D, 2012, J MOL CELL CARDIOL, V52, P550, DOI 10.1016/j.yjmcc.2011.09.009; Wu CG, 2011, ANTIOXID REDOX SIGN, V15, P2565, DOI 10.1089/ars.2010.3831; Ohashi J, 2012, CIRC J, V76, P1768, DOI 10.1253/circj.CJ-12-0197; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Burgoyne JR, 2012, HYPERTENSION, V60, P1301, DOI 10.1161/HYPERTENSIONAHA.112.198754; Liao DF, 2000, J BIOL CHEM, V275, P189, DOI 10.1074/jbc.275.1.189; Shibata R, 2001, CIRCULATION, V103, P284; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; Satoh K, 2014, J MOL CELL CARDIOL, V73, P50, DOI 10.1016/j.yjmcc.2013.12.022; Damsker JM, 2007, J LEUKOCYTE BIOL, V82, P613, DOI 10.1189/jlb.0506317; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Ikeda S, 2014, ARTERIOSCL THROM VAS, V34, P1260, DOI 10.1161/ATVBAHA.114.303320; Shimizu T, 2013, ARTERIOSCL THROM VAS, V33, P2780, DOI 10.1161/ATVBAHA.113.301357; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hattori T, 2004, CIRCULATION, V109, P2234, DOI 10.1161/01.CIR.0000127939.16111.58; Sandow SL, 2004, CLIN EXP PHARMACOL P, V31, P563, DOI 10.1111/j.1440-1681.2004.04048.x; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Sawada N, 2000, CIRCULATION, V101, P2030; Kikuchi Y, 2011, J AM COLL CARDIOL, V58, P1231, DOI 10.1016/j.jacc.2011.05.046; CHEN G, 1988, BRIT J PHARMACOL, V95, P1165; Nakajima S, 2012, CIRC RES, V111, P87, DOI 10.1161/CIRCRESAHA.112.270215; Prysyazhna O, 2012, NAT MED, V18, P286, DOI 10.1038/nm.2603; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246; Satoh K, 2010, CIRC J, V74, P2249, DOI 10.1253/circj.CJ-10-0904; Vanhoutte PM, 2001, J CLIN INVEST, V107, P23, DOI 10.1172/JCI11832; Morikawa K, 2003, J CLIN INVEST, V112, P1871, DOI 10.1172/JCI200319351; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI 10.1152/ajpheart.00327.2011; Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1302.105938; Takaki A, 2008, J EXP MED, V205, P2053, DOI 10.1084/jem.20080106; Weintraub NL, 2009, NEW ENGL J MED, V361, P1114, DOI 10.1056/NEJMcibr0905244; Shimokawa H, 2010, PFLUG ARCH EUR J PHY, V459, P915, DOI 10.1007/s00424-010-0790-8; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Sauzeau V, 2001, CIRC RES, V88, P1102, DOI 10.1161/hh1101.092034; Fukumoto Y, 2005, HEART, V91, P391, DOI 10.1136/hrt.2003.029470; GRIENDLING KK, 1994, CIRC RES, V74, P1141; Matsumoto Y, 2004, ARTERIOSCL THROM VAS, V24, P181, DOI 10.1161/01.ATV.0000105053.46994.5B; Suzuki J, 2006, CIRC RES, V98, P811, DOI 10.1161/01.RES.0000216405.85080.a6; Fukumoto Y, 2013, CIRC J, V77, P2619, DOI 10.1253/circj.CJ-13-0443; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Funakoshi Y, 2001, HYPERTENSION, V38, P100; Berk BC, 2001, PHYSIOL REV, V81, P999; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; BERK BC, 1986, SCIENCE, V232, P87, DOI 10.1126/science.3485309; Cohen RA, 2006, TRENDS CARDIOVAS MED, V16, P109, DOI 10.1016/j.tcm.2006.02.001; Elias-Al-Mamun M, 2014, CIRC J, V78, P967, DOI 10.1253/circj.CJ-13-1174; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Eto Y., 2000, AM J PHYSIOL-HEART C, V278, pH1744; Feletou M, 2007, ANN MED, V39, P495, DOI 10.1080/07853890701491000; Griendling KK, 1987, HYPERTENSION, V9; Hizume T, 2006, CIRC RES, V99, P767, DOI 10.1161/01.RES.0000244093.69985.2f; Khromykh LM, 2007, CELL IMMUNOL, V249, P46, DOI 10.1016/j.cellimm.2007.11.002; Kishi H, 2000, J BIOCHEM-TOKYO, V128, P719; Mohri M, 2003, J AM COLL CARDIOL, V41, P15, DOI 10.1016/S0735-1097(02)02632-3; Neco P, 2004, J BIOL CHEM, V279, P27450, DOI 10.1074/jbc.M311462200; Nihei T, 2012, CIRC J, V76, P2892, DOI 10.1253/circj.CJ-12-1238; Nihei T, 2014, CIRC J, V78, P1183, DOI 10.1253/circj.CJ-13-1458; Nishida M, 2006, MICROCIRCULATION, V13, P535, DOI 10.1080/10739680600885111; Rashid M, 2009, CIRC J, V73, P361; Satoh K, 2013, CIRC J, V77, P447, DOI 10.1253/circj.CJ-12-0805; Satoh K, 2008, CIRCULATION, V117, P3088, DOI 10.1161/CIRCULATIONAHA.107.756106; Satoh K, 2006, CIRCULATION, V113, P1442, DOI 10.1161/CIRCULATIONAHA.105.583732; Satoh K, 2009, CARDIOVASC RES, V81, P226, DOI 10.1093/cvr/cvn244; Sauzeau V, 2000, AM J PHYSIOL-HEART C, V278, pH1751; Seasholtz TM, 1999, CIRC RES, V84, P1186; Shimizu S, 2014, HANDB EXP PHARMACOL, V223, P767, DOI 10.1007/978-3-319-05161-1_3; Shimokawa Hiroaki, 2002, Journal of Cardiovascular Pharmacology, V40, P751, DOI 10.1097/00005344-200211000-00013; SHIMOKAWA H, 1983, SCIENCE, V221, P560, DOI 10.1126/science.6408736; Shimokawa H., 2014, EUR HEART J IN PRESS; Shimokawa H, 2002, J CARDIOVASC PHARM, V39, P319, DOI 10.1097/00005344-200203000-00001; Shimokawa H, 2000, JPN CIRC J, V64, P1, DOI 10.1253/jcj.64.1; Shimokawa H, 2001, CARDIOVASC RES, V51, P169, DOI 10.1016/S0008-6363(01)00291-7; Soe NN, 2013, ARTERIOSCL THROM VAS, V33, P2147, DOI 10.1161/ATVBAHA.113.301894; Takagi Y, 2009, CIRC J, V73, P767; Takaki A, 2008, J CARDIOVASC PHARM, V52, P510, DOI 10.1097/FJC.0b013e318190358b; Takeda K, 2001, ARTERIOSCL THROM VAS, V21, P868; Tsuburaya R, 2012, EUR HEART J, V33, P791, DOI 10.1093/eurheartj/ehr145; Amerongen GPV, 2000, CIRC RES, V87, P335; Vanhoutte PM, 2000, J AUTONOM NERV SYST, V81, P271, DOI 10.1016/S0165-1838(00)00126-0; Wang L, 2010, J CLIN IMMUNOL, V30, P24, DOI 10.1007/s10875-009-9329-1	108	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0160-2446	1533-4023		J CARDIOVASC PHARM	J. Cardiovasc. Pharmacol.	MAY	2015	65	5					412	418				7	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	CJ3FR	WOS:000355369300003		
J	Ohkura, Y; Obayashi, S; Yamada, K; Yamada, M; Kubota, T				Ohkura, Yoshinori; Obayashi, Satoshi; Yamada, Kazuki; Yamada, Mikiko; Kubota, Toshiro			S-equol Partially Restored Endothelial Nitric Oxide Production in Isoflavone-deficient Ovariectomized Rats	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY			English	Article						S-equol; isoflavone; nitric oxide; endothelial nitric oxide synthase; vascular endothelial cells	ESTROGEN-RECEPTOR-ALPHA; HUMAN UTERINE ARTERIES; HORMONE REPLACEMENT THERAPY; RANDOMIZED CONTROLLED-TRIAL; POSTMENOPAUSAL WOMEN; INTIMAL HYPERPLASIA; PROSTAGLANDIN I-2; GENE-EXPRESSION; PLUS PROGESTIN; CAROTID-ARTERY	Background: S-equol is known as an estrogenic substance, but its ability to restore vascular endothelial function is unknown. The aim of this study was to investigate the impact of S-equol on endothelial function and intimal thickening under isoflavone- and estrogen-deficient circumstances. Methods: Twelve-week-old female Sprague Dawley rats were bilaterally ovariectomized and assigned to one of the 3 groups: control, isoflavone-deficient (ID), or ID plus equol (n = 12, respectively). The control group received a normal diet containing isoflavones, while ID and ID plus equol groups received isoflavones-free diet. At 16th week, subcutaneous administration of S-equol (200 mu g/d) started in the ID plus equol group. At 18th week, endothelial denudation of the left common carotid artery was performed in all groups, and thoracic and carotid arteries were collected at 20th week. Results: In thoracic artery, endothelium-dependent relaxation, cyclic guanosine monophosphate levels in the tissue, and endothelial nitric oxide (NO) synthase expression and phosphorylation were significantly higher in the groups of ID plus equol and control than in the ID. The ratio of intima to media of the injured carotid artery in the control group was the lowest. Conclusions: Removal of dietary soy isoflavones decreased endothelium-derived NO level in ovariectomized rats. S-equol supplementation partially improved NO-related endothelial function.	[Ohkura, Yoshinori; Obayashi, Satoshi; Yamada, Kazuki; Yamada, Mikiko; Kubota, Toshiro] Tokyo Med & Dent Univ, Grad Sch, Dept Comprehens Reprod Med, Tokyo 1138519, Japan	Obayashi, S (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Comprehens Reprod Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	s.obayashi.gyne@tmd.ac.jp			Saga Nutraceuticals Research Institute; Otsuka Pharmaceutical Co, Ltd; Ministry of Education, Culture, Sports, Science and Technology, Japan [23592438]	Supported by Saga Nutraceuticals Research Institute and Otsuka Pharmaceutical Co, Ltd and supported in part by grants-in-aid for scientific research to S. Obayashi (Project Number: 23592438) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Hwang CS, 2006, J STEROID BIOCHEM, V101, P246, DOI 10.1016/j.jsbmb.2006.06.020; Tan EQ, 1999, CARDIOVASC RES, V43, P788, DOI 10.1016/S0008-6363(99)00159-5; Setchell KDR, 2002, J NUTR, V132, P3577; Cushman M, 2004, JAMA-J AM MED ASSOC, V292, P1573, DOI 10.1001/jama.292.13.1573; Muthyala RS, 2004, BIOORGAN MED CHEM, V12, P1559, DOI 10.1016/j.bmc.2003.11.035; Nagel SC, 1998, P SOC EXP BIOL MED, V217, P300; Fanti P, 1999, J AM SOC NEPHROL, V10, P864; Jackson RL, 2011, NUTR REV, V69, P432, DOI 10.1111/j.1753-4887.2011.00400.x; Oseni T, 2008, PLANTA MED, V74, P1656, DOI 10.1055/s-0028-1088304; Simoncini T, 2000, NATURE, V407, P538; Tousen Y, 2011, MENOPAUSE, V18, P563, DOI 10.1097/gme.0b013e3181f85aa7; Cardozo L, 1998, OBSTET GYNECOL, V92, P722, DOI 10.1016/S0029-7844(98)00175-6; Nelson HD, 2004, JAMA-J AM MED ASSOC, V291, P1610, DOI 10.1001/jama.291.13.1610; Bath PMW, 2005, BRIT MED J, V330, P342, DOI 10.1136/bmj.38331.655347.8F; Ishibahshi T, 2006, J CARDIOVASC PHARM, V47, P37, DOI 10.1097/01.fjc.0000192149.83008.dc; Aso T, 2012, J WOMENS HEALTH, V21, P92, DOI 10.1089/jwh.2011.2753; Chambliss KL, 2002, ENDOCR REV, V23, P665, DOI 10.1210/er.2001.0045; Setchell KDR, 2005, AM J CLIN NUTR, V81, P1072; Curtis PJ, 2013, AM J CLIN NUTR, V97, P936, DOI 10.3945/ajcn.112.043745; Cai Y, 2012, BRIT J NUTR, V108, P1698, DOI 10.1017/S0007114511007331; Lund TD, 2004, BIOL REPROD, V70, P1188, DOI 10.1095/biolreprod.103.023713; Brouchet L, 2001, CIRCULATION, V103, P423; Akaza H, 2004, JPN J CLIN ONCOL, V34, P86, DOI 10.1093/jjco/hyh015; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; AZUMA H, 1995, BRIT J PHARMACOL, V114, P902; Finking G, 1999, CORONARY ARTERY DIS, V10, P607, DOI 10.1097/00019501-199912000-00010; Haynes MP, 2002, VASC PHARMACOL, V38, P99, DOI 10.1016/S0306-3623(02)00133-7; Kang JS, 2007, INT IMMUNOPHARMACOL, V7, P491, DOI 10.1016/j.intimp.2006.12.004; LUNDH TJO, 1988, J ASSOC OFF ANA CHEM, V71, P938; Makela S, 1999, P NATL ACAD SCI USA, V96, P7077, DOI 10.1073/pnas.96.12.7077; Obayashi S, 1996, BRIT J PHARMACOL, V119, P1072; Obayashi S, 2001, J CARDIOVASC PHARM, V38, P240, DOI 10.1097/00005344-200108000-00010; Rosenfeld CR, 2003, J SOC GYNECOL INVEST, V10, P205, DOI 10.1016/S1071-5576(03)00049-2; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321; Schwen RJ, 2012, FOOD CHEM TOXICOL, V50, P1741, DOI 10.1016/j.fct.2012.02.039; Shor D, 2012, EUR J NUTR, V51, P389, DOI 10.1007/s00394-012-0331-7; Usui T, 2013, CLIN ENDOCRINOL, V78, P365, DOI 10.1111/j.1365-2265.2012.04400.x; Wells G, 2002, ENDOCR REV, V23, P529, DOI 10.1210/er.2001.5002; Yoneda T, 2011, MENOPAUSE, V18, P814, DOI 10.1097/gme.0b013e318208fb0d; Yu JY, 2008, J PHARMACOL SCI, V107, P90, DOI 10.1254/jphs.08001FP	40	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0160-2446	1533-4023		J CARDIOVASC PHARM	J. Cardiovasc. Pharmacol.	MAY	2015	65	5					500	507				8	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	CJ3FR	WOS:000355369300014		
J	Nashun; Iwami, K; Umeda, N				Nashun; Iwami, Kentaro; Umeda, Norihiro			Microfabrication of a Free-Standing NiW Alloy Film as a Wavelength-Selective Surface	JOURNAL OF COMPUTATIONAL AND THEORETICAL NANOSCIENCE			English	Article						MEMS; Ni-W Alloy; Wavelength-Selective Surface; Microfabrication; Thermophotovoltaic Power	THERMAL-RADIATION; THERMOPHOTOVOLTAIC GENERATION; RESONANCES; TRANSPORT; GRATINGS	We here report a method for fabricating a heat-resistant alloy based on NiW electroplating and silicon lost-molding processes. A periodic micropattern was fabricated on a silicon mold by electron-beam lithography and deep reactive-ion etching. A heat-resistive NiW alloy film with a thickness of 2.1 mu m was subsequently electroplated onto an Au seed layer deposited on the silicon mold, following which the silicon mold was finally etched, and a free-standing NiW alloy film was released. The NiW film was characterized by energy-dispersive X-ray spectrometry and Fourier transform infrared spectrophotometer. The film contained 24.6 at% tungsten, and its melting point was estimated to be 1675 degrees C. Modification of the film's spectral reflectivity was confirmed, and an emission peak at 1.4 mu m was observed; This emission wavelength agrees well with the absorption band of a conventional infrared photovoltaic cell of Ge. Thermophotovoltaic power generation was demonstrated using a Ge photodiode and Joule heating of the nnicropatterned NiW film, and a radiation efficiency of 9.13 x 10(-6) was achieved.	[Nashun; Iwami, Kentaro; Umeda, Norihiro] Tokyo Univ Agr & Technol, Dept Mech Syst Engn, Koganei, Tokyo 1848588, Japan	Iwami, K (reprint author), Tokyo Univ Agr & Technol, Dept Mech Syst Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.		Iwami, Kentaro/B-9325-2008	Iwami, Kentaro/0000-0002-4458-5704	Japan Society for the Promotions of Science (JSPS) [23686016]; VLSI Design and Education Center (VDEC) at the University of Tokyo	This work was supported by a Grant-in-Aid (No. 23686016) for scientific research from the Japan Society for the Promotions of Science (JSPS). This work was also supported by the VLSI Design and Education Center (VDEC) at the University of Tokyo.	Abu-Salih S, 2014, J COMPUT THEOR NANOS, V11, P1074, DOI 10.1166/jctn.2014.3464; Adhikari S. M., 2013, QUANTUM MATTER, V2, P455; Maruyama S, 2001, APPL PHYS LETT, V79, P1393, DOI 10.1063/1.1397759; Raffah BM, 2014, J COMPUT THEOR NANOS, V11, P1049, DOI 10.1166/jctn.2014.3461; Sai H, 2004, APPL PHYS LETT, V85, P3399, DOI 10.1063/1.1807031; Eliaz N, 2005, ELECTROCHIM ACTA, V50, P2893, DOI 10.1016/j.electacta.2004.11.038; Lopez-Rios T, 1998, PHYS REV LETT, V81, P665, DOI 10.1103/PhysRevLett.81.665; Florescu M, 2007, SOL ENERG MAT SOL C, V91, P1599, DOI 10.1016/j.solmat.2007.05.001; Mustafa M, 2014, J COMPUT THEOR NANOS, V11, P1107, DOI 10.1166/jctn.2014.3469; Bermel P, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-549; Bose P. K., 2012, QUANTUM MATTER, V1, P89; Celasun S., 2013, REV THEOR SCI, V1, P319; Fiscaletti D., 2013, REV THEOR SCI, V1, P103; Han YF, 2014, J COMPUT THEOR NANOS, V11, P702, DOI 10.1166/jctn.2014.3414; Herman A., 2013, REV THEOR SCI, V1, P3; Ibrahim M., 2013, REV THEOR SCI, V1, P368; Ikeda H., 1999, IEE JAPAN E, V119-E, P598; Khrennikov A., 2013, REV THEOR SCI, V1, P34; Kirikae D, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/10/104006; Okamoto H., 2010, DESK HDB PHASE DIAGR, P626; Olszewski S., 2013, REV THEOR SCI, V1, P344; Paitya N., 2013, J COMPUT THEOR NANOS, V1, P165; Pankratov E. L, 2013, REV THEOR SCI, V1, P58; Pankratov E. L., 2013, REV THEOR SCI, V1, P307; Sai H, 2004, AIP CONF PROC, V738, P206; Wang J. F., 2013, QUANTUM MATTER, V2, P289; Wu C., 2012, J OPT, V14; Zhao Q., 2013, REV THEOR SCI, V1, P83	28	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1546-1955	1546-1963		J COMPUT THEOR NANOS	J. Comput. Theor. Nanosci.	MAY	2015	12	5			SI		814	819		10.1166/jctn.2015.3809		6	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CJ6AI	WOS:000355575000021		
J	Hamano, M				Hamano, Masashige			International equity and bond positions in a DSGE model with variety risk in consumption	JOURNAL OF INTERNATIONAL ECONOMICS			English	Article						Real exchange rate; Home biased equity puzzle; Firm entry; Firm heterogeneity	DIVERSIFICATION PUZZLE; MONOPOLISTIC COMPETITION; BUSINESS CYCLES; TRADE; PRODUCTIVITY; PORTFOLIOS; THINK	This paper analyzes equity and bond positions in a two-country Dynamic Stochastic General Equilibrium model where the number of varieties, i.e., the extensive margins of products available to consumers, is endogenously determined. Fluctuations in the welfare-based real exchange rate, including those in the number of varieties, matter to international consumption risk sharing. We investigate the implication of such "variety risk" for the optimal portfolio choice and show that the variety risk generates home-biased equity positions, strengthening those obtained with the standard model in the literature. We also find preliminary empirical support for the mechanism. (C) 2014 Elsevier B.V. All rights reserved.	[Hamano, Masashige] Sophia Univ, Tokyo 1028554, Japan; [Hamano, Masashige] Univ Luxembourg, CREA, Luxembourg, Luxembourg	Hamano, M (reprint author), Sophia Univ, Chiyoda Ku, Yotsuya Campus,2 Go Kan,1123,7-1 Kioi Cho, Tokyo 1028554, Japan.	masahige.hamano@gmail.com			National Research Fund, Luxembourg; European Commission [1029180]; JSPS KAKENHI [25885071]	I would like to thank E. Van Wincoop, two anonymous referees and Philippe Martin for their encouragement and guidance. I would also like to thank Marta Arespa Castello, Nicolas Coeurdacier, Michael B. Devereux, Ippei Fujiwara, Fabio Ghironi, Robert Kollmann, Isabelle Mejean, Pierre M. Picard, Ridwan D. Rusli and Simeon Vosen for providing helpful comments and discussions. This project is supported by the National Research Fund, Luxembourg, and cofounded under the Marie Curie Actions of the European Commission (FP7-COFUND) (Grant Number 1029180) and JSPS KAKENHI Grant Number 25885071. Of course, all remaining errors are my own.	Heathcote J, 2013, J POLIT ECON, V121, P1108, DOI 10.1086/674143; Bernard AB, 2003, AM ECON REV, V93, P1268, DOI 10.1257/000282803769206296; Heathcote J, 2002, J MONETARY ECON, V49, P601, DOI 10.1016/S0304-3932(02)00103-4; Devereux MB, 2011, J EUR ECON ASSOC, V9, P337, DOI 10.1111/j.1542-4774.2010.01010.x; Melitz MJ, 2003, ECONOMETRICA, V71, P1695, DOI 10.1111/1468-0262.00467; Sercu P, 2008, REV FINANC, V12, P587, DOI 10.1093/rof/rfn021; Tille C, 2010, J INT ECON, V80, P157, DOI 10.1016/j.jinteco.2009.11.003; Gourinchas PO, 2007, J POLIT ECON, V115, P665, DOI 10.1086/521966; DIXIT AK, 1977, AM ECON REV, V67, P297; Bilbiie FO, 2012, J POLIT ECON, V120, P304, DOI 10.1086/665825; Obstfeld M, 2001, NBER MACROECON ANN, V15, P339; Hummels D, 2005, AM ECON REV, V95, P704, DOI 10.1257/0002828054201396; Broda C, 2004, AM ECON REV, V94, P139, DOI 10.1257/0002828041301443; Lane PR, 2007, J INT ECON, V73, P223, DOI 10.1016/j.jinteco.2007.02.003; Coeurdacier N, 2009, J INT ECON, V77, P86, DOI 10.1016/j.jinteco.2008.10.005; Broda C, 2010, AM ECON REV, V100, P691, DOI 10.1257/aer.100.3.691; Schmitt-Grohe S, 2003, J INT ECON, V61, P163, DOI 10.1016/S0022-1996(02)00056-9; Baxter M, 1997, AM ECON REV, V87, P170; Benassy JP, 1996, ECON LETT, V52, P41, DOI 10.1016/0165-1765(96)00834-8; Broda C, 2006, Q J ECON, V121, P541, DOI 10.1162/qjec.2006.121.2.541; Coeurdacier N, 2010, J INT ECON, V80, P100, DOI 10.1016/j.jinteco.2009.05.006; Coeurdacier N., 2011, CEPR DISCUSSION PAPE, V8649; Coeurdacier N., 2009, NBER INT SEM MACR 20, P231; Collard F., 2007, NBER WORKING PAPERS, V13612; Corsetti G, 2007, J INT ECON, V73, P99, DOI 10.1016/j.jinteco.2006.08.005; Devereux MB, 2010, J INT ECON, V80, P129, DOI 10.1016/j.jinteco.2009.06.001; Engel C., 2009, IMF WORKING PAPERS, V09; Engel C, 2009, AM ECON J-MACROECON, V1, P155, DOI 10.1257/mac.1.2.155; FRENCH KR, 1991, AM ECON REV, V81, P222; Ghironi F, 2005, Q J ECON, V120, P865, DOI 10.1093/qje/120.3.865; Hamano M, 2013, J INT MONEY FINANC, V36, P26, DOI 10.1016/j.jimonfin.2013.03.001; Klenow P., 2013, 2013 M PAPERS SOC EC, V471; Lane P. R., 2003, CEPR DISCUSSION PAPE, V3769; Lane P.R., 2007, G7 CURRENT ACCOUNT I, P67; Matsumoto A., 2007, IMF WORKING PAPERS, V07; Uhlig H., 1998, QM RBC CODES QUANTIT; van Wincoop E, 2010, J INT MONEY FINANC, V29, P1108, DOI 10.1016/j.jimonfin.2009.12.003	37	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1996	1873-0353		J INT ECON	J. Int. Econ.	MAY	2015	96	1					212	226		10.1016/j.jinteco.2014.12.002		15	Economics	Business & Economics	CJ4ZY	WOS:000355498400014		
J	Morrison, S				Morrison, Scott			Secularizing Islamists? Jama'at-e-Islami and Jama'at-ud-Da'wa in Urban Pakistan	JOURNAL OF ISLAMIC STUDIES			English	Book Review									[Morrison, Scott] Akita Univ, Akita 010, Japan	Morrison, S (reprint author), Akita Univ, Akita 010, Japan.	smsmorrison@gmail.com					IQTIDAR H, 2014, SECULARIZING ISLAMIS	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0955-2340	1471-6917		J ISLAM STUD	J. Islam. Stud.	MAY	2015	26	2					229	232		10.1093/jis/etu090		4	Humanities, Multidisciplinary	Arts & Humanities - Other Topics	CJ7JV	WOS:000355672100013		
J	Kawasaki, R				Kawasaki, Ryo			Roth-Postlewaite stability and von Neumann-Morgenstern stability	JOURNAL OF MATHEMATICAL ECONOMICS			English	Article						Market with indivisibilities; RP-stable allocations; VNM-stable set	INDIVISIBLE GOODS; SOCIAL SITUATIONS; ALLOCATION; MARKETS; GAME	In the framework of the indivisible goods market defined in Shapley and Scarf (1974), Roth and Postlewaite (1977) define an allocation to be (RP-)stable if no coalition of agents can benefit from a reallocation of goods after the allocation has been decided upon. In this paper, we show that the set of RP-stable allocations is the unique von Neumann-Morgenstern (vNM-) stable set of the following domination relation: an allocation y dominates x if there is a coalition S that blocks x using allocation y in the market with x as its initial endowment. This connection between the two stability concepts also carries over for the indivisible goods market with multiple types of Konishi et al. (2001). (C) 2015 Elsevier B.V. All rights reserved.	Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Dept Social Engn, Meguro Ku, Tokyo 1528552, Japan	Kawasaki, R (reprint author), Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Dept Social Engn, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528552, Japan.	kawasaki.r.aa@m.titech.ac.jp	Kawasaki, Ryo/B-8859-2015	Kawasaki, Ryo/0000-0001-9159-8121	Japan Society for the Promotion of Science (JSPS) [22830010, 26780115]	The author thanks Keisuke Bando, Jun Wako, two anonymous referees, the editor-in-chief, and participants at the UECE Lisbon Meetings 2014 Game Theory and Applications for very valuable comments that have immensely improved this paper. The author also thanks the Japan Society for the Promotion of Science (JSPS) for Financial support through the Research Activities Start-up (No. 22830010) and the Grants-in-Aid for Young Scientists (B) (No. 26780115).	Anno H., 2014, 2014201 WZB SPII; Bloch F, 2013, SOC CHOICE WELFARE, V40, P1, DOI 10.1007/s00355-011-0566-x; GREENBERG J, 1989, J ECON THEORY, V49, P278, DOI 10.1016/0022-0531(89)90082-3; Greenberg J., 1990, THEORY SOCIAL SITUAT; Kamijo Y, 2010, J MATH ECON, V46, P214, DOI 10.1016/j.jmateco.2009.11.005; Kawasaki R, 2010, MATH SOC SCI, V59, P46, DOI 10.1016/j.mathsocsci.2009.10.006; Klaus B, 2008, J MATH ECON, V44, P919, DOI 10.1016/j.jmateco.2007.05.013; Klaus B, 2010, J MATH ECON, V46, P817, DOI 10.1016/j.jmateco.2010.06.006; Konishi H., 2001, J MATH ECON, V25, P1; Kurino M, 2014, AM ECON J-MICROECON, V6, P258, DOI 10.1257/mic.6.1.258; Moulin H., 1995, COOPERATIVE MICROECO; Nakanishi N, 1999, GAME ECON BEHAV, V27, P132, DOI 10.1006/game.1998.0677; OLADI R, 2005, REV INT ECON, V13, P205, DOI 10.1111/j.1467-9396.2005.00499.x; Roth A. E., 1977, J MATH ECON, V4, P131, DOI 10.1016/0304-4068(77)90004-0; Serrano R, 2008, ECON J, V118, P1719, DOI 10.1111/j.1468-0297.2008.02187.x; Shapley L., 1974, J MATH ECON, V1, P23, DOI 10.1016/0304-4068(74)90033-0; SHITOVIT.B, 1973, ECONOMETRICA, V41, P467, DOI 10.2307/1913371; Sonmez T., 2011, HDB SOCIAL EC A, V1A, P781; von Neumann J., 1953, THEORY GAMES EC BEHA; Wako J, 2005, MATH SOC SCI, V49, P179, DOI 10.1016/j.mathsocsci.2004.08.003; Wako J., 2007, NONEXISTENCE VNM STA; Wako J., 2009, ENCY COMPLEXITY SY 3, P1518	22	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0304-4068			J MATH ECON	J. Math. Econ.	MAY	2015	58						1	6		10.1016/j.jmateco.2015.02.002		6	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	CJ2XP	WOS:000355348300001		
J	Naruse, T; Taguchi, A; Kuwahara, Y; Nagata, S; Sakai, M; Watai, I; Murashima, S				Naruse, Takashi; Taguchi, Atsuko; Kuwahara, Yuki; Nagata, Satoko; Sakai, Mahiro; Watai, Izumi; Murashima, Sachiyo			The effect of skill mix in non-nursing assistants on work engagements among home visiting nurses in Japan	JOURNAL OF NURSING MANAGEMENT			English	Article						community care; nursing management; skill mix; work engagement	REGISTERED NURSES; MEDIATING ROLE; JOB DEMANDS; RESOURCES; ENVIRONMENTS; PREDICTORS; COMMITMENT; BURNOUT; MODEL; CARE	Aim This study evaluated the effect of a skill-mix programme intervention on work engagement in home visiting nurses. Background A skill-mix programme in which home visiting nurses are assisted by non-nursing workers is assumed to foster home visiting nurses' work engagement. Method Pre- and post-intervention evaluations of work engagement were conducted using self-administered questionnaires. A skill-mix programme was introduced in the intervention group of home visiting nurses. After 6 months, their pre- and post-intervention work engagement ratings were compared with those of a control group. Result Baseline questionnaires were returned by 174 home visiting nurses (44 in the intervention group, 130 in the control group). Post-intervention questionnaires were returned by 38 and 97 home visiting nurses from each group. The intervention group's average work engagement scores were 2.2 at baseline and 2.3 at post-intervention; the control group's were 3.3 and 2.6. Generalised linear regression showed significant between-group differences in score changes. Conclusion The skill-mix programme might foster home visiting nurses' work engagement by improving the quality of care for each client. Future research is needed to explain the exact mechanisms that underlie its effectiveness. Implications for nursing management In order to improve the efficiency of services provided by home visiting nurses and foster their work engagement, skill-mix programmes might be beneficial.	[Naruse, Takashi; Nagata, Satoko; Sakai, Mahiro] Univ Tokyo, Grad Sch Med, Dept Community Hlth Nursing, Tokyo 1130033, Japan; [Taguchi, Atsuko] Tohoku Univ, Grad Sch Med, Nursing Sci Community Hlth Care Syst, Hlth Dev Nursing Sci,Hlth Sci, Sendai, Miyagi 980, Japan; [Watai, Izumi] Nagoya Univ, Grad Sch Med, Dept Nursing, Tokyo, Japan; [Murashima, Sachiyo] Oita Univ Nursing & Hlth Sci, Oita, Japan	Naruse, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Community Hlth Nursing, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	takanaruse-tky@umin.ac.jp			Health Care Science Institute, in Japan; Health Labour Sciences Research programme, in Japan	Financial support for this study was provided by the Health Care Science Institute and the Health Labour Sciences Research programme, both in Japan.	Abdelhadi N., 2011, J ADV NURS, V13, P1; Laschinger HKS, 2009, J NURS MANAGE, V17, P636, DOI 10.1111/j.1365-2834.2008.00907.x; Opie T, 2010, AUST J RURAL HEALTH, V18, P235, DOI 10.1111/j.1440-1584.2010.01161.x; Schaufeli WB, 2004, J ORGAN BEHAV, V25, P293, DOI 10.1002/job.248; Hobfoll SE, 2002, REV GEN PSYCHOL, V6, P307, DOI 10.1037//1089-2680.6.4.307; Simpson MR, 2009, WESTERN J NURS RES, V31, P44, DOI 10.1177/0193945908319993; Salanova M, 2011, J ADV NURS, V67, P2256, DOI 10.1111/j.1365-2648.2011.05652.x; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Gregory DM, 2007, HEALTH CARE MANAGE R, V32, P119; James B., 2002, B WORLD HEALTH ORGAN, V80, P79; Japan Visiting Nurse Foundation, 2011, HLTH LAB SCI RES REP, P80; Jenaro C, 2011, J ADV NURS, V67, P865, DOI 10.1111/j.1365-2648.2010.05526.x; Kanste O, 2011, SCAND J CARING SCI, V25, P754, DOI 10.1111/j.1471-6712.2011.00888.x; Langhorne R.C., 2006, VIRGINIA NURSES TODA, V14, P26; Lawrence H.P., 2010, J GERONTOLOGICAL NUR, V36, P18; Mary B.W., 2007, GLOBAL HLTH GLOBAL A, P15; Naruse T., 2013, HOME HLTH CARE MANAG, V25, P18; Naruse T, 2011, PUBLIC HEALTH NURS, V28, P223, DOI 10.1111/j.1525-1446.2010.00915.x; Naruse T, 2013, JPN J NURS SCI, V10, P267, DOI 10.1111/jjns.12003; O'Brien-Pallas L., 2000, NURS INQ, V7, P248, DOI 10.1046/j.1440-1800.2000.00072.x; Schaufeli WB, 2002, J HAPPINESS STUD, V3, P71, DOI DOI 10.1023/A:1015630930326; Shimazu A, 2008, APPL PSYCHOL-INT REV, V57, P510, DOI 10.1111/j.1464-0597.2008.00333.x; Shimazu A., 2007, J OCCUP HEALTH, V49, P77; Sidani B., 1998, EVALUATING NURSING I, P87; Simoens S, 2005, OECD HLTH WORKING PA, V19; Social Statistics Division Japan, 2010, SURV I EST LONG TERM; Laschinger HKS, 2006, J NURS ADMIN, V36, P259; Vinje Hege Forbech, 2008, J Nurses Staff Dev, V24, P195, DOI 10.1097/01.NND.0000320695.16511.08; Westman M., 2001, HUM RELAT, V54, P557, DOI [10.1177/0018726701546002, DOI 10.1177/0018726701546002]	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0966-0429	1365-2834		J NURS MANAGE	J. Nurs. Manag.	MAY	2015	23	4					532	541		10.1111/jonm.12167		10	Management; Nursing	Business & Economics; Nursing	CJ6RS	WOS:000355621900014		
J	Yamamoto, T				Yamamoto, Tetsuji			Frontier innovations for control of sarcomas	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Editorial Material									Kagawa Univ, Dept Orthopaed Surg, Miki, Kagawa 7610793, Japan	Yamamoto, T (reprint author), Kagawa Univ, Dept Orthopaed Surg, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	sanutetu@med.kagawa-u.ac.jp					Thomas D, 2010, LANCET ONCOL, V11, P275, DOI 10.1016/S1470-2045(10)70010-3; Le Cesne A, 2012, EUR J CANCER, V48, P3036, DOI 10.1016/j.ejca.2012.05.012; Long JA, 2012, UROLOGY, V80, P608, DOI 10.1016/j.urology.2012.02.081; Hameed M., 2014, EXPERT REV MOL DIAGN, V9, P1; Kasper B, 2011, FUTURE ONCOL, V7, P1373, DOI [10.2217/fon.11.116, 10.2217/FON.11.116]; Kataoka K, 2014, JPN J CLIN ONCOL, V44, P765, DOI 10.1093/jjco/hyu080; Yang JC, 2013, PEDIATR BLOOD CANCER, V60, P1616, DOI 10.1002/pbc.24502	7	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAY	2015	20	3					449	451		10.1007/s00776-015-0707-7		3	Orthopedics	Orthopedics	CJ6IV	WOS:000355598400001		
J	Shimaoka, M				Shimaoka, Motomu			Strategic career planning for physician-scientists	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							HAPPINESS; LEADERSHIP; SUCCESS	Building a successful professional career in the physician-scientist realm is rewarding but challenging, especially in the dynamic and competitive environment of today's modern society. This educational review aims to provide readers with five important career development lessons drawn from the business and social science literatures. Lessons 1-3 describe career strategy, with a focus on promoting one's strengths while minimizing fixing one's weaknesses (Lesson 1); effective time management in the pursuit of long-term goals (Lesson 2); and the intellectual flexibility to abandon/modify previously made decisions while embracing emerging opportunities (Lesson 3). Lesson 4 explains how to maximize the alternative benefits of English-language fluency (i.e., functions such as signaling and cognition-enhancing capabilities). Finally, Lesson 5 discusses how to enjoy happiness and stay motivated in a harsh, zero-sum game society.	[Shimaoka, Motomu] Mie Univ, Grad Sch Med, Dept Mol Pathobiol & Cell Adhes Biol, Tsu, Mie 5148507, Japan; [Shimaoka, Motomu] Mie Univ, Int Ctr Bioengn Res & Educ, Tsu, Mie 5148507, Japan	Shimaoka, M (reprint author), Mie Univ, Grad Sch Med, Dept Mol Pathobiol & Cell Adhes Biol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	shimaoka@doc.medic.mie-u.ac.jp					Ackerly DC, 2011, ACAD MED, V86, P575, DOI 10.1097/ACM.0b013e318212e51b; Boehm JK, 2008, J CAREER ASSESSMENT, V16, P101, DOI 10.1177/1069072707308140; Keysar B, 2012, PSYCHOL SCI, V23, P661, DOI 10.1177/0956797611432178; Pinsky LE, 1998, ADV HEALTH SCI EDUC, V3, P207, DOI 10.1023/A:1009749323352; Morewedge CK, 2010, TRENDS COGN SCI, V14, P435, DOI 10.1016/j.tics.2010.07.004; Boyce CJ, 2011, PSYCHOL SCI, V22, P1397, DOI 10.1177/0956797611421790; Costa A, 2014, NAT REV NEUROSCI, V15, P336, DOI 10.1038/nrn3709; Haase CM, 2012, PERS SOC PSYCHOL B, V38, P1093, DOI 10.1177/0146167212444906; Atesok KI, 2012, ACAD MED, V87, P592, DOI 10.1097/ACM.0b013e31824d2b57; Bhide AV, 1999, ORIGIN EVOLUTION NEW; Bongard B A, 1998, Imprint, V45, P34; BRICKMAN P, 1978, J PERS SOC PSYCHOL, V36, P917, DOI 10.1037/0022-3514.36.8.917; Covey S R, 1991, Natl Med Leg J, V2, P8; Drucker PF, 2004, HARVARD BUS REV, V82, P58; Duda Rosemary B, 2004, Curr Surg, V61, P175, DOI 10.1016/j.cursur.2003.08.018; Ghemawat P, 2005, HARVARD BUS REV, V83, P98; Gilbert Daniel, 2006, STUMBLING HAPPINESS; Groysberg B, 2010, HARVARD BUS REV, V88, P80; Hobin JA, 2014, CBE-LIFE SCI EDUC, V13, P49, DOI 10.1187/cbe-13-04-0085; Janke KK, 2011, AM J PHARM EDUC, V75; Porta CR, 2013, CLIN COLON RECT SURG, V26, P239, DOI 10.1055/s-0033-1356724; Shimaoka M, 2014, FLEXIBLE THINKING LI; Shimaoka M, 2009, MOTIVATIONAL GUIDE R; WEISS A, 1995, J ECON PERSPECT, V9, P133	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAY	2015	20	3					452	456		10.1007/s00776-015-0697-5		5	Orthopedics	Orthopedics	CJ6IV	WOS:000355598400002		
J	Shino, K; Mae, T; Tachibana, Y				Shino, Konsei; Mae, Tatsuo; Tachibana, Yuta			Anatomic ACL reconstruction: rectangular tunnel/bone-patellar tendon-bone or triple-bundle/semitendinosus tendon grafting	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							CRUCIATE LIGAMENT RECONSTRUCTION; CROSS-SECTIONAL AREA; TENSION	Anatomic ACL reconstruction is the reasonable approach to restore stability without loss of motion after ACL tear. To mimic the normal ACL like a ribbon, our preferred procedures is the anatomic rectangular tunnel (ART) technique with a bone-patellar tendon-bone (BTB) graft or the anatomic triple bundle (ATB) procedure with a hamstring (HS) tendon graft. It is important to create tunnel apertures inside the attachment areas to lessen the tunnel widening. To identify the crescent-shaped ACL femoral attachment area, the upper cartilage margin, the posterior cartilage margin and the resident's ridge are used as landmarks. To delineate the C-shaped tibial insertion, medial intercondylar ridge, Parson's knob and anterior horn of the lateral meniscus are helpful. In ART-BTB procedure which is suitable for male patients engaged in contact sports, the parallelepiped tunnels with rectangular apertures are made within the femoral and tibial attachment areas. In ATB-HS technique which is mainly applied to female athletes engaged in non-contact sports including skiing or basketball, 2 femoral and 3 tibial round tunnels are created inside the attachment areas. These techniques make it possible for the grafts to run as the native ACL without impingement to the notch or PCL. After femoral fixation with an interference screw or cortical fixation devices including Endobutton, the graft is pretensioned in situ by repetitive manual pulls at 15-20 degrees of flexion, monitoring the graft tension with tensioners on a tensioning boot installed on the calf. Tibial fixation with pullout sutures is achieved using Double Spike Plate and a screw at the pre-determined amount of tension of 10-20N. While better outcomes with less failure rate are being obtained compared to those in the past, higher graft tear rate remains a problem. Improved preventive training may be required to avoid secondary ACL injuries.	[Shino, Konsei] Yukioka Hosp, Sports Orthopaed Ctr, Kita Ku, Osaka 5300021, Japan; [Mae, Tatsuo; Tachibana, Yuta] Osaka Univ, Sch Med, Osaka, Japan	Shino, K (reprint author), Yukioka Hosp, Sports Orthopaed Ctr, Kita Ku, 2-2-3 Ukita, Osaka 5300021, Japan.	shinok0220@gmail.com			Smith & Nephew, Inc., Andover, MA, USA	One of the authors (KS) has received funding from Smith & Nephew, Inc., Andover, MA, USA.	Mae T, 2010, ARTHROSCOPY, V26, P1289, DOI 10.1016/j.arthro.2010.02.017; Hamada M, 2005, ARTHROSCOPY, V21, P917, DOI 10.1016/j.arthro.2005.05.006; Hamada M, 1998, ARTHROSCOPY, V14, P696, DOI 10.1016/S0749-8063(98)70096-9; Otsubo H, 2007, KNEE SURG SPORT TR A, V15, P720, DOI 10.1007/s00167-006-0274-8; NOYES FR, 1984, J BONE JOINT SURG AM, V66A, P344; Mae T, 2013, ARTHROSCOPY, V29, P213, DOI 10.1016/j.arthro.2012.08.012; Tanaka Y, 2012, KNEE SURG SPORT TR A, V20, P95, DOI 10.1007/s00167-011-1551-8; Hutchinson MR, 2003, ARTHROSCOPY, V19, P931, DOI 10.1016/S0749-8063(03)00809-0; Purnell ML, 2008, AM J SPORT MED, V36, P2083, DOI 10.1177/0363546508319896; Shino K, 2010, KNEE SURG SPORT TR A, V18, P1164, DOI 10.1007/s00167-009-0979-6; Shino K, 2005, ARTHROSCOPY, V21, P1402, DOI 10.1016/j.arthro.2005.08.017; Fujie H, 2011, KNEE SURG SPORT TR A, V19, pS47, DOI 10.1007/s00167-011-1513-1; Matsuo T, 2014, KNEE SURG SPORT TR A, V22, P2128, DOI 10.1007/s00167-013-2646-1; Shino K, 2012, CLIN ORTHOP RELAT R, V470, P843, DOI 10.1007/s11999-011-1948-1; Otsubo H, 2012, KNEE SURG SPORT TR A, V20, P127, DOI 10.1007/s00167-011-1576-z; Shino K, 2008, ARTHROSCOPY, V24, P1178, DOI 10.1016/j.arthro.2008.06.010; BERG EE, 1993, CLIN ORTHOP RELAT R, P229; Feretti M, 2007, ARTHROSCOPY, V23, P1218; Iwahashi T, 2010, ARTHROSCOPY, V26, pS13, DOI 10.1016/j.arthro.2010.01.023; Mae T, 2014, A P SMART, V1, P90; Norwood L A, 1979, Am J Sports Med, V7, P23, DOI 10.1177/036354657900700106; Shino K, 2005, OPER TECH ORTHOP, V15, P130, DOI 10.1053/j.oto.2004.10.012; Shino K, 2002, TECH KNEE SURG, V1, P78; Shino K, 2002, ARTHROSCOPY, V18, P908, DOI 10.1053/jars.2002.35267; Siebold R, 2015, KNEE SURG SPORT TR A, V23, P3136, DOI 10.1007/s00167-014-3058-6; Suzuki T, 2014, ARTHROSCOPY, V30, P1294, DOI 10.1016/j.arthro.2014.05.027; Suzuki T, 2011, KNEE SURG SPORT TR A, V19, pS29, DOI 10.1007/s00167-011-1481-5; Tachibana Y, 2015, KNEE SURG SPORT TR A, V23, P3591, DOI 10.1007/s00167-014-3252-6; Toritsuka Y, 2009, KNEE SURG SPORT TR A, V17, P456, DOI 10.1007/s00167-008-0707-7	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAY	2015	20	3					457	468		10.1007/s00776-015-0705-9		12	Orthopedics	Orthopedics	CJ6IV	WOS:000355598400003		
J	Yoshida, K; Sekiguchi, M; Otani, K; Mashiko, H; Shioda, H; Wakita, T; Niwa, S; Kikuchi, S; Konno, S				Yoshida, Katshuhiro; Sekiguchi, Miho; Otani, Koji; Mashiko, Hirobumi; Shioda, Harumi; Wakita, Takafumi; Niwa, Shin-ichi; Kikuchi, Shin-ichi; Konno, Shin-ichi			Computational psychological study of the Brief Scale for Psychiatric Problems in Orthopaedic Patients (BS-POP) for patients with chronic low back pain: verification of responsiveness	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							PRIMARY-CARE; NATURAL-HISTORY; DEPRESSION; DISABILITY; TRIAL; QUESTIONNAIRE; ASSOCIATION; PREDICTORS; EFFICACY; OPIOIDS	Background We developed the Brief Scale for Psychiatric Problems in Orthopaedic Patients (BS-POP, physician and patient versions) and have previously shown that the BS-POP is reliable and has construct validity, criterion validity, and reproducibility. The present study aimed to proactively verify the responsiveness of the BS-POP with regard to chronic low back pain (LBP) patients. Methods The study subjects included 193 chronic LBP patients (81 males, 112 females; mean age 62 years) who had suffered from persistent LBP for >= 3 months. During the first test (before the treatment), the BS-POP, the Minnesota Multiphasic Personality Inventory (MMPI), the Profile of Mood States (POMS), the 36-item Short-form Health Survey version 2 (SF-36 v2), and the Roland-Morris Disability Questionnaire (RDQ) were conducted. The BS-POP, POMS, SF-36 v2, and RDQ for the third test were conducted (4-6 weeks after treatment) on all patients who had participated in the first test to determine the responsiveness of the BS-POP. The responsiveness of the BS-POP was investigated statistically. Results The total crude BS-POP scores were significantly lower for both physician and patient versions in the third test than in the first test. Moreover, the crude RDQ scores and SF-36 v2 items, physical functioning (PF), bodily pain (BP), MH, VT, and GH, and POMS items, tension-anxiety (T-A), D, F, and confusion (C) improved significantly, confirming responsiveness to treatment. Discussion The present findings indicate that the BS-POP possesses sufficient responsiveness from a computational psychology perspective. The BS-POP constitutes a tool enabling orthopaedists to easily identify psychiatric problems in orthopaedic patients.	[Yoshida, Katshuhiro; Sekiguchi, Miho; Otani, Koji; Kikuchi, Shin-ichi; Konno, Shin-ichi] Fukushima Med Univ, Sch Med, Dept Orthopaed Surg, Fukushima 9601295, Japan; [Mashiko, Hirobumi; Shioda, Harumi; Niwa, Shin-ichi] Fukushima Med Univ, Sch Med, Dept Psychiat, Fukushima 9601295, Japan; [Wakita, Takafumi] Kansai Univ, Dept Social Psychol, Osaka, Japan; [Wakita, Takafumi] Inst Hlth Outcomes & Proc Evaluat Res iHope Int, Kyoto, Japan	Yoshida, K (reprint author), Fukushima Med Univ, Sch Med, Dept Orthopaed Surg, 1 Hikarigaoka, Fukushima 9601295, Japan.	kacchiro1031@hotmail.com			Japanese Orthopaedic Association; Japanese Orthopaedic Association [2007-1]	The authors would like to thank the many individuals who participated in the present study and the physicians who provided valuable advice. This study was supported by Research Aid from the Japanese Orthopaedic Association. This research is the Japanese Orthopaedic Association Subsidized Science Project Research 2007-1.	Trescot A, 2008, PAIN PHYSICIAN, V11, pS181; van der Windt D, 2008, SPINE, V33, P81, DOI 10.1097/BRS.0b013e31815e39f9; Trief PM, 2000, SPINE, V25, P2616, DOI 10.1097/00007632-200010150-00012; Bair MJ, 2008, PSYCHOSOM MED, V70, P890, DOI 10.1097/PSY.0b013e318185c510; Verdu B, 2008, DRUGS, V68, P2611, DOI 10.2165/0003495-200868180-00007; Linton SJ, 2006, SPINE, V31, P853, DOI 10.1097/01.brs.0000209258.42037.02; Smeets RJEM, 2006, J PAIN, V7, P261, DOI 10.1016/j.jpain.2005.10.011; Kroenke K, 2008, PAIN, V134, P209, DOI 10.1016/j.pain.2007.09.021; van Kleef M, 1999, SPINE, V24, P1937, DOI 10.1097/00007632-199909150-00013; Boos N, 1995, SPINE, V20, P2613, DOI 10.1097/00007632-199512150-00002; Ballantyne JC, 2008, CLIN J PAIN, V24, P469, DOI 10.1097/AJP.0b013e31816b2f26; FLOR H, 1992, PAIN, V49, P221, DOI 10.1016/0304-3959(92)90145-2; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Clark MR, 2009, CURR PSYCHIAT REP, V11, P243; Fukuhara S, 2004, MANUAL SF 36V2 JAPAN; GARRATT AM, 1993, BRIT MED J, V306, P1440; Hagen KB, 2000, SPINE, V25, P2480, DOI 10.1097/00007632-200010010-00010; Hathaway SR, 1983, MINNESOTA MULTIPHASI; Javik JG, 2005, SPINE, V30, P1541; KRISHNAN KRR, 1985, PAIN, V22, P279, DOI 10.1016/0304-3959(85)90028-4; McNair D. M., 1992, PROFILE MOOD STATES; Michel A, 1997, SPINE, V22, P296, DOI 10.1097/00007632-199702010-00013; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; ROLAND M, 1983, SPINE, V8, P145, DOI 10.1097/00007632-198303000-00005; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Schieir O, 2009, J RHEUMATOL, V36, P231, DOI 10.3899/jrheum.080147; SPENGLER DM, 1980, SPINE, V5, P356, DOI 10.1097/00007632-198007000-00008; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; WILTSE LL, 1975, J BONE JOINT SURG AM, VA 57, P478; Yoshida K, 2011, J ORTHOP SCI, V16, P7, DOI 10.1007/s00776-010-0012-4	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAY	2015	20	3					469	474		10.1007/s00776-015-0694-8		6	Orthopedics	Orthopedics	CJ6IV	WOS:000355598400004		
J	Yoshida, M; Goto, H; Nozaki, M; Nishimori, Y; Takenaga, T; Murase, A; Nagaya, Y; Iguchi, H; Kobayashi, M; Sugimoto, K; Otsuka, T				Yoshida, Masahito; Goto, Hideyuki; Nozaki, Masahiro; Nishimori, Yasuhiro; Takenaga, Tetsuya; Murase, Atsunori; Nagaya, Yuko; Iguchi, Hirotaka; Kobayashi, Masaaki; Sugimoto, Katsumasa; Otsuka, Takanobu			Postoperative evaluation of drill holes for arthroscopic Bankart repair with suture anchors by the use of computed tomography	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							AXILLARY NERVE; SHOULDER-JOINT; MIGRATION; INSERTION; SCREW	Background Here we investigated the angle and placement of bone holes for suture anchors using postoperative computed-tomography scapula scans. Methods The study group comprised 20 shoulders from 20 consecutive patients (13 males and seven females; mean age 23.4 years) who underwent arthroscopic Bankart repair. All anchors were inserted through the anterior portal after establishing a bone hole at the edge of the glenoid articular surface using a drill. Computed tomography images of the scapula were taken 1 month postoperatively and used to create three-dimensional scapula models with Mimics and Magics software. Bone holes in the anterior-inferior (3: 00-6: 00) position were assigned either to the non-perforated group if they were positioned entirely inside the glenoid bone or to the perforated group if the far cortex of the glenoid was penetrated by the drill. The angle between the glenoid articular surface and the bone hole was measured in the oblique coronal and transverse plane views. The length of the bone hole was also assessed. Results Of the 85 bone holes investigated, 42 were in the 3: 00-6: 00 position. Perforation was detected in 16 of these 42 holes (38.2 %). The angle in the oblique coronal plane view and the length of the bone hole were significantly larger in the non-perforated group than in the perforated group; however, the angle in the transverse plane view did not significantly differ between the two groups. Conclusions Before inserting an implant in the anterior-inferior area, the angle between the drill guide and the glenoid surface in the oblique coronal plane view should be carefully checked to ensure that the length of the hole inside the glenoid bone is adequate.	[Yoshida, Masahito; Goto, Hideyuki; Nozaki, Masahiro; Nishimori, Yasuhiro; Takenaga, Tetsuya; Murase, Atsunori; Nagaya, Yuko; Kobayashi, Masaaki; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthoped Surg, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Iguchi, Hirotaka] Nagoya City Univ, Grad Sch Med Sci, Dept Arthroplast Med, Nagoya, Aichi 4678601, Japan; [Sugimoto, Katsumasa] Nagoya Sports Clin, Nagoya, Aichi, Japan	Goto, H (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Orthoped Surg, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	hide-g@fj8.so-net.ne.jp					Eakin CL, 1998, AM J SPORT MED, V26, P505; Freehill MQ, 2003, AM J SPORT MED, V31, P643; DAVIDSON PA, 1995, ARTHROSCOPY, V11, P519, DOI 10.1016/0749-8063(95)90126-4; Bankart ASB, 1938, BRIT J SURG, V26, P23, DOI 10.1002/bjs.18002610104; Bostman OM, 1998, J BONE JOINT SURG AM, V80A, P1791; BRYAN WJ, 1986, AM J SPORT MED, V14, P113, DOI 10.1177/036354658601400203; Ekelund A, 1998, J SHOULDER ELB SURG, V7, P537, DOI 10.1016/S1058-2746(98)90208-7; Glueck D, 2005, AM J SPORT MED, V33, P742, DOI 10.1177/0363546504269254; Ilahi OA, 2004, ARTHROSCOPY, V20, P609, DOI 10.1016/j.arthro.2004.04.063; Lehtinen JT, 2004, ARTHROSCOPY, V20, P175, DOI 10.1016/j.arthro.2003.11.029; Lim TK, 2013, ARTHROSCOPY, V29, P31, DOI 10.1016/j.arthro.2012.08.013; Matthews L S, 1985, Arthroscopy, V1, P33, DOI 10.1016/S0749-8063(85)80076-1; Price, 2004, J BONE JT SURG AM, V86-A, P2135; Silver MD, 2000, ARTHROSCOPY, V16, P102, DOI 10.1016/S0749-8063(00)90136-1; Take Y, 2008, ARTHROSCOPY, V24, P251, DOI 10.1016/j.arthro.2008.01.007; Takubo Yoshinori, 2008, J Shoulder Elbow Surg, V17, pe16, DOI 10.1016/j.jse.2008.02.014; WOLF E M, 1989, Arthroscopy, V5, P201, DOI 10.1016/0749-8063(89)90172-2	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAY	2015	20	3					481	487		10.1007/s00776-015-0703-y		7	Orthopedics	Orthopedics	CJ6IV	WOS:000355598400006		
J	Tawada, K; Iguchi, H; Tanaka, N; Watanabe, N; Murakami, S; Hasegawa, S; Otsuka, T				Tawada, Kaneaki; Iguchi, Hirotaka; Tanaka, Nobuhiko; Watanabe, Nobuyuki; Murakami, Satona; Hasegawa, Shinichi; Otsuka, Takanobu			Is the canal flare index a reliable means of estimation of canal shape? Measurement of proximal femoral geometry by use of 3D models of the femur	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							HIP; MORPHOLOGY	Background The canal flare index (CFI; the ratio of the diameter of the femoral canal at the isthmus in the anteroposterior (A-P) view to the diameter of the medullary canal 20 mm above the lesser trochanter) is often used as a canal characteristic. Clinically, however, CFI measurements are sometimes untrustworthy because of femoral rotation and, especially, greater anteversion among Japanese patients. Our objectives were to analyze femoral geometry, by use of 3D CAD models, to evaluate the effects of rotational error, and to seek an index less affected by rotation. Methods Computed axial tomography (CAT) scan data from 60 femurs were used. By use of CAD software, 3D femoral models were created. The outside of the femur and the inside canal width 20 mm (P20) and 10 mm proximal (P10), and 10 mm (D10), 20 mm (D20), 30 mm (D30), and 40 mm (D40) distal from the center of the lesser trochanter, and at the isthmus were measured for different angles of femoral rotation. CFI, FFI (femoral flare index; the ratio of the extra-cortical diameters at the same levels as for the CFI), and other canal ratios (P20/D10, P20/D20, P20/D30, and P20/D40) were then calculated and the effect of rotational errors was investigated. Results Mean CFI, FFI, P20/D10, P20/D20, P20/D30, and P20/D40 were 4.29, 2.08, 2.05, 2.49, 2.85, and 3.09 in the position without rotational error. CFI was not related to anteversion but had a negative correlation with isthmus canal width (only). In contrast FFI was almost constant at approximately 2.1 for different anteversion and age. With regard to the effect of rotational error, CFI changed by 1.31, FFI by 0.40, P20/D10 by 0.41, P20/D20 by 0.40, P20/D30 by 0.59, and P20/D40 by 0.80 for a variety of rotational angles. Conclusions Outside femoral shape was little different for any person; as a result, FFI was almost constant. In contrast, CFI was revealed to be affected by canal width at the isthmus only. With regard to the effect of rotation, P20/D20 was much less affected by rotation than CFI; it could, therefore, be an appropriate index for expressing proximal canal shape.	[Tawada, Kaneaki; Tanaka, Nobuhiko; Watanabe, Nobuyuki; Murakami, Satona; Hasegawa, Shinichi; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthoped Surg, Nagoya, Aichi 4678601, Japan; [Iguchi, Hirotaka] Nagoya City Univ, Grad Sch Med Sci, Dept Arthroplast Med, Nagoya, Aichi 4678601, Japan	Tawada, K (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Orthoped Surg, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	mh23232004@yahoo.co.jp		Watanabe, Nobuyuki/0000-0001-9607-8328			Sariali E, 2009, J BONE JOINT SURG BR, V91B, P333, DOI 10.1302/0301-620X.91B3.21390; SMITH RW, 1964, SCIENCE, V145, P156, DOI 10.1126/science.145.3628.156; NOBLE PC, 1995, CLIN ORTHOP RELAT R, P31; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; RUBIN PJ, 1992, J BONE JOINT SURG BR, V74, P28; Leali A, 2007, INT ORTHOP, V31, P845, DOI 10.1007/s00264-006-0267-8; Khang G, 2003, CLIN ORTHOP RELAT R, P116, DOI 10.1097/01.blo.0000030502.43495.c1; Eckrich S G, 1994, J Arthroplasty, V9, P419, DOI 10.1016/0883-5403(94)90053-1; Husmann O, 1997, J ARTHROPLASTY, V12, P444, DOI 10.1016/S0883-5403(97)90201-1; BARTKO JJ, 1966, PSYCHOL REP, V19, P3; Clohisy JC, 2009, CLIN ORTHOP RELAT R, V467, P128, DOI 10.1007/s11999-008-0481-3; Fuku H, 1994, Nihon Seikeigeka Gakkai Zasshi, V68, P763; Hagiwara M, 1995, Nihon Seikeigeka Gakkai Zasshi, V69, P1147; Hirade T, 2008, NIHON JINKOUKANSETSU, V38, P568; Iguch H., 2008, NIHON JINKOUKANNSETS, V38, P110; NOBLE PC, 1988, CLIN ORTHOP RELAT R, P148; RUFF C B, 1982, Science (Washington D C), V217, P945, DOI 10.1126/science.7112107; Scuetz A., 1999, 85 SCI ASS ANN M NOV; Walker PS, 2000, CLIN ORTHOP RELAT R, P164; Xu HJ, 2010, CLIN ORTHOP RELAT R, V468, P3371, DOI 10.1007/s11999-010-1386-5	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAY	2015	20	3					498	506		10.1007/s00776-015-0704-x		9	Orthopedics	Orthopedics	CJ6IV	WOS:000355598400008		
J	Yoshimura, I; Kanazawa, K; Hagio, T; Minokawa, S; Asano, K; Naito, M				Yoshimura, Ichiro; Kanazawa, Kazuki; Hagio, Tomonobu; Minokawa, So; Asano, Kei; Naito, Masatoshi			The relationship between the lesion-to-ankle articular length ratio and clinical outcomes after bone marrow stimulation for small osteochondral lesions of the talus	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							ARTHROSCOPIC TREATMENT; TALAR DOME; DEFECT SIZE; STEM-CELLS; FOLLOW-UP; MICROFRACTURE; CARTILAGE; AGE; TRANSPLANTATION; REHABILITATION	Purpose The purpose of this study was to determine the relationship between the defect-to-ankle articular length ratio and clinical outcomes after arthroscopic bone marrow stimulation. Methods Seventeen male and 24 female patients (mean age 36.0 years, height 160.7 cm, weight 62.5 kg, body mass index 24.0) with an osteochondral lesion of the talus were treated with arthroscopic bone marrow stimulation and assessed using the Japanese Society for Surgery of the Foot (JSSF) ankle-hindfoot scale, Berndt and Harty scales and clinical outcome criteria. The lengths of the tibial and talar articular surfaces were defined from the anterior tip to posterior tip of the articular cartilage on sagittal magnetic resonance imaging scans. The size of the defect area was defined and determined for each patient on magnetic resonance images using coronal length, sagittal length, and area. The relationship between clinical outcome and sagittal tibia ratio (sagittal length of defect/length of tibia articular cartilage) and sagittal talus ratio (sagittal length of defect/length of talus articular cartilage) were assessed. Results The mean lesion length was 11 mm (range 6-14 mm), lesion size was 67 mm(2) (range 19-134 mm(2)), sagittal tibia ratio was 0.42 (range 0.21-0.75), and sagittal talus ratio was 0.32 (range 0.16-0.58). The mean JSSF scale improved from 74 (range 18-90) to 89 (range 67-100) postoperatively. Lesion area was not associated with the JSSF scale (r = -0.10, P = 0.52). Talus articular length (r = 0.64, P < 0.0001) and tibia articular length (r = 0.64, P < 0.0001) were correlated with patient height. The sagittal talus ratio and sagittal tibia ratio were not associated with the JSSF scale (r = -0.10, P = 0.55; r = -0.02, P = 0.90). Conclusion Arthroscopic bone marrow stimulation provides good clinical outcomes in small osteochondral lesions of the talus (< 15 mm). For small lesions, the lesion size is not a prognostic factor. Level of evidence: IV Retrospective Case Series.	[Yoshimura, Ichiro; Kanazawa, Kazuki; Hagio, Tomonobu; Minokawa, So; Asano, Kei; Naito, Masatoshi] Fukuoka Univ, Dept Orthoped Surg, Fac Med, Jonan Ku, Fukuoka 8140180, Japan	Yoshimura, I (reprint author), Fukuoka Univ, Dept Orthoped Surg, Fac Med, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	ichiroy813@gmail.com					Angthong C, 2013, KNEE SURG SPORT TR A, V21, P1418, DOI 10.1007/s00167-013-2364-8; Saxena A, 2007, AM J SPORT MED, V35, P1680, DOI 10.1177/0363546507303561; Hepple S, 1999, FOOT ANKLE INT, V20, P789; Cuttica DJ, 2011, FOOT ANKLE INT, V32, P1045, DOI 10.3113/FAI.2011.1045; RAMSEY PL, 1976, J BONE JOINT SURG AM, V58, P356; Bergman RJ, 1996, J BONE MINER RES, V11, P568; Niki H, 2005, J ORTHOP SCI, V10, P466, DOI 10.1007/s00776-005-0937-1; BERNDT AL, 1959, J BONE JOINT SURG AM, V41, P988; Choi WJ, 2009, AM J SPORT MED, V37, P1974, DOI 10.1177/0363546509335765; Zengerink M, 2010, KNEE SURG SPORT TR A, V18, P238, DOI 10.1007/s00167-009-0942-6; Tol JL, 2000, FOOT ANKLE INT, V21, P119; Ferkel RD, 2007, FOOT ANKLE INT, V28, P24, DOI 10.3113/FAI.2007.0005; Shepherd DET, 1999, ANN RHEUM DIS, V58, P27, DOI 10.1136/ard.58.1.27; D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115; Ferkel RD, 2008, AM J SPORT MED, V36, P1750, DOI 10.1177/0363546508316773; Schuman L, 2002, J BONE JOINT SURG BR, V84B, P364, DOI 10.1302/0301-620X.84B3.11723; Becher C, 2010, KNEE SURG SPORT TR A, V18, P656, DOI 10.1007/s00167-009-1036-1; Choi WJ, 2012, AM J SPORT MED, V40, P419, DOI 10.1177/0363546511423739; Choi WJ, 2013, AM J SPORT MED, V41, P126, DOI 10.1177/0363546512453302; CHRISTENSEN JC, 1994, J AM PODIAT MED ASSN, V84, P537; Chuckpalwong B, 2008, ARTHROSCOPY, V24, P106, DOI 10.1016/j.arthro.2007.07.022; Gobbi A, 2006, ARTHROSCOPY, V22, P1085, DOI 10.1016/j.arthro.2006.05.016; Hunt KJ, 2012, AM J SPORT MED, V40, P895, DOI 10.1177/0363546511434404; Lee KB, 2010, KNEE SURG SPORT TR A, V18, P247, DOI 10.1007/s00167-009-0914-x; Lee KB, 2009, AM J SPORT MED, V37, p63S, DOI 10.1177/0363546509348471; O'Loughlin PF, 2010, AM J SPORT MED, V38, P392, DOI 10.1177/0363546509336336; PAL GP, 1991, ANAT REC, V230, P570, DOI 10.1002/ar.1092300417; Robinson DE, 2003, J BONE JOINT SURG BR, V85B, P989, DOI 10.1302/0301-620X.85B7.13959; Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362; Sugimoto K, 2005, ARTHROSCOPY, V21, P401, DOI 10.1016/j.arthro.2004.12.005; Takao M, 2004, AM J SPORT MED, V32, P332, DOI 10.1177/0363546503261718; Takao M, 2012, AM J SPORT MED, V40, P447, DOI 10.1177/0363546511428581; Takao M, 2010, AM J SPORT MED, V38, P1653, DOI 10.1177/0363546510364839; van Bergen CJA, 2013, J BONE JOINT SURG AM, V95A, P519, DOI 10.2106/JBJS.L.00675; van Eekeren ICM, 2012, SPORTS MED, V42, P857, DOI 10.2165/11635420-000000000-00000; Yoshimura I, 2013, AM J SPORT MED, V41, P528, DOI 10.1177/0363546512472979	36	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAY	2015	20	3					507	512		10.1007/s00776-015-0699-3		6	Orthopedics	Orthopedics	CJ6IV	WOS:000355598400009		
J	Begum, RA; Ali, L; Takahashi, O; Fukui, T; Rahman, M				Begum, Rowshan Ara; Ali, Liaquat; Takahashi, Osamu; Fukui, Tsuguya; Rahman, Mahbubur			Bone mineral density: reference values and correlates for Bangladeshi women aged 16-65 years	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							DEPOT MEDROXYPROGESTERONE ACETATE; X-RAY ABSORPTIOMETRY; FEMALES 10-24 YEARS; ORAL-CONTRACEPTIVES; FEMORAL-NECK; YOUNG-WOMEN; PREMENOPAUSAL WOMEN; LUMBAR SPINE; PEAK; MASS	Background Studies examining the reference values of bone mineral density (BMD) and their patterns at different ages are largely based on data generated from developed countries. The objective of this study was to estimate reference values of BMD, along with their correlates, for women living in urban and suburban areas of Bangladesh. Methods Dual-energy X-ray absorptiometry scans were performed on 500 women 16-65 years of age. Reference values at the lumbar spine (LS) and femoral neck (FN) were estimated after adjusting for height and weight. In addition, multiple linear regression analysis was used to examine correlates of BMD at the LS and FN. Results Mean BMD was highest at the LS and FN in women 16-19 (1.001-1.007 g/cm(2)) and 16-22 years of age (0.880-0.888 g/cm(2)), respectively, and gradually declined with increasing age thereafter. BMD decreased at an annual rate of 0.0027 g/cm(2) at the LS and 0.0046 g/cm(2) at the FN among women aged 16-45 years. For women 46-65 years of age, the respective figures were 0.0073 and 0.0083 g/cm(2). In both age groups, body weight was positively associated with BMD at both sites, and with height only at the LS. In addition, years of pill use was positively associated with BMD at the LS among women aged 16-45 years. BMD levels at both sites began to decline during the early twenties among Bangladeshi women. Conclusions Age-specific BMD data generated in this study could be useful for interpreting bone densitometry data among women in Bangladesh and other South Asian countries.	[Begum, Rowshan Ara] Bangladesh Univ Hlth Sci, Dept Reprod & Child Hlth, Dhaka, Bangladesh; [Ali, Liaquat] Bangladesh Univ Hlth Sci, Dept Biochem & Cell Biol, Dhaka, Bangladesh; [Takahashi, Osamu; Fukui, Tsuguya] St Lukes Int Hosp, Ctr Clin Epidemiol, Chuo Ku, Tokyo 1048560, Japan; [Rahman, Mahbubur] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Rahman, Mahbubur] Univ Texas Med Branch, Ctr Interdisciplinary Res Womens Hlth, Galveston, TX 77555 USA	Rahman, M (reprint author), Univ Texas Med Branch, Dept Obstet & Gynecol, 301 Univ Blvd,John Sealy Annex,Room 3-108-D, Galveston, TX 77555 USA.	marahman@utmb.edu			St. Luke's Life Science Institute, Tokyo, Japan	Support for this study was provided by a grant from St. Luke's Life Science Institute, Tokyo, Japan. We thank Dr. Faisal Kabir, Director, Centre for Nuclear Medicine and Ultrasound, Sir Salimullah Medical College and Mitford Hospital, for providing us space and other facilities in order to conduct the interviewer-administered questionnaire survey.	Shin CS, 2010, BONE, V47, P378, DOI 10.1016/j.bone.2010.03.017; THEINTZ G, 1992, J CLIN ENDOCR METAB, V75, P1060, DOI 10.1210/jc.75.4.1060; Zemel BS, 2011, J CLIN ENDOCR METAB, V96, P3160, DOI 10.1210/jc.2011-1111; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Baim S, 2005, J CLIN DENSITOM, V8, P371, DOI 10.1385/JCD:8:4:371; Handa R, 2008, BEST PRACT RES CL RH, V22, P693, DOI 10.1016/j.berh.2008.04.002; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cromer BA, 2004, J ADOLESCENT HEALTH, V35, P434, DOI 10.1016/j.jadohealth.2004.07.005; Sabatier JP, 1996, OSTEOPOROSIS INT, V6, P141, DOI 10.1007/BF01623938; Begum RA, 2014, J COMMUN HEALTH, V39, P1071, DOI 10.1007/s10900-014-9853-7; Berenson AB, 2008, OBSTET GYNECOL, V112, P788, DOI 10.1097/AOG.0b013e3181875b78; Berenson AB, 2009, OSTEOPOROSIS INT, V20, P1439, DOI 10.1007/s00198-008-0817-6; Stevens J. A., 2006, Morbidity and Mortality Weekly Report, V55, P1221; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cromer BA, 2008, FERTIL STERIL, V90, P2060, DOI 10.1016/j.fertnstert.2007.10.070; Endrikat J, 2004, CONTRACEPTION, V69, P179, DOI 10.1016/j.contraception.2003.10.002; Haddock L, 1996, P R Health Sci J, V15, P5; Henry YM, 2004, OSTEOPOROSIS INT, V15, P263, DOI 10.1007/s00198-003-1542-9; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Kolle E, 2005, OSTEOPOROSIS INT, V16, P914, DOI 10.1007/s00198-004-1783-2; Lazcano-Ponce E, 2003, OSTEOPOROSIS INT, V14, P539, DOI 10.1007/s00198-002-1363-2; Lim JS, 2010, J CLIN DENSITOM, V13, P68, DOI 10.1016/j.jocd.2009.09.006; Lin YC, 2003, BONE, V32, P546, DOI 10.1016/S8756-3282(03)00062-0; Lloyd T, 1998, ARCH PEDIAT ADOL MED, V152, P998; MAIS V, 1993, CONTRACEPTION, V48, P445, DOI 10.1016/0010-7824(93)90134-S; Moyad MA, 2004, UROL CLIN N AM, V31, P321, DOI 10.1016/j.ucl.2004.01.008; Nappi C, 2003, CONTRACEPTION, V67, P355, DOI 10.1016/6S0010-7824(03)00025-8; Pitukcheewanont Pisit, 2013, Pediatr Endocrinol Rev, V10, P318; POLATTI F, 1995, CONTRACEPTION, V51, P221, DOI 10.1016/0010-7824(95)00036-A; Ravaud P, 1999, J BONE MINER RES, V14, P1449, DOI 10.1359/jbmr.1999.14.8.1449; Sabatier JP, 1999, OSTEOPOROSIS INT, V9, P476, DOI 10.1007/s001980050173; Sousa MDB, 2013, J CLIN DENSITOM, V16, P360, DOI 10.1016/j.jocd.2013.01.005; World Health Organization, 1999, SMOK QUEST MONICA 3; Yi KH, 2004, J BONE MINER METAB, V32, P281	34	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAY	2015	20	3					522	528		10.1007/s00776-015-0695-7		7	Orthopedics	Orthopedics	CJ6IV	WOS:000355598400012		
J	Usman, MA; Nakasa, T; Shoji, T; Kato, T; Kawanishi, Y; Hamanishi, M; Kamei, N; Ochi, M				Usman, Muhammad Andry; Nakasa, Tomoyuki; Shoji, Takeshi; Kato, Tomohiro; Kawanishi, Yoshitaka; Hamanishi, Michio; Kamei, Naosuke; Ochi, Mitsuo			The effect of administration of double stranded MicroRNA-210 on acceleration of Achilles tendon healing in a rat model	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							INJECTION; RUPTURES; REPAIR; EXPRESSION; LIGAMENT; ARTHRITIS; COLLAGEN; HYPOXIA	Background Achilles tendons heal slower than other tissues, therefore requiring the developmnent of a strategy for accelerating the process. Vascular supply plays an important role in primary tendon healing, especially during the early healing phase. MicroRNA (miR)-210 has been reported as being crucial for angiogenesis, which is a key factor of tissue repair. We report herein that local injection of synthetic miR-210 into the injured Achilles tendon of a rat accelerated healing of the tendon. Methods Achilles tendons were transected and repaired via the Kessler suture technique in Sprague-Dawley rats. Then, double stranded (ds) miR-210 was injected into the repaired sites. The control group was injected with non-functioned dsRNA. At 2, 6 and 12 weeks, histological evaluations were performed. At two and six weeks, mechanical testing and angiogenesis were evaluated. Gene expression analysis using real-time polymerase chain reaction (PCR) and immunohistochemistry were performed at two weeks. Result At two and six weeks, regular dense collagen tissue in the miR-210 group was observed and the diameter of collagen fiber in the miR-210 group was significantly higher than in the control. At two weeks, the ultimate failure load was significantly higher than in the control group, and expression of VEGF, FGF2 and type I collagen was upregulated. Abundant vessels in the miR-210 group were observed at two weeks, but there was no significant difference in vessel numbers between the two groups at six weeks. At 12 weeks, repaired Achilles tendons in the miR-210 group consisted of parallel and dense fibers, whereas wavy and loose fibers were still observed in the control group. Conclusion The current study showed that single local injection of synthetic miR-210 promotes Achilles tendon healing in the early phase.	[Usman, Muhammad Andry; Nakasa, Tomoyuki; Shoji, Takeshi; Kato, Tomohiro; Kawanishi, Yoshitaka; Hamanishi, Michio; Kamei, Naosuke; Ochi, Mitsuo] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Orthopaed Surg Integrated Hlth & Sci, Minami Ku, Hiroshima 7348551, Japan; [Usman, Muhammad Andry] Hasanuddin Univ, Dept Orthopaed & Traumatol, Fac Med, Tamalanrea 90245, Makassar, Indonesia	Usman, MA (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Orthopaed Surg Integrated Hlth & Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	m.andry.usman@gmail.com			MEXT KAKENHI [21249079, 25293324, 24592234]	This research was supported by MEXT KAKENHI Grant-in-Aid for Scientific Research (A) Grant Number 21249079 (M.O.), Scientific Research (B) Grant number 25293324 (N.K.) and Scientific Research (C) Grant Number 24592234 (T.N.).	Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Wilkins R, 2012, AM J SPORT MED, V40, P2154, DOI 10.1177/0363546512453293; Willits K, 2010, J BONE JOINT SURG AM, V92A, P2767, DOI 10.2106/JBJS.I.01401; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; PERSSON A, 1979, INT ORTHOP, V3, P149; GELBERMAN RH, 1991, J BONE JOINT SURG AM, V73A, P868; Leppilahti J, 1996, ACTA ORTHOP SCAND, V67, P277; Kashiwagi K, 2004, SCAND J PLAST RECONS, V38, P193, DOI 10.1080/02844310410029110; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Nakasa T, 2008, ARTHRITIS RHEUM, V58, P1284, DOI 10.1002/art.23429; Virchenko O, 2005, SCAND J MED SCI SPOR, V15, P260, DOI 10.1111/j.1600-0838.2005.00462.x; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Shoji T, 2012, AM J SPORT MED, V40, P2470, DOI 10.1177/0363546512458894; Zhang F, 2003, PLAST RECONSTR SURG, V112, P1613, DOI 10.1097/01.PRS.0000086772.72535.A4; INGLIS AE, 1976, J BONE JOINT SURG AM, V58, P990; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Nilsson-Helander K, 2010, AM J SPORT MED, V38, P2186, DOI 10.1177/0363546510376052; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004; Aspenberg P, 2004, ACTA ORTHOP SCAND, V75, P93, DOI 10.1080/00016470410001708190; Yamasaki K, 2009, ARTHRITIS RHEUM, V60, P1035, DOI 10.1002/art.24404; Hu S, 2010, CIRCULATION S, V122, P2124; Huang TF, 2013, AM J SPORT MED, V41, P1117, DOI 10.1177/0363546513480786; LIU SH, 1995, CLIN ORTHOP RELAT R, P265; Nakasa T, 2011, ARTHRITIS RHEUM-US, V63, P1582, DOI 10.1002/art.30321	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAY	2015	20	3					538	546		10.1007/s00776-015-0709-5		9	Orthopedics	Orthopedics	CJ6IV	WOS:000355598400014		
J	Watanabe, H; Horiguchi, I; Hayasaka, S; Hagiwara, K; Sugawara, R; Inoue, H; Takeshita, K; Marui, E; Kikkawa, I				Watanabe, Hideaki; Horiguchi, Istuko; Hayasaka, Shinya; Hagiwara, Kayo; Sugawara, Ryo; Inoue, Hirokazu; Takeshita, Katsushi; Marui, Eiji; Kikkawa, Ichiro			Determining the general utilization and characteristics of orthopedic complementary and alternative medicine using a self-administered online questionnaire in Japan	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article								Background Acupuncture and moxibustion, massage, bone-setting, manual therapy, and chiropractic treatments are representative components of orthopedic complementary and alternative medicine (OCAM) in Japan. However, the state of their utilization and characteristics are unclear, and have yet to be thoroughly surveyed. The objective of this study was to survey the utilization and characteristics of OCAM in the general public. Materials and methods In January 2011, we conducted a self-administered online questionnaire survey with 10,400 members of the general public, who were registered as consumer reviewers at the internet survey company. Survey topics were the use of OCAM within one month prior to the survey, the objective of using OCAM, and the presence or absence of consultation with and recommendation or referral by a physician. The subjects were divided into those who used and did not use OCAM as user and non-user groups, respectively, and the age, sex, and prevalence of past treatment for orthopedic diseases at medical institutions were compared between the groups. Data of 3,211 subjects (1,611 males and 1,600 females, mean age: 44.7 years old) were analyzed. Results Four hundred and thirty-eight subjects (13.6 %) used OCAM within one month prior to the survey. The subjects in their forties used OCAM most frequently, followed by those in their twenties. The most frequent objective of OCAM usage was treatment, accounting for 63 % (275 subjects) of the subjects. Fifty-three subjects (12.1 %) consulted a physician, and 48 (11 %) were recommended or referred by a physician. Upon logistic regression analysis, significant differences were detected in age, sex, and prevalence of treatment at a medical institution in the user group. A decreasing trend in the odds ratio correlated with subjects having received previous treatment at a medical institution, female subjects, and subjects of a younger age (p = 0.01; odds ratio = 4.33, 1.43, and 1.01, respectively), and these factors were independent. Conclusion It was determined that 13.6 % of the subjects had used OCAM, and many relatively young females (especially those in their forties or twenties) with a past medical history used it based on their own judgment.	[Watanabe, Hideaki; Hagiwara, Kayo; Sugawara, Ryo; Kikkawa, Ichiro] Jichi Childrens Med Ctr, Dept Paediat Orthopaed Surg, Shimotsuke, Tochigi 3290498, Japan; [Horiguchi, Istuko; Marui, Eiji] Juntendo Univ, Sch Med, Dept Pub Hlth, Tokyo 1138421, Japan; [Hayasaka, Shinya] Daito Bunka Univ, Dept Hlth Sci, Saitama 3558501, Japan; [Inoue, Hirokazu; Takeshita, Katsushi] Jichi Med Univ, Dept Orthoped Surg, Shimotsuke, Tochigi 3290498, Japan	Watanabe, H (reprint author), Jichi Childrens Med Ctr, Dept Paediat Orthopaed Surg, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	watahide1968@jichi.ac.jp					Yamashita H, 2002, COMPLEMENT THER MED, V10, P84, DOI 10.1054/ctim.2002.0519; MacLennan AH, 1996, LANCET, V347, P569, DOI 10.1016/S0140-6736(96)91271-4; Ernst E, 2000, COMPLEMENT THER MED, V8, P32, DOI 10.1054/ctim.2000.0341; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Hikoyoshi J, 2007, J THER, V89, P849; Horikawa H., 2011, Japanese Journal of Nutrition and Dietetics, V69, P193, DOI 10.5264/eiyogakuzashi.69.193; Kenyon S, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-55; Lavelle K, 2005, BMC HEALTH SERV RES, V28, P113; Okuma Y, 2012, J CLIN SPORT MED, V20, P351	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAY	2015	20	3					547	550		10.1007/s00776-015-0708-6		4	Orthopedics	Orthopedics	CJ6IV	WOS:000355598400015		
J	Kanzaki, N; Nishiyama, T; Takakura, Y; Takakura, Y; Fujishiro, T; Hayashi, S; Hashimoto, S; Kuroda, R; Kurosaka, M				Kanzaki, Noriyuki; Nishiyama, Takayuki; Takakura, Yoshiyuki; Takakura, Yoshinori; Fujishiro, Takaaki; Hayashi, Shinya; Hashimoto, Shingo; Kuroda, Ryosuke; Kurosaka, Masahiro			Tibialis spastic varus foot without tarsal coalition: a report of two cases	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article									[Kanzaki, Noriyuki; Nishiyama, Takayuki; Fujishiro, Takaaki; Hayashi, Shinya; Hashimoto, Shingo; Kuroda, Ryosuke; Kurosaka, Masahiro] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Tyuo Ku, Kobe, Hyogo 6500017, Japan; [Takakura, Yoshiyuki; Takakura, Yoshinori] Takakura Orthopaed & Sports Clin, Dept Orthopaed Surg, Nada Ku, Kobe, Hyogo 6570033, Japan	Kanzaki, N (reprint author), Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Tyuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kanzaki@med.kobe-u.ac.jp					Okuda R, 2003, CLIN ORTHOP RELAT R, P149, DOI 10.1097/01.blo.0000068769.86536.37; INOUE A, 1985, Kurume Medical Journal, V32, P147; Irvine GB, 1991, J BONE JOINT SURG BR, V73, P39; JAYAKUMAR S, 1977, CLIN ORTHOP RELAT R, P77; MAUDSLEY R H, 1956, Proc R Soc Med, V49, P181; MOSIER KM, 1984, J BONE JOINT SURG AM, V66A, P976; Nabeshima Y, 2007, FOOT ANKLE INT, V28, P727; SIMMONS E H, 1965, J Bone Joint Surg Br, V47, P533; Stuecker R D, 1993, Foot Ankle, V14, P540	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAY	2015	20	3					551	554		10.1007/s00776-013-0486-y		4	Orthopedics	Orthopedics	CJ6IV	WOS:000355598400016		
J	Ikeda, O; Sugano, M; Yamazaki, M; Minami, N; Ikegawa, N; Koda, M; Morinaga, T				Ikeda, Osamu; Sugano, Masahiko; Yamazaki, Masashi; Minami, Norihiko; Ikegawa, Naoshi; Koda, Masao; Morinaga, Tatsuo			Symptomatic C2-3 instability in an elderly man with a longstanding atlantoaxial immobility	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							AXIAL ROTATORY FIXATION; CERVICAL-SPINE; DEGENERATIVE SPONDYLOLISTHESIS; RHEUMATOID-ARTHRITIS; C2/3 INSTABILITY; SUBLUXATION; MYELOPATHY; CHILD		[Ikeda, Osamu; Sugano, Masahiko; Minami, Norihiko; Ikegawa, Naoshi; Morinaga, Tatsuo] Kashiwa City Kashiwa Hosp, Dept Orthoped Surg, Kashiwa, Chiba 2770825, Japan; [Yamazaki, Masashi] Univ Tsukuba, Dept Orthoped Surg, Tsukuba, Ibaraki, Japan; [Koda, Masao] Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chiba, Japan	Ikeda, O (reprint author), Kashiwa City Kashiwa Hosp, Dept Orthoped Surg, 1-3 Fuse, Kashiwa, Chiba 2770825, Japan.	ikdosm.dti@dream.jp					Al-Habib A, 2013, CHILD NERV SYST, V29, P163, DOI 10.1007/s00381-012-1950-2; Woiciechowsky C, 2004, EUR SPINE J, V13, P680, DOI 10.1007/s00586-004-0673-9; YONEZAWA T, 1995, SPINE, V20, P208, DOI 10.1097/00007632-199501150-00015; Dean CL, 2009, SPINE J, V9, P439, DOI 10.1016/j.spinee.2008.11.010; Yurube T, 2012, SPINE, V37, P2136, DOI 10.1097/BRS.0b013e31826def1c; FIELDING JW, 1977, J BONE JOINT SURG AM, V59, P37; ONO K, 1985, SPINE, V10, P602, DOI 10.1097/00007632-198509000-00002; Wu SK, 2007, EUR SPINE J, V16, P1435, DOI 10.1007/s00586-007-0372-4; Yurube T, 2011, SPINE, V36, P647, DOI 10.1097/BRS.0b013e3181da21c5; Jiang SD, 2011, INT ORTHOP, V35, P869, DOI 10.1007/s00264-010-1203-5; Shigematsu H, 2010, EUR SPINE J, V19, P720, DOI 10.1007/s00586-010-1338-5; Park MS, 2013, SPINE, V38, pE205, DOI 10.1097/BRS.0b013e31827de4fd; DEBURGE A, 1995, J BONE JOINT SURG BR, V77B, P122; Citow JS, 1998, PEDIATR NEUROSURG, V28, P143, DOI 10.1159/000028638; CLARK CR, 1986, SPINE, V11, P1048, DOI 10.1097/00007632-198612000-00020; Crossman JE, 2004, J NEUROSURG, V100, P307, DOI 10.3171/spi.2004.100.3.0307; Japanese Orthopaedic Association, 1994, J JPN ORTHOP ASSOC, V68, P490; Yoshida G, 2010, J NEUROSURG-SPINE, V13, P443, DOI 10.3171/2010.4.SPINE09662	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAY	2015	20	3					563	567		10.1007/s00776-013-0507-x		5	Orthopedics	Orthopedics	CJ6IV	WOS:000355598400019		
J	Katagiri, H; Sugiyama, H; Takahashi, M; Murata, H; Wasa, J; Hosaka, S; Miyagi, M				Katagiri, Hirohisa; Sugiyama, Harutoshi; Takahashi, Mitsuru; Murata, Hideki; Wasa, Junji; Hosaka, Seiichi; Miyagi, Michihito			Osteosarcoma of the pelvis treated successfully with repetitive intra-arterial chemotherapy and radiation therapy: a report of a case with a 21-year follow-up	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							SOFT-TISSUE SARCOMA; SURGICAL-TREATMENT; EXTREMITY; SURVIVAL; TUMORS; BONE		[Katagiri, Hirohisa; Takahashi, Mitsuru; Murata, Hideki; Wasa, Junji; Hosaka, Seiichi; Miyagi, Michihito] Shizuoka Canc Ctr Hosp, Div Orthopaed Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Sugiyama, Harutoshi] Jouhoku Sugiyama Orthopaed Clin, Aoi ku, Shizuoka 4200884, Japan	Katagiri, H (reprint author), Shizuoka Canc Ctr Hosp, Div Orthopaed Oncol, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	h.katagiri@scchr.jp					Fuchs B, 2009, CLIN ORTHOP RELAT R, V467, P510, DOI 10.1007/s11999-008-0495-x; Ozaki T, 2003, J CLIN ONCOL, V21, P334, DOI 10.1200/JCO.2003.01.142; Tsuchiya H, 1999, CLIN ORTHOP RELAT R, P27; ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241; Bacci G, 2001, EUR J SURG ONCOL, V27, P98, DOI 10.1053/ejso.2000.1056; Isakoff MS, 2012, CLIN ORTHOP RELAT R, V470, P2007, DOI 10.1007/s11999-012-2284-9; Matsunobu A, 2012, CANCER-AM CANCER SOC, V118, P4555, DOI 10.1002/cncr.27451; Davis AM, 1996, QUAL LIFE RES, V5, P508, DOI 10.1007/BF00540024; Schwarz R, 2009, CANC TREAT, V152, P147, DOI 10.1007/978-1-4419-0284-9_7; Bacci G, 1996, Chir Organi Mov, V81, P369; Dabes A, 2005, PEDIAT BLOOD CANC, V45, P663; Donati D, 2004, EJSO, V30, P332, DOI 10.1016/j.ejso.2003.12.004; ESTRADAAGUILAR J, 1992, CANCER, V69, P1137; FAHEY M, 1992, J BONE JOINT SURG AM, V74A, P321; Grimer RJ, 1999, J BONE JOINT SURG BR, V81B, P796, DOI 10.1302/0301-620X.81B5.9241; Ham SJ, 2000, EUR J SURG ONCOL, V26, P53, DOI 10.1053/ejso.1999.0741; Hernberg MM, 2011, MED ONCOL, V28, P1475, DOI 10.1007/s12032-010-9592-2; Hugate RR, 2008, CLIN ORTHOP RELAT R, V466, P1292, DOI 10.1007/s11999-008-0252-1; Jaffe N, 2002, CANCER, V95, P2202, DOI 10.1002/cncr.10944; OGIHARA Y, 1984, CANCER, V53, P2615, DOI 10.1002/1097-0142(19840615)53:12<2615::AID-CNCR2820531208>3.0.CO;2-S; Pennacchioli E, 2009, EXPERT REV ANTICANC, V9, P199, DOI 10.1586/14737140.9.2.199; Unni KK, 2010, DAHLINS BONE TUMORS	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAY	2015	20	3					568	573		10.1007/s00776-013-0511-1		6	Orthopedics	Orthopedics	CJ6IV	WOS:000355598400020		
J	Kuroki, H; Inomata, N; Hamanaka, H; Higa, K; Chosa, E; Tajima, N				Kuroki, Hiroshi; Inomata, Naoki; Hamanaka, Hideaki; Higa, Kiyoshi; Chosa, Etsuo; Tajima, Naoya			Two siblings with neuropathic scoliosis caused by Chiari malformation type I with syringomyelia	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							POSTERIOR CRANIAL FOSSA; OF-THE-LITERATURE; FAMILIAL SYRINGOMYELIA; CHILDREN		[Kuroki, Hiroshi; Inomata, Naoki; Hamanaka, Hideaki; Higa, Kiyoshi; Chosa, Etsuo] Miyazaki Univ, Fac Med, Dept Orthopaed Surg, Miyazaki 8891692, Japan; [Tajima, Naoya] Nozaki Higashi Hosp, Dept Orthopaed Surg, Miyazaki, Japan	Kuroki, H (reprint author), Miyazaki Univ, Fac Med, Dept Orthopaed Surg, 5200 Kihara Kiyotake, Miyazaki 8891692, Japan.	hiroshik@med.miyazaki-u.ac.jp					Boyles AL, 2006, AM J MED GENET A, V140A, P2776, DOI 10.1002/ajmg.a.31546; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Tubbs RS, 2011, J NEUROSURG-PEDIATR, V7, P248, DOI 10.3171/2010.12.PEDS10379; ISU T, 1992, CHILD NERV SYST, V8, P97, DOI 10.1007/BF00298449; Tubbs RS, 2006, CHILD NERV SYST, V22, P1351, DOI 10.1007/s00381-006-0079-6; Meadows J, 2000, J NEUROSURG, V92, P920, DOI 10.3171/jns.2000.92.6.0920; NAGIB MG, 1994, PEDIATR NEUROSURG, V21, P31, DOI 10.1159/000120811; Nishikawa M, 1997, J NEUROSURG, V86, P40, DOI 10.3171/jns.1997.86.1.0040; Tubbs RS, 2008, J NEUROS-PEDIATR, V1, P21, DOI 10.3171/PED-08/01/021; Loukas M, 2008, CHILD NERV SYST, V24, P407, DOI 10.1007/s00381-007-0535-y; BARKOVICH AJ, 1986, AM J NEURORADIOL, V7, P795; Steinbok P, 2004, CHILD NERV SYST, V20, P329, DOI 10.1007/s00381-003-0879-x; Zhang ZQ, 2008, SPINAL CORD, V46, P358, DOI 10.1038/sj.sc.3102141; Fujisawa H, 2002, J NEUROSURG, V97, P396, DOI 10.3171/jns.2002.97.2.0396; HERMAN M D, 1990, Pediatric Neurosurgery, V16, P183, DOI 10.1159/000120522; Inoue M, 2003, SPINE, V28, P40, DOI 10.1097/00007632-200301010-00011; Mavinkurve GG, 2005, CHILD NERV SYST, V21, P955, DOI 10.1007/s00381-005-1146-0; OLDFIELD EH, 1994, J NEUROSURG, V80, P3, DOI 10.3171/jns.1994.80.1.0003; Schanker BD, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.6.FOCUS11104; Schimmenti LA, 1999, HUM MUTAT, V14, P369, DOI 10.1002/(SICI)1098-1004(199911)14:5<369::AID-HUMU2>3.0.CO;2-E; Speer MC, 2000, NEUROSURG FOCUS, V8, P1, DOI 10.3171/foc.2000.8.3.12; Szewka AJ, 2006, PEDIATR NEUROL, V34, P481, DOI 10.1016/j.pediatrneurol.2005.09.008; Weisfeld-Adams JD, 2007, PEDIATR NEUROSURG, V43, P533, DOI 10.1159/000108803; Yabe I, 2002, CLIN NEUROL NEUROSUR, V105, P69, DOI 10.1016/S0303-8467(02)00091-4; ZAKERI A, 1995, SURG NEUROL, V44, P48, DOI 10.1016/0090-3019(96)85515-7	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAY	2015	20	3					579	583		10.1007/s00776-013-0520-0		5	Orthopedics	Orthopedics	CJ6IV	WOS:000355598400022		
J	Yamamura, H; Suzuki, Y; Imaizumi, Y				Yamamura, Hisao; Suzuki, Yoshiaki; Imaizumi, Yuji			New light on ion channel imaging by total internal reflection fluorescence (TIRF) microscopy	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Review						TIRF imaging; Single-molecule imaging; Ion channel; FRET; Subunit stoichiometry	SMOOTH-MUSCLE-CELLS; SINGLE-PARTICLE TRACKING; MOUSE URINARY-BLADDER; CA2+-INDUCED CA2+ RELEASE; CA(V)1.2 CALCIUM-CHANNELS; RESONANCE ENERGY-TRANSFER; PIG VAS-DEFERENS; PLASMA-MEMBRANE; POTASSIUM CHANNEL; K+ CHANNELS	Ion channels play pivotal roles in a wide variety of cellular functions; therefore, their physiological characteristics, pharmacological responses, and molecular structures have been extensively investigated. However, the mobility of an ion channel itself in the cell membrane has not been examined in as much detail. A total internal reflection fluorescence (TIRF) microscope allows fluorophores to be imaged in a restricted region within an evanescent field of less than 200 nm from the interface of the coverslip and plasma membrane in living cells. Thus the TIRF microscope is useful for selectively visualizing the plasmalemmal surface and subplasmalemmal zone. In this review, we focused on a single-molecule analysis of the dynamic movement of ion channels in the plasma membrane using TIRF microscopy. We also described two single-molecule imaging techniques under TIRF microscopy: fluorescence resonance energy transfer (FRET) for the identification of molecules that interact with ion channels, and subunit counting for the determination of subunit stoichiometry in a functional channel. TIRF imaging can also be used to analyze spatiotemporal Ca2+ events in the subplasmalemma. Single-molecule analyses of ion channels and localized Ca2+ signals based on TIRF imaging provide beneficial pharmacological and physiological information concerning the functions of ion channels. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.	[Yamamura, Hisao; Suzuki, Yoshiaki; Imaizumi, Yuji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Nagoya, Aichi 4678603, Japan	Yamamura, H (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Mizuho Ku, 3-1 Tanabedori, Nagoya, Aichi 4678603, Japan.	yamamura@phar.nagoya-cu.ac.jp		Suzuki, Yoshiaki/0000-0002-7879-6059	Ministry of Education, Culture, Sports, Science, and Technology [25136717]; Japan Society for the Promotion of Science [26293021, 25460104, 26860059]; Takeda Science Foundation	We thank Dr. Susumu Ohya (Kyoto Pharmaceutical University, Japan) for reading of this manuscript. This investigation was supported by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology (25136717; to Y.I.) and Grant-in-Aids for Scientific Research (B) (26293021; to Y.I.), Scientific Research (C) (25460104; to H.Y.), and Young Scientists (B) (26860059; to Y.S.) from the Japan Society for the Promotion of Science. This work was also supported by a Grant-in-Aid from Takeda Science Foundation (to H.Y.).	Tanaka Y, 2004, J PHARMACOL SCI, V94, P339, DOI 10.1254/jphs.94.339; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Demuro A, 2011, P NATL ACAD SCI USA, V108, P17832, DOI 10.1073/pnas.1114814108; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Bartoi T, 2014, P NATL ACAD SCI USA, V111, P8281, DOI 10.1073/pnas.1324060111; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Kusumi A, 2014, NAT CHEM BIOL, V10, P524, DOI [10.1038/nchembio.1558, 10.1038/NCHEMBIO.1558]; Ishijima A, 2001, TRENDS BIOCHEM SCI, V26, P438, DOI 10.1016/S0968-0004(01)01860-6; Notelaers K, 2014, BBA-MOL CELL RES, V1843, P544, DOI 10.1016/j.bbamcr.2013.11.019; Bal M, 2010, J NEUROSCI, V30, P2311, DOI 10.1523/JNEUROSCI.5175-09.2010; Demuro A, 2005, J GEN PHYSIOL, V126, P179, DOI 10.1085/jgp.200509331; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235; Khakh BS, 2005, J NEUROSCI, V25, P6911, DOI 10.1523/JNEUROSCI.0561-05.2005; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Yamazaki D, 2011, CELL METAB, V14, P231, DOI 10.1016/j.cmet.2011.05.011; Lu R, 2006, J PHYSIOL-LONDON, V570, P65; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Bharill S, 2014, P NATL ACAD SCI USA, V111, P6491, DOI 10.1073/pnas.1400248111; Suzuki Y, 2013, J BIOL CHEM, V288, P36750, DOI 10.1074/jbc.M113.511485; Di Biase V, 2011, J NEUROSCI, V31, P13682, DOI 10.1523/JNEUROSCI.2300-11.2011; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Crane JM, 2008, BIOPHYS J, V94, P702, DOI 10.1529/biophysj.107.115121; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Bal M, 2008, J PHYSIOL-LONDON, V586, P2307, DOI 10.1113/jphysiol.2008.152777; Bal M, 2008, J BIOL CHEM, V283, P30668, DOI 10.1074/jbc.M805216200; Bankston JR, 2012, P NATL ACAD SCI USA, V109, P7899, DOI 10.1073/pnas.1201997109; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Burli T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011507; Durisic N, 2012, J NEUROSCI, V32, P12915, DOI 10.1523/JNEUROSCI.2050-12.2012; Haggie PM, 2008, J BIOL CHEM, V283, P23510, DOI 10.1074/jbc.C800100200; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Hotta S, 2007, J PHARMACOL SCI, V103, P121, DOI 10.1254/jphs.SC0060213; Ide T, 2002, JPN J PHYSIOL, V52, P429, DOI 10.2170/jjphysiol.52.429; Imaizumi Y, 1999, JPN J PHARMACOL, V80, P1, DOI 10.1254/jjp.80.1; Imaizumi Y, 1998, J PHYSIOL-LONDON, V510, P705, DOI 10.1111/j.1469-7793.1998.705bj.x; Ishikawa-Ankerhold HC, 2012, MOLECULES, V17, P4047, DOI 10.3390/molecules17044047; Jin S, 2007, BIOPHYS J, V93, P1079, DOI 10.1529/biophysj.106.102244; Kim EY, 2010, EMBO J, V29, P3924, DOI 10.1038/emboj.2010.260; Kitamura K, 2001, JPN J PHARMACOL, V85, P351, DOI 10.1254/jjp.85.351; Kobrinsky E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005587; Korovkina VP, 2004, J BIOL CHEM, V279, P1217, DOI 10.1074/jbc.M309158200; Lambers TT, 2007, MOL CELL BIOL, V27, P1486, DOI 10.1128/MCB.01468-06; Morimura K, 2006, AM J PHYSIOL-CELL PH, V290, pC388, DOI 10.1152/ajpcell.00409.2005.; Nechyporuk-Zloy V, 2008, AM J PHYSIOL-CELL PH, V294, pC1096, DOI 10.1152/ajpcell.00252.2007; Notelaers K, 2012, BBA-BIOMEMBRANES, V1818, P3131, DOI 10.1016/j.bbamem.2012.08.010; Ohara-Imaizumi Mica, 2004, Biochemical Journal, V381, P13; Ohi Y, 2001, J PHYSIOL-LONDON, V534, P313, DOI 10.1111/j.1469-7793.2001.t01-3-00313.x; Ohno A, 2009, J PHARMACOL SCI, V110, P78, DOI 10.1254/jphs.09037FP; Ohshiro J, 2014, BIOCHEM BIOPH RES CO, V443, P518, DOI 10.1016/j.bbrc.2013.11.117; Peran M, 2001, CELL MOTIL CYTOSKEL, V50, P89, DOI 10.1002/cm.1043; Pochynyuk O, 2007, J BIOL CHEM, V282, P14576, DOI 10.1074/jbc.M701348200; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Santana LF, 2008, CLIN EXP PHARMACOL P, V35, P1121, DOI 10.1111/j.1440-1681.2007.04867.x; Schindl R, 2008, CELL CALCIUM, V43, P260; Suzuki Y, 2013, BIOCHEM BIOPH RES CO, V430, P1169, DOI 10.1016/j.bbrc.2012.12.015; Tamkun MM, 2007, J CELL SCI, V120, P2413, DOI 10.1242/jcs.007351; Veliz LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013290; Vogel Steven S, 2006, Sci STKE, V2006, pre2, DOI 10.1126/stke.3312006re2; Won S, 2010, BIOPHYS J, V99, P2853, DOI 10.1016/j.bpj.2010.08.049; Xie L, 2013, TRAFFIC, V14, P428, DOI 10.1111/tra.12047; Yamamura H, 2012, BIOCHEM BIOPH RES CO, V427, P54, DOI 10.1016/j.bbrc.2012.08.145; Yamamura H, 2013, AM J PHYSIOL-CELL PH, V305, pC299, DOI 10.1152/ajpcell.00065.2013; Yamamura H, 2012, AM J PHYSIOL-CELL PH, V302, pC1257, DOI 10.1152/ajpcell.00191.2011; Yu Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2257	75	1	1	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAY	2015	128	1					1	7		10.1016/j.jphs.2015.04.004		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CJ5VE	WOS:000355559300001		
J	Uzu, M; Sato, H; Yamada, R; Kashiba, T; Shibata, Y; Yamaura, K; Ueno, K				Uzu, Miaki; Sato, Hiromi; Yamada, Ryota; Kashiba, Tatsuro; Shibata, Yukihiro; Yamaura, Katsunori; Ueno, Koichi			Effect of enhanced expression of connexin 43 on sunitinib-induced cytotoxicity in mesothelioma cells	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Connexin; Mesothelioma; Chemotherapy; Sunitinib; Drug resistance	MALIGNANT PLEURAL MESOTHELIOMA; CISPLATIN-INDUCED CYTOTOXICITY; GAP-JUNCTIONS; PHASE-II; GROWTH-INHIBITION; INDUCED APOPTOSIS; GLIOMA-CELLS; BAX-CLEAVAGE; CANCER; DEATH	Connexin (Cx) makes up a type of intercellular channel called gap junction (GJ). GJ plays a regulatory role in cellular physiology. The Cx expression level is often decreased in cancer cells compared to that in healthy ones, and the restoration of its expression has been shown to exert antiproliferative effects. This work aims to evaluate the effect of the restoration of connexin 43 (Cx43) (the most ubiquitous Cx subtype) expression on sunitinib (SU)-induced cytotoxicity in malignant mesothelioma (MM) cells. Increased Cx43 expression in an MM cell line (H28) improved the ability of SU to inhibit receptor tyrosine kinase (RTK) signaling. Moreover, higher Cx43 expression promoted SU-induced apoptosis. The cell viability test revealed that Cx43 enhanced the cytotoxic effect of SU in a GJ-independent manner. The effect of Cx43 on a proapoptotic factor, Bax, was then investigated. The interaction between Cx43 and Bax was confirmed by immunoprecipitation. Furthermore, higher Cx43 expression increased the production of a cleaved (active) form of Bax during SU-induced apoptosis with no alteration in total Bax expression. These findings indicate that Cx43 most likely increases sensitivity to SU in H28 through direct interaction with Bax. In conclusion, we found that Cx43 overcame the chemoresistance of MM cells. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.	[Uzu, Miaki; Sato, Hiromi; Yamada, Ryota; Kashiba, Tatsuro; Shibata, Yukihiro; Yamaura, Katsunori] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Geriatr Pharmacol & Therapeut, Chiba, Chiba 2608675, Japan; [Ueno, Koichi] Chiba Univ, Ctr Prevent Med Sci, Chiba, Chiba 2608675, Japan	Sato, H (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Geriatr Pharmacol & Therapeut, 1-8-1 Inohana, Chiba, Chiba 2608675, Japan.	hiromi-s@chiba-u.jp			Leading Graduate School at Chiba University; Japan Society for the Promotion of Sciences [24790529]; Takeda Science Foundation	We appreciate the valuable advice given by Dr. Akihiro Hisaka (Chiba University) throughout this entire work, Dr. Tomohiro Yano (Toyo University), Dr. Christian C. Naus, Dr. John Bechberger and Dr. Wun Chey Sin (The University of British Columbia) for technical support concerning intercellular communicating analyses. This study was partly supported by a research grant from Leading Graduate School at Chiba University, a Grant-in-Aid for Young Scientists (B) #24790529 from the Japan Society for the Promotion of Sciences, and a research grant from the Takeda Science Foundation.	Zhang YW, 2003, J BIOL CHEM, V278, P44852, DOI 10.1074/jbc.M305072200; de Assis LVM, 2014, BBA-REV CANCER, V1845, P232, DOI 10.1016/j.bbcan.2014.01.008; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Stains JP, 2005, MOL BIOL CELL, V16, P64, DOI 10.1091/mbc.E04-04-0339; Immonen A, 2004, MOL THER, V10, P967, DOI 10.1016/j.ymthe.2004.08.002; Masood R, 2003, INT J CANCER, V104, P603, DOI 10.1002/ijc.10996; Leithe Edward, 2006, Critical Reviews in Oncogenesis, V12, P225; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Laurie SA, 2011, J THORAC ONCOL, V6, P1950, DOI 10.1097/JTO.0b013e3182333df5; Yamasaki H, 1996, CARCINOGENESIS, V17, P1199, DOI 10.1093/carcin/17.6.1199; Zauderer MG, 2014, LUNG CANCER, V84, P271, DOI 10.1016/j.lungcan.2014.03.006; Welti JC, 2011, ONCOGENE, V30, P1183, DOI 10.1038/onc.2010.503; Crespin S, 2010, J CELL BIOCHEM, V110, P589, DOI 10.1002/jcb.22554; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9; Kandouz M, 2010, EXPERT OPIN THER TAR, V14, P681, DOI 10.1517/14728222.2010.487866; Decrock E, 2009, CELL DEATH DIFFER, V16, P524, DOI 10.1038/cdd.2008.196; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; Yang Y, 2014, ONCOL REP, V31, P540, DOI 10.3892/or.2013.2894; Zucali PA, 2011, CANCER TREAT REV, V37, P543, DOI 10.1016/j.ctrv.2011.01.001; Kumar-Singh S, 1999, J PATHOL, V189, P72, DOI 10.1002/(SICI)1096-9896(199909)189:1<72::AID-PATH401>3.0.CO;2-0; Yang HN, 2008, CURR TREAT OPTION ON, V9, P147, DOI 10.1007/s11864-008-0067-z; Garland LL, 2007, J CLIN ONCOL, V25, P2406, DOI 10.1200/JCO.2006.09.7634; Chow LQM, 2007, J CLIN ONCOL, V25, P884, DOI 10.1200/JCO.2006.06.3602; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Sun Y, 2012, INT J ONCOL, V41, P941, DOI 10.3892/ijo.2012.1524; Camidge DR, 2013, CANCER CHEMOTH PHARM, V71, P307, DOI 10.1007/s00280-012-2008-6; Curigliano G, 2013, BREAST, V22, P650, DOI 10.1016/j.breast.2013.07.037; Kreisl TN, 2013, J NEURO-ONCOL, V111, P41, DOI 10.1007/s11060-012-0988-z; Govindan R, 2005, CLIN CANCER RES, V11, P2300, DOI 10.1158/1078-0432.CCR-04-1940; Ariyama H, 2006, J CELL BIOCHEM, V97, P724, DOI 10.1002/jcb.20678; Cottin S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-141; Guo YH, 1999, AM J PHYSIOL-LUNG C, V276, pL1018; Herrero-Gonzalez S, 2010, ONCOGENE, V29, P5712, DOI 10.1038/onc.2010.299; Honda M, 2012, CELL PHYSIOL BIOCHEM, V29, P667, DOI 10.1159/000176386; Hong XT, 2012, CANCER LETT, V317, P165, DOI 10.1016/j.canlet.2011.11.019; Kashiwagi K, 2011, EXP THER MED, V2, P719, DOI 10.3892/etm.2011.270; Langerak AW, 1996, J PATHOL, V178, P151; Liang JY, 2008, CELL BIOL INT, V32, P1371, DOI 10.1016/j.cellbi.2008.08.007; Mott Frank E, 2012, Ochsner J, V12, P70; Raymond E, 2012, TARGET ONCOL, V7, P117, DOI 10.1007/s11523-012-0220-2; Rokudai S, 2000, J CELL PHYSIOL, V182, P290, DOI 10.1002/(SICI)1097-4652(200002)182:2<290::AID-JCP18>3.0.CO;2-8; Sato H, 2009, J PHARMACOL SCI, V110, P466, DOI 10.1254/jphs.08327FP; Tekpli X, 2010, TOXICOL APPL PHARM, V242, P231, DOI 10.1016/j.taap.2009.10.012; Wood DE, 2000, EXP CELL RES, V256, P375, DOI 10.1006/excr.2000.4859; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034	47	1	1	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAY	2015	128	1					17	26		10.1016/j.jphs.2015.04.002		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CJ5VE	WOS:000355559300003		
J	Eguchi, R; Akao, S; Otsuguro, KI; Yamaguchi, S; Ito, S				Eguchi, Ryota; Akao, Sanae; Otsuguro, Ken-ichi; Yamaguchi, Soichiro; Ito, Shigeo			Different mechanisms of extracellular adenosine accumulation by reduction of the external Ca2+ concentration and inhibition of adenosine metabolism in spinal astrocytes	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						ATP; Gap junction hemichannels; Nucleoside transporters; Adenosine kinase; Adenosine deaminase	ATP RELEASE; NUCLEOSIDE TRANSPORTERS; CONNEXIN HEMICHANNELS; SYNAPTIC-TRANSMISSION; NEONATAL-RATS; KINASE; HYPOXIA; CALCIUM; HIPPOCAMPUS; INVOLVEMENT	Extracellular adenosine is a neuromodulator in the central nervous system. Astrocytes mainly participate in adenosine production, and extracellular adenosine accumulates under physiological and pathophysiological conditions. Inhibition of intracellular adenosine metabolism and reduction of the external Ca2+ concentration ([Ca2+](e)) participate in adenosine accumulation, but the precise mechanisms remain unclear. This study investigated the mechanisms underlying extracellular adenosine accumulation in cultured rat spinal astrocytes. The combination of adenosine kinase and deaminase (ADK/ADA) inhibition and a reduced [Ca2+](e) increased the extracellular adenosine level. ADK/ADA inhibitors increased the level of extracellular adenosine but not of adenine nucleotides, which was suppressed by inhibition of equilibrative nucleoside transporter (ENT) 2. Unlike ADK/ADA inhibition, a reduced [Ca2+](e) increased the extracellular level not only of adenosine but also of ATP. This adenosine increase was enhanced by ENT2 inhibition, and suppressed by sodium polyoxotungstate (ecto-nucleoside triphosphate diphosphohydrolase inhibitor). Gap junction inhibitors suppressed the increases in adenosine and adenine nucleotide levels by reduction of [Ca2+](e). These results indicate that extracellular adenosine accumulation by ADK/ADA inhibition is due to the adenosine release via ENT2, while that by reduction of [Ca2+] e is due to breakdown of ATP released via gap junction hemichannels, after which ENT2 incorporates adenosine into the cells. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.	[Eguchi, Ryota; Akao, Sanae; Otsuguro, Ken-ichi; Yamaguchi, Soichiro; Ito, Shigeo] Hokkaido Univ, Grad Sch Vet Med, Pharmacol Lab, Kita Ku, Sapporo, Hokkaido 0600818, Japan	Otsuguro, KI (reprint author), Hokkaido Univ, Grad Sch Vet Med, Pharmacol Lab, Kita Ku, Kita 18,Nishi 9, Sapporo, Hokkaido 0600818, Japan.	otsuguro@vetmed.hokudai.ac.jp	Otsuguro, Ken-ichi/A-4840-2012		JSPS [26450440]	This work was supported by a Grant-in-Aid for Scientific Research from JSPS (No. 26450440 to K.O.). All experiments were conducted in compliance with the ARRIVE guidelines.	Dale N, 2000, J PHYSIOL-LONDON, V526, P143, DOI 10.1111/j.1469-7793.2000.00143.x; Decking UKM, 1997, CIRC RES, V81, P154; Ciccarelli R, 2001, INT J DEV NEUROSCI, V19, P395, DOI 10.1016/S0736-5748(00)00084-8; Oishi S, 2012, J PHARMACOL SCI, V120, P296, DOI 10.1254/jphs.12202FP; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Muller CE, 2006, BIOORG MED CHEM LETT, V16, P5943, DOI 10.1016/j.bmcl.2006.09.003; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Kristian T, 1998, STROKE, V29, P705; Wink MR, 2006, NEUROSCIENCE, V138, P421, DOI 10.1016/j.neuroscience.2005.11.039; Etherington LAV, 2009, NEUROPHARMACOLOGY, V56, P429, DOI 10.1016/j.neuropharm.2008.09.016; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Sawynok J, 1998, EUR J PHARMACOL, V347, P1, DOI 10.1016/S0014-2999(97)01605-1; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P1208, DOI 10.1167/iovs.04-1181; Frenguelli BG, 2007, J NEUROCHEM, V101, P1400, DOI 10.1111/j.1471-4159.2006.04425.x; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; Birder LA, 2003, AM J PHYSIOL-RENAL, V285, pF423, DOI 10.1152/ajprenal.00056.2003; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; CRAIG CG, 1993, J NEUROCHEM, V60, P1073, DOI 10.1111/j.1471-4159.1993.tb03256.x; Dora CD, 1998, J NEUROTRAUM, V15, P473, DOI 10.1089/neu.1998.15.473; Garre JM, 2010, P NATL ACAD SCI USA, V107, P22659; LINDBERG B, 1967, J BIOL CHEM, V242, P350; Lynch JJ, 1998, NEUROSCI LETT, V252, P207, DOI 10.1016/S0304-3940(98)00376-0; Otsuguro K, 2006, J PHYSIOL-LONDON, V574, P835, DOI 10.1113/jphysiol.2006.109660; PALELLA TD, 1980, J BIOL CHEM, V255, P5264; Sabirov R, 2009, J PHYSIOL SCI, V59, P3, DOI 10.1007/s12576-008-0008-4; Takahashi T, 2010, BRIT J PHARMACOL, V161, P1806, DOI 10.1111/j.1476-5381.2010.01002.x; Wall MJ, 2008, NEUROPHARMACOLOGY, V55, P1251, DOI 10.1016/j.neuropharm.2008.08.005; Yao SYM, 1997, J BIOL CHEM, V272, P28423, DOI 10.1074/jbc.272.45.28423	37	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAY	2015	128	1					47	53		10.1016/j.jphs.2015.04.008		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CJ5VE	WOS:000355559300006		
J	Uchida, S; Mitani, A; Gunji, E; Takahashi, T; Yamamoto, K				Uchida, Saeko; Mitani, Akiko; Gunji, Emi; Takahashi, Teisuke; Yamamoto, Koji			In vitro characterization of luseogliflozin, a potent and competitive sodium glucose co-transporter 2 inhibitor: Inhibition kinetics and binding studies	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Sodium glucose co-transporter 2 inhibitor; Inhibition model; Binding kinetics	JAPANESE PATIENTS; SGLT2 INHIBITOR; SAFETY; EFFICACY; 12-WEEK; TS-071; BLIND	In this study, we evaluated an inhibition model of luseogliflozin on sodium glucose co-transporter 2 (SGLT2). We also analyzed the binding kinetics of the drug to SGLT2 protein using [H-3]-luseogliflozin. Luseogliflozin competitively inhibited human SGLT2 (hSGLT2)-mediated glucose uptake with a Ki value of 1.10 nM. In the absence of glucose, [H-3]-luseogliflozin exhibited a high affinity for hSGLT2 with a Kd value of 1.3 nM. The dissociation half-time was 7 h, suggesting that luseogliflozin dissociates rather slowly from hSGLT2. These profiles of luseogliflozin might contribute to the long duration of action of this drug. (C) 2015 Taisho Pharmaceutical Co., Ltd. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.	[Uchida, Saeko; Mitani, Akiko; Gunji, Emi; Takahashi, Teisuke; Yamamoto, Koji] Taisho Pharmaceut Co Ltd, Pharmacol Lab, Saitama Shi, Saitama 3319530, Japan	Takahashi, T (reprint author), Taisho Pharmaceut Co Ltd, Pharmacol Lab, Kita Ku, 1-403 Yoshino Cho, Saitama Shi, Saitama 3319530, Japan.	te-takahashi@so.taisho.co.jp					Inagaki N, 2013, DIABETES OBES METAB, V15, P1136, DOI 10.1111/dom.12149; Sasaki T, 2014, ADV THER, V31, P345, DOI 10.1007/s12325-014-0102-3; Grempler R, 2012, DIABETES OBES METAB, V14, P83, DOI 10.1111/j.1463-1326.2011.01517.x; Suzuki M, 2012, J PHARMACOL EXP THER, V341, P692, DOI 10.1124/jpet.112.191593; List JF, 2009, DIABETES CARE, V32, P650, DOI 10.2337/dc08-1863; Kakinuma H, 2010, J MED CHEM, V53, P3247, DOI 10.1021/jm901893x; Yamamoto K, 2011, BRIT J PHARMACOL, V164, P181, DOI 10.1111/j.1476-5381.2011.01340.x; Seino Y, 2014, CURR MED RES OPIN, V30, P1219, DOI 10.1185/03007995.2014.901943; Ghezzi C, 2014, PHYSL REP, V2; Hummel CS, 2012, AM J PHYSIOL-CELL PH, V302, pC373, DOI 10.1152/ajpcell.00328.2011; Hummel CS, 2011, AM J PHYSIOL-CELL PH, V300, pC14, DOI 10.1152/ajpcell.00388.2010; Pajor AM, 2008, J PHARMACOL EXP THER, V324, P985, DOI 10.1124/jpet.107.129825	12	1	2	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAY	2015	128	1					54	57		10.1016/j.jphs.2015.04.001		4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CJ5VE	WOS:000355559300007		
J	Shimosato, T; Geddawy, A; Tawa, M; Imamura, T; Okamura, T				Shimosato, Takashi; Geddawy, Ayman; Tawa, Masashi; Imamura, Takeshi; Okamura, Tomio			Chronic administration of nicotine-free cigarette smoke extract impaired endothelium-dependent vascular relaxation in rats via increased vascular oxidative stress (vol 118, pg 206, 2012)	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Correction									[Shimosato, Takashi; Geddawy, Ayman; Tawa, Masashi; Imamura, Takeshi; Okamura, Tomio] Shiga Univ Med Sci, Dept Pharmacol, Otsu, Shiga 5202192, Japan; [Shimosato, Takashi] NISSEI BILIS Co Ltd, Res Dept, Koka, Shiga 5280052, Japan	Okamura, T (reprint author), Shiga Univ Med Sci, Dept Pharmacol, Otsu, Shiga 5202192, Japan.	okamura@belle.shiga-med.ac.jp					Shimosato T, 2012, J PHARMACOL SCI, V118, P206, DOI 10.1254/jphs.11187FP	1	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	MAY	2015	128	1					58	58		10.1016/j.jphs.2015.04.006		1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CJ5VE	WOS:000355559300008		
J	Dugave, M; Gohmann, F; Kozlowski, KK; Suzuki, J				Dugave, Maxime; Goehmann, Frank; Kozlowski, Karol K.; Suzuki, Junji			On form-factor expansions for the XXZ chain in the massive regime	JOURNAL OF STATISTICAL MECHANICS-THEORY AND EXPERIMENT			English	Article						correlation functions; form factors; quantum integrability (Bethe Ansatz); critical exponents and amplitudes (theory)	BETHE-ANSATZ EQUATIONS; FINITE-SIZE CORRECTIONS; FREE-FIELD CONSTRUCTION; HEISENBERG CHAIN; 8-VERTEX MODEL; EXCITED-STATES; GROUND-STATE; BOSE-GAS; REPRESENTATION; 6-VERTEX	We study the large-volume-L limit of form factors of the longitudinal spin operators for the XXZ spin-1/2 chain in the massive regime. We find that the individual form factors decay as L-n, n being an even integer counting the number of physical excitations-the holes-that constitute the excited state. Our expression allows us to derive the form-factor expansion of two-point spin-spin correlation functions in the thermodynamic limit L -> +infinity. The staggered magnetisation appears naturally as the first term in this expansion. We show that all other contributions to the two-point correlation function are exponentially small in the large-distance regime.	[Dugave, Maxime; Goehmann, Frank] Berg Univ Wuppertal, Fachbereich Phys C, D-42097 Wuppertal, Germany; [Kozlowski, Karol K.] Univ Bourgogne, CNRS, UMR 5584, IMB, F-21078 Dijon, France; [Suzuki, Junji] Shizuoka Univ, Dept Phys, Shizuoka, Shizuoka 4228017, Japan	Dugave, M (reprint author), Berg Univ Wuppertal, Fachbereich Phys C, D-42097 Wuppertal, Germany.	dugave@uni-wuppertal.de; goehmann@uni-wuppertal.de; karol.kozlowski@u-bourgogne.fr; sjsuzuk@ipc.shizuoka.ac.jp	Suzuki, Junji/A-1430-2015		Volkswagen Foundation; Deutsche Forschungsgemeinschaft [Go 825/7-1]; CNRS; Burgundy region PARI grant; Burgundy region FABER grant; ANR [SIMI 1 2010-BLAN-0120-02]; JSPS [24540399]	The authors would like to thank A Klumper and N Kitanine for fruitful discussions. MD and FG acknowledge financial support by the Volkswagen Foundation and by the Deutsche Forschungsgemeinschaft under grant number Go 825/7-1. KKK is supported by the CNRS. His work has been partly financed by the Burgundy region PARI 2013 & 2014 FABER grants 'Structures et asymptotiques d'integrales multiples'. KKK also enjoys support from the ANR 'DIADEMS' SIMI 1 2010-BLAN-0120-02. JS is supported by a JSPS Grant-in-Aid for Scientific Research (C) No. 24540399. MD, FG and JS are grateful for the warm hospitality extended to them at the IMB, Universite de Bourgogne. KKK and JS would like to express their gratitude to the physics department of the University of Wuppertal for providing a stimulating work environment during their visit.	Aizenberg I A, 1978, GRADUATE TEXTS MATH, V58; DESTRI C, 1982, NUCL PHYS B, V205, P369, DOI 10.1016/0550-3213(82)90363-7; Kozlowski KK, 2011, J MATH PHYS, V52, DOI 10.1063/1.3625628; JOHNSON JD, 1973, PHYS REV A, V8, P2526, DOI 10.1103/PhysRevA.8.2526; SLAVNOV NA, 1990, THEOR MATH PHYS+, V82, P273, DOI 10.1007/BF01029221; ORBACH R, 1958, PHYS REV, V112, P309, DOI 10.1103/PhysRev.112.309; Lashkevich M, 2002, NUCL PHYS B, V621, P587, DOI 10.1016/S0550-3213(01)00598-3; LIEB EH, 1963, PHYS REV, V130, P1605, DOI 10.1103/PhysRev.130.1605; SLAVNOV NA, 1989, THEOR MATH PHYS+, V79, P502, DOI 10.1007/BF01016531; Kitanine N, 2009, J MATH PHYS, V50, DOI 10.1063/1.3136683; Karbach M, 1997, PHYS REV B, V55, P12510, DOI 10.1103/PhysRevB.55.12510; Kitanine N, 1999, NUCL PHYS B, V554, P647, DOI 10.1016/S0550-3213(99)00295-3; Lashkevich M, 1998, NUCL PHYS B, V516, P623, DOI 10.1016/S0550-3213(98)00086-8; YANG CN, 1966, PHYS REV, V150, P321, DOI 10.1103/PhysRev.150.321; Lukyanov S, 2003, NUCL PHYS B, V654, P323, DOI 10.1016/S0550-3213(02)01141-0; KAROWSKI M, 1978, NUCL PHYS B, V139, P455, DOI 10.1016/0550-3213(78)90362-0; DESTRI C, 1992, PHYS REV LETT, V69, P2313, DOI 10.1103/PhysRevLett.69.2313; DEVEGA HJ, 1985, NUCL PHYS B, V251, P439, DOI 10.1016/0550-3213(85)90271-8; Bethe H, 1931, Z PHYS, V71, P205, DOI 10.1007/BF01341708; Destri C, 1997, NUCL PHYS B, V504, P621, DOI 10.1016/S0550-3213(97)00468-9; KIRILLOV AN, 1987, PHYS LETT B, V198, P506, DOI 10.1016/0370-2693(87)90908-7; BABELON O, 1983, NUCL PHYS B, V220, P13, DOI 10.1016/0550-3213(83)90131-1; KLUMPER A, 1990, J PHYS A-MATH GEN, V23, pL189, DOI 10.1088/0305-4470/23/5/002; Baxter R J, 1973, J STAT PHYS, V9, P145, DOI 10.1007/BF01016845; Belliard S, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/10/P10017; Bogoliubov N M, 1993, CAMBRIDGE MONOGRAPHS; Bougourzi A H, 1994, ARXIVHEPTH9407062; Caux JS, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/01/P01007; Dugave M, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/07/P07010; Dugave M, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/04/P04012; Faddeev L D, 1981, ZAP NAUCHN SEMIN LOM, V109, P134; Gohberg I., 2000, OPERATOR THEORY ADV, V116; Izergin AG, 1999, NUCL PHYS B, V554, P679, DOI 10.1016/S0550-3213(99)00273-4; Jimbo M, 1995, C BOARD MATH SCI; Takahashi M, 2004, J PHYS SOC JPN, V73, P245, DOI 10.1143/JPSJ.73.245; Kirillov A N, 1988, J MATH SCI, V40, P13, DOI 10.1007/BF01084936; Kitanine N, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/05/P05028; Kitanine N, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/05/P05011; Kitanine N, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/04/P04003; Kitanine N, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/09/P09001; Kitanine N, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/12/P12010; KLUMPER A, 1991, J PHYS A-MATH GEN, V24, P3111, DOI 10.1088/0305-4470/24/13/025; Kozlowski KK, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/03/P03019; Kozlowski KK, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/03/P03018; Levy-Bencheton D, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/04/P04014; Smirnov F.A., 1992, ADV SERIES MATH PHYS, V14; VIROSZTEK A, 1984, J PHYS A-MATH GEN, V17, P3029, DOI 10.1088/0305-4470/17/15/020; VLADIMIROV AA, 1986, THEOR MATH PHYS+, V66, P102, DOI 10.1007/BF01028945; WOYNAROVICH F, 1982, J PHYS A-MATH GEN, V15, P2985, DOI 10.1088/0305-4470/15/9/044	49	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1742-5468			J STAT MECH-THEORY E	J. Stat. Mech.-Theory Exp.	MAY	2015									P05037	10.1088/1742-5468/2015/05/P05037		49	Mechanics; Physics, Mathematical	Mechanics; Physics	CJ6FG	WOS:000355588600037		
J	Shiraki, Y; Kabashima, Y				Shiraki, Yoshifumi; Kabashima, Yoshiyuki			Typical reconstruction limits for distributed compressed sensing based on l(2,1)-norm minimization and Bayesian optimal reconstruction	JOURNAL OF STATISTICAL MECHANICS-THEORY AND EXPERIMENT			English	Article						message-passing algorithms; source and channel coding; communication; supply and information networks	MULTIPLE-MEASUREMENT VECTORS; INFORMATION	The distributed compressed sensing framework provides an efficient compression scheme of multichannel signals that are sparse in some domains and highly correlated with one another. In particular, a signal model called the joint sparse model 2 (JSM-2) or multiple measurement vector problem, in which all sparse signals share their support, is important for dealing with practical problems such as magnetic resonance imaging and magnetoencephalography. In this paper, we investigate the typical reconstruction performance of JSM-2 problems for two schemes. One is l(2,1)-norm minimization reconstruction and the other is Bayesian optimal reconstruction. Employing the replica method, we show that the reconstruction performance of both schemes which exploit the knowledge of the sharing of the signal support overcomes that of their corresponding approaches for the single-channel compressed sensing problem. We also develop a computationally feasible approximate algorithm for performing the Bayes optimal scheme to validate our theoretical estimation. Our replica-based analysis numerically indicates that the spinodal point of the Bayesian reconstruction disappears, which implies that a fundamental reconstruction limit can be achieved by the BP-based approximate algorithm in a practical amount of time when the number of channels is sufficiently large. The results of the numerical experiments of both reconstruction schemes agree excellently with the theoretical evaluation.	[Shiraki, Yoshifumi] NTT Corp, NTT Commun Sci Lab, Atsugi, Kanagawa 2430198, Japan; [Shiraki, Yoshifumi; Kabashima, Yoshiyuki] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 2268502, Japan	Shiraki, Y (reprint author), NTT Corp, NTT Commun Sci Lab, Atsugi, Kanagawa 2430198, Japan.	shiraki.yoshifumi@lab.ntt.co.jp; kaba@dis.titech.ac.jp			KAKENHI [25120013]	This work was partially supported by KAKENHI No. 25120013 (YK).	HUBBARD J, 1959, PHYS REV LETT, V3, P77, DOI 10.1103/PhysRevLett.3.77; Lee K, 2012, IEEE T INFORM THEORY, V58, P3613, DOI 10.1109/TIT.2012.2189196; Donoho DL, 2009, P NATL ACAD SCI USA, V106, P18914, DOI 10.1073/pnas.0909892106; Baraniuk RG, 2010, IEEE T INFORM THEORY, V56, P1982, DOI 10.1109/TIT.2010.2040894; Ziniel J, 2013, IEEE T SIGNAL PROCES, V61, P340, DOI 10.1109/TSP.2012.2222382; SLEPIAN D, 1973, IEEE T INFORM THEORY, V19, P471, DOI 10.1109/TIT.1973.1055037; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Kim JM, 2012, IEEE T INFORM THEORY, V58, P278, DOI 10.1109/TIT.2011.2171529; Candes EJ, 2005, IEEE T INFORM THEORY, V51, P4203, DOI 10.1109/TIT.2005.858979; Cotter SF, 2005, IEEE T SIGNAL PROCES, V53, P2477, DOI 10.1109/TSP.2005.849172; Chen J, 2006, IEEE T SIGNAL PROCES, V54, P4634, DOI 10.1109/TSP.2006.881263; Baron D., 2009, ARXIV09013403; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Chen W, 2011, 2011 IEEE INT C COMM, P1, DOI 10.1109/NTMS.2011.5721146; Deng W, 2013, P SOC PHOTO-OPT INS, V8858; Donoho D L, 2011, ARXIV11111041; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Donoho DL, 2013, IEEE T INFORM THEORY, V59, P7434, DOI 10.1109/TIT.2013.2274513; Dotsenko V, 2005, INTRO REPLICA THEORY; He ZS, 2008, LECT NOTES COMPUT SC, V5263, P237; James W., 1961, P 4 BERK S MATH STAT, V1, P361; Kabashima Y, 2003, J PHYS A-MATH GEN, V36, P11111, DOI 10.1088/0305-4470/36/43/030; Kabashima Y, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/L09003; Krzakala F, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.021005; Le Roux J, 2013, INT CONF ACOUST SPEE, P4310, DOI 10.1109/ICASSP.2013.6638473; Mezard M., 2009, INFORM PHYS COMPUTAT; Murayama Tatsuto, 2008, Journal of Physics: Conference Series, V95, DOI 10.1088/1742-6596/95/1/012010; Nishimori H, 2001, STAT PHYS SPIN GLASS, V187; Sakata A, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/28008; Takeda K, 2006, EUROPHYS LETT, V76, P1193, DOI [10.1209/epl/i2006-10380-5, 10.1209/ep1/i2006-10380-5]; Xu YY, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/11/P11015; Zhang W, 2010, 2 IEEE INT C NETW IN, P80, DOI 10.1109/ICNIDC.2010.5657901; Ziniel J, AMP MMV V1	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1742-5468			J STAT MECH-THEORY E	J. Stat. Mech.-Theory Exp.	MAY	2015									P05029	10.1088/1742-5468/2015/05/P05029		22	Mechanics; Physics, Mathematical	Mechanics; Physics	CJ6FG	WOS:000355588600029		
J	Yano, R				Yano, Ryosuke			Problems with the linear q-Fokker Planck equation	JOURNAL OF STATISTICAL MECHANICS-THEORY AND EXPERIMENT			English	Article						brownian motion; kinetic theory of gases and liquids; large deviations in non-equilibrium systems; Boltzmann equation	ANOMALOUS DIFFUSION; STATISTICS	In this letter, we discuss the linear q-Fokker Planck equation, whose solution follows Tsallis distribution, from the viewpoint of kinetic theory. Using normal definitions of moments, we can expand the distribution function with infinite moments for 0 <= q < 1, whereas we cannot expand the distribution function with infinite moments for 1 < q owing to emergences of characteristic points in moments. From Grad's 13 moment equations for the linear q-Fokker Planck equation, the dissipation rate of the heat flux via the linear q-Fokker Planck equation diverges at 0 <= q < 2/3. In other words, the thermal conductivity, which defines the heat flux with the spatial gradient of the temperature and the thermal conductivity, which defines the heat flux with the spacial gradient of the density, jumps to zero at q = 2/3, discontinuously.	Univ Tokyo, Dept Adv Energy, Kashiwa, Chiba 2778561, Japan	Yano, R (reprint author), Univ Tokyo, Dept Adv Energy, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.	yano@k.u-tokyo.ac.jp					Abe S, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07027; Abe S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041116; GRAD H, 1949, COMMUN PUR APPL MATH, V2, P331, DOI 10.1002/cpa.3160020403; Plastino AR, 1995, PHYSICA A, V222, P347, DOI 10.1016/0378-4371(95)00211-1; Tsallis C, 1998, PHYSICA A, V261, P534, DOI 10.1016/S0378-4371(98)00437-3; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Tsallis C, 1996, PHYS REV E, V54, pR2197; Cercignani C., 1988, APPL MATH SCI, V67; Chapman S., 1970, MATH THEORY NONUNIFO; Chavanis PH, 2004, PHYSICA A, V341, P145, DOI 10.1016/j.physa.2004.04.102; Kaniadakis G, 2000, PHYS REV E, V62, P3246, DOI 10.1103/PhysRevE.62.3246; Van der Straeten E, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051101; Yano R, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3122804; Yano R, 2014, PHYSICA A, V416, P231, DOI 10.1016/j.physa.2014.08.067	14	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1742-5468			J STAT MECH-THEORY E	J. Stat. Mech.-Theory Exp.	MAY	2015									P05005	10.1088/1742-5468/2015/05/P05005		10	Mechanics; Physics, Mathematical	Mechanics; Physics	CJ6FG	WOS:000355588600005		
J	Song, D; Tanaka, E; Lee, K; Sato, S; Koga, M; Kim, YD; Nagatsuka, K; Toyoda, K; Heoa, JH				Song, Dongbeom; Tanaka, Eijirou; Lee, Kijeong; Sato, Shoichiro; Koga, Masatoshi; Kim, Young Dae; Nagatsuka, Kazuyuki; Toyoda, Kazunori; Heoa, Ji Hoe			Factors Associated with Early Hospital Arrival in Patients with Acute Ischemic Stroke	JOURNAL OF STROKE			English	Article						Acute stroke therapy; Cerebral infarction; Early hospital arrival; Prehospital delay; Emergency medical service; Countries	PREHOSPITAL DELAY; PLASMINOGEN-ACTIVATOR; PUBLIC AWARENESS; POPULATION; MANAGEMENT; TRIAL; KOREA; GUIDELINES; HEALTH; JAPAN	Background and Purpose Factors associated with early arrival may vary according to the characteristics of the hospital. We investigated the factors associated with early hospital arrival in two different stroke centers located in Korea and Japan. Methods Consecutive patients with ischemic stroke arrived hospital within 48 hours of onset between January 2011 and December 2012 were identified and the clinical and time variables were retrieved from the prospective stroke registries of Severance Hospital of Yonsei University Health System (YUNS; Seoul, Korea) and National Cerebral and Cardiovascular Center (NCVC; Osaka, Japan). Subjects were dichotomized into early (time from onset to arrival <= 4.5 hours) and late (>4.5 hours) arrival groups. Univariate and multivariate analyses were performed to evaluate factors associated with early hospital arrival. Results A total of 1,966 subjects (992 from YUHS; 974 from NCVC) were included in this study. The median time from onset to arrival was 6.1 hours [interquartile range, 1.7-17.8 hours]. In multivariate analysis, the factors associated with early arrival were atrial fibrillation (Odds ratio [OR], 1.505; 95% confidence interval [Cl], [1.168-1.939]), higher initial National Institute of Health Stroke Scale scores (OR, 1.037; 95% Cl [1.023-1.051]), onset during daytime (OR, 2.799; 95% CI [2.173-3.605]), and transport by an emergency medical service (OR, 2.127; 95% CI [1.700-2.661]). These factors were consistently associated with early arrival in both hospitals. Conclusions Despite differences between the hospitals, there were common factors related to early arrival. Efforts to identify and modify these factors may promote early hospital arrival and improve stroke outcome.	[Song, Dongbeom; Lee, Kijeong; Kim, Young Dae; Heoa, Ji Hoe] Yonsei Univ, Dept Neurol, Coll Med, Severance Stroke Ctr, Seoul 120752, South Korea; [Tanaka, Eijirou; Sato, Shoichiro; Koga, Masatoshi; Toyoda, Kazunori] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan; [Nagatsuka, Kazuyuki] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka, Japan	Heoa, JH (reprint author), Yonsei Univ, Dept Neurol, Coll Med, 50 Yonsei Ro, Seoul 120752, South Korea.	jhheo@yuhs.ac	Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845	Korea Healthcare Technology Research and Development Project, Ministry for Health and Welfare, Republic of Korea [HI10C2020, HI08C2149]; Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center [H23-4-3]	This work was supported by a grant from the Korea Healthcare Technology Research and Development Project, Ministry for Health and Welfare, Republic of Korea (HI10C2020, HI08C2149). The NCVC Stroke Registry is partially supported by an Intramural Research Fund (H23-4-3) for Cardiovascular Diseases of National Cerebral and Cardiovascular Center.	Jin HQ, 2012, STROKE, V43, P362, DOI 10.1161/STROKEAHA.111.623512; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Sakamoto Y, 2014, J STROKE CEREBROVASC, V23, P1877, DOI 10.1016/j.jstrokecerebrovasdis.2014.02.015; Miyashita F, 2014, J STROKE CEREBROVASC, V23, P1385, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.016; Kim YS, 2012, STROKE, V43, P1146, DOI 10.1161/STROKEAHA.111.638460; Ferro JM, 2003, LANCET NEUROL, V2, P177, DOI 10.1016/S1474-4422(03)00324-7; Morris DL, 2000, STROKE, V31, P2585; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Minematsu K, 2013, J STROKE CEREBROVASC, V22, P571, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.001; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fassbender K, 2013, LANCET NEUROL, V12, P585, DOI 10.1016/S1474-4422(13)70100-5; la Rosa FD, 2012, STROKE, V43, P1591, DOI 10.1161/STROKEAHA.111.645986; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Derex L, 2002, STROKE, V33, P153, DOI 10.1161/hs0102.100533; Faiz KW, 2013, EMERG MED J, V30, P669, DOI 10.1136/emermed-2012-201543; Gorelick Philip B, 2013, J Stroke, V15, P78, DOI 10.5853/jos.2013.15.2.78; Hong Keun-Sik, 2013, J Stroke, V15, P67, DOI 10.5853/jos.2013.15.2.67; Inatomi Y, 2008, J NEUROL SCI, V270, P127, DOI 10.1016/j.jns.2008.02.018; Kim YS, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-2; Miyamatsu N, 2013, CEREBROVASC DIS, V35, P241, DOI 10.1159/000347066; Yanagida T, 2014, J CLIN GERONTOL GERI, V5, P77	22	0	0	KOREAN STROKE SOC	SEOUL	C/O CHIN-SANG CHUNG, DEPT NEUROL, SAMSUNG MED CTR, SUNGKYUNKWAN UNIV, SCH MED, IRWON-RO, GANGNAM-GU, SEOUL, 135-710, SOUTH KOREA	2287-6391	2287-6405		J STROKE	J. Stroke	MAY	2015	17	2					159	167		10.5853/jos.2015.17.2.159		9	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CJ7WV	WOS:000355712000009		
J	Manor, E; Martens, WL; Marui, A; Cabrera, D				Manor, Ella; Martens, William L.; Marui, Atsushi; Cabrera, Densil			Nearfield Crosstalk Increases Listener Preferences for Headphone-Reproduced Stereophonic Imagery	JOURNAL OF THE AUDIO ENGINEERING SOCIETY			English	Article								This paper presents the results of an investigation that combines the findings of two separate experiments in which listeners were presented with short excerpts of stereophonic popular music reproduced via headphones for perceptual evaluation. The evaluation required listeners to compare between stimuli treated using selected spatial post-processing algorithms and make ratings of overall preference and also ratings of an auditory attribute termed Ensemble Stage Width (ESW). The results of Experiment 1 were similar to previous studies that had evaluated loudspeaker crosstalk simulation intended for headphone-reproduced stereophonic music. The results suggested the design of a novel approach to the simulation of loudspeaker crosstalk (termed Nearfield Crosstalk Simulation) that subsequently was tested in Experiment 2. The surprising results indicate, perhaps for the first time, that headphone-reproduced music submitted to a form of crosstalk simulation may be preferred over the original unprocessed version. In addition to new results this report provides a more comprehensive treatment of data that previously was presented and published in two ABS convention papers.	[Manor, Ella] Univ Sydney, Sydney, NSW 2006, Australia; [Martens, William L.] Univ Sydney, Fac Architecture Design & Planning, Grad Res Studies, Sydney, NSW 2006, Australia; [Cabrera, Densil] Univ Sydney, Audio & Acoust, Postgrad Coursework Program Architectural Sci, Sydney, NSW 2006, Australia; [Marui, Atsushi] Tokyo Univ Arts, Adachi Ku, Tokyo, Japan	Manor, E (reprint author), Univ Sydney, Sydney, NSW 2006, Australia.	ella.manor@sydney.edu.au; william.martens@sydney.edu.au; marui@ms.geidai.ac.jp; densil.cabrera@sydney.edu.au					Rumsey F, 2002, J AUDIO ENG SOC, V50, P651; Kendall GS, 1995, COMPUT MUSIC J, V19, P71, DOI 10.2307/3680992; Boueri M., 2004, 117 CONV AUD ENG SOC; Duda RO, 1998, J ACOUST SOC AM, V104, P3048, DOI 10.1121/1.423886; Kirkeby O., 2002, 22 INT C VIRT SYNTH; Lorho G., 2005, 118 CONV AUD ENG SOC; Lorho G., 2002, AES 22 INT C VIRT SY; Manor E., 2012, 133 AUD ENG SOC CONV; Marui A., 2006, 120 CONV AUD ENG SOC; Nunnally J. C., 1994, PSYCHOMETRIC THEORY; Olive S., 2001, 110 CONV AUD ENG SOC; Page M., 2011, EVEN ALBUM SALES FAL; Pulkki V., 2011, DAFX DIGITAL AUDIO E; Rumsey F., 2001, SPATIAL AUDIO, Vxi, P240; Rumsey F., 1998, AES 15 INT C AUD AC; Zolzer U., 2002, DAFX DIGITAL AUDIO E	16	0	0	AUDIO ENGINEERING SOC	NEW YORK	60 E 42ND ST, NEW YORK, NY 10165-2520 USA	1549-4950			J AUDIO ENG SOC	J. Audio Eng. Soc.	MAY	2015	63	5					324	335				12	Acoustics; Engineering, Multidisciplinary	Acoustics; Engineering	CJ8TZ	WOS:000355777700002		
J	Kaneda, Y				Kaneda, Yutaka			Noise Reduction Performance of Various Signals for Impulse Response Measurement	JOURNAL OF THE AUDIO ENGINEERING SOCIETY			English	Article								In the measurement of impulse response, ambient noise is included leading to a decrease in measurement quality. To solve this problem the use of several measurement signals (or excitation signals) has been proposed. However, the relationship between measurement signals and the noise reduction performance (NRP) has not been quantitatively examined thus far. In this study the NRP characteristics of different measurement signals were theoretically examined to derive equations that can determine NRP from the spectra of the measurement signal and noise. From the theoretical and experimental examinations the following results were obtained. The NRP for white signals and noise-whitening signals is actually the same. Only the minimum noise (MN) signal that minimizes the noise component showed a significant improvement in NRP. A pink spectrum measurement signal showed good NRP in the presence of 1/k(2) spectrum noise, where k is the discrete frequency number, but worse performance with other types of noise. This supports the conclusion that using the MN signal, which has a power spectrum that is the square root of the power spectrum of the noise, is the best method of reducing the effect of noise on the measured impulse response.	Tokyo Denki Univ, Fac Engn, Dept Informat & Commun Engn, Adachi Ku, Tokyo 1208551, Japan	Kaneda, Y (reprint author), Tokyo Denki Univ, Fac Engn, Dept Informat & Commun Engn, Adachi Ku, 5 Senju Asahi Cho, Tokyo 1208551, Japan.	kaneda@c.dendai.ac.jp					RIFE DD, 1989, J AUDIO ENG SOC, V37, P419; Stan GB, 2002, J AUDIO ENG SOC, V50, P249; AOSHIMA N, 1981, J ACOUST SOC AM, V69, P1484, DOI 10.1121/1.385782; Blauert J., 1983, SPATIAL HEARING; BORISH J, 1983, J AUDIO ENG SOC, V31, P478; DUNN C, 1993, J AUDIO ENG SOC, V41, P314; Farina A., 2000, 108 CONV AUD ENG SOC; Fujimoto T., 1999, P AUT M AC SOC JPN S, P433; Huang Y., 2004, AUDIO SIGNAL PROCESS; Kuttruff H, 1991, ROOM ACOUSTICS; Moriya N., 2008, J ACOUST SOC JPN, V64, P695; Moriya N., 2007, Acoustical Science and Technology, V28, DOI 10.1250/ast.28.43; Muller S, 2001, J AUDIO ENG SOC, V49, P443; SUZUKI Y, 1995, J ACOUST SOC AM, V97, P1119, DOI 10.1121/1.412224; Weinzierl S., 2009, 126 CONV AUD ENG SOC	15	0	0	AUDIO ENGINEERING SOC	NEW YORK	60 E 42ND ST, NEW YORK, NY 10165-2520 USA	1549-4950			J AUDIO ENG SOC	J. Audio Eng. Soc.	MAY	2015	63	5					348	357				10	Acoustics; Engineering, Multidisciplinary	Acoustics; Engineering	CJ8TZ	WOS:000355777700004		
J	Li, C; Liu, Y; Zhang, B; Wang, T; Guo, Q; Sheng, K; Yin, Y				Li, Can; Liu, Yan; Zhang, Bin; Wang, Tao; Guo, Qing; Sheng, Kuang; Yin, You			The effect of h-BN buffer layers in bilayer graphene on Co (111)	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Graphene; Co; Interface	HEXAGONAL BORON-NITRIDE; CHEMICAL-VAPOR-DEPOSITION; FIELD-EFFECT TRANSISTORS	Understanding of the interface of Co/graphene is essential for applications of graphene-based devices, as well as in the process of graphene synthesis. In this paper, the Co/graphene interface, including five structures of bilayer graphene (BLG) on Co (111) surface with bilayer or monolayer BN buffer sheets, is investigated by using density functional theory calculations. The corresponding atomic and electronic structures and Mulliken charge populations are also analyzed. The bilayer BN sheets are found to be the thinnest insulator for the backside Co metal gate, which shields BLG from Co substrate pining, decreases the charges influenced by the substrate, and improves BLG transport mobility.	[Li, Can] China Jiliang Univ, Sch Mat Sci & Engn, Ctr Coordinat Bond Engn, Hangzhou 310018, Zhejiang, Peoples R China; [Liu, Yan; Zhang, Bin; Wang, Tao; Guo, Qing; Sheng, Kuang] Zhejiang Univ, Affiliated Hosp 2, Dept Radiol, Coll Elect Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Yin, You] Gunma Univ, Div Elect & Informat, Kiryu, Gunma 3768515, Japan	Wang, T (reprint author), Zhejiang Univ, Affiliated Hosp 2, Dept Radiol, Coll Elect Engn, Hangzhou 310027, Zhejiang, Peoples R China.	twang@zju.edu.cn	Li, Can/I-2866-2012	Li, Can/0000-0002-0370-2695	National Natural Science Foundation of China [61176101]; Ph.D. Programs Foundation of Ministry of Education of China [20120101120156]; Key Laboratory of Nanodevices and Applications, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences [14JG01]	The research work is supported by the National Natural Science Foundation of China (Grant No. 61176101), by The Ph.D. Programs Foundation of Ministry of Education of China (20120101120156) and by the Key Laboratory of Nanodevices and Applications, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences (14JG01).	Nag A, 2010, ACS NANO, V4, P1539, DOI 10.1021/nn9018762; Olsen T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.156401; Wang SM, 2013, NEW J CHEM, V37, P1616, DOI 10.1039/c3nj41136b; Wang LF, 2014, ADV MATER, V26, P1559, DOI 10.1002/adma.201304937; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Lin YM, 2010, IEEE ELECTR DEVICE L, V31, P68, DOI 10.1109/LED.2009.2034876; Hashmi A, 2014, J KOREAN PHYS SOC, V64, P1370, DOI 10.3938/jkps.64.1370; Zhang CX, 2014, J APPL PHYS, V115, DOI 10.1063/1.4870825; Tsakoumis NE, 2010, CATAL TODAY, V154, P162, DOI 10.1016/j.cattod.2010.02.077; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Zhi CY, 2009, ADV MATER, V21, P2889, DOI 10.1002/adma.200900323; Kim KK, 2012, NANO LETT, V12, P161, DOI 10.1021/nl203249a; Wang T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4818120; Meric I, 2013, P IEEE, V101, P1609, DOI 10.1109/JPROC.2013.2257634; Gong C, 2010, J APPL PHYS, V108, DOI 10.1063/1.3524232; Song L, 2010, NANO LETT, V10, P3209, DOI 10.1021/nl1022139; PAINE RT, 1990, CHEM REV, V90, P73, DOI 10.1021/cr00099a004; BLASE X, 1995, PHYS REV B, V51, P6868, DOI 10.1103/PhysRevB.51.6868; Gao Y., 2013, ACS NANO, V5199; Giovannetti G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026803; Jain N, 2013, CARBON, V54, P396, DOI 10.1016/j.carbon.2012.11.054; Liu HL, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/2/026802; Lopez S. B., 2010, PHYS REV LETT, V104; Sipahi GM, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/10/104204; Swart JCW, 2009, PHYS CHEM CHEM PHYS, V11, P803, DOI 10.1039/b814664k	25	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	MAY	2015	66	10					1631	1636		10.3938/jkps.66.1631		6	Physics, Multidisciplinary	Physics	CJ8JW	WOS:000355747300032		
J	Rashid, MH; Heinzelmann, G; Kuyucak, S				Rashid, M. Harunur; Heinzelmann, Germano; Kuyucak, Serdar			Calculation of free energy changes due to mutations from alchemical free energy simulations	JOURNAL OF THEORETICAL & COMPUTATIONAL CHEMISTRY			English	Article						Molecular design via mutation; free energy perturbation; thermodynamic integration; toxin peptides; ion channels	ASPARTATE TRANSPORTER GLT(PH); POTASSIUM CHANNEL INHIBITOR; PROTEIN-LIGAND INTERACTIONS; SEA-ANEMONE TOXIN; MEMORY T-CELLS; AUTOIMMUNE-DISEASES; BIOMOLECULAR SIMULATION; MOLECULAR-MECHANICS; BINDING AFFINITIES; KV1.3 CHANNELS	How a mutation affects the binding free energy of a ligand is a fundamental problem in molecular biology/biochemistry with many applications in pharmacology and biotechnology, e.g. design of drugs and enzymes. Free energy change due to a mutation can be determined most accurately by performing alchemical free energy calculations in molecular dynamics (MD) simulations. Here we discuss the necessary conditions for success of free energy calculations using toxin peptides that bind to ion channels as examples. We show that preservation of the binding mode is an essential requirement but this condition is not always satisfied, especially when the mutation involves a charged residue. Otherwise problems with accuracy of results encountered in mutation of charged residues can be overcome by performing the mutation on the ligand in the binding site and bulk simultaneously and in the same system. The proposed method will be useful in improving the affinity and selectivity profiles of drug leads and enzymes via computational design and protein engineering.	[Rashid, M. Harunur] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Rashid, M. Harunur; Heinzelmann, Germano] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan; [Heinzelmann, Germano; Kuyucak, Serdar] Univ Fed Santa Catarina, Dept Fis, BR-88040900 Florianopolis, SC, Brazil	Kuyucak, S (reprint author), Univ Fed Santa Catarina, Dept Fis, BR-88040900 Florianopolis, SC, Brazil.	serdar@physics.usyd.edu.au					Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Regaya I, 2004, J BIOL CHEM, V279, P55690, DOI 10.1074/jbc.M410055200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Mobley DL, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4769292; Gilson MK, 1997, BIOPHYS J, V72, P1047; Heinzelmann G, 2013, J PHYS CHEM B, V117, P5486, DOI 10.1021/jp4010423; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Chodera JD, 2011, CURR OPIN STRUC BIOL, V21, P150, DOI 10.1016/j.sbi.2011.01.011; Christ CD, 2010, J COMPUT CHEM, V31, P1569, DOI 10.1002/jcc.21450; Singh N, 2010, PROTEINS, V78, P1705, DOI 10.1002/prot.22687; Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h; Savarin P, 1999, PROTEIN SCI, V8, P2672; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Rashid MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04509; Rashid MH, 2012, J PHYS CHEM B, V116, P4812, DOI 10.1021/jp300639x; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Brown SP, 2009, J MED CHEM, V52, P3159, DOI 10.1021/jm801444x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Enyedy IJ, 2008, J COMPUT AID MOL DES, V22, P161, DOI 10.1007/s10822-007-9165-4; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; Billen B, 2008, CURR PHARM DESIGN, V14, P2492, DOI 10.2174/138161208785777423; de Ruiter A, 2011, CURR OPIN CHEM BIOL, V15, P547, DOI 10.1016/j.cbpa.2011.05.021; Dixit SB, 2001, J PHYS CHEM A, V105, P9795, DOI 10.1021/jp011878v; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; ZACHARIAS M, 1994, J CHEM PHYS, V100, P9025, DOI 10.1063/1.466707; Rashid MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078712; Brooijmans N, 2003, ANNU REV BIOPH BIOM, V32, P335, DOI 10.1146/annurev.biophys.32.110601.142532; Heinzelmann G, 2011, BIOPHYS J, V101, P2380, DOI 10.1016/j.bpj.2011.10.010; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Norton RS, 2004, CURR MED CHEM, V11, P3041; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Michel J, 2010, J COMPUT AID MOL DES, V24, P639, DOI 10.1007/s10822-010-9363-3; Rocklin GJ, 2013, J MOL BIOL, V425, P4569, DOI 10.1016/j.jmb.2013.07.030; Ashcroft F. M., 2000, ION CHANNELS DIS CHA; Bastug T, 2009, BIOPHYS J, V96, P4006, DOI 10.1016/j.bpj.2009.02.041; Chipot C, 2013, WILEY INTERDISCIP RE, V4, P71; Chipot C., 2007, FREE ENERGY CALCULAT, VSpringer; Fersht A., 1999, STRUCTURE MECH PROTE; Heinzelmann G, 2014, J PHYS CHEM B, V118, P1813, DOI 10.1021/jp412195m; Hille B., 2001, IONIC CHANNELS EXCIT; Rashid MH, 2014, J PHYS CHEM B, V118, P707, DOI 10.1021/jp410950h	53	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-6336	1793-6888		J THEOR COMPUT CHEM	J. Theor. Comput. Chem.	MAY	2015	14	3							1550023	10.1142/S0219633615500236		19	Chemistry, Multidisciplinary	Chemistry	CJ3JR	WOS:000355379700008		
J	Kamiya, J; Hikichi, Y; Kinsho, M; Ogiwara, N; Fukuda, M; Hamatani, N; Hatanaka, K; Kamakura, K; Takahisa, K				Kamiya, Junichiro; Hikichi, Yusuke; Kinsho, Michikazu; Ogiwara, Norio; Fukuda, Mitsuhiro; Hamatani, Noriaki; Hatanaka, Kichiji; Kamakura, Keita; Takahisa, Keiji			Titanium alloy as a potential low radioactivation vacuum material	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A			English	Article							SURFACE TREATMENTS; STAINLESS-STEEL; ALUMINUM	For the vacuum systems of high-intensity beam accelerators, low radioactivation materials with good vacuum characteristics and high mechanical strength are required. The titanium alloy Ti-6Al-4V was investigated as a potential low activation vacuum material with high mechanical strength for the fabrication of vacuum components, particularly the flanges of beam pipes, in the J-PARC 3GeV synchrotron. The dose rate of Ti-6Al-4V when irradiated by a 400 MeV proton was observed to decrease more rapidly than that of stainless steel. Furthermore, the generated radioactive isotopes were nuclides with relatively short half-lives. The outgassing rate per unit area of Ti-6Al-4V was approximately 10(-8) Pa m(3)/s m(2) after pumping for 100 h, which is the same as the typical value for stainless steel. Additionally, the hydrogen concentration in bulk Ti-6Al-4V was reduced to approximately 1 ppm by vacuum firing at 700 degrees C for 9 h; the mechanical strength was not reduced by this process. These results indicate that Ti-6Al-4V is a good candidate for use as a low activation vacuum material with high mechanical strength. (C) 2015 American Vacuum Society.	[Kamiya, Junichiro; Hikichi, Yusuke; Kinsho, Michikazu; Ogiwara, Norio] J PARC Ctr, Japan Atom Energy Agcy, Naka, Ibaraki 3191195, Japan; [Fukuda, Mitsuhiro; Hamatani, Noriaki; Hatanaka, Kichiji; Kamakura, Keita; Takahisa, Keiji] Osaka Univ, Nucl Phys Res Ctr, Osaka 5670047, Japan	Kamiya, J (reprint author), J PARC Ctr, Japan Atom Energy Agcy, 2-4 Shirane Shirakata, Naka, Ibaraki 3191195, Japan.	kamiya.junichiro@jaea.go.jp					Redhead PA, 2002, J VAC SCI TECHNOL A, V20, P1667, DOI 10.1116/1.1496783; CHEN JR, 1985, J VAC SCI TECHNOL A, V3, P2188, DOI 10.1116/1.573276; DYLLA HF, 1993, J VAC SCI TECHNOL A, V11, P2623, DOI 10.1116/1.578617; Firestone R.B., 1996, TABLE ISOTOPES; FULMER CB, 1964, NUCL INSTRUM METHODS, V31, P45, DOI 10.1016/0029-554X(64)90320-9; Hotchi H, 2014, P 2014 INT PART ACC, P899; Hotchi H., 2012, P 52 ICFA ADV BEAM D, P68; Inayoshi S, 1999, VACUUM, V53, P325, DOI 10.1016/S0042-207X(98)00422-9; ISHIMARU H, 1989, J VAC SCI TECHNOL A, V7, P2439, DOI 10.1116/1.575916; Japan Aluminium Association, 2001, HDB AL; Kamiya J, 2014, NUCL INSTRUM METH A, V763, P329, DOI 10.1016/j.nima.2014.06.062; Kamiya J., 2013, J VAC SOC JPN, V56, P167; Kamiya J., 2013, P 2013 INT PART ACC, P3327; Mizuno Y, 2001, J VAC SCI TECHNOL A, V19, P2571, DOI 10.1116/1.1392396; Ogiwara N, 2008, J PHYS CONF SER, V100, DOI 10.1088/1742-6596/100/9/092024; The Japan Institute of Metals and Material, 2004, DAT BOOK OF MET; Website of Aerospace Specification Metals Inc., MET DISTR	17	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0734-2101	1520-8559		J VAC SCI TECHNOL A	J. Vac. Sci. Technol. A	MAY	2015	33	3							031605	10.1116/1.4916934		8	Materials Science, Coatings & Films; Physics, Applied	Materials Science; Physics	CJ8HW	WOS:000355741800031		
J	Sano, K; Niibe, M; Kawakami, R; Nakano, Y				Sano, Keiji; Niibe, Masahito; Kawakami, Retsuo; Nakano, Yoshitaka			Recovery of x-ray absorption spectral profile in etched TiO2 thin films	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A			English	Article							LIGHT; PLASMA; DAMAGE	Near edge x-ray absorption fine structure (NEXAFS) spectra of plasma-etched TiO2 thin films were observed using the total fluorescence yield method involving visible emission. The disrupted spectrum recovered its as-grown (nonetched) profile, upon soft x-ray (SX) irradiation. This recovery was investigated by ultraviolet (UV) irradiation, spatial distribution measurements, exposing recovered samples to air, and NEXAFS measurements of ultrafine TiO2 particles. The spectral profile recovered upon UV irradiation, and at sample positions outside of the SX irradiation site. The recovered spectral profiles were disrupted again, upon exposure to air. Nonetched ultrafine TiO2 particles also exhibited a disrupted spectral profile, which was recovered upon SX irradiation. The spectral recovery is explained by a model involving electrons trapped in oxygen vacancies generated by etching. (C) 2015 American Vacuum Society.	[Sano, Keiji; Niibe, Masahito] Univ Hyogo, Lab Adv Sci & Technol Ind, Kamigori, Hyogo 6781205, Japan; [Kawakami, Retsuo] Univ Tokushima, Inst Sociotechno Sci Technol, Tokushima, Tokushima 7708506, Japan; [Nakano, Yoshitaka] Chubu Univ, Inst Sci & Technol Res, Kasugai, Aichi 4878501, Japan	Sano, K (reprint author), Univ Hyogo, Lab Adv Sci & Technol Ind, Kamigori, Hyogo 6781205, Japan.	niibe@lasti.u-hyogo.ac.jp			Japan Society for the Promotion of Science (JSPS) [26390066]	This research was supported by the Japan Society for the Promotion of Science (JSPS), Grants-in-Aid for Scientific Research (C), Grant No. 26390066.	Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; Choi KR, 2013, VACUUM, V92, P85, DOI 10.1016/j.vacuum.2012.11.009; Kucheyev SO, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.245102; EISEBITT S, 1993, PHYS REV B, V47, P14103, DOI 10.1103/PhysRevB.47.14103; Berger T, 2005, J PHYS CHEM B, V109, P6061, DOI 10.1021/jp0404293; Lee KE, 2011, J PHYS CHEM C, V115, P5692, DOI 10.1021/jp109869z; Park JB, 2009, J KOREAN PHYS SOC, V54, P976; Kawakami R, 2013, J PHYS CONF SER, V441, DOI 10.1088/1742-6596/441/1/012038; Kawakami R, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.08KD01; Kawakami R, 2008, THIN SOLID FILMS, V516, P3478, DOI 10.1016/j.tsf.2007.08.019; Kawakami R, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.08HB04; Kawakami R, 2010, VACUUM, V84, P1393, DOI 10.1016/j.vacuum.2010.01.006; Niibe M., 2013, J PHYS C SER, V425; Niibe M, 2013, J APPL PHYS, V113, DOI 10.1063/1.4798301; Niibe M, 2004, AIP CONF PROC, V705, P576; Okada K., 2009, SURF SCI NANOTECHNOL, V7, P290; Stevanovic A, 2012, J AM CHEM SOC, V134, P324, DOI 10.1021/ja2072737; Stohr J., 1992, NEXAFS SPECTROSCOPY; Ushiki T, 1999, MICROELECTRON RELIAB, V39, P327, DOI 10.1016/S0026-2714(99)00005-0; Yogi C, 2011, J PHYS CHEM C, V115, P6554, DOI 10.1021/jp110581J; Zhong N, 2011, AIP ADV, V1, DOI 10.1063/1.3646525	21	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0734-2101	1520-8559		J VAC SCI TECHNOL A	J. Vac. Sci. Technol. A	MAY	2015	33	3							031403	10.1116/1.4917012		4	Materials Science, Coatings & Films; Physics, Applied	Materials Science; Physics	CJ8HW	WOS:000355741800012		
J	Yoshikawa, J; Susa, Y; Ventzek, PLG				Yoshikawa, Jun; Susa, Yoshio; Ventzek, Peter L. G.			Measurements and modeling of the impact of weak magnetic fields on the plasma properties of a planar slot antenna driven plasma source	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A			English	Article							MICROWAVE-DISCHARGE; DENSITY; SIMULATION; ENERGY	The radial line slot antenna plasma source is a type of surface wave plasma source driven by a planar slot antenna. Microwave power is transmitted through a slot antenna structure and dielectric window to a plasma characterized by a generation zone adjacent to the window and a diffusion zone that contacts a substrate. The diffusion zone is characterized by a very low electron temperature. This renders the source useful for soft etch applications and thin film deposition processes requiring low ion energy. Another property of the diffusion zone is that the plasma density tends to decrease from the axis to the walls under the action of ambipolar diffusion at distances far from where the plasma is generated. A previous simulation study [Yoshikawa and. Ventzek, J. Vac. Sci. Technol. A 31, 031306 (2013)] predicted that the anisotropy in transport parameters due to weak static magnetic fields less than 50 G could be leveraged to manipulate the plasma profile in the radial direction. These simulations motivated experimental tests in which weak magnetic fields were applied to a radial line slot antenna source. Plasma absorption probe measurements of electron density and etch rate showed that the magnetic fields remote from the wafer were able to manipulate both parameters. A summary of these results is presented in this paper. Argon plasma simulation trends are compared with experimental plasma and etch rate measurements. A test of the impact of magnetic fields on charge up damage showed no perceptible negative effect. (C) 2015 American Vacuum Society.	[Yoshikawa, Jun; Susa, Yoshio; Ventzek, Peter L. G.] Tokyo Electron Ltd, Minato Ku, Tokyo 1076325, Japan	Yoshikawa, J (reprint author), Tokyo Electron Ltd, Minato Ku, Akasaka Biz Tower,3-1 Akasaka 5 Chome, Tokyo 1076325, Japan.	jun.yoshikawa@tel.com					Sugai H, 2000, APPL PHYS LETT, V77, P3523, DOI 10.1063/1.1329322; MOISAN M, 1991, J PHYS D APPL PHYS, V24, P1025, DOI 10.1088/0022-3727/24/7/001; LEE C, 1995, J VAC SCI TECHNOL A, V13, P368, DOI 10.1116/1.579366; BUTTERBAUGH JW, 1991, J VAC SCI TECHNOL B, V9, P1461, DOI 10.1116/1.585451; Gudmundsson JT, 2007, PLASMA SOURCES SCI T, V16, P399, DOI 10.1088/0963-0252/16/2/025; Brcka J, 2009, PLASMA PROCESS POLYM, V6, pS776, DOI 10.1002/ppap.200931903; FANG SC, 1992, IEEE ELECTR DEVICE L, V13, P288, DOI 10.1109/55.145056; GOTO HH, 1993, IEEE T SEMICONDUCT M, V6, P58, DOI 10.1109/66.210658; HARPER JME, 1981, J ELECTROCHEM SOC, V128, P1077, DOI 10.1149/1.2127554; Kono A, 2002, APPL SURF SCI, V192, P115, DOI 10.1016/S0169-4332(02)00023-5; Kousaka H, 2006, THIN SOLID FILMS, V506, P503, DOI 10.1016/j.tsf.2005.08.108; Nakamura K, 2003, J VAC SCI TECHNOL A, V21, P325, DOI 10.1116/1.1532740; Nakamura S, 1999, J APPL PHYS, V85, P2534, DOI 10.1063/1.369571; Ohmi T, 2006, J PHYS D APPL PHYS, V39, pR1, DOI 10.1088/0022-3727/39/1/R01; Raja LL, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4798362; Tian C, 2006, J VAC SCI TECHNOL A, V24, P1421, DOI 10.1116/1.2167983; Yasaka Y, 2004, IEEE T PLASMA SCI, V32, P101, DOI 10.1109/TPS.2004.823977; Yoshikawa J, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4802737	18	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0734-2101	1520-8559		J VAC SCI TECHNOL A	J. Vac. Sci. Technol. A	MAY	2015	33	3							031303	10.1116/1.4916018		5	Materials Science, Coatings & Films; Physics, Applied	Materials Science; Physics	CJ8HW	WOS:000355741800007		
J	Trang, NT; Hirai, T; Ngan, PH; Lan, NT; Fuke, N; Toyama, K; Yamamoto, T; Yamaguchi, R				Nguyen Thi Trang; Hirai, Takuya; Pham Hong Ngan; Nguyen Thi Lan; Fuke, Naoyuki; Toyama, Keiko; Yamamoto, Tsukasa; Yamaguchi, Ryoji			Enhanced detection of Porcine reproductive and respiratory syndrome virus in fixed tissues by in situ hybridization following tyramide signal amplification	JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION			English	Article						In situ hybridization; lung; Porcine reproductive and respiratory syndrome virus	POLYMERASE-CHAIN-REACTION; MYSTERY SWINE DISEASE; LELYSTAD VIRUS; FORMALIN FIXATION; EPIDEMIC ABORTION; MESSENGER-RNA; INFECTED-PIGS; IMMUNOHISTOCHEMISTRY; GRADE	This study evaluated the sensitivity of biotinyl-tyramide-based in situ hybridization (TISH) method by comparison with chromogenic in situ hybridization (CISH) and immunohistochemical staining (IHC) methods. This study also determined the effect of fixative and fixation time on the detection of Porcine reproductive and respiratory syndrome virus (PRRSV) in paraffin-embedded tissues. Lung samples were fixed in 4% paraformaldehyde (PFA) or 10% neutral buffered formalin (NBF) for various times before paraffin embedding. Of 30 paraffin-embedded lung samples, fixed for 1 day in 4% PFA or 10% NBF, 18 (60%) were positive for PRRSV by nested reverse transcription polymerase chain reaction (nRT-PCR). All 18 lung samples (100%) also were positive for PRRSV by TISH, but only 10 of these 18 specimens (56%) were positive for PRRSV by IHC and CISH. We demonstrated that TISH can detect PRRSV RNA in paraffin-embedded tissues after up to 90 days of fixation. PRRSV nucleic acids and antigens were better preserved in 4% PFA than in 10% NBF. Compared with CISH and IHC testing methods, TISH appeared to be more sensitive for the detection of PRRSV in paraffin-embedded tissues.	[Nguyen Thi Trang; Hirai, Takuya; Fuke, Naoyuki; Toyama, Keiko; Yamaguchi, Ryoji] Miyazaki Univ, Fac Agr, Dept Vet Pathol, Miyazaki 8892192, Japan; [Nguyen Thi Trang; Pham Hong Ngan] Hanoi Univ Agr, Dept Vet Publ Hlth, Fac Vet Med, Hanoi, Vietnam; [Nguyen Thi Lan] Hanoi Univ Agr, Dept Vet Pathol, Fac Vet Med, Hanoi, Vietnam	Hirai, T (reprint author), Miyazaki Univ, Fac Agr, Dept Vet Pathol, Nishi 1-1, Miyazaki 8892192, Japan.	t-hirai@cc.miyazaki-u.ac.jp			Japanese Society for the Promotion of Science (JSPS) [23580425]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by a Japanese Society for the Promotion of Science (JSPS) Grant (no. 23580425).	Matsuda Y, 2011, J HISTOCHEM CYTOCHEM, V59, P68, DOI 10.1369/jhc.2010.957217; Rossow KD, 1998, VET PATHOL, V35, P1; KERSTENS HMJ, 1995, J HISTOCHEM CYTOCHEM, V43, P347; Yang H, 1999, J HISTOCHEM CYTOCHEM, V47, P431; Andreyev VG, 1997, ARCH VIROL, V142, P993, DOI 10.1007/s007050050134; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; Nelsen CJ, 1999, J VIROL, V73, P270; BENFIELD DA, 1992, J VET DIAGN INVEST, V4, P127; Benson JE, 2002, J VET DIAGN INVEST, V14, P8; Cheon DS, 2000, J VET DIAGN INVEST, V12, P582; Cheon DS, 1999, J COMP PATHOL, V120, P79, DOI 10.1053/jcpa.1998.0257; Evans MF, 2002, MODERN PATHOL, V15, P1339, DOI 10.1038/modpathol.3880698; Kubelka-Sabit KB, 2008, BALK J MED GEN, V11, P41, DOI 10.2478/v10034-008-0016-y; Mizuno T, 1998, DIAGN MOL PATHOL, V7, P202, DOI 10.1097/00019606-199808000-00004; Mostegl MM, 2011, J VET DIAGN INVEST, V23, P1212, DOI 10.1177/1040638711425584; Shin Jin-Ho, 2002, J Vet Sci, V3, P87; Speel EJM, 1998, HISTOCHEM CELL BIOL, V110, P571, DOI 10.1007/s004180050319; Tanizaki Y, 2006, PATHOL INT, V56, P510, DOI 10.1111/j.1440-1827.2006.01999.x; TERPSTRA C, 1991, VET QUART, V13, P131; Van Alstine WG, 2002, J VET DIAGN INVEST, V14, P504; WENSVOORT G, 1991, VET QUART, V13, P121; Yoshii M, 2004, J VET DIAGN INVEST, V16, P342; Zhou YJ, 2009, VET MICROBIOL, V138, P1, DOI 10.1016/j.vetmic.2009.01.041	23	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1040-6387	1943-4936		J VET DIAGN INVEST	J. Vet. Diagn. Invest.	MAY	2015	27	3					326	331		10.1177/1040638715579260		6	Veterinary Sciences	Veterinary Sciences	CJ7RH	WOS:000355695500008		
J	Harada, K; Ukai, Y; Kanakubo, K; Yamano, S; Lee, J; Kurosawa, TA; Uechi, M				Harada, Kayoko; Ukai, Yoshimi; Kanakubo, Kayo; Yamano, Shigeki; Lee, Junseok; Kurosawa, Tsumugi Anne; Uechi, Masami			Comparison of the diuretic effect of furosemide by different methods of administration in healthy dogs	JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE			English	Article						edema; heart failure; hemodynamics; hypertension; loop diuretics	CONGESTIVE-HEART-FAILURE; CONTINUOUS-INFUSION; SUBCUTANEOUS FUROSEMIDE; BOLUS INJECTION; FRUSEMIDE; EFFICACY; ALBUMIN; SYSTEM; EDEMA	ObjectiveTo compare the diuretic effects of subcutaneous (SC) administration of furosemide to conventional methods of administration including intravenous (IV), per os (PO), and constant rate infusion (CRI) in healthy dogs. DesignProspective, randomized, cross-over study. SettingVeterinary university research facility. AnimalsSeven healthy, adult mongrel dogs (3 males, 4 females). InterventionEach dog in the study was randomly assigned to receive a 2 mg/kg dose of furosemide via a single SC, IV, or PO dose at the beginning (time 0) of an 8-hour study, or via CRI during an 8-hour study period. Urine was collected by emptying the bladder using an indwelling catheter and blood samples were obtained via venipuncture at time 0 for baseline measurements and at 1, 2, 4, 6, and 8 hours into the study. Hourly urine output was calculated in all dogs for each study. Complete blood count, plasma total protein, blood urea nitrogen, creatinine, and renin concentration were measured for each sample. Measurements and Main ResultsThe SC administration of furosemide resulted in a urine output per hour (UOP/h) that peaked at 1 hour with UOP/h returning to baseline at 4 hours after injection. Following IV administration, UOP/h also peaked at 1 hour but returned more rapidly to baseline levels at 2 hours after injection. With PO administration, UOP/h reached a maximum UOP/h at 2 hours but time to return to baseline levels was prolonged to 6 hours after administration. With CRI administration, the time to the maximum UOP/h was delayed to 4 hours after injection but UOP/h was then maintained throughout the study period. ConclusionsTotal urine output following SC administration of furosemide in healthy dogs was similar when compared to the IV and PO route. Subcutaneous route may be an effective means for administration of furosemide in dogs, particularly when IV access is difficult.	[Harada, Kayoko; Ukai, Yoshimi; Yamano, Shigeki; Lee, Junseok; Kurosawa, Tsumugi Anne; Uechi, Masami] Nihon Univ, Sect Vet Internal Med, Dept Vet Med, Coll Bioresource Sci, Tokyo 102, Japan; [Ukai, Yoshimi; Kanakubo, Kayo; Yamano, Shigeki; Uechi, Masami] Kitasato Univ, Vet Teaching Hosp, Sch Vet Med & Anim Sci, Tokyo, Japan	Uechi, M (reprint author), Japan Anim Specialty Med Inst Inc, JASMINE Vet Cardiovasc Med Ctr, Tsuzuki Ku, 2-7-3 Nakagawa, Yokohama, Kanagawa 2240001, Japan.	uechi.masami@cardiovets.jp					Johansson AM, 2003, J VET INTERN MED, V17, P887, DOI 10.1892/0891-6640(2003)017<0887:FCRIIT>2.3.CO;2; Nicholls MG, 1998, J HUM HYPERTENS, V12, P295, DOI 10.1038/sj.jhh.1000638; LAHAV M, 1992, CHEST, V102, P725, DOI 10.1378/chest.102.3.725; Dormans TPJ, 1996, J AM COLL CARDIOL, V28, P376, DOI 10.1016/0735-1097(96)00161-1; Adin DB, 2003, J VET INTERN MED, V17, P632, DOI 10.1892/0891-6640(2003)017<0632:IBIVCI>2.3.CO;2; Brater DC, 1998, NEW ENGL J MED, V339, P387; PONTO LLB, 1990, CLIN PHARMACOKINET, V18, P381; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Ansel HC, 1999, PHARM DOSAGE FORMS D, V7th, P60; BESSEGHIR K, 1989, AM J PHYSIOL, V256, pF475; BIDDLE TL, 1979, AM J CARDIOL, V43, P86, DOI 10.1016/0002-9149(79)90049-3; BRANCH RA, 1977, BRIT J CLIN PHARMACO, V4, P121; Brater D. Craig, 1994, British Heart Journal, V72, pS40; DAVIDOV M, 1967, J AMER MED ASSOC, V200, P824, DOI 10.1001/jama.200.10.824; Doungngern T, 2012, AM J CRIT CARE, V21, P280, DOI 10.4037/ajcc2012999; ELSAYED MGA, 1981, ARCH INT PHARMACOD T, V253, P4; Farless LB, 2013, AM J HOSP PALLIAT ME, V30, P791, DOI 10.1177/1049909112465795; Feldman S, 1987, STERILE DOSAGE FORMS, P101; FRANCIS GS, 1985, ANN INTERN MED, V103, P1; Franklin MR, 2000, REMINGTON SCI PRACTI, P1098; FURTADO D, 1976, INVEST UROL, V13, P414; Hori Y, 2008, AM J VET RES, V69, P1664, DOI 10.2460/ajvr.69.12.1664; KAOJARERN S, 1982, KIDNEY INT, V22, P69, DOI 10.1038/ki.1982.134; Kim EJ, 2000, J PHARM PHARMACOL, V52, P1337, DOI 10.1211/0022357001777487; Kittleson MD, 1998, SMALL ANIMAL CARDIOV, P149; LAWSON DH, 1978, BRIT MED J, V2, P476; Newton M, 1992, NURSING, V22, P3; OBIKA LFO, 1988, PHARMACOL RES, V20, P49, DOI 10.1016/S0031-6989(88)80606-4; Perazella MA, 2003, J NUCL CARDIOL, V10, P184, DOI 10.1067/mnc.2003.392; Pivac N, 1998, INT J CLIN PHARM RES, V18, P121; Plumb DC, 2002, VET DRUG HDB, V4th, P394; PONTO LLB, 1990, CLIN PHARMACOKINET, V18, P460; Reiter P, 1998, PHARMACOTHERAPY, V18, P63; Unger T, 2002, AM J CARDIOL, V89, P3, DOI 10.1016/S0002-9149(01)02321-9; vansMeyel JJ, 1992, CLIN PHARMACOL THER, V51, P440; Verma AK, 2004, ANN PHARMACOTHER, V38, P544, DOI 10.1345/aph.1D332; Vincent P, 1999, DRUG METAB DISPOS, V27, P81; Zacharias H, 2011, PALLIATIVE MED, V25, P658, DOI 10.1177/0269216311399490	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1479-3261	1476-4431		J VET EMERG CRIT CAR	J. Vet. Emerg. Crit. Care	MAY-JUN	2015	25	3					364	371		10.1111/vec.12301		8	Veterinary Sciences	Veterinary Sciences	CJ8RM	WOS:000355771200005		
J	Sato, Y; Matsushima, S; Inaba, Y; Sano, T; Yannaura, H; Kato, M; Shimizu, Y; Senda, Y; Ishiguchi, T				Sato, Yozo; Matsushima, Shigeru; Inaba, Yoshitaka; Sano, Tsuyoshi; Yannaura, Hidekazu; Kato, Mina; Shimizu, Yasuhiro; Senda, Yoshiki; Ishiguchi, Tsuneo			Preoperative Estimation of Future Remnant Liver Function Following Portal Vein Embolization Using Relative Enhancement on Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging	KOREAN JOURNAL OF RADIOLOGY			English	Article						Future remnant liver function; Gd-EOB-DTPA-enhanced MR imaging; Portal vein embolization	GD-EOB-DTPA; INDOCYANINE GREEN TEST; EXTENDED HEPATECTOMY; HEPATIC RESECTION; CONTRAST AGENT; PULSE SPECTROPHOTOMETRY; HEPATOCYTE-PHASE; BILIARY CANCER; RESERVE; IMAGES	Objective: To retrospectively evaluate relative enhancement (RE) in the hepatobiliary phase of gadoxetic acid disodium-enhanced magnetic resonance (MR) imaging as a preoperative estimation of future remnant liver (FRL) function in a patients who underwent portal vein embolization (PVE). Materials and Methods: In 53 patients, the correlation between the indocyanine green clearance (ICG-K) and RE imaging was analyzed before hepatectomy (first analysis). Twenty-three of the 53 patients underwent PVE followed by a repeat RE imaging and ICG test before an extended hepatectomy and their results were further analyzed (second analysis). Whole liver function and FRL function were calculated on the MR imaging as follows: RE x total Liver volume (RE Index) and FRL-RE x FRL volume (Rem RE Index), respectively. Regarding clinical outcome, posthepatectomy liver failure (PHLF) was evaluated in patients undergoing PVE. Results: Indocyanine green clearance correlated with the RE Index (r = 0.365, p = 0.007), and ICG-K of FRL (ICG-Krem) strongly correlated with the Rem RE Index (r = 0.738, p < 0.001) in the first analysis. Both the ICG-Krem and the Rem RE Index were significantly correlated after PVE (r = 0.508, p = 0.013) at the second analysis. The rate of improvement of the Rem RE Index from before PVE to after PVE was significantly higher than that of ICG-Krem (p = 0.014). Patients with PHLF had a significantly lower Rem RE Index than patients without PHLF (p = 0.023). Conclusion: Relative enhancement imaging can be used to estimate FRL function after PVE.	[Sato, Yozo; Ishiguchi, Tsuneo] Aichi Med Univ, Dept Radiol, Aichi 4801195, Japan; [Sato, Yozo; Matsushima, Shigeru; Inaba, Yoshitaka; Yannaura, Hidekazu; Kato, Mina] Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Nagoya, Aichi 4648681, Japan; [Sano, Tsuyoshi; Shimizu, Yasuhiro; Senda, Yoshiki] Aichi Canc Ctr Hosp, Dept Gastroenterol Surg, Nagoya, Aichi 4648681, Japan	Sato, Y (reprint author), Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ysato@aichi-cc.jp					Kitao A, 2011, EUR RADIOL, V21, P2056, DOI 10.1007/s00330-011-2165-8; Leonhardt M, 2010, DRUG METAB DISPOS, V38, P1024, DOI 10.1124/dmd.110.032862; Ohwada S, 2006, BRIT J SURG, V93, P339, DOI 10.1002/bjs.5258; Yumoto Y, 2010, BRIT J SURG, V97, P934, DOI 10.1002/bjs.7025; Sano T, 2006, ANN SURG, V244, P240, DOI 10.1097/01.sla.0000217605.66519.38; Ebata T, 2012, DIGEST SURG, V29, P23, DOI 10.1159/000335718; Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269; Vogl TJ, 1996, RADIOLOGY, V200, P59; Imamura H, 2005, J HEPATO-BILIARY-PAN, V12, P16, DOI 10.1007/s00534-004-0965-9; Geisel D, 2013, EUR RADIOL, V23, P2555, DOI 10.1007/s00330-013-2859-1; Nassif A, 2012, RADIOLOGY, V264, P741, DOI 10.1148/radiol.12112061; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; Sakka SG, 2007, CURR OPIN CRIT CARE, V13, P207, DOI 10.1097/MCC.0b013e328012b268; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; van Lienden KP, 2013, CARDIOVASC INTER RAD, V36, P25, DOI 10.1007/s00270-012-0440-y; Abdalla EK, 2002, ARCH SURG-CHICAGO, V137, P675, DOI 10.1001/archsurg.137.6.675; Bluemke DA, 2005, RADIOLOGY, V237, P89, DOI 10.1148/radiol.2371031842; Reimer P, 2004, EUR RADIOL, V14, P559, DOI 10.1007/s00330-004-2236-1; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Komori K, 2006, BRIT J SURG, V93, P745, DOI 10.1002/bjs.5332; Okochi O, 2002, J SURG RES, V103, P109, DOI 10.1006/jsre.2001.6328; MATSUMATA T, 1987, WORLD J SURG, V11, P678; Seyama Y, 2009, HEPATOL RES, V39, P107, DOI 10.1111/j.1872-034X.2008.00441.x; Utsunomiya T, 2012, J GASTROENTEROL, V47, P470, DOI 10.1007/s00535-011-0513-8; Yamada A, 2011, RADIOLOGY, V260, P727, DOI 10.1148/radiol.11100586; Kim HY, 2013, J GASTROENTEROL, V48, P1180, DOI 10.1007/s00535-012-0740-7; Matsushima S, 2014, MAGN RESON IMAGING, V32, P654, DOI 10.1016/j.mri.2014.02.017; SCHUHMANNGIAMPIERI G, 1992, RADIOLOGY, V183, P59; Wibmer A, 2013, RADIOLOGY, V269, P777, DOI 10.1148/radiol.13130210	29	0	0	KOREAN RADIOLOGICAL SOC	SEOUL	121-8 YANGJAE-DONG, SEOCHO-GU, SEOUL 137-130, SOUTH KOREA	1229-6929	2005-8330		KOREAN J RADIOL	Korean J. Radiol.	MAY-JUN	2015	16	3					523	530		10.3348/kjr.2015.16.3.523		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CJ6XS	WOS:000355639100003		
J	Irie, T; Mawatari, T; Ikemura, S; Matsui, G; Iguchi, T; Mitsuyasu, H				Irie, Tomoko; Mawatari, Taro; Ikemura, Satoshi; Matsui, Gen; Iguchi, Takahiro; Mitsuyasu, Hiroaki			Brown Tumor of the Patella Caused by Primary Hyperparathyroidism: A Case Report	KOREAN JOURNAL OF RADIOLOGY			English	Editorial Material						Brown tumor; Patella; Hungry bone syndrome	SECONDARY HYPERPARATHYROIDISM; FRACTURE; DIAGNOSIS	It has been reported that the common sites of brown tumors are the jaw, pelvis, ribs, femurs and clavicles. We report our experience in a case of brown tumor of the patella caused by primary hyperparathyroidism. An initial radiograph and CT showed an osteolytic Lesion and MR images showed a mixed solid and multiloculated cystic tumor in the right patella. One month after the parathyroidectomy, rapid bone formation was observed on both radiographs and CT images.	[Irie, Tomoko; Mawatari, Taro; Ikemura, Satoshi; Matsui, Gen; Iguchi, Takahiro; Mitsuyasu, Hiroaki] Hamanomachi Hosp, Dept Orthopaed Surg, Fukuoka 8108539, Japan	Mawatari, T (reprint author), Hamanomachi Hosp, Dept Orthopaed Surg, Chuo Ku, 3-3-1 Nagahama, Fukuoka 8108539, Japan.	mawtaro@gmail.com					Hong WS, 2011, SKELETAL RADIOL, V40, P205, DOI 10.1007/s00256-010-0979-0; Knowles NG, 2008, J MAGN RESON IMAGING, V28, P759, DOI 10.1002/jmri.21441; Lacativa PGS, 2009, SAO PAULO MED J, V127, P71, DOI 10.1590/S1516-31802009000200004; Bhagat S, 2008, KNEE SURG, V21, P212; Campanacci M., 1999, BONE SOFT TISSUE TUM, V2nd, P877; CHEW FS, 1993, AM J ROENTGENOL, V160, P752; Di Daniele N, 2009, INT J ENDOCRINOL, DOI 10.1155/2009/827652; Hsieh MC, 2004, ARCH ORTHOP TRAUM SU, V124, P498, DOI 10.1007/s00402-004-0697-y; Jouan A, 2008, JOINT BONE SPINE, V75, P209, DOI 10.1016/j.jbspin.2007.03.004; Singh J, 2009, EUR RADIOL, V19, P701, DOI 10.1007/s00330-008-1180-x; Takeshita Tohru, 2006, Radiat Med, V24, P631, DOI 10.1007/s11604-006-0068-4; Vernace N, 2014, ORTHOPEDICS, V37, P506, DOI 10.3928/01477447-20140728-01; Vestergaard P, 2000, BRIT MED J, V321, P598, DOI 10.1136/bmj.321.7261.598; Wang XQ, 2014, INT J CLIN EXP PATHO, V7, P7094; Witteveen JE, 2013, EUR J ENDOCRINOL, V168, pR45, DOI 10.1530/EJE-12-0528	15	0	0	KOREAN RADIOLOGICAL SOC	SEOUL	121-8 YANGJAE-DONG, SEOCHO-GU, SEOUL 137-130, SOUTH KOREA	1229-6929	2005-8330		KOREAN J RADIOL	Korean J. Radiol.	MAY-JUN	2015	16	3					613	616		10.3348/kjr.2015.16.3.613		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CJ6XS	WOS:000355639100013		
J	Ohsugi, IJ; Tokunaga, D; Kato, M; Yoneda, S; Isoda, Y				Ohsugi, I. J.; Tokunaga, D.; Kato, M.; Yoneda, S.; Isoda, Y.			Dissociation and sublimation of tellurium from the thermoelectric tellurides	MATERIALS RESEARCH INNOVATIONS			English	Article						Thermoelectric material; PbTe; SnTe; Bi2Te3; X-ray diffraction analysis		The authors have recently reported that Te in Pb(1-x) SnxTe (0 <= x <= 1) system compounds will be dissociated and sublimated at high temperatures over 400 degrees C on the basis of experimental results. In the experiment, the thermal expansion was tested and the thermogravimetry-differential thermal analysis was carried out from the room temperature to 500 degrees C. In the present work, a high-temperature X-ray diffraction profiles are observed to investigate the change in the crystal structure of PbTe and Bi2Te3. It is concluded from the experimental results that Te will be dissociated and move onto the sample surface to form a liquid or amorphous state at temperatures ranging from 200 to 400 degrees C and that Te on the sample surface will be volatilised at higher temperatures than 400 degrees C. It is also concluded that in Bi2Te3, Te might be sublimated even at lower temperatures than 400 degrees C.	[Ohsugi, I. J.] TEX EG Co Ltd, Machida, Tokyo 1940215, Japan; [Tokunaga, D.; Kato, M.] Salesian Polytech, Machida, Tokyo 1940215, Japan; [Yoneda, S.] Kanagawa Univ, Yokohama, Kanagawa 2218686, Japan; [Isoda, Y.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Ohsugi, IJ (reprint author), TEX EG Co Ltd, 2-3-28 Oyamagaoka, Machida, Tokyo 1940215, Japan.	ohsugii@texeg.co.jp					Chen L., 1998, P INT C THERM 24 28, P251; Hikage Y., 2008, T MAT RES SOC JPN, V33, P1123; Yoneda S., 1996, IMPROVEMENT THERMAL, P575; Yoneda S., 2013, J THEOR APPL PHYS, V7, P11; Yoneda S, 1999, J CRYST GROWTH, V204, P229, DOI 10.1016/S0022-0248(99)00177-3; Yoneda S, 2010, J APPL PHYS, V107, DOI 10.1063/1.3361282	6	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1432-8917	1433-075X		MATER RES INNOV	Mater. Res. Innov.	MAY	2015	19			5			301	303		10.1179/1432891714Z.0000000001097		3	Materials Science, Multidisciplinary	Materials Science	CJ3JT	WOS:000355379900057		
J	Toyoda, R; Tawata, M; Hashimoto, M; Matsumura, Y				Toyoda, R.; Tawata, M.; Hashimoto, M.; Matsumura, Y.			Internal stress control of transition-metal thin films	MATERIALS RESEARCH INNOVATIONS			English	Article						Sputtered thin film; Ion bombardment; Ion momentum; Internal stress	ION-BOMBARDMENT; MAGNETOSTRICTIVE PROPERTIES	The characteristics of sputtered thin films are affected by ion bombardment during sputter deposition. An ion bombardment parameter Pi, which is based on the magnitude of the ion momentum and the impingement ratio of ions to metal particles, has been previously proposed as a means of expressing the effects of ion bombardment. In this study, the effects of ion bombardment parameter P-i on the internal stress of thin films were evaluated. Consequently, the internal stress of Ni and Cu thin films were observed to increase linearly with the increase of P-i; however, a Mo thin film exhibited the converse result. The results presented herein indicate that the characteristics of thin films, irrespective of the target, can be controlled via manipulation of parameter P-i.	[Toyoda, R.; Matsumura, Y.] Tokai Univ, Grad Sch Engn, Dept Appl Sci, Hiratsuka, Kanagawa 2591292, Japan; [Tawata, M.] Tokai Univ, Sch Engn, Dept Mech Engn, Hiratsuka, Kanagawa 2591292, Japan; [Hashimoto, M.] Tokai Univ, Sch Engn, Dept Nucl Engn, Hiratsuka, Kanagawa 2591292, Japan	Matsumura, Y (reprint author), Tokai Univ, Grad Sch Engn, Dept Appl Sci, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	ncc1701d@keyaki.cc.u-tokai.ac.jp			Japan Society for the Promotion of Science (JSPS) [24560859]	This study was financially supported by the Japan Society for the Promotion of Science (JSPS) through a Grant-in-Aid for Scientific Research (C) 'Control of properties for thin film actuator materials' (No. 24560859). This study was also carried out as part of the 'Creation of Advanced Energy Materials, Future Science & Technology Joint Research Center', Tokai University.	Amemiya H., 1985, Journal of the Vacuum Society of Japan, V28; QUANDT E, 1994, J APPL PHYS, V76, P7000, DOI 10.1063/1.358068; WINDISCHMANN H, 1991, J VAC SCI TECHNOL A, V9, P2431, DOI 10.1116/1.577295; Stoney GG, 1909, P R SOC LOND A-CONTA, V82, P172, DOI 10.1098/rspa.1909.0021; Esho S., 1976, AIP C P, V34, P331; Heiman N., 1975, AIP C P, V24, P573; HOFFMAN DW, 1980, J VAC SCI TECHNOL, V17, P425, DOI 10.1116/1.570473; Makita K, 2009, APPL SURF SCI, V256, P1265, DOI 10.1016/j.apsusc.2009.05.085; Makita K, 2008, J JPN I MET, V72, P714, DOI 10.2320/jinstmet.72.714; Morimoto M., 2003, NIPPON OYO JIKI GAKK, V27, P269; Na SM, 2003, J APPL PHYS, V93, P8507, DOI 10.1063/1.1543870; Shinohara Y, 2010, J JPN I MET, V74, P610, DOI 10.2320/jinstmet.74.610; THORNTON JA, 1977, ANNU REV MATER SCI, V7, P239, DOI 10.1146/annurev.ms.07.080177.001323; Uchida H, 2002, J MAGN MAGN MATER, V239, P540, DOI 10.1016/S0304-8853(01)00659-X; Zwingman R., 1976, AIP C P, V34, P334	15	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1432-8917	1433-075X		MATER RES INNOV	Mater. Res. Innov.	MAY	2015	19			5			325	327		10.1179/1432891714Z.0000000001103		3	Materials Science, Multidisciplinary	Materials Science	CJ3JT	WOS:000355379900063		
J	Amano, M; Niyomwaitaya, C; Ooba, Y; Sakai, A; Matsumura, Y				Amano, M.; Niyomwaitaya, C.; Ooba, Y.; Sakai, A.; Matsumura, Y.			Effects of excess energy on supersaturated Fe-IIIB thin films with ion-plating process	MATERIALS RESEARCH INNOVATIONS			English	Article						Dual vapour source; Supersaturated solid solution; Ion-plating; Excess energy; Thin films; Magnetostriction		In this study, Fe-IIIB thin films were prepared by dual vapour source ion-plating process and the effects of excess energy on their nanostructure and magnetostrictive characteristics were investigated. The samples of Fe-40 at.-% Al, Fe-17 at.-%Ga and Fe-1.5 at.-% In showed the maximum value of magnetostriction were about 150, 200 and 80 ppm at 1200 kA m(-1), respectively. The excess energy incidences of ions onto depositing films surfaces are key parameters for magnetostrictive properties. The excess energy was increased by escalating the impinging energy of evaporation particles with rising anode probe voltage and substrate bias voltage. In the ion-plating process, the excess energy was more than a mixture enthalpy of Fe and IIIB. The accumulated lattice distortion energy was enlarged by increasing the lattice expansion of the alpha-Fe bcc lattice. The excess energy in the ion-plating process can control the solid solubility limit and crystallographic characterisation of films.	[Amano, M.; Niyomwaitaya, C.; Matsumura, Y.] Tokai Univ, Grad Sch Engn, Dept Appl Sci, Hiratsuka, Kanagawa 2591292, Japan; [Ooba, Y.; Sakai, A.] Tokai Univ, Sch Engn, Dept Nucl Engn, Hiratsuka, Kanagawa 2591292, Japan	Matsumura, Y (reprint author), Tokai Univ, Grad Sch Engn, Dept Appl Sci, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	ncc1701d@keyaki.cc.u-tokai.ac.jp			Japan Society for the Promotion of Science (JSPS) [24560859]	This study was financially supported by the Japan Society for the Promotion of Science (JSPS) through a Grant in-Aid for Scientific Research (C) 'Control of properties for thin film actuator materials' (No. 24560859). This study was also carried out as part of the 'Creation of Advanced Energy Materials, Future Science & Technology Joint Research Center', Tokai University.	WINDISCHMANN H, 1991, J VAC SCI TECHNOL A, V9, P2431, DOI 10.1116/1.577295; CARTER G, 1994, J PHYS D APPL PHYS, V27, P1046, DOI 10.1088/0022-3727/27/5/024; Chatz F., 1994, J APPL PHYS, V76, P5380; Kikuchi N., 2007, J VAC SOC JPN, V50, P15; Makita K, 2008, ACTUATOR, P730; Massalski T. B., 1990, BINARY ALLOY PHASE D, P1712; Massalski T.B., 1990, BINARY ALLOY PHASE D, p[147, 149]; Restrepo J., 2000, AM PHYS SOC, V61, P5880; Takeuchi M., 2004, P 9 INT C NEW ACT AC, P581; THORNTON JA, 1977, ANNU REV MATER SCI, V7, P239, DOI 10.1146/annurev.ms.07.080177.001323; TSUNASHIMA S, 1978, IEEE T MAGN, V14, P844, DOI 10.1109/TMAG.1978.1059907; Uchida H, 2002, J MAGN MAGN MATER, V239, P540, DOI 10.1016/S0304-8853(01)00659-X; UCHIDA HH, 1994, J ALLOY COMPD, V212, P455; Zwingman R., 1976, AIP C P, V34, P334	14	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1432-8917	1433-075X		MATER RES INNOV	Mater. Res. Innov.	MAY	2015	19			5			331	336		10.1179/1432891714Z.0000000001105		6	Materials Science, Multidisciplinary	Materials Science	CJ3JT	WOS:000355379900065		
J	Wu, D; Qi, JG; Li, Y; Qiu, H				Wu, D.; Qi, J. G.; Li, Y.; Qiu, H.			Determination of retained austenite content in Fe-Cr-Ni weld metal	MATERIALS RESEARCH INNOVATIONS			English	Article						Steel weld metal; Dilatometry; XRD; Magnetisation measurement; Retained austenite	X-RAY-DIFFRACTION; MECHANICAL-PROPERTIES; TRIP STEEL; MICROSTRUCTURE; CARBON; TRANSFORMATION; DEFORMATION	Several techniques, including dilatometry, X-ray diffraction, electron backscattering diffraction and magnetisation measurement, were applied and compared in order to reliably determine the retained austenite content of Fe-Cr-Ni steel weld metal. In this work, based on a proposed novel numeric solution for martensite transformation kinetics, it was found that the dilatometric method presented consistent results along with the magnetisation method in the quantification of mechanically unstable or stable retained austenite. By contrast, the X-ray diffraction method was inaccurate and time-consuming for the measurement of mechanically unstable retained austenite. However, the X-ray diffraction method was relatively successful when the retained austenite was mechanically stable. In addition, the magnetisation method seemed to be the only reliable way to detect small amounts (less than 5 vol.-%) of retained austenite in Fe-Cr-Ni weld metal.	[Wu, D.; Qi, J. G.; Li, Y.] Liaoning Univ Technol, Coll Mat Sci & Engn, Jinzhou 121000, Peoples R China; [Qiu, H.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Qi, JG (reprint author), Liaoning Univ Technol, Coll Mat Sci & Engn, Jinzhou 121000, Peoples R China.	qijingang1974@sina.com			National Natural Science Foundation of China [51354001]; project of Higher education innovation team of Liaoning Province [LT2013014]; basic research project of Provincial Key Laboratory of Liaoning Education Department [LZ2014031]	This material is based upon work supported by the National Natural Science Foundation of China (No. 51354001), the project of Higher education innovation team of Liaoning Province (No.LT2013014) and the basic research project of Provincial Key Laboratory of Liaoning Education Department (No.LZ2014031).	Jackson HF, 2013, CORROS SCI, V77, P210, DOI 10.1016/j.corsci.2013.08.004; Zhao L, 2002, J MATER SCI, V37, P1585, DOI 10.1023/A:1014941424093; Petrov R, 2007, MAT SCI ENG A-STRUCT, V447, P285, DOI 10.1016/j.msea.2006.10.023; Chen SH, 2013, MAT SCI ENG A-STRUCT, V571, P33, DOI 10.1016/j.msea.2013.02.001; Bilmes PD, 2001, MATER CHARACT, V46, P285, DOI 10.1016/S1044-5803(00)00099-1; Jacques P, 1998, METALL MATER TRANS A, V29, P2383, DOI 10.1007/s11661-998-0114-1; Basuki A, 1999, SCRIPTA MATER, V40, P1003, DOI 10.1016/S1359-6462(98)00496-5; Cahn J. W., 1996, PHYS METALLURGY, V3, P2558; Chen SC, 2006, TETSU TO HAGANE, V92, P557; JEONG WC, 1993, MAT SCI ENG A-STRUCT, V165, P1, DOI 10.1016/0921-5093(93)90620-T; LADRIERE JH, 1986, MATER SCI ENG, V77, P133, DOI 10.1016/0025-5416(86)90361-7; Qiu H, 2013, MATER SCI TECH-LOND, V29, P594, DOI 10.1179/1743284712Y.0000000194; Qiu H, 2013, MAT SCI ENG A-STRUCT, V565, P102, DOI 10.1016/j.msea.2012.12.020; Radu M, 2005, SCRIPTA MATER, V52, P525, DOI 10.1016/j.scriptamat.2004.10.034; Tavares SSM, 2006, J MATER SCI, V41, P4732, DOI 10.1007/s10853-006-0025-8; Yamamoto J, 2007, Q J JPN WELD SOC, V25, P560, DOI 10.2207/qjjws.25.560; Yaso M, 2008, MAT SCI ENG A-STRUCT, V481, P770, DOI 10.1016/j.msea.2007.03.114; Zhao L, 2001, MAT SCI ENG A-STRUCT, V313, P145, DOI 10.1016/S0921-5093(01)00965-0	18	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1432-8917	1433-075X		MATER RES INNOV	Mater. Res. Innov.	MAY	2015	19			5			410	414		10.1179/1432891714Z.0000000001120		5	Materials Science, Multidisciplinary	Materials Science	CJ3JT	WOS:000355379900080		
J	Gong, SJ; Peng, QC; Zhao, XW				Gong, S. J.; Peng, Q. C.; Zhao, X. W.			Simulation of graphene-GaAs Schottky barrier solar cell with AMPS-1D	MATERIALS RESEARCH INNOVATIONS			English	Article						Graphene; GaAs; Schottky barrier; Solar cells; Simulation		In this paper, a new model of graphene-GaAs solar cell was first presented. The performance of the solar cell was simulated by analysis of microelectronic and photonic structures (AMPS). The effects of doping elements and doping concentrations on the performance of the solar cell, such as the conversion efficiency (Eff), open-circuit voltage (V-OC), short-circuit current density (J(SC)) and fill factor FF, were studied, and a conversion efficiency of 14.46% was obtained under optimisation.	[Gong, S. J.; Peng, Q. C.] Xihua Univ, Sch Mat Sci & Engn, Chengdu 610039, Peoples R China; [Zhao, X. W.] Tokyo Univ Sci, Dept Phys, Tokyo 1628601, Japan	Peng, QC (reprint author), Xihua Univ, Sch Mat Sci & Engn, Chengdu 610039, Peoples R China.	pengaqc@126.com			Chunhui program of Education Department, P.R. China [Z2011071]	This work is partly sponsored by Chunhui program of Education Department, P.R. China (grant no. Z2011071).	Adams A. R., 1990, PROPERTIES GALLIUM A; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872; Nair RR, 2008, SCIENCE, V320, P1308, DOI 10.1126/science.1156965; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Stauber T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085432; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Novoselov KS, 2007, SCIENCE, V315, P1379, DOI 10.1126/science.1137201; Liu E. K., 1999, SEMICONDUCTOR PHYS; Lu X. P., 2013, PHYS EXPT, V33, P1; Sze M., 2003, SEMICONDUCTOR DEVICE; Zhang Z. W., 2003, AEROSPACE SHANGHAI, V3, P33	13	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1432-8917	1433-075X		MATER RES INNOV	Mater. Res. Innov.	MAY	2015	19			5			760	763		10.1179/1432891714Z.0000000001189		4	Materials Science, Multidisciplinary	Materials Science	CJ3JT	WOS:000355379900147		
J	Takeda, K; Starzynski, C; Mori, A; Yanagida, M				Takeda, Kojiro; Starzynski, Caroline; Mori, Ayaka; Yanagida, Mitsuhiro			The critical glucose concentration for respiration-independent proliferation of fission yeast, Schizosaccharomyces pombe	MITOCHONDRION			English	Article						Cell cycle; Respiration; Antimycin A; Glucose concentration threshold; Fission yeast	ACTIVATED PROTEIN-KINASE; PATHWAY; MUSCLE; GENE; TRANSLOCATION; TRANSCRIPTION; MITOCHONDRIA; BIOGENESIS; METABOLISM; GENOME	Glucose is the fundamental energy source for life; thus cells need to respond appropriately to changes in available glucose concentration. We investigated the relationship between media glucose concentration and respiration-dependency of proliferation, using Schizosaccharomyces pombe. In media containing >= 0.2% glucose, neither antimycin A, an inhibitor of Complex III, nor gene deletions of essential electron transfer chain components, impaired cell division, while these factors completely inhibited cell division in media containing <= 0.1% glucose. These results indicate the existence of a threshold in glucose concentration that governs respiration-dependency of S. pombe proliferation. (C) 2015 The Authors. Elsevier B.V. and Mitochondria Research Society.	[Takeda, Kojiro; Starzynski, Caroline; Mori, Ayaka; Yanagida, Mitsuhiro] Okinawa Inst Sci & Technol, GO Cell Unit, Onna, Okinawa 9041111, Japan	Takeda, K (reprint author), Konan Univ, Fac Sci & Engn, Dept Biol, Higashinada Ku, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan.	takeda@center.konan-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; OIST Graduate University	We are greatly indebted to Dr. Nathalie Bonnefoy (Centre de Genetique Moleculaire du CNRS, Gif-Sur-Yvette, France) for anti-Cox2 antibody, to Dr. Steven D. Aird (OIST) for editing the manuscript, and to Mr. Mahiro Ishii for technical assistance. This study was partly supported by Special Ordinary Expense Subsidies for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. We also appreciate support from OIST Graduate University to the G0 Cell Unit.	Schafer B, 2003, CURR GENET, V43, P311, DOI 10.1007/s00294-003-0404-5; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Hoffman CS, 2005, BIOCHEM SOC T, V33, P257; Yanagida M, 2011, PHILOS T R SOC B, V366, P3508, DOI 10.1098/rstb.2011.0124; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Hirota K, 2006, EUKARYOT CELL, V5, P1980, DOI 10.1128/EC.00272-06; HOFFMAN CS, 1991, GENE DEV, V5, P561, DOI 10.1101/gad.5.4.561; MORAIS R, 1979, J CELL PHYSIOL, V101, P77; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Witczak CA, 2007, DIABETES, V56, P1403, DOI 10.2337/db06-1230; Sakurai M, 2004, FEMS YEAST RES, V4, P649, DOI 10.1016/j.femsyr.2003.12.009; HESLOT H, 1970, J BACTERIOL, V104, P473; Flores CL, 2000, FEMS MICROBIOL REV, V24, P507, DOI 10.1016/S0168-6445(00)00037-1; Hanyu Y, 2009, GENES CELLS, V14, P539, DOI 10.1111/j.1365-2443.2009.01290.x; Gaisne M, 2006, FEMS YEAST RES, V6, P869, DOI 10.1111/j.1567-1364.2006.00083.x; Wright DC, 2004, DIABETES, V53, P330, DOI 10.2337/diabetes.53.2.330; Saitoh S, 2014, FEBS LETT, V588, P2373, DOI 10.1016/j.febslet.2014.04.047; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Ojuka EO, 2002, AM J PHYSIOL-ENDOC M, V282, pE1008, DOI 10.1152/ajpendo.00512.2001; Galdieri L, 2010, OMICS, V14, P629, DOI 10.1089/omi.2010.0069; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; [Anonymous], 1991, METHOD ENZYMOL; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Cohen A, 2014, J BIOL CHEM, V289, P21727, DOI 10.1074/jbc.M114.573824; Hatano T, 2015, CELL CYCLE, V14, P848, DOI 10.1080/15384101.2014.1000215; Ikai N, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110007; Madrid M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-34; Nagao K, 2004, NATURE, V430, P1044, DOI 10.1038/nature02803; Roux AE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000408; Saitoh S, 2015, MOL BIOL CELL, V26, P373, DOI 10.1091/mbc.E14-11-1503	31	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1567-7249	1872-8278		MITOCHONDRION	Mitochondrion	MAY	2015	22						91	95		10.1016/j.mito.2015.04.003		5	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CJ7YD	WOS:000355715400011		
J	Makino, N; Oyama, J; Maeda, T; Koyanagi, M; Higuchi, Y; Tsuchida, K				Makino, Naoki; Oyama, Jun-ichi; Maeda, Toyoki; Koyanagi, Masamichi; Higuchi, Yoshihiro; Tsuchida, Keiko			Calorie restriction increases telomerase activity, enhances autophagy, and improves diastolic dysfunction in diabetic rat hearts	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Calorie restriction; Diabetes; Autophagy; Diastolic function	ENDOTHELIAL-CELLS; SENESCENCE; ATHEROSCLEROSIS; LONGEVITY; RESPONSES; STRESS; MODEL	The aims of this study were to investigate the impact of caloric restriction (CR) on cardiac telomere biology in an animal model of diabetes and to examine the signal transduction involved in cell senescence as well as cardiac function. Male 8-week-old Otsuka Long-Evans Tokushima fatty (OLETF) diabetic rats were divided into twogroups: a group fed ad libitum (OLETF-AL) and a group fed with CR (OLETF-CR: 30 % energy reduction). Long-Evans Tokushima Otsuka (LETO) non-diabetic rats were used as controls. LETO rats were also divided into two groups: a CR (LETO-CR) group and a group fed AL (LETO-AL). At 40 weeks of age, the body weight was decreased by 9.7 % and the insulin resistance was less in OLETF-CR rats. Telomerase activity in OLETF-CR rats was significantly increased, and telomerase reverse transcriptase was more highly expressed in those rats. However, the telomere length (TL) was not different between AL-and CR-treated rats of each strain. The protein expressions for FoxO1 and FoxO3 were increased in OLETF-AL rats, but the levels of phosphorylated (p)-Akt were decreased compared to those in OLETFC-Rrats. AutophagicLC3II signals revealed significant increases in OLETF-CR rats. Echocardiography showed that OLETF-CR improved the left ventricular diastolic dysfunction without changes in the left ventricular dimension. This study revealed that CR increases cardiac telomerase activity without TL attrition, and significantly ameliorates diastolic dysfunction. These findings suggest that cardiac telomerase activity may play an important role in the maintenance of normal cardiac function.	[Makino, Naoki; Oyama, Jun-ichi; Maeda, Toyoki; Koyanagi, Masamichi; Higuchi, Yoshihiro; Tsuchida, Keiko] Kyushu Univ, Div Mol & Clin Gerontol, Dept Mol & Cellular Biol, Med Inst Bioregulat, Beppu, Oita 8740838, Japan	Makino, N (reprint author), Kyushu Univ, Div Mol & Clin Gerontol, Dept Mol & Cellular Biol, Med Inst Bioregulat, 4546 Tsurumihara, Beppu, Oita 8740838, Japan.	makino0108@gmail.com			Ministry of Education, Science, and Culture of Japan	The OLETF and LETO rats were a generous gift from the Tokushima Research Institute, Otsuka Pharmaceutical (Tokushima, Japan). We thank Ms. Keiko Tsuchida and Yasuko Ueda for their technical assistance. This work was supported in part by a Grant-in-Aid from the Ministry of Education, Science, and Culture of Japan.	Adaikalakoteswari A, 2005, DIABETIC MED, V22, P1151, DOI 10.1111/j.1464-5491.2005.01574.x; Goraya TY, 2002, J AM COLL CARDIOL, V40, P946, DOI 10.1016/S0735-1097(02)02065-X; Kondo M, 2009, J BIOL CHEM, V284, P1718, DOI 10.1074/jbc.M805301200; Wong LSM, 2009, CARDIOVASC RES, V81, P244, DOI 10.1093/cvr/cvn337; Cuervo AM, 2005, AUTOPHAGY, V1, P131; Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Mizushima Noboru, 2007, Autophagy, V3, P542; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Sukhanov S, 2007, ARTERIOSCL THROM VAS, V27, P2684, DOI 10.1161/ATVBAHA.107.156257; Weiss EP, 2011, AM J PHYSIOL-HEART C, V301, pH1205, DOI 10.1152/ajpheart.00685.2011; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Farhat N, 2008, CAN J PHYSIOL PHARM, V86, P761, DOI 10.1139/Y08-082; Shinmura K, 2011, J MOL CELL CARDIOL, V50, P117, DOI 10.1016/j.yjmcc.2010.10.018; Makino N, 2009, AM J PHYSIOL-HEART C, V297, pH2188, DOI 10.1152/ajpheart.00421.2009; Testa R, 2011, DIABETIC MED, V28, P1388, DOI 10.1111/j.1464-5491.2011.03370.x; Mizushige K, 2000, CIRCULATION, V101, P899; Borges A, 1997, J MOL CELL CARDIOL, V29, P2717, DOI 10.1006/jmcc.1997.0503; Dolinsky VW, 2010, HYPERTENSION, V56, P412, DOI 10.1161/HYPERTENSIONAHA.110.154732; Iwai-Kanai Eri, 2008, Autophagy, V4, P322; Makino N, 2011, J MOL CELL CARDIOL, V50, P670, DOI 10.1016/j.yjmcc.2010.12.014; Mehta LH, 2009, ANN NY ACAD SCI, V1172, P28, DOI 10.1111/j.1749-6632.2009.04409.x; Minamiyama Y, 2007, J PHARMACOL EXP THER, V320, P535, DOI 10.1124/jpet.106.110460; Spindler SR, 2007, ANNU REV NUTR, V27, P193, DOI 10.1146/annurev.nutr.27.061406.093743	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	MAY	2015	403	1-2					1	11		10.1007/s11010-015-2327-0		11	Cell Biology	Cell Biology	CJ4CT	WOS:000355432700001		
J	Sobue, S; Yamai, K; Ito, M; Ohno, K; Ito, M; Iwamoto, T; Qiao, S; Ohkuwa, T; Ichihara, M				Sobue, Sayaka; Yamai, Kazuaki; Ito, Mikako; Ohno, Kinji; Ito, Masafumi; Iwamoto, Takashi; Qiao, Shanlou; Ohkuwa, Tetsuo; Ichihara, Masatoshi			Simultaneous oral and inhalational intake of molecular hydrogen additively suppresses signaling pathways in rodents	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Molecular hydrogen; Gene expression; NF-kappa B; p38; ERK	THERAPEUTIC ANTIOXIDANT; DRINKING-WATER; INJURY; GENES; LIVER; MICE; GAS; PREVENTS; CELLS; METABOLISM	Molecular hydrogen (H-2) is an agent with potential applications in oxidative stress-related and/or inflammatory disorders. H-2 is usually administered by inhaling H-2-containing air (HCA) or by oral intake of H-2-rich water (HRW). Despite mounting evidence, the molecular mechanism underlying the therapeutic effects and the optimal method of H-2 administration remain unclear. Here, we investigated whether H-2 affects signaling pathways and gene expression in a dosage-or dose regimen-dependent manner. We first examined the H-2 concentrations in blood and organs after its administration and found that oral intake of HRW rapidly but transiently increased H-2 concentrations in the liver and atrial blood, while H-2 concentrations in arterial blood and the kidney were one-tenth of those in the liver and atrial blood. In contrast, inhalation of HCA increased H-2 equally in both atrial and arterial blood. We next examined whether H-2 alters gene expression in normal mouse livers using DNA microarray analysis after administration of HCA and HRW. Ingenuity Pathway Analysis revealed that H-2 suppressed the expression of nuclear factor-kappa B (NF-kappa B)-regulated genes. Western blot analysis showed that H-2 attenuated ERK, p38 MAPK, and NF-kappa B signaling in mouse livers. Finally, we evaluated whether the changes in gene expression were influenced by the route of H-2 administration and found that the combination of both HRW and HCA had the most potent effects on signaling pathways and gene expression in systemic organs, suggesting that H-2 may act not only through a dose-dependent mechanism but also through a complex molecular network.	[Sobue, Sayaka; Yamai, Kazuaki; Iwamoto, Takashi; Qiao, Shanlou; Ichihara, Masatoshi] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan; [Yamai, Kazuaki; Ohkuwa, Tetsuo] Nagoya Inst Technol, Dept Mat Sci & Engn, Grad Sch Engn, Nagoya, Aichi 4668555, Japan; [Ito, Mikako; Ohno, Kinji] Nagoya Univ, Grad Sch Med, Div Neurogenet, Ctr Neurol Dis & Canc, Nagoya, Aichi 4668550, Japan; [Ito, Mikako] Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Tokyo 1730015, Japan	Ichihara, M (reprint author), Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan.	ichihara@isc.chubu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	We thank Takae Hiraide, Taeko Nagano, and Ken-ichi Yoshida for technical assistance. This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Kawamura T, 2013, AM J PHYSIOL-LUNG C, V304, pL646, DOI 10.1152/ajplung.00164.2012; Feuerhake F, 2005, BLOOD, V106, P1392, DOI 10.1182/blood-2004-12-4901; Kajiyama S, 2008, NUTR RES, V28, P137, DOI 10.1016/j.nutres.2008.01.008; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Campbell JS, 2011, INT J BIOCHEM CELL B, V43, P180, DOI 10.1016/j.biocel.2010.08.002; Fukuda KI, 2007, BIOCHEM BIOPH RES CO, V361, P670, DOI 10.1016/j.bbrc.2007.07.088; Ohno K, 2012, OXID MED CELL LONGEV, DOI 10.1155/2012/353152; Ambade A, 2012, HEPATOLOGY, V55, P1585, DOI 10.1002/hep.24802; Cardinal JS, 2010, KIDNEY INT, V77, P101, DOI 10.1038/ki.2009.421; Xu XF, 2013, PHYSIOL RES, V62, P395; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Nakai Y, 2011, BIOSCI BIOTECH BIOCH, V75, P774, DOI 10.1271/bbb.100819; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Bunting K, 2007, J IMMUNOL, V178, P7097; Fujita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007247; Kamimura N, 2011, OBESITY, V19, P1396, DOI 10.1038/oby.2011.6; Itoh T, 2011, BIOCHEM BIOPH RES CO, V411, P143, DOI 10.1016/j.bbrc.2011.06.116; Nagata K, 2009, NEUROPSYCHOPHARMACOL, V34, P501, DOI 10.1038/npp.2008.95; Ito Mikako, 2012, Med Gas Res, V2, P15, DOI 10.1186/2045-9912-2-15; Liu C, 2014, SCI REP-UK, V4, DOI 10.1038/srep05485; Matsumoto A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03273; Naamane N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-55; Nakao A, 2009, J CLIN BIOCHEM NUTR, V44, P1, DOI 10.3164/jcbn.08-193R; Ohta S, 2014, PHARMACOL THERAPEUT, V144, P1, DOI 10.1016/j.pharmthera.2014.04.006; Sobue S, 2008, ONCOGENE, V27, P6023, DOI 10.1038/onc.2008.198; Takase O, 2008, CLIN EXP NEPHROL, V12, P181, DOI 10.1007/s10157-008-0038-5	28	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	MAY	2015	403	1-2					231	241		10.1007/s11010-015-2353-y		11	Cell Biology	Cell Biology	CJ4CT	WOS:000355432700023		
J	Kokubo, M				Kokubo, Mitsuru			Constraints on the temperature inhomogeneity in quasar accretion discs from the ultraviolet-optical spectral variability	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						accretion, accretion discs; galaxies: active; galaxies: nuclei; quasars: general	ACTIVE GALACTIC NUCLEI; DIGITAL SKY SURVEY; BROAD-LINE REGION; SDSS STRIPE 82; CONTINUUM COLOR VARIABILITY; DAMPED RANDOM-WALK; 7TH DATA RELEASE; X-RAY; SEYFERT-GALAXIES; OPTICAL/ULTRAVIOLET VARIABILITY	The physical mechanisms of the quasar ultraviolet (UV)-optical variability are not well understood despite the long history of observations. Recently, Dexter & Agol presented a model of quasar UV-optical variability, which assumes large local temperature fluctuations in the quasar accretion discs. This inhomogeneous accretion disc model is claimed to describe not only the single-band variability amplitude, but also microlensing size constraints and the quasar composite spectral shape. In this work, we examine the validity of the inhomogeneous accretion disc model in the light of quasar UV-optical spectral variability by using five-band multi-epoch light curves for nearly 9 000 quasars in the Sloan Digital Sky Survey (SDSS) Stripe 82 region. By comparing the values of the intrinsic scatter sigma(int) of the two-band magnitude-magnitude plots for the SDSS quasar light curves and for the simulated light curves, we show that Dexter & Agol's inhomogeneous accretion disc model cannot explain the tight inter-band correlation often observed in the SDSS quasar light curves. This result leads us to conclude that the local temperature fluctuations in the accretion discs are not the main driver of the several years' UV-optical variability of quasars, and consequently, that the assumption that the quasar accretion discs have large localized temperature fluctuations is not preferred from the viewpoint of the UV-optical spectral variability.	[Kokubo, Mitsuru] Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Kokubo, Mitsuru] Univ Tokyo, Inst Astron, Mitaka, Tokyo 1810015, Japan	Kokubo, M (reprint author), Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mkokubo@ioa.s.u-tokyo.ac.jp			Alfred P. Sloan Foundation; National Science Foundation; US Department of Energy; National Aeronautics and Space Administration; Japanese Monbukagakusho; Max Planck Society; Higher Education Funding Council for England; American Museum of Natural History; Astrophysical Institute Potsdam; University of Basel; University of Cambridge; Case Western Reserve University; University of Chicago; Drexel University; Fermilab; Institute for Advanced Study; Japan Participation Group; Johns Hopkins University; Joint Institute for Nuclear Astrophysics; Kavli Institute for Particle Astrophysics and Cosmology; Korean Scientist Group; Chinese Academy of Sciences; Los Alamos National Laboratory; Max Planck Institute for Astronomy; Max Planck Institute for Astrophysics; New Mexico State University; Ohio State University; University of Pittsburgh; University of Portsmouth; Princeton University; United States Naval Observatory; University of Washington	Funding for SDSS and SDSS-II has been provided by the Alfred P. Sloan Foundation, the participating institutions, the National Science Foundation, the US Department of Energy, the National Aeronautics and Space Administration, the Japanese Monbukagakusho, the Max Planck Society and the Higher Education Funding Council for England. The SDSS website is http://www.sdss.org/.; SDSS is managed by the Astrophysical Research Consortium for the participating institutions, which are the American Museum of Natural History, Astrophysical Institute Potsdam, University of Basel, University of Cambridge, Case Western Reserve University, University of Chicago, Drexel University, Fermilab, the Institute for Advanced Study, the Japan Participation Group, Johns Hopkins University, the Joint Institute for Nuclear Astrophysics, the Kavli Institute for Particle Astrophysics and Cosmology, the Korean Scientist Group, the Chinese Academy of Sciences, Los Alamos National Laboratory, the Max Planck Institute for Astronomy, the Max Planck Institute for Astrophysics, New Mexico State University, Ohio State University, University of Pittsburgh, University of Portsmouth, Princeton University, the United States Naval Observatory and the University of Washington.	Ai YL, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/4/90; Andrae R., 2013, Astronomy & Astrophysics, V554, DOI 10.1051/0004-6361/201321335; Nandra K, 1998, ASTROPHYS J, V505, P594, DOI 10.1086/306181; MacLeod CL, 2010, ASTROPHYS J, V721, P1014, DOI 10.1088/0004-637X/721/2/1014; Kelly BC, 2009, ASTROPHYS J, V698, P895, DOI 10.1088/0004-637X/698/1/895; Cristiani S, 1997, ASTRON ASTROPHYS, V321, P123; Zheng W, 1997, ASTROPHYS J, V475, P469, DOI 10.1086/303560; Korista KT, 2001, ASTROPHYS J, V553, P695, DOI 10.1086/320964; Schmidt KB, 2010, ASTROPHYS J, V714, P1194, DOI 10.1088/0004-637X/714/2/1194; Suganuma M, 2006, ASTROPHYS J, V639, P46, DOI 10.1086/499326; Kishimoto M, 2007, ASTRON ASTROPHYS, V476, P713, DOI 10.1051/0004-6361:20077911; Kishimoto M, 2008, NATURE, V454, P492, DOI 10.1038/nature07114; Hirose S, 2009, ASTROPHYS J, V691, P16, DOI 10.1088/0004-637X/691/1/16; Ai YL, 2010, ASTROPHYS J LETT, V716, pL31, DOI 10.1088/2041-8205/716/1/L31; Dai X, 2010, ASTROPHYS J, V709, P278, DOI 10.1088/0004-637X/709/1/278; Hewett PC, 2010, MON NOT R ASTRON SOC, V405, P2302, DOI 10.1111/j.1365-2966.2010.16648.x; Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Collier S, 2001, ASTROPHYS J, V555, P775, DOI 10.1086/321517; Lira P, 2011, MON NOT R ASTRON SOC, V415, P1290, DOI 10.1111/j.1365-2966.2011.18774.x; Wilhite BC, 2005, ASTROPHYS J, V633, P638, DOI 10.1086/430821; Bauer A, 2009, ASTROPHYS J, V696, P1241, DOI 10.1088/0004-637X/696/2/1241; McHardy IM, 2014, MON NOT R ASTRON SOC, V444, P1469, DOI 10.1093/mnras/stu1636; Cackett EM, 2007, MON NOT R ASTRON SOC, V380, P669, DOI 10.1111/j.1365-2966.2007.12098.x; Aretxaga I, 1997, MON NOT R ASTRON SOC, V286, P271; Arevalo P, 2008, MON NOT R ASTRON SOC, V389, P1479, DOI 10.1111/j.1365-2966.2008.13719.x; Vaughan S, 2003, MON NOT R ASTRON SOC, V345, P1271, DOI 10.1046/j.1365-2966.2003.07042.x; Ulrich MH, 1997, ANNU REV ASTRON ASTR, V35, P445, DOI 10.1146/annurev.astro.35.1.445; TERLEVICH R, 1992, MON NOT R ASTRON SOC, V255, P713; Kozlowski S, 2010, ASTROPHYS J, V708, P927, DOI 10.1088/0004-637X/708/2/927; Sesar B, 2007, ASTRON J, V134, P2236, DOI 10.1086/521819; OBRIEN PT, 1995, MON NOT R ASTRON SOC, V275, P1125; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; WINKLER H, 1992, MON NOT R ASTRON SOC, V257, P659; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Adelman-McCarthy JK, 2007, ASTROPHYS J SUPPL S, V172, P634; Sakata Y, 2010, ASTROPHYS J, V711, P461, DOI 10.1088/0004-637X/711/1/461; Frieman JA, 2008, ASTRON J, V135, P338, DOI 10.1088/0004-6256/135/1/338; HAWKINS MRS, 1993, NATURE, V366, P242, DOI 10.1038/366242a0; De Vries WH, 2005, ASTRON J, V129, P615, DOI 10.1086/427393; BLANDFORD RD, 1982, ASTROPHYS J, V255, P419, DOI 10.1086/159843; BALDWIN J, 1995, ASTROPHYS J, V455, pL119, DOI 10.1086/309827; Wilhite BC, 2008, MON NOT R ASTRON SOC, V383, P1232, DOI 10.1111/j.1365-2966.2007.12655.x; Peterson BM, 2004, ASTRON NACHR, V325, P248, DOI 10.1002/asna.200310207; Schneider DP, 2010, ASTRON J, V139, P2360, DOI 10.1088/0004-6256/139/6/2360; Giveon U, 1999, MON NOT R ASTRON SOC, V306, P637, DOI 10.1046/j.1365-8711.1999.02556.x; Graham MJ, 2014, MON NOT R ASTRON SOC, V439, P703, DOI 10.1093/mnras/stt2499; Korista KT, 2004, ASTROPHYS J, V606, P749, DOI 10.1086/383193; Li SL, 2008, MON NOT R ASTRON SOC, V387, pL41, DOI 10.1111/j.1745-3933.2008.00480.x; Antonucci R, 1996, ASTROPHYS J, V472, P502, DOI 10.1086/178083; ARETXAGA I, 1994, MON NOT R ASTRON SOC, V269, P462; Butler NR, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/3/93; Chelouche D, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/9; Chelouche D, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/140; Choi YM, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/1/37; Choloniewski J., 1981, Acta Astronomica, V31; Fernandes RC, 2000, ASTROPHYS J, V544, P123; Collier S, 1999, MON NOT R ASTRON SOC, V302, pL24, DOI 10.1046/j.1365-8711.1999.02250.x; COURVOISIER TJL, 1991, ASTRON ASTROPHYS, V248, P389; CUTRI RM, 1985, ASTROPHYS J, V296, P423, DOI 10.1086/163461; Czerny B, 2007, ASTRON ASTROPHYS, V464, P167, DOI 10.1051/0004-6361:20066521; Czerny B, 2008, MON NOT R ASTRON SOC, V386, P1557, DOI 10.1111/j.1365-2966.2008.13131.x; Czerny B, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201220832; D'Agostini G., 2005, ARXIVASTRPH0511182; Dexter J, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/1/L24; DiClemente A, 1996, ASTROPHYS J, V463, P466, DOI 10.1086/177261; Edelson R, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/1/2; Edelson R., 2015, ARXIV150105951; Feigelson ED, 2012, MODERN STATISTICAL METHODS FOR ASTRONOMY: WITH R APPLICATIONS, P1, DOI 10.1017/CBO9781139015653; Frank J., 1992, ACCRETION POWER ASTR; Gallastegui-Aizpun U, 2014, MON NOT R ASTRON SOC, V444, P3078, DOI 10.1093/mnras/stu1648; Gaskel CM, 2008, REV MEX AST ASTR, V32, P1; Gaskell CM, 2011, BALT ASTRON, V20, P392; Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136; Gezari S, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/60; Goicoechea LJ, 2012, J PHYS CONF SER, V372, DOI 10.1088/1742-6596/372/1/012058; Gu MF, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201219521; GULL SF, 1989, FUND THEOR, V36, P511; HagenThorn VA, 1997, ASTRON LETT+, V23, P19; Hao H, 2010, ASTROPHYS J LETT, V724, pL59, DOI 10.1088/2041-8205/724/1/L59; Hawkins MRS, 2002, MON NOT R ASTRON SOC, V329, P76, DOI 10.1046/j.1365-8711.2002.04939.x; Hawkins MRS, 2003, MON NOT R ASTRON SOC, V344, P492, DOI 10.1046/j.1365-8711.2003.06828.x; Hernitschek N., 2014, ARXIV14126531; Hogg D. W., 2010, ARXIV10084686; Honig SF, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/200912676; Ivezic Z., 2008, ARXIV08052366; Jiang YF, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/148; Jimenez-Vicente J, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/47; Kato S., 2008, BLACK HOLE ACCRETION; Kawaguchi T, 2001, ASTROPHYS J, V546, P966, DOI 10.1086/318297; Kawaguchi T, 1998, ASTROPHYS J, V504, P671, DOI 10.1086/306105; Kelly BC, 2007, ASTROPHYS J, V665, P1489, DOI 10.1086/519947; Kishimoto M, 2005, MON NOT R ASTRON SOC, V364, P640, DOI 10.1111/j.1365-2966.2005.09577.x; Kokubo M, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/46; KORISTA KT, 1995, ASTROPHYS J SUPPL S, V97, P285, DOI 10.1086/192144; Koshida S, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/159; KROLIK JH, 1991, ASTROPHYS J, V371, P541, DOI 10.1086/169918; LaMassa S. M., 2014, ARXIV14122136; Liu HT, 2008, ASTROPHYS J, V677, P884, DOI 10.1086/529361; Lohfink AM, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/10; MacLeod CL, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/106; Meusinger H, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015520; Meusinger H, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201322410; Morganson E, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/2/92; Novikov I. D., 1973, BLACK HOLES, P343; Oknyansky VL, 2014, ASTRON LETT+, V40, P527, DOI 10.1134/S1063773714090011; Palanque-Delabrouille N, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201016254; Park D, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/1/6; Pereyra NA, 2006, ASTROPHYS J, V642, P87, DOI 10.1086/500919; Pooley D, 2007, ASTROPHYS J, V661, P19, DOI 10.1086/512115; Ruan JJ, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/105; Sakata Y, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/50; Sako M., 2014, ARXIV14013317; Schmidt KB, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/147; Sergeev SG, 2005, ASTROPHYS J, V622, P129, DOI 10.1086/427820; Shappee BJ, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/48; Shen Y, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/2/45; Sun YH, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/54; Tomita H, 2006, ASTROPHYS J, V652, pL13, DOI 10.1086/509878; Torricelli-Ciamponi G, 2000, ASTRON ASTROPHYS, V358, P57; Uttley P, 2014, SPACE SCI REV, V183, P453, DOI 10.1007/s11214-014-0072-4; Uttley P, 2006, ASTR SOC P, V360, P101; Vanden Berk D. E., 2004, Astrophysical Journal, V601, DOI 10.1086/380563; Vanden Berk DE, 2001, ASTRON J, V122, P549, DOI 10.1086/321167; Voevodkin A., 2011, ARXIV11074244; Wall JV, 2012, CAMB OBSERVING HANDB, P1, DOI 10.1017/CBO9781139031998; Winkler H, 1997, MON NOT R ASTRON SOC, V292, P273; Zu Y, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/106; Zuo WW, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/104	128	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	MAY 1	2015	449	1					94	106		10.1093/mnras/stv241		13	Astronomy & Astrophysics	Astronomy & Astrophysics	CJ2WO	WOS:000355345600009		
J	Wilkinson, DM; Maraston, C; Thomas, D; Coccato, L; Tojeiro, R; Cappellari, M; Belfiore, F; Bershady, M; Blanton, M; Bundy, K; Cales, S; Cherinka, B; Drory, N; Emsellem, E; Fu, H; Law, D; Li, C; Maiolino, R; Masters, K; Tremonti, C; Wake, D; Wang, E; Weijmans, AM; Xiao, T; Yan, RB; Zhang, K; Bizyaev, D; Brinkmann, J; Kinemuchi, K; Malanushenko, E; Malanushenko, V; Oravetz, D; Pan, KK; Simmons, A				Wilkinson, David M.; Maraston, Claudia; Thomas, Daniel; Coccato, Lodovico; Tojeiro, Rita; Cappellari, Michele; Belfiore, Francesco; Bershady, Matthew; Blanton, Mike; Bundy, Kevin; Cales, Sabrina; Cherinka, Brian; Drory, Niv; Emsellem, Eric; Fu, Hai; Law, David; Li, Cheng; Maiolino, Roberto; Masters, Karen; Tremonti, Christy; Wake, David; Wang, Enci; Weijmans, Anne-Marie; Xiao, Ting; Yan, Renbin; Zhang, Kai; Bizyaev, Dmitry; Brinkmann, Jonathan; Kinemuchi, Karen; Malanushenko, Elena; Malanushenko, Viktor; Oravetz, Daniel; Pan, Kaike; Simmons, Audrey			P-MaNGA: full spectral fitting and stellar population maps from prototype observations	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						techniques: spectroscopic; galaxies: evolution; galaxies: formation; galaxies: general; galaxies: stellar content; galaxies: structure	EARLY-TYPE GALAXIES; DIGITAL SKY SURVEY; INITIAL MASS FUNCTION; STAR-FORMATION HISTORY; SPATIALLY-RESOLVED SPECTROSCOPY; ELEMENT ABUNDANCE RATIOS; SDSS-III/BOSS GALAXIES; ACTIVE GALACTIC NUCLEI; 2.5 M TELESCOPE; ELLIPTIC GALAXIES	MaNGA (Mapping Nearby Galaxies at Apache Point Observatory) is a 6-yr SDSS-IV (Sloan Digital Sky Survey IV) survey that will obtain resolved spectroscopy from 3600 to 10 300 angstrom for a representative sample of over 10 000 nearby galaxies. In this paper, we derive spatially resolved stellar population properties and radial gradients by performing full spectral fitting of observed galaxy spectra from P-MaNGA, a prototype of the MaNGA instrument. These data include spectra for 18 galaxies, covering a large range of morphological type. We derive age, metallicity, dust, and stellar mass maps, and their radial gradients, using high spectral-resolution stellar population models, and assess the impact of varying the stellar library input to the models. We introduce a method to determine dust extinction which is able to give smooth stellar mass maps even in cases of high and spatially non-uniform dust attenuation. With the spectral fitting, we produce detailed maps of stellar population properties which allow us to identify galactic features among this diverse sample such as spiral structure, smooth radial profiles with little azimuthal structure in spheroidal galaxies, and spatially distinct galaxy sub-components. In agreement with the literature, we find the gradients for galaxies identified as early type to be on average flat in age, and negative (-0.15 dex/R-e) in metallicity, whereas the gradients for late-type galaxies are on average negative in age (-0.39 dex/R-e) and flat in metallicity. We demonstrate how different levels of data quality change the precision with which radial gradients can be measured. We show how this analysis, extended to the large numbers of MaNGA galaxies, will have the potential to shed light on galaxy structure and evolution.	[Wilkinson, David M.; Maraston, Claudia; Thomas, Daniel; Coccato, Lodovico; Masters, Karen] Univ Portsmouth, Inst Cosmol & Gravitat, Portsmouth PO1 3FX, Hants, England; [Coccato, Lodovico; Emsellem, Eric] European So Observ, D-85748 Garching, Germany; [Tojeiro, Rita; Weijmans, Anne-Marie] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Cappellari, Michele] Univ Oxford, Dept Phys, Subdept Astrophys, Oxford OX1 3RH, England; [Belfiore, Francesco; Maiolino, Roberto] Univ Cambridge, Kavli Inst Cosmol, Cambridge CB3 0HA, England; [Belfiore, Francesco; Maiolino, Roberto] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HA, England; [Bershady, Matthew; Tremonti, Christy; Wake, David] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Blanton, Mike] NYU, Dept Phys, Ctr Cosmol & Particle Phys, New York, NY 10003 USA; [Bundy, Kevin] Univ Tokyo, Todai Inst Adv Study, Kavli Inst Phys & Math Universe, Kashiwa, Chiba 2778583, Japan; [Cales, Sabrina] Yale Univ, Yale Ctr Astron & Astrophys, New Haven, CT 06520 USA; [Cherinka, Brian] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Drory, Niv] Univ Texas Austin, Dept Astron, McDonald Observ, Austin, TX 78712 USA; [Emsellem, Eric] Univ Lyon 1, Observ Lyon, Ctr Rech Astrophys Lyon, F-69230 St Genis Laval, France; [Emsellem, Eric] Ecole Normale Super Lyon, F-69230 St Genis Laval, France; [Fu, Hai] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Law, David] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Li, Cheng; Wang, Enci; Xiao, Ting; Zhang, Kai] Shanghai Astron Observ, Max Planck Inst Astrophys, Partner Grp, Shanghai 200030, Peoples R China; [Yan, Renbin; Zhang, Kai] Univ Kentucky, Dept Phys & Astron, Lexington, KY 40506 USA; [Bizyaev, Dmitry; Brinkmann, Jonathan; Kinemuchi, Karen; Malanushenko, Elena; Malanushenko, Viktor; Oravetz, Daniel; Pan, Kaike; Simmons, Audrey] Apache Point Observ, Sunspot, NM 88349 USA; [Bizyaev, Dmitry; Brinkmann, Jonathan; Kinemuchi, Karen; Malanushenko, Elena; Malanushenko, Viktor; Oravetz, Daniel; Pan, Kaike; Simmons, Audrey] New Mexico State Univ, Sunspot, NM 88349 USA	Wilkinson, DM (reprint author), Univ Portsmouth, Inst Cosmol & Gravitat, Portsmouth PO1 3FX, Hants, England.	david.wilkinson@port.ac.uk			Alfred P. Sloan Foundation; National Science Foundation; US Department of Energy Office of Science; University of Arizona; Brazilian Participation Group; Brookhaven National Laboratory; Carnegie Mellon University; University of Florida; French Participation Group; German Participation Group; Harvard University; Instituto de Astrofisica de Canarias; Michigan State/Notre Dame/JINA Participation Group; Johns Hopkins University; Lawrence Berkeley National Laboratory; Max Planck Institute for Astrophysics; Max Planck Institute for Extraterrestrial Physics; New Mexico State University; New York University; Ohio State University; Pennsylvania State University; University of Portsmouth; Princeton University; Spanish Participation Group; University of Tokyo; University of Utah; Vanderbilt University; University of Virginia; University of Washington; Yale University; Colorado University, Boulder; Harvard-Smithsonian Center for Astrophysics Participation Group; Kavli Institute for the Physics and Mathematics of the Universe Max-Planck-Institut fuer Astrophysik (MPA Garching); Max-Planck-Institut fuer Extraterrestrische Physik (MPE); Max-Planck-Institut fuer Astronomie (MPIA Heidelberg); National Astronomical Observatory of China; Penn State University; Shanghai Astronomical Observatory; United Kingdom Participation Group; University of Wisconsin	Funding for SDSS-III and SDSS-IV has been provided by the Alfred P. Sloan Foundation and Participating Institutions. Additional funding for SDSS-III comes from the National Science Foundation and the US Department of Energy Office of Science. Further information about both projects is available at www.sdss3.org.; SDSS is managed by the Astrophysical Research Consortium for the Participating Institutions in both collaborations. In SDSS-III, these include the University of Arizona, the Brazilian Participation Group, Brookhaven National Laboratory, Carnegie Mellon University, University of Florida, the French Participation Group, the German Participation Group, Harvard University, the Instituto de Astrofisica de Canarias, the Michigan State/Notre Dame/JINA Participation Group, Johns Hopkins University, Lawrence Berkeley National Laboratory, Max Planck Institute for Astrophysics, Max Planck Institute for Extraterrestrial Physics, New Mexico State University, New York University, Ohio State University, Pennsylvania State University, University of Portsmouth, Princeton University, the Spanish Participation Group, University of Tokyo, University of Utah, Vanderbilt University, University of Virginia, University of Washington, and Yale University.; The Participating Institutions in SDSS-IV are Carnegie Mellon University, Colorado University, Boulder, Harvard-Smithsonian Center for Astrophysics Participation Group, Johns Hopkins University, Kavli Institute for the Physics and Mathematics of the Universe Max-Planck-Institut fuer Astrophysik (MPA Garching), Max-Planck-Institut fuer Extraterrestrische Physik (MPE), Max-Planck-Institut fuer Astronomie (MPIA Heidelberg), National Astronomical Observatory of China, New Mexico State University, New York University, The Ohio State University, Penn State University, Shanghai Astronomical Observatory, United Kingdom Participation Group, University of Portsmouth, University of Utah, University of Wisconsin, and Yale University.	Adelman-McCarthy JK, 2008, ASTROPHYS J SUPPL S, V175, P297, DOI 10.1086/524984; Aihara H, 2011, ASTROPHYS J SUPPL S, V193, DOI 10.1088/0067-0049/193/2/29; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Kauffmann G, 2003, MON NOT R ASTRON SOC, V346, P1055, DOI 10.1111/j.1365-2966.2003.07154.x; Spiniello C, 2014, MON NOT R ASTRON SOC, V438, P1483, DOI 10.1093/mnras/stt2282; Barker MK, 2007, ASTRON J, V133, P1138, DOI 10.1086/511186; Wu H, 2005, ASTROPHYS J, V622, P244, DOI 10.1086/427821; Cappellari M, 2004, PUBL ASTRON SOC PAC, V116, P138, DOI 10.1086/381875; Sanchez-Blazquez P, 2006, MON NOT R ASTRON SOC, V371, P703, DOI 10.1111/j.1365-2966.2006.10699.x; Williams BF, 2009, ASTROPHYS J LETT, V695, pL15, DOI 10.1088/0004-637X/695/1/L15; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Ferreras I, 2013, MON NOT R ASTRON SOC, V429, pL15, DOI 10.1093/mnrasl/sls014; MacArthur LA, 2009, MON NOT R ASTRON SOC, V395, P28, DOI 10.1111/j.1365-2966.2009.14519.x; Thomas D, 2013, MON NOT R ASTRON SOC, V431, P1383, DOI 10.1093/mnras/stt261; Bershady MA, 2010, ASTROPHYS J, V716, P198, DOI 10.1088/0004-637X/716/1/198; Rawle TD, 2008, MON NOT R ASTRON SOC, V389, P1891, DOI 10.1111/j.1365-2966.2008.13720.x; Kewley LJ, 2001, ASTROPHYS J, V556, P121, DOI 10.1086/321545; Pforr J, 2012, MON NOT R ASTRON SOC, V422, P3285, DOI 10.1111/j.1365-2966.2012.20848.x; Croom SM, 2012, MON NOT R ASTRON SOC, V421, P872, DOI 10.1111/j.1365-2966.2011.20365.x; Thomas D, 2005, ASTROPHYS J, V621, P673, DOI 10.1086/426932; Kuntschner H, 2010, MON NOT R ASTRON SOC, V408, P97, DOI 10.1111/j.1365-2966.2010.17161.x; Yoachim P, 2008, ASTROPHYS J, V683, P707, DOI 10.1086/590246; VEILLEUX S, 1987, ASTROPHYS J SUPPL S, V63, P295, DOI 10.1086/191166; Gustafsson B, 2008, ASTRON ASTROPHYS, V486, P951, DOI 10.1051/0004-6361:200809724; Tamura N, 2000, ASTRON J, V119, P2134, DOI 10.1086/301333; Fukugita M, 1996, ASTRON J, V111, P1748, DOI 10.1086/117915; Driver SP, 2011, MON NOT R ASTRON SOC, V413, P971, DOI 10.1111/j.1365-2966.2010.18188.x; Thomas D, 2003, MON NOT R ASTRON SOC, V339, P897, DOI 10.1046/j.1365-8711.2003.06248.x; Calzetti D, 2000, ASTROPHYS J, V533, P682, DOI 10.1086/308692; Sarzi M, 2006, MON NOT R ASTRON SOC, V366, P1151, DOI 10.1111/j.1365-2966.2005.09839.x; Ocvirk P, 2006, MON NOT R ASTRON SOC, V365, P46, DOI 10.1111/j.1365-2966.2005.09182.x; Liddle AR, 2007, MON NOT R ASTRON SOC, V377, pL74, DOI 10.1111/j.1745-3933.00306.x; Annibali F, 2007, ASTRON ASTROPHYS, V463, P455, DOI 10.1051/0004-6361:20054726; Saglia RP, 2002, ASTROPHYS J, V579, pL13, DOI 10.1086/344742; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Leitherer C, 1999, ASTROPHYS J SUPPL S, V123, P3, DOI 10.1086/313233; Bacon R, 2001, MON NOT R ASTRON SOC, V326, P23, DOI 10.1046/j.1365-8711.2001.04612.x; BALDWIN JA, 1981, PUBL ASTRON SOC PAC, V93, P5, DOI 10.1086/130766; Kewley LJ, 2006, MON NOT R ASTRON SOC, V372, P961, DOI 10.1111/j.1365-2966.2006.10859.x; Le Borgne JF, 2003, ASTRON ASTROPHYS, V402, P433, DOI 10.1051/0004-6361:20030243; Mehlert D, 2003, ASTRON ASTROPHYS, V407, P423, DOI 10.1051/0004-6361:20030886; Chen YM, 2012, MON NOT R ASTRON SOC, V421, P314, DOI 10.1111/j.1365-2966.2011.20306.x; Thomas D, 2011, MON NOT R ASTRON SOC, V412, P2183, DOI 10.1111/j.1365-2966.2010.18049.x; Kauffmann G, 2003, MON NOT R ASTRON SOC, V341, P33, DOI 10.1046/j.1365-8711.2003.06291.x; Cappellari M, 2003, MON NOT R ASTRON SOC, V342, P345, DOI 10.1046/j.1365-8711.2003.06541.x; Thomas D, 2010, MON NOT R ASTRON SOC, V404, P1775, DOI 10.1111/j.1365-2966.2010.16427.x; Johansson J, 2012, MON NOT R ASTRON SOC, V421, P1908, DOI 10.1111/j.1365-2966.2011.20316.x; Sanchez-Blazquez P, 2011, MON NOT R ASTRON SOC, V415, P709, DOI 10.1111/j.1365-2966.2011.18749.x; Maraston C, 2013, MON NOT R ASTRON SOC, V435, P2764, DOI 10.1093/mnras/stt1424; Maraston C, 2006, ASTROPHYS J, V652, P85, DOI 10.1086/508143; Cappellari M, 2011, MON NOT R ASTRON SOC, V413, P813, DOI 10.1111/j.1365-2966.2010.18174.x; Gunn JE, 2006, ASTRON J, V131, P2332, DOI 10.1086/500975; Conroy C, 2009, ASTROPHYS J, V699, P486, DOI 10.1088/0004-637X/699/1/486; Tojeiro R, 2007, MON NOT R ASTRON SOC, V381, P1252, DOI 10.1111/j.1365-2966.2007.12323.x; Beifiori A, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201016323; Belfiore F., 2014, MNRAS; Blanc GA, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/5/138; Bundy K, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/7; Fernandes RC, 2010, MON NOT R ASTRON SOC, V403, P1036, DOI 10.1111/j.1365-2966.2009.16185.x; Fernandes RC, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201220616; Fernandes RC, 2005, MON NOT R ASTRON SOC, V358, P363, DOI 10.1111/j.1365-2966.2005.08752.x; Conroy C, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/71; DAVIDGE TJ, 1995, ASTRON J, V109, P1433, DOI 10.1086/117373; Dawson KS, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/1/10; Drory N, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/2/77; Eisenstein DJ, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/3/72; Falcon-Barroso J, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116842; Fioc M, 1997, ASTRON ASTROPHYS, V326, P950; Folkes S, 1999, MON NOT R ASTRON SOC, V308, P459, DOI 10.1046/j.1365-8711.1999.02721.x; Gerssen J, 2012, MON NOT R ASTRON SOC, V420, P197, DOI 10.1111/j.1365-2966.2011.20025.x; Delgado RMG, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322011; Delgado RMG, 2005, MON NOT R ASTRON SOC, V357, P945, DOI 10.1111/j.1365-2966.2005.08692.x; Iglesias-Paramo J, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201321460; Kauffmann G, 2014, MON NOT R ASTRON SOC, V441, P2717, DOI 10.1093/mnras/stu752; Kobayashi C, 1999, ASTROPHYS J, V527, P573, DOI 10.1086/308092; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; KURUCZ RL, 1979, ASTROPHYS J SUPPL S, V40, P1, DOI 10.1086/190589; Lancon A, 2000, ASTRON ASTROPHYS SUP, V146, P217, DOI 10.1051/aas:2000269; Li C., 2015, APJ; Maraston C, 2005, MON NOT R ASTRON SOC, V362, P799, DOI 10.1111/j.1365-2966.2005.09270.x; Maraston C, 1998, MON NOT R ASTRON SOC, V300, P872, DOI 10.1046/j.1365-8711.1998.01947.x; Maraston C, 2011, MON NOT R ASTRON SOC, V418, P2785, DOI 10.1111/j.1365-2966.2011.19738.x; Prugniel P., 2007, ASTROPH0703658; Prugniel P, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201116769; Saglia RP, 2000, ASTRON ASTROPHYS, V360, P911; Sanchez SF, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117353; Sanchez-Blazquez P, 2007, MON NOT R ASTRON SOC, V377, P759, DOI 10.1111/j.1365-2966.2007.11647.x; Sanchez-Blazquez P, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201423635; Sharp R, 2015, MON NOT R ASTRON SOC, V446, P1551, DOI 10.1093/mnras/stu2055; SHIELDS GA, 1978, ASTROPHYS J, V222, P821, DOI 10.1086/156201; Smee SA, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/2/32; Thomas D, 2004, MON NOT R ASTRON SOC, V351, pL19, DOI 10.1111/j.1365-2966.2004.07944.x; Vazdekis A, 1996, ASTROPHYS J SUPPL S, V106, P307, DOI 10.1086/192340; Vazdekis A, 2010, MON NOT R ASTRON SOC, V404, P1639, DOI 10.1111/j.1365-2966.2010.16407.x; Worthey G, 1997, ASTROPHYS J SUPPL S, V111, P377, DOI 10.1086/313021; Wuyts S, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/114	96	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	MAY 1	2015	449	1					328	360		10.1093/mnras/stv301		33	Astronomy & Astrophysics	Astronomy & Astrophysics	CJ2WO	WOS:000355345600025		
J	Kakuwa, J; Toma, K; Asano, K; Kusunose, M; Takahara, F				Kakuwa, Jun; Toma, Kenji; Asano, Katsuaki; Kusunose, Masaaki; Takahara, Fumio			Synchrotron self-Compton emission by relativistic electrons under stochastic acceleration: application to Mrk 421 and Mrk 501	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						acceleration of particles; radiation mechanisms: non-thermal; BL Lacertae objects: individual: Mrk 421; BL Lacertae objects: individual: Mrk 501	HIGH-ENERGY EMISSION; 2ND-ORDER FERMI ACCELERATION; ACTIVE GALACTIC NUCLEI; GAMMA-RAY EMISSION; BL-LAC OBJECTS; PARTICLE-ACCELERATION; MULTIWAVELENGTH OBSERVATIONS; SPECTRAL EVOLUTION; BLAZAR EMISSION; MAGNETIC-FIELD	We examine the applicability of the stochastic electron acceleration to two high synchrotron peaked blazars, Mrk 421 and Mrk 501, assuming synchrotron self-Compton emission of gamma-rays. Our model considers an emitting region moving at relativistic speed, where non-thermal electrons are accelerated and attain a steady-state energy spectrum together with the photons they emit. The kinetic equations of the electrons and photons are solved numerically, given a stationary wavenumber spectrum of the magnetohydrodynamic (MHD) disturbances, which are responsible for the electron acceleration and escape. Our simple formulation appears to reproduce the two well-sampled, long-term averaged photon spectra. In order to fit the model to the emission component from the radio to the X-ray bands, we need both a steeper wave spectral index than the Kolmogorov spectrum and efficient particle escape. Although the model provides a natural explanation for the high-energy cutoff of the electron energy distribution, the derived physical parameters raise a problem with an energy budget if the MHD waves with the Alfven velocity are assumed to be the acceleration agent.	[Kakuwa, Jun] Hiroshima Univ, Dept Phys Sci, Higashihiroshima, Hiroshima 7398526, Japan; [Toma, Kenji] Tohoku Univ, Astron Inst, Sendai, Miyagi 9808578, Japan; [Toma, Kenji] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808578, Japan; [Asano, Katsuaki] Univ Tokyo, Inst Cosm Ray Res, Kashiwa, Chiba 2778582, Japan; [Kusunose, Masaaki] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Phys, Sanda 6691337, Japan; [Takahara, Fumio] Osaka Univ, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan	Kakuwa, J (reprint author), Hiroshima Univ, Dept Phys Sci, Higashihiroshima, Hiroshima 7398526, Japan.	junkakuwa@hiroshima-u.ac.jp			National Aeronautics and Space Administration	The authors thank D. Paneque for giving us the nu F<INF>nu</INF> data shown in Abdo et al. (2011a,b). This research has made use of the NASA/IPAC Extragalactic Database (NED) operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with the National Aeronautics and Space Administration.	Abdo AA, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/131; Abdo AA, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/129; Abdo AA, 2010, ASTROPHYS J, V716, P30, DOI 10.1088/0004-637X/716/1/30; Aharonian F, 2009, ASTROPHYS J LETT, V696, pL150, DOI 10.1088/0004-637X/696/2/L150; Fossati G, 1998, MON NOT R ASTRON SOC, V299, P433, DOI 10.1046/j.1365-8711.1998.01828.x; Becker PA, 2006, ASTROPHYS J, V647, P539, DOI 10.1086/505319; URRY CM, 1995, PUBL ASTRON SOC PAC, V107, P803, DOI 10.1086/133630; HALL DE, 1967, PHYS FLUIDS, V10, P2620, DOI 10.1063/1.1762084; JONES FC, 1968, PHYS REV, V167, P1159, DOI 10.1103/PhysRev.167.1159; Tavecchio F, 2010, MON NOT R ASTRON SOC, V401, P1570, DOI 10.1111/j.1365-2966.2009.15784.x; BLANDFORD R, 1987, PHYS REP, V154, P1, DOI 10.1016/0370-1573(87)90134-7; Inoue S, 1996, ASTROPHYS J, V463, P555, DOI 10.1086/177270; Massaro E, 2006, ASTRON ASTROPHYS, V448, P861, DOI 10.1051/0004-6361:20053644; Yan DH, 2012, MON NOT R ASTRON SOC, V424, P2173, DOI 10.1111/j.1365-2966.2012.21376.x; Li H, 2000, ASTROPHYS J, V536, P729, DOI 10.1086/308960; Lemoine M, 2006, MON NOT R ASTRON SOC, V366, P635, DOI 10.1111/j.1365-2966.2005.09912.x; Tagliaferri G, 2008, ASTROPHYS J, V679, P1029, DOI 10.1086/586731; Stawarz L, 2008, ASTROPHYS J, V681, P1725, DOI 10.1086/588813; Niemiec J, 2004, ASTROPHYS J, V610, P851, DOI 10.1086/421730; Cao G, 2013, PUBL ASTRON SOC JPN, V65; GOLDSTEIN ML, 1995, ANNU REV ASTRON ASTR, V33, P283, DOI 10.1146/annurev.astro.33.1.283; Park BT, 1996, ASTROPHYS J SUPPL S, V103, P255, DOI 10.1086/192278; Krawczynski H, 2004, ASTROPHYS J, V601, P151, DOI 10.1086/380393; Ushio M, 2010, ASTROPHYS J, V724, P1509, DOI 10.1088/0004-637X/724/2/1509; Finke JD, 2008, ASTROPHYS J, V686, P181, DOI 10.1086/590900; Asano K, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/64; Bednarz J, 1996, MON NOT R ASTRON SOC, V283, P447; BLUMENTH.GR, 1970, REV MOD PHYS, V42, P237, DOI 10.1103/RevModPhys.42.237; Dermer C, 2012, J PHYS CONF SER, V355, DOI 10.1088/1742-6596/355/1/012010; Kataoka J, 1999, ASTROPHYS J, V514, P138, DOI 10.1086/306918; Kataoka J, 2000, ASTROPHYS J, V528, P243, DOI 10.1086/308154; Kataoka J., 2008, P SCI SISSA TRIEST, P015; Katarzynski K, 2006, ASTRON ASTROPHYS, V453, P47, DOI 10.1051/0004-6361:20054176; Kino M, 2002, ASTROPHYS J, V564, P97, DOI 10.1086/323363; Kusunose M, 2008, ASTROPHYS J, V682, P784, DOI 10.1086/589233; Kusunose M, 2000, ASTROPHYS J, V536, P299, DOI 10.1086/308928; Lefa E, 2011, ASTROPHYS J LETT, V743, DOI 10.1088/2041-8205/743/1/L19; Longair M. S., 1992, HIGH ENERGY ASTROPHY; Maraschi L., 1994, P IAU S, V159, P221; Marscher AP, 2010, LECT NOTES PHYS, V794, P173, DOI 10.1007/978-3-540-76937-8_7; Mastichiadis A, 1997, ASTRON ASTROPHYS, V320, P19; Mertsch P, 2011, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2011/12/010; Ostrowski M, 1997, ASTROPART PHYS, V6, P271, DOI 10.1016/S0927-6505(96)00061-8; Press W.H., 1992, NUMERICAL RECIPES C; Rani B, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201321058; Rybicki G. B., 1979, RAD PROCESSES ASTROP; Schlickeiser R., 2002, COSMIC RAY ASTROPHYS; Sikora M, 1997, ASTROPHYS J, V484, P108, DOI 10.1086/304305; Sikora M, 2001, AIP CONF PROC, V558, P275; Tavecchio F, 2001, ASTROPHYS J, V554, P725, DOI 10.1086/321394; Tramacere A, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/66; Ushio M, 2009, ASTROPHYS J, V699, P1964, DOI 10.1088/0004-637X/699/2/1964; Weidinger M., 2010, ASTROPHYS SPACE SCI, V6, P1; WENTZEL DG, 1974, ANNU REV ASTRON ASTR, V12, P71, DOI 10.1146/annurev.aa.12.090174.000443; Zhang J, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/157	55	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	MAY 1	2015	449	1					551	558		10.1093/mnras/stv281		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CJ2WO	WOS:000355345600040		
J	Fujii, MS; Zwart, SP				Fujii, M. S.; Zwart, S. Portegies			The initial mass function of star clusters that form in turbulent molecular clouds	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						methods: numerical; open clusters and associations: general; open clusters and associations: individual: Carina; galaxies: individual: M51, M31, M83; galaxies: star clusters: general	N-BODY SIMULATIONS; STELLAR EVOLUTION; BROWN DWARFS; GAS; RADIATION; GALAXIES; REGIONS; ENVIRONMENT; DISRUPTION; LUMINOSITY	We simulate the formation and evolution of young star clusters using the combination of smoothed particle hydrodynamics (SPH) simulations and direct N-body simulations. We start by performing SPH simulations of the giant molecular cloud (GMC) with a turbulent velocity field, a mass of 4 x 10(4) to 5 x 10(6) M-circle dot, and a density between rho similar to 1.7 x 10(3) and 170 cm(-3). We continue the hydrodynamical simulations for a free-fall time-scale (t(ff) similar or equal to 0.83 and 2.5 Myr), and analyse the resulting structure of the collapsed cloud. We subsequently replace a density-selected subset of SPH particles with stars by adopting a local star formation efficiency proportional to rho(1/2). As a consequence, the local star formation efficiency exceeds 30 per cent, whereas globally only a few percent of the gas is converted to stars. The stellar distribution by the time gas is converted to stars is very clumpy, with typically a dozen bound conglomerates that consist of 100-10(4) stars. We continue to evolve the stars dynamically using the collisional N-body method, which accurately treats all pairwise interactions, stellar collisions and stellar evolution. We analyse the results of the N-body simulations when the stars have an age of 2 and 10 Myr. During the dynamical simulations, massive clusters grow via hierarchical merging of smaller clusters. The shape of the cluster mass function that originates from an individual molecular cloud is consistent with a Schechter function with a power-law slope of beta = -1.73 at 2 Myr and beta = -1.67 at 10 Myr, which fits to observed cluster mass function of the Carina region. The superposition of mass functions have a power-law slope of less than or similar to -2, which fits the observed mass function of star clusters in the Milky Way, M31 and M83. We further find that the mass of the most massive cluster formed in a single molecular cloud with a mass of M-g scales with 6.1M(g)(0.51) which also agrees with recent observation of the GMC and young clusters in M51.	[Fujii, M. S.] Natl Astron Observ Japan, Div Theoret Astron, Mitaka, Tokyo 1818588, Japan; [Zwart, S. Portegies] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands	Fujii, MS (reprint author), Natl Astron Observ Japan, Div Theoret Astron, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	michiko.fujii@nao.ac.jp			Postdoctoral Fellowship for Research Abroad of the Japan Society for the Promotion of Science (JSPS); Netherlands Research Council NWO [612.071.305, 639.073.803, 614.061.608]; Netherlands Research School for Astronomy (NOVA)	The authors would like to thank Annie Hughes for providing the observational data of M51, Nate Bastian for useful comments on the manuscript, and Inti Pelupessy, Kengo Tomida and Yusuke Tsukamoto for their advise on the simulations. The authors are also grateful to the anonymous referee for the detailed comments. This work was supported by Postdoctoral Fellowship for Research Abroad of the Japan Society for the Promotion of Science (JSPS) the Netherlands Research Council NWO [grants #612.071.305 (LGM), #639.073.803 (VICI) and #614.061.608 (AMUSE)] and by the Netherlands Research School for Astronomy (NOVA). Numerical computations were carried out on CrayXT-4 and XC30 CPU-cluster at the Center for Computational Astrophysics (CfCA) of the National Astronomical Observatory of Japan and the Little Green Machine (GPU cluster) at Leiden Observatory.	Ade PAR, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201116472; Andre P, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014666; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Bonnell IA, 2003, MON NOT R ASTRON SOC, V343, P413, DOI 10.1046/j.1365-8711.2003.06687.x; Bastian N, 2011, MON NOT R ASTRON SOC, V417, pL6, DOI 10.1111/j.1745-3933.2011.01103.x; Bastian N, 2010, ANNU REV ASTRON ASTR, V48, P339, DOI 10.1146/annurev-astro-082708-101642; Parker RJ, 2014, MON NOT R ASTRON SOC, V438, P620, DOI 10.1093/mnras/stt2231; Eisenstein DJ, 1998, ASTROPHYS J, V498, P137, DOI 10.1086/305535; Nitadori K, 2008, NEW ASTRON, V13, P498, DOI 10.1016/j.newast.2008.01.010; Elmegreen BG, 2004, ANNU REV ASTRON ASTR, V42, P211, DOI 10.1146/annurev.astro.41.011802.094859; Keto E, 2006, ASTROPHYS J, V637, P850, DOI 10.1086/498611; Bate MR, 2003, MON NOT R ASTRON SOC, V339, P577, DOI 10.1046/j.1365-8711.2003.06210.x; Mckee CF, 2007, ANNU REV ASTRON ASTR, V45, P565, DOI 10.1146/annurev.astro.45.051806.110602; Peters T, 2010, ASTROPHYS J, V711, P1017, DOI 10.1088/0004-637X/711/2/1017; Portegies Zwart S, 2009, NEW ASTRON, V14, P369, DOI 10.1016/j.newast.2008.10.006; Bressert E, 2010, MON NOT R ASTRON SOC, V409, pL54, DOI 10.1111/j.1745-3933.2010.00946.x; [Anonymous], 2015, MNRAS, V449, P726; Nieten C, 2006, ASTRON ASTROPHYS, V453, P459, DOI 10.1051/0004-6361:20035672; Gerritsen JPE, 1997, ASTRON ASTROPHYS, V325, P972; Pflamm-Altenburg J, 2007, ASTROPHYS J, V671, P1550, DOI 10.1086/523033; Bastian N, 2012, MON NOT R ASTRON SOC, V419, P2606, DOI 10.1111/j.1365-2966.2011.19909.x; Bonnell IA, 2008, MON NOT R ASTRON SOC, V389, P1556, DOI 10.1111/j.1365-2966.2008.13679.x; Bonnell IA, 2011, MON NOT R ASTRON SOC, V410, P2339, DOI 10.1111/j.1365-2966.2010.17603.x; Piskunov AE, 2008, ASTRON ASTROPHYS, V487, P557, DOI 10.1051/0004-6361:200809505; Kruijssen JMD, 2012, MON NOT R ASTRON SOC, V419, P841, DOI 10.1111/j.1365-2966.2011.19748.x; Moeckel N, 2012, MON NOT R ASTRON SOC, V425, P450, DOI 10.1111/j.1365-2966.2012.21494.x; Weidner C, 2005, ASTROPHYS J, V625, P754, DOI 10.1086/429867; Hurley JR, 2000, MON NOT R ASTRON SOC, V315, P543, DOI 10.1046/j.1365-8711.2000.03426.x; Sanchez N, 2010, ASTROPHYS J, V720, P541, DOI [10.1088/0004-637X/720/1/541, 10.1088/0004-637X1720/1/541]; Weidner C, 2010, MON NOT R ASTRON SOC, V401, P275, DOI 10.1111/j.1365-2966.2009.15633.x; Elmegreen BG, 1996, ASTROPHYS J, V471, P816, DOI 10.1086/178009; Fujii MS, 2011, SCIENCE, V334, P1380, DOI 10.1126/science.1211927; Springel V, 2002, MON NOT R ASTRON SOC, V333, P649, DOI 10.1046/j.1365-8711.2002.05445.x; Moeckel N, 2010, MON NOT R ASTRON SOC, V404, P721, DOI 10.1111/j.1365-2966.2010.16347.x; Zinnecker H, 2007, ANNU REV ASTRON ASTR, V45, P481, DOI 10.1146/annurev.astro.44.051905.092549; Bate MR, 2012, MON NOT R ASTRON SOC, V419, P3115, DOI 10.1111/j.1365-2966.2011.19955.x; Bonnell IA, 2004, MON NOT R ASTRON SOC, V349, P735, DOI 10.1111/j.1365-2966.2004.07543.x; Crosthwaite LP, 2002, ASTRON J, V123, P1892, DOI 10.1086/339479; Elmegreen BG, 2002, ASTROPHYS J, V577, P206, DOI 10.1086/342177; Elmegreen BG, 2006, ASTROPHYS J, V648, P572, DOI 10.1086/505785; Feigelson ED, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/1/9; Fujii MS, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/85; Fujii M, 2009, ASTROPHYS J, V695, P1421, DOI 10.1088/0004-637X/695/2/1421; HERNQUIST L, 1989, ASTROPHYS J SUPPL S, V70, P419, DOI 10.1086/191344; Hughes A, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/44; KING IR, 1966, ASTRON J, V71, P64, DOI 10.1086/109857; Kirk JM, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/58; Federrath C, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/156; Krumholz MR, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/9; Krumholz MR, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/71; Krumholz MR, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/69; Krumholz MR, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/155; Lada CJ, 2003, ANNU REV ASTRON ASTR, V41, P57, DOI 10.1146/annurev.astro.41.011802.094844; Larson R. B., 2003, ASP C SER, P65; Murray N, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/133; Pelupessy F. I., 2005, THESIS LEIDEN U; Pelupessy FI, 2004, ASTRON ASTROPHYS, V422, P55, DOI 10.1051/0004-6361:20047071; Pelupessy FI, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321252; Plummer H.C., 1911, Monthly Notices of the Royal Astronomical Society, V71; Portegies Zwart S, 2013, COMPUT PHYS COMMUN, V183, P456, DOI [10.1016/j.cpc.2012.09.024, DOI 10.1016/J.CPC.2012.09.024]; Portegies Zwart S, 2014, ASTROPHYS J LETT, V785, DOI 10.1088/2041-8205/785/1/L3; Portegies Zwart S, 2010, ANNU REV ASTRON ASTR, V48, P431, DOI 10.1146/annurev-astro-081309-130834; Sabbi E, 2012, ASTROPHYS J LETT, V754, DOI 10.1088/2041-8205/754/2/L37; Toonen S, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201218966; Vansevicius V, 2009, ASTROPHYS J, V703, P1872, DOI 10.1088/0004-637X/703/2/1872; Zapata LA, 2008, ASTRON ASTROPHYS, V479, pL25, DOI 10.1051/0004-6361:20078846	66	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	MAY 1	2015	449	1					726	740		10.1093/mnras/stv293		15	Astronomy & Astrophysics	Astronomy & Astrophysics	CJ2WO	WOS:000355345600053		
J	Willett, KW; Schawinski, K; Simmons, BD; Masters, KL; Skibba, RA; Kaviraj, S; Melvin, T; Wong, OI; Nichol, RC; Cheung, E; Lintott, CJ; Fortson, L				Willett, Kyle W.; Schawinski, Kevin; Simmons, Brooke D.; Masters, Karen L.; Skibba, Ramin A.; Kaviraj, Sugata; Melvin, Thomas; Wong, O. Ivy; Nichol, Robert C.; Cheung, Edmond; Lintott, Chris J.; Fortson, Lucy			Galaxy Zoo: the dependence of the star formation-stellar mass relation on spiral disc morphology	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						galaxies: spiral; galaxies: star formation	DIGITAL-SKY-SURVEY; FORMATION RATES; PHYSICAL-PROPERTIES; FORMING GALAXIES; MERGING GALAXIES; DATA RELEASE; EVOLUTION; SEQUENCE; GAS; RED	We measure the stellar mass-star formation rate (SFR) relation in star-forming disc galaxies at z <= 0.085, using Galaxy Zoo morphologies to examine different populations of spirals as classified by their kiloparsec-scale structure. We examine the number of spiral arms, their relative pitch angle, and the presence of a galactic bar in the disc, and show that both the slope and dispersion of the M-*-SFR relation is constant when varying all the above parameters. We also show that mergers (both major and minor), which represent the strongest conditions for increases in star formation at a constant mass, only boost the SFR above the main relation by similar to 0.3 dex; this is significantly smaller than the increase seen in merging systems at z > 1. Of the galaxies lying significantly above the M-*-SFR relation in the local Universe, more than 50 per cent are mergers. We interpret this as evidence that the spiral arms, which are imperfect reflections of the galaxy's current gravitational potential, are either fully independent of the various quenching mechanisms or are completely overwhelmed by the combination of outflows and feedback. The arrangement of the star formation can be changed, but the system as a whole regulates itself even in the presence of strong dynamical forcing.	[Willett, Kyle W.; Fortson, Lucy] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Schawinski, Kevin] ETH, Inst Astron, Dept Phys, CH-8093 Zurich, Switzerland; [Simmons, Brooke D.; Kaviraj, Sugata; Lintott, Chris J.] Oxford Astrophys, Oxford OX1 3RH, England; [Masters, Karen L.; Melvin, Thomas; Nichol, Robert C.] Univ Portsmouth, Inst Cosmol & Gravitat, Portsmouth PO1 3FX, Hants, England; [Masters, Karen L.; Nichol, Robert C.] SEPnet, South East Phys Network, Southampton, Hants, England; [Skibba, Ramin A.] Univ Calif San Diego, Ctr Astrophys & Space Sci, San Diego, CA 92093 USA; [Kaviraj, Sugata] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Wong, O. Ivy] Univ Western Australia, Int Ctr Radio Astron Res, Crawley, WA 6009, Australia; [Cheung, Edmond] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Cheung, Edmond] Univ Tokyo, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan	Willett, KW (reprint author), Univ Minnesota, Sch Phys & Astron, 116 Church St SE, Minneapolis, MN 55455 USA.	willett@physics.umn.edu			Leverhulme Trust; US National Science Foundation [DRL-0941610]; Swiss National Science Foundation [PP00P2_138979/1]; Alfred P. Sloan Foundation; National Science Foundation; US Department of Energy; National Aeronautics and Space Administration; Japanese Monbukagakusho; Max Planck Society; Higher Education Funding Council for England; American Museum of Natural History; Astrophysical Institute Potsdam; University of Basel; University of Cambridge; Case Western Reserve University; University of Chicago; Drexel University; Fermilab; Institute for Advanced Study; Japan Participation Group; Johns Hopkins University; Joint Institute for Nuclear Astrophysics; Kavli Institute for Particle Astrophysics and Cosmology; Korean Scientist Group; Chinese Academy of Sciences (LAMOST); Los Alamos National Laboratory; Max-Planck-Institute for Astronomy (MPIA); Max-Planck-Institute for Astrophysics (MPA); New Mexico State University; Ohio State University; University of Pittsburgh; University of Portsmouth; Princeton University; United States Naval Observatory; University of Washington	We thank Rory Smith, Lucio Mayer, and Bruce Elmegreen for useful discussions. This research made use of TOPCAT, an interactive graphical viewer and editor for tabular data (Taylor 2005) and Astropy, a community-developed core PYTHON package for astronomy (Astropy Collaboration et al. 2013). The development of GZ2 was supported by The Leverhulme Trust. KWW and LFF are supported by the US National Science Foundation under grant DRL-0941610. KS gratefully acknowledges support from Swiss National Science Foundation Grant PP00P2_138979/1.; Funding for the SDSS and SDSS-II has been provided by the Alfred P. Sloan Foundation, the Participating Institutions, the National Science Foundation, the US Department of Energy, the National Aeronautics and Space Administration, the Japanese Monbukagakusho, the Max Planck Society, and the Higher Education Funding Council for England. The SDSS website is http://www.sdss.org/.; The SDSS is managed by the Astrophysical Research Consortium for the Participating Institutions. The Participating Institutions are the American Museum of Natural History, Astrophysical Institute Potsdam, University of Basel, University of Cambridge, Case Western Reserve University, University of Chicago, Drexel University, Fermilab, the Institute for Advanced Study, the Japan Participation Group, Johns Hopkins University, the Joint Institute for Nuclear Astrophysics, the Kavli Institute for Particle Astrophysics and Cosmology, the Korean Scientist Group, the Chinese Academy of Sciences (LAMOST), Los Alamos National Laboratory, the Max-Planck-Institute for Astronomy (MPIA), the Max-Planck-Institute for Astrophysics (MPA), New Mexico State University, Ohio State University, University of Pittsburgh, University of Portsmouth, Princeton University, the United States Naval Observatory, and the University of Washington.	Abramson LE, 2014, ASTROPHYS J LETT, V785, DOI 10.1088/2041-8205/785/2/L36; Hopkins PF, 2008, ASTROPHYS J SUPPL S, V175, P356, DOI 10.1086/524362; Kauffmann G, 2003, MON NOT R ASTRON SOC, V346, P1055, DOI 10.1111/j.1365-2966.2003.07154.x; Masters KL, 2012, MON NOT R ASTRON SOC, V424, P2180, DOI 10.1111/j.1365-2966.2012.21377.x; Noeske KG, 2007, ASTROPHYS J, V660, pL43, DOI 10.1086/517926; Omand CMB, 2014, MON NOT R ASTRON SOC, V440, P843, DOI 10.1093/mnras/stu331; Daddi E, 2007, ASTROPHYS J, V670, P156, DOI 10.1086/521818; Dutton AA, 2010, MON NOT R ASTRON SOC, V405, P1690, DOI 10.1111/j.1365-2966.2010.16620.x; Darg DW, 2010, MON NOT R ASTRON SOC, V401, P1043, DOI 10.1111/j.1365-2966.2009.15686.x; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; Lintott C, 2011, MON NOT R ASTRON SOC, V410, P166, DOI 10.1111/j.1365-2966.2010.17432.x; Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Ellison SL, 2011, MON NOT R ASTRON SOC, V416, P2182, DOI 10.1111/j.1365-2966.2011.19195.x; Cameron E, 2010, MON NOT R ASTRON SOC, V409, P346, DOI 10.1111/j.1365-2966.2010.17314.x; Hopkins PF, 2014, MON NOT R ASTRON SOC, V445, P581, DOI 10.1093/mnras/stu1738; Hoyle B, 2011, MON NOT R ASTRON SOC, V415, P3627, DOI 10.1111/j.1365-2966.2011.18979.x; Masters KL, 2010, MON NOT R ASTRON SOC, V405, P783, DOI 10.1111/j.1365-2966.2010.16503.x; Martig M, 2009, ASTROPHYS J, V707, P250, DOI 10.1088/0004-637X/707/1/250; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Brinchmann J, 2004, MON NOT R ASTRON SOC, V351, P1151, DOI 10.1111/j.1365-2966.2004.07881.x; Masters KL, 2011, MON NOT R ASTRON SOC, V411, P2026, DOI 10.1111/j.1365-2966.2010.17834.x; BALDWIN JA, 1981, PUBL ASTRON SOC PAC, V93, P5, DOI 10.1086/130766; van den Bosch FC, 2008, MON NOT R ASTRON SOC, V387, P79, DOI 10.1111/j.1365-2966.2008.13230.x; Schiminovich D, 2007, ASTROPHYS J SUPPL S, V173, P315, DOI 10.1086/524659; Willett KW, 2013, MON NOT R ASTRON SOC, V435, P2835, DOI 10.1093/mnras/stt1458; Casteels KRV, 2013, MON NOT R ASTRON SOC, V429, P1051, DOI 10.1093/mnras/sts391; Bamford SP, 2009, MON NOT R ASTRON SOC, V393, P1324, DOI 10.1111/j.1365-2966.2008.14252.x; Skibba RA, 2009, MON NOT R ASTRON SOC, V399, P966, DOI 10.1111/j.1365-2966.2009.15334.x; Strauss MA, 2002, ASTRON J, V124, P1810, DOI 10.1086/342343; Kauffmann G, 2003, MON NOT R ASTRON SOC, V341, P33, DOI 10.1046/j.1365-8711.2003.06291.x; De Lucia G, 2012, MON NOT R ASTRON SOC, V423, P1277, DOI 10.1111/j.1365-2966.2012.20983.x; Bouche N, 2010, ASTROPHYS J, V718, P1001, DOI 10.1088/0004-637X/718/2/1001; Salim S, 2007, ASTROPHYS J SUPPL S, V173, P267, DOI 10.1086/519218; Daddi E, 2010, ASTROPHYS J LETT, V714, pL118, DOI 10.1088/2041-8205/714/1/L118; Sheth K, 2008, ASTROPHYS J, V675, P1141, DOI 10.1086/524980; Astropy Collaboration, 2013, ASTRON ASTROPHYS, V558, pA33, DOI DOI 10.1051/0004-6361/201322068; Cardamone C, 2009, MON NOT R ASTRON SOC, V399, P1191, DOI 10.1111/j.1365-2966.2009.15383.x; Cheung E, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/162; Cheung E, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/131; Cortese L, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201219443; Darg DW, 2010, MON NOT R ASTRON SOC, V401, P1552, DOI 10.1111/j.1365-2966.2009.15786.x; Elbaz D, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117239; ELMEGREEN BG, 1986, ASTROPHYS J, V311, P554, DOI 10.1086/164795; Fang JJ, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/63; Foyle K, 2010, ASTROPHYS J, V725, P534, DOI 10.1088/0004-637X/725/1/534; Hinshaw G, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/19; Kaviraj S, 2014, MON NOT R ASTRON SOC, V440, P2944, DOI 10.1093/mnras/stu338; Kaviraj S, 2013, MON NOT R ASTRON SOC, V429, pL40, DOI 10.1093/mnrasl/sls019; Kelson D. D., 2014, ARXIV14065191; Lang P, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/11; Lee N., 2015, ARXIV150101080; Lilly SJ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/119; Peng YJ, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/4; Peng YJ, 2010, ASTROPHYS J, V721, P193, DOI 10.1088/0004-637X/721/1/193; Rodighiero G, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L40; Taylor MB, 2005, ASTR SOC P, V347, P29; Whitaker KE, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/104	57	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	MAY 1	2015	449	1					820	827		10.1093/mnras/stv307		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CJ2WO	WOS:000355345600060		
J	Belfiore, F; Maiolino, R; Bundy, K; Thomas, D; Maraston, C; Wilkinson, D; Sanchez, SF; Bershady, M; Blanc, GA; Bothwell, M; Cales, SL; Coccato, L; Drory, N; Emsellem, E; Fu, H; Gelfand, J; Law, D; Masters, K; Parejko, J; Tremonti, C; Wake, D; Weijmans, A; Yan, R; Xiao, T; Zhang, K; Zheng, T; Bizyaev, D; Kinemuchi, K; Oravetz, D; Simmons, A				Belfiore, F.; Maiolino, R.; Bundy, K.; Thomas, D.; Maraston, C.; Wilkinson, D.; Sanchez, S. F.; Bershady, M.; Blanc, G. A.; Bothwell, M.; Cales, S. L.; Coccato, L.; Drory, N.; Emsellem, E.; Fu, H.; Gelfand, J.; Law, D.; Masters, K.; Parejko, J.; Tremonti, C.; Wake, D.; Weijmans, A.; Yan, R.; Xiao, T.; Zhang, K.; Zheng, T.; Bizyaev, D.; Kinemuchi, K.; Oravetz, D.; Simmons, A.			P-MaNGA Galaxies: emission-lines properties - gas ionization and chemical abundances from prototype observations	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						galaxies: abundances; galaxies: active; galaxies: evolution; galaxies: fundamental parameters; galaxies: ISM	STAR-FORMING GALAXIES; DIGITAL SKY SURVEY; MASS-METALLICITY RELATION; H-II REGIONS; INTEGRAL FIELD SPECTROSCOPY; DISTRIBUTED ELECTRON ENERGIES; STELLAR POPULATION SYNTHESIS; LUMINOUS INFRARED GALAXIES; HIGH-SPECTRAL-RESOLUTION; ACTIVE GALACTIC NUCLEI	MaNGA (Mapping Nearby Galaxies at Apache Point Observatory) is a 6-yr Sloan Digital Sky Survey (SDSS-IV) survey that will obtain spatially resolved spectroscopy from 3600 to 10 300 angstrom for a representative sample of ove10 000 nearby galaxies. In this paper, we present the analysis of nebular emission-line properties using observations of 14 galaxies obtained with P-MaNGA, a prototype of the MaNGA instrument. By using spatially resolved diagnostic diagrams, we find extended star formation in galaxies that are centrally dominated by Seyfert/LINER-like emission, which illustrates that galaxy characterizations based on single fibre spectra are necessarily incomplete. We observe extended low ionization nuclear emission-line regions (LINER)-like emission (up to 1R(e)) in the central regions of three galaxies. We make use of the Ha equivalent width [EW(H alpha)] to argue that the observed emission is consistent with ionization from hot evolved stars. We derive stellar population indices and demonstrate a clear correlation between D-n(4000) and EW(H delta(A)) and the position in the ionization diagnostic diagram: resolved galactic regions which are ionized by a Seyfert/LINER-like radiation field are also devoid of recent star formation and host older and/or more metal-rich stellar populations. We also detect extraplanar LINER-like emission in two highly inclined galaxies, and identify it with diffuse ionized gas. We investigate spatially resolved metallicities and find a positive correlation between metallicity and star formation rate surface density. We further study the relation between N/O versus O/H on resolved scales. We find that, at given N/O, regions within individual galaxies are spread towards lower metallicities, deviating from the sequence defined by galactic central regions as traced by Sloan 3-arcsec fibre spectra. We suggest that the observed dispersion can be a tracer for gas flows in galaxies: infalls of pristine gas and/or the effect of a galactic fountain.	[Belfiore, F.; Maiolino, R.; Bothwell, M.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Belfiore, F.; Maiolino, R.; Bothwell, M.] Univ Cambridge, Kavli Inst Cosmol, Cambridge CB3 0HE, England; [Bundy, K.] Univ Tokyo, Todai Inst Adv Study, Kavli Inst Phys & Math Universe, Kashiwa, Chiba 2778583, Japan; [Thomas, D.; Maraston, C.; Wilkinson, D.; Masters, K.] Univ Portsmouth, Inst Cosmol & Gravitat, Portsmouth PO1 3FX, Hants, England; [Sanchez, S. F.] Univ Nacl Autonoma Mexico, Inst Astron, Mexico City 04510, DF, Mexico; [Bershady, M.; Tremonti, C.; Wake, D.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Blanc, G. A.] Carnegie Inst Washington Observ, Pasadena, CA 91101 USA; [Cales, S. L.; Parejko, J.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Coccato, L.; Emsellem, E.] European So Observ, D-85748 Garching, Germany; [Drory, N.] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Emsellem, E.] Univ Lyon 1, Observ Lyon, Ctr Rech Astrophys Lyon, F-69230 St Genis Laval, France; [Emsellem, E.] Univ Lyon 1, Observ Lyon, Ecole Normale Super Lyon, F-69230 St Genis Laval, France; [Fu, H.; Zheng, T.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Gelfand, J.] New York Univ, Dept Phys, Ctr Cosmol & Particle Phys, New York, NY 10003 USA; [Gelfand, J.] NYU Abu Dhabi, Abu Dhabi, U Arab Emirates; [Law, D.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Wake, D.] Open Univ, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England; [Weijmans, A.] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Yan, R.] Univ Kentucky, Dept Phys & Astron, Lexington, KY 40506 USA; [Xiao, T.] Shanghai Astron Observ, Max Planck Inst Astrophys, Partner Grp, Shanghai 200030, Peoples R China; [Zhang, K.] Shanghai Astron Observ, Cosmol & Galaxy Ctr, Shanghai 200030, Peoples R China; [Bizyaev, D.; Kinemuchi, K.; Oravetz, D.; Simmons, A.] Apache Point Observ, Sunspot, NM 88349 USA	Belfiore, F (reprint author), Univ Cambridge, Cavendish Lab, 19 JJ Thomson Ave, Cambridge CB3 0HE, England.	fb338@cam.ac.uk			STFC, UK; World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; Alfred P. Sloan Foundation; National Science Foundation; US Department of Energy Office of Science; University of Arizona; Brazilian Participation Group; Brookhaven National Laboratory; Carnegie Mellon University; University of Florida; French Participation Group; German Participation Group; Harvard University; Instituto de Astrofisica de Canarias; Michigan State/Notre Dame/JINA Participation Group; Johns Hopkins University; Lawrence Berkeley National Laboratory; Max Planck Institute for Astrophysics; Max Planck Institute for Extraterrestrial Physics; New Mexico State University; New York University; Ohio State University; Pennsylvania State University; University of Portsmouth; Princeton University; Spanish Participation Group; University of Tokyo; University of Utah; Vanderbilt University; University of Virginia; University of Washington; Yale University; University of Colorado Boulder; Harvard-Smithsonian Center for Astrophysics Participation Group; Kavli Institute for the Physics and Mathematics of the Universe; Max-Planck-Institut fuer Astrophysik (MPA Garching); Max-Planck-Institut fuer Extraterrestrische Physik (MPE); Max-Planck-Institut fuer Astronomie (MPIA Heidelberg); National Astronomical Observatory of China; Shanghai Astronomical Observatory; United Kingdom Participation Group; University of Wisconsin	We acknowledge Cheng Li and Enci Wang for their contributions to the analysis of the stellar population indices. We thank Michele Cappellari and the referee for their insightful comments. This work was supported by the STFC, UK and World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan.; Funding for SDSS-III and SDSS-IV has been provided by the Alfred P. Sloan Foundation and Participating Institutions. Additional funding for SDSS-III comes from the National Science Foundation and the US Department of Energy Office of Science. Further information about both projects is available at www.sdss3.org.; SDSS is managed by the Astrophysical Research Consortium for the Participating Institutions in both collaborations. In SDSS-III, these include the University of Arizona, the Brazilian Participation Group, Brookhaven National Laboratory, Carnegie Mellon University, University of Florida, the French Participation Group, the German Participation Group, Harvard University, the Instituto de Astrofisica de Canarias, the Michigan State/Notre Dame/JINA Participation Group, Johns Hopkins University, Lawrence Berkeley National Laboratory, Max Planck Institute for Astrophysics, Max Planck Institute for Extraterrestrial Physics, New Mexico State University, New York University, Ohio State University, Pennsylvania State University, University of Portsmouth, Princeton University, the Spanish Participation Group, University of Tokyo, University of Utah, Vanderbilt University, University of Virginia, University of Washington, and Yale University.; The Participating Institutions in SDSS-IV are Carnegie Mellon University, University of Colorado Boulder, Harvard-Smithsonian Center for Astrophysics Participation Group, Johns Hopkins University, Kavli Institute for the Physics and Mathematics of the Universe, Max-Planck-Institut fuer Astrophysik (MPA Garching), Max-Planck-Institut fuer Extraterrestrische Physik (MPE), Max-Planck-Institut fuer Astronomie (MPIA Heidelberg), National Astronomical Observatory of China, New Mexico State University, New York University, The Ohio State University, Pennsylvania State University, Shanghai Astronomical Observatory, United Kingdom Participation Group, University of Portsmouth, University of Utah, University of Wisconsin, and Yale University.	Alonso-Herrero A, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201014746; Andrews BH, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/140; Kauffmann G, 2003, MON NOT R ASTRON SOC, V346, P1055, DOI 10.1111/j.1365-2966.2003.07154.x; TERLEVICH R, 1985, MON NOT R ASTRON SOC, V213, P841; Pettini M, 2004, MON NOT R ASTRON SOC, V348, pL59, DOI 10.1111/j.1365-2966.2004.07591.x; Lopez-Sanchez AR, 2012, MON NOT R ASTRON SOC, V426, P2630, DOI 10.1111/j.1365-2966.2012.21145.x; Cappellari M, 2004, PUBL ASTRON SOC PAC, V116, P138, DOI 10.1086/381875; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Ho LC, 1997, ASTROPHYS J, V487, P579, DOI 10.1086/304642; Pilyugin LS, 2005, ASTROPHYS J, V631, P231, DOI 10.1086/432408; Kobulnicky HA, 2004, ASTROPHYS J, V617, P240, DOI 10.1086/425299; Bershady MA, 2010, ASTROPHYS J, V716, P198, DOI 10.1088/0004-637X/716/1/198; Rossa J, 2003, ASTRON ASTROPHYS, V406, P505, DOI 10.1051/0004-6361:20030698; Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Schawinski K, 2010, ASTROPHYS J, V711, P284, DOI 10.1088/0004-637X/711/1/284; Thomas D, 2006, MON NOT R ASTRON SOC, V366, P510, DOI 10.1111/j.1365-2966.2005.09871.x; Kewley LJ, 2001, ASTROPHYS J, V556, P121, DOI 10.1086/321545; Croom SM, 2012, MON NOT R ASTRON SOC, V421, P872, DOI 10.1111/j.1365-2966.2011.20365.x; VEILLEUX S, 1987, ASTROPHYS J SUPPL S, V63, P295, DOI 10.1086/191166; Kewley LJ, 2008, ASTROPHYS J, V681, P1183, DOI 10.1086/587500; Denicolo G, 2002, MON NOT R ASTRON SOC, V330, P69, DOI 10.1046/j.1365-8711.2002.05041.x; Tremonti CA, 2004, ASTROPHYS J, V613, P898, DOI 10.1086/423264; Dayal P, 2013, MON NOT R ASTRON SOC, V430, P2891, DOI 10.1093/mnras/stt083; Yates RM, 2012, MON NOT R ASTRON SOC, V422, P215, DOI 10.1111/j.1365-2966.2012.20595.x; Sarzi M, 2006, MON NOT R ASTRON SOC, V366, P1151, DOI 10.1111/j.1365-2966.2005.09839.x; Bothwell MS, 2013, MON NOT R ASTRON SOC, V433, P1425, DOI 10.1093/mnras/stt817; Balogh ML, 1999, ASTROPHYS J, V527, P54, DOI 10.1086/308056; Asari NV, 2007, MON NOT R ASTRON SOC, V381, P263, DOI 10.1111/j.1365-2966.2007.12255.x; de Zeeuw PT, 2002, MON NOT R ASTRON SOC, V329, P513; Bigiel F, 2008, ASTRON J, V136, P2846, DOI 10.1088/0004-6256/136/6/2846; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Brinchmann J, 2004, MON NOT R ASTRON SOC, V351, P1151, DOI 10.1111/j.1365-2966.2004.07881.x; BALDWIN JA, 1981, PUBL ASTRON SOC PAC, V93, P5, DOI 10.1086/130766; Blanc GA, 2009, ASTROPHYS J, V704, P842, DOI 10.1088/0004-637X/704/1/842; van Zee L, 2006, ASTROPHYS J, V636, P214, DOI 10.1086/498017; VILACOSTAS MB, 1992, MON NOT R ASTRON SOC, V259, P121; Kewley LJ, 2006, MON NOT R ASTRON SOC, V372, P961, DOI 10.1111/j.1365-2966.2006.10859.x; Le Borgne JF, 2003, ASTRON ASTROPHYS, V402, P433, DOI 10.1051/0004-6361:20030243; Kewley LJ, 2002, ASTROPHYS J SUPPL S, V142, P35, DOI 10.1086/341326; Sarzi M, 2010, MON NOT R ASTRON SOC, V402, P2187, DOI 10.1111/j.1365-2966.2009.16039.x; Ho IT, 2014, MON NOT R ASTRON SOC, V444, P3894, DOI 10.1093/mnras/stu1653; Werk JK, 2010, ASTROPHYS J, V715, P656, DOI 10.1088/0004-637X/715/1/656; BINETTE L, 1994, ASTRON ASTROPHYS, V292, P13; Cullen F, 2014, MON NOT R ASTRON SOC, V440, P2300, DOI 10.1093/mnras/stu443; Maiolino R, 2008, ASTRON ASTROPHYS, V488, P463, DOI 10.1051/0004-6361:200809678; Koppen J, 2005, ASTRON ASTROPHYS, V434, P531, DOI 10.1051/0004-6361:20042266; Kauffmann G, 2003, MON NOT R ASTRON SOC, V341, P33, DOI 10.1046/j.1365-8711.2003.06291.x; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; LEQUEUX J, 1979, ASTRON ASTROPHYS, V80, P155; Ho LC, 1997, ASTROPHYS J, V487, P568, DOI 10.1086/304638; Coziol R, 1999, ASTRON ASTROPHYS, V345, P733; Leroy AK, 2008, ASTRON J, V136, P2782, DOI 10.1088/0004-6256/136/6/2782; Cappellari M, 2003, MON NOT R ASTRON SOC, V342, P345, DOI 10.1046/j.1365-8711.2003.06541.x; Pilyugin LS, 2010, ASTROPHYS J, V720, P1738, DOI 10.1088/0004-637X/720/2/1738; Nagao T, 2006, ASTRON ASTROPHYS, V459, P85, DOI 10.1051/0004-6361:20065216; Thomas D, 2010, MON NOT R ASTRON SOC, V404, P1775, DOI 10.1111/j.1365-2966.2010.16427.x; Henry RBC, 2000, ASTROPHYS J, V541, P660, DOI 10.1086/309471; Johansson J, 2012, MON NOT R ASTRON SOC, V421, P1908, DOI 10.1111/j.1365-2966.2011.20316.x; Haffner LM, 2009, REV MOD PHYS, V81, P969, DOI 10.1103/RevModPhys.81.969; Sharples R, 2006, NEW ASTRON REV, V50, P370, DOI 10.1016/j.newar.2006.02.014; Izotov YI, 2006, ASTRON ASTROPHYS, V448, P955, DOI 10.1051/0004-6361:20053763; Cappellari M, 2011, MON NOT R ASTRON SOC, V413, P813, DOI 10.1111/j.1365-2966.2010.18174.x; Perez-Montero E, 2009, MON NOT R ASTRON SOC, V398, P949, DOI 10.1111/j.1365-2966.2009.15145.x; Mannucci F, 2010, MON NOT R ASTRON SOC, V408, P2115, DOI 10.1111/j.1365-2966.2010.17291.x; Cresci G, 2010, NATURE, V467, P811, DOI 10.1038/nature09451; Bacon R, 2010, PROC SPIE, V7735, DOI 10.1117/12.856027; Arribas S, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201323324; Barth AJ, 2000, PUBL ASTRON SOC PAC, V112, P753, DOI 10.1086/316583; Berg DA, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/98; Binette L, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201219515; Blanc GA, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/5/138; Blanton MR, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/1/31; Yan RB, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/61; Bregman JN, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/57; Bundy K, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/7; Calzetti D, 2001, PUBL ASTRON SOC PAC, V113, P1449, DOI 10.1086/324269; Fernandes RC, 2010, MON NOT R ASTRON SOC, V403, P1036, DOI 10.1111/j.1365-2966.2009.16185.x; Fernandes RC, 2011, MON NOT R ASTRON SOC, V413, P1687, DOI 10.1111/j.1365-2966.2011.18244.x; Dave R., 2011, MNRAS, V421, P98; Diaz AI, 2007, MON NOT R ASTRON SOC, V382, P251, DOI 10.1111/j.1365-2966.2007.12351.x; Diaz AI, 2000, MON NOT R ASTRON SOC, V318, P462; Dopita MA, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/10; Drory N, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/2/77; Edmunds M. G., 1978, MNRAS, V185, P77; Flores-Fajardo N, 2011, MON NOT R ASTRON SOC, V415, P2182, DOI 10.1111/j.1365-2966.2011.18848.x; Fogarty LMR, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/169; Garcia-Benito R., 2014, ARXIV14098302; GARNETT DR, 1990, ASTROPHYS J, V363, P142, DOI 10.1086/169324; GARNETT DR, 1992, ASTRON J, V103, P1330, DOI 10.1086/116146; Delgado RMG, 2005, MON NOT R ASTRON SOC, V357, P945, DOI 10.1111/j.1365-2966.2005.08692.x; Delgado RMG, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/1/L16; Gonzalez-Martin O, 2009, ASTRON ASTROPHYS, V506, P1107, DOI 10.1051/0004-6361/200912288; Goudfrooij P., 1999, ASP C SER, V163, P55; HECKMAN TM, 1980, ASTRON ASTROPHYS, V87, P152; Hoopes CG, 2003, ASTROPHYS J, V586, P902, DOI 10.1086/367954; Hughes TM, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201218822; Husemann B, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220582; Kehrig C, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201118357; KENNICUTT RC, 1989, ASTRON J, V97, P1022, DOI 10.1086/115046; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Korn AJ, 2005, ASTRON ASTROPHYS, V438, P685, DOI 10.1051/0004-6361:20042126; Lara-Lopez MA, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201014803; Li C., 2015, ARXIV150207040; Lipari S, 2004, MON NOT R ASTRON SOC, V355, P641, DOI 10.1111/j.1365-2966.2004.08368.x; Maraston C, 2011, MON NOT R ASTRON SOC, V418, P2785, DOI 10.1111/j.1365-2966.2011.19738.x; Marino RA, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201321956; MATTEUCCI F, 1986, PUBL ASTRON SOC PAC, V98, P973, DOI 10.1086/131854; Moran SM, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/66; Nava A, 2006, ASTROPHYS J, V645, P1076, DOI 10.1086/504416; Nicholls DC, 2013, ASTROPHYS J SUPPL S, V207, DOI 10.1088/0067-0049/207/2/21; ODONNELL JE, 1994, ASTROPHYS J, V422, P158, DOI 10.1086/173713; Oey MS, 2007, ASTROPHYS J, V661, P801, DOI 10.1086/517867; Osterbrock D. E., 2006, ASTROPHYSICS GASEOUS; PAGEL BEJ, 1992, MON NOT R ASTRON SOC, V255, P325; Papaderos P, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321681; Peng YJ, 2010, ASTROPHYS J, V721, P193, DOI 10.1088/0004-637X/721/1/193; Perez E, 2013, ASTROPHYS J LETT, V764, DOI 10.1088/2041-8205/764/1/L1; Perez-Montero E, 2014, MON NOT R ASTRON SOC, V441, P2663, DOI 10.1093/mnras/stu753; Pilyugin LS, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/6/131; RAND RJ, 1990, ASTROPHYS J, V352, pL1, DOI 10.1086/185679; Rich JA, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/87; Rich JA, 2014, ASTROPHYS J LETT, V781, DOI 10.1088/2041-8205/781/1/L12; Rosales-Ortega FF, 2011, MON NOT R ASTRON SOC, V415, P2439, DOI 10.1111/j.1365-2966.2011.18870.x; Rossa J, 2004, ASTRON J, V128, P674, DOI 10.1086/422489; Almeida JS, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/45; Sanchez SF, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201424873; Sanchez SF, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117353; Sanchez SF, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219578; Sanchez SF, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201220669; Sanchez SF, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201322343; Sanchez-Blazquez P, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201423635; Sharp R, 2015, MON NOT R ASTRON SOC, V446, P1551, DOI 10.1093/mnras/stu2055; Sharp RG, 2010, ASTROPHYS J, V711, P818, DOI 10.1088/0004-637X/711/2/818; Singh R, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322062; Smee SA, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/2/32; Stasinska G, 2005, ASTRON ASTROPHYS, V434, P507, DOI 10.1051/0004-6361:20042216; Stasinska G, 2006, MON NOT R ASTRON SOC, V371, P972, DOI 10.1111/j.1365-2966.2006.10732.x; Steidel CC, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/165; Thomas D, 2004, MON NOT R ASTRON SOC, V351, pL19, DOI 10.1111/j.1365-2966.2004.07944.x; Torres-Papaqui JP, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/144; Troncoso P, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201322099; VILACOSTAS MB, 1993, MON NOT R ASTRON SOC, V265, P199; Williams RJ, 2014, MON NOT R ASTRON SOC, V443, P3780, DOI 10.1093/mnras/stu1422; Worthey G, 1997, ASTROPHYS J SUPPL S, V111, P377, DOI 10.1086/313021; Wu YZ, 2013, MON NOT R ASTRON SOC, V436, P934, DOI 10.1093/mnras/stt1630; Wuyts S., 2014, APJ, V789, pL40; Zahid HJ, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/2/130	147	6	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	MAY 1	2015	449	1					867	900		10.1093/mnras/stv296		34	Astronomy & Astrophysics	Astronomy & Astrophysics	CJ2WO	WOS:000355345600064		
J	Pacucci, F; Ferrara, A; Marassi, S				Pacucci, Fabio; Ferrara, Andrea; Marassi, Stefania			Gravitational waves from direct collapse black holes formation	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						gravitational waves; galaxies: formation; galaxies: high-redshift; cosmology: observations; cosmology: theory; early Universe	COSMOLOGICAL COMPACT BINARIES; ROTATING SUPERMASSIVE STAR; DARK-MATTER HALOES; STELLAR COLLAPSE; POPULATION-III; 1ST STARS; EVOLUTION; SIMULATIONS; ACCRETION; RADIATION	The possible formation of direct collapse black holes (DCBHs) in the first metal-free atomic cooling haloes at high redshifts (z greater than or similar to 10) is nowadays object of intense study and several methods to prove their existence are currently under development. The abrupt collapse of a massive (similar to 10(4)-10(5)M(circle dot)) and rotating object is a powerful source of gravitational waves emission. In this work, we employ modern waveforms and the improved knowledge on the DCBHs formation rate to estimate the gravitational signal emitted by these sources at cosmological distances. Their formation rate is very high (similar to 10(4) yr(-1) up to z similar to 20), but due to a short duration of the collapse event (similar to 2-30 s, depending on the DCBH mass), the integrated signal from these sources is characterized by a very low duty-cycle (D similar to 10(-3)), i.e. a shot-noise signal. Our results show that the estimated signal lies above the foreseen sensitivity of the Ultimate-Deci-hertz Interferometer Gravitational wave Observatory in the frequency range (0.8-300) mHz, with a peak amplitude Omega(gw) = 1.1 x 10(-54) at nu(max) = 0.9 mHz and a peak signal-to-noise ratio SNR similar to 22 at. = 20 mHz. This amplitude is lower than the Galactic confusion noise, generated by binary systems of compact objects in the same frequency band. For this reason, advanced techniques will be required to separate this signal from background and foreground noise components. As a proof-of-concept, we conclude by proposing a simple method, based on the autocorrelation function, to recognize the presence of a D << 1 signal buried into the continuous noise. The aim of this work is to test the existence of a large population of high-z DCBHs, by observing the gravitational waves emitted during their infancy.	[Pacucci, Fabio; Ferrara, Andrea] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Ferrara, Andrea] Univ Tokyo, Todai Inst Adv Study, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; [Marassi, Stefania] INAF Osservatorio Astron Roma, I-00040 Monte Porzio Catone, Italy	Pacucci, F (reprint author), Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56126 Pisa, Italy.	fabio.pacucci@sns.it			European Research Council under the European Union's Seventh Framework Programme (FP)/ERC [306476]	FP thanks Raffaella Schneider, Stefania Salvadori, Bence Kocsis and Bin Yue for their very valuable comments and for useful discussions. The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement no. 306476.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Amaro-Seoane P., 2013, GW NOTES, V6, P4; Gammie CF, 2004, ASTROPHYS J, V602, P312, DOI 10.1086/380996; Fialkov A, 2012, MON NOT R ASTRON SOC, V424, P1335, DOI 10.1111/j.1365-2966.2012.21318.x; Bromm V, 2011, ANNU REV ASTRON ASTR, V49, P373, DOI 10.1146/annurev-astro-081710-102608; Regan JA, 2009, MON NOT R ASTRON SOC, V396, P343, DOI 10.1111/j.1365-2966.2009.14579.x; Li GJ, 2012, MON NOT R ASTRON SOC, V425, P2407, DOI 10.1111/j.1365-2966.2012.21206.x; Bromm V, 2003, ASTROPHYS J, V596, P34, DOI 10.1086/377529; Kocsis B, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.041101; Farmer AJ, 2003, MON NOT R ASTRON SOC, V346, P1197, DOI 10.1111/j.1365-2966.2003.07176.x; Suwa Y, 2007, ASTROPHYS J, V665, pL43, DOI 10.1086/521078; Volonteri M, 2008, MON NOT R ASTRON SOC, V383, P1079, DOI 10.1111/j.1365-2966.2007.12589.x; Miralda-Escude J, 2003, SCIENCE, V300, P1904, DOI 10.1126/science.1085325; Pacucci F, 2015, MON NOT R ASTRON SOC, V448, P104, DOI 10.1093/mnras/stv018; Li J, 2010, GEN RELAT GRAVIT, V42, P2511, DOI 10.1007/s10714-010-1001-9; Ott CD, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/20/204015; LOEB A, 1994, ASTROPHYS J, V432, P52, DOI 10.1086/174548; Saijo M, 2002, ASTROPHYS J, V569, P349, DOI 10.1086/339268; Shang C, 2010, MON NOT R ASTRON SOC, V402, P1249, DOI 10.1111/j.1365-2966.2009.15960.x; Schneider R, 2001, MON NOT R ASTRON SOC, V324, P797, DOI 10.1046/j.1365-8711.2001.04217.x; EISENSTEIN DJ, 1995, ASTROPHYS J, V443, P11, DOI 10.1086/175498; Volonteri M, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/12/124901; Dijkstra M, 2014, MON NOT R ASTRON SOC, V442, P2036, DOI 10.1093/mnras/stu1007; Regimbau T, 2010, J PHYS CONF SER, V228, DOI 10.1088/1742-6596/228/1/012009; THORNE KS, 1974, ASTROPHYS J, V191, P507, DOI 10.1086/152991; Sugimura K, 2014, MON NOT R ASTRON SOC, V445, P544, DOI 10.1093/mnras/stu1778; Agarwal B, 2012, MON NOT R ASTRON SOC, V425, P2854, DOI 10.1111/j.1365-2966.2012.21651.x; Marassi S, 2011, MON NOT R ASTRON SOC, V411, P2549, DOI 10.1111/j.1365-2966.2010.17861.x; Lodato G, 2006, MON NOT R ASTRON SOC, V371, P1813, DOI 10.1111/j.1365-2966.2006.10801.x; PACZYNSKI B, 1982, ASTROPHYS J, V253, P897, DOI 10.1086/159689; Abbott BP, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.102002; Ott CD, 2004, ASTROPHYS J, V600, P834, DOI 10.1086/379822; Yagi K, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.044011; Plowman JE, 2010, MON NOT R ASTRON SOC, V401, P2706, DOI 10.1111/j.1365-2966.2009.15853.x; Inayoshi K, 2012, MON NOT R ASTRON SOC, V422, P2539, DOI 10.1111/j.1365-2966.2012.20812.x; Pan Y, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.084006; Smith SC, 1996, ASTROPHYS J, V458, P236, DOI 10.1086/176807; Shibata M, 2002, ASTROPHYS J, V572, pL39, DOI 10.1086/341516; Ferrara A, 2014, MON NOT R ASTRON SOC, V443, P2410, DOI 10.1093/mnras/stu1280; Davis AJ, 2010, MON NOT R ASTRON SOC, V407, P691, DOI 10.1111/j.1365-2966.2010.16956.x; Yue B, 2013, MON NOT R ASTRON SOC, V433, P1556, DOI 10.1093/mnras/stt826; Schneider R, 2000, MON NOT R ASTRON SOC, V317, P385, DOI 10.1046/j.1365-8711.2000.03596.x; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Begelman MC, 2006, MON NOT R ASTRON SOC, V370, P289, DOI [10.1111/j.1365-2966.2006.10467.x, 10.1111/j.1365-2966.10467.x]; Nelemans G, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/9/094030; Yue B, 2014, MON NOT R ASTRON SOC, V440, P1263, DOI 10.1093/mnras/stu351; Machacek ME, 2001, ASTROPHYS J, V548, P509, DOI 10.1086/319014; Latif MA, 2013, MON NOT R ASTRON SOC, V433, P1607, DOI 10.1093/mnras/stt834; Ajith P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.241101; Sekiguchi Y, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.084013; Marassi S, 2009, MON NOT R ASTRON SOC, V398, P293, DOI 10.1111/j.1365-2966.2009.15120.x; Camp JB, 2004, ANNU REV NUCL PART S, V54, P525, DOI 10.1146/annurev.nucl.070103.181251; Reisswig C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.151101; BEGELMAN MC, 1982, ASTROPHYS J, V253, P873, DOI 10.1086/159688; Buonanno A, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.124018; Cappelluti N, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/68; Comastri A., 2015, A A L, V574L, P10; Consortium eLISA, 2013, PREPRINT ARXIV 1305; Crowder J, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.043008; Franci L, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.104028; Johnson JL, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/66; Kawamura S, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/9/094011; Moenchmeyer R., 1991, ASTRON ASTROPHYS, V246, P417; Regimbau T, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.122001; Sadowski A, 2009, ASTROPHYS J SUPPL S, V183, P171, DOI 10.1088/0067-0049/183/2/171; Sadowski A., 2011, PREPRINTV ARXIV E PR; SAENZ RA, 1978, ASTROPHYS J, V221, P286, DOI 10.1086/156028; Sathyaprakash BS, 2009, LIVING REV RELATIV, V12; Shapiro SL, 2003, AIP CONF PROC, V686, P50; SOLTAN A, 1982, MON NOT R ASTRON SOC, V200, P115; Volonteri M, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/94; Volonteri M, 2010, ASTR SOC P, V427, P3; Volonteri M., 2014, PREPRINT ARXIV E PRI; Yu QJ, 2002, MON NOT R ASTRON SOC, V335, P965, DOI 10.1046/j.1365-8711.2002.05532.x	74	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	MAY 1	2015	449	1					1076	1083		10.1093/mnras/stv317		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CJ2WO	WOS:000355345600077		
J	Martus, HJ; Hayashi, M; Honma, M; Kasper, P; Gollapudi, B; Mueller, L; Schoeny, R; Uno, Y; Kirkland, DJ				Martus, Hans-Joerg; Hayashi, Makoto; Honma, Masamitsu; Kasper, Peter; Gollapudi, Bhaskar; Mueller, Lutz; Schoeny, Rita; Uno, Yoshifumi; Kirkland, David J.			Summary of major conclusions from the 6th International Workshop on Genotoxicity Testing (IWGT), Foz do Iguacu, Brazil	MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS			English	Editorial Material						Genotoxicity; IWGT workshop 2014; Conclusions	ASSAY		[Martus, Hans-Joerg] Novartis Inst BioMed Res, Preclin Safety, CH-4002 Basel, Switzerland; [Hayashi, Makoto] Publ Interest Inc Fdn BioSafety Res Ctr, Iwata, Japan; [Honma, Masamitsu] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo 1588501, Japan; [Kasper, Peter] Fed Inst Drugs & Med Devices BfArM, Bonn, Germany; [Gollapudi, Bhaskar] Exponent Inc, Ctr Toxicol & Mechanist Biol, Midland, MI 48640 USA; [Mueller, Lutz] F Hoffmann La Roche & Cie AG, Pharmaceut Sci, Roche Innovat Ctr, CH-4070 Basel, Switzerland; [Schoeny, Rita] US EPA, Off Sci Policy, Off Res & Dev, Washington, DC 20460 USA; [Uno, Yoshifumi] Mitsubishi Tanabe Pharma Co, Safety Res Labs, Chiba 2920818, Japan; [Kirkland, David J.] Kirkland Consulting, Tadcaster LS24 0AS, England	Martus, HJ (reprint author), Novartis Inst BioMed Res, Preclin Safety, CH-4002 Basel, Switzerland.	Hansjoerg.Martus@Novartis.com					[Anonymous], 2011, OECD GUIDELINES TEST; [Anonymous], 1997, OECD GUIDELINES TEST; [Anonymous], 2014, OECD GUIDELINES TEST; Burlinson B, 2007, MUTAT RES-GEN TOX EN, V627, P31, DOI 10.1016/j.mrgentox.2006.08.011; Hayashi M, 2000, ENVIRON MOL MUTAGEN, V35, P234, DOI 10.1002/(SICI)1098-2280(2000)35:3<234::AID-EM10>3.0.CO;2-L; Dertinger SD, 2011, MUTAT RES-GEN TOX EN, V721, P163, DOI 10.1016/j.mrgentox.2011.01.009	6	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1383-5718	1879-3592		MUTAT RES-GEN TOX EN	Mutat. Res. Genet. Toxicol. Environ. Mutagen.	MAY 1	2015	783				SI		1	5		10.1016/j.mrgentox.2015.02.004		5	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CJ2YX	WOS:000355351700001		
J	Speit, G; Kojima, H; Burlinson, B; Collins, AR; Kasper, P; Plappert-Helbig, U; Uno, Y; Vasquez, M; Beevers, C; De Boeck, M; Escobark, PA; Kitamoto, S; Pant, K; Pfuhler, S; Tanaka, J; Levy, DD				Speit, Guenter; Kojima, Hajime; Burlinson, Brian; Collins, Andrew R.; Kasper, Peter; Plappert-Helbig, Ulla; Uno, Yoshifumi; Vasquez, Marie; Beevers, Carol; De Boeck, Marlies; Escobark, Patricia A.; Kitamoto, Sachiko; Pant, Kamala; Pfuhler, Stefan; Tanaka, Jin; Levy, Dan D.			Critical issues with the in vivo comet assay: A report of the comet assay working group in the 6th International Workshop on Genotoxicity Testing (IWGT)	MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS			English	Article						Genotoxicity testing; Laboratory proficiency; Test protocol; Tissue toxicity	DNA-DAMAGE; CELLS; RAT; REPAIR; RECOMMENDATIONS; CYTOTOXICITY; CARCINOGENS; VITRO; VARIABILITY; ORGANS	As a part of the 6th IWGT, an expert working group on the comet assay evaluated critical topics related to the use of the in vivo comet assay in regulatory genotoxicity testing. The areas covered were: identification of the domain of applicability and regulatory acceptance, identification of critical parameters of the protocol and attempts to standardize the assay, experience with combination and integration with other in vivo studies, demonstration of laboratory proficiency, sensitivity and power of the protocol used, use of different tissues, freezing of samples, and choice of appropriate measures of cytotoxicity. The standard protocol detects various types of DNA lesions but it does not detect all types of DNA damage. Modifications of the standard protocol may be used to detect additional types of specific DNA damage (e.g., cross-links, bulky adducts, oxidized bases). In addition, the working group identified critical parameters that should be carefully controlled and described in detail in every published study protocol. In vivo comet assay results are more reliable if they were obtained in laboratories that have demonstrated proficiency. This includes demonstration of adequate response to vehicle controls and an adequate response to a positive control for each tissue being examined. There was a general agreement that freezing of samples is an option but more data are needed in order to establish generally accepted protocols. With regard to tissue toxicity, the working group concluded that cytotoxicity could be a confounder of comet results. It is recommended to look at multiple parameters such as histopathological observations, organ-specific clinical chemistry as well as indicators of tissue inflammation to decide whether compound-specific toxicity might influence the result. The expert working group concluded that the alkaline in vivo comet assay is a mature test for the evaluation of genotoxicity and can be recommended to regulatory agencies for use. (C) 2014 Elsevier B.V. All rights reserved.	[Speit, Guenter] Univ Ulm, Inst Human Genet, D-89069 Ulm, Germany; [Kojima, Hajime] Natl Inst Hlth Sci, Japanese Ctr Validat Alternat Methods, Tokyo, Japan; [Burlinson, Brian] Huntingdon Life Sci, Huntingdon, England; [Collins, Andrew R.] Univ Oslo, Dept Nutr, Oslo, Norway; [Kasper, Peter] Fed Inst Drugs & Med Devices BfArM, Bonn, Germany; [Plappert-Helbig, Ulla] Novartis Inst BioMed Res, Preclin Safety, Basel, Switzerland; [Uno, Yoshifumi] Mitsubishi Tanabe Pharma Co, Chiba, Japan; [Vasquez, Marie] Helix3 Inc, RTP, Morrisville, NC USA; [Beevers, Carol] Covance Labs Ltd, Harrogate, Yorks, England; [De Boeck, Marlies] Janssen Res & Dev, Beerse, Belgium; [Escobark, Patricia A.] Boehringer Ingelheim Pharmaceut Inc, Nonclin Drug Safety, Ridgefield, CT 06877 USA; [Kitamoto, Sachiko] Sumitomo Chem Co Ltd, Osaka, Japan; [Pant, Kamala] BioReliance SAFC, Rockville, MD USA; [Pfuhler, Stefan] Procter & Gamble Co, Global Prod Stewardship, Mason, OH USA; [Tanaka, Jin] Public Interest Inc Fdn Biosafety Res Ctr, Shizuoka, Japan; [Levy, Dan D.] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA	Speit, G (reprint author), Univ Ulm, Inst Human Genet, D-89069 Ulm, Germany.	guenter.speit@uni-ulm.de					Anderson D, 1997, TERATOGEN CARCIN MUT, V17, P115, DOI 10.1002/(SICI)1520-6866(1997)17:3<115::AID-TCM3>3.3.CO;2-F; Pfuhler S, 1996, ENVIRON MOL MUTAGEN, V27, P196, DOI 10.1002/(SICI)1098-2280(1996)27:3<196::AID-EM4>3.0.CO;2-D; Rothfuss A, 2011, MUTAT RES-GEN TOX EN, V723, P108, DOI 10.1016/j.mrgentox.2010.12.005; Merk O, 1999, ENVIRON MOL MUTAGEN, V33, P167, DOI 10.1002/(SICI)1098-2280(1999)33:2<167::AID-EM9>3.0.CO;2-D; [Anonymous], 2014, REPORTS JACVAM INITI; Jackson P, 2012, NANOTOXICOLOGY, V6, P486, DOI 10.3109/17435390.2011.587902; Lorenzo Y, 2013, MUTAGENESIS, V28, P427, DOI 10.1093/mutage/get018; Rothfuss A, 2010, MUTAT RES-GEN TOX EN, V702, P40, DOI 10.1016/j.mrgentox.2010.07.006; [Anonymous], 2014, VIVO MAMMALIAN ALKAL; Bright J, 2011, PHARM STAT, V10, P485, DOI 10.1002/pst.530; Hartmann A, 2004, MUTAGENESIS, V19, P51, DOI 10.1093/mutage/geg038; Speit G, 2014, MUTAGENESIS, V29, P267, DOI 10.1093/mutage/geu015; Dusinska M, 2008, MUTAGENESIS, V23, P191, DOI 10.1093/mutage/gen007; Vasquez MZ, 2010, MUTAGENESIS, V25, P187, DOI 10.1093/mutage/gep060; Azqueta A, 2013, MUTAGENESIS, V28, P271, DOI 10.1093/mutage/get002; Ersson C, 2013, MUTAGENESIS, V28, P279, DOI 10.1093/mutage/get001; Azqueta A, 2011, MUTAGENESIS, V26, P393, DOI 10.1093/mutage/geq105; Vasquez MZ, 2012, MUTAT RES-GEN TOX EN, V747, P142, DOI 10.1016/j.mrgentox.2012.05.002; Forchhammer L, 2010, MUTAGENESIS, V25, P113, DOI 10.1093/mutage/gep048; Struwe M, 2008, PHOTOCH PHOTOBIO SCI, V7, P240, DOI 10.1039/b715756h; [Anonymous], 2014, PEER REV REPORT JACV; Burlinson B, 2007, MUTAT RES-GEN TOX EN, V627, P31, DOI 10.1016/j.mrgentox.2006.08.011; Smith CC, 2008, MUTAGENESIS, V23, P233, DOI 10.1093/mutage/gen008; Downs TR, 2012, MUTAT RES-GEN TOX EN, V745, P38, DOI 10.1016/j.mrgentox.2012.03.012; Johansson C, 2010, MUTAGENESIS, V25, P125, DOI 10.1093/mutage/gep055; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Guerard M, 2014, ENVIRON MOL MUTAGEN, V55, P114, DOI 10.1002/em.21835; Sekihashi K, 2002, MUTAT RES-GEN TOX EN, V517, P53, DOI 10.1016/S1383-5718(02)00034-7; Recio L, 2012, ENVIRON MOL MUTAGEN, V53, P101, DOI 10.1002/em.20694; Bowen DE, 2011, MUTAT RES-GEN TOX EN, V722, P7, DOI 10.1016/j.mrgentox.2011.02.009; Nesslany F, 2007, MUTAT RES-GEN TOX EN, V630, P28, DOI 10.1016/jmrgentox.2007.02.010; BrendlerSchwaab SY, 1997, MUTAT RES-GEN TOX EN, V393, P175, DOI 10.1016/S1383-5718(97)00106-X; Ding W, 2011, TOXICOL SCI, V123, P103, DOI 10.1093/toxsci/kfr153; Kirkland D, 2008, MUTAT RES-GEN TOX EN, V654, P114, DOI 10.1016/j.mrgentox.2008.05.002; Morita T, 1997, MUTAT RES-GEN TOX EN, V389, P3, DOI 10.1016/S1383-5718(96)00070-8; Neuss S, 2010, MUTAT RES-GEN TOX EN, V695, P61, DOI 10.1016/j.mrgentox.2009.12.001; Ryan TP, 2000, STAT METHODS QUALITY, V2nd; Sasaki YF, 2000, CRIT REV TOXICOL, V30, P629, DOI 10.1080/10408440008951123; SPEIT G, 1995, MUTAGENESIS, V10, P555, DOI 10.1093/mutage/10.6.555; Spelt G., 2007, MUTAGENESIS, V22, P387; Struwe M, 2009, J INVEST DERMATOL, V129, P699, DOI 10.1038/jid.2008.263; Toyoizumi T, 2011, MUTAT RES-GEN TOX EN, V726, P175, DOI 10.1016/j.mrgentox.2011.09.009; Uno Y., 2014, MUTAT RES UNPUB; van der Leede B.J., 2014, MUTAT RES IN PRESS; Wada K, 2012, MUTAT RES-GEN TOX EN, V742, P26, DOI 10.1016/j.mrgentox.2011.11.008; Wang A, 2007, MUTAT RES-GEN TOX EN, V634, P51, DOI 10.1016/j.nugentox.2007.06.004	46	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1383-5718	1879-3592		MUTAT RES-GEN TOX EN	Mutat. Res. Genet. Toxicol. Environ. Mutagen.	MAY 1	2015	783				SI		6	12		10.1016/j.mrgentox.2014.09.006		7	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CJ2YX	WOS:000355351700002		
J	Uno, Y; Morita, T; Luijten, M; Beevers, C; Hamada, S; Itoh, S; Ohyama, W; Takasawa, H				Uno, Yoshifumi; Morita, Takeshi; Luijten, Mirjam; Beevers, Carol; Hamada, Shuichi; Itoh, Satoru; Ohyama, Wakako; Takasawa, Hironao			Recommended protocols for the liver micronucleus test: Report of the IWGT working group	MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS			English	Article						Micronucleus test; Liver; Protocol; Rodent; IWGT	COLLABORATIVE STUDY-GROUP; MUTAGENICITY STUDY-GROUP; STUDY-GROUP MMS; CHROMOSOME-ABERRATION INDUCERS; YOUNG-RATS; BONE-MARROW; MOUSE-LIVER; PARTIAL-HEPATECTOMY; ADULT RATS; ASSAY	At the 6th International Workshop on Genotoxicity Testing (IWGT), the liver micronucleus test working group discussed practical aspects of the in vivo rodent liver micronucleus test (LMNT). The group members focused on the three methodologies currently used, i.e., a partial hepatectomy (PH) method, a juvenile/young rat (JR) method, and a repeated-dose (RD) method in adult rodents. Since the liver is the main organ that metabolizes chemicals, the LMNT is expected to detect clastogens, especially those that need metabolic activation in the liver, and aneugens. Based on current data the three methods seem to have a high sensitivity and specificity, but more data, especially on non-genotoxic but toxic substances, would be needed to fully evaluate the test performance. The three methods can be combined with the micronucleus test (MNT) using bone marrow (BM) and/or peripheral blood (PB). The ability of the PH method to detect both clastogens and aneugens has already been established, but the methodology is technically challenging. The JR method is relatively straightforward, but animal metabolism might not be fully comparable to adult animals, and data on aneugens are limited. These two methods also have the advantage of a short testing period. The RD method is also straightforward and can be integrated into repeated-dose (e.g. 2 or 4 weeks) toxicity studies, but again data on aneugens are limited. The working group concluded that the LMNT could be used as a second in vivo test when a relevant positive result in in vitro mammalian cell genotoxicity tests is noted (especially under the condition of metabolic activation), and a negative result is observed in the in vivo BM/PB-MNT. The group members discussed LMNT protocols and reached consensus about many aspects of test procedures. However, data gaps as mentioned above remain, and further data are needed to fully establish the LMNT protocol. (C) 2014 Elsevier B.V. All rights reserved.	[Uno, Yoshifumi] Mitsubishi Tanabe Pharma Co, Chiba, Japan; [Morita, Takeshi] Natl Inst Hlth Sci, Tokyo, Japan; [Luijten, Mirjam] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands; [Beevers, Carol] Covance Labs Ltd, Harrogate, N Yorkshire, England; [Hamada, Shuichi; Takasawa, Hironao] LSI Medience, Ibaraki, Japan; [Itoh, Satoru] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Ohyama, Wakako] Yakult Honsha Co Ltd, Tokyo, Japan	Uno, Y (reprint author), Mitsubishi Tanabe Pharma Co, Chiba, Japan.	Uno.Yoshifumi@ma.mt-pharma.co.jp					Rothfuss A, 2011, MUTAT RES-GEN TOX EN, V723, P108, DOI 10.1016/j.mrgentox.2010.12.005; [Anonymous], 1997, TEST 474 MAMMALIAN E; Suzuki H, 2005, MUTAT RES-GEN TOX EN, V583, P133, DOI 10.1016/j.mrgentox.2005.03.012; Rothfuss A, 2010, MUTAT RES-GEN TOX EN, V702, P40, DOI 10.1016/j.mrgentox.2010.07.006; [Anonymous], 2011, EC TRADE UPDATE, V8, P9; Narumi K, 2012, MUTAT RES-GEN TOX EN, V747, P234, DOI 10.1016/j.mrgentox.2012.05.012; Hayashi M, 2007, MUTAT RES-GEN TOX EN, V627, P10, DOI 10.1016/j.mrgentox.2006.08.010; Takasawa H, 2013, MUTAT RES-GEN TOX EN, V751, P12, DOI 10.1016/j.mrgentox.2012.10.004; [Anonymous], 2008, TEST 407 REPEATED DO; Udroiu I, 2006, ENVIRON MOL MUTAGEN, V47, P320, DOI 10.1002/em.20209; Takasawa H, 2010, MUTAT RES-GEN TOX EN, V698, P30, DOI 10.1016/j.mrgentox.2010.02.009; Morita T, 2011, MUTAGENESIS, V26, P223, DOI 10.1093/mutage/geq066; Takasawa H, 2010, MUTAT RES-GEN TOX EN, V698, P24, DOI 10.1016/j.mrgentox.2010.02.010; [Anonymous], 2011, TEST 488 TRANSGENIC; TATES AD, 1980, MUTAT RES, V74, P11, DOI 10.1016/0165-1161(80)90187-9; Igarashi M, 1997, MUTAT RES-GEN TOX EN, V391, P49, DOI 10.1016/S0165-1218(97)00031-1; Hayashi M, 2000, ENVIRON MOL MUTAGEN, V35, P234, DOI 10.1002/(SICI)1098-2280(2000)35:3<234::AID-EM10>3.0.CO;2-L; Suzuki H, 2009, MUTAGENESIS, V24, P9, DOI 10.1093/mutage/gen047; Narumi K, 2013, MUTAT RES-GEN TOX EN, V755, P100, DOI 10.1016/j.mrgentox.2013.03.012; BRAITHWAITE I, 1988, MUTAT RES, V203, P23, DOI 10.1016/0165-1161(88)90004-0; GEORGE E, 1991, CARCINOGENESIS, V12, P2233, DOI 10.1093/carcin/12.12.2233; Hamada S., 2014, MUTAT RES UNPUB; Igarashi M, 2010, J TOXICOL SCI, V35, P881, DOI 10.2131/jts.35.881; Igarashi M, 2007, MUTAT RES-GEN TOX EN, V632, P89, DOI 10.1016/j.mrgentox.2007.04.012; Ishii H., 2012, J TOXICOL SCI S, V37, P244; Itoh S, 2012, MUTAT RES-GEN TOX EN, V747, P98, DOI 10.1016/j.mrgentox.2012.04.007; Itoh S, 2012, TOXICOL LETT, V214, P296, DOI 10.1016/j.toxlet.2012.09.003; Morita T, 1997, MUTAT RES-GEN TOX EN, V391, P259; Ogawa I, 2015, MUTAT RES-GEN TOX EN, V780, P25, DOI 10.1016/j.mrgentox.2014.05.007; Parton JW, 1997, ENVIRON MOL MUTAGEN, V29, P379, DOI 10.1002/(SICI)1098-2280(1997)29:4<379::AID-EM6>3.0.CO;2-5; Roy SK, 2005, MUTAT RES-GEN TOX EN, V586, P28, DOI 10.1016/j.mrgentox.2005.05.007; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shimada K., 2013, 11 ICEM, P292; Suzuki H, 2004, CYTOGENET GENOME RES, V104, P299, DOI 10.1159/0077506; URYVAEVA IV, 1995, MUTAT RES-ENVIR MUTA, V334, P71, DOI 10.1016/0165-1161(95)90032-2	35	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1383-5718	1879-3592		MUTAT RES-GEN TOX EN	Mutat. Res. Genet. Toxicol. Environ. Mutagen.	MAY 1	2015	783				SI		13	18		10.1016/j.mrgentox.2014.10.010		6	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CJ2YX	WOS:000355351700003		
J	Uno, Y; Morita, T; Luijten, M; Beevers, C; Hamada, S; Itoh, S; Ohyama, W; Takasawa, H				Uno, Yoshifumi; Morita, Takeshi; Luijten, Mirjam; Beevers, Carol; Hamada, Shuichi; Itoh, Satoru; Ohyama, Wakako; Takasawa, Hironao			Micronucleus test in rodent tissues other than liver or erythrocytes: Report of the IWGT working group	MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS			English	Article						Micronucleus test; Stomach; Colon; Gastrointestinal (GI) tract; IWGT	IN-VIVO; BONE-MARROW; GLANDULAR STOMACH; EPITHELIAL-CELLS; COLON; ASSAY; MICE; 1,2-DIMETHYLHYDRAZINE; CARCINOGENS; VALIDATION	At the 6th International Workshop on Genotoxicity Testing, the liver micronucleus test (MNT) working group briefly discussed the MNT using tissues other than liver/erythrocytes. Many tissues other than liver/erythrocytes have been studied, primarily for research purposes. They have included the colon and intestinal epithelium, skin, spleen, lung, stomach, bladder, buccal mucosa, vagina, and fetal/neonatal tissues. These tissues were chosen because they were target sites of carcinogens, and/or relevant to a specific route of exposure. Recently, there has been particular focus on the gastrointestinal (GI) tract as it is a contact site associated with high exposure following oral gavage. Furthermore GI tumors are observed with high frequency in human populations. A collaborative study of the rat glandular stomach and colon MNT was conducted in conjunction with a collaborative study of the repeated-dose liver MNT. Based on limited data currently available, the rodent MNT using the glandular stomach and/or colon seems to detect genotoxic carcinogens with GI tract target-organ specificity. The working group concluded that the GI tract MNT would be a promising method to examine clastogenicity or aneugenicity of test chemicals in the stomach and/or colon. Further data will be needed to fully establish the methods, and to identify the sensitivity and specificity of the GI tract MNT. (C) 2015 Elsevier B.V. All rights reserved.	[Uno, Yoshifumi] Mitsubishi Tanabe Pharma Co, Chiba, Japan; [Morita, Takeshi] Natl Inst Hlth Sci, Tokyo, Japan; [Luijten, Mirjam] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Beevers, Carol] Covance Labs Ltd, Harrogate, Yorks, England; [Hamada, Shuichi; Takasawa, Hironao] LSI Medience, Ibaraki, Japan; [Itoh, Satoru] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Ohyama, Wakako] Yakult Honsha Co Ltd, Tokyo, Japan	Uno, Y (reprint author), Mitsubishi Tanabe Pharma Co, Chiba, Japan.	Uno.Yoshifumi@ma.mt-pharma.co.jp					[Anonymous], 2011, EC TRADE UPDATE, V8, P9; Bazin E, 2012, ENVIRON TOXICOL, V27, P277, DOI 10.1002/tox.20640; Hayashi M, 2007, MUTAT RES-GEN TOX EN, V627, P10, DOI 10.1016/j.mrgentox.2006.08.010; Morita T, 2011, MUTAGENESIS, V26, P223, DOI 10.1093/mutage/geq066; Uno Y, 2015, MUTAT RES-GEN TOX EN, V783, P13, DOI 10.1016/j.mrgentox.2014.10.010; Hayashi M, 2000, ENVIRON MOL MUTAGEN, V35, P234, DOI 10.1002/(SICI)1098-2280(2000)35:3<234::AID-EM10>3.0.CO;2-L; Le Hegarat L, 2006, ENVIRON TOXICOL, V21, P55, DOI 10.1002/tox.20154; Celik A, 2005, MUTAGENESIS, V20, P125, DOI 10.1093/mutage/gei020; Coffing S, 2011, ENVIRON MOL MUTAGEN, V52, P269, DOI 10.1002/em.20616; GOLDBERG MT, 1983, MUTAT RES, V109, P91, DOI 10.1016/0027-5107(83)90098-2; Hamada S., 2015, MUTAT RES IN PRESS; Ishidate Jr M, 1981, GANN MONOGR CANCER R, V27, P95; Ohyama W, 2002, MUTAT RES-GEN TOX EN, V518, P39, DOI 10.1016/S1383-5718(02)00061-X; Ohyama W, 2013, MUTAT RES-GEN TOX EN, V755, P141, DOI 10.1016/j.mrgentox.2013.06.016; Ohyama W., 1996, ENV MUTAGEN RES COMM, V17, P265; Okada E, 2013, MUTAT RES-GEN TOX EN, V758, P87, DOI 10.1016/j.mrgentox.2013.10.002; Okada E, 2008, MUTAT RES-GEN TOX EN, V657, P39, DOI 10.1016/j.mrgentox.2008.08.018; Poul M, 2009, FOOD CHEM TOXICOL, V47, P443, DOI 10.1016/j.fct.2008.11.034; Sycheva LP, 2000, B EXP BIOL MED+, V129, P581, DOI 10.1007/BF02434883; Sycheva LP, 2011, MUTAT RES-GEN TOX EN, V726, P8, DOI 10.1016/j.mrgentox.2011.07.010; Vanhauwaert A, 2001, MUTAGENESIS, V16, P39, DOI 10.1093/mutage/16.1.39; Zhurkov VS, 1996, MUTAT RES-GENET TOX, V368, P115, DOI 10.1016/0165-1218(95)00108-5	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1383-5718	1879-3592		MUTAT RES-GEN TOX EN	Mutat. Res. Genet. Toxicol. Environ. Mutagen.	MAY 1	2015	783				SI		19	22		10.1016/j.mrgentox.2015.03.001		4	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CJ2YX	WOS:000355351700004		
J	Gollapudi, BB; Lynch, AM; Heflich, RH; Dertinger, SD; Dobrovolsky, VN; Froetschl, R; Horibata, K; Kenyon, MO; Kimoto, T; Lovell, DP; Stankowski, LF; White, PA; Witt, KL; Tanir, JY				Gollapudi, B. Bhaskar; Lynch, Anthony M.; Heflich, Robert H.; Dertinger, Stephen D.; Dobrovolsky, Vasily N.; Froetschl, Roland; Horibata, Katsuyoshi; Kenyon, Michelle O.; Kimoto, Takafumi; Lovell, David P.; Stankowski, Leon F., Jr.; White, Paul A.; Witt, Kristine L.; Tanir, Jennifer Y.			The in vivo Pig-a assay: A report of the International Workshop On Genotoxicity Testing (IWGT) Workgroup	MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS			English	Article						Red blood cells; Reticulocytes; Glycosylphosphatidylinositol; Flow cytometry; CD59; Mutation	GENE MUTATION ASSAY; ETHYL-N-NITROSOUREA; RED-BLOOD-CELLS; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; SPLEEN T-CELLS; FLOW-CYTOMETRIC DETECTION; BONE-MARROW ERYTHROIDS; LESCH-NYHAN-SYNDROME; END-POINTS; 1,3-PROPANE SULTONE	The in vivo Pig-a assay uses flow cytometry to measure phenotypic variants for antibody binding to cell surface glycosylphosphatidylinositol (GPI)-anchored proteins. There is good evidence suggesting that the absence of antibody binding is the result of a mutation in the endogenous X-linked Pig-a gene, which forms the rationale for the assay. Although the assay has been performed with several types of hematopoietic cells and in a variety of mammalian species, including humans, currently it' is optimized only for measuring CD59-deficient (presumed Pig-a mutant) erythrocytes in the peripheral blood of rats. An expert workgroup formed by the International Workshop on Genotoxicity Testing considered the state of assay development and the potential of the assay for regulatory use. Consensus was reached on what is known about the Pig-a assay and how it should be conducted, and recommendations were made on additional data and refinements that would help to further enhance the assay for use in hazard identification and risk assessment. Published by Elsevier B.V.	[Gollapudi, B. Bhaskar] Exponent, Midland, MI USA; [Lynch, Anthony M.] GlaxoSmithKline, Stevenage, Herts, England; [Heflich, Robert H.; Dobrovolsky, Vasily N.] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Dertinger, Stephen D.] Litron Labs, Rochester, NY USA; [Froetschl, Roland] Fed Inst Drugs & Med Devices, Bonn, Germany; [Horibata, Katsuyoshi] Natl Inst Hlth Sci, Tokyo, Japan; [Kenyon, Michelle O.] Pfizer Global Res & Dev, Groton, CT USA; [Kimoto, Takafumi] Teijin Pharma, Tokyo, Japan; [Lovell, David P.] Univ London, London WC1E 7HU, England; [Stankowski, Leon F., Jr.] BioReliance, Rockville, MD USA; [White, Paul A.] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Witt, Kristine L.] NIEHS, NIH, Div Natl Toxicol Program, Res Triangle Pk, NC 27709 USA; [Tanir, Jennifer Y.] Hlth & Environm Sci Inst, Washington, DC USA	Heflich, RH (reprint author), US FDA, Natl Ctr Toxicol Res, 3900 NCTR Rd, Jefferson, AR 72079 USA.	robert.heflich@fda.hhs.gov			National Institute of Health/National Institute of Environmental Health Sciences (NIEHS) [R44ES021973]	The views expressed in this report are not necessarily shared by the institutions at which the workgroup members are employed. The information in these materials is not a formal dissemination of information by the U.S. Food and Drug Administration and does not represent agency position or policy. Data presented in this communication were partially funded by a grant from the National Institute of Health/National Institute of Environmental Health Sciences (NIEHS; grant no. R44ES021973). The contents of this report are solely the responsibility of the authors, and do not necessarily represent the official views of the NIEHS.	Torous DK, 2012, ENVIRON MOL MUTAGEN, V53, P420, DOI 10.1002/em.21709; Dobrovolsky VN, 2009, MUTAT RES-GEN TOX EN, V673, P21, DOI 10.1016/j.mrgentox.2008.11.006; Dertinger SD, 2011, ENVIRON MOL MUTAGEN, V52, P690, DOI 10.1002/em.20672; Phonethepswath S, 2010, TOXICOL SCI, V114, P59, DOI 10.1093/toxsci/kfp289; Dertinger SD, 2011, ENVIRON MOL MUTAGEN, V52, P748, DOI 10.1002/em.20671; Dobrovolsky VN, 2010, ENVIRON MOL MUTAGEN, V51, P825, DOI 10.1002/em.20627; Dertinger SD, 2014, ENVIRON MOL MUTAGEN, V55, P299, DOI 10.1002/em.21846; Guerard M, 2013, TOXICOL SCI, V135, P309, DOI 10.1093/toxsci/kft148; Miura D, 2008, ENVIRON MOL MUTAGEN, V49, P622, DOI 10.1002/em.20413; Cammerer Z, 2011, ENVIRON MOL MUTAGEN, V52, P721, DOI 10.1002/em.20686; Bhalli JA, 2011, ENVIRON MOL MUTAGEN, V52, P731, DOI 10.1002/em.20675; Phonethepswath S, 2008, MUTAT RES-GEN TOX EN, V657, P122, DOI 10.1016/j.mrgentox.2008.08.011; Dobrovolsky VN, 2011, ENVIRON MOL MUTAGEN, V52, P784, DOI 10.1002/em.20667; Miura D, 2008, ENVIRON MOL MUTAGEN, V49, P614, DOI 10.1002/em.20414; McDaniel LP, 2012, MUTAT RES-GEN TOX EN, V742, P72, DOI 10.1016/j.mrgentox.2011.12.011; Kimoto T, 2011, MUTAT RES-GEN TOX EN, V723, P36, DOI 10.1016/j.mrgentox.2011.03.016; Mortazavi Y, 2003, BLOOD, V101, P2833, DOI 10.1182/blood-2002-07-2095; Araten DJ, 1999, P NATL ACAD SCI USA, V96, P5209, DOI 10.1073/pnas.96.9.5209; Bryce SM, 2008, ENVIRON MOL MUTAGEN, V49, P256, DOI 10.1002/em.20379; Nafa K, 1998, BLOOD CELL MOL DIS, V24, P370, DOI 10.1006/bcmd.1998.0203; Lemieux CL, 2011, ENVIRON MOL MUTAGEN, V52, P756, DOI 10.1002/em.20688; Miura D, 2011, ENVIRON MOL MUTAGEN, V52, P419, DOI 10.1002/em.20654; WARE RE, 1995, BLOOD, V86, P1586; Dertinger SD, 2011, ENVIRON MOL MUTAGEN, V52, P681, DOI 10.1002/em.20685; Kimoto T, 2013, MUTAT RES-GEN TOX EN, V755, P126, DOI 10.1016/j.mrgentox.2013.06.006; ROSSE WF, 1995, BLOOD, V86, P3277; Peruzzi B, 2010, MUTAT RES-REV MUTAT, V705, P3, DOI 10.1016/j.mrrev.2009.12.004; Dobrovolsky VN, 2010, ENVIRON MOL MUTAGEN, V51, P138, DOI 10.1002/em.20519; Schuler M, 2011, ENVIRON MOL MUTAGEN, V52, P685, DOI 10.1002/em.20687; Aral B, 1996, HUM MUTAT, V7, P52, DOI 10.1002/(SICI)1098-1004(1996)7:1<52::AID-HUMU7>3.0.CO;2-R; Avlasevich SL, 2014, ENVIRON MOL MUTAGEN, V55, P400, DOI 10.1002/em.21862; Bhalli JA, 2011, ENVIRON MOL MUTAGEN, V52, P766, DOI 10.1002/em.20682; Bhalli JA, 2013, MUTAGENESIS, V28, P447, DOI 10.1093/mutage/get022; Bhalli JA, 2013, MUTAT RES-GEN TOX EN, V753, P82, DOI 10.1016/j.mrgentox.2013.03.002; Custer L.L., 2012, ANN M GEN TOX ASS OC; DEMARINI DM, 1989, MUTAT RES, V220, P11, DOI 10.1016/0165-1110(89)90006-7; Dertinger SD, 2011, MUTAT RES-GEN TOX EN, V721, P163, DOI 10.1016/j.mrgentox.2011.01.009; Dertinger SD, 2012, TOXICOL SCI, V130, P328, DOI 10.1093/toxsci/kfs258; Dertinger SD, 2014, TOXICOL SCI, V140, P307, DOI 10.1093/toxsci/kfu078; Dertinger SD, 2010, TOXICOL SCI, V115, P401, DOI 10.1093/toxsci/kfq070; Dobo KL, 2011, MUTAT RES-GEN TOX EN, V725, P13, DOI 10.1016/j.mrgentox.2011.06.005; Dobrovolsky VN, 2000, ENVIRON MOL MUTAGEN, V36, P283, DOI 10.1002/1098-2280(2000)36:4<283::AID-EM4>3.0.CO;2-8; Dobrovolsky VN, 2002, ENVIRON MOL MUTAGEN, V39, P342, DOI 10.1002/em.10074; Dobrovolsky VN, 2012, ENVIRON MOL MUTAGEN, V53, P440, DOI 10.1002/em.21704; Fiedler RD, 2010, MUTAT RES-GEN TOX EN, V703, P122, DOI 10.1016/j.mrgentox.2010.08.006; Hayashi M, 2011, MUTAT RES-GEN TOX EN, V723, P87, DOI 10.1016/j.mrgentox.2010.09.007; Kimoto T, 2012, J TOXICOL SCI, V37, P943; Kimoto T, 2011, ENVIRON MOL MUTAGEN, V52, P774, DOI 10.1002/em.20677; Kinoshita T, 1995, ADV IMMUNOL, V60, P57, DOI 10.1016/S0065-2776(08)60584-2; Lambert Iain B, 2005, Mutat Res, V590, P1, DOI 10.1016/j.mrrev.2005.04.002; Lynch AM, 2011, ENVIRON MOL MUTAGEN, V52, P699, DOI 10.1002/em.20691; Miura D, 2009, MUTAT RES-GEN TOX EN, V677, P86, DOI 10.1016/j.mrgentox.2009.05.014; OECD, 2008, OECD GUID TEST CHEM; OECD, 2005, ENVJMMONO200514 OECD; OECD Guidelines for the Testing of Chemicals Test, 1998, OECD GUID TEST CHEM; Organization for Economic Cooperation and Development (OECD), 2013, GUID TEST CHEM TRANS; Puig JG, 1998, EUR J CLIN INVEST, V28, P950; Roberts D.J., 2012, ENVIRON MOL MUTAGEN, V53, pS54; ROBINSON DR, 1994, MUTAT RES-ENVIR MUTA, V313, P227, DOI 10.1016/0165-1161(94)90053-1; Shi J, 2011, ENVIRON MOL MUTAGEN, V52, P711, DOI 10.1002/em.20678; Stankowski Jr L.F., 2011, ENVIRON MOL MUTAGEN, V52, pS60; Stankowski Jr L.F., 2013, ENVIRON MOL MUTAGEN, V54, pS47; Stankowski LF, 2011, ENVIRON MOL MUTAGEN, V52, P738, DOI 10.1002/em.20692; Torres RJ, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-48; Tweats DJ, 2007, MUTAT RES-GEN TOX EN, V627, P92, DOI 10.1016/j.mrgentox.2006.10.006; Walker VE, 1999, MUTAT RES-FUND MOL M, V431, P371, DOI 10.1016/S0027-5107(99)00180-3	66	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1383-5718	1879-3592		MUTAT RES-GEN TOX EN	Mutat. Res. Genet. Toxicol. Environ. Mutagen.	MAY 1	2015	783				SI		23	35		10.1016/j.mrgentox.2014.09.007		13	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CJ2YX	WOS:000355351700005		
J	Yauk, CL; Aardema, MJ; van Benthem, J; Bishop, JB; Dearfield, KL; DeMarini, DM; Dubrova, YE; Honma, M; Lupski, JR; Marchetti, F; Meistrich, ML; Pacchierotti, F; Stewart, J; Waters, MD; Douglas, GR				Yauk, Carole L.; Aardema, Marilyn J.; van Benthem, Jan; Bishop, Jack B.; Dearfield, Kerry L.; DeMarini, David M.; Dubrova, Yuri E.; Honma, Masamitsu; Lupski, James R.; Marchetti, Francesco; Meistrich, Marvin L.; Pacchierotti, Francesca; Stewart, Jane; Waters, Michael D.; Douglas, George R.			Approaches for identifying germ cell mutagens: Report of the 2013 IWGT workshop on germ cell assays	MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS			English	Review						Germ cell mutation; Genetic disease; Reproductive health; Copy number variants; Gene; mutation; Chromosome aberrations	COPY-NUMBER VARIANTS; BLOOD-TESTIS BARRIER; MARROW MICRONUCLEUS TEST; REPRODUCTIVE END-POINTS; DOMINANT LETHAL ASSAY; SPERM DNA-DAMAGE; RISK-ASSESSMENT; BONE-MARROW; HUMAN GENOME; IN-VIVO	This workshop reviewed the current science to inform and recommend the best evidence-based approaches on the use of germ cell genotoxicity tests. The workshop questions and key outcomes were as follows. (1) Do genotoxicity and mutagenicity assays in somatic cells predict germ cell effects? Limited data suggest that somatic cell tests detect most germ cell mutagens, but there are strong concerns that dictate caution in drawing conclusions. (2) Should germ cell tests be done, and when? If there is evidence that a chemical or its metabolite(s) will not reach target germ cells or gonadal tissue, it is not necessary to conduct germ cell tests, notwithstanding somatic outcomes. However,,it was recommended that negative somatic cell mutagens with clear evidence for gonadal exposure and evidence of toxicity in germ cells could be considered for germ cell mutagenicity testing. For somatic mutagens that are known to reach the gonadal compartments and expose germ cells, the chemical could be assumed to be a germ cell mutagen without further testing. Nevertheless, germ cell mutagenicity testing would be needed for quantitative risk assessment. (3) What new assays should be implemented and how? There is an immediate need for research on the application of whole genome sequencing in heritable mutation analysis in humans and animals, and integration of germ cell assays with somatic cell genotoxicity tests. Focus should be on environmental exposures that can cause de novo mutations, particularly newly recognized types of genomic changes. Mutational events, which may occur by exposure of germ cells during embryonic development, should also be investigated. Finally, where there are indications of germ cell toxicity in repeat dose or reproductive toxicology tests, consideration should be given to leveraging those studies to inform of possible germ cell genotoxicity. Crown Copyright (C) 2015 Published by Elsevier B.V.	[Yauk, Carole L.; Marchetti, Francesco; Douglas, George R.] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Aardema, Marilyn J.] Marilyn Aardema Consulting, Fairfield, OH USA; [van Benthem, Jan] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Bishop, Jack B.] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA; [Dearfield, Kerry L.] USDA, Food Safety & Inspect Serv, Washington, DC 20250 USA; [DeMarini, David M.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Dubrova, Yuri E.] Univ Leicester, Leicester LE1 7RH, Leics, England; [Honma, Masamitsu] Natl Inst Hlth Sci, Tokyo, Japan; [Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Meistrich, Marvin L.] Univ Texas MD Anderson Canc Ctr, Houston, TX USA; [Marchetti, Francesco] Italian Natl Agcy New Technol, ENEA, Energy & Sustainable Econ Dev, Milan, Italy; [Stewart, Jane] AstraZeneca, Bangalore, Karnataka, India; [Waters, Michael D.] Integrated Lab Syst Inc, Res Triangle Pk, NC USA	Yauk, CL (reprint author), Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada.	Carole.Yauk@hc-sc.gc.ca; George.Douglas@hc-sc.gc.ca		Dubrova, Yuri/0000-0001-5281-7539; Yauk, Carole/0000-0003-4919-876X; Marchetti, Francesco/0000-0002-9435-4867	IWGT	Funding for this workshop was provided by the IWGT.	ADLER ID, 1994, MUTAT RES-FUND MOL M, V309, P295, DOI 10.1016/0027-5107(94)90105-8; ADLER ID, 1988, MUTAT RES, V206, P379, DOI 10.1016/0165-1218(88)90124-3; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; GORCZYCA W, 1993, CANCER RES, V53, P1945; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Marchetti F, 2011, P NATL ACAD SCI USA, V108, P12811, DOI 10.1073/pnas.1106896108; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Robbins WA, 1997, NAT GENET, V16, P74, DOI 10.1038/ng0597-74; Robinson L, 2012, HUM REPROD, V27, P2908, DOI 10.1093/humrep/des261; AMES BN, 1973, P NATL ACAD SCI USA, V70, P2281, DOI 10.1073/pnas.70.8.2281; Verhofstad N, 2008, MUTAGENESIS, V23, P241, DOI 10.1093/mutage/gen022; Eastmond DA, 2009, MUTAGENESIS, V24, P341, DOI 10.1093/mutage/gep014; Ku CS, 2013, J MED GENET, V50, P203, DOI 10.1136/jmedgenet-2013-101519; Davis AP, 1998, GENETICS, V148, P7; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Aitken RJ, 2009, INT J ANDROL, V32, P46, DOI 10.1111/j.1365-2605.2008.00943.x; Dertinger SD, 2011, MUTAGENESIS, V26, P139, DOI 10.1093/mutage/geq055; Frias S, 2003, CANCER RES, V63, P44; Allard P, 2010, P NATL ACAD SCI USA, V107, P20405, DOI 10.1073/pnas.1010386107; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Lewis SEM, 2010, HUM FERTIL, V13, P201, DOI 10.3109/14647273.2010.528823; Gilissen C, 2014, NATURE, V511, P344, DOI 10.1038/nature13394; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Liu PF, 2012, CURR OPIN GENET DEV, V22, P211, DOI 10.1016/j.gde.2012.02.012; VANZEELAND AA, 1990, MUTAT RES, V231, P55, DOI 10.1016/0027-5107(90)90176-5; DeMarini DM, 2012, ENVIRON MOL MUTAGEN, V53, P166, DOI 10.1002/em.21685; Azqueta A, 2013, ARCH TOXICOL, V87, P949, DOI 10.1007/s00204-013-1070-0; Oostlander AE, 2004, CLIN GENET, V66, P488, DOI 10.1111/j.1399-0004.2004.00322.x; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Lupski JR, 2010, NAT GENET, V42, P1036, DOI 10.1038/ng1210-1036; Beal MA, 2012, MUTAT RES-REV MUTAT, V750, P96, DOI 10.1016/j.mrrev.2011.11.002; FAVOR J, 1995, MUTAT RES-FUND MOL M, V330, P23, DOI 10.1016/0027-5107(93)E0261-N; Haines GA, 2002, BIOL REPROD, V67, P854, DOI 10.1095/biolreprod.102.004382; Robbins WA, 1997, ENVIRON MOL MUTAGEN, V30, P175, DOI 10.1002/(SICI)1098-2280(1997)30:2<175::AID-EM10>3.0.CO;2-A; Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939; Yauk CL, 2007, CANCER RES, V67, P5103, DOI 10.1158/0008-5472.CAN-07-0279; Singer TM, 2010, ENVIRON MOL MUTAGEN, V51, P919, DOI 10.1002/em.20613; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; D'Onofrio BM, 2014, JAMA PSYCHIAT, V71, P432, DOI 10.1001/jamapsychiatry.2013.4525; Aitken RJ, 2013, MOL HUM REPROD, V19, P475, DOI 10.1093/molehr/gat025; SETCHELL BP, 1980, J ANDROL, V1, P3; Morita T, 2011, MUTAGENESIS, V26, P223, DOI 10.1093/mutage/geq066; Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Gollapudi BB, 2013, ENVIRON MOL MUTAGEN, V54, P8, DOI 10.1002/em.21727; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Haines GA, 2001, MUTAT RES-GEN TOX EN, V495, P21, DOI 10.1016/S1383-5718(01)00181-4; Barnett LB, 2002, ENVIRON MOL MUTAGEN, V40, P251, DOI 10.1002/em.10114; Vilarino-Guell C, 2003, MUTAT RES-FUND MOL M, V526, P63, DOI 10.1016/S0027-5107(03)00016-2; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; van Delft JHM, 1998, MUTAT RES-GEN TOX EN, V415, P85, DOI 10.1016/S1383-5718(98)00063-1; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; OKUMURA K, 1975, J PHARMACOL EXP THER, V194, P89; Girirajan S, 2010, HUM MOL GENET, V19, pR176, DOI 10.1093/hmg/ddq366; Schulte RT, 2010, J ASSIST REPROD GEN, V27, P3, DOI 10.1007/s10815-009-9359-x; EHLING UH, 1988, RISK ANAL, V8, P45, DOI 10.1111/j.1539-6924.1988.tb01153.x; Cordelli E, 2012, ENVIRON MOL MUTAGEN, V53, P429, DOI 10.1002/em.21703; Knight AW, 2009, REGUL TOXICOL PHARM, V55, P188, DOI 10.1016/j.yrtph.2009.07.004; Avlasevich SL, 2006, ENVIRON MOL MUTAGEN, V47, P56, DOI 10.1002/em.20170; Arlt MF, 2014, ENVIRON MOL MUTAGEN, V55, P103, DOI 10.1002/em.21840; Marchetti F, 2004, BIOL REPROD, V70, P616, DOI 10.1095/biolreprod.103.023044; Hayashi M, 2000, ENVIRON MOL MUTAGEN, V35, P234, DOI 10.1002/(SICI)1098-2280(2000)35:3<234::AID-EM10>3.0.CO;2-L; Campbell CD, 2013, TRENDS GENET, V29, P575, DOI 10.1016/j.tig.2013.04.005; Cimino MC, 2006, ENVIRON MOL MUTAGEN, V47, P362, DOI 10.1002/em.20216; Somers CM, 2002, P NATL ACAD SCI USA, V99, P15904, DOI 10.1073/pnas.252499499; Moller P, 2000, CANCER EPIDEM BIOMAR, V9, P1005; Allard P, 2013, ENVIRON HEALTH PERSP, V121, P717, DOI 10.1289/ehp.1206301; Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Dittwald P, 2013, GENOME RES, V23, P1395, DOI 10.1101/gr.152454.112; Yauk CL, 2002, MUTAT RES-FUND MOL M, V500, P147, DOI 10.1016/S0027-5107(02)00005-2; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Barber RC, 2009, MUTAT RES-FUND MOL M, V664, P6, DOI 10.1016/j.mrfmmm.2009.01.011; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Witt KL, 2003, ENVIRON MOL MUTAGEN, V41, P111, DOI 10.1002/em.10139; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; Arlt MF, 2011, P NATL ACAD SCI USA, V108, P17360, DOI 10.1073/pnas.1109272108; Armour JAL, 1999, MUTAT RES-GEN TOX EN, V445, P73, DOI 10.1016/S1383-5718(99)00144-8; Beal MA, 2012, ENVIRON MOL MUTAGEN, V53, P599, DOI 10.1002/em.21726; Bois P, 1998, GENOMICS, V49, P122, DOI 10.1006/geno.1998.5228; Boone PM, 2013, GENET MED, V15, P45, DOI 10.1038/gim.2012.95; BREWEN JG, 1975, MUTAT RES, V33, P239, DOI 10.1016/0027-5107(75)90200-6; Campbell IM, 2014, AM J HUM GENET, V95, P345, DOI 10.1016/j.ajhg.2014.08.010; Chapin RE, 1998, REPROD TOXICOL, V12, P489, DOI 10.1016/S0890-6238(98)00026-4; Chapin RE, 1997, FUND APPL TOXICOL, V38, P129, DOI 10.1006/faat.1997.2341; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; CLIET I, 1993, MUTAT RES, V292, P105, DOI 10.1016/0165-1161(93)90137-O; Cosentino L, 2000, MUTAT RES-FUND MOL M, V454, P1, DOI 10.1016/S0027-5107(00)00125-1; Dubrova YE, 2002, AM J HUM GENET, V71, P801, DOI 10.1086/342729; DUBROVA YE, 1993, NAT GENET, V5, P92, DOI 10.1038/ng0993-92; Dubrova YE, 2002, SCIENCE, V295, P1037, DOI 10.1126/science.1068102; Dubrova YE, 2000, MUTAT RES-FUND MOL M, V453, P17, DOI 10.1016/S0027-5107(00)00068-3; Dubrova YE, 1998, P NATL ACAD SCI USA, V95, P6251, DOI 10.1073/pnas.95.11.6251; DYM M, 1973, ANAT REC, V175, P639, DOI 10.1002/ar.1091750402; Dym M, 1970, Biology Reprod., V3, P308; Evenson DP, 2013, METHOD MOL BIOL, V92, P147, DOI DOI 10.1007/978-1-62703-038-0_; EVENSON DP, 1980, SCIENCE, V210, P1131, DOI 10.1126/science.7444440; FAN YJ, 1995, INT J RADIAT BIOL, V68, P177, DOI 10.1080/09553009514551081; Glen CD, 2008, CANCER RES, V68, P3630, DOI 10.1158/0008-5472.CAN-08-0484; GREEN S, 1987, MUTAT RES, V189, P167, DOI 10.1016/0165-1218(87)90022-X; Groen JN, 2014, INT J BIOCHEM CELL B, V54, P350, DOI 10.1016/j.biocel.2014.05.008; GULATI DK, 1991, FUND APPL TOXICOL, V17, P270, DOI 10.1016/0272-0590(91)90218-S; Guo CH, 2005, ENVIRON TOXICOL PHAR, V20, P135, DOI 10.1016/j.etap.2004.11.007; Hardwick RJ, 2009, MOL BIOL EVOL, V26, P2647, DOI 10.1093/molbev/msp182; Hurles M, 2012, NAT GENET, V44, P1174, DOI 10.1038/ng.2448; ICH, 2011, UID GEN TESTS DAT IN; ICH, 2005, DET TOX REP MED PROD; JAGETIA GC, 1993, RADIAT ENVIRON BIOPH, V32, P109, DOI 10.1007/BF01212797; Johnson GE, 2014, ENVIRON MOL MUTAGEN, V55, P609, DOI 10.1002/em.21870; Lambert Iain B, 2005, Mutat Res, V590, P1, DOI 10.1016/j.mrrev.2005.04.002; LEVINE N, 1975, J REPROD FERTIL, V43, P547; Linschooten JO, 2013, FASEB J, V27, P2873, DOI 10.1096/fj.13-227694; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; MacGregor JT, 2015, MUTAT RES-GEN TOX EN, V783, P66, DOI 10.1016/j.mrgentox.2014.10.008; MacGregor JT, 2015, MUTAT RES-GEN TOX EN, V783, P55, DOI 10.1016/j.mrgentox.2014.09.011; Marchetti Francesco, 2005, Birth Defects Res C Embryo Today, V75, P112, DOI 10.1002/bdrc.20040; Marchetti Francesco, 2003, Adv Exp Med Biol, V518, P131; MATSUDA Y, 1989, MUTAT RES, V211, P65, DOI 10.1016/0027-5107(89)90107-3; May CA, 2000, MUTAT RES-FUND MOL M, V453, P67, DOI 10.1016/S0027-5107(00)00085-3; McLay RN, 1997, BIOL REPROD, V57, P822, DOI 10.1095/biolreprod57.4.822; MEISTRICH ML, 1993, HUM REPROD, V8, P8; Mitchard T, 2012, BIRTH DEFECTS RES B, V95, P410, DOI 10.1002/bdrb.21030; OECD, 2001, TEST 416 2 GEN REPR; OECD, 1995, TEST 421 REPR DEV KT; OECD, 2001, TEST 422 COMB REP DO; OECD, 2001, TEST 414 PREN DEV TO; OECD, 1997, TEST 483 AMAMM SPERM; OECD, 2009, ENVJMMONO20097 OECD; OECD, 2011, EXT ON GEN REPR TOX, V443; OECD, 1984, TEST 478 ROD DOM LET; OECD, 2011, SER TEST ASS, V117; OECD, 1986, TEST 485 MOUS HER TR; OECD, 2014, TEST 489 VIVO MAMM A; OECD, 2001, TEST 408 REP DOS 90; OECD, 2013, TEST 488 TRANSG KROD; OECD Guidelines, 2001, OECD GUID TEST CHEM; PACCHIEROTTI F, 1994, MUTAT RES-FUND MOL M, V309, P273, DOI 10.1016/0027-5107(94)90102-3; Pham J, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.285; RUSSELL LB, 1980, MUTAT RES, V75, P279, DOI 10.1016/0165-1110(80)90030-5; SEGA GA, 1974, P NATL ACAD SCI USA, V71, P4955, DOI 10.1073/pnas.71.12.4955; SEGA GA, 1978, MUTAT RES, V52, P87; Shanks M, 2008, MUTAT RES-FUND MOL M, V641, P58, DOI 10.1016/j.mrfmmm.2008.03.006; Shen YP, 2009, CLIN CHEM, V55, P659, DOI 10.1373/clinchem.2008.112821; Sills E Scott, 2004, J Obstet Gynaecol, V24, P74; Simon Luke, 2013, Methods Mol Biol, V927, P137; Singer TM, 2006, MUTAT RES-FUND MOL M, V598, P164, DOI 10.1016/j.mrfmmm.2006.01.017; Sobels F., 1982, PARALLELOGRAM INDIRE, P323; Somers CM, 2004, SCIENCE, V304, P1008, DOI 10.1126/science.1095815; Spelt G., 2009, MUTAT RES, V681, P3; TANAKA N, 1981, CYTOGENET CELL GENET, V31, P145, DOI 10.1159/000131640; TATES AD, 1992, MUTAGENESIS, V7, P411, DOI 10.1093/mutage/7.6.411; TURNER TT, 1995, J ANDROL, V16, P417; UN, 2013, GLOB HARM SYST CLASS; U.S. EPA, 2012, EPA100R12001; Waites G M, 1973, Adv Biosci, V10, P101; WATERS MD, 1994, MUTAT RES-GENET TOX, V341, P109, DOI 10.1016/0165-1218(94)90093-0; Wijnholds J, 1998, J EXP MED, V188, P797, DOI 10.1084/jem.188.5.797; Wiszniewska J, 2014, EUR J HUM GENET, V22, P79, DOI 10.1038/ejhg.2013.77; Wyrobek AJ, 2005, ENVIRON MOL MUTAGEN, V45, P271, DOI 10.1002/em.20121; Yank C., 2008, P NATL ACAD SCI USA, V105, P605; Yauk CL, 2013, MUTAT RES-REV MUTAT, V752, P6, DOI 10.1016/j.mrrev.2012.08.002	165	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1383-5718	1879-3592		MUTAT RES-GEN TOX EN	Mutat. Res. Genet. Toxicol. Environ. Mutagen.	MAY 1	2015	783				SI		36	54		10.1016/j.mrgentox.2015.01.008		19	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CJ2YX	WOS:000355351700006		
J	MacGregor, JT; Frotschl, R; White, PA; Crump, KS; Eastmond, DA; Fukushima, S; Gueard, M; Hayashi, M; Soeteman-Hernadez, LG; Kasamatsu, T; Levy, DD; Morita, T; Muller, L; Schoeny, R; Schuler, MJ; Thybaud, V; Johnson, GE				MacGregor, James T.; Froetschl, Roland; White, Paul A.; Crump, Kenny S.; Eastmond, David A.; Fukushima, Shoji; Guerard, Melanie; Hayashi, Makoto; Soeteman-Hernandez, Lya G.; Kasamatsu, Toshio; Levy, Dan D.; Morita, Takeshi; Mueller, Lutz; Schoeny, Rita; Schuler, Maik J.; Thybaud, Veronique; Johnson, George E.			IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs)	MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS			English	Article						Genotoxicity; Quantitative risk assessment; Points of departure; Benchmark dose	PREDICTING RODENT CARCINOGENICITY; GENETIC TOXICITY ASSAYS; CONTINUOUS END-POINTS; THRESHOLD; TOXICOLOGY; POTENCY; CHEMICALS; LIMITS	This report summarizes the discussion, conclusions, and points of consensus of the IWGT Working Group on Quantitative Approaches to Genetic Toxicology Risk Assessment (QWG) based on a meeting in Foz do Iguacu, Brazil October 31 November 2, 2013. Topics addressed included (1) the need for quantitative dose response analysis, (2) methods to analyze exposure response relationships & derive point of departure (PoD) metrics, (3) points of departure (PoD) and mechanistic threshold considerations, (4) approaches to define exposure-related risks, (5) empirical relationships between genetic damage (mutation) and cancer, and (6) extrapolations across test systems and species. This report discusses the first three of these topics and a companion report discusses the latter three. The working group critically examined methods for determining point of-departure metrics (PoDs) that could be used to estimate low-dose risk of genetic damage and from which extrapolation to acceptable exposure levels could be made using appropriate mode of action information and uncertainty factors. These included benchmark doses (BMDs) derived from fitting families of exponential models, the No Observed Genotoxic Effect Level (NOGEL), and "threshold" or breakpoint dose (BPD) levels derived from bilinear models when mechanistic data supported this approach. The QWG recognizes that scientific evidence suggests that thresholds below which genotoxic effects do not occur likely exist for both DNA-reactive and DNA-nonreactive substances, but notes that small increments of the spontaneous level cannot be unequivocally excluded either by experimental measurement or by mathematical modeling. Therefore, rather than debating the theoretical possibility of such low-dose effects, emphasis should be placed on determination of PoDs from which acceptable exposure levels can be determined by extrapolation using available mechanistic information and appropriate uncertainty factors. This approach places the focus on minimization of the genotoxic risk, which protects against the risk of the development of diseases resulting from the genetic damage. Based on analysis of the strengths and weaknesses of each method, the QWG concluded that the order of preference of PoD metrics is the statistical lower bound on the BMD > the NOGEL > a statistical lower bound on the BPD. A companion report discusses the use of these metrics in genotoxicity risk assessment, including scaling and uncertainty factors to be considered when extrapolating below the PoD and/or across test systems and to the human. (C) 2014 The Authors. Published by Elsevier B.V.	[MacGregor, James T.] Toxicol Consulting Serv, Bonita Springs, FL 14620 USA; [Froetschl, Roland] Bundesinst Arzneimittel & Medizinprod, Bonn, Germany; [White, Paul A.] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Eastmond, David A.] Univ Calif Riverside, Riverside, CA 92521 USA; [Fukushima, Shoji] Japan Bioassay Res Ctr, Hadano, Kanagawa, Japan; [Guerard, Melanie] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland; [Hayashi, Makoto] Biosafety Res Ctr Foods Drugs & Pesticides, Shizuoka, Japan; [Soeteman-Hernandez, Lya G.] RIVM Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Kasamatsu, Toshio] Kao Corp, Haga Gun, Tochigi, Japan; [Levy, Dan D.] US FDA, College Pk, MD USA; [Morita, Takeshi] Natl Inst Hlth Sci, Tokyo, Japan; [Mueller, Lutz] Hoffmann La Roche AG, Basel, Switzerland; [Schoeny, Rita] US EPA, Washington, DC 20460 USA; [Schuler, Maik J.] Pfizer Inc, Groton, CT 06340 USA; [Thybaud, Veronique] Sanofi Rech, Vitry Sur Seine, France; [Johnson, George E.] Swansea Univ, Swansea, W Glam, Wales	MacGregor, JT (reprint author), Toxicol Consulting Serv, Bonita Springs, FL 14620 USA.	jtmacgregor@earthlink.net; paul.white@hc-sc.gc.ca	Johnson, George/J-2488-2014	Johnson, George/0000-0001-5643-9942	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [NC/K500033/1]; Health Canada under the Chemicals Management Plan Research Fund	We acknowledge support from the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs, contract number NC/K500033/1) for Dr. Johnson. Funding for the development of the G4 genetic toxicity dose-response database described by Gollapudi et al. [29] and Johnson et al. [30] and of R-based procedures for derivation of genetic toxicology PoDs (i.e., drsmooth), and for support of open access of this publication, was provided by Health Canada under the Chemicals Management Plan Research Fund. We thank the ILSI/HESI Quantitative Working Group for sharing data and analyses collected and employed by that Working Group, and note that their analyses were a critical component of our deliberations.	Ames B.N., 1973, HLTH PERSPECT, V6, P115; Eastmond DA, 2009, MUTAGENESIS, V24, P341, DOI 10.1093/mutage/gep014; Slob W, 2014, CRIT REV TOXICOL, V44, P270, DOI 10.3109/10408444.2013.853726; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P5135, DOI 10.1073/pnas.72.12.5135; Crump K, 2002, CRIT REV TOXICOL, V32, P133; FAVOR J, 1995, MUTAT RES-FUND MOL M, V330, P23, DOI 10.1016/0027-5107(93)E0261-N; Budtz-Jorgensen E, 2001, BIOMETRICS, V57, P698, DOI 10.1111/j.0006-341X.2001.00698.x; Hernandez LG, 2011, ENVIRON MOL MUTAGEN, V52, P518, DOI 10.1002/em.20651; Bolt HM, 2004, TOXICOL LETT, V151, P29, DOI 10.1016/j.toxlet.2004.04.004; Gocke E, 2009, TOXICOL LETT, V190, P298, DOI 10.1016/j.toxlet.2009.03.008; Lutz WK, 2009, MUTAT RES-GEN TOX EN, V678, P118, DOI 10.1016/j.mrgentox.2009.05.010; Gollapudi BB, 2013, ENVIRON MOL MUTAGEN, V54, P8, DOI 10.1002/em.21727; Slob W, 2002, TOXICOL SCI, V66, P298, DOI 10.1093/toxsci/66.2.298; Cheeseman MA, 1999, FOOD CHEM TOXICOL, V37, P387, DOI 10.1016/S0278-6915(99)00024-1; [Anonymous], 2007, DRUG ADM TOX PRINC; Kirkland D, 2005, MUTAT RES-GEN TOX EN, V584, P1, DOI 10.1016/j.mrgentox.2005.02.004; [Anonymous], 2012, ICH HARMONIZED TRIPA, V77, p[110, 33748]; Crump KS, 2011, CRIT REV TOXICOL, V41, P637, DOI 10.3109/10408444.2011.566258; Snyder RD, 2001, MUTAT RES-REV MUTAT, V488, P151, DOI 10.1016/S1383-5742(01)00055-2; Elhajouji A, 2011, MUTAGENESIS, V26, P199, DOI 10.1093/mutage/geq089; Brusick DJ., 1994, METHODS GENETIC RISK; Budtz-Jorgensen E, 2013, RISK ANAL, V33, P450, DOI 10.1111/j.1539-6924.2012.01882.x; Clarke JJ, 2012, ENVIRON MOL MUTAGEN, V53, P631, DOI 10.1002/em.21733; CRUMP K, 1995, RISK ANAL, V15, P523, DOI 10.1111/j.1539-6924.1995.tb00345.x; CRUMP KS, 1984, FUND APPL TOXICOL, V4, P854, DOI 10.1016/0272-0590(84)90107-6; Davis JA, 2011, TOXICOL APPL PHARM, V254, P181, DOI 10.1016/j.taap.2010.10.016; Department of National Health and Welfare and the Department of Environment Advisory Committee on Mutagenesis, 1988, ENVIRON MOL MUTAGEN, V11, P261; EFSA, 2009, EFSA J, V1150, P1; Elespuru RK, 2009, TOXICOL SCI, V109, P172, DOI 10.1093/toxsci/kfp067; European Medicines Agency, 2008, EMEACHMP3822562008; European Medicines Agency Committee for Medicinal Products for Human Use, 2006, EMEACHMPQWP251344200; Fellows MD, 2011, MUTAGENESIS, V26, P529, DOI 10.1093/mutage/ger012; Fetterman BA, 1997, ENVIRON MOL MUTAGEN, V29, P312, DOI 10.1002/(SICI)1098-2280(1997)29:3<312::AID-EM12>3.0.CO;2-H; Flamm W.G., 1977, J ENVIRON PATHOL TOX, V1, P301; GAYLOR DW, 1990, NEUROTOXICOLOGY, V11, P211; Guerard M., 2014, MUTAT RES; Health Canada, 1996, HEALTHB TOL DAIL INT; CLAYSON DB, 1993, ENVIRON MOL MUTAGEN, V21, P15; Hernandez L. G., 2012, 3407000072012 RIVM; Hixon G., 2014, DRSMOOTH DOSE RESPON; Hollaender A., 1978, CHEM MUT PRINC METH, P287; Johnson GE, 2014, ENVIRON MOL MUTAGEN, V55, P609, DOI 10.1002/em.21870; Kirkland DJ, 2007, MUTAT RES-GEN TOX EN, V627, P5, DOI 10.1016/j.mrgentox.2006.08.009; Lewtas J., 1994, METHODS GENETIC RISK, P125; Lynch A, 2003, MUTAGENESIS, V18, P345, DOI 10.1093/mutage/geg003; MacGregor JT, 2015, MUTAT RES-GEN TOX EN, V783, P66, DOI 10.1016/j.mrgentox.2014.10.008; Muggeo V.M.R., 2008, R NEWS, P20; Muller L, 2003, MUTAT RES-GEN TOX EN, V540, P177, DOI 10.1016/j.mrgentox.2003.07.007; National Academy of Sciences, 1983, RISK ASS FED GOV MAN; National Academy of Sciences (US), 2000, TOX EFF METH NAT AC; Rulis A.M., 1986, FOOD PROTECTION TECH, P29; Schildcrout JS, 1999, ENVIRON MOL MUTAGEN, V33, P59, DOI 10.1002/(SICI)1098-2280(1999)33:1<59::AID-EM7>3.0.CO;2-9; Sofuni T, 2000, MUTAT RES-GEN TOX EN, V464, P97, DOI 10.1016/S1383-5718(99)00170-9; Thompson C.M., 2014, DERIVING POINT DEPAT; Thybaud V, 2007, MUTAT RES-GEN TOX EN, V633, P67, DOI 10.1016/j.mrgentox.2007.05.010; Thybaud V, 2011, MUTAT RES-GEN TOX EN, V723, P121, DOI 10.1016/j.mrgentox.2010.09.002; U.S. Environmental Protection Agency, 2005, GUID CANC RISK ASS; U.S. Environmental Protection Agency, 2002, EPA600P98001F; U.S. Food and Drug Administration, 2006, REC APPR INT GEN TOX; U.S. Food and Drug Administration, 2005, DRUG ADM EST MAX SAF; U.S. Food and Drug Administration Guidance for Industry, 2008, US FOOD DRUG ADM GUI; Wassom JS, 2010, ENVIRON MOL MUTAGEN, V51, P746, DOI 10.1002/em.20589; WEST RW, 1993, COMMUN STAT THEORY, V22, P3363, DOI 10.1080/03610929308831221; Witt KL, 2000, ENVIRON MOL MUTAGEN, V36, P163, DOI 10.1002/1098-2280(2000)36:3<163::AID-EM1>3.0.CO;2-P	64	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1383-5718	1879-3592		MUTAT RES-GEN TOX EN	Mutat. Res. Genet. Toxicol. Environ. Mutagen.	MAY 1	2015	783				SI		55	65		10.1016/j.mrgentox.2014.09.011		11	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CJ2YX	WOS:000355351700007		
J	MacGregor, JT; Frotschl, R; White, PA; Crump, KS; Eastmond, DA; Fukushima, S; Guerard, M; Hayashi, M; Soeteman-Hernandez, LG; Johnson, GE; Kasamatsu, T; Levy, DD; Morita, T; Muller, L; Schoeny, R; Schuler, MJ; Thybaud, V				MacGregor, James T.; Froetschl, Roland; White, Paul A.; Crump, Kenny S.; Eastmond, David A.; Fukushima, Shoji; Guerard, Melanie; Hayashi, Makoto; Soeteman-Hernandez, Lya G.; Johnson, George E.; Kasamatsu, Toshio; Levy, Dan D.; Morita, Takeshi; Mueller, Lutz; Schoeny, Rita; Schuler, Maik J.; Thybaud, Veronique			IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk	MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS			English	Article						Genotoxic risk assessment; Point of departure; Benchmark dose; Breakpoint dose; Extrapolation; Low-dose risk	DOSE-RESPONSE RELATIONSHIPS; SALMONELLA-MICROSOME TEST; GENETIC TOXICITY ASSAYS; DNA ADDUCT DATA; IN-VITRO; RODENT CARCINOGENICITY; 21ST-CENTURY ROADMAP; HEMOGLOBIN ADDUCTS; CREATING CONTEXT; END-POINTS	This is the second of two reports from the International Workshops on Genotoxicity Testing (IWGT) Working Group on Quantitative Approaches to Genetic Toxicology Risk Assessment (the QWG). The first report summarized the discussions and recommendations of the QWG related to the need for quantitative dose-response analysis of genetic toxicology data, the existence and appropriate evaluation of threshold responses, and methods to analyze exposure-response relationships and derive points of departure (PoDs) from which acceptable exposure levels could be determined. This report summarizes the QWG discussions and recommendations regarding appropriate approaches to evaluate exposure-related risks of genotoxic damage, including extrapolation below identified PoDs and across test systems and species. Recommendations include the selection of appropriate genetic endpoints and target tissues, uncertainty factors and extrapolation methods to be considered, the importance and use of information on mode of action, toxicokinetics, metabolism, and exposure biomarkers when using quantitative exposure-response data to determine acceptable exposure levels in human populations or to assess the risk associated with known or anticipated exposures. The empirical relationship between genetic damage (mutation and chromosomal aberration) and cancer in animal models was also examined. It was concluded that there is a general correlation between cancer induction and mutagenic and/or clastogenic damage for agents thought to act via a genotoxic mechanism, but that the correlation is limited due to an inadequate number of cases in which mutation and cancer can be compared at a sufficient number of doses in the same target tissues of the same species and strain exposed under directly comparable routes and experimental protocols. (C) 2014 The Authors. Published by Elsevier B.V.	[MacGregor, James T.] Toxicol Consulting Serv, Bonita Springs, FL USA; [Froetschl, Roland] Bundesinst Arzneimittel & Medizinprod, Bonn, Germany; [White, Paul A.] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Eastmond, David A.] Univ Calif Riverside, Riverside, CA 92521 USA; [Fukushima, Shoji] Japan Bioassay Res Ctr, Haden, Kanagawa, Japan; [Guerard, Melanie; Mueller, Lutz] F Hoffmann La Roche & Co Ltd, Pharmaceut Sci & Early Dev Innovat Ctr, Basel, Switzerland; [Hayashi, Makoto] Publ Interest Inc Fdn BioSafety Res Ctr, Shizuoka, Japan; [Soeteman-Hernandez, Lya G.] RIVM Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Johnson, George E.] Swansea Univ, Coll Med, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales; [Kasamatsu, Toshio] Kao Corp, Haga Gun, Tochigi, Japan; [Levy, Dan D.] US FDA, College Pk, MD USA; [Morita, Takeshi] Natl Inst Hlth Sci, Tokyo, Japan; [Schoeny, Rita] US EPA, Washington, DC 20460 USA; [Schuler, Maik J.] Pfizer Inc, Groton, CT 06340 USA; [Thybaud, Veronique] Sanofi Rech, Vitry Sur Seine, France	MacGregor, JT (reprint author), Toxicol Consulting Serv, Bonita Springs, FL USA.	jtmacgregor@earthlink.net	Johnson, George/J-2488-2014	Johnson, George/0000-0001-5643-9942			Adeleye Y., 2014, TOXICOLOGY; AMES B N, 1973, Environmental Health Perspectives, V6, P115, DOI 10.2307/3428066; Straif K, 2009, LANCET ONCOL, V10, P453; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Swenberg JA, 2008, CHEM RES TOXICOL, V21, P253, DOI 10.1021/tx700408t; Simon TW, 2014, CRIT REV TOXICOL, V44, P17, DOI 10.3109/10408444.2014.931925; Yoon M, 2012, CRIT REV TOXICOL, V42, P633, DOI 10.3109/10408444.2012.692115; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P5135, DOI 10.1073/pnas.72.12.5135; Dorne JLCM, 2005, TOXICOL SCI, V86, P20, DOI 10.1093/toxsci/kfi160; [Anonymous], 1997, INT C HARM TECHN REQ; Pastoor TP, 2014, CRIT REV TOXICOL, V44, P1, DOI 10.3109/10408444.2014.931923; Vinken M, 2013, TOXICOLOGY, V312, P158, DOI 10.1016/j.tox.2013.08.011; Crump KS, 2010, ENVIRON HEALTH PERSP, V118, P1350, DOI 10.1289/ehp.1001931; Hernandez LG, 2011, ENVIRON MOL MUTAGEN, V52, P518, DOI 10.1002/em.20651; [Anonymous], 2014, INT C HARM TECHN REQ; Gocke E, 2009, TOXICOL LETT, V190, P298, DOI 10.1016/j.toxlet.2009.03.008; Lutz WK, 2009, MUTAT RES-GEN TOX EN, V678, P118, DOI 10.1016/j.mrgentox.2009.05.010; TENNANT RW, 1987, SCIENCE, V236, P933, DOI 10.1126/science.3554512; Slob W, 2002, TOXICOL SCI, V66, P298, DOI 10.1093/toxsci/66.2.298; Jarabek AM, 2009, CRIT REV TOXICOL, V39, P659, DOI 10.1080/10408440903164155; Yauk CL, 2013, ENVIRON MOL MUTAGEN, V54, P79, DOI 10.1002/em.21757; Matthews EJ, 2006, REGUL TOXICOL PHARM, V44, P83, DOI 10.1016/j.yrtph.2005.11.003; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Himmelstein MW, 2009, CRIT REV TOXICOL, V39, P679, DOI 10.1080/10408440903164163; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Embry MR, 2014, CRIT REV TOXICOL, V44, P6, DOI 10.3109/10408444.2014.931924; Elhajouji A, 2011, MUTAGENESIS, V26, P199, DOI 10.1093/mutage/geq089; DeMarini DM, 1997, ENVIRON MOL MUTAGEN, V30, P440, DOI 10.1002/(SICI)1098-2280(1997)30:4<440::AID-EM9>3.0.CO;2-M; Brusick DJ., 1994, METHODS GENETIC RISK; Cao XF, 2014, ENVIRON MOL MUTAGEN, V55, P385, DOI 10.1002/em.21854; Captan Task Force, SCI AN DAT KREL RECL; Crump KS, 2010, ENVIRON HEALTH PERSP, V118, P585, DOI 10.1289/ehp.0901249; Department of National Health and Welfare and the Department of Environment Advisory Committee on Mutagenesis, 1988, ENVIRON MOL MUTAGEN, V11, P261; DERELANKO MJ, 1987, FUND APPL TOXICOL, V9, P271, DOI 10.1016/0272-0590(87)90049-2; Eastmond DA, 2012, MUTAT RES-REV MUTAT, V751, P49, DOI 10.1016/j.mrrev.2012.04.001; EFSA, 2009, EFSA J, V1150, P1; European Medicines Agency, 2006, EMEACHMPQWP251344; European Medicines Agency, 2008, EMEACHMP3822562008; FENNELL TR, 1992, BIOMARK PREY, V1, P213; Fetterman BA, 1997, ENVIRON MOL MUTAGEN, V29, P312, DOI 10.1002/(SICI)1098-2280(1997)29:3<312::AID-EM12>3.0.CO;2-H; Fukushima S, 2002, JPN J CANCER RES, V93, P1076; Fukushima S., 2010, CANC RISK ASSESSMENT, P207; Fume J.K., 2003, J LAB CLIN MED, V142, P52; Glatt H, 1998, CHEM-BIOL INTERACT, V109, P195, DOI 10.1016/S0009-2797(97)00133-6; Gordon E, 2007, J APPL TOXICOL, V27, P519, DOI 10.1002/jat.1265; Granath FN, 1999, RISK ANAL, V19, P309; Groothuis F.A., 2013, TOXICOLOGY; Hayashi M., 2013, IDENTIFICATION EVALU, V1, P32; Health Canada, 1996, HLTH BAS KTOL DAIL I; Hernandez L.G., 2012, 340700007 RIVM; Herrman JL, 1999, REGUL TOXICOL PHARM, V30, pS109, DOI 10.1006/rtph.1999.1335; Honda H, 2014, TOXICOL APPL PHARM, V275, P213, DOI 10.1016/j.taap.2014.01.010; Hoshi M, 2004, TOXICOL SCI, V81, P273, DOI 10.1093/toxsci/kfh241; Johnson TE, 1996, ENVIRON MOL MUTAGEN, V28, P51, DOI 10.1002/(SICI)1098-2280(1996)28:1<51::AID-EM8>3.0.CO;2-H; KUSHIDA H, 1994, CANCER LETT, V83, P31, DOI 10.1016/0304-3835(94)90295-X; Lambert Iain B, 2005, Mutat Res, V590, P1, DOI 10.1016/j.mrrev.2005.04.002; Lave T, 2009, TOXICOL LETT, V190, P310, DOI 10.1016/j.toxlet.2009.07.031; Lewtas J., 1994, METHODS GENETIC RISK, P125; Li Z, 2014, TOXICOL SCI, V137, P371, DOI 10.1093/toxsci/kft259; Lynch A, 2003, MUTAGENESIS, V18, P345, DOI 10.1093/mutage/geg003; Macgregor J.T., 2014, MUTAT RES; Mailing H.V., 1971, MUTAT RES, V13, P425; MCCANN J, 1988, MUTAT RES, V205, P183, DOI 10.1016/0165-1218(88)90017-1; MCCANN J, 1975, ANN NY ACAD SCI, V269, P21; McCarroll NE, 2002, MUTAT RES-REV MUTAT, V512, P1, DOI 10.1016/S1383-5742(02)00026-1; MCCOY EC, 1982, BIOCHEM BIOPH RES CO, V108, P1362, DOI 10.1016/0006-291X(82)92150-7; Meselson M., 1977, ORIGINS HUMAN CANCER, P1473; Miller E.C., 1971, CHEM MUTAGENS PRINCI, P83; MILLER EC, 1966, PHARMACOL REV, V18, P805; MIRSALIS JC, 1995, ANNU REV PHARMACOL, V35, P145; National Research Council (NRC) Committee on Toxicity Testing and Assessment of Environmental Agents, 2007, TOXICOLOGY; Naumann B., 2005, RISK POLICY REP; Nohmi T, 2000, MUTAT RES-FUND MOL M, V455, P191, DOI 10.1016/S0027-5107(00)00077-4; Nohmi T., 2012, GENES ENV, V34, P142; OECD Chemical Testing Program, 1997, CHEM TESTS PROGRAM T; OECD Chemical Testing Program, 2014, CHEM TEST PROGRA ADV; OECD Chemical Testing Program, 2014, VIV MAMMA ALK COM AS; OECD Chemical Testing Program, 1997, TEST 471 BACT REV MU; Ogawa M, 2006, J OCCUP HEALTH, V48, P314, DOI 10.1539/joh.48.314; PARODI S, 1982, MUTAT RES, V93, P1, DOI 10.1016/0027-5107(82)90121-X; Phillips DH, 2005, MUTAT RES-FUND MOL M, V577, P284, DOI 10.1016/j.mrfmmm.2005.03.008; PIEGORSCH WW, 1988, MUTAT RES, V196, P161, DOI 10.1016/0165-1110(88)90018-8; POZHARISSKI KM, 1975, INT J CANCER, V15, P673, DOI 10.1002/ijc.2910150417; PRIVAL MJ, 1984, MUTAT RES, V136, P33, DOI 10.1016/0165-1218(84)90132-0; PRIVAL MJ, 1982, MUTAT RES, V97, P103, DOI 10.1016/0165-1161(82)90008-5; PURCHASE IFH, 1976, NATURE, V264, P624, DOI 10.1038/264624a0; ROSENKRANZ HS, 1975, BIOCHEM BIOPH RES CO, V66, P520, DOI 10.1016/0006-291X(75)90541-0; Singer B., 1983, MOL BIOL MUTAGENS CA; Thybaud V, 2007, MUTAT RES-GEN TOX EN, V633, P67, DOI 10.1016/j.mrgentox.2007.05.010; Thybaud V, 2007, MUTAT RES-GEN TOX EN, V627, P41, DOI 10.1016/j.mrgentox.2006.10.003; UK Committee on Mutagenicity of Chemicals in Food Consumer Products and the Environment (COM), 2010, CONS PROD ENV COM; Uno Y., 2014, MUTAT RES; U.S. Environmental Protection Agency, 2005, GUID CANC RISK ASS; U.S. Environmental Protection Agency, EPA630R97002; U.S. Environmental Protection Agency, 2010, INTEGR RISK INF SYST; US Environmental Protection Agency, 2002, EPA630P02OO2F; U.S. Environmental Protection Agency, 2011, EPA100J11001; U.S. Environmental Protection Agency, 2011, CARC ASS TRICHL AC I; U.S. Food and Drug Administration, 1982, FED REGISTER, V47, P49629; U.S. Food and Drug Administration, 2007, TOX PRINC SAF ASS FO; Van Putten L.M., 1958, BLOOD, V13, P789; von Stedingk H., 2012, ROYAL SOC CHEM, P1; Walker R, 1998, FOOD ADDIT CONTAM, V15, P11; WATABE T, 1982, SCIENCE, V215, P403, DOI 10.1126/science.6800033; World Health Organization International Programme on Chemical Safety, 1987, HLTH CRIT, P70; Yano Y, 2010, EXP THER MED, V1, P657, DOI 10.3892/etm_00000103; Zeiger E., 1990, ENVIRON MOL MUTAGEN, V18, P1; ZEIGER E, 1987, CANCER RES, V47, P1287	110	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1383-5718	1879-3592		MUTAT RES-GEN TOX EN	Mutat. Res. Genet. Toxicol. Environ. Mutagen.	MAY 1	2015	783				SI		66	78		10.1016/j.mrgentox.2014.10.008		13	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CJ2YX	WOS:000355351700008		
J	Abe, Y; Rozqie, R; Matsumura, Y; Kawamura, T; Nakaki, R; Tsurutani, Y; Tanimura-Inagaki, K; Shiono, A; Magoori, K; Nakamura, K; Ogi, S; Kajimura, S; Kimura, H; Tanaka, T; Fukami, K; Osborne, TF; Kodama, T; Aburatani, H; Inagaki, T; Sakai, J				Abe, Yohei; Rozqie, Royhan; Matsumura, Yoshihiro; Kawamura, Takeshi; Nakaki, Ryo; Tsurutani, Yuya; Tanimura-Inagaki, Kyoko; Shiono, Akira; Magoori, Kenta; Nakamura, Kanako; Ogi, Shotaro; Kajimura, Shingo; Kimura, Hiroshi; Tanaka, Toshiya; Fukami, Kiyoko; Osborne, Timothy F.; Kodama, Tatsuhiko; Aburatani, Hiroyuki; Inagaki, Takeshi; Sakai, Juro			JMJD1A is a signal-sensing scaffold that regulates acute chromatin dynamics via SWI/SNF association for thermogenesis	NATURE COMMUNICATIONS			English	Article							CHROMOSOME CONFORMATION CAPTURE; HISTONE DEMETHYLASE JMJD1A; METABOLIC GENE-EXPRESSION; BROWN FAT-CELLS; ADRENERGIC-RECEPTOR; TRANSCRIPTION; BETA(3); JHDM2A; MICE; IDENTIFICATION	Histone 3 lysine 9 (H3K9) demethylase JMJD1A regulates beta-adrenergic-induced systemic metabolism and body weight control. Here we show that JMJD1A is phosphorylated at S265 by protein kinase A (PKA), and this is pivotal to activate the beta 1-adrenergic receptor gene (Adrb1) and downstream targets including Ucp1 in brown adipocytes (BATs). Phosphorylation of JMJD1A by PKA increases its interaction with the SWI/SNF nucleosome remodelling complex and DNA-bound PPAR gamma. This complex confers beta-adrenergic-induced rapid JMJD1A recruitment to target sites and facilitates long-range chromatin interactions and target gene activation. This rapid gene induction is dependent on S265 phosphorylation but not on demethylation activity. Our results show that JMJD1A has two important roles in regulating hormone-stimulated chromatin dynamics that modulate thermogenesis in BATs. In one role, JMJD1A is recruited to target sites and functions as a cAMP-responsive scaffold that facilitates long-range chromatin interactions, and in the second role, JMJD1A demethylates H3K9 di-methylation.	[Abe, Yohei; Rozqie, Royhan; Matsumura, Yoshihiro; Tsurutani, Yuya; Tanimura-Inagaki, Kyoko; Shiono, Akira; Magoori, Kenta; Nakamura, Kanako; Ogi, Shotaro; Tanaka, Toshiya; Inagaki, Takeshi; Sakai, Juro] Univ Tokyo, RCAST, Div Metab Med, Tokyo 1538904, Japan; [Rozqie, Royhan] Gadjah Mada Univ, Fac Med, Dept Cardiol & Vasc Med, Yogyakarta 55281, Indonesia; [Kawamura, Takeshi; Tanaka, Toshiya] Univ Tokyo, RCAST, Lab Syst Biol & Med, Tokyo 1538904, Japan; [Kawamura, Takeshi; Magoori, Kenta; Tanaka, Toshiya; Aburatani, Hiroyuki; Inagaki, Takeshi; Sakai, Juro] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Translat Syst Biol & Med Initiat, Tokyo 1138655, Japan; [Nakaki, Ryo; Aburatani, Hiroyuki] Univ Tokyo, RCAST, Genome Sci Div, Tokyo 1538904, Japan; [Kajimura, Shingo] Univ Calif San Francisco, Ctr Diabet, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignals, Tokyo 1920392, Japan; [Osborne, Timothy F.] Sanford Burnham Med Res Inst, Metab Dis Program, Orlando, FL 32827 USA	Inagaki, T (reprint author), Univ Tokyo, RCAST, Div Metab Med, Tokyo 1538904, Japan.	inagaki@lsbm.org; jmsakai-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [22229009, 25291002, 17054004]	We thank Dr Mitsuyoshi Nakao for helpful discussion, Dr Tadashi Shiraishi for reading the manuscript, Drs Yoichi Shinkai and Makoto Tachibana for Jmjd1a-/- mice, Noriko Nagao, Aoi Uchida, Saki Kawashima, Reiko Kuwahara, Akashi Taguchi-Izumi and Ayano Yoshida for their technical assistance, and other members of the Sakai laboratory for their helpful discussion. This work was supported in Grant-in-Aid for Scientific Research (S) (grant number 22229009) and (B) (grant number 25291002), the Project for Developing Innovation Systems of MEXT and, in part, by Grants-in-Aid for Scientific Research on Priority Areas (17054004) from the Ministry of Education, Culture, Sports, Science and Technology.	Naumova N, 2012, METHODS, V58, P192, DOI 10.1016/j.ymeth.2012.07.022; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Osawa T, 2013, CANCER RES, V73, P3019, DOI 10.1158/0008-5472.CAN-12-3231; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483; Myers SA, 2009, MOL CELL ENDOCRINOL, V309, P101, DOI 10.1016/j.mce.2009.05.006; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Bengtsson T, 2000, BIOCHEM J, V347, P643, DOI 10.1042/0264-6021:3470643; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; KOZAK UC, 1994, MOL CELL BIOL, V14, P59; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Cho HS, 2012, INT J CANCER, V131, pE179, DOI 10.1002/ijc.26501; Ueta CB, 2012, J ENDOCRINOL, V214, P359, DOI 10.1530/JOE-12-0155; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Watanabe T, 2012, MOL CELL BIOL, V32, P1529, DOI 10.1128/MCB.06478-11; Lowell BB, 2000, NATURE, V404, P652; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Zhao J, 1998, AM J PHYSIOL-REG I, V275, pR2002; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Bengtsson T, 1996, J BIOL CHEM, V271, P33366; Daigo K, 2011, J BIOL CHEM, V286, P674, DOI 10.1074/jbc.M110.154732; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Fujinoki M, 2004, COMP BIOCHEM PHYS B, V137, P509, DOI 10.1016/j.cbpc.2004.02.006; HAUSDORFF WP, 1990, FASEB J, V4, P2881; Hoang Stephen A, 2011, BMC Res Notes, V4, P288, DOI 10.1186/1756-0500-4-288; Parrish JK, 2015, ONCOGENE, V34, P257, DOI 10.1038/onc.2013.541; Revelli JP, 1997, J CLIN INVEST, V100, P1098, DOI 10.1172/JCI119620; Tanaka T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05412; Waki H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002311	42	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7052	10.1038/ncomms8052		14	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5ME	WOS:000355530900003		
J	Bachman, JC; Kavian, R; Graham, DJ; Kim, DY; Noda, S; Nocera, DG; Shao-Horn, Y; Lee, SW				Bachman, John C.; Kavian, Reza; Graham, Daniel J.; Kim, Dong Young; Noda, Suguru; Nocera, Daniel G.; Shao-Horn, Yang; Lee, Seung Woo			Electrochemical polymerization of pyrene derivatives on functionalized carbon nanotubes for pseudocapacitive electrodes	NATURE COMMUNICATIONS			English	Article							RECHARGEABLE LITHIUM BATTERIES; ENERGY-STORAGE DEVICES; REDOX FLOW BATTERY; LI-ION BATTERIES; ORGANIC ELECTRODE; POLYCYCLIC-HYDROCARBONS; AROMATIC-HYDROCARBONS; POLYANILINE; CHALLENGES; CAPACITORS	Electrochemical energy-storage devices have the potential to be clean and efficient, but their current cost and performance limit their use in numerous transportation and stationary applications. Many organic molecules are abundant, economical and electrochemically active; if selected correctly and rationally designed, these organic molecules offer a promising route to expand the applications of these energy-storage devices. In this study, polycyclic aromatic hydrocarbons are introduced within a functionalized few-walled carbon nanotube matrix to develop high-energy, high-power positive electrodes for pseudocapacitor applications. The reduction potential and capacity of various polycyclic aromatic hydrocarbons are correlated with their interaction with the functionalized few-walled carbon nanotube matrix, chemical configuration and electronic structure. These findings provide rational design criteria for nanostructured organic electrodes. When combined with lithium negative electrodes, these nanostructured organic electrodes exhibit energy densities of similar to 350 Wh kg(electrode)(-1) at power densities of similar to 10 kW kg(electrode)(-1) for over 10,000 cycles.	[Bachman, John C.; Shao-Horn, Yang] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Kavian, Reza; Lee, Seung Woo] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Graham, Daniel J.; Nocera, Daniel G.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kim, Dong Young; Noda, Suguru] Waseda Univ, Dept Appl Chem, Shinjuku Ku, Tokyo 1698555, Japan; [Shao-Horn, Yang] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Nocera, DG (reprint author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	dnocera@fas.harvard.edu; shaohorn@mit.edu; seung.lee@me.gatech.edu	Noda, Suguru/C-1365-2008; Lee, Seung Woo/B-5820-2013	Noda, Suguru/0000-0002-7305-5307; Lee, Seung Woo/0000-0002-2695-7105	National Science Foundation [1122374]; MRSEC Program of the National Science Foundation [DMR-0819762]	J.C.B. is supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. 1122374 and by the MRSEC Program of the National Science Foundation under award No. DMR-0819762.	Alexiou C, 2001, COORDIN CHEM REV, V216, P45, DOI 10.1016/S0010-8545(01)00350-2; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; LIU ML, 1991, J ELECTROCHEM SOC, V138, P1896, DOI 10.1149/1.2085896; WALTMAN RJ, 1985, J ELECTROANAL CHEM, V194, P49, DOI 10.1016/0022-0728(85)87005-4; Byon HR, 2013, ADV FUNCT MATER, V23, P1037, DOI 10.1002/adfm.201200697; WALTMAN RJ, 1986, CAN J CHEM, V64, P76, DOI 10.1139/v86-015; Figueira-Duarte TM, 2011, CHEM REV, V111, P7260, DOI 10.1021/cr100428a; Song ZP, 2010, ANGEW CHEM INT EDIT, V49, P8444, DOI 10.1002/anie.201002439; Naoi K, 2012, ENERG ENVIRON SCI, V5, P9363, DOI 10.1039/c2ee21675b; Beguin F, 2014, ADV MATER, V26, P2219, DOI 10.1002/adma.201304137; Lee SW, 2012, ENERG ENVIRON SCI, V5, P5437, DOI 10.1039/c1ee02409d; Le Gall T, 2003, J POWER SOURCES, V119, P316, DOI 10.1016/S0378-7753(03)00167-8; Kim DY, 2011, CARBON, V49, P1972, DOI 10.1016/j.carbon.2011.01.022; Hammett LP, 1937, J AM CHEM SOC, V59, P96, DOI 10.1021/ja01280a022; Song ZP, 2012, NANO LETT, V12, P2205, DOI 10.1021/nl2039666; Etacheri V, 2011, ENERG ENVIRON SCI, V4, P3243, DOI 10.1039/c1ee01598b; Novak P, 1997, CHEM REV, V97, P207, DOI 10.1021/cr941181o; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Brushett FR, 2012, ADV ENERGY MATER, V2, P1390, DOI 10.1002/aenm.201200322; Nokami T, 2012, J AM CHEM SOC, V134, P19694, DOI 10.1021/ja306663g; MERMILLIOD N, 1986, J ELECTROCHEM SOC, V133, P1073, DOI 10.1149/1.2108788; Wang W, 2013, ADV FUNCT MATER, V23, P970, DOI 10.1002/adfm.201200694; Song ZP, 2013, ENERG ENVIRON SCI, V6, P2280, DOI 10.1039/c3ee40709h; Goodenough JB, 2010, CHEM MATER, V22, P587, DOI 10.1021/cm901452z; Frackowiak E, 2001, CARBON, V39, P937, DOI 10.1016/S0008-6223(00)00183-4; BOSCHI R, 1974, J CHEM PHYS, V60, P4406, DOI 10.1063/1.1680919; OYAMA N, 1995, NATURE, V373, P598, DOI 10.1038/373598a0; Poizot P, 2011, ENERG ENVIRON SCI, V4, P2003, DOI 10.1039/c0ee00731e; Lee M, 2013, ANGEW CHEM INT EDIT, V52, P8322, DOI 10.1002/anie.201301850; Chen H, 2008, CHEMSUSCHEM, V1, P348, DOI 10.1002/cssc.200700161; NAGATOMO T, 1987, J ELECTROCHEM SOC, V134, P305, DOI 10.1149/1.2100451; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Morita Y, 2011, NAT MATER, V10, P947, DOI [10.1038/nmat3142, 10.1038/NMAT3142]; Duduta M, 2011, ADV ENERGY MATER, V1, P511, DOI 10.1002/aenm.201100152; Simon P, 2014, SCIENCE, V343, P1210, DOI 10.1126/science.1249625; Burkhardt SE, 2012, ENERG ENVIRON SCI, V5, P7176, DOI 10.1039/c2ee21255b; Lee M, 2014, ADV MATER, V26, P2558, DOI 10.1002/adma.201305005; MACDIARMID AG, 1987, SYNTHETIC MET, V18, P393, DOI 10.1016/0379-6779(87)90911-8; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Lee SW, 2010, NAT NANOTECHNOL, V5, P531, DOI [10.1038/nnano.2010.116, 10.1038/NNANO.2010.116]; Miller JR, 2008, SCIENCE, V321, P651, DOI 10.1126/science.1158736; Hauffman G, 2013, J POLYM SCI POL CHEM, V51, P101, DOI 10.1002/pola.26279; Liang YL, 2012, ADV ENERGY MATER, V2, P742, DOI 10.1002/aenm.201100795; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Kawai T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04EN05; KITANI A, 1985, DENKI KAGAKU, V53, P592; Osaka TN T, 1990, ELECTROCHEM SOC P, V90-5, P170; Osaka TN T., 1989, N0001488K0360 U MINN; Pampanin D. M., 2013, POLYCYCLIC AROMATIC; PEOVER ME, 1967, J ELECTROANAL CHEM, V13, P93, DOI 10.1016/0022-0728(67)80097-4; WALTMAN RJ, 1985, J ELECTROCHEM SOC, V132, P631, DOI 10.1149/1.2113918	51	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7040	10.1038/ncomms8040		9	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5MA	WOS:000355530400004		
J	Chepelianskii, AD; Watanabe, M; Nasyedkin, K; Kono, K; Konstantinov, D				Chepelianskii, Alexei D.; Watanabe, Masamitsu; Nasyedkin, Kostyantyn; Kono, Kimitoshi; Konstantinov, Denis			An incompressible state of a photo-excited electron gas	NATURE COMMUNICATIONS			English	Article							ZERO-RESISTANCE STATES; MAGNETIC-FIELD; LIQUID-HELIUM; PHOTOGALVANIC CURRENT; SURFACE; MAGNETOCONDUCTIVITY; EXCITATION; TRANSPORT; GRAPHENE; SYSTEMS	Two-dimensional electrons in a magnetic field can form new states of matter characterized by topological properties and strong electronic correlations as displayed in the integer and fractional quantum Hall states. In these states, the electron liquid displays several spectacular characteristics, which manifest themselves in transport experiments with the quantization of the Hall resistance and a vanishing longitudinal conductivity or in thermodynamic equilibrium when the electron fluid becomes incompressible. Several experiments have reported that dissipationless transport can be achieved even at weak, non-quantizing magnetic fields when the electrons absorb photons at specific energies related to their cyclotron frequency. Here we perform compressibility measurements on electrons on liquid helium demonstrating the formation of an incompressible electronic state under these resonant excitation conditions. This new state provides a striking example of irradiation-induced self-organization in a quantum system.	[Chepelianskii, Alexei D.] Univ Paris 11, CNRS, UMR 8502, LPS, F-91405 Orsay, France; [Chepelianskii, Alexei D.] Univ Cambridge, Cavendish Lab, Cambridge CB3 OHE, England; [Watanabe, Masamitsu] RIKEN, Low Temp Phys Lab, Wako, Saitama 3510198, Japan; [Nasyedkin, Kostyantyn; Kono, Kimitoshi] RIKEN, CEMS, Quantum Condensed Phases Res Team, Wako, Saitama 3510198, Japan; [Kono, Kimitoshi] Natl Chiao Tung Univ, Inst Phys, Hsinchu 30010, Taiwan; [Kono, Kimitoshi] Kazan Fed Univ, Inst Phys, Kazan 420008, Russia; [Konstantinov, Denis] Okinawa Inst Sci & Technol, Onna, Okinawa 9040412, Japan	Chepelianskii, AD (reprint author), Univ Paris 11, CNRS, UMR 8502, LPS, F-91405 Orsay, France.	alexei.chepelianskii@u-psud.fr	Kono, Kimitoshi/H-3329-2012	Kono, Kimitoshi/0000-0002-4446-4419	JSPS KAKENHI [24000007]; E. Oppenheimer fellowship; St Catharine college in Cambridge; Okinawa Institute of Science and Technology Graduate University	We are thankful to H. Bouchiat for fruitful discussions and acknowledge support from JSPS KAKENHI Grant Number 24000007. One of us, A.C. acknowledges support from the E. Oppenheimer fellowship and from St Catharine college in Cambridge. D.K. is supported by internal grant from Okinawa Institute of Science and Technology Graduate University.	Andrei E. Y., 1997, 2 DIMENSIONAL ELECT; Konstantinov D, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266808; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Hecht F, 2012, J NUMER MATH, V20, P251, DOI 10.1515/jnum-2012-0013; Dorozhkin SI, 2011, NAT PHYS, V7, P336, DOI [10.1038/nphys1895, 10.1038/NPHYS1895]; Mani RG, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205320; Wiedmann S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.026804; Durst AC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.086803; Willett RL, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.026804; Zudov MA, 2006, PHYS REV LETT, V96, DOI [10.1103/PhysRevLett.96.236804, 10.1103/PhysrevLett.96.236804]; Zudov MA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.046807; Dmitriev IA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.226802; Tessmer SH, 1998, NATURE, V392, P51; Konstantinov D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.266802; Chepelianskii AD, 2007, EUR PHYS J B, V60, P225, DOI 10.1140/cpjb/e2007-00341-x; Zhirov OV, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035410; DOLGOPOLOV VT, 1992, PHYS REV B, V46, P12560, DOI 10.1103/PhysRevB.46.12560; Dmitriev IA, 2012, REV MOD PHYS, V84, P1709, DOI 10.1103/RevModPhys.84.1709; Mikhailov SA, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.155303; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Smet JH, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.116804; Monarkha YP, 2012, LOW TEMP PHYS+, V38, P451, DOI 10.1063/1.4723658; Koulakov AA, 1996, PHYS REV LETT, V76, P499, DOI 10.1103/PhysRevLett.76.499; Konstantinov D, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.226801; Monarkha YP, 2011, LOW TEMP PHYS+, V37, P655, DOI 10.1063/1.3652923; Mani RG, 2002, NATURE, V420, P646, DOI 10.1038/nature01277; Mani RG, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.085308; Bolotin KI, 2009, NATURE, V462, P196, DOI 10.1038/nature08582; Badrutdinov AO, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.075305; Chepelianskii AD, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.241308; Closa F., 2014, EUR PHYS J B, V87, P1; Entin MV, 2014, JETP LETT+, V98, P816, DOI 10.1134/S0021364013250103; Entin MV, 2013, JETP LETT+, V98, P38, DOI 10.1134/S0021364013140063; Ezawa, 2008, QUANTUM HALL EFFECT; GOLDEN KI, 1993, PHYS REV B, V48, P8882, DOI 10.1103/PhysRevB.48.8882; Jain JK, 2007, COMPOSITE FERMIONS, P1, DOI 10.1017/CBO9780511607561; JEANNERET B, 1995, PHYS REV B, V51, P9752, DOI 10.1103/PhysRevB.51.9752; Klitzing K. V., 1980, PHYS REV LETT, V45, P494, DOI DOI 10.1103/PHYSREVLETT.45.494; Konstantinov D, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.093601; KOVDRYA YZ, 1993, J LOW TEMP PHYS, V91, P371, DOI 10.1007/BF00125430; Lea MJ, 1997, PHYS REV B, V55, P16280, DOI 10.1103/PhysRevB.55.16280; Levin AD, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.161304; Monarkha Yu. P., 2004, 2 DIMENSIONAL COULOM; Platzman R. M., 1999, SCIENCE, V284, P1967; TSUI DC, 1982, PHYS REV LETT, V48, P1559, DOI 10.1103/PhysRevLett.48.1559; Watanabe M., ADDITIONAL EXPT DATA; WILEN L, 1988, J LOW TEMP PHYS, V72, P353, DOI 10.1007/BF00682147	47	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7210	10.1038/ncomms8210		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5OP	WOS:000355537600001		
J	Kato, HE; Kamiya, M; Sugo, S; Ito, J; Taniguchi, R; Orito, A; Hirata, K; Inutsuka, A; Yamanaka, A; Maturana, AD; Ishitani, R; Sudo, Y; Hayashi, S; Nureki, O				Kato, Hideaki E.; Kamiya, Motoshi; Sugo, Seiya; Ito, Jumpei; Taniguchi, Reiya; Orito, Ayaka; Hirata, Kunio; Inutsuka, Ayumu; Yamanaka, Akihiro; Maturana, Andres D.; Ishitani, Ryuichiro; Sudo, Yuki; Hayashi, Shigehiko; Nureki, Osamu			Atomistic design of microbial opsin-based blue-shifted optogenetics tools	NATURE COMMUNICATIONS			English	Article							SENSORY RHODOPSIN-II; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; RETINAL PROTEINS; BACTERIORHODOPSIN MUTANTS; PHARAONIS PHOBORHODOPSIN; MOLECULAR-DYNAMICS; PROTON AFFINITY; NEURAL ACTIVITY; SCHIFF-BASE	Microbial opsins with a bound chromophore function as photosensitive ion transporters and have been employed in optogenetics for the optical control of neuronal activity. Molecular engineering has been utilized to create colour variants for the functional augmentation of optogenetics tools, but was limited by the complexity of the protein-chromophore interactions. Here we report the development of blue-shifted colour variants by rational design at atomic resolution, achieved through accurate hybrid molecular simulations, electrophysiology and X-ray crystallography. The molecular simulation models and the crystal structure reveal the precisely designed conformational changes of the chromophore induced by combinatory mutations that shrink its p-conjugated system which, together with electrostatic tuning, produce large blue shifts of the absorption spectra by maximally 100 nm, while maintaining photosensitive ion transport activities. The design principle we elaborate is applicable to other microbial opsins, and clarifies the underlying molecular mechanism of the blue-shifted action spectra of microbial opsins recently isolated from natural sources.	[Kato, Hideaki E.; Taniguchi, Reiya; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Kamiya, Motoshi; Sugo, Seiya; Hayashi, Shigehiko] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan; [Ito, Jumpei; Maturana, Andres D.] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Hirata, Kunio] RIKEN, SPring Ctr 8, Kobe, Hyogo 6795148, Japan; [Inutsuka, Ayumu; Yamanaka, Akihiro] Nagoya Univ, Environm Med Res Inst, Dept Neurosci 2, Nagoya, Aichi 4648601, Japan; [Sudo, Yuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan	Kato, HE (reprint author), Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan.	hayashig@kuchem.kyoto-u.ac.jp; nureki@bs.s.u-tokyo.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [25104004, 25291034, 23687019, 24227004]; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	We thank A. Kurabayashi and Sawako Tabuchi for technical support, and the beamline staff members at BL32XU of SPring-8 (Hyogo, Japan) for technical help during data collection. We also thank Keiichi Inoue for assistance with the AR3 experiments. This work was financially supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology to S.H. (25104004 and 25291034), to Y.S. (23687019) and to O.N. (24227004), the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry to S.H. Some computations were performed at the Research Center for Computational Science, Okazaki, Japan.	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Ren L, 2001, BIOCHEMISTRY-US, V40, P13906, DOI 10.1021/bi0116487; Hayashi S, 2000, J PHYS CHEM B, V104, P10678, DOI 10.1021/jp001508r; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Tajkhorshid E, 2000, BIOPHYS J, V78, P683; Kosugi T, 2012, J AM CHEM SOC, V134, P7045, DOI 10.1021/ja212117m; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; NINA M, 1995, BIOPHYS J, V68, P25; Kosugi T, 2012, J CHEM THEORY COMPUT, V8, P322, DOI 10.1021/ct2005837; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/nmeth.2836, 10.1038/NMETH.2836]; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Tajkhorshid E, 1999, J PHYS CHEM B, V103, P5581, DOI 10.1021/jp983742b; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Inutsuka A, 2014, NEUROPHARMACOLOGY, V85, P451, DOI 10.1016/j.neuropharm.2014.06.015; Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Coto PB, 2006, P NATL ACAD SCI USA, V103, P17154, DOI 10.1073/pnas.0604048103; Rajput J, 2010, ANGEW CHEM INT EDIT, V49, P1790, DOI 10.1002/anie.200905061; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Aston-Jones G, 2013, BRAIN RES, V1511, P1, DOI 10.1016/j.brainres.2013.01.026; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Ferre N, 2003, J AM CHEM SOC, V125, P6868, DOI 10.1021/ja035087d; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Govorunova EG, 2013, J BIOL CHEM, V288, P29911, DOI 10.1074/jbc.M113.505495; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Wang WJ, 2012, SCIENCE, V338, P1340, DOI 10.1126/science.1226135; Fujimoto K, 2007, J CHEM THEORY COMPUT, V3, P605, DOI 10.1021/ct6002687; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI [10.1038/nmeth.f.324, 10.1038/NMETH.F.324]; Hayashi S, 2001, J PHYS CHEM B, V105, P10124, DOI 10.1021/jp011362b; Baudry J, 1997, J CHEM INF COMP SCI, V37, P1018, DOI 10.1021/ci9702398; Chang YF, 2012, NEUROSCI RES, V73, P341, DOI 10.1016/j.neures.2012.05.007; Deisseroth K, 2010, SCI AM, V303, P48, DOI 10.1038/scientificamerican1110-48; Engqvist M. K., 2015, J MOL BIOL, V427, P206; KREBS MP, 1993, P NATL ACAD SCI USA, V90, P1987, DOI 10.1073/pnas.90.5.1987; MacKerell JAD, 2004, J COMPUT CHEM, V25, P1400; MacKerell JAD, 1998, J PHYS CHEM B, V102, P3586, DOI DOI 10.1021/JP973084F; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039933; Schlenkrich Michael, 1996, P31; Schulten K., 2014, QUANTUM EFFECTS BIOL; Shimono K, 2000, PHOTOCHEM PHOTOBIOL, V72, P141; Shimono K, 2001, BBA-BIOMEMBRANES, V1515, P92, DOI 10.1016/S0005-2736(01)00394-7; SOPPA J, 1989, J BIOL CHEM, V264, P13049; Spudich EN, 2012, J MOL BIOL, V415, P455, DOI 10.1016/j.jmb.2011.11.025; Sudo Y, 2013, J BIOL CHEM, V288, P20624, DOI 10.1074/jbc.M113.475533; Sudo Y, 2011, J BIOL CHEM, V286, P11328, DOI 10.1074/jbc.M110.187948; Sudo Y, 2009, BIOCHEMISTRY-US, V48, P10136, DOI 10.1021/bi901338d; Tajkhorshid E, 1997, J PHYS CHEM B, V101, P8021, DOI 10.1021/jp971283t; TAKAHASHI T, 1990, BIOCHEMISTRY-US, V29, P8467, DOI 10.1021/bi00488a038; Wanko M, 2005, J PHYS CHEM B, V109, P3606, DOI 10.1021/jp0463060; Watanabe Hiroshi C, 2010, Biophysics, V6, DOI 10.2142/biophysics.6.67	66	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7177	10.1038/ncomms8177		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5OG	WOS:000355536700004		
J	Kraus, PM; Tolstikhin, OI; Baykusheva, D; Rupenyan, A; Schneider, J; Bisgaard, CZ; Morishita, T; Jensen, F; Madsen, LB; Worner, HJ				Kraus, P. M.; Tolstikhin, O. I.; Baykusheva, D.; Rupenyan, A.; Schneider, J.; Bisgaard, C. Z.; Morishita, T.; Jensen, F.; Madsen, L. B.; Woerner, H. J.			Observation of laser-induced electronic structure in oriented polyatomic molecules	NATURE COMMUNICATIONS			English	Article							MULTIELECTRON DYNAMICS; PHOTOIONIZATION; IONIZATION; DELAY	All attosecond time-resolved measurements have so far relied on the use of intense near-infrared laser pulses. In particular, attosecond streaking, laser-induced electron diffraction and high-harmonic generation all make use of non-perturbative light-matter interactions. Remarkably, the effect of the strong laser field on the studied sample has often been neglected in previous studies. Here we use high-harmonic spectroscopy to measure laser-induced modifications of the electronic structure of molecules. We study high-harmonic spectra of spatially oriented CH3F and CH3Br as generic examples of polar polyatomic molecules. We accurately measure intensity ratios of even and odd-harmonic orders, and of the emission from aligned and unaligned molecules. We show that these robust observables reveal a substantial modification of the molecular electronic structure by the external laser field. Our insights offer new challenges and opportunities for a range of emerging strong-field attosecond spectroscopies.	[Kraus, P. M.; Baykusheva, D.; Rupenyan, A.; Schneider, J.; Woerner, H. J.] ETH, Lab Phys Chem, CH-8093 Zurich, Switzerland; [Tolstikhin, O. I.] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Russia; [Bisgaard, C. Z.] FOSS Analyt AS, DK-3400 Hillerod, Denmark; [Morishita, T.] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan; [Jensen, F.] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark; [Madsen, L. B.] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark	Worner, HJ (reprint author), ETH, Lab Phys Chem, CH-8093 Zurich, Switzerland.	woerner@phys.chem.ethz.ch	Tolstikhin, Oleg/L-1899-2013; Worner, Hans Jakob/B-1802-2013	Tolstikhin, Oleg/0000-0001-7603-2322; 	Swiss National Science Foundation [PP00P2_128274]; ETH Zurich [ETH-33 10-3]; Russian Foundation for Basic Research [14-02-92110]; Ministry of Education and Science of Russia [3.679.2014/K]; Danish Center for Scientific Computation; VKR Centre of Excellence QUSCOPE; ERC [277767-TDMET, 307270-ATTOSCOPE]	We gratefully acknowledge funding from the Swiss National Science Foundation (PP00P2_128274), ETH Zurich (ETH-33 10-3), the Russian Foundation for Basic Research (Grant No. 14-02-92110), the Ministry of Education and Science of Russia (State assignment No. 3.679.2014/K), the Danish Center for Scientific Computation, the VKR Centre of Excellence QUSCOPE and ERC Starting Grants (Project Nos. 277767-TDMET and 307270-ATTOSCOPE). We thank Paul Hockett for valuable discussions about the calculation of photorecombination matrix elements.	Klunder K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.143002; Madsen LB, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.053404; Dimitrovski D, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.053404; Eckle P, 2008, SCIENCE, V322, P1525, DOI 10.1126/science.1163439; Rupenyan A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.033903; Natalense APP, 1999, J CHEM PHYS, V111, P5344, DOI 10.1063/1.479794; Worner HJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.233904; Kraus PM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.233903; Madsen LB, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013406; Goulielmakis E, 2010, NATURE, V466, P739, DOI 10.1038/nature09212; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Madsen LB, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033412; Jensen F, 2005, THEOR CHEM ACC, V113, P267, DOI 10.1007/s00214-005-0635-2; Kamta GL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.203003; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; Sansone G, 2010, NATURE, V465, P763, DOI 10.1038/nature09084; Farrell JP, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.023420; Okunishi M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.143001; Baggesen JC, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/11/115601; Tolstikhin OI, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.043417; Haessler S, 2010, NAT PHYS, V6, P200, DOI 10.1038/NPHYS1511; Etches A, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/15/155602; Schultze M, 2010, SCIENCE, V328, P1658, DOI 10.1126/science.1189401; Jensen F, 2001, J CHEM PHYS, V115, P9113, DOI 10.1063/1.1413524; Aidas K, 2014, WIRES COMPUT MOL SCI, V4, P269, DOI 10.1002/wcms.1172; GIANTURCO FA, 1994, J CHEM PHYS, V100, P6464, DOI 10.1063/1.467237; Pazourek R, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.163001; Wong MCH, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.033006; Morishita T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013903; Ray D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.143002; Shiner AD, 2011, NAT PHYS, V7, P464, DOI [10.1038/nphys1940, 10.1038/NPHYS1940]; Holmegaard L, 2010, NAT PHYS, V6, P428, DOI [10.1038/nphys1666, 10.1038/NPHYS1666]; Kamta GL, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.033415; Dimitrovski D, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.103005; Etches A, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.023818; Hamilton E, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.043402; Jordan G, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/025035; Kraus PM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.023001; Le AT, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.013401; Le AT, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.063406; LEE AM, 1994, J CHEM PHYS, V101, P9704, DOI 10.1063/1.468443; Lein M, 2007, J PHYS B-AT MOL OPT, V40, pR135, DOI 10.1088/0953-4075/40/16/R01; Mauritsson J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073003; Minemoto S, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.061402; piewanowski S M. D., 2013, PHYS REV A, V87; Rupenyan A, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.033409; Tehlar A, 2013, MOL PHYS, V111, P2057, DOI 10.1080/00268976.2013.782439; Tolstikhin OI, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.013421; Tolstikhin OI, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.053423; Worner HJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.103901	50	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7039	10.1038/ncomms8039		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5MA	WOS:000355530400003		
J	Sentef, MA; Claassen, M; Kemper, AF; Moritz, B; Oka, T; Freericks, JK; Devereaux, TP				Sentef, M. A.; Claassen, M.; Kemper, A. F.; Moritz, B.; Oka, T.; Freericks, J. K.; Devereaux, T. P.			Theory of Floquet band formation and local pseudospin textures in pump-probe photoemission of graphene	NATURE COMMUNICATIONS			English	Article							HGTE QUANTUM-WELLS; TOPOLOGICAL INSULATORS; DIRAC POINTS; SPIN; REALIZATION; TRANSITION; LATTICE; MODEL	Ultrafast materials science promises optical control of physical properties of solids. Continuous-wave circularly polarized laser driving was predicted to induce a light-matter coupled state with an energy gap and a quantum Hall effect, coined Floquet topological insulator. Whereas the envisioned Floquet topological insulator requires high-frequency pumping to obtain well-separated Floquet bands, a follow-up question regards the creation of Floquet-like states in graphene with realistic low-frequency laser pulses. Here we predict that short optical pulses attainable in experiments can lead to local spectral gaps and novel pseudospin textures in graphene. Pump-probe photoemission spectroscopy can track these states by measuring sizeable energy gaps and Floquet band formation on femtosecond time scales. Analysing band crossings and pseudospin textures near the Dirac points, we identify new states with optically induced nontrivial changes of sublattice mixing that leads to Berry curvature corrections of electrical transport and magnetization.	[Sentef, M. A.; Moritz, B.; Devereaux, T. P.] Stanford Univ, SIMES, Menlo Pk, CA 94025 USA; [Sentef, M. A.; Moritz, B.; Devereaux, T. P.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Sentef, M. A.] Univ Bonn, HISKP, D-53115 Bonn, Germany; [Claassen, M.; Devereaux, T. P.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Kemper, A. F.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Moritz, B.] Univ N Dakota, Dept Phys & Astrophys, Grand Forks, ND 58202 USA; [Oka, T.] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Freericks, J. K.] Georgetown Univ, Dept Phys, Washington, DC 20057 USA	Sentef, MA (reprint author), Stanford Univ, SIMES, Menlo Pk, CA 94025 USA.	michael.sentef@hiskp.uni-bonn.de; tpd@stanford.edu	Moritz, Brian/D-7505-2015; Sentef, Michael/L-5717-2013; 	Moritz, Brian/0000-0002-3747-8484; Sentef, Michael/0000-0002-7946-0282; Kemper, Alexander/0000-0002-5426-5181	Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-76SF00515, DE-FG02-08ER46542, DE-SC0007091]; Department of Energy, Office of Science [DE-AC02-05CH11231]; McDevitt bequest at Georgetown; Laboratory Directed Research and Development Program of Lawrence Berkeley National Laboratory under U.S. Department of Energy [DE-AC02-05CH11231]	We acknowledge helpful discussions with Patrick Kirchmann, Sri Raghu, Xiao-Liang Qi, Shou-Cheng Zhang, and Bruce Normand. This work was supported by the Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Contract Nos. DE-AC02-76SF00515 (Stanford/SIMES), DE-FG02-08ER46542 (Georgetown) and DE-SC0007091 (for the collaboration). Computational resources were provided by the National Energy Research Scientific Computing Center supported by the Department of Energy, Office of Science, under Contract No. DE-AC02-05CH11231. J.K.F. was also supported by the McDevitt bequest at Georgetown. A.F.K. was supported by the Laboratory Directed Research and Development Program of Lawrence Berkeley National Laboratory under U.S. Department of Energy Contract No. DE-AC02-05CH11231.	Kitagawa T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235108; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Xu XD, 2014, NAT PHYS, V10, P343, DOI 10.1038/NPHYS2942; Uehlinger T, 2013, EUR PHYS J-SPEC TOP, V217, P121, DOI 10.1140/epjst/e2013-01761-y; Fausti D, 2011, SCIENCE, V331, P189, DOI 10.1126/science.1197294; Sobota JA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.117403; Morell ES, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.125449; Rudner MS, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.031005; Gu ZH, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.216601; Lindner NH, 2011, NAT PHYS, V7, P490, DOI 10.1038/NPHYS1926; Fregoso BM, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.155129; Freericks JK, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.136401; Tarruell L, 2012, NATURE, V483, P302, DOI 10.1038/nature10871; Wu SF, 2013, NAT PHYS, V9, P149; Gierz I, 2013, NAT MATER, V12, P1119, DOI [10.1038/nmat3757, 10.1038/NMAT3757]; Min HK, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155416; Kundu A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.236803; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Cayssol J, 2013, PHYS STATUS SOLIDI-R, V7, P101, DOI 10.1002/pssr.201206451; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Caviglia AD, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.136801; Iadecola T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.176603; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Zhang HJ, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.066801; Calvo HL, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3597412; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; WALLACE PR, 1947, PHYS REV, V71, P622, DOI 10.1103/PhysRev.71.622; Wang YH, 2013, SCIENCE, V342, P453, DOI 10.1126/science.1239834; Tahir M, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.125438; Johannsen JC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.027403; Oka T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.081406; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Kitagawa T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.235114; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Dahlhaus J. P., 2014, PREPRINT; Dehghani H, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.195429; Dora B, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.056602; Freericks J. K., 2014, PREPRINT; Grushin AG, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.156801; Kumar A, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.241108; Perez-Piskunow PM, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.121401; Sentef M, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041033	43	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7047	10.1038/ncomms8047		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5MC	WOS:000355530700003		
J	Sun, R; Wang, ZC; Saito, M; Shibata, N; Ikuhara, Y				Sun, Rong; Wang, Zhongchang; Saito, Mitsuhiro; Shibata, Naoya; Ikuhara, Yuichi			Atomistic mechanisms of nonstoichiometry-induced twin boundary structural transformation in titanium dioxide	NATURE COMMUNICATIONS			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; TILT GRAIN-BOUNDARY; SCALE; TIO2; RESOLUTION; ALUMINA; THERMODYNAMICS; NANOCRYSTALS; INTERFACE; LATTICE	Grain boundary (GB) phase transformations often occur in polycrystalline materials while exposed to external stimuli and are universally implicated in substantially affecting their properties, yet atomic-scale knowledge on the transformation process is far from developed. In particular, whether GBs loaded with defects due to treatments can still be conventionally considered as disordered areas with kinetically trapped structure or turn ordered is debated. Here we combine advanced electron microscopy, spectroscopy and first-principles calculations to probe individual TiO2 GB subject to different atmosphere, and to demonstrate that stimulated structural defects can self-assemble at GB, forming an ordered structure, which results in GB nonstoichiometry and structural transformations at the atomic scale. Such structural transformation is accompanied with electronic transition at GB. The three-dimensional transformations afford new perspectives on the structural defects at GBs and on the development of strategies to manipulate practically significant GB transformations.	[Sun, Rong; Shibata, Naoya; Ikuhara, Yuichi] Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan; [Wang, Zhongchang; Saito, Mitsuhiro; Ikuhara, Yuichi] Tohoku Univ, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Ikuhara, Yuichi] Japan Fine Ceram Ctr, Nanostruct Res Lab, Nagoya, Aichi 4568587, Japan	Wang, ZC (reprint author), Tohoku Univ, Adv Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	zcwang@wpi-aimr.tohoku.ac.jp; ikuhara@sigma.t.u-tokyo.ac.jp	Shibata, Naoya/E-5327-2013; Ikuhara, Yuichi/N-1001-2015; Ikuhara, Yuichi/F-3066-2010	Ikuhara, Yuichi/0000-0003-3886-005X; 	MEXT of Japan [12024046]; Elements Strategy Initiative for Structural Materials (ESISM) via MEXT by Japan; JSPS; MEXT scholarship; Challenging Exploratory Research [15K14117]; NSFC [11332013]; CAS under Japan-China Scientific Cooperation Program; Murata Science Foundation; Shorai Foundation for Science and Technology; JST-PRESTO; JSPS KAKENHI [26289234]; JSPS under Japan-China Scientific Cooperation Program;  [15H04114]	We thank R. Ishikawa for experimental assistance. This work was conducted in part at the GRENE (Green Network of Excellence) and the Nanotechnology Platform (project No. 12024046) at the University of Tokyo supported by MEXT of Japan, and was supported in part by the Elements Strategy Initiative for Structural Materials (ESISM) via MEXT by Japan and JSPS Grant-in-Aid for Scientific Research on Innovative Areas 'Nano Informatics'. R.S. was supported by the MEXT scholarship. Z.W. thanks the financial supports from the Scientific Research (B; grant no. 15H04114), the Challenging Exploratory Research (grant no. 15K14117), NSFC (grant no. 11332013), JSPS and CAS under Japan-China Scientific Cooperation Program, Murata Science Foundation and the Shorai Foundation for Science and Technology. N.S. thanks the support from the JST-PRESTO and the JSPS KAKENHI (grant no. 26289234). Calculations were conducted at the ISSP, University of Tokyo.	Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Rodriguez JA, 2007, SCIENCE, V318, P1757, DOI 10.1126/science.1150038; ISHIZUKA K, 1977, ACTA CRYSTALLOGR A, V33, P740, DOI 10.1107/S0567739477001879; Baram M, 2011, SCIENCE, V332, P206, DOI 10.1126/science.1201596; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Wang ZC, 2011, NATURE, V479, P380, DOI 10.1038/nature10593; Findlay SD, 2010, ULTRAMICROSCOPY, V110, P903, DOI 10.1016/j.ultramic.2010.04.004; PENNYCOOK SJ, 1988, NATURE, V336, P565, DOI 10.1038/336565a0; Abou-Ras D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.075502; Chen XB, 2011, SCIENCE, V331, P746, DOI 10.1126/science.1200448; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Ikuhara Y, 2011, J ELECTRON MICROSC, V60, pS173, DOI 10.1093/jmicro/dfr049; Browning ND, 1999, APPL PHYS LETT, V74, P2638, DOI 10.1063/1.123922; Shibata N, 2009, NAT MATER, V8, P654, DOI [10.1038/nmat2486, 10.1038/NMAT2486]; Nowotny J, 2007, J PHYS CHEM C, V111, P9769, DOI 10.1021/jp067869; Mishin Y, 2009, ACTA MATER, V57, P3771, DOI 10.1016/j.actamat.2009.04.044; Nellist PD, 2004, SCIENCE, V305, P1741, DOI 10.1126/science.1100965; Epifani M, 2008, J PHYS CHEM C, V112, P19540, DOI 10.1021/jp804916g; Trani F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.245410; Muller DA, 2009, NAT MATER, V8, P263, DOI [10.1038/nmat2380, 10.1038/NMAT2380]; Buban JP, 2006, SCIENCE, V311, P212, DOI 10.1126/science.1119839; Findlay SD, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3265946; Urban KW, 2008, SCIENCE, V321, P506, DOI 10.1126/science.1152800; Jia CL, 2004, SCIENCE, V303, P2001, DOI 10.1126/science.1093617; Browning ND, 1998, PHYS REV B, V58, P8289, DOI 10.1103/PhysRevB.58.8289; Colliex C, 2007, NATURE, V450, P622, DOI 10.1038/450622a; Frolov T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2919; Gemming S., 2007, PHYS REV B, V76; Korner W, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205315; Lartigue-Korinek S, 2011, ACTA MATER, V59, P3519, DOI 10.1016/j.actamat.2011.02.025; McKenna KP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6740; Moeck P, 2014, CRYST RES TECHNOL, V49, P708, DOI 10.1002/crat.201400071; Ohno T, 2004, MATER TRANS, V45, P2117, DOI 10.2320/matertrans.45.2117; Prabhumirashi P, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2046734; Saito M, 2013, J MATER SCI, V48, P5470, DOI 10.1007/s10853-013-7340-7; Shibata N, 2007, SCIENCE, V316, P82, DOI 10.1126/science.1136155; Sinnott SB, 2000, PHYS REV B, V61, P15645, DOI 10.1103/PhysRevB.61.15645; Sutton A.P., 1995, INTERFACE CRYSTALLIN; Wallis DJ, 1997, J AM CERAM SOC, V80, P499; Wang ZC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4239	40	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7120	10.1038/ncomms8120		7	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5MW	WOS:000355533000008		
J	Sung, BH; Ketova, T; Hoshino, D; Zijlstra, A; Weaver, AM				Sung, Bong Hwan; Ketova, Tatiana; Hoshino, Daisuke; Zijlstra, Andries; Weaver, Alissa M.			Directional cell movement through tissues is controlled by exosome secretion	NATURE COMMUNICATIONS			English	Article							LAMELLIPODIAL PERSISTENCE; EXTRACELLULAR-MATRIX; CANCER PROGRESSION; TETRASPANIN CD151; IN-VIVO; MIGRATION; MOTILITY; ADHESION; FIBRONECTIN; TRAFFICKING	Directional cell movement through tissues is critical for multiple biological processes and requires maintenance of polarity in the face of complex environmental cues. Here we use intravital imaging to demonstrate that secretion of exosomes from late endosomes is required for directionally persistent and efficient in vivo movement of cancer cells. Inhibiting exosome secretion or biogenesis leads to defective tumour cell migration associated with increased formation of unstable protrusions and excessive directional switching. In vitro rescue experiments with purified exosomes and matrix coating identify adhesion assembly as a critical exosome function that promotes efficient cell motility. Live-cell imaging reveals that exosome secretion directly precedes and promotes adhesion assembly. Fibronectin is found to be a critical motility-promoting cargo whose sorting into exosomes depends on binding to integrins. We propose that autocrine secretion of exosomes powerfully promotes directionally persistent and effective cell motility by reinforcing otherwise transient polarization states and promoting adhesion assembly.	[Sung, Bong Hwan; Zijlstra, Andries; Weaver, Alissa M.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Ketova, Tatiana; Zijlstra, Andries; Weaver, Alissa M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Hoshino, Daisuke] Kanagawa Canc Ctr, Div Canc Cell Res, Yokohama, Kanagawa 2418515, Japan; [Weaver, Alissa M.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Zijlstra, A (reprint author), Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA.	andries.zijlstra@vanderbilt.edu; alissa.weaver@vanderbilt.edu			NCI grants [R01 CA163592, U01CA143069, U19 CA179514, CA143081]; American Cancer Society [RSG-09-170-01-CSM]; American Heart Association Research Grant-in-Aid [13GRNT16580020];  [CA68485];  [DK20593];  [DK58404];  [HD15052];  [DK59637];  [EY08126]	This study was funded by NCI grants R01 CA163592, U01CA143069, U19 CA179514 to A.M.W. and CA143081 to A.Z., by American Cancer Society RSG-09-170-01-CSM to A.M.W. and American Heart Association Research Grant-in-Aid 13GRNT16580020 to A.M.W. The Vanderbilt Cell Imaging Shared Resource (CISR) and/or Flow Cytometry facilities are supported by grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126. We thank Irina Kaverina and Matt Tyska for use of their TIRF microscopes and Robert Coffey for use of NanoSight. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. In addition, we are grateful to Tyson Foods Inc. for generously providing the chick embryos for these studies.	Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2001.01.003; Shen BY, 2011, J BIOL CHEM, V286, P44162, DOI 10.1074/jbc.M111.274803; Reid CR, 2012, P NATL ACAD SCI USA, V109, P17490, DOI 10.1073/pnas.1215037109; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Sung BH, 2011, CURR BIOL, V21, P1460, DOI 10.1016/j.cub.2011.06.065; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Ewoldt RH, 2007, SOFT MATTER, V3, P634, DOI 10.1039/b615546d; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Mu W, 2013, NEOPLASIA, V15, P875, DOI 10.1593/neo.13786; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; Deng ZB, 2012, AM J PATHOL, V180, P390, DOI 10.1016/j.ajpath.2011.09.023; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Millarte V, 2012, SCI WORLD J, DOI 10.1100/2012/498278; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; Palmer TD, 2014, CANCER RES, V74, P173, DOI 10.1158/0008-5472.CAN-13-0275; Chen TY, 2011, J IMMUNOL, V186, P2219, DOI 10.4049/jimmunol.1002991; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Tamai K, 2010, BIOCHEM BIOPH RES CO, V399, P384, DOI 10.1016/j.bbrc.2010.07.083; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Borm B, 2005, EXP CELL RES, V302, P83, DOI 10.1016/j.yexcr.2004.08.034; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; DENNY M, 1980, SCIENCE, V208, P1288, DOI 10.1126/science.208.4449.1288; Hoshino D, 2013, CELL REP, V5, P1159, DOI 10.1016/j.celrep.2013.10.050; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Benesh EC, 2013, MOL BIOL CELL, V24, P3496, DOI 10.1091/mbc.E12-07-0539; Berginski Matthew E, 2013, F1000Res, V2, P68, DOI 10.12688/f1000research.2-68.v1; Cho C. F., 2011, J VIS EXP, V52, pe2808, DOI [10.3791/2808, DOI 10.3791/2808]; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Kain KH, 2014, DEV DYNAM, V243, P216, DOI 10.1002/dvdy.24093; Koumangoye RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024234; Palmer TD, 2011, J VIS EXP, V51, pe2815, DOI [10.3791/2815, DOI 10.3791/2815]; Proux-Gillardeaux V, 2007, BIOL CELL, V99, P261, DOI 10.1042/BC20060097; Théry Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15	49	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7164	10.1038/ncomms8164		14	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5NK	WOS:000355534400001		
J	Tokoro, H; Yoshikiyo, M; Imoto, K; Namai, A; Nasu, T; Nakagawa, K; Ozaki, N; Hakoe, F; Tanaka, K; Chiba, K; Makiura, R; Prassides, K; Ohkoshi, S				Tokoro, Hiroko; Yoshikiyo, Marie; Imoto, Kenta; Namai, Asuka; Nasu, Tomomichi; Nakagawa, Kosuke; Ozaki, Noriaki; Hakoe, Fumiyoshi; Tanaka, Kenji; Chiba, Kouji; Makiura, Rie; Prassides, Kosmas; Ohkoshi, Shin-ichi			External stimulation-controllable heat-storage ceramics	NATURE COMMUNICATIONS			English	Article							THERMAL-ENERGY STORAGE; PHASE-CHANGE MATERIALS; HIGH-PRESSURE PHASES; METAL TRANSITION; CHARGE-TRANSFER; LIGHT; STATE; TRANSFORMATION; COMPOUND	Commonly available heat-storage materials cannot usually store the energy for a prolonged period. If a solid material could conserve the accumulated thermal energy, then its heat-storage application potential is considerably widened. Here we report a phase transition material that can conserve the latent heat energy in a wide temperature range, T<530 K and release the heat energy on the application of pressure. This material is stripe-type lambda-trititanium pentoxide, lambda-Ti3O5, which exhibits a solid-solid phase transition to beta-trititanium pentoxide, beta-Ti3O5. The pressure for conversion is extremely small, only 600 bar (60MPa) at ambient temperature, and the accumulated heat energy is surprisingly large (230 kJ L-1). Conversely, the pressure-produced beta-trititanium pentoxide transforms to lambda-trititanium pentoxide by heat, light or electric current. That is, the present system exhibits pressure-and-heat, pressure-and-light and pressure-and-current reversible phase transitions. The material may be useful for heat storage, as well as in sensor and switching memory device applications.	[Tokoro, Hiroko; Yoshikiyo, Marie; Imoto, Kenta; Namai, Asuka; Nasu, Tomomichi; Nakagawa, Kosuke; Ozaki, Noriaki; Hakoe, Fumiyoshi; Tanaka, Kenji; Ohkoshi, Shin-ichi] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Tokoro, Hiroko; Ohkoshi, Shin-ichi] JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan; [Tokoro, Hiroko] Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, Tsukuba, Ibaraki 3058577, Japan; [Chiba, Kouji] Ryoka Syst Inc, Sci & Technol Syst Div, Sumida Ku, Tokyo 1310045, Japan; [Makiura, Rie] Osaka Prefecture Univ, Nanosci & Nanotechnol Res Ctr, Naka Ku, Osaka 5998570, Japan; [Makiura, Rie] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Prassides, Kosmas] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Ohkoshi, S (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ohkoshi@chem.s.u-tokyo.ac.jp	Prassides, Kosmas/C-9804-2009		MEXT; JST; JSPS; WPI Research Center Initiative for Atoms, Molecules and Materials, SCF for Promoting Science and Technology; Izumi Foundation; Kurata Foundation; APSA from MEXT	We are grateful to Mr Y. Kakegawa, Mr H. Tsunakawa and Mr S. Ohtsuka (The University of Tokyo) for collecting the TEM and SEM images and we also recognize the Cryogenic Research Center and the Center for Nano Lithography and Analysis, The University of Tokyo, which are supported by MEXT. We are grateful to Mr R. Uemura (Nippon Steel and Sumikin Technology Co., Ltd.) for the thermal conductivity measurement and Mr T. Tomiura and Mr Y. Okada (NIKKISO Co., Ltd.) for the knowledge of the pressure experiment. The present research was supported in part by the CREST project of JST, the Grant-in-Aid for Young Scientists (A), (B), Research Activity Start-up and the NEXT programme from JSPS, the WPI Research Center Initiative for Atoms, Molecules and Materials, SCF for Promoting Science and Technology and APSA from MEXT, Izumi Foundation and Kurata Foundation. M.Y. and N.O. are grateful to JSPS Research Fellowship for Young Scientists. M.Y. is grateful to ALPS and T.N. is grateful to MERIT from MEXT.	Al-Jabri KS, 2005, CEMENT CONCRETE RES, V35, P1472, DOI 10.1016/j.cemconres.2004.08.018; Ahart M, 2008, NATURE, V451, P545, DOI 10.1038/nature06459; Takabayashi Y, 2009, SCIENCE, V323, P1585, DOI 10.1126/science.1169163; Crabtree GW, 2007, PHYS TODAY, V60, P37, DOI 10.1063/1.2718755; Cao Q, 2006, EUR POLYM J, V42, P2931, DOI 10.1016/j.eurpolymj.2006.07.020; Ohkoshi S, 2014, NAT PHOTONICS, V8, P65, DOI [10.1038/nphoton.2013.310, 10.1038/NPHOTON.2013.310]; Miyano K, 1997, PHYS REV LETT, V78, P4257, DOI 10.1103/PhysRevLett.78.4257; BENSON DK, 1986, SOL ENERG MATER, V13, P133, DOI 10.1016/0165-1633(86)90040-7; SLICHTER CP, 1972, J CHEM PHYS, V56, P2142, DOI 10.1063/1.1677511; Hanfland M, 2000, NATURE, V408, P174; Sharma A, 2009, RENEW SUST ENERG REV, V13, P318, DOI 10.1016/j.rser.2007.10.005; Karzel H, 1996, PHYS REV B, V53, P11425, DOI 10.1103/PhysRevB.53.11425; Cartlidge E, 2011, SCIENCE, V334, P922, DOI 10.1126/science.334.6058.922; Ikeda S, 2010, NAT MATER, V9, P721, DOI [10.1038/nmat2804, 10.1038/NMAT2804]; Ohkoshi S, 2011, NAT CHEM, V3, P564, DOI 10.1038/nchem.1067; TOLBERT SH, 1994, SCIENCE, V265, P373, DOI 10.1126/science.265.5170.373; Avdeev M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.064105; Collet E, 2003, SCIENCE, V300, P612, DOI 10.1126/science.1082001; Yamanouchi M, 2004, NATURE, V428, P539, DOI 10.1038/nature02441; Fiebig M, 1998, SCIENCE, V280, P1925, DOI 10.1126/science.280.5371.1925; Huang LP, 2006, NAT MATER, V5, P977, DOI 10.1038/nmat1760; Tomuta DG, 2001, J PHYS-CONDENS MAT, V13, P4543, DOI 10.1088/0953-8984/13/20/315; Li WP, 1999, THERMOCHIM ACTA, V326, P183, DOI 10.1016/S0040-6031(98)00497-3; GUTLICH P, 1994, ANGEW CHEM INT EDIT, V33, P2024, DOI 10.1002/anie.199420241; Medvedev S, 2009, NAT MATER, V8, P630, DOI [10.1038/nmat2491, 10.1038/NMAT2491]; Asamitsu A, 1997, NATURE, V388, P50, DOI 10.1038/40363; KOSHIHARA S, 1990, PHYS REV B, V42, P6853, DOI 10.1103/PhysRevB.42.6853; Gur I, 2012, SCIENCE, V335, P1454, DOI 10.1126/science.1218761; Ohkoshi SI, 2012, ACCOUNTS CHEM RES, V45, P1749, DOI 10.1021/ar300068k; Ohkoshi S, 2010, NAT CHEM, V2, P539, DOI [10.1038/nchem.670, 10.1038/NCHEM.670]; Mujica A, 2003, REV MOD PHYS, V75, P863, DOI 10.1103/RevModPhys.75.863; Wuttig M, 2007, NAT MATER, V6, P824, DOI 10.1038/nmat2009; Kolobov AV, 2004, NAT MATER, V3, P703, DOI 10.1038/nmat1215; Azuma M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1361; Barrio M, 1996, J SOLID STATE CHEM, V124, P29, DOI 10.1006/jssc.1996.0203; BUSICO V, 1980, SOL ENERGY, V24, P575, DOI 10.1016/0038-092X(80)90356-4; Farid MM, 2004, ENERG CONVERS MANAGE, V45, P1597, DOI 10.1016/j.enconman.2003.09.015; GREY IE, 1994, J SOLID STATE CHEM, V113, P62, DOI 10.1006/jssc.1994.1342; Letard JF, 1999, J AM CHEM SOC, V121, P10630, DOI 10.1021/ja991476p; Lipinska-Kalita KE, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.094123; McMahon MI, 1998, PHYS REV LETT, V80, P5564, DOI 10.1103/PhysRevLett.80.5564; Nahas MK, 1938, NATURE, V142, P837, DOI 10.1038/142837b0; Nayak AP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4731; Nelmes RJ, 1996, PHYS REV LETT, V77, P663, DOI 10.1103/PhysRevLett.77.663; Onoda M, 1998, J SOLID STATE CHEM, V136, P67, DOI 10.1006/jssc.1997.7657; SATO H, 1991, SCIENCE, V251, P786, DOI 10.1126/science.251.4995.786	46	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7037	10.1038/ncomms8037		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5MA	WOS:000355530400001		
J	Yamamoto, D; Nakajima, C; Shioi, A; Krafft, MP; Yoshikawa, K				Yamamoto, Daigo; Nakajima, Chika; Shioi, Akihisa; Krafft, Marie Pierre; Yoshikawa, Kenichi			The evolution of spatial ordering of oil drops fast spreading on a water surface	NATURE COMMUNICATIONS			English	Article							SELF-ORGANIZATION; MOTION; FLUCTUATIONS; INTERFACE; CHEMISTRY; DYNAMICS; BEHAVIOR; DRIVEN	The design of dynamically self-assembled systems is of high interest in science and technology. Here, we report a unique cascade in the self-ordering of droplets accompanied by a dewetting transition. The dynamic self-emergent droplets are observed when a thin liquid layer of an immiscible fluorocarbon oil (perfluorooctyl bromide, PFOB) is placed on a water surface. Due to the gradual evaporation of PFOB, a circular PFOB-free domain appears as a result of a local dewetting transition. A circular pearling structure is generated at the rim with the growth of the dewetting hole. As the next stage, linear arrays of droplets are generated in a radial manner from the centre of the hole. These one-dimensional arrangements then evolve into two-dimensional hexagonal arrays of microdroplets through collective rhythmical shrinking/expanding motions. The emergence of such dynamic patterns is discussed in terms of the nonlinear kinetics of the dewetting transition under thermodynamically dissipative conditions.	[Yamamoto, Daigo; Nakajima, Chika; Shioi, Akihisa] Doshisha Univ, Dept Chem Engn & Mat Sci, Kyoto 6100321, Japan; [Krafft, Marie Pierre] Univ Strasbourg, CNRS, Inst Charles Sadron, Fluorinated Soft Matter Grp, F-67034 Strasbourg, France; [Yoshikawa, Kenichi] Doshisha Univ, Fac Life & Med Sci, Lab Life Phys, Kyoto 6100394, Japan	Yamamoto, D (reprint author), Doshisha Univ, Dept Chem Engn & Mat Sci, Kyoto 6100321, Japan.	dyamamot@mail.doshisha.ac.jp; krafft@unistra.fr		Yoshikawa, Kenichi/0000-0002-2751-7136	Japan Society for the Promotion of Science; KAKENHI [23240044, 25103012, 25610111]	We thank Dr Yong-Jun Chen (Shaoxing University) for useful suggestions concerning Supplementary Note 1. M.P.K. acknowledges the Japan Society for the Promotion of Science for a research grant. This study was partially supported by Grants-in-Aid, KAKENHI (23240044; 25103012; 25610111).	Paxton WF, 2004, J AM CHEM SOC, V126, P13424, DOI 10.1021/ja047697z; DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Riess JG, 2001, CHEM REV, V101, P2797, DOI 10.1021/cr970143c; Parrish JK, 2002, BIOL BULL, V202, P296, DOI 10.2307/1543482; Zhang HP, 2010, P NATL ACAD SCI USA, V107, P13626, DOI 10.1073/pnas.1001651107; Yoshida R, 2010, ADV MATER, V22, P3463, DOI 10.1002/adma.200904075; Fialkowski M, 2006, J PHYS CHEM B, V110, P2482, DOI 10.1021/jp054153q; Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063; Krafft MP, 2009, CHEM REV, V109, P1714, DOI 10.1021/cr800260k; Ibele M, 2009, ANGEW CHEM INT EDIT, V48, P3308, DOI 10.1002/anie.200804704; Grzybowski BA, 2000, NATURE, V405, P1033; Antoine C, 2013, LANGMUIR, V29, P14935, DOI 10.1021/la403678r; Bates CM, 2008, LANGMUIR, V24, P7193, DOI 10.1021/la800105h; Chen YJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016303; Hemelrijk CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022479; Ikura YS, 2012, J PHYS CHEM B, V116, P992, DOI 10.1021/jp210990a; Karthaus O, 1999, CHAOS, V9, P308, DOI 10.1063/1.166407; Krafft MP, 2012, ACCOUNTS CHEM RES, V45, P514, DOI 10.1021/ar200178a; Krafft MP, 2007, J POLYM SCI POL CHEM, V45, P1185, DOI 10.1002/pola.21937; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Pimienta V, 2011, ANGEW CHEM INT EDIT, V50, P10728, DOI 10.1002/anie.201104261; Pockels A., 1891, NATURE, V43, P437; Rayleigh L., 1890, P R SOC LONDON, V47, P364; Yamamoto D, 2015, KONA POWDER PART J, P2	26	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7189	10.1038/ncomms8189		6	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5OI	WOS:000355536900008		
J	Yan, Y; Wladyka, C; Fujii, J; Sockanathan, S				Yan, Ye; Wladyka, Cynthia; Fujii, Junichi; Sockanathan, Shanthini			Prdx4 is a compartment-specific H2O2 sensor that regulates neurogenesis by controlling surface expression of GDE2	NATURE COMMUNICATIONS			English	Article							RETICULUM-LOCALIZED PEROXIREDOXIN; MOTOR-NEURON DIVERSITY; ENDOPLASMIC-RETICULUM; STEM/PROGENITOR CELLS; REDOX HOMEOSTASIS; PROTEIN; DIFFERENTIATION; PEROXIDASE; ACTIVATION; IDENTITY	Neural progenitors and terminally differentiated neurons show distinct redox profiles, suggesting that coupled-redox cascades regulate the initiation and progression of neuronal differentiation. Discrete cellular compartments have different redox environments and how they contribute to differentiation is unclear. Here we show that Prdx4, an endoplasmic reticulum (ER) enzyme that metabolizes H2O2, acts as a tunable regulator of neurogenesis via its compartmentalized thiol-oxidative function. Prdx4 ablation causes premature motor neuron differentiation and progenitor depletion, leading to imbalances in subtype-specific motor neurons. GDE2, a six-transmembrane protein that induces differentiation by down-regulating Notch signalling through surface cleavage of GPI-anchored proteins, is targeted by Prdx4 oxidative activity. Prdx4 dimers generated by H2O2 metabolism oxidize two cysteine residues within the GDE2 enzymatic domain, which blocks GDE2 trafficking to the plasma membrane and prevents GDE2 neurogeneic function. Thus, Prdx4 oxidative activity acts as a sensor to directly couple neuronal differentiation with redox environments in the ER.	[Yan, Ye; Wladyka, Cynthia; Sockanathan, Shanthini] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Fujii, Junichi] Yamagata Univ, Dept Biochem & Mol Biol, Yamagata 9909585, Japan	Sockanathan, S (reprint author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, PCTB1004,725 N Wolfe St, Baltimore, MD 21205 USA.	ssockan1@jhmi.edu			Muscular Dystrophy Association	We thank Ben Novitch and Thomas Jessell for antibodies; Donna Zhang for the ARE-luciferase plasmid; Changhee Lee and Leiming Wang for their help with statistics; Clint Cave II and Sungjin Park for their critical comments on the manuscript, and members of the Sockanathan laboratory for their valuable discussions and suggestions. This work was funded by a grant from the Muscular Dystrophy Association.	Kakihana T, 2012, ANTIOXID REDOX SIGN, V16, P763, DOI 10.1089/ars.2011.4238; Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042; Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516; Iuchi Y, 2009, BIOCHEM J, V419, P149, DOI 10.1042/BJ20081526; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Palande K, 2011, J CELL SCI, V124, P3695, DOI 10.1242/jcs.089656; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Wang K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.50; Pelham HRB, 1996, CELL STRUCT FUNCT, V21, P413; Rodriguez M, 2012, DEVELOPMENT, V139, P3870, DOI 10.1242/dev.081083; Park S, 2013, SCIENCE, V339, P324, DOI 10.1126/science.1231921; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Urao N, 2013, FREE RADICAL BIO MED, V54, P26, DOI 10.1016/j.freeradbiomed.2012.10.532; Garcia NVDM, 2008, NEURON, V57, P217, DOI 10.1016/j.neuron.2007.11.033; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Okado-Matsumoto A, 2000, J BIOCHEM-TOKYO, V127, P493; Yoneyama M, 2010, NEUROCHEM INT, V56, P740, DOI 10.1016/j.neuint.2009.11.018; Sabharwal P, 2011, NEURON, V71, P1058, DOI 10.1016/j.neuron.2011.07.028; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Francius C, 2014, CELL MOL LIFE SCI, V71, P813, DOI 10.1007/s00018-013-1398-x; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Giguere P, 2007, FEBS LETT, V581, P3863, DOI 10.1016/j.febslet.2007.07.011; Kaludercic N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00285; Kuhn TB, 2003, METHOD CELL BIOL, V71, P67, DOI 10.1016/S0091-679X(03)01005-7; Putker M, 2014, BIOCHEM SOC T, V42, P971, DOI 10.1042/BST20140097; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; Zito E, 2013, ANTIOXID REDOX SIGN, V18, P1666, DOI 10.1089/ars.2012.4966	36	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7006	10.1038/ncomms8006		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5LR	WOS:000355529500003		
J	Yoshida, H; Asakura, K; Fukuda, J; Ozaki, M				Yoshida, H.; Asakura, K.; Fukuda, J.; Ozaki, M.			Three-dimensional positioning and control of colloidal objects utilizing engineered liquid crystalline defect networks	NATURE COMMUNICATIONS			English	Article							NANOPARTICLES; MANIPULATION; DYNAMICS; KNOTS	Topological defects in liquid crystals not only affect the optical and rheological properties of the host, but can also act as scaffolds in which to trap nano or micro-sized colloidal objects. The creation of complex defect shapes, however, often involves confining the liquid crystals in curved geometries or adds complex-shaped colloidal objects, which are unsuitable for device applications. Using topologically patterned substrates, here we demonstrate the controlled generation of three-dimensional defect lines with non-trivial shapes and even chirality, in a flat slab of nematic liquid crystal. By using the defect lines as templates and the electric response of the liquid crystals, colloidal superstructures are constructed, which can be reversibly reconfigured at a voltage as low as 1.3V. Three-dimensional engineering of the defect shapes in liquid crystals is potentially useful in the fabrication of self-healing composites and in stabilizing artificial frustrated phases.	[Yoshida, H.; Asakura, K.; Ozaki, M.] Osaka Univ, Div Elect Elect & Informat Engn, Osaka 5650871, Japan; [Fukuda, J.] Natl Inst Adv Ind Sci & Technol, AIST, Nanosyst Res Inst, Tsukuba, Ibaraki 3058568, Japan	Yoshida, H (reprint author), Osaka Univ, Div Elect Elect & Informat Engn, 2-1 Yamada Oka,Suita, Osaka 5650871, Japan.	yoshida@eei.eng.osaka-u.ac.jp			PRESTO programme from JST; Photonics Advanced Research Center (PARC) at Osaka University; JSPS [25400437]	This study was partly supported by the PRESTO programme from JST and the Photonics Advanced Research Center (PARC) at Osaka University. J.F. is supported by JSPS Grant-in-Aid (KAKENHI) for Scientific Research (C) (grant number 25400437). We thank DIC Corporation for kindly providing the photoaligning material.	Agha H, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12082-1; Zapotocky M, 1999, SCIENCE, V283, P209, DOI 10.1126/science.283.5399.209; Yamamoto T, 2012, LANGMUIR, V28, P8463, DOI 10.1021/la3001784; Marrucci L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.163905; Slussarenko S, 2011, OPT EXPRESS, V19, P4085, DOI 10.1364/OE.19.004085; Yu YL, 2003, NATURE, V425, P145, DOI 10.1038/425145a; Nakata M, 2007, SCIENCE, V318, P1276, DOI 10.1126/science.1143826; Cavallaro M, 2013, P NATL ACAD SCI USA, V110, P18804, DOI 10.1073/pnas.1313551110; Senyuk B, 2013, NATURE, V493, P200, DOI 10.1038/nature11710; Nagaosa N, 2013, NAT NANOTECHNOL, V8, P899, DOI [10.1038/nnano.2013.243, 10.1038/NNANO.2013.243]; Senyuk B, 2012, NANO LETT, V12, P955, DOI 10.1021/nl204030t; Skarabot M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031705; Mawet D, 2009, OPT EXPRESS, V17, P1902, DOI 10.1364/OE.17.001902; Higashiguchi K, 2012, POLYM J, V44, P632, DOI 10.1038/pj.2012.44; BOWICK MJ, 1994, SCIENCE, V263, P943, DOI 10.1126/science.263.5149.943; ADAM D, 1994, NATURE, V371, P141, DOI 10.1038/371141a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Martinez A, 2011, P NATL ACAD SCI USA, V108, P20891, DOI 10.1073/pnas.1112849108; Silvestre NM, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.225501; MADHUSUDANA NV, 1982, MOL CRYST LIQ CRYST, V89, P249, DOI 10.1080/00268948208074481; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Fukuda J, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041706; Lapointe CP, 2009, SCIENCE, V326, P1083, DOI 10.1126/science.1176587; Smalyukh II, 2010, NAT MATER, V9, P139, DOI [10.1038/nmat2592, 10.1038/NMAT2592]; Nersisyan SR, 2013, OPT EXPRESS, V21, P8205, DOI 10.1364/OE.21.008205; Chandrasekhar S., 1992, LIQUID CRYSTALS; de Lozar A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051713; Fukuda J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1250; Pires D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247801; Fleury JB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.267801; Kleman M., 2003, SOFT MATTER PHYS INT; Martinez A, 2014, NAT MATER, V13, P259, DOI [10.1038/nmat3840, 10.1038/NMAT3840]; Murray BS, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052501; Nych A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2486; Ohzono T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1709; Plum E, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/7/074009; Ravnik M, 2010, FARADAY DISCUSS, V144, P159, DOI 10.1039/b908676e; Tkalec U, 2011, SCIENCE, V333, P62, DOI 10.1126/science.1205705; Urayama K, 2008, POLYM J, V40, P669, DOI 10.1295/polymj.PJ2008033; VOLOVIK GE, 1983, ZH EKSP TEOR FIZ+, V85, P1997; Yeh P., 2010, OPTICS OF LIQUID CRY; Zhuang ZZ, 2000, APPL PHYS LETT, V76, P3005, DOI 10.1063/1.126560	42	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								UNSP 7180	10.1038/ncomms8180		8	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5OG	WOS:000355536700007		
J	Zhou, Y; Zhu, JG; Schermann, G; Ohle, C; Bendrin, K; Sugioka-Sugiyama, R; Sugiyama, T; Fischer, T				Zhou, Yang; Zhu, Jianguo; Schermann, Geza; Ohle, Corina; Bendrin, Katja; Sugioka-Sugiyama, Rie; Sugiyama, Tomoyasu; Fischer, Tamas			The fission yeast MTREC complex targets CUTs and unspliced pre-mRNAs to the nuclear exosome	NATURE COMMUNICATIONS			English	Article							SELECTIVE ELIMINATION; CRYSTAL-STRUCTURE; TRAMP COMPLEX; PERVASIVE TRANSCRIPTION; SURVEILLANCE MACHINERY; PHYLOGENETIC ANALYSIS; POLY(A) POLYMERASE; GENE-EXPRESSION; QUALITY-CONTROL; MEIOTIC GENES	Cryptic unstable transcripts (CUTs) are rapidly degraded by the nuclear exosome. However, the mechanism by which they are recognized and targeted to the exosome is not fully understood. Here we report that the MTREC complex, which has recently been shown to promote degradation of meiotic mRNAs and regulatory ncRNAs, is also the major nuclear exosome targeting complex for CUTs and unspliced pre-mRNAs in Schizosaccharomyces pombe. The MTREC complex specifically binds to CUTs, meiotic mRNAs and unspliced pre-mRNA transcripts and targets these RNAs for degradation by the nuclear exosome, while the TRAMP complex has only a minor role in this process. The MTREC complex physically interacts with the nuclear exosome and with various RNA-binding and RNA-processing complexes, coupling RNA processing to the RNA degradation machinery. Our study reveals the central role of the evolutionarily conserved MTREC complex in RNA quality control, and in the recognition and elimination of CUTs.	[Zhou, Yang; Zhu, Jianguo; Schermann, Geza; Ohle, Corina; Bendrin, Katja; Fischer, Tamas] Heidelberg Univ, Biochem Ctr BZH, D-69120 Heidelberg, Germany; [Sugioka-Sugiyama, Rie] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Sugiyama, Tomoyasu] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan	Sugiyama, T (reprint author), Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan.	sugiyamt@tara.tsukuba.ac.jp; tamas.fischer@bzh.uni-heidelberg.de			German Research Foundation (DFG) Collaborative Research Centre [SFB 638]; Japan Society for the Promotion of Science (JSPS) KAKENHI [22687013]; Precursory Research for Embryonic Science and Technology (PRESTO) of the Japan Science and Technology Agency (JST); China Scholarship Council (CSC)	We thank Jutta Worsch for her excellent technical assistance and Emmalene Bartlett for proofreading the manuscript. We thank David Ibberson and the CellNetworks Deep Sequencing Core Facility at Heidelberg University for the cDNA library preparation. We also thank Prof. Masayuki Yamamoto for providing the pla1-ts37 strain. This work was supported by a grant from the German Research Foundation (DFG) Collaborative Research Centre 'SFB 638' (to T.F.); the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 22687013 (to T.S.); and Precursory Research for Embryonic Science and Technology (PRESTO) of the Japan Science and Technology Agency (JST) (to T.S.). Y.Z. and J.Z. were supported by the China Scholarship Council (CSC).	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; St-Andre O, 2010, J BIOL CHEM, V285, P27859, DOI 10.1074/jbc.M110.150748; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Halbach F, 2013, CELL, V154, P814, DOI 10.1016/j.cell.2013.07.017; Hallais M, 2013, NAT STRUCT MOL BIOL, V20, P1358, DOI 10.1038/nsmb.2720; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Andersen PR, 2013, NAT STRUCT MOL BIOL, V20, P1367, DOI 10.1038/nsmb.2703; Castresana J, 2000, MOL BIOL EVOL, V17, P540; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Jensen TH, 2013, MOL CELL, V52, P473, DOI 10.1016/j.molcel.2013.10.032; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Lee NN, 2013, CELL, V155, P1061, DOI 10.1016/j.cell.2013.10.027; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Yamashita A, 2013, NUCLEIC ACIDS RES, V41, P9680, DOI 10.1093/nar/gkt763; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Hiriart E, 2012, EMBO J, V31, P2296, DOI 10.1038/emboj.2012.105; Egan ED, 2014, RNA, V20, P867, DOI 10.1261/rna.044479.114; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Tashiro S, 2013, GENES CELLS, V18, P327, DOI 10.1111/gtc.12038; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Sugiyama T, 2011, EMBO J, V30, P1027, DOI 10.1038/emboj.2011.32; Schneider C, 2013, TRENDS BIOCHEM SCI, V38, P485, DOI 10.1016/j.tibs.2013.06.013; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Schneider C, 2012, MOL CELL, V48, P422, DOI 10.1016/j.molcel.2012.08.013; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Gudipati RK, 2012, MOL CELL, V48, P409, DOI [10.1016/j.molcel.2012.08.018, 10.1016/j.molce1.2012.08.018]; Yamashita A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120014; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Chen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026804; Falk S, 2014, MOL CELL, V55, P856, DOI 10.1016/j.molcel.2014.07.020; Hurt JA, 2009, J CELL BIOL, V185, P265, DOI 10.1083/jcb.200811072; Jackson RN, 2010, EMBO J, V29, P2205, DOI 10.1038/emboj.2010.107; Jia HJ, 2011, CELL, V145, P890, DOI 10.1016/j.cell.2011.05.010; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Schlackow M, 2013, RNA, V19, P1617, DOI 10.1261/rna.040675.113; Schuch B, 2014, EMBO J, V33, P2829, DOI 10.15252/embj.201488757; Schwanhausser B., 2011, NATURE, V473, P337, DOI DOI 10.1038/NATURE10098; Sugiyama T, 2013, NUCLEIC ACIDS RES, V41, P6674, DOI 10.1093/nar/gkt363; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Zofall M., 2011, SCIENCE, V335, P96	55	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7050	10.1038/ncomms8050		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5ME	WOS:000355530900001		
J	Kuroda, H; Fujihara, K; Kushimoto, S; Aoki, M				Kuroda, Hiroshi; Fujihara, Kazuo; Kushimoto, Shigeki; Aoki, Masashi			Novel clinical grading of delayed neurologic sequelae after carbon monoxide poisoning and factors associated with outcome	NEUROTOXICOLOGY			English	Article						Delayed neurologic sequelae; Clinical grading; Outcome; Cerebrospinal fluid; Myelin basic protein	MYELIN BASIC-PROTEIN; CEREBROSPINAL-FLUID; WHITE-MATTER; HYPERBARIC-OXYGEN; PREDICTIVE MARKER; INTOXICATION; ENCEPHALOPATHY; BRAIN; SPECTROSCOPY; DISEASE	Introduction: Delayed neurologic sequelae (DNS) after carbon monoxide (CO) poisoning manifest as a relapse of neurologic deficits. However, the long-term outcome of DNS has not been fully clarified. Myelin basic protein (MBP) levels in the cerebrospinal fluid (CSF) have been reported to be elevated in DNS. However, the precise timing and clinical value of the CSF examination have not been fully evaluated. We aimed to clarify the long-term outcome and the factors predicting the outcome of DNS and to evaluate the utility of CSF-MBP for predicting the development and severity of DNS. Methods: This work was designed as a single-center, prospective, observational study. We graded DNS severity as Grade 1 (consistent independence), Grade 2 (temporary dependence), or Grade 3 (persistent dependence). We analyzed the percentage categorized in each grade and the parameters associated with outcome. Results: Of 100 patients experiencing acute CO poisoning (median age: 46 years; 69% male), 20 (20%) developed DNS, including six Grade 1(30%), ten Grade 2 (50%), and four Grade 3 (20%) cases. The Grade 3 patients [median: 77 years; interquartile range (IQR): 76-82] were older than the Grade 1 patients [42; 30-46] (P < 0.01); the DNS onset of the Grade 1 patients [median interval after poisoning: 35 days; IQR: 32-56] occurred later than that of the Grade 3 patients [10; 9-13] P < 0.001) and the Grade 2 patients [25; 23-27] (P <0.05). The CSF-MBP levels of the DNS patients were higher than those of the non-DNS patients (P < 0.0001). The 1-month CSF-MBP levels of the Grade 3 patients were higher than those of the Grade 1 patients (P < 0.05); the MBP index, defined as [(Age) x (1-month CSF-MBP)1, was higher in the Grade 3 patients than in the Grade 1 patients (P < 0.01). Severe DNS were associated with advanced age (>72.5 years), earlier onset (<18 days), higher 1-month CSF-MBP (>252 pg/ml), and higher MBP index (>20.9 year x ng/ml). Conclusions: Poor DNS outcomes were associated with advanced age and earlier onset. CSF-MBP can serve as a sensitive predictor of both the development and outcomes of DNS. (C) 2015 Elsevier Inc. All rights reserved.	[Kuroda, Hiroshi; Fujihara, Kazuo; Aoki, Masashi] Tohoku Univ Grad Sch Med, Dept Neurol, Sendai, Miyagi 9808574, Japan; [Fujihara, Kazuo] Tohoku Univ Grad Sch Med, Dept Multiple Sclerosis Therapeut, Sendai, Miyagi 9808574, Japan; [Kushimoto, Shigeki] Tohoku Univ Grad Sch Med, Div Emergency & Crit Care Med, Sendai, Miyagi 9808574, Japan	Kuroda, H (reprint author), Tohoku Univ Grad Sch Med, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	dakuro@med.tohoku.ac.jp; fujikazu@med.tohoku.ac.jp; kussie@emergency-medicine.med.tohoku.ac.jp; aokim@med.tohoku.ac.jp			Ministry of Education, Science, and Technology of Japan [24592728]	We thank the staff of the Tohoku University Hospital Emergency Medical Center for recruiting and treating patients who experienced acute CO poisoning. This study was supported by a grant-in-aid for scientific research (grant number 24592728) from the Ministry of Education, Science, and Technology of Japan.	Raub JA, 2000, TOXICOLOGY, V145, P1, DOI 10.1016/S0300-483X(99)00217-6; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.037; CHANG KH, 1992, RADIOLOGY, V184, P117; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; MCLEAN BN, 1990, BRAIN, V113, P1269, DOI 10.1093/brain/113.5.1269; Hu HJ, 2011, AM J EMERG MED, V29, P261, DOI 10.1016/j.ajem.2009.09.030; Beppu T, 2010, NEURORADIOLOGY, V52, P735, DOI 10.1007/s00234-009-0649-x; GORMAN DF, 1992, ANAESTH INTENS CARE, V20, P311; Ide T, 2008, AM J EMERG MED, V26, P908, DOI 10.1016/j.ajem.2007.11.021; Thom SR, 2004, P NATL ACAD SCI USA, V101, P13660, DOI 10.1073/pnas.0405642101; Young NP, 2010, BRAIN, V133, P333, DOI 10.1093/brain/awp321; Beppu T, 2011, J NEUROL NEUROSUR PS, V82, P869, DOI 10.1136/jnnp.2010.222422; CHOI IS, 1983, ARCH NEUROL-CHICAGO, V40, P433; COBB N, 1991, JAMA-J AM MED ASSOC, V266, P659; Ellison D, 2008, GREENFIELDS NEUROPAT, V8th, P96; HOROWITZ AL, 1987, RADIOLOGY, V162, P787; Hsiao Cheng-Lung, 2004, Acta Neurol Taiwan, V13, P64; Kamijo Y, 2007, AM J EMERG MED, V25, P483, DOI 10.1016/j.ajem.2006.06.019; Kondziella D, 2009, J NEUROL, V256, P970, DOI 10.1007/s00415-009-5057-y; Kuo CJ, 2008, SOC PSYCH PSYCH EPID, V43, P286, DOI 10.1007/s00127-007-0300-2; Kuroda H, 2012, AJNR Am J Neuroradiol, V33, pE52, DOI 10.3174/ajnr.A2600; Lin WC, 2009, AM J NEURORADIOL, V30, P1248, DOI 10.3174/ajnr.A1517; MIN SK, 1986, ACTA PSYCHIAT SCAND, V73, P80, DOI 10.1111/j.1600-0447.1986.tb02671.x; Murata M, 2005, J NEUROL SCI, V235, P69, DOI 10.1016/j.jns.2005.04.005; Terajima K, 2008, EUR NEUROL, V59, P55, DOI 10.1159/000109262; Thom Stephen R., 1995, Annals of Emergency Medicine, V25, P474, DOI 10.1016/S0196-0644(95)70261-X; VIEREGGE P, 1989, J NEUROL, V236, P478, DOI 10.1007/BF00328511; ZAGAMI AS, 1993, J NEUROL, V240, P113, DOI 10.1007/BF00858727	28	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	MAY	2015	48						35	43		10.1016/j.neuro.2015.03.002		9	Neurosciences; Pharmacology & Pharmacy; Toxicology	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	CJ6YR	WOS:000355641600004		
J	Kinoshita, S; Sho, M; Yanagimoto, H; Satoi, S; Akahori, T; Nagai, M; Nishiwada, S; Yamamoto, T; Hirooka, S; Yamaki, S; Ikeda, N; Kwon, AH; Nakajima, Y				Kinoshita, Shoichi; Sho, Masayuki; Yanagimoto, Hiroaki; Satoi, Sohei; Akahori, Takahiro; Nagai, Minako; Nishiwada, Satoshi; Yamamoto, Tomohisa; Hirooka, Satoshi; Yamaki, So; Ikeda, Naoya; Kwon, A-Hon; Nakajima, Yoshiyuki			Potential role of surgical resection for pancreatic cancer in the very elderly	PANCREATOLOGY			English	Article						Elderly; Pancreatic adenocarcinoma; Pancreatectomy; Chemotherapy; Surgery; Prognosis	INTERNATIONAL STUDY-GROUP; ADJUVANT CHEMOTHERAPY; DUCTAL ADENOCARCINOMA; 1ST-LINE CHEMOTHERAPY; SURGERY ISGPS; PHASE-III; PANCREATICODUODENECTOMY; GEMCITABINE; OLDER; DEFINITION	Background: There is increasing need to evaluate the surgical indication of pancreatic cancer in very elderly patients. However, the available clinical data are limited, and the optimal treatment is still controversial. The aim of this study was to evaluate the benefit of pancreatic resection in pancreatic cancer patients over the age of 80. Methods: Between 2005 and 2012, 26 octogenarian patients who received pancreatic resection and 20 who received chemotherapy for pancreatic cancer were retrospectively reviewed. Clinicopathological factors, chemotherapy administration status, and survival were compared. Univariate and multivariate analysis of prognostic factors for survival was performed. Results: Postoperative major complication rate was 8%, with no mortality. The one-year survival rate and median survival time of the surgery and chemotherapy groups were 50% and 45%, and 12.4 months and 11.7 months, respectively (P = 0.263). Of the 26 resected cases, 6 completed the planned adjuvant chemotherapy treatment course. The median survival time of those 6 completed cases was significantly longer than that of the 20 not completed cases (23.4 versus 10.0 months, P = 0.034). Furthermore, a multivariate analysis of the 26 resected cases showed that distant metastasis (HR 3.206, 95%CI 1.005 -10.22, P = 0.049) and completion of the planned adjuvant therapy (HR 4.078, 95%CI 1.162-1430, P = 0.028) were independent prognostic factors of surgical resection. Conclusions: Surgical resection was safe, but not superior to chemotherapy for pancreatic cancer in octogenarians. In the very elderly, only selected patients may benefit from pancreatic resection. Copyright (C) 2015, IAP and EPC. Published by Elsevier India, a division of Reed Elsevier India Pvt. Ltd. All rights reserved.	[Kinoshita, Shoichi; Sho, Masayuki; Akahori, Takahiro; Nagai, Minako; Nishiwada, Satoshi; Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 6348522, Japan; [Yanagimoto, Hiroaki; Satoi, Sohei; Yamamoto, Tomohisa; Hirooka, Satoshi; Yamaki, So; Kwon, A-Hon] Kansai Med Univ, Dept Surg, Moriguchi, Osaka, Japan; [Ikeda, Naoya] Nara Prefecture Western Med Ctr, Dept Surg, Nara, Japan	Sho, M (reprint author), Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	m-sho@naramed-u.ac.jp					Turrini O, 2013, EJSO-EUR J SURG ONC, V39, P171, DOI 10.1016/j.ejso.2012.08.017; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; [Anonymous], 2012, CANC STAT WHIT BOOK; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Lee MK, 2010, J GASTROINTEST SURG, V14, P1838, DOI 10.1007/s11605-010-1345-1; Hatzaras I, 2011, J AM COLL SURGEONS, V212, P373, DOI 10.1016/j.jamcollsurg.2010.10.015; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Aparicio T, 2013, J CLIN ONCOL, V31, P1464, DOI 10.1200/JCO.2012.42.9894; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Wente MN, 2007, SURGERY, V142, P20, DOI 10.1016/j.surg.2007.02.001; Melis M, 2012, HPB, V14, P583, DOI 10.1111/j.1477-2574.2012.00484.x; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; Horowitz DP, 2011, INT J RADIAT ONCOL, V80, P1391, DOI 10.1016/j.ijrobp.2010.04.003; Extermann M, 2012, CANCER-AM CANCER SOC, V118, P3377, DOI 10.1002/cncr.26646; Sehgal R, 2014, PANCREAS, V43, P306, DOI 10.1097/MPA.0000000000000091; Khan S, 2010, J GASTROINTEST SURG, V14, P1826, DOI 10.1007/s11605-010-1294-8; Nagrial AM, 2014, BRIT J CANCER, V110, P313, DOI 10.1038/bjc.2013.722; Bautmans I, 2014, CURR PHARM DESIGN, V20, P3215; Makary MA, 2006, J GASTROINTEST SURG, V10, P347, DOI 10.1016/j.gassur.2005.12.014; Sho M, 2011, J HEPATO-BIL-PAN SCI, V18, P235, DOI 10.1007/s00534-010-0336-7; Valle JW, 2014, J CLIN ONCOL, V32, P504, DOI 10.1200/JCO.2013.50.7657; Malvezzi M, 2014, ANN ONCOL, V25, P1650, DOI 10.1093/annonc/mdu138; Oguro S, 2013, LANGENBECK ARCH SURG, V398, P531, DOI 10.1007/s00423-013-1072-7; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Tani M, 2009, J HEPATO-BILIARY-PAN, V16, P675, DOI 10.1007/s00534-009-0106-6; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Hashimoto A, 2012, AM J ROENTGENOL, V198, P923, DOI 10.2214/AJR.11.6751; Howlader N, 2013, SEER CANC STAT REV 1; Kanda M, 2011, BRIT J SURG, V98, P268, DOI 10.1002/bjs.7305; Lee DY, 2014, AM J SURG, V207, P540, DOI 10.1016/j.amjsurg.2013.07.042; Sho M, 2011, J HEPATOBILIARY PANC, V18, P239; Sho M, 2013, J HEPATO-BIL-PAN SCI, V20, P197, DOI 10.1007/s00534-012-0532-8; Sobin LH, 2009, TNM CLASSIFICATION M; Sohn T A, 1998, J Gastrointest Surg, V2, P79, DOI 10.1016/S1091-255X(98)80107-8; Yamagishi Y, 2010, J GASTROENTEROL, V45, P1146, DOI 10.1007/s00535-010-0258-9	36	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1424-3903	1424-3911		PANCREATOLOGY	Pancreatology	MAY-JUN	2015	15	3					240	246		10.1016/j.pan.2015.03.015		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK1IF	WOS:000355960300006		
J	Mitsuyama, T; Uchida, K; Sumimoto, K; Fukui, Y; Ikeura, T; Fukui, T; Nishio, A; Shikata, N; Uemura, Y; Satoi, S; Mizuno, N; Notohara, K; Shimosegawa, T; Zamboni, G; Frulloni, L; Okazaki, K				Mitsuyama, Toshiyuki; Uchida, Kazushige; Sumimoto, Kimi; Fukui, Yuri; Ikeura, Tsukasa; Fukui, Toshiro; Nishio, Akiyoshi; Shikata, Nobuaki; Uemura, Yoshiko; Satoi, Sohei; Mizuno, Nobumasa; Notohara, Kenji; Shimosegawa, Tooru; Zamboni, Giuseppe; Frulloni, Luca; Okazaki, Kazuichi			Comparison of neutrophil infiltration between type 1 and type 2 autoimmune pancreatitis	PANCREATOLOGY			English	Article						Type 1 AIP; Type 2 AIP; Neutrophils; GCP-2; IL-8; Chemokines	LYMPHOPLASMACYTIC SCLEROSING PANCREATITIS; GRANULOCYTE CHEMOTACTIC PROTEIN-2; OBSTRUCTIVE PULMONARY-DISEASE; PLASMA-CELL INFILTRATION; REGULATORY T-CELLS; HELICOBACTER-PYLORI; JAPANESE POPULATION; CXC CHEMOKINES; RECEPTORS; INTERLEUKIN-8	Background: Characteristics of type 2 autoimmune pancreatitis (AIP) is granulocyte epithelial lesions, called idiopathic duct-centric pancreatitis (IDCP). To clarify pathogenesis of IDCP, we investigated mechanism of neutrophil infiltration in type 1 AIP, called lymphoplasmacytic sclerosing pancreatitis (LPSP) and IDCP. Method: This study was performed on resected pancreata from patients with alcoholic chronic pancreatitis (ACP, n = 10), LPSP (n = 10) and IDCP (n = 12). The number of neutrophils around the pancreatic ducts was counted. The expression of neutrophils chemoattractants granulocyte chemotactic protein-2 (GCP-2) and interleukin-8 (IL-8) in the pancreatic duct epithelia was examined using immunohistochemistry. The cell staining intensity is scored as negative (0), weak (1), moderate (2) or strong (3). Results: The median number of neutrophils around the interlobular pancreatic ducts was significantly higher in IDCP (15.16; interquartile range [IQR]: 9.74-18.41) than in ACP (2.66; IQR: 1.33-4.33) (P < 0.05) and LPSP (3.16; IQR: 2.74-4.57) (P < 0.01). There was no significant difference in the median number of neutrophils around the intralobular pancreatic ducts among ACP (1.16; IQR: 0.33-3.41), LPSP (3.16; IQR: 0.74-5.5) and IDCP (3.00; IQR: 1.08-7.91). The median score of GCP-2 in the interlobular pancreatic duct epithelia was significantly higher in IDCP (1.5; IQR: 0.25-2) than in ACP (0; IQR: 0-0.75) (P < 0.05) and LPSP (0; IQR: 0-0.75) (P < 0.05). There was no significant difference in the median score of IL-8 in the interlobular pancreatic duct epithelia among ACP (0; IQR: 0-0.75), LPSP (1; IQR: 0-1.75) and IDCP (0.5; IQR: 0-1). Conclusions: Significantly increased neutrophil infiltration around the interlobular pancreatic duct in IDCP may depend on GCP-2. Copyright (C) 2015, IAP and EPC. Published by Elsevier India, a division of Reed Elsevier India Pvt. Ltd. All rights reserved.	[Mitsuyama, Toshiyuki; Uchida, Kazushige; Sumimoto, Kimi; Fukui, Yuri; Ikeura, Tsukasa; Fukui, Toshiro; Nishio, Akiyoshi; Okazaki, Kazuichi] Kansai Med Univ, Dept Gastroenterol & Hepatol, Hirakata, Osaka 5731197, Japan; [Shikata, Nobuaki; Uemura, Yoshiko] Kansai Med Univ, Dept Pathol, Hirakata, Osaka 5731197, Japan; [Satoi, Sohei] Kansai Med Univ, Dept Surg, Hirakata, Osaka 5731197, Japan; [Mizuno, Nobumasa] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Notohara, Kenji] Kurashiki Cent Hosp, Dept Pathol, Kurashiki, Okayama, Japan; [Shimosegawa, Tooru] Tohoku Univ, Dept Gastroenterol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Zamboni, Giuseppe] Univ Verona, Dept Pathol, I-37100 Verona, Italy; [Frulloni, Luca] Univ Verona, Pancreas Ctr, Dept Med, I-37100 Verona, Italy	Okazaki, K (reprint author), Kansai Med Univ, Dept Internal Med 3, Div Gastroenterol & Hepatol, 2-3-1 Shinmachi, Hirakata, Osaka 5731197, Japan.	okazaki@hirakata.kmu.ac.jp		Frulloni, Luca/0000-0001-7417-2655	Ministry of Culture and Science of Japan [23591017, 24591020]; Ministry of Labor and Welfare of Japan; CREST Japan Science and Technology Agency; NEXT-Supported Program for Strategic Research Foundation at Private Universities	This study was partially supported by (1) Grant-in-Aid for Scientific Research (C) of the Ministry of Culture and Science of Japan (23591017, 24591020), (2) Grant-in-Aid for "Research for Intractable Diseases" Program from the Ministry of Labor and Welfare of Japan, and (3) Grants-in-Aid from CREST Japan Science and Technology Agency, (4) NEXT-Supported Program for Strategic Research Foundation at Private Universities.	Miyoshi H, 2008, PANCREAS, V36, P133, DOI 10.1097/MPA.0b013e3181577553; Williams EJ, 2000, J PATHOL, V192, P533; Watanabe T, 2013, J GASTROENTEROL, V48, P247, DOI 10.1007/s00535-012-0626-8; Watanabe T, 2012, ARTHRITIS RHEUM-US, V64, P914, DOI 10.1002/art.33386; Zamboni G, 2004, VIRCHOWS ARCH, V445, P552, DOI 10.1007/s00428-004-1140-z; KAWAGUCHI K, 1991, HUM PATHOL, V22, P387, DOI 10.1016/0046-8177(91)90087-6; Kaplan MJ, 2011, NAT REV RHEUMATOL, V7, P691, DOI 10.1038/nrrheum.2011.132; Harada K, 2009, CLIN EXP IMMUNOL, V157, P261, DOI 10.1111/j.1365-2249.2009.03947.x; Raman D, 2011, EXP CELL RES, V317, P575, DOI 10.1016/j.yexcr.2011.01.005; Meijer M, 2013, EXPERT REV CLIN IMMU, V9, P1055, DOI 10.1586/1744666X.2013.851347; Kountouras J, 2005, J CELL MOL MED, V9, P196, DOI 10.1111/j.1582-4934.2005.tb00349.x; Okazaki K, 2013, J GASTROENTEROL, V48, P303, DOI 10.1007/s00535-012-0744-3; Umemura T, 2006, GUT, V55, P1367, DOI 10.1136/gut.2006.095059; Koyabu M, 2010, J GASTROENTEROL, V45, P732, DOI 10.1007/s00535-010-0199-3; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Kaur M, 2013, J PHARMACOL EXP THER, V347, P173, DOI 10.1124/jpet.112.201855; SARLES H, 1961, AM J DIG DIS, V6, P688, DOI 10.1007/BF02232341; Nakagome K, 2012, INT ARCH ALLERGY IMM, V158, P96, DOI 10.1159/000337801; Ahuja SK, 1996, J BIOL CHEM, V271, P20545; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Kusuda T, 2011, PANCREAS, V40, P1120, DOI 10.1097/MPA.0b013e31821fc796; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Wolf M, 1998, EUR J IMMUNOL, V28, P164, DOI 10.1002/(SICI)1521-4141(199801)28:01<164::AID-IMMU164>3.3.CO;2-J; Notohara K, 2003, AM J SURG PATHOL, V27, P1119, DOI 10.1097/00000478-200308000-00009; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Kawa S, 2002, GASTROENTEROLOGY, V122, P1264, DOI 10.1053/gast.2002.33022; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; Zhang L, 2007, MODERN PATHOL, V20, P23, DOI 10.1038/modpathol.3800689; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Lee KE, 2013, WORLD J GASTROENTERO, V19, P8192, DOI 10.3748/wjg.v19.i45.8192; Fukui Y, 2014, J GASTROENT IN PRESS; Fukui Y, 2013, J GASTROENTEROL, V48, P751, DOI 10.1007/s00535-012-0677-x; Hussain F, 2010, CYTOKINE, V49, P134, DOI 10.1016/j.cyto.2009.11.010; Kawashima A, 2013, INT ARCH ALLERGY IMM, V161, P10, DOI 10.1159/000350335; Kloppel G, 2010, J GASTROENTEROL, V45, P787, DOI 10.1007/s00535-010-0265-x; Kuruma S, 2014, INTERNAL MED, V53, P541, DOI 10.2169/internalmedicine.53.0963; Kusuda T, 2010, INTERNAL MED, V49, P2569, DOI 10.2169/internalmedicine.49.4165; Motoo Yoshiharu, 2004, JOP, V5, P138; Notohara K, 2012, MODERN PATHOL, V25, p447A; Ota M, 2011, DIS MARKERS, V31, P223, DOI 10.3233/DMA-2011-0820; PROOST P, 1993, J IMMUNOL, V150, P1000; Sumimoto K, 2014, PANCREATOLOGY, V14, P193, DOI 10.1016/j.pan.2014.02.004; Szekanecz Zoltan, 2010, Front Biosci (Schol Ed), V2, P153; Uchida K, 2000, AM J GASTROENTEROL, V95, P2788, DOI 10.1016/S0002-9270(00)01980-8; Uchida K, 2002, LAB INVEST, V82, P411; VanDamme J, 1997, J LEUKOCYTE BIOL, V62, P563; Wright HL, 2014, NAT REV RHEUMATOL, V10, P1; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209	51	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1424-3903	1424-3911		PANCREATOLOGY	Pancreatology	MAY-JUN	2015	15	3					271	280		10.1016/j.pan.2015.03.005		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK1IF	WOS:000355960300011		
J	Hiroshima, Y; Maawy, A; Zhang, Y; Murakami, T; Momiyama, M; Mori, R; Matsuyama, R; Chishima, T; Tanaka, K; Ichikawa, Y; Endo, I; Hoffman, RM; Bouvet, M				Hiroshima, Yukihiko; Maawy, Ali; Zhang, Yong; Murakami, Takashi; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru; Hoffman, Robert M.; Bouvet, Michael			Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC)	PANCREATOLOGY			English	Article						Fluorescence-guided surgery; Pancreatic cancer; Patient derived orthotopic xenograft; Neoadjuvant chemotherapy; CEA; PDOX	ANTI-CEA ANTIBODY; GEMCITABINE-BASED CHEMORADIATION; HUMAN COLON-CANCER; NUDE-MOUSE MODEL; IMAGING-SYSTEM; TUMOR-TISSUE; MICE; SURVIVAL; RESECTION; TRANSPLANTATION	Background: The aim of this study is to determine the efficacy of neoadjuvant chemotherapy (NAC) with gemcitabine (GEM) in combination with fluorescence-guided surgery (FGS) on a pancreatic cancer patient derived orthotopic xenograft (PDOX) model. Methods: A PDOX model was established from a CEA-positive tumor from a patient who had undergone a pancreaticoduodenectomy for pancreatic adenocarcinoma. Mice were randomized to 4 groups: bright light surgery (BLS) only; BLS + NAC; FGS only; and FGS + NAC. An anti-CEA antibody conjugated to DyLight 650 was administered intravenously via the tail vein of mice with a pancreatic cancer PDOX 24 h before surgery. Results: The PDOX was clearly labeled with fluorophore-conjugated anti-CEA antibody. Only one out of 8 mice had local recurrence in the FGS only group and zero out of 8 mice had local recurrence in the FGS + NAC which was significantly lower than BLS only or BLS + NAC mice, where local disease recurred in 6 out of 8 mice in each treatment group (p = 0.041 and p = 0.007, respectively). NAC did not significantly reduce recurrence rates when combined with either FGS or BLS. Conclusion: These results indicate that FGS can significantly reduce local recurrence compared to BLS in pancreatic cancer resistant to NAC. Copyright (C) 2015, IAP and EPC. Published by Elsevier India, a division of Reed Elsevier India Pvt. Ltd. All rights reserved.	[Hiroshima, Yukihiko; Zhang, Yong; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Hiroshima, Yukihiko; Maawy, Ali; Hoffman, Robert M.; Bouvet, Michael] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Murakami, Takashi; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan	Bouvet, M (reprint author), Univ Calif San Diego, Dept Surg, Moores Canc Ctr, 3855 Hlth Sci Dr 0987, La Jolla, CA 92093 USA.	mbouvet@ucsd.edu			National Cancer Institute [CA132971, 142669]; JSPS [26830081, 26462070, 24592009]	This study was supported in part by National Cancer Institute grants CA132971 and 142669 (to M.B. and Anti Cancer, Inc.) and JSPS KAKENHI Grant Numbers 26830081 to Y.H., 26462070 to I.E and 24592009 to K.T.	Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Metildi CA, 2012, J AM COLL SURGEONS, V215, P126, DOI 10.1016/j.jamcollsurg.2012.02.021; Maawy AA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.126016; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; McElroy M, 2008, WORLD J SURG, V32, P1057, DOI 10.1007/s00268-007-9452-1; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Katz MHG, 2012, CANCER-AM CANCER SOC, V118, P5749, DOI 10.1002/cncr.27636; Takahashi H, 2010, ANN SURG, V251, P461, DOI 10.1097/SLA.0b013e3181cc90a3; Katz MHG, 2010, ANN SURG ONCOL, V17, P1794, DOI 10.1245/s10434-010-0943-1; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; FURUKAWA T, 1993, CANCER RES, V53, P3070; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; Evans DB, 2008, J CLIN ONCOL, V26, P3496, DOI 10.1200/JCO.2007.15.8634; Bouvet M, 2011, SCI TRANSL MED, V3, P110; EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FURUKAWA T, 1993, INT J CANCER, V54, P397, DOI 10.1002/ijc.2910540308; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Kato K, 2009, PANCREAS, V38, P605, DOI 10.1097/MPA.0b013e3181a4891d; Metildi CA, 2012, J AM COLL SURGEONS, V215, P135, DOI [DOI 10.1016/J.JAMCOLLSURG.2012.02.021, 10.1016/j.jamcollsurg.2012.02.021]; Metildi CA, 2014, ANN SURG ONCOL, V21, P1405, DOI 10.1245/s10434-014-3495-y; Rosenthal EL, 2013, MOL IMAGING BIOL, V15, P647, DOI 10.1007/s11307-013-0662-7	24	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1424-3903	1424-3911		PANCREATOLOGY	Pancreatology	MAY-JUN	2015	15	3					295	301		10.1016/j.pan.2015.02.008		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CK1IF	WOS:000355960300014		
J	Takeda, N; Naruse, T				Takeda, Norio; Naruse, Tomohiro			Optimal design of welded structure with structural and local-notch stresses based on International Institute of Welding recommendations	STRUCTURAL AND MULTIDISCIPLINARY OPTIMIZATION			English	Article						Welded structures; Structural optimization; Fatigue failure; Structural stress; Local-notch stress	FATIGUE ASSESSMENT; JOINTS	A procedure for optimally designing light-weight and reliable welded structures is proposed and applied to the structural design of an illustrative welded structure used in construction and transportation machinery. To verify the effectiveness of the design procedure, the designed structures were experimentally produced, and then the fatigue lives of them were evaluated. The proposed design procedure is composed of two major processes; one is thickness-design process, and the other one is the process for designing weld type. Since the design for thickness and weld type is conducted sequentially, the thickness of welded structures can be determined in an optimization process without considering weld type; hence, the proposed design procedure is not computational demanding. In the thickness-design process, the thickness of a target welded structure is optimized by constraining structural stress that is estimated on the basis of the International Institute of Welding recommendations. After the thickness optimization, weld type of welded joints is designed by using local-notch stress, which is also defined in the IIW recommendations. Two kinds of test pieces based on the designed welded structure were experimentally produced by changing the weld type of a joint, and the test pieces were fatigue tested to verify their fatigue resistance. Since the produced welded structures had expected fatigue resistance, it can be concluded that welded structures can be optimally designed by using the proposed design procedure.	[Takeda, Norio; Naruse, Tomohiro] Hitachi Ltd, Hitachi Res Lab, Hitachinaka, Ibaraki, Japan	Takeda, N (reprint author), Hitachi Ltd, Hitachi Res Lab, Hitachinaka, Ibaraki, Japan.	norio.takeda.uf@hitachi.com; tomohiro.naruse.az@hitachi.com					Radaj D, 2009, INT J FATIGUE, V31, P2, DOI 10.1016/j.ijfatigue.2008.05.019; Hobbacher AF, 2009, INT J FATIGUE, V31, P50, DOI 10.1016/j.ijfatigue.2008.04.002; TANESE R, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P434; [Anonymous], 2007, ASME BOIL PRESS VESS; Dong P, 2001, INT J FATIGUE, V23, P865, DOI 10.1016/S0142-1123(01)00055-X; Eurocode 3, 2005, DES STEEL STRUCT; Hobbacher A., 2008, 132151R307151254R307; Jarmai K, 1999, J CONSTR STEEL RES, V50, P115, DOI 10.1016/S0143-974X(98)00241-7; Maddox SJ, 2001, P 11 INT OFFSH POL E; Niemi E, 2006, 12143000 IIW; Selvakumar P, 2013, PROCEDIA ENGINEER, V55, P374, DOI 10.1016/j.proeng.2013.03.268; Simoes LMC, 2009, P 8 WORLD C STRUCT M; Soncino CM, 2012, INT J FATIGUE, V34, P2; Takeda N, 2011, P 9 WORLD C STRUCT M; Takeda N, 2013, P 10 WORLD C STRUCT; Vogt M, 2012, INT J FATIGUE, V34, P47, DOI 10.1016/j.ijfatigue.2011.01.017	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1615-147X	1615-1488		STRUCT MULTIDISCIP O	Struct. Multidiscip. Optim.	MAY	2015	51	5					1133	1147		10.1007/s00158-014-1201-0		15	Computer Science, Interdisciplinary Applications; Engineering, Multidisciplinary; Mechanics	Computer Science; Engineering; Mechanics	CJ8NP	WOS:000355760000011		
J	Otomori, M; Yamada, T; Izui, K; Nishiwaki, S				Otomori, Masaki; Yamada, Takayuki; Izui, Kazuhiro; Nishiwaki, Shinji			Matlab code for a level set-based topology optimization method using a reaction diffusion equation	STRUCTURAL AND MULTIDISCIPLINARY OPTIMIZATION			English	Article						Education; Matlab code; Topology optimization; Level set method; Topological derivative; Reaction diffusion equation	STRUCTURAL OPTIMIZATION; SHAPE OPTIMIZATION; SENSITIVITY; WRITTEN	This paper presents a simple Matlab implementation for a level set-based topology optimization method in which the level set function is updated using a reaction diffusion equation, which is different from conventional level set-based approaches (Allaire et al. 2002, 2004; Wang et al. 2003) that use the Hamilton-Jacobi equation to update the level set function. With this method, the geometrical complexity of optimized configurations can be easily controlled by appropriately setting a regularization parameter. We explain the code in detail, and also the derivation of the topological derivative that is used in the level set-based topology optimization. Numerical results for stiffness maximization problems are provided to facilitate the reader's understanding. The presented code is intended for educational purposes only. This paper was inspired by previously published papers presenting Matlab code for a SIMP method (Sigmund 2001; Andreassen et al. 2011), a level set-based method (Challis 2010), and FreeFem ++ code for a structural optimization method (Allaire and Pantz 2006). Readers can investigate results provided by these different methods and discover the prominent aspects of each particular method. The code presented here can be downloaded from http://www.osdel.me.kyoto-u.ac.jp/members/yamada/codes.html.	[Otomori, Masaki; Yamada, Takayuki; Izui, Kazuhiro; Nishiwaki, Shinji] Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto 6158540, Japan	Yamada, T (reprint author), Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto 6158540, Japan.	takayuki@me.kyoto-u.ac.jp	Yamada, Takayuki/C-9652-2010; 	Yamada, Takayuki/0000-0002-5349-6690; Izui, Kazuhiro/0000-0002-8875-7758			Allaire G., 2002, APPL MATH SCI, V146; Allaire G, 2006, STRUCT MULTIDISCIP O, V32, P173, DOI 10.1007/s00158-006-0017-y; Allaire G, 2005, CONTROL CYBERN, V34, P59; Guzina BB, 2004, Q J MECH APPL MATH, V57, P161, DOI 10.1093/qjmam/57.2.161; Allaire G, 2004, J COMPUT PHYS, V194, P363, DOI 10.1016/j.jcp.2003.09.032; Andreassen E, 2011, STRUCT MULTIDISCIP O, V43, P1, DOI 10.1007/s00158-010-0594-7; Wang MY, 2003, COMPUT METHOD APPL M, V192, P227, DOI 10.1016/S0045-7825(02)00559-5; Challis VJ, 2010, STRUCT MULTIDISCIP O, V41, P453, DOI 10.1007/s00158-009-0430-0; BENDSOE MP, 1988, COMPUT METHOD APPL M, V71, P197, DOI 10.1016/0045-7825(88)90086-2; Allaire G, 2002, CR MATH, V334, P1125, DOI 10.1016/S1631-073X(02)02412-3; Sigmund O, 2001, STRUCT MULTIDISCIP O, V21, P120; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Yamada T, 2010, COMPUT METHOD APPL M, V199, P2876, DOI 10.1016/j.cma.2010.05.013; BendsOe MP, 1989, STRUCTURAL OPTIMIZAT, V1, P193, DOI DOI 10.1007/BF01650949; ESCHENAUER HA, 1994, STRUCT OPTIMIZATION, V8, P42, DOI 10.1007/BF01742933; Howell HH, 2001, COMPLIANT MECH	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1615-147X	1615-1488		STRUCT MULTIDISCIP O	Struct. Multidiscip. Optim.	MAY	2015	51	5					1159	1172		10.1007/s00158-014-1190-z		14	Computer Science, Interdisciplinary Applications; Engineering, Multidisciplinary; Mechanics	Computer Science; Engineering; Mechanics	CJ8NP	WOS:000355760000013		
J	Morimoto, S; Serizawa, S				Morimoto, Shuhei; Serizawa, Shigehiro			Strategy-proofness and efficiency with non-quasi-linear preferences: A characterization of minimum price Walrasian rule	THEORETICAL ECONOMICS			English	Article						Minimum price Walrasian equilibrium; simultaneous ascending auction; strategy-proofness; efficiency; heterogeneous objects; non-quasi-linear preferences	VICKREY ALLOCATION RULE; PURE EXCHANGE ECONOMIES; INDIVISIBLE GOODS; MULTIITEM AUCTIONS; RESTRICTED DOMAINS; HOUSE ALLOCATION; FAIR ALLOCATION; MECHANISMS; INEFFICIENCY; EQUILIBRIUM	We consider the problem of allocating objects to a group of agents and how much agents should pay. Each agent receives at most one object and has non-quasi-linear preferences. Non-quasi-linear preferences describe environments where payments influence agents' abilities to utilize objects or derive benefits from them. The minimum price Walrasian (MPW) rule is the rule that assigns a minimum price Walrasian equilibrium allocation to each preference profile. We establish that the MPW rule is the unique rule satisfying strategy-proofness, efficiency, individual rationality, and no subsidy for losers. Since the outcome of the MPW rule coincides with that of the simultaneous ascending (SA) auction, our result supports SA auctions adopted by many governments.	[Morimoto, Shuhei] Kobe Univ, Grad Sch Econ, Kobe, Hyogo, Japan; [Serizawa, Shigehiro] Osaka Univ, Inst Social & Econ Res, Suita, Osaka 565, Japan	Morimoto, S (reprint author), Kobe Univ, Grad Sch Econ, Kobe, Hyogo, Japan.	morimoto@people.kobe-u.ac.jp; serizawa@iser.osaka-u.ac.jp			JSPS Research Fellowships for Young Scientists (JSPS KAKENHI) [25.2188]	We are very grateful to the co-editor and four anonymous referees for their many detailed and helpful comments. This article was presented at the conference honoring Barbera at the Universitat Autonoma de Barcelona in 2011, Frontiers of Market Design at Ascona, Switzerland in 2012, the 2012 Annual Conference of the Association for Public Economic Theory, the 2012 Meeting of the Society for Social Choice and Welfare, the 2012 Autumn Meeting of the Japanese Economic Association, the 2013 North American Summer Meeting of the Econometric Society, the 2013 Conference on Economic Design, the 2013 Asian Meeting of the Econometric Society, and CIREQ Montreal Matching Conference in 2014. We thank participants at those conferences for their valuable comments. We are also grateful to seminar participants at Hitotsubashi, Indian Statistical Institute, Keio, Kobe, Kyoto, Rice, Rochester, Stanford, Tohoku, Tokyo, and Waseda for their comments. We specially thank Ahmet Alkan, Tommy Andersson, Itai Ashlagi, Salvador Barbera, Anna Bogomolnaia, Jeremy Bulow, Atsushi Kajii, Fuhito Kojima, Paul Milgrom, Debasis Mishra, Herve Moulin, Shinji Ohseto, Motty Perry, Marek Pycia, John Roberts, Alvin Roth, Toyotaka Sakai, James Schummer, Ilya Segal, Arunava Sen, Lars-Gunnar Svensson, William Thomson, and Jun Wako for their detailed comments. Morimoto is a Research Fellow of Japan Society for the Promotion of Science (JSPS), and gratefully acknowledges the financial support from JSPS Research Fellowships for Young Scientists (JSPS KAKENHI Grant 25.2188). Remaining errors are ours.	Adachi T, 2014, SOC CHOICE WELFARE, V42, P813, DOI 10.1007/s00355-013-0752-0; Alaei Saeed, 2013, COMPETITIVE EQ UNPUB, DOI [10.1145/1998549.1998556, DOI 10.1145/1998549.1998556]; Alkan A., 1990, Games and Economic Behavior, V2, DOI 10.1016/0899-8256(90)90017-O; ALKAN A, 1991, ECONOMETRICA, V59, P1023, DOI 10.2307/2938172; Andersson T, 2013, ANN OPER RES, V211, P27, DOI 10.1007/s10479-013-1344-1; BARBERA S, 1995, ECONOMETRICA, V63, P51, DOI 10.2307/2951697; Serizawa S, 2002, J ECON THEORY, V106, P219, DOI 10.1006/jeth.2002.2940; GROVES T, 1973, ECONOMETRICA, V41, P617, DOI 10.2307/1914085; Serizawa S, 2003, J ECON THEORY, V109, P246, DOI 10.1016/S0022-0531(03)00019-X; HOLMSTROM B, 1979, ECONOMETRICA, V47, P1137, DOI 10.2307/1911954; Ausubel LM, 2004, AM ECON REV, V94, P1452, DOI 10.1257/0002828043052330; SATTERTHWAITE MA, 1981, REV ECON STUD, V48, P587, DOI 10.2307/2297198; Zhou L, 1991, SOC CHOICE WELFARE, V8, P247; Mishra D, 2007, J ECON THEORY, V132, P335, DOI 10.1016/j.jet.2005.09.004; McAfee RP, 1996, J ECON PERSPECT, V10, P159; DEMANGE G, 1985, ECONOMETRICA, V53, P873, DOI 10.2307/1912658; DEMANGE G, 1986, J POLIT ECON, V94, P863, DOI 10.1086/261411; Andersson T, 2014, ECONOMETRICA, V82, P507, DOI 10.3982/ECTA10893; Ashlagi I, 2012, SOC CHOICE WELFARE, V38, P531, DOI 10.1007/s00355-011-0535-4; Ausubel Lawrence M., 2002, THEORETICAL EC, V1, P1, DOI [10.2202/1534-5955.1019, DOI 10.2202/1534-5955.1019]; Ausubel LM, 2006, AM ECON REV, V96, P602, DOI 10.1257/aer.96.3.602; Baisa Brian, 2013, WORKING PAPER; Chew SH, 2007, ECON THEOR, V33, P393, DOI 10.1007/s00199-006-0130-6; Clarke E, 1971, PUBLIC CHOICE, V11, P17, DOI DOI 10.1007/BF01726210; Foley D.K., 1967, YALE ECON ESSAYS, V7, P45; Gul F, 2000, J ECON THEORY, V92, P66, DOI 10.1006/jeth.1999.2580; Hayashi T, 2013, J ECON THEORY, V148, P279, DOI 10.1016/j.jet.2012.12.017; Hurwicz L., 1972, DECISION ORG, P297; Marshall A., 1920, PRINCIPLES EC; Maskin Eric S., 1987, ARROW FDN THEORY EC, P341; Mishra D, 2010, J MATH ECON, V46, P6, DOI 10.1016/j.jmateco.2009.05.008; Miyagawa E, 2001, J ECON THEORY, V100, P329, DOI 10.1006/jeth.2000.2703; Miyake M, 1998, INT J GAME THEORY, V27, P1; Mukherjee C, 2014, SOC CHOICE WELFARE, V42, P289, DOI 10.1007/s00355-013-0733-3; Ohseto S, 2006, ECON THEOR, V29, P111, DOI 10.1007/s00199-005-0014-1; Roth A., 1990, 2 SIDED MATCHING STU, DOI [10.1017/CCOL052139015X, DOI 10.1017/CCOL052139015X]; Saitoh H, 2008, ECON THEOR, V35, P391, DOI 10.1007/s00199-007-0235-6; Sakai T, 2013, REV ECON DES, V17, P17, DOI 10.1007/s10058-012-0135-5; Sakai T, 2008, ECON THEOR, V37, P347, DOI 10.1007/s00199-007-0311-y; Schummer J, 2000, GAME ECON BEHAV, V30, P293, DOI 10.1006/game.1999.0718; Schummer J, 1997, SOC CHOICE WELFARE, V14, P47; Schummer James, 2007, J ECON THEORY, V132, P95, DOI [10.1016/j.jet.2005.07.010, DOI 10.1016/J.JET.2005.07.010]; Sun N, 2003, ECON LETT, V81, P73, DOI 10.1016/S0165-1765(03)00151-4; Svensson Lars-Gunnar, 2004, WORKING PAPER; Svensson LG, 2002, ECON THEOR, V20, P483, DOI 10.1007/s001990100232; SVENSSON LG, 1983, ECONOMETRICA, V51, P939, DOI 10.2307/1912044; Svensson LG, 2009, ECON THEOR, V40, P227, DOI 10.1007/s00199-008-0366-4; TADENUMA K, 1991, ECONOMETRICA, V59, P1755, DOI 10.2307/2938288; TADENUMA K, 1995, GAME ECON BEHAV, V9, P191, DOI 10.1006/game.1995.1015; VICKREY W, 1961, J FINANC, V16, P8, DOI 10.2307/2977633; VIVES X, 1987, REV ECON STUD, V54, P87, DOI 10.2307/2297448	51	0	0	ECONOMETRIC SOCIETY	NEW YORK	NEW YORK UNIV, DEPT ECONOMICS, 19 W 4 ST, NEW YORK, NY 10012 USA	1933-6837	1555-7561		THEOR ECON	Theor. Econ.	MAY	2015	10	2					445	487		10.3982/TE1470		43	Economics	Business & Economics	CJ6WB	WOS:000355634800006		
J	Kawasaki, Y; Ito, A; Kakoi, N; Shimada, S; Itoh, J; Mitsuzuka, K; Arai, Y				Kawasaki, Yoshihide; Ito, Akihiro; Kakoi, Narihiko; Shimada, Shuichi; Itoh, Jun; Mitsuzuka, Koji; Arai, Yoichi			Ganglioside, Disialosyl Globopentaosylceramide (DSGb5), Enhances the Migration of Renal Cell Carcinoma Cells	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						disialosyl globopentaosylceramide; ganglioside; metastasis; migration; renal cell carcinoma	LIMITING DILUTION; GROWTH; ANTIBODIES; LIGAND; TUMOR	About one third of renal cell carcinoma (RCC) patients exhibit metastasis upon initial presentation. However, the molecular basis for RCC metastasis is not fully understood. A ganglioside, disialosyl globopentaosylceramide (DSGb5), was originally isolated from RCC tissue extracts, and its expression is correlated with RCC metastatic potential. DSGb5 is synthesized by GaINAc alpha 2,6-sialyltransferase VI (ST6GaINAcVI) and is expressed on the surface of RCC cells. Importantly, DSGb5 binds to sialic acid-binding Ig-like lectin-7 (Siglec-7) expressed on natural killer (NK) cells, thereby inhibiting NK-cell cytotoxicity. However, the role of DSGb5 in RCC progression remains obscure. To address this issue, we used ACHN cells derived from malignant pleural effusion of a patient with metastatic RCC. Using the limiting dilution method, we isolated three independent clones with different DSGb5 expression levels. Comparison of these clones indicated that the cloned cells with high DSGb5 expression levels exhibited greater migration potential, compared to the clone with low DSGb5 expression levels. In contrast, DSGb5 expression levels exerted no significant effect on cell proliferation. We then established the ACHN-derived cell lines that stably expressed siRNA against ST6GaINAcVI mRNA or control siRNA. Importantly, the ST6GaINAcVI-knockdown cells expressed low levels of DSGb5. We thus demonstrated the significantly decreased migration potential of the ST6GaINAcVI-knockdown cells with low DSGb5 expression levels, compared to the control siRNA-transfected cells expressing high DSGb5 levels, but no significant difference in the cell proliferation. Thus, DSGb5 expression may ensure the migration of RCC cells. We propose that DSGb5 expressed on RCC cells may determine their metastatic capability. (C) 2015 Tohoku University Medical Press	[Kawasaki, Yoshihide; Ito, Akihiro; Kakoi, Narihiko; Shimada, Shuichi; Itoh, Jun; Mitsuzuka, Koji; Arai, Yoichi] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi 9808574, Japan	Ito, A (reprint author), Tohoku Univ, Grad Sch Med, Dept Urol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	itoaki@uro.med.tohoku.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [21390437, 25462465, 26430153]	This study was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (Grant Nos. 21390437, 25462465, and 26430153 to Y.A., A.I., and Y.K.).	Battula VL, 2012, J CLIN INVEST, V122, P2066, DOI 10.1172/JCI59735; Bukowski RM, 1997, CANCER, V80, P1198, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1198::AID-CNCR3>3.0.CO;2-H; Wang RF, 2013, BBA-MOL CELL RES, V1833, P3195, DOI 10.1016/j.bbamcr.2013.09.007; Shimada S, 2014, PROSTATE CANCER P D, V17, P199, DOI 10.1038/pcan.2014.9; Ito A, 2001, J BIOL CHEM, V276, P16695, DOI 10.1074/jbc.M011791200; Zhou H, 2005, J BIOL CHEM, V280, P10624, DOI 10.1074/jbc.M411900200; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Ahmed M, 2014, FEBS LETT, V588, P288, DOI 10.1016/j.febslet.2013.11.030; Ito A, 2001, GLYCOCONJUGATE J, V18, P475, DOI 10.1023/A:1016281002344; Mitsuzuka K, 2005, J BIOL CHEM, V280, P35545, DOI 10.1074/jbc.M505630200; Butterworth AS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-95; GRENMAN R, 1989, INT J CANCER, V44, P131, DOI 10.1002/ijc.2910440123; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Ito Akihiro, 2001, FEBS Letters, V504, P82, DOI 10.1016/S0014-5793(01)02734-X; Kawasaki Y, 2010, GLYCOBIOLOGY, V20, P1373, DOI 10.1093/glycob/cwq116; Kopitz J, 2012, NEUROCHEM RES, V37, P1267, DOI 10.1007/s11064-011-0693-x; Li Y, 2013, MOL CELL BIOCHEM, V382, P83, DOI 10.1007/s11010-013-1720-9; Liu Y, 2010, ONCOGENE, V29, P3297, DOI 10.1038/onc.2010.85; SAITO S, 1994, J BIOL CHEM, V269, P5644; SAITO S, 1991, INT J CANCER, V49, P329; Sarkar TR, 2014, ONCOGENE; Senda M, 2007, BIOCHEM J, V402, P459, DOI 10.1042/BJ20061118; Shang D, 2012, UROLOGY, V79, P966	23	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	MAY	2015	236	1					1	7		10.1620/tjem.236.1		7	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CJ7WF	WOS:000355710400001		
J	Shimizu, U; Mitadera, Y; Aoki, H; Akazawa, K				Shimizu, Utako; Mitadera, Yuji; Aoki, Hagiko; Akazawa, Kouhei			Dialysis Patients' Utilization of Health Care Services Covered by Long-Term Care Insurance in Japan	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						care needs; dialysis facilities; dialysis patients; long-term care insurance; transportation service costs	HEMODIALYSIS; MODALITY; SYSTEM; REFORM	Hemodialysis patients in Japan are aging and thus more patients need support for attending hemodialysis facilities. This study aimed to clarify how dialysis patients utilize the services covered by Japan's public long-term care insurance (LTCI) system. This cross-sectional study was based on LTCI data of March 31, 2009, the latest available data provided by Niigata City, located on the northwest coast of Honshu. Among 30,349 LTCI users in Niigata City, there were 234 dialysis patients. To clarify the characteristics of the dialysis patients, we compared the utilization of LTCI services between the dialysis patients (234 users) and randomly selected 765 non-dialysis users. We also calculated the annual transportation service costs per patient for dialysis patients who continued home care (home care group) and those who switched to long-term hospital care at LTCI care levels 4 and 5 (hospital admission group). These care levels indicate difficulty in walking or maintaining a sitting posture without assistance. The dialysis group more frequently utilized home care and equipment services, such as renting or purchasing care-support products and support for home equipment repair, and utilized facility services and short-stay services (respite care) less frequently (both p < 0.001). Cost per patient was higher in the home care group than in the hospital admission group, because the transportation services for dialysis patients at care levels 4 and 5 involve higher costs. These findings indicate that LTCI services usable for dialysis patients were limited. Therefore, instead of merely subsidizing transportation expenses, transportation services must be improved. (C) 2015 Tohoku University Medical Press	[Shimizu, Utako; Aoki, Hagiko] Niigata Univ, Fac Med, Sch Hlth Sci, Niigata, Niigata 9518518, Japan; [Mitadera, Yuji] Niigata Univ, Grad Sch Med & Dent Sci, Dept Med Informat & Stat, Niigata, Niigata 9518518, Japan; [Akazawa, Kouhei] Niigata Univ Med & Dent Hosp, Dept Med Informat, Niigata, Niigata 9518518, Japan	Shimizu, U (reprint author), Niigata Univ, Fac Med, Sch Hlth Sci, Chuo Ku, 2-746 Asahimachi Dori, Niigata, Niigata 9518518, Japan.	shirakaba@clg.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank the Elderly Care Division of Niigata City Health and Welfare Department for providing the long-term care eligibility assessment data used in this study. This study was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Shaw C, 2013, NEPHRON CLIN PRACT, V123, P29, DOI 10.1159/000353321; Tsutsui T, 2007, J AM GERIATR SOC, V55, P1458, DOI 10.1111/j.1532-5415.2007.01281.x; Canaud B, 2011, CLIN J AM SOC NEPHRO, V6, P1651, DOI 10.2215/CJN.03530410; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Campbell JC, 2003, SOC POLICY ADMIN, V37, P21, DOI 10.1111/1467-9515.00321; Just PM, 2008, NEPHROL DIAL TRANSPL, V23, P2365, DOI 10.1093/ndt/gfm939; Diamant MJ, 2010, CLIN J AM SOC NEPHRO, V5, P268, DOI 10.2215/CJN.05190709; Fukui H, 2004, THER APHER DIAL, V8, P56; Ikegami N, 2004, GERIATR GERONTOL INT, V4, pS146, DOI 10.1111/j.1447-0594.2004.00182.x; Ikegami N., 2007, SOCIAL POLICY SOC, V6, P423, DOI 10.1017/S1474746407003739; Japan Association of Kidney Disease Patients, 2012, HEM PAT SURV REP 201, P100; Ministry of Health Labour and Welfare Japan, 2014, SURV GRANT LONG TERM; Ministry of Health Labour and Welfare Japan, 2009, SURV GRANT LONG TERM; Ministry of Health Labour and Welfare Japan, 2009, REP IMPL STAT LONG T; Ministry of Health Labour and Welfare Japan, 2011, BAS SURV WAG STRUCT; Ministry of Internal Affairs and Communications, 2011, RET PRIC SURV 2010; Nakai S, 2014, THER APHER DIAL, V18, P535, DOI 10.1111/1744-9987.12281; Niigata City, 2012, POP BAS RES REG MARC; Statistics and Information Department Minister's Secretariat Ministry of Health Labour and Welfare Japan, 2010, HDB HLTH WELF STAT 2, P22; The Japanese Society for Dialysis Therapy, 2014, OV REG DIAL TREATM J; United States Renal Data System, 2014, USRDS ANN DAT REP 20	22	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	MAY	2015	236	1					9	19		10.1620/tjem.236.9		11	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CJ7WF	WOS:000355710400002		
J	Saitoh, H; Koizumi, N; Seto, J; Ajitsu, S; Fujii, A; Takasaki, S; Yamakage, S; Aoki, S; Nakayama, K; Ashino, Y; Chagan-Yasutan, H; Kiyomoto, H; Hattori, T				Saitoh, Hiroki; Koizumi, Nobuo; Seto, Junji; Ajitsu, Satoshi; Fujii, Akio; Takasaki, Satoshi; Yamakage, Shu; Aoki, Satoshi; Nakayama, Keisuke; Ashino, Yugo; Chagan-Yasutan, Haorile; Kiyomoto, Hideyasu; Hattori, Toshio			Leptospirosis in the Tohoku Region: Re-emerging Infectious Disease	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						disaster; global warming; hemodialysis; leptospirosis; outbreak	PHILIPPINES; PREFECTURE	Leptospirosis is a zoonotic and disaster-related infectious disease. It is mainly endemic in subtropical or tropical countries and has not been reported since 2009 in the Tohoku region (northern Japan), including the Yamagata and Miyagi Prefectures. However, we experienced four patients with leptospirosis in the Tohoku region from 2012 to 2014; three patients (#1-3) live in the agricultural areas of the Yannagata Prefecture and one patient (#4) was a visitor to the Miyagi Prefecture. Patient 1 (81-year-old female) is a villager, with a rat bite, while Patient 2 (77-year-old male) and Patient 3 (84-year-old female) are farmers and were infected probably during agriculture work. Patient 4 (40-year-old male US citizen) was infected while traveling in Thailand. They had chief complaint of fever, headache, and myalgia and showed manifestations of hyperbilirubinemia (mean, 4.35 mg/dL), thrombocytopenia and acute kidney injury (AKI). All patients were diagnosed by polymerase chain reaction using blood and/or urine samples and a microscopic agglutination test for the anti-Leptospira antibody. All the patients were treated with infused antibiotics, including minocycline. The patients underwent hemodialysis due to severe AKI (mean serum creatinine, 4.44 mg/dL), except for Patient 2 with the normal serum creatinine level (1.12 mg/dL). All the patients recovered and were discharged. The presence of the three patients in the Yamagata Prefecture implies that leptospirosis does re-emerge in the Tohoku region. Therefore, careful survey of the pathogen is necessary for febrile patients with AKI who engage in agriculture or have a recent history of travelling in subtropical or tropical countries. (C) 2015 Tohoku University Medical Press	[Saitoh, Hiroki; Ashino, Yugo; Chagan-Yasutan, Haorile; Hattori, Toshio] Tohoku Univ, Grad Sch Med, Dept Internal Med, Div Emerging Infect Dis, Sendai, Miyagi 9808575, Japan; [Koizumi, Nobuo] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Seto, Junji] Yamagata Prefectural Inst Publ Hlth, Dept Microbiol, Yamagata, Yamagata 9900031, Japan; [Ajitsu, Satoshi] Okitama Publ Gen Hosp, Dept Internal Med, Yamagata, Japan; [Fujii, Akio] Shinjo Tokushukai Hosp, Dept Internal Med, Shinjyo, Yamagata, Japan; [Takasaki, Satoshi; Yamakage, Shu] Yamagata Prefectural Cent Hosp, Dept Internal Med, Yamagata, Yamagata, Japan; [Aoki, Satoshi; Nakayama, Keisuke] Tohoku Univ, Grad Sch Med, Dept Internal Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 9808575, Japan; [Ashino, Yugo; Chagan-Yasutan, Haorile; Hattori, Toshio] Tohoku Univ, Int Res Inst Disaster Sci, Lab Disaster Related Infect Dis, Sendai, Miyagi 9808575, Japan; [Kiyomoto, Hideyasu] Tohoku Univ, Tohoku Med Megabank Org, Div Integrated Nephrol & Telemed, Sendai, Miyagi 9808575, Japan	Hattori, T (reprint author), Tohoku Univ, Int Res Inst Disaster Sci, Lab Disaster Related Infect Dis, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	hatoriaoi@gmail.com			Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT); Joint Research Program of the Research Center for Zoonosis Control at Hokkaido University; IRIDeS at Tohoku University	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) and the Joint Research Program of the Research Center for Zoonosis Control at Hokkaido University. This study was also supported by a special research project from IRIDeS at Tohoku University.	Akiyama K, 2001, JPN J INFECT DIS, V54, P156; Koizumi N, 2008, JPN J INFECT DIS, V61, P465; Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Saito M, 2014, APPL ENVIRON MICROB, V80, P6926, DOI 10.1128/AEM.02568-14; Koizumi N, 2013, J MED MICROBIOL, V62, P630, DOI 10.1099/jmm.0.050039-0; Dolhnikoff M, 2007, CURR OPIN PULM MED, V13, P230, DOI 10.1097/MCP.0b013e3280f9df74; Chagan-Yasutan H, 2013, J CLIN VIROL, V58, P635, DOI 10.1016/j.jcv.2013.10.022; Daher EF, 2009, NEPHRON CLIN PRACT, V112, pC25, DOI 10.1159/000210571; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; Hartskeerl R A, 2006, Indian J Med Microbiol, V24, P309; Infectious Agents Surveillance Report (IASR), 2014, NIID, V35, P16; Infectious Agents Surveillance Report (IASR), 2012, NIID, V33, P14; Koizumi N., 2006, MODERN MEDIA, V52, P299; WHO, 2006, COMM DIS FOLL NAT DI; World Health Organisation W, 1999, WKLY EPIDEMIOL REC, V74, P237; World Health Organization, 2003, HUM LEPT GUID DIAGN	17	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	MAY	2015	236	1					33	37		10.1620/tjem.236.33		5	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CJ7WF	WOS:000355710400004		
J	Kagaya, H; Yokoyama, M; Saitoh, E; Kanamori, D; Susa, C; German, RZ; Palmer, JB				Kagaya, Hitoshi; Yokoyama, Michio; Saitoh, Eiichi; Kanamori, Daisuke; Susa, Chiaki; German, Rebecca Z.; Palmer, Jeffrey B.			Isolated Pharyngeal Swallow Exists during Normal Human Feeding	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						consecutive pharyngeal swallow; deglutition; isolated pharyngeal swallow; model; videofluoroscopic examination of swallowing	REFLEX; PIG; CONSISTENCY; MECHANISMS; INITIATION; TRANSPORT; VOLUNTARY	Swallowing is one of the basic activities in humans. The pharynx functions as an airway and a food channel, and a pharyngeal swallow usually occurs after bolus transport from the oral cavity. However, direct fluid infusion through a catheter into the hypopharynx produces a pharyngeal swallow without the oral stage in experimental situations. The purpose of this study was to examine whether a pharyngeal swallow, which is not accompanied by bolus transport, can occur during normal human feeding. Fifty-three healthy volunteers (25-89 years) were recorded, via videofluoroscopic examination of swallowing, during 3 different swallowing trials: command swallow of 10 ml liquid barium, chew-swallow of corned beef, and chew-swallow of a mixture of corned beef and liquid barium. Subsequently each swallow was classified as being either a consecutive pharyngeal swallow (CPS), following transport, or an isolated pharyngeal swallow (IFS), without immediately prior transport. The location of the bolus at swallow initiation was also noted. Of 307 trials, 681 swallows were identified, which included 43 IFS and 638 CPS. IFS only occurred as the first swallow of a trial, but the frequency of IPS did not differ between 28 younger (< 60 years) and 25 older 60 years) people. Of the three food types, IFS occurred more frequently with the mixed food than with liquid. These results suggest that IFS may represent an airway protective mechanism. In conclusion, IFS occurs in normal swallowing during a daily eating situation. Swallowing is more complex than a simple reflex. (C) 2015 Tohoku University Medical Press	[Kagaya, Hitoshi; Yokoyama, Michio; Saitoh, Eiichi; Kanamori, Daisuke; Susa, Chiaki] Fujita Hlth Univ, Sch Med, Dept Rehabil Med 1, Toyoake, Aichi 4701192, Japan; [German, Rebecca Z.] Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD USA; [Palmer, Jeffrey B.] Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA; [Palmer, Jeffrey B.] Johns Hopkins Univ, Ctr Funct Anat & Evolut, Baltimore, MD USA	Kagaya, H (reprint author), Fujita Hlth Univ, Sch Med, Dept Rehabil Med 1, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	hkagaya2@fujita-hu.ac.jp					German RZ, 2009, J NEUROPHYSIOL, V102, P1017, DOI 10.1152/jn.00100.2009; Thexton AJ, 2012, J APPL PHYSIOL, V112, P1512, DOI 10.1152/japplphysiol.00450.2011; SHAKER R, 1994, GASTROENTEROLOGY, V107, P396; NISHINO T, 1993, ANESTHESIOLOGY, V79, P588, DOI 10.1097/00000542-199309000-00024; Ertekin C, 2001, DYSPHAGIA, V16, P40, DOI 10.1007/s004550000041; Hiiemae KM, 1999, DYSPHAGIA, V14, P31, DOI 10.1007/PL00009582; Ertekin C, 2000, BRAIN, V123, P125, DOI 10.1093/brain/123.1.125; DODDS WJ, 1990, AM J ROENTGENOL, V154, P965; Saitoh E, 2007, DYSPHAGIA, V22, P100, DOI 10.1007/s00455-006-9060-5; Ertekin C, 2011, DYSPHAGIA, V26, P183, DOI 10.1007/s00455-010-9319-8; Humbert IA, 2012, J APPL PHYSIOL, V112, P1698, DOI 10.1152/japplphysiol.01534.2011; Feinberg Michael J., 1993, Dysphagia, V8, P356, DOI 10.1007/BF01321779; Linden P, 1989, Dysphagia, V4, P146, DOI 10.1007/BF02408037; Palmer J.B., 1997, JPN J DYSPHAGIA REHA, V1, P15; Palmer JB, 1998, ARCH PHYS MED REHAB, V79, P691, DOI 10.1016/S0003-9993(98)90046-6; Palmer JB, 1997, ARCH ORAL BIOL, V42, P429, DOI 10.1016/S0003-9969(97)00020-4; PALMER J B, 1992, Dysphagia, V7, P187, DOI 10.1007/BF02493469; Pouderoux P, 1996, AM J PHYSIOL-GASTR L, V270, pG347; Prochazka A, 2000, EXP BRAIN RES, V130, P417, DOI 10.1007/s002219900250; SHAKER R, 1995, DYSPHAGIA, V10, P216, DOI 10.1007/BF00431413; Thexton AJ, 2007, J APPL PHYSIOL, V102, P587, DOI 10.1152/japplphysiol.00456.2006	21	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	MAY	2015	236	1					39	43		10.1620/tjem.236.39		5	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CJ7WF	WOS:000355710400005		
J	Fujimura, M; Tominaga, T				Fujimura, Miki; Tominaga, Teiji			Current Status of Revascularization Surgery for Moyamoya Disease: Special Consideration for Its 'Internal Carotid-External Carotid (IC-EC) Conversion' as the Physiological Reorganization System	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Review						cerebral blood flow; extracranial-intracranial bypass; moyamoya disease; perioperative management; single-photon emission computed tomography	CEREBRAL-ARTERY ANASTOMOSIS; EXTRACRANIAL-INTRACRANIAL BYPASS; MICE LACKING RNF213; NEUROLOGICAL DETERIORATION; SURGICAL REVASCULARIZATION; SPONTANEOUS OCCLUSION; SUSCEPTIBILITY GENE; CLINICAL-FEATURES; HYPERPERFUSION; JAPAN	Moyamoya disease is a chronic cerebrovascular disease with unknown etiology, which is characterized by bilateral steno-occlusive changes at the terminal portion of the internal carotid artery and an abnormal vascular network formation at the base of the brain. Moyamoya disease is known to have unique and dynamic nature to convert the vascular supply for the brain from internal carotid (IC) system to the external carotid (EC) system, as indicated by Suzuki's angiographic staging established in 1969. Insufficiency of this 'IC-EC conversion system' may result in cerebral ischemia, as well as in intracranial hemorrhage from inadequate collateral vascular network, both of which represent the clinical presentation of moyamoya disease. Therefore, surgical revascularization by extracranial-intracranial bypass is the preferred procedure for moyamoya disease to complement 'IC-EC conversion' and thus to avoid cerebral infarction and/or intracranial hemorrhage. Long-term outcome of revascularization surgery for moyamoya disease is favorable, but rapid increase in cerebral blood flow on the affected hemisphere could temporarily cause unfavorable phenomenon such as cerebral hyperperfusion syndrome. We would review the current status of revascularization surgery for moyamoya disease based on its basic pathology, and sought to discuss the significance of measuring cerebral blood flow in the acute stage and intensive perioperative management. (C) 2015 Tohoku University Medical Press	[Fujimura, Miki; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 9808574, Japan	Fujimura, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	fujimur@nsg.med.tohoku.ac.jp					SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; Sonobe S, 2014, BRAIN RES, V1552, P64, DOI 10.1016/j.brainres.2014.01.011; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Ikeda H, 1999, AM J HUM GENET, V64, P533, DOI 10.1086/302243; Kang HS, 2010, J NEUROL NEUROSUR PS, V81, P673, DOI 10.1136/jnnp.2009.191817; Houkin K, 1997, CLIN NEUROL NEUROSUR, V99, pS142; Fujimura M, 2012, NEUROL MED-CHIR, V52, P327; Fujimura M, 2009, SURG NEUROL, V72, P476, DOI 10.1016/j.surneu.2008.10.009; Kaku Y, 2012, ACTA NEUROCHIR, V154, P2151, DOI 10.1007/s00701-012-1472-4; Fujimura M, 2007, SURG NEUROL, V67, P273, DOI 10.1016/j.surneu.2006.07.017; Yamauchi T, 2000, STROKE, V31, P930; Kim SJ, 2010, STROKE, V41, P173, DOI 10.1161/STROKEAHA.109.562264; Fujimura M, 2012, CEREBROVASC DIS, V33, P436, DOI 10.1159/000336765; [Anonymous], 2012, NEUROL MED CHIR TOKY, V52, P245; Uchino H, 2012, STROKE, V43, P2610, DOI 10.1161/STROKEAHA.112.654723; Miyamoto S, 2014, STROKE, V45, P1415, DOI 10.1161/STROKEAHA.113.004386; Kuroda S, 2005, STROKE, V36, P2148, DOI 10.1161/01.STR.0000182256.32489.99; Hayashi K, 2014, CLIN NEUROL NEUROSUR, V124, P1, DOI 10.1016/j.clineuro.2014.06.010; Fujimura M, 2009, SURG NEUROL, V71, P442, DOI 10.1016/j.surneu.2008.02.031; Fujimura M, 2011, NEUROSURGERY, V68, P957, DOI 10.1227/NEU.0b013e318208f1da; Fujimura M, 2009, NEUROSURG REV, V32, P245, DOI 10.1007/s10143-009-0184-6; Fujimura M, 2014, NEUROSURGERY, V74, P163, DOI 10.1227/NEU.0000000000000238; Fujimura M, 2009, SURG NEUROL, V71, P223, DOI 10.1016/j.surneu.2007.07.077; Fujimura M., 2015, SURG CEREB STROKE, V43, P136; Fujimura M, 2008, CHILD NERV SYST, V24, P827, DOI 10.1007/s00381-007-0551-y; Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238; Hayashi T, 2010, J NEUROSURG-PEDIATR, V6, P73, DOI 10.3171/2010.4.PEDS09478; Hone N, 2014, ACTA NEUROCHIR WIEN, V156, P919; Hwang JW, 2013, BRIT J ANAESTH, V110, P773, DOI 10.1093/bja/aes470; Inoue TK, 2000, J CHILD NEUROL, V15, P179, DOI 10.1177/088307380001500307; Ito A, 2015, BRAIN RES, V1594, P310, DOI 10.1016/j.brainres.2014.11.014; Kim JE, 2008, CEREBROVASC DIS, V25, P580, DOI 10.1159/000132205; Kuroda S, 2007, STROKE, V38, P1430, DOI 10.1161/STROKEAHA.106.478297; Kuroda S, 2015, NEUROL MED-CHIR, V55, P194, DOI 10.2176/nmc.ra.2014-0305; Nakagawa A, 2009, J NEUROSURG, V111, P1158, DOI 10.3171/2009.4.JNS08585; Ohue S, 2008, SURG NEUROL, V69, P281, DOI 10.1016/j.surneu.2007.01.047; Sakata H., 2015, J STROKE CE IN PRESS; Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6; Uchino H, 2014, ACTA NEUROCHIR, V156, P1753, DOI 10.1007/s00701-014-2161-2; Yuan M, 2015, NEUROSCI LETT, V584, P77, DOI 10.1016/j.neulet.2014.10.021	40	3	3	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	MAY	2015	236	1					45	53		10.1620/tjem.236.45		9	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CJ7WF	WOS:000355710400006		
J	Sato, S; Watanabe, M; Taniuchi, S; Kasajima, A; Mitsuzuka, K; Nakamura, Y; Fujishima, F; Arai, Y; Sasano, H				Sato, Satoko; Watanabe, Mika; Taniuchi, Shinji; Kasajima, Atsuko; Mitsuzuka, Koji; Nakamura, Yasuhiro; Fujishima, Fumiyoshi; Arai, Yoichi; Sasano, Hironobu			Precise Preoperative Localization of Prostate Cancer Employing 12-Core Needle Biopsy with a Tissue-Marking Method for Effective Surgical Strategy	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						biopsy; extraprostatic extension; histopathology; multifocality; tissue marking	RADICAL PROSTATECTOMY; EXTRACAPSULAR EXTENSION; INDEPENDENT PREDICTOR; PROGRESSION; CARCINOMA; SPECIMENS; SEXTANT; MARGIN	Prostate needle biopsy plays a pivotal role not only in the diagnosis but also the management of patients with prostate cancer. Prostate cancer is often multifocal and diagnosis of the lesion could therefore be difficult with diagnostic imaging only; thus, multiple core biopsies are taken from several different regions of the prostate. In current practice, 10- or 12-core needle biopsy is considered the clinical standard. Several techniques have been reported to improve the orientation of the specimens, but tissue marking, which could theoretically provide important information on the location of the lesion in the prostate, has been rarely reported. Therefore, in this study, we evaluated the clinical significance of systematic 12-core needle biopsy with tissue marking for preoperative prediction of lesion sites and clinicopathological features of patients. We evaluated 93 patients who underwent 12-core prostate biopsy and subsequent radical prostatectomy. We correlated the biopsy results to the prostate sites in which biopsies were performed and prognostic factors of the patients, especially the degree of extraprostatic extension (EPE) obtained in surgical specimens. Among 253 cancer foci detected in 93 prostatectomy specimens, 168 (66.4%) foci were detected by biopsy. All patients had proven cancer. EPE-positive cancers were associated with a larger number of positive cores, larger tumor length, and higher percentage of cancer tissue in the corresponding cores. Systematic 12-core prostate biopsy with tissue marking is useful for preoperative detection of cancer foci and provides valuable information that enables effective surgical strategies. (C) 2015 Tohoku University Medical Press	[Sato, Satoko; Watanabe, Mika; Taniuchi, Shinji; Kasajima, Atsuko; Fujishima, Fumiyoshi; Sasano, Hironobu] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi 9808574, Japan; [Nakamura, Yasuhiro; Sasano, Hironobu] Tohoku Univ, Grad Sch Med, Dept Anat Pathol, Sendai, Miyagi 980, Japan; [Mitsuzuka, Koji; Arai, Yoichi] Tohoku Univ, Sch Med, Dept Urol, Sendai, Miyagi 980, Japan	Sato, S (reprint author), Tohoku Univ Hosp, Dept Pathol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	satoshio@patholo2.med.tohoku.ac.jp					Bjurlin MA, 2013, J UROLOGY, V189, P2039, DOI 10.1016/j.juro.2013.02.072; Arora R, 2004, CANCER, V100, P2362, DOI 10.1002/cncr.20243; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Babaian RJ, 2000, J UROLOGY, V163, P152, DOI 10.1016/S0022-5347(05)67993-1; Stamey TA, 1999, JAMA-J AM MED ASSOC, V281, P1395, DOI 10.1001/jama.281.15.1395; Ohori M, 2004, J UROLOGY, V171, P1844, DOI 10.1097/01.ju.0000121693.05077.3d; Andreoiu M, 2010, HUM PATHOL, V41, P781, DOI 10.1016/j.humpath.2010.02.011; Eskew LA, 1997, J UROLOGY, V157, P199, DOI 10.1016/S0022-5347(01)65322-9; BOSTWICK DG, 1994, AM J CLIN PATHOL, V102, pS38; Cheng L, 2005, MODERN PATHOL, V18, P1022, DOI 10.1038/modpathol.3800431; Firoozi F, 2009, UROL ONCOL-SEMIN ORI, V27, P21, DOI 10.1016/j.urolonc.2007.09.002; Galosi A.B., 2011, PROSTATE CANC, V2011; Gao X, 2000, J UROLOGY, V164, P1982, DOI 10.1016/S0022-5347(05)66933-9; Ishizaki F, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-68; Meeks JJ, 2013, BJU INT, V112, P308, DOI 10.1111/bju.12015; Orikasa K, 2008, INT J UROL, V15, P900, DOI 10.1111/j.1442-2042.2008.02106.x; Quinn DI, 2003, CANCER, V97, P1884, DOI 10.1002/cncr.11263; Sonoda T, 2004, CANCER SCI, V95, P238, DOI 10.1111/j.1349-7006.2004.tb02209.x; Terris MK, 2002, PROSTATE, V50, P247, DOI 10.1002/pros.10053; Yamanaka H, 2013, UROLOGY, V81, P986, DOI 10.1016/j.urology.2012.12.050	20	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	MAY	2015	236	1					55	61		10.1620/tjem.236.55		7	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CJ7WF	WOS:000355710400007		
J	Ehara, S; Takahashi, K; Nishida, J; Uetani, M; Ohashi, K; Aoki, T				Ehara, Shigeru; Takahashi, Kei; Nishida, Jun; Uetani, Masataka; Ohashi, Kenjirou; Aoki, Takatoshi			Hand Osteolysis in Patients with Adult T-Cell Leukemia-Lymphoma: Radiographic Characteristics	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						adult T-cell leukemia-lymphoma; hyperparathyroidism; osteolysis; parathyroid hormone-related peptide; radiography	HORMONE-RELATED PROTEIN; VIRUS TYPE-I; RENAL OSTEODYSTROPHY; EXPRESSION; GENE; JAPAN	Adult T-cell leukemia-lymphoma (ATLL) is caused by human T-cell lymphotrophic virus I (HTLV-I) infection. Among ATLL cases, 70% of patients present with leukemia and the remaining patients present with lymphoma. Hand osteolysis in the patients with ATLL is considered as paraneoplastic syndrome and caused by parathyroid hormone-related peptide (PTHrP) released from tumor cells. Radiographic features are similar to hyperparathyroidism, but the distribution of osteolysis in hands appears to be slightly different with the authors' experiences. The objective of this study was to identify radiographic characteristics of hand osteolysis associated with ATLL. We included six ATLL patients (5 men and 1 woman; age range, 45-71 years). All the patients presented with acute leukemia, and three were associated with hypercalcemia and pain in various locations including hands. Patterns of osteolysis on hand radiographs were evaluated and recorded independently by three musculoskeletal radiologists. We analyzed the distribution of the bone resorption in the ray distribution of the hand, finger predilection, and the difference between the ulnar and radial sides. The bone resorption was characterized by frequent involvement of the distal and proximal phalanges, predilection of ring fingers and prominent involvement on the ulnar side, compared with frequent involvement of proximal and middle phalanges, index and middle fingers, and on the radial side in the bone resorption of typical hyperparathyroidism. Such distribution may be a characteristic feature of hand osteolysis in patients with ATLL. The present findings are helpful for physicians to differentiate PTHrP-mediated osteolysis in ATLL from parathyroid hormone-mediated hyperparathyroidism. (C) 2015 Tohoku University Medical Press	[Ehara, Shigeru] Iwate Med Univ, Sch Med, Dept Radiol, Morioka, Iwate 0208505, Japan; [Takahashi, Kei] Iwate Med Univ, Sch Liberal Arts, Morioka, Iwate 0208505, Japan; [Nishida, Jun] Iwate Med Univ, Sch Med, Dept Orthoped Surg, Morioka, Iwate 0208505, Japan; [Uetani, Masataka] Nagasaki Univ, Sch Med, Dept Radiol, Nagasaki 852, Japan; [Ohashi, Kenjirou] St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa, Japan; [Aoki, Takatoshi] Univ Occupat & Environm Hlth, Sch Med, Dept Radiol, Kitakyushu, Fukuoka 807, Japan	Ehara, S (reprint author), Iwate Med Univ, Sch Med, Dept Radiol, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	ehara@iwate-med.ac.jp			National Cancer Center Research and Development Fund (Japan)	This work has been partly supported by the National Cancer Center Research and Development Fund (Japan).	WYSOLMERSKI JJ, 1994, ANNU REV MED, V45, P189, DOI 10.1146/annurev.med.45.1.189; Qayyum S, 2014, ARCH PATHOL LAB MED, V138, P282, DOI 10.5858/arpa.2012-0379-RS; Yamaguchi K, 2002, INT J HEMATOL, V76, P240; AOKI J, 1987, SKELETAL RADIOL, V16, P412; AUSTIN CB, 1987, RADIOLOGY, V164, P787; Kessar P, 1996, CLIN RADIOL, V51, P299, DOI 10.1016/S0009-9260(96)80352-7; MEEMA HE, 1978, J CAN ASSOC RADIOL, V29, P175; MOTOKURA T, 1989, ANN INTERN MED, V111, P484; MOTOKURA T, 1988, BIOCHEM BIOPH RES CO, V154, P1182, DOI 10.1016/0006-291X(88)90265-3; NIITSU Y, 1988, BLOOD, V71, P263; OHUCHIDA T, 1985, SKELETAL RADIOL, V14, P194; RESNICK D, 1981, AM J ROENTGENOL, V136, P711; SUNDARAM M, 1979, AM J ROENTGENOL, V133, P25; WANO Y, 1987, J CLIN INVEST, V80, P911, DOI 10.1172/JCI113152; WATANABE T, 1990, J EXP MED, V172, P759, DOI 10.1084/jem.172.3.759; YAMAGUCHI K, 1994, LANCET, V343, P213, DOI 10.1016/S0140-6736(94)90994-6	16	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	MAY	2015	236	1					63	69		10.1620/tjem.236.63		7	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CJ7WF	WOS:000355710400008		
J	Wijdenes, LO; Gomi, H; Brenner, E				Wijdenes, Leonie Oostwoud; Gomi, Hiroaki; Brenner, Eli			Vision Research special issue on the "On-line Visual Control of Action"	VISION RESEARCH			English	Editorial Material									[Wijdenes, Leonie Oostwoud] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Gomi, Hiroaki] NTT Commun Sci Labs, Atsugi, Kanagawa 24301, Japan; [Brenner, Eli] Vrije Univ, Fac Human Movement Sci, NL-1081 BT Amsterdam, Netherlands	Wijdenes, LO (reprint author), UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, 33 Queen Sq, London WC1N 3BG, England.	l.wijdenes@ucl.ac.uk; gomi.hiroalci@lab.nttcojp; e.brenner@fbw.vu.nl	Oostwoud Wijdenes, Leonie/M-1262-2015	Oostwoud Wijdenes, Leonie/0000-0002-7264-7853				0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	MAY	2015	110		B		SI		143	143		10.1016/j.visres.2014.12.017		1	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CJ2XX	WOS:000355349100001		
J	Aoki, K; Mitsutsuka, S; Yamazaki, A; Nagai, K; Tezuka, A; Tsuji, Y				Aoki, Kouhei; Mitsutsuka, Syuuhei; Yamazaki, Ato; Nagai, Kazumi; Tezuka, Atsuko; Tsuji, Yamato			Effects of seasonal changes in dietary energy on body weight of captive Japanese macaques (Macaca fuscata)	ZOO BIOLOGY			English	Article						captivity; diet; energy; primates; seasonal variation	ACTIVITY BUDGETS; HOME-RANGE; MONKEYS; WILD; YAKUSHIMA; KINKAZAN; TEMPERATURE; ORANGUTANS; PROTEIN; FOREST	Food availability varies seasonally for wild animals, and body weight fluctuates accordingly in the wild. In contrast, controlling availability of diet under captive condition is difficult from keepers' standpoint, and monotonous diet often causes health problems in captive animals. We evaluated the effects of a seasonally controlled diet on body weight of captive Japanese macaques (Macaca fuscata) in an outside enclosure at Ueno Zoo, Tokyo, Japan. We fed a high-energy diet in spring and fall, and a more restricted diet in summer and winter for 3 years (2011-2013). Seasonal changes in body weight were similar to those that occur in wild macaques: for both sexes, body weight was higher in spring and fall and lower in winter. A decrease in body weight between fall and winter occurred only in adults, which implied that reducing dietary intake in winter had a more severe effect on adults than on juveniles. Different from wild populations, the body weight of captive macaques did not decrease between spring and summer, which we attributed to a lack of movement within the enclosure and to excess energy intake in summer. In addition to controlling dietary composition, providing large enclosure with complex structure and making efforts of giving unpredictability in feeding are necessary to motivate the captive animals to be more active, which would cause the macaques to show seasonal change in body weight, which is found in wild. Zoo Biol. 34:255-261, 2015. (c) 2015 Wiley Periodicals Inc.	[Aoki, Kouhei; Mitsutsuka, Syuuhei; Yamazaki, Ato] Ueno Zool Gardenz, Tokyo, Japan; [Nagai, Kazumi; Tezuka, Atsuko] Tokyo Zoo Volunteers, Tokyo, Japan; [Tsuji, Yamato] Kyoto Univ, Primate Res Inst, Kyoto, Aichi, Japan	Aoki, K (reprint author), 9-83 Ueno Koen,Taito Ku, Tokyo 1108711, Japan.	kouhei_aoki@tzps.or.jp					Agetsuma N, 1998, PRIMATES, V39, P275, DOI 10.1007/BF02573077; AGETSUMA N, 1995, INT J PRIMATOL, V16, P611; WATANUKI Y, 1993, PRIMATES, V34, P419, DOI 10.1007/BF02382651; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Terranova CJ, 1997, ZOO BIOL, V16, P17; Goossens E, 2005, VET PARASITOL, V127, P303, DOI 10.1016/j.vetpar.2004.10.013; Tsuji Y, 2008, PRIMATES, V49, P157, DOI 10.1007/s10329-007-0070-1; Araujo A, 2000, INT J PRIMATOL, V21, P317, DOI 10.1023/A:1005433722475; BLASETTI A, 1988, ZOO BIOL, V7, P69, DOI 10.1002/zoo.1430070108; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Chiba H., 1966, Journal of the Mammalogical Society of Japan, V3, P8; Frankham R, 2002, INTRO CONSERVATION G, P617; Fujimoto T, 2011, J JPN ASS ZOO AQU, V52, P1; Furuichi T., 2000, NATURAL SOC JAPANESE, P97; FURUICHI T, 1983, Primates, V24, P445, DOI 10.1007/BF02381678; Go M, 2010, PRIMATES, V51, P149, DOI 10.1007/s10329-009-0179-5; Gresl TA, 2000, ZOO BIOL, V19, P193, DOI 10.1002/1098-2361(2000)19:3<193::AID-ZOO3>3.0.CO;2-M; Hamada Y., 2008, MAMMALOGY IN JAPAN, P53; Hanya G, 2004, INT J PRIMATOL, V25, P55, DOI 10.1023/B:IJOP.0000014645.78610.32; Hasegawa M., 1983, NURSING BEHAV WILD J, P96; Hayama Shin-ichi, 1999, Japanese Journal of Zoo and Wildlife Medicine, V4, P111; Hosey G, 2011, ZOO ANIMALS BEHAV MA, P621; HUBERT HB, 1983, CIRCULATION, V67, P968; Iwamoto T., 1988, ECOLOGY BEHAV FOOD E, P79; Izawa K, 2009, RES WILD JAPANESE MA, P414; Jaman MF, 2008, AM J PRIMATOL, V70, P1133, DOI 10.1002/ajp.20612; Kleiman DG, 2010, WILD MAMMALS CAPTIVI, P645; Ko S, 2005, FUNDAMENTAL NUTR SCI, P218; Kurita H, 2002, INT J PRIMATOL, V23, P411, DOI 10.1023/A:1013895830970; Matsuoka S, 2000, MONKEYS EMIT COO CAL, P209; Matsuzawa Y, 1989, JPN J LIVEST MANAG, V25, P41; Ministry of Agriculture Forestry and Fisheres, 1995, STAND TABL FEED COMP, P293; Ministry of Education, 2010, STAND TABL FOOD COMP, P510; MORI A, 1979, Primates, V20, P371, DOI 10.1007/BF02373390; Morimitsu Y, 1997, THESIS NIPPON VET A; Muroyama Y, 2006, PRIMATES, V47, P355, DOI 10.1007/s10329-006-0184-x; Nakagawa N, 1997, AM J PRIMATOL, V41, P267, DOI 10.1002/(SICI)1098-2345(1997)41:4<267::AID-AJP1>3.0.CO;2-V; NAKAGAWA N, 1989, PRIMATES, V30, P1, DOI 10.1007/BF02381206; Nakagawa N, 1994, VARIOUS VIEW POINTS, P285; Nakagawa N, 1999, ECOLOGY FEEDING SPEE, P287; Nakayama Y, 1999, ECOL RES, V14, P291, DOI 10.1046/j.1440-1703.1999.143306.x; Nigi H., 1982, JAPANESE MACAQUES PH, P309; Nitta M., 2008, FUNDAMENTAL GEOGRAPH, P9; PERKINS LA, 1992, ZOO BIOL, V11, P177, DOI 10.1002/zoo.1430110306; Plowman AB, 2005, APPL ANIM BEHAV SCI, V90, P155, DOI 10.1016/j.applanim.2004.08.014; Primate Research Institute Kyoto University, 2010, GUID CAR US NONH PRI; R Development Core Team, 2012, R LANG ENV STAT COMP; Reinhardt V., 1996, Animal Welfare, V5, P361; Shepherdson D., 1998, 2 NATURE ENV ENRICHM, P376; SUGIYAMA Y, 1982, FOLIA PRIMATOL, V39, P238, DOI 10.1159/000156080; Sugiyama Y., 1988, Primate Research, V4, P33; Takahata Y, 1998, PRIMATES, V39, P339, DOI 10.1007/BF02573082; Tsuji Y, 2004, ECOL RES, V19, P381, DOI 10.1111/j.1440-1703.2004.00648.x; Tsuji Y., 2010, JAPANESE MACAQUES, P95; Tsuji Y, 2012, INT J PRIMATOL, V33, P489, DOI 10.1007/s10764-012-9589-0; Ueno Zoological Gardens, 2012, J JPN ASS ZOO AQU, V52, P105; Wada K., 1994, MONKEYS OVERCOME WIN, P226; Waterhouse M, 1971, Ecologist, V1, P19; Wilson S.F., 1982, Zoo Biology, V1, P201, DOI 10.1002/zoo.1430010304; Wolfensohn S, 2005, HDB PRIMATE HUSBANDR, P180; Yokota N, 2000, FEEDING STRATEGY SUB, P293	61	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-3188	1098-2361		ZOO BIOL	Zoo Biol.	MAY-JUN	2015	34	3					255	261		10.1002/zoo.21210		7	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CK0FF	WOS:000355880200008		
J	Hirai, G; Sodeoka, M				Hirai, Go; Sodeoka, Mikiko			Focused Library with a Core Structure Extracted from Natural Products and Modified: Application to Phosphatase Inhibitors and Several Biochemical Findings	ACCOUNTS OF CHEMICAL RESEARCH			English	Review							PROTEIN-TYROSINE PHOSPHATASES; DUAL-SPECIFICITY PHOSPHATASES; STRUCTURE-BASED DESIGN; CELL-CYCLE; CDC25B PHOSPHATASE; CRYSTAL-STRUCTURE; CATALYTIC SITE; 2B CALCINEURIN; DERIVATIVES; VHR	Synthesis of a focused library is an important strategy to create novel modulators of specific classes of proteins. Compounds in a focused library are composed of a common core structure and different diversity structures. In this Account, we describe our design and synthesis of libraries focused on selective inhibitors of protein phosphatases (PPases). We considered that core structures having structural and electronic features similar to those of PPase substrates, phosphate esters, would be a reasonable choice. Therefore, we extracted core structures from natural products already identified as PPase inhibitors. Since many PPases share similar active-site structures, such phosphate-mimicking core structures should interact with many enzymes in the same family, and therefore the choice of diversity structures is pivotal both to increase the binding affinity and to achieve specificity for individual enzymes. Here we present case studies of application of focused libraries to obtain PPase inhibitors, covering the overall process from selection of core structures to identification and evaluation of candidates in the focused libraries. To synthesize a library focused on protein serine-threonine phosphatases (PPs), we chose norcantharidin as a core structure, because norcantharidin dicarboxylate shows a broad inhibition profile toward several PPs. From the resulting focused library, we identified a highly selective PP2B inhibitor, NCA-01. On the other hand, to find inhibitors of dual-specificity protein phosphatases (DSPs), we chose 3-acyltetronic acid extracted from natural product RK-682 as a core structure, because its structure resembles the transition state in the dephosphorylation reaction of DSPs. However, a highly selective inhibitor was not found in the resulting focused library. Furthermore, an inherent drawback of compounds having the highly acidic 3-acyltetronic acid as a core structure is very weak potency in cellulo, probably due to poor cell membrane permeability. Therefore, we next modified the core structure from acidic to neutral by transformation to the enamine derivative and constructed a second-generation focused library (RE derivatives). The resulting compounds showed dramatically improved cell membrane permeability and inhibitory selectivity and included VHR (vaccinia VH1-related)-selective RE12 and CDC25A/B (cell division cycle 25A/B)-selective RE44. These inhibitors act on target enzymes in cellulo and do not generate reactive oxygen species, which is a potential problem with quinoid-type inhibitors of CDC25s. The cellular activity of RE12 was further improved by replacement of the side chain to afford RE176, which showed more potent antiproliferative activity than RE12 against HeLa cells. The dramatic change of inhibitory selectivity obtained by core structure modification from 3-acyltetronic acid to its enamine derivative was associated with a change in the mode of action. Namely, RE derivatives were found to be noncompetitive inhibitors with respect to a small-molecular substrate of CDC25A/B, whereas RK-682 was a competitive inhibitor of VHR. We identified the binding site of RE derivatives on the CDC25A as a pocket adjacent to the active site; this appears to be a promising target site for development of further novel inhibitors of CDC25s.	[Hirai, Go] RIKEN, Synthet Organ Chem Lab, Wako, Saitama 3510198, Japan; RIKEN Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan; CREST JST, Kawaguchi, Saitama 3320012, Japan	Hirai, G (reprint author), RIKEN, Synthet Organ Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	gohirai@riken.jp; sodeoka@riken.jp	Sodeoka, Mikiko/A-9952-2008	Sodeoka, Mikiko/0000-0002-1344-364X	RIKEN; Uehara Memorial Foundation;  [16073203];  [15310144];  [26102744];  [24102534];  [19710195]	The work described was partially supported by Project Funding from RIKEN, a grant from Uehara Memorial Foundation, and Grants-in-Aid for Scientific Research (No. 16073203, No. 15310144, No. 26102744, No. 24102534, and No. 19710195).	Lavecchia A, 2012, MINI-REV MED CHEM, V12, P62; Contour-Galcera MO, 2007, PHARMACOL THERAPEUT, V115, P1, DOI 10.1016/j.pharmthera.2007.03.009; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Verhelst SHL, 2007, ANGEW CHEM INT EDIT, V46, P1284, DOI 10.1002/anie.200603811; Baba Y, 2003, J AM CHEM SOC, V125, P9740, DOI 10.1021/ja034694y; Bialy L, 2005, ANGEW CHEM INT EDIT, V44, P3814, DOI 10.1002/anie.200461517; Stockwell BR, 2004, NATURE, V432, P846, DOI 10.1038/nature03196; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616; Wetzel S, 2011, ANGEW CHEM INT EDIT, V50, P10800, DOI 10.1002/anie.201007004; Pu LX, 2002, J BIOL CHEM, V277, P46877, DOI 10.1074/jbc.M207902200; Sodeoka M, 2001, J MED CHEM, V44, P3216, DOI 10.1021/jm0100741; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Huigens RW, 2013, NAT CHEM, V5, P195, DOI [10.1038/nchem.1549, 10.1038/NCHEM.1549]; JAFFE CL, 1980, BIOCHEMISTRY-US, V19, P4423, DOI 10.1021/bi00560a007; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Brisson M, 2005, MOL PHARMACOL, V68, P1810; Kar S, 2003, BIOCHEMISTRY-US, V42, P10490, DOI 10.1021/bi027418p; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Lund G, 2015, ACS CHEM BIOL, V10, P390, DOI 10.1021/cb500883h; Reynolds RA, 1999, J MOL BIOL, V293, P559, DOI 10.1006/jmbi.1999.3168; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Lavecchia A, 2012, J MED CHEM, V55, P4142, DOI 10.1021/jm201624h; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Bertini I, 2009, J MED CHEM, V52, P4838, DOI 10.1021/jm900610k; Arantes GM, 2010, PROTEINS, V78, P3017, DOI 10.1002/prot.22826; Arino J., 2004, TOPICS CURRENT GENET; Baba Y, 2004, BIOORG MED CHEM LETT, V14, P2963, DOI 10.1016/j.bmcl.2004.02.097; Baba Y, 2005, BIOORGAN MED CHEM, V13, P5164, DOI 10.1016/j.bmc.2005.05.013; Bannwarth W., 2006, METHODS PRINCIPLES M, V26; Brisson M, 2004, MOL PHARMACOL, V66, P824, DOI 10.1124/mol.104.001784; Cao SG, 2005, BIOORGAN MED CHEM, V13, P999, DOI 10.1016/j.bmc.2004.11.039; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; Fauman EB, 1998, CELL, V93, P617, DOI 10.1016/S0092-8674(00)81190-3; HAMAGUCHI T, 1995, FEBS LETT, V372, P54, DOI 10.1016/0014-5793(95)00953-7; Hirai G, 2011, CHEMMEDCHEM, V6, P617, DOI 10.1002/cmdc.201100107; Ishida K, 2004, MOL CANCER THER, V3, P1069; Lyon MA, 2002, NAT REV DRUG DISCOV, V1, P961, DOI 10.1038/nrd963; Rudolph J, 2004, MOL PHARMACOL, V66, P780, DOI 10.1124/mol.104.004788; SCHREIBER SL, 1993, ACCOUNTS CHEM RES, V26, P412, DOI 10.1021/ar00032a004; Shimizu T, 2012, CHEM-ASIAN J, V7, P1221, DOI 10.1002/asia.201200077; Sodeoka M, 1997, BIOORG MED CHEM LETT, V7, P1833, DOI 10.1016/S0960-894X(97)00316-8; Sohn Jungsan, 2005, Biochemistry, V44, P16563, DOI 10.1021/bi0516879; Thuaud F, 2014, BIOORGAN MED CHEM, V22, P2771, DOI 10.1016/j.bmc.2014.03.012; Trabocchi A., 2013, DIVERSITY ORIENTED S; Tsuchiya A, 2012, ACS MED CHEM LETT, V3, P294, DOI 10.1021/ml2002778; Tsuchiya A, 2013, MOL BIOSYST, V9, P1026, DOI 10.1039/c3mb00003f; Usui T, 2001, CHEM BIOL, V8, P1209, DOI 10.1016/S1074-5521(01)00089-8; Wilborn M, 2001, BIOCHEMISTRY-US, V40, P14200, DOI 10.1021/bi015638h; Wu SD, 2009, J MED CHEM, V52, P6716, DOI 10.1021/jm901016k	49	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0001-4842	1520-4898		ACCOUNTS CHEM RES	Accounts Chem. Res.	MAY	2015	48	5					1464	1473		10.1021/acs.accounts.5b00048		10	Chemistry, Multidisciplinary	Chemistry	CI8XT	WOS:000355055700026		
J	Sawada, J; Aoki, D; Uchida, S; Otsuka, H; Takata, T				Sawada, Jun; Aoki, Daisuke; Uchida, Satoshi; Otsuka, Hideyuki; Takata, Toshikazu			Synthesis of Vinylic Macromolecular Rotaxane Cross-Linkers Endowing Network Polymers with Toughness	ACS MACRO LETTERS			English	Article							SLIDE-RING GELS; MACROCYCLIC POLYMERS; CROWN ETHER)S; POLYMERIZATION; DYNAMICS; BIS(5-CARBOXY-1,3-PHENYLENE)-32-CROWN-10; COMPONENTS; DISULFIDE; HYDROGELS; STIMULUS	Macromolecular rotaxane cross-linkers having two radically polyrnerizable vinyl groups (RCs) were first synthesized and used to prepare network polymers. A crown ether/sec-ammonium-type pseudorotaxane initiator having an OH terminal-containing axle and a crown ether wheel with a vinyl group was subjected to the living ring-opening polymerization of delta-valerolactone followed by end-capping with a bulky isocyanate to yield a polyester axle-tethering macromolecular [2]rotaxane cross-linker (RC). Rotaxane cross-linked polymers (RCPs) were prepared by the radical polymerization of n-butyl acrylate in the presence of RCs (0.25, 0.50 mol %). The properties of the RCPs and covalently cross-linked polymers (CCPs) were characterized mainly by mechanical properties. Both fracture stress and strain values of RCPs were much higher than those of CCPs, probably owing to the increased network homogeneity by the rotaxane cross-link. The hybrid-type RCPs obtained from a mixture of RC and covalently connected cross-linker (CC) showed poorer mechanical properties similar to that of CCPs, indicating the importance of RCs in increasing the toughness of the network polymers.	[Sawada, Jun; Aoki, Daisuke; Uchida, Satoshi; Otsuka, Hideyuki; Takata, Toshikazu] Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan	Takata, T (reprint author), Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan.	ttakata@polymer.titech.ac.jp			ACT-C program of JST from the Ministry of Education, Culture, Sports, Science, and Technology, Japan [26102512, 26886006]	This research was financially supported by the ACT-C program of JST, a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (No. 26102512, 26886006).	Kato K, 2013, MACROMOLECULES, V46, P310, DOI 10.1021/ma3021135; Frampton MJ, 2007, ANGEW CHEM INT EDIT, V46, P1028, DOI 10.1002/anie.200601780; Suzaki Y, 2011, J MATER CHEM, V21, P930, DOI 10.1039/c0jm02219e; Kato K, 2013, REACT FUNCT POLYM, V73, P405, DOI 10.1016/j.reactfunctpolym.2012.04.021; Ogawa M, 2011, POLYM J, V43, P909, DOI 10.1038/pj.2011.84; Okumura Y, 2001, ADV MATER, V13, P485, DOI 10.1002/1521-4095(200104)13:7<485::AID-ADMA485>3.0.CO;2-T; Dong SY, 2012, ADV MATER, V24, P3191, DOI 10.1002/adma.201200837; Ito K, 2007, POLYM J, V39, P489, DOI 10.1295/polymj.PJ2006239; Guidry EN, 2007, J AM CHEM SOC, V129, P8944, DOI 10.1021/ja0725100; Caputo CB, 2013, ANGEW CHEM INT EDIT, V52, P960, DOI 10.1002/anie.201207783; Gibson HW, 2004, MACROMOLECULES, V37, P7514, DOI 10.1021/ma049218m; Mayumi K, 2012, SOFT MATTER, V8, P8179, DOI 10.1039/c2sm25508a; HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0; Aoki D, 2014, ACS MACRO LETT, V3, P324, DOI 10.1021/mz5001306; Aoki D, 2013, ACS MACRO LETT, V2, P461, DOI 10.1021/mz400197d; Appel EA, 2014, BIOMATERIALS, V35, P9897, DOI 10.1016/j.biomaterials.2014.08.001; Arai T, 2013, CHEM-EUR J, V19, P5917, DOI 10.1002/chem.201204402; Bilig T, 2008, MACROMOLECULES, V41, P8496, DOI 10.1021/ma801687y; de Gennes PG, 1999, PHYSICA A, V271, P231, DOI 10.1016/S0378-4371(99)00227-7; DELAVIZ Y, 1992, MACROMOLECULES, V25, P18, DOI 10.1021/ma00027a004; DELAVIZ Y, 1992, MACROMOLECULES, V25, P4859, DOI 10.1021/ma00045a005; Furuhashi Y, 2001, J POLYM SCI POL PHYS, V39, P2622, DOI 10.1002/polb.10024; Gibson HW, 1997, TETRAHEDRON, V53, P15197, DOI 10.1016/S0040-4020(97)00957-5; Gong C. G., 1998, CHEM PHYS, V199, P1801; Gong CG, 1997, J AM CHEM SOC, V119, P8585, DOI 10.1021/ja971385x; Iijima K, 2014, POLYM J, V46, P67, DOI 10.1038/pj.2013.63; Imran AB, 2014, NAT COMMUN, V5, P5124; Ji X. F., 2013, J AM CHEM SOC, V135, P74; KOLCHINSKI AG, 1995, J CHEM SOC CHEM COMM, P1289, DOI 10.1039/c39950001289; Koyama Y, 2013, PURE APPL CHEM, V85, P835, DOI 10.1351/PAC-CON-12-08-14; Ogoshi T, 2010, MACROMOLECULES, V43, P7068, DOI 10.1021/ma101320z; Suzaki Y, 2013, DALTON T, V42, P16222, DOI 10.1039/c3dt51597d; Yamaguchi N, 1999, ANGEW CHEM INT EDIT, V38, P143, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<143::AID-ANIE143>3.3.CO;2-P	33	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	MAY	2015	4	5					598	601		10.1021/acsmacrolett.5b00242		4	Polymer Science	Polymer Science	CI9BY	WOS:000355066600026		
J	Campbell, JE; Kuntz, KW; Knutson, SK; Warholic, NM; Keilhack, H; Wigle, TJ; Raimondi, A; Klaus, CR; Rioux, N; Yokoi, A; Kawano, S; Minoshima, Y; Choi, HW; Scott, MP; Waters, NJ; Smith, JJ; Chesworth, R; Moyer, MP; Copeland, RA				Campbell, John E.; Kuntz, Kevin W.; Knutson, Sarah K.; Warholic, Natalie M.; Keilhack, Heike; Wigle, Tim J.; Raimondi, Alejandra; Klaus, Christine R.; Rioux, Nathalie; Yokoi, Akira; Kawano, Satoshi; Minoshima, Yukinori; Choi, Hyeong-Wook; Scott, Margaret Porter; Waters, Nigel J.; Smith, Jesse J.; Chesworth, Richard; Moyer, Mikel P.; Copeland, Robert A.			EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity	ACS MEDICINAL CHEMISTRY LETTERS			English	Article						Methyltransferase; PRC2; EZH2; B cell lymphoma; KARPAS-422; xenograft; in vivo chemical probe	HISTONE METHYLTRANSFERASE; LYMPHOMA; IDENTIFICATION; METHYLATION; COMPLEX; CELLS	Inhibitors of the protein methyltransferase Enhancer of Zeste Homolog 2 (EZH2) may have significant therapeutic potential for the treatment of B cell lymphomas and other cancer indications. The ability of the scientific community to explore fully the spectrum of EZH2-associated pathobiology has been hampered by the lack of in vivo-active tool compounds for this enzyme. Here we report the discovery and characterization of EPZ011989, a potent, selective, orally bioavailable inhibitor of EZH2 with useful pharmacokinetic properties. EPZ011989 demonstrates significant tumor growth inhibition in a mouse xenograft model of human B cell lymphoma. Hence, this compound represents a powerful tool for the expanded exploration of EZH2 activity in biology.	[Campbell, John E.; Kuntz, Kevin W.; Knutson, Sarah K.; Warholic, Natalie M.; Keilhack, Heike; Wigle, Tim J.; Raimondi, Alejandra; Klaus, Christine R.; Rioux, Nathalie; Scott, Margaret Porter; Waters, Nigel J.; Smith, Jesse J.; Chesworth, Richard; Moyer, Mikel P.; Copeland, Robert A.] Epizyme Inc, Cambridge, MA 02139 USA; [Yokoi, Akira; Kawano, Satoshi; Minoshima, Yukinori] Eisai & Co Ltd, Tsukuba, Ibaraki 3002635, Japan; [Choi, Hyeong-Wook] Eisai Inc, Andover, MA 01810 USA	Campbell, JE (reprint author), Epizyme Inc, 400 Technol Sq,Fourth Floor, Cambridge, MA 02139 USA.	jcampbell@epizyme.com					Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Wang SW, 2004, GENE, V343, P69, DOI 10.1016/j.gene.2004.09.006; Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133j, 10.1021/cb400133J]; Nasveschuk CG, 2014, ACS MED CHEM LETT, V5, P378, DOI 10.1021/ml400494b; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/nchembio.1084, 10.1038/NCHEMBIO.1084]; Garapaty-Rao S, 2013, CHEM BIOL, V20, P1329, DOI 10.1016/j.chembiol.2013.09.013; Bradley WD, 2014, CHEM BIOL, V21, P1463, DOI 10.1016/j.chembiol.2014.09.017; Knutson SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111840; Sneeringer C. J., 2011, P NATL ACAD SCI USA, V107, P20980	15	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-5875			ACS MED CHEM LETT	ACS Med. Chem. Lett.	MAY	2015	6	5					491	495		10.1021/acsmedchemlett.5b00037		5	Chemistry, Medicinal	Pharmacology & Pharmacy	CI6ZO	WOS:000354912900003		
J	Sugiyama, A; Nishie, H; Takeuchi, S; Yoshinari, M; Furue, M				Sugiyama, A.; Nishie, H.; Takeuchi, S.; Yoshinari, M.; Furue, M.			Hashimoto's disease is a frequent comorbidity and an exacerbating factor of chronic spontaneous urticaria	ALLERGOLOGIA ET IMMUNOPATHOLOGIA			English	Article						Autoimmune urticaria; Autoreactivity; Chronic spontaneous urticaria; Hashimoto's disease; Thyroid autoantibodies; Thyroid hormone	CHRONIC IDIOPATHIC URTICARIA; SERUM SKIN-TEST; THYROID AUTOIMMUNITY; AUTOANTIBODIES; ASSOCIATION; ANGIOEDEMA; MODULATION; ANTIBODIES; DIAGNOSIS; RECEPTOR	Background: The precise pathogenesis of chronic spontaneous urticaria (CSU) remains unknown. However, an important association between CSU and autoimmune disorders such as Hashimoto's disease (HD) has been reported. We investigated the frequency of HD as a comorbidity of CSU and the prevalence rate of autoreactivity among CSU patients with HD. Patients and methods: The presence of thyroid autoantibodies and the levels of thyroid hormones were examined in 40 CSU patients who showed urticaria symptoms for >4 weeks. Patients who were diagnosed with HD, including subclinical ones, and were in need of treatment received thyroid therapy, and the changes in their urticarial symptoms were observed. An autologous serum skin test (ASST) was also performed to examine the relation of CSU with autoreactivity. Results: Eleven of the 40 CSU patients were diagnosed with HD, and 4 of the 5 patients who received and completed thyroid therapy showed considerable remission of urticarial symptoms during and after treatment. In addition, the rate of positive ASST results tended to be higher in CSU patients with HD (5 of 7) than in those without HD (2 of 6). Conclusions: The comorbidity rate of HD in CSU patients was high, and such patients tended to have a positive ASST. Thyroid therapy in CSU patients with HD can lead to a considerable remission of urticarial symptoms, which may suggest that HD is possibly involved in the aetiology of CSU, or is at least a potential exacerbating factor for CSU. (C) 2013 SEICAP Published by Elsevier Espana, S.L.U. All rights reserved.	[Sugiyama, A.; Nishie, H.] Natl Hosp Org, Natl Fukuoka Hosp, Dept Dermatol, Minami Ku, Fukuoka 8111394, Japan; [Takeuchi, S.; Furue, M.] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 8128582, Japan; [Yoshinari, M.] Yoshinari Med Clin, Minami Ku, Fukuoka 8150082, Japan	Sugiyama, A (reprint author), Natl Hosp Org, Natl Fukuoka Hosp, Dept Dermatol, Minami Ku, 4-39-1 Yakatabaru, Fukuoka 8111394, Japan.	aki0407@dermatol.med.kyushu-u.ac.jp					Altrich ML, 2009, ALLERGY ASTHMA PROC, V30, P28, DOI 10.2500/aap.2009.30.3185; LEZNOFF A, 1989, J ALLERGY CLIN IMMUN, V84, P66, DOI 10.1016/0091-6749(89)90180-2; Kavvoura FK, 2007, J CLIN ENDOCR METAB, V92, P3162, DOI 10.1210/jc.2007-0147; Ferrer M, 1998, J ALLERGY CLIN IMMUN, V101, P672; LEZNOFF A, 1983, ARCH DERMATOL, V119, P636, DOI 10.1001/archderm.119.8.636; Mocellin R, 2007, CNS DRUGS, V21, P799, DOI 10.2165/00023210-200721100-00002; Asero R, 2001, CLIN EXP ALLERGY, V31, P1105, DOI 10.1046/j.1365-2222.2001.01131.x; Jacobson EM, 2007, J AUTOIMMUN, V28, P85, DOI 10.1016/j.jaut.2007.02.006; Confino-Cohen R, 2012, J ALLERGY CLIN IMMUN, V129, P1307, DOI 10.1016/j.jaci.2012.01.043; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; HIDE M, 1993, NEW ENGL J MED, V328, P1599, DOI 10.1056/NEJM199306033282204; Turktas I, 1997, INT J DERMATOL, V36, P187, DOI 10.1046/j.1365-4362.1997.00187.x; Maurer M, 2013, BRIT J DERMATOL, V168, P455, DOI 10.1111/j.1365-2133.2012.11171.x; Hide M, 2012, ALLERGOL INT, V61, P517, DOI 10.2332/allergolint.12-RAI-0497; Sabroe RA, 1999, BRIT J DERMATOL, V140, P446; Konstantinou GN, 2009, ALLERGY, V64, P1256, DOI 10.1111/j.1398-9995.2009.02132.x; Toubi E, 2004, ALLERGY, V59, P869, DOI 10.1111/j.1398-9995.2004.00473.x; Cebeci F, 2006, EUR J DERMATOL, V16, P402; Chistiakov D. A., 2005, J AUTOIMMUNE DIS, V2, P1, DOI 10.1186/1740-2557-2-1; COLLET E, 1995, ANN DERMATOL VENER, V122, P413; Fadeyev VV, 2010, HORM-INT J ENDOCRINO, V9, P245; Faridhosseni R, 2006, MED J MUMS, V48, P373; Fiebiger E, 1995, J CLIN INVEST, V96, P2606, DOI 10.1172/JCI118325; Gaig P, 2000, J INVEST ALLERG CLIN, V10, P342; Gangemi S, 2009, J ENDOCRINOL INVEST, V32, P107; Hide M, 2011, JPN J DERMATOL, V121, P1339; Hodkinson CF, 2009, J ENDOCRINOL, V202, P55, DOI 10.1677/JOE-08-0488; Japan Thyroid Association, HORMONES ATHENS; Klecha AJ, 2006, J ENDOCRINOL, V189, P45, DOI 10.1677/joe.1.06137; Mozena JD, 2010, J INVEST DERMATOL, V130, P1860, DOI 10.1038/jid.2010.35; Nakazawa D., 2008, AUTOIMMUNE EPIDEMIC, P32; Palma-Carlos A G, 2005, Eur Ann Allergy Clin Immunol, V37, P143; Verneuil L, 2004, DERMATOLOGY, V208, P98, DOI 10.1159/000076480; Zauli D, 2001, ALLERGY ASTHMA PROC, V22, P93, DOI 10.2500/108854101778250625	34	0	0	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0301-0546	1578-1267		ALLERGOL IMMUNOPATH	Allergol. Immunopath.	MAY-JUN	2015	43	3					249	253		10.1016/j.aller.2014.02.007		5	Allergy; Immunology	Allergy; Immunology	CI8ZH	WOS:000355059700003		
J	Kawashima, S; Wang, YZ				Kawashima, Shuichi; Wang, Yu-Zhu			Global existence and asymptotic behavior of solutions to the generalized cubic double dispersion equation	ANALYSIS AND APPLICATIONS			English	Article						Generalized cubic double dispersion equation; global existence; asymptotic decay; linear approximation	DISSIPATIVE PLATE EQUATION; LINEAR HYPERBOLIC SYSTEMS; BOUNDARY-VALUE-PROBLEM; CAUCHY-PROBLEM; WAVE-EQUATION; BOUSSINESQ EQUATION; CLASSICAL-SOLUTIONS; DECAY PROPERTY; MULTIDIMENSIONS	In this paper, we study the initial value problem for the generalized cubic double dispersion equation in n-dimensional space. Under a small condition on the initial data, we prove the global existence and asymptotic decay of solutions for all space dimensions n >= 1. Moreover, when n >= 2, we show that the solution can be approximated by the linear solution as time tends to infinity.	[Kawashima, Shuichi] Kyushu Univ, Fac Math, Fukuoka 8190395, Japan; [Wang, Yu-Zhu] North China Univ Water Resources & Elect Power, Sch Math & Informat Sci, Zhengzhou 450011, Peoples R China	Kawashima, S (reprint author), Kyushu Univ, Fac Math, Fukuoka 8190395, Japan.	kawashim@math.kyushu-u.ac.jp; wangyuzhu@ncwu.edu.cn			NNSF of China [11101144];  [22244009]	This work is supported in part by Grant-in-Aid for Scientific Research (A) 22244009. The second author is partially supported by the NNSF of China (Grant No. 11101144).	Ono K, 2003, DISCRETE CONT DYN S, V9, P651; NAKAO M, 1993, MATH Z, V214, P325, DOI 10.1007/BF02572407; Sugitani Y, 2010, J HYPERBOL DIFFER EQ, V7, P471, DOI 10.1142/S0219891610002207; Polat N, 2009, J MATH ANAL APPL, V349, P10, DOI 10.1016/j.jmaa.2008.08.025; Nishihara K, 2003, MATH Z, V244, P631, DOI 10.1007/s00209-003-0516-0; Ide K, 2008, MATH MOD METH APPL S, V18, P647, DOI 10.1142/S0218202508002802; Chen GW, 2008, ACTA MATH SCI, V28, P573; Chen GW, 2004, J MATH ANAL APPL, V299, P563, DOI 10.1016/j.jmaa.2004.05.044; Dai WR, 2007, J DIFFER EQUATIONS, V235, P127, DOI 10.1016/j.jde.2006.12.020; Kong DX, 2003, COMMUN PART DIFF EQ, V28, P1203, DOI 10.1081/PDE-120021192; Li T. T., 1989, NONLINEAR EVOLUTION; Liu YQ, 2011, DISCRETE CONT DYN S, V29, P1113, DOI 10.3934/dcds.2011.29.1113; Liu YQ, 2011, KINET RELAT MOD, V4, P531, DOI 10.3934/krm.2011.4.531; Liu YQ, 2011, J HYPERBOL DIFFER EQ, V8, P591, DOI 10.1142/S0219891611002500; Liu YQ, 2008, DISCRETE CONT DYN S, V20, P1013; Samsonov A. M., 1994, CISM COURSES LECT, V341, P349; Samsonov A. M., 1989, NONLINEAR WAVES ACTI, P99; Umeda T., 1984, JAPAN J APPL MATH, V1, P435; Wang SB, 2013, APPL ANAL, V92, P1179, DOI 10.1080/00036811.2012.661044; Wang SB, 2012, J DIFFER EQUATIONS, V252, P4243, DOI 10.1016/j.jde.2011.12.016; Wang SB, 2006, NONLINEAR ANAL-THEOR, V64, P159, DOI 10.1016/j.na.2005.06.017; Wang WK, 2010, J MATH ANAL APPL, V366, P226, DOI 10.1016/j.jmaa.2009.12.013; Wang Y.-Z., 2012, J MATH PHYS, V53; Wang YZ, 2009, NONLINEAR ANAL-THEOR, V70, P465, DOI 10.1016/j.na.2007.12.018; Wang YZ, 2012, J MATH ANAL APPL, V385, P836, DOI 10.1016/j.jmaa.2011.07.010; Wang YZ, 2010, NONLINEAR ANAL-THEOR, V72, P4500, DOI 10.1016/j.na.2010.02.025; Xu RZ, 2009, NONLINEAR ANAL-THEOR, V71, P4977, DOI 10.1016/j.na.2009.03.069; Yang Z., 2007, J DIFFER EQUATIONS, V242, P269, DOI 10.1016/j.jde.2007.08.004; Zheng S., 2004, MONOGRAPHS SURVEYS P, V133	29	1	1	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5305	1793-6861		ANAL APPL	Anal. Appl.	MAY	2015	13	3					233	254		10.1142/S021953051450002X		22	Mathematics, Applied; Mathematics	Mathematics	CJ4KJ	WOS:000355453400001		
J	Sato, Y; Shinka, T; Nozawa, S; Yoshiike, M; Koh, E; Kanaya, J; Namiki, M; Matsumiya, K; Tsujimura, A; Komatsu, K; Itoh, N; Eguchi, J; Yamauchi, A; Iwamoto, T; Nakahori, Y				Sato, Y.; Shinka, T.; Nozawa, S.; Yoshiike, M.; Koh, E.; Kanaya, J.; Namiki, M.; Matsumiya, K.; Tsujimura, A.; Komatsu, K.; Itoh, N.; Eguchi, J.; Yamauchi, A.; Iwamoto, T.; Nakahori, Y.			Y chromosome haplogroup D2a1 is significantly associated with high levels of luteinizing hormone in Japanese men	ANDROLOGY			English	Article						Japanese population; sex hormone; Y chromosome haplogroup	GONADOTROPIN-RELEASING-HORMONE; CORONARY-ARTERY-DISEASE; PROSTATE-CANCER; SPERMATOGENIC FAILURE; METABOLIC SYNDROME; TESTOSTERONE; POPULATION; REGION; MALES; GENE	The association between the Y chromosome haplogroup D2 and risk of azoospermia and low sperm motility has been previously studied, and it was indicated that haplogroups DE (YAP lineage) are associated with prostate cancer risk in Japanese males. Our assumption had been that Y chromosome haplogroups may be associated with sex hormone levels, because sex hormones have been deemed responsible for spermatogenesis and carcinogenesis. In this study, we assessed the association between Y chromosome haplogroups and sex hormone levels, including those of testosterone, sex hormone-binding globulin (SHBG), follicle-stimulating hormone (FSH), luteinizing hormone (LH), inhibin-B, and calculated free testosterone (cFT), in 901 young men from the general Japanese population (cohort 1) and 786 Japanese men of proven fertility (cohort 2). We found that the haplogroup D2a1 was significantly associated with high LH levels in a combined analysis involving two cohorts (=0.068, SE=0.025, p=0.0075), following correction for multiple testing. To date, this result is the first evidence that implicates Y chromosome haplogroups in an association with sex hormone levels.	[Sato, Y.; Yamauchi, A.] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmaceut Informat Sci, Tokushima 7708505, Japan; [Sato, Y.; Shinka, T.; Nakahori, Y.] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Human Genet & Publ Hlth, Tokushima 7708505, Japan; [Nozawa, S.; Yoshiike, M.; Iwamoto, T.] St Marianna Univ, Sch Med, Dept Urol, Kawasaki, Kanagawa, Japan; [Koh, E.; Kanaya, J.; Namiki, M.] Kanazawa Univ, Grad Sch Med Sci, Dept Urol, Kanazawa, Ishikawa, Japan; [Matsumiya, K.] Osaka Police Hosp, Dept Urol, Osaka, Japan; [Tsujimura, A.] Osaka Univ, Grad Sch Med, Dept Urol, Fac Med, Osaka, Japan; [Komatsu, K.] Harasanshinkai Hosp, Dept Urol, Fukuoka, Japan; [Itoh, N.] Sapporo Med Univ, Dept Urol, Sapporo, Hokkaido, Japan; [Eguchi, J.] Nagasaki Univ, Dept Urol, Nagasaki 852, Japan; [Iwamoto, T.] Int Univ Hlth & Welf Hosp, Ctr Infertil & IVF, Nasushiobara, Tochigi, Japan	Sato, Y (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmaceut Informat Sci, 1-78-1 Sho Machi, Tokushima 7708505, Japan.	youichi.sato@tokushima-u.ac.jp			Ministry of Health and Welfare of Japan [1013201]; European Union [BMH4-CT96-0314]	We thank all the volunteers who participated in this study. We are grateful to Miss Yukiko Unemi and Keiko Tsuji for their excellent technical assistance. This study was supported by the Ministry of Health and Welfare of Japan (1013201) and the European Union (BMH4-CT96-0314).	Charchar FJ, 2012, LANCET, V379, P915, DOI 10.1016/S0140-6736(11)61453-0; Yang Y, 2008, J MED GENET, V45, P210, DOI 10.1136/jmg.2007.054478; Russo P, 2008, ARTERIOSCL THROM VAS, V28, P1569, DOI 10.1161/ATVBAHA.108.168641; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Bloomer LDS, 2013, ARTERIOSCL THROM VAS, V33, P1722, DOI 10.1161/ATVBAHA.113.301608; Ewis AA, 2006, PROSTATE CANCER P D, V9, P303, DOI 10.1038/sj.pcan.4500876; Araujo AB, 2011, J CLIN ENDOCR METAB, V96, P3007, DOI 10.1210/jc.2011-1137; Kupelian V, 2006, J CLIN ENDOCR METAB, V91, P843, DOI 10.1210/jc.2005-1326; Schlatt S, 2014, SEMIN CELL DEV BIOL, V29, P2, DOI 10.1016/j.semcdb.2014.03.007; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Charchar FJ, 2002, HYPERTENSION, V39, P353, DOI 10.1161/hy0202.103413; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; LABRIE F, 1982, CLIN INVEST MED, V5, P267; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Kuroki Y, 1999, J HUM GENET, V44, P289, DOI 10.1007/s100380050162; Vikan T, 2009, EUR J ENDOCRINOL, V161, P435, DOI 10.1530/EJE-09-0284; Krausz C, 2001, HUM MOL GENET, V10, P1873, DOI 10.1093/hmg/10.18.1873; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Charchar FJ, 2004, ARTERIOSCL THROM VAS, V24, P308, DOI 10.1161/01.ATV.0000113291.39267.0a; ATKIN NB, 1985, HUM GENET, V70, P359, DOI 10.1007/BF00295378; Bloomer LDS, 2014, ATHEROSCLEROSIS, V233, P160, DOI 10.1016/j.atherosclerosis.2013.12.012; Bosland MC., 2000, J NATL CANC I MONOGR, V27, P39; Haring R, 2009, DIABETES, V58, P2027, DOI 10.2337/db09-0031; Hiura Y, 2008, HYPERTENS RES, V31, P1687, DOI 10.1291/hypres.31.1687; Iwamoto T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002222; Iwamoto T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002223; Kostrzewa G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068155; Lindstrom S, 2008, CLIN CANCER RES, V14, P6712, DOI 10.1158/1078-0432.CCR-08-0658; Lu CC, 2007, J HUM GENET, V52, P659, DOI 10.1007/s10038-007-0160-3; Nakahori Y, 1996, HORM RES, V46, P20; OHNUKI Y, 1980, CANCER RES, V40, P524; Puzuka A, 2011, Genetika, V47, P394; Ran J, 2013, GENET MOL RES, V12, P59, DOI 10.4238/2012.January.22.4; Sato Y, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105718; Sato Y, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.118810; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SMITH MA, 1981, ENDOCRINOLOGY, V108, P752; Wang ZM, 2012, HUM GENET, V131, P1173, DOI 10.1007/s00439-012-1139-5	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2047-2919	2047-2927		ANDROLOGY-US	Andrology	MAY	2015	3	3					520	525		10.1111/andr.12026		6	Andrology	Endocrinology & Metabolism	CJ2RS	WOS:000355332800013		
J	Ahmed, MHM; Muraza, O; Al-Amer, AM; Miyake, K; Nishiyama, N				Ahmed, Mohamed H. M.; Muraza, Oki; Al-Amer, Adnan M.; Miyake, Koji; Nishiyama, Norikazu			Development of hierarchical EU-1 zeolite by sequential alkaline and acid treatments for selective dimethyl ether to propylene (DTP)	APPLIED CATALYSIS A-GENERAL			English	Article							NANOSIZED ZEOLITES; CATALYTIC-PROPERTIES; OLEFINS; DEALUMINATION; DESILICATION; CONVERSION; PERFORMANCE; CRACKING; ACCESSIBILITY; MESOPOROSITY	Developing mesoporosity on the surface of the one-dimensional zeolite provides stronger impact as compared with three-dimensional zeolites because the 1D pore zeolites suffers from diffusion limitation. Recently, we worked to create mesopores on EU-1 (EUO) by alkaline treatment, which yielded significant decrease in micropore volume and the total surface area. The decrease of microporosity corresponded with blockage of active acid sites due to the deposition of many Al species on the pore mouth of zeolites. In this work, desilicated EU-1 samples treated with different NaOH concentrations were again treated with different concentrations of HNO3 to remove the deposited Al species. The effects of NaOH and HNO3 concentrations on the crystallinity, morphology, Si/Alratio, surface area, pore size distribution and acidity of EU-1 were investigated. The samples characterized by XRD, EDX, SEM, BET and NH3-TPD. The optimum condition for sequential alkaline-acid treatment was obtained with 0.5 M of NaOH followed by 4M of HNO3 solution. The mesoporosity increased by 15% for EU-1 the aforementioned sample as compared with the parent zeolite. The total acidity also increased from 0.27 to 0.52 mmol/g. The hierarchical EU-1 samples were evaluated on the conversion of dimethyl ether to olefins. The conversion increased from 37% to 48% together with the increased selectivity of propylene from 11% to 24%, when the parent EU-1 was replaced by the optimized hierarchical EU-1. (C) 2015 Elsevier B.V. All rights reserved.	[Ahmed, Mohamed H. M.; Muraza, Oki; Al-Amer, Adnan M.] King Fand Univ Petr & Minerals, Ctr Res Excellence Nanotechnol, Dhahran 31261, Saudi Arabia; [Miyake, Koji; Nishiyama, Norikazu] Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, Toyonaka, Osaka 5608531, Japan	Ahmed, MHM (reprint author), King Fand Univ Petr & Minerals, Ctr Res Excellence Nanotechnol, Dhahran 31261, Saudi Arabia.	omuraza@kfupm.edu.sa	Muraza, Oki/B-6765-2015	Muraza, Oki/0000-0002-8348-8085	King Abdulaziz City for Science and Technology (KACST) through the Science & Technology Unit in Center of Research Excellence in Nanotechnology [11-NAN2166-04]; King Fand University of Petroleum & Minerals (KFUPM) as part of the National Science, Technology and Innovation Plan	The authors would like to express sincere gratitude for Mr. Muhammed Qamaruddin and Mr. Jerwin Separa for part of N<INF>2</INF> adsorption-desorption and FE-SEM experiments. The authors would like to acknowledge the funding provided by King Abdulaziz City for Science and Technology (KACST) through the Science & Technology Unit in Center of Research Excellence in Nanotechnology at King Fand University of Petroleum & Minerals (KFUPM) for supporting this work through project No. 11-NAN2166-04 as part of the National Science, Technology and Innovation Plan.	Ahmed MHM, 2014, J ALLOY COMPD, V617, P408, DOI 10.1016/j.jallcom.2014.08.028; Al-Dughaither AS, 2014, FUEL, V138, P52, DOI 10.1016/j.fuel.2014.07.026; Groen JC, 2006, J MATER CHEM, V16, P2121, DOI 10.1039/b517510k; Tao YS, 2006, CHEM REV, V106, P896, DOI 10.1021/cr040204o; Verboekend D, 2011, CRYSTENGCOMM, V13, P3408, DOI 10.1039/c0ce00966k; Muraza O, 2014, FUEL, V135, P105, DOI 10.1016/j.fuel.2014.06.045; Ahmed MHM, 2015, MICROPOR MESOPOR MAT, V207, P9, DOI 10.1016/j.micromeso.2015.01.006; Larlus O, 2006, MICROPOR MESOPOR MAT, V96, P405, DOI 10.1016/j.micromeso.2006.07.024; Zhao TS, 2006, CATAL COMMUN, V7, P647, DOI 10.1016/j.catcom.2005.11.009; Inagaki S, 2010, CHEM COMMUN, V46, P2662, DOI 10.1039/b925408k; Cui Y, 2013, PARTICUOLOGY, V11, P468, DOI 10.1016/j.partic.2012.12.009; Verboekend D, 2012, ADV FUNCT MATER, V22, P916, DOI 10.1002/adfm.201102411; Matias P, 2011, APPL CATAL A-GEN, V399, P100, DOI 10.1016/j.apcata.2011.03.049; Tarach K, 2014, J CATAL, V312, P46, DOI 10.1016/j.jcat.2014.01.009; Zheng JJ, 2011, CATAL TODAY, V168, P124, DOI 10.1016/j.cattod.2011.01.006; Mintova S, 2013, NANOSCALE, V5, P6693, DOI 10.1039/c3nr01629c; Schmidt I, 2000, INORG CHEM, V39, P2279, DOI 10.1021/ic991280q; Verboekend D, 2010, CHEM MATER, V22, P4679, DOI 10.1021/cm100886y; Qin ZX, 2011, J CATAL, V278, P266, DOI 10.1016/j.jcat.2010.12.013; Batonneau-gener I, 2008, MICROPOR MESOPOR MAT, V110, P480, DOI 10.1016/j.micromeso.2007.06.037; Groen JC, 2005, MICROPOR MESOPOR MAT, V87, P153, DOI 10.1016/j.micromeso.2005.07.050; van Laak ANC, 2010, J CATAL, V276, P170, DOI 10.1016/j.jcat.2010.09.011; Boveri M, 2006, CATAL TODAY, V114, P217, DOI 10.1016/j.cattod.2006.01.012; Chen FQ, 2012, CATAL COMMUN, V18, P110, DOI 10.1016/j.catcom.2011.11.033; Covarrubias C, 2009, MICROPOR MESOPOR MAT, V117, P118, DOI 10.1016/j.micromeso.2008.06.013; Giordano G, 2009, J MOL CATAL A-CHEM, V305, P34, DOI 10.1016/j.molcata.2008.12.024; Hu S, 2012, CATAL COMMUN, V28, P95, DOI 10.1016/j.catcom.2012.08.011; Martins J, 2013, MICROPOR MESOPOR MAT, V171, P230, DOI 10.1016/j.micromeso.2013.01.009; Peixoto DPB, 2003, MATER LETT, V57, P3933, DOI 10.1016/S0167-577X(03)00243-X; Couto CS, 2012, EUR J INORG CHEM, P4190, DOI 10.1002/ejic.201200386; Teketel S., 2011, ACS CATAL, V2, P26; Wang Y.W.S., 2013, J ADV MAT, V1, P13; You SJ, 2014, MICROPOR MESOPOR MAT, V186, P121, DOI 10.1016/j.micromeso.2013.11.042; Zhou HQ, 2008, APPL CATAL A-GEN, V341, P112, DOI 10.1016/j.apcata.2008.02.030	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-860X	1873-3875		APPL CATAL A-GEN	Appl. Catal. A-Gen.	MAY	2015	497						127	134		10.1016/j.apcata.2015.03.011		8	Chemistry, Physical; Environmental Sciences	Chemistry; Environmental Sciences & Ecology	CI8WL	WOS:000355052300014		
J	Poonjarernsilp, C; Sano, N; Tamon, H				Poonjarernsilp, Chantamanee; Sano, Noriaki; Tamon, Hajime			Simultaneous esterification and transesterification for biodiesel synthesis by a catalyst consisting of sulfonated single-walled carbon nanohorn dispersed with Fe/Fe2O3 nanoparticles	APPLIED CATALYSIS A-GENERAL			English	Article						Biodiesel; Solid acid catalyst; Sulfonation; Single-walled carbon nanohorn; Iron oxide nanoparticle	SOLID CATALYSTS; PALMITIC ACID; OIL	The simultaneous esterification of palmitic acid and transesterification of tributyrin is investigated using a solid acid catalyst newly developed. This catalyst consists of porous single-walled carbon nanohorn (SWCNH) dispersed with Fe/Fe2O3-mixed nanoparticles. The esterfication of palmitic acid is initially catalyzed by this catalyst, and the transesterification of tributyrin can be observed after most of palmitic acid was consumed. Contrary to a general expectation that the addition of a free fatty acid usually has poisonous effect on transesterification of tributyrin, the addition of palmitic acid shows an effect to enhance the yield of methyl butyrate. As one of the reasons, the palmitic acid adsorbed on Fe/Fe2O3 particles placed in the pores of the catalyst may attract tributyrin molecules, and tributyrin concentrated thereon may diffuse to the acidic sites on the catalyst. However, this effect seems to be reduced significantly when the reaction temperature is high. (C) 2015 Elsevier B.V. All rights reserved.	[Poonjarernsilp, Chantamanee; Sano, Noriaki; Tamon, Hajime] Kyoto Univ, Grad Sch Engn, Dept Chem Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Poonjarernsilp, Chantamanee] Rajamangala Univ Technol Krungthep, Fac Engn, Dept Chem Engn, Bangkok 10120, Thailand	Poonjarernsilp, C (reprint author), Rajamangala Univ Technol Krungthep, Bangkok 10120, Thailand.	chantamanee.w@rmutk.ac.th			JSPS Postdoctoral Fellowship for Foreign Researchers FY; JSPS KAKENHI [24360327]	This work was financially supported by a JSPS Postdoctoral Fellowship for Foreign Researchers FY 2012 and JSPS KAKENHI Grant Number 24360327.	Berrios M, 2007, FUEL, V86, P2383, DOI 10.1016/j.fuel.2007.02.002; Singh SP, 2010, RENEW SUST ENERG REV, V14, P200, DOI 10.1016/j.rser.2009.07.017; Wen ZZ, 2010, BIORESOURCE TECHNOL, V101, P9570, DOI 10.1016/j.biortech.2010.07.066; Melero JA, 2009, GREEN CHEM, V11, P1285, DOI 10.1039/b902086a; Rattanaphra D, 2012, FUEL, V97, P467, DOI 10.1016/j.fuel.2012.01.031; Jiang YJ, 2011, J NANOPART RES, V13, P463, DOI 10.1007/s11051-010-0153-6; Peng-Lim B, 2012, ENERGY, V46, P132, DOI 10.1016/j.energy.2012.09.013; Tan KT, 2010, J SUPERCRIT FLUID, V53, P88, DOI 10.1016/j.supflu.2010.01.012; Atabani AE, 2013, RENEW SUST ENERG REV, V18, P211, DOI 10.1016/j.rser.2012.10.013; Poonjarernsilp C, 2014, APPL CATAL B-ENVIRON, V147, P726, DOI 10.1016/j.apcatb.2013.10.006; Yan SL, 2009, APPL CATAL A-GEN, V353, P203, DOI 10.1016/j.apcata.2008.10.053; Melero JA, 2010, CHEM ENG J, V161, P323, DOI 10.1016/j.cej.2009.12.037; Corro G, 2013, APPL CATAL B-ENVIRON, V129, P39, DOI 10.1016/j.apcatb.2012.09.004; Zabeti M, 2009, FUEL PROCESS TECHNOL, V90, P770, DOI 10.1016/j.fuproc.2009.03.010; Shu Q, 2009, FUEL PROCESS TECHNOL, V90, P1002, DOI 10.1016/j.fuproc.2009.03.007; Cano M, 2012, GREEN CHEM, V14, P1786, DOI 10.1039/c2gc35270b; Leung DYC, 2010, APPL ENERG, V87, P1083, DOI 10.1016/j.apenergy.2009.10.006; Iglesias J, 2011, CATAL TODAY, V167, P46, DOI 10.1016/j.cattod.2010.11.060; Jain S, 2010, RENEW SUST ENERG REV, V14, P3140, DOI 10.1016/j.rser.2010.07.047; Kansedo J, 2012, BIOMASS BIOENERG, V40, P96, DOI 10.1016/j.biombioe.2012.02.006; Li QH, 2012, J MATER RES, V27, P3083, DOI 10.1557/jmr.2012.360; Nuithitikul K., 2011, INT J CHEM REACT ENG, P9; Ong LK, 2013, ENERGY, V57, P615, DOI 10.1016/j.energy.2013.05.069; Patel A, 2013, CATAL SCI TECHNOL, V3, P3317, DOI 10.1039/c3cy00591g; Poonjarernsilp C, 2014, GREEN CHEM, V16, P4936, DOI 10.1039/c4gc00262h; Poonjarernsilp C, 2011, CARBON, V49, P4920, DOI 10.1016/j.carbon.2011.07.016; Reinoso DM, 2012, APPL CATAL A-GEN, V449, P88, DOI 10.1016/j.apcata.2012.09.014; Rojas Gonzalez A.F., 2009, INGENIERIA E INVESTI, V29, P17; Roldan L, 2012, CARBON, V50, P1363, DOI 10.1016/j.carbon.2011.11.008; Sano N., 2012, J APPL PHYS, P112; Sano N, 2006, MATER CHEM PHYS, V99, P447, DOI 10.1016/j.matchemphys.2005.11.019; Yaakob A.Q., 2004, INT ISLAMIC U MALAYS, V5, P35; Zhai DW, 2011, CATAL COMMUN, V12, P593, DOI 10.1016/j.catcom.2010.12.020	33	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-860X	1873-3875		APPL CATAL A-GEN	Appl. Catal. A-Gen.	MAY	2015	497						145	152		10.1016/j.apcata.2015.03.013		8	Chemistry, Physical; Environmental Sciences	Chemistry; Environmental Sciences & Ecology	CI8WL	WOS:000355052300016		
J	Nagashima, S; Nagashima, H; Furukawa, S; Kamiguchi, S; Kurokawa, H; Chihara, T				Nagashima, Sayoko; Nagashima, Hiroshi; Furukawa, Shota; Kamiguchi, Satoshi; Kurokawa, Hideki; Chihara, Teiji			Catalytic ring-opening addition of thiols to epoxides in the gas-phase over molecular rhenium sulfide cluster complexes [Re6S8X6] (X = Cl, OH, H2O) with retention of their octahedral metal frameworks	APPLIED CATALYSIS A-GENERAL			English	Article						Rhenium sulfide cluster; Chlorido ligand; Bronsted acid; Thiol; Epoxide	DEHYDROGENATION; ACIDITY	A series of molecular rhenium sulfide clusters K-4[Re5S8Cl6] (1), K-4[Re6S8(OH)(6)], and [Re6S8(H2O)(6)]SO4 supported on silica gel catalyze ring-opening addition of thiols to epoxides to yield beta-hydroxy sulfides in a stream of hydrogen at temperatures ranging from 175 to 250 degrees C. The thermal activation mechanisms of 1 is studied. Powder X-ray diffraction analyses and Raman spectrometry reveal the retention of integrity of the octahedral cluster framework up to 500 degrees C. Thermogravimetry and elemental analyses of the silica gel-supported 1 show the loss of chlorido ligands, and evolution of hydrogen chloride is observed on activation. No coordinatively unsaturated metal site is observed by CO titration. Titration of the activated cluster shows the appearance of weak Bronsted acid sites with H-0 approximate to 1.8. The catalytically active site of the silica gel-supported 1 is a hydroxo ligand that is formed by reaction with silanol groups. (C) 2015 Elsevier B.V. All rights reserved.	[Nagashima, Sayoko; Nagashima, Hiroshi; Furukawa, Shota; Kurokawa, Hideki; Chihara, Teiji] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama, Saitama 3388570, Japan; [Kamiguchi, Satoshi] RIKEN, Organometall Chem Lab, Wako, Saitama 3510198, Japan	Nagashima, S (reprint author), Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama, Saitama 3388570, Japan.	nagasima@apc.saitama-u.ac.jp					[Anonymous], 1992, JP Patent, Patent No. [1992-352764A, 1992352764]; Froment GF, 2008, CATAL REV, V50, P1, DOI 10.1080/01614940701803960; Kamiguchi S, 2015, J CLUST SCI, V26, P653, DOI 10.1007/s10876-014-0781-6; PARRY EP, 1963, J CATAL, V2, P371, DOI 10.1016/0021-9517(63)90102-7; Iida T, 1997, J AM CHEM SOC, V119, P4783, DOI 10.1021/ja9702576; Brylev KA, 2007, INORG CHEM, V46, P7414, DOI 10.1021/ic7005265; Kamiguchi S, 2013, J CLUST SCI, V24, P559, DOI 10.1007/s10876-012-0534-3; Dufresne P, 2007, APPL CATAL A-GEN, V322, P67, DOI 10.1016/j.apcata.2007.01.013; Lanke SR, 2013, CATAL COMMUN, V41, P29, DOI 10.1016/j.catcom.2013.06.032; Kamiguchi S, 2003, J MOL CATAL A-CHEM, V195, P159, DOI 10.1016/S1381-1169(02)00546-0; Azizi N, 2012, CATAL SCI TECHNOL, V2, P2445, DOI 10.1039/c2cy20456h; Azizi N, 2006, CATAL COMMUN, V7, P224, DOI 10.1016/j.catcom.2005.11.003; Badiceanu AD, 2014, CATAL COMMUN, V47, P67, DOI 10.1016/j.catcom.2014.01.005; Boskovic G., 2004, BASIC PRINCIPLES APP, P479; Chisholm M.H., 1995, EARLY TRANSITION MET; CHLEBICKI J, 1986, POL J CHEM, V60, P485; Concellon JM, 2007, TETRAHEDRON, V63, P2805, DOI 10.1016/j.tet.2007.01.052; Dalpozzo R, 2009, SYNTHESIS-STUTTGART, P3433, DOI 10.1055/s-0029-1216956; Fedin VP, 1998, INORG CHIM ACTA, V271, P228, DOI 10.1016/S0020-1693(97)05935-5; Fringuelli F, 2003, TETRAHEDRON LETT, V44, P6785, DOI 10.1016/S0040-4039(03)01704-0; JOHNSON O, 1955, J PHYS CHEM-US, V59, P827, DOI 10.1021/j150531a007; Kamiguchi S, 2007, CHEM LETT, V36, P1340, DOI 10.1246/cl.2007.1340; Kamiguchi S, 2014, METALS-BASEL, V4, P84, DOI 10.3390/met4020084; Kamiguchi S, 2009, J CLUST SCI, V20, P683, DOI 10.1007/s10876-009-0271-4; KOKNAT FW, 1974, INORG CHEM, V13, P1699, DOI 10.1021/ic50137a032; Kulmala M., 1995, J AEROSOL SCI     S1, V26, pS463, DOI 10.1016/0021-8502(95)97139-6; LUTZ HD, 1993, J ALLOY COMPD, V190, P181, DOI 10.1016/0925-8388(93)90396-5; Mingos D. M. P., 1990, INTRO CLUSTER CHEM; Mojtahedi MM, 2012, J MOL CATAL A-CHEM, V361, P68, DOI 10.1016/j.molcata.2012.05.004; Nagashima S, 2011, J CLUST SCI, V22, P647, DOI 10.1007/s10876-011-0411-5; Nagashima S, 2014, J CLUST SCI, V25, P1203, DOI 10.1007/s10876-014-0700-x; Nagashima S, 2014, METALS-BASEL, V4, P235, DOI 10.3390/met4020235; Nannelli P., 1970, INORG SYNTH, V12, P170; Polshettiwar V, 2004, CATAL COMMUN, V5, P515, DOI 10.1016/j.catcom.2004.06.008; Selby HD, 2005, COMMENT INORG CHEM, V26, P75, DOI 10.1080/02603590590920569; Shabunya SI, 2003, CHEM ENG PROCESS, V42, P789, DOI 10.1016/S0255-2701(03)00007-2; Shivani A.K., 2007, MOL CATAL A, V263, P137; Sun JT, 2009, TETRAHEDRON LETT, V50, P548, DOI 10.1016/j.tetlet.2008.11.060; Yadav JS, 2002, CHEM LETT, P906, DOI 10.1246/cl.2002.906; YAMASHITA H, 1985, CHEM LETT, P1643, DOI 10.1246/cl.1985.1643	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-860X	1873-3875		APPL CATAL A-GEN	Appl. Catal. A-Gen.	MAY	2015	497						167	175		10.1016/j.apcata.2015.03.007		9	Chemistry, Physical; Environmental Sciences	Chemistry; Environmental Sciences & Ecology	CI8WL	WOS:000355052300019		
J	Harada, T; Sakata, H				Harada, Tomohiro; Sakata, Hajime			Polarization circulation effect in microbend-induced long-period fiber gratings for polarization-insensitive filter response	APPLIED OPTICS			English	Article							DEPENDENT LOSS; OPTICAL-FIBER; BIREFRINGENCE; COMPENSATION	We analyze the reduction mechanism of polarization dependence in loss-peak wavelength for microbend-induced long-period fiber gratings (M-LPFGs) formed in twisted fibers. The analysis model consists of the stress-induced birefringence associated with the microbend as well as the optical activity induced by the twisted fiber. We verify the analysis model by measuring the variation in the state of polarization through the torsion M-LPFG. We reveal that the efficient circulation of the polarization components occurs in the torsion M-LPFG such that the polarization dependence of the loss-peak wavelengths is reduced. In the experiments, the M-LPFG is controlled by an electromagnet in the combination of a coil spring. The experimental results demonstrate a good agreement with the calculated expectation for the polarization-insensitive M-LPFGs. (C) 2015 Optical Society of America	[Harada, Tomohiro; Sakata, Hajime] Shizuoka Univ, Grad Sch Engn, Dept Elect & Elect Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan	Sakata, H (reprint author), Shizuoka Univ, Grad Sch Engn, Dept Elect & Elect Engn, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.	thsakat@ipc.shizuoka.ac.jp			Japan Society for the Promotion of Science [24560044]; Mitutoyo Association for Science and Technology [R1306]	Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (24560044); Mitutoyo Association for Science and Technology (R1306).	Rego G, 2008, OPT COMMUN, V281, P255, DOI 10.1016/j.optcom.2007.08.063; Savin S, 2000, OPT LETT, V25, P710, DOI 10.1364/OL.25.000710; ULRICH R, 1979, APPL OPTICS, V18, P2241, DOI 10.1364/AO.18.002241; Vengsarkar AM, 1996, J LIGHTWAVE TECHNOL, V14, P58, DOI 10.1109/50.476137; Kim CS, 2005, OPT LETT, V30, P20, DOI 10.1364/OL.30.000020; SAKAI JI, 1981, IEEE J QUANTUM ELECT, V17, P1041, DOI 10.1109/JQE.1981.1071213; Bhatia V, 1997, OPT LETT, V22, P648, DOI 10.1364/OL.22.000648; Cho JY, 2002, OPT COMMUN, V213, P281, DOI 10.1016/S0030-4018(02)02077-1; Ivanov OV, 2004, OPT COMMUN, V232, P159, DOI 10.1016/j.optcom.2003.12.058; POOLE CD, 1991, J LIGHTWAVE TECHNOL, V9, P598; PROBST CB, 1989, J LIGHTWAVE TECHNOL, V7, P55, DOI 10.1109/50.17733; Rao YJ, 2004, OPT COMMUN, V229, P209, DOI 10.1016/j.optcom.2003.10.048; Rashleigh S. C., 1983, Journal of Lightwave Technology, VLT-1, DOI 10.1109/JLT.1983.1072121; Sakata H, 2014, IEEE PHOTONIC TECH L, V26, P904, DOI 10.1109/LPT.2014.2309701; Sakata H, 2010, OPT LETT, V35, P1061, DOI 10.1364/OL.35.001061; SMITH AM, 1980, APPL OPTICS, V19, P2606, DOI 10.1364/AO.19.002606	16	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	MAY 1	2015	54	13					3937	3942		10.1364/AO.54.003937		6	Optics	Optics	CH4DC	WOS:000353980900033		
J	Maeda, Y; Miyazaki, D; Maekawa, S				Maeda, Yuki; Miyazaki, Daisuke; Maekawa, Satoshi			Volumetric aerial three-dimensional display based on heterogeneous imaging and image plane scanning	APPLIED OPTICS			English	Article							OPTICAL-IMAGE; FELIX	A volumetric display system that creates a distortion-free three-dimensional (3D) image in midair using a novel imaging system is reported. A roof mirror array forms an aerial real image with an image deformation by retro-reflection. The image deformation can be reduced by constructing an imaging system using two roof mirror arrays arranged in a parallel manner. A cross-sectional image of a 3D object is formed by the proposed imaging system in midair and swept by a galvanometer mirror scanner to create a 3D volume image. An aerial 3D volume image formation without the image deformation was confirmed by an experimental volumetric display system. (C) 2015 Optical Society of America.	[Maeda, Yuki; Miyazaki, Daisuke] Osaka City Univ, Grad Sch Engn, Sumiyoshi Ku, Osaka 5588585, Japan; [Maekawa, Satoshi] Par Innovat Co Ltd, Seika, Kyoto, Japan	Maeda, Y (reprint author), Osaka City Univ, Grad Sch Engn, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	maeda@picasso.elec.eng.osaka-cu.ac.jp					Maeda Y, 2013, APPL OPTICS, V52, pA182, DOI 10.1364/AO.52.00A182; Maeda Y, 2013, OPT EXPRESS, V21, P27074, DOI 10.1364/OE.21.027074; Yano S, 2002, DISPLAYS, V23, P191, DOI 10.1016/S0141-9382(02)00038-0; Bahr D, 1996, P SOC PHOTO-OPT INS, V2650, P265, DOI 10.1117/12.237011; Berlin Jr E. P., 1977, U.S. patent, Patent No. [4,160,973, 4160973]; Blundell B. G., 2000, VOLUMETRIC 3 DIMENSI; Cossairt OS, 2007, APPL OPTICS, V46, P1244, DOI 10.1364/AO.46.001244; Favalora G. E., 2000, IEEE GLOBECOM 2000 C; Favalora GE, 2002, P SOC PHOTO-OPT INS, V4712, P300, DOI 10.1117/12.480930; Imura M., 2011, INTERNATIONAL CONFER, P170; Ishihara Y., 2008, P 21 ACM S US INT SO, P77; Kijima R, 2009, IEEE VIRTUAL REALITY 2009, PROCEEDINGS, P297; Langhans K, 2002, P SOC PHOTO-OPT INS, V4660, P176, DOI 10.1117/12.468031; Maeda Y., 2012, P IDW AD 12, P1247; Maeda Y., 2013, P INT DISPL WORKSH, P1090; Maeda Y, 2013, PROC SPIE, V8648, DOI 10.1117/12.2003024; Maekawa S, 2008, PROC SPIE, V6803, DOI 10.1117/12.767198; Maekawa Satoshi, 2006, Proceedings of the SPIE - The International Society for Optical Engineering, V6392, DOI 10.1117/12.690574; Miyazaki D, 2006, OPT EXPRESS, V14, P12760, DOI 10.1364/OE.14.012760; Miyazaki D, 2001, APPL OPTICS, V40, P3354, DOI 10.1364/AO.40.003354; Smithwick Q., 2012, SID S, V43, P792; Vasilevskiy V., 2012, Method and device for forming an aerosol projection screen, Patent No. [WO2014046566 A1, 2014046566]; Vrachan J. L., 2006, U.S. Patent, Patent No. [7,614,749, 7614749]; Ishikawa H, 2011, PROC SPIE, V7863, DOI 10.1117/12.872397; Yamamoto H., 2013, SID S, V44, P895; Yamamoto H, 2013, PROC SPIE, V8648, DOI 10.1117/12.2005674	26	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	MAY 1	2015	54	13					4109	4115		10.1364/AO.54.004109		7	Optics	Optics	CH4DC	WOS:000353980900055		
J	Mizutani, A; Urakawa, S; Kikuta, H				Mizutani, Akio; Urakawa, Shinji; Kikuta, Hisao			Highly sensitive refractive index sensor using a resonant grating waveguide on a metal substrate	APPLIED OPTICS			English	Article							SURFACE-PLASMON RESONANCE; BIOSENSOR	A highly sensitive refractive index (RI) sensor using a resonant grating waveguide on a metal substrate was developed. A fully etched low RI grating on a metal substrate was used as the resonant grating. Since the RI of the grating waveguide was low, the light-coupling condition covered with the liquid to be measured was sensitive to changes in the RI of the liquid. The calculated sensitivity of the resonant angle to changes in the RI was 154 degrees/RIU, and the full width at half maximum (FWHM) of the resonant angle was 0.2 degrees. A sensitivity of 123 degrees/RIU and FWHM of 1.2 degrees were experimentally obtained. (C) 2015 Optical Society of America	[Mizutani, Akio; Urakawa, Shinji; Kikuta, Hisao] Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, Sakai, Osaka 5998531, Japan	Mizutani, A (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	mizutani@me.osakafu-u.ac.jp					Lalanne P, 1996, J OPT SOC AM A, V13, P779, DOI 10.1364/JOSAA.13.000779; Schmid JH, 2009, OPT EXPRESS, V17, P18371, DOI 10.1364/OE.17.018371; Ymeti A, 2007, NANO LETT, V7, P394, DOI 10.1021/nl062595n; MAGNUSSON R, 1992, APPL PHYS LETT, V61, P1022, DOI 10.1063/1.107703; Cunningham B, 2002, SENSOR ACTUAT B-CHEM, V85, P219, DOI 10.1016/S0925-4005(02)00111-9; Magnusson R, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3690951; Wawro D, 2000, PROC SPIE, V3911, P86, DOI 10.1117/12.384889; Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9; Lee KJ, 2014, OPT EXPRESS, V22, P9271, DOI 10.1364/OE.22.009271; Hsieh HV, 2004, BIOSENS BIOELECTRON, V19, P653, DOI 10.1016/S0956-5663(03)00271-9; Born M., 1980, PRINCIPLES OPTICS, V6th, P705; Kikuta H., 2005, P SOC PHOTO-OPT INS, V5931, P178; Li X, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/48/485001; MOHARAM MG, 1995, J OPT SOC AM A, V12, P1077, DOI 10.1364/JOSAA.12.001077; Pietroy D, 2008, OPT LETT, V33, P2053, DOI 10.1364/OL.33.002053; Sharon A, 1997, J OPT SOC AM A, V14, P588, DOI 10.1364/JOSAA.14.000588; Vos K.D., 2007, OPT EXPRESS, V15, P7610; Yariv A., 2006, PHOTONICS OPTICAL EL, P110	18	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	MAY 1	2015	54	13					4161	4166		10.1364/AO.54.004161		6	Optics	Optics	CH4DC	WOS:000353980900062		
J	Kawamura, S; Imai, T; Miyazu, J; Sakamoto, T; Kobayashi, J				Kawamura, Sohan; Imai, Tadayuki; Miyazu, Jun; Sakamoto, Tadashi; Kobayashi, Junya			2.5-fold increase in lens power of a KTN varifocal lens by employing an octagonal structure	APPLIED OPTICS			English	Article							ACOUSTIC GRADIENT-INDEX; FOCAL-LENGTH; MICROSCOPY; CRYSTALS	We successfully improved the variable lens power range of a KTN varifocal lens by changing the lens structure. An octagonal structure was proposed based on the concept that an increase in the curvature of the electric field lines is important in terms of increasing the lens power. The optimum lens structure was investigated using the finite element method, and we concluded that the optimum angle between the electrodes and the optical axis was 26.5 degrees, because this provided both minimum wave aberration and increased lens power. We also found by simulation that the octagonal lens contained both convex and concave lens parts. In addition, the simulation revealed that the concave lens parts corrected the wave aberrations induced by the convex lens parts. Our experimental results agreed well with the simulation results. Our octagonal structure achieved a 2.5 times greater lens power than the conventional rectangular structure. (C) 2015 Optical Society of America	[Kawamura, Sohan; Imai, Tadayuki; Miyazu, Jun; Sakamoto, Tadashi; Kobayashi, Junya] NTT Corp, NTT Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan	Kawamura, S (reprint author), NTT Corp, NTT Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan.	kawamura.sohan@lab.ntt.co.jp	Kobayashi, Junjiro/J-8547-2015				Imai T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.022501; Wang B, 2004, APPL OPTICS, V43, P3420, DOI 10.1364/AO.43.003420; Dean KM, 2014, OPT EXPRESS, V22, P26141, DOI 10.1364/OE.22.026141; Olivier N, 2009, OPT LETT, V34, P1684, DOI 10.1364/OL.34.001684; Duocastella M, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.050505; Imai T, 2012, APPL OPTICS, V51, P1532, DOI 10.1364/AO.51.001532; Berge B., EUR PHYS J E, V3, P159; Duocastella M, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/7/075102; Duocastella M, 2014, OPT EXPRESS, V22, DOI 10.1364/OE.22.019293; Imai T, 2013, ELECTRON LETT, V49, P1470, DOI 10.1049/el.2013.1962; Inagaki T, 2013, OPT LETT, V38, P2673, DOI 10.1364/OL.38.002673; KANEKO T, 1995, IEICE T ELECTRON, VE78C, P123; Mermillod-Blondin A, 2008, OPT LETT, V33, P2146, DOI 10.1364/OL.33.002146; Mermillod-Blondin A, 2008, APPL PHYS A-MATER, V93, P231, DOI 10.1007/s00339-008-4653-5; Sasaura M, 2005, J CRYST GROWTH, V275, pE2099, DOI 10.1016/j.jcrysgro.2004.10.149; SHIBAGUCHI T, 1992, JPN J APPL PHYS 1, V31, P3196, DOI 10.1143/JJAP.31.3196; Zong WJ, 2015, CELL RES, V25, P254, DOI 10.1038/cr.2014.124	17	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	MAY 1	2015	54	13					4197	4201		10.1364/AO.54.004197		5	Optics	Optics	CH4DC	WOS:000353980900067		
J	Kim, Y; Hibino, K; Sugita, N; Mitsuishi, M				Kim, Yangjin; Hibino, Kenichi; Sugita, Naohiko; Mitsuishi, Mamoru			Surface profile measurement of a highly reflective silicon wafer by phase-shifting interferometry	APPLIED OPTICS			English	Article							FIZEAU INTERFEROMETER; MEASUREMENT ALGORITHM; DESIGN; ERRORS; DERIVATION	In phase-shifting Fizeau interferometers, the phase-shift error and multiple-beam interference are the most common sources of systematic error affecting high-precision phase measurements. The nonsinusoidal waveforms can be minimized by applying synchronous detection with more than 4-sample. However, when the phase-shift calibration is inaccurate, these algorithms cannot eliminate the effects of nonsinusoidal characteristics. Moreover, when measuring the surface profile of highly reflective samples, the calculated phase is critically determined not only by the decrease in the fringe contrast but also by the coupling error between the harmonics and phase-shift error. In this paper, the phase errors calculated by conventional phase-shifting algorithms were estimated by considering the coupling error. We show that the 4N - 3 algorithm, comprising the polynomial window function and the DFT term, has the smallest phase error among the conventional phase-shifting algorithms. The surface profile of the highly reflective silicon wafer was measured using a wavelength-tuning Fizeau interferometer and the 4N - 3 algorithm. (C) 2015 Optical Society of America	[Kim, Yangjin; Sugita, Naohiko; Mitsuishi, Mamoru] Univ Tokyo, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Hibino, Kenichi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058563, Japan	Kim, Y (reprint author), Univ Tokyo, Dept Mech Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	yangjin@nml.t.u-tokyo.ac.jp					AI CY, 1993, APPL OPTICS, V32, P3470, DOI 10.1364/AO.32.003470; FREISCHLAD K, 1990, J OPT SOC AM A, V7, P542, DOI 10.1364/JOSAA.7.000542; de Groot PJ, 2014, APPL OPTICS, V53, P4334, DOI 10.1364/AO.53.004334; BRUNING JH, 1974, APPL OPTICS, V13, P2693, DOI 10.1364/AO.13.002693; Kim Y, 2014, OPT EXPRESS, V22, P21145, DOI 10.1364/OE.22.021145; Hibino K, 1997, J OPT SOC AM A, V14, P918, DOI 10.1364/JOSAA.14.000918; Hibino K, 2003, APPL OPTICS, V42, P3888, DOI 10.1364/AO.42.003888; Dorrio BV, 1996, APPL OPTICS, V35, P61, DOI 10.1364/AO.35.000061; SCHWIDER J, 1983, APPL OPTICS, V22, P3421; MOORE RC, 1980, APPL OPTICS, V19, P2196, DOI 10.1364/AO.19.002196; Hanayama R, 2004, OPT REV, V11, P337, DOI 10.1007/s10043-004-0337-3; Hibino K, 1999, OPT REV, V6, P529, DOI 10.1007/s10043-999-0529-y; SCHWIDER J, 1993, OPT ENG, V32, P1883, DOI 10.1117/12.143340; SURREL Y, 1993, APPL OPTICS, V32, P3598, DOI 10.1364/AO.32.003598; HIBINO K, 1995, J OPT SOC AM A, V12, P761, DOI 10.1364/JOSAA.12.000761; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; HARIHARAN P, 1987, APPL OPTICS, V26, P2506, DOI 10.1364/AO.26.002506; LIU K, 1981, OPT LETT, V6, P117, DOI 10.1364/OL.6.000117; Surrel Y, 1996, APPL OPTICS, V35, P51, DOI 10.1364/AO.35.000051; Kim Y, 2014, OPT EXPRESS, V22, P18203, DOI 10.1364/OE.22.018203; CREATH K, 1994, APPL OPTICS, V33, P24, DOI 10.1364/AO.33.000024; Onodera R, 1996, J OPT SOC AM A, V13, P139, DOI 10.1364/JOSAA.13.000139; HARIHARAN P, 1987, APPL OPTICS, V26, P2504, DOI 10.1364/AO.26.002504; LARKIN KG, 1992, J OPT SOC AM A, V9, P1740, DOI 10.1364/JOSAA.9.001740; Surrel Y, 1997, APPL OPTICS, V36, P805, DOI 10.1364/AO.36.000805; STETSON KA, 1985, APPL OPTICS, V24, P3631; SCHMIT J, 1995, APPL OPTICS, V34, P3610, DOI 10.1364/AO.34.003610; Creath K, 2000, P SOC PHOTO-OPT INS, V4101, P47; Creath K., 1988, Progress in optics. Vol.XXVI, DOI 10.1016/S0079-6638(08)70178-1; DEGROOT P, 1995, APPL OPTICS, V34, P4723; DEGROOT P, 1995, APPL OPTICS, V34, P2856; Hibino K, 2004, OPT EXPRESS, V12, P5579, DOI 10.1364/OPEX.12.005579; WYANT JC, 1984, ASLE TRANS, V27, P101	33	4	4	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	MAY 1	2015	54	13					4207	4213		10.1364/AO.54.004207		7	Optics	Optics	CH4DC	WOS:000353980900069		
J	Hakko, M; Kiire, T; Barada, D; Yatagai, T; Hayasaki, Y				Hakko, Manabu; Kiire, Tomohiro; Barada, Daisuke; Yatagai, Toyohiko; Hayasaki, Yoshio			Shape estimation of diffractive optical elements using high-dynamic range scatterometry	APPLIED OPTICS			English	Article								High-dynamic range scatterometry enables us to use simultaneously weak scattered light and strong diffracted light for shape estimation of a diffractive optical element. Weak scattered light is especially effective in identifying the nanostructure despite being considered undesirable to diffraction efficiency and image contrast. We devised a shape estimation method based on high-dynamic range scatterometry, which is composed of modeling targets, numerical simulation of light propagation from the target, optical measurement, determination of signature region, noise reduction, data matching, and sample shape estimation. The use of the weak scattered light improved the accuracy of the shape estimation compared with using only the diffraction peaks. The shape estimation method was consistent with values measured using scanning electron microscopy. (C) 2015 Optical Society of America	[Hakko, Manabu] Canon Inc, Corp R&D Headquarters, Opt Technol Dev Ctr, Utsunomiya, Tochigi 3213298, Japan; [Kiire, Tomohiro; Barada, Daisuke; Yatagai, Toyohiko; Hayasaki, Yoshio] Utsunomiya Univ, CORE, Utsunomiya, Tochigi 3218585, Japan	Hayasaki, Y (reprint author), Utsunomiya Univ, CORE, 7-1-2 Yoto, Utsunomiya, Tochigi 3218585, Japan.	hayasaki@opt.utsunomiya-u.ac.jp					Gross H, 2012, APPL OPTICS, V51, P7384, DOI 10.1364/AO.51.007384; Caley A. J., 2006, P SOC PHOTO-OPT INS, V6185, p6185E; Gu H. Y., 2009, INT J COMPUTATIONAL, V14, P363; Hakko M, 2013, OPT LETT, V38, P3862, DOI 10.1364/OL.38.003862; Kiire T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.022501; Kiryanov VP, 2002, P SOC PHOTO-OPT INS, V4900, P977, DOI 10.1117/12.484490; Lee S. H., 2006, J OPT SOC KOREA, V10, P105; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; Zhou P, 2007, APPL OPTICS, V46, P657, DOI 10.1364/AO.46.000657	9	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	MAY 1	2015	54	13					4255	4261		10.1364/AO.54.004255		7	Optics	Optics	CH4DC	WOS:000353980900075		
J	Ohi, F				Ohi, Fumio			Steady-state bounds for multi-state systems' reliability via modular decompositions	APPLIED STOCHASTIC MODELS IN BUSINESS AND INDUSTRY			English	Article						multi-state system; modular decomposition; stochastic bound		A concept of modular decomposition plays a crucial role for theoretical and practical evaluation of reliability performances of systems, because real systems are usually composed of modules, and the components of the systems are arranged to form these modules. In this paper, we give stochastic bounds for multi-state coherent systems by utilizing modular decompositions where the state spaces are assumed to be totally ordered sets. The presented bounds are shown to be better than those derived directly from the total systems and are extensions of the well-known bounds for binary state systems to multi-state cases. The results of this paper allows systems engineers or designers to have better stochastic approximations for the performance of a system by simply stacking stochastic bounds along with the hierarchy formed by the modules of the system. Copyright (c) 2014 John Wiley & Sons, Ltd.	Nagoya Inst Technol, Omohi Coll, Showa Ku, Nagoya, Aichi 4668555, Japan	Ohi, F (reprint author), Nagoya Inst Technol, Omohi Coll, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	ohi.fumio@nitech.ac.jp			JSPS [25350441]	This work is supported by grant #25350441, Grant-in-Aid for Scientific Research (c) from JSPS(2013 - 2015).	Levitin G, 2004, RELIAB ENG SYST SAFE, V84, P285, DOI 10.1016/j.ress.2003.12.002; ELNEWEIHI E, 1978, J APPL PROBAB, V15, P675, DOI 10.2307/3213425; Barlow R. E., 1978, Mathematics of Operations Research, V3, DOI 10.1287/moor.3.4.275; Barlows RE, 1975, STAT THEORY RELIABIL; BIRNBAUM ZW, 1961, TECHNOMETRICS, V3, P55, DOI 10.2307/1266477; Birnbaums ZW, 1965, SIAM J APPL MATH, V13, P444, DOI 10.1137/0113027; BODIN LD, 1970, TECHNOMETRICS, V12, P335, DOI 10.2307/1267238; ESARY JD, 1963, TECHNOMETRICS, V5, P191, DOI 10.2307/1266063; Griffiths ES, 1980, J APPL PROBAB, V17, P735; Huang JS, 2003, IIE TRANS, V35, P527, DOI 10.1080/07408170390193053; Levitin G, 2013, IEEE T RELIAB, V62, P648, DOI 10.1109/TR.2013.2270418; Levitins G, 2008, HDB PERFORMABILITY E, P447, DOI 10.1007/978-1-84800-131-2_29; Levitins G, 2005, UNIVERSAL GENERATING; Lisnianski A, 2010, MULTI-STATE SYSTEM RELIABILITY ANALYSIS AND OPTIMIZATION FOR ENGINEERS AND INDUSTRIAL MANAGERS, P1, DOI 10.1007/978-1-84996-320-6; Lisnianskis A, 2003, MULTISTATE SYSTEMS R; Mines H, 1959, CT, VCT-6, P138; NATVIG B, 1982, ADV APPL PROBAB, V14, P434, DOI 10.2307/1426529; Natvigs B, 2011, MULTISTATE SYSTEMS R; Ohis F, 2012, ADV RELIABILITY MAIN, P374; Ohis F, 2010, STOCHASTIC RELIABILI, P3; Ohis F, 1983, J JAPAN STAT SOC, V13, P165; Ohis F, 1984, IEEE T RELIAB, VR-33, P284; Ohis F, 2013, RELIAB ENG SYST SAFE, V116, P86; Ohis F, 1984, LECT NOTES EC MATH S, V235; Ohis F, 1989, MATH JPN, V34, P403; Ushakov I, 1987, SOV J COMPUT SYST SC, V25, P61; Ushakov I, 2000, EUR J OPER RES, V125, P316, DOI 10.1016/S0377-2217(99)00462-2; Yus K, 1994, IEEE T RELIAB, V43, P242	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1524-1904	1526-4025		APPL STOCH MODEL BUS	Appl. Stoch. Models. Bus. Ind.	MAY-JUN	2015	31	3			SI		307	324		10.1002/asmb.2044		18	Operations Research & Management Science; Mathematics, Interdisciplinary Applications; Statistics & Probability	Operations Research & Management Science; Mathematics	CI8DF	WOS:000354998300004		
J	Jin, L				Jin, Lu			Optimal decision procedure for an operation-dependent deteriorating system	APPLIED STOCHASTIC MODELS IN BUSINESS AND INDUSTRY			English	Article						Markov decision process (MDP); monotone procedure; stochastic increasing	MAINTENANCE POLICIES; MARKOVIAN DETERIORATION; UNCERTAIN INFORMATION; OPTIMAL INSPECTION	Highly flexible and integrated systems can perform one of several operations at a time, which allows the decision-maker to select which operation to perform in the safest and most effective way. There are strong dynamic interactions between a system's deterioration and the operations it performs. In this research, optimal decision-making was investigated for operation-dependent deteriorating systems under variable operations while formulating the problem as a Markov decision process with the operation as a parameter. The decision-maker selects the operation that will minimize the total expected cost over an infinite horizon on the basis of the current state. The properties of the resulting optimal expected cost function were examined, and the optimal decision procedure was found to be given by a monotone procedure under certain conditions. This research provides a generalization of the keep, inspection, and replacement' problem that was initially introduced by Derman (Mathematical Optimization Techniques: 201-210, 1963) and has been studied extensively since then. Copyright (c) 2014 John Wiley & Sons, Ltd.	Univ Electrocommun, Dept Informat, Tokyo, Japan	Jin, L (reprint author), Univ Electrocommun, Dept Informat, Tokyo, Japan.	jinlu@inf.uec.ac.jp					Abeygunawardane SK, 2013, IEEE T POWER SYST, V28, P3194, DOI 10.1109/TPWRS.2012.2237042; American Cancer Society, 2013, BREAST CANC FACTS FI; OHNISHI M, 1986, EUR J OPER RES, V27, P117, DOI 10.1016/S0377-2217(86)80014-5; Chhatwal J, 2010, OPER RES, V58, P1577, DOI 10.1287/opre.1100.0877; Byon E, 2010, IEEE T RELIAB, V59, P393, DOI 10.1109/TR.2010.2046804; Wang HZ, 2002, EUR J OPER RES, V139, P469, DOI 10.1016/S0377-2217(01)00197-7; ROSENFIELD D, 1976, OPER RES, V24, P141, DOI 10.1287/opre.24.1.141; Endrenyi J, 1998, IEEE T POWER SYST, V13, P576, DOI 10.1109/59.667385; [Anonymous], 2008, IEEE GUID INT GAS GE; Celen M., 2012, CIRP J MANUFACTURING, V5, P296; Dermans C, 1963, OPTIMAL DECISION PRO, P201; Guenthers RB, 1988, PARTIAL DIFFERENTIAL; Kurt M, 2010, EUR J OPER RES, V205, P368, DOI 10.1016/j.ejor.2010.01.009; Maillart LM, 2006, IIE TRANS, V38, P463, DOI 10.1080/074081791009059; Marshalls AW, 1979, INEQUALITIES THEORY; MONAHAN GE, 1982, MANAGE SCI, V28, P1, DOI 10.1287/mnsc.28.1.1; Putermans ML, 1994, MARKOV DECISION PROC; ROSENFIELD D, 1976, NAV RES LOG, V23, P389, DOI 10.1002/nav.3800230303; Ross S.M., 1970, APPL PROBABILITY MOD; Rosss SM, 1971, MANAGE SCI, V17, P589; Tamuras N, 2004, J RELIABILITY ENG AS, V26, P699; WHITE CC, 1978, J OPER RES SOC, V29, P235, DOI 10.2307/3009450; Yang ZM, 2007, IIE TRANS, V39, P1111, DOI 10.1080/07408170701315339; Zhou J, 2007, IIE TRANS, V39, P1085, DOI 10.1080/07408170701291779; Zijuans L, 2011, P INN SMART GRID TEC, P1	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1524-1904	1526-4025		APPL STOCH MODEL BUS	Appl. Stoch. Models. Bus. Ind.	MAY-JUN	2015	31	3			SI		394	404		10.1002/asmb.2077		11	Operations Research & Management Science; Mathematics, Interdisciplinary Applications; Statistics & Probability	Operations Research & Management Science; Mathematics	CI8DF	WOS:000354998300010		
J	Igwe, O; Fukuoka, H				Igwe, O.; Fukuoka, H.			The effect of water-saturation on the stability of problematic slopes at the Iva Valley area, Southeast Nigeria	ARABIAN JOURNAL OF GEOSCIENCES			English	Article						Landslides; Complete liquefaction; Slope stability; Iva Valley; Nigeria	RING-SHEAR TESTS; PORE-PRESSURE; DEBRIS FLOW; SANDS; LIQUEFACTION; INSTABILITY; STRENGTH	The Iva Valley area has one of the highest densities of landslides in Nigeria, and impacts the residents, local economy, and the environment. Slopes in the area sit on unconsolidated, cross-bedded, friable sandstone units with interbeds of claystone. Past research efforts had proposed theories explaining the mechanism of failure based on the limited-liquefaction behavior of the slope materials. But as landslide prevention works on the slopes began to fail, it became apparent that those theories were inadequate solutions to the devastating effect of mass wasting processes. This paper presents the results of landslide susceptibility assessment based on the new evidence of complete-liquefaction behavior observed in the samples when back-pressure is employed to accomplish full saturation. Loose, saturated specimens failed after attaining maximum strength at shear displacements less than 1 mm. The failure was marked by rapid reduction in shear strength and accompanied by a steady increase in pore water pressure until the ratio of pore pressure and normal stress approached unity indicating complete liquefaction. This behavior simulated the response of the slope soils to varying stress and drainage conditions in the field, and seems an adequate mechanism for the incessant failure of slopes and prevention works. Because the geology of a vast area of the South-East Nigeria is similar, the results obtained at the study area are also applicable in other areas within the region for sustainable preventive and mitigating measures.	[Igwe, O.] Univ Nigeria, Dept Geol, Fac Phys Sci, Nsukka, Nigeria; [Fukuoka, H.] Kyoto Univ, Disaster Prevent Res Inst, Res Ctr Landslides, Kyoto, Japan	Igwe, O (reprint author), Univ Nigeria, Dept Geol, Fac Phys Sci, Nsukka, Nigeria.	igwejames@hotmail.com; fukuoka@landslide.dpri.kyoto-u.ac.jp			International Program on Landslides - UNESCO [150]; UNISDR; ISDR; Japanese Government	This research was conducted under the auspices of the International Program on Landslides (Project No. 150) supported by UNESCO, UNISDR, ISDR, and the Japanese Government. We deeply appreciate Professor Sassa Kyoji, founding president of the International Consortium on Landslides, and Professor Fawu Wang of the Department of Geosciences, Shimane University, Japan for their continuous support. The head and staff of the Department of Geology, University of Nigeria, Nsukka are acknowledged for their great role in the research.	Pradhan B, 2010, ARAB J GEOSCI, V3, P319, DOI 10.1007/s12517-009-0089-2; Iverson RM, 2000, WATER RESOUR RES, V36, P1897, DOI 10.1029/2000WR900090; Igwe O, 2013, LANDSLIDES, V10, P515, DOI 10.1007/s10346-013-0401-9; Iverson NR, 2010, ENG GEOL, V114, P84, DOI 10.1016/j.enggeo.2010.04.006; [Anonymous], 1977, J GEOTECH ENG DIV AS; Sassa K, 2003, GEOTECH TEST J, V26, P257; Missoum H, 2013, ARAB J GEOSCI, V6, P615, DOI 10.1007/s12517-011-0387-3; Wang GH, 2003, ENG GEOL, V69, P109, DOI 10.1016/S0013-7952(02)00268-5; Emam A, 2012, ARAB J GEOSCI, V5, P607, DOI 10.1007/s12517-010-0201-7; Sarkar K, 2012, ARAB J GEOSCI, V5, P73, DOI 10.1007/s12517-010-0148-8; Sujatha ER, 2013, ARAB J GEOSCI, V6, P429, DOI 10.1007/s12517-011-0356-x; Igwe O, 2007, LANDSLIDES, V4, P43, DOI 10.1007/s10346-006-0051-2; Pourghasemi HR, 2013, ARAB J GEOSCI, V6, P2351, DOI 10.1007/s12517-012-0532-7; Casagrande A., 1936, J BOSTON SOC CIV ENG, V23, P13; Chu J, 2003, CAN GEOTECH J, V40, P873, DOI 10.1139/T03-039; Crozier MJ, 1984, SLOPE INSTABILITY; Crozier M.J., 1986, LANDSLIDES CAUSES CO; Duc MD, 2013, LANDSLIDES, V10, P219; Igwe O, 2014, ENVIRON EARTH SCI, V71, P2465, DOI 10.1007/s12665-013-2647-x; Igwe O, 2010, INT J EROSION CONTRO, V3, P102; Igwe Ogbonnaya, 2012, Landslides, V9, DOI 10.1007/s10346-012-0324-x; Igwe O, 2014, GEOSCI J, V18, P31, DOI 10.1007/s12303-013-0049-4; Knapen J, 2006, GEOMORPHOLOGY, V73, P149; LADE PV, 1992, J GEOTECH ENG-ASCE, V118, P51, DOI 10.1061/(ASCE)0733-9410(1992)118:1(51); Matori A, 2012, ARAB J GEOSCI, V5, P1069, DOI 10.1007/s12517-011-0309-4; Okada Y, 2004, ENG GEOL, V75, P325, DOI 10.1016/j.enggeo.2004.07.001; Sadrekarimi A, 2011, GEOTECH TEST J, V26, P1; Sassa K, 1988, P 5 INT S LANDSL LAU, V1, P37; Sassa K, 2000, P GEOENG2000 MELB, P1671; Sharma LP, 2012, ARAB J GEOSCI, V5, P789, DOI 10.1007/s12517-010-0272-5; Shoaei Z, 1994, B DIS PREV RES I KYO, V44, P1; TAKAHASHI T, 1980, J HYDR ENG DIV-ASCE, V106, P381; TAKAHASHI T, 1978, J HYDR ENG DIV-ASCE, V104, P1153; Takahashi T, 1991, IAHR MONOGRAPH; Wafid M.A, 2004, LANDSLIDES, V1, P101	35	4	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1866-7511	1866-7538		ARAB J GEOSCI	Arab. J. Geosci.	MAY	2015	8	5					3223	3233		10.1007/s12517-014-1398-7		11	Geosciences, Multidisciplinary	Geology	CI2WQ	WOS:000354609000063		
J	Kitagawa, Y; Namiki, M				Kitagawa, Yasuhide; Namiki, Mikio			Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia	ASIAN JOURNAL OF ANDROLOGY			English	Review						free prostate-specific antigen; pro-prostate-specific antigen; prostate cancer; prostate cancer gene 3; prostate-specific antigen-based population screening; serum prostate-specific antigen distribution	UROLOGICAL-ASSOCIATION GUIDELINES; FREE/TOTAL PSA RATIO; PCA3 URINE ASSAY; 10.0 NG/ML; CUMULATIVE PROBABILITY; CLINICAL UTILITY; REFERENCE RANGES; RISK-ASSESSMENT; REPEAT BIOPSY; MEN	In Western countries, clinical trials on prostate cancer screening demonstrated a limited benefit for patient survival. In the Asia-Pacific region, including Japan, the rate of prostate-specific antigen (PSA) testing remains very low compared with Western countries, and the benefits of population-based screening remain unclear. This review describes the current status of population screening and diagnosis for prostate cancer in Japan and discusses the efficacy of population screening for the Asian population. Since the 1990s, screening systems have been administered by each municipal government in Japan, and decreases in the prostate cancer mortality rate are expected in some regions where the exposure rate to PSA screening has increased markedly. A population-based screening cohort revealed that the proportion of metastatic disease in cancer detected by screening gradually decreased according to the increased exposure rate, and a decreasing trend in the proportion of cancer with high serum PSA levels after population screening was started. The prognosis of the prostate cancer detected by population screening was demonstrated to be more favorable than those diagnosed outside of the population screening. Recent results in screening cohorts demonstrated the efficacy of PSA. These recent evidences regarding population-based screening in Japan may contribute to establishing the optimal prostate cancer screening system in Asian individuals.	[Kitagawa, Yasuhide; Namiki, Mikio] Kanazawa Univ, Dept Integrat Canc Therapy & Urol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208640, Japan	Kitagawa, Y (reprint author), Kanazawa Univ, Dept Integrat Canc Therapy & Urol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208640, Japan.	yasukita@med.kanazawa-u.ac.jp					Andriole GL, 2005, J NATL CANCER I, V97, P433, DOI 10.1093/jnci/dji065; Le BV, 2010, J UROLOGY, V183, P1355, DOI 10.1016/j.juro.2009.12.056; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Catalona WJ, 2011, J UROLOGY, V185, P1650, DOI 10.1016/j.juro.2010.12.032; Ito K, 2004, INT J CANCER, V109, P455, DOI 10.1002/ijc.11711; Zhang JJ, 2012, EUR J CANCER PREV, V21, P480, DOI 10.1097/CEJ.0b013e328351c732; Roddam AW, 2005, EUR UROL, V48, P386, DOI 10.1016/j.eururo.2005.04.015; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Glass AS, 2013, UROLOGY, V82, P60, DOI 10.1016/j.urology.2013.01.072; Marks LS, 2007, UROLOGY, V69, P532, DOI 10.1016/j.urology.2006.12.014; Kumar A, 1997, CANCER RES, V57, P3111; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Haese A, 2008, EUR UROL, V54, P1081, DOI 10.1016/j.eururo.2008.06.071; Sokoll LJ, 2010, CANCER EPIDEM BIOMAR, V19, P1193, DOI 10.1158/1055-9965.EPI-10-0007; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Fujimoto H, 2011, INT J UROL, V18, P876, DOI 10.1111/j.1442-2042.2011.02895.x; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Ochiai A, 2013, BJU INT, V111, P928, DOI 10.1111/j.1464-410X.2012.11683.x; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Groskopf J, 2006, CLIN CHEM, V52, P1089, DOI 10.1373/clinchem.2005.063289; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Ito K, 2014, NAT REV UROL, V11, P197, DOI 10.1038/nrurol.2014.42; Aus G, 2004, EUR UROL, V45, P160, DOI 10.1016/j.eururo.2003.09.008; Battikhi MNG, 2003, PROSTATE CANCER P D, V6, P256, DOI 10.1038/sj.pcan.4500656; Bouchardy C, 2008, INT J CANCER, V123, P421, DOI 10.1002/ijc.23520; Brawley O W, 1998, Semin Urol Oncol, V16, P187; Fujimoto H, 2005, INT J UROL, V12, P46; Candas B, 2006, J UROLOGY, V175, P510, DOI 10.1016/S0022-5347(05)00165-5; Casey RG, 2012, ISRN ONCOL; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; Naito S, 2010, INT J UROL, V17, P830, DOI 10.1111/j.1442-2042.2010.02613.x; COONER WH, 1990, J UROLOGY, V143, P1146; Finne P, 2008, EUR UROL, V54, P362, DOI 10.1016/j.eururo.2007.10.056; Fukagai Takashi, 2009, V472, P455, DOI 10.1007/978-1-60327-492-0_22; Hugosson J, 2004, CANCER, V100, P1397, DOI 10.1002/cncr.20126; Ilic D, 2013, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004720.PUB3; Ishidoya S, 2008, JPN J CLIN ONCOL, V38, P844, DOI 10.1093/jjco/hyn107; Ito K, 2003, UROLOGY, V61, P760, DOI 10.1016/S0090-4295(02)02427-5; Ito K, 2008, INT J UROL, V15, P763, DOI 10.1111/j.1442-2042.2008.02125.x; Ito K, 2009, INT J UROL, V16, P458, DOI 10.1111/j.1442-2042.2009.02293.x; Ito K, 2013, WORLD J UROL, V31, P305, DOI 10.1007/s00345-012-0927-9; Ito K, 2005, CANCER, V103, P242, DOI 10.1002/cncr.20739; Ito K, 2003, PROSTATE, V57, P8, DOI 10.1002/pros.10268; Ito K, 2000, UROLOGY, V56, P278, DOI 10.1016/S0090-4295(00)00613-0; Kakehi Y, 2008, JPN J CLIN ONCOL, V38, P122, DOI 10.1093/jjco/hym161; Kato T, 2010, AKTUEL UROL, V41, pS53, DOI 10.1055/s-0029-1224653; Kitagawa Y, 2014, INT J UROL, V21, P1120, DOI 10.1111/iju.12523; Kitagawa Y, 2011, INT J UROL, V18, P592, DOI 10.1111/j.1442-2042.2011.02796.x; Kitagawa Y, 2014, ASIAN J ANDROL; Kitagawa Y, 2014, INT J UROL, V21, P461, DOI 10.1111/iju.12304; Kitagawa Y, 2014, J CANCER RES CLIN, V140, P53, DOI 10.1007/s00432-013-1543-9; Kitagawa Yasuhide, 2013, Prostate Int, V1, P65, DOI 10.12954/PI.12017; Kobori Y, 2008, INT J CLIN ONCOL, V13, P229, DOI 10.1007/s10147-007-0742-2; Krumholtz JS, 2002, UROLOGY, V60, P469, DOI 10.1016/S0090-4295(02)01875-7; Kubota Y, 2002, PROSTATE, V50, P262, DOI 10.1002/pros.10057; Lee SE, 2000, UROLOGY, V56, P1007, DOI 10.1016/S0090-4295(00)00837-2; Liu ZY, 2009, ASIAN J ANDROL, V11, P100, DOI 10.1038/aja.2008.17; Makinen T, 2004, CLIN CANCER RES, V10, P2231, DOI 10.1158/1078-0432.CCR-03-0338; Miller AB, 1985, PRINCIPLES SCREENING, P3; Miller AB, 1985, SCREENING CANC, P325; Namiki M, 2010, JPN J CLIN ONCOL, V40, pi70, DOI 10.1093/jjco/hyq130; Ohno Y, 2004, WHITE PAPER CANC STA, P201; Okihara K, 2008, INT J UROL, V15, P156, DOI 10.1111/j.1442-2042.2007.01957.x; Park HK, 2006, UROLOGY, V68, P85, DOI 10.1016/j.urology.2006.01.067; Pelzer AE, 2005, BJU INT, V96, P995, DOI 10.1111/j.1464-410X.2005.05800.x; Postma R, 2007, EUR UROL, V52, P89, DOI 10.1016/j.eururo.2007.01.030; Rabah DM, 2010, PROSTATE CANCER P D, V13, P191, DOI 10.1038/pcan.2009.60; Sawada K, 2014, INT J UROL, V21, P560, DOI 10.1111/iju.12380; Schroder FH, 2001, EUR UROL, V39, P49, DOI 10.1159/000052588; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sothilingam S, 2010, UROL ONCOL-SEMIN ORI, V28, P670, DOI 10.1016/j.urolonc.2009.12.014; Takechi H, 2005, JPN J UROL SURG, V18, P997; Zhang HF, 2004, CHINESE MED J-PEKING, V117, P67	75	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1008-682X	1745-7262		ASIAN J ANDROL	Asian J. Androl.	MAY	2015	17	3					475	480		10.4103/1008-682X.143756		6	Andrology; Urology & Nephrology	Endocrinology & Metabolism; Urology & Nephrology	CH6FC	WOS:000354130800023		
J	Rinchai, D; Riyapa, D; Buddhisa, S; Utispan, K; Titball, RW; Stevens, MP; Stevens, JM; Ogawa, M; Tanida, I; Koike, M; Uchiyama, Y; Ato, M; Lertmemongkolchai, G				Rinchai, Darawan; Riyapa, Donporn; Buddhisa, Surachat; Utispan, Kusumawadee; Titball, Richard W.; Stevens, Mark P.; Stevens, Joanne M.; Ogawa, Michinaga; Tanida, Isei; Koike, Masato; Uchiyama, Yasuo; Ato, Manabu; Lertmemongkolchai, Ganjana			Macroautophagy is essential for killing of intracellular Burkholderia pseudomallei in human neutrophils	AUTOPHAGY			English	Article						autophagy; Burkholderia pseudomallei; LC3-II; melioidosis; neutrophils; T3SS	AUTOPHAGY; INFECTION; MELIOIDOSIS; BACTERIAL; SURVIVAL; BEHAVIOR	Neutrophils play a key role in the control of Burkholderia pseudomallei, the pathogen that causes melioidosis. Here, we show that survival of intracellular B. pseudomallei was significantly increased in the presence of 3-methyladenine or lysosomal cathepsin inhibitors. The LC3-flux was increased in B. pseudomallei-infected neutrophils. Concordant with this result, confocal microscopy analyses using anti-LC3 antibodies revealed that B. pseudomallei-containing phagosomes partially overlapped with LC3-positive signal at 3 and 6h postinfection. Electron microscopic analyses of B. pseudomallei-infected neutrophils at 3h revealed B. pseudomallei-containing phagosomes that occasionally fused with phagophores or autophagosomes. Following infection with a B. pseudomallei mutant lacking the Burkholderia secretion apparatus Bsa Type III secretion system, neither this characteristic structure nor bacterial escape into the cytosol were observed. These findings indicate that human neutrophils are able to recruit autophagic machinery adjacent to B. pseudomallei-containing phagosomes in a Type III secretion system-dependent manner.	[Rinchai, Darawan; Riyapa, Donporn; Buddhisa, Surachat; Utispan, Kusumawadee; Lertmemongkolchai, Ganjana] Khon Kaen Univ, Res Ctr, Cellular & Mol Immunol Unit, Khon Kaen, Thailand; [Rinchai, Darawan; Riyapa, Donporn; Buddhisa, Surachat; Utispan, Kusumawadee; Lertmemongkolchai, Ganjana] Khon Kaen Univ, Fac Associated Med Sci, Dev Med Diagnost Labs CMDL, Khon Kaen, Thailand; [Titball, Richard W.] Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter, Devon, England; [Stevens, Mark P.; Stevens, Joanne M.] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Stevens, Mark P.; Stevens, Joanne M.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland; [Ogawa, Michinaga] Natl Inst Infect Dis, Dept Microbiol, Tokyo, Japan; [Tanida, Isei] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Koike, Masato] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Tokyo, Japan; [Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Neuropathol, Tokyo, Japan; [Rinchai, Darawan; Ato, Manabu] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan	Lertmemongkolchai, G (reprint author), Khon Kaen Univ, Res Ctr, Cellular & Mol Immunol Unit, Khon Kaen, Thailand.	ato@nih.go.jp; ganja_le@kku.ac.th	Koike, Masato/F-9584-2010; 	Koike, Masato/0000-0002-3174-5684; Rinchai, Darawan/0000-0001-8851-7730	National Institutes of Health: NIAID Cooperative Center for Translational Research on Human Immunology and Biodefense [U01 AI0 82110]; Faculty of Associated Medical Sciences, Khon Kaen University (AMS Incubator Postdoctoral Training Program); Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0215/2550]; Ministry of Education, Science, Sports and Culture of Japan [18076005]; Ministry of Health, Labor and Welfare of Japan	This work was supported in part by the National Institutes of Health: NIAID Cooperative Center for Translational Research on Human Immunology and Biodefense (U01 AI0 82110), Faculty of Associated Medical Sciences, Khon Kaen University (AMS Incubator Postdoctoral Training Program to D.R.), and the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0215/2550 to D.R. and G.L.), and in part by Grants-in-Aid for Scientific Research on Priority Areas "Proteolysis in the Regulation of Biological Processes" from the Ministry of Education, Science, Sports and Culture of Japan (18076005 to I.T. and M.K.) and the Ministry of Health, Labor and Welfare of Japan (I.T., M.O, and M.A.).	Cullinane M, 2008, AUTOPHAGY, V4, P744; Mori Y, 2008, TRAFFIC, V9, P1728, DOI 10.1111/j.1600-0854.2008.00796.x; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2005.04528.x; Wiersinga WJ, 2009, CURR OPIN INFECT DIS, V22, P102, DOI 10.1097/QCO.0b013e328322e727; Sakurai A, 2010, J BIOL CHEM, V285, P22666, DOI 10.1074/jbc.M109.100131; Tanida I, 2005, AUTOPHAGY, V1, P84; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Dupont N, 2009, AUTOPHAGY, V5, P1222, DOI 10.1016/j.chom.2009.07.005; Klionsky DJ, 2008, AUTOPHAGY, V4, P151; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Riyapa D, 2012, INFECT IMMUN, V80, P3921, DOI 10.1128/IAI.00806-12; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Jones AL, 1996, INFECT IMMUN, V64, P782; Birmingham CL, 2006, AUTOPHAGY, V2, P156; Wang CH, 2012, P NATL ACAD SCI USA, V109, P11008, DOI 10.1073/pnas.1203952109; Py BF, 2007, AUTOPHAGY, V3, P117; Chanchamroen S, 2009, INFECT IMMUN, V77, P456, DOI 10.1128/IAI.00503-08; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Gong L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017852; MAEGRAITH BG, 1964, LANCET, V1, P862; Narni-Mancinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002457; RIKIHISA Y, 1984, ANAT REC, V208, P319, DOI 10.1002/ar.1092080302; Suparak S, 2005, J BACTERIOL, V187, P6556, DOI 10.1128/JB.187.18.6556-6560.2005	30	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1554-8627	1554-8635		AUTOPHAGY	Autophagy	MAY	2015	11	5					748	755		10.1080/15548627.2015.1040969		8	Cell Biology	Cell Biology	CJ2OH	WOS:000355323800003		
J	Hashimoto, W; Ochiai, A; Hong, CS; Murata, K; Chakrabarty, AM				Hashimoto, Wataru; Ochiai, Akihito; Hong, Chang Soo; Murata, Kousaku; Chakrabarty, Ananda M.			Structural studies on Laz, a promiscuous anticancer Neisserial protein	BIOENGINEERED			English	Article						azurin; disorder; H.8 epitope; laz; neisseria; X-ray crystallography	PSEUDOMONAS-AERUGINOSA AZURIN; BACTERIAL LIPOPROTEINS; CRYSTAL-STRUCTURE; CANCER-CELLS; H.8 EPITOPE; APOPTOSIS; GROWTH; INHIBITION; P53; SPECIFICITY	Azurin and Laz (lipidated azurin) are 2 bacterial proteins with anticancer, anti-viral and anti-parasitic activities. Azurin, isolated from the bacterium Pseudomonas aeruginosa, termed Paz, demonstrates anticancer activity against a range of cancers but not against brain tumors. In contrast, Laz is produced by members of Gonococci/Meningococci, including Neisseria meningitides which can cross the blood-brain barrier to infect brain meninges. It has been previously reported that Laz has an additional 39 amino acid moiety, called an H.8 epitope, in the N-terminal part of the azurin moiety that allows Laz to cross the entry barrier to brain tumors such as glioblastomas. Exactly, how the H.8 epitope helps the azurin moiety of Laz to cross the entry barriers to attack glioblastoma cells is unknown. In this paper, we describe the structural features of the H.8 moiety in Laz using X-ray crystallography and demonstrate that while the azurin moiety of Laz adopts a beta-sandwich fold with 2 beta-sheets arranged in the Greek key motif, the H.8 epitope was present as a disordered structure outside the Greek key motif. Structures of Paz and H.8 epitope-deficient Laz are well superimposed. The structural flexibility of the H.8 motif in Laz explains the extracellular location of Laz in Neisseria where it can bind the key components of brain tumor cells to disrupt their tight junctions and allow entry of Laz inside the tumors to exert cytotoxicity.	[Hashimoto, Wataru; Ochiai, Akihito; Murata, Kousaku] Kyoto Univ, Grad Sch Agr, Lab Basic & Appl Mol Biotechnol, Uji, Kyoto, Japan; [Hong, Chang Soo; Chakrabarty, Ananda M.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA	Chakrabarty, AM (reprint author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	pseudomo@uic.edu					Yamada T, 2005, CELL MICROBIOL, V7, P1418, DOI 10.1111/j.1462-5822.2005.00567.x; Yamada T, 2004, P NATL ACAD SCI USA, V101, P4770, DOI 10.1073/pnas.0400899101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Daughdrill GW, 1998, BIOCHEMISTRY-US, V37, P1076, DOI 10.1021/bi971952t; Warso MA, 2013, BRIT J CANCER, V108, P1061, DOI 10.1038/bjc.2013.74; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Chrencik JE, 2007, J BIOL CHEM, V282, P36505, DOI 10.1074/jbc.M706340200; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Yamada T, 2002, INFECT IMMUN, V70, P7054, DOI 10.1128/IAI.70.12.7054-7062.2002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Chakrabarty AM, 2014, BIOENGINEERED, V5, P234, DOI 10.4161/bioe.29266; Chaudhari A, 2007, BIOCHEMISTRY-US, V46, P1799, DOI 10.1021/bi061661x; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chaudhari A, 2006, CELL CYCLE, V5, P1642, DOI 10.4161/cc.5.15.2992; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Lancaster KM, 2011, J AM CHEM SOC, V133, P4865, DOI 10.1021/ja1093919; Savelieff MG, 2010, J BIOL INORG CHEM, V15, P461, DOI 10.1007/s00775-010-0625-2; Taylor BN, 2009, CANCER RES, V69, P537, DOI 10.1158/0008-5472.CAN-08-2932; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Yamada T, 2004, CELL CYCLE, V3, P1182; ARVIDSSON RHA, 1989, EUR J BIOCHEM, V179, P195, DOI 10.1111/j.1432-1033.1989.tb14540.x; CANNON JG, 1989, CLIN MICROBIOL REV, V2, pS1; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Delano WL, 2004, PYMOL MOL GRAPHICS S; Fialho AM, 2007, CURR OPIN BIOTECH, V18, P279, DOI 10.1016/j.copbio.2007.04.001; Goto M, 2003, MOL MICROBIOL, V47, P549, DOI 10.1046/j.1365-2958.2003.03317.x; Hiraoka Y, 2004, P NATL ACAD SCI USA, V101, P6427, DOI 10.1073/pnas.0401631101; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hong CS, 2006, CELL CYCLE, V5, P1633, DOI 10.4161/cc.5.15.2991; Hong CS, 2010, US patent, Patent No. 7807183; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Mahfouz M, 2007, PLASMID, V57, P4, DOI 10.1016/j.plasmid.2006.11.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naguleswaran A, 2008, ANTIMICROB AGENTS CH, V52, P402, DOI 10.1128/AAC.01005-07; NAR H, 1992, EUR J BIOCHEM, V205, P1123, DOI 10.1111/j.1432-1033.1992.tb16881.x; NAR H, 1991, J MOL BIOL, V218, P427, DOI 10.1016/0022-2836(91)90723-J; Narita S, 2006, FEBS LETT, V580, P1164, DOI 10.1016/j.febslet.2005.10.038; Nishikawa K, 2009, SEIBUTSU BUTSURI, V49, P4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Punj V, 2004, ONCOGENE, V23, P2367, DOI 10.1038/sj.onc.1207376; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Ray TD, 2011, J IMMUNOL, V186, P4881, DOI 10.4049/jimmunol.1003623; Sambrook J., 1989, LAB MANUAL; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0	48	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	2165-5979	2165-5987		BIOENGINEERED	Bioengineered	MAY-JUN	2015	6	3					141	148		10.1080/21655979.2015.1022303		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CJ2VB	WOS:000355341700004		
J	Nakajima, T; Fujikawa, Y; Matsubara, T; Karita, M; Sano, A				Nakajima, Toshiyuki; Fujikawa, Yoshiyuki; Matsubara, Toshiyuki; Karita, Mimi; Sano, Akiko			Differentiation of a free-living alga into forms with ecto- and endosymbiotic associations with heterotrophic organisms in a 5-year microcosm culture	BIOSYSTEMS			English	Article						Algae; Bacteria; Ciliates; Symbiosis; Evolution; Speciation; Selection	PREDATOR-MEDIATED COMPETITION; BACTERIAL-POPULATIONS; EVOLUTIONARY CHANGES; TETRAHYMENA-THERMOPHILA; PHYLOGENETIC ANALYSIS; ECOLOGICAL TRAITS; ESCHERICHIA-COLI; MICRACTINIUM SP.; JIAOZHOU BAY; PR-CHINA	The ecological mechanisms underlying the diversification of autotrophic species into endosymbiotic lifestyles and the ways in which the evolution of endosymbiotic species is ecologically and evolutionarily affected by sister lineages/lines that are adapted to extra-host environments remain unclear. In this paper, we investigated a differentiation process of algal species in which an endosymbiotic type was differentiated phenotypically from a free-living ancestral clone, by using an experimental model called the CET microcosm, which contains a green alga (Micractinium sp.), a bacterium (Escherichia coli), and a ciliate (Tetrahymena thermophila) cultured together without an external resource supply for over 5 years. We then analyzed the algal diversification process by comparing algal phenotypic properties regarding cell-aggregate formation and their effects on the survival of Tetrahymena (using a clone isolated on day 2668) in the absence of bacteria. We examined 13 Micractinium clones, including both ancestral and derived clones isolated from long-term (day 1819-1847) CET microcosm cultures. The results revealed that the free-living ancestral algal strain diversified in sympatry into an aggregap-forming type that associates with E. coli, and a non-aggregate-forming type that associates with Tetrahymena. Furthermore, a competition experiment revealed that the endosymbiotic (non-aggregate-forming) type was less adapted to the extracellular environment than the aggregate-forming type. This result suggests that severe competition with a nonendosymbiotic sister line in the extra-host environment favors the host-benefiting phenotype in an endosymbiotic line, because such symbionts can enhance the longevity of the host, thereby enabling the survival and reproduction of the symbiont within the host. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Nakajima, Toshiyuki; Fujikawa, Yoshiyuki; Matsubara, Toshiyuki; Karita, Mimi; Sano, Akiko] Ehime Univ, Dept Biol, Matsuyama, Ehime 7908577, Japan	Nakajima, T (reprint author), Ehime Univ, Dept Biol, Bunkyo Cho 2-5, Matsuyama, Ehime 7908577, Japan.	nakajima@sci.ehime-u.ac			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25440240-0]	This work was partly supported by a Grant-in-Aid for Scientific Research (No. 25440240-0) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to T. N. We also thank Yuya Takemoto for his technical assistance.	Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.2307/2410237; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Meyer JR, 2007, NATURE, V446, P432, DOI 10.1038/nature05599; Hoshina R, 2008, PROTIST, V159, P53, DOI 10.1016/j.protis.2007.08.002; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Howe CJ, 2008, PHILOS T R SOC B, V363, P2675, DOI 10.1098/rstb.2008.0050; Friesen ML, 2004, EVOLUTION, V58, P245, DOI 10.1111/j.0014-3820.2004.tb01642.x; Proschold T, 2011, ENVIRON MICROBIOL, V13, P350, DOI 10.1111/j.1462-2920.2010.02333.x; Nowack ECM, 2010, PHILOS T R SOC B, V365, P699, DOI 10.1098/rstb.2009.0188; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; HELLING RB, 1987, GENETICS, V116, P349; Luo W, 2010, PLANT BIOLOGY, V12, P545, DOI 10.1111/j.1438-8677.2009.00221.x; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Joy JB, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2820; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; MOUGET JL, 1995, FEMS MICROBIOL ECOL, V18, P35, DOI 10.1016/0168-6496(95)00038-C; Raven JA, 2009, J EXP BOT, V60, P3975, DOI 10.1093/jxb/erp282; Sachs JL, 2006, P ROY SOC B-BIOL SCI, V273, P425, DOI 10.1098/rspb.2005.3346; BULL JJ, 1991, J THEOR BIOL, V149, P63, DOI 10.1016/S0022-5193(05)80072-4; Guo Z, 2014, J APPL PHYCOL, V26, P1483, DOI 10.1007/s10811-013-0186-1; Kovacevic G, 2012, INT J DEV BIOL, V56, P627, DOI 10.1387/ijdb.123510gk; Watanabe K, 2005, FEMS MICROBIOL ECOL, V51, P187, DOI 10.1016/j.femsec.2004.08.004; Day T, 2004, BIOSCIENCE, V54, P101, DOI 10.1641/0006-3568(2004)054[0101:CAFED]2.0.CO;2; Douglas A. E., 1994, SYMBIOTIC INTERACTIO; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; Germond A, 2013, BIOSYSTEMS, V114, P164, DOI 10.1016/j.biosystems.2013.08.005; Germond A, 2014, EUR J PHYCOL, V49, P526, DOI 10.1080/09670262.2014.978393; Germond A, 2013, EUR J PHYCOL, V48, P485, DOI 10.1080/09670262.2013.860482; Gou WL, 2003, J EXP MAR BIOL ECOL, V296, P135, DOI 10.1016/S0022-0981(03)00242-9; Habetha M, 2003, ZOOLOGY, V106, P101, DOI 10.1078/0944-2006-00104; Herre A.H., 1993, SCIENCE, V259, P1442; Hoshina R, 2013, PHYCOL RES, V61, P7, DOI 10.1111/j.1440-1835.2012.00664.x; Huss Volker A.R., 1994, Endocytobiosis and Cell Research, V10, P35; Imase M, 2008, FEMS MICROBIOL ECOL, V63, P273, DOI 10.1111/j.1574-6941.2007.00434.x; Itino T, 2001, ECOL RES, V16, P787, DOI 10.1046/j.1440-1703.2001.00442.x; KARAKASHIAN STEPHEN J., 1963, PHYSIOL ZOOL, V36, P52; Kovacevic G., 2010, J ENDOCYT CELL RES, V20, P13; Maruyama S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-105; Nakajima T, 2013, BIOSYSTEMS, V113, P127, DOI 10.1016/j.biosystems.2013.05.012; Nakajima T, 2009, BIOSYSTEMS, V96, P127, DOI 10.1016/j.biosystems.2008.12.006; NAKAJIMA T, 1994, OIKOS, V71, P24, DOI 10.2307/3546168; NAKAJIMA T, 1994, OIKOS, V71, P35, DOI 10.2307/3546169; NAKAJIMA T, 1994, OIKOS, V69, P217, DOI 10.2307/3546141; Porto I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002160; Reisser W., 1986, Progress in Protistology, V1, P195; Saldarriaga JF, 2001, J MOL EVOL, V53, P204, DOI 10.1007/s002390010210; Santos SR, 2004, J PHYCOL, V40, P395, DOI 10.1111/j.1529-8817.2004.03186.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Summerer M, 2008, J PHYCOL, V44, P77, DOI 10.1111/j.1529-8817.2007.00455.x; Turner PE, 1996, ECOLOGY, V77, P2119, DOI 10.2307/2265706; Vieira A.A.H., 2006, ACTA LIMNOL BRAS, V18, P1; Wallin IE, 1927, SYMBIONTICISM ORIGIN; Yamashita H, 2013, PHYCOL RES, V61, P68, DOI 10.1111/pre.12004	57	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0303-2647	1872-8324		BIOSYSTEMS	Biosystems	MAY	2015	131						9	21		10.1016/j.biosystems.2015.03.005		13	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	CJ3CQ	WOS:000355361400002		
J	Sasaki, T; Okada, I				Sasaki, Tatsuya; Okada, Isamu			Cheating is evolutionarily assimilated with cooperation in the continuous snowdrift game	BIOSYSTEMS			English	Article						Evolution of cooperation; Snowdrift game; Replicator dynamics; Adaptive dynamics; Evolutionary branching; Speciation in reverse	CONTINUOUS PRISONERS-DILEMMA; LINEAR REACTIVE STRATEGIES; 2-PLAYER CONTINUOUS GAMES; VARIABLE INVESTMENT; RIGOROUS FRAMEWORK; ADAPTIVE DYNAMICS; DIVERSITY; ALTRUISM; ORIGIN; POPULATIONS	It is well known that in contrast to the Prisoner's Dilemma, the snowdrift game can lead to a stable coexistence of cooperators and cheaters. Recent theoretical evidence on the snowdrift game suggests that gradual evolution for individuals choosing to contribute in continuous degrees can result in the social diversification to a 100% contribution and 0% contribution through so-called evolutionary branching. Until now, however, game-theoretical studies have shed little light on the evolutionary dynamics and consequences of the loss of diversity in strategy. Here, we analyze continuous snowdrift games with quadratic payoff functions in dimorphic populations. Subsequently, conditions are clarified under which gradual evolution can lead a population consisting of those with 100% contribution and those with 0% contribution to merge into one species with an intermediate contribution level. The key finding is that the continuous snowdrift game is more likely to lead to assimilation of different cooperation levels rather than maintenance of diversity. Importantly, this implies that allowing the gradual evolution of cooperative behavior can facilitate social inequity aversion in joint ventures that otherwise could cause conflicts that are based on commonly accepted notions of fairness. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.	[Sasaki, Tatsuya] Univ Vienna, Fac Math, A-1090 Vienna, Austria; [Sasaki, Tatsuya] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria; [Okada, Isamu] Soka Univ, Dept Business Adm, Tokyo 1928577, Japan; [Okada, Isamu] Vienna Univ Econ & Business, Dept Informat Syst & Operat, A-1020 Vienna, Austria	Sasaki, T (reprint author), Univ Vienna, Fac Math, Oskar Morgenstern Pl 1, A-1090 Vienna, Austria.	tatsuya.sasaki@univie.ac.at	Sasaki, Tatsuya/A-9993-2012	Sasaki, Tatsuya/0000-0002-4635-1389	Austrian Science Fund (FWF) [P27018-G11, TECT I-106 G11]; Japan Society for the Promotion of Science [22520160, 26330387]	T.S. was supported by the Austrian Science Fund (FWF): P27018-G11. T.S. also thanks to former financial support by the Austrian Science Fund (FWF): TECT I-106 G11 to Ulf Dieckmann at IIASA through a grant for the research project The Adaptive Evolution of Mutualistic Interactions as part of the multinational collaborative research project Mutualisms, Contracts, Space, and Dispersal (BIOCONTRACT) selected by the European Science Foundation as part of the European Collaborative Research (EUROCORES) Programme The Evolution of Cooperation and Trading (TECT). I.O. acknowledges support by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science 22520160 and 26330387.	Roberts G, 1998, NATURE, V394, P175, DOI 10.1038/28160; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Kun A, 2006, BEHAV ECOL, V17, P633, DOI 10.1093/beheco/ark009; Chen XJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066133; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Shutters ST, 2013, J THEOR BIOL, V321, P40, DOI 10.1016/j.jtbi.2012.12.026; Santos FC, 2012, J THEOR BIOL, V299, P88, DOI 10.1016/j.jtbi.2011.09.003; Brannstrom A, 2011, J MATH BIOL, V63, P263, DOI 10.1007/s00285-010-0367-3; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Tanimoto J, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022105; Geritz SAH, 1998, EVOL ECOL, V12, P35; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Le Galliard JF, 2005, AM NAT, V165, P206, DOI 10.1086/427090; Dieckmann U, 2006, THEOR POPUL BIOL, V69, P263, DOI 10.1016/j.tpb.2005.12.001; Geritz SAH, 1997, PHYS REV LETT, V78, P2024, DOI 10.1103/PhysRevLett.78.2024; Cressman R, 2012, J THEOR BIOL, V299, P144, DOI 10.1016/j.jtbi.2011.07.030; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; BISHOP DT, 1978, J THEOR BIOL, V70, P85, DOI 10.1016/0022-5193(78)90304-1; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Zhang YL, 2013, J THEOR BIOL, V334, P52, DOI 10.1016/j.jtbi.2013.05.011; Tanimoto J, 2007, BIOSYSTEMS, V90, P105, DOI 10.1016/j.biosystems.2006.07.005; McNamara JM, 2008, NATURE, V451, P189, DOI 10.1038/nature06455; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Boza G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-336; Brannstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P1609, DOI 10.1098/rspb.2005.3116; Brown JS, 2008, P ROY SOC B-BIOL SCI, V275, P1985, DOI 10.1098/rspb.2007.1685; Chan NWH, 2013, PHYSICA A, V392, P168, DOI 10.1016/j.physa.2012.07.078; Chen XJ, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/38003; Cressman R, 2014, P NATL ACAD SCI USA, V111, P10810, DOI 10.1073/pnas.1400823111; Deng K., 2011, PLOS ONE, V6, P25496; Doebeli M, 2013, J THEOR BIOL, V336, P240, DOI 10.1016/j.jtbi.2013.05.035; Fujita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093670; Doebeli M, 2004, SCIENCE, V306, P859, DOI 10.1126/science.1101456; Hilbe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077886; Jiang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064677; Killingback T, 1999, P ROY SOC B-BIOL SCI, V266, P1723; Killingback T, 2002, AM NAT, V160, P421, DOI 10.1086/342070; Lambert G, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0029; Maynard Smith J., 1982, EVOLUTION THEORY GAM; McGill BJ, 2007, ANNU REV ECOL EVOL S, V38, P403, DOI 10.1146/annurev.ecolsys.36.091704.175517; McKinnon JS, 2012, NATURE, V482, P313, DOI 10.1038/482313a; Meszena G, 2001, SELECTION, V2, P193, DOI DOI 10.1556/SELECT.2.2001.1-2.14; Nakamaru M, 2009, J THEOR BIOL, V257, P1, DOI 10.1016/j.jtbi.2008.09.004; Parvinen K, 2010, P ROY SOC B-BIOL SCI, V277, P2493, DOI 10.1098/rspb.2010.0191; Parvinen K, 2011, B MATH BIOL, V73, P2605, DOI 10.1007/s11538-011-9638-4; Sasaki T., 2015, ARXIV150203779; Sigmund K., 1998, EVOLUTIONARY GAMES P; Sugden R., 1986, EC RIGHTS COOPERATIO; Tanimoto J, 2007, BIOSYSTEMS, V90, P568, DOI 10.1016/j.biosystems.2006.12.008; Torney CJ, 2010, P NATL ACAD SCI USA, V107, P20394, DOI 10.1073/pnas.1014316107; Valori L, 2012, P NATL ACAD SCI USA, V109, P1068, DOI 10.1073/pnas.1109514109; Wahl LM, 1999, J THEOR BIOL, V200, P323, DOI 10.1006/jtbi.1999.0997; Wahl LM, 1999, J THEOR BIOL, V200, P307, DOI 10.1006/jtbi.1999.0996; Xu C, 2011, PHYSICA A, V390, P1607, DOI 10.1016/j.physa.2010.12.044; Xu M, 2015, PHYSICA A, V424, P322, DOI 10.1016/j.physa.2015.01.029; Zhong LX, 2012, PHYSICA A, V391, P2322, DOI 10.1016/j.physa.2011.10.013; Zhong LX, 2008, CHINESE PHYS LETT, V25, P2315, DOI 10.1088/0256-307X/25/6/107; Zhong W, 2012, BIOSYSTEMS, V107, P89, DOI DOI 10.1016/J.BI0SYSTEMS.2011.10.001	61	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0303-2647	1872-8324		BIOSYSTEMS	Biosystems	MAY	2015	131						51	59		10.1016/j.biosystems.2015.04.002		9	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	CJ3CQ	WOS:000355361400006		
J	Nagao, T; Oshikawa, G; Ishida, S; Akiyama, H; Umezawa, Y; Nogami, A; Kurosu, T; Miura, O				Nagao, T.; Oshikawa, G.; Ishida, S.; Akiyama, H.; Umezawa, Y.; Nogami, A.; Kurosu, T.; Miura, O.			A novel MYD88 mutation, L265RPP, in Waldenstrom macroglobulinemia activates the NF-kappa B pathway to upregulate Bcl-xL expression and enhances cell survival	BLOOD CANCER JOURNAL			English	Letter							MONOCLONAL GAMMOPATHY; SOMATIC MUTATION		[Nagao, T.; Oshikawa, G.; Ishida, S.; Akiyama, H.; Umezawa, Y.; Nogami, A.; Kurosu, T.; Miura, O.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan	Miura, O (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan.	miura.hema@tmd.ac.jp					Jimenez C, 2013, LEUKEMIA, V27, P1722, DOI 10.1038/leu.2013.62; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Yang G, 2013, BLOOD, V122, P1222, DOI 10.1182/blood-2012-12-475111; Xu L, 2013, BLOOD, V121, P2051, DOI 10.1182/blood-2012-09-454355; Gelman AE, 2004, J IMMUNOL, V172, P6065; Varettoni M, 2013, BLOOD, V121, P2522, DOI 10.1182/blood-2012-09-457101; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Dimopoulos MA, 2014, BLOOD, V124, P1404, DOI 10.1182/blood-2014-03-565135; Hunter ZR, 2013, BLOOD, V123, P1637; Lu X, 2014, CYTOKINE GROWTH F R, V26, P7; Narayanan KB, 2015, APOPTOSIS, V20, P196, DOI 10.1007/s10495-014-1073-1; Rossi Davide, 2014, Hematology Am Soc Hematol Educ Program, V2014, P113, DOI 10.1182/asheducation-2014.1.113; Wang JQ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00367; Xu L, 2014, LEUKEMIA, V28, P1698, DOI 10.1038/leu.2014.65	14	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2044-5385			BLOOD CANCER J	Blood Cancer J.	MAY	2015	5								e314	10.1038/bcj.2015.36		4	Oncology	Oncology	CJ2AG	WOS:000355285800006		
J	Shimizu, S; Tanaka, T; Tohyama, M; Miyata, S				Shimizu, Shoko; Tanaka, Takashi; Tohyama, Masaya; Miyata, Shingo			Yokukansan normalizes glucocorticoid receptor protein expression in oligodendrocytes of the corpus callosum by regulating microRNA-124a expression after stress exposure	BRAIN RESEARCH BULLETIN			English	Article						HPA axis; Glucocorticoid receptor; microRNA; Corpus callosum; Yokukansan; Stress responses	YI-GAN-SAN; PSYCHOLOGICAL SYMPTOMS; HERBAL MEDICINE; NONCODING RNAS; ADRENAL AXIS; DEMENTIA; BRAIN; BEHAVIOR; MOUSE; NEUROGENESIS	Stressful events are known to down-regulate expression levels of glucocorticoid receptors (GRs) in the brain. Recently, we reported that stressed mice with elevated plasma levels of corticosterone exhibit morphological changes in the oligodendrocytes of nerve fiber bundles, such as those in the corpus callosum. However, little is known about the molecular mechanism of GR expression regulation in oligodendrocytes after stress exposure. A previous report has suggested that GR protein levels might be regulated by microRNA (miR)-18 and/or -124a in the brain. In this study, we aimed to elucidate the GR regulation mechanism in oligodendrocytes and evaluate the effects of yokukansan (YKS), a Kampo medicine, on GR protein regulation. Acute exposure to stress increased plasma corticosterone levels, decreased GR protein expression, and increased miR-124a expression in the corpus callosum of adult male mice, though the GR mRNA and miR-18 expression levels were not significant changes. YKS normalized the stress-induced changes in the plasma corticosterone, GR protein, and miR124a expression levels. An oligodendrocyte primary culture study also showed that YKS down-regulated miR-124a, but not miR-18, expression levels in dexamethasone-treated cells. These results suggest that the down-regulation of miR124a expression might be involved in the normalization of stress-induced decreases in GR protein in oligodendrocytes by YKS. This effect may imply the molecular mechanisms underlying the ameliorative effects of YKS on psychological symptoms and stress-related behaviors. (C) 2015 Elsevier Inc. All rights reserved.	[Shimizu, Shoko; Tanaka, Takashi; Tohyama, Masaya; Miyata, Shingo] Kinki Univ, Res Inst Tradit Asian Med, Div Mol Brain Sci, Osakasayama, Osaka 5898511, Japan; [Tohyama, Masaya] Osaka Prefectural Hosp Org, Osaka 5588558, Japan	Miyata, S (reprint author), Kinki Univ, Res Inst Tradit Asian Med, Div Mol Brain Sci, 337-2 Ohno Higashi, Osakasayama, Osaka 5898511, Japan.	smiyata@med.kindai.ac.jp			Japan Society for the Promotion of Science; Sakamoto Research Foundation of Psychiatric Diseases;  [26117519];  [25430079]	We thank Drs. T. Takeda, J. Horiguchi, T. Miyaoka, M. Tabuchi, K. Sekiguchi, T. Katayama, S. Matsuzaki, S. Shimada, and Y. Shigeyoshi for their valuable comments. We thank A. Matsumura, A Kawakami, E. Hisamatsu, and the members of the Central Research Facilities of Faculty of Medicine, Kinki University and Center for Medical Research and Education of Graduate School of Medicine for their technical assistance. This work was supported in part by the Japan Society for the Promotion of Science, a Grant-in-Aid for Scientific Research on Innovative Areas (grant 26117519), a Grant-in-Aid for Scientific Research (C) (grant 25430079), and the Sakamoto Research Foundation of Psychiatric Diseases. We are grateful to Tsumura & Co. (Tokyo, Japan) for generously providing the Yokukansan (TJ-54).	Dalmay T, 2008, J INTERN MED, V263, P366, DOI 10.1111/j.1365-2796.2008.01926.x; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1193/annals.1314.001; Wang Y, 2007, FRONT BIOSCI, V12, P2316, DOI 10.2741/2234; Matsumoto K, 2013, J PHARMACOL SCI, V122, P257, DOI 10.1254/jphs.13R03CR; Kuang X, 2014, FREE RADICAL BIO MED, V71, P165, DOI 10.1016/j.freeradbiomed.2014.03.028; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P1612; Uchida S, 2008, EUR J NEUROSCI, V27, P2250, DOI 10.1111/j.1460-9568.2008.06218.x; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Schaaf MJM, 2002, J STEROID BIOCHEM, V83, P37, DOI 10.1016/S0960-0760(02)00263-7; VIELKIND U, 1990, J NEUROSCI RES, V27, P360, DOI 10.1002/jnr.490270315; Ji F, 2013, J GENET GENOMICS, V40, P61, DOI 10.1016/j.jgg.2012.12.008; Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Xin JW, 2013, CURR NEUROVASC RES, V10, P304; Aguilera G, 2000, REGUL PEPTIDES, V96, P23, DOI 10.1016/S0167-0115(00)00196-8; Mizukami K, 2009, INT J NEUROPSYCHOPH, V12, P191, DOI 10.1017/S146114570800970X; Hayashi Y, 2010, PROG NEURO-PSYCHOPH, V34, P541, DOI 10.1016/j.pnpbp.2010.02.016; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Matsuda Y, 2013, HUM PSYCHOPHARM CLIN, V28, P80, DOI 10.1002/hup.2286; Vreugdenhil E, 2009, ENDOCRINOLOGY, V150, P2220, DOI 10.1210/en.2008-1335; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Matsusue Y, 2014, J HISTOCHEM CYTOCHEM, V62, P211, DOI 10.1369/0022155413517700; Myers B, 2014, FRONT NEUROENDOCRIN, V35, P180, DOI 10.1016/j.yfrne.2013.12.003; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Imamura S, 2011, CELL MOL NEUROBIOL, V31, P787, DOI 10.1007/s10571-011-9676-3; Kawanabe T, 2010, PROG NEURO-PSYCHOPH, V34, P284, DOI 10.1016/j.pnpbp.2009.11.019; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kushida H, 2013, BIOMED CHROMATOGR, V27, P1647, DOI 10.1002/bmc.2974; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P248; BARTANUSZ V, 1993, ENDOCRINOLOGY, V132, P895, DOI 10.1210/en.132.2.895; Bian S, 2013, CURR OPIN NEUROBIOL, V23, P928, DOI 10.1016/j.conb.2013.08.002; Chiu H, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00283; DEKLOET ER, 1987, PSYCHONEUROENDOCRINO, V12, P83, DOI 10.1016/0306-4530(87)90040-0; DeRijk RH, 2003, MOL BRAIN RES, V116, P17, DOI 10.1016/S0169-328X(03)00209-2; Durairaj RV, 2014, GEN COMP ENDOCR, V199, P26, DOI 10.1016/j.ygcen.2014.01.005; Gold PW, 2002, AM J PSYCHIAT, V159, P1826, DOI 10.1176/appi.ajp.159.11.1826; Gräff Johannes, 2011, Physiol Rev, V91, P603, DOI 10.1152/physrev.00012.2010; Hiratsuka T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013280; Iwasaki Katsunori, 2012, Folia Pharmacologica Japonica, V140, P66; Kanno H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116275; Kendler X. S., 1999, AM J PSYCHIAT, V156, P837; Liu Y, 2014, BRAIN RES, V1543, P300, DOI 10.1016/j.brainres.2013.11.015; Miyata S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019859; Miyata S., 2015, BIOMED RES INT, V2015, DOI [10.1155/2015/492367, DOI 10.1155/2015/492367]; Nagata K, 2012, PHYTOMEDICINE, V19, P524, DOI 10.1016/j.phymed.2012.02.008; Nishi A, 2012, NEUROSCIENCE, V207, P124, DOI 10.1016/j.neuroscience.2012.01.037; Okahara K, 2010, PROG NEURO-PSYCHOPH, V34, P532, DOI 10.1016/j.pnpbp.2010.02.013; Shimizu S, 2014, GLIA, V62, P709, DOI 10.1002/glia.22636; Shinno H, 2008, PROG NEURO-PSYCHOPH, V32, P1749, DOI 10.1016/j.pnpbp.2008.06.015; Tabuchi M, 2012, CELL MOL NEUROBIOL, V32, P1139, DOI 10.1007/s10571-012-9839-x; Tohyama M., ANAT SCI IN IN PRESS; Tsuji M, 2014, PHYTOMEDICINE, V21, P363, DOI 10.1016/j.phymed.2013.08.025; Zhu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035823	59	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	MAY	2015	114						49	55		10.1016/j.brainresbull.2015.03.007		7	Neurosciences	Neurosciences & Neurology	CJ3EG	WOS:000355365600006		
J	Castro-Dominguez, B; Leelachaikul, P; Messaoud, SB; Takagaki, A; Sugawara, T; Kikuchi, R; Oyama, ST				Castro-Dominguez, Bernardo; Leelachaikul, Pornravee; Messaoud, Souha Belhaj; Takagaki, Atsushi; Sugawara, Takashi; Kikuchi, Ryuji; Oyama, S. Ted			The optimal point within the Robeson upper boundary	CHEMICAL ENGINEERING RESEARCH & DESIGN			English	Article						Membrane process; Techno-economical optimization; Robeson's correlation; Optimal permeability; Optimal selectivity	GAS SEPARATION PROCESSES; CARBON-DIOXIDE CAPTURE; OPERATING-CONDITIONS; MEMBRANE PROCESSES; NATURAL-GAS; ACID GASES; OPTIMIZATION; PARAMETERS; PRESSURE; REMOVAL	The Robeson correlation is an empirical plot that shows a tradeoff between selectivity and permeability of gases whose upper boundary is often used to evaluate the performance of a membrane system. This work shows that it is possible to define an optimum permeability/selectivity point on this boundary based on economic optimization. Examples are presented for the separation of four gas pairs: CO2/N-2, O-2/N-2, CO2/CH4, and N-2/CH4. The constraints used to limit the optimal point are based on the cost of the membrane, the number of units required to achieve a specific separation, and the compression requirements. The total costs include the fees for utilities and capital costs, and interest payments. The model results are verified against other studies, while initial and targeted parameters are subject to a sensitivity analysis. The optimum points obtained at an operating pressure of 1 MPa were for CO2/N-2 a permeability of 3200 barrers and a selectivity of 24, for O-2/N-2 a permeability of 550 barrers and a selectivity of 4, for CO2/CH4 a permeability of 2000 barrers and a selectivity of 20, and for N-2/CH4 a permeability of 110 barrers and a selectivity of 2. A wide range of permeability and selectivity requirements exist for a separation, which depend on a particular gas pair. (C) 2015 The Institution of Chemical Engineers. Published by Elsevier B.V. All rights reserved.	[Castro-Dominguez, Bernardo; Leelachaikul, Pornravee; Messaoud, Souha Belhaj; Takagaki, Atsushi; Sugawara, Takashi; Kikuchi, Ryuji; Oyama, S. Ted] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Oyama, S. Ted] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA	Oyama, ST (reprint author), Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	oyama@vt.edu	Kikuchi, Ryuji/H-4255-2015; Takagaki, Atsushi/E-6788-2010	Takagaki, Atsushi/0000-0002-7829-3451	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [22360335]; Japanese Government (MEXT)	This work was supported by a Grant-in-Aid Scientific Research (B) (No. 22360335) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. B.C.D., S.B.M. and P.L. are grateful for scholarships from the Japanese Government (MEXT).	Yong WF, 2012, J MEMBRANE SCI, V407, P47, DOI 10.1016/j.memsci.2012.03.038; Lin HQ, 2013, IND ENG CHEM RES, V52, P10820, DOI 10.1021/ie401464z; Huang Y, 2014, J MEMBRANE SCI, V463, P33, DOI 10.1016/j.memsci.2014.03.016; Low BT, 2013, J MEMBRANE SCI, V431, P139, DOI 10.1016/j.memsci.2012.12.014; BHIDE BD, 1993, J MEMBRANE SCI, V81, P209, DOI 10.1016/0376-7388(93)85175-V; BHIDE BD, 1993, J MEMBRANE SCI, V81, P239, DOI 10.1016/0376-7388(93)85176-W; Japip S, 2014, J MEMBRANE SCI, V467, P162, DOI 10.1016/j.memsci.2014.05.025; Khatib SJ, 2013, SEP PURIF TECHNOL, V111, P20, DOI 10.1016/j.seppur.2013.03.032; VANDERSLUIJS JP, 1992, ENERG CONVERS MANAGE, V33, P429, DOI 10.1016/0196-8904(92)90040-4; Lua AC, 2013, CHEM ENG J, V220, P441, DOI 10.1016/j.cej.2012.11.140; Koros WJ, 2000, J MEMBRANE SCI, V175, P181, DOI 10.1016/S0376-7388(00)00418-X; Iarikov DD, 2011, CHEM ENG J, V166, P401, DOI 10.1016/j.cej.2010.10.060; Merkel TC, 2010, J MEMBRANE SCI, V359, P126, DOI 10.1016/j.memsci.2009.10.041; Ramasubramanian K, 2012, J MEMBRANE SCI, V421, P299, DOI 10.1016/j.memsci.2012.07.029; Qi R, 1998, SEP PURIF TECHNOL, V13, P209, DOI 10.1016/S1383-5866(98)00044-6; Khalilpour R, 2013, CHEM ENG RES DES, V91, P332, DOI 10.1016/j.cherd.2012.07.009; Ku AY, 2011, J MEMBRANE SCI, V367, P233, DOI 10.1016/j.memsci.2010.10.066; Pires JCM, 2011, CHEM ENG RES DES, V89, P1446, DOI 10.1016/j.cherd.2011.01.028; Baker RW, 2002, IND ENG CHEM RES, V41, P1393, DOI 10.1021/ie0108088; Cabasso I., 1986, U.S. Patent, Patent No. [4,602,922, 4602922]; Carreon MA, 2008, ADV MATER, V20, P729, DOI 10.1002/adma.200701280; Gollan A., 1984, P 6 ANN IND EN TECHN, V1, P298; Hinchliffe AB, 1997, IND ENG CHEM RES, V36, P821, DOI 10.1021/ie9603272; Hosseini SS, 2009, J MEMBRANE SCI, V328, P174, DOI 10.1016/j.memsci.2008.12.005; Lim H, 2012, J MEMBRANE SCI, V396, P119, DOI 10.1016/j.memsci.2012.01.004; Mansourizadeh A, 2014, CHEM ENG RES DES, V92, P181, DOI 10.1016/j.cherd.2013.06.028; Moparthi A, 2010, CHEM ENG RES DES, V88, P1088, DOI 10.1016/j.cherd.2010.01.013; Prasad R., 1994, POLYM GAS SEPARATION, P514; ROBESON LM, 1991, J MEMBRANE SCI, V62, P165, DOI 10.1016/0376-7388(91)80060-J; Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030; Seider W. D., 2003, PRODUCT PROCESS DESI; Singh B., 2011, 2 INT C ENV SCI TECH, V6; Vareltzis P, 2003, CHEM ENG RES DES, V81, P525, DOI 10.1205/026387603765444483	33	0	0	INST CHEMICAL ENGINEERS	RUGBY	165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND	0263-8762	1744-3563		CHEM ENG RES DES	Chem. Eng. Res. Des.	MAY	2015	97						109	119		10.1016/j.cherd.2015.03.002		11	Engineering, Chemical	Engineering	CI8PM	WOS:000355034200012		
J	Rousselle, SD; Brants, IK; Sakaoka, A; Hubbard, B; Jackson, ND; Wicks, JR; Dillon, KN; Naiche, LA; Hart, R; Garza, JA; Tellez, A				Rousselle, Serge D.; Brants, Irena K.; Sakaoka, Atsushi; Hubbard, Brad; Jackson, Nicolette D.; Wicks, Joan R.; Dillon, Krista N.; Naiche, L. A.; Hart, Randy; Garza, Javier A.; Tellez, Armando			Neuromatous Regeneration as a Nerve Response After Catheter-Based Renal Denervation Therapy in a Large Animal Model Immunohistochemical Study	CIRCULATION-CARDIOVASCULAR INTERVENTIONS			English	Article						models, animal; nerve regeneration; renal denervation	TREATMENT-RESISTANT HYPERTENSION; RAT SCIATIC-NERVE; WALLERIAN DEGENERATION; SYMPATHETIC DENERVATION; CONTROLLED-TRIAL; PORCINE MODEL; RADIOFREQUENCY CATHETER; NONNEURONAL CELLS; GROWTH-FACTOR; SPINAL-CORD	Background-Renal denervation (RDN) emerged as a therapeutic option for resistant hypertension. Nerve regrowth after RDN has been questioned. We aimed to characterize the nerve response after RDN. Methods and Results-Swine underwent bilateral RDN and were followed up for 7, 30, and 90 days and evaluated with S100 (Schwann cell), tyrosine hydroxylase (TH; efferent nerves), and growth-associated protein 43 (neurite regeneration) markers. At 7 days, nerve changes consisted of necrosis associated with perineurial fibrosis and distal atrophy with inflammation. At 30 days changes were substituted by healing changes (ie, fibrosis). This response progressed through 90 days resulting in prominent neuroma formation. Immunohistochemistry at 7 days: TH staining was strongly decreased in treated nerves. Early regenerative attempts were observed with strongly TH and growth-associated protein 43 positive and weak S100 disorganized nerve sprouts within the thickened perineurium. Distal atrophic nerves show weak staining for all 3 markers. At 30 days, affected nerves show a weak TH and S100 staining. Evident growth-associated protein 43+ disorganized neuromatous tangles in the thickened perineurium of severed nerves were observed. At 90 days, some TH expression was observed together with prominent S100+ and growth-associated protein 43+ neuromatous tangles with disorganized architecture. The potential for regenerative activity is unlikely based on the disrupted architecture of these neuromatous tangles at the radiofrequency lesion sites. Conclusions-This study is the first documentation that a progressive regenerative response occurs as early as 7 days after RDN, resulting in a poorly organized neuromatous regeneration. This finding is of paramount importance to further establish the potential functional significance of a regeneration after RDN.	[Rousselle, Serge D.; Jackson, Nicolette D.; Wicks, Joan R.; Dillon, Krista N.; Naiche, L. A.; Hart, Randy; Garza, Javier A.; Tellez, Armando] Alizee Pathol LLC, Thurmont, MD USA; [Brants, Irena K.; Hubbard, Brad] Translat Testing & Training T3 Labs, Atlanta, GA USA; [Sakaoka, Atsushi] Terumo Co Ltd, Shibuya, Kanagawa, Japan	Tellez, A (reprint author), Alizee Pathol, 20 Frederick Rd, Thurmont, MD 21788 USA.	atellez@alizeepathology.com					Persell SD, 2011, HYPERTENSION, V57, P1076, DOI 10.1161/HYPERTENSIONAHA.111.170308; Atherton DS, 2012, CLIN ANAT, V25, P628, DOI 10.1002/ca.21280; Schlaich MP, 2013, J AM COLL CARDIOL, V62, P2031, DOI 10.1016/j.jacc.2013.08.1616; Rippy MK, 2011, CLIN RES CARDIOL, V100, P1095, DOI 10.1007/s00392-011-0346-8; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Esler MD, 2014, EUR HEART J, V35, P1752, DOI 10.1093/eurheartj/ehu209; Esler MD, 2012, CIRCULATION, V126, P2976, DOI 10.1161/CIRCULATIONAHA.112.130880; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Steigerwald K, 2012, J HYPERTENS, V30, P2230, DOI 10.1097/HJH.0b013e32835821e5; Mahfoud F, 2013, CIRCULATION, V128, P132, DOI 10.1161/CIRCULATIONAHA.112.000949; Tellez A, 2013, TRANSL RES, V162, P381, DOI 10.1016/j.trsl.2013.07.002; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Sakakura K, 2014, J AM COLL CARDIOL, V64, P635, DOI 10.1016/j.jacc.2014.03.059; Schwab ME, 1996, PHYSIOL REV, V76, P319; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Faroni A, 2015, ADV DRUG DELIVER REV, V82-83, P160, DOI 10.1016/j.addr.2014.11.010; KRAUSE TL, 1994, J NEUROSCI, V14, P6638; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Hirata K, 1999, J NEUROCYTOL, V28, P685, DOI 10.1023/A:1007012916530; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; GRIFFIN JW, 1992, J NEUROIMMUNOL, V40, P153, DOI 10.1016/0165-5728(92)90129-9; BARAJAS L, 1990, AM J PHYSIOL, V259, pF503; Batsakis JG, 1974, TUMORS HEAD NECK, P231; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Bhatt DL, 2014, SYMPLICITY HTN 3 PRO; CHAUDHRY V, 1992, NEUROL CLIN, V10, P613; FERGUSON M, 1985, NEUROSCI LETT, V60, P183, DOI 10.1016/0304-3940(85)90241-1; GAZDAR AF, 1970, NEW ENGL J MED, V283, P222, DOI 10.1056/NEJM197007302830502; HAN MH, 1989, ACTA HISTOCHEM CYTOC, V22, P161; HANSEN JM, 1994, CLIN SCI, V87, P13; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; Honton B, 2014, EUROINTERVENTION, V9, P1385, DOI 10.4244/EIJV9I12A235; JACOBSON RD, 1986, J NEUROSCI, V6, P1843; Jiang XJ, 2013, EUROINTERVENTION, V9, P684, DOI [10.4244/EIJV9I6A111, 10.4244/EIJV916A111]; Kopp UC, 2011, AM J PHYSIOL-REG I, V300, pR298, DOI 10.1152/ajpregu.00469.2010; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; LIU HM, 1995, J NEUROPATH EXP NEUR, V54, P487, DOI 10.1097/00005072-199507000-00002; Mazor M, 2013, J AM COLL CARDIOL, V62, pB150; NOMURA G, 1972, J APPL PHYSIOL, V33, P649; NORVELL JE, 1979, TRANSPLANTATION, V27, P69; NORVELL JE, 1970, TRANSPLANTATION, V9, P168; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014; THOMAS PK, 1974, J NEUROCYTOL, V3, P497, DOI 10.1007/BF01098736; Thorp AA, 2013, CURR OPIN NEPHROL HY, V22, P607, DOI 10.1097/MNH.0b013e328365adb1; Vink EE, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00029; Waller A., 1850, PHILOS T R SOC LOND, V140, P423, DOI 10.1098/rstl.1850.0021; Whitbourn R, 2013, TCT 58 TRANSC CARD T	50	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-7640	1941-7632		CIRC-CARDIOVASC INTE	Circ.-Cardiovasc. Interv.	MAY	2015	8	5							e002293	10.1161/CIRCINTERVENTIONS.114.002293		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI4TT	WOS:000354747400013		
J	Szekvolgyi, L; Ohta, K; Nicolas, A				Szekvoelgyi, Lorant; Ohta, Kunihiro; Nicolas, Alain			Initiation of Meiotic Homologous Recombination: Flexibility, Impact of Histone Modifications, and Chromatin Remodeling	COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; YEAST SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; GENETIC-RECOMBINATION; FISSION YEAST; DNA BREAKS; HOT-SPOT; SWR-C; MEIOSIS; SITES	Meiotic recombination is initiated by the formation of DNA double-strand breaks (DSBs) catalyzed by the evolutionary conserved Spo11 protein and accessory factors. DSBs are nonrandomly distributed along the chromosomes displaying a significant (similar to 400-fold) variation of frequencies, which ultimately establishes local and long-range "hot" and "cold" domains for recombination initiation. This remarkable patterning is set up within the chromatin context, involving multiple layers of biochemical activity. Predisposed chromatin accessibility, but also a range of transcription factors, chromatin remodelers, and histone modifiers likely promote local recruitment of DSB proteins, as well as mobilization, sliding, and eviction of nucleosomes before and after the occurrence of meiotic DSBs. Here, we assess our understanding of meiotic DSB formation and methods to change its patterning. We also synthesize current heterogeneous knowledge on how histone modifications and chromatin remodeling may impact this decisive step in meiotic recombination.	[Szekvoelgyi, Lorant] Univ Debrecen, Fac Med, Dept Biophys & Cell Biol, H-4032 Debrecen, Hungary; [Ohta, Kunihiro] Univ Tokyo, Dept Life Sci, Tokyo 1138654, Japan; [Nicolas, Alain] Univ Paris 06, CNRS, Inst Curie Ctr Rech, UMR3244, F-75248 Paris 05, France	Szekvolgyi, L (reprint author), Univ Debrecen, Fac Med, Dept Biophys & Cell Biol, H-4032 Debrecen, Hungary.	lorantsz@med.unideb.hu; alain.nicolas@curie.fr			Meiogenix SA; European Union (FP7/MCA-CIG); CRP-ICGEB (Trieste, Italy); Hungarian Scientific Research Fund (OTKA-PD); European Social Fund [TAMOP-4.2.4.A/2-11/1-2012-0001]; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS)	Work in the A. Nicolas laboratory was supported by a grant from Meiogenix SA. L.S. was supported by the European Union (FP7/MCA-CIG), CRP-ICGEB (Trieste, Italy), and the Hungarian Scientific Research Fund (OTKA-PD), cofinanced by the European Social Fund in the framework of TAMOP-4.2.4.A/2-11/1-2012-0001 National Excellence Program. K.O. was supported by a Grant-in-Aid for Scientific Research on Innovative Areas and Platform for Dynamic Approaches to Living System from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS).	Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; de Castro E, 2012, EMBO J, V31, P124, DOI 10.1038/emboj.2011.350; Watanabe Y, 2012, NAT REV MOL CELL BIO, V13, P370, DOI 10.1038/nrm3349; Zhang LR, 2011, P NATL ACAD SCI USA, V108, P20036, DOI 10.1073/pnas.1117937108; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Yamada S, 2013, NUCLEIC ACIDS RES, V41, P3504, DOI 10.1093/nar/gkt049; Ito M, 2014, GENES CELLS, V19, P359, DOI 10.1111/gtc.12138; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Vader G, 2011, NATURE, V477, P115, DOI 10.1038/nature10331; Sommermeyer V, 2013, MOL CELL, V49, P43, DOI 10.1016/j.molcel.2012.11.008; Borde V, 2004, MOL CELL, V13, P389, DOI 10.1016/S1097-2765(04)00034-6; XU LH, 1995, EMBO J, V14, P5115; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110; Yen KY, 2013, CELL, V154, P1246, DOI 10.1016/j.cell.2013.08.043; Qiao H, 2014, NAT GENET, V46, P194, DOI 10.1038/ng.2858; Yamashita K, 2004, P NATL ACAD SCI USA, V101, P11380, DOI 10.1073/pnas.0400078101; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Chen XF, 2012, NATURE, V489, P576, DOI 10.1038/nature11355; OHTA K, 1994, EMBO J, V13, P5754; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Watanabe S, 2013, SCIENCE, V340, P195, DOI 10.1126/science.1229758; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mellor J, 2004, BBA-GENE STRUCT EXPR, V1677, P100, DOI 10.1016/j.bbaexp.2003.10.014; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Choi KH, 2013, NAT GENET, V45, P1327, DOI 10.1038/ng.2766; Wagner CR, 2010, NATURE, V467, P839, DOI 10.1038/nature09429; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Baker CL, 2014, GENOME RES, V24, P724, DOI 10.1101/gr.170167.113; Kong A, 2014, NAT GENET, V46, P11, DOI 10.1038/ng.2833; Fan QQ, 1997, GENETICS, V145, P661; Reynolds A, 2013, NAT GENET, V45, P269, DOI 10.1038/ng.2541; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Campbell CD, 2013, TRENDS GENET, V29, P575, DOI 10.1016/j.tig.2013.04.005; Acquaviva L, 2013, SCIENCE, V339, P215, DOI 10.1126/science.1225739; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Robine N, 2007, MOL CELL BIOL, V27, P1868, DOI 10.1128/MCB.02063-06; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Neumann FR, 2012, GENE DEV, V26, P369, DOI 10.1101/gad.176156.111; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Bai L, 2011, MOL CELL, V42, P465, DOI 10.1016/j.molcel.2011.03.028; Blitzblau HG, 2013, ELIFE, V2, DOI 10.7554/eLife.00844; Bowring FJ, 2006, CURR GENET, V50, P115, DOI 10.1007/s00294-006-0066-1; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Cole F, 2010, MOL CELL, V39, P700, DOI 10.1016/j.molcel.2010.08.017; Cromie GA, 2007, PLOS GENET, V3, P1496, DOI 10.1371/journal.pgen.0030141; Drouaud J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003922; Farah JA, 2009, P NATL ACAD SCI USA, V106, P9356, DOI 10.1073/pnas.0902793106; Fowler KR, 2014, GENOME RES, V24, P1650, DOI 10.1101/gr.172122.114; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gray S, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130019; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Hodgson A, 2011, DNA REPAIR, V10, P138, DOI 10.1016/j.dnarep.2010.11.008; KOLODKIN AL, 1986, CELL, V46, P733, DOI 10.1016/0092-8674(86)90349-1; Lam I, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016634; Lao JP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003978; Malkova A, 2000, P NATL ACAD SCI USA, V97, P14500, DOI 10.1073/pnas.97.26.14500; Mieczkowski PA, 2007, P NATL ACAD SCI USA, V104, P3955, DOI 10.1073/pnas.0700412104; Miyoshi T, 2012, MOL CELL, V47, P722, DOI 10.1016/j.molcel.2012.06.023; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Nimonkar AV, 2012, J BIOL CHEM, V287, P28727, DOI 10.1074/jbc.M112.373290; Pecina A, 2002, CELL, V111, P173, DOI 10.1016/S0092-8674(02)01002-4; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; ROCCO V, 1992, P NATL ACAD SCI USA, V89, P12068, DOI 10.1073/pnas.89.24.12068; Schwartzentruber J, 2012, NATURE, V482, P226, DOI 10.1038/nature10833; Serrentino ME, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003416; Sleutels F, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-8; Szekvolgyi L, 2010, FEBS J, V277, P571, DOI 10.1111/j.1742-4658.2009.07502.x; Wippo CJ, 2011, EMBO J, V30, P1277, DOI 10.1038/emboj.2011.43; Yamada T, 2004, EMBO J, V23, P1792, DOI 10.1038/sj.emboj.7600138; Yodh J, 2013, ADV EXP MED BIOL, V973, P263, DOI 10.1007/978-1-4614-5037-5_13; Zickler D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016626	79	1	1	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1943-0264			CSH PERSPECT BIOL	Cold Spring Harbor Perspect. Biol.	MAY	2015	7	5							a016527	10.1101/cshperspect.a016527		16	Cell Biology	Cell Biology	CJ0VM	WOS:000355197000004		
J	Zhanikeev, M				Zhanikeev, Marat			A Cloud Visitation Platform to Facilitate Cloud Federation and Fog Computing	COMPUTER			English	Article								Evolving from hybrid clouds to true cloud federations and, ultimately, fog computing will require that cloud platforms allow for-and embrace-local hardware awareness.	Kyushu Inst Technol, Comp Sci & Engn, Fukuoka, Japan	Zhanikeev, M (reprint author), Kyushu Inst Technol, Comp Sci & Engn, Fukuoka, Japan.	maratishe@gmail.com					Cisco Research, RFP2013078 CISC RES; Keahay K., 2012, P 2012 WORKSH CLOUD, P33; Zhanikeev M., 2014, ADV CONTENT DELIVERY	3	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0018-9162	1558-0814		COMPUTER	Computer	MAY	2015	48	5					80	83				4	Computer Science, Hardware & Architecture; Computer Science, Software Engineering	Computer Science	CJ0WV	WOS:000355201000015		
J	Iwao, S; Yoshino, M; Edo, M; Kuroda, S				Iwao, Shohei; Yoshino, Michihide; Edo, Masakazu; Kuroda, Shu			Corrosion Behavior of Alloy A3003 After Brazing in HCl, CH3COOH, and Mixed Solutions	CORROSION			English	Article						acetic acids; aluminum alloy; corrosion potential; hydrochloric acid; pitting potential	ACETIC-ACID	Dip and dry corrosion tests were carried out on Alloy A3003 (UNS A93003) using hydrochloric acid (HCl), acetic acid (CH3COOH), and a mixed solution. After 50 corrosion test cycles with the HCl solution, pitting corrosion occurred in some parts at higher concentrations, but corrosion weight loss was very low. In the case of the CH3COOH solution, general corrosion occurred, thickness decreased, and weight loss significantly increased as the concentration grew. In the case of the mixed solution, both general corrosion and pitting corrosion occurred, and corrosion mass loss increased as the HCl concentration grew. Also, in concentrations of more than 50 ppm of HCl, the number of pits significantly increased. Electrochemical polarization measurements were done to understand the corrosion forms for each acid. In the electrochemical polarization, the pitting potential became less noble with increasing concentration of HCl. No distinct effect of CH3COOH on the pitting potential was confirmed, but corrosion current density increased with increasing concentration of CH3COOH. For the mixed solution, both of these effects were confirmed. These electrochemical polarization results correspond well with the dip and dry corrosion test results.	[Iwao, Shohei; Yoshino, Michihide; Edo, Masakazu; Kuroda, Shu] Mitsubishi Aluminum Co Ltd, Prod Res & Dev Dept, Susono City, Shizuoka, Japan	Iwao, S (reprint author), Mitsubishi Aluminum Co Ltd, Prod Res & Dev Dept, 85 Hiramatsu, Susono City, Shizuoka, Japan.	iwao@malco.co.jp					Adachi T., 2009, INT J AUTOMOTIVE ENG, V39, P1047; BOHNI H, 1969, J ELECTROCHEM SOC, V116, P906; Kim JK, 2009, CORROS SCI, V51, P2716, DOI 10.1016/j.corsci.2009.07.008; Mathis U, 2005, ENVIRON SCI TECHNOL, V39, P1887, DOI 10.1021/es049578p; Chang S, 1999, J MATER SCI LETT, V18, P419, DOI 10.1023/A:1006613624476; Cuevas C., 2001, APPL THERM ENG, V31, P2474; Fujii T., 1975, CORROSION ENG, V24, P185; Horst R. L., 1977, MATER PERFORMANCE, V16, P20; Iwao Shohei, 2009, Journal of Japan Institute of Light Metals, V59, DOI 10.2464/jilm.59.108; Jones D. A., PRINCIPLES PREVENTIO, V2nd; Kaesche H., 1963, WERKST KORROS, V14, P557; Kass M. D., 2005010657 SAE; Kreso AM, 981422 SAE; LUNARSKA E, 1987, CORROSION, V43, P219; Mellors G. W., 1958, J ELECTROCHEM SOC, V105, P333; Oya Y., 2013, FURUKAWA SKY REV, V9, P34; Seri R., 1985, J JPN I LIGHT METALS, V35, P98; Seri R., 1988, J JPN I LIGHT METALS, V38, P29; Tohma K., 1981, J JPN I LIGHT METALS, V31, P422; Tran T, 2014, CORROSION, V70, DOI 10.5006/0933; Yamashita A., 2011, INT J AUTOMOTIVE ENG, V42, P735; Yao SZ, 1997, CORROSION, V53, P195; Yoshino Michihide, 2009, Journal of Japan Institute of Light Metals, V59, DOI 10.2464/jilm.59.229; Zelenka P, 980190 SAE; Zhang B., 2009, CORROS SCI, V51, P368	25	0	0	NATL ASSOC CORROSION ENG	HOUSTON	1440 SOUTH CREEK DRIVE, HOUSTON, TX 77084-4906 USA	0010-9312	1938-159X		CORROSION-US	Corrosion	MAY	2015	71	5					598	605		10.5006/1332		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CJ2QI	WOS:000355329200004		
J	Ohashi, K				Ohashi, Kazumasa			Roles of cofilin in development and its mechanisms of regulation	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Review						actin cytoskeleton; cofilin; development; LIM kinase; slingshot	ACTIN-DEPOLYMERIZING FACTOR; CYCLASE-ASSOCIATED PROTEIN; SCHWANN-CELL MYELINATION; LIM-KINASE ACTIVATION; TESTICULAR GERM-CELLS; CYTOSKELETAL DYNAMICS; RHO-GTPASES; SLINGSHOT PHOSPHATASE; DROSOPHILA EYE; AXONAL GROWTH	Reorganization of the actin cytoskeleton is essential for cellular processes during animal development. Cofilin and actin depolymerizing factor (ADF) are potent actin-binding proteins that sever and depolymerize actin filaments, acting to generate the dynamics of the actin cytoskeleton. The activity of cofilin is spatially and temporally regulated by a variety of intracellular molecular mechanisms. Cofilin is regulated by cofilin binding molecules, is phosphorylated at Ser-3 (inactivation) by LIM-kinases (LIMKs) and testicular protein kinases (TESKs), and is dephosphorylated (reactivation) by slingshot protein phosphatases (SSHs). Although studies of the molecular mechanisms of cofilin-induced reorganization of the actin cytoskeleton have been ongoing for decades, the multicellular functions of cofilin and its regulation in development are just becoming apparent. This review describes the molecular mechanisms of generating actin dynamics by cofilin and the intracellular signaling pathways for regulating cofilin activity. Furthermore, recent findings of the roles of cofilin in the development of several tissues and organs, especially neural tissues and cells, in model animals are described. Recent developmental studies have indicated that cofilin and its regulatory mechanisms are involved in cellular proliferation and migration, the establishment of cellular polarity, and the dynamic regulation of organ morphology.	Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Ohashi, K (reprint author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kohashi@biology.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23112005, 25440076]	I thank Professor K. Mizuno for helpful suggestions. This work was supported by a Grant-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23112005 and 25440076 to K.O.).	Abe T, 2014, DEVELOPMENT, V141, P4716, DOI 10.1242/dev.113308; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Oleinik NV, 2010, ONCOGENE, V29, P6233, DOI 10.1038/onc.2010.356; Edwards DC, 1999, NAT CELL BIOL, V1, P253; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382; Nakano K, 2003, EXP CELL RES, V287, P219, DOI 10.1016/S0014-4827(03)00136-8; Raymond K, 2004, J CELL SCI, V117, P2777, DOI 10.1242/jcs.01123; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; FernandezValle C, 1997, J NEUROSCI, V17, P241; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Okano I, 1995, J BIOL CHEM, V270, P31321; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; Sumi T, 2001, J BIOL CHEM, V276, P23092, DOI 10.1074/jbc.C100196200; Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Benlali A, 2000, CELL, V101, P271, DOI 10.1016/S0092-8674(00)80837-5; Peche VS, 2013, CELL MOL LIFE SCI, V70, P527, DOI 10.1007/s00018-012-1142-y; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Kiuchi T, 2011, J CELL BIOL, V193, P365, DOI 10.1083/jcb.201101035; Sumi T, 2001, J BIOL CHEM, V276, P670; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Flynn KC, 2012, NEURON, V76, P1091, DOI 10.1016/j.neuron.2012.09.038; Yamauchi K, 2013, DEVELOPMENT, V140, P333, DOI 10.1242/dev.089524; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Agrawal PB, 2012, HUM MOL GENET, V21, P2341, DOI 10.1093/hmg/dds053; Ikeda S, 2003, HUM MOL GENET, V12, P1029, DOI 10.1093/hmg/ddg112; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Endo M, 2003, J NEUROSCI, V23, P2527; Kousaka K, 2008, GENESIS, V46, P246, DOI 10.1002/dvg.20389; Arber S, 1998, NATURE, V393, P805; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Spratley SJ, 2011, J BIOL CHEM, V286, P34254, DOI 10.1074/jbc.M111.259424; Sparrow N, 2012, J NEUROSCI, V32, P5284, DOI 10.1523/JNEUROSCI.6207-11.2012; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; MIZUNO K, 1994, ONCOGENE, V9, P1605; Meng YH, 2004, NEUROPHARMACOLOGY, V47, P746, DOI 10.1016/j.neuropharm.2004.06.030; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.1631.01631; Nomura K, 2012, J CELL SCI, V125, P4077, DOI 10.1242/jcs.104950; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Takemura M, 2009, J BIOL CHEM, V284, P28554, DOI 10.1074/jbc.M109.006296; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Chen GC, 2005, MOL CELL BIOL, V25, P979, DOI 10.1128/MCB.25.3.979-987.2005; Ahmed T, 2008, CELL SIGNAL, V20, P1320, DOI 10.1016/j.cellsig.2008.02.021; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Toshima J, 2001, MOL BIOL CELL, V12, P1131; Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Hatanaka H, 1996, CELL, V85, P1047, DOI 10.1016/S0092-8674(00)81305-7; Barisic S, 2011, EMBO REP, V12, P527, DOI 10.1038/embor.2011.53; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Poukkula M, 2011, CYTOSKELETON, V68, P471, DOI 10.1002/cm.20530; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Mori T, 1997, MOL BRAIN RES, V45, P247, DOI 10.1016/S0169-328X(96)00257-4; Ren N, 2007, GENETICS, V176, P2223, DOI 10.1534/genetics.107.072959; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Moriyama K, 2002, J CELL SCI, V115, P1591; Zhang LJ, 2011, DEVELOPMENT, V138, P455, DOI 10.1242/dev.046870; Chu DD, 2012, DEVELOPMENT, V139, P3561, DOI 10.1242/dev.079491; Yang N, 1998, NATURE, V393, P809; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Huang WN, 2011, MOL CELL BIOL, V31, P388, DOI 10.1128/MCB.00969-10; Ashworth S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012626; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Ayscough KR, 1998, CURR OPIN CELL BIOL, V10, P102, DOI 10.1016/S0955-0674(98)80092-6; BAMBURG JR, 1980, FEBS LETT, V121, P178, DOI 10.1016/0014-5793(80)81292-0; Baum B, 2000, CURR BIOL, V10, P964, DOI 10.1016/S0960-9822(00)00640-0; BERNARD O, 1994, CELL GROWTH DIFFER, V5, P1159; Blair A, 2006, DEVELOPMENT, V133, P1789, DOI 10.1242/dev.02320; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fass Joseph, 2004, Anatomical Science International, V79, P173, DOI 10.1111/j.1447-073x.2004.00087.x; Garg P, 2010, J BIOL CHEM, V285, P22676, DOI 10.1074/jbc.M110.122929; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Kuure S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001176; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; MOON A, 1995, MOL BIOL CELL, V6, P1423; NUNOUE K, 1995, ONCOGENE, V11, P701; Ohashi K, 2014, MOL BIOL CELL, V25, P828, DOI 10.1091/mbc.E13-09-0540; Ohashi K, 2011, J BIOL CHEM, V286, P36340, DOI 10.1074/jbc.M111.259135; Ono S, 1999, J CELL BIOL, V145, P491, DOI 10.1083/jcb.145.3.491; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; ONO S, 1994, J BIOL CHEM, V269, P15280; Pham H, 2008, DEV BIOL, V318, P82, DOI 10.1016/j.ydbio.2008.03.006; Phan KD, 2010, J NEUROSCI, V30, P15430, DOI 10.1523/JNEUROSCI.4117-10.2010; PROSCHEL C, 1995, ONCOGENE, V11, P1271; Rice DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047168; Rosario M, 2012, GENE DEV, V26, P1743, DOI 10.1101/gad.191593.112; Saito A, 2013, GENES CELLS, V18, P533, DOI 10.1111/gtc.12054; Sese M, 2006, J CELL SCI, V119, P5047, DOI 10.1242/jcs.03294; Takahashi H, 2002, DEV BIOL, V241, P259, DOI 10.1006/dbio.2001.0512; Toshima J, 1995, J BIOL CHEM, V270, P31331; vansRheenen J, 2007, J CELL BIOL, V179, P1247	135	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	MAY	2015	57	4			SI		275	290		10.1111/dgd.12213		16	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CJ1FP	WOS:000355228300001		
J	Tojima, T; Kamiguchi, H				Tojima, Takuro; Kamiguchi, Hiroyuki			Exocytic and endocytic membrane trafficking in axon development	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Review						axon guidance; axon outgrowth; endocytosis; exocytosis; membrane trafficking	GROWTH CONE GUIDANCE; ROOT GANGLION NEURONS; CLATHRIN-MEDIATED ENDOCYTOSIS; REGULATES NEURITE OUTGROWTH; L1 ADHESION MOLECULE; SRC TYROSINE KINASE; NERVE GROWTH; PLASMA-MEMBRANE; ENDOSOMAL TRAFFICKING; SEMAPHORIN 3A	In the complex neuronal circuits in the nervous systems, billions of neurons are precisely interconnected by long, thin processes called the axons. The growth cone, a highly motile structure at the tip of an extending axon, navigates by responding to a variety of extracellular molecular cues toward their distant target cells and make synaptic connections. Emerging evidence indicates that exocytic and endocytic membrane trafficking systems play multiple important roles in the regulation of such axonal morphogenetic processes. Exocytosis and endocytosis organize the subcellular distribution of membrane-associated molecules, such as receptors, cell adhesion molecules, and cytoskeletal regulators, to control intracellular signaling and driving machineries. Furthermore, the exocytosis of trophic factors and extracellular proteinases act on surrounding microenvironments to affect growth cone motility. In this Review Article, we summarize our current understanding of the regulation and function of exocytic and endocytic membrane trafficking in axon morphogenesis during development, and discuss potential mechanisms of how the membrane trafficking systems exert such morphological changes.	[Tojima, Takuro; Kamiguchi, Hiroyuki] RIKEN Brain Sci Inst, Lab Neuronal Growth Mech, Wako, Saitama 3510198, Japan	Tojima, T (reprint author), RIKEN Brain Sci Inst, Lab Neuronal Growth Mech, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tojima@brain.riken.jp			Japan Science and Technology Agency PRESTO Program; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Ministry of Education, Culture, Sports, Science and Technology of Japan [23110005, 24500393, 22700353]	We apologize to researchers whose studies could not be cited in this review because of space limitations. We are grateful to Carmen Chan and Rurika Itofusa for their helpful comments on this manuscript. Our work was funded by the Japan Science and Technology Agency PRESTO Program (T.T.), Mochida Memorial Foundation for Medical and Pharmaceutical Research (T.T.), and Grants-in-Aid for Scientific Research on Innovative Areas (23110005, T.T.), Scientific Research (C) (24500393, T.T.), and Young Scientists (B) (22700353, T.T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akiyama H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000196; Akiyama H, 2010, J BIOL CHEM, V285, P41740, DOI 10.1074/jbc.M110.156489; Akiyama H, 2015, DEV NEUROBIOL, V75, P411, DOI 10.1002/dneu.22157; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; Tojima T, 2014, J NEUROSCI, V34, P7165, DOI 10.1523/JNEUROSCI.5261-13.2014; Bartoe JL, 2006, J NEUROSCI, V26, P3192, DOI 10.1523/JNEUROSCI.3469-05.2006; Zuo J, 1998, J NEUROSCI, V18, P5203; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; Gomez TM, 2014, J NEUROCHEM, V129, P221, DOI 10.1111/jnc.12506; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Buck KB, 2002, J NEUROSCI, V22, P9358; Kabayama H, 2008, NEUROSCI LETT, V436, P340, DOI 10.1016/j.neulet.2008.03.061; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Ferraro GB, 2011, J BIOL CHEM, V286, P31418, DOI 10.1074/jbc.M111.249169; Petkovic M, 2014, NAT CELL BIOL, V16, P434, DOI 10.1038/ncb2937; Kamiguchi H, 2001, J NEUROSCI, V21, P9194; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Sutherland DJ, 2014, TRENDS NEUROSCI, V37, P424, DOI [10.1016/j.tins.2014.05.008, 10.1016/j.tins.2014.06.008]; Wu BB, 2008, MOL BIOL CELL, V19, P4611, DOI 10.1091/mbc.E08-06-0603; Marsick BM, 2010, DEV NEUROBIOL, V70, P565, DOI 10.1002/dneu.20800; Williams KC, 2011, J BIOL CHEM, V286, P43405, DOI 10.1074/jbc.M111.297069; Winkle CC, 2014, J CELL BIOL, V205, P217, DOI 10.1083/jcb.201311003; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Itofusa R, 2011, MOL CELL NEUROSCI, V48, P332, DOI 10.1016/j.mcn.2011.03.007; Zylbersztejn K, 2012, J CELL BIOL, V196, P37, DOI 10.1083/jcb.201106113; Tojima T, 2012, NEUROSCI RES, V73, P269, DOI 10.1016/j.neures.2012.05.010; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Tojima T, 2010, NEURON, V66, P370, DOI 10.1016/j.neuron.2010.04.007; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Steffen A, 2008, CURR BIOL, V18, P926, DOI 10.1016/j.cub.2008.05.044; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Burgo A, 2012, DEV CELL, V23, P166, DOI 10.1016/j.devcel.2012.04.019; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Carcea I, 2010, J NEUROSCI, V30, P15317, DOI 10.1523/JNEUROSCI.1821-10.2010; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Takano T, 2012, J NEUROSCI, V32, P6587, DOI 10.1523/JNEUROSCI.5317-11.2012; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Ponomareva OY, 2014, J NEUROSCI, V34, P9235, DOI 10.1523/JNEUROSCI.0561-14.2014; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Moore SW, 2007, ADV EXP MED BIOL, V621, P17, DOI 10.1007/978-0-387-76715-4_2; Kolpak AL, 2009, J NEUROSCI, V29, P10488, DOI 10.1523/JNEUROSCI.2355-09.2009; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Cosker KE, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020669; DAVIES AM, 1995, CURR BIOL, V5, P723, DOI 10.1016/S0960-9822(95)00144-8; Wang T, 2011, DEV CELL, V21, P431, DOI 10.1016/j.devcel.2011.07.007; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Sakane A, 2010, MOL CELL BIOL, V30, P1077, DOI 10.1128/MCB.01067-09; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Schlager MA, 2010, EMBO J, V29, P1637, DOI 10.1038/emboj.2010.51; Bouchard JF, 2008, J NEUROCHEM, V107, P398, DOI 10.1111/j.1471-4159.2008.05609.x; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Dudanova I, 2013, TRENDS NEUROSCI, V36, P295, DOI 10.1016/j.tins.2013.01.007; HUBER LA, 1995, MOL CELL BIOL, V15, P918; OsenSand A, 1996, J COMP NEUROL, V367, P222, DOI 10.1002/(SICI)1096-9861(19960401)367:2<222::AID-CNE5>3.0.CO;2-7; Onishi K, 2013, J NEUROSCI, V33, P19071, DOI 10.1523/JNEUROSCI.2800-13.2013; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Colombo F, 2014, P NATL ACAD SCI USA, V111, P16943, DOI 10.1073/pnas.1406097111; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Jaworski J, 2007, EUR J CELL BIOL, V86, P513, DOI 10.1016/j.ejcb.2007.04.007; Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931; Osmani N, 2010, J CELL BIOL, V191, P1261, DOI 10.1083/jcb.201003091; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; Alberts P, 2006, MOL BIOL CELL, V17, P1194, DOI 10.1091/mbc.E05-07-0643; Eva R, 2012, J NEUROSCI, V32, P10352, DOI 10.1523/JNEUROSCI.1409-12.2012; Kabayama H, 2011, J NEUROSCI, V31, P7357, DOI 10.1523/JNEUROSCI.2718-10.2011; Kasai H, 2012, PHYSIOL REV, V92, P1915, DOI 10.1152/physrev.00007.2012; Zheng JQ, 1996, J NEUROSCI, V16, P1140; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Galko MJ, 2000, SCIENCE, V289, P1365, DOI 10.1126/science.289.5483.1365; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Saxena S, 2005, J NEUROSCI, V25, P10930, DOI 10.1523/JNEUROSCI.2029-05.2005; Igarashi M, 1996, J CELL BIOL, V134, P205, DOI 10.1083/jcb.134.1.205; Robles E, 2005, J NEUROSCI, V25, P7669, DOI 10.1523/JNEUROSCI.2680-05.2005; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Kamiguchi H, 2000, J NEUROSCI, V20, P3676; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Hopker VH, 1999, NATURE, V401, P69; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Hong K, 2000, NATURE, V403, P93; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Nakazawa H, 2012, J NEUROSCI, V32, P12712, DOI 10.1523/JNEUROSCI.0989-12.2012; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Soeda H, 1997, NEUROSCIENCE, V77, P1187, DOI 10.1016/S0306-4522(96)00465-4; Eva R, 2014, CURR OPIN NEUROBIOL, V27, P179, DOI 10.1016/j.conb.2014.03.018; Bloom OE, 2011, MOL CELL NEUROSCI, V48, P339, DOI 10.1016/j.mcn.2011.04.003; Bucci Cecilia, 2014, Membranes (Basel), V4, P642, DOI 10.3390/membranes4040642; Castellani V, 2004, MOL CELL NEUROSCI, V26, P89, DOI 10.1016/j.mcn.2004.01.010; Cotrufo T, 2011, J NEUROSCI, V31, P14463, DOI 10.1523/JNEUROSCI.3018-11.2011; DAI JW, 1995, CELL, V83, P693; Dequidt C, 2007, MOL BIOL CELL, V18, P3131, DOI 10.1091/mbc.E06-12-1101; DisGiovanni S., 2005, J BIOL CHEM, V280, P2084; Dupraz S, 2009, J NEUROSCI, V29, P13292, DOI 10.1523/JNEUROSCI.3907-09.2009; Eguchi K, 2012, NEURON, V74, P517, DOI 10.1016/j.neuron.2012.03.028; Falk J, 2014, J NEUROSCI, V34, P373, DOI 10.1523/JNEUROSCI.0876-13.2014; Fujita A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079689; Gauthier NC, 2009, MOL BIOL CELL, V20, P3261, DOI 10.1091/mbc.E09-01-0071; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Hasan N, 2010, EXP CELL RES, V316, P12, DOI 10.1016/j.yexcr.2009.10.007; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Hirling H, 2000, EUR J NEUROSCI, V12, P1913, DOI 10.1046/j.1460-9568.2000.00076.x; Igarashi M, 1997, J NEUROSCI, V17, P1460; Igarashi M, 2000, J NEUROSCI RES, V60, P743, DOI 10.1002/1097-4547(20000615)60:6<743::AID-JNR6>3.0.CO;2-T; Kabayama H, 2009, MOL CELL NEUROSCI, V40, P27, DOI 10.1016/j.mcn.2008.08.009; Kamiguchi H, 1998, J NEUROSCI, V18, P5311; Liu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3005; Mann F, 2003, J NEUROBIOL, V57, P323, DOI 10.1002/neu.10303; Martinez-Arca S, 2001, J NEUROSCI, V21, P3830; Morihara T, 1999, NEUROSCIENCE, V91, P695, DOI 10.1016/S0306-4522(98)00671-X; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Romi E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5058; Ros O, 2015, J NEUROSCI, V35, P5156, DOI 10.1523/JNEUROSCI.0124-14.2015; Sabo SL, 2003, NAT NEUROSCI, V6, P1264, DOI 10.1038/nn1149; Santiago-Medina M, 2015, DEVELOPMENT, V142, P486, DOI 10.1242/dev.108266; Shirasu M, 2000, NEUROSCI RES, V37, P265, DOI 10.1016/S0168-0102(00)00125-5; Tatsumi H, 1995, NEUROSCI LETT, V202, P25, DOI 10.1016/0304-3940(95)12187-0; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Tojima T, 2009, J NEUROSCI, V29, P7886, DOI 10.1523/JNEUROSCI.0087-09.2009; VansBergeijk P., 2015, NATURE, V518, P111; Villarroel-Campos D, 2014, J NEUROCHEM, V129, P240, DOI 10.1111/jnc.12676; Wu CS, 2011, MOL CELL BIOL, V31, P4874, DOI 10.1128/MCB.05593-11; Wu KY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005334; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Zhou Q, 2000, J NEUROSCI RES, V61, P321, DOI 10.1002/1097-4547(20000801)61:3<321::AID-JNR10>3.0.CO;2-L	153	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	MAY	2015	57	4			SI		291	304		10.1111/dgd.12218		14	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CJ1FP	WOS:000355228300002		
J	Ito, N; Ohta, K				Ito, Naofumi; Ohta, Kunimasa			Reprogramming of human somatic cells by bacteria	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Review						bacteria; eukaryotic cells; multipotency; reprogramming	HELICOBACTER-PYLORI CAGA; INFLAMMATORY-BOWEL-DISEASE; GASTRIC EPITHELIAL-CELLS; NF-KAPPA-B; GUT MICROBIOTA; LEPROSY BACILLI; GENERATES CELLS; INTERFERON-BETA; INNATE IMMUNITY; STEM-CELLS	In general, it had been believed that the cell fate restriction of terminally differentiated somatic cells was irreversible. In 1952, somatic cell nuclear transfer (SCNT) was introduced to study early embryonic development in frogs. So far, various mammalian species have been successfully cloned using the SCNT technique, though its efficiency is very low. Embryonic stem (ES) cells were the first pluripotent cells to be isolated from an embryo and have a powerful potential to differentiate into more than 260 types of cells. The generation of induced pluripotent stem (iPS) cells was a breakthrough in stem cell research, and the use of these iPS cells has solved problems such as low efficiency and cell fate restriction. These cells have since been used for clinical application, disease investigation, and drug selection. As it is widely accepted that the endosymbiosis of Archaea into eukaryotic ancestors resulted in the generation of eukaryotic cells, we examined whether bacterial infection could alter host cell fate. We previously showed that when human dermal fibroblast (HDF) cells were incorporated with lactic acid bacteria (LAB), the LAB-incorporated HDF cells formed clusters and expressed a subset of common pluripotent markers. Moreover, LAB-incorporated cell clusters could differentiate into cells derived from each of the three germinal layers both in vivo and in vitro, indicating successful reprogramming of host HDF cells by LAB. In the current review, we introduce the existing examples of cellular reprogramming by bacteria and discuss their nuclear reprogramming mechanisms.	[Ito, Naofumi; Ohta, Kunimasa] Kumamoto Univ, Fac Life Sci, Div Dev Neurobiol, Chuo Ku, Kumamoto 8608556, Japan	Ohta, K (reprint author), Kumamoto Univ, Fac Life Sci, Div Dev Neurobiol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	ohta9203@gpo.kumamoto-u.ac.jp			KAKENHI [25650082]; Kumamoto University Advanced Research Project "Stem Cell-Based Tissue Regeneration Research and Education Unit"; Yakult Bio-Science Foundation; Institute for Fermentation Osaka; Mitsubishi Foundation	This work was supported by KAKENHI (25650082), Kumamoto University Advanced Research Project "Stem Cell-Based Tissue Regeneration Research and Education Unit", Yakult Bio-Science Foundation, Institute for Fermentation Osaka, and Mitsubishi Foundation. We thank all members of our laboratory for their helpful support and discussions.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; ALBERTS B., 2008, MOL BIOL CELL; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Tapinos N, 2006, NAT MED, V12, P961, DOI 10.1038/nm1433; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Lad SP, 2007, P NATL ACAD SCI USA, V104, P2933, DOI 10.1073/pnas.0608393104; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Kleiner M, 2012, P NATL ACAD SCI USA, V109, pE1173, DOI 10.1073/pnas.1121198109; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Ashida H, 2011, CURR OPIN MICROBIOL, V14, P16, DOI 10.1016/j.mib.2010.08.014; Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Wagnerova A, 2013, GENE THER, V20, P1111, DOI 10.1038/gt.2013.43; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Moura MLN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002093; Fujii Y, 2012, P NATL ACAD SCI USA, V109, P20584, DOI 10.1073/pnas.1208651109; Taniguchi S, 2010, CANCER SCI, V101, P1925, DOI 10.1111/j.1349-7006.2010.01628.x; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; Correa P, 2010, AM J GASTROENTEROL, V105, P493, DOI 10.1038/ajg.2009.728; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Bessede E, 2014, ONCOGENE, V33, P4123, DOI 10.1038/onc.2013.380; Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Vaughan EE, 2005, FEMS MICROBIOL REV, V29, P477, DOI 10.1016/j.femsre.2005.04.009; Shimoji Y, 1999, P NATL ACAD SCI USA, V96, P9857, DOI 10.1073/pnas.96.17.9857; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Matsuura Y, 2012, ISME J, V6, P397, DOI 10.1038/ismej.2011.103; Schneider BG, 2013, EPIGENETICS-US, V8, P1153, DOI 10.4161/epi.26072; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Hong XX, 2013, J BIOL CHEM, V288, P16196, DOI 10.1074/jbc.M112.435461; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Kawashima T, 2013, IMMUNITY, V38, P1187, DOI 10.1016/j.immuni.2013.02.024; Collins SM, 2014, NAT REV GASTRO HEPAT, V11, P497, DOI 10.1038/nrgastro.2014.40; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Kawaguchi M, 2010, PLANT CELL PHYSIOL, V51, P1377, DOI 10.1093/pcp/pcq125; Kruger C, 2002, NAT BIOTECHNOL, V20, P702, DOI 10.1038/nbt0702-702; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Martin R, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-71; Masaki T, 2014, CELL REPROGRAM, V16, P9, DOI 10.1089/cell.2013.0064; Nakaya Y., 2014, J POULT SCI, V52, P1; Ohta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051866; Ohta K, 2008, DEV GROWTH DIFFER, V50, P253, DOI [10.1111/j.1440-169X.2008.01006.x, 10.1111/j.1440-169x.2008.01006.x]; Pennini ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000995; Rodrigues da Cunha L., 2012, GUT MICROBES, V3, P15; Saito A, 2008, MICROBES ENVIRON, V23, P73, DOI 10.1264/jsme2.23.73; Tabouret G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001159; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tanabe Shihori, 2013, World J Stem Cells, V5, P61, DOI 10.4252/wjsc.v5.i3.61	61	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	MAY	2015	57	4			SI		305	312		10.1111/dgd.12209		8	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CJ1FP	WOS:000355228300003		
J	Kondo, T; Hayashi, S				Kondo, Takefumi; Hayashi, Shigeo			Mechanisms of cell height changes that mediate epithelial invagination	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Review						cell height change; epithelial invagination; tissue morphogenesis	NEURAL-TUBE CLOSURE; DRIVE APICAL CONSTRICTION; WING DISC EPITHELIA; ADHERENS JUNCTIONS; VENTRAL FURROW; MICROTUBULE ORGANIZATION; TISSUE MORPHOGENESIS; SHAPE CHANGE; MOLECULAR-MECHANISMS; MYOSIN-II	Epithelial invagination is a morphogenetic process that converts flat cell sheets into tubular structures and contributes to the formation of three-dimensional organs during development. Because the cells in tubular structures have smaller apical than basal surfaces, apical constriction is thought to be critical for the process of epithelial invagination. In addition, the invagination process is also accompanied by cell elongation, followed by cell shortening and basal expansion. While the mechanisms involved in apical constriction have been well-characterized, recent technical advances are just beginning to unravel the mechanisms involved in cell height control, which include cytoskeletal changes, cortical tension generation, cell adhesion, and cytoplasmic flow. Furthermore, cell height changes associated with mitosis and apoptosis have recently been shown to contribute to epithelial invagination. To develop a comprehensive understanding of epithelial invagination, it is important to elucidate the mechanisms that mediate cell shape changes and facilitate their coordination. In this review, we summarize the recent advances in this field, focusing on the mechanisms that control cell height.	[Kondo, Takefumi; Hayashi, Shigeo] RIKEN Ctr Dev Biol, Lab Morphogenet Signaling, Wako, Saitama, Japan; [Hayashi, Shigeo] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan	Kondo, T (reprint author), RIKEN Ctr Dev Biol, Lab Morphogenet Signaling, Wako, Saitama, Japan.	take-kondo@cdb.riken.jp; shayashi@cdb.riken.jp			MEXT/JSPS [24770197, 22111007]	We apologize to all the colleagues whose works could not be cited and discussed due to the limitation of space. Work by the authors was supported by a MEXT/JSPS Grant-in-Aid for Young Scientists (B), grant number 24770197 (to TK), and a Grant-in-Aid for Scientific Research on Innovative Areas, grant number 22111007 (to SH). TK was a RIKEN Special Postdoctoral Fellow.	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Widmann TJ, 2009, J CELL SCI, V122, P1362, DOI 10.1242/jcs.044271; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Lancaster OM, 2013, DEV CELL, V25, P270, DOI 10.1016/j.devcel.2013.03.014; Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Gelbart MA, 2012, P NATL ACAD SCI USA, V109, P19298, DOI 10.1073/pnas.1205258109; Hiramatsu R, 2013, DEV CELL, V27, P131, DOI 10.1016/j.devcel.2013.09.026; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Ogura Y, 2011, DEVELOPMENT, V138, P577, DOI 10.1242/dev.053132; Lee C, 2007, DEVELOPMENT, V134, P1431, DOI 10.1242/dev.02828; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; SWEETON D, 1991, DEVELOPMENT, V112, P775; Meyer EJ, 2011, CURR BIOL, V21, P485, DOI 10.1016/j.cub.2011.02.002; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Shen J, 2005, SCIENCE, V307, P1789, DOI 10.1126/science.1104784; Corrigall D, 2007, DEV CELL, V13, P730, DOI 10.1016/j.devcel.2007.09.015; He B, 2014, NATURE, V508, P392, DOI 10.1038/nature13070; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Nishimura M, 2007, DEVELOPMENT, V134, P4273, DOI 10.1242/dev.010397; Pouille PA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015005; Plageman TF, 2010, DEVELOPMENT, V137, P405, DOI 10.1242/dev.045369; Mason FM, 2013, NAT CELL BIOL, V15, P926, DOI 10.1038/ncb2796; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Sherrard K, 2010, CURR BIOL, V20, P1499, DOI 10.1016/j.cub.2010.06.075; Manjon C, 2007, NAT CELL BIOL, V9, P57, DOI 10.1038/ncb1518; Honda H, 2004, J THEOR BIOL, V226, P439, DOI 10.1016/j.jtbi.2003.10.001; Yonemura S, 2011, CURR OPIN CELL BIOL, V23, P515, DOI 10.1016/j.ceb.2011.07.001; Kondo T, 2013, NATURE, V494, P125, DOI 10.1038/nature11792; Sai X, 2008, CURR BIOL, V18, P976, DOI 10.1016/j.cub.2008.05.049; Conte V, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016010; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lee JY, 2007, DEV BIOL, V311, P40, DOI 10.1016/j.ydbio.2007.08.010; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Pope KL, 2008, DEVELOPMENT, V135, P2227, DOI 10.1242/dev.019802; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Harris TJC, 2007, DEV CELL, V12, P727, DOI 10.1016/j.devcel.2007.02.011; Amano M, 1996, J BIOL CHEM, V271, P20246; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Martin AC, 2014, DEVELOPMENT, V141, P1987, DOI 10.1242/dev.102228; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Miyoshi J, 2008, BBA-BIOMEMBRANES, V1778, P670, DOI 10.1016/j.bbamem.2007.12.014; Osterfield M, 2013, DEV CELL, V24, P400, DOI 10.1016/j.devcel.2013.01.017; Monier B, 2015, NATURE, V518, P245, DOI 10.1038/nature14152; Fletcher AG, 2014, BIOPHYS J, V106, P2291, DOI 10.1016/j.bpj.2013.11.4498; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Brodland GW, 2010, P NATL ACAD SCI USA, V107, P22111, DOI 10.1073/pnas.1006591107; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Vasquez CG, 2014, J CELL BIOL, V206, P435, DOI 10.1083/jcb.201402004; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; Hannezo E, 2014, P NATL ACAD SCI USA, V111, P27, DOI 10.1073/pnas.1312076111; Suzuki M, 2010, DEVELOPMENT, V137, P2329, DOI 10.1242/dev.048769; Wang YC, 2012, NATURE, V484, P390, DOI 10.1038/nature10938; Rauzi M, 2013, BIOPHYS J, V105, P3, DOI 10.1016/j.bpj.2013.05.039; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Chauhan BK, 2011, P NATL ACAD SCI USA, V108, P18289, DOI 10.1073/pnas.1108993108; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Polyakov O, 2014, BIOPHYS J, V107, P998, DOI 10.1016/j.bpj.2014.07.013; Booth AJR, 2014, DEV CELL, V29, P562, DOI 10.1016/j.devcel.2014.03.023; BURNSIDE B, 1973, AM ZOOL, V13, P989; Conte V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034473; Costa M., 1993, DEV DROSOPHILA MELAN, V1, P425; Eiraku M, 2012, BIOESSAYS, V34, P17, DOI 10.1002/bies.201100070; ETTENSOHN CA, 1985, Q REV BIOL, V60, P289, DOI 10.1086/414426; Fernandes V. M., 2014, CELL REP, V9, P1; Gomez JM, 2012, J CELL BIOL, V199, P1131, DOI 10.1083/jcb.201207150; Gutzman JH, 2010, DEVELOPMENT, V137, P795, DOI 10.1242/dev.042705; Kolahi KS, 2009, DEV BIOL, V331, P129, DOI 10.1016/j.ydbio.2009.04.028; Lee H. O, 2012, TRENDS CELL BIOL, V23, P141; LEWIS WH, 1947, ANAT REC, V97, P139, DOI 10.1002/ar.1090970203; Melani M, 2008, CURR BIOL, V18, P532, DOI 10.1016/j.cub.2008.03.024; Morita H, 2012, DEVELOPMENT, V139, P1417, DOI 10.1242/dev.073239; PERRY MM, 1966, J EMBRYOL EXP MORPH, V15, P317; Picone R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000542; PORTER K, 1973, J CELL BIOL, V57, P815, DOI 10.1083/jcb.57.3.815; Suzuki M, 2012, DEV GROWTH DIFFER, V54, P266, DOI 10.1111/j.1440-169X.2012.01346.x; Wang Y, 2007, CURR BIOL, V17, P1349, DOI 10.1016/j.cub.2007.06.067	89	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	MAY	2015	57	4			SI		313	323		10.1111/dgd.12224		11	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CJ1FP	WOS:000355228300004		
J	Kumano, G				Kumano, Gaku			Evolution of germline segregation processes in animal development	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Review						embryogenesis; epigenesis; germline segregation; multipotent cells; preformation	SOMATIC STEM-CELLS; SMALL MICROMERE LINEAGE; POSTERIOR GROWTH ZONE; MESSENGER-RNA; SEA-URCHIN; CIONA-INTESTINALIS; ASCIDIAN EMBRYOS; SPECIFICATION MECHANISMS; INTRACELLULAR INJECTION; CAENORHABDITIS-ELEGANS	Germline segregation is a complex process by which germline cells are separated from somatic tissues during development. Recent animal studies on germline segregation allow for comparisons of the mechanisms used by different species and to propose evolutionary scenarios underlying the diversification of these processes. In this review, several proposed models of germline segregation are presented, and in addition, recent findings from the increasing number of studies are discussed, particularly concerning the need to reconsider these models based on available data.	Tohoku Univ, Grad Sch Life Sci, Asamushi Res Ctr Marine Biol, Asamushi, Aomori 0393501, Japan	Kumano, G (reprint author), Tohoku Univ, Grad Sch Life Sci, Asamushi Res Ctr Marine Biol, 9 Sakamoto, Asamushi, Aomori 0393501, Japan.	kumano@m.tohoku.ac.jp			JSPS KAKENHI [23570252]	I would like to thank Drs Takuya Minokawa and Ayaki Nakagawa for critical reading of the manuscript. The author gratefully acknowledges support from JSPS KAKENHI Grant Number 23570252.	Agata K, 2006, SEMIN CELL DEV BIOL, V17, P503, DOI 10.1016/j.semcdb.2006.05.004; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Render J, 1997, DEV BIOL, V189, P301, DOI 10.1006/dbio.1997.8654; NISHIDA H, 1985, DEV BIOL, V110, P440, DOI 10.1016/0012-1606(85)90102-2; Evans T, 2014, SCIENCE, V344, P200, DOI 10.1126/science.1249325; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; Aramaki S, 2013, DEV CELL, V27, P516, DOI 10.1016/j.devcel.2013.11.001; Fujimura M, 2000, DEV GENES EVOL, V210, P64, DOI 10.1007/s004270050012; Rebscher N, 2007, DEV BIOL, V306, P599, DOI 10.1016/j.ydbio.2007.03.521; Chan XY, 2014, DEV GENES EVOL, V224, P159, DOI 10.1007/s00427-014-0474-z; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Mochizuki K, 2001, DEV GENES EVOL, V211, P299, DOI 10.1007/s004270100156; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Takamura K, 2002, DEV GENES EVOL, V212, P11, DOI 10.1007/s00427-001-0204-1; Funayama N, 2010, DEV GROWTH DIFFER, V52, P1, DOI 10.1111/j.1440-169X.2009.01162.x; Ewen-Campen B, 2012, CURR BIOL, V22, P2278, DOI 10.1016/j.cub.2012.10.019; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Brown FD, 2009, DEVELOPMENT, V136, P3485, DOI 10.1242/dev.037754; ILLMENSEE K, 1976, EXP CELL RES, V97, P127, DOI 10.1016/0014-4827(76)90662-5; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; BUEHR ML, 1970, J EMBRYOL EXP MORPH, V23, P375; Johnson AD, 2011, REPRODUCTION, V141, P291, DOI 10.1530/REP-10-0474; Seipel K, 2004, INT J DEV BIOL, V48, P1, DOI 10.1387/ijdb.15005568; Pfister D, 2008, DEV BIOL, V319, P146, DOI 10.1016/j.ydbio.2008.02.045; Machado RJ, 2005, DEV BIOL, V287, P289, DOI 10.1016/j.ydbio.2005.08.044; Juliano C, 2010, SCIENCE, V329, P640, DOI 10.1126/science.1194037; Hanyu-Nakamura K, 2008, NATURE, V451, P730, DOI 10.1038/nature06498; MOSQUERA L, 1993, DEVELOPMENT, V117, P377; Funayama N, 2010, EVOL DEV, V12, P275, DOI 10.1111/j.1525-142X.2010.00413.x; Ewen-Campen B, 2010, MOL REPROD DEV, V77, P3, DOI 10.1002/mrd.21091; Leclere L, 2012, DEV BIOL, V364, P236, DOI 10.1016/j.ydbio.2012.01.018; HAY B, 1990, DEVELOPMENT, V109, P425; Nishida H, 2008, DEV GROWTH DIFFER, V50, pS239, DOI 10.1111/j.1440-169X.2008.01035.x; Extavour CG, 2005, EVOL DEV, V7, P201, DOI 10.1111/j.1525-142X.2005.05023.x; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V320, P592, DOI 10.1016/j.bbrc.2004.06.009; Juliano CE, 2010, DEVELOPMENT, V137, P4113, DOI 10.1242/dev.047969; Donoughe S, 2014, P NATL ACAD SCI USA, V111, P4133, DOI 10.1073/pnas.1400525111; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Ewen-Campen B, 2013, CURR BIOL, V23, P835, DOI 10.1016/j.cub.2013.03.063; Alie A, 2011, DEV BIOL, V350, P183, DOI 10.1016/j.ydbio.2010.10.019; Breitwieser W, 1996, GENE DEV, V10, P2179, DOI 10.1101/gad.10.17.2179; Iseto T, 1999, DEV GROWTH DIFFER, V41, P601; Extavour CGM, 2007, INTEGR COMP BIOL, V47, P770, DOI 10.1093/icb/icm027; Bontems F, 2009, CURR BIOL, V19, P414, DOI 10.1016/j.cub.2009.01.038; ILLMENSEE K, 1976, DEV BIOL, V49, P40, DOI 10.1016/0012-1606(76)90257-8; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Chatfield J, 2014, DEVELOPMENT, V141, P2429, DOI 10.1242/dev.105346; BLACKLER AW, 1962, J EMBRYOL EXP MORPH, V10, P641; BOUNOURE LOUIS, 1934, ANN SCI NAT ZOOL, V17, P67; CHO S-J, 2014, MOL BIOL EVOL, V31, P1; Crampton H. E., 1896, WILHELM ROUX ARCH EN, V3, P1; DesMulder K., 2009, DEV BIOL, V334, P198; Lopes SMCDS, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-140; Dill KK, 2008, DEV GENES EVOL, V218, P453, DOI 10.1007/s00427-008-0236-x; Fujii S, 2008, DEV GENES EVOL, V218, P69, DOI 10.1007/s00427-008-0205-4; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Hanazawa M, 2011, J CELL BIOL, V192, P929, DOI 10.1083/jcb.201010106; Hopf C, 2011, DEV GENES EVOL, V221, P209, DOI 10.1007/s00427-011-0373-5; Huettner A. F., 1923, J MORPHOL, V2, P385; IKENISHI K, 1986, DEV GROWTH DIFFER, V28, P563; ILLMENSE.K, 1974, P NATL ACAD SCI USA, V71, P1016, DOI 10.1073/pnas.71.4.1016; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Juliano CE, 2006, DEV BIOL, V300, P406, DOI 10.1016/j.ydbio.2006.07.035; Juliano CE, 2010, DEV BIOL, V337, P220, DOI 10.1016/j.ydbio.2009.10.030; Kang D, 2002, DEV BIOL, V245, P28, DOI 10.1006/dbio.2002.0615; Kato Y, 2013, DEV BIOL, V379, P246, DOI 10.1016/j.ydbio.2013.04.028; Kumano G., 2014, NEW PRINCIPLES DEV P, P3; Kumano G, 2011, CURR BIOL, V21, P1308, DOI 10.1016/j.cub.2011.06.050; Leininger S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4905; NIEUWKOOP P. D., 1959, ARCH ANAT MICROSC ET MORPHOL EXPTL, V48 bis, P189; Nieuwkoop P.D., 1981, PRIMORDIAL GERM CELL; Nishida H, 2014, ZOOL SCI, V31, P645, DOI 10.2108/zs140117; Rabinowitz JS, 2008, CURR BIOL, V18, P331, DOI 10.1016/j.cub.2008.01.055; Ransick A, 1996, P NATL ACAD SCI USA, V93, P6759, DOI 10.1073/pnas.93.13.6759; Rebscher N, 2014, INT J DEV BIOL, V58, P403, DOI 10.1387/ijdb.140125nr; Rebscher N, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-9; Rebscher N, 2008, DEV DYNAM, V237, P1736, DOI 10.1002/dvdy.21562; Saitou M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008375; Shirae-Kurabayashi M, 2006, DEVELOPMENT, V133, P2683, DOI 10.1242/dev.02446; Shirae-Kurabayashi M, 2011, DEVELOPMENT, V138, P2871, DOI 10.1242/dev.058131; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sutasurya L. A., 1979, PRIMORDIAL GERM CELL; Swartz SZ, 2008, DEV GENES EVOL, V218, P107, DOI 10.1007/s00427-008-0203-6; Torras R, 2004, EVOL DEV, V6, P362, DOI 10.1111/j.1525-142X.2004.04044.x; Voronina E, 2008, DEV BIOL, V314, P276, DOI 10.1016/j.ydbio.2007.11.039; WANG C, 1994, DEV DYNAM, V199, P103; Wilson EB, 1904, J EXP ZOOL, V1, P1, DOI 10.1002/jez.1400010102; Yajima M, 2011, DEVELOPMENT, V138, P237, DOI 10.1242/dev.054940; Ying Y., 2001, DEV BIOL, V300, P406	89	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	MAY	2015	57	4			SI		324	332		10.1111/dgd.12211		9	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CJ1FP	WOS:000355228300005		
J	Fukuhara, S; Fukui, H; Wakayama, Y; Ando, K; Nakajima, H; Mochizuki, N				Fukuhara, Shigetomo; Fukui, Hajime; Wakayama, Yuki; Ando, Koji; Nakajima, Hiroyuki; Mochizuki, Naoki			Looking back and moving forward: Recent advances in understanding of cardiovascular development by imaging of zebrafish	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Review						cardiovascular development; cell responses; fluorescence; imaging; zebrafish	CELL-CYCLE PROGRESSION; CARDIOMYOCYTE PROLIFERATION; CARDIAC REGENERATION; FLUORESCENT PROTEIN; HEART REGENERATION; ENDODERM FORMATION; ACTIVATION; MIGRATION; VESSELS; CATENIN	Development requires cell proliferation, migration, differentiation, apoptosis, and many kinds of cell responses. Cells prepare intracellular conditions to respond to extracellular cues from neighboring cells. We have studied the development of the cardiovascular system (CVS) by visualizing morphology and signaling simultaneously using zebrafish, which express probes for both. Endodermal sheet is required for the bilateral cardiac precursor cell (CPC) migration toward the midline. Endothelial cells (ECs) proliferate specifically in the certain regions of blood vessels. Bone morphogenetic proteins (BMP) induce the remodeling of the caudal vein plexus (CVP) to form the caudal vein (CV). Our findings point to the pre-existing neighboring cells as the cells exhibiting certain responses during the development of CVS. In this review, we introduce recent results of our research on angiogenesis and cardiogenesis by spotlighting the mechanism by which ECs and CPCs are regulated by the cells next to themselves. In addition, we discuss the unanswered questions that should be clarified in the future in the field of CVS development.	[Fukuhara, Shigetomo; Fukui, Hajime; Wakayama, Yuki; Ando, Koji; Nakajima, Hiroyuki; Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Cell Biol, Suita, Osaka 5658565, Japan; [Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr, JST CREST, Suita, Osaka 5658565, Japan	Mochizuki, N (reprint author), Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Cell Biol, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	nmochizu@ri.ncvc.go.jp					Kikuchi K, 2011, DEVELOPMENT, V138, P2895, DOI 10.1242/dev.067041; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; Fukuhara S, 2014, DEV BIOL, V393, P10, DOI 10.1016/j.ydbio.2014.06.015; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Osborne N, 2008, CURR BIOL, V18, P1882, DOI 10.1016/j.cub.2008.10.061; Weber T, 2013, METHODS, V62, P279, DOI 10.1016/j.ymeth.2013.07.028; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Kikuchi K, 2012, ANNU REV CELL DEV BI, V28, P719, DOI 10.1146/annurev-cellbio-101011-155739; Fujita M, 2011, DEVELOPMENT, V138, P1705, DOI 10.1242/dev.058776; Choi WY, 2013, DEVELOPMENT, V140, P660, DOI 10.1242/dev.088526; Fukuda K, 2005, DEV GROWTH DIFFER, V47, P343; Takeuchi T, 2014, DEV GROWTH DIFFER, V56, P402, DOI 10.1111/dgd.12134; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Kohli V, 2013, DEV CELL, V25, P196, DOI 10.1016/j.devcel.2013.03.017; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Covassin LD, 2009, DEV BIOL, V329, P212, DOI 10.1016/j.ydbio.2009.02.031; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Trinh LA, 2013, DEV GROWTH DIFFER, V55, P434, DOI 10.1111/dgd.12055; Kim JD, 2012, DEV CELL, V23, P441, DOI 10.1016/j.devcel.2012.07.007; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Pan YA, 2013, DEVELOPMENT, V140, P2835, DOI 10.1242/dev.094631; Chappell JC, 2012, CELLS TISSUES ORGANS, V195, P94, DOI 10.1159/000331398; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Pantazis P, 2014, NAT REV MOL CELL BIO, V15, P327, DOI 10.1038/nrm3786; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Fox K. E., 1999, J EXP ZOOL, V285, P283; Fukui H, 2014, DEV CELL, V31, P128, DOI 10.1016/j.devcel.2014.08.014; Heisenberg CP, 2002, SEMIN CELL DEV BIOL, V13, P471, DOI 10.1016/S1084952102001003; Kashiwada T, 2015, DEVELOPMENT, V142, P497, DOI 10.1242/dev.115576; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; Kohli V., 2011, J VISUALIZED EXP, V56, pe3172; Lippincott-Schwartz J, 2011, ANNU REV BIOCHEM, V80, P327, DOI 10.1146/annurev-biochem-121010-125553; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Phng LK, 2015, DEV CELL, V32, P123, DOI 10.1016/j.devcel.2014.11.017; Porrello ER, 2014, STEM CELL RES, V13, P556, DOI 10.1016/j.scr.2014.06.003; Sadok A, 2014, SMALL GTPASES, V5, DOI DOI 10.4161/SGTP.29710); Shcherbakova DM, 2014, ANNU REV BIOPHYS, V43, P303, DOI 10.1146/annurev-biophys-051013-022836; VANSBERLO JH, 2014, NATURE, V509, P337; Wakabayashi T, 2013, INVEST OPHTH VIS SCI, V54, P6686, DOI 10.1167/iovs.13-12342; Wakayama Y, 2015, DEV CELL, V32, P109, DOI 10.1016/j.devcel.2014.11.024; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	MAY	2015	57	4			SI		333	340		10.1111/dgd.12210		8	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CJ1FP	WOS:000355228300006		
J	Hayashi, S; Yokoyama, H; Tamura, K				Hayashi, Shinichi; Yokoyama, Hitoshi; Tamura, Koji			Roles of Hippo signaling pathway in size control of organ regeneration	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Review						Hippo pathway; organ regeneration; size control; Xenopus; Yap	AMPHIBIAN LIMB REGENERATION; TADPOLE TAIL REGENERATION; TUMOR-SUPPRESSOR PATHWAY; STEM-CELL PROLIFERATION; PROTEIN YAP; TISSUE REGENERATION; XENOPUS TADPOLE; GROWTH-CONTROL; IN-VIVO; CARDIOMYOCYTE PROLIFERATION	Animals have an intrinsic regeneration ability for injured tissues and organs. Species that have high regeneration ability such as newts can regenerate an organ with exactly the same size and shape as those of the original one. It has been unclear how a regenerating organ grows and ceases growth at an appropriate size. Organ size control in regeneration is seen in various organs of various species that have high regeneration ability. In animal species that do not have sufficient regeneration ability, a wound heals (the injury is closed, but lost parts are not regenerated), but an organ cannot be restored to its original size. On the other hand, perturbation of regeneration sometimes results in oversized or extra structures. In this sense, organ size control plays essential roles in proper regeneration. In this article, we introduce the concept of size control in organ regeneration regulated by the Hippo signaling pathway. We focused on the transcriptional regulator Yap, which shuttles between the nuclei and cytoplasm to exert a regulatory function in a context-dependent manner. The Yap-mediated Hippo pathway is thought to sense cell density, extracellular matrix (ECM) contact and cell position and to regulate gene expression for control of organ size. This mechanism can reasonably explain size control of organ regeneration.	[Hayashi, Shinichi; Yokoyama, Hitoshi; Tamura, Koji] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808578, Japan	Hayashi, S (reprint author), Univ Minnesota, Dept Genet Cell Biol & Dev, 321 Church St SE, Minneapolis, MN 55455 USA.	shayashi@umn.edu			Funding Program for Next Generation world-Leading Researchers from the Cabinet Office, Government of Japan [LS007]; MEXT; JSPS KAKENHI [22124005, 25870058]	We thank Dr Tetsuya Bando for valuable discussion on animal regeneration and Hippo signaling. This study was supported by Funding Program for Next Generation world-Leading Researchers from the Cabinet Office, Government of Japan to KT (LS007), MEXT and JSPS KAKENHI Grant Number 22124005 to HY, and JSPS KAKENHI Grant Number 25870058 to HY.	Agata K, 2012, DEV GROWTH DIFFER, V54, P143, DOI 10.1111/j.1440-169X.2011.01323.x; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Judson RN, 2012, J CELL SCI, V125, P6009, DOI 10.1242/jcs.109546; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Tseng AS, 2007, DEV BIOL, V301, P62, DOI 10.1016/j.ydbio.2006.10.048; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Ide H, 2012, DEV DYNAM, V241, P435, DOI 10.1002/dvdy.23728; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Agata K, 2007, DEV GROWTH DIFFER, V49, P73, DOI 10.1111/j.1440-169x.2007.00919.x; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Beck CW, 2009, DEV DYNAM, V238, P1226, DOI 10.1002/dvdy.21890; Slack JMW, 2004, PHILOS T ROY SOC B, V359, P745, DOI 10.1098/rstb.2004.1463; Lin G, 2008, DEV BIOL, V316, P323, DOI 10.1016/j.ydbio.2008.01.032; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Jiang Q, 2009, BIOCHEM BIOPH RES CO, V384, P114, DOI 10.1016/j.bbrc.2009.04.070; Ohgo S, 2010, DEV BIOL, V338, P148, DOI 10.1016/j.ydbio.2009.11.026; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Jeong H, 2010, FASEB J, V24, P3310, DOI 10.1096/fj.09-151324; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; DENT JN, 1962, J MORPHOL, V110, P61, DOI 10.1002/jmor.1051100105; Li YC, 2012, STEM CELLS, V30, P741, DOI 10.1002/stem.1030; Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Lin AYT, 2014, DEVELOPMENT, V141, P1197, DOI 10.1242/dev.101915; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Gaffney CJ, 2012, GENE, V509, P215, DOI 10.1016/j.gene.2012.08.025; Endo T, 2000, DEV BIOL, V220, P296, DOI 10.1006/dbio.2000.9641; Yakushiji N, 2007, DEV BIOL, V312, P171, DOI 10.1016/j.ydbio.2007.09.022; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Bely AE, 2010, TRENDS ECOL EVOL, V25, P161, DOI 10.1016/j.tree.2009.08.005; Kumar A, 2007, CR BIOL, V330, P485, DOI 10.1016/j.crvi.2007.01.006; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; Hao YW, 2008, J BIOL CHEM, V283, P5496; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; ITEN LE, 1976, J EXP ZOOL, V196, P293, DOI 10.1002/jez.1401960304; Slack JMW, 2008, CELL MOL LIFE SCI, V65, P54, DOI 10.1007/s00018-007-7431-1; Mercader N, 2005, DEVELOPMENT, V132, P4131, DOI 10.1242/dev.01976; Murawala P, 2012, SEMIN CELL DEV BIOL, V23, P954, DOI 10.1016/j.semcdb.2012.09.013; Fernando WA, 2011, DEV BIOL, V350, P301, DOI 10.1016/j.ydbio.2010.11.035; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hilman D, 2011, MOL BIOL EVOL, V28, P2403, DOI 10.1093/molbev/msr065; Gardiner DM, 2002, SEMIN CELL DEV BIOL, V13, P345, DOI 10.1016/S1084-9521(02)00090-3; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Grusche FA, 2011, DEV BIOL, V350, P255, DOI 10.1016/j.ydbio.2010.11.020; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Bando T, 2009, DEVELOPMENT, V136, P2235, DOI 10.1242/dev.035204; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Yakushiji N, 2009, SEMIN CELL DEV BIOL, V20, P565, DOI 10.1016/j.semcdb.2008.12.007; Van Hateren NJ, 2011, DEVELOPMENT, V138, P1893, DOI 10.1242/dev.064204; Nacu E, 2013, DEVELOPMENT, V140, P513, DOI 10.1242/dev.081752; Beck Caroline W, 2006, Mech Dev, V123, P674, DOI 10.1016/j.mod.2006.07.001; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Cai HQ, 2014, SCIENCE, V343, P1329, DOI 10.1126/science.1249531; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; Demircan T, 2013, STEM CELLS DEV, V22, P2174, DOI 10.1089/scd.2013.0006; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Fernandez LA, 2009, GENE DEV, V23, P2729, DOI DOI 10.1101/GAD.1824509; Flink IL, 2002, ANAT EMBRYOL, V205, P235, DOI 10.1007/s00429-002-0249-6; Gaete M, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-13; Gee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020309; Han Manjong, 2005, Anatomical Record Part B:The New Anatomist, V287, P14, DOI 10.1002/ar.b.20082; Hayashi S, 2014, DEV BIOL, V388, P57, DOI 10.1016/j.ydbio.2014.01.018; Hayashi S, 2014, DEV BIOL, V396, P31, DOI 10.1016/j.ydbio.2014.09.018; Hayashi S, 2007, DEV GROWTH DIFFER, V49, P229, DOI 10.1111/j.1440-169x.2007.00923.x; Heber-Katz E, 2013, CURR TOP MICROBIOL, V367, P253, DOI 10.1007/82_2012_294; Ivanova AS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01279; Kashio S, 2014, DEV GROWTH DIFFER, V56, P368, DOI 10.1111/dgd.12139; McLean KE, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-50; Nakamura T, 2008, CELL MOL LIFE SCI, V65, P64, DOI 10.1007/s00018-007-7432-0; Stocum DL, 2012, REGENERATIVE BIOLOGY AND MEDICINE, 2ND EDITION, P1; Suzuki M, 2006, THESCIENTIFICWORLDJO, V6, P26, DOI 10.1100/tsw.2006.325; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024288; Watt KI, 2010, BIOCHEM BIOPH RES CO, V393, P619, DOI 10.1016/j.bbrc.2010.02.034; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200	100	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	MAY	2015	57	4			SI		341	351		10.1111/dgd.12212		11	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CJ1FP	WOS:000355228300007		
J	Garbacz, M; Araki, H; Flis, K; Bebenek, A; Zawada, AE; Jonczyk, P; Makiela-Dzbenska, K; Fijalkowska, IJ				Garbacz, Marta; Araki, Hiroyuki; Flis, Krzysztof; Bebenek, Anna; Zawada, Anna E.; Jonczyk, Piotr; Makiela-Dzbenska, Karolina; Fijalkowska, Iwona J.			Fidelity consequences of the impaired interaction between DNA polymerase epsilon and the GINS complex	DNA REPAIR			English	Article						Fidelity of replication; DNA polymerase epsilon; GINS complex; DNA polymerase zeta; DNA polymerase delta; DNA leading strand	YEAST SACCHAROMYCES-CEREVISIAE; EUKARYOTIC REPLICATION FORK; ZETA-DEPENDENT MUTAGENESIS; ERROR-PRONE REPLICATION; CELL NUCLEAR ANTIGEN; CHROMOSOMAL DNA; BUDDING YEAST; NONCATALYTIC SUBUNIT; EXONUCLEASE ACTIVITY; SPONTANEOUS MUTATION	DNA polymerase epsilon interacts with the CMG (Cdc45-MCM-GINS) complex by Dpb2p, the noncatalytic subunit of DNA polymerase epsilon. It is postulated that CMG is responsible for targeting of Pot epsilon to the leading strand. We isolated a mutator dpb2-100 allele which encodes the mutant form of Dpb2p. We showed previously that Dpb2-100p has impaired interactions with Pol2p, the catalytic subunit of Pol epsilon. Here, we present that Dpb2-100p has strongly impaired interaction with the Psfl and Psf3 subunits of the GINS complex. Our in vitro results suggest that while dpb2-100 does not alter Pol epsilon's biochemical properties including catalytic efficiency, processivity or proofreading activity - it moderately decreases the fidelity of DNA synthesis. As the in vitro results did not explain the strong in vivo mutator effect of the dpb2-100 allele we analyzed the mutation spectrum in vivo. The analysis of the mutation rates in the dpb2-100 mutant indicated an increased participation of the error-prone DNA polymerase zeta in replication. However, even in the absence of Pol zeta activity the presence of the dpb2-100 allele was mutagenic, indicating that a significant part of mutagenesis is Pot zeta-independent. A strong synergistic mutator effect observed for transversions in the triple mutant dpb2-100 pol2-4 rev3 Delta as compared to pol2-4 rev3 Delta and dpb2-100 rev3 Delta suggests that in the presence of the dpb2-100 allele the number of replication errors is enhanced. We hypothesize that in the dpb2-100 strain, where the interaction between Pol epsilon and GINS is weakened, the access of Pol delta to the leading strand may be increased. The increased participation of Pol delta on the leading strand in the dpb2-100 mutant may explain the synergistic mutator effect observed in the dpb2-100 pol3-5DV double mutant. (C) 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Garbacz, Marta; Flis, Krzysztof; Zawada, Anna E.; Jonczyk, Piotr; Makiela-Dzbenska, Karolina; Fijalkowska, Iwona J.] Polish Acad Sci, Inst Biochem & Biophys, Lab Mutagenesis & DNA Repair, PL-02106 Warsaw, Poland; [Araki, Hiroyuki] Natl Inst Genet, Div Microbial Genet, Mishima, Shizuoka 4118540, Japan; [Bebenek, Anna] Polish Acad Sci, Inst Biochem & Biophys, Dept Mol Biol, PL-02106 Warsaw, Poland	Fijalkowska, IJ (reprint author), Polish Acad Sci, Inst Biochem & Biophys, Lab Mutagenesis & DNA Repair, Pawinskiego 5A, PL-02106 Warsaw, Poland.	kmakiela@ibb.waw.pl; fijalkowska.iwona@gmail.com			Ministry of Science and Higher Education, Poland [N N301 333439]; Foundation for Polish Science; European Union - Regional Development Fund [TEAM/2011-8/1]; NIG Collaborative Research [2009-A, 2011-A72, 2012-A9]	This work was supported by the Ministry of Science and Higher Education, Poland [N N301 333439]; Foundation for Polish Science co financed from European Union - Regional Development Fund [TEAM/2011-8/1] ("New players involved in the maintenance of genomic stability"); and NIG Collaborative Research [2009-A, 2011-A72, 2012-A9].	Abdulovic AL, 2008, NUCLEIC ACIDS RES, V36, P2082, DOI 10.1093/nar/gkn054; Adams A, 1997, METHODS YEAST GENETI; Aksenova A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001209; Albertson TM, 2006, CURR BIOL, V16, pR209, DOI 10.1016/j.cub.2006.02.031; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Zhong XJ, 2006, NUCLEIC ACIDS RES, V34, P4731, DOI 10.1093/nar/gkl465; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482; Sengupta S, 2013, CURR BIOL, V23, P543, DOI 10.1016/j.cub.2013.02.011; Larrea AA, 2010, P NATL ACAD SCI USA, V107, P17674, DOI 10.1073/pnas.1010178107; Hiraga SI, 2005, GENES CELLS, V10, P297, DOI 10.1111/j.1365-2443.2005.00843.x; Jaszczur M, 2009, MUTAT RES-FUND MOL M, V669, P27, DOI 10.1016/j.mrfmmm.2009.04.012; MORRISON A, 1993, EMBO J, V12, P1467; ARAKI H, 1991, NUCLEIC ACIDS RES, V19, P4867, DOI 10.1093/nar/19.18.4867; Langston LD, 2014, P NATL ACAD SCI USA, V111, P15390, DOI 10.1073/pnas.1418334111; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; SIKORSKI RS, 1989, GENETICS, V122, P19; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Henninger EE, 2014, IUBMB LIFE, V66, P339, DOI 10.1002/iub.1276; Tsubota T, 2003, GENES CELLS, V8, P873, DOI 10.1046/j.1365-2443.2003.00683.x; Rannou O, 2013, NUCLEIC ACIDS RES, V41, P5303, DOI 10.1093/nar/gkt207; Lawrence CW, 2002, DNA REPAIR, V1, P425, DOI 10.1016/S1568-7864(02)00038-1; Jin YH, 2005, MOL CELL BIOL, V25, P461, DOI 10.1128/MCB.25.1.471-471.2005; Kunkel TA, 2011, CURR OPIN CHEM BIOL, V15, P620, DOI 10.1016/j.cbpa.2011.07.025; Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Garcia-Diaz M, 2006, TRENDS BIOCHEM SCI, V31, P206, DOI 10.1016/j.tibs.2006.02.004; Grabowska E, 2014, MOL MICROBIOL, V92, P659, DOI 10.1111/mmi.12580; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; KUNKEL TA, 1994, P NATL ACAD SCI USA, V91, P6830, DOI 10.1073/pnas.91.15.6830; Shcherbakova PV, 1996, GENETICS, V142, P717; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; Ohya T, 2002, J BIOL CHEM, V277, P28099, DOI 10.1074/jbc.M111573200; Huebscher Ulrich, 2009, V521, P19, DOI [10.1007/978-1-60327-815-7_2, 10.1007/978-1-60327-817-5_2]; Fukui T, 2004, GENES CELLS, V9, P179, DOI 10.1111/j.1365-2443.2004.00716.x; MORRISON A, 1991, P NATL ACAD SCI USA, V88, P9473, DOI 10.1073/pnas.88.21.9473; Shcherbakova PV, 2003, J BIOL CHEM, V278, P43770, DOI 10.1074/jbc.M306893200; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Georgescu RE, 2014, NAT STRUCT MOL BIOL, V21, P664, DOI 10.1038/nsmb.2851; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200; SIMON M, 1991, EMBO J, V10, P2165; HARPER JW, 1993, CELL, V75, P805; Reha-Krantz LJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1049, DOI 10.1016/j.bbapap.2009.06.012; Karthikeyan R, 2000, J MOL BIOL, V299, P405, DOI 10.1006/jmbi.2000.3744; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Northam MR, 2006, EMBO J, V25, P4316, DOI 10.1038/sj.emboj.7601320; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Bermudez VP, 2011, J BIOL CHEM, V286, P28963, DOI 10.1074/jbc.M111.256289; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI [10.1016/j.tcb.2008.08.005, 10.1016/i.tcb.2008.08.005]; Watt DL, 2011, DNA REPAIR, V10, P897, DOI 10.1016/j.dnarep.2011.05.009; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Fortune JM, 2005, J BIOL CHEM, V280, P29980, DOI 10.1074/jbc.M505236200; ARAKI H, 1992, EMBO J, V11, P733; Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; ARAKI H, 1991, P NATL ACAD SCI USA, V88, P4601, DOI 10.1073/pnas.88.11.4601; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Bebenek A., 2002, GENETICS, V162, P10003; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; CASSIER C, 1980, GENETICS, V96, P841; Chilkova O, 2003, J BIOL CHEM, V278, P14082, DOI 10.1074/jbc.M211818200; Dua R, 1998, J BIOL CHEM, V273, P30046, DOI 10.1074/jbc.273.45.30046; Endo K, 2007, GENES GENET SYST, V82, P35, DOI 10.1266/ggs.82.35; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Goksenin AY, 2012, J BIOL CHEM, V287, P42675, DOI 10.1074/jbc.M112.422733; HAMATAKE RK, 1990, J BIOL CHEM, V265, P4072; Hashimoto K, 2003, BIOCHEMISTRY-US, V42, P14207, DOI 10.1021/bi0348359; Hogg Matthew, 2012, Subcell Biochem, V62, P237, DOI 10.1007/978-94-007-4572-8_13; Isoz I, 2012, NUCLEIC ACIDS RES, V40, P11545, DOI 10.1093/nar/gks880; Jaszczur M, 2008, GENETICS, V178, P633, DOI 10.1534/genetics.107.082818; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Kraszewska J, 2012, MUTAT RES-FUND MOL M, V737, P34, DOI 10.1016/j.mrfmmm.2012.06.002; Kroutil LC, 1998, J MOL BIOL, V278, P135, DOI 10.1006/jmbi.1998.1676; LEE SH, 1991, J BIOL CHEM, V266, P22707; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Miyabe I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002407; MORRISON A, 1993, PROG NUCLEIC ACID RE, V46, P93, DOI 10.1016/S0079-6603(08)61019-3; Nick McElhinny Stephanie A, 2010, Proc Natl Acad Sci U S A, V107, P4949, DOI 10.1073/pnas.0914857107; Nick McElhinny Stephanie A, 2010, Nat Chem Biol, V6, P774, DOI 10.1038/nchembio.424; Ohya T, 2000, NUCLEIC ACIDS RES, V28, P3846, DOI 10.1093/nar/28.20.3846; Pavlov YI, 2010, MUTAT RES-FUND MOL M, V685, P45, DOI 10.1016/j.mrfmmm.2009.08.002; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; Pospiech Helmut, 2003, ScientificWorldJournal, V3, P87; QUAH SK, 1980, GENETICS, V96, P819; ROBERTS JD, 1991, P NATL ACAD SCI USA, V88, P3465, DOI 10.1073/pnas.88.8.3465; ROCHE H, 1994, GENETICS, V137, P637; Rose M.D., 1990, METHODS YEAST GENETI; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Sambrook J., 1989, MOL CLONING LAB MANU; Shimizu K, 2002, J BIOL CHEM, V277, P37422, DOI 10.1074/jbc.M204476200; Stillman B, 2008, MOL CELL, V30, P259, DOI 10.1016/j.molcel.2008.04.011; SUGINO A, 1995, TRENDS BIOCHEM SCI, V20, P319, DOI 10.1016/S0968-0004(00)89059-3; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; Tanaka S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010371; Tsubotao T, 2006, J BIOL CHEM, V281, P32898, DOI 10.1074/jbc.M606637200	107	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	MAY	2015	29				SI		23	35		10.1016/j.dnarep.2015.02.007		13	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CJ2ZA	WOS:000355352000004		
J	Kanao, R; Yokoi, M; Ohkumo, T; Sakurai, Y; Dotsu, K; Kura, S; Nakatsu, Y; Tsuzuki, T; Masutani, C; Hanaoka, F				Kanao, Rie; Yokoi, Masayuki; Ohkumo, Tsuyoshi; Sakurai, Yasutaka; Dotsu, Kantaro; Kura, Shinobu; Nakatsu, Yoshimichi; Tsuzuki, Teruhisa; Masutani, Chikahide; Hanaoka, Fumio			UV-induced mutations in epidermal cells of mice defective in DNA polymerase eta and/or iota	DNA REPAIR			English	Article						DNA polymerase eta; DNA polymerase iota; Translesion synthesis; UV-induced mutagenesis; Xeroderma pigmentosum variant (XP-V)	CYCLOBUTANE PYRIMIDINE DIMERS; AFFECT SOMATIC HYPERMUTATION; PIGMENTOSUM VARIANT CELLS; ERROR-FREE; TRANSLESION SYNTHESIS; IN-VIVO; REPLICATIVE BYPASS; DEFICIENT MICE; THYMINE DIMER; KAPPA	Xeroderma pigmentosum variant (XP-V) is a human rare inherited recessive disease, predisposed to sunlight-induced skin cancer, which is caused by deficiency in DNA polymerase eta (Pol eta). Pol eta catalyzes accurate translesion synthesis (TLS) past pyrimidine dimers, the most prominent UV-induced lesions. DNA polymerase iota (Pol iota) is a paralog of Pol eta that has been suggested to participate in TLS past UV-induced lesions, but its function in vivo remains uncertain. We have previously reported that Pol eta-deficient and Pol eta/Pol iota double-deficient mice showed increased susceptibility to UV-induced carcinogenesis. Here, we investigated UV-induced mutation frequencies and spectra in the epidermal cells of Pol eta- and/or Pol iota-deficient mice. While Pol eta-deficient mice showed significantly higher UV-induced mutation frequencies than wild-type mice, Pol iota deficiency did not influence the frequencies in the presence of Pol eta. Interestingly, the frequencies in Pol eta/Pol iota double-deficient mice were statistically lower than those in Pol eta-deficient mice, although they were still higher than those of wild-type mice. Sequence analysis revealed that most of the UV-induced mutations in Pol eta-deficient and Pol eta/Pol iota double-deficient mice were base substitutions at dipyrimidine sites. An increase in UV-induced mutations at both G:C and A:T pairs associated with Pol eta deficiency suggests that Pol eta contributes to accurate TLS past both thymine- and cytosine-containing dimers in vivo. A significant decrease in G:C to A:T transition in Pol eta/Pol iota, double-deficient mice when compared with Pol eta-deficient mice suggests that Pol iota is involved in error-prone TLS past cytosine-containing dimers when Pol eta is inactivated. (C) 2015 Elsevier B.V. All rights reserved.	[Kanao, Rie; Yokoi, Masayuki; Ohkumo, Tsuyoshi; Sakurai, Yasutaka; Dotsu, Kantaro; Masutani, Chikahide; Hanaoka, Fumio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Kanao, Rie; Hanaoka, Fumio] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Kanao, Rie; Yokoi, Masayuki; Sakurai, Yasutaka; Dotsu, Kantaro; Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Toshima Ku, Tokyo 1718588, Japan; [Kanao, Rie; Masutani, Chikahide] Nagoya Univ, Environm Med Res Inst, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yokoi, Masayuki; Masutani, Chikahide; Hanaoka, Fumio] Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Tokyo, Japan; [Kura, Shinobu; Nakatsu, Yoshimichi; Tsuzuki, Teruhisa] Kyushu Univ, Fac Med Sci, Fukuoka 8128582, Japan	Hanaoka, F (reprint author), Gakushuin Univ, Fac Sci, Toshima Ku, 1-5-1 Mejiro, Tokyo 1718588, Japan.	fumio.hanaoka@gakushuin.ac.jp	Masutani, Chikahide/I-6160-2014		KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [17013053]; Solution Oriented Research for Science and Technology from the Japan Science and Technology Agency	We thank all of the members of the Hanaoka Laboratory at Osaka University for critical discussions and helpful comments. We are grateful to Dr. Haruo Ohmori (Gakushuin University) for his critical reading of the manuscript and valuable suggestions. This study was supported by KAKENHI (Grant-in Aid for Scientific Research) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (17013053 to F.H.) and by Solution Oriented Research for Science and Technology from the Japan Science and Technology Agency.	Gueranger Q, 2008, DNA REPAIR, V7, P1551, DOI 10.1016/j.dnarep.2008.05.012; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Jansen JG, 2005, NUCLEIC ACIDS RES, V33, P356, DOI 10.1093/nar/gki189; Egashira A, 2002, DNA REPAIR, V1, P881, DOI 10.1016/S1568-7864(02)00113-1; Watanabe N, 2013, J BIOL CHEM, V288, P10459, DOI 10.1074/jbc.M112.421966; Ohkumo T, 2006, MOL CELL BIOL, V26, P7696, DOI 10.1128/MCB.01076-06; Burger A, 2003, MUTAT RES-FUND MOL M, V522, P145, DOI 10.1016/S0027-5107(02)00310-X; Kannouche P, 2003, EMBO J, V22, P1223; Frank EG, 2007, J BIOL CHEM, V282, P24689, DOI 10.1074/jbc.M702159200; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Jansen JG, 2006, J EXP MED, V203, P319, DOI 10.1084/jem.20052227; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lange SS, 2013, P NATL ACAD SCI USA, V110, pE687, DOI 10.1073/pnas.1217425110; Busuttil RA, 2008, CANCER RES, V68, P2081, DOI 10.1158/0008-5472.CAN-07-6274; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Wittschieben JP, 2010, CANCER RES, V70, P2770, DOI 10.1158/0008-5472.CAN-09-4267; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; McNally K, 2008, DNA REPAIR, V7, P597, DOI 10.1016/j.dnarep.2007.12.013; Petta TB, 2008, EMBO J, V27, P2883, DOI 10.1038/emboj.2008.210; Haracska L, 2000, NAT GENET, V25, P458; Akagi JI, 2009, DNA REPAIR, V8, P585, DOI 10.1016/j.dnarep.2008.12.006; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Mouron S, 2013, NAT STRUCT MOL BIOL, V20, P1383, DOI 10.1038/nsmb.2719; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ogi T, 2006, NAT CELL BIOL, V8, P640, DOI 10.1038/ncb1417; Choi JH, 2006, MUTAT RES-FUND MOL M, V599, P58, DOI 10.1016/j.mrfmmm.2006.01.003; Choi JH, 2005, DNA REPAIR, V4, P211, DOI 10.1016/j.dnarep.2004.09.006; Dumstorf CA, 2006, P NATL ACAD SCI USA, V103, P18083, DOI 10.1073/pnas.0605247103; Friedberg EC, 2006, DNA REPAIR MUTAGENES; Gibbs P.E.M., 2007, P NATL ACAD SCI USA, V8, P4186; JIANG N, 1993, BIOCHEMISTRY-US, V32, P472, DOI 10.1021/bi00053a011; Lee DH, 2008, MUTAT RES-FUND MOL M, V641, P19, DOI 10.1016/j.mrfmmm.2008.02.006; Lin QC, 2006, CANCER RES, V66, P87, DOI 10.1158/0008-5472.CAN-05-1862; McCulloch SD, 2009, NUCLEIC ACIDS RES, V37, P2830, DOI 10.1093/nar/gkp103; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; Narita T, 2010, GENES CELLS, V15, P1228, DOI 10.1111/j.1365-2443.2010.01457.x; Ohashi E, 2000, GENE DEV, V14, P1589; O-Wang J., 2001, CANCER RES, V61, P5366; Pelle E, 2003, J INVEST DERMATOL, V121, P177, DOI 10.1046/j.1523-1747.2003.12330.x; Rogozin IB, 2001, HUM MUTAT, V17, P83, DOI 10.1002/1098-1004(200102)17:2<83::AID-HUMU1>3.0.CO;2-E; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2; Shimizu T, 2003, IMMUNOL LETT, V86, P265, DOI 10.1016/S0165-2478(03)00046-4; Sonneveld E, 2001, ONCOGENE, V20, P538, DOI 10.1038/sj.onc.1204125; Stary A, 2003, J BIOL CHEM, V278, P18767, DOI 10.1074/jbc.M211838200; Takasawa T., 2004, NUCLEIC ACIDS RES, V32, P1738; TESSMAN I, 1992, P NATL ACAD SCI USA, V89, P1159, DOI 10.1073/pnas.89.4.1159; Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259; Vaisman A, 2006, DNA REPAIR, V5, P210, DOI 10.1016/j.dnarep.2005.09.011; Vaisman A, 2003, DNA REPAIR, V2, P991, DOI 10.1016/S1568-7864(03)00094-6; Wang Y, 2007, CANCER RES, V67, P3018, DOI 10.1158/0008-5472.CAN-06-3073; WANG YC, 1993, MOL CELL BIOL, V13, P4276; Yagi Y, 2005, DNA REPAIR, V4, P1252, DOI 10.1016/j.dnarep.2005.06.010; Zhang YB, 2001, NUCLEIC ACIDS RES, V29, P928, DOI 10.1093/nar/29.4.928; Zvi O., 2009, P NATL ACAD SCI USA, V106, P11552	60	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	MAY	2015	29				SI		139	146		10.1016/j.dnarep.2015.02.006		8	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CJ2ZA	WOS:000355352000015		
J	Maki, Y; Furukawa, S; Kodama, Y; Sameshima, H; Ikenoue, T				Maki, Yohei; Furukawa, Seishi; Kodama, Yuki; Sameshima, Hiroshi; Ikenoue, Tsuyomu			Amniocentesis for threatened preterm labor with intact membranes and the impact on adverse outcome in infants born at 22 to 28 weeks of gestation	EARLY HUMAN DEVELOPMENT			English	Article						Amniocentesis; Chorioamnionitis; Intact membrane; Intra-amniotic infection; Long-term; Outcome; Preterm labor	INTRAAMNIOTIC INFECTION; INTRAUTERINE INFECTION; CLINICAL-SIGNIFICANCE; PREMATURE RUPTURE; INTERLEUKIN-6	Background: It remains unclear whether performing amniocentesis to detect intra-amniotic infection is useful for improving neonatal outcomes. Aims: To determine the efficacy of amniocentesis on the neonatal outcomes in women exhibiting threatened preterm labor and intact membranes. Study design: Retrospective cohort study Subjects: A total of 174 women with threatened preterm labor and intact membranes at 22 to 33 weeks of gestation. Women with obvious clinical chorioamnionitis, multifetal pregnancy and/or major anomalies were excluded. Outcome Measures: Neonatal short- and long-term outcomes Results: Sixty-seven women underwent amniocentesis (Tap group), while the remaining 107 did not. The prevalence of a positive Gram stain or a positive culture result was 10% in the Tap group. The overall outcomes were not statistically different between the two groups, with the exception of borderline significance (p = 0.052) in long-term outcomes, favoring the Tap group. We performed a subgroup analysis focusing on infants born at 22-28 weeks of gestation. Consequently, the Tap group had better neonatal outcomes than the no-Tap group with respect to both short-term (OR 0.19, 95%CI 0.07-0.55) and long-term (OR 0.15, 0.05-0.46) outcomes. A multivariate analysis revealed that after adjusting confounding factors, the gestational age at delivery (OR 0.4, 0.3-0.7) and amniocentesis (OR 0.1, 0.02-0.3) remained significantly different. Conclusions: Amniocentesis is useful for improving neonatal outcomes in infants born at 22-28 weeks of gestation to women exhibiting preterm labor and intact membranes. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Maki, Yohei; Furukawa, Seishi; Kodama, Yuki; Sameshima, Hiroshi; Ikenoue, Tsuyomu] Miyazaki Univ, Dept Obstet & Gynecol, Fac Med, Ctr Perinatal Med, Kiyotake, Miyazaki 8891692, Japan	Sameshima, H (reprint author), Miyazaki Univ, Dept Obstet & Gynecol, Fac Med, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	yohei_maki@med.miyazaki-u.ac.jp; seishi_furukawa@mcpsed.miyazaki-u.ac.jp; yuki_kodama@med.miyazaki-u.ac.jp; hsameshima@med.miyazaki-u.ac.jp; tsuyomu_ikenoue@med.miyazaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [79-258]; JAOG Ogyaa Donation Foundation; Japan Society for the Promotion of Science [24592476, 24592477]	This study was supported by a grant (no. 79-258) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, a grant from the JAOG Ogyaa Donation Foundation, and a Grant-in-Aid for Scientific Research (nos. 24592476 and 24592477) from the Japan Society for the Promotion of Science.	Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1124, DOI 10.1067/mob.2000.109035; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; CHAIM W, 1992, ARCH GYNECOL OBSTET, V251, P9, DOI 10.1007/BF02718273; Leviton A, 2010, PEDIATR RES, V67, P95, DOI 10.1203/PDR.0b013e3181bf5fab; FEINSTEIN SJ, 1986, OBSTET GYNECOL, V68, P147; GIBBS RS, 1991, AM J OBSTET GYNECOL, V164, P1317; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P839; Kim CJ, 2001, AM J OBSTET GYNECOL, V185, P496, DOI 10.1067/mob.2001.116689; Cunningham FG, 2014, WILLIAMS OBSTET, P842; Gleason CA, 2011, AVERYS DIS NEWBORN, P538; Lau J, 2005, AM J OBSTET GYNECOL, V193, P706; Maritinelli P, 2012, J MATERN FETAL NE S4, V25, P29; Morales W J, 1987, J Perinatol, V7, P105	16	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-3782	1872-6232		EARLY HUM DEV	Early Hum. Dev.	MAY	2015	91	5					333	337		10.1016/j.earlhumdev.2015.03.006		5	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CI8OB	WOS:000355030500007		
J	Sukhbaatar, U; Mijiddorj, T; Oride, A; Kanasaki, H				Sukhbaatar, Unurjargal; Mijiddorj, Tselmeg; Oride, Aki; Kanasaki, Haruhiko			Stimulation of delta subunit-containing GABAA receptor by DS1 increases GnRH receptor expression but reduces GnRH mRNA expression in GnRH-producing GT1-7 cells	ENDOCRINE			English	Article						GABA(A) receptor; GnRH; GnRH receptor; PACAP; Kisspeptin	GONADOTROPIN-RELEASING-HORMONE; GAMMA-AMINOBUTYRIC-ACID; DIFFERENTIAL REGULATION; GENE-EXPRESSION; L-BETA-T2 CELLS; NEURONS; ACTIVATION; INHIBITION; PUBERTY; MOUSE	Acting via ionotropic GABA(A) receptors, the neurotransmitter c-aminobutyric acid (GABA) is an important modulator of gonadotropin-releasing hormone (GnRH) neurons. In the present study, we examined the effect of DS1, a GABA(A) alpha 4 beta 3 delta receptor agonist, on a strain of mouse hypothalamic immortalized GnRH neuronal cells, the GT1-7 cell line. DS1 increased the activities of serum-response element (SRE) and cAMP-response element (CRE) promoters, which reflect the activities of extracellular signal-regulated kinase and cAMP/protein kinase A (PKA) pathways, respectively. In G protein-coupled receptor 54 (GPR54)-overexpressing GT1-7 cells, both DS1 and kisspeptin-10 stimulated SRE promoter activity, and combined treatment with DS1 and kisspeptin further increased SRE promoter activity compared with DS1 or kisspeptin alone. Pituitary adenylate cyclase-activating polypeptide (PACAP) increased CRE promoter activity in PACAP type I receptor-overexpressing GT1-7 cells, with an effect similar to that of DS1 alone, and combined stimulation with PACAP and DS1 potentiated their individual effects. DS1 stimulated the transcriptional activity of GnRH receptor, and DS1 induced GnRH receptor mRNA and protein expression. PACAP-increased GnRH receptor expression was enhanced in the presence of DS1. However, DS1 significantly inhibited the basal expression of GnRH mRNA in GT1-7 cells. Our current observations suggest that DS1 exerts its stimulatory effect on the intracellular signal transduction system via GABA(A) alpha 4 beta 3 delta receptors in GnRH-producing neurons. Stimulation with DS1 increased the expression of GnRH receptor but decreased the basal expression of GnRH mRNA.	[Sukhbaatar, Unurjargal; Mijiddorj, Tselmeg; Oride, Aki; Kanasaki, Haruhiko] Shimane Univ, Sch Med, Dept Obstet & Gynecol, Izumo, Shimane 6938501, Japan	Kanasaki, H (reprint author), Shimane Univ, Sch Med, Dept Obstet & Gynecol, 89-1 Enya, Izumo, Shimane 6938501, Japan.	kanasaki@med.shimane-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (H.K.).	Keen KL, 1999, ENDOCRINOLOGY, V140, P5257, DOI 10.1210/en.140.11.5257; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Chandra D, 2010, NEUROPSYCHOPHARMACOL, V35, P999, DOI 10.1038/npp.2009.203; Yin C, 2008, J NEUROENDOCRINOL, V20, P566, DOI 10.1111/j.1365-2826.2008.01697.x; Pape JP, 2001, NEUROENDOCRINOLOGY, V74, P300, DOI 10.1159/000054697; DeFazio RA, 2002, MOL ENDOCRINOL, V16, P2872, DOI 10.1210/me.2002-0163; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Bhattarai JP, 2011, ENDOCRINOLOGY, V152, P1551, DOI 10.1210/en.2010-1191; Krsmanovic LZ, 1999, ENDOCRINOLOGY, V140, P1423, DOI 10.1210/en.140.3.1423; ADLER BA, 1986, ENDOCRINOLOGY, V118, P91; Maguire J, 2007, J NEUROSCI, V27, P2155, DOI 10.1523/JNEUROSCI.4945-06.2007; Moenter SM, 2005, ENDOCRINOLOGY, V146, P5374, DOI 10.1210/en.2005-0788; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Jackson G L, 2002, Reprod Suppl, V59, P15; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; Ferreira SA, 1998, BIOL REPROD, V58, P1038, DOI 10.1095/biolreprod58.4.1038; Herbison AE, 2011, J NEUROENDOCRINOL, V23, P557, DOI 10.1111/j.1365-2826.2011.02145.x; Spergel DJ, 1999, J NEUROSCI, V19, P2037; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; Beltran-Parrazal L, 2001, ENDOCRINE, V14, P189, DOI 10.1385/ENDO:14:2:189; Crowley W F Jr, 1985, Recent Prog Horm Res, V41, P473; Garyfallou VT, 2006, BRAIN RES, V1086, P50, DOI 10.1016/j.brainres.2006.02.105; HALES TG, 1994, NEUROENDOCRINOLOGY, V59, P297, DOI 10.1159/000126671; Kanasaki H, 2009, BIOL REPROD, V81, P465, DOI 10.1095/biolreprod.108.074765; Kanasaki H, 2013, GEN COMP ENDOCR, V193, P95, DOI 10.1016/j.ygcen.2013.07.013; Kanasaki H, 2011, REGUL PEPTIDES, V167, P227, DOI 10.1016/j.regpep.2011.02.010; KROGSGAARDLARSEN P, 1979, J NEUROCHEM, V32, P1717, DOI 10.1111/j.1471-4159.1979.tb02284.x; LERANTH C, 1985, NEUROENDOCRINOLOGY, V40, P536, DOI 10.1159/000124127; Martin C, 2007, NEUROENDOCRINOLOGY, V85, P257, DOI 10.1159/000103557; Martinez-Fuentes AJ, 2004, MOL ENDOCRINOL, V18, P1808, DOI 10.1210/me.2003-0321; Shintani N, 2000, BBA-BIOMEMBRANES, V1509, P195, DOI 10.1016/S0005-2736(00)00295-9; Sukhbaatar U, 2014, ENDOCR J, V61, P25; Sukhbaatar U, 2013, GEN COMP ENDOCR, V194, P94, DOI 10.1016/j.ygcen.2013.09.002; Sun W, 1997, BRAIN RES, V747, P70, DOI 10.1016/S0006-8993(96)01228-0; Wafford KA, 2009, NEUROPHARMACOLOGY, V56, P182, DOI 10.1016/j.neuropharm.2008.08.004; Watanabe M, 2009, BIOL REPROD, V81, P327, DOI 10.1095/biolreprod.108.074583; Wray S, 1996, DEV BIOL, V180, P631, DOI 10.1006/dbio.1996.0334	41	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1355-008X	1559-0100		ENDOCRINE	Endocrine	MAY	2015	49	1					222	230		10.1007/s12020-014-0464-y		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CJ1GM	WOS:000355231900027		
J	Taguchi, T; Nakajima, H; Terada, Y				Taguchi, Takafumi; Nakajima, Hideki; Terada, Yoshio			Graves' dermopathy and acropachy	ENDOCRINE			English	Editorial Material									[Taguchi, Takafumi; Terada, Yoshio] Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Nankoku, Kochi 7838505, Japan; [Nakajima, Hideki] Kochi Univ, Kochi Med Sch, Dept Dermatol, Nankoku, Kochi 7838505, Japan	Taguchi, T (reprint author), Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Oko Cho, Nankoku, Kochi 7838505, Japan.	ttagu27k@axel.ocn.ne.jp					Fatourechi V, 2003, THYROID, V13, P1141, DOI 10.1089/10507250360731541; Verma Shyam, 2013, Dermatol Online J, V19, P9	2	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1355-008X	1559-0100		ENDOCRINE	Endocrine	MAY	2015	49	1					296	297		10.1007/s12020-014-0389-5		2	Endocrinology & Metabolism	Endocrinology & Metabolism	CJ1GM	WOS:000355231900039		
J	Wakui, T; Yokoyama, R				Wakui, Tetsuya; Yokoyama, Ryohei			Optimal structural design of residential cogeneration systems with battery based on improved solution method for mixed-integer linear programming	ENERGY			English	Article						Cogeneration; Battery; Structural design; Operational planning; Optimization; Mixed-integer linear programming	ENERGY SUPPLY-SYSTEMS; DISTRIBUTED GENERATION SYSTEMS; POWER INTERCHANGE OPERATION; MICRO-COMBINED HEAT; CHP SYSTEMS; TRIGENERATION SYSTEMS; ENVIRONMENTAL ASPECTS; GAS-ENGINE; OPTIMIZATION; DISPATCH	An optimal structural design model of residential cogeneration systems with a battery is developed using an MILP (mixed-integer linear programming) approach. A battery is introduced as a device candidate to increase operational flexibility of cogeneration units without electric power export. In this model, the selection from device candidates and multi-period operation of selected devices, in which various operational restrictions are considered, are simultaneously optimized so as to minimize annual primary energy consumption. For a battery, not only charging and discharging losses and an upper limit of charging and discharging electric power but also charging-discharging status and electric power consumption in a built-in bidirectional inverter are uniquely incorporated into the model. In addition, the solution method for this MILP problem is improved using a simple decomposition approach. The developed model is then applied to the structural design of a residential cogeneration system with a battery for simulated energy demands in Japan. The results reveal the effectiveness of the simple decomposition approach and the increase in the energy-saving effect of the residential cogeneration system by the introduction of the battery, as a consequence of the increase in the electric capacity factor of the cogeneration unit by the charge of surplus electric power. Moreover, it is shown that this increase strongly depends on the battery performances. (C) 2015 Elsevier Ltd. All rights reserved.	[Wakui, Tetsuya; Yokoyama, Ryohei] Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, Sakai, Osaka 5998531, Japan	Wakui, T (reprint author), Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	wakui@ese.me.osakafu-u.ac.jp					Wakui T, 2011, ENERGY, V36, P3816, DOI 10.1016/j.energy.2010.09.025; Onovwiona HI, 2006, RENEW SUST ENERG REV, V10, P389, DOI 10.1016/j.rser.2004.07.005; Wakui T, 2010, ENERGY, V35, P740, DOI 10.1016/j.energy.2009.09.029; Ren H, 2008, APPL THERM ENG, V28, P514, DOI 10.1016/j.applthermaleng.2007.05.001; Ashouri A, 2013, ENERGY, V59, P365, DOI 10.1016/j.energy.2013.06.053; Bianchi M, 2013, APPL ENERG, V112, P928, DOI 10.1016/j.apenergy.2013.01.088; Bianchi M, 2012, APPL ENERG, V97, P673, DOI 10.1016/j.apenergy.2011.11.023; Fubara TC, 2014, APPL ENERG, V114, P327, DOI 10.1016/j.apenergy.2013.09.069; Kavvadias KC, 2010, ENERG CONVERS MANAGE, V51, P833, DOI 10.1016/j.enconman.2009.11.019; Rubio-Maya C, 2011, APPL ENERG, V88, P449, DOI 10.1016/j.apenergy.2010.07.009; Carvalho M, 2012, APPL ENERG, V91, P245, DOI 10.1016/j.apenergy.2011.09.029; Hawkes A, 2005, J POWER SOURCES, V149, P72, DOI 10.1016/j.jpowsour.2005.01.008; Austin BT, 2011, RENEW SUST ENERG REV, V15, P4013, DOI 10.1016/j.rser.2011.07.021; Carvalho M, 2011, ENERGY, V36, P3779, DOI 10.1016/j.energy.2010.09.023; Horiuchi K, 2013, ECS TRANSACTIONS, V57, P3, DOI 10.1149/05701.0003ecst; Winter M, 2004, CHEM REV, V104, P4245, DOI 10.1021/cr020730k; Arcuri P, 2007, ENERGY, V32, P1430, DOI 10.1016/j.energy.2006.10.023; Pruitt KA, 2013, APPL ENERG, V102, P386, DOI 10.1016/j.apenergy.2012.07.030; Fazlollahi S, 2012, ENERGY, V45, P12, DOI 10.1016/j.energy.2012.02.046; Lozano MA, 2010, ENERGY, V35, P794, DOI 10.1016/j.energy.2009.08.022; Wakui T, 2014, ENERGY, V68, P29, DOI 10.1016/j.energy.2014.01.110; [Anonymous], 2012, GAMS SOLV MAN, P85; Yokoyama R, 2002, ENERG CONVERS MANAGE, V43, P771, DOI 10.1016/S0196-8904(01)00075-9; Arun P, 2008, ENERGY, V33, P1155, DOI 10.1016/j.energy.2008.02.008; Fux SF, 2013, RENEW ENERG, V55, P438, DOI 10.1016/j.renene.2012.12.034; Maghanki MM, 2013, RENEW SUST ENERG REV, V28, P510, DOI 10.1016/j.rser.2013.07.053; Azit AH, 2009, IEEE T ENERGY CONVER, V24, P950, DOI 10.1109/TEC.2009.2026620; Beihong Z., 2006, ENERG BUILDINGS, V38, P189, DOI DOI 10.1016/J.ENBUILD.2005.05.009; Buoro D, 2012, ENERG CONVERS MANAGE, V60, P96, DOI 10.1016/j.enconman.2012.02.008; Fragaki A, 2008, ENERGY, V33, P1659, DOI 10.1016/j.energy.2008.05.011; Inada R, 2009, ELECT ENG JPN, V166, P9; Institute for Building Environment and Energy Conservation, CALC METH PRIM EN CO; Ito Y, 2011, INT GAS RES C P, V3, P2339; Kim J, 2010, ENERGY, V35, P5121, DOI 10.1016/j.energy.2010.08.003; Pruitt KA, 2014, OPTIM ENG, V15, P167, DOI 10.1007/s11081-013-9226-6; Rosenthal R. E., 2012, GAMS USERS GUIDE; Shaneb OA, 2011, ENERG BUILDINGS, V43, P1991, DOI 10.1016/j.enbuild.2011.04.005; Tanaka H, 2011, INT GAS RES C P, V4, P2597; Wakui T, 2014, ENERGY, V64, P719, DOI 10.1016/j.energy.2013.10.002; Wakui T, 2012, ENERGY, V41, P65, DOI 10.1016/j.energy.2011.06.056; Wakui T, 2014, ENERG CONVERS MANAGE, V77, P40, DOI 10.1016/j.enconman.2013.09.018; Wakui T, 2012, ENERG CONVERS MANAGE, V60, P170, DOI 10.1016/j.enconman.2012.01.021; Wakui T, 2015, ENERGY, V81, P120, DOI 10.1016/j.energy.2014.12.002; Wakui T, 2009, ENERGY, V34, P2092, DOI 10.1016/j.energy.2008.08.019; Yokoyama R, 2014, ENERG CONVERS MANAGE, V84, P196, DOI 10.1016/j.enconman.2014.03.045; Yokoyama R, 2015, J ENG GAS TURB POWER, V137, DOI 10.1115/1.4028211; Zhang XW, 2013, ENERGY, V52, P165, DOI 10.1016/j.energy.2013.01.013	47	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0360-5442	1873-6785		ENERGY	Energy	MAY 1	2015	84						106	120		10.1016/j.energy.2015.02.056		15	Thermodynamics; Energy & Fuels	Thermodynamics; Energy & Fuels	CI8QD	WOS:000355035900012		
J	Morimoto, M; Sato, T; Araki, S; Tanaka, R; Yamamoto, H; Sato, S; Takanohashi, T				Morimoto, Masato; Sato, Takashi; Araki, Sadao; Tanaka, Ryuzo; Yamamoto, Hideki; Sato, Shinya; Takanohashi, Toshimasa			Mapping the Degree of Asphaltene Aggregation, Determined Using Rayleigh Scattering Measurements and Hansen Solubility Parameters	ENERGY & FUELS			English	Article							PETROLEUM ASPHALTENES; MODEL	The degree of asphaltene aggregation (D-agg) over a wide range of concentrations in various solvents under ambient conditions was examined using a quantitative index derived from Rayleigh scattering measurements by ultraviolet-visible spectrometry and the Hansen solubility parameter (HSP). The source of asphaltene was Canadian oil sand bitumen. The target concentration was <= 10%, and the source of the solvent was organic solvents having Delta delta <= 5.5 MPa0.5 of the HSP distance between each solvent and the asphaltene, such as toluene (TL), bromobenzene (BB), and toluene pentane (TL-PT), toluene-bromobenzene (TL-BB), and toluene quinoline (TL-QL) mixed solvents. Through these measurements, the effects of the concentration and solvent on D-agg were examined quantitatively, which enabled the mapping of D-agg. The D-agg map obtained facilitates estimation of D-agg under desired conditions, understanding of asphaltene aggregation behavior, and creation of a reasonable aggregation model.	[Morimoto, Masato; Sato, Shinya; Takanohashi, Toshimasa] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Adv Fuel Grp, Tsukuba, Ibaraki 3058569, Japan; [Sato, Takashi; Araki, Sadao; Yamamoto, Hideki] Kansai Univ, Fac Environm & Urban Engn, Dept Chem Energy & Environm Engn, Suita, Osaka 5648680, Japan; [Tanaka, Ryuzo] Japan Petr Energy Ctr, Adv Technol & Res Inst, Petrole Lab, Midori Ku, Chiba 2670056, Japan	Morimoto, M (reprint author), Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Adv Fuel Grp, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	m.morimoto@aist.go.jp			Japan Petroleum Energy Center (JPEC)	This research was supported by the Japan Petroleum Energy Center (JPEC) as a technological development project entrusted by the Ministry of Economy, Trade, and Industry. Prof. Murray Gray provided the asphaltene and valuable suggestions regarding Rayleigh scattering measurements.	Derakhshesh M, 2013, ENERG FUEL, V27, P680, DOI 10.1021/ef3015958; Hoepfner MP, 2013, LANGMUIR, V29, P15423, DOI 10.1021/la403531w; Sato T, 2014, ENERG FUEL, V28, P891, DOI 10.1021/ef402065j; Buckley JS, 1998, PET SCI TECHNOL, V16, P251, DOI 10.1080/10916469808949783; Redelius P, 2004, ENERG FUEL, V18, P1087, DOI 10.1021/ef0400058; Tanaka R, 2004, ENERG FUEL, V18, P1118, DOI 10.1021/ef034082z; Gray MR, 2011, ENERG FUEL, V25, P3125, DOI 10.1021/ef200654p; Tanaka R, 2003, ENERG FUEL, V17, P127, DOI 10.1021/ef020019i; Barre L, 2009, OIL GAS SCI TECHNOL, V64, P617, DOI 10.2516/ogst/2009022; Hoepfner MP, 2013, LANGMUIR, V29, P8799, DOI 10.1021/la401406k; Mullins OC, 2012, ENERG FUEL, V26, P3986, DOI 10.1021/ef300185p; Eyssautier J, 2011, J PHYS CHEM B, V115, P6827, DOI 10.1021/jp111468d; Dechaine G. P., 2010, THESIS U ALBERTA EDM; Dechaine GP, 2011, ENERG FUEL, V25, P509, DOI 10.1021/ef101050a; Hansen C M, 2007, HANSEN SOLUBILITY PA; Mullins O.C., 2007, ASPHALTENES HEAVY OI; Redelius P., 2007, HANSEN SOLUBILITY PA, V2nd, P151, DOI 10.1201/9781420006834.ch9; van de Hulst H C, 1981, LIGHT SCATTERING SMA; Yen T. F., 1994, ASPHALTENES ASPHALTS, V1	19	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	MAY	2015	29	5					2808	2812		10.1021/ef502053c		5	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CJ0IE	WOS:000355158200008		
J	Li, X; Priyanto, DE; Ashida, R; Miura, K				Li, Xian; Priyanto, Dedy Eka; Ashida, Ryuichi; Miura, Kouichi			Two-Stage Conversion of Low-Rank Coal or Biomass into Liquid Fuel under Mild Conditions	ENERGY & FUELS			English	Article							CROSS-LINKING REACTIONS; DIRECT LIQUEFACTION; HYDROTHERMAL TREATMENT; RAPID LIQUEFACTION; BROWN-COAL; LIGNITE; RESIDUE; REACTOR; YIELD	The authors have recently proposed a novel degradative solvent extraction method that upgrades and fractionates various types of low-rank coals or biomass wastes into several different molecular weight fractions at around 350 degrees C. The lowest molecular weight fraction that was recovered as solid (termed soluble) by the yield of 19.4-71.7 wt % on a carbon basis had unique and almost raw-material-independent properties: almost free from ash and moisture, average molecular weight of around 300, carbon content of as high as 81.5-84.8 wt %, and oxygen content of as low as 6.5-12.1 wt %. In this work, the combination of the proposed extraction method and the liquefaction of the soluble under mild conditions was investigated as a two-stage liquefaction method to produce liquid fuel. A rice straw (RS) and a brown coal (LY) were extracted by the proposed extraction method to produce solubles by the yields of 31.5 and 21.7 wt %, respectively. The solubles produced were then liquefied at 400 degrees C using FeOOH/sulfur as the catalyst under the H-2 pressure of as low as 2.0 MPa (at room temperature). Then, 62.1 wt % of RS soluble and 56.8 wt % of LY soluble were converted to the liquid fraction (oil), excluding H2O. The oxygen contents of the oils produced from the two-stage liquefactions of RS and LY were as low as 2.2 and 3.9 wt %, respectively, much lower than those from the direct liquefaction of the raw materials (single-stage liquefaction). Furthermore, both the amount of CO2 emitted and the amount of H-2 consumed during the two-stage liquefaction were much less than those of the single-stage liquefaction. Thus, it was shown that combining the degradative solvent extraction method and the liquefaction of the soluble is a promising method to produce high-quality liquid fuel from low-rank coals and/or biomass wastes.	[Li, Xian; Priyanto, Dedy Eka; Ashida, Ryuichi; Miura, Kouichi] Kyoto Univ, Dept Chem Engn, Nishigyo Ku, Kyoto 6158510, Japan	Miura, K (reprint author), Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan.	miura@iae.kyoto-u.ac.jp					Wannapeera J, 2012, ENERG FUEL, V26, P4521, DOI 10.1021/ef3003153; Wang C, 2008, BIORESOURCE TECHNOL, V99, P2778, DOI 10.1016/j.biortech.2007.06.023; DERBYSHIRE F, 1986, FUEL, V65, P1233, DOI 10.1016/0016-2361(86)90235-8; Behrendt F, 2008, CHEM ENG TECHNOL, V31, P667, DOI 10.1002/ceat.200800077; Yamada T, 1999, BIORESOURCE TECHNOL, V70, P61, DOI 10.1016/S0960-8524(99)00008-5; Liu ZY, 2010, CHEM ENG SCI, V65, P12, DOI 10.1016/j.ces.2009.05.014; SONG C, 1989, FUEL, V68, P287, DOI 10.1016/0016-2361(89)90089-6; Lv DM, 2015, FUEL, V145, P143, DOI 10.1016/j.fuel.2014.12.075; Li X, 2012, ENERG FUEL, V26, P6897, DOI 10.1021/ef301364p; Wang ZQ, 2012, FUEL PROCESS TECHNOL, V94, P34, DOI 10.1016/j.fuproc.2011.10.007; SOLOMON PR, 1990, ENERG FUEL, V4, P42, DOI 10.1021/ef00019a009; Ghani ZA, 2011, ASIA-PAC J CHEM ENG, V6, P581, DOI 10.1002/apj.442; Inoue T, 2012, ENERG FUEL, V26, P2198, DOI 10.1021/ef300095s; Inoue T, 2012, ENERG FUEL, V26, P5821, DOI 10.1021/ef300999r; Zhang JB, 2013, CARBON, V55, P221, DOI 10.1016/j.carbon.2012.12.030; Cheng SN, 2010, ENERG FUEL, V24, P4659, DOI 10.1021/ef901218w; Cai JQ, 2008, FUEL, V87, P3388, DOI 10.1016/j.fuel.2008.06.001; DERBYSHIRE F, 1987, FUEL, V66, P1741, DOI 10.1016/0016-2361(87)90375-9; Li X., 2013, P 12 JAP CHIN S COAL; Li Y, 2012, FUEL, V94, P617, DOI 10.1016/j.fuel.2011.10.031; Makino M., 2010, P 27 INT PITTSB COAL, P11; Miura K., 1998, P 15 INT PITTSB COAL; Mott R. A., 1940, FUEL, V19, P242; Okuma O., 2004, ADV SCI VICTORIAN BR, P401, DOI 10.1016/B978-008044269-3/50009-1; Sugano M, 2012, FUEL, V101, P228, DOI 10.1016/j.fuel.2010.12.002; Sun QY, 2005, ENERG FUEL, V19, P1160, DOI 10.1021/ef049859i; Wang ZQ, 2010, FUEL PROCESS TECHNOL, V91, P410, DOI 10.1016/j.fuproc.2009.05.010; Yilgin M, 2004, ENERG CONVERS MANAGE, V45, P2687, DOI 10.1016/j.enconman.2003.12.010; Zhang Z., 2015, P 8 INT S COAL COMB	29	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	MAY	2015	29	5					3127	3133		10.1021/ef502574b		7	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CJ0IE	WOS:000355158200043		
J	Ikeura, H; Sato, K				Ikeura, Hiromi; Sato, Kanami			Pelletizing of spinach and honewort plant parts, and analysis of their pellet inorganic components and combustion ash	ENVIRONMENTAL PROGRESS & SUSTAINABLE ENERGY			English	Article						pellet; combustion; spinach; honewort		Recently, plant factory is becoming widespread and drumming up in Japan. Agricultural residues have generated from there, are disposed of as waste after harvesting. We aimed to demonstrate the effectiveness of honewort leaves, stems and roots, and spinach roots as a pellet material, and investigated combustion tests in order to pelletize honewort leaves, stems and roots and spinach roots. Moreover, inorganic component in their pellets and combustion ash of their pellets was analyzed. Honewort leaves, stems and roots, and spinach roots could be pelletized in 11% wet. Next, although honewort pellets could not be combusted continuously, spinach pellets could be combusted the same level as wood pellets. Inorganic contents in their pellets combustion ash were significantly higher than those in wood pellets. These results indicated that spinach pellets and its combustion ash can be utilized as an energy source and fertilizer. (c) 2014 American Institute of Chemical Engineers Environ Prog, 34: 819-822, 2015	[Ikeura, Hiromi] Meiji Univ, Org Strateg Coordinat Res & Intellectual Properti, Tama Ku, Kawasaki, Kanagawa 2148571, Japan; [Sato, Kanami] Meiji Univ, Sch Agr, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Ikeura, H (reprint author), Meiji Univ, Org Strateg Coordinat Res & Intellectual Properti, Tama Ku, 1-1-1 Higashimita, Kawasaki, Kanagawa 2148571, Japan.	hikeura@meiji.ac.jp					Akahoshi Y., 2009, J JPN I ENERGY, V88, P900; Samuelsson R, 2009, FUEL PROCESS TECHNOL, V90, P1129, DOI 10.1016/j.fuproc.2009.05.007; FADRUS H, 1975, ANALYST, V100, P549, DOI 10.1039/an9750000549; Kulcu R, 2004, BIORESOURCE TECHNOL, V93, P49, DOI 10.1016/j.biortech.2003.10.007; Gonzalez JF, 2004, BIOMASS BIOENERG, V27, P145, DOI 10.1016/j.biombioc.2004.01.004; BASSON WD, 1981, FRESEN Z ANAL CHEM, V307, P373, DOI 10.1007/BF00480116; Gill M. V., 2010, BIORESOURCE TECHNOLO, V101, P8859; GOH KM, 1972, J SCI FOOD AGR, V23, P275, DOI 10.1002/jsfa.2740230303; Ikeda H., 2010, PLANT FACTORY BUSINE, P26; Olsson M, 2004, BIOMASS BIOENERG, V27, P607, DOI 10.1016/j.biombioe.2003.08.018; Peksa-Blauchard M., 2007, GLOBAL WOOD PELLETS; RESCH H, 1982, HOLZFORSCH HOLZVERW, V34, P69; Sakuma M., 2007, REPORTS FUJI BAMBOO, V51, P129; Sato Kanami, 2012, Journal of the Japan Society of Material Cycles and Waste Management, V23, DOI 10.3985/jjsmcwm.1111002; Tani Y., 2009, JAPAN TAPPI J, V63, P1465; Uchiyama T., 2001, KINKI CHUGOKU AGR RE, V102, P12; Watanabe K., 2010, ENGEISAKUMOTSU NO EI, P28; Woods JT, 1941, IND ENG CHEM, V13, P0760, DOI 10.1021/i560099a003	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1944-7442	1944-7450		ENVIRON PROG SUSTAIN	Environ. Prog. Sustain. Energy	MAY-JUN	2015	34	3					819	822		10.1002/ep.12048		4	Engineering, Environmental; Engineering, Chemical; Engineering, Industrial; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CJ1GI	WOS:000355231200022		
J	Chen, IC; Kikuchi, Y; Fukushima, Y; Sugiyama, H; Hirao, M				Chen, I-Ching; Kikuchi, Yasunori; Fukushima, Yasuhiro; Sugiyama, Hirokazu; Hirao, Masahiko			Developing technology introduction strategies based on visualized scenario analysis: Application in energy systems design	ENVIRONMENTAL PROGRESS & SUSTAINABLE ENERGY			English	Article						strategic policy making; trade-off visualization; scenario performance and behaviors; technology combination	LIFE-CYCLE ASSESSMENT; ENVIRONMENTAL ASSESSMENT; FUTURE ENERGY; SUSTAINABILITY; ELECTRICITY; OPTIMIZATION; INNOVATION; ROADMAPS; JAPAN	Management of emerging technologies may play a significant role in the advancement towards sustainable development. While the development of consistent management policies requires inputs from a wide spectrum of specialists and other stakeholders, current platforms for facilitating their participation are insufficient. In this study, we present a framework for a visualized scenario analysis that comprehensively assesses combinations of multiple technologies. This framework (1) helps our understanding of scenario performance and behaviors of technology-introduction, (2) identifies the relationships and trade-offs based on evaluation indices, and (3) allows for visualization of various technology-introduction scenarios accounting for time frame. The applicability of this methodology is demonstrated using case studies that evaluate scenario performances and behaviors when implementing various power generation technologies in the Japanese electricity supply system. Different scenarios (e.g., renewable energy-based power generation, operation choice of nuclear power) are visualized to assist stakeholders with evaluation of the trade-offs. (c) 2014 American Institute of Chemical Engineers Environ Prog, 34: 832-840, 2015	[Chen, I-Ching; Kikuchi, Yasunori; Sugiyama, Hirokazu; Hirao, Masahiko] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Kikuchi, Yasunori] Univ Tokyo, Ito Int Res Ctr, Presidential Endowed Chair Platinum Soc, Bunkyo Ku, Tokyo 1130033, Japan; [Fukushima, Yasuhiro] Natl Cheng Kung Univ, Dept Environm Engn, Tainan 701, Taiwan	Chen, IC (reprint author), Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	chen@pse.t.u-tokyo.ac.jp	Fukushima, Yasuhiro/C-4037-2008	Fukushima, Yasuhiro/0000-0002-1525-7242	JSPS KAKENHI [23360404]; JSPS G8 Research Councils Initiative	This study was supported in part by JSPS KAKENHI Grant Number 23360404, and JSPS G8 Research Councils Initiative.	Agency for Natural Resources and Energy Ministry of Economy Trade and Industry (METI), 2010, COMPR EN STAT; Williams JH, 2012, SCIENCE, V335, P53, DOI 10.1126/science.1208365; Thuy NTH, 2011, ENVIRON PROG SUSTAIN, V30, P675, DOI 10.1002/ep.10517; Sagar AD, 2006, ENERG POLICY, V34, P2601, DOI 10.1016/j.enpol.2005.04.012; BARKER D, 1995, LONG RANGE PLANN, V28, P21, DOI 10.1016/0024-6301(95)98586-H; Yasunaga Y, 2009, TECHNOL FORECAST SOC, V76, P61, DOI 10.1016/j.techfore.2008.06.004; Rebitzer G, 2004, ENVIRON INT, V30, P701, DOI 10.1016/j.envint.2003.11.005; Martinot E, 2007, ANNU REV ENV RESOUR, V32, P205, DOI 10.1146/annurev.energy.32.080106.133554; Saritas O, 2007, TECHNOL FORECAST SOC, V74, P1374, DOI 10.1016/j.techfore.2006.07.005; Balachandra P, 2003, ENERG CONVERS MANAGE, V44, P411, DOI 10.1016/S0196-8904(02)00058-4; Baumann H., 2004, HITCH HIKERS GUIDE L; BERRIE TW, 1986, ENERG POLICY, V14, P515, DOI 10.1016/0301-4215(86)90004-2; Chen IC, 2012, INT J LIFE CYCLE ASS, V17, P270, DOI 10.1007/s11367-011-0359-6; Chen IC, 2012, INT J LIFE CYCLE ASS, V17, P119, DOI 10.1007/s11367-011-0356-9; Deb K., 2005, MULTIOBJECTIVE OPTIM, P273; Fukushima Y, 2011, J CHEM ENG JPN, V44, P365, DOI 10.1252/jcej.11we094; Fukushima Y, 2004, J POWER SOURCES, V131, P327, DOI 10.1016/j.jpowsour.2003.11.093; Fukushima Y, 2002, INT J LIFE CYCLE ASS, V7, P317, DOI 10.1065/lca2002.06.085; Gibson RB, 2013, IMPACT ASSESS PROJ A, V31, P2, DOI 10.1080/14615517.2013.764633; Imamura E., 2010, Y09027 CENTR RES I E; Johnson J, 2009, ENVIRON SCI TECHNOL, V43, P2234, DOI 10.1021/es801700a; Kato Y., 2010, ENERGY 20 FUTURES BU; Kornov L, 2000, IMPACT ASSESS PROJ A, V18, P191, DOI 10.3152/147154600781767402; Koyama M, 2014, J CHEM ENG JPN, V47, P499, DOI 10.1252/jcej.13we345; Ministry of Economy Trade and Industry (METI), 2010, STRAT EN PLAN JAP M; Ministry of Economy Trade and Industry (METI), 2010, SPREAD STRAT NEXT GE; Ministry of Economy Trade and Industry (METI), 2013, EN WHIT PAP 2013; Ministry of Economy Trade and Industry (METI), 2014, EN BAS PLAN; Pehnt M, 2003, INT J LIFE CYCLE ASS, V8, P283, DOI 10.1065/lca2003.07.128; Pesonen H-L, 2000, INT J LCA, V5, P21, DOI DOI 10.1007/BF02978555; Prakash R, 2009, RENEW SUST ENERG REV, V13, P2716; Rees W. E., 1988, ENVIRON IMPACT ASSES, V8, P273, DOI 10.1016/0195-9255(88)90021-2; Shadiya OO, 2013, ENVIRON PROG SUSTAIN, V32, P762, DOI 10.1002/ep.11666; Weidema B. P., 2004, SCENARIOS LIFE CYCLE	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1944-7442	1944-7450		ENVIRON PROG SUSTAIN	Environ. Prog. Sustain. Energy	MAY-JUN	2015	34	3					832	840		10.1002/ep.12064		9	Engineering, Environmental; Engineering, Chemical; Engineering, Industrial; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CJ1GI	WOS:000355231200024		
J	Ueda, K; Murakami, J; Sano, F; Hayashi, M; Suga, K; Hamano, K				Ueda, Kazuhiro; Murakami, Junichi; Sano, Fumiho; Hayashi, Masataro; Suga, Kazuyoshi; Hamano, Kimikazu			Similar radiopathological features, but different postoperative recurrence rates, between Stage I lung cancers arising in emphysematous lungs and those arising in nonemphysematous lungs	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Pulmonary emphysema; PET; Chronic obstructive pulmonary disease; Maximum standardized uptake value; Lung cancer	OBSTRUCTIVE PULMONARY-DISEASE; COMPUTED-TOMOGRAPHY; ADENOCARCINOMA; SMOKERS; CELLS; PROLIFERATION; DENSITOMETRY; QUANTITATION; FIBROBLASTS; PERFORMANCE	OBJECTIVES: The aim of the present study was to clarify the differences between lung cancer arising in emphysematous lungs and that arising in nonemphysematous lungs with regard to radiopathological features and the postoperative recurrence rate. METHODS: We retrospectively reviewed a prospective database of 212 patients who underwent major lung resection for clinically diagnosed Stage I primary lung cancer. Emphysematous lungs were identified on the basis of quantitative computed tomography (CT). The biological features of the primary tumour were diagnosed according to the presence or absence of a ground-glass component on high-resolution CT and the maximum standardized uptake value in [F-18]-fluorodeoxyglucose positron emission tomography, in addition to conventional characteristic factors. RESULTS: The risk factors for postoperative recurrence were underlying emphysema, a high maximum standardized uptake value, the absence of a ground-glass component, the pathological grade and lymph node metastasis, whereas the risk factors for lymph node metastasis were a high maximum standardized uptake value, the absence of a ground-glass component and the pathological grade. Surprisingly, these risk factors were entirely matched between patients with and without emphysematous lungs, regardless of the fact that patients with emphysematous lungs had a higher recurrence rate. CONCLUSIONS: Similar clinicopathological features, but different postoperative recurrence rates, were found between Stage I lung cancers arising in emphysematous lungs and those arising in nonemphysematous lungs. It may be valuable to search for underlying molecular mechanisms that promote metastasis from primary tumours arising in emphysema, such as paracrine effects between the tumour and pulmonary emphysema.	[Ueda, Kazuhiro; Murakami, Junichi; Sano, Fumiho; Hayashi, Masataro; Hamano, Kimikazu] Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Div Chest Surg, Ube, Yamaguchi 7558505, Japan; [Suga, Kazuyoshi] St Hill Hosp, Dept Radiol, Ube, Yamaguchi, Japan	Ueda, K (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Div Chest Surg, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	kaueda@c-able.ne.jp					Okada M, 2011, J THORAC CARDIOV SUR, V141, P1384, DOI 10.1016/j.jtcvs.2011.02.007; KINSELLA M, 1990, CHEST, V97, P315, DOI 10.1378/chest.97.2.315; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503; Kawaguchi T, 2010, J THORAC ONCOL, V5, P620, DOI 10.1097/JTO.0b013e3181d2dcd9; Yokohori N, 2004, CHEST, V125, P626, DOI 10.1378/chest.125.2.626; Gould MK, 2003, ANN INTERN MED, V139, P879; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240; Ueda K, 2006, CLIN CANCER RES, V12, P6730, DOI 10.1158/1078-0432.CCR-06-1196; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Park KJ, 1999, RADIOLOGY, V211, P541; Subramanian J, 2007, J THORAC ONCOL, V2, P827, DOI 10.1097/JTO.0b013e318145af79; Wald O, 2011, J THORAC CARDIOV SUR, V141, P1503, DOI 10.1016/j.jtcvs.2010.11.056; Ishikawa S, 2004, CLIN CANCER RES, V10, P6579, DOI 10.1158/1078-0432.CCR-04-0272; Mook ORF, 2004, BBA-REV CANCER, V1705, P69, DOI 10.1016/j.bbcan.2004.09.006; Ohnishi K, 1998, LAB INVEST, V78, P1077; Colice GL, 2007, CHEST, V132, p161S, DOI 10.1378/chest.07-1359; D'Armiento JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056352; Kim YS, 2011, NEOPLASMA, V58, P245, DOI 10.4149/neo_2011_03_245; LAMERS RJ, 1994, RADIOLOGY, V193, P109; Nomori Hiroaki, 2009, Gen Thorac Cardiovasc Surg, V57, P184, DOI 10.1007/s11748-008-0371-3; Sanchez-Cespedes M, 2001, CANCER RES, V61, P2092; Sanchez-Cespedes M, 2001, CANCER RES, V61, P1309; STOLLER JK, 1986, AM REV RESPIR DIS, V134, P1129; Sy SMH, 2003, LUNG CANCER-J IASLC, V41, P91, DOI 10.1016/S0169-5002(03)00138-7; TOCKMAN MS, 1987, ANN INTERN MED, V106, P512	25	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	MAY	2015	47	5					905	911		10.1093/ejcts/ezu311		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CJ0YV	WOS:000355208200036		
J	Kinoshita, T; Asai, T				Kinoshita, Takeshi; Asai, Tohru			The left and right internal thoracic arteries may not have equivalent histological structures Reply	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Letter						Internal thoracic artery; Coronary artery bypass surgery; Histology			[Kinoshita, Takeshi; Asai, Tohru] Shiga Univ Med Sci, Div Cardiovasc Surg, Otsu, Shiga 52021, Japan	Kinoshita, T (reprint author), Shiga Univ Med Sci, Div Cardiovasc Surg, Otsu, Shiga 52021, Japan.	kinotake@belle.shiga-med.ac.jp					Gomes WJ, 2015, EUR J CARDIO-THORAC, V47, P941, DOI 10.1093/ejcts/ezu300; Kinoshita T, 2014, EUR J CARDIO-THORAC, V45, P726, DOI 10.1093/ejcts/ezt430; KOBAYASHI H, 1993, SURG TODAY, V23, P697; Ribeiro MFL, 2008, REV BRAS CIR CARDIOV, V23, P1, DOI 10.1590/S0102-76382008000100002	4	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	MAY	2015	47	5					942	942		10.1093/ejcts/ezu301		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CJ0YV	WOS:000355208200050		
J	Matsuba, T; Hisashi, Y; Yotsumoto, G; Imoto, Y				Matsuba, Tomoyuki; Hisashi, Yosuke; Yotsumoto, Goichi; Imoto, Yutaka			A rare cardiac haemangioma in the right ventricle diagnosed accurately using F-18-fluorodeoxyglucose-positron emission tomography	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Haemangioma; Cavernous; Heart ventricles; Positron emission tomography	PENETRATING INJURIES	A right ventricular cardiac tumour was incidentally detected in a 61-year-old man during a preoperative examination for coronary artery bypass grafting (CABG). Findings on computed tomography and magnetic resonance imaging suggested the differential diagnoses of myxoma, haemangioma and haemangiosarcoma, and it was difficult to identify whether the tumour was benign or malignant. F-18-fluorodeoxyglucose-positron emission tomography strongly suggested a benign tumour. We enucleated the tumour, because an intraoperative frozen section also strongly suggested a benign origin. After resection, CABG under cardiopulmonary bypass was performed. Histopathological and immunohistochemical analysis indicated a cavernous haemangioma without evidence of malignant tissue. The patient has survived 20 months after surgery with no evidence of tumour recurrence.	[Matsuba, Tomoyuki; Hisashi, Yosuke; Yotsumoto, Goichi; Imoto, Yutaka] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc & Gastroenterol Surg, Kagoshima 8908520, Japan	Matsuba, T (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc & Gastroenterol Surg, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	matsuba0926@yahoo.co.jp					BUCHAN K, 1995, EUR J CARDIO-THORAC, V9, P90, DOI 10.1016/S1010-7940(05)80025-9; Demetriades D, 1997, J CARDIAC SURG, V12, P173; Endara SA, 2001, ANN THORAC SURG, V72, P2106, DOI 10.1016/S0003-4975(01)02584-X; Fouquet O, 2013, EUR J CARDIO-THORAC, V44, P391, DOI 10.1093/ejcts/ezt151; PATE JW, 1993, ANN THORAC SURG, V55, P586	5	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	MAY	2015	47	5					E223	E228		10.1093/ejcts/ezu540		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CJ0YV	WOS:000355208200011		
J	Matsuura, K; Mogi, K; Takahara, Y				Matsuura, Kaoru; Mogi, Kenji; Takahara, Yoshiharu			Off-pump waffle procedure using an ultrasonic scalpel for constrictive pericarditis	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						off-pump surgery; pericardium	MANAGEMENT	Radical pericardiectomy alone is not effective in patients with constrictive pericarditis accompanied by epicardial constriction. However, a waffle procedure is very effective in these patients, as we demonstrate in this paper. Firstly, we performed a radical pericardiectomy via a median sternotomy. We used an ultrasonic scalpel for this procedure, and an apical suction device was useful for lifting the heart. This technique is similar to that used in off-pump coronary artery bypass grafting. After the whole heart was dissected from the markedly thickened parietal pericardium, a waffle procedure was performed on the left ventricle first. Multiple longitudinal and transverse incisions were made on the thickened epicardium using an ultrasonic scalpel. After the left ventricle was fully relieved of constriction, the same procedure was performed on the right ventricle. Thereafter, a remarkable improvement of our patient's haemodynamic status was obtained. The whole procedure can be done without cardiopulmonary bypass. We describe tips for performing the waffle procedure without cardiopulmonary bypass using an ultrasonic scalpel and apical suction device, as well as pitfalls to avoid.	[Matsuura, Kaoru; Mogi, Kenji; Takahara, Yoshiharu] Funabashi Municipal Med Ctr, Dept Cardiovasc Surg, Funabashi, Chiba, Japan	Matsuura, K (reprint author), Funabashi Municipal Med Ctr, Dept Cardiovasc Surg, 1-21-1 Kanasugi, Funabashi, Chiba, Japan.	km4717jp@yahoo.co.jp					Higami T, 2000, ANN THORAC SURG, V70, P307, DOI 10.1016/S0003-4975(00)01436-3; Athanasiou T, 2003, ANN THORAC SURG, V76, P1126, DOI 10.1016/S0003-4975(03)00815-4; Fukumoto Atsushi, 2007, Asian Cardiovasc Thorac Ann, V15, pe69; HEIMBECKER RO, 1983, ANN THORAC SURG, V36, P605; Hoit BD, 2002, CIRCULATION, V105, P2939, DOI 10.1161/01.CIR.0000019421.07529.C5; Uchida T, 2001, ANN THORAC SURG, V72, P924, DOI 10.1016/S0003-4975(00)02436-X	6	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	MAY	2015	47	5					E220	E222		10.1093/ejcts/ezu554		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CJ0YV	WOS:000355208200010		
J	Okamura, K; Suematsu, Y; Morizumi, S; Kawata, M				Okamura, Kenichi; Suematsu, Yoshihiro; Morizumi, Sei; Kawata, Mitsuhiro			Hybrid stenting therapy for dysphagia aortica with Rokitansky's diverticulum concomitant with thoracic aortic aneurysm	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Thoracic aortic aneurysm; Rokitansky's diverticulum; Oesophageal stenting; Thoracic endovascular aneurysm repair		An 87-year old man with a past medical history of a descending aortic aneurysm for 20 years presented with progressive dysphagia and aspiration pneumonia. Computed tomography angiography demonstrated the impending rupture of the thoracic aortic aneurysm (TAA) and endoscopic examinations revealed the extrinsic compression of the middle oesophagus with Rokitansky's diverticulum proximal to the compression area. He underwent urgent thoracic endovascular aortic aneurysm repair, followed by oesophageal stenting. The patient's symptoms immediately improved, and the postoperative period was uneventful. This report is the first to describe a hybrid stenting therapy for dysphagia aortica with Rokitansky's diverticulum concomitant with a TAA.	[Okamura, Kenichi; Suematsu, Yoshihiro; Morizumi, Sei; Kawata, Mitsuhiro] Tsukuba Mem Hosp, Dept Cardiovasc Surg, Tsukuba, Ibaraki 3002622, Japan	Suematsu, Y (reprint author), Tsukuba Mem Hosp, Dept Cardiovasc Surg, 1187-299 Kaname, Tsukuba, Ibaraki 3002622, Japan.	suematsu@tf7.so-net.ne.jp					Cao DB, 2012, ANN THORAC SURG, V94, P656, DOI 10.1016/j.athoracsur.2012.02.020; Coelho-Prabhu Nayantara, 2009, Gastroenterology, V137, pe1, DOI 10.1053/j.gastro.2009.02.011; Hiller HG, 2007, THORAC SURG SCI, V4; Lau H, 2001, SURGERY, V129, P763, DOI 10.1067/msy.2001.109496; Wilkinson JM, 1997, EUR J CARDIO-THORAC, V11, P222, DOI 10.1016/S1010-7940(96)01053-6	5	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	MAY	2015	47	5					E229	E231		10.1093/ejcts/ezv102		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CJ0YV	WOS:000355208200012		
J	Iwama, R; Kobayashi, S; Ohta, A; Horiuchi, H; Fukuda, R				Iwama, Ryo; Kobayashi, Satoshi; Ohta, Akinori; Horiuchi, Hiroyuki; Fukuda, Ryouichi			Alcohol dehydrogenases and an alcohol oxidase involved in the assimilation of exogenous fatty alcohols in Yarrowia lipolytica	FEMS YEAST RESEARCH			English	Article						Yarrowia lipolytica; n-alkane; fatty alcohol; alcohol dehydrogenase; fatty alcohol oxidase	HYDROPHOBIC SUBSTRATE UTILIZATION; N-DECANE ASSIMILATION; SACCHAROMYCES-CEREVISIAE; YEAST; ALKANE; GENES; ACID; OXIDATION; METABOLISM; CLONING	The yeast Yarrowia lipolytica can assimilate hydrophobic substrates, including n-alkanes and fatty alcohols. Here, eight alcohol dehydrogenase genes, ADH1-ADH7 and FADH, and a fatty alcohol oxidase gene, FAO1, were analyzed to determine their roles in the metabolism of hydrophobic substrates. A mutant deleted for all of these genes (ALCY02 strain) showed severely defective growth on fatty alcohols, and enhanced sensitivity to fatty alcohols in glucose-containing media. The ALCY02 strain grew normally on n-tetradecane or n-hexadecane, but exhibited slightly defective growth on n-decane or n-dodecane. It accumulated more 1-dodecanol and less dodecanoic acid than the wild-type strain when n-dodecane was fed. Expression of ADH1, ADH3 or FAO1, but not that of other ADH genes or FADH, in the ALCY02 strain restored its growth on fatty alcohols. In addition, a triple deletion mutant of ADH1, ADH3 and FAO1 showed similarly defective growth on fatty alcohols and on n-dodecane to the ALCY02 strain. Microscopic observation suggests that Adh1p and Adh3p are localized in the cytosol and Fao1p is in the peroxisome. These results suggest that Adh1p, Adh3p and Fao1p are responsible for the oxidation of exogenous fatty alcohols but play less prominent roles in the oxidation of fatty alcohols derived from n-alkanes.	[Iwama, Ryo; Kobayashi, Satoshi; Horiuchi, Hiroyuki; Fukuda, Ryouichi] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Ohta, Akinori] Chubu Univ, Coll Biosci & Biotechnol, Dept Biol Chem, Kasugai, Aichi 4878501, Japan	Fukuda, R (reprint author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	afukuda@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25.7284, 24380045]	This work was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant Nos. 25.7284 and 24380045). RI is a Research Fellow of the Japan Society for the Promotion of Science (DC-1).	Fukuda R, 2013, BIOSCI BIOTECH BIOCH, V77, P1149, DOI 10.1271/bbb.130164; Yamagami S, 2004, J BIOL CHEM, V279, P22183, DOI 10.1074/jbc.M313313200; de Smidt O, 2012, FEMS YEAST RES, V12, P33, DOI 10.1111/j.1567-1364.2011.00760.x; Mauersberger S, 2001, J BACTERIOL, V183, P5102, DOI 10.1128/JB.183.17.5102-5109.2001; Yamagami S, 2001, BIOCHEM BIOPH RES CO, V282, P832, DOI 10.1006/bbrc.2001.4653; GANZHORN AJ, 1987, J BIOL CHEM, V262, P3754; Nicaud JM, 2012, YEAST, V29, P409, DOI 10.1002/yea.2921; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Sabirova JS, 2011, MICROB BIOTECHNOL, V4, P47, DOI 10.1111/j.1751-7915.2010.00187.x; Nelson David R., 2009, Human Genomics, V4, P59; de Smidt O, 2008, FEMS YEAST RES, V8, P967, DOI 10.1111/j.1567-1364.2008.00387.x; Hirakawa K, 2009, J BIOL CHEM, V284, P7126, DOI 10.1074/jbc.M806864200; Groenewald M, 2014, CRIT REV MICROBIOL, V40, P187, DOI 10.3109/1040841X.2013.770386; Xue ZX, 2013, NAT BIOTECHNOL, V31, P734, DOI 10.1038/nbt.2622; Fickers P, 2005, FEMS YEAST RES, V5, P527, DOI 10.1016/j.femsyr.2004.09.004; Barth G., 1996, NONCONVENTIONAL YEAS, P313; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Cheng Q, 2005, BBA-MOL CELL BIOL L, V1735, P192, DOI 10.1016/j.bbalip.2005.06.006; Cheng Q, 2004, FEBS LETT, V574, P62, DOI 10.1016/j.febslet.2004.07.086; Eirich LD, 2004, APPL ENVIRON MICROB, V70, P4872, DOI 10.1128/AEM.70.8.4872-4879.2004; Endoh-Yamagami S, 2007, EUKARYOT CELL, V6, P734, DOI 10.1128/EC.00412-06; Fukuda R, 2013, YARROWIA LIPOLYTICA, P111; Gatter M, 2014, FEMS YEAST RES, V14, P858, DOI 10.1111/1567-1364.12176; Iida Toshiya, 2000, Yeast, V16, P1077, DOI 10.1002/1097-0061(20000915)16:12<1077::AID-YEA601>3.0.CO;2-K; Iida T, 1998, YEAST, V14, P1387; Iwama R, 2014, J BIOL CHEM, V289, P33275, DOI 10.1074/jbc.M114.596890; KEMP GD, 1994, APPL MICROBIOL BIOT, V40, P873, DOI 10.1007/s002530050083; Kobayashi S, 2013, FUNGAL GENET BIOL, V61, P100, DOI 10.1016/j.fgb.2013.09.008; MAUERSBERGER S, 1987, J BASIC MICROB, V27, P565, DOI 10.1002/jobm.3620271005; Mori K, 2013, FEMS YEAST RES, V13, P233, DOI 10.1111/1567-1364.12025; Napora-Wijata Kamila, 2013, Biomolecules, V3, P449, DOI 10.3390/biom3030449; Rajangam AS, 2013, PLANT PHYSIOL, V161, P72, DOI 10.1104/pp.112.208264; Scheller U, 1998, J BIOL CHEM, V273, P32528, DOI 10.1074/jbc.273.49.32528; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; Sumita T, 2002, BIOCHEM BIOPH RES CO, V294, P1071, DOI 10.1016/S0006-291X(02)00607-1; Takai H, 2012, FUNGAL GENET BIOL, V49, P58, DOI 10.1016/j.fgb.2011.11.003; Vanhanen S, 2000, J BIOL CHEM, V275, P4445, DOI 10.1074/jbc.275.6.4445; Zhao S, 2008, BIOTECHNOL PROGR, V24, P773, DOI 10.1021/bp0703533	38	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1567-1356	1567-1364		FEMS YEAST RES	FEMS Yeast Res.	MAY	2015	15	3							fov014	10.1093/femsyr/fov014		12	Biotechnology & Applied Microbiology; Microbiology; Mycology	Biotechnology & Applied Microbiology; Microbiology; Mycology	CJ2NV	WOS:000355322600008		
J	Nishikawa, H; Toyoda, T; Masuda, S; Ishikawa, Y; Sasaki, Y; Igarashi, H; Sakai, M; Seito, M; Awaji, T				Nishikawa, Haruka; Toyoda, Takahiro; Masuda, Shuhei; Ishikawa, Yoichi; Sasaki, Yuji; Igarashi, Hiromichi; Sakai, Mitsuo; Seito, Masaki; Awaji, Toshiyuki			Wind-induced stock variation of the neon flying squid (Ommastrephes bartramii) winter-spring cohort in the subtropical North Pacific Ocean	FISHERIES OCEANOGRAPHY			English	Article						data assimilation; ecosystem model; mixed layer depth; neon flying squid; wind system	DATA ASSIMILATION; STATE; CEPHALOPODA; ECOSYSTEM; MODEL; SIZE	Our examination of the neon flying squid (Ommastrephes bartramii) winter-spring cohort catch per unit effort (CPUE, an index of stock) revealed significant positive correlations with the interannual variations of observed chlorophyll-a (Chl-a) concentration and autumn-winter mixed layer depth (MLD) in the winter-spring feeding grounds of paralarvae and juveniles (130-170 degrees E, 20-27 degrees N). These correlations suggest the importance of integrated bottom-up effects by the autumn-winter MLD for the neon flying squid stocks. However, the influence of autumn-winter MLD interannual variation in the forage availability for paralarvae and juveniles, i.e., particulate organic matter and zooplankton, has still been unclear. In this study, we use the lower trophic ecosystem model NEMURO, which uses the physical environmental data from the ocean reanalysis dataset obtained by the four-dimensional variational (4DVAR) data assimilation method. The model-based investigation enables us to clarify how the autumn-winter MLD controls the particulate organic matter and zooplankton abundance in the feeding grounds. Further, our investigation of the autumn-winter MLD interannual variation demonstrates that the stronger autumn wind in the feeding grounds develops a deeper mixed layer. Therefore, the deep mixed layer entrains nutrient-rich water and enhances photosynthesis, which results in good feeding conditions for paralarvae and juveniles. Our results underline that the wind system interannual variation has critical roles on the winter-spring cohort of the neon flying squid stock.	[Nishikawa, Haruka; Masuda, Shuhei; Ishikawa, Yoichi; Sasaki, Yuji; Igarashi, Hiromichi; Awaji, Toshiyuki] Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Toyoda, Takahiro] Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan; [Sakai, Mitsuo] Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, Hachinohe Stn, Hachinohe, Aomori 0310841, Japan; [Seito, Masaki] Aomori prefectural Ind Technol Res Ctr, Fisheries Res Inst, Hiranai, Aomori 0393381, Japan; [Awaji, Toshiyuki] Kyoto Univ, Sakyo Ku, Kyoto, Kyoto 6068501, Japan	Nishikawa, H (reprint author), Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	harukan@jamstec.go.jp			Research Program on Climate Change Adaptation (RECCA) under the Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported by the Research Program on Climate Change Adaptation (RECCA) under the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Noh Y, 1999, J GEOPHYS RES-OCEANS, V104, P15621, DOI 10.1029/1999JC900068; Sakurai Y, 2000, ICES J MAR SCI, V57, P24, DOI 10.1006/jmsc.2000.0667; Masuda S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017604; Yatsu A, 1998, MAR BIOL, V131, P275, DOI 10.1007/s002270050320; Nishikawa H, 2014, FISH OCEANOGR, V23, P289, DOI 10.1111/fog.12064; Ichii T, 2004, FISH OCEANOGR, V13, P295, DOI 10.1111/j.1365-2419.2004.00293.x; Kishi MJ, 2007, ECOL MODEL, V202, P12, DOI 10.1016/j.ecolmodel.2006.08.021; Usui N, 2006, ADV SPACE RES, V37, P806, DOI 10.1016/j.asr.2005.09.022; Uchikawa K, 2009, FISHERIES SCI, V75, P317, DOI 10.1007/s12562-008-0036-2; QIU B, 1995, J PHYS OCEANOGR, V25, P2374, DOI 10.1175/1520-0485(1995)025<2374:VOTNAA>2.0.CO;2; Sugimoto T, 1998, FISH OCEANOGR, V7, P289, DOI 10.1046/j.1365-2419.1998.00070.x; QIU B, 1993, J PHYS OCEANOGR, V23, P2027, DOI 10.1175/1520-0485(1993)023<2027:UOHBIT>2.0.CO;2; Kishi MJ, 2009, J MARINE SYST, V78, P278, DOI 10.1016/j.jmarsys.2009.02.012; Awaji T, 2003, J OCEANOGR, V59, P931, DOI 10.1023/B:JOCE.0000009582.24737.6f; BAILEY KM, 1989, ADV MAR BIOL, V25, P1, DOI 10.1016/S0065-2881(08)60187-X; Bower J. R., 1994, THESIS U HAWAII; Hurtt GC, 1996, DEEP-SEA RES PT II, V43, P653, DOI 10.1016/0967-0645(96)00007-0; Japan Meteorological Agency, 2014, OC MAR MET OBS RES V; LARGE WG, 1981, J PHYS OCEANOGR, V11, P324, DOI 10.1175/1520-0485(1981)011<0324:OOMFMI>2.0.CO;2; Masuda S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004953; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; Roper C. F. E., 1984, FAO FISH SYNOP, V3, p[277, 125]; Tetens V. O., 1930, Z GEOPHYS, V6, P297; Toyoda T, 2013, PROG OCEANOGR, V119, P90, DOI 10.1016/j.pocean.2013.08.008; Yatsu A, 1997, FISH RES, V29, P257, DOI 10.1016/S0165-7836(96)00541-3; Yatsu A, 1998, INT S LARG PEL SQUID, P31	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1054-6006	1365-2419		FISH OCEANOGR	Fish Oceanogr.	MAY	2015	24	3					229	241		10.1111/fog.12106		13	Fisheries; Oceanography	Fisheries; Oceanography	CJ1WH	WOS:000355275100003		
J	Higuchi, Y; Steinberg, G				Higuchi, Yujiro; Steinberg, Gero			Early endosomes motility in filamentous fungi: How and Why they move	FUNGAL BIOLOGY REVIEWS			English	Review						early endosome; effector protein; filamentous fungi; membrane trafficking; microtubule; motor protein; polysome	LONG-DISTANCE MOVEMENT; MICROTUBULE PLUS-ENDS; BINDING PROTEIN RRM4; USTILAGO-MAYDIS; ASPERGILLUS-NIDULANS; SIGNAL-TRANSDUCTION; ENDOCYTIC PATHWAY; RAB CONVERSION; DYNEIN; TRANSPORT	Elongate hyphae of filamentous fungi grow predominantly at their tips, whereas organelles are positioned in the subapical parts of the cell. Organelle positioning and long-distance intracellular communication involves active, energy-dependent transport along microtubules (MTs). This is mediated by specialized molecular motors, named kinesins and dynein, which utilize ATP hydrolysis to "walk" along the tubulin polymers. Work in the basidiomycete Ustilago maydis and the ascomycete Aspergillus nidulans has shown that early endosomes (EEs) are one of the major cargos of MT-dependent motors in fungi. EEs are part of the early endocytic pathway, and their motility behavior and the underlying transport machinery is well understood. However, the physiological role of constant bi-directional EE motility remains elusive. Recent reports, conducted in the corn smut fungus U. maydis, have provided novel insights into the cellular function of EE motility. They show that EE motility is crucial for the distribution of the protein synthesis machinery, and also that EEs transmit signals during plant infection that trigger the production of fungal effector proteins, required for successful invasion into host plants. (C) 2015 The British Mycological Society. Published by Elsevier Ltd. All rights reserved.	[Higuchi, Yujiro] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Fukuoka 8128581, Japan; [Steinberg, Gero] Univ Exeter, Biosci, Exeter EX4 4QD, Devon, England	Higuchi, Y (reprint author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	y.higuchi@agr.kyushu-u.ac.jp; G.Steinberg@exeter.ac.uk			Biotechnology & Biological Science Research Council [BB/H019774/1, BB/J009903/1]	We would like to thank Dr. Martin Schuster for providing images, shown in Fig. 1. We are also grateful to Prof. Sarah J. Gurr for helpful comments on the manuscript. This work in the lab of G.S. was supported by the Biotechnology & Biological Science Research Council (BB/H019774/1; BB/J009903/1).	Zhang J, 2014, J CELL BIOL, V204, P1009, DOI 10.1083/jcb.201308009; Wedlich-Soldner R, 2002, EMBO J, V21, P2946, DOI 10.1093/emboj/cdf296; Wedlich-Soldner R, 2000, EMBO J, V19, P1974, DOI 10.1093/emboj/19.9.1974; Penalva MA, 2010, CURR OPIN MICROBIOL, V13, P684, DOI 10.1016/j.mib.2010.09.005; Zhang J, 2010, J CELL SCI, V123, P3596, DOI 10.1242/jcs.075259; Fuchs U, 2006, PLANT CELL, V18, P2066, DOI 10.1105/tpc.105.039388; Becht P, 2006, J CELL SCI, V119, P4964, DOI 10.1242/jcs.03287; Schuster M, 2011, EMBO J, V30, P652, DOI 10.1038/emboj.2010.360; Higuchi Y, 2006, BIOCHEM BIOPH RES CO, V340, P784, DOI 10.1016/j.bbrc.2005.12.077; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Baumann S, 2014, EMBO REP, V15, P94, DOI 10.1002/embr.201338037; Xu L, 2008, MOL BIOL CELL, V19, P5059, DOI 10.1091/mbc.E08-05-0473; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516; Baumann S, 2012, J CELL SCI, V125, P2740, DOI 10.1242/jcs.101212; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Lesche R, 1997, MAMM GENOME, V8, P879, DOI 10.1007/s003359900604; VANDERSLUIJS P, 1991, P NATL ACAD SCI USA, V88, P6313, DOI 10.1073/pnas.88.14.6313; Steinberg G, 2014, CURR OPIN MICROBIOL, V20, P10, DOI 10.1016/j.mib.2014.04.001; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Konig J, 2009, EMBO J, V28, P1855, DOI 10.1038/emboj.2009.145; Steinberg G, 1998, J CELL SCI, V111, P2235; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Gaillard CLB, 2011, MOL BIOL CELL, V22, P4549, DOI 10.1091/mbc.E11-05-0405; Shoji JY, 2014, CURR OPIN MICROBIOL, V20, P1, DOI 10.1016/j.mib.2014.03.002; Schuster M, 2011, MOL BIOL CELL, V22, P3645, DOI [10.1091/mbc.E11-03-0217, 10.1091/E11-03-0217]; Howe CL, 2004, J NEUROBIOL, V58, P207, DOI 10.1002/neu.10323; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Yao XL, 2014, MOL BIOL CELL, V25, P2181, DOI 10.1091/mbc.E14-04-0873; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Bielska E, 2014, J CELL BIOL, V204, P989, DOI 10.1083/jcb.201309022; Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Sunio A, 1999, MOL BIOL CELL, V10, P847; Abenza JF, 2012, MOL BIOL CELL, V23, P1889, DOI 10.1091/mbc.E11-11-0925; Egan MJ, 2012, CURR OPIN MICROBIOL, V15, P637, DOI 10.1016/j.mib.2012.10.003; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Abenza JF, 2010, MOL BIOL CELL, V21, P2756, DOI 10.1091/mbc.E10-02-0119; Seaman MNJ, 2008, CELL MOL LIFE SCI, V65, P2842, DOI 10.1007/s00018-008-8354-1; Brefort T, 2009, ANNU REV PHYTOPATHOL, V47, P423, DOI 10.1146/annurev-phyto-080508-081923; Ge XC, 2010, NEURON, V65, P191, DOI 10.1016/j.neuron.2010.01.011; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; Maldonado-Baez L, 2013, J CELL BIOL, V201, P233, DOI 10.1083/jcb.201208172; Lemmon MA, 2003, TRAFFIC, V4, P201; Penalva MA, 2005, FUNGAL GENET BIOL, V42, P963, DOI 10.1016/j.fgb.2005.09.004; Bielska E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6097; Djamei A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002955; Higuchi Y, 2009, EUKARYOT CELL, V8, P37, DOI 10.1128/EC.00207-08; Higuchi Y, 2014, J CELL BIOL, V204, P343, DOI 10.1083/jcb.201307164; Miaczynska M, 2010, CURR OPIN CELL BIOL, V22, P535, DOI 10.1016/j.ceb.2010.05.007; Saxena M, 2000, SEMIN IMMUNOL, V12, P387, DOI 10.1006/smim.2000.0219; Seidel C, 2013, EUKARYOT CELL, V12, P1020, DOI 10.1128/EC.00081-13; Steinberg G, 2007, NAT REV MICROBIOL, V5, P309, DOI 10.1038/nrmicro1618; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923	61	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1749-4613	1878-0253		FUNGAL BIOL REV	Fungal Biol. Rev.	MAY	2015	29	1					1	6		10.1016/j.fbr.2015.02.002		6	Mycology	Mycology	CJ2XR	WOS:000355348500001		
J	Miwa, H; Era, T				Miwa, Hiroyuki; Era, Takumi			Generation and characterization of PDGFR-GFPCreER(t2) knock-In mouse line	GENESIS			English	Article						PDGFR; CreER(T2); knock-in; mesoderm; neural crest; mesenchyme	PDGF RECEPTOR-ALPHA; GROWTH-FACTOR; CELL-DEVELOPMENT; MICE; EXPRESSION; MUTATION; GENE; DIFFERENTIATION; EMBRYOGENESIS; MORPHOGENESIS	Platelet-derived growth factor (PDGF) and its receptor play an important role in embryogenesis. PDGF receptor (PDGFR) is expressed specifically in the embryonic day 7.5 (E7.5) mesoderm and in the E9.5 neural crest among other tissues. PDGFR-expressing cells and their descendants are involved in the formation of various tissues. To trace PDGFR-expressing cells in vivo, we generated a knock-in mouse line that expressed a fusion protein of green fluorescent protein (GFP), Cre recombinase (Cre), and mutated estrogen receptor ligand-binding domain (ERT2) under the control of the PDGFR promoter. In these mice, Cre activity in PDGFR-expressing cells could be induced by tamoxifen treatment. Taken together, our results suggest that the knock-in mouse line generated here could be useful for studying PDGFR-expressing cells and their descendants in vivo at various stages of development. genesis 53:329-336, 2015. (c) 2015 Wiley Periodicals, Inc.	[Miwa, Hiroyuki; Era, Takumi] Kumamoto Univ, Dept Cell Modulat, Inst Mol Embryol & Genet, Kumamoto, Japan	Miwa, H (reprint author), Kumamoto Univ, Dept Cell Modulat, Inst Mol Embryol & Genet, Kumamoto, Japan.	lm314v21@kumamoto-u.ac.jp			Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency; Health and Labor Sciences Research Grants from Ministry of Health, Labor, and Welfare of Japan	Contract grant sponsor: Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency; Health and Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare of Japan	Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Ikeya M, 2005, INT J DEV BIOL, V49, P807, DOI 10.1387/ijdb.051975mi; Hamasaki M, 2012, STEM CELLS, V30, P2437, DOI 10.1002/stem.1221; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Heldin CH, 1999, PHYSIOL REV, V79, P1283; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Karlsson L, 1999, DEVELOPMENT, V126, P2611; Houzelstein D, 1997, MECH DEVELOP, V65, P123, DOI 10.1016/S0925-4773(97)00065-8; Xu X, 2005, DEV DYNAM, V232, P75, DOI 10.1002/dvdy.20197; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Kitagawa M, 2012, J BIOL CHEM, V287, P27983, DOI 10.1074/jbc.M112.350074; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Nakahara M, 2013, MAMM GENOME, V24, P228, DOI 10.1007/s00335-013-9452-4; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takakura N, 1996, J INVEST DERMATOL, V107, P770, DOI 10.1111/1523-1747.ep12371802; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; Soriano P, 1997, DEVELOPMENT, V124, P2691; Ding G, 2013, DEV DYNAM, V242, P254, DOI 10.1002/dvdy.23923; Bleyl SB, 2007, EUR J HUM GENET, V15, P950, DOI 10.1038/sj.ejhg.5201872; Matsumura H, 2004, BIOCHEM BIOPH RES CO, V321, P275, DOI 10.1016/j.bbrc.2004.06.139; ORRURTREGER A, 1992, DEVELOPMENT, V115, P289; ORRURTREGER A, 1992, DEVELOPMENT, V115, P1045; SCHATTEMAN GC, 1992, DEVELOPMENT, V115, P123; Sun T, 2000, DEVELOPMENT, V127, P4519; Takakura N, 1997, J HISTOCHEM CYTOCHEM, V45, P883	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-954X	1526-968X		GENESIS	Genesis	MAY	2015	53	5					329	336		10.1002/dvg.22853		8	Developmental Biology; Genetics & Heredity	Developmental Biology; Genetics & Heredity	CJ1HY	WOS:000355235900004		
J	Sawazaki, K; Kimura, H; Shiomi, K; Uchida, N; Takagi, R; Snieder, R				Sawazaki, Kaoru; Kimura, Hisanori; Shiomi, Katsuhiko; Uchida, Naoki; Takagi, Ryota; Snieder, Roel			Depth-dependence of seismic velocity change associated with the 2011 Tohoku earthquake, Japan, revealed from repeating earthquake analysis and finite-difference wave propagation simulation	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						Time-series analysis; Interferometry; Body waves; Wave scattering and diffraction; Wave propagation	KARADERE-DUZCE BRANCH; NORTH ANATOLIAN FAULT; OKI EARTHQUAKE; TEMPORAL-CHANGES; TRENCH AXIS; CRUST; ZONE; SLIP; INTERFEROMETRY; DISPLACEMENT	We detect time-lapse changes in seismic velocity associated with the 2011 Tohoku earthquake, Japan (M-w 9.0), by applying the moving time window cross-correlation analysis to repeating earthquake records registered by Hi-net borehole seismograms. The phase delay curve of the repeating earthquake records demonstrates up to 0.2 per cent apparent velocity reduction for S-wave time windows, while the reduction is only 0.1 per cent at the maximum for P-wave time windows. The apparent velocity reductions for S-wave time windows are especially large for offshore region near the large slip area of the Tohoku earthquake. To investigate the sensitivity of the phase delay curve to partial velocity change, we perform a finite difference (FD) wave propagation simulation using short-wavelength random inhomogeneous media. We found that a 1 per cent velocity reduction at the top 150 m depth (shallow zone) is the most possible model to explain the observed phase delay curve. The evaluated velocity reduction at the shallow zone is consistent with previous studies that detected velocity changes due to strong ground motion. Through the FD simulation, we also found that displacement of the source location after the Tohoku earthquake is not likely the primary cause of the observed apparent velocity change. The average velocity reduction at depths from 150 m to 80 km (deep zone) is evaluated to be much smaller than 0.1 per cent. This small velocity reduction at the deep zone can be caused by a static strain change due to the Tohoku earthquake and its post-seismic deformation.	[Sawazaki, Kaoru; Kimura, Hisanori; Shiomi, Katsuhiko] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan; [Sawazaki, Kaoru; Snieder, Roel] Colorado Sch Mines, Dept Geophys, Ctr Wave Phenomena, Golden, CO 80401 USA; [Uchida, Naoki; Takagi, Ryota] Tohoku Univ, Grad Sch Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Takagi, Ryota] Univ Tokyo, Earthquake Res Inst, Tokyo 113, Japan	Sawazaki, K (reprint author), Natl Res Inst Earth Sci & Disaster Prevent, 3-1 Tennodai, Tsukuba, Ibaraki 3050006, Japan.	sawa@bosai.go.jp			Japan Society for the Promotion of Science (JSPS) [22.1224]	The Hi-net records are available through the webpage of NIED (http://www.hinet.bosai.go.jp/?LANG=en). We are grateful to Dr T. Iinuma for providing us with the slip distribution model, and thank Dr K.H. Chen for useful comments and suggestions. We also thank Dr J. Trampert, editor-in-Chief of Geophysical Journal International, and two anonymous reviewers for thoughtful comments to improve our manuscript. This study is partly supported by Japan Society for the Promotion of Science (JSPS grants 22.1224). Seismic Analysis Code (SAC) and Generic Mapping Tools (GMT) are used for signal processing and figure plotting, respectively.	Margerin L, 2000, J GEOPHYS RES-SOL EA, V105, P7873, DOI 10.1029/1999JB900359; Brenguier F, 2008, SCIENCE, V321, P1478, DOI 10.1126/science.1160943; Fujiwara T, 2011, SCIENCE, V334, P1240, DOI 10.1126/science.1211554; [Anonymous], 2005, J GEOPHYS RES-SOL EA; Obermann A, 2013, GEOPHYS J INT, V194, P372, DOI 10.1093/gji/ggt043; Wegler U, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005869; Snieder R, 2002, SCIENCE, V295, P2253, DOI 10.1126/science.1070015; Yamaoka K, 2001, ISL ARC, V10, P336, DOI 10.1046/j.1440-1738.2001.00332.x; Yoshida Y, 2011, EARTH PLANETS SPACE, V63, P565, DOI 10.5047/eps.2011.05.011; Brenguier F, 2014, SCIENCE, V345, P80, DOI 10.1126/science.1254073; Satake K, 2013, B SEISMOL SOC AM, V103, P1473, DOI 10.1785/0120120122; Kido M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050057; GARDNER GHF, 1974, GEOPHYSICS, V39, P770, DOI 10.1190/1.1440465; Wegler U, 2007, GEOPHYS J INT, V168, P1029, DOI 10.1111/j.1365-246X.2006.03284.x; Sanchez-Sesma FJ, 2006, B SEISMOL SOC AM, V96, P1182, DOI 10.1785/0120050181; Obara K, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1854197; Peng ZG, 2004, GEOPHYS J INT, V159, P253, DOI 10.1111/j.1365-246X.2004.02379.x; Iinuma T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009186; POUPINET G, 1984, J GEOPHYS RES, V89, P5719, DOI 10.1029/JB089iB07p05719; Hobiger M, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009402; Kodaira S, 2012, NAT GEOSCI, V5, P646, DOI [10.1038/ngeo1547, 10.1038/NGEO1547]; Sato M, 2011, SCIENCE, V332, P1395, DOI 10.1126/science.1207401; Suzuki W, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049136; Peng ZG, 2006, PURE APPL GEOPHYS, V163, P567, DOI 10.1007/s00024-005-0034-6; Uchida N, 2013, EARTH PLANET SC LETT, V374, P81, DOI 10.1016/j.epsl.2013.05.021; Ozawa S, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009120; Aster RC, 2011, PARAMETER ESTIMATION; Chen KH, 2008, EARTH PLANET SC LETT, V276, P262, DOI 10.1016/j.epsl.2008.09.021; Chester FM, 2013, SCIENCE, V342, P1208, DOI 10.1126/science.1243719; Furumura T, 2011, LANDSLIDES, V8, P333, DOI 10.1007/s10346-011-0279-3; HEARMON RFS, 1953, ACTA CRYSTALLOGR, V6, P331, DOI 10.1107/S0365110X53000909; ITO A, 1990, TECTONOPHYSICS, V175, P47, DOI 10.1016/0040-1951(90)90129-V; Maeda T, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008464; Maeda T, 2010, EARTH PLANETS SPACE, V62, P685, DOI 10.5047/eps.2010.08.006; MINATO S, 2012, GEOPHYS RES LETT, V39; Murnaghan F.D., 1967, FINITE DEFORMATION E; Nakajima J, 2001, J GEOPHYS RES, V106, P843, DOI DOI 10.1029/2000JB000008; Nishimura T, 2005, EARTH PLANETS SPACE, V57, P491; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; Prioul R, 2004, GEOPHYSICS, V69, P415, DOI 10.1190/1.1707061; Rivet D, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047151; Rubinstein JL, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004463; Rubinstein JL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023189; Sato H, 2012, SEISMIC WAVE PROPAGA; Sato H, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005524; Sawazaki K, 2013, GEOPHYS J INT, V193, P238, DOI 10.1093/gji/ggs080; Shiomi K., 2003, Zisin. Journal of the Seismological Society of Japan, V56; Snieder R, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003317; Takagi R, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051342; Tsvankin I., 2001, SEISMIC SIGNATURES A; Uchida N, 2015, J GEOPHYS RES-SOL EA, V120, P259, DOI 10.1002/2013JB010933; WEAVER RL, 1982, J ACOUST SOC AM, V71, P1608, DOI 10.1121/1.387816; Yang W., 2014, EARTHQUAKE SCI, V27, P599; Yu WC, 2013, B SEISMOL SOC AM, V103, P2797, DOI 10.1785/0120120354	54	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0956-540X	1365-246X		GEOPHYS J INT	Geophys. J. Int.	MAY	2015	201	2					741	763		10.1093/gji/ggv014		23	Geochemistry & Geophysics	Geochemistry & Geophysics	CJ2NB	WOS:000355320500015		
J	Yoshioka, S; Takagi, R; Matsumoto, T				Yoshioka, Shoichi; Takagi, Rumi; Matsumoto, Takumi			Relationship between temperatures and fault slips on the upper surface of the subducting Philippine Sea plate beneath the Kanto district, central Japan	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						Heat flow; Subduction zone processes; Heat generation and transport	LOW-FREQUENCY EARTHQUAKES; SOUTHWEST JAPAN; BOSO PENINSULA; SLOW-SLIP; THERMAL CONSTRAINTS; SEISMOGENIC ZONE; DATA INVERSION; NANKAI TROUGH; MODEL; INTERPLATE	To elucidate the relationship between interplate temperatures and generation mechanisms for megathrust earthquakes and slow slip events (SSEs) in the Kanto district, central Japan, we performed numerical simulations on the thermal state. For this purpose, we newly developed a 2-D box-type thermal convection model that is able to handle the subduction of two oceanic plates: the young oceanic Philippine Sea (PHS) plate subducts following subduction of the old oceanic Pacific (PAC) plate beneath it. To constrain temperatures on the upper surface of the PHS plate, we used high-density Hi-net heat flow data on land. We found that low heat flow in the Kanto district was caused mostly by subduction of the cold PHS plate. To explain the heat flow distribution in the Kanto district in more detail, we needed to incorporate frictional heating at the plate interface on the seaward side of the corner of the mantle wedge, and temperature changes due to surface erosion and sedimentation associated with crustal deformation during the Quaternary on land into the models. The most suitable pore pressure ratio to explain the heat flow data was 0.98. The thermally estimated seismogenic zone corresponded well to the fault planes of the 1923 Taisho Kanto earthquake and the western half of the 1707 Genroku Kanto earthquake. The eastern half of the fault plane of the 1707 Genroku Kanto earthquake could be divided into two areas; the northwestern fault plane corresponded to the thermally estimated seismogenic zone, whereas the relationship between the southeastern fault plane and interplate temperatures was ambiguous. The off-Boso SSEs occurred on the plate interface at temperatures lower than approximately 250 degrees C, and the slipped region passed through the 150 degrees C isotherm, corresponding to the clay mineral phase transformation from smectite to illite. This might suggest that the SSEs occurred in relation to a dehydration process.	[Yoshioka, Shoichi] Kobe Univ, Res Ctr Urban Safety & Secur, Kobe, Hyogo 6578501, Japan; [Takagi, Rumi] Nihon Unisys Ltd, Tokyo 1358560, Japan; [Matsumoto, Takumi] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan	Yoshioka, S (reprint author), Kobe Univ, Res Ctr Urban Safety & Secur, Rokkodai Cho 1-1,Nada Ward, Kobe, Hyogo 6578501, Japan.	yoshioka@port.kobe-u.ac.jp					CARISTAN Y, 1982, J GEOPHYS RES, V87, P6781, DOI 10.1029/JB087iB08p06781; Saffer DM, 2003, EARTH PLANET SC LETT, V215, P219, DOI 10.1016/S0012-821X(03)00424-2; WALD DJ, 1995, B SEISMOL SOC AM, V85, P159; Sagiya T, 2004, PURE APPL GEOPHYS, V161, P2327, DOI 10.1007/s0024-004-2566-6; Nakajima J, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004770; Hirose F, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005274; McCaffrey R, 2008, NAT GEOSCI, V1, P316, DOI 10.1038/ngeo178; HYNDMAN RD, 1995, J GEOPHYS RES-SOL EA, V100, P15373, DOI 10.1029/95JB00153; Ozawa S, 2007, EARTH PLANETS SPACE, V59, P1241; Ozawa S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016665; Wada I, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002570; Kobayashi R, 2005, EARTH PLANETS SPACE, V57, P261; Burkett E.R., 2010, GEOCHEM GEOPHY GEOSY, V11, P11012; Byelee J.D., 1978, PURE APPL GEOPHYS, V116, P615; Cabinet Office Government of Japan, 2013, REP FAULT MOD SEISM; Currie CA, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000886; Fukahata Y, 2000, GEOPHYS J INT, V141, P271, DOI 10.1046/j.1365-246x.2000.00120.x; Furukawa Y., 1995, TERRESTRIAL HEAT FLO, P203; Grose CJ, 2012, EARTH PLANET SC LETT, V333, P250, DOI 10.1016/j.epsl.2012.03.037; Hirose H., 2013, REP RCUSS KOBE U, V17, P13; Hirose H, 2014, GEOPHYS RES LETT, V41, P2778, DOI 10.1002/2014GL059791; Honda S, 1997, IWANAMI KOZA EARTH P, P73; HYNDMAN RD, 1993, J GEOPHYS RES-SOL EA, V98, P2039, DOI 10.1029/92JB02279; Nakajima J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036865; Noda A, 2013, GEOPHYS J INT, V193, P61, DOI 10.1093/gji/ggs129; Noguchi S., 2004, SEISM SOC JPN FALL M, V2004, P39; Noguchi S, 1998, B EARTHQ RES I TOKYO, V73, P73; Omori S, 2009, GONDWANA RES, V16, P458, DOI 10.1016/j.gr.2009.07.003; Ranalli G., 1995, RHEOLOGY EARTH; Sdrolias M, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001090; Sella GF, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000033; Seno T, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005889; Stein A.C., 1992, NATURE, V369, P123; Suenaga N., 2015, GEOPHYS RES IN PRESS; The Research Group for Quaternary Tectonic Map, 1969, QUAT TECT MAP JAP, P1; Torii Y, 2007, TECTONOPHYSICS, V445, P200, DOI 10.1016/j.tecto.2007.08.003; Turcotte D.L., 2002, GEODYNAMICS, P456; WANG KL, 1995, TECTONOPHYSICS, V248, P53, DOI 10.1016/0040-1951(95)00028-L; WESSEL P, 1998, EOS T AGU, V0079; Yabe S, 2014, EARTH PLANETS SPACE, V66, DOI 10.1186/s40623-014-0142-6; Yamano M, 2004, HEAT FLOW DATA JAPAN; YOSHII T, 1975, EARTH PLANET SC LETT, V25, P305, DOI 10.1016/0012-821X(75)90246-0; Yoshikawa T., 1974, B DEP GEOGRAPHY U TO, V6, P1; Yoshioka S, 2008, EARTH PLANET SC LETT, V272, P189, DOI 10.1016/j.epsl.2008.04.039; YOSHIOKA S, 1994, TECTONOPHYSICS, V229, P181, DOI 10.1016/0040-1951(94)90028-0; Yoshioka S, 2007, GEOPHYS J INT, V171, P302, DOI 10.1111/j.1365-246X.2007.03510.x; Yoshioka S, 2013, TECTONOPHYSICS, V608, P1094, DOI 10.1016/j.tecto.2013.07.003; Yoshioka S, 2002, GEOPHYS J INT, V151, P69, DOI 10.1046/j.1365-246X.2002.01735.x	48	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0956-540X	1365-246X		GEOPHYS J INT	Geophys. J. Int.	MAY	2015	201	2					878	890		10.1093/gji/ggv032		13	Geochemistry & Geophysics	Geochemistry & Geophysics	CJ2NB	WOS:000355320500023		
J	Yoshida, K; Hasegawa, A; Okada, T				Yoshida, Keisuke; Hasegawa, Akira; Okada, Tomomi			Spatially heterogeneous stress field in the source area of the 2011 M-w 6.6 Fukushima-Hamadori earthquake, NE Japan, probably caused by static stress change	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						Seismicity and tectonics; Intraplate processes; Fractures and faults; High strain deformation zones	TOHOKU EARTHQUAKE; PACIFIC COAST; CRUSTAL STRESS; FAULT; CALIFORNIA; OKI	In order to know whether principal stress orientations in the source area rotated after the 2011 April 11 M-w 6.6 Fukushima-Hamadori earthquake in NE Japan, we investigated detailed spatial distributions of stress orientations for both the pre- and post-main shock periods using a large amount of focal mechanism data. We applied stress tensor inversions to focal mechanism data from Japan's National Research Institute for Earth Science and Disaster Prevention's F-net broadband seismic network and the Japan Meteorological Agency (JMA). The sigma(3)-axes estimated for the pre-main shock period are predominantly oriented WSW-ENE, and are relatively homogeneously in space. In contrast, the orientations of the sigma(3)-axes show a significantly heterogeneous distribution in space for the post-main shock period. In the northern subarea of the focal region, the sigma(3)-axes are oriented NW-SE. In the east and west portions of the central subarea, they are oriented NNW-SSE and WNW-ESE, respectively, almost perpendicular to each other. In the southern subarea, the sigma(3)-axes are oriented WSW-ENE. On the whole, the sigma(3)-axis orientations show concentric circle-like distribution surrounding the large slip area of the M-w M-w 6.6 main shock rupture. The change of principal stress axis orientations after the earthquake is not significant because of the sparse data set for the pre-main shock period. We calculated static stress changes from the M-w 6.6 main shock and three M-w > 5.5 earthquakes to compare with the observed stress axis orientations in the post-main shock period. The sigma(3)-axis orientations of the calculated total static stress change show a concentric circle-like distribution surrounding the large slip area of the main shock, similar to that noted above. This observation strongly suggests that the spatially heterogeneous stress orientations in the post-main shock period were caused by the static stress change from the M-w 6.6 main shock and other large earthquakes. In order to estimate the differential stress magnitude in the focal area, we calculated deviatoric stress tensors in the post-main shock period by assuming that they are the sum of the deviatoric stress tensors in the pre-main shock period and the static stress changes. Comparison of the calculated and observed stress tensors revealed differential stress magnitudes of 2-30 MPa that explain the observed stress orientations, considering the probable range of estimated stress ratios in the pre-main shock period.	[Yoshida, Keisuke] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan; [Hasegawa, Akira; Okada, Tomomi] Tohoku Univ, Grad Sch Sci, Res Ctr Predict Earthquakes & Volcan Erupt, Aoba Ku, Sendai, Miyagi 9808578, Japan	Yoshida, K (reprint author), Natl Res Inst Earth Sci & Disaster Prevent, 3-1 Tennodai, Tsukuba, Ibaraki 3050006, Japan.	k.yoshida0729@gmail.com			Japan Society for the Promotion of Science (JSPS); JSPS KAKENHI [25-3578]; Global Education and Research Center for Earth and Planetary Dynamics, Global COE Program, at Tohoku University	The authors would like to thank the Editor (Professor Egill Hauksson) and two anonymous reviewers for their helpful comments. KY is grateful for support from the Japan Society for the Promotion of Science (JSPS). This work was supported by JSPS KAKENHI Grant Number 25-3578, and in part by the Global Education and Research Center for Earth and Planetary Dynamics, Global COE Program, at Tohoku University.	KAGAN YY, 1991, GEOPHYS J INT, V106, P709, DOI 10.1111/j.1365-246X.1991.tb06343.x; Kato A, 2011, EARTH PLANETS SPACE, V63, P745, DOI 10.5047/eps.2011.06.014; Holt RA, 2013, EARTH PLANET SC LETT, V383, P173, DOI 10.1016/j.epsl.2013.09.041; MICHAEL AJ, 1990, GEOPHYS RES LETT, V17, P1441, DOI 10.1029/GL017i009p01441; Hasegawa A, 2012, EARTH PLANET SC LETT, V355, P231, DOI 10.1016/j.epsl.2012.08.042; Hasegawa A, 2011, EARTH PLANETS SPACE, V63, P703, DOI 10.5047/eps.2011.06.007; Hardebeck JL, 2001, J GEOPHYS RES-SOL EA, V106, P21859, DOI 10.1029/2001JB000292; ZOBACK ML, 1989, NATURE, V341, P291, DOI 10.1038/341291a0; Mizoguchi K, 2012, B SEISMOL SOC AM, V102, P1949, DOI 10.1785/0120110308; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; Toda S, 2013, B SEISMOL SOC AM, V103, P1584, DOI 10.1785/0120120281; Wesson RL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029189; MICHAEL AJ, 1987, J GEOPHYS RES-SOLID, V92, P357, DOI 10.1029/JB092iB01p00357; Hardebeck JL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053438; Heidbach O, 2007, TECTONICS, V26, DOI 10.1029/2007TC002133; Hikima K, 2012, J SEISMOL SOC JAPAN, V64, P243; Imanishi K, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051491; MICHAEL AJ, 1984, J GEOPHYS RES, V89, P1517, DOI 10.1029/JB089iB13p11517; Okada T, 2011, EARTH PLANETS SPACE, V63, P749, DOI 10.5047/eps.2011.06.027; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; The Research Group for Active Faults of Japan, 1991, ACT FAULTS JAP; Ueno H., 2002, Q J SEISMOL, V65, P123; Utsu T., 2001, THE SEISMOLOGY; Yoshida K, 2015, TECTONOPHYSICS, V647, P63, DOI 10.1016/j.tecto.2015.02.013; Yoshida K, 2014, J GEOPHYS RES-SOL EA, V119, P9016, DOI 10.1002/2014JB011291; Yoshida K, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049729; Zhao DP, 1997, GEOPHYS RES LETT, V24, P519, DOI 10.1029/97GL00258	27	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0956-540X	1365-246X		GEOPHYS J INT	Geophys. J. Int.	MAY	2015	201	2					1062	1071		10.1093/gji/ggv068		10	Geochemistry & Geophysics	Geochemistry & Geophysics	CJ2NB	WOS:000355320500033		
J	Takizawa, O; Urushihara, H; Tanaka, S; Kawakami, K				Takizawa, Osamu; Urushihara, Hisashi; Tanaka, Shiro; Kawakami, Koji			Price difference as a predictor of the selection between brand name and generic statins in Japan	HEALTH POLICY			English	Article						Brand name drugs; Generic drugs; Price difference; Claims database; Out-of-hospital pharmacies; Logistic regression analysis	1984 DRUG-ACT; SUBSTITUTION; MEDICINES; COST; PHARMACEUTICALS; DETERMINANTS; PERCEPTIONS; EFFICIENCY; COUNTRIES; ATTITUDES	Objectives: This study aimed to explore the predictors of the selection between brand name drug (BR) and generic drug (GE) and to clarify the quantitative relationship about selection. Methods: We identified "incident users" who dispensed statins between April 2008 and June 2011 in commercially databases consisted of dispensing claims databases (DCD) of out-of-hospital pharmacies and hospital claims databases (HCD) of in-house pharmacies in Japan. Predictors of the selection between BR and GE, including price difference (PD), the price of BR, their interaction and percent change of the price of GE relative to BR were explored by logistic regression using DCD and HCD separately. Results: We extracted records of 670 patients who have opportunity for selection both BR and GE. Logistic regression analysis demonstrated that PD, the price of BR, interaction between them, and prescriber affiliation were factors significantly associated with the selection in the DCD; logit (p) = 9.735 - 0.251 x PD - 0.071 x the price of BR+0.002 x PD x the price of BR -1.816 x affiliation + 0.220 x gender 0.008 x age + 0.038 x monthly medical fee. PD was inversely proportional to BR choice in DCD and lead to the opposite result in HCD. Numerical simulation of selection revealed that the quantitative relationships heavily depend on situations. Conclusions: PD and the price of BR are predictors of the selection between BR and GE interactively in out-of-hospital pharmacies, but not in in-house pharmacies of medical facilities. Results may support policies which increase the power of out-of-hospital pharmacies for selection. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Takizawa, Osamu; Urushihara, Hisashi; Tanaka, Shiro; Kawakami, Koji] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Sakyo Ku, Kyoto 6068501, Japan	Kawakami, K (reprint author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.	kawakami.koji.4e@kyoto-u.ac.jp					GRABOWSKI HG, 1992, J LAW ECON, V35, P331, DOI 10.1086/467257; Shrank WH, 2011, ANN PHARMACOTHER, V45, P31, DOI 10.1345/aph.1P389; Hassali Mohamed A A, 2009, Int J Pharm Pract, V17, P79; Godman B, 2010, EXPERT REV PHARM OUT, V10, P707, DOI [10.1586/erp.10.72, 10.1586/ERP.10.72]; Dylst P, 2011, PHARMACOECONOMICS, V29, P875, DOI 10.2165/11585970-000000000-00000; Kanavos PG, 2011, HEALTH ECON POLICY L, V6, P337, DOI 10.1017/S1744133111000090; Quintal C, 2012, HEALTH POLICY, V104, P61, DOI 10.1016/j.healthpol.2011.10.001; Barros PP, 2010, ADV HEALTH ECON HEAL, V22, P3, DOI 10.1108/S0731-2199(2010)0000022004; Chong CP, 2011, HEALTH POLICY, V99, P139, DOI 10.1016/j.healthpol.2010.08.002; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Chang CH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002040; Chen J, 2010, ADV HEALTH ECON HEAL, V22, P221, DOI 10.1108/S0731-2199(2010)0000022013; Dalen DM, 2011, EUR J HEALTH ECON, V12, P49, DOI 10.1007/s10198-010-0226-6; Decollogny A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-17; Farfan-Portet MI, 2012, EUR J HEALTH ECON, V13, P301, DOI 10.1007/s10198-012-0377-8; Frank RG, 1997, J ECON MANAGE STRAT, V6, P75, DOI 10.1162/105864097567039; Fujimura S, 2012, J INFECT CHEMOTHER, V18, P421, DOI 10.1007/s10156-012-0437-0; Gibson TB, 2010, ADV HEALTH ECON HEAL, V22, P195, DOI 10.1108/S0731-2199(2010)0000022012; Godman Brian, 2010, Front Pharmacol, V1, P141, DOI 10.3389/fphar.2010.00141; GRABOWSKI H, 1986, AM ECON REV, V76, P195; Iizuka T, 2011, HEALTH ECON POLICY L, V6, P369; Johnston A, 2010, BRIT J CLIN PHARMACO, V70, P320, DOI 10.1111/j.1365-2125.2010.03681.x; Kanavos P., 2008, ECON POLICY, V23, P499, DOI 10.1111/j.1468-0327.2008.00207.x; Kimura S, 2010, J EPIDEMIOL, V20, P413, DOI 10.2188/jea.JE20090066; Kobayashi E, 2011, HEALTH POLICY, V99, P60, DOI 10.1016/j.healthpol.2010.07.006; Kunisawa S, 2013, J HEALTH SERV RES PO, V18, P138, DOI 10.1177/1355819612473593; Liew D, 2012, NETHERLANDS HEART J, V20, P197; McGinn D, 2010, EXPERT REV PHARM OUT, V10, P73, DOI [10.1586/erp.09.73, 10.1586/ERP.09.73]; Ministry of Health Labour and Welfare, 2015, POL INF; Ortiz M, 2010, MED J AUSTRALIA, V192, P370; Pechlivanoglou P, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-89; Saha A, 2006, INT J EC BUSINESS, V13, P5; Simoens S, 2013, CARDIOVASC DRUG THER, V27, P49, DOI 10.1007/s10557-012-6432-y; Toverud EL, 2011, EUR J CLIN PHARMACOL, V67, P33, DOI 10.1007/s00228-010-0935-x; Vandoros S, 2014, HEALTH ECON, V23, P621, DOI 10.1002/hec.2935	35	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8510	1872-6054		HEALTH POLICY	Health Policy	MAY	2015	119	5					612	619		10.1016/j.healthpol.2015.01.010		8	Health Care Sciences & Services; Health Policy & Services	Health Care Sciences & Services	CI8OP	WOS:000355031900007		
J	Igarashi, T; Inami, M				Igarashi, Takeo; Inami, Masahiko			Exploration of Alternative Interaction Techniques for Robotic Systems	IEEE COMPUTER GRAPHICS AND APPLICATIONS			English	Article									[Igarashi, Takeo] Univ Tokyo, Sch Informat Sci & Technol, Tokyo 1138654, Japan; [Inami, Masahiko] Keio Univ, Grad Sch Media Design, Tokyo 108, Japan	Igarashi, T (reprint author), Univ Tokyo, Sch Informat Sci & Technol, Tokyo 1138654, Japan.	takeo@acm.org; inami@kmd.keio.ac.jp					DRASCIC D, 1993, HUMAN FACTORS IN COMPUTING SYSTEMS, P521; Ishii H., 2007, HUMAN COMPUTER INTER; Ishii K., 2013, P 14 IFIP TC13 C HUM, P420; Nishio S., 2007, HUMANOID ROBOTS NEW; Noh S., 2013, VISUAL COMPUT, V30, P467; Seifried T., 2009, P ACM INT C INT TABL, P37; Sugiura Y., 2012, P 2012 ACM ANN C HUM, P725; Sugiura Y., 2009, P ACM SIGGR 2009 EM; Sugiura Y, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P2427; Sugiura Y., 2014, P 27 ANN ACM S US IN, P149; Sugiura Y., 2011, P 24 ANN ACM S US IN, P509; Tachi S., THEORY PRACTICE ROBO, P245; Zhao SD, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P173	13	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0272-1716	1558-1756		IEEE COMPUT GRAPH	IEEE Comput. Graph. Appl.	MAY-JUN	2015	35	3					31	39				9	Computer Science, Software Engineering	Computer Science	CJ0YT	WOS:000355208000007		
J	Fujikura, M; Murakami, H; Ushigami, Y; Arai, S; Iwata, K				Fujikura, Masahiro; Murakami, Hidekuni; Ushigami, Yoshiyuki; Arai, Satoshi; Iwata, Keiji			Effects of Cu Precipitates on Magnetic Properties of Nonoriented Electrical Steel	IEEE TRANSACTIONS ON MAGNETICS			English	Article						Domain wall pinning; high tensile strength steel; precipitation hardening; Si-Fe	COPPER	Tests to measure the effects of the precipitating size of Cu on the magnetic properties of nongrain-oriented (NGO) electrical steel were carried out. The hysteresis loss had a maximum value when the diameter of the precipitates was around the thickness of the domain wall and decreased rapidly with decreasing size of the precipitates. Alternatively, yield point (YP) rose steeply with reduction in the size of Cu precipitates. It can be confirmed that the precipitating Cu has an ability of rising over 100 MPa in YP without deteriorating core loss. Regarding the effects of Cu precipitates on the hysteresis loss, the surface tension effect might be dominant for the case in which precipitates are smaller than the domain wall thickness, and internal magnetic poles are effective for the larger precipitates.	[Fujikura, Masahiro; Murakami, Hidekuni; Ushigami, Yoshiyuki] Nippon Steel & Sumitomo Met Corp, Yawata Res & Dev Lab, Kitakyushu 8048501, Japan; [Arai, Satoshi] Nippon Steel & Sumitomo Met Corp, Elect Steel Sheet Res Lab, Chiba 2938511, Japan; [Iwata, Keiji] Nippon Steel & Sumitomo Met Corp, Math Sci & Technol Res Lab, Chiba 2938511, Japan	Fujikura, M (reprint author), Nippon Steel & Sumitomo Met Corp, Yawata Res & Dev Lab, Kitakyushu 8048501, Japan.	fujikura.y3m.masahiro@jp.nssmc.com					HORNBOGEN E, 1960, T AM I MIN MET ENG, V218, P1064; Jenkins K, 2008, J MAGN MAGN MATER, V320, P2423, DOI 10.1016/j.jmmm.2008.03.062; Chikazumi S., 1984, PHYS FERROMAGNETISM, V2, P174; DIJKSTRA LJ, 1950, PHYS REV, V79, P979, DOI 10.1103/PhysRev.79.979; Murakami H., Japanese Patent, Patent No. [JP5000 136, 5000136]; Ohmura K., Japanese Patent, Patent No. [JP4 265 400, 4265400]; Speich G. R., 1965, PRECIPITATION IRON B; Takahashi J, 2012, MAT SCI ENG A-STRUCT, V535, P144, DOI 10.1016/j.msea.2011.12.056; Turner S., 2010, J APPL PHYS, V107	9	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9464	1941-0069		IEEE T MAGN	IEEE Trans. Magn.	MAY	2015	51	5							2001604	10.1109/TMAG.2014.2365442		4	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CJ0XU	WOS:000355204800003		
J	Nishio, H				Nishio, Hiroaki			Effect of Anisotropy Constants on Squareness Ratio in Sr-La-Co High-Performance Sintered Ferrite Magnets at Elevated Temperatures	IEEE TRANSACTIONS ON MAGNETICS			English	Article						Demagnetization curve; irreversible demagnetization; quadratic anisotropy constant; quartic anisotropy constant; squareness ratio; Sr-La-Co ferrite magnet	COERCIVITY	To decrease the irreversible demagnetization of Sr-La-Co sintered ferrite magnets at elevated temperatures, it is required to remarkably improve the squareness ratio (H-k/H-cJ), where H-k and H-cJ are the knee field and coercivity, respectively. It is very important to find out the main reason behind the effects on H-k/H-cJ at high temperature. Particular attention has been paid to the effect of the ratio of anisotropy constant (K-u2/K-u1) on H-k/H-cJ for Sr1-xLaxFe12-xCoxO19(x = 0-0.4) sintered ferrite magnets above room temperature, where K-u2, K-u1, and x are the quartic and quadratic anisotropy constants, and the substituted amount, respectively. The value of H-k/H-cJ linearly decreases as x value increases at every temperature. Furthermore, it decreases with higher temperatures. The value of K-u2/K-u1 remarkably increases with increasing x value at elevated temperatures. The value of H-k/H-cJ linearly decreases in the order of x value as K-u2/K-u1 increases for all the magnets above room temperature. Uniaxial anisotropy term (K-u1 + K-u2) has an effect on the orientation in the direction of easy magnetization. However, biaxial anisotropy term (K-u2/2) has two different directions of easy magnetization. The difference in easy direction of biaxial anisotropy makes an angle of pi/4 to each other. An excessive increase in K-u2/K-u1 is not necessarily effective to increase H-k/H-cJ. The decrease in H-k/H-cJ is mainly caused by the increase in K-u2/K-u1 at elevated temperatures.	Res Inst Measurement Magnet Mat, Yokohama, Kanagawa 2400026, Japan	Nishio, H (reprint author), Res Inst Measurement Magnet Mat, Yokohama, Kanagawa 2400026, Japan.	qyy02334@nifty.ne.jp					Morimoto S, 2014, IEEE T IND ELECTRON, V61, P5749, DOI 10.1109/TIE.2013.2289856; Nishio H, 2011, IEEE T MAGN, V47, P3641, DOI 10.1109/TMAG.2011.2144571; LOTGERING FK, 1959, J INORG NUCL CHEM, V9, P113, DOI 10.1016/0022-1902(59)80070-1; Nishio H, 2009, IEEE T MAGN, V45, P5281, DOI 10.1109/TMAG.2009.2026044; Vagati A, 2014, IEEE T IND APPL, V50, P1768, DOI 10.1109/TIA.2013.2284302; Chikazumi S., 1964, PHYS MAGNETISM, P331; Iida K., 1999, J MAGN SOC JAPAN, V23, P1093, DOI 10.3379/jmsjmag.23.1093; Mcguire T. R., 1969, MAGNETISM METALLURGY, p[64, 137]; Nishio H, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2013.2281415; PENOYER RF, 1959, REV SCI INSTRUM, V30, P711, DOI 10.1063/1.1716730; Perigo EA, 2009, IEEE T MAGN, V45, P4431, DOI 10.1109/TMAG.2009.2025190; Shimoda T., 1981, P 5 INT WORKSH RE MA, P595	12	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9464	1941-0069		IEEE T MAGN	IEEE Trans. Magn.	MAY	2015	51	5							2100204	10.1109/TMAG.2014.2381156		4	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CJ0XU	WOS:000355204800004		
J	Mori, M; Koide, T; Matsui, Y; Matsuda, T				Mori, Miyu; Koide, Tetsuro; Matsui, Yuriyo; Matsuda, Toru			A case of early detection of bisphosphonate-related osteonecrosis of the jaw	INDIAN JOURNAL OF PHARMACOLOGY			English	Article						Magnetic resonance imaging; minodronate; rheumatoid arthritis; T1-weight images; teriparatide		Osteonecrosis of the jaws is an adverse reaction associated with the use of bisphosphonates. Although the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ) is based on symptomatology, it is often detected late because the patients become symptomatic only after osteonecrosis is well established. We describe a case of early oral BRONJ detected by magnetic resonance imaging (MRI) accidentally. Head MRI revealed low signal of T1-weight images in left mandibula. Patient had been treated with minodronate for osteoporosis during 18 months. Based on the MRI findings and medication history, early stage BRONJ could be considered. Therefore minodronate was switched to teriparatide. Thereafter mandible pares-thesias, odontalgia and exposed bone were not observed. This case suggests that MRI is useful for the early detection of BRONJ.	[Mori, Miyu; Koide, Tetsuro] Kuwana West Med Ctr, Dept Pharm, Kuwana, Japan; [Matsui, Yuriyo; Matsuda, Toru] Kuwana West Med Ctr, Dept Orthopaed Surg, Kuwana, Japan	Mori, M (reprint author), Kuwana West Med Ctr, Dept Pharm, Kuwana, Japan.	yakuzai.kch@kuwanacmc.or.jp					Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239; Bocanegra-Perez MS, 2012, MED ORAL PATOL ORAL, V17, pE948, DOI 10.4317/medoral.17946; Haworth AE, 2012, BRIT J RADIOL, V85, P1333, DOI 10.1259/bjr/99102700; Kiyama T, 2013, TOHOKU J EXP MED, V230, P141, DOI 10.1620/tjem.230.141; Park W, 2010, OSTEOPOROSIS INT, V21, P527, DOI 10.1007/s00198-009-0973-3; Stopeck Alison, 2010, Clin Adv Hematol Oncol, V8, P159	7	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0253-7613	1998-3751		INDIAN J PHARMACOL	Indian J. Pharmacol.	MAY-JUN	2015	47	3					334	335		10.4103/0253-7613.157137		2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CJ2NL	WOS:000355321600020		
J	Nakajima, J; Sunohara, D; Kawashima, H				Nakajima, Junya; Sunohara, Daisuke; Kawashima, Hisashi			Congenital cytomegalovirus infection in monozygotic twins with twin-to-twin transfusion syndrome	INDIAN PEDIATRICS			English	Article						Intrauterine infection; Outcome; TORCH infection	PREGNANCY	Symptoms of congenital cytomegalovirus infection remains unclear. Extremely low birth weight twins with twin-to-twin transfusion syndrome were infected with cytomegalovirus congenitally. The donor showed neuronal impairment, whereas the recipient showed hepatic dysfunction. Intrauterine hemodynamics may be important in pathophysiology of congenital cytomegalovirus infection.	[Nakajima, Junya; Sunohara, Daisuke; Kawashima, Hisashi] Tokyo Med Univ, Dept Pediat, Tokyo 1600023, Japan	Nakajima, J (reprint author), Tokyo Med Univ, Dept Pediat, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	ob1.3po@hotmail.co.jp					AHLFORS K, 1988, EARLY HUM DEV, V18, P125, DOI 10.1016/0378-3782(88)90049-7; Lougheed J, 2001, J AM COLL CARDIOL, V38, P1533, DOI 10.1016/S0735-1097(01)01549-2; Swanson EC, 2013, PEDIATR CLIN N AM, V60, P335, DOI 10.1016/j.pcl.2012.12.008; Chen FP, 2007, J REPROD MED, V52, P317; Gabrielli L, 2003, J CLIN MICROBIOL, V41, P1329, DOI 10.1128/JCM.41.3.1329-1331.2003; Galea P, 2005, PRENATAL DIAG, V25, P777, DOI 10.1002/pd.1264; Griesmaier E, 2010, KLIN PADIATR, V222, P312, DOI 10.1055/s-0030-1263130; Lazzarotto T, 2003, PEDIATRICS, V112, pE153, DOI 10.1542/peds.112.2.e153; Llorente AM, 2012, APPL NEUROPSYCH-CHIL, V1, P63, DOI 10.1080/21622965.2012.677605; Tarui T, 2012, AM J NEURORADIOL, V33, P1121, DOI 10.3174/ajnr.A2922	10	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0019-6061	0974-7559		INDIAN PEDIATR	Indian Pediatrics	MAY	2015	52	5					429	431		10.1007/s13312-015-0650-x		3	Pediatrics	Pediatrics	CJ0UG	WOS:000355193400014		
J	Nakayoshi, M; Kanda, M; Shi, R; de Dear, R				Nakayoshi, Makoto; Kanda, Manabu; Shi, Rui; de Dear, Richard			Outdoor thermal physiology along human pathways: a study using a wearable measurement system	INTERNATIONAL JOURNAL OF BIOMETEOROLOGY			English	Article						Mobile observation; Globe thermometer; Outdoor thermal comfort; Outdoor thermal physiology; Mean radiant temperature; Sweat rate	TEMPERATURE; COMFORT; ENVIRONMENTS; UTCI	An outdoor summer study on thermal physiology along subjects' pathways was conducted in a Japanese city using a unique wearable measurement system that measures all the relevant thermal variables: ambient temperature, humidity, wind speed (U) and short/long-wave radiation (S and L), along with some physio-psychological parameters: skin temperature (Tskin), pulse rate, subjective thermal sensation and state of body motion. U, S and L were measured using a globe anemo-radiometer adapted use with pedestrian subjects. The subjects were 26 healthy Japanese adults (14 males, 12 females) ranging from 23 to 74 years in age. Each subject wore a set of instruments that recorded individual microclimate and physiological responses along a designated pedestrian route that traversed various urban textures. The subjects experienced varying thermal environments that could not be represented by fixed-point routine observational data. S fluctuated significantly reflecting the mixture of sunlit/shade distributions within complex urban morphology. U was generally low within urban canyons due to drag by urban obstacles such as buildings but the subjects' movements enhanced convective heat exchanges with the atmosphere, leading to a drop in T-skin. The amount of sweating increased as standard effective temperature (SET*) increased. A clear dependence of sweating on gender and body size was found; males sweated more standard/underweight subjects. T-skin had a linear relationship with SET* and a similarly clear dependence on gender and body size differences. T-skin of the higher-sweating groups was lower than that of the lower-sweating groups, reflecting differences in evaporative cooling by perspiration.	[Nakayoshi, Makoto] Tokyo Univ Sci, Dept Civil Engn, Noda, Chiba 2788510, Japan; [Kanda, Manabu; Shi, Rui] Tokyo Inst Technol, Dept Int Dev Engn, Tokyo 152, Japan; [de Dear, Richard] Univ Sydney, Fac Architecture Design & Planning, Sydney, NSW 2006, Australia	Nakayoshi, M (reprint author), Tokyo Univ Sci, Dept Civil Engn, 2641 Yamasaki, Noda, Chiba 2788510, Japan.	nakayoshi@rs.tus.ac.jp			MEXT/JSPS KAKENHI [227335]; Ministry of Education, Culture, Sports, Science and Technology, Japan	This research was financially supported by the MEXT/JSPS KAKENHI Grant Number 227335 (Grant-in-Aid for JSPS Fellows) and the Research Program on Climate Change Adaptation (RECCA) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The research group also extends its appreciation to city employees in the Tajimi municipal government.	Thorsson S, 2007, ENVIRON BEHAV, V39, P660, DOI 10.1177/0013916506294937; Thorsson S, 2007, INT J CLIMATOL, V27, P1983, DOI 10.1002/joc.1537; Hardy JD, 1938, J NUTR, V15, P461; Ahmed KS, 2003, ENERG BUILDINGS, V35, P103, DOI 10.1016/S0378-7788(02)00085-3; Bernard T, 1997, EUR J APPL PHYSIOL O, V75, P170, DOI 10.1007/s004210050143; Niimi Y, 1997, J AUTONOM NERV SYST, V63, P61, DOI 10.1016/S0165-1838(96)00134-8; de Dear R, 2011, BUILD RES INF, V39, P108, DOI 10.1080/09613218.2011.552269; Pantavou K, 2013, BUILD ENVIRON, V66, P82, DOI 10.1016/j.buildenv.2013.02.014; Jendritzky G, 2012, INT J BIOMETEOROL, V56, P421, DOI 10.1007/s00484-011-0513-7; Spagnolo J, 2003, BUILD ENVIRON, V38, P721, DOI 10.1016/S0360-1323(02)00209-3; de Dear R, 1987, J AIR COND, V60, P10; FOX RH, 1969, J APPL PHYSIOL, V26, P444; Gagge AP, 1971, ASHRAE T, V77, P246; Ishii T, 2009, P 7 INT C URB CLIM I; Johansson E, 2014, URBAN CLIMA IN PRESS; Kanda M, 2006, BOUND-LAY METEOROL, V121, P339, DOI 10.1007/s10546-006-9063-7; Lovegrove BG, 2009, J COMP PHYSIOL B, V179, P451, DOI 10.1007/s00360-008-0329-x; Nakayoshi M, GLOBE ANEMORAD UNPUB; Sugawara H, 2004, J APPL METEOROL, V43, P1168, DOI 10.1175/1520-0450(2004)043<1168:RATOTH>2.0.CO;2; Vennon HM, 1932, J IND HYG, V14, P95	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0020-7128	1432-1254		INT J BIOMETEOROL	Int. J. Biometeorol.	MAY	2015	59	5					503	515		10.1007/s00484-014-0864-y		13	Biophysics; Environmental Sciences; Meteorology & Atmospheric Sciences; Physiology	Biophysics; Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences; Physiology	CJ2TR	WOS:000355338000002		
J	Shimada, S; Vaidya, S; Khindri, S; Tashiro, N; Cheng, Y; Hara, H; Majumdar, T; Woessner, R; Furihata, K; Kobayashi, K				Shimada, Sayaka; Vaidya, Soniya; Khindri, Sanjeev; Tashiro, Natsuka; Cheng, Yi; Hara, Hisanori; Majumdar, Tapan; Woessner, Ralph; Furihata, Kenichi; Kobayashi, Kiyoshi			Pharmacokinetics of QMF149 in Japanese versus Caucasian subjects: an open-label, randomized phase I study	INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS			English	Article						QMF149; indacaterol; mometasone furoate; pharmacokinetics; Japanese; Caucasian; ethnic variation	OBSTRUCTIVE PULMONARY-DISEASE; FLUTICASONE PROPIONATE; MOMETASONE FUROATE; PERSISTENT ASTHMA; SALMETEROL; INHALER; SAFETY; THERAPY; POPULATIONS; INDACATEROL	Objectives: This study aimed to evaluate influence of ethnic factors on the pharmacokinetics of orally inhaled QMF149, a novel combination of an approved long-acting beta(2)-agonist, indacaterol (Onbrez (R) Breezhaler (R) for COPD), and an approved inhaled corticosteroid, mometasone furoate (MF), (Asmanex (R) Twisthaler (R) for asthma), following multiple dose administration of QMF149 (indacaterol acetate/MF) 150/80 mu g and 150/320 mu g via the Breezhaler (R) device in healthy Japanese and Caucasian subjects. Methods: This was a single-center, open-label, multiple-dose, two-period, complete crossover study that randomized healthy Japanese and, age and weight matched Caucasian subjects to QMF149 150/80 mu g or 150/320 mu g once daily (o.d.) for 14 days in each period. Pharmacokinetics (PK) were assessed up to 24 hours on days 1 and 14. Results: 24 Japanese and 24 Caucasian healthy subjects were enrolled. Indacaterol and MF had similar PK profiles across both the doses and both ethnic groups. The maximum geometric mean ratios (90% confidence interval (CI)) for Japanese vs. Caucasian subjects for C-max were 1.23 (1.11 - 1.38) and 1.24 (1.11 1.38) for indacaterol and MF, respectively. For AUC, the maximum ratios were 1.22 (1.09 - 1.36) and 1.30 (1.18 - 1.44) for indacaterol and MF, respectively. The mild trend towards higher exposure in Japanese subjects could be explained by the fact that the mean body weight was 14% higher for Caucasians compared to their Japanese counterparts. No serious adverse events or discontinuations related to study medication were reported. Conclusion: The study demonstrated increase of mean exposure parameters in Japanese subjects vs. Caucasian subjects, which ranged between 19 - 23% and 17 - 30%, for indacaterol and MF components, respectively. Multiple doses of both the QMF149 dose levels were safe and well-tolerated in all subjects. Body weight was considered a key contributory factor for the observed difference in exposure. These results suggest no dose adjustment for QMF149 is required in Asian populations.	[Shimada, Sayaka; Tashiro, Natsuka; Kobayashi, Kiyoshi] Novartis Pharma KK, Translat Sci, Tokyo 1056633, Japan; [Vaidya, Soniya] Novartis Inst BioMed Res, Clin Pharmacokinet Pharmacodynam, Drug Metab & Pharmacokinet, Cambridge, MA USA; [Khindri, Sanjeev] Novartis Inst BioMed Res, Translat Med, Horsham, W Sussex, England; [Cheng, Yi] Beijing Novartis Pharma Co Ltd, Shanghai, Peoples R China; [Hara, Hisanori; Woessner, Ralph] Novartis Inst BioMed Res, Drug Metab & Pharmacokinet, Basel, Switzerland; [Majumdar, Tapan] Novartis Inst BioMed Res, Drug Metab & Pharmacokinet, E Hanover, NJ USA; [Furihata, Kenichi] Keikokai Med Corp, Clin P 1, Tokyo, Japan	Shimada, S (reprint author), Novartis Pharma KK, Minato Ku, 23-1 Toranomon 1 Chome, Tokyo 1056633, Japan.	sayaka.shimada@novartis.com			Novartis Pharma K.K., Tokyo Japan	The study has been sponsored by Novartis Pharma K.K., Tokyo Japan. SS, SV, SK, NT, RW, KK, HH, TM, and YC were employees of Novartis at the time of study conduct. KF reports personal fees from Kissei Pharmaceutical Co., outside the submitted work.	American Thoracic Society European Respiratory Society, 2004, STAND DIAGN MAN PAT; O'Donnell DE, 2006, CHEST, V130, P647, DOI 10.1378/chest.130.3.647; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; [Anonymous], 2010, ONBREZ BREEZHALER SU; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Myrand SP, 2008, CLIN PHARMACOL THER, V84, P347, DOI 10.1038/sj.clpt.6100482; [Anonymous], 2011, ASMANEX TWISTHALER 1; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Stoloff SW, 2004, J ALLERGY CLIN IMMUN, V113, P245, DOI 10.1016/j.jaci.2003.10.011; Yasuda SU, 2008, CLIN PHARMACOL THER, V84, P417, DOI 10.1038/clpt.2008.141; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; McCormack PL, 2006, DRUGS, V66, P1151, DOI 10.2165/00003495-200666080-00011; Hanania NA, 2003, CHEST, V124, P834, DOI 10.1378/chest.124.3.834; Johnson JA, 1997, J PHARM SCI, V86, P1328, DOI 10.1021/js9702168; LaForce C, 2009, CURR MED RES OPIN, V25, P2353, DOI 10.1185/03007990903143143; Beasley R, 2013, THORAX, V68, P119, DOI 10.1136/thoraxjnl-2012-202483; Beasley R, 2010, LANCET, V376, P750, DOI 10.1016/S0140-6736(10)61158-0; British Thoracic Society/SIGN, 2012, BRIT GUID MAN ASTHM; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Chuchalin AG, 2007, RESP MED, V101, P2065, DOI 10.1016/j.rmed.2007.06.002; GOLD, GLOB STRAT DIAGN MAN; Goldsmith P, 2011, EUR RESPIR J, V38, P3988; Hosoe M, 2011, CLIN DRUG INVEST, V31, P247, DOI 10.2165/11586520-000000000-00000; Karpel JP, 2007, CURR MED RES OPIN, V23, P2897, DOI 10.1185/030079907X242485; Levenson MS, 2008, JOINT M PULM ALL DRU; Matsushima S, 2012, INT J CLIN PHARM TH, V50, P545, DOI 10.5414/CP201719; National Asthma Education and Prevention Program, 2007, 3 NAT ASTHM ED PREV; Rodrigo GJ, 2012, THORAX, V67, P342, DOI 10.1136/thx.2010.155648; Stempel DA, 2005, RESP MED, V99, P1263, DOI 10.1016/j.rmed.2005.03.002; US Department of Health and Human Services NH Lung and Blood Institute, 3 US DEP HLTH HUM SE; Vaidya S, 2012, EUR RESPIR J, V40, P2145; Wood AJJ, 1998, THER DRUG MONIT, V20, P525, DOI 10.1097/00007691-199810000-00013	33	0	0	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0946-1965			INT J CLIN PHARM TH	Int. J. Clin. Pharmacol. Ther.	MAY	2015	53	5					398	407		10.5414/CP202239		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CJ4YU	WOS:000355495400007		
J	Chen, X; Matsuzawa, T; Hitsu, E; Zhong, W; Qian, Z; Jiang, J; Hu, P				Chen, Xia; Matsuzawa, Takayasu; Hitsu, Ei; Zhong, Wen; Qian, Zhao; Jiang, Ji; Hu, Pei			Model of the dermatopharmacokinetic profile of two loxoprofen patches for bioequivalence confirmation	INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS			English	Letter									[Chen, Xia; Zhong, Wen; Qian, Zhao; Jiang, Ji; Hu, Pei] Beijing Union Med Coll Hosp, Clin Pharmacol Res Ctr, Phase Unit 1, Beijing 100032, Peoples R China; [Matsuzawa, Takayasu] EPS Corp, China Business Div, Philadelphia, PA USA; [Hitsu, Ei] Lead Chem Co Ltd, Sapporo, Hokkaido, Japan	Hu, P (reprint author), Beijing Union Med Coll Hosp, Clin Pharmacol Res Ctr, Phase Unit 1, 41 Damucang Hutong, Beijing 100032, Peoples R China.	pei.hu.pumc@gmail.com					ANDERSON RL, 1973, J INVEST DERMATOL, V61, P30, DOI 10.1111/1523-1747.ep12674117; [Anonymous], 2003, GUIDELINE BIOEQUIVAL; Chen X, 2014, INT J CLIN PHARM TH, V52, P927, DOI 10.5414/CP202165; Herkenne C, 2007, J INVEST DERMATOL, V127, P887, DOI 10.1038/sj.jid.5700642	4	0	0	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0946-1965			INT J CLIN PHARM TH	Int. J. Clin. Pharmacol. Ther.	MAY	2015	53	5					412	413		10.5414/CP202281		2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CJ4YU	WOS:000355495400009		
J	Yukawa, M; Watatani, M; Isono, S; Fujiwara, Y; Tsujie, M; Kitani, K; Hara, J; Kato, H; Takeyama, H; Kanaizumi, H; Kogata, S; Ohta, Y; Inoue, M				Yukawa, Masao; Watatani, Masahiro; Isono, Sayuri; Fujiwara, Yoshinori; Tsujie, Masanori; Kitani, Kotaro; Hara, Johji; Kato, Hiroaki; Takeyama, Hiroshi; Kanaizumi, Hirofumi; Kogata, Shuhei; Ohta, Yoshio; Inoue, Masatoshi			Management of Granulomatous Mastitis: A Series of 13 Patients Who Were Evaluated for Treatment Without Corticosteroids	INTERNATIONAL SURGERY			English	Article						Breast; Granulomatous mastitis; Drainage	LOBULAR MASTITIS; BREAST-CANCER; DIAGNOSIS; THERAPY	Granulomatous mastitis (GM) is a rare chronic inflammatory breast condition with unknown etiology. There is still no generally accepted optimal treatment for GM. Corticosteroid treatment and/or wide excision is most commonly reported in the literature. Incision and drainage or limited excision alone has little benefit because of a strong tendency of recurrence. Corticosteroids also have a high failure rate and possible side effects. In the current series, we treated GM patients without corticosteroids, except for one patient. We also devised multidirectional deep drainage for advanced and complicated abscesses, which are characteristic of GM. This retrospective study included 13 women who met the required histologic criteria of GM. The mean age of the patients was 41 years. All of the patients were premenopausal. Six patients had breast-fed in the last 5 years. Five patients were under medication with antidepressants. A total of 11 patients developed abscesses during the clinical course, and the abscesses penetrated the retromammary space in 4 patients. We treated 2 of these 4 patients with multidirectional deep drainage and obtained complete remission in 5 and 6.5 months, respectively. These times were much shorter than those in the other 2 patients. The time to resolution in 11 patients was 4 to 28 months. This overall outcome was comparable with that of corticosteroid treatment reported in the literature. Because the natural history of GM is thought to be self-limiting, close observation and minimally required drainage of abscesses without corticosteroid administration remain the treatment modality of choice.	[Yukawa, Masao; Watatani, Masahiro; Isono, Sayuri; Fujiwara, Yoshinori; Tsujie, Masanori; Kitani, Kotaro; Hara, Johji; Kato, Hiroaki; Takeyama, Hiroshi; Kanaizumi, Hirofumi; Kogata, Shuhei; Inoue, Masatoshi] Kinki Univ, Nara Hosp, Fac Med, Dept Surg, Ikoma, Nara, Japan; [Ohta, Yoshio] Kinki Univ, Nara Hosp, Fac Med, Dept Pathol & Lab Med, Ikoma, Nara, Japan	Yukawa, M (reprint author), Kinki Univ, Nara Hosp, Fac Med, Dept Surg, 1248-1 Otoda Cho, Ikoma, Nara, Japan.	yukawa@nara.med.kindai.ac.jp					Al-Khaffaf B, 2008, J AM COLL SURGEONS, V206, P269, DOI 10.1016/j.jamcollsurg.2007.07.041; Imoto S, 1997, JPN J CLIN ONCOL, V27, P274, DOI 10.1093/jjco/27.4.274; Hugon-Rodin J, 2012, GYNECOL ENDOCRINOL, V28, P921, DOI 10.3109/09513590.2012.683075; DEHERTOGH DA, 1980, NEW ENGL J MED, V303, P799, DOI 10.1056/NEJM198010023031406; Coker F, 2010, CNS DRUGS, V24, P563, DOI 10.2165/11533140-000000000-00000; Pereira FA, 2012, INT J DERMATOL, V51, P142, DOI 10.1111/j.1365-4632.2011.05168.x; KESSLER E, 1972, AM J CLIN PATHOL, V58, P642; Azlina AF, 2003, WORLD J SURG, V27, P515, DOI 10.1007/s00268-003-6806-1; Lee JH, 2006, YONSEI MED J, V47, P78; Amsterdam JD, 1997, J AFFECT DISORDERS, V46, P151, DOI 10.1016/S0165-0327(97)00086-4; GOING JJ, 1987, J CLIN PATHOL, V40, P535, DOI 10.1136/jcp.40.5.535; Heer R, 2003, BREAST, V12, P283, DOI 10.1016/S0960-9776(03)00032-8; Erozgen F, 2010, BREAST CANCER RES TR, V123, P447, DOI 10.1007/s10549-010-1041-6; Sakurai K, 2011, SURG TODAY, V41, P333, DOI 10.1007/s00595-009-4292-2; Baslaim MM, 2007, WORLD J SURG, V31, P1677, DOI 10.1007/s00268-007-9116-1; Dixon JM, 2010, DIS BREAST, V4th, P42; DIXON JM, 1995, BRIT J SURG, V82, P1143, DOI 10.1002/bjs.1800820853; Larsen LJH, 2009, AM J ROENTGENOL, V193, P574, DOI 10.2214/AJR.08.1528; Lester SC, 2005, BREAST J, V11, P534, DOI 10.1111/j.1075-122X.2005.00175.x; Meguid MM, 2004, BREAST COMPREHENSIVE, V3rd, P93; Ogura K, 2010, HISTOPATHOLOGY, V57, P39, DOI 10.1111/j.1365-2559.2010.03581.x; Rosen PP, 2009, ROSENS BREAST PATHOL, V3rd, P33; SALAM IMA, 1995, BRIT J SURG, V82, P214; Wilson JP, 2007, AM SURGEON, V73, P798; Yilmaz E, 2001, EUR RADIOL, V11, P2236, DOI 10.1007/s003300100965	25	1	1	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	MAY	2015	100	5					774	782		10.9738/INTSURG-D-14-00231.1		9	Surgery	Surgery	CJ0UF	WOS:000355193300002		
J	Kishikawa, J; Kawai, K; Tsuno, NH; Ishihara, S; Yamaguchi, H; Sunami, E; Watanabe, T				Kishikawa, Junko; Kawai, Kazushige; Tsuno, Nelson H.; Ishihara, Soichiro; Yamaguchi, Hironori; Sunami, Eiji; Watanabe, Toshiaki			Characteristics and Prognosis of Colorectal Cancer Associated With Rheumatic Disease	INTERNATIONAL SURGERY			English	Article						Colorectal cancer; Rheumatic disease; Host immunity; Prognosis	INFLAMMATORY-BOWEL-DISEASE; SYSTEMIC-SCLEROSIS; ARTHRITIS; RISK; COHORT; POPULATION; MALIGNANCY; MORTALITY; SURVIVAL; DEATH	It is well known that host immunity plays an important role in the defense against colorectal cancer (CRC) progression. The effects of autoimmune diseases, such as rheumatic disease (RD) in which the immune system is deregulated, on this immunity have not been fully investigated. The medical records of 1299 consecutive patients diagnosed with primary colorectal cancer who underwent surgical resection were retrospectively reviewed. The clinicopathologic factors of 28 subjects with RD (RD group) were compared with those of 1271 patients without RD (non-RD group). Compared to the non-RD group, the RD group was typified by a predominance of females (P < 0.01), older age (P < 0.01), and a lower incidence of rectal cancer (P = 0.02). Although no difference was observed between the groups in terms of TNM classification, disease-free and overall survival were significantly poorer in the RD group in both univariate and multivariate analyses. Subjects who had RD for more than 10 years tended to have a higher frequency of lymph node metastasis (P = 0.06) and a significantly higher incidence of synchronous distant metastasis (P = 0.035) at the time of cancer diagnosis. RD was associated with a significantly poorer prognosis of colorectal cancer, suggesting that deregulation of the immune system by autoimmune diseases may adversely affect the host immune defense against colorectal cancer progression.	[Kishikawa, Junko; Kawai, Kazushige; Tsuno, Nelson H.; Ishihara, Soichiro; Yamaguchi, Hironori; Sunami, Eiji; Watanabe, Toshiaki] Univ Tokyo, Fac Med, Dept Surg Oncol, Tokyo 113, Japan; [Tsuno, Nelson H.] Univ Tokyo, Fac Med, Dept Transfus Med, Tokyo 113, Japan	Kishikawa, J (reprint author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	takei-tky@umin.ac.jp					Andras C, 2006, RHEUMATOL INT, V26, P376, DOI 10.1007/s00296-005-0005-3; Ekstrom K, 2003, ARTHRITIS RHEUM, V48, P963, DOI 10.1002/art.10939; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; Olesen AB, 2010, BRIT J DERMATOL, V163, P800, DOI 10.1111/j.1365-2133.2010.09861.x; Benedix F, 2010, DIS COLON RECTUM, V53, P57, DOI 10.1007/DCR.0b013e3181c703a4; Parikh-Patel A, 2008, CANCER CAUSE CONTROL, V19, P887, DOI 10.1007/s10552-008-9151-8; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Dyson JK, 2012, WORLD J GASTROENTERO, V18, P3839, DOI 10.3748/wjg.v18.i29.3839; Alamanos Y, 2006, SEMIN ARTHRITIS RHEU, V36, P182, DOI 10.1016/j.semarthrit.2006.08.006; Ropponen KM, 1997, J PATHOL, V182, P318, DOI 10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6; Sihvonen S, 2004, SCAND J RHEUMATOL, V33, P221, DOI 10.1080/03009740410005845; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Shah AA, 2011, CURR OPIN RHEUMATOL, V23, P530, DOI 10.1097/BOR.0b013e32834a5081; Franks AL, 2012, ANTICANCER RES, V32, P1119; Ahmadi A, 2009, WORLD J GASTROENTERO, V15, P61, DOI 10.3748/wjg.15.61; Thiers BH, 2009, CA-CANCER J CLIN, V59, P73, DOI 10.3322/caac.20005; Bologna C, 1997, ANN RHEUM DIS, V56, P97, DOI 10.1136/ard.56.2.97; Chen YJ, 2010, AM J MED, V123; FRIES JF, 1985, AM J MED, V78, P56, DOI 10.1016/0002-9343(85)90247-5; Huang WK, 2014, RHEUMATOL INT, V34, P1379, DOI 10.1007/s00296-014-2982-6; Llorca J, 2007, SEMIN ARTHRITIS RHEU, V37, P31, DOI 10.1016/j.semarthrit.2007.01.002; Riise T, 2001, CLIN RHEUMATOL, V20, P123, DOI 10.1007/PL00011191; Smitten AL, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2404; Swede H, 2014, INT J CANCER, V134, P1862, DOI 10.1002/ijc.28504; SYMMONS DPM, 1984, ANN RHEUM DIS, V43, P132, DOI 10.1136/ard.43.2.132	25	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	MAY	2015	100	5					783	789		10.9738/INTSURG-D-14-00154.1		7	Surgery	Surgery	CJ0UF	WOS:000355193300003		
J	Kochi, M; Fujii, M; Hagiwara, K; Tamegai, H; Watanabe, M; Matsuno, Y; Takayama, Y; Suda, H; Takayama, T				Kochi, Mitsugu; Fujii, Masashi; Hagiwara, Ken; Tamegai, Hidenori; Watanabe, Megumu; Matsuno, Yoritaka; Takayama, Yuriko; Suda, Hiroshi; Takayama, Tadatoshi			Effect of Preoperative Colonic Drainage for Obstructing Colorectal Cancer	INTERNATIONAL SURGERY			English	Article						Intestinal obstruction; Colorectal cancer; Colonic decompression; Survival; Safety	EMERGENCY-SURGERY; CARCINOMA; MORBIDITY; PROGNOSIS; MORTALITY; SURVIVAL	Obstructing colorectal cancer (OCRC) is believed to indicate poorer long-term survival. The purpose of this study was to compare retrospectively perioperative safety and longterm results in patients undergoing surgery for OCRC following preoperative colonic decompression with that in those undergoing elective surgery alone for nonobstructing colorectal cancer (CRC). A total of 656 consecutive CRC patients undergoing colectomy between 2001 and 2011 at our institute were eligible for inclusion in the study. The patients were divided into an OCRC group, which included 104 patients undergoing colectomy with preoperative colonic decompression, and a CRC group, which included 552 patients undergoing colectomy alone. Morbidity, mortality, and prognosis were assessed. In the OCRC group, decompression was performed by nasointestinal tube in 42 patients (40.4%), transanal tube in 15 (14.4%), and colostomy in 47 (45.2%). The mortality rate was 0% in the OCRC group and 0.4% in the CRC group (2 of 552 patients). The morbidity rate was 44.8% in the OCRC group (48 of 104 patients) and 36.6% in the CRC group (202 of 552 patients). The 5-year overall survival rate was 69.5% in the OCRC group and 72.9% in the CRC group [hazard ratio 0.76; 95% confidence interval, 0.35 to 1.16; P = 0.48)]. No statistically significant difference in survival was observed between the 2 groups in stage II, III, or IV, or overall. No difference was observed in safety or survival between advanced OCRC patients undergoing preoperative colonic decompression and advanced non-obstructing CRC patients undergoing surgery alone.	[Kochi, Mitsugu; Fujii, Masashi; Hagiwara, Ken; Tamegai, Hidenori; Watanabe, Megumu; Matsuno, Yoritaka; Takayama, Yuriko; Suda, Hiroshi; Takayama, Tadatoshi] Nihon Univ, Sch Med, Dept Digest Surg, Tokyo 1738610, Japan	Takayama, T (reprint author), Nihon Univ, Sch Med, Dept Digest Surg, 30-1 Ohyaguchi Kamimachi,Itabashi Ku, Tokyo 1738610, Japan.	kochi.mitsugu@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [24249068]	This work was mainly supported by a Grant-in-Aid for Scientific Research (A) 24249068 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Alvarez JA, 2005, DIGEST SURG, V22, P174, DOI 10.1159/000087436; OHMAN U, 1982, AM J SURG, V143, P742, DOI 10.1016/0002-9610(82)90050-2; Baccari P, 2006, HEPATO-GASTROENTEROL, V53, P698; PHILLIPS RKS, 1985, BRIT J SURG, V72, P296, DOI 10.1002/bjs.1800720417; van den Berg MW, 2014, BRIT J SURG, V101, P867, DOI 10.1002/bjs.9521; Carraro PGS, 2001, DIS COLON RECTUM, V44, P243; ANDERSON JH, 1992, BRIT J SURG, V79, P706, DOI 10.1002/bjs.1800790739; UMPLEBY HC, 1984, DIS COLON RECTUM, V27, P299, DOI 10.1007/BF02555634; GARCIAVALDECASAS JC, 1991, DIS COLON RECTUM, V34, P759, DOI 10.1007/BF02051066; IRVIN TT, 1977, BRIT J SURG, V64, P741, DOI 10.1002/bjs.1800641015; Isbister WH, 1997, INT J COLORECTAL DIS, V12, P285, DOI 10.1007/s003840050107; Karabulut M, 2014, BRIT J SURG, V101, P121; Karakayali F, 2008, INT SURG, V93, P339; Lee HJ, 2014, DIS COLON RECTUM, V57, P694, DOI 10.1097/DCR.0000000000000061; Nozoe T, 2000, J CLIN GASTROENTEROL, V31, P156, DOI 10.1097/00004836-200009000-00014; SERPELL JW, 1989, BRIT J SURG, V76, P965, DOI 10.1002/bjs.1800760932; Sloothaak DAM, 2014, BRIT J SURG, V101, P1751, DOI 10.1002/bjs.9645; Tentes AAK, 2009, LANGENBECK ARCH SURG, V394, P49, DOI 10.1007/s00423-008-0307-5; VIGDER L, 1985, ARCH SURG-CHICAGO, V120, P825; Wang HS, 2004, AM J SURG, V187, P497, DOI 10.1016/j.amjsurg.2003.12.028	20	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	MAY	2015	100	5					790	796		10.9738/INTSURG-D-14-00262.1		7	Surgery	Surgery	CJ0UF	WOS:000355193300004		
J	Kaneko, K; Kawai, K; Tsuno, NH; Ishihara, S; Yamaguchi, H; Sunami, E; Watanabe, T				Kaneko, Kensuke; Kawai, Kazushige; Tsuno, Nelson H.; Ishihara, Soichiro; Yamaguchi, Hironori; Sunami, Eiji; Watanabe, Toshiaki			Perioperative Allogeneic Blood Transfusion Is Associated With Surgical Site Infection After Abdominoperineal Resection-a Space for the Implementation of Patient Blood Management Strategies	INTERNATIONAL SURGERY			English	Article						Colorectal cancer; Abdominoperineal resection; Surgical site infection; Allogeneic blood transfusion; Patient blood management	INCREASED 30-DAY MORTALITY; COLORECTAL-CANCER SURGERY; RISK-FACTORS; GENERAL-SURGERY; INTRAOPERATIVE TRANSFUSION; PREOPERATIVE RADIOTHERAPY; ELECTIVE RESECTION; RECTAL-CANCER; 1 U; IMMUNOMODULATION	Allogeneic blood transfusion (ABT) has been reported as a major risk factor for surgical site infection (SSI) in patients undergoing colorectal surgery. However, the association of ABT with SSI in patients undergoing abdominoperineal resection (APR) and total pelvic exenteration (TPE) still remains to be evaluated. Here, we aim to elucidate this association. The medical records of all patients undergoing APR and TPE at our institution in the period between January 2000 and December 2012 were reviewed. Patients without SSI (no SSI group) were compared with patients who developed SSI (SSI group), in terms of clinicopathologic features, including ABT. In addition, data for 262 patients who underwent transabdominal rectal resection at our institution in the same period were also enrolled, and their data on differential leukocyte counts were evaluated. Multivariate analysis showed that intraoperative transfusion was an independent predictive factor for SSI after APR and TPE (P = 0.004). In addition, the first-operative day lymphocyte count of patients undergoing APR, TPE, and transabdominal rectal resection was significantly higher in nontransfusion patients compared with transfusion ones (P = 0.026). ABT in the perioperative period of APR and TPE may have an important immunomodulatory effect, leading to an increased incidence of SSI. This fact should be carefully considered, and efforts to avoid allogeneic blood exposure while still achieving adequate patient blood management would be very important for patients undergoing APR and TPE as well.	[Kaneko, Kensuke; Kawai, Kazushige; Tsuno, Nelson H.; Ishihara, Soichiro; Yamaguchi, Hironori; Sunami, Eiji; Watanabe, Toshiaki] Univ Tokyo, Fac Med, Dept Surg Oncol, Tokyo 113, Japan; [Tsuno, Nelson H.] Univ Tokyo, Fac Med, Dept Transfus Med, Tokyo 113, Japan	Kaneko, K (reprint author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130034, Japan.	kkaneko-tky@umin.ac.jp					Neumayer L, 2007, J AM COLL SURGEONS, V204, P1178, DOI 10.1016/j.jamcollsurg.2007.03.022; Biondo S, 2012, COLORECTAL DIS, V14, pe95, DOI 10.1111/j.1463-1318.2011.02798.x; Bernard AC, 2009, J AM COLL SURGEONS, V208, P931, DOI 10.1016/j.jamcollsurg.2008.11.019; Blajchman MA, 2005, HEMATOLOGY, V10, P208, DOI 10.1080/10245330512331390447; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; Shander A, 2012, MT SINAI J MED, V79, P56, DOI 10.1002/msj.21290; Tang RP, 2001, ANN SURG, V234, P181, DOI 10.1097/00000658-200108000-00007; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Talbot TR, 2004, CLIN INFECT DIS, V38, P1378, DOI 10.1086/386334; Leaper DJ, 2010, BRIT J SURG, V97, P1601, DOI 10.1002/bjs.7275; Heiss MM, 1997, SHOCK, V8, P402, DOI 10.1097/00024382-199712000-00002; Kashimura N, 2012, SURG TODAY, V42, P639, DOI 10.1007/s00595-012-0126-8; Bullard KM, 2005, DIS COLON RECTUM, V48, P438, DOI 10.1007/s10350-004-0827-1; Christian CK, 2005, DIS COLON RECTUM, V48, P43, DOI 10.1007/s10350-004-0855-x; Weber WP, 2009, TRANSFUSION, V49, P1964, DOI 10.1111/j.1537-2995.2009.02204.x; Zorcolo L, 2011, COLORECTAL DIS, V13, P1407, DOI 10.1111/j.1463-1318.2010.02536.x; Acheson AG, 2012, ANN SURG, V256, P235, DOI 10.1097/SLA.0b013e31825b35d5; Poon JT, 2009, ANN SURG, V249, P77, DOI 10.1097/SLA.0b013e31819279e3; Serra-Aracil X, 2011, ARCH SURG-CHICAGO, V146, P606, DOI 10.1001/archsurg.2011.90; Vamvakas EC, 2007, BLOOD REV, V21, P327, DOI 10.1016/j.blre.2007.07.003; Degrate L, 2011, INT J COLORECTAL DIS, V26, P61, DOI 10.1007/s00384-010-1057-8; Gervaz P, 2012, BRIT J SURG, V99, P589, DOI 10.1002/bjs.8656; Pendlimari R, 2012, J AM COLL SURGEONS, V214, P574, DOI 10.1016/j.jamcollsurg.2011.12.023; Artioukh DY, 2007, COLORECTAL DIS, V9, P362, DOI 10.1111/j.1463-1318.2006.01159.x; Richardson JD, 2009, J AM COLL SURGEONS, V208, P938; Bernard AC, 2009, J AM COLL SURGEONS, V208; Blajchman Morris A, 2002, Am J Ther, V9, P389, DOI 10.1097/00045391-200209000-00005; Fiorio M, 2006, INFECTION, V34, P310, DOI 10.1007/s15010-006-6632-0; Ishijima N, 1998, HEPATO-GASTROENTEROL, V45, P1011; Iwanaga T, 1999, DIGEST DIS SCI, V44, P1601, DOI 10.1023/A:1026619111897; Kobayashi M, 2010, SURG TODAY, V40, P326, DOI 10.1007/s00595-008-4075-1; Pendlimari R, 2012, J AM COLL SURGEONS, V214, P80; Yamauchi H, 1998, CYTOKINE, V10, P549, DOI 10.1006/cyto.1997.0322; Ydy LRA, 2007, WORLD J SURG, V31, P2044, DOI 10.1007/s00268-007-9159-3	34	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	MAY	2015	100	5					797	804		10.9738/INTSURG-D-14-00174.1		8	Surgery	Surgery	CJ0UF	WOS:000355193300005		
J	Urabe, M; Yamagata, Y; Aikou, S; Mori, K; Yamashita, H; Nomura, S; Shibahara, J; Fukayama, M; Seto, Y				Urabe, Masayuki; Yamagata, Yukinori; Aikou, Susumu; Mori, Kazuhiko; Yamashita, Hiroharu; Nomura, Sachiyo; Shibahara, Junji; Fukayama, Masashi; Seto, Yasuyuki			Solitary Fibrous Tumor of the Greater Omentum, Mimicking Gastrointestinal Stromal Tumor of the Small Intestine: A Case Report	INTERNATIONAL SURGERY			English	Article						Mesothelial tumor; Extrathoracic location	PLEURA; CD34	Solitary fibrous tumor (SFT) is one of the mesenchymal tumors, which rarely arises in the abdominal space. We report a very rare case of abdominal SFT, mimicking another mesenchymal tumor. A 52-year-old Japanese man was referred to our hospital for further evaluation and treatment of gallbladder polyp. Contrast-enhanced computed tomography (CT) showed an enhanced nodule within the gallbladder, and incidentally, also showed a well-circumscribed mass adjacent to the small intestine. The mass was depicted as slightly high density in plain CT, and with contrast-enhancement, the mass was partially stained in early phase and the stained area spread heterogeneously in delayed phase. Magnetic resonance imaging showed that the abdominal mass was depicted as slightly high intensity on T2-weighted imaging and low intensity on T1-weighted imaging. With double-balloon endoscopy and capsule endoscopy, we did not find any tumor inside the small intestine. These visual findings lead us to diagnose it as gastrointestinal stromal tumor of the small intestine with extraluminal growth. We planned to resect both the gallbladder polyp and the intraperitoneal tumor at the same time for pathologic diagnosis and treatment. When the operation was performed, we found a milk-white lobulated tumor on the greater omentum and the tumor was entirely resected. Microscopically, the gallbladder polyp was diagnosed as tubular adenoma, and the omental tumor was diagnosed as SFT. It is important to bear in mind that omental SFTs sometimes mimic other mesenchymal tumors and should be included in the differential diagnosis of abdominal tumor not revealed by endoscopy.	[Urabe, Masayuki; Yamagata, Yukinori; Aikou, Susumu; Mori, Kazuhiko; Yamashita, Hiroharu; Nomura, Sachiyo; Seto, Yasuyuki] Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Tokyo 1138655, Japan; [Shibahara, Junji; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1138655, Japan	Urabe, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	urabe-tky@umin.ac.jp					Ali SZ, 1997, CANCER CYTOPATHOL, V81, P116, DOI 10.1002/(SICI)1097-0142(19970425)81:2<116::AID-CNCR5>3.0.CO;2-Q; Robinson DR, 2013, NAT GENET, V45, P180, DOI 10.1038/ng.2509; Chan JKC, 1997, HISTOPATHOLOGY, V31, P568, DOI 10.1046/j.1365-2559.1997.2400897.x; Chmielecki J, 2013, NAT GENET, V45, P131, DOI 10.1038/ng.2522; ENGLAND DM, 1989, AM J SURG PATHOL, V13, P640, DOI 10.1097/00000478-198908000-00003; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; WESTRA WH, 1994, AM J SURG PATHOL, V18, P992, DOI 10.1097/00000478-199410000-00003; Gold JS, 2002, CANCER, V94, P1057, DOI 10.1002/cncr.10328; Fletcher CDM, 2002, WHO CLASSIFICATION T; Klemperer P, 1931, ARCH PATH, V11, P385; RENSHAW AA, 1994, APPL IMMUNOHISTOCHEM, V2, P94; Robinson Lary A, 2006, Cancer Control, V13, P264; Vallat-Decouvelaere AV, 1998, AM J SURG PATHOL, V22, P1501, DOI 10.1097/00000478-199812000-00007; Zong L, 2012, WORLD J GASTROENTERO, V18, P6515, DOI 10.3748/wjg.v18.i44.6515	14	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	MAY	2015	100	5					836	840		10.9738/INTSURG-D-14-00141.1		5	Surgery	Surgery	CJ0UF	WOS:000355193300011		
J	Shimura, T; Suzuki, H; Araki, K; Kobayashi, T; Yashima, R; Kohunato, Y; Okada, R; Shibata, M; Kuwano, H; Takenoshita, S				Shimura, Tatsuo; Suzuki, Hideki; Araki, Kenichiro; Kobayashi, Tsutomu; Yashima, Rei; Kohunato, Yasuhide; Okada, Ryou; Shibata, Masahiko; Kuwano, Hiroyuki; Takenoshita, Seiichi			Our Contrivances to Diminish Complications After Pylorus-Preserving Pancreaticoduodenectomy	INTERNATIONAL SURGERY			English	Article						Pylorus-preserving pancreaticoduodenectomy (PPPD); Internal stent; Omental wrapping; Postoperative stay	PROSPECTIVE RANDOMIZED-TRIAL; CONSECUTIVE PANCREATICODUODENECTOMIES; RECONSTRUCTION METHOD; PANCREATICOJEJUNOSTOMY; PANCREATICOGASTROSTOMY; PANCREATOGASTROSTOMY; MORTALITY; RESECTION; DRAINAGE; DUCT	The objective of this study is to diminish postoperative complications after pylorus-preserving pancreaticoduodenectomy. Pylorus-preserving pancreaticoduodenectomy is still associated with major complications, especially leakage at pancreatojejunostomy and delayed gastric emptying. Traditional pylorus-preserving pancreaticoduodenectomy was performed in group A, while the novel procedure, an antecolic vertical duodenojejunostomy and internal pancreatic drainage with omental wrapping, was performed in group B (n = 40 each). We compared the following characteristics between the 2 groups: operation time, blood loss, time required before removal of nasogastric tube and resumption of food intake, length of hospital stay, and postoperative complications. The novel procedure required less time and was associated with less blood loss (both P < 0.0001). In the comparison of the 2 groups, group B showed less time for removal of nasogastric tubes and resumption of food intake, shorter hospital stays, and fewer postoperative complications (all P < 0.0001). The novel procedure appears to be a safe and effective alternative to traditional pancreaticoduodenectomy techniques.	[Shimura, Tatsuo; Kobayashi, Tsutomu; Yashima, Rei; Kohunato, Yasuhide; Okada, Ryou; Shibata, Masahiko; Takenoshita, Seiichi] Fukushima Med Univ, Dept Organ Regulatory Surg, Fukushima, Fukushima 9601295, Japan; [Suzuki, Hideki; Araki, Kenichiro; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Gunma, Japan	Shimura, T (reprint author), Fukushima Med Univ, Dept Organ Regulatory Surg, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan.	tatsuoshimura@gmail.com					Satoi S, 2008, PANCREAS, V37, P128, DOI 10.1097/MPA.0b013e318162cb53; Sugiyama M, 2004, AM J SURG, V187, P743, DOI 10.1016/j.amjsurg.2003.10.013; Shrikhande SV, 2005, WORLD J SURG, V29, P1642, DOI 10.1007/s00268-005-0137-3; Duffas JP, 2005, AM J SURG, V189, P720, DOI 10.1016/j.amjsurg.2005.03.015; Poon RTP, 2007, ANN SURG, V246, P425, DOI 10.1097/SLA.0b013e3181492c28; Tran KTC, 2004, ANN SURG, V240, P738, DOI 10.1097/01.sla.0000143248.71964.29; Park YC, 2003, J AM COLL SURGEONS, V196, P859, DOI 10.1016/S1072-7515(03)00127-3; Nikfarjam M, 2009, J GASTROINTEST SURG, V13, P1674, DOI 10.1007/s11605-009-0944-1; Bassi C, 2003, SURGERY, V134, P766, DOI 10.1016/S0039-6060(03)00345-3; Tani M, 2009, SURG TODAY, V39, P219, DOI 10.1007/s00595-008-3847-y; Aranha GV, 2003, J AM COLL SURGEONS, V197, P223, DOI 10.1016/S1072-7515(03)00331-4; Standop J, 2005, WORLD J SURG, V29, P505, DOI 10.1007/s00268-004-7741-5; Tani M, 2010, AM J SURG, V199, P759, DOI 10.1016/j.amjsurg.2009.04.017; Aranha GV, 2003, J GASTROINTEST SURG, V7, P672, DOI 10.1016/S1091-255X(02)00432-8; Butler TJ, 2004, CAN J SURG, V47, P333; Castro SMM, 2005, BRIT J SURG, V92, P1117; Chamberlain RS, 2009, J SURG RES, V157, P279, DOI 10.1016/j.jss.2009.05.008; Iqbal N, 2008, EJSO-EUR J SURG ONC, V34, P1237, DOI 10.1016/j.ejso.2007.12.004; Kakita A, 2001, J Hepatobiliary Pancreat Surg, V8, P230, DOI 10.1007/s005340170022; Kunstman JW, 2013, J AM COLL SURGEONS, V217, P481, DOI 10.1016/j.jamcollsurg.2013.04.031; Matsumoto T, 2002, HEPATO-GASTROENTEROL, V49, P635; Oida T, 2009, HEPATO-GASTROENTEROL, V56, P565; Sato M, 2003, HEPATO-GASTROENTEROL, V50, P867; Suzuki Y, 2005, WORLD J SURG, V29, P1409, DOI 10.1007/s00268-005-0152-4	24	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	MAY	2015	100	5					882	890		10.9738/INTSURG-D-14-00246.1		9	Surgery	Surgery	CJ0UF	WOS:000355193300018		
J	Nakamura, K; Beppu, T; Hayashi, H; Okabe, H; Imai, K; Nitta, H; Chikamoto, A; Ishiko, T; Sasaki, M; Baba, H				Nakamura, Kenichi; Beppu, Toru; Hayashi, Hiromitsu; Okabe, Hirohisa; Imai, Kastunori; Nitta, Hidetoshi; Chikamoto, Akira; Ishiko, Takatoshi; Sasaki, Masato; Baba, Hideo			Recurrence-Free Survival of a Hepatocellular Carcinoma Patient With Tumor Thrombosis of the Inferior Vena Cava After Treatment With Sorafenib and Hepatic Resection	INTERNATIONAL SURGERY			English	Article						Hepatocellular carcinoma; Hepatic vein tumor thrombosis; Sorafenib transarterial chemoembolization; Hepatic resection	SURGICAL RESECTION; RADIATION-THERAPY; INVASION; CHEMOEMBOLIZATION; CHEMOTHERAPY; THROMBECTOMY; VEIN; HCC	Sorafenib (Nexabar, Bayer, Berlin, Germany), one of multikinase inhibitors, can infrequently downstage advanced hepatocellular carcinoma (HCC). There are some reports that sorafenib in combination with other modalities, such as transcatheter arterial chemoembolization (TACE) or radiation therapy, could represent a bridge to surgery. We have observed a progressive HCC case with hepatic vein tumor thrombosis proceeding to the inferior vena cava (IVC-HVTT) convert to a state of feasible curative resection after a multidisciplinary treatment which included sorafenib. The patient underwent a successful resection in consequence of this therapy. A 45-year-old male with Hepatitis B Virus-associated chronic hepatitis was diagnosed as HCC with IVC-HVTT. To obtain oncological curative resection, we performed TACE, radiation therapy followed by administration of sorafenib (800 mg per day, total 72 g). The tumor including IVC-HVTT remarkably shrank, therefore, an extended posterior sectionectomy and total removal of the IVC-HVTT was successfully performed. The operation time was 736 minutes and the amount of intraoperative hemorrhage was 805 mL. No postoperative complication occurred. Adjuvant therapy with sorafenib was started four weeks after the operation and continued for 6 months (800 mg per day, total 144 g). The patient is alive without recurrence for about 4 years from the initial therapy. Multidisciplinary therapy including sorafenib, TACE, radiation, and hepatic resection may be an effective strategy to treat HCC patients with IVC-HVTT.	[Nakamura, Kenichi; Beppu, Toru; Hayashi, Hiromitsu; Okabe, Hirohisa; Imai, Kastunori; Nitta, Hidetoshi; Chikamoto, Akira; Ishiko, Takatoshi; Baba, Hideo] Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan; [Beppu, Toru] Kumamoto Univ Hosp, Innovat Ctr Translat Res, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto 8608556, Japan; [Sasaki, Masato] Kumamoto Rosai Hosp, Dept Internal Med, Yatsusiro, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Ikai I, 1998, ANN SURG, V227, P433, DOI 10.1097/00000658-199803000-00016; Fukuda S, 2002, SURGERY, V131, P300, DOI 10.1067/msy.2002.120668; Irtan S, 2011, LIVER INT, V31, P740, DOI 10.1111/j.1478-3231.2010.02441.x; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Beppu T, 2011, J GASTROENTEROL, V46, P938, DOI 10.1007/s00535-011-0406-x; Nitta H, 2013, WORLD J SURG, V37, P1034, DOI 10.1007/s00268-013-1957-1; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Beppu T, 2012, HEPATO-GASTROENTEROL, V59, P542, DOI 10.5754/hge09737; Ikai I, 2004, CANCER, V101, P796, DOI 10.1002/cncr.20426; Toya R, 2007, RADIOTHER ONCOL, V84, P266, DOI 10.1016/j.radonc.2007.07.005; Kudo M, 2010, ONCOLOGY-BASEL, V78, P154, DOI 10.1159/000315245; Kashima Y, 1999, J GASTROEN HEPATOL, V14, P922, DOI 10.1046/j.1440-1746.1999.01966.x; Le Treut YP, 2006, J GASTROINTEST SURG, V10, P855, DOI 10.1016/j.gassur.2005.12.011; Asahara T, 1999, HEPATO-GASTROENTEROL, V46, P1862; Bai W, 2013, J DIGEST DIS, V14, P181, DOI 10.1111/1751-2980.12038; Barbier L, 2011, INT J HEPATOL, V2011, DOI DOI 10.4061/2011/791013]; Chan GSW, 2000, FORENSIC SCI INT, V108, P215, DOI 10.1016/S0379-0738(99)00212-1; Chan SL, 2012, CURR ONCOL REP, V14, P257, DOI 10.1007/s11912-012-0233-0; Curtit E, 2011, J CLIN ONCOL, V29, pE330, DOI 10.1200/JCO.2010.32.6785; Hou JZ, 2012, INT J RADIAT ONCOL, V84, P362, DOI 10.1016/j.ijrobp.2011.12.024; Jung H, 2011, HEPATO-GASTROENTEROL, V58, P1694, DOI 10.5754/hge10653; Nonami T, 1997, HEPATO-GASTROENTEROL, V44, P798; Shirabe K, 2001, INT SURG, V86, P141; Sugiyama S, 2007, HEPATO-GASTROENTEROL, V54, P1779; Tanaka A, 1996, HEPATO-GASTROENTEROL, V43, P1172	26	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	MAY	2015	100	5					908	914		10.9738/INTSURG-D-14-00133.1		7	Surgery	Surgery	CJ0UF	WOS:000355193300022		
J	Okamoto, K; Tani, Y; Yamaguchi, T; Ogino, K; Tsuchioka, T; Nakajima, M; Yamaguchi, S; Sasaki, K; Kato, H; Ohya, T				Okamoto, Kentaro; Tani, Yukiko; Yamaguchi, Takeshi; Ogino, Kei; Tsuchioka, Takashi; Nakajima, Masanobu; Yamaguchi, Satoru; Sasaki, Kinro; Kato, Hiroyuki; Ohya, Toshiki			Asymptomatic Mesenchymal Hamartoma of the Chest Wall in Child With Fluorodeoxyglucose Uptake on PET/CT-Report of a Case	INTERNATIONAL SURGERY			English	Article						Mesenchymal hamartoma; Child; PET/CT	TUMORS; MANAGEMENT; INFANTS; BONE; LUNG	We had experience with a case of mesenchymal hamartoma of the chest wall (MHCW) with fluorodeoxyglucose (FDG) uptake on positron emission tomography/computed tomography (PET/CT). We reported the first case of asymptomatic MHCW in a child with preoperative PET/CT. Mesenchymal hamartoma of the chest wall is a rare benign tumor that usually presents as a visible chest wall mass or respiratory problems secondary to compression of the lung in early infancy. It is often reported that malignant transformation is extraordinarily rare. Positron emission tomography/CT is useful for diagnosis of malignancy. There is no report of MHCW in a child with preoperative PET/CT before. We examined an asymptomatic 1-year-old girl with an incidental finding on a chest x-ray. Scans of CT and PET/CT were performed before surgical resection. After surgery, the resected tumor was examined histologically. Chest x-ray and CTscan of the chest confirmed a 25-320-mm round shaped intrapleural mass containing calcification and destructing the rib, arising from the third rib. Scan of PET/CT demonstrated the mass with light FDG accumulation. Histologically, the mass was homogenous, with thick funicular of hyaline cartilage interdigitating with scattered fiber. There were no malignant cells. No malignant MHCW was demonstrated in the mass, with light FDG accumulation by PET/CT. PET/CT might be a useful tool to distinguish malignant MHCW in children.	[Okamoto, Kentaro; Tani, Yukiko; Yamaguchi, Takeshi; Ogino, Kei; Tsuchioka, Takashi; Nakajima, Masanobu; Yamaguchi, Satoru; Sasaki, Kinro; Kato, Hiroyuki] Dokkyo Med Univ, Sch Med, Dept Surg 1, Shimotsuga, Tochigi 3210293, Japan; [Ohya, Toshiki] Kamisagi Kids Clin, Pediat Surg, Nakano Ku, Tokyo, Japan	Okamoto, K (reprint author), Dokkyo Med Univ, Sch Med, Dept Surg 1, 880 Kitakobayashi, Shimotsuga, Tochigi 3210293, Japan.	rx8_twinsunroof@yahoo.co.jp					BASILE A, 1989, THORAX, V44, P232, DOI 10.1136/thx.44.3.232; Zhao ZH, 2013, J NUCL MED, V54, P499, DOI 10.2967/jnumed.112.113472; AYALA AG, 1993, SKELETAL RADIOL, V22, P569; Begent J, 2011, EUR J CANCER, V47, P389, DOI 10.1016/j.ejca.2010.09.039; Bertocchini A, 2007, ANN THORAC SURG, V84, P2091, DOI 10.1016/j.athoracsur.2007.06.042; Cameron D, 2001, J PEDIATR SURG, V36, P1346, DOI 10.1053/jpsu.2001.26366; DOUNIES R, 1994, ANN THORAC SURG, V57, P868; ESKELINEN M, 1991, ANN THORAC SURG, V52, P291; Freeburn AM, 2001, ARCH DIS CHILD, V85, P244, DOI 10.1136/adc.85.3.244; Groom KR, 2002, RADIOLOGY, V222, P205; Hamada K, 2008, ANN NUCL MED, V22, P699, DOI 10.1007/s12149-008-0173-9; HEDLUNG GL, 1989, RADIOLOGY, V173, P77; Hoshi M, 2012, ARCH ORTHOP TRAUM SU, V132, P1561, DOI 10.1007/s00402-012-1588-2; JAIN SK, 1993, THORAX, V48, P407, DOI 10.1136/thx.48.4.407; Lisle D A, 2003, Australas Radiol, V47, P78, DOI 10.1046/j.1440-1673.2003.01111.x; MCLEOD RA, 1979, RADIOLOGY, V131, P657; Odaka A, 2005, J PEDIATR SURG, V40, DOI 10.1016/j.jpedsurg.2005.02.012; Ozbudak IH, 2008, J PEDIATR SURG, V43, P1909, DOI 10.1016/j.jpedsurg.2008.06.007; Pawel BR, 2006, PEDIATR SURG INT, V22, P398, DOI 10.1007/s00383-005-1607-2; Serrano-Egea A, 2001, PATHOL RES PRACT, V197, P835; Sodhi KS, 2009, J PEDIATR SURG, V44, P464, DOI 10.1016/j.jpedsurg.2008.10.035; Tsuji Y, 2012, PEDIATR SURG INT, V28, P939, DOI 10.1007/s00383-012-3152-0; van den Berg H, 2008, J PEDIAT HEMATOL ONC, V30, P214, DOI 10.1097/MPH.0b013e318162bd54	23	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	MAY	2015	100	5					915	919		10.9738/INTSURG-D-14-00083.1		5	Surgery	Surgery	CJ0UF	WOS:000355193300023		
J	Mori, K; Koike, Y; Inoue, M; Ohtake, K; Tanaka, K; Uchida, K; Mohri, Y; Kusunoki, M				Mori, Koichiro; Koike, Yuhki; Inoue, Mikihiro; Ohtake, Kohei; Tanaka, Koji; Uchida, Keichi; Mohri, Yasuhiko; Kusunoki, Masato			Success of Minimally Invasive Transumbilical Single-Incision Laparoscopic Surgery (T-SILS) Plus Double-Balloon Endoscopy (DBE) for Pediatric Intestinal Angiodysplasia: A Case Report	INTERNATIONAL SURGERY			English	Article						Transumbilical single-incision laparoscopic surgery (T-SILS); Double-balloon endoscopy (DBE); Angiodysplasia; Small intestine	GASTROINTESTINAL ANGIODYSPLASIA; CLINICAL-OUTCOMES; EFFICACY; ENTEROSCOPY; PREVENTION; EXPERIENCE; DIAGNOSIS; RECURRENT; OCCULT; TRACT	We describe here a child with angiodysplasia of the small intestine, diagnosed by double-balloon endoscopy (DBE), who was treated with transumbilical single-incision laparoscopic surgery (T-SILS). A 9-year-old boy presented to another hospital with intermittent fresh melena of a duration of 5 months and 4 days. Anoscopy and gastric mucosal membrane scintigraphy were unsuccessful diagnostically, and he was referred to our hospital for further examination and treatment. Under general anesthesia, we performed DBE by an anal route, with the ileum assessed for a distance of about 150 cm from the ileocecal valve. Although no bleeding lesion was found in the colon, a flat elevated venous lake approximately 20 mm in size was observed 20 cm from the ileocecal valve, suggesting angiodysplasia of the small intestine. A tattoo was made under DBE, and wedge resection by T-SILS was performed 1 month later under general anesthesia. The excised specimen appeared as a flat, elevated venous lake approximately 20 mm in size. Histopathologic analysis revealed several dilated and distorted veins within the submucosa of the small intestine. The patient was diagnosed with angiodysplasia of the small intestine. His postoperative course was uneventful, and he remained free of recurrent gastrointestinal bleeding 18 months after the operation. This is the first case report showing the diagnosis, localization, and tattooing of an obscure gastrointestinal bleeding lesion of the small intestine by preoperative DBE and removal of the lesion by subsequent T-SILS in children.	[Mori, Koichiro; Koike, Yuhki; Inoue, Mikihiro; Ohtake, Kohei; Tanaka, Koji; Uchida, Keichi; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Tsu, Mie 5148507, Japan	Kusunoki, M (reprint author), Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	koichiromori@clin.medic.mie-u.ac.jp					Tam YH, 2010, J PEDIATR SURG, V45, P2381, DOI 10.1016/j.jpedsurg.2010.08.036; Laituri CA, 2011, J LAPAROENDOSC ADV S, V21, P193, DOI 10.1089/lap.2010.0169; Schmit A, 1996, DIGEST DIS SCI, V41, P2348, DOI 10.1007/BF02100126; CAPPELL MS, 1992, AM J GASTROENTEROL, V87, P201; Kaffes AJ, 2007, GASTROINTEST ENDOSC, V66, P304, DOI 10.1016/j.gie.2007.02.044; St Peter SD, 2011, SEMIN PEDIATR SURG, V20, P219, DOI 10.1053/j.sempedsurg.2011.05.006; FOUTCH PG, 1993, AM J GASTROENTEROL, V88, P807; Zuckerman GR, 2000, GASTROENTEROLOGY, V118, P201, DOI 10.1016/S0016-5085(00)70430-6; LAU WY, 1987, GUT, V28, P869, DOI 10.1136/gut.28.7.869; Yamamoto H, 2004, CLIN GASTROENTEROL H, V2, P1010, DOI 10.1053/S1542-3565(04)00453-7; Junquera F, 2001, GASTROENTEROLOGY, V121, P1073, DOI 10.1053/gast.2001.28650; Arakawa D, 2009, GASTROINTEST ENDOSC, V69, P866, DOI 10.1016/j.gie.2008.06.008; Cave D R, 1996, Gastrointest Endosc Clin N Am, V6, P793; Duchini A, ANGIODYSPLASIA COLON; Garey CL, 2011, J PEDIATR SURG, V46, P904, DOI 10.1016/j.jpedsurg.2011.02.020; GUPTA N, 1995, DIS COLON RECTUM, V38, P979, DOI 10.1007/BF02049736; Hattori Kengo, 2012, Asian J Endosc Surg, V5, P172, DOI 10.1111/j.1758-5910.2012.00150.x; Inoue Mikihiro, 2013, Asian J Endosc Surg, V6, P48, DOI 10.1111/j.1758-5910.2012.00162.x; Junquera F, 2007, AM J GASTROENTEROL, V102, P254, DOI 10.1111/j.1572-0241.2007.01053.x; LEWIS BS, 1994, GASTROENTEROL CLIN N, V23, P67; RESS AM, 1992, AM J SURG, V163, P94, DOI 10.1016/0002-9610(92)90259-T; RICHTER JM, 1989, DIGEST DIS SCI, V34, P1542, DOI 10.1007/BF01537107; Yeh TS, 2009, SURG ENDOSC, V23, P739, DOI 10.1007/s00464-008-0050-6	23	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	MAY	2015	100	5					920	923		10.9738/INTSURG-D-14-00129.1		4	Surgery	Surgery	CJ0UF	WOS:000355193300024		
J	Kajiwara, N; Maeda, J; Yoshida, K; Kato, Y; Hagiwara, M; Kakihana, M; Ohira, T; Kawate, N; Ikeda, N				Kajiwara, Naohiro; Maeda, Junichi; Yoshida, Koichi; Kato, Yasufumi; Hagiwara, Masaru; Kakihana, Masatoshi; Ohira, Tatsuo; Kawate, Norihiko; Ikeda, Norihiko			Maximizing Use of Robot-Arm No. 3 in Da Vinci-Assisted Thoracic Surgery	INTERNATIONAL SURGERY			English	Article						Robotic surgery; da Vinci Surgical System; Robot arm		We have previously reported on the importance of appropriate robot-arm settings and replacement of instrument ports in robot-assisted thoracic surgery, because the thoracic cavity requires a large space to access all lesions in various areas of the thoracic cavity from the apex to the diaphragm and mediastinum and the chest wall.(1-3) Moreover, it can be difficult to manipulate the da Vinci Surgical System using only arms No. 1 and No. 2 depending on the tumor location. However, arm No. 3 is usually positioned on the same side as arm No. 2, and sometimes it is only used as an assisting-arm to avoid conflict with other arms (Fig. 1). In this report, we show how robot-arm No. 3 can be used with maximum effectiveness in da Vinci-assisted thoracic surgery.	[Kajiwara, Naohiro; Maeda, Junichi; Yoshida, Koichi; Kato, Yasufumi; Hagiwara, Masaru; Kakihana, Masatoshi; Ohira, Tatsuo; Ikeda, Norihiko] Tokyo Med Univ, Dept Surg, Tokyo 1600023, Japan; [Kajiwara, Naohiro; Kawate, Norihiko] Waseda Univ, Sch Human Sci, Dept Hlth Sci & Social Welf, Saitama, Japan	Kajiwara, N (reprint author), Tokyo Med Univ, Dept Surg, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	kajiwara@tokyo-med.ac.jp					Giulianotti PC, 2010, INTERACT CARDIOV TH, V11, P388, DOI 10.1510/icvts.2010.239541; Bodner J, 2004, EUR J CARDIO-THORAC, V25, P844, DOI 10.1016/j.ejcts.2004.02.001; Kajiwara N, 2011, INTERACT CARDIOV TH, V12, P112, DOI 10.1510/icvts.2010.251652; Kajiwara N, 2014, ANN THORAC SURG, V97, P2182, DOI 10.1016/j.athoracsur.2013.08.026; Kajiwara Naohiro, 2012, Asian Cardiovasc Thorac Ann, V20, P308, DOI 10.1177/0218492311434332	5	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	MAY	2015	100	5					930	933		10.9738/INTSURG-D-14-00259.1		4	Surgery	Surgery	CJ0UF	WOS:000355193300027		
J	Matsubara, T; Hirahara, N; Hyakudomi, R; Fujii, Y; Kaji, S; Taniura, T; Tajima, Y				Matsubara, Takeshi; Hirahara, Noriyuki; Hyakudomi, Ryoji; Fujii, Yusuke; Kaji, Shunsuke; Taniura, Takahito; Tajima, Yoshitsugu			Early Gastric Cancer Associated With Gastric Sarcoidosis	INTERNATIONAL SURGERY			English	Article						Laparoscopic gastrectomy; Gastric carcinoma; Gastric sarcoidosis	CROHNS-DISEASE; CARCINOMA; SURVEILLANCE	Sarcoidosis is a multisystemic disorder that is characterized by the formation of noncaseating granulomas. Although sarcoidosis can affect any organ, gastrointestinal tract involvement in sarcoidosis is very rare, and gastric cancer associated with gastric sarcoidosis has hardly been reported. A 64-year-old female with a 10-year history of the medical treatment of gastric sarcoidosis received a routine follow-up gastrointestinal endoscopy and an irregular-shaped, elevated lesion was detected in the gastric corpus. The gastric mucosal surface was nodular and ulcerated throughout the stomach. The gastric lumen was narrow, and the gastric wall was stiff and nondistensible, resembling linitis plastica. The biopsies of the elevated lesion in the gastric corpus revealed well-differentiated adenocarcinoma. An endoscopic ultrasonography was then performed, but it failed to assess precisely the depth of cancer invasion because of sarcoidosis-related gastritis and fibrosis of the gastric wall. The patient underwent a laparoscopic total gastrectomy under the diagnosis of gastric cancer associated with gastric sarcoidosis. Histologic examination of the surgical specimen demonstrated well-differentiated adenocarcinoma in the gastric corpus, and the histologic mapping of cancer cells revealed that the tumor spread within the mucosal layer of the stomach. No lymph node metastasis was found. The patient's postoperative course was uneventful. We experienced a rare case of early gastric cancer associated with gastric sarcoidosis, which identified the troublesome issue that the assessment of depth of cancer invasion is difficult, because patients with longstanding gastric sarcoidosis may involve various degrees of fibrosis of the gastric wall.	[Matsubara, Takeshi; Hirahara, Noriyuki; Hyakudomi, Ryoji; Fujii, Yusuke; Kaji, Shunsuke; Taniura, Takahito; Tajima, Yoshitsugu] Shimane Univ, Fac Med, Dept Digest & Gen Surg, Izumo, Shimane 6938501, Japan	Matsubara, T (reprint author), Shimane Univ, Fac Med, Dept Digest & Gen Surg, Enyacho 89-1, Izumo, Shimane 6938501, Japan.	nanadai@med.shimane-u.ac.jp					Akinyemi E, 2006, J NATL MED ASSOC, V98, P948; Askling J, 1999, AM J RESP CRIT CARE, V160, P1668; Afshar K, 2010, J NATL MED ASSOC, V102, P419; Schaumann J, 1936, BRIT J DERMATOL SYPH, V48, P399, DOI 10.1111/j.1365-2133.1936.tb10366.x; Boffetta P, 2009, INT J CANCER, V124, P2697, DOI 10.1002/ijc.24261; Farman J, 1997, ABDOM IMAGING, V22, P248, DOI 10.1007/s002619900182; Fireman Z, 1997, J CLIN GASTROENTEROL, V24, P97, DOI 10.1097/00004836-199703000-00011; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kaneki T, 2001, HEPATO-GASTROENTEROL, V48, P1209; KORELITZ BI, 1990, MED CLIN N AM, V74, P189; KORSAGER S, 1979, SCAND J RESPIR DIS, V60, P24; ROTH D, 1994, AM J GASTROENTEROL, V89, P1589; STAHL TJ, 1992, DIS COLON RECTUM, V35, P850, DOI 10.1007/BF02047872; The Japan Lung, 2010, GEN RUL CLIN PATH RE, V7th; Yamaguchi M, 1991, Sarcoidosis, V8, P51	15	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	MAY	2015	100	5					949	953		10.9738/INTSURG-D-15-00028		5	Surgery	Surgery	CJ0UF	WOS:000355193300030		
J	Tamura, T; Inagawa, S; Terashima, H; Akashi, Y; Hisakura, K; Enomoto, T; Ohkohchi, N				Tamura, Takafumi; Inagawa, Satoshi; Terashima, Hideo; Akashi, Yoshimasa; Hisakura, Katsuji; Enomoto, Tsuyoshi; Ohkohchi, Nobuhiro			A Long-Term Follow-Up Result of Pouch Plasty for Severe Dysfunction of Jejunal Pouch Reconstruction After Total Gastrectomy: A Case Report	INTERNATIONAL SURGERY			English	Article						Jejunal pouch reconstruction; Gastrectomy; Delayed emptying; Pouch plasty	PROXIMAL GASTRECTOMY; INTERPOSITION; CANCER	A 78-year-old woman with malignant lymphoma of the stomach underwent total gastrectomy with a jejunal-pouch (J-pouch) reconstruction in 1994. Twelve years after surgery the patient began to suffer epigastric distress and reflux symptoms. Eventually, she was unable to take anything by mouth. A series of diagnostic images seemed to indicate that the main cause of the dysfunction was flaccidity of the J-pouch and deformity of the outflow route induced by chronic excessive dilatation of the pouch wall. Because all conservative managements only led to temporary improvement and ended in failure, she hoped to receive the operation. We designed "pouch plasty" capable of ameliorating the pouch dysfunction. The aim of pouch plasty was to improve uneven tension of the pouch wall and repair deformity of the outflow route of the food. After the operation, the J-pouch resumed adequate drainage and had good reservoir function. More than 7 years later, the patient had no further complications.	[Tamura, Takafumi; Inagawa, Satoshi; Terashima, Hideo; Akashi, Yoshimasa; Hisakura, Katsuji; Enomoto, Tsuyoshi; Ohkohchi, Nobuhiro] Univ Tsukuba, Fac Med, Dept Surg, Div Gastroenterol & Hepatobiliary Surg & Organ Tr, Tsukuba, Ibaraki, Japan	Tamura, T (reprint author), 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	t.tamura@md.tsukuba.ac.jp	Akashi, Yoshihiro/E-5227-2011	Akashi, Yoshihiro/0000-0001-7670-7326			Adachi Shinya, 2003, Gastric Cancer, V6, P24, DOI 10.1007/s101200300003; Kono K, 2003, AM J SURG, V185, P150, DOI 10.1016/S0002-9610(02)01211-4; Katsube T, 2005, EJSO, V31, P1036, DOI 10.1016/j.ejso.2005.07.009; Miyoshi K, 2000, JPN J GASTROENTEROL, V33, P427; Morar P, 2012, ANN R COLL SURG ENGL, V94, P113; Nakane Y, 1997, SURG TODAY, V27, P696; NAKANE Y, 1995, ANN SURG, V222, P27, DOI 10.1097/00000658-199507000-00005; Takeshita K, 2007, SURG TODAY, V37, P754, DOI 10.1007/s00595-007-3497-5; Tono C, 2003, WORLD J SURG, V27, P1113, DOI 10.1007/s00268-003-7030-8	9	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	MAY	2015	100	5					954	957		10.9738/INTSURG-D-14-00181.1		4	Surgery	Surgery	CJ0UF	WOS:000355193300031		
J	Arbustini, E; Narula, N; Kodama, T				Arbustini, Eloisa; Narula, Nupoor; Kodama, Takahide			Clinical Imaging of ACS With Ruptured or Intact Fibrous Caps	JACC-CARDIOVASCULAR IMAGING			English	Editorial Material						culprit plaque; optical coherence tomography; percutaneous coronary intervention; plaque erosion; ST-segment elevation myocardial infarction	CORONARY ATHEROSCLEROTIC PLAQUES; OPTICAL COHERENCE TOMOGRAPHY; THROMBOSIS; EROSION; DIAGNOSIS; ARTERIES; NODULES		[Arbustini, Eloisa; Narula, Nupoor; Kodama, Takahide] IRCCS Fdn Policlin San Matte, Ctr Inherited Cardiovasc Dis, Pavia, Italy; [Narula, Nupoor] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Kodama, Takahide] Toranomon Gen Hosp, Cardiovasc Ctr, Tokyo, Japan	Arbustini, E (reprint author), IRCCS Fdn Policlin San Matte, Ctr Inherited Cardiovasc Dis, I-27100 Pavia, Italy.	e.arbustini@smatteo.pv.it		Arbustini, Eloisa/0000-0003-2948-7994			Farb A, 1996, CIRCULATION, V93, P1354; Lee JB, 2011, AM J CARDIOL, V108, P1547, DOI 10.1016/j.amjcard.2011.07.014; Ozaki Y, 2011, EUR HEART J, V32, P2814, DOI 10.1093/eurheartj/ehr189; Xu YJ, 2012, CIRCULATION, V126, P537, DOI 10.1161/CIRCULATIONAHA.111.055004; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Prati F, 2010, EUR HEART J, V31, P401, DOI 10.1093/eurheartj/ehp433; VANDERWAL AC, 1994, CIRCULATION, V89, P36; ARBUSTINI E, 1991, AM J CARDIOL, V68, pB36, DOI 10.1016/0002-9149(91)90383-V; Arbustini E, 1999, HEART, V82, P269; Di Vito L, 2015, EUR HEART J CAR 0114; Fuentes E, 2013, PLATELETS, V24, P255, DOI 10.3109/09537104.2012.690113; Prati F, 2013, JACC-CARDIOVASC IMAG, V6, P283, DOI 10.1016/j.jcmg.2012.12.007; Saia Francesco, 2015, JACC Cardiovasc Imaging, V8, P566, DOI 10.1016/j.jcmg.2015.01.018; Souteyrand G, 2015, EUROINTERVE IN PRESS; Yahagi K, 2015, ATHEROSCLEROSIS, V239, P260, DOI 10.1016/j.atherosclerosis.2015.01.017	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-878X	1876-7591		JACC-CARDIOVASC IMAG	JACC-Cardiovasc. Imag.	MAY	2015	8	5					576	578		10.1016/j.jcmg.2015.03.004		3	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CI9CR	WOS:000355068500012		
J	Delahaye-Sourdeix, M; Anantharaman, D; Timofeeva, MN; Gaborieau, V; Chabrier, A; Vallee, MP; Lagiou, P; Holcatova, I; Richiardi, L; Kjaerheim, K; Agudo, A; Castellsague, X; Macfarlane, TV; Barzan, L; Canova, C; Thakker, NS; Conway, DI; Znaor, A; Healy, CM; Ahrens, W; Zaridze, D; Szeszenia-Dabrowska, N; Lissowska, J; Fabianova, E; Mates, IN; Bencko, V; Foretova, L; Janout, V; Curado, MP; Koifman, S; Menezes, A; Wunsch, V; Eluf-Neto, J; Boffetta, P; Garrote, LF; Polesel, J; Lener, M; Jaworowska, E; Lubinski, J; Boccia, S; Rajkumar, T; Samant, TA; Mahimkar, MB; Matsuo, K; Franceschi, S; Byrnes, G; Brennan, P; Mckay, JD				Delahaye-Sourdeix, Manon; Anantharaman, Devasena; Timofeeva, Maria N.; Gaborieau, Valerie; Chabrier, Amelie; Vallee, Maxime P.; Lagiou, Pagona; Holcatova, Ivana; Richiardi, Lorenzo; Kjaerheim, Kristina; Agudo, Antonio; Castellsague, Xavier; Macfarlane, Tatiana V.; Barzan, Luigi; Canova, Cristina; Thakker, Nalin S.; Conway, David I.; Znaor, Ariana; Healy, Claire M.; Ahrens, Wolfgang; Zaridze, David; Szeszenia-Dabrowska, Neonilia; Lissowska, Jolanta; Fabianova, Eleonora; Mates, Ioan Nicolae; Bencko, Vladimir; Foretova, Lenka; Janout, Vladimir; Curado, Maria Paula; Koifman, Sergio; Menezes, Ana; Wuensch-Filho, Victor; Eluf-Neto, Jose; Boffetta, Paolo; Garrote, Leticia Fernandez; Polesel, Jerry; Lener, Marcin; Jaworowska, Ewa; Lubinski, Jan; Boccia, Stefania; Rajkumar, Thangarajan; Samant, Tanuja A.; Mahimkar, Manoj B.; Matsuo, Keitaro; Franceschi, Silvia; Byrnes, Graham; Brennan, Paul; Mckay, James D.			A Rare Truncating BRCA2 Variant and Genetic Susceptibility to Upper Aerodigestive Tract Cancer	JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE			English	Article							SQUAMOUS-CELL CARCINOMA; GENOME-WIDE ASSOCIATION; POLYMORPHIC STOP CODON; FANCONI-ANEMIA; HOMOLOGOUS RECOMBINATION; RISK; HEAD; INACTIVATION; POPULATION; PREVALENCE	Deleterious BRCA2 genetic variants markedly increase risk of developing breast cancer. A rare truncating BRCA2 genetic variant, rs11571833 (K3326X), has been associated with a 2.5-fold risk of lung squamous cell carcinoma but only a modest 26% increase in breast cancer risk. We analyzed the association between BRCA2 SNP rs11571833 and upper aerodigestive tract (UADT) cancer risk with multivariable unconditional logistic regression adjusted by sex and combinations of study and country for 5942 UADT squamous cell carcinoma case patients and 8086 control patients from nine different studies. All statistical tests were two-sided. rs11571833 was associated with UADT cancers (odds ratio = 2.53, 95% confidence interval = 1.89 to 3.38, P = 3x10(-10)) and was present in European, Latin American, and Indian populations but extremely rare in Japanese populations. The association appeared more apparent in smokers (current or former) compared with never smokers (P-het = .026). A robust association between a truncating BRCA2 variant and UADT cancer risk suggests that treatment strategies orientated towards BRCA2 mutations may warrant further investigation in UADT tumors.	[Delahaye-Sourdeix, Manon; Chabrier, Amelie; Vallee, Maxime P.; Mckay, James D.] Int Agcy Res Canc, Genet Canc Susceptibil Grp, F-69372 Lyon, France; [Anantharaman, Devasena; Timofeeva, Maria N.; Gaborieau, Valerie; Brennan, Paul] Int Agcy Res Canc, Genet Epidemiol Grp, F-69372 Lyon, France; [Franceschi, Silvia] Int Agcy Res Canc, Infect & Canc Epidemiol Grp, F-69372 Lyon, France; [Byrnes, Graham] Int Agcy Res Canc, Biostat Grp, F-69372 Lyon, France; [Timofeeva, Maria N.] Univ Edinburgh, Inst Genet & Mol Med, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland; [Timofeeva, Maria N.] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Lagiou, Pagona] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Holcatova, Ivana; Bencko, Vladimir] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague, Czech Republic; [Richiardi, Lorenzo] Univ Turin, Dept Med Sci, Canc Epidemiol Unit, Turin, Italy; [Kjaerheim, Kristina] Canc Registry Norway, Oslo, Norway; [Agudo, Antonio; Castellsague, Xavier] IDIBELL, ICO, Barcelona, Spain; [Castellsague, Xavier] CIBER Epidemiol & Salud Publ, Murcia, Spain; [Macfarlane, Tatiana V.] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Barzan, Luigi] Gen Hosp Pordenone, Pordenone, Italy; [Canova, Cristina] Univ Padua, Dept Environm Med & Publ Hlth, Padua, Italy; [Canova, Cristina] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth Resp Epidemiol & Publ, Natl Heart & Lung Inst, London, England; [Thakker, Nalin S.] Univ Manchester, Sch Dent, Manchester, Lancs, England; [Conway, David I.] Univ Glasgow, Sch Dent, Glasgow, Lanark, Scotland; [Znaor, Ariana] Natl Inst Publ Hlth, Croatian Natl Canc Registry, Zagreb, Croatia; [Healy, Claire M.] Univ Dublin Trinity Coll, Sch Dent Sci, Dublin 2, Ireland; [Ahrens, Wolfgang] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Ahrens, Wolfgang] Univ Bremen, Fac Math & Comp Sci, D-28359 Bremen, Germany; [Zaridze, David] Russian Acad Med Sci, Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia; [Szeszenia-Dabrowska, Neonilia] Inst Occupat Med, Dept Epidemiol, Lodz, Poland; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Occupat Med, Lodz, Poland; [Fabianova, Eleonora] Reg Author Publ, Banska Bystrica, Slovakia; [Mates, Ioan Nicolae] Carol Davila Univ Med & Pharm, St Mary Gen & Esophageal Surg Clin, Bucharest, Romania; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Janout, Vladimir] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Curado, Maria Paula] Int Prevent Res Inst, Ecully, France; [Koifman, Sergio] Fiocruz MS, Natl Sch Publ Hlth, BR-21045900 Rio De Janeiro, Brazil; [Menezes, Ana] Univ Fed Pelotas, Pelotas, Brazil; [Wuensch-Filho, Victor; Eluf-Neto, Jose] Univ Sao Paulo, Sao Paulo, Brazil; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Garrote, Leticia Fernandez] Inst Oncol & Radiobiol, Havana, Cuba; [Polesel, Jerry] IRCSS, Unit Epidemiol & Biostat, Ctr Riferimento Oncol, Aviano, Italy; [Lener, Marcin; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; [Jaworowska, Ewa] Pomeranian Med Univ, Dept Otolaryngol & Laryngol Oncol, Szczecin, Poland; [Boccia, Stefania] Univ Cattolica Sacro Cuore, Fac Med, Sect Hyg, Inst Publ Hlth, Rome, Italy; [Rajkumar, Thangarajan] Inst Canc Res, Dept Mol Oncol, Chennai, Tamil Nadu, India; [Samant, Tanuja A.; Mahimkar, Manoj B.] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Canc Res Inst, Navi Mumbai, India; [Matsuo, Keitaro] Kyushu Dent Univ, Div Oral Pathol, Dept Hlth Promot, Kitakyushu, Fukuoka, Japan	Mckay, JD (reprint author), Int Agcy Res Canc IARC WHO, Genet Canc Susceptibil Grp GCS, 150 Cours Albert Thomas, F-69372 Lyon 08, France.	gcs@iarc.fr	Menezes, Ana/G-7266-2012; Szeszenia-Dabrowska, Neonila/F-7190-2010; Eluf-Neto, Jose/B-2522-2009	Eluf-Neto, Jose/0000-0001-7504-2115	National Institutes of Health [R01 CA092039 05/05S1]; National Institute of Dental and Craniofacial Research [1R03DE020116]	This work was supported the National Institutes of Health (R01 CA092039 05/05S1) and the National Institute of Dental and Craniofacial Research (1R03DE020116).	Anantharaman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088240; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Akbari MR, 2011, HUM GENET, V129, P573, DOI 10.1007/s00439-011-0951-7; Akbari MR, 2008, ONCOGENE, V27, P1290, DOI 10.1038/sj.onc.1210739; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Negri E, 2009, INT J CANCER, V124, P394, DOI 10.1002/ijc.23848; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Cramer-Morales K, 2013, BLOOD, V122, P1293, DOI 10.1182/blood-2013-05-501072; Martin ST, 2005, ONCOGENE, V24, P3652, DOI 10.1038/sj.onc.1208411; Lok BH, 2013, ONCOGENE, V32, P3552, DOI 10.1038/onc.2012.391; Rosenberg PS, 2003, BLOOD, V101, P822, DOI 10.1182/blood-2002-05-1498; Oze I, 2010, CANCER SCI, V101, P1875, DOI 10.1111/j.1349-7006.2010.01599.x; Wang YF, 2014, NAT GENET, V46, P736, DOI 10.1038/ng.3002; Anantharaman D, 2013, JNCI-J NATL CANCER I, V105, P536, DOI 10.1093/jnci/djt053; Alter BP, 2003, CANCER, V97, P425, DOI 10.1002/cncr.11046; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Yan W, 2011, AM J CANCER RES, V1, P275; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; van Asperen CJ, 2005, J MED GENET, V42, P711, DOI 10.1136/jmg.2004.028829; Wu KJ, 2005, CANCER RES, V65, P417; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Ribeiro KB, 2011, INT J EPIDEMIOL, V40, P489, DOI 10.1093/ije/dyq249; Scully C, 2000, ORAL ONCOL, V36, P256, DOI 10.1016/S1368-8375(00)00007-5; Stewart BW, 2003, WORLD CANC REPORT; Thacker J, 1999, BIOCHIMIE, V81, P77, DOI 10.1016/S0300-9084(99)80041-8; The Breast Cancer Linkage Consortium, 1999, J NATL CANCER I, V91, P1310, DOI DOI 10.1093/JNCI/91.15.1310; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	29	2	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0027-8874	1460-2105		JNCI-J NATL CANCER I	JNCI-J. Natl. Cancer Inst.	MAY	2015	107	5							djv037	10.1093/jnci/djv037		4	Oncology	Oncology	CI9KJ	WOS:000355088600010		
J	Han, WJ; Yamauchi, M; Hasegawa, U; Noda, M; Fukui, K; van der Vlies, AJ; Uchiyama, S; Uyama, H				Han, Wenjuan; Yamauchi, Mika; Hasegawa, Urara; Noda, Masanori; Fukui, Kiichi; van der Vlies, Andre J.; Uchiyama, Susumu; Uyama, Hiroshi			Pepsin immobilization on an aldehyde-modified polymethacrylate monolith and its application for protein analysis	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Monolith; Pepsin; Online digestion; Thermally induced phase separation; Polymethacrylate	INDUCED PHASE-SEPARATION; MAGNETIC SILICA MICROSPHERES; POROUS POLYMER MONOLITHS; ENZYMATIC DIGESTION; LIQUID-CHROMATOGRAPHY; MASS SPECTROMETRY; TRYPSIN; PROTEOMICS; EXCHANGE; SYSTEM	Polymer-based monoliths with interconnected porous structure have attracted much attention as a high-performance stationary phase for online digestion liquid chromatography-mass spectrometry (LC-MS) system. In this study, a poly(glycidyl methacrylate-co-methyl methacrylate) (PGM) monolith prepared via thermally induced phase separation (TIPS) was used as a solid support to covalently immobilize pepsin. The PGM monolith was modified with aminoacetal to yield an aldehyde-bearing (PGM-CHO) monolith. Pepsin was immobilized onto the PGM-CHO monolith via reductive amination. The immobilized pepsin showed better pH and thermal stability compared with free pepsin. Furthermore, the PGM-CHO monolith modified with pepsin was applied for online protein digestion followed by LC-MS and LC-MS/MS analyses. As a result, a larger number of peptides are reproducibly identified compared to those by polystyrene/divinylbenzene particle (POROS)-based online pepsin column. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Han, Wenjuan; Hasegawa, Urara; van der Vlies, Andre J.; Uyama, Hiroshi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Hasegawa, Urara] Osaka Univ, Grad Sch Engn, Frontier Res Base Young Researchers, Suita, Osaka 5650871, Japan; [Yamauchi, Mika; Noda, Masanori] U Med Inc, Suita, Osaka 5650871, Japan; [Noda, Masanori; Fukui, Kiichi; Uchiyama, Susumu] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan	Uyama, H (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	uyama@chem.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science [25121722, 25288090]; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Manufacturing Technology Research of Biologics from METI; China Scholarship Council (CSC)	This study is financially supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to S. U and H. U. (25121722 and 25288090, respectively) a Project for Creating Start-ups from Advanced Research and Technology, Ministry of Education, Culture, Sports, Science and Technology (MEXT) to H. U., and Manufacturing Technology Research of Biologics from METI to S. U. Also, W. H. acknowledges financial support from the China Scholarship Council (CSC).	Abzalimov RR, 2013, ANAL CHEM, V85, P9173, DOI 10.1021/ac401868b; Li SJ, 2004, BIOSYSTEMS, V77, P25, DOI 10.1016/j.biosystems.2004.03.001; Lill JR, 2007, MASS SPECTROM REV, V26, P657, DOI 10.1002/mas.20140; Li JH, 2009, POLYMER, V50, P1526, DOI 10.1016/j.polymer.2009.01.049; Nandi M, 2011, FUNCT MATER LETT, V4, P407, DOI 10.1142/S1793604711002317; Rivera JG, 2012, J SEP SCI, V35, P1514, DOI 10.1002/jssc.201200073; Li Y, 2007, J PROTEOME RES, V6, P2367, DOI 10.1021/pr060558r; Yao CH, 2009, J MATER CHEM, V19, P767, DOI 10.1039/b816712e; Liese A, 2013, CHEM SOC REV, V42, P6236, DOI 10.1039/c3cs35511j; van der Vlies AJ, 2014, J BIOMATER TISS ENG, V4, P28, DOI 10.1166/jbt.2014.1135; Buchmeiser MR, 2007, POLYMER, V48, P2187, DOI 10.1016/j.polymer.2007.02.045; Sun W, 2006, MOL CELL PROTEOMICS, V5, P769, DOI 10.1074/mcp.T500022-MCP200; Xin YR, 2012, POLYMER, V53, P2847, DOI 10.1016/j.polymer.2012.04.029; Nandi M, 2014, RSC ADV, V4, P20847, DOI 10.1039/c4ra02057j; Yoneda S, 2014, POLYMER, V55, P3212, DOI 10.1016/j.polymer.2014.05.031; Zhong HW, 2009, J SEP SCI, V32, P10, DOI 10.1002/jssc.200800546; Marcsisin SR, 2010, ANAL BIOANAL CHEM, V397, P967, DOI 10.1007/s00216-010-3556-4; Geiser L, 2008, J CHROMATOGR A, V1188, P88, DOI 10.1016/j.chroma.2008.02.075; Zhang ZQ, 2012, ANAL CHEM, V84, P4942, DOI 10.1021/ac300535r; Angel TE, 2012, CHEM SOC REV, V41, P3912, DOI 10.1039/c2cs15331a; Kanamori K, 2006, ADV MATER, V18, P2407, DOI 10.1002/adma.200601026; Sun XX, 2014, COLLOID POLYM SCI, V292, P1073, DOI 10.1007/s00396-013-3155-y; Hashem AM, 2000, BIORESOURCE TECHNOL, V75, P219, DOI 10.1016/S0960-8524(00)00055-9; Kim BC, 2009, PROTEOMICS, V9, P1893, DOI 10.1002/pmic.200800591; Okada K, 2011, CHEM COMMUN, V47, P7422, DOI 10.1039/c1cc12402a; Peterson DS, 2002, ANAL CHEM, V74, P4081, DOI 10.1021/ac020180q; Colard CAL, 2009, ADV MATER, V21, P2894, DOI 10.1002/adma.200803007; Switzar L, 2013, J PROTEOME RES, V12, P1067, DOI 10.1021/pr301201x; Li Y, 2007, PROTEOMICS, V7, P2330, DOI 10.1002/pmic.200700112; Patel AC, 2006, NANO LETT, V6, P1042, DOI 10.1021/nl0604560; Barlow KJ, 2014, POLYM CHEM-UK, V5, P722, DOI 10.1039/c3py01015e; Shimazaki Y, 2012, ANAL BIOCHEM, V422, P55, DOI 10.1016/j.ab.2011.12.023; Guiochon G, 2007, J CHROMATOGR A, V1168, P101, DOI 10.1016/j.chroma.2007.05.090; Calleri E, 2005, J PROTEOME RES, V4, P481, DOI 10.1021/pr049796h; Wang LT, 2002, MOL CELL PROTEOMICS, V1, P132, DOI 10.1074/mcp.M100009-MCP200; Bandari R, 2007, MACROMOL RAPID COMM, V28, P2090, DOI 10.1002/marc.200700441; Cheng G, 2014, ANAL CHIM ACTA, V812, P65, DOI 10.1016/j.aca.2013.12.035; Feng S, 2006, J PROTEOME RES, V5, P422, DOI 10.1021/pr0502727; Han WJ, 2014, POLYM DEGRAD STABIL, V109, P362, DOI 10.1016/j.polymdegradstab.2014.05.032; Hasegawa G, 2011, POLYMER, V52, P4644, DOI 10.1016/j.polymer.2011.08.028; Hosoda N, 2014, POLYM J, V46, P301, DOI 10.1038/pj.2014.1; Kato M, 2004, ANAL CHEM, V76, P1896, DOI 10.1021/ac035107u; Mateo C, 2000, BIOMACROMOLECULES, V1, P739, DOI 10.1021/bm000071q; Park SB, 2013, POLYM DEGRAD STABIL, V99, P99; Park SB, 2013, POLYMER, V54, P6114, DOI 10.1016/j.polymer.2013.09.014; Sun X., 2013, NANOSCALE RES LETT, V8, P1; Sun XX, 2013, POLYM J, V45, P1101, DOI 10.1038/pj.2013.18; Walsh Z, 2008, CHEM COMMUN, P6504, DOI 10.1039/b816958f; Xin YR, 2012, CHEM LETT, V41, P1509, DOI 10.1246/cl.2012.1509	49	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					505	510		10.1016/j.jbiosc.2014.10.018		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100002		
J	Kimura, Y; Urata, M; Okamoto, R				Kimura, Yoshio; Urata, Maho; Okamoto, Reiko			Characterizing activities of eukaryotic-like protein kinases with atypical catalytic loop motifs from Myxococcus xanthus	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Myxococcus xanthus; Eukaryotic-like protein kinase; Dual-specificity kinase; MBP kinase activity; Atypical catalytic loop	PHOSPHORYLATION	Myxococcus xanthus has eukaryotic-like protein kinases (EPKS) with different atypical catalytic loop motifs. Seven out of 14 recombinant M. xanthus EPKs containing atypical motifs in the catalytic loop showed protein kinase activity against myelin basic protein and four autophosphorylated EPKS were detected using anti-phosphotyrosine antibody by western blotting. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Kimura, Yoshio; Urata, Maho; Okamoto, Reiko] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 7610795, Japan	Kimura, Y (reprint author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 7610795, Japan.	kimura@ag.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25440087]	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25440087).	Grant BD, 1998, BIOCHEMISTRY-US, V37, P7708, DOI 10.1021/bi972987w; Kaiser D, 2004, ANNU REV MICROBIOL, V58, P75, DOI 10.1146/annurev.micro.58.030603.123620; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Zhou J, 1997, BIOCHEMISTRY-US, V36, P2977, DOI 10.1021/bi9619132; Jelsbak L, 2003, J MICROBIOL METH, V55, P829, DOI 10.1016/.jmimet.2003.08.007; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; JANSSEN GR, 1977, J BACTERIOL, V130, P561; KISHIMOTO A, 1985, J BIOL CHEM, V260, P2492; Okamoto R, 2014, J BIOCHEM, V155, P99, DOI 10.1093/jb/mvt101; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Reddy MM, 2006, ARCH BIOCHEM BIOPHYS, V455, P99, DOI 10.1016/j.abb.2006.09.009; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Weiwad M, 2000, FEBS LETT, V478, P39, DOI 10.1016/S0014-5793(00)01794-4; Zhao X, 2002, J BIOL CHEM, V277, P4722, DOI 10.1074/jbc.M107803200	16	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					511	514		10.1016/j.jbiosc.2014.10.002		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100003		
J	Malik, A; Hapsari, MT; Ohtsu, I; Ishikawa, S; Takagi, H				Malik, Amarila; Hapsari, Maria Tyas; Ohtsu, Iwao; Ishikawa, Shu; Takagi, Hiroshi			Cloning and heterologous expression of the ftfCNC-2(1) gene from Weissella confusa MBFCNC-2(1) as an extracellular active fructansucrase in Bacillus subtilis	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Fructansucrase; Fructosyltransferase; ftf; Inulosucrase; Weissella confusa; Bacillus subtilis	LACTIC-ACID BACTERIA; LACTOBACILLUS-SANFRANCISCENSIS; STREPTOCOCCUS-MUTANS; INULIN; LEVAN; LEVANSUCRASE; STRAINS; FRUCTOSYLTRANSFERASE; EXOPOLYSACCHARIDES; GLUCANSUCRASE	Fructan-exopolysaccharides (fructan-EPS) (inulin and levan) and their oligosaccharides (fructooligosaccharides, FOS) have drawn considerable interest in the food and pharmaceutical industries. EPS-producing lactic acid bacteria have been reported to produce beta-fructans (inulin and levan), as well as alpha-glucans, by the function of sucrase enzymes, i.e., fructansucrase and glucansucrase. A fructansucrase ftfCNC-2(1) gene from Weissella confusa strain MBFCNC-2(1) was previously cloned in Escherichia coli. In this study, we aimed to express the ftf[CNC-2(1)] gene in Bacillus subtilis to obtain the active form of the extracellular recombinant protein FTF[CNC-2(1)]. This cloning was achieved by inserting the gene in-fusion with the signal sequence of the B. subtilis subtilisin E. SDS-polyacrylamide gel electrophoresis analysis and in situ activity assay with Periodic Acid-Schiff staining revealed that the recombinant FTF[CNC-2(1)] was successfully expressed as an extracellular protein from B. subtilis DB403 in its active form, which was confirmed using sucrose and raffinose. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Malik, Amarila; Hapsari, Maria Tyas] Univ Indonesia, Fac Pharm, Pharmaceut Biotechnol Res Grp, Depok 16424, Indonesia; [Ohtsu, Iwao; Ishikawa, Shu; Takagi, Hiroshi] Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Nara 6300101, Japan	Malik, A (reprint author), Univ Indonesia, Fac Pharm, Pharmaceut Biotechnol Res Grp, Kampus UI Depok, Depok 16424, Indonesia.	amarila.malik@ui.ac.id			Ministry of Education and Culture, Republic of Indonesia [DIPA: 0541/023-04.1.01/00/2012, 2468/H2.R12/HKP.05.00/2013]; Nara Institute of Science and Technology (NAIST), Japan	This work was supported by the Competence Grant 2012-2013 from the Ministry of Education and Culture, Republic of Indonesia (No. DIPA: 0541/023-04.1.01/00/2012 and 2468/H2.R12/HKP.05.00/2013) to A.M. This work was also supported by Summer Research Program Fellowship 2013, Nara Institute of Science and Technology (NAIST), Japan to M.T.H. Authors would like to thank M. Sahlan, H. Suryadi, N. Triwinanti and D. Septi for scientific and technical assistances.	SHIROZA T, 1988, J BACTERIOL, V170, P810; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; Kralj S, 2004, MICROBIOL-SGM, V150, P3681, DOI 10.1099/mic.0.27321-0; van Hijum SAFT, 2001, FEMS MICROBIOL LETT, V205, P323, DOI 10.1016/S0378-1097(01)00490-6; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Tieking M, 2003, APPL ENVIRON MICROB, V69, P945, DOI 10.1128/AEM.69.2.945-952.2003; Anwar MA, 2010, MICROBIOL-SGM, V156, P1264, DOI 10.1099/mic.0.036616-0; TANAKA T, 1979, J BIOCHEM-TOKYO, V85, P287; Van Geel-Schutten GH, 1999, APPL ENVIRON MICROB, V65, P3008; Hinrichs WLJ, 2001, INT J PHARM, V215, P163, DOI 10.1016/S0378-5173(00)00677-3; Korakli M, 2001, J AGR FOOD CHEM, V49, P5194, DOI 10.1021/jf0102517; TANAKA T, 1980, J BIOCHEM-TOKYO, V87, P297; van Hijum SAFT, 2003, FEBS LETT, V534, P207, DOI 10.1016/S0014-5793(02)03841-3; van Hijum SAFT, 2002, APPL ENVIRON MICROB, V68, P4390, DOI 10.1128/AEM.68.9.4390-4398.2002; Korakli M, 2002, J APPL MICROBIOL, V92, P958, DOI 10.1046/j.1365-2672.2002.01607.x; Anwar MA, 2008, APPL ENVIRON MICROB, V74, P3426, DOI 10.1128/AEM.00377-08; SIMMS PJ, 1990, CARBOHYD RES, V208, P193, DOI 10.1016/0008-6215(90)80099-O; Hinrichs WLJ, 2005, J CONTROL RELEASE, V103, P465, DOI 10.1016/j.jconrel.2004.12.011; Malik A, 2009, FEMS MICROBIOL LETT, V300, P131, DOI 10.1111/j.1574-6968.2009.01772.x; Ben Ammar Y, 2002, J BIOTECHNOL, V99, P111, DOI 10.1016/S0168-1656(02)00160-8; CARLSSON J, 1970, Caries Research, V4, P97, DOI 10.1215/lt-18260523-JBW-TC-01; EBISU S, 1975, J BIOCHEM-TOKYO, V78, P879; HANCOCK RA, 1976, CARBOHYD RES, V49, P351, DOI 10.1016/S0008-6215(00)83152-3; ISHIWA H, 1985, JPN J GENET, V60, P235, DOI 10.1266/jjg.60.235; Malik A., 2012, ASIA PACIFIC J MOL B, V20, P33; Olivares-Illana V, 2002, J IND MICROBIOL BIOT, V28, P112, DOI 10.1038/sj.jim.7000224; Robbins J. H., 1980, CAN J CHEM, V58, P339; ROBYT JF, 1979, CARBOHYD RES, V68, P95, DOI 10.1016/S0008-6215(00)84059-8; ROSELL KG, 1974, ACTA CHEM SCAND B, VB 28, P589, DOI 10.3891/acta.chem.scand.28b-0589; Takagi H, 2000, J BIOCHEM-TOKYO, V127, P617; Tieking M, 2005, APPL MICROBIOL BIOT, V66, P655, DOI 10.1007/s00253-004-1773-5	32	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					515	520		10.1016/j.jbiosc.2014.09.024		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100004		
J	Yanagihara, S; Kato, S; Ashida, N; Yamamoto, N				Yanagihara, Sae; Kato, Shinji; Ashida, Nobuhisa; Yamamoto, Naoyuki			Lactobacillus acidophilus CP23 with weak immunomodulatory activity lacks anchoring structure for surface layer protein	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Lactobacillus acidophilus; Surface layer protein A; Cell surface anchoring; Reconstitution assay; LiCl treatment; slpA gene sequence	CELL-WALL BINDING; STRAIN L-92; ATOPIC-DERMATITIS; DOMAINS; IDENTIFICATION; SYMPTOMS; CHILDREN	To determine the reason for the low levels of Surface layer protein A (SlpA) on CP23 cells, which might play a crucial role in the immunomodulatory effect of Lactobacillus acidophilus, the DNA sequence of the slpA gene of CP23 and L-92 strains, including the upstream region, were analyzed. Unexpectedly, there was no significant difference in the predicted amino acid sequence of the C-terminus needed for cell anchoring, and only an additional Ala-Val-Ala sequence inserted in the N-terminal region of the mature CP23 protein. Therefore, anchoring of SlpA on the cell wall of CP23 and L-92 was evaluated by a reconstitution assay, which showed that SlpA released by LiCl treatment from both CP23 and L-92 was successfully anchored on Lid-treated L-92 cells, but not on Lid-treated CP23 cells. Moreover, quantitative analysis of SlpA protein in the culture medium of CP23 and L-92 by ELISA revealed higher levels of SlpA secretion in CP23 cells than in L-92 cells. Collectively, these results suggest that the lower levels of SlpA on the surface of CP23 cells might be caused by less cell wall capacity for SlpA anchoring, leading to an accumulation of SlpA in the culture medium of CP23 cells. The present study supports the importance of cell surface structure of L acidophilus L-92 for SlpA anchoring on the cell surface needed for immunomodulatory effect. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Yanagihara, Sae; Kato, Shinji] Calpis Co Ltd, Microbiol & Fermentat Lab, Chuo Ku, Sagamihara, Kanagawa 2520206, Japan; [Ashida, Nobuhisa] Calpis Co Ltd, Feed Technol Grp, Feed Div, Chuo Ku, Sagamihara, Kanagawa 2520206, Japan; [Yamamoto, Naoyuki] Calpis Co Ltd, Res & Dev Planning Dept, Chuo Ku, Sagamihara, Kanagawa 2520206, Japan	Yamamoto, N (reprint author), Calpis Co Ltd, Res & Dev Planning Dept, Chuo Ku, 5-11-10 Fuchinobe, Sagamihara, Kanagawa 2520206, Japan.	sae.yanagihara@calpis.co.jp; Shinji.kato@calpis.co.jp; nobuhisa.ashida@calpis.co.jp; naoyuki.yamamoto@calpis.co.jp					Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Dohm N, 2011, ARCH MICROBIOL, V193, P251, DOI 10.1007/s00203-010-0670-9; BHATIA SJ, 1989, J CLIN MICROBIOL, V27, P2328; Ishida Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1652, DOI 10.1271/bbb.69.1652; Torii S, 2011, INT ARCH ALLERGY IMM, V154, P236, DOI 10.1159/000321110; Mohseni MJ, 2013, IRAN J PEDIATR, V23, P430; Hynonen U, 2013, APPL MICROBIOL BIOT, V97, P5225, DOI 10.1007/s00253-013-4962-2; Ashida N, 2011, J BIOSCI BIOENG, V112, P333, DOI 10.1016/j.jbiosc.2011.06.001; Antikainen J, 2002, MOL MICROBIOL, V46, P381, DOI 10.1046/j.1365-2958.2002.03180.x; Rojas M, 2002, APPL ENVIRON MICROB, V68, P2330, DOI 10.1128/AEM.68.5.2330-2336.2002; Avall-Jaaskelainen S, 2005, FEMS MICROBIOL REV, V29, P511, DOI 10.1016/j.femsre.2005.04.003; Avall-Jaaskelainen S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-165; Chen XY, 2009, J MICROBIOL BIOTECHN, V19, P1176, DOI 10.4014/jmb.0901.010; Ikeda N., 2000, J NUTR FOOD, V3, P59; Iovieno A, 2008, GRAEF ARCH CLIN EXP, V246, P435, DOI 10.1007/s00417-007-0682-6; Ishida Y, 2005, J DAIRY SCI, V88, P527; Ries W, 1997, J BACTERIOL, V179, P3892; Shah MM, 2010, MICROBIOL IMMUNOL, V54, P523, DOI 10.1111/j.1348-0421.2010.00251.x; Smit E, 2001, J MOL BIOL, V305, P245, DOI 10.1006/jmbi.2000.4258; Smit E, 2002, J BACTERIOL, V184, P4617, DOI 10.1128/JB.184.16.4617-4619.2002; Torii Akiko, 2007, Allergol Int, V56, P293, DOI 10.2332/allergolint.O-06-459; YAMAMOTO N, 1995, APPL ENVIRON MICROB, V61, P698	22	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					521	525		10.1016/j.jbiosc.2014.10.003		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100005		
J	Sasano, Y; Yamagishi, K; Tanikawa, M; Nakazawa, T; Sugiyama, M; Kaneko, Y; Harashima, S				Sasano, Yu; Yamagishi, Kazuo; Tanikawa, Marie; Nakazawa, Toshimasa; Sugiyama, Minetaka; Kaneko, Yoshinobu; Harashima, Satoshi			Stabilization of mini-chromosome segregation during mitotic growth by overexpression of YCR041W and its application to chromosome engineering in Saccharomyces cerevisiae	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						YCR041W; Chromosome engineering; Sir4; Zds1; Yeast artificial chromosome; PCR-mediated chromosome splitting; Mini-chromosome; Chromosome segregation	YEAST SILENT CHROMATIN; STABILITY; SIR3; TRANSFORMATION; CONSTRUCTION; PLASMIDS; PROTEINS; DELETION; STRAINS; REGIONS	Chromosome engineering enables large-scale genome manipulation and can be used as a novel technology for breeding of yeasts. PCR-mediated chromosome splitting (PCS) offers a powerful tool for chromosome engineering by enabling a yeast chromosome to be split at any desired site. By applying PCS, a huge variety of chromosome combinations can be created and the best strain under specific conditions can be selected a technology that we have called genome reorganization. Once the optimal strain is obtained, chromosome constitutions need to be maintained stably; however, mini-chromosomes of less than 50 kb are at relatively high frequency lost during cultivation. To overcome this problem, in this study we screened for multicopy suppressors of the high loss of mini-chromosomes by using a multicopy genomic library of Saccharomyces cerevisiae. We identified a novel gene, YCR041W, that stabilizes mini-chromosomes. The translational product of YCR041W was suggested to play an important role in increasing stability for mini-chromosome maintenance, probably by decreasing the rate of loss during mitotic cell division. The stabilization of mini-chromosomes conferred by YCR041W overexpression was completely dependent on the silencing protein Sir4, suggesting that a process related to telomere function might be involved in mini-chromosome stabilization. Overexpression of YCR041W stabilized not only a yeast artificial chromosome vector, but also a mini-chromosome derived from a natural chromosome. Taking these results together, we propose that YCR041W overexpression can be used as a novel chromosome engineering tool for controlling mini-chromosome maintenance and loss. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Sasano, Yu; Yamagishi, Kazuo; Tanikawa, Marie; Nakazawa, Toshimasa; Sugiyama, Minetaka; Kaneko, Yoshinobu; Harashima, Satoshi] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan	Harashima, S (reprint author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	harashima@bio.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [24658081, 19658132, 24380048, 23780080]	This work is supported by Grant-in-Aid for Challenging Exploratory Research [24658081, 19658132] (to S. H.), Grant-in-Aid for Scientific Research (B) [24380048] (to S. H.) and Grant-in-Aid for Young Scientists (B) [23780080] (to M. S.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. We thank Dr. Ohya (University of Tokyo) for kindly providing the genomic library of S. cerevisiae (pYO325).	Lee JY, 2011, BIOTECHNOL BIOENG, V108, P742, DOI 10.1002/bit.22989; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Murakami K, 2007, APPL MICROBIOL BIOT, V75, P589, DOI 10.1007/s00253-007-0859-2; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Oppikofer M, 2013, GENE, V527, P10, DOI 10.1016/j.gene.2013.05.088; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; MURRAY AW, 1983, NATURE, V305, P189, DOI 10.1038/305189a0; Swinnen S, 2012, FEMS YEAST RES, V12, P215, DOI 10.1111/j.1567-1364.2011.00777.x; Roy N, 2000, CURR BIOL, V10, P111, DOI 10.1016/S0960-9822(00)00298-0; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Mukaiyama H, 2002, GENES CELLS, V7, P75, DOI 10.1046/j.1356-9597.2001.00499.x; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; Ruault M, 2011, J CELL BIOL, V192, P417, DOI 10.1083/jcb.201008007; Rossio V, 2011, J CELL BIOL, V193, P445, DOI 10.1083/jcb.201101134; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; BROACH JR, 1979, GENE, V8, P121, DOI 10.1016/0378-1119(79)90012-X; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; DANI GM, 1983, P NATL ACAD SCI-BIOL, V80, P3406, DOI 10.1073/pnas.80.11.3406; Gasser SM, 2004, COLD SPRING HARB SYM, V69, P327, DOI 10.1101/sqb.2004.69.327; Kaboli S, 2014, NUCLEIC ACIDS RES, V42, P9838, DOI 10.1093/nar/gku576; Kim Y, 2005, J BIOSCI BIOENG, V99, P55, DOI 10.1263/jbb.99.055; KOSHLAND D, 1985, CELL, V40, P393, DOI 10.1016/0092-8674(85)90153-9; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Roy N, 1999, CHROMOSOMA, V108, P146, DOI 10.1007/s004120050364; Sugiyama M, 2009, APPL MICROBIOL BIOT, V84, P1045, DOI 10.1007/s00253-009-2144-z; Sugiyama M, 2005, BIOTECHNIQUES, V38, P909, DOI 10.2144/05386RR01; Sugiyama M, 2008, APPL MICROBIOL BIOT, V80, P545, DOI 10.1007/s00253-008-1609-9; SUROSKY RT, 1986, P NATL ACAD SCI USA, V83, P414, DOI 10.1073/pnas.83.2.414; Ueda Y, 2012, J BIOSCI BIOENG, V113, P675, DOI 10.1016/j.jbiosc.2012.01.013; Zhang W, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-46	32	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					526	531		10.1016/j.jbiosc.2014.10.006		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100006		
J	Hirayama, S; Shimizu, M; Tsuchiya, N; Furukawa, S; Watanabe, D; Shimoi, H; Takagi, H; Ogihara, H; Morinaga, Y				Hirayama, Satoru; Shimizu, Masashi; Tsuchiya, Noriko; Furukawa, Soichi; Watanabe, Daisuke; Shimoi, Hitoshi; Takagi, Hiroshi; Ogihara, Hirokazu; Morinaga, Yasushi			Awa1p on the cell surface of sake yeast inhibits biofilm formation and the co-aggregation between sake yeasts and Lactobacillus plantarum ML11-11	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Awa1p; Sake yeast; Lactobacillus plantarum; Co-aggregation; Mixed-species biofilm	LACTIC-ACID BACTERIA; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; FOAM FORMATION; GENE; MUTANTS; FLOCCULATION; PROTEINS; CLONING; BEER	We examined mixed-species biofilm formation between Lactobacillus plantarum ML11-11 and both foaming and non-foaming mutant strains of Saccharomyces cerevisiae sake yeasts. Wild-type strains showed significantly lower levels of biofilm formation compared with the non-foaming mutants. Awa1p, a protein involved in foam formation during sake brewing, is a glycosylphosphatidylinositol (GPI)-anchored protein and is associated with the cell wall of sake yeasts. The AWA1 gene of the non-foaming mutant strain Kyokai no. 701 (K701) has lost the C-terminal sequence that includes the GPI anchor signal. Mixed-species biofilm formation and co-aggregation of wild-type strain Kyokai no. 7 (K7) were significantly lower than K701 UT-1 (K701) ura3/ura3 trp1/trp1), while the levels of strain K701 UT-1 carrying the AWA1 on a plasmid were comparable to those of K7. The levels of biofilm formation and co-aggregation of the strain 1(701 UT-1 harboring AWA1 with a deleted GPI anchor signal were similar to those of K701 UT-1. These results clearly demonstrate that Awa1p present on the surface of sake yeast strain K7 inhibits adhesion between yeast cells and L plantarum ML11-11, consequently impeding mixed-species biofilm formation. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Hirayama, Satoru; Tsuchiya, Noriko; Furukawa, Soichi; Ogihara, Hirokazu; Morinaga, Yasushi] Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa 2520880, Japan; [Shimizu, Masashi; Shimoi, Hitoshi] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Hiroshima 7398530, Japan; [Watanabe, Daisuke; Shimoi, Hitoshi] Natl Res Inst Brewing, Hiroshima 7390046, Japan; [Watanabe, Daisuke; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Shimoi, Hitoshi] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan	Morinaga, Y (reprint author), Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	morinaga@brs.nihon-u.ac.jp			JSPS KAKENHI [13J00712]	This work was supported by JSPS KAKENHI Grant Number 13J00712 (to S. H.).	Abe A, 2013, APPL BIOCHEM BIOTECH, V171, P72, DOI 10.1007/s12010-013-0360-6; AKIYAMA H, 1969, Journal of the Society of Brewing (Tokyo), V64, P243; Akiyama H., 1965, J FERM TECH, V43, P629; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Miyashita K, 2004, J BIOSCI BIOENG, V97, P14, DOI 10.1016/S1389-1723(04)70158-9; Katakura Y, 2010, APPL MICROBIOL BIOT, V86, P319, DOI 10.1007/s00253-009-2295-y; OUCHI K, 1971, AGR BIOL CHEM TOKYO, V35, P1024; Blasco L, 2011, INT MICROBIOL, V14, P61, DOI 10.2436/20.1501.01.136; Hirayama S, 2012, BIOCHEM BIOPH RES CO, V419, P652, DOI 10.1016/j.bbrc.2012.02.068; Blasco L, 2011, YEAST, V28, P437, DOI 10.1002/yea.1849; Blasco L, 2012, J AGR FOOD CHEM, V60, P10796, DOI 10.1021/jf3027974; Furukawa S, 2012, BIOSCI BIOTECH BIOCH, V76, P326, DOI 10.1271/bbb.110714; Furukawa S, 2011, BIOSCI BIOTECH BIOCH, V75, P1430, DOI 10.1271/bbb.100817; Furukawa S, 2010, BIOSCI BIOTECH BIOCH, V74, P2316, DOI 10.1271/bbb.100350; Golowczyc MA, 2009, J DAIRY RES, V76, P111, DOI 10.1017/S0022029908003749; KITAMOTO K, 1990, AGR BIOL CHEM TOKYO, V54, P2979; KODAMA K, 1993, YEAST, V5, P129; LIEVENS K, 1994, COLLOID SURFACE B, V2, P189, DOI 10.1016/0927-7765(94)80034-0; Mizuno K, 2014, BIOSCI BIOTECH BIOCH, V78, P1626, DOI 10.1080/09168451.2014.921562; MOMOSE H, 1969, J GEN APPL MICROBIOL, V15, P19, DOI 10.2323/jgam.15.19; Narisawa N, 2005, J BIOSCI BIOENG, V99, P78, DOI 10.1263/jbb.99.78; Nozaka Soma, 2014, Biosci Microbiota Food Health, V33, P79, DOI 10.12938/bmfh.33.79; Ouchi K., 2010, J BREW SOC JPN, V105, P184; Peng X, 2001, APPL MICROBIOL BIOT, V55, P777, DOI 10.1007/s002530000564; Petrezer G., 2005, J BACTERIOL, V187, P6128; Shimoi H, 2002, APPL ENVIRON MICROB, V68, P2018, DOI 10.1128/AEM.68.4.2018-2025.2002; Takahashi G., 1916, J SOC BREW JAPAN, V11, P15; Tiukova I, 2014, BIOTECHNOL APPL BIOC, V61, P40, DOI 10.1002/bab.1135	28	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					532	537		10.1016/j.jbiosc.2014.10.007		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100007		
J	Sato, O; Suzuki, Y; Sato, Y; Sasaki, S; Sonoki, T				Sato, Osamu; Suzuki, Yuma; Sato, Yuki; Sasaki, Shinsuke; Sonoki, Tomonori			Water-insoluble material from apple pomace makes changes in intracellular NAD(+)/NADH ratio and pyrophosphate content and stimulates fermentative production of hydrogen	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Apple pomace; NAD(+)/NADH; Pyrophosphate; Lactate; Hydrogen	BEIJERINCKII NCIMB 8052; CLOSTRIDIUM-BEIJERINCKII; BIOHYDROGEN PRODUCTION; DARK FERMENTATION; ENERGY-SOURCE; CULTURE; ACID	Apple pomace is one of the major agricultural residues in Aomori prefecture, Japan, and it would be useful to develop effective applications for it. As apple pomace contains easily fermentable sugars such as glucose, fructose and sucrose, it can be used as a feedstock for the fermentation of fuels and chemicals. We previously isolated a new hydrogen-producing bacterium, Clostridium beijerinckii HU-1, which could produce H-2 at a production rate of 14.5 mmol of H-2/L/h in a fed-batch culture at 37 degrees C, pH 6.0. In this work we found that the HU-1 strain produces H-2 at an approximately 20% greater rate when the fermentation medium contains the water-insoluble material from apple pomace. The water-insoluble material from apple pomace caused a metabolic shift that stimulated H-2 production. HU-1 showed a decrease of lactate production, which consumes NADH, accompanied by an increase of the intracellular pyrophosphate content, which is an inhibitor of lactate dehydrogenase. The intracellular NAD(+)/NADH ratios of HU-1 during H-2 fermentation were maintained in a more reductive state than those observed without the addition of the water insoluble material. To correct the abnormal intracellular redox balance, caused by the repression of lactate production, H-2 production with NADH oxidation must be stimulated. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Sato, Osamu; Suzuki, Yuma; Sato, Yuki; Sonoki, Tomonori] Hirosaki Univ, Grad Sch Agr & Life Sci, Hirosaki, Aomori 0368561, Japan; [Sasaki, Shinsuke] Sanbongi High Sch Agr, Towada, Aomori 0348578, Japan	Sonoki, T (reprint author), Hirosaki Univ, Grad Sch Agr & Life Sci, 3 Bunkyo Cho, Hirosaki, Aomori 0368561, Japan.	sonoki@cc.hirosaki-u.ac.jp			Hirosaki University	We thank Mr. Nobuyoshi Osato, President of Yamadai Co., Ltd. for supplying the apple pomace. This work was supported in part by a Hirosaki University Institutional Research Grant for Young Scientists (TS) and a Hirosaki University Grant for Exploratory Research by Young Scientists (TS).	Wong YM, 2014, RENEW SUST ENERG REV, V34, P471, DOI 10.1016/j.rser.2014.03.008; KLINGSHIRN LM, 1987, AM J ENOL VITICULT, V38, P207; Elam CC, 2003, INT J HYDROGEN ENERG, V28, P601, DOI 10.1016/S0360-3199(02)00147-7; Cai GQ, 2013, BIOTECHNOL BIOENG, V110, P338, DOI 10.1002/bit.24596; EDWARDS CG, 1990, AM J ENOL VITICULT, V41, P48; Shi Z, 2008, APPL ENVIRON MICROB, V74, P7709, DOI 10.1128/AEM.01948-08; Lee DJ, 2011, BIORESOURCE TECHNOL, V102, P8393, DOI 10.1016/j.biortech.2011.03.041; Chin HL, 2003, BIOTECHNOL PROGR, V19, P383, DOI 10.1021/bp0200604; Sinha P, 2011, INT J HYDROGEN ENERG, V36, P7460, DOI 10.1016/j.ijhydene.2011.03.077; Kothari R, 2012, RENEW SUST ENERG REV, V16, P2337, DOI 10.1016/j.rser.2012.01.002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Palmfeldt J, 2004, APPL ENVIRON MICROB, V70, P5477, DOI 10.1128/AEM.70.9.5477-5484.2004; Zhao X, 2011, BIORESOURCE TECHNOL, V102, P8432, DOI 10.1016/j.biortech.2011.02.086; Barrow G. I., 1993, COWAN STEELS MANUAL; Bielen AAM, 2010, FEMS MICROBIOL LETT, V307, P48, DOI 10.1111/j.1574-6968.2010.01957.x; Boyles D.T, 1984, BIOENERGY TECHNOLOGY; CRUDEN DL, 1983, APPL ENVIRON MICROB, V46, P1403; DELFINI C, 1993, AM J ENOL VITICULT, V44, P86; JONAS HA, 1972, J BACTERIOL, V111, P397; Lee SM, 2008, ENERG FUEL, V22, P3459, DOI 10.1021/ef800076j; Miyake J, 2014, MICROBIAL PRODUCTION, P263; Sneath P., 1986, BERGEYS MANUAL SYSTE, V2; Wang Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-102; WILKINSON SR, 1995, J BACTERIOL, V177, P439; Willquist K, 2010, METAB ENG, V12, P282, DOI 10.1016/j.ymben.2010.01.001; Winpenny J. W. T., 1972, J BACTERIOL, V111, P24; Ye XF, 2011, APPL MICROBIOL BIOT, V92, P855, DOI 10.1007/s00253-011-3571-1; Zhang YP, 2009, J BACTERIOL, V191, P5526, DOI 10.1128/JB.00585-09	28	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					543	547		10.1016/j.jbiosc.2014.10.017		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100009		
J	Okamoto, S; Chin, T; Nagata, K; Takahashi, T; Ohara, H; Aso, Y				Okamoto, Shusuke; Chin, Taejun; Nagata, Keisuke; Takahashi, Tetsuya; Ohara, Hitomi; Aso, Yuji			Production of itaconic acid in Escherichia coli expressing recombinant alpha-amylase using starch as substrate	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						alpha-Amylase; Bacillus amyloliquefaciens; Escherichia coli; Itaconic acid; Starch; Streptococcus bovis	ASPERGILLUS-TERREUS; RAW-STARCH; BACILLUS-AMYLOLIQUEFACIENS; MOLECULAR-CLONING; FUSION PROTEINS; CELL-SURFACE; CORN STARCH; PURIFICATION; STREPTOCOCCUS-BOVIS-148; DECARBOXYLASE	Several studies on fermentative production of a vinyl monomer itaconic acid from hydrolyzed starch using Aspergillus terreus have been reported. Herein, we report itaconic acid production by Escherichia coli expressing recombinant alpha-amylase, using soluble starch as its sole carbon source. To express alpha-amylase in E. coli, we first constructed recombinant plasmids expressing alpha-amylases by using cell surface display technology derived from two amylolytic bacteria, Bacillus amyloliquefaciens NBRC 15535(T) and Streptococcus bovis NRIC 1535. The recombinant alpha-amylase from S. bovis (SBA) showed activity at 28 degrees C, which is the optimal temperature for production of itaconic acid, while alpha-amylase from B. amyloliquefaciens displayed no noticeable activity. E. coli cells expressing SBA produced 0.15 g/L itaconic acid after 69 h cultivation under pH-stat conditions, using 1% starch as the sole carbon source. In fact, E. coli cells expressing SBA had similar growth rates when grown in the presence of 1% glucose or starch, thereby highlighting the expression of an active alpha-amylase that enabled utilization of starch to produce itaconic acid in E. coli. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Okamoto, Shusuke; Chin, Taejun; Nagata, Keisuke; Ohara, Hitomi; Aso, Yuji] Kyoto Inst Technol, Dept Biobased Mat Sci, Sakyo Ku, Kyoto 6068585, Japan; [Takahashi, Tetsuya] Shimane Univ, Fac Educ, Matsue, Shimane 6908504, Japan	Aso, Y (reprint author), Kyoto Inst Technol, Dept Biobased Mat Sci, Sakyo Ku, 1 Hashigami Cho, Kyoto 6068585, Japan.	aso@kit.ac.jp			Japan Society for the Promotion of Science [24580110]; Adaptable and Seamless Technology Transfer Program Through Target-Driven R&D of the Japan Science and Technology Agency [AS232Z01368E]	We thank the National BioResource Project (National Institute of Genetics, Japan) for providing us with pVUB3 and pGBM1. We also thank Coli Genetic Stock Center (Yale University, USA), NITE Biological Resource Center (Chiba, Japan), and NODAI Culture Collection Center (Tokyo University of Agriculture, Japan) for providing us with pCP20 and pKD46, B. amyloliquefaciens NBRC 15535, and S. bovis NRIC 1535, respectively. This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (24580110) and the Adaptable and Seamless Technology Transfer Program Through Target-Driven R&D of the Japan Science and Technology Agency (AS232Z01368E).	Ali MA, 2013, MACROMOLECULES, V46, P3719, DOI 10.1021/ma400395b; Reddy CSK, 2002, BIORESOURCE TECHNOL, V85, P69, DOI 10.1016/S0960-8524(02)00075-5; Cote-Sierra J, 1998, GENE, V221, P25, DOI 10.1016/S0378-1119(98)00437-5; Okuda T, 2012, MACROMOLECULES, V45, P4166, DOI 10.1021/ma300387j; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Tateno T, 2007, APPL MICROBIOL BIOT, V74, P1213, DOI [10.1007/00253-006-0766-y, 10.1007/s00253-006-0766-y]; Yahiro K, 1997, J FERMENT BIOENG, V84, P375, DOI 10.1016/S0922-338X(97)89265-3; Kirimura K, 1997, APPL MICROBIOL BIOT, V47, P127; Tateno T, 2009, APPL MICROBIOL BIOT, V82, P115, DOI 10.1007/s00253-008-1751-4; Yu C, 2011, APPL MICROBIOL BIOT, V89, P573, DOI 10.1007/s00253-010-2970-z; Okamoto S, 2014, J GEN APPL MICROBIOL, V60, P191, DOI 10.2323/jgam.60.191; Okabe M, 2009, APPL MICROBIOL BIOT, V84, P597, DOI 10.1007/s00253-009-2132-3; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204; Narita J, 2006, APPL ENVIRON MICROB, V72, P269, DOI 10.1128/AEM.72.1.269-275.2006; Jantama K, 2008, BIOTECHNOL BIOENG, V99, P1140, DOI 10.1002/bit.21694; Kanamasa S, 2008, APPL MICROBIOL BIOT, V80, P223, DOI 10.1007/s00253-008-1523-1; Willke T, 2001, APPL MICROBIOL BIOT, V56, P289; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Li A, 2011, FUNGAL GENET BIOL, V48, P602, DOI 10.1016/j.fgb.2011.01.013; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Manen D, 1997, GENE, V186, P197, DOI 10.1016/S0378-1119(96)00702-0; BONNARME P, 1995, J BACTERIOL, V177, P3573; Nam TW, 2001, EMBO J, V20, P491, DOI 10.1093/emboj/20.3.491; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Charpentier B, 1998, J BACTERIOL, V180, P6476; Cornelis P, 1996, BIO-TECHNOL, V14, P203, DOI 10.1038/nbt0296-203; Demirkan ES, 2005, PROCESS BIOCHEM, V40, P2629, DOI 10.1016/j.procbio.2004.08.015; Dwiarti L, 2007, BIORESOURCE TECHNOL, V98, P3329, DOI 10.1016/j.biortech.2006.03.016; Gangadharan D, 2010, BIOLOGIA, V65, P392, DOI 10.2478/s11756-010-0042-6; GRANUM PE, 1979, J FOOD BIOCHEM, V3, P1, DOI 10.1111/j.1745-4514.1979.tb00631.x; Narita J, 2004, J BIOSCI BIOENG, V97, P423, DOI 10.1016/S1389-1723(04)70230-3; Petruccioli M, 1999, LETT APPL MICROBIOL, V28, P309, DOI 10.1046/j.1365-2672.1999.00528.x; Sambrook J, 2001, MOL CLONING LAB MANU; Satoh E, 1997, APPL ENVIRON MICROB, V63, P4941; SATOH E, 1993, APPL ENVIRON MICROB, V59, P3669; Tate B. E., 1981, KIRK OTHMER ENCY CHE, V3, P865; Tsao G T, 1999, Adv Biochem Eng Biotechnol, V65, P243	37	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					548	553		10.1016/j.jbiosc.2014.10.021		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100010		
J	Sato, S; Morita, T; Fukuoka, T; Kitamoto, D; Habe, H				Sato, Shun; Morita, Tomotake; Fukuoka, Tokuma; Kitamoto, Dai; Habe, Hiroshi			Microbial resolution of DL-glyceric acid for L-glyceric acid production with newly isolated bacterial strains	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						L-Glyceric acid; Microbial resolution; Pseudomonas sp.; Serratia sp.; L-Sugar synthesis	ASYMMETRIC DEGRADING ACTIVITY	To produce L-glyceric acid (L-GA) from DL-GA, microbial resolution was investigated using newly isolated bacterial strains capable of enantiospecific degradation of D-GA. Strains GA3R and GA72P, identified as Serratia and Pseudomonas species, respectively, exhausted D-GA within 72 h, resulting in production of L-GA with enantiomeric purity >= 89%. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Sato, Shun; Morita, Tomotake; Fukuoka, Tokuma; Kitamoto, Dai; Habe, Hiroshi] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki 3058565, Japan	Habe, H (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba Cent 5-2,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	hiroshi.habe@aist.go.jp					Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Takahashi E, 1997, APPL MICROBIOL BIOT, V47, P347; UMEMURA I, 1992, APPL MICROBIOL BIOT, V36, P722; Lee JC, 2004, CHEM-EUR J, V10, P399, DOI 10.1002/chem.200305096; Eriksson CJP, 2007, METABOLISM, V56, P895, DOI 10.1016/j.metabol.2007.01.019; Guaragna A, 2010, J ORG CHEM, V75, P3558, DOI 10.1021/jo100077k; Habe H, 2009, APPL ENVIRON MICROB, V75, P7760, DOI 10.1128/AEM.01535-09; HANDA S S, 1986, Fitoterapia, V57, P307; Mochizuki K, 2007, ENZYME MICROB TECH, V41, P318, DOI 10.1016/j.enzmictec.2007.02.013; Rosseto R, 2008, TETRAHEDRON LETT, V49, P3500, DOI 10.1016/j.tetlet.2008.03.084; Takahashi E, 1997, APPL MICROBIOL BIOT, V47, P173	11	0	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					554	557		10.1016/j.jbiosc.2014.10.016		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100011		
J	Tang, LH; Sakai, Y; Ueda, Y; Katsuda, S				Tang, Lihua; Sakai, Yasuo; Ueda, Yoshimichi; Katsuda, Shogo			Effects of oral administration of tripeptides derived from type I collagen (collagen tripeptide) on atherosclerosis development in hypercholesterolemic rabbits	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Collagen tripeptide; Atherosclerosis; Plaque; Kurosawa and Kusanagi-hypercholesterolemic rabbit; Smooth muscle cells; Total cholesterol	OXIDATIVE DNA-DAMAGE; KHC RABBITS; ATHEROGENESIS; MECHANISMS; DISEASE; LESIONS; STRESS; MATRIX; REPAIR; CELLS	Digestion of type I collagen with a collagenase-type protease yields a collagen tripeptide (Ctp) fraction comprising Gly-X-Y sequences that exhibit diverse biological activities. We previously demonstrated that Ctp inhibits the proliferation and migration of cultured aortic smooth muscle cells (SMCs) in vitro. These cells contribute to the pathogenesis of atherosclerosis and other cardiovascular diseases. In order to evaluate the effects of Ctp on atherosclerosis development in vivo, here we used the Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbit model of familial hypercholesterolemia to determine the effects of oral administration of Ctp for three months. Ctp induced a significant decrease in the area occupied by atherosclerotic plaques in the aorta and in the level of total serum cholesterol. The components of atherosclerotic plaques underwent distinct changes, including reduction in the populations of macrophages and SMCs and a significant decrease in the proportion of macrophages to SMCs. Ctp administration decreased the number of cells in plaques that expressed proliferating cell nuclear antigen and the number of cells with oxidative damage to DNA as indicated by 8-hydroxy-2'-deoxyguanine detection. These findings are the first to define the mechanism underlying the inhibitory effects of Ctp on atherosclerosis development in hypercholesterolemic rabbits, and suggest that Ctp provides an effective therapy for treating atherosclerosis. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Tang, Lihua; Ueda, Yoshimichi; Katsuda, Shogo] Kanazawa Med Univ, Dept Pathophysiol & Expt Pathol, Uchinada, Ishikawa 9200293, Japan; [Sakai, Yasuo] Jellice Co Ltd, Cent Res Inst, Tagajo, Miyagi 9850833, Japan	Sakai, Y (reprint author), Jellice Co Ltd, Cent Res Inst, 4-4-1 Sakae, Tagajo, Miyagi 9850833, Japan.	sakai@jellice.com					OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; Tsuruoka N, 2007, BIOSCI BIOTECH BIOCH, V71, P2680, DOI 10.1271/bbb.70287; PRASAD K, 1993, AM HEART J, V125, P958, DOI 10.1016/0002-8703(93)90102-F; Yan ZQ, 2007, IMMUNOL REV, V219, P187, DOI 10.1111/j.1600-065X.2007.00554.x; Saito M, 2009, J AGR FOOD CHEM, V57, P10477, DOI 10.1021/jf902355m; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/hh0302.105345; Madamanchi NR, 2005, J THROMB HAEMOST, V3, P254, DOI 10.1111/j.1538-7836.2004.01085.x; Okawa T, 2012, J DERMATOL SCI, V66, P136, DOI 10.1016/j.jdermsci.2012.02.004; Toyokuni S, 1997, LAB INVEST, V76, P365; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Vogiatzi G, 2009, HELL J CARDIOL, V50, P402; FALK E, 1995, CIRCULATION, V92, P657; Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21; Martinet W, 2001, CIRC RES, V88, P733, DOI 10.1161/hh0701.088684; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Kouguchi T, 2013, BIOSCI BIOTECH BIOCH, V77, P691, DOI 10.1271/bbb.120718; Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323; Falk E, 2006, J AM COLL CARDIOL, V47, P7, DOI DOI 10.1016/JJACC.2005.09.068; Iizuka A, 2000, J Atheroscler Thromb, V6, P49; Katsuda S, 2009, HYPERTENS RES, V32, P944, DOI 10.1038/hr.2009.144; Katsuda S, 2004, AM J HYPERTENS, V17, P181, DOI 10.1016/j.amjhyper.2003.10.008; Kouguchi T., 2012, ATHEROGENESE, V26, P557; KUROSAWA T, 1995, LAB ANIM SCI, V45, P385; Mitchell R. N., 2013, ATHEROSCLEROSIS, P335; O'Leary D H, 1992, Ann Epidemiol, V2, P147; RAINES EW, 1993, BRIT HEART J, V69, pS30; Ratnayake WMN, 1997, BRIT J NUTR, V78, P459, DOI 10.1079/BJN19970163; Rosamond W, 2007, CIRCULATION, V115, P69; Ross R, 1999, NEW ENGL J MED, V340, P115; Rudijanto Achmad, 2007, Acta Med Indones, V39, P86; Saha P, 2009, CURR OPIN PHARMACOL, V9, P109, DOI 10.1016/j.coph.2008.12.017; Sakai Y., 2001, FRAGRANCE J, V2, P73; Sakai Y, 1998, BIOL PHARM BULL, V21, P330; Tang L. H., 2009, J KANAZAWA MED U, V34, P93; Virmani R, 2006, J AM COLL CARDIOL, V47, P13; Yamato R., 2005, FFI J, V210, P854	37	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					558	563		10.1016/j.jbiosc.2014.10.011		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100012		
J	Kobayashi, F; Maki, T; Kakikawa, M; Yamada, M; Puspitasari, F; Iwasaka, Y				Kobayashi, Fumihisa; Maki, Teruya; Kakikawa, Makiko; Yamada, Maromu; Puspitasari, Findya; Iwasaka, Yasunobu			Bioprocess of Kosa bioaerosols: Effect of ultraviolet radiation on airborne bacteria within Kosa (Asian dust)	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Bioaerosol; Airborne bacteria; Bioprocess; Kosa; Asian dust; Sampling using airplane; UV radiation; Bacillus sp.	RECOMBINANT YEAST; WATER; ATMOSPHERE; SPORES; JAPAN	Kosa (Asian dust) is a well-known weather phenomenon in which aerosols are carried by the westerly winds from inland China to East Asia. Recently, the frequency of this phenomenon and the extent of damage caused have been increasing. The airborne bacteria within Kosa are called Kosa bioaerosols. Kosa bioaerosols have affected ecosystems, human health and agricultural productivity in downwind areas. In order to develop a new and useful bacterial source and to identify the source region of Kosa bioaerosols, sampling, isolation, identification, measurement of ultraviolet (UV) radiation tolerance and experimental simulation of UV radiation conditions were performed during Kosa bioaerosol transportation. We sampled these bioaerosols using a Cessna 404 airplane and a bioaerosol sampler at an altitude of approximately 2900 m over the Noto Peninsula on March 27, 2010. The bioaerosol particles were isolated and identified as Bacillus sp. BASZHR 1001. The results of the UV irradiation experiment showed that the UV radiation tolerance of Kosa bioaerosol bacteria was very high compared with that of a soil bacterium. Moreover, the UV radiation tolerance of Kosa bioaerosol spores was higher than that of soil bacterial spores. This suggested that Kosa bioaerosols are transported across the atmosphere as living spores. Similarly, by the experimental simulation of IN radiation conditions, the limited source region of this Kosa bioaerosol was found to be southern Russia and there was a possibility of transport from the Kosa source area. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Kobayashi, Fumihisa; Maki, Teruya] Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Kakikawa, Makiko] Kanazawa Univ, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9201192, Japan; [Yamada, Maromu] Natl Inst Occupat Safety & Hlth, Tama Ku, Kawasaki, Kanagawa 2148585, Japan; [Puspitasari, Findya] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Iwasaka, Yasunobu] Univ Shiga Prefecture, Board Directors, Hikone, Shiga 5228533, Japan	Kobayashi, F (reprint author), Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa 9201192, Japan.	fumihisa@se.kanazawa-u.ac.jp			Japanese Ministry of the Environment [B-0901, C-1155];  [23405003];  [24403002];  [26281005];  [26304003]	The authors thank Mr. Shinji Morosawa (Graduate School of Kanazawa University) and Mr. Hiroaki Ikeda (Kanazawa University) for technical assistance. This research was supported in part by the Global Environment Research Fund (B-0901 and C-1155) of the Japanese Ministry of the Environment and a Grant-in-Aid for Scientific Research (B) (no. 23405003), (B) (no. 24403002), (B) (no. 26281005), and (B) (no. 26304003). We would like to thank the staff of Nakanihon Air Service Co., Ltd for the sampling of bioaerosol using airplane. The authors are deeply grateful to National Institute for Environmental Studies (NIES), Toyama Prefectural Environmental Science Research Center (TESC) and Nagasaki Prefectural Institute of Public Health and Environmental Science for the Lidar observation data used in this publication. The authors gratefully acknowledge the NOAA Air Resources Laboratory (ARL) for provision of the HYSPLIT transport and dispersion model and the READY website.	Air Environment Division Environmental Management Bureau Ministry of the Environment, 2005, ABSTR SPEC COMM REP; Saffary R, 2002, FEMS MICROBIOL LETT, V215, P163, DOI 10.1016/S0378-1097(02)00953-9; Hua NP, 2007, AEROBIOLOGIA, V23, P291, DOI 10.1007/s10453-007-9076-9; Setlow P, 2001, ENVIRON MOL MUTAGEN, V38, P97, DOI 10.1002/em.1058; Maki T, 2010, SCI TOTAL ENVIRON, V408, P4556, DOI 10.1016/j.scitotenv.2010.04.002; Carrasco IJ, 2007, INT J SYST EVOL MICR, V57, P2084, DOI 10.1099/ijs.0.65162-0; Yoon JH, 2004, INT J SYST EVOL MICR, V54, P803, DOI 10.1099/ijs.0.02678-0; Kobayashi F, 2003, J CHEM TECHNOL BIOT, V78, P985, DOI 10.1002/jctb.894; Meerak J, 2007, J GEN APPL MICROBIOL, V53, P315, DOI 10.2323/jgam.53.315; Maki T, 2008, AIR QUAL ATMOS HLTH, V1, P81, DOI 10.1007/s11869-008-0016-9; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Maki T, 2013, ATMOS ENVIRON, V74, P73, DOI 10.1016/j.atmosenv.2013.03.029; Jaenicke R, 2005, SCIENCE, V308, P73, DOI 10.1126/science.1106335; Bauer H, 2002, ATMOS RES, V64, P109, DOI 10.1016/S0169-8095(02)00084-4; Bailey J.E., 1986, BIOCH ENG FUNDAMENTA; Biological Resource Center (NBRC) in National Institute of Technology and Evaluation (NITE), 2004, MICR DISTR CAT 10158; Draxier RR, 1998, AUST METEOROL MAG, V47, P295; Gibson T., 1974, BERGEYS MANUAL DETER, P529; Global Environment Issues Division: Global Environment Bureau Ministry of the Environment, 2008, DUST SANDST KOS 2 VE; Griffin Dale W., 2004, Aerobiologia, V20, P135, DOI 10.1023/B:AERO.0000032948.84077.12; Hu B, 2008, ADV ATMOS SCI, V25, P885, DOI 10.1007/s00376-008-0885-8; Iwasaka Y, 2009, AIR QUAL ATMOS HLTH, V2, P29, DOI 10.1007/s11869-009-0031-5; Kellogg Christina A., 2004, Aerobiologia, V20, P99, DOI 10.1023/B:AERO.0000032947.88335.bb; Kobayashi F, 2004, BIOCHEM ENG J, V18, P133, DOI 10.1016/j.bej.2003.08.001; Kobayashi Fumihisa, 2011, Asian Journal of Atmospheric Environment, V5, P164; Kobayshi F., 2007, EAROZORU KENKYU, V22, P218; Liu B, 2014, CLIN IMMUNOL, V10, P10; Maki T, 2013, AEROBIOLOGIA, V29, P341, DOI 10.1007/s10453-012-9284-9; Maki Teruya, 2010, Earozoru Kenkyu, V25; Ministry of the Environment, 2014, REP KOS EX COND CLAR; National astronomical observatory of Japan, 2009, RIKA NENPYO; Ogura Y., 1984, GEN METEOROLOGY IPPA; Rikhvanov EG, 1999, APPL ENVIRON MICROB, V65, P4292; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Wang YY, 2010, WORLD J MICROB BIOT, V26, P1369, DOI 10.1007/s11274-010-0309-7; Weisburg W. G., 1991, J BACTERIOL, V173, P693	36	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					570	579		10.1016/j.jbiosc.2014.10.015		10	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100014		
J	Hirokawa, Y; Suzuki, I; Hanai, T				Hirokawa, Yasutaka; Suzuki, Iwane; Hanai, Taizo			Optimization of isopropanol production by engineered cyanobacteria with a synthetic metabolic pathway	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Cyanobacteria; Synthetic metabolic pathway; Isopropanol production; Dark and anaerobic condition; Acetate utilization	CARBON-DIOXIDE; FLUX ANALYSIS; ACCUMULATION; LIGHT	Cyanobacterium is an attractive host for the production of various chemicals and alternative fuels using solar energy and carbon dioxide. In previous study, we succeeded to produce isopropanol using engineered Synechococcus elongatus PCC 7942 under dark and anaerobic conditions (0.43 mM, 26.5 mg/l). In the present study, we report the further optimization of this isopropanol producing condition. We then optimized growth conditions for production of isopropanol by the engineered cyanobacteria, including the use of cells in early stationary phase and buffering of the production medium to neutral pH. We observed that shifting of cultures from dark and anaerobic to light and aerobic conditions during the production phase dramatically increased isopropanol production by conversion to isopropanol from acetate, byproduct under dark and anaerobic condition. Under the optimized production conditions, the titer of isopropanol was elevated 6-fold, to 2.42 mM (146 mg/l). (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Hirokawa, Yasutaka; Hanai, Taizo] Kyushu Univ, Lab Bioinformat, Grad Sch Syst Biosci, Higashi Ku, Fukuoka 8128582, Japan; [Suzuki, Iwane] Univ Tsukuba, Lab Plant Physiol & Metab, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Hanai, T (reprint author), Kyushu Univ, Lab Bioinformat, Grad Sch Syst Biosci, Higashi Ku, 804 Westwing,3-1-1 Maidashi, Fukuoka 8128582, Japan.	taizo@brs.kyushu-u.ac.jp			Japan Science and Technology Agency (JST)	This study was supported financially by the Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST).	Ananyev GM, 2012, J BIOTECHNOL, V162, P97, DOI 10.1016/j.jbiotec.2012.03.026; Andersson CR, 2000, METHOD ENZYMOL, V305, P527; Oliver JWK, 2014, METAB ENG, V22, P76, DOI 10.1016/j.ymben.2014.01.001; KIBBY CL, 1973, J CATAL, V29, P144, DOI 10.1016/0021-9517(73)90213-3; Hanai T, 2007, APPL ENVIRON MICROB, V73, P7814, DOI 10.1128/AEM.01140-07; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1111/j.1574-6976.1997.tb00350.x; Lan EI, 2011, METAB ENG, V13, P353, DOI 10.1016/j.ymben.2011.04.004; Dexter J, 2009, ENERG ENVIRON SCI, V2, P857, DOI 10.1039/b811937f; Zhou J, 2012, METAB ENG, V14, P394, DOI 10.1016/j.ymben.2012.03.005; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024; Yu Y, 2013, MAR DRUGS, V11, P2894, DOI 10.3390/md11082894; Holtman CK, 2005, DNA RES, V12, P103, DOI 10.1093/dnares/12.2.103; Young JD, 2011, METAB ENG, V13, P656, DOI 10.1016/j.ymben.2011.08.002; Sharma L, 2005, BIORESOURCE TECHNOL, V96, P1304, DOI 10.1016/j.biortech.2004.10.009; Kusakabe T, 2013, METAB ENG, V20, P101, DOI 10.1016/j.ymben.2013.09.007; Alagesan S, 2013, PHOTOSYNTH RES, V118, P191, DOI 10.1007/s11120-013-9911-5; Wang B, 2013, METAB ENG, V16, P68, DOI 10.1016/j.ymben.2013.01.001; BUSTOS SA, 1991, J BACTERIOL, V173, P7525; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; Koksharova O. A., 2002, APPL MICROBIOL BIOT, V58, P123; Kotani H, 1994, DNA Res, V1, P303, DOI 10.1093/dnares/1.6.303; McEwen JT, 2012, CURR OPIN BIOTECH, V23, P744, DOI 10.1016/j.copbio.2011.12.019; Molenda J, 2004, PRZEM CHEM, V83, P320; Monshupanee T., 2013, J APPL MICROBIOL, V116, P830; Panda B., 2006, LETT APPL MICROBIOL, V44, P194; Rosegaard L, 2012, J BIOTECHNOL, V162, P134; Suzuki E, 2010, APPL ENVIRON MICROB, V76, P3153, DOI 10.1128/AEM.00397-08; Takahashi H, 1998, BIOTECHNOL LETT, V20, P183, DOI 10.1023/A:1005392827791; Wang B, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00344	29	3	3	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					585	590		10.1016/j.jbiosc.2014.10.005		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100016		
J	Ito, A; Yamamoto, M; Ikeda, K; Sato, M; Kawabe, Y; Kamihira, M				Ito, Akira; Yamamoto, Masahiro; Ikeda, Kazushi; Sato, Masanori; Kawabe, Yoshinori; Kamihira, Masamichi			Effects of type IV collagen on myogenic characteristics of IGF-I gene-engineered myoblasts	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Skeletal muscle; Myogenic differentiation; Myoblast; IGF-I; Type IV collagen	GROWTH-FACTOR-I; MUSCLE REGENERATION; SKELETAL MYOBLASTS; CELLS; DIFFERENTIATION; STIMULATION; MIGRATION; PROLIFERATION; HYPERTROPHY; EXPRESSION	Skeletal muscle regeneration requires migration, proliferation and fusion of myoblasts to form multinucleated myotubes. In our previous study, we showed that insulin-like growth factor (IGF)-I gene delivery stimulates the proliferation and differentiation of mouse myoblast C2C12 cells and promotes the contractile force generated by tissue-engineered skeletal muscles. The aim of this study was to investigate the effects of the extracellular matrix on IGF-I gene-engineered C2C12 cells in vitro. Retroviral vectors for doxycycline (Dox)-inducible expression of the IGF-I gene were transduced into C2C12 cells. When cultured on a type IV collagen-coated surface, we observed significant increases in the migration speed and number of IGF-I gene-engineered C2C12 cells with Dox addition, designated as C2C12/IGF (+) cells. Co-culture of C2C12/IGF (+) cells and parental C2C12 cells, which had been cultured in differentiation medium for 3 days, greatly enhanced myotube formation. Moreover, type IV collagen supplementation promoted the fusion of C2C12/IGF (+) cells with differentiated C2C12 cells and increased the number of myotubes with striations. Myotubes formed by C2C12/IGF (+) cells cultured on type IV collagen showed a dynamic contractile activity in response to electrical pulse stimulation. These findings indicate that type IV collagen promotes skeletal muscle regeneration mediated by IGF-I-expressing myoblasts, which may have important clinical implications in the design of myoblast-based therapies. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Ito, Akira; Yamamoto, Masahiro; Sato, Masanori; Kawabe, Yoshinori; Kamihira, Masamichi] Kyushu Univ, Dept Chem Engn, Fac Engn, Nishi Ku, Fukuoka 8190395, Japan; [Ikeda, Kazushi; Kamihira, Masamichi] Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, Fukuoka 8190395, Japan	Kamihira, M (reprint author), Kyushu Univ, Dept Chem Engn, Fac Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	kamihira@chem-eng.kyushu-u.ac.jp			Japan Society for the Promotion of Science, Japan [26289315]	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, Japan (grant number: 26289315).	OCALAN M, 1988, DEV BIOL, V125, P158, DOI 10.1016/0012-1606(88)90068-1; Stern MM, 2009, BIOMATERIALS, V30, P2393, DOI 10.1016/j.biomaterials.2008.12.069; Siegel AL, 2009, STEM CELLS, V27, P2527, DOI 10.1002/stem.178; Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109; Singleton JR, 2001, NEUROBIOL DIS, V8, P541, DOI 10.1006/nbdi.2001.0416; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Wu XY, 2010, CELL TISSUE RES, V340, P549, DOI 10.1007/s00441-010-0978-4; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Briggs D, 2013, FEBS J, V280, P4281, DOI 10.1111/febs.12273; Suzuki J, 2000, MOL CELL BIOL, V20, P4658, DOI 10.1128/MCB.20.13.4658-4665.2000; Vaz R, 2012, CELL TISSUE RES, V348, P569, DOI 10.1007/s00441-012-1364-1; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; Song YH, 2013, TRENDS ENDOCRIN MET, V24, P310, DOI 10.1016/j.tem.2013.03.004; Tedesco FS, 2012, CURR OPIN NEUROL, V25, P597, DOI 10.1097/WCO.0b013e328357f288; Chowdhury SR, 2009, J BIOSCI BIOENG, V108, P174, DOI 10.1016/j.jbiosc.2009.03.005; Philippou A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P208; Lund DK, 2013, FEBS J, V280, P4089, DOI 10.1111/febs.12171; Beattie J, 2010, J CELL PHYSIOL, V224, P605, DOI 10.1002/jcp.22183; Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383; Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106; COHICK WS, 1993, ANNU REV PHYSIOL, V55, P131, DOI 10.1146/annurev.ph.55.030193.001023; Arnesen S, 2004, CONNECT TISSUE RES, V45, P238, DOI 10.1080/03008200490888424; Doerr ME, 1996, J BIOL CHEM, V271, P2443; Ito A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04781; Kiihl U., 1984, DIFFERENTIATION, V28, P164; Kiihl U., 1982, DEV BIOL, V93, P344; Napier JR, 1999, J ENDOCRINOL, V163, P63; Przewozniak M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061760; Sato M, 2011, J BIOSCI BIOENG, V112, P273, DOI 10.1016/j.jbiosc.2011.05.007; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; WATT DJ, 1994, NATURE, V368, P406, DOI 10.1038/368406a0	33	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					596	603		10.1016/j.jbiosc.2014.10.008		8	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100018		
J	Tani, H; Torimura, M				Tani, Hidenori; Torimura, Masaki			Development of cytotoxicity-sensitive human cells using overexpression of long non-coding RNAs	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Non-coding RNA; Biosensor; Human cells; Cellular stress; Cytotoxicity	IDENTIFICATION; TRANSCRIPTION; REVEALS; MAMMALS	Biosensors using live cells are analytical devices that have the advantage of being highly sensitive for their targets. Although attention has primarily focused on reporter gene assays using functional promoters, cell viability assays are still efficient. We focus on long non-coding RNAs (IncRNAs) that are involved in the molecular mechanisms associated with responses to cellular stresses as a new biological material. Here we have developed human live cells transfected with IncRNAs that can be used as an intelligent sensor of cytotoxicity for a broad range of environmental stresses. We identified three IncRNAs (GAS5, IDI2-AS1, and SNHG15) that responded to cycloheximide in HEK293 cells. Overexpression of these IncRNAs sensitized human cells to cell death in response to various stresses (cycloheximide, ultraviolet irradiation, mercury II chloride, or hydrogen peroxide). In particular, dual IncRNA (GAS5 plus ID12-AS1, or GASS plus SNHG15) overexpression sensitized cells to cell death by more cellular stresses. We propose a method for highly sensitive biosensors using overexpression of IncRNAs that can potentially measure the cytotoxicity signals of various environmental stresses. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Tani, Hidenori; Torimura, Masaki] Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Tsukuba, Ibaraki 3058569, Japan	Tani, H (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	h.tani@aist.go.jp			JSPS [26810100]	This work was supported by the JSPS Grant-in-Aid for Young Scientists (B) Grant Number 26810100.	Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Tani H, 2013, BIOCHEM BIOPH RES CO, V439, P547, DOI 10.1016/j.bbrc.2013.09.006; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Keusgen M, 2002, NATURWISSENSCHAFTEN, V89, P433, DOI 10.1007/s00114-002-0358-3; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Bergmann JH, 2014, CURR OPIN CELL BIOL, V26, P10, DOI 10.1016/j.ceb.2013.08.005; Mizutani R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034949; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Pasco NF, 2011, ANAL BIOANAL CHEM, V400, P931, DOI 10.1007/s00216-011-4663-6; Sonkoly E, 2005, J BIOL CHEM, V280, P24159, DOI 10.1074/jbc.M501704200; Tani H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055684; Wada IC., 2005, BIOTECHNOL BIOENG, V92, P410; Wada KI, 2007, BIOTECHNOL BIOENG, V97, P871, DOI 10.1002/bit.21293	20	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					604	608		10.1016/j.jbiosc.2014.10.012		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100019		
J	Horie, M; Ito, A; Maki, T; Kawabe, Y; Kamihira, M				Horie, Masanobu; Ito, Akira; Maki, Takeshi; Kawabe, Yoshinori; Kamihira, Masamichi			Magnetically labeled feeder system for mouse pluripotent stem cell culture	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Pluripotent stem cells; Feeder cells; E-cadherin; Cell separation; Magnetite nanoparticles	CATIONIC LIPOSOMES; EMBRYOS; GROWTH	We report here a magnetically labeled feeder system for mouse embryonic stem/induced pluripotent stem (ES/iPS) cells. Magnetic attraction of feeder cells labeled with magnetite nanoparticles significantly increased ES/iPS colony-forming efficiency. Magnetic labeling of feeder cells also facilitated separation of ES/iPS cells from feeder cells. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Horie, Masanobu; Ito, Akira; Maki, Takeshi; Kawabe, Yoshinori; Kamihira, Masamichi] Kyushu Univ, Fac Engn, Dept Chem Engn, Nishi Ku, Fukuoka 8190395, Japan	Kamihira, M (reprint author), Kyushu Univ, Fac Engn, Dept Chem Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	kamihira@chem-eng.kyushu-u.ac.jp					MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Shinkai M, 1996, JPN J CANCER RES, V87, P1179; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ito A, 2004, TISSUE ENG, V10, P873, DOI 10.1089/1076327041348446; Zou CL, 2012, STEM CELLS DEV, V21, P2298, DOI 10.1089/scd.2011.0688; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Horie M, 2010, J BIOSCI BIOENG, V110, P582, DOI 10.1016/j.jbiosc.2010.06.002; Horie M., 2013, J BIOPROCESS BIOTE S, VS3; Ito A, 2009, TISSUE ENG PART C-ME, V15, P413, DOI 10.1089/ten.tec.2008.0496; Shi YT, 2006, CELL BIOL INT, V30, P1041, DOI 10.1016/j.cellbi.2006.08.003; Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008067	12	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAY	2015	119	5					614	616		10.1016/j.jbiosc.2014.10.020		3	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CI8ZB	WOS:000355059100021		
J	Kanakubo, M; Harris, KR				Kanakubo, Mitsuhiro; Harris, Kenneth R.			Density of 1-Butyl-3-methylimidazolium Bis(trifluoromethanesulfonyl)amide and 1-Hexyl-3-methylimidazolium Bis(trifluoromethanesulfonyl)amide over an Extended Pressure Range up to 250 MPa	JOURNAL OF CHEMICAL AND ENGINEERING DATA			English	Article							LIQUIDS 1-METHYL-3-OCTYLIMIDAZOLIUM HEXAFLUOROPHOSPHATE; EQUATION-OF-STATE; IONIC LIQUIDS; VOLUMETRIC PROPERTIES; THERMOPHYSICAL PROPERTIES; THERMODYNAMIC PROPERTIES; TRANSPORT-PROPERTIES; ISOTHERMAL COMPRESSIBILITIES; ELECTRICAL-CONDUCTIVITY; TEMPERATURE	Densities of the ionic liquid 1-butyl-3-methylimidazolium bis(trifluoromethanesulfonyl)amide ([BMIM][Tf2N]) between (273 and 363) K over an extended pressure range up to 250 MPa and densities for 1-hexyl-3-methylimidazolium bis(trifluoromethanesulfonyl)amide ([HMIM][Tf2N]) at 288.15 K to 175 MPa and between (273 and 363) K at 0.1 MPa are reported. The high-pressure densities were measured with a metal bellows volumometer, whereas the atmospheric pressure densities were determined with a vibrating tube densimeter. The overall uncertainties are estimated to be 0.02 % at atmospheric pressure and 0.1 % at higher pressures. The standard Tait equation of state with temperature dependent parameters B(T) and C(T) was used to represent the temperature and pressure dependences of the densities, with a standard uncertainty of 0.6 kg/m(3) or 0.03 %. The isothermal compressibility, isobaric expansivity, and the internal pressure were obtained from differentiation of the equation of state, but as the calculation of the two latter properties is known to be sensitive to the form adopted for the temperature dependence of the Tait coefficients, a comparison is made with other methods. It is concluded that great care must be taken in determining expansivities from the differentiation of pVT equations of state and that the internal pressure is best obtained by direct measurement.	[Kanakubo, Mitsuhiro; Harris, Kenneth R.] Natl Inst Ind Sci & Technol AIST, Miyagino Ku, Sendai, Miyagi 9838551, Japan; [Harris, Kenneth R.] Univ New S Wales, Sch Phys Environm & Math Sci, Canberra Bc, ACT 2610, Australia	Kanakubo, M (reprint author), Natl Inst Ind Sci & Technol AIST, Miyagino Ku, 4-2-1 Nigatake, Sendai, Miyagi 9838551, Japan.	m-kanakubo@aist.go.jp; k.harris@adfa.edu.au	Harris, Kenneth/C-3883-2011		AIST from the Japan Society for the Promotion of Science; (Australian) Prime Minister's Education Assistance Program for Japan	K.R.H. gratefully acknowledges the receipt of a short-term fellowship at AIST from the Japan Society for the Promotion of Science in 2007 and a travel grant from the (Australian) Prime Minister's Education Assistance Program for Japan, in response to the Great East Japan Earthquake on 11 March 2011, in 2012, in support of this research.	Navia P, 2010, J CHEM ENG DATA, V55, P590, DOI 10.1021/je900407u; de Azevedo RG, 2005, J CHEM THERMODYN, V37, P888, DOI 10.1016/j.jct.2005.04.018; Muhammad A, 2008, J CHEM THERMODYN, V40, P1433, DOI 10.1016/j.jct.2008.04.016; Harris KR, 2008, J PHYS CHEM B, V112, P9830, DOI 10.1021/jp8021375; Iguchi M, 2014, J CHEM ENG DATA, V59, P709, DOI 10.1021/je4007844; EASTEAL AJ, 1985, J CHEM THERMODYN, V17, P49, DOI 10.1016/0021-9614(85)90031-X; EASTEAL AJ, 1985, INT J THERMOPHYS, V6, P331, DOI 10.1007/BF00500267; Jacquemin J, 2007, J CHEM ENG DATA, V52, P2204, DOI 10.1021/je700224j; Wojnarowska Z, 2014, PHYS CHEM CHEM PHYS, V16, P20444, DOI 10.1039/c4cp02253j; Widegren JA, 2007, J CHEM ENG DATA, V52, P2331, DOI 10.1021/je700329a; Kolbeck C, 2010, J PHYS CHEM B, V114, P17025, DOI 10.1021/jp1068413; Vranes M, 2012, J CHEM ENG DATA, V57, P1072, DOI 10.1021/je2010837; Harris KR, 2012, FARADAY DISCUSS, V154, P425, DOI 10.1039/c1fd00085c; Machida H, 2011, J CHEM ENG DATA, V56, P923, DOI 10.1021/je1008747; Harris KR, 2005, J CHEM ENG DATA, V50, P1777, DOI 10.1021/je050147b; Marcus Y, 2013, CHEM REV, V113, P6536, DOI 10.1021/cr3004423; Jacquemin J, 2008, J CHEM ENG DATA, V53, P2133, DOI 10.1021/je8002817; Harris KR, 2006, J CHEM ENG DATA, V51, P1161, DOI 10.1021/je060082s; Regueira T, 2013, J CHEM THERMODYN, V58, P440, DOI 10.1016/j.jct.2012.10.004; Jacquemin J, 2008, J CHEM ENG DATA, V53, P716, DOI 10.1021/je700707y; Harris KR, 2011, J CHEM ENG DATA, V56, P4672, DOI 10.1021/je2006049; Safarov J, 2013, J MOL LIQ, V187, P137, DOI 10.1016/j.molliq.2013.05.032; Regueira T, 2012, J CHEM THERMODYN, V48, P213, DOI 10.1016/j.jct.2011.12.030; Gu ZY, 2002, J CHEM ENG DATA, V47, P339, DOI 10.1021/je010242u; Assael MJ, 2001, INT J THERMOPHYS, V22, P789, DOI 10.1023/A:1010774932124; Cerdeirina CA, 2001, PHYS CHEM CHEM PHYS, V3, P5230, DOI 10.1039/b104891k; Kanakubo M, 2007, J PHYS CHEM B, V111, P2062, DOI 10.1021/jp067328k; Gardas RL, 2007, J CHEM ENG DATA, V52, P1881, DOI 10.1021/je700205n; Makino T, 2014, FLUID PHASE EQUILIBR, V362, P300, DOI 10.1016/j.fluid.2013.10.031; Machida H, 2008, FLUID PHASE EQUILIBR, V264, P147, DOI 10.1016/j.fluid.2007.11.005; Kanakubo M, 2007, FLUID PHASE EQUILIBR, V261, P414, DOI 10.1016/j.fluid.2007.06.019; Kandil ME, 2007, J CHEM ENG DATA, V52, P2382, DOI 10.1021/je7003484; Gacino FM, 2015, J CHEM THERMODYN, V81, P124, DOI 10.1016/j.jct.2014.09.014; Marsh KN, 2009, PURE APPL CHEM, V81, P781, DOI 10.1351/PAC-REP-08-09-21; BACK PJ, 1982, J PHYS E SCI INSTRUM, V15, P360, DOI 10.1088/0022-3735/15/3/027; Curras MR, 2014, IND ENG CHEM RES, V53, P10791, DOI 10.1021/ie5008568; Driver G, UNPUB; Esperanca JMSS, 2008, J CHEM ENG DATA, V53, P867, DOI 10.1021/je700628w; BAONZA VG, 1995, PHYS REV B, V51, P28, DOI 10.1103/PhysRevB.51.28; Gonzalez EJ, 2012, J CHEM THERMODYN, V47, P300, DOI 10.1016/j.jct.2011.11.007; Harris KR, 2007, J CHEM ENG DATA, V52, P1080, DOI 10.1021/je700032n; Harris KR, 2008, J CHEM ENG DATA, V53, P1230, DOI 10.1021/je800236d; Hiraga Y, 2015, J CHEM ENG DATA, V60, P876, DOI 10.1021/je5009679; Kanakubo M, 2007, J PHYS CHEM B, V111, P13867, DOI 10.1021/jp709609e; KUMAGAI A, 1979, J CHEM ENG DATA, V24, P261, DOI 10.1021/je60083a004; Lopez ER, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3575184; MACDONAL.JR, 1969, REV MOD PHYS, V41, P316, DOI 10.1103/RevModPhys.41.316; MALHOTRA R, 1993, INT J THERMOPHYS, V14, P1021, DOI 10.1007/BF00505673; Nunhez JR, 2004, FLUID PHASE EQUILIBR, V220, P171, DOI 10.1016/j.fluid.2004.04.003; Paluch M., 2014, COMMUNICATION; SONG Y, 1993, FLUID PHASE EQUILIBR, V88, P25, DOI 10.1016/0378-3812(93)87098-L; Widowati E, 2013, J CHEM THERMODYN, V63, P95, DOI 10.1016/j.jct.2013.04.008; Woolf LA, 1997, INT J THERMOPHYS, V18, P65, DOI 10.1007/BF02575202	53	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-9568			J CHEM ENG DATA	J. Chem. Eng. Data	MAY	2015	60	5					1408	1418		10.1021/je501118w		11	Thermodynamics; Chemistry, Multidisciplinary; Engineering, Chemical	Thermodynamics; Chemistry; Engineering	CI6ZF	WOS:000354912000024		
J	Kanakubo, M; Harris, KR; Tsuchihashi, N; Ibuki, K; Ueno, M				Kanakubo, Mitsuhiro; Harris, Kenneth R.; Tsuchihashi, Noriaki; Ibuki, Kazuyasu; Ueno, Masakatsu			Temperature and Pressure Dependence of the Electrical Conductivity of 1-Butyl-3-methylimidazolium Bis(trifluoromethanesulfonyl)amide	JOURNAL OF CHEMICAL AND ENGINEERING DATA			English	Article							IONIC LIQUIDS; TRANSPORT-PROPERTIES; ELECTROLYTIC CONDUCTIVITY; VISCOSITY; HEXAFLUOROPHOSPHATE; DENSITIES; BIS(TRIFLUOROMETHYLSULFONYL)IMIDE; ANION	The electrical conductivities of the ionic liquid 1-butyl-3-methylimidazolium bis(trifluoromethanesulfonyl)amide ([BMIM][Tf2N]) have been determined between (273 and 353) K over an extended pressure range up to 250 MPa by both electrochemical impedance spectroscopy and conductance bridge techniques. The results obtained by the two techniques are generally in good agreement, within 3%, though the conductance bridge results yield lower values outside the experimental uncertainties at higher conductivities, that is, at higher temperature and lower pressures where the maximum deviation is -7%. The temperature and pressure dependence of both the conductivity and molar conductivity have been represented by modified Vogel-Fulcher-Tammann equations. The molar conductivity scales with the viscosity, with overlapping isobars and isotherms, so that a Walden plot, the logarithmic projection of molar conductivity versus fluidity (reciprocal viscosity), is a straight line with a similar slope (0.924) to those obtained for other 1,3-dialkylimidazolium ionic liquids.	[Kanakubo, Mitsuhiro] Natl Inst Ind Sci & Technol AIST, Miyagino Ku, Sendai, Miyagi 9838551, Japan; [Harris, Kenneth R.] Univ New S Wales, Sch Phys Environm & Math Sci, Canberra Bc, ACT 2610, Australia; [Tsuchihashi, Noriaki; Ibuki, Kazuyasu; Ueno, Masakatsu] Doshisha Univ, Fac Sci & Engn, Dept Mol Sci & Biochem, Kyoto 6100321, Japan	Kanakubo, M (reprint author), Natl Inst Ind Sci & Technol AIST, Miyagino Ku, 4-2-1 Nigatake, Sendai, Miyagi 9838551, Japan.	m-kanakubo@aist.go.jp	Harris, Kenneth/C-3883-2011		Japan Society for the Promotion of Science; (Australian) Prime Minister's Education Assistance Program for Japan	K.R.H. gratefully acknowledges the receipt of a short-term fellowship at AIST from the Japan Society for the Promotion of Science in 2007 and a travel grant from the (Australian) Prime Minister's Education Assistance Program for Japan, in response to the Great East Japan Earthquake on 11 March 2011, in 2012, in support of this research.	Andriola A, 2010, J PHYS CHEM B, V114, P11709, DOI 10.1021/jp1044404; Rupp A, 2014, CHEM-EUR J, V20, P9794, DOI 10.1002/chem.201400168; Tokuda H, 2004, J PHYS CHEM B, V108, P16593, DOI 10.1021/jp047480r; Harris KR, 2008, J PHYS CHEM B, V112, P9830, DOI 10.1021/jp8021375; Ruther T, 2013, CHEM-EUR J, V19, P17733, DOI 10.1002/chem.201302258; Wojnarowska Z, 2014, PHYS CHEM CHEM PHYS, V16, P20444, DOI 10.1039/c4cp02253j; Harris KR, 2012, FARADAY DISCUSS, V154, P425, DOI 10.1039/c1fd00085c; Widegren JA, 2005, J CHEM THERMODYN, V37, P569, DOI 10.1016/j.jct.2005.04.009; Harris KR, 2011, J CHEM ENG DATA, V56, P4672, DOI 10.1021/je2006049; Pan YF, 2011, J ELECTROCHEM SOC, V158, pF1, DOI 10.1149/1.3505006; ANGELL CA, 1988, J PHYS CHEM SOLIDS, V49, P863, DOI 10.1016/0022-3697(88)90002-9; Kanakubo M, 2007, J PHYS CHEM B, V111, P2062, DOI 10.1021/jp067328k; Vranes M, 2014, J CHEM THERMODYN, V68, P98, DOI 10.1016/j.jct.2013.08.034; Makino T, 2014, FLUID PHASE EQUILIBR, V362, P300, DOI 10.1016/j.fluid.2013.10.031; Jin H, 2008, J PHYS CHEM B, V112, P81, DOI 10.1021/jp076462h; Kanakubo M, 2007, FLUID PHASE EQUILIBR, V261, P414, DOI 10.1016/j.fluid.2007.06.019; Kanakubo M, 2015, J CHEM ENG DATA, V60, P1408, DOI 10.1021/je501118w; Kanakubo M, 2011, FLUID PHASE EQUILIBR, V302, P10, DOI 10.1016/j.fluid.2010.11.001; BENSON GC, 1945, J CHEM PHYS, V13, P473, DOI 10.1063/1.1723981; BRAUNSTE.J, 1971, J CHEM EDUC, V48, P52; Bulut S, 2011, CHEMPHYSCHEM, V12, P2296, DOI 10.1002/cphc.201100214; Harris KR, 2007, J CHEM ENG DATA, V52, P1080, DOI 10.1021/je700032n; HOOVER TB, 1970, J PHYS CHEM-US, V74, P2667, DOI 10.1021/j100707a013; Makino T, 2012, J CHEM ENG DATA, V57, P751, DOI 10.1021/je200864h; Makino T, 2013, J CHEM ENG DATA, V58, P370, DOI 10.1021/je3010062; Pratt KW, 2001, PURE APPL CHEM, V73, P1783, DOI 10.1351/pac200173111783; ROBBINS GD, 1969, J ELECTROCHEM SOC, V116, P813, DOI 10.1149/1.2412059; Robinson R. A., 1965, ELECTROLYTE SOLUTION; Spiro M., 1986, PHYSICAL METHODS CHE, V2, P663; Wojnarowska Z, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.225703; Wojnarowska Z, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4705274; Yu L, 2012, J PHYS CHEM B, V116, P6553, DOI 10.1021/jp301883e	32	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-9568			J CHEM ENG DATA	J. Chem. Eng. Data	MAY	2015	60	5					1495	1503		10.1021/acs.jced.5b00071		9	Thermodynamics; Chemistry, Multidisciplinary; Engineering, Chemical	Thermodynamics; Chemistry; Engineering	CI6ZF	WOS:000354912000035		
J	Set, S; Ford, D; Kita, M				Set, Seng; Ford, David; Kita, Masakazu			Effects of Metal Ions on Viscosity of Aqueous Sodium Carboxylmethylcellulose Solution and Development of Dropping Ball Method on Viscosity	JOURNAL OF CHEMICAL EDUCATION			English	Article						High School/Introductory Chemistry; First-Year Undergraduate/General; Laboratory Instruction; Physical Chemistry; Polymer Chemistry; Hands-On Learning/Manipulatives; Laboratory Equipment/Apparatus		This research revealed that metal ions with different charges could significantly affect the viscosity of aqueous sodium carboxylmethylcellulose (CMC) solution. On the basis of an Ostwald viscometer, an improvised apparatus using a dropping ball for examining the viscosity of liquids/solutions has been developed. The results indicate that the colloidal size of CMC aggregations is changed mainly by the metal cation charge. The improvised apparatus was introduced to high school students in a lesson on viscosity and intermolecular interaction where the students could examine the viscosity of several solutions and compare it with an aqueous sodium CMC solution. Although there are some limitations, the results show that the apparatus can be useful in helping high school students to understand the concept of viscosity.	[Set, Seng; Kita, Masakazu] Okayama Univ, Fac Educ, Dept Chem, Okayama 7008530, Japan; [Ford, David] Royal Univ Phnom Penh, Fac Sci, Dept Chem, Phnom Penh 12101, Cambodia	Set, S (reprint author), Okayama Univ, Fac Educ, Dept Chem, Okayama 7008530, Japan.	setseng2004@yahoo.com			Ministry of Education, Science, Sports and Culture of Japan through Japan Society for the Promotion of Science (JSPS)	The authors would like to thank the Ministry of Education, Science, Sports and Culture of Japan for financial support in this research through Japan Society for the Promotion of Science (JSPS).	Yang XH, 2007, CELLULOSE, V14, P409, DOI 10.1007/s10570-007-9137-9; Li J, 2007, ELECTROCHEM SOLID ST, V10, pA17, DOI 10.1149/1.2398725; Sengupta S, 2000, APPL MICROBIOL BIOT, V53, P732, DOI 10.1007/s002530000327; Cheng C. K., 2011, BIOMACROMOLECULES, V12, P730; Hicyilmaz C, 2006, ENERG FUEL, V20, P2037, DOI 10.1021/ef060063o; HOLLABAUGH CB, 1945, IND ENG CHEM, V37, P943, DOI 10.1021/ie50430a015; Li J., 2008, J AGR FOOD CHEM, V56, P13336; Mohammad M. D., 2010, J CHEM EDUC, V87, P1411; Sorrell A. C., 1971, J CHEM EDUC, V48, P252; Su F. J., 2010, CARBOHYD POLYM, V79, P145; Tang YL, 2009, LANGMUIR, V25, P21, DOI 10.1021/la803111b; Urian RC, 1998, J CHEM EDUC, V75, P1135; Weast C. B., 1988, CRC HDB CHEM PHYS, V69th, p[F, F]	13	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-9584	1938-1328		J CHEM EDUC	J. Chem. Educ.	MAY	2015	92	5					946	949		10.1021/ed500694h		4	Chemistry, Multidisciplinary; Education, Scientific Disciplines	Chemistry; Education & Educational Research	CI8YJ	WOS:000355057300034		
J	Kobayashi, T; Boase, J; Suzuki, T; Suzuki, T				Kobayashi, Tetsuro; Boase, Jeffrey; Suzuki, Tsutomu; Suzuki, Takahisa			Emerging From the Cocoon? Revisiting the Tele-Cocooning Hypothesis in the Smartphone Era	JOURNAL OF COMPUTER-MEDIATED COMMUNICATION			English	Article						Social Capital; Weak Ties; Tele-Cocooning; Smartphones; Field Experiment	COGNITIVE-SOCIAL-STRUCTURES; NETWORK; TIES; COMMUNICATION; MEDIA; STRENGTH; ONLINE; DECAY; WEAK	The tele-cocooning hypothesis posits that mobile communication increases interaction with communication rich ties, while simultaneously weakening interaction with communication weak ties. In this study, we demonstrate how smartphones can be used to mitigate tele-cocooning behavior by stimulating interaction with communication weak ties. Using a smartphone application to collect non-identifying mobile communication log data, we conducted a field experiment with 193 Japanese participants. The treatment consisted of onscreen reminders designed to stimulate interaction with communication weak ties. The results indicate that the treatment promoted the activation of communication weak ties and the acquisition of information through those ties, suggesting that smartphones can be utilized to promote access to social capital.	[Kobayashi, Tetsuro] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Boase, Jeffrey] Univ Toronto, Inst Commun Culture & Informat Technol, Mississauga, ON L5L 1C6, Canada; [Suzuki, Tsutomu] Tohoku Gakuin Univ, Fac Liberal Arts, Izumi Ku, Sendai, Miyagi 9813193, Japan; [Suzuki, Takahisa] Grad Univ Adv Studies, Dept Informat, Sch Multidisciplinary Sci, Chiyoda Ku, Tokyo 1018430, Japan	Kobayashi, T (reprint author), Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, 2-1-2 Hitotsubashi, Tokyo 1018430, Japan.	k-tetsu@nii.ac.jp; j.boase@utoronto.ca; t-suzuki@mail.tohoku-gakuin.ac.jp; s-takahisa@nii.ac.jp					Gergen KJ, 2008, HANDBOOK OF MOBILE COMMUNICATION STUDIES, P297; MARSDEN PV, 1984, SOC FORCES, V63, P482, DOI 10.2307/2579058; Hampton KN, 2011, NEW MEDIA SOC, V13, P1031, DOI 10.1177/1461444810390342; Steinfield C, 2008, J APPL DEV PSYCHOL, V29, P434, DOI 10.1016/j.appdev.2008.07.002; Brewer DD, 2000, SOC NETWORKS, V22, P29, DOI 10.1016/S0378-8733(99)00017-9; Ishii K, 2006, J COMMUN, V56, P346, DOI 10.1111/j.1460-2466.2006.00023.x; Levin DZ, 2011, ORGAN SCI, V22, P923, DOI 10.1287/orsc.1100.0576; Burt RS, 2002, SOC NETWORKS, V24, P333, DOI 10.1016/S0378-8733(02)00017-5; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Stefanone MA, 2012, J COMPUT-MEDIAT COMM, V17, P451, DOI 10.1111/j.1083-6101.2012.01585.x; KRACKHARDT D, 1987, SOC NETWORKS, V9, P109, DOI 10.1016/0378-8733(87)90009-8; Gilbert E, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P211; Hampton KN, 2011, INFORM COMMUN SOC, V14, P130, DOI 10.1080/1369118X.2010.513417; Haythornthwaite C, 2002, INFORM SOC, V18, P385, DOI 10.1080/01972240290108195; Brands RA, 2013, J ORGAN BEHAV, V34, pS82, DOI 10.1002/job.1890; BERNARD HR, 1990, SOC NETWORKS, V12, P179, DOI 10.1016/0378-8733(90)90005-T; Feld SL, 2002, SOC NETWORKS, V24, P365, DOI 10.1016/S0378-8733(02)00013-8; MCPHERSON JM, 1992, AM SOCIOL REV, V57, P153, DOI 10.2307/2096202; Banford Jamie, 2010, Proceedings 2010 6th International Conference on Wireless and Mobile Communications (ICWMC 2010), DOI 10.1109/ICWMC.2010.40; Boase J., AM BEHAV SC IN PRESS; Boase J, 2013, J COMPUT-MEDIAT COMM, V18, P508, DOI 10.1111/jcc4.12021; BROWN J. J, 1987, RES CONSUMER BEHAV, V14, P350, DOI DOI 10.1086/209118; Campbell SW, 2012, NEW MEDIA SOC, V14, P262, DOI 10.1177/1461444811411676; GRANOVET.MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Green Donald P., 2012, FIELD EXPT DESIGN AN; Greene W. H., 2000, ECONOMETRIC ANAL; Habuchi I, 2005, PERSONAL, PORTABLE, PEDESTRIAN: MOBILE PHONES IN JAPANESE LIFE, P165; HAMMER M, 1984, SOC NETWORKS, V6, P341, DOI 10.1016/0378-8733(84)90008-X; Haythornthwaite C., 2005, Information Communication & Society, V8, DOI 10.1080/13691180500146185; Homans G. C, 1950, HUMAN GROUP; Jones JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052168; Kobayashi T, 2014, J COMPUT-MEDIAT COMM, V19, P681, DOI 10.1111/jcc4.12064; Kobayashi T., 2012, COMMUNICATION METHOD, V6, P126; Lin N., 2008, HDB SOCIAL CAPITAL, P50; Lin N., 2001, SOCIAL CAPITAL THEOR; Ling R., 2008, NEW TECH NEW TIES MO; Raeder T, 2011, SOC NETWORKS, V33, P245, DOI 10.1016/j.socnet.2011.07.002; Steinfield Charles, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI DOI 10.1111/J.1083-6101.2007.00367.X; Zhang H., 2010, 2010 IEEE INT C INT, DOI [10.1109/ISI.2010.5484780, DOI 10.1109/ISI.2010.5484780]	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1083-6101			J COMPUT-MEDIAT COMM	J. Comput.-Mediat. Commun.	MAY	2015	20	3					330	345		10.1111/jcc4.12116		16	Communication; Information Science & Library Science	Communication; Information Science & Library Science	CJ1GH	WOS:000355231100006		
J	Makiguchi, T; Yokoo, S; Hashikawa, K; Miyazaki, H; Terashi, H				Makiguchi, Takaya; Yokoo, Satoshi; Hashikawa, Kazunobu; Miyazaki, Hidetaka; Terashi, Hiroto			Evaluation of Bone Height of the Free Fibula Flap in Mandible Reconstruction	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						bone height; bone resorption; fibula flap; mandible reconstruction; risk factor	GRAFTS; MASS	Background: Use of a vascularized free fibula flap has become a preferred method of mandible reconstruction after oncologic surgical ablation. Despite its many advantages, the low vertical height of the graft is a potential drawback and severe long-term atrophy of fibular bones may cause stress fracture and is disadvantageous for osseointegrated dental implants and facial contours. Therefore, it is important to investigate the degree of resorption based on the fibular height and the factors related to resorption over time. The influence of aspects of the intraoperative surgical procedure, such as preservation of a nutrient artery from the peroneal artery to the fibula bone marrow and the number of segmental osteotomies, has not been examined previously. Therefore, the purpose of this study was to examine the change in fibular height and the factors influencing resorption, including those associated with the surgical procedure. Patients and Methods: A retrospective analysis was performed in 19 patients who underwent free vascularized fibular mandibular reconstruction for oncologic surgical defects without radiotherapy. Postoperative Panorex examinations were used to evaluate fibular height, and 7 factors with a potential influence on long-term fibular height were evaluated: age, gender, length of the mandible defect, number of segmental osteotomies, preservation of a direct nutrient artery from the peroneal artery to the fibula bone marrow, length of follow-up, and delayed placement of osseointegrated dental implants. Results: Fibular bone height decreased in 13 patients (68%), was unchanged in 2 (11%), and increased in 4 (21%). Segmental osteotomies and female gender were significant factors promoting fibular bone resorption (P< 0.001 and P< 0.001, respectively), and preservation of a nutrient artery to the bone marrow, male gender, and delayed placement of osseointegrated dental implants were significant factors inhibiting bone resorption (P< 0.01, P< 0.001, and P< 0.05, respectively). Age, length of follow-up period, and length of the mandibular defect showed no significant relationship with bone resorption (P = 0.77, P = 0.78, and P = 0.105, respectively). Conclusion: The results of this study showed that fibular height in mandibular reconstruction can be maintained by preservation of a direct nutrient artery to bone marrow, avoidance of osteotomies, and delayed placement of osseointegrated dental implants, all of which inhibit fibular bone resorption.	[Makiguchi, Takaya; Yokoo, Satoshi; Miyazaki, Hidetaka] Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, Maebashi, Gunma 3718511, Japan; [Hashikawa, Kazunobu; Terashi, Hiroto] Kobe Univ, Grad Sch Med, Dept Plast Surg, Kobe, Hyogo 657, Japan	Makiguchi, T (reprint author), Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	takayamakiguchi@gmail.com					WEI FC, 1994, PLAST RECONSTR SURG, V93, P294, DOI 10.1097/00006534-199402000-00009; Hidalgo DA, 2002, PLAST RECONSTR SURG, V110, P438, DOI 10.1097/00006534-200208000-00010; Sieg P, 2002, BRIT J ORAL MAX SURG, V40, P322, DOI 10.1016/S0266-4356(02)00134-1; Disa JJ, 1999, PLAST RECONSTR SURG, V103, P1371, DOI 10.1097/00006534-199904050-00005; Disa JJ, 1997, AM J SURG, V174, P503; El-Gammal TA, 2002, MICROSURG, V22, P367, DOI 10.1002/micr.10066; Ferri J, 1997, J ORAL MAXILLOFAC SU, V55, P448; Ferri J, 1997, J ORAL MAXIL SURG, V55, P440, DOI 10.1016/S0278-2391(97)90685-6; HIDALGO DA, 1989, PLAST RECONSTR SURG, V84, P71, DOI 10.1097/00006534-198907000-00014; Hölzle Frank, 2007, Plast Reconstr Surg, V119, P151; JONES NF, 1988, PLAST RECONSTR SURG, V81, P378, DOI 10.1097/00006534-198803000-00011; Levin Lawrence, 2003, Facial Plast Surg, V19, P87, DOI 10.1055/s-2003-39138; Mathes SJ, 1997, PRINCIPLES ANATOMY T, P1353; Schmelzeisen R, 1996, PLAST RECONSTR SURG, V97, P719, DOI 10.1097/00006534-199604000-00005; Siciliano S, 1998, J CRANIO MAXILL SURG, V26, P386, DOI 10.1016/S1010-5182(98)80072-3; Wei FC, 1994, PLAST RECONSTR SURG, V93, P305	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2015	26	3					673	676		10.1097/SCS.0000000000001509		4	Surgery	Surgery	CJ1IG	WOS:000355236700050		
J	Okumoto, T; Sakamoto, Y; Kondo, S; Ogata, H; Kishi, K; Yoshimura, Y				Okumoto, Takayuki; Sakamoto, Yoshiaki; Kondo, Suguru; Ogata, Hisao; Kishi, Kazuo; Yoshimura, Yohko			Salt as a New Colored Solid Model for Simulation Surgery	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Solid model; simulation surgery; salt; craniomaxillofacial surgery; distraction osteogenesis; hemifacial microsomia	DISTRACTION OSTEOGENESIS; HEMIFACIAL MICROSOMIA; STEREOLITHOGRAPHY; ACCURACY; BONE	Background: Simulated craniomaxillofacial surgery is critical for planning the procedure, shortening operative time, and practicing the procedure. However, typical models are expensive, given their solid materials, and the surgical sensations do not accurately reflect the procedure performed using human bone. To solve these problems, a new solid salt model has been developed. Method: Stereolithography data was generated using computed tomography data, and a salt model was created using a 3D inkjet printer. By extracting specific data for elements such as the teeth and mandibular canal, these elements were highlighted in the solid model using different colored material. Also, we compared the maximum load and plastic deformation of the salt model, a stereolithographic resin model, and a pig limb. Result: The salt model had similar tenacity to bone, and the risk of damage to the teeth and inferior alveolar nerve was easily confirmed. Conclusion: The material cost of the salt model is extremely low, and the salt model may provide a more accurate sensation of cutting human bone. Thus, this model is useful for both simulated operation and practice for inexperienced surgeons.	[Okumoto, Takayuki; Kondo, Suguru; Yoshimura, Yohko] Fujita Hlth Univ, Sch Med, Dept Plast & Reconstruct Surg, Aichi, Japan; [Sakamoto, Yoshiaki; Ogata, Hisao; Kishi, Kazuo] Keio Univ, Dept Plast & Reconstruct Surg, Sch Med, Tokyo 1608582, Japan	Sakamoto, Y (reprint author), Keio Univ, Dept Plast & Reconstruct Surg, Sch Med, 35 Shinanomachi, Tokyo 1608582, Japan.	ysakamoto@z8.keio.jp			Sony EMCS; Tomita Pharmaceutical	The authors would like to thank Sony EMCS and Tomita Pharmaceutical for their support.	Waran V, 2014, J NEUROSURG, V120, P489, DOI 10.3171/2013.11.JNS131066; Brown GA, 2002, J ORTHOP TRAUMA, V16, P347, DOI 10.1097/00005131-200205000-00010; Watzinger F, 1997, J CRANIO MAXILL SURG, V25, P198, DOI 10.1016/S1010-5182(97)80076-5; Sakamoto Y, 2013, CLEFT PALATE-CRAN J, V50, P623, DOI 10.1597/11-264; Chang PSH, 2003, J CRANIOFAC SURG, V14, P164, DOI 10.1097/00001665-200303000-00006; Fujino Toyomi, 1993, Keio Journal of Medicine, V42, P104; Gateno J, 2000, J ORAL MAXIL SURG, V58, P985, DOI 10.1053/joms.2000.8740; KOBAYASHI M, 1993, EUR J PLAST SURG, V16, P47; LAMBRECHT JT, 1995, DENTOMAXILLOFAC RAD, V24, P147; Mutoh Tatsushi, 2010, Surg Neurol Int, V1, P74, DOI 10.4103/2152-7806.72626; NAKAJIMA T, 1995, PLAST RECONSTR SURG, V96, P1020, DOI 10.1097/00006534-199510000-00003; Ogata H, 2012, J CRANIOFAC SURG, V23, P1362, DOI 10.1097/SCS.0b013e31824e648d	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2015	26	3					680	681		10.1097/SCS.0000000000001539		2	Surgery	Surgery	CJ1IG	WOS:000355236700052		
J	Iwai, T; Omura, S; Aoki, N; Tohnai, I				Iwai, Toshinori; Omura, Susumu; Aoki, Noriaki; Tohnai, Iwai			Use of Self-Tapping Metal Screws for Temporary Fixation of a Resorbable Plate System in Maxillofacial Surgery	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Resorbable plate system; maxillofacial surgery; self-tapping metal screw; temporary fixation		Resorbable plate systems have been used in maxillofacial surgery to obviate the need for plate removal. However, resorbable plates and screws are very costly, and refixation with additional screws may be necessary when reduction or repositioning of the bone segment is inaccurate. Here we report the use of self-tapping metal screws for temporary fixation of a resorbable plating system in maxillofacial surgery to avoid the use of additional screws following inaccurate fixation or the reuse of resorbable screws, which may result in loosening.	[Iwai, Toshinori; Tohnai, Iwai] Yokohama City Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa 232, Japan; [Omura, Susumu] Yokohama City Univ, Med Ctr, Dept Oral & Maxillofacial Surg Orthodont, Yokohama, Kanagawa 232, Japan; [Aoki, Noriaki] Saiseikai Yokohamashi Nanbu Hosp, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa, Japan	Iwai, T (reprint author), 3-9 Fukuura,Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan.	iwai104oams@yahoo.co.jp					Eppley BL, 2005, J ORAL MAXIL SURG, V63, P385, DOI 10.1016/j.joms.2004.11.011; Eppley BL, 2007, J CRANIOFAC SURG, V18, P818, DOI 10.1097/scs.0b013e3180684933; Kim CY, 2011, J CRANIOFAC SURG, V22, P1215, DOI 10.1097/SCS.0b013e31821c0d84	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2015	26	3					891	892		10.1097/SCS.0000000000001415		2	Surgery	Surgery	CJ1IG	WOS:000355236700100		
J	Omura, S; Iwai, T; Honda, K; Shibutani, N; Fujita, K; Yamashita, Y; Takasu, H; Murata, S; Tohnai, I				Omura, Susumu; Iwai, Toshinori; Honda, Koji; Shibutani, Naoki; Fujita, Koichi; Yamashita, Yosuke; Takasu, Hikaru; Murata, Shogo; Tohnai, Iwai			Vital Staining of Palatal Soft Tissue in Horseshoe Le Fort I Osteotomy for Superior Repositioning of the Maxilla	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Orthognathic surgery; superior repositioning; Le Fort I osteotomy; horseshoe Le Fort I osteotomy; vital staining	ALVEOLAR OSTEOTOMY; COMPLICATIONS; LIGATION; SURGERY; ARTERY	In maxillary orthognathic surgery, superior repositioning of the maxilla is sometimes difficult, and removal of the bony interference, especially around the descending palatine artery, is very time-consuming in cases of severe maxillary impaction. A useful method introduced for superior repositioning of the maxilla is horseshoe-shaped osteotomy combined with Le Fort I osteotomy (horseshoe Le Fort I osteotomy). However, injury to the palatal soft tissue during horseshoe-shaped osteotomy may cause aseptic complications of the maxilla. Therefore, a safe method is required to prevent such injury to reduce the risk for aseptic necrosis. We describe here vital staining of palatal soft tissue in horseshoe Le Fort I osteotomy for safer superior repositioning of the maxilla.	[Omura, Susumu; Shibutani, Naoki; Fujita, Koichi; Yamashita, Yosuke; Takasu, Hikaru; Murata, Shogo] Yokohama City Univ, Med Ctr, Dept Oral & Maxillofacial Surg Orthodont, Yokohama, Kanagawa 2360004, Japan; [Iwai, Toshinori; Honda, Koji; Tohnai, Iwai] Yokohama City Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa 2360004, Japan	Iwai, T (reprint author), Yokohama City Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	iwai104oams@yahoo.co.jp					Siebert JW, 1997, PLAST RECONSTR SURG, V100, P843, DOI 10.1097/00006534-199709001-00004; Gauthier A, 2002, SURG RADIOL ANAT, V24, P13, DOI 10.1007/s00276-002-0012-y; BELL WH, 1977, ORAL SURG ORAL MED O, V44, P493, DOI 10.1016/0030-4220(77)90292-4; Bell WH, 1980, SURG CORRECTION DENT; VANOTTERLOO JJD, 1991, J CRANIO MAXILL SURG, V19, P217; Santos TD, 2012, J CRANIOFAC SURG, V23, pE423, DOI 10.1097/SCS.0b013e31825e49c1; Dodson TB, 1997, J ORAL MAXIL SURG, V55, P51, DOI 10.1016/S0278-2391(97)90446-8; HALL HD, 1975, J ORAL SURG, V33, P180; Harada K, 2002, EUR J ORTHODONT, V24, P471, DOI 10.1093/ejo/24.5.471; Harada K, 2004, ORAL SURG ORAL MED O, V97, P12, DOI 10.1016/j.tripleo.2003.08.028; Ho MW, 2011, BRIT J ORAL MAX SURG, V49, P562, DOI 10.1016/j.bjoms.2010.09.018; Kramer FJ, 2004, J CRANIOFAC SURG, V15, P971, DOI 10.1097/00001665-200411000-00016; Lanigan DT, 1997, J ORAL MAXIL SURG, V55, P1502, DOI 10.1016/S0278-2391(97)90676-5; LANIGAN DT, 1990, J ORAL MAXIL SURG, V48, P142; Shimazaki K, 2014, ANGLE ORTHOD, V84, P374, DOI 10.2319/050513-344.1; Shimo T, 2013, ACTA MED OKAYAMA, V67, P55; WOLFORD LM, 1975, J ORAL SURG, V33, P842; Yoshioka I, 2009, INT J ORAL MAX SURG, V38, P1250, DOI 10.1016/j.ijom.2009.07.003	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2015	26	3					911	913		10.1097/SCS.0000000000001420		3	Surgery	Surgery	CJ1IG	WOS:000355236700105		
J	Maeda, T; Oyama, A; Funayama, E; Furukawa, H; Cho, K; Yamamoto, Y				Maeda, Taku; Oyama, Akihiko; Funayama, Emi; Furukawa, Hiroshi; Cho, Kazutoshi; Yamamoto, Yuhei			Successful Conservative Management of a Large Congenital Scalp and Skull Defect	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Large scalp and skull defects; cleft palate; conservative treatment; Safetac technology; Mepilex Transfer	APLASIA-CUTIS-CONGENITA; SAGITTAL SINUS HEMORRHAGE; SURGICAL-MANAGEMENT; CLASSIFICATION; AGENESIS; BONES; DURA	The authors report a case of a female baby born with large congenital scalp and skull defects with exposure of the cranial arachnoid mater. The female patient was delivered by Caesarean section following diagnosis of a large cranial skin defect by ultrasound. The skin defect was present at the time of birth, measured 8.5 cm x 8.0 cm, and involved the full thickness of the cranium. The cranial arachnoid mater was exposed and veins running on the surface of the brain were observed. There was no means to cover the large defect surgically and conservative treatment was initiated. Complete epithelialization of the scalp defect was acquired without fatal problems. In the course of treatment, Mepilex Transfer was very effective. The repair of congenital defects of the scalp and skull is a major challenge not only because of the rarity but also because of severe morbidity. A surgical or conservative approach is chosen according to the situation. This rare case highlights two important clinical issues: that the congenital defects of the scalp and skull could not be managed with a surgical approach and in its place, a conservative approach using the special dressing Mepilex Transfer proved highly effective.	[Maeda, Taku; Oyama, Akihiko; Funayama, Emi; Furukawa, Hiroshi; Yamamoto, Yuhei] Hokkaido Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Sapporo, Hokkaido, Japan; [Cho, Kazutoshi] Hokkaido Univ, Grad Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan	Maeda, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kita Ku, 106 Nishi 7 Chome,Kita 15 Jo, Sapporo, Hokkaido, Japan.	takumaeda1105@yellow.plala.or.jp					FRIEDEN IJ, 1986, J AM ACAD DERMATOL, V14, P646, DOI 10.1016/S0190-9622(86)70082-0; Saraiya HA, 2002, BRIT J PLAST SURG, V55, P707, DOI 10.1054/bjps.2002.3963; ARGENTA LC, 1986, PLAST RECONSTR SURG, V77, P650, DOI 10.1097/00006534-198604000-00026; Basterzi Y, 2007, J CRANIOFAC SURG, V18, P427; de Oliveira RS, 2006, CHILD NERV SYST, V22, P1072, DOI 10.1007/s00381-006-0074-y; HOBAR PC, 1993, PLAST RECONSTR SURG, V92, P405; JONES EM, 1992, PEDIATR DERMATOL, V9, P293, DOI 10.1111/j.1525-1470.1992.tb00351.x; Kim CS, 2001, ARCH OTOLARYNGOL, V127, P71; Kinoshita O, 2010, J ARTIF ORGANS, V13, P126, DOI 10.1007/s10047-010-0500-5; LEBOUCQ N, 1994, NEURORADIOLOGY, V36, P480; MUAKKASSA KF, 1982, J NEUROSURG, V56, P711, DOI 10.3171/jns.1982.56.5.0711; Perlyn CA, 2005, PLAST RECONSTR SURG, V115, P1129, DOI 10.1097/01.PRS.0000156217.33683.2B; SCHNEIDER BM, 1980, PEDIATRICS, V66, P948; SELA M, 1979, J NEUROSURG, V50, P674, DOI 10.3171/jns.1979.50.5.0674; Sharma AK, 2001, PEDIATR SURG INT, V17, P452, DOI 10.1007/s003830000511; VINOCUR CD, 1976, ARCH SURG-CHICAGO, V111, P1160	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2015	26	3					E275	E277		10.1097/SCS.0000000000001798		3	Surgery	Surgery	CJ1IG	WOS:000355236700031		
J	Takahashi, Y; Miyazaki, H; Chan, W; Kakizaki, H				Takahashi, Yasuhiro; Miyazaki, Hidetaka; Chan, WengOnn; Kakizaki, Hirohiko			Lower Eyelid Reconstruction for Iatrogenic Eyelid-to-Globe Malposition	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Ear cartilage; eyelid-to-globe malposition; lateral periosteal sling procedure; lower eyelid ectropion; medial tarsal strip procedure	TARSAL STRIP; PLICATION	An 86-year-old man with iatrogenic eyelid-to-globe malposition had a combination of medial tarsal strip, lateral periosteal sling, and inferior tarsal support with the ear cartilage. An appropriate apposition between the globe and lower eyelid was established post-operatively with good tear meniscus and acceptable cosmetic results.	[Takahashi, Yasuhiro; Kakizaki, Hirohiko] Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi 4801195, Japan; [Miyazaki, Hidetaka] Gunma Univ, Grad Sch Med, Dept Stomatol & Oral Surg, Gunma, Japan; [Chan, WengOnn] Univ Adelaide, South Australian Inst Ophthalmol, Adelaide, SA 5005, Australia; [Chan, WengOnn] Univ Adelaide, Discipline Ophthalmol & Visual Sci, Adelaide, SA 5005, Australia	Kakizaki, H (reprint author), Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi 4801195, Japan.	cosme@d1.dion.ne.jp					Kakizaki H, 2008, OPHTHAL PLAST RECONS, V24, P126, DOI 10.1097/IOP.0b013e3181647cb2; ANDERSON RL, 1979, ARCH OPHTHALMOL-CHIC, V97, P2192; Maloof A, 2001, OPHTHALMIC PLAST REC, V17, P96, DOI 10.1097/00002341-200103000-00004; Demirci H, 2007, OPHTHAL PLAST RECONS, V23, P384, DOI 10.1097/IOP.0b013e3181469e3c; Elner Victor M, 2003, Arch Facial Plast Surg, V5, P427, DOI 10.1001/archfaci.5.5.427; Fante RG, 2001, OPHTHALMIC PLAST REC, V17, P16, DOI 10.1097/00002341-200101000-00004; JORDAN DR, 1990, ARCH OPHTHALMOL-CHIC, V108, P120; Kakizaki H, 2009, ANN PLAS SURG, V63, P344, DOI 10.1097/SAP.0b013e31818c4b22; Kakizaki Hirohiko, 2007, Clin Ophthalmol, V1, P141; Smith B, 1970, OCULOPLASTIC SURG, P92	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2015	26	3					E268	E270		10.1097/SCS.0000000000001772		3	Surgery	Surgery	CJ1IG	WOS:000355236700028		
J	Zhao, MZ; Liu, XY; Ding, Y; Sugie, A; Kobata, H; Liu, WD				Zhao, Ming-Zhu; Liu, Xiang-Yang; Ding, Yong; Sugie, Akira; Kobata, Hitoshi; Liu, Wei-Dong			Surgical Repair of Lacerated Anterior Cerebral Artery Presented With Massive Intracerebral Hemorrhage	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Anterior cerebral artery; direct surgery; massive cerebral hemorrhage; traumatic brain injury; traumatic pseudoaneurysm	PERICALLOSAL ARTERY; ENDOVASCULAR MANAGEMENT; TRAUMATIC ANEURYSM; HEAD TRAUMA; PSEUDOANEURYSM; PATIENT; RUPTURE	Objective and Importance: Traumatic intracranial aneurysms present diagnostic and therapeutic challenges. Owing to their fragile nature, endovascular intervention has become the first-line treatment; however, direct surgery has an advantage in certain cases. Clinical Presentation: A 34-year-old man in coma was admitted after a motor vehicle accident. Brain computed tomographic scans revealed deep bifrontal, left intraventricular, and subarachnoid hemorrhages. Three-dimensional computed tomographic angiography and digital subtraction angiography revealed an aneurysm arising from the left pericallosal artery. Intervention: A massive intracerebral hematoma prompted us to perform emergency surgical intervention. We immediately removed the hematoma and extirpated the aneurysm. After hematoma evacuation via the interhemispheric approach, a pulsating red sphere projecting from the pericallosal artery, with no obvious solid wall or neck, was encountered. While retracting the frontal lobe, it suddenly ruptured. Under temporary trapping of the parent artery, the point of bleeding was identified. No aneurysm wall or fibrous tissue was present, whereas a 1.5-mm laceration was observed at the pericallosal artery close to its branching point. The laceration was sutured with 10-0 nylon. Postoperative digital subtraction angiography confirmed patency of the pericallosal artery. Conclusions: Although recent technologic advances of intravascular surgery have enabled successful treatment of traumatic pseudoaneurysms, open surgical intervention still has some advantages of providing definitive hemostasis, allowing for parent artery reconstruction, and facilitating mass reduction. The case in the current study was quite unusual in that angiographic aneurysm had disrupted easily, leaving arterial laceration. This finding implies the probability of unavoidable parent artery occlusion when endovascular treatment is applied.	[Zhao, Ming-Zhu; Liu, Xiang-Yang; Ding, Yong; Liu, Wei-Dong] Pu Nan Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Zhao, Ming-Zhu; Liu, Xiang-Yang; Sugie, Akira; Kobata, Hitoshi] Mishima Emergency & Crit Care Med Ctr, Dept Neurosurg, Osaka, Japan	Liu, WD (reprint author), Pu Nan Hosp, Dept Neurosurg, 519 Nan Ma Tou Rd, Shanghai, Peoples R China.	13601812220@163.com					Amagasa M, 1987, SURG CEREB STROKE, V15, P205; Cummings TJ, 2000, NEUROL RES, V22, P165; Asari S, J NEUROSURG, V46, P795; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; Cohen JE, 2005, J NEUROSURG, V102, P555, DOI 10.3171/jns.2005.102.3.0555; Cohen JE, 2008, NEUROSURGERY, V63, P476, DOI 10.1227/01.NEU.0000324995.57376.79; Dunn IF, 2007, J NEUROSURG, V106, P153, DOI 10.3171/ped.2007.106.2.153; Egashira Y, 2005, JPN J NEUROSURG TOKY, V14, P635; Horowitz M, 2005, NEUROSURGERY, V57, P374, DOI 10.1227/01.NEU.0000168016.02106.0C; Hsieh CT, 2007, J CLIN NEUROSCI, V14, P1120, DOI 10.1016/j.jocn.2006.03.014; Komiyama M, 2001, NEUROL MED-CHIR, V41, P264, DOI 10.2176/nmc.41.264; Larson PS, 2000, NEUROSURG FOCUS, V8, P1, DOI 10.3171/foc.2000.8.1.1829; Medel R, 2009, J NEUROS-PEDIATR, V4, P445, DOI 10.3171/2009.6.PEDS09104; OPESKIN K, 1995, AM J FOREN MED PATH, V16, P11, DOI 10.1097/00000433-199503000-00002; Sasaoka Y, 1997, NEUROL SURG TOKYO, V25, P337; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; Sim SY, 2008, SURG NEUROL, V69, P418, DOI 10.1016/j.surneu.2007.02.042; Tokuno T, 1994, SHINKEI GEKA, V11, P1073; Yang TC, 2007, EUR NEUROL, V58, P239, DOI 10.1159/000107970; YOKOTA H, 1983, Neurological Surgery, V11, P521; YUGE T, 1990, Neurologia Medico-Chirurgica, V30, P412, DOI 10.2176/nmc.30.412	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2015	26	3					E270	E272		10.1097/SCS.0000000000001330		3	Surgery	Surgery	CJ1IG	WOS:000355236700029		
J	Hashiguchi, Y; Lee, JM; Shiraishi, M; Komatsu, S; Miki, S; Shimasaki, Y; Mochioka, N; Kusakabe, T; Oshima, Y				Hashiguchi, Y.; Lee, J. M.; Shiraishi, M.; Komatsu, S.; Miki, S.; Shimasaki, Y.; Mochioka, N.; Kusakabe, T.; Oshima, Y.			Characterization and evolutionary analysis of tributyltin-binding protein and pufferfish saxitoxin and tetrodotoxin-binding protein genes in toxic and nontoxic pufferfishes	JOURNAL OF EVOLUTIONARY BIOLOGY			English	Article						concerted evolution; gene duplication; lipocalin; molecular evolution; neofunctionalization; pufferfish saxitoxin and tetrodotoxin-binding protein; Tetraodontidae; tributyltin-binding protein	DETECTING POSITIVE SELECTION; TAKIFUGU-RUBRIPES; PARALICHTHYS-OLIVACEUS; JAPANESE FLOUNDER; ALPHA-1-ACID GLYCOPROTEIN; TIGER PUFFER; PURIFICATION; FISH; PLASMA; NEOFUNCTIONALIZATION	Understanding the evolutionary mechanisms of toxin accumulation in pufferfishes has been long-standing problem in toxicology and evolutionary biology. Pufferfish saxitoxin and tetrodotoxin-binding protein (PSTBP) is involved in the transport and accumulation of tetrodotoxin and is one of the most intriguing proteins related to the toxicity of pufferfishes. PSTBPs are fusion proteins consisting of two tandem repeated tributyltin-binding protein type 2 (TBT-bp2) domains. In this study, we examined the evolutionary dynamics of TBT-bp2 and PSTBP genes to understand the evolution of toxin accumulation in pufferfishes. Database searches and/or PCR-based cDNA cloning in nine pufferfish species (6 toxic and 3 nontoxic) revealed that all species possessed one or more TBT-bp2 genes, but PSTBP genes were found only in 5 toxic species belonging to genus Takifugu. These toxic Takifugu species possessed two or three copies of PSTBP genes. Phylogenetic analysis of TBT-bp2 and PSTBP genes suggested that PSTBPs evolved in the common ancestor of Takifugu species by repeated duplications and fusions of TBT-bp2 genes. In addition, a detailed comparison of Takifugu TBT-bp2 andPSTBP gene sequences detected a signature of positive selection underthe pressure of gene conversion. The complicated evolutionary dynamics of TBT-bp2 and PSTBP genes may reflect the diversity of toxicity in pufferfishes.	[Hashiguchi, Y.] Osaka Med Coll, Dept Biol, Takatsuki, Osaka 569, Japan; [Lee, J. M.; Kusakabe, T.] Kyushu Univ, Fac Agr, Lab Silkworm Sci, Fukuoka 812, Japan; [Shiraishi, M.; Komatsu, S.; Miki, S.; Shimasaki, Y.; Oshima, Y.] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Lab Marine Environm Sci, Fukuoka 812, Japan; [Mochioka, N.] Kyushu Univ, Fac Agr, Lab Bioresource Sci, Fukuoka 812, Japan	Hashiguchi, Y (reprint author), Daigaku Machi 2-7, Takatsuki, Osaka 5698686, Japan.	bio007@art.osaka-med.ac.jp			MEXT/JSPS KAKENHI [23380125, 22770236, 25840145]	We are grateful to two anonymous referees for helpful comments that improved the manuscript substantially. This work was supported by MEXT/JSPS KAKENHI Grant Numbers 23380125 to YO, and 22770236 and 25840145 to YH.	Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Caley MJ, 2003, P ROY SOC B-BIOL SCI, V270, P667, DOI 10.1098/rspb.2002.2263; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Yotsu-Yamashita M, 2001, EUR J BIOCHEM, V268, P5937, DOI 10.1046/j.0014-2956.2001.02547.x; Nakamura O, 2009, COMP BIOCHEM PHYS A, V153, P222, DOI 10.1016/j.cbpa.2009.02.018; Noguchi T, 2008, MAR DRUGS, V6, P220, DOI 10.3390/md20080011; Yamanoue Y, 2009, MOL BIOL EVOL, V26, P623, DOI 10.1093/molbev/msn283; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315; Shimasaki Y, 2002, ENVIRON TOXICOL CHEM, V21, P1229, DOI 10.1897/1551-5028(2002)021<1229:PAIOAT>2.0.CO;2; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; Santini F, 2013, J EVOLUTION BIOL, V26, P1003, DOI 10.1111/jeb.12112; Ritson-Williams R, 2006, P NATL ACAD SCI USA, V103, P3176, DOI 10.1073/pnas.0506093103; MATSUMURA K, 1995, NATURE, V378, P563, DOI 10.1038/378563b0; Oba Y, 2007, J BIOCHEM, V142, P229, DOI 10.1093/jb/mvm119; Casewell NR, 2011, MOL BIOL EVOL, V28, P2637, DOI 10.1093/molbev/msr091; Yotsu-Yamashita M, 2013, TOXICON, V72, P23, DOI 10.1016/j.toxicon.2013.06.002; Casewell NR, 2013, TRENDS ECOL EVOL, V28, P219, DOI 10.1016/j.tree.2012.10.020; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Satone H, 2011, AQUAT TOXICOL, V103, P79, DOI 10.1016/j.aquatox.2011.02.009; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Feroudj H, 2014, TOXICON, V77, P68, DOI 10.1016/j.toxicon.2013.10.030; Graur D., 2000, FUNDAMENTALS MOL EVO; Gutierrez G, 2000, BBA-PROTEIN STRUCT M, V1482, P35, DOI 10.1016/S0167-4838(00)00151-5; HWANG DF, 1990, TOXICON, V28, P1133, DOI 10.1016/0041-0101(90)90113-L; Osada N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000305; Jansa SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020997; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KODAMA M, 1986, TOXICON, V24, P819, DOI 10.1016/0041-0101(86)90107-8; Kosakovsky P. S. L., 2011, MOL BIOL EVOL, V28, P3033, DOI DOI 10.1093/M0LBEV/MSR125; Kosakovsky PSL, 2006, MOL BIOL EVOL, V23, P1891, DOI DOI 10.1093/MOLBEV/MSL051; Lee J. H., 2007, TOXICON, V49, P393; Machnes Z, 2008, HORM BEHAV, V54, P442, DOI 10.1016/j.yhbeh.2008.03.014; Matsumoto T, 2011, TOXICON, V57, P304, DOI 10.1016/j.toxicon.2010.12.007; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nassef M, 2011, MAR POLLUT BULL, V62, P412, DOI 10.1016/j.marpolbul.2010.12.005; Nelson JS, 2006, FISHES WORLD; Oba Y, 2011, COMP BIOCHEM PHYS C, V153, P17, DOI 10.1016/j.cbpc.2010.07.009; Ohno S., 1970, EVOLUTION GENE DUPLI; Satone H, 2008, AQUAT TOXICOL, V90, P292, DOI 10.1016/j.aquatox.2008.08.019; Sawyer S.A., 1999, GENECONV COMPUTER PA; Shimizu D, 2007, NIPPON SUISAN GAKK, V73, P461, DOI 10.2331/suisan.73.461; Soong W. T., 2006, TRENDS GENET, V22, P621; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Tatsuno R, 2013, BIOSCI BIOTECH BIOCH, V77, P208, DOI 10.1271/bbb.120701; Teshima KM, 2008, GENETICS, V178, P1385, DOI 10.1534/genetics.107.082933; THUESEN EV, 1988, J EXP MAR BIOL ECOL, V116, P249, DOI 10.1016/0022-0981(88)90030-5; Venkatesh B, 2005, CURR BIOL, V15, P2069, DOI 10.1016/j.cub.2005.10.068; Williams M. T., 2010, MAR DRUGS, V8, P381; Yamanoue Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017410; Yotsu-Yamashita M, 2010, TOXICON, V55, P1119, DOI 10.1016/j.toxicon.2009.12.021	54	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1010-061X	1420-9101		J EVOLUTION BIOL	J. Evol. Biol.	MAY	2015	28	5					1103	1118		10.1111/jeb.12634		16	Ecology; Evolutionary Biology; Genetics & Heredity	Environmental Sciences & Ecology; Evolutionary Biology; Genetics & Heredity	CI8HQ	WOS:000355012700011		
J	Badmaev, V; Hatakeyama, Y; Yamazaki, N; Noro, A; Mohamed, F; Ho, CT; Pan, MH				Badmaev, Vladimir; Hatakeyama, Yoshitaka; Yamazaki, Noriyuki; Noro, Akira; Mohamed, Faizal; Ho, Chi-Tang; Pan, Min-Hsiung			Preclinical and clinical effects of Coleus forskohlii, Salacia reticulata and Sesamum indicum modifying pancreatic lipase inhibition in vitro and reducing total body fat	JOURNAL OF FUNCTIONAL FOODS			English	Article						Coleus forskohlii; Salacia reticulata; Sesamum indicum; Pancreatic lipase; Body fat	EXTRACTS; DIET	The herbal composition of Coleus forskohlii, Salacia reticulata, and Sesamum indicum, standardized for forskolin, mangiferin, and sesamin, respectively, were shown, in vitro, to inhibit pancreatic lipase with differing degrees and dynamics. In the placebo controlled six weeks clinical study the daily intake of 1000 mg C. forskohlii stand-alone standardized for 10% forskolin, showed statistically significant lowering of total body fat vs. baseline and placebo group (p <0.05). The computerized tomography showed decrease of total body fat and visceral fat in C.forskohlii group in comparison to the baseline. The potential of three herbal extracts preventing dietary fat absorption was emphasized by the in vitro synergy between C. forskohlii and S. reticulata inhibiting pancreatic lipase at higher rate than the fat-blocking activity generated by each component alone. The in vitro addition of S. indicum to the formula was found to synergistically assist inhibition of the pancreatic lipase in a lower dose range, while moderating the pancreatic lipase inhibition in a higher dose range. This dual mechanism of S. indicum was postulated as a safety mechanism preventing any potential side effects resulting from excessive inhibition of pancreatic lipase activity. (C) 2015 Elsevier Ltd. All rights reserved.	[Badmaev, Vladimir] Amer Med Holdings Inc, New York, NY 10314 USA; [Hatakeyama, Yoshitaka; Yamazaki, Noriyuki; Noro, Akira] New Drug Res Ctr Inc, Eniwa, Hokkaido, Japan; [Mohamed, Faizal] Bio Act Japan KK, Tokyo, Japan; [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Pan, Min-Hsiung] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10617, Taiwan; [Pan, Min-Hsiung] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan; [Pan, Min-Hsiung] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan	Pan, MH (reprint author), Natl Taiwan Univ, Inst Food Sci & Technol, 1 Roosevelt Rd,Sect 4, Taipei 10617, Taiwan.	mhpan@ntu.edu.tw			National Taiwan University [NTU-102R7777]; National Science Council Taiwan [NSC 101-2628-B-022-001-MY4, 102-2628-B-002-053-MY3]	This study was supported by the National Taiwan University NTU-102R7777; National Science Council Taiwan NSC 101-2628-B-022-001-MY4, 102-2628-B-002-053-MY3.	Angulo P., 2002, J GASTROENTEROLOG S1, V1, P86; Filippatos TD, 2008, DRUG SAFETY, V31, P53; Kerfelec B, 2008, PROTEINS, V73, P828, DOI 10.1002/prot.22109; Shivaprasad HN, 2013, J MED FOOD, V16, P564, DOI 10.1089/jmf.2013.2751; Lunder M, 2005, J LIPID RES, V46, P1512, DOI 10.1194/jlr.M500048-JLR200; Ellrichmann M, 2008, J CLIN ENDOCR METAB, V93, P3995, DOI 10.1210/jc.2008-0924; Wu YHS, 2013, J FUNCT FOODS, V5, P923, DOI 10.1016/j.jff.2013.02.002; Sung YY, 2014, J FUNCT FOODS, V6, P428, DOI 10.1016/j.jff.2013.11.009; Chen QP, 2014, J FUNCT FOODS, V9, P148, DOI 10.1016/j.jff.2014.03.034; Godard MP, 2005, OBES RES, V13, P1335, DOI 10.1038/oby.2005.162; Lee EM, 2010, MOLECULES, V15, P8251, DOI 10.3390/molecules15118251; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Badmaev V., 2002, NutraCos, V1, P6; FDA, 2010, FDA DRUG SAF COMM CO; Mirmiran Parvin, 2013, Arch Iran Med, V16, P651, DOI 0131611/AIM.008	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1756-4646			J FUNCT FOODS	J. Funct. Food.	MAY	2015	15						44	51		10.1016/j.jff.2015.03.007		8	Food Science & Technology	Food Science & Technology	CJ1JV	WOS:000355240800005		
J	Kobori, M; Takahashi, Y; Akimoto, Y; Sakurai, M; Matsunaga, I; Nishimuro, H; Ippoushi, K; Oike, H; Ohnishi-Kameyama, M				Kobori, Masuko; Takahashi, Yumiko; Akimoto, Yukari; Sakurai, Mutsumi; Matsunaga, Izumi; Nishimuro, Haruno; Ippoushi, Katsunari; Oike, Hideaki; Ohnishi-Kameyama, Mayumi			Chronic high intake of quercetin reduces oxidative stress and induces expression of the antioxidant enzymes in the liver and visceral adipose tissues in mice	JOURNAL OF FUNCTIONAL FOODS			English	Article						Quercetin; Antioxidant enzymes; Nuclear factor E2-related factor 2; Malondialdehyde; Oxidative stress	HEPATIC GENE-EXPRESSION; METABOLIC SYNDROME; IN-VIVO; CARDIOVASCULAR-DISEASE; FLAVONOID INTAKE; OXIDANT STRESS; OBESITY; RATS; IDENTIFICATION; VARIETIES	To obtain knowledge regarding the safe intake of quercetin-rich functional foods, we examined the effect of chronic and high intake of quercetin. We fed mice a standard diet containing 0.05 or 1% quercetin for 20 weeks. Both quercetin diets did not significantly affect the body weight, fat accumulation, and blood components. However, 0.05% quercetin significantly increased the glutathione/oxidized glutathione ratio in the liver. The 1% quercetin diet reduced the lipid peroxidation marker malondialdehyde in the liver, epididymal adipose tissues, and small intestine. The 1% quercetin diet significantly induced the expression of the antioxidant enzymes Gpx1, Cat, and Sod1 in the liver and Gpx1 and Cat in the epididymal adipose tissues. The transcription factor nuclear factor E2-related factor 2 (Nrf2) was slightly induced in the nuclear fraction of the livers of mice fed the 1% quercetin diet. Quercetin may induce antioxidant enzymes by activating the Nrf2 pathway in the liver. (C) 2015 Elsevier Ltd. All rights reserved.	[Kobori, Masuko; Takahashi, Yumiko; Akimoto, Yukari; Sakurai, Mutsumi; Matsunaga, Izumi; Nishimuro, Haruno; Ippoushi, Katsunari; Oike, Hideaki; Ohnishi-Kameyama, Mayumi] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Nishimuro, Haruno] Seitoku Univ, Matsudo, Chiba 2718555, Japan	Kobori, M (reprint author), Natl Agr & Food Res Org, Natl Food Res Inst, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	kobori@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries (MAFF); Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO); Ministry of Education, Culture, Sports, Science, and Technology, Japan [24501024]	This work was financially supported in part by a grant from the Ministry of Agriculture, Forestry and Fisheries (MAFF) research project for new demand creation of agricultural products, by a grant from the Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO), and by a grant-in-aid for Science Research (24501024) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Albishi T, 2013, J FUNCT FOODS, V5, P930, DOI 10.1016/j.jff.2013.02.005; Day AJ, 2001, FREE RADICAL RES, V35, P941, DOI 10.1080/10715760100301441; Giuliani C, 2014, FOOD CHEM TOXICOL, V66, P23, DOI 10.1016/j.fct.2014.01.016; Terao J, 2008, ASIA PAC J CLIN NUTR, V17, P291; Knekt P, 2002, AM J CLIN NUTR, V76, P560; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Kobori M, 2009, MOL NUTR FOOD RES, V53, P859, DOI 10.1002/mnfr.200800310; Vomhof-DeKrey EE, 2012, J NUTR BIOCHEM, V23, P1201, DOI 10.1016/j.jnutbio.2012.03.005; Kumashiro N, 2008, DIABETES, V57, P2083, DOI 10.2337/db08-0144; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI200421625]; Arai Y, 2000, J NUTR, V130, P2243; Fujita K, 2006, CIRC J, V70, P1437, DOI 10.1253/circj.70.1437; Chun OK, 2008, J NUTR, V138, P753; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Santos MR, 2008, BRIT J PHARMACOL, V153, P1750, DOI 10.1038/bjp.2008.46; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; Shen Y, 2013, FREE RADICAL BIO MED, V65, P908, DOI 10.1016/j.freeradbiomed.2013.08.185; Albishi T, 2013, J FUNCT FOODS, V5, P1191, DOI 10.1016/j.jff.2013.04.002; Rohn S, 2004, J AGR FOOD CHEM, V52, P4725, DOI 10.1021/jf0496797; Egert S, 2011, ADV NUTR, V2, P8, DOI [10.3945/an.110.000026., 10.3945/an.110.000026]; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Graf BA, 2006, J NUTR, V136, P39; Justino GC, 2004, ARCH BIOCHEM BIOPHYS, V432, P109, DOI 10.1016/j.abb.2004.09.007; Egert S, 2008, J NUTR, V138, P1615; Peterson JJ, 2012, NUTR REV, V70, P491, DOI 10.1111/j.1753-4887.2012.00508.x; Panchal SK, 2012, J NUTR, V142, P1026, DOI 10.3945/jn.111.157263; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S; Boesch-Saadatmandi C, 2012, PHARMACOL RES, V65, P523, DOI 10.1016/j.phrs.2012.02.007; Choi EJ, 2003, EUR J PHARMACOL, V482, P281, DOI 10.1016/j.ejphar.2003.09.067; Choi EJ, 2005, FOOD CHEM TOXICOL, V43, P793, DOI 10.1016/j.fct.2004.12.012; Hoek-van den Hil EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051588; Hollman PCH, 2011, J NUTR, V141, p989S, DOI 10.3945/jn.110.131490; Kawai Y, 2009, BIOSCI BIOTECH BIOCH, V73, P517, DOI 10.1271/bbb.80516; Kobori M, 2012, FOOD CHEM TOXICOL, V50, P2547, DOI 10.1016/j.fct.2012.04.017; Mennen LI, 2005, AM J CLIN NUTR, V81, p326S; Murota Kaeko, 2007, J Med Invest, V54, P370, DOI 10.2152/jmi.54.370; Nishimuro H, 2015, NUTRIENTS, V7, P2345, DOI 10.3390/nu7042345; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177; Wiczkowski W, 2014, J FUNCT FOODS, V11, P121, DOI 10.1016/j.jff.2014.09.013; Williamson G, 2005, AM J CLIN NUTR, V81, P243	43	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1756-4646			J FUNCT FOODS	J. Funct. Food.	MAY	2015	15						551	560		10.1016/j.jff.2015.04.006		10	Food Science & Technology	Food Science & Technology	CJ1JV	WOS:000355240800053		
J	Hayashi, D; Ueda, S; Yamanoue, M; Saito, N; Ashida, H; Shirai, Y				Hayashi, Daiki; Ueda, Shuji; Yamanoue, Minoru; Saito, Naoki; Ashida, Hitoshi; Shirai, Yasuhito			Epigallocatechin-3-gallate activates diacylglycerol kinase alpha via a 67 kDa laminin receptor: A possibility of galloylated catechins as functional food to prevent and/or improve diabetic renal dysfunctions	JOURNAL OF FUNCTIONAL FOODS			English	Article						Diacylglycerol kinase; 67 kDa laminin receptor; Catechin; Vitamin E; Diabetic renal dysfunction; Protein kinase C	SUBTYPE-SPECIFIC TRANSLOCATION; PANCREATIC-ISLETS; C ACTIVATION; PROTEIN; RATS; PHOSPHOLIPIDS; GLUCOSE; COMPLICATIONS; EXPRESSION; TOCOPHEROL	To develop a functional food for improvement and/or prevention of diabetic nephropathy, we investigated whether catechins can activate DGK alpha, which is involved in the vitamin E-induced improvement of diabetic renal dysfunction. Among the catechins tested, (-)-epicatechin-3-gallate, (-)-epigallocatechin-3-gallate (EGCg), (-)-catechin-3-gallate and (-)-gallocatechin-3-gallate induced DGKa translocation from the cytoplasm to the plasma membrane, which is an index of DGKa activation. In contrast, (-)-epicatechin, (-)epigallocatechin and gallic acid did not induce the translocation. Among the four galloylated catechins, EGCg was most effective, dose-dependent and subtype-specific among type I DGKs. Importantly, EGCg did indeed up-regulate DGK alpha activity. In addition, we found that a 67 kDa laminin receptor (67LR) mediates the EGCg-induced activation of DGKa, and both 67LR and DGK alpha; are expressed in podocyte among glomerular cells. Finally, the EGCg-induced translocation of DGKa was confirmed in cultured podocytes. Thus, EGCg activates DGKa via 67LR, providing the possibility that EGCg may improve and/or prevent diabetic renal dysfunction. (C) 2015 Elsevier Ltd. All rights reserved.	[Hayashi, Daiki; Ueda, Shuji; Yamanoue, Minoru; Shirai, Yasuhito] Kobe Univ, Fac Agr, Lab Chem & Utilizat Anim Prod Resources, Grad Sch Agr Sci, Kobe, Hyogo, Japan; [Saito, Naoki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo, Japan; [Ashida, Hitoshi] Kobe Univ, Fac Agr, Grad Sch Agr Sci, Lab Biochem Frontiers, Kobe, Hyogo, Japan	Shirai, Y (reprint author), Kobe Univ, Fac Agr, Lab Chem & Utilizat Anim Prod Resources, Grad Sch Agr Sci, Kobe, Hyogo, Japan.	shirai@kobe-u.ac.jp			Hyogo Science and Technology Association; Honjo International Scholarship Foundation	This work was supported in part by research grants by the Hyogo Science and Technology Association and the Honjo International Scholarship Foundation. We sincerely thank Dr. Tachibana at Kyusyu Univ. for giving us useful information about catechins and 67LR.	ANILKUMAR N, 1993, BIOCHEM MOL BIOL INT, V31, P201; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; BERNE C, 1975, BIOCHEM J, V152, P667; INOGUCHI T, 1992, P NATL ACAD SCI USA, V89, P11059, DOI 10.1073/pnas.89.22.11059; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.neuro.17.1.551; Koya D, 1997, J AM SOC NEPHROL, V8, P426; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Kumazoe M, 2013, J CLIN INVEST, V123, P787, DOI 10.1172/JCI64768; Chan CY, 2011, LIFE SCI, V89, P779, DOI 10.1016/j.lfs.2011.09.006; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Bao S., 2013, MOL NUTR FOOD RES, V58, P677; Budhiraja S, 2008, FUND CLIN PHARMACOL, V22, P231, DOI 10.1111/j.1472-8206.2008.00583.x; Craven A. P., 1990, DIABETES, V47, P667; CRAVEN PA, 1989, J CLIN INVEST, V83, P1667, DOI 10.1172/JCI114066; DUNLOP ME, 1985, BIOCHEM BIOPH RES CO, V132, P467, DOI 10.1016/0006-291X(85)91157-X; Fujimura Y, 2008, ARCH BIOCHEM BIOPHYS, V476, P133, DOI 10.1016/j.abb.2008.03.002; Fukunaga-Takenaka R, 2005, GENES CELLS, V10, P311, DOI 10.1111/j.1365-2443.2005.00842.x; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Kanoh H, 2002, J BIOCHEM, V131, P629; Koya D., 1998, BIOFACTORS OXFORD EN, V7, P951; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Rea V E A, 2012, Infez Med, V20 Suppl 2, P8; Ruan X., 1996, AM J PHYSIOL, V270, P945; SHIBA T, 1993, AM J PHYSIOL, V265, pE783; Shirai Y, 2000, J BIOL CHEM, V275, P24760, DOI 10.1074/jbc.M003151200; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Williams B, 1997, DIABETES, V46, P1497, DOI 10.2337/diabetes.46.9.1497	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1756-4646			J FUNCT FOODS	J. Funct. Food.	MAY	2015	15						561	569		10.1016/j.jff.2015.04.005		9	Food Science & Technology	Food Science & Technology	CJ1JV	WOS:000355240800054		
J	Kamiya, T; Maeda, K; Sakai, S				Kamiya, Toshio; Maeda, Ken; Sakai, Shin-ichiro			Comparison of Preshaping Profilers for Reducing Residual Vibrations After Rest-to-Rest Maneuvers	JOURNAL OF GUIDANCE CONTROL AND DYNAMICS			English	Article							INPUT SHAPERS; FLEXIBLE SPACECRAFT; SYSTEMS; MOTION	Generally, spacecraft with large flexible structures have multiple flexible modes with large effective masses and various mode shapes; therefore, the presence of uncertain high-order flexible modes should be considered in high-accuracy controller design. However, most researchers have proposed input preshaping algorithms that are valid only for a few flexible modes. Consequently, when these algorithms are applied to a flexible spacecraft having uncertain high-order flexible modes, residual vibrations might not be reduced sufficiently. This paper presents a smooth feedforward control algorithm for rest-to-rest maneuvers that significantly reduces residual vibrations at the endpoint of a maneuver. The new preshaping profiler is based on a filtering technique that combines a pair of sinc functions. The new profiler is compared to several conventional preshaping profilers. In addition, residual vibrations at the endpoint of maneuvers in the presence of unknown higher modes are found to be much smaller than those in other techniques. Only a hybrid-type profiler shows similar level of small residual vibrations comparable with the new profiler. The new profiler is suitable for rest-to-rest rotational maneuvers of a flexible spacecraft, especially when fine pointing accuracy is required at the endpoint of maneuvers; such accuracy is sometimes required for missions involving scientific observations.	[Kamiya, Toshio; Maeda, Ken] NEC Corp Ltd, Div Space Syst, Fuchu, Tokyo 1838501, Japan; [Sakai, Shin-ichiro] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan	Kamiya, T (reprint author), NEC Corp Ltd, Div Space Syst, Fuchu, Tokyo 1838501, Japan.				NEC Corporation; NEC TOSHIBA Space Systems, Ltd.	This research was supported by all members of the Astro-G team at the Japan Aerospace Exploration Agency (JAXA), NEC Corporation, and NEC TOSHIBA Space Systems, Ltd. Commercial use of the nil-mode-exciting method requires written permission from JAXA, NEC Corporation, and NEC TOSHIBA Space Systems, Ltd.	Singhose W, 2010, J GUID CONTROL DYNAM, V33, P1697, DOI 10.2514/1.50270; Singer N, 1999, EUR J CONTROL, V5, P208; Singhose W, 2009, INT J PRECIS ENG MAN, V10, P153, DOI [10.1007/S12541-009-0084-2, 10.1007/s12541-009-0084-2]; LIU QA, 1992, J GUID CONTROL DYNAM, V15, P597, DOI 10.2514/3.20880; Singhose WE, 1997, J DYN SYST-T ASME, V119, P198, DOI 10.1115/1.2801233; SINGER NC, 1990, J DYN SYST-T ASME, V112, P76, DOI 10.1115/1.2894142; Eloundou R., 2002, 2 IFAC C MECH SYST, P25; Farrenkopf R. L., 1979, Journal of Guidance and Control, V2, DOI 10.2514/3.55914; Kamiya T., 2012, U. S. Patent, Patent No. [8,186,627, 8186627]; Kamiya T., 2007, IFAC P 17 IFAC S AUT, P283; Meckl P. H., 1984, THESIS MIT CAMBRIDGE; Meckl PH, 1998, P AMER CONTR CONF, P2627, DOI 10.1109/ACC.1998.688324; MECKL PH, 1985, J VIB ACOUST, V107, P378; Meckl P.H., 1990, ASME J DYNAMIC SYSTE, V112, P159, DOI [10.1115/1.2896122., DOI 10.1115/1.2896122]; Singer N. C., 1989, THESIS MIT CAMBRIDGE; SINGHOSE W, 1994, J MECH DESIGN, V116, P654, DOI 10.1115/1.2919428; Singhose W, 1996, J GUID CONTROL DYNAM, V19, P385, DOI 10.2514/3.21630; Singhose WE, 1997, J DYN SYST-T ASME, V119, P320, DOI 10.1115/1.2801257; SMITH OJM, 1957, P IRE, V45, P1249; Smith O. J. M., 1958, FEEDBACK CONTROL SYS, P331; SWIGERT CJ, 1980, J GUID CONTROL, V3, P460, DOI 10.2514/3.56021; WIE B, 1992, J GUID CONTROL DYNAM, V15, P935, DOI 10.2514/3.20927	22	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0731-5090	1533-3884		J GUID CONTROL DYNAM	J. Guid. Control Dyn.	MAY	2015	38	5					874	885		10.2514/1.G000146		12	Engineering, Aerospace; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CH5YB	WOS:000354110800006		
J	Kadowaki, S; Omori, T; Nishiaki, Y				Kadowaki, Seiji; Omori, Takayuki; Nishiaki, Yoshihiro			Variability in Early Ahmarian lithic technology and its implications for the model of a Levantine origin of the Protoaurignacian	JOURNAL OF HUMAN EVOLUTION			English	Article						Upper Palaeolithic; Levant; Lithic technology; Ahmarian; Protoaurignacian; Homo sapiens	HUMAN-CLIMATE INTERACTION; MODERN HUMANS; PROTO-AURIGNACIAN; ADAPTIVE SHIFT; EUROPE; CHRONOLOGY; MIDDLE; DISPERSAL; AGE; TRANSITION	This paper re-examines lithic technological variability of the Early Ahmarian, one of the early Upper Palaeolithic cultural entities in the Levant, which has often been regarded as a precursor of the Protoaurignacian (the early Upper Palaeolithic in Europe) in arguments for the occurrence of a cultural spread in association with the dispersal of Homo sapiens from the Levant to Europe. Using quantitative data on several lithic techno-typological attributes, we demonstrate that there is a significant degree of variability in the Early Ahmarian between the northern and southern Levant, as previously pointed out by several researchers. In addition, we suggest that the technology similar to the southern Early Ahmarian also existed in the northern Levant, i.e., the Ksar Akil Phase 4 group (the KA 4 group), by introducing new Upper Palaeolithic assemblages from Wadi Kharar 16R, inland Syria. We then review currently available stratigraphic records and radiocarbon dates (including a new date from Wadi Kharar 16R), with special attention to their methodological background. As a result, we propose alternative chronological scenarios, including one that postulates that the southern Early Ahmarian and the KA 4 group appeared later than the northern Early Ahmarian with little or no overlap. On the basis of the alternative scenarios of chronological/geographical patterns of the Early Ahmarian variability, we propose four possible relationships between the Protoaurignacian and the Early Ahmarian, including a new scenario that the appearance of the Protoaurignacian preceded those of similar technological entities in the Levant, i.e., the southern Early Ahmarian and the KA 4 group. If the last hypothesis is substantiated, it requires us to reconsider the model of a Levantine origin of the Protoaurignacian and its palaeoanthropological implications. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Kadowaki, Seiji] Nagoya Univ, Nagoya Univ Museum, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Omori, Takayuki; Nishiaki, Yoshihiro] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan	Kadowaki, S (reprint author), Nagoya Univ, Nagoya Univ Museum, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	kadowaki@num.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [22101001]	This research derives from a joint investigation, entitled "Archaeological Research of the Learning Behaviors of the Neanderthals and Early Modern Humans," directed by Yoshihiro Nishiaki (The University of Tokyo), as part of the "Replacement of Neanderthals by Modern Humans" project, directed by Takeru Akazawa (Kochi University of Technology) and funded by the Grant-in-Aid for Scientific Research on Innovative Areas (Grant No. 22101001) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We are grateful to members of our archaeological fieldwork in Syria: Shogo Kume, Hiroto Nakata, Kazuya Shimogama, and Masashi Abe. We thank Mark Diab for editorial corrections. We also appreciate comments from anonymous reviewers, who helped us clarify the paper. Any errors in this paper, however, are our own responsibility.	MELLARS P, 1989, ANTIQUITY, V63, P761; Bird MI, 1999, RADIOCARBON, V41, P127; Ramsey CB, 2004, RADIOCARBON, V46, P155; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Douka K, 2012, J HUM EVOL, V62, P286, DOI 10.1016/j.jhevol.2011.11.009; White M, 2012, EUR J ARCHAEOL, V15, P392, DOI 10.1179/1461957112Y.0000000019; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Higham T, 2010, P NATL ACAD SCI USA, V107, P20234, DOI 10.1073/pnas.1007963107; Wood RE, 2012, QUAT GEOCHRONOL, V9, P16, DOI 10.1016/j.quageo.2012.02.003; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1; Higham T, 2009, QUATERNARY SCI REV, V28, P1257, DOI 10.1016/j.quascirev.2008.12.018; Banks WE, 2013, J HUM EVOL, V65, P810, DOI 10.1016/j.jhevol.2013.08.004; Banks WE, 2013, J HUM EVOL, V64, P39, DOI 10.1016/j.jhevol.2012.10.001; Bar-Yosef O, 2013, QUATERN INT, V285, P30, DOI 10.1016/j.quaint.2011.07.043; Bar-Yosef O, 2007, DIOGENES, V54, P3, DOI 10.1177/0392192107076869; Bar-Yosef O., 2004, EURASIAN PREHISTORY, V2, P145; BarYosef O, 1996, J ARCHAEOL SCI, V23, P297, DOI 10.1006/jasc.1996.0028; Belfer A., 1977, PREHISTORIC INVESTIG, P42; Bergman C., 1981, PREHISTOIRE LEVANT, P319; Bergman C., 1988, PALEORIENT, V14, P223, DOI 10.3406/paleo.1988.5116; Bergman C. A., 2003, MORE MEETS EYE, P185; Bergman C.A., 1989, PALEORIENT, V16, P99; Bietti A, 2004, COLLEGIUM ANTROPOL, V28, P41; Bordes J.-G., 2006, TRABALHOS ARQUEOLOGI, V45, P147; Bordes J.-G., 2009, MEDITERRANEAN 50000, P11; Brauer G, 2008, EVOL ANTHROPOL, V17, P22, DOI 10.1002/evan.20157; Bronk R. C., 2009, RADIOCARBON, V51, P337, DOI DOI 10.2458/RC.V51I1.3494; Coinman N., 2003, MORE MEETS EYE, P151; Coinman N.R., 1995, PREHISTORIC CULTURAL, P133; Copeland L., 1975, PROBLEMS PREHISTORY, P317; Davidzon A., 2003, J ISRAEL PREHISTORIC, V33, P75; Douka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072931; Douka K., 2010, RADIOCARBON, V522, P735; EVIN J, 1983, RADIOCARBON, V25, P59; FERRING CR, 1988, U MUS SYMP, V1, P333; Ferring C., 1977, PREHISTORY PALAEOENV, VII, P81; Fortea Perez J., 1999, EXCAVACIONES ARQUEOL, V4, P31; Fox J., 2003, MORE MEETS EYE STUDI, P80; Fox JR, 2004, EARLY UPPER PALEOLITHIC BEYOND WESTERN EUROPE, P97; Garrod D.A.E., 1953, J WORLD HIST, V1, P13; GILEAD I, 1991, J WORLD PREHIST, V5, P105, DOI 10.1007/BF00974677; Gilead I., 1981, PREHISTOIRE LEVANT, P331; Goring-Morris A.N., 2006, ANTHROPOLOGIE, V44, P93; Goring-Morris A.N., 2006, DEFINITION AURIGNACI, P297; Goring-Morris A.N., 1995, ATIQOT, V27, P1; Goring-Morris A.N., 2003, MORE MEETS EYE STUDI; Goring-Morris N., 2003, MORE MEETS EYE STUDI, P1; HAAS H, 1975, RADIOCARBON, V17, P354; Hahn J., 1977, AURIGNACIEN ALTERE J; Hedges R.E., 1994, ARCHAEOMETRY, V36, P337, DOI DOI 10.1111/J.1475-4754.1994.TB00975.X; HEDGES REM, 1990, ARCHAEOMETRY, V32, P101, DOI 10.1111/j.1475-4754.1990.tb01086.x; Hershkovitz I., 2015, NATURE; Housley R.A., 1994, LATE QUATERNARY CHRO, P55; Hublin J.-J., 2014, QUATERN SCI REV; Hublin JJ, 2013, ORIGINS OF MODERN HUMANS: BIOLOGY RECONSIDERED, 2ND EDITION, P223; Jones M., 1983, PREHISTORY PALAEOENV, VIII, P283; Kadowaki S., 2013, DYNAMICS LEARNING NE, V1, P59; Kadowaki S., 2014, ENCY GLOBAL ARCHAEOL, P7769; Kozlowski J., 2007, RETHINKING HUMAN REV, P317; Kuhn S., 2003, MORE MEETS EYE STUDI, P106; Kuhn SL, 2009, J HUM EVOL, V56, P87, DOI 10.1016/j.jhevol.2008.07.014; Maillo Fernandez J.M., 2001, ESPACIO TIEMPO FOR 1, V14, P145; Marks A.E., 1983, PREHISTORY PALEOEN 3, VIII, P15; Marks A.E., 2003, MORE MEETS EYE STUDI, P249; Marks A.E., 1981, PREHISTOIRE LEVANT, P299; Mellars P., 2009, MEDITERRANEAN 50000, P339; Mellars P, 2006, EVOL ANTHROPOL, V15, P167, DOI 10.1002/evan.20103; Monigal K., 2003, MORE MEETS EYE STUDI, P118; Neuville R., 1934, REV BIBLIQUE, V43, P237; Nigst R.R., 2014, P NATL ACAD SCI USA, V111, P14394; Nishiaki Y., 2012, RAFIDAN, V33, P1; Ohnuma K., 1988, BAR INT SERIES, V426; Ohnuma K., 1990, EMERGENCE MODERN HUM, P91; Palma di Cesnola A., 1999, FACIES LEPTOLITHIQUE, P185; Phillips J.L., 1989, PALEORIENT, V15, P113; Phillips J.L., 1988, PALEORIENT, V14, P183, DOI 10.3406/paleo.1988.4467; Phillips J.L., 1994, LATE QUATERNARY CHRO, P169; Ploux S., 2003, PALEORIENT, V29, P5; Rebollo NR, 2011, J ARCHAEOL SCI, V38, P2424, DOI 10.1016/j.jas.2011.05.010; Ronchitelli A, 2014, J HUM EVOL, V73, P107, DOI 10.1016/j.jhevol.2013.12.010; Shea J., 2013, TOOLS PALEOLITHIC NE; Shea JJ, 2006, J ARCHAEOL SCI, V33, P823, DOI 10.1016/j.jas.2005.10.015; Skrdra P., 2003, J ISRAEL PREHISTORIC, V33, P37; Straus L.G., 1993, EVOLUTIONARY ANTHR, V2, P195, DOI 10.1002/evan.1360020604; Svoboda J., 2007, RETHINKING HUMAN REV, P329; Svoboda J., 2003, AM SCH PREHISTORIC R, V47; Szmidt CC, 2010, J ARCHAEOL SCI, V37, P3320, DOI 10.1016/j.jas.2010.08.001; Szmidt CC, 2010, J ARCHAEOL SCI, V37, P758, DOI 10.1016/j.jas.2009.11.006; Talamo S, 2012, J ARCHAEOL SCI, V39, P175, DOI 10.1016/j.jas.2011.09.019; Tostevin G.B., 2012, SEEING LITHICS MIDDL; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; Tsanova T., 2008, BAR INT SERIES, V1752; Tsanova T, 2012, ANTHROPOLOGIE, V116, P469, DOI 10.1016/j.anthro.2011.10.005; Villa P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096424; Volkman P., 1983, PREHISTORY PALEOENVI, VIII, P127; WEINSTEIN JM, 1984, RADIOCARBON, V26, P297; Williams J. K., 2010, PALEORIENT, V36, P117; Wood RE, 2014, J HUM EVOL, V69, P91, DOI 10.1016/j.jhevol.2013.12.017; Ziffer D., 1978, PALEORIENT, V4, P237; Zilhao J, 2013, DYNAMICS LEARNING NE, V1, P21; Zillfao J., 2006, EVOL ANTHROPOL, V15, P183	103	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0047-2484			J HUM EVOL	J. Hum. Evol.	MAY	2015	82						67	87		10.1016/j.jhevol.2015.02.017		21	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	CI8OC	WOS:000355030600005		
J	Terasawa, K; Rajapakshe, AR; Podyma-Inoue, KA; Mishima-Tsumagari, C; Yanagishita, M; Hara-Yokoyama, M				Terasawa, Kazue; Rajapakshe, Anupama R.; Podyma-Inoue, Katarzyna A.; Mishima-Tsumagari, Chiemi; Yanagishita, Masaki; Hara-Yokoyama, Miki			Preferential recognition of isocitrate dehydrogenase by a rabbit monoclonal antibody (ab124797) against the C-terminal peptide of RANKL	JOURNAL OF IMMUNOLOGICAL METHODS			English	Article						Rabbit mAb; ab124797; Peptide; RANKL; Isocitrate dehydrogenase; Mitochondria	RECEPTOR; GROWTH; LIGAND	A rabbit monoclonal antibody (Abcam ab124797), with high affinity for a synthetic peptide corresponding to the C-terminal region of the receptor activator of nuclear factor (NF)-kappa B ligand (RANKL), specifically recognizes a 37 kDa protein by immunoblotting, in good agreement with the molecular mass of RANKL. However, our mass spectroscopy analysis revealed that the protein recognized by the antibody is the alpha-subunit of NAD(+)-dependent isocitrate dehydrogenase (ICDH), a key Krebs cycle enzyme in mitochondria. Consistently, immunocytochemical staining with the antibody revealed a network organization characteristic of mitochondria, which overlapped with staining by MitoTracker and was lost after the siRNA-mediated downregulation of ICDH. The C-terminal peptide of ICDH contains similar chemical characteristics to that of the RANKL peptide and interacts with the antibody, although the affinity is a hundred times weaker. The present study provides an example of the preferential recognition of a surrogate protein by a rabbit monoclonal antibody. (C) 2015 Elsevier B.V. All rights reserved.	[Terasawa, Kazue; Rajapakshe, Anupama R.; Podyma-Inoue, Katarzyna A.; Yanagishita, Masaki; Hara-Yokoyama, Miki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hard Tissue Engn, Biochem Sect,Bunkyo Ku, Tokyo 1138549, Japan; [Mishima-Tsumagari, Chiemi] RIKEN, Ctr Life Sci Technol, Div Struct & Synthet Biol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Hara-Yokoyama, M (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hard Tissue Engn, Biochem Sect,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	m.yokoyama.bch@tmd.ac.jp			MEXT [22592060, 25463072, 23650319, 26463087]	We thank Makiko Nawa (Tokyo Medical and Dental University) for the mass spectrometric analysis and Prof. Noboru Mizushima (Tokyo University) for kindly providing the MEF cells. This work was supported by Grants-in-Aid for Scientific Research 22592060 and 25463072 (to M.H.) and 23650319 and 26463087 (to K.A.I.) from MEXT.	Leibbrandt A, 2009, ADV EXP MED BIOL, V647, P130, DOI 10.1007/978-0-387-89520-8_9; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Taylor AB, 2008, J BIOL CHEM, V283, P10872, DOI 10.1074/jbc.M708719200; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Trier NH, 2012, METHODS, V56, P136, DOI 10.1016/j.ymeth.2011.12.001; Ito S, 2002, J BIOL CHEM, V277, P6631, DOI 10.1074/jbc.M106525200; Brown MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028718; Fortunato MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097567; Goodman SL, 2012, BIOL OPEN, V1, P329, DOI 10.1242/bio.2012364; Miller DL, 2011, J ALZHEIMERS DIS, V23, P293, DOI 10.3233/JAD-2010-101341; Pageau SC, 2009, MABS, V1, P210; Rajapakshe AR, 2015, EXP CELL RES, V331, P211, DOI 10.1016/j.yexcr.2014.09.014; Rocha R, 2008, PATHOL RES PRACT, V204, P655, DOI 10.1016/j.prp.2008.03.010; Yam PC, 2014, METHODS MOL BIOL, V1131, P71, DOI 10.1007/978-1-62703-992-5_5; Yu YL, 2013, BIOCHEM BIOPH RES CO, V436, P543, DOI 10.1016/j.bbrc.2013.06.007	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1759	1872-7905		J IMMUNOL METHODS	J. Immunol. Methods	MAY	2015	420						1	10		10.1016/j.jim.2015.03.006		10	Biochemical Research Methods; Immunology	Biochemistry & Molecular Biology; Immunology	CJ3AC	WOS:000355354800001		
J	Nishide, Y; Tanaka, S; Saeki, S				Nishide, Yudai; Tanaka, Seiji; Saeki, Shinjiro			Egg hatching of two locusts, Schistocerca gregaria and Locusta migratoria, in response to light and temperature cycles	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Egg hatching; Locusta migratoria; Photoperiod; Schistocerca gregaria; Thermoperiod	RHYTHM	The present study showed that the eggs of the desert locust, Schistocerca gregaria, and the migratory locust, Locusta migratoria, responded to photoperiod by hatching when placed on sand in the laboratory. S. gregaria mainly hatched during the dark phase and L migratoria during the light phase. The importance of light as a hatching cue depended on the magnitude of the temperature change during the thermoperiod; photoperiod played a more important role in the control of hatching time in both species when the magnitude of the temperature change was small. In addition, the eggs of the two species that were covered with sand did not respond to photoperiod and hatched during both the light and dark phases, indicating that light did not penetrate through the sand. Because locust eggs are normally laid as egg pods and a foam plug is deposited between the egg mass and the ground surface, we tested a possibility that naturally deposited eggs perceived light through the foam plug. The eggs that were deposited and left undisturbed in the sand hatched during the light and dark phases at similar frequencies. These results suggest that the eggs of both locust species responded to light and controlled their hatching timing accordingly but would not use light as a hatching cue in the field. The evolutionary significance of the ability of eggs to respond to light in these locusts was discussed. (C) 2015 Elsevier Ltd. All rights reserved.	[Nishide, Yudai; Tanaka, Seiji; Saeki, Shinjiro] Natl Inst Agrobiol Sci Ohwashi, Locust Res Lab, Tsukuba, Ibaraki, Japan; [Saeki, Shinjiro] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo, Japan	Tanaka, S (reprint author), Natl Inst Agrobiol Sci Ohwashi, Locust Res Lab, Tsukuba, Ibaraki, Japan.				Kakenhi Grant of Japan [23380038]	We thank Ms. H. Ikeda, Ms. N. Totsuka and Ms. M. Higuchi for maintaining the locust colonies. Thanks are also due to Dr. Takashi Suzuki (University of Western Ontario) for his stimulating discussion and information on the light perception mechanisms. We are indebted to Dr. Sinzo Masaki (Professor emeritus of Hirosaki University) for his invaluable comments on the manuscript and correcting our English. This study was founded in part by a Kakenhi Grant of Japan (No. 23380038) to S.T. The grass used was raised by the Field Management Section of NIASO and we would like to thank Mr. Kameo Tsukada for growing the grass. Two anonymous reviewers greatly improved the manuscript.	Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Arai T, 2012, B RECORDS RES ACTIVI, V5, P1; ARAI T, 1977, Kontyu, V45, P107; Ellis P. E., 1957, ANTILOCUST B, V25, P1; Nishide Y, 2015, J INSECT PHYSIOL, V72, P79, DOI 10.1016/j.jinsphys.2014.12.003; PADGHAM DE, 1981, PHYSIOL ENTOMOL, V6, P191, DOI 10.1111/j.1365-3032.1981.tb00641.x; PFLUGER W, 1971, OECOLOGIA, V7, P262, DOI 10.1007/BF00345216; Popov G. B., 1958, Anti-Locust Bulletin, Vno. 31, P1; SAUNDERS DS, 1976, J COMP PHYSIOL, V110, P111; Saunders D.S., 2002, INSECT CLOCKS; Shimizu Toru, 1997, Japanese Journal of Entomology, V65, P335; Stower W. J., 1958, Anti-Locust Bulletin, Vno. 30, P1; TOMIOKA K, 1991, J INSECT PHYSIOL, V37, P365, DOI 10.1016/0022-1910(91)90087-G; Uvarov B. P., 1966, GRASSHOPPERS LOCUSTS, V1; White R.H., 1978, ADV INSECT PHYSL, V13, P35, DOI 10.1016/S0065-2806(08)60264-7	16	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	MAY	2015	76						24	29		10.1016/j.jinsphys.2015.03.010		6	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	CJ3CK	WOS:000355360800004		
J	Gu, ZC; Amemiya, T; Ishikawa, A; Atsumi, Y; Kang, J; Hiratani, T; Hayashi, Y; Suzuki, J; Nishiyama, N; Tanaka, T; Arai, S				Gu, ZhiChen; Amemiya, Tomohiro; Ishikawa, Atsushi; Atsumi, Yuki; Kang, JoonHyun; Hiratani, Takuo; Hayashi, Yusuke; Suzuki, Junichi; Nishiyama, Nobuhiko; Tanaka, Takuo; Arai, Shigehisa			Investigation of Optical Interconnection by using Photonic Wire Bonding	JOURNAL OF LASER MICRO NANOENGINEERING			English	Article						Photonic integration; Photonic wire bonding; direct laser writing; III-V semiconductor; Si photonics	LASER; INP; PHOTOPOLYMERIZATION; FABRICATION; CIRCUITS	Photonic wire bonding based on direct laser writing of three-dimensional polymer structure was discussed as one of practical approaches for photonic integration of heterogeneous optical components. Here we assessed the coupling efficiency between photonic wire bond and III-V/Si optical components, and demonstrate the fabrication of photonic wire bond between two III-V semiconductor chips.	[Gu, ZhiChen; Atsumi, Yuki; Kang, JoonHyun; Hiratani, Takuo; Hayashi, Yusuke; Suzuki, Junichi; Nishiyama, Nobuhiko; Arai, Shigehisa] Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo 1521552, Japan; [Amemiya, Tomohiro; Arai, Shigehisa] Tokyo Inst Technol, Quantum Nanoelect Res Ctr, Tokyo 1521552, Japan; [Ishikawa, Atsushi; Tanaka, Takuo] RIKEN, Metamat Lab, Saitama 3510198, Japan	Gu, ZC (reprint author), Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo 1521552, Japan.	gu.z.ab@m.titech.ac.jp	Ishikawa, Atsushi/J-3649-2015		JSPS KAKENHI [24246061, 25709026, 25420321, 13J08096, 14J02327]	This work was supported by JSPS KAKENHI Grant Numbers #24246061, #25709026, #25420321, #13J08096, #14J02327.	Amemiya T, 2014, OPT LETT, V39, P212, DOI 10.1364/OL.39.000212; Sun HB, 2000, OPT LETT, V25, P1110, DOI 10.1364/OL.25.001110; Okumura T, 2009, OPT EXPRESS, V17, P12564, DOI 10.1364/OE.17.012564; Doi K, 2014, IEEE J QUANTUM ELECT, V50, P321, DOI 10.1109/JQE.2014.2309700; Shindo T, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2013.2244573; Fang AW, 2006, OPT EXPRESS, V14, P9203, DOI 10.1364/OE.14.009203; Okamoto T, 2003, IEEE J SEL TOP QUANT, V9, P1361, DOI 10.1109/JSTQE.2003.819495; Gunn C, 2006, IEEE MICRO, V26, P58, DOI 10.1109/MM.2006.32; Soref R, 2006, IEEE J SEL TOP QUANT, V12, P1678, DOI 10.1109/JSTQE.2006.883151; Maruo S, 1997, OPT LETT, V22, P132, DOI 10.1364/OL.22.000132; Lindenmann N, 2012, OPT EXPRESS, V20, P17667, DOI 10.1364/OE.20.017667; Roelkens G, 2006, OPT EXPRESS, V14, P8154, DOI 10.1364/OE.14.008154; Stankovic S, 2011, IEEE PHOTONIC TECH L, V23, P1781, DOI 10.1109/LPT.2011.2169397; Duan XM, 2004, THIN SOLID FILMS, V453, P518, DOI 10.1016/j.tsf.2003.11.126; Chen KJ, 1996, IEEE ELECTR DEVICE L, V17, P127, DOI 10.1109/55.485189; Gibis R, 2000, J CRYST GROWTH, V209, P463, DOI 10.1016/S0022-0248(99)00599-0; Hamacher M., 2000, P IND PHOSPH REL MAT, P21; Ishikawa A, 2012, J LASER MICRO NANOEN, V7, P11, DOI 10.2961/jlmn.2012.01.0002; Jalali B, 2006, P SOC PHOTO-OPT INS, V6183, P18314, DOI 10.1117/12.669074; Koos C, 2013, PROC SPIE, V8613, DOI 10.1117/12.2003096; Koos C., 2013, P 15 INT C TRANSP OP, P1202; Kubacki R. M., 2006, P 56 EL COMP TECHN C, P776; Lai N.D., 2005, OPT COMMUN, V258, P97; Miwa M, 2001, APPL PHYS A-MATER, V73, P561, DOI 10.1007/s003390100934; Nunoya N, 2001, IEEE J SEL TOP QUANT, V7, P249, DOI 10.1109/2944.954137; Okumura T., 2009, P IEEE 21 INT C IND, P178; Okumura Tadashi, 2009, IEEE Photonics Technology Letters, V21, DOI 10.1109/LPT.2008.2010780; Shindo T, 2013, IEEE PHOTONIC TECH L, V25, P1282, DOI 10.1109/LPT.2013.2261980; Umbach A, 1996, ELECTRON LETT, V32, P2142, DOI 10.1049/el:19961421	29	1	1	JAPAN LASER PROCESSING SOC	OSAKA	OSAKA UNIV, 11-1 MIHOGAOKA, IBARAKI C/O KATAYAMA LAB, JOINING & WELDING RES INST, OSAKA, 567-0047, JAPAN	1880-0688			J LASER MICRO NANOEN	J. Laser Micro Nanoeng.	MAY	2015	10	2					148	153		10.2961/jlmn.2015.02.0007		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Optics; Physics, Applied	Science & Technology - Other Topics; Materials Science; Optics; Physics	CI7RP	WOS:000354962400007		
J	Nakamura, D; Tetsuyama, N; Shimogaki, T; Sato, Y; Mizokami, Y; Higashihata, M; Okada, T				Nakamura, Daisuke; Tetsuyama, Norihiro; Shimogaki, Tetsuya; Sato, Yuta; Mizokami, Yasuaki; Higashihata, Mitsuhiro; Okada, Tatsuo			Optical Characterization of ZnO Microsphere Produced by Laser Ablation in Air	JOURNAL OF LASER MICRO NANOENGINEERING			English	Article						ZnO; microsphere; whispering-gallery-mode; lasing; electroluminescence	LASING CHARACTERISTICS; PHOTOLUMINESCENCE; GROWTH; DEPOSITION; NANOWIRES; NANORODS; MODES	We have succeeded in growing the ZnO microspheres by a simple laser ablation in the air, and we have obtained UV whispering-gallery-mode (WGM) lasing from the sphere under pulsed laser excitation. In this study, we observed resonances of WGM in visible region under cw laser pumping. In addition, possible refractive index of the ZnO microsphere was estimated from the WGM peaks. Furthermore, we obtained room-temperature electroluminescence from the ZnO microsphere/p-GaN heterojunction under forward bias.	[Nakamura, Daisuke; Tetsuyama, Norihiro; Shimogaki, Tetsuya; Sato, Yuta; Mizokami, Yasuaki; Higashihata, Mitsuhiro; Okada, Tatsuo] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Nishi Ku, Fukuoka 8190395, Japan	Nakamura, D (reprint author), Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	dnakamura@ees.kyushu-u.ac.jp			Japan Society for the Promotion of Science [25286071]	A part of this study has been financially supported by Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (No. 25286071).	Kawakami M, 2003, JPN J APPL PHYS 2, V42, pL33, DOI 10.1143/JJAP.42.L33; SCHILLER S, 1991, OPT LETT, V16, P1138, DOI 10.1364/OL.16.001138; Zhang SB, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.075205; SCHILLER S, 1993, APPL OPTICS, V32, P2181, DOI 10.1364/AO.32.002181; Vayssieres L, 2003, ADV MATER, V15, P464, DOI 10.1002/adma.200390108; Lyu SC, 2002, CHEM PHYS LETT, V363, P134, DOI 10.1016/S0009-2614(02)01145-4; Wan H, 2010, J MATER SCI-MATER EL, V21, P1014, DOI 10.1007/s10854-010-0118-7; Yoshikawa H, 1997, JPN J APPL PHYS 1, V36, P6237, DOI 10.1143/JJAP.36.6237; Vanheusden K, 1996, APPL PHYS LETT, V68, P403, DOI 10.1063/1.116699; Okazaki K, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4768696; Chen R, 2011, ADV MATER, V23, P2199, DOI 10.1002/adma.201100423; Okada T, 2004, APPL PHYS A-MATER, V79, P1417, DOI 10.1007/s00339-004-2797-5; Okazaki K, 2011, OPT EXPRESS, V19, P20389, DOI 10.1364/OE.19.020389; Sun Y, 2006, CHEM PHYS LETT, V431, P352, DOI 10.1016/j.cplett.2006.09.100; Guo Q. R., 2008, APPL PHYS A, V93, P843; Guo R, 2009, APPL PHYS B-LASERS O, V94, P33, DOI 10.1007/s00340-008-3257-2; Liu JZ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2952763; Moirangthem RS, 2013, OPT EXPRESS, V21, P3010, DOI 10.1364/OE.21.003010; Moirangthem RS, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4817273; Nakamura D, 2013, J LASER MICRO NANOEN, V8, P296, DOI 10.2961/jlmn.2013.03.0018; Pauzauskie J. P., 2006, PHYS REV LETT, V96; Vugt K. L., 2006, NANO LETT, V6, P2707; Zimmler A. M., 2010, SEMICOND SCI TECH, V25	23	0	0	JAPAN LASER PROCESSING SOC	OSAKA	OSAKA UNIV, 11-1 MIHOGAOKA, IBARAKI C/O KATAYAMA LAB, JOINING & WELDING RES INST, OSAKA, 567-0047, JAPAN	1880-0688			J LASER MICRO NANOEN	J. Laser Micro Nanoeng.	MAY	2015	10	2					162	165		10.2961/jlmn.2015.02.0010		4	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Optics; Physics, Applied	Science & Technology - Other Topics; Materials Science; Optics; Physics	CI7RP	WOS:000354962400010		
J	Tasei, Y; Yamakami, T; Kawamura, L; Fujito, T; Ushida, K; Sato, M; Naito, A				Tasei, Yugo; Yamakami, Takuya; Kawamura, Lzuru; Fujito, Teruaki; Ushida, Kiminori; Sato, Motoyasu; Naito, Akira			Mechanism for microwave heating of 1-(4 '-cyanophenyl)-4-propylcyclohexane characterized by in situ microwave irradiation NMR spectroscopy	JOURNAL OF MAGNETIC RESONANCE			English	Article						Microwave irradiation NMR spectroscopy; Microwave heating; Non-equilibrium local heating; High temperature heating; Liquid crystalline phase; Isotropic phase	ENZYME-CATALYZED REACTIONS; ORGANIC-SYNTHESIS; TEMPERATURE; THERMOMETER; CALIBRATION; CHEMISTRY; METHANOL; PROTEIN; OVENS	Microwave heating is widely used to accelerate organic reactions and enhance the activity of enzymes. However, the detailed molecular mechanism for the effect of microwave on chemical reactions is not yet fully understood. To investigate the effects of microwave heating on organic compounds, we have developed an in situ microwave irradiation NMR spectroscopy. H-1 NMR spectra of 1-(4'-cyanophenyl)-4-propylcyclohexane (PCH3) in the liquid crystalline and isotropic phases were observed under microwave irradiation. When the temperature was regulated at slightly higher than the phase transition temperature (T-c = 45 degrees C) under a gas flow temperature control system, liquid crystalline phase mostly changed to the isotropic phase. Under microwave irradiation and with the gas flow temperature maintained at 20 degrees C, which is 25 degrees C below the T-c, the isotropic phase appeared stationary as an approximately 2% fraction in the liquid crystalline phase. The temperature of the liquid crystalline state was estimated to be 38 degrees C according to the line width, which is at least 7 degrees C lower than the T-c. The temperature of this isotropic phase should be higher than 45 degrees C, which is considered to be a non-equilibrium local heating state induced by microwave irradiation. Microwaves at a power of 195 W were irradiated to the isotropic phase of PCH3 at 50 degrees C and after 2 min, the temperature reached 220 degrees C. The temperature of PCH3 under microwave irradiation was estimated by measurement of the chemical shift changes of individual protons in the molecule. These results demonstrate that microwave heating generates very high temperature within a short time using an in situ microwave irradiation NMR spectrometer. (C) 2015 Elsevier Inc. All rights reserved.	[Tasei, Yugo; Kawamura, Lzuru; Naito, Akira] Yokohama Natl Univ, Grad Sch Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Yamakami, Takuya; Ushida, Kiminori] Kitasato Univ, Sch Sci, Dept Chem, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Fujito, Teruaki] Probe Lab Inc, Hamura, Tokyo 2050021, Japan; [Sato, Motoyasu] Chubu Univ, Fac Engn, Kasugai, Aichi 4578501, Japan	Naito, A (reprint author), Yokohama Natl Univ, Grad Sch Engn, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	naito@ynu.ac.jp	Kawamura, Izuru/M-4585-2014	Kawamura, Izuru/0000-0002-8163-9695	Ministry of Education, Culture, Sports, Science and Technology of Japan [24121709, 26102514, 26104513, 24570127]	This work was supported by a Grant-in-Aid for Scientific Research on Priority Area (24121709) and Innovative area (26102514 and 26104513), and a Grant-in-aid for Scientific Research (C) (24570127) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	AKASAKA K, 1995, J PHYS CHEM-US, V99, P9523, DOI 10.1021/j100023a034; Kappe CO, 2013, ANGEW CHEM INT EDIT, V52, P1088, DOI 10.1002/anie.201204103; VANGEET AL, 1970, ANAL CHEM, V42, P679, DOI 10.1021/ac60288a022; Tanaka M, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2403870; GEDYE R, 1986, TETRAHEDRON LETT, V27, P279, DOI 10.1016/S0040-4039(00)83996-9; Gomez MV, 2010, CHEM COMMUN, V46, P4514, DOI 10.1039/b924936b; VANGEET AL, 1968, ANAL CHEM, V40, P2227, DOI 10.1021/ac50158a064; Pramanik BN, 2002, PROTEIN SCI, V11, P2676, DOI 10.1110/ps.0213702; Adam D, 2003, NATURE, V421, P571, DOI 10.1038/421571a; AKASAKA K, 1991, J AM CHEM SOC, V113, P4688, DOI 10.1021/ja00012a052; GIGUERE RJ, 1986, TETRAHEDRON LETT, V27, P4945, DOI 10.1016/S0040-4039(00)85103-5; Perreux L, 2001, TETRAHEDRON, V57, P9199, DOI 10.1016/S0040-4020(01)00905-X; Obermayer D, 2009, ANGEW CHEM INT EDIT, V48, P8321, DOI 10.1002/anie.200904185; BIELECKI A, 1995, J MAGN RESON SER A, V116, P215; Bogdal D, 2003, TETRAHEDRON, V59, P649, DOI 10.1016/S0040-4020(02)01533-8; Huang W, 2005, J MOL CATAL B-ENZYM, V35, P113, DOI 10.1016/j.molcatb.2005.06.004; Kanno M, 2012, J PHYS CHEM A, V116, P2177, DOI 10.1021/jp212460v; Kappe CO, 2004, ANGEW CHEM INT EDIT, V43, P6250, DOI 10.1002/anie.200400655; Koshijima T., 1994, MICROWAVE HEATING TE, P9; Lin SS, 2005, J AM SOC MASS SPECTR, V16, P581, DOI 10.1016/j.jasms.2005.01.012; NAITO A, 1991, J MAGN RESON, V92, P85, DOI 10.1016/0022-2364(91)90249-S; Naito A., 1996, J CHEM PHYS, V105, P4502; Naito A., 2010, MAT SCI TECHNOL, P2886; Naito A., 2007, STRUCTURAL STUDIES L, P85; Parker MC, 1996, TETRAHEDRON LETT, V37, P8383, DOI 10.1016/0040-4039(96)01544-4; Tsukahara Y, 2010, J PHYS CHEM C, V114, P8965, DOI 10.1021/jp100509h; West R.C., 1984, CRC HDB CHEM PHYS, V64th, pE50; Yamada S, 2014, POLYM CHEM-UK, V5, P5283, DOI 10.1039/c4py00639a; Yoshimura Y, 2005, TETRAHEDRON LETT, V46, P4701, DOI 10.1016/j.tetlet.2005.05.046; Zuo C.S., 1998, J MAGN RESON, V133, P55	30	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	MAY	2015	254						27	34		10.1016/j.jmr.2015.02.002		8	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Biochemistry & Molecular Biology; Physics; Spectroscopy	CI9DR	WOS:000355071100004		
J	Nishiyama, K; Watanabe, Y; Harada, T; Kamada, K; Kawai, H				Nishiyama, Katsura; Watanabe, Yasuhiro; Harada, Takashi; Kamada, Kenji; Kawai, Hideki			Generation of amplified spontaneous emission from rare-earth complexes dispersed in phenol plus AOT self-assembled organogels	JOURNAL OF MOLECULAR LIQUIDS			English	Article						Organogel; Soft material; Self-healing material; Eu complex; Laser material	EU(III) COMPLEX	The rare-earth complex Eu(hfa)(3)(phen) is dispersed in the self-assembled organogel of p-chlorophenol and surfactant AOT. The time profiles of the emission intensity observed from the complex-organogel system suggest the possible generation of amplified stimulated emission when excited with a strong excitation pulse. As the host material, the organogel can support eight times as much of the complex along with better emission quantum yield. A theoretical estimation of the laser gain factor of the complex-organogel also suggested that this system might have application in laser systems. (C) 2014 Elsevier B.V. All rights reserved.	[Nishiyama, Katsura; Watanabe, Yasuhiro; Harada, Takashi] Shimane Univ, Fac Educ, Matsue, Shimane 6908504, Japan; [Kamada, Kenji] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan; [Kawai, Hideki] Shizuoka Univ, Grad Sch Engn, Dept Appl Chem & Biochem Engn, Hamamatsu, Shizuoka 4328011, Japan	Nishiyama, K (reprint author), Shimane Univ, Fac Educ, Matsue, Shimane 6908504, Japan.	katsura_nishiyama@edu.shimane-u.ac.jp; rohkawa@ipc.shizuoka.ac.jp			JSPS KAKENHI [25410211]; JST A-STEP [AS242Z01279M]; Mazda Foundation; Electric Technology Research Foundation of Chugoku	We thank Professor Toshiyuki Takamuku at Saga University for the refractive index measurements. KN acknowledges financial support from JSPS KAKENHI (Grant Number 25410211), JST A-STEP (AS242Z01279M), the Mazda Foundation, and the Electric Technology Research Foundation of Chugoku. We thank the Cooperative Research Project of Research Institute of Electronics, Shizuoka University.	Iwanaga K, 2010, INT J PHARMACEUT, V388, P123, DOI 10.1016/j.ijpharm.2009.12.045; Nakamura K, 2007, J PHYS CHEM A, V111, P3029, DOI 10.1021/jp067672h; Mukhopadhyay P, 2010, ANGEW CHEM INT EDIT, V49, P6338, DOI 10.1002/anie.201001382; Yu XD, 2012, SOFT MATTER, V8, P3329, DOI 10.1039/c2sm07309a; Werts MHV, 2002, PHYS CHEM CHEM PHYS, V4, P1542, DOI 10.1039/b107770h; Dehn S, 2011, NEW J CHEM, V35, P1466, DOI 10.1039/c1nj20085b; Edelsztein V.C., 2012, J MATER CHEM, V2012, P21857; Hasegawa Y, 2003, APPL PHYS LETT, V83, P3599, DOI 10.1063/1.1616207; Kang SH, 2008, CHEM MATER, V20, P5532, DOI 10.1021/cm800867b; Nishiyama K, 2012, CHEM LETT, V41, P1697, DOI 10.1246/cl.2012.1697; Nishiyama K, 2012, CHEM PHYS LETT, V529, P39, DOI 10.1016/j.cplett.2012.01.050; Nishiyama K., UNPUB; Simmons B, 2002, NANO LETT, V2, P1037, DOI 10.1021/nl015691r; Simmons BA, 2001, J AM CHEM SOC, V123, P2414, DOI 10.1021/ja0037926; Yariv A., 1991, QUANTUM ELECT, V4th	15	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7322	1873-3166		J MOL LIQ	J. Mol. Liq.	MAY	2015	205				SI		93	97		10.1016/j.molliq.2014.05.020		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CI8KY	WOS:000355022400016		
J	Kuramochi, K; Tsubaki, K				Kuramochi, Kouji; Tsubaki, Kazunori			Synthesis and Structural Characterization of Natural Benzofuranoids	JOURNAL OF NATURAL PRODUCTS			English	Article							GROWTH INHIBITING PROPERTIES; USTUS TC 1118; ASPERGILLUS-USTUS; FUNGAL METABOLITE; ALGORITHM; (+)-PSEUDODEFLECTUSIN; PSEUDODEFLECTUSIN; ISOCHROMAN; CONFORMERS; TMC-120A	The synthesis of ustusoranes A, B, and E, pergillin, dihydropergillin, (+/-)-penicisochroman A, and (-)-brassicadiol, starting from optically active (R)-benzolactone, is described. The synthesis of ustusoranes A and E established the absolute configurations of these natural products. The synthesis of pergillin and ()-penicisochroman A led to the structural revision of aspergiones E and F. This study clearly indicates that (R)-benzolactone is a potential intermediate in the synthesis of natural benzofuranoids.	[Kuramochi, Kouji; Tsubaki, Kazunori] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan	Kuramochi, K (reprint author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan.	kuramoch@kpu.ac.jp			 [25850083]	This work was supported in part by a Grant-in-Aid for Young Scientists (B) (25850083). This study was carried out using the mass spectrometers in the Joint Usage/Research Center (JURC) at the Institute for Chemical Research, Kyoto University. We are grateful to Prof. M. Nakamura, Prof. H. Takaya, and Prof. K. Isozald of Kyoto University for assistance with HRMS measurements.	ATKINS GM, 1968, J AM CHEM SOC, V90, P4744, DOI 10.1021/ja01019a052; Gabriele B, 2008, J ORG CHEM, V73, P7336, DOI 10.1021/jo801444n; ISHII H, 1992, CHEM PHARM BULL, V40, P1148; ARHART RJ, 1972, J AM CHEM SOC, V94, P5003, DOI 10.1021/ja00769a036; LUCHE JL, 1978, J AM CHEM SOC, V100, P2226, DOI 10.1021/ja00475a040; GOTO H, 1989, J AM CHEM SOC, V111, P8950, DOI 10.1021/ja00206a046; Simonetti SO, 2013, NAT PROD REP, V30, P941, DOI 10.1039/c3np70014c; Simonetti SO, 2012, ORG BIOMOL CHEM, V10, P4124, DOI 10.1039/c2ob25067e; Asai T, 2012, TETRAHEDRON LETT, V53, P2239, DOI 10.1016/j.tetlet.2012.02.088; Ayer W. A., 1987, J NAT PRODUCTS, V50, P408; CUTLER HG, 1981, J AGR FOOD CHEM, V29, P981, DOI 10.1021/jf00107a023; CUTLER HG, 1980, J AGR FOOD CHEM, V28, P989, DOI 10.1021/jf60231a017; Frisch M. J., 2009, GAUSSIAN 09 REVISION; GOTO H, 1993, J CHEM SOC PERK T 2, P187, DOI 10.1039/p29930000187; GOTO H, 1992, TETRAHEDRON LETT, V33, P1343; Kohno J, 1999, J ANTIBIOT, V52, P913; Kohno J, 1999, TETRAHEDRON, V55, P11247, DOI 10.1016/S0040-4020(99)00648-1; Kuramochi K, 2010, BIOSCI BIOTECH BIOCH, V74, P1635, DOI 10.1271/bbb.100241; Kuramochi K, 2013, J NAT PROD, V76, P1737, DOI 10.1021/np400460m; Li W., 2003, J NAT PRODUCTS, V66, P57; Lu ZY, 2009, J NAT PROD, V72, P1761, DOI 10.1021/np900268z; Ogawa A, 2004, BIOORG MED CHEM LETT, V14, P3539, DOI 10.1016/j.bmcl.2004.04.050; Saito F, 2006, EUR J ORG CHEM, P4796, DOI 10.1002/ejoc.200600702; Sato Y, 2011, TETRAHEDRON LETT, V52, P626, DOI 10.1016/j.tetlet.2010.11.153; Trisuwan K, 2010, TETRAHEDRON, V66, P4484, DOI 10.1016/j.tet.2010.04.073	25	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864	1520-6025		J NAT PROD	J. Nat. Prod.	MAY	2015	78	5					1056	1066		10.1021/np5010483		11	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CJ0IF	WOS:000355158300010		
J	Win, NN; Ito, T; Aimaiti, S; Imagawa, H; Ngwe, H; Abe, I; Morita, H				Win, Nwet Nwet; Ito, Takuya; Aimaiti, Simayijiang; Imagawa, Hiroshi; Ngwe, Hla; Abe, Ikuro; Morita, Hiroyuki			Kaempulchraols A-H, Diterpenoids from the Rhizomes of Kaempferia pulchra Collected in Myanmar	JOURNAL OF NATURAL PRODUCTS			English	Article							PIMARANE DITERPENES; BOESENBERGIA-PANDURATA; SECONDARY METABOLITES; ANTICANCER AGENTS; KAYEA-ASSAMICA; FLOWER	Eight new diterpenoids, kaempulchraols A-H (1-8), along with five known analogues were isolated from the CHCl3-soluble extract of rhizomes of Kaempferia pulchra of Myanmar. The structures of these compounds were elucidated using extensive spectroscopic techniques including X-ray diffraction analysis. All the isolates were tested for their antiproliferative activity against a panel of five human cancer cell lines (A549, human lung cancer; HeLa, human cervix cancer; PANC-1 and PSN-1, human pancreatic cancer; MDA-MB-231, human breast cancer) and TIG-3, normal human primary fibroblast cells. Kaempulchraol F (6) exhibited weak activity against the human pancreatic PSN-1 cell line with an IC50 value of 12.3 mu M.	[Win, Nwet Nwet; Ito, Takuya; Aimaiti, Simayijiang; Morita, Hiroyuki] Toyama Univ, Inst Nat Med, Toyama 9300194, Japan; [Win, Nwet Nwet; Ngwe, Hla] Univ Yangon, Dept Chem, Yangon 11041, Myanmar; [Imagawa, Hiroshi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Yamashiro, Tokushima 7708514, Japan; [Abe, Ikuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Morita, H (reprint author), Toyama Univ, Inst Nat Med, 2630 Sugitani, Toyama 9300194, Japan.	hmorita@inm.u-toyama.ac.jp	Abe, Ikuro/E-4449-2010		Ministry of Education, Culture, Sports, Science and Technology, Japan; Tokyo Biochemical Research Foundation	This work was supported in part by a Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (H.M. and I.A.) and by a grant from Tokyo Biochemical Research Foundation (H.M. and N.N.W.). We also thank M. Tanaka and Y. Okamoto (Tokushima Bunri University, Tokushima, Japan) for their technical assistance with NMR, MS, and X-ray diffraction measurements.	Spek AL, 2009, ACTA CRYSTALLOGR D, V65, P148, DOI 10.1107/S090744490804362X; Prasad S, 2010, J BIOL CHEM, V285, P26987, DOI 10.1074/jbc.M110.121061; Win NN, 2008, BIOORG MED CHEM LETT, V18, P4688, DOI 10.1016/j.bmcl.2008.07.001; Win NN, 2008, BIOORGAN MED CHEM, V16, P8653, DOI 10.1016/j.bmc.2008.07.091; Win NN, 2008, CHEM PHARM BULL, V56, P491, DOI 10.1248/cpb.56.491; Win NN, 2007, J NAT PROD, V70, P1582, DOI 10.1021/np070286m; TUCHINDA P, 1994, PHYTOCHEMISTRY, V36, P731, DOI 10.1016/S0031-9422(00)89806-4; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Xia XK, 2012, BIOORG MED CHEM LETT, V22, P3017, DOI 10.1016/j.bmcl.2012.01.055; [Anonymous], 1990, TRAD MED FORM US MYA; Thongnest S, 2005, J NAT PROD, V68, P1632, DOI 10.1021/np050186l; Nagashima F, 2003, PHYTOCHEMISTRY, V64, P1319, DOI 10.1016/j.phytochem.2003.08.022; Li F, 2009, BIOL PHARM BULL, V32, P2075, DOI 10.1248/bpb.32.2075; Chang CI, 2005, CHEM PHARM BULL, V53, P286, DOI 10.1248/cpb.53.286; Ferlay J., 2013, IARC CANCERBASE; PRAWAT U, 1993, PHYTOCHEMISTRY, V32, P991, DOI 10.1016/0031-9422(93)85242-J; Rocha AB, 2001, CURR OPIN PHARMACOL, V1, P364; Sheldrick G.M., 2014, SHELXL2014	18	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864	1520-6025		J NAT PROD	J. Nat. Prod.	MAY	2015	78	5					1113	1118		10.1021/acs.jnatprod.5b00108		6	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CJ0IF	WOS:000355158300016		
J	Ohishi, K; Toume, K; Arai, MA; Koyano, T; Kowithayakorn, T; Mizoguchi, T; Itoh, M; Ishibashi, M				Ohishi, Kensuke; Toume, Kazufumi; Arai, Midori A.; Koyano, Takashi; Kowithayakorn, Thaworn; Mizoguchi, Takamasa; Itoh, Motoyuki; Ishibashi, Masami			9-Hydroxycanthin-6-one, a beta-Carboline Alkaloid from Eurycoma longifolia, Is the First Wnt Signal Inhibitor through Activation of Glycogen Synthase Kinase 3 beta without Depending on Casein Kinase 1 alpha	JOURNAL OF NATURAL PRODUCTS			English	Article							COLON-CANCER CELLS; CATENIN; ZEBRAFISH; PATHWAY; DIFFERENTIATION; GROWTH; STEM; LEF1	Wnt signaling regulates various processes such as cell proliferation, differentiation, and embryo development. However, numerous diseases have been attributed to the aberrant transduction of Wnt signaling. We screened a plant extract library targeting TCF/beta-catenin transcriptional modulating activity with a cell-based luciferase assay. Activity-guided fractionation of the MeOH extract of the E. longifolia root led to the isolation of 9-hydroxycanthin-6-one (1). Compound 1 exhibited TCF/beta-catenin inhibitory activity. Compound 1 decreased the expression of Wnt signal target genes, mitf and zic2a, in zebrafish embryos. Treatment of SW480 cells with 1 decreased beta-catenin and increased phosphorylated beta-catenin (Ser 33, 37, Tyr 41) protein levels. The degradation of beta-catenin by 1 was suppressed by GSK3 beta-siRNA, while compound 1 decreased beta-catenin even in the presence of CK1 alpha-siRNA. These results suggest that 1 inhibits Wnt signaling through the activation of GSK3 beta independent of CK1 alpha.	[Ohishi, Kensuke; Toume, Kazufumi; Arai, Midori A.; Mizoguchi, Takamasa; Itoh, Motoyuki; Ishibashi, Masami] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Koyano, Takashi] Temko Corp, Nakano Ku, Tokyo 1640012, Japan; [Kowithayakorn, Thaworn] Khon Kaen Univ, Fac Agr, Khon Kaen 40002, Thailand	Ishibashi, M (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	mish@chiba-u.jp	Ishibashi, Masami /E-5328-2015; Arai, Midori/O-4613-2015; Toume, Kazufumi/A-2632-2012	Ishibashi, Masami /0000-0002-2839-1045; Toume, Kazufumi/0000-0002-3315-145X	JSPS KAKENHI [26293022, 26305001, 25670045, 25870128, 23404007]; MEXT KAKENHI [23102008]; Cosmetology Research Foundation; Hamaguchi Foundation for the Advancement of Biochemistry; Uehara Memorial Foundation	We would like to thank Prof. J. Nathans (John Hopkins University School of Medicine) for the STF/293 cells and Prof. R. T. Moon (University of Washington) for the Super-FOPFlash plasmid. This study was supported by JSPS KAKENHI Grant Numbers 26293022, 26305001, 25670045, 25870128, and 23404007 and MEXT KAKENHI Grant Number 23102008 (a Grant-in-Aid for Scientific Research on Innovative Areas in "Chemical Biology of Natural Products"), the Cosmetology Research Foundation, the Hamaguchi Foundation for the Advancement of Biochemistry, and the Uehara Memorial Foundation.	Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Waaler J, 2012, CANCER RES, V72, P2822, DOI 10.1158/0008-5472.CAN-11-3336; Dorsky RI, 2000, GENE DEV, V14, P158; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Sadot E, 2002, J CELL SCI, V115, P2771; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Ishitani T, 2005, NAT CELL BIOL, V7, P1106, DOI 10.1038/ncb1311; Hao JJ, 2013, CELL REP, V4, P898, DOI 10.1016/j.celrep.2013.07.047; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Kim CH, 2000, NATURE, V407, P913; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Toume K, 2013, ORG LETT, V15, P6106, DOI 10.1021/ol4029995; Ota S, 2012, EMBO J, V31, P1904, DOI 10.1038/emboj.2012.46; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Nishiya N, 2014, CHEM BIOL, V21, P530, DOI 10.1016/j.chembiol.2014.02.015; Park HY, 2014, CHEMBIOCHEM, V15, P872, DOI 10.1002/cbic.201300786; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Gwak J, 2012, CELL RES, V22, P237, DOI 10.1038/cr.2011.127; DePaula JR, 1997, PHYTOCHEMISTRY, V44, P1449, DOI 10.1016/S0031-9422(96)00747-9; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Li XF, 2009, CHEM-ASIAN J, V4, P540, DOI 10.1002/asia.200800354; Grinblat Y, 2001, DEV DYNAM, V222, P688, DOI 10.1002/dvdy.1221; Kanchanapoom T, 2001, PHYTOCHEMISTRY, V56, P383, DOI 10.1016/S0031-9422(00)00363-0; KARDONO LBS, 1991, J NAT PROD, V54, P1360, DOI 10.1021/np50077a020; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; Nyholm MK, 2007, DEVELOPMENT, V134, P735, DOI 10.1242/dev.02756; Pai R, 2004, MOL BIOL CELL, V15, P2156, DOI 10.1091/mbc.E03-12-0894; Ryas M., 1997, P NATL ACAD SCI USA, V94, P10330; Taylor KL, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-11	36	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864	1520-6025		J NAT PROD	J. Nat. Prod.	MAY	2015	78	5					1139	1146		10.1021/acs.jnatprod.5b00153		8	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CJ0IF	WOS:000355158300019		
J	Nakabayashi, R; Yang, ZG; Nishizawa, T; Mori, T; Saito, K				Nakabayashi, Ryo; Yang, Zhigang; Nishizawa, Tomoko; Mori, Tetsuya; Saito, Kazuki			Top-down Targeted Metabolomics Reveals a Sulfur-Containing Metabolite with Inhibitory Activity against Angiotensin-Converting Enzyme in Asparagus officinalis	JOURNAL OF NATURAL PRODUCTS			English	Article							FLAVONOIDS; MS/MS	The discovery of bioactive natural compounds containing sulfur, which is crucial for inhibitory activity against angiotensin-converting enzyme (ACE), is a challenging task in metabolomics. Herein, a new S-containing metabolite, asparaptine (1), was discovered in the spears of Asparagus officinalis by targeted metabolomics using mass spectrometry for S-containing metabolites. The contribution ratio (2.2%) to the IC50 value in the crude extract showed that asparaptine (1) is a new ACE inhibitor.	[Nakabayashi, Ryo; Yang, Zhigang; Nishizawa, Tomoko; Mori, Tetsuya; Saito, Kazuki] RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Nakabayashi, R (reprint author), RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	ryo.nakabayashi@riken.jp; kazuki.saito@riken.jp	Saito, Kazuki/D-2670-2009		Strategic International Collaborative Research Program (SICORP); JST; Japan Advanced Plant Science Network	We would like to thank D. Fine, D. Wheritt, and L. Sumner (Noble Foundation, Ardmore, OK, USA) for useful advice on structure elucidation, and M. Kitajima and H. Takayama (Chiba University) for collecting data on asparaptine (1). We also thank K. Takano and Y. Okazaki for providing freeze-dried samples, Y. Yamada and T. Sakurai (RIKEN CSRS) for technical help in mining S-ions, and T. Tohge (Max-Planck Institute, Potsdam, Germany) for useful comments on the manuscript. This work was partially supported by Strategic International Collaborative Research Program (SICORP), JST, and Japan Advanced Plant Science Network.	Afendi FM, 2012, PLANT CELL PHYSIOL, V53, DOI 10.1093/pcp/pcr165; Al Shukor N, 2013, J AGR FOOD CHEM, V61, P11832, DOI 10.1021/jf404641v; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Acharya KR, 2003, NAT REV DRUG DISCOV, V2, P891, DOI 10.1038/nrd1227; Nakabayashi R, 2014, PLANT J, V77, P367, DOI 10.1111/tpj.12388; Agati G, 2010, NEW PHYTOL, V186, P786, DOI 10.1111/j.1469-8137.2010.03269.x; Sawada Y, 2012, PHYTOCHEMISTRY, V82, P38, DOI 10.1016/j.phytochem.2012.07.007; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Rose P, 2005, NAT PROD REP, V22, P351, DOI 10.1039/b417639c; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Nakabayashi R, 2013, ANAL CHEM, V85, P1310, DOI 10.1021/ac302733c; Nakabayashi R, 2013, ANAL BIOANAL CHEM, V405, P5005, DOI 10.1007/s00216-013-6869-2; Aoyagi Y, 2006, PHYTOCHEMISTRY, V67, P618, DOI 10.1016/j.phytochem.2005.12.002; Dawid C, 2012, J AGR FOOD CHEM, V60, P11889, DOI 10.1021/jf304085j; Haj-Yehia A. I., 2005, HAJYEHIA AI, Patent No. 20,030,777,134; Imai S, 2002, NATURE, V419, P685, DOI 10.1038/419685a; Izawa H, 2012, J JPN SOC FOOD SCI, V59, P348; Kuhl JC, 2004, PLANT CELL, V16, P114, DOI 10.1105/tpc.017202; Mitchell SC, 2014, PHYTOCHEMISTRY, V97, P5, DOI 10.1016/j.phytochem.2013.09.014; Nakabayashi R., J NUTR IN PRESS; Sanae M, 2013, J AGR FOOD CHEM, V61, P5520, DOI 10.1021/jf3041066; Sevin DC, 2015, CURR OPIN BIOTECH, V34, P1, DOI 10.1016/j.copbio.2014.10.001; Yang ZG, 2014, METABOLOMICS, V10, P543, DOI 10.1007/s11306-013-0619-5	23	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864	1520-6025		J NAT PROD	J. Nat. Prod.	MAY	2015	78	5					1179	1183		10.1021/acs.jnatprod.5b00092		5	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CJ0IF	WOS:000355158300026		
J	Yoshino, Y; Mori, Y; Ochi, S; Numata, S; Ishimaru, T; Yamazaki, K; Ohmori, T; Ueno, S				Yoshino, Yuta; Mori, Yoko; Ochi, Shinichiro; Numata, Shusuke; Ishimaru, Takashi; Yamazaki, Kiyohiro; Ohmori, Tetsuro; Ueno, Shu-ichi			No abnormal hexanucleotide repeat expansion of C9ORF72 in Japanese schizophrenia patients	JOURNAL OF NEURAL TRANSMISSION			English	Article						Schizophrenia; C9ORF72; Hexanucleotide repeat expansion; Psychotic symptoms; Japanese population	BIPOLAR DISORDER; FTD; ALS	Abnormal hexanucleotide repeat expansion of C9ORF72 is known to cause neurodegenerative disorders such as frontotemporal dementia. Additionally, patients with psychotic symptoms are more likely to have abnormal hexanucleotide repeat expansion than are patients without them. We investigated the hexanucleotide repeat sizes of C9ORF72 in 466 Japanese schizophrenia patients. We found no abnormal hexanucleotide repeat expansion. In conclusion, C9ORF72 may not be responsible for schizophrenia susceptibility in the Japanese population.	[Yoshino, Yuta; Mori, Yoko; Ochi, Shinichiro; Ishimaru, Takashi; Yamazaki, Kiyohiro; Ueno, Shu-ichi] Ehime Univ, Grad Sch Med, Dept Neuropsychiat Mol & Funct, Toon, Ehime 7910295, Japan; [Numata, Shusuke; Ohmori, Tetsuro] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Psychiat,Course Integrated Brain Sci,Med Inf, Tokushima 7708503, Japan	Yoshino, Y (reprint author), Ehime Univ, Grad Sch Med, Dept Neuropsychiat Mol & Funct, Toon, Ehime 7910295, Japan.	whisperoftheheart2@yahoo.co.jp					Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Galimberti D, 2014, BIPOLAR DISORD, V16, P448, DOI 10.1111/bdi.12169; Beck J, 2013, AM J HUM GENET, V92, P345, DOI 10.1016/j.ajhg.2013.01.011; INGVAR DH, 1974, ACTA PSYCHIAT SCAND, V50, P425, DOI 10.1111/j.1600-0447.1974.tb09707.x; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; Meisler MH, 2013, BIPOLAR DISORD, V15, P326, DOI 10.1111/bdi.12063; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Galimberti D, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.004; Huey ED, 2013, NEUROBIOL AGING, V34, P1309, DOI 10.1016/j.neurobiolaging.2012.08.011; Ogaki K., 2012, NEUROBIOL AGING, V33, pe11, DOI DOI 10.1016/J.NEUR0BI0LAGING.2012.05.011; Pliner HA, 2014, ACTA NEUROPATHOL, V127, P391, DOI 10.1007/s00401-014-1250-x; Rademakers R, 2012, LANCET NEUROL, V11, P297, DOI 10.1016/S1474-4422(12)70046-7	12	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	MAY	2015	122	5					731	732		10.1007/s00702-014-1295-y		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CJ2WD	WOS:000355344500012		
J	Tanaka, Y; Tsuboi, T; Watanabe, H; Kajita, Y; Fujimoto, Y; Ohdake, R; Yoneyama, N; Masuda, M; Hara, K; Senda, J; Ito, M; Atsuta, N; Horiguchi, S; Yamamoto, M; Wakabayashi, T; Sobue, G				Tanaka, Yasuhiro; Tsuboi, Takashi; Watanabe, Hirohisa; Kajita, Yasukazu; Fujimoto, Yasushi; Ohdake, Reiko; Yoneyama, Noritaka; Masuda, Michihito; Hara, Kazuhiro; Senda, Joe; Ito, Mizuki; Atsuta, Naoki; Horiguchi, Satoshi; Yamamoto, Masahiko; Wakabayashi, Toshihiko; Sobue, Gen			Voice features of Parkinson's disease patients with subthalamic nucleus deep brain stimulation	JOURNAL OF NEUROLOGY			English	Article						Parkinson's disease; Deep brain stimulation; Dysarthria; Voice disorders; Acoustic analysis; Voice handicap index	ACOUSTIC ANALYSIS; FOLLOW-UP; SPEECH; DYSFUNCTION; TRACT; TASK; DBS	Voice and speech disorders are one of the most important issues after subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson's disease patients; however, their characteristics remain unclear. We performed a comprehensive voice evaluation including the multi-dimensional voice program for acoustic analysis, the GRBAS scale for perceptual analysis, and the evaluation of the voice handicap index (VHI) for psychosocial analysis. In total, 68 patients who had undergone STN-DBS (37 assessed in the on- and off-stimulation conditions) and 40 who had been treated with medical therapy alone were evaluated. Further, we performed laryngoscopic examinations in 13 STN-DBS and 19 medical-therapy-alone patients. The STN-DBS group, especially females, showed widespread impairment of voice parameters and significantly poorer VHI scores than the medical-therapy-alone group. The degree of voiceless (DUV) and strained voice were the most impaired factors in the STN-DBS group; and DUV significantly improved after stopping stimulation. Furthermore strained voice, breathiness, and asthenia improved after stopping stimulation. Laryngoscopic examination showed that abnormal laryngeal muscle contraction and incomplete glottal closure were more prominent in the STN-DBS group than in the medical-therapy-alone group. We demonstrated that (1) more widespread voice impairment in females, (2) poorer voice-related QOL, (3) worse DUV and strained voice, and (4) abnormal laryngeal muscle contraction were the characteristic voice and laryngeal findings in the STN-DBS group compared with those in the medical-therapy-alone group.	[Tanaka, Yasuhiro; Tsuboi, Takashi; Watanabe, Hirohisa; Ohdake, Reiko; Yoneyama, Noritaka; Masuda, Michihito; Hara, Kazuhiro; Senda, Joe; Ito, Mizuki; Atsuta, Naoki; Sobue, Gen] Nagoya Univ, Dept Neurol, Showa Ku, Nagoya, Aichi 4668560, Japan; [Kajita, Yasukazu; Wakabayashi, Toshihiko] Nagoya Univ, Dept Neurosurg, Nagoya, Aichi 4668560, Japan; [Fujimoto, Yasushi] Nagoya Univ, Dept Otorhinolaryngol, Nagoya, Aichi 4668560, Japan; [Horiguchi, Satoshi] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Minami Ku, Sagamihara, Kanagawa 228, Japan; [Yamamoto, Masahiko] Aichi Gakuin Univ, Dept Hlth Sci, Nisshin, Aichi, Japan	Sobue, G (reprint author), Nagoya Univ, Dept Neurol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668560, Japan.	sobueg@med.nagoya-u.ac.jp		Tsuboi, Takashi/0000-0001-5042-3181			Appleby BS, 2007, MOVEMENT DISORD, V22, P1722, DOI 10.1002/mds.21551; Gervais-Bernard H, 2009, J NEUROL, V256, P225, DOI 10.1007/s00415-009-0076-2; Pollo C, 2014, BRAIN, V137, P2015, DOI 10.1093/brain/awu102; Kent RD, 2003, J COMMUN DISORD, V36, P281, DOI 10.1016/S0021-9924(03)00016-9; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Astrom M, 2010, STEREOT FUNCT NEUROS, V88, P224, DOI 10.1159/000314357; Mate MA, 2012, J VOICE, V26, P496, DOI 10.1016/j.jvoice.2011.03.006; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; HONJO I, 1980, ARCH OTOLARYNGOL, V106, P149; SMITH ME, 1995, J VOICE, V9, P453, DOI 10.1016/S0892-1997(05)80210-3; Garcia MJV, 2011, J VOICE, V25, P208, DOI 10.1016/j.jvoice.2009.08.007; Kent RD, 1999, J COMMUN DISORD, V32, P141, DOI 10.1016/S0021-9924(99)00004-0; Amir O, 2009, BIOMED SIGNAL PROCES, V4, P202, DOI 10.1016/j.bspc.2008.11.002; Klostermann F, 2008, J NEUROL NEUROSUR PS, V79, P522, DOI 10.1136/jnnp.2007.123323; Midi I, 2008, ACTA NEUROL SCAND, V117, P26, DOI 10.1111/j.1600-0404.2007.00965.x; Tommasi G, 2008, J NEUROL NEUROSUR PS, V79, P813, DOI 10.1136/jnnp.2007.117507; Carding PN, 2004, CLIN OTOLARYNGOL, V29, P538, DOI 10.1111/j.1365-2273.2004.00846.x; HUGHES AJ, 1992, NEUROLOGY, V42, P1142; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Sidtis DV, 2010, J SPEECH LANG HEAR R, V53, P1167, DOI 10.1044/1092-4388(2010/09-0154); Lee VS, 2008, J COMMUN DISORD, V41, P485, DOI 10.1016/j.jcomdis.2008.02.001; BOHME G, 1970, FOLIA PHONIATR, V22, P176; D'Alatri L, 2008, J VOICE, V22, P365, DOI 10.1016/j.jvoice.2006.10.010; Deliyski D, 1998, ASHA 98, P1; Deliyski D, 1989, 12 C TRAIT SIGN IM F, P973; Deliyski D, 1993, 3 C SPEECH COMM TECH, P1969; Dromey C., 2011, PARKINSONS DIS, V2011, P1; Espay AJ, 2010, MOVEMENT DISORD, V25, P1456, DOI 10.1002/mds.23111; Frost E, 2010, INT J SPEECH-LANG PA, V12, P399, DOI 10.3109/17549507.2010.497560; Gan J, 2007, J NEUROL, V254, P99, DOI 10.1007/s00415-006-0297-6; González J, 2002, Acta Otorrinolaringol Esp, V53, P256; Hirano M, 1981, CLIN EXAMINATION VOI; Hoffman-Ruddy B, 2001, CLIN LINGUIST PHONET, V15, P97, DOI 10.3109/02699200109167638; Hollien H., 1987, J VOICE, V1, P2, DOI 10.1016/S0892-1997(87)80018-8; Jacobson BH, 1997, AM J SPEECH-LANG PAT, V6, P66; Kent RD, 2000, FOLIA PHONIATR LOGO, V52, P48, DOI 10.1159/000021512; Kleiner-Fisman G, 2006, MOV DISORD S14, V21, P290; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Linville SE, 1996, J VOICE, V10, P190, DOI 10.1016/S0892-1997(96)80046-4; Manfredi C, 1996, MEASUREMENTS, V117, P219; MUELLER PB, 1984, EAR NOSE THROAT J, V63, P292; MYSAK ED, 1959, J SPEECH HEAR RES, V2, P46; Natour Y, 2002, FLORIDA J CHEM DIS, V20, P23; Nishio M., 2011, J COMMUNICATION RES, V2, P1; Nishio M, 2002, SOGO RIHABIRITESHON, V30, P927; Pentax Kay, 2008, SOFTWARE INSTRUCTION, P139; Ramig LA, 1985, ANN OTO RHINOL LARYN, V95, P288; Shiromoto O, 2011, JAPAN J LOGOP PHONIA, V52, P254; Tanaka S, 2014, J NEUROL SCI, V337, P193, DOI 10.1016/j.jns.2013.12.010; Tanaka Y, 2011, FOLIA PHONIATR LOGO, V63, P223, DOI 10.1159/000322059; Tsuboi T, 2015, J NEUROL NE IN PRESS; Valalik I, 2011, CLIN NEUROL NEUROSUR, V113, P188, DOI 10.1016/j.clineuro.2010.11.002; Weiss D, 2010, J NEUROL NEUROSUR PS, V81, P1002, DOI 10.1136/jnnp.2009.196691; Xie Y, 2011, J VOICE, V25, P751, DOI 10.1016/j.jvoice.2010.08.002; Yim SH, 2013, J NEUROL SCI, V334, P63, DOI 10.1016/j.jns.2013.07.015	56	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	MAY	2015	262	5					1173	1181		10.1007/s00415-015-7681-z		9	Clinical Neurology	Neurosciences & Neurology	CI7NN	WOS:000354950500009		
J	Sasaki, M; Ohba, C; Iai, M; Hirabayashi, S; Osaka, H; Hiraide, T; Saitsu, H; Matsumoto, N				Sasaki, Masayuki; Ohba, Chihiro; Iai, Mizue; Hirabayashi, Shinichi; Osaka, Hitoshi; Hiraide, Takuya; Saitsu, Hirotomo; Matsumoto, Naomichi			Sporadic infantile-onset spinocerebellar ataxia caused by missense mutations of the inositol 1,4,5-triphosphate receptor type 1 gene	JOURNAL OF NEUROLOGY			English	Article						Spinocerebellar ataxia type 15/29 (SCA15/29); Infantile-onset; Whole-exome sequencing (WES); Inositol 1,4,5-triphosphate receptor type 1 (ITPR1); ITPR1-related SCA	CEREBELLAR ATAXIAS; ITPR1; DELETION; SCA15; CHILDHOOD; FAMILIES; PREVALENCE; ATROPHY	Mutations in the inositol 1,4,5-triphosphate receptor type 1 gene (ITPR1) have been identified in families with early-onset spinocerebellar ataxia type 29 (SCA29) and late-onset SCA15, but have not been found in sporadic infantile-onset cerebellar ataxia. We examined if mutations of ITPR1 are also involved in sporadic infantile-onset SCA. Sixty patients with childhood-onset cerebellar atrophy of unknown etiology and their families were examined by whole-exome sequencing. We found de novo heterozygous ITPR1 missense mutations in four unrelated patients with sporadic infantile-onset, nonprogressive cerebellar ataxia. Patients displayed nystagmus, tremor, and hypotonia from very early infancy. Nonprogressive ataxia, motor delay, and mild cognitive deficits were common clinical findings. Brain magnetic resonance imaging revealed slowly progressive cerebellar atrophy. ITPR1 missense mutations cause infantile-onset cerebellar ataxia. ITPR1-related SCA includes sporadic infantile-onset cerebellar ataxia as well as SCA15 and SCA29.	[Sasaki, Masayuki; Hiraide, Takuya] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Kodaira, Tokyo 1878551, Japan; [Ohba, Chihiro; Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan; [Iai, Mizue; Osaka, Hitoshi] Kanagawa Children Med Ctr, Dept Neurol, Yokohama, Kanagawa, Japan; [Hirabayashi, Shinichi] Nagano Childrens Hosp, Dept Neurol, Azumino, Japan; [Osaka, Hitoshi] Jichi Med Sch, Dept Pediat, Shimotsuke, Tochigi, Japan	Sasaki, M (reprint author), Natl Ctr Neurol & Psychiat, Dept Child Neurol, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878551, Japan.	masasaki@ncnp.go.jp; t116017g@yokohama-cu.ac.jp; miai@kcmc.jp; shirarin@naganoch.gr.jp; hosaka@jichi.ac.jp; thiraide@ncnp.go.jp; hsaitsu@yokohama-cu.ac.jp; naomat@yokohama-cu.ac.jp			Ministry of Health, Labor and Welfare of Japan [24-7]; Japan Society for the Promotion of Science [25293085, 26670505, 13313587]; Takeda Science Foundation; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japan Science and Technology Agency; Strategic Research Program for Brain Sciences [11105137]; Ministry of Education, Culture, Sports, Science and Technology of Japan [12024421]	We thank all the patients and their families for their participation in this study. This study was supported by the Ministry of Health, Labor and Welfare of Japan [Research Grant for Nervous and Mental Disorders (24-7)]; the Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research (B; 25293085), a Grant-in-Aid for challenging Exploratory Research (26670505), and a Grant-in-Aid for Scientific Research (A) (13313587)]; the Takeda Science Foundation; the fund for the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Japan Science and Technology Agency; the Strategic Research Program for Brain Sciences (11105137); and a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (12024421).	Al-Maawali A, 2012, J CHILD NEUROL, V27, P1121, DOI 10.1177/0883073812448680; Ohba C, 2013, NEUROGENETICS, V14, P225, DOI 10.1007/s10048-013-0375-8; Synofzik M, 2011, J MED GENET, V48, P407, DOI 10.1136/jmg.2010.087023; Sawyer SL, 2014, HUM MUTAT, V35, P45, DOI 10.1002/humu.22451; Marelli C, 2011, ARCH NEUROL-CHICAGO, V68, P637, DOI 10.1001/archneurol.2011.81; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6; Hara K, 2008, NEUROLOGY, V71, P547, DOI 10.1212/01.wnl.0000311277.71046.a0; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Iwaki A, 2008, J MED GENET, V45, P32, DOI 10.1136/jmg.2007.053942; Castrioto A, 2011, EUR J NEUROL, V18, P1263, DOI 10.1111/j.1468-1331.2011.03366.x; Di Gregorio E, 2010, CEREBELLUM, V9, P115, DOI 10.1007/s12311-009-0154-0; Dudding TE, 2004, NEUROLOGY, V63, P2288; Fogel BL, 2014, JAMA NEUROL, V71, P1237, DOI 10.1001/jamaneurol.2014.1944; Fogel BL, 2012, J CHILD NEUROL, V27, P1138, DOI 10.1177/0883073812448231; Huang LJ, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-67; Musselman KE, 2014, NEUROLOGY, V82, P80, DOI 10.1212/01.wnl.0000438224.25600.6c; Novak MJU, 2010, MOVEMENT DISORD, V25, P2176, DOI 10.1002/mds.23223; Obayashi M, 2012, J HUM GENET, V57, P202, DOI 10.1038/jhg.2012.5; Storey Elsdon, 2012, Handb Clin Neurol, V103, P561, DOI 10.1016/B978-0-444-51892-7.00037-1; Sugawara T, 2013, J NEUROSCI, V33, P12186, DOI 10.1523/JNEUROSCI.0545-13.2013; van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108; van de Leemput J, 2010, MOVEMENT DISORD, V25, P771, DOI 10.1002/mds.22970; Yamazaki H, 2011, BIOCHEM BIOPH RES CO, V410, P754, DOI 10.1016/j.bbrc.2011.06.043	25	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	MAY	2015	262	5					1278	1284		10.1007/s00415-015-7705-8		7	Clinical Neurology	Neurosciences & Neurology	CI7NN	WOS:000354950500021		
J	Togawa, J; Nakaoku, Y; Hagiwara, M; Murakami, G; Mitsueda-Ono, T; Ueno, R; Kusunoki, S; Matsui, M				Togawa, Jumpei; Nakaoku, Yuriko; Hagiwara, Mai; Murakami, Gaku; Mitsueda-Ono, Takahiro; Ueno, Rino; Kusunoki, Susumu; Matsui, Masaru			Similarities of serum anti-ganglioside antibodies in first and third episodes of recurrent Guillain-Barre syndrome: case report	JOURNAL OF NEUROLOGY			English	Letter									[Togawa, Jumpei; Nakaoku, Yuriko; Hagiwara, Mai; Murakami, Gaku; Mitsueda-Ono, Takahiro; Matsui, Masaru] Otsu Red Cross Hosp, Dept Neurol, Otsu, Shiga 5208511, Japan; [Ueno, Rino; Kusunoki, Susumu] Kinki Univ, Sch Med, Dept Neurol, Osaka, Osaka 5898511, Japan; [Togawa, Jumpei; Nakaoku, Yuriko] Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto 6068507, Japan	Togawa, J (reprint author), Otsu Red Cross Hosp, Dept Neurol, 1-1-35 Nagara, Otsu, Shiga 5208511, Japan.	togawa-kyt@umin.org					Visser LH, 1998, J NEUROL NEUROSUR PS, V64, P242, DOI 10.1136/jnnp.64.2.242; Mossberg N, 2012, ACTA NEUROL SCAND, V126, P154, DOI 10.1111/j.1600-0404.2012.01667.x; Kuitwaard K, 2009, J NEUROL NEUROSUR PS, V80, P56, DOI 10.1136/jnnp.2008.156463; Tagawa Y, 1998, J NEUROL NEUROSUR PS, V65, P952, DOI 10.1136/jnnp.65.6.952	4	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	MAY	2015	262	5					1360	1362		10.1007/s00415-015-7714-7		3	Clinical Neurology	Neurosciences & Neurology	CI7NN	WOS:000354950500031		
J	Yamamoto, M; Taguchi, S; Sato, S; Surugaya, N				Yamamoto, Masahiko; Taguchi, Shigeo; Sato, Soichi; Surugaya, Naoki			Evaluation of plutonium(IV) extraction rate between nitric acid and tri-n-butylphosphate solution using a glass chip microchannel	JOURNAL OF SEPARATION SCIENCE			English	Article						Extraction rates; Glass chips; Microchannels; Plutonium; Solvent extraction	NORMAL-BUTYL-PHOSPHATE; SOLVENT-EXTRACTION; INORGANIC NITRATES; METAL-IONS; KINETICS; SEPARATION; LIQUID; FLOW; MICROFLUIDICS; TEMPERATURE	Extraction of Pu(IV) with tri-n-butylphosphate is performed using a glass chip microchannel to evaluate the extraction rate. Two-phase flow forms in the microchannel by introducing a solution of Pu(IV) and tri-n-butylphosphate with flow rates above 5 L/min. The Pu(IV) extraction reaction proceeds at the interface between the two phases. To evaluate the extraction rate, the contact time between the two phases is varied from 0.48 to 4.8 s by changing the confluent length of the microchannel and the flow rate. The Pu concentration of each phase collected from the microchannel is measured with an alpha liquid scintillation counter, and the contact time dependence of Pu(IV) extraction is obtained. An extraction model based on diffusion in the microchannel and the reaction at the interface is proposed and applied to determine the extraction rate. The extraction process is assumed to follow pseudo-first-order kinetics, and the extraction rate constant of Pu(IV) is determined to be 1.5 x 10(-2) cm/s. The investigation demonstrates that a microfluidic device can be a new tool to determine Pu(IV) extraction rates.	[Yamamoto, Masahiko; Taguchi, Shigeo; Sato, Soichi; Surugaya, Naoki] Japan Atom Energy Agcy, Tokai, Ibaraki 3191194, Japan	Yamamoto, M (reprint author), Japan Atom Energy Agcy, Tokai Reproc Technol Dev Ctr, Nucl Fuel Cycle Engn Labs, 4-33 Muramatsu, Tokai, Ibaraki 3191194, Japan.	yamamoto.masahiko@jaea.go.jp					ALCOCK K, 1958, J INORG NUCL CHEM, V6, P328, DOI 10.1016/0022-1902(58)80116-5; Aota A, 2009, LAB CHIP, V9, P2470, DOI 10.1039/b904430m; Maruyama T, 2004, ANAL CHEM, V76, P4495, DOI 10.1021/ac049844h; Hotokezaka H, 2005, PROG NUCL ENERG, V47, P439, DOI 10.1016/j.pnucene.2005.05.045; Nichols KP, 2011, J AM CHEM SOC, V133, P15721, DOI 10.1021/ja206020u; Oh D, 2010, J SEP SCI, V33, P1109, DOI 10.1002/jssc.200900766; SAJUN MS, 1981, THERMOCHIM ACTA, V47, P277, DOI 10.1016/0040-6031(81)80107-4; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Nash KL, 1997, SEP SCI TECHNOL, V32, P255, DOI 10.1080/01496399708003198; Wang PL, 2010, J SEP SCI, V33, P2039, DOI 10.1002/jssc.201000162; Ban Y, 2011, J NUCL SCI TECHNOL, V48, P1313, DOI 10.3327/jnst.48.1313; Aota A, 2007, ANGEW CHEM INT EDIT, V46, P878, DOI 10.1002/anie.200600122; Aota A, 2009, MICROCHIM ACTA, V164, P249, DOI 10.1007/s00604-008-0085-3; BAUMGART.F, 1970, J PHYS CHEM-US, V74, P108, DOI 10.1021/j100696a019; BEST GF, 1957, J INORG NUCL CHEM, V4, P315, DOI 10.1016/0022-1902(57)80013-X; HORNER DE, 1980, IND ENG CHEM FUND, V19, P287, DOI 10.1021/i160075a009; HUANG TC, 1988, IND ENG CHEM RES, V27, P1675, DOI 10.1021/ie00081a019; Knoch W., 1964, J CHEM ENG DATA, V9, P60, DOI 10.1021/je60020a017; MAILEN JC, 1981, SEPAR SCI TECHNOL, V16, P1373, DOI 10.1080/01496398108058307; MAILEN JC, 1980, SEPAR SCI TECHNOL, V15, P959, DOI 10.1080/01496398008076280; MATSUDA T, 1986, J NUCL SCI TECHNOL, V23, P529; Morss L. R., 2006, CHEM ACTINIDE TRANSA, V2, P841; Nishihama S, 2006, ARS SEPARATORIA ACTA, V4, P18; NORD L, 1987, ANAL CHIM ACTA, V194, P221, DOI 10.1016/S0003-2670(00)84775-3; Ooe K., 2007, J NUCL RADIOCHEM SCI, V8, P59; RAMANUJAM A, 1978, J INORG NUCL CHEM, V40, P1167, DOI 10.1016/0022-1902(78)80529-6; Sato K, 2000, ANAL SCI, V16, P455, DOI 10.2116/analsci.16.455	27	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	MAY	2015	38	10					1807	1812		10.1002/jssc.201401315		6	Chemistry, Analytical	Chemistry	CJ1GX	WOS:000355233100023		
J	Lantukh, DV; Russell, RP; Campagnola, S				Lantukh, Demyan V.; Russell, Ryan P.; Campagnola, Stefano			V-Infinity Leveraging Boundary-Value Problem and Application in Spacecraft Trajectory Design	JOURNAL OF SPACECRAFT AND ROCKETS			English	Article							MISSION	Interplanetary and intermoon tour missions have benefited from the implementation of leveraging maneuvers that efficiently change spacecraft energy relative to a flyby body. In the current work, these v(infinity) leveraging maneuvers are generalized and reformulated into a boundary-value problem suitable for broad trajectory searches using only one additional continuous degree of freedom. The presented method naturally incorporates noncircular orbits and arbitrary ephemeris locations for bodies as well as leveraging maneuvers between different bodies. These advantages come from using the same boundary conditions as the Lambert problem, which also maintains the Lambert-based outer-loop search architecture used in many trajectory design tools. The general maneuver formulation of the presented method allows it to be used for interplanetary or intermoon trajectories and allows the incorporation of nontangent leveraging transfers. Some examples of the new formulation's utility are also explored using representative transfers; these examples present some of the families of leveraging solutions and show that bielliptic transfers are a special case of interbody leveraging.	[Lantukh, Demyan V.; Russell, Ryan P.] Univ Texas Austin, Dept Aerosp Engn & Engn Mech, Austin, TX 78712 USA; [Campagnola, Stefano] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Dept Space Flight Syst, Sagamihara, Kanagawa 2525210, Japan	Lantukh, DV (reprint author), Univ Texas Austin, Dept Aerosp Engn & Engn Mech, Austin, TX 78712 USA.	demyan@utexas.edu; ryan.russell@utexas.edu; stefano.campagnola@jaxa.jp			NASA Office of the Chief Technologist through a NASA Space Technology Research Fellowship (NSTRF) [NNX12AI77H]; W. M. Keck Foundation Endowed Graduate Fellowship in Engineering	This work was supported in part by a contract with the Johns Hopkins University Applied Physics Laboratory. The authors especially thank Yanping Guo for her programmatic efforts and technical support and guidance. The authors also thank Uday Shankar, Jim McAdams, Martin Ozimek, Justin Atchison, Chris Scott, Fazle Siddique, and Dawn Moessner. This work was also supported in part by the NASA Office of the Chief Technologist through a NASA Space Technology Research Fellowship (NSTRF, grant number NNX12AI77H). The authors thank Claudia Meyer and Stephen Broschart for their support and guidance associated with the NSTRF. The authors also thank the W. M. Keck Foundation for supporting, in part, the presented work through the W. M. Keck Foundation Endowed Graduate Fellowship in Engineering.	Sims JA, 1997, J GUID CONTROL DYNAM, V20, P409, DOI 10.2514/2.4064; PERALTA F, 1995, CONTROL ENG PRACT, V3, P1603, DOI 10.1016/0967-0661(95)00171-P; Campagnola S, 2010, J GUID CONTROL DYNAM, V33, P463, DOI 10.2514/1.44258; Campagnola S, 2010, CELEST MECH DYN ASTR, V108, P165, DOI 10.1007/s10569-010-9295-1; Farquhar RW, 1995, J ASTRONAUT SCI, V43, P353; McAdams JV, 2006, J SPACECRAFT ROCKETS, V43, P1054, DOI 10.2514/1.18178; Mueller R. B. D., 1971, FUNDAMENTALS ASTRODY; Russell RP, 2005, J SPACECRAFT ROCKETS, V42, P138, DOI 10.2514/1.5571; Strange NJ, 2001, ADV ASTRONAUT SCI, V109, P1959; Sweetser T.H., 1993, ADV ASTRONAUTICAL SC, V85, P417; Vasile M, 2006, J SPACECRAFT ROCKETS, V43, P794, DOI 10.2514/1.17413; Williams S., 1990, THESIS PURDUE U W LA	12	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0022-4650	1533-6794		J SPACECRAFT ROCKETS	J. Spacecr. Rockets	MAY	2015	52	3					697	710		10.2514/1.A32918		14	Engineering, Aerospace	Engineering	CI8DC	WOS:000354997900006		
J	Sarli, BV; Kawakatsu, Y; Arai, T				Sarli, Bruno Victorino; Kawakatsu, Yasuhiro; Arai, Tomoko			Design of a Multiple Flyby Mission to the Phaethon-Geminid Complex	JOURNAL OF SPACECRAFT AND ROCKETS			English	Article								A B-type near-Earth asteroid, (3200) Phaethon, is the parent body of the Geminid meteor shower. Unlike most parent bodies of meteor showers, Phaethon is dynamically an asteroid with few cometary features. Asteroids (155140) 2005 UD and (225416) 1999 YC are likely fragments originating from Phaethon, collectively known as the Phaethon-Geminid complex. A mission to this group could provide key information on their origins and solve fundamental issues in thermal and dynamic evolution of comet-asteroid transition bodies. This study assesses the feasibility of a multiple flyby mission for Phaethon, 2005 UD, and 1999 YC by a small-class mission. The objective is to design a simple multiple flyby mission based on ballistic transfers combined with gravity-assisted maneuvers that fly by some or all members of the Phaethon-Geminid complex. The results show periodic launch opportunities to all three asteroids with the best case for Phaethon requiring less than 1km/s of Earth excess velocity. No direct transfer can be made to 1999 YC with less than 4km/s. However, with a gravity-assist maneuver at Mars, an Earth-Mars-1999 YC transfer requires less than 3km/s. It is also found that, with a maximum of 3km/s, there is not a single transfer that connects all asteroids. However, launch windows in the years 2026 and 2027 allow a flyby of Phaethon and later 2005 UD by conducting an Earth gravity-assist maneuver.	[Sarli, Bruno Victorino] Grad Univ Adv Studies, Dept Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Kawakatsu, Yasuhiro] Japan Aerosp Explorat Agcy, Dept Space Flight Syst, Sagamihara, Kanagawa 2525210, Japan; [Arai, Tomoko] Chiba Inst Technol, Planetary Explorat Res Ctr, Chiba 2750016, Japan	Sarli, BV (reprint author), Grad Univ Adv Studies, Dept Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan.	sarli@ac.jaxa.jp; kawakatsu.yasuhiro@jaxa.jp; tomoko.arai@it-chiba.ac.jp					Ohtsuka K, 2006, ASTRON ASTROPHYS, V450, pL25, DOI [10.1051/0004-6361:200600022, 10.1051/0004-6361:20060022]; Jewitt D, 2010, ASTRON J, V140, P1519, DOI 10.1088/0004-6256/140/5/1519; Battin R., 1999, AIAA ED SERIES, P295; Blume WH, 2005, SPACE SCI REV, V117, P23, DOI 10.1007/s11214-005-3386-4; Cochran A., 2006, EARTH MOON PLANETS, V89, P289, DOI [10.1023/A:1021567007750, DOI 10.1023/A:1021567007750EMPLD30167-9295]; de Leon J, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200913609; Jewitt D, 2013, ASTROPHYS J LETT, V771, DOI 10.1088/2041-8205/771/2/L36; Kasuga T, 2009, EARTH MOON PLANETS, V105, P321, DOI 10.1007/s11038-009-9311-1; Perozzi E, 2001, PLANET SPACE SCI, V49, P3, DOI 10.1016/S0032-0633(00)00124-0; Vallado D. A., 2007, FUNDAMENTAL ASTRODYN, P448	10	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0022-4650	1533-6794		J SPACECRAFT ROCKETS	J. Spacecr. Rockets	MAY	2015	52	3					739	745		10.2514/1.A33130		7	Engineering, Aerospace	Engineering	CI8DC	WOS:000354997900009		
J	Saeki, N; Hara, S; Otsuki, M; Yamada, Y				Saeki, Naoaki; Hara, Susumu; Otsuki, Masatsugu; Yamada, Yoji			Analytical and Experimental Investigation of Base-Extension Separation Mechanism for Spacecraft Landing	JOURNAL OF SPACECRAFT AND ROCKETS			English	Article							EXCHANGE-IMPACT-DAMPER; SYSTEM	Future planetary exploration requires spacecraft to land softly on rough terrain and in severe environments. Since conventional landing methods have problems such as high rebounds and excessive resource consumption, the base-extension separation mechanism, which combines springs and separable units, is proposed as a novel landing mechanism. Although the mechanism performed good soft landings, the performance evaluation was limited. Therefore, this study evaluated its performance multilaterally. The proposed technology was analytically compared with two other landing technologies: a generalized-hybrid momentum exchange impact damper and an aluminum foam landing gear. The proposed technology suppressed rebound and acceleration better than the generalized momentum exchange impact damper. Once the components of the proposed technology had been lightened, its energy conversion efficiency matched that of the aluminum foam landing gear. In addition, experiments were conducted using small-scale models to confirm the feasibility. The experiments showed that the proposed technology has good soft landing performance, matching the results of the simulations. Finally, design optimization was discussed for further performance improvements. It was clarified that both the spring stroke and the pre-tension length of the spring should be large. Optimizing the design of the spring improved its performance and compensated for its disadvantages.	[Saeki, Naoaki] Nagoya Univ, Dept Mech Sci & Engn, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Hara, Susumu; Yamada, Yoji] Nagoya Univ, Dept Mech Sci & Engn, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Otsuki, Masatsugu] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan	Saeki, N (reprint author), Nagoya Univ, Dept Mech Sci & Engn, Grad Sch Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.				Mitsubishi Foundation [24132]; Japan Society for the Promotion of Science [23360104, 26249023]	This work was supported in part by the Mitsubishi Foundation (grant 24132) and Grant-in-Aid for Scientific Research: (B) (grant 23360104) and (A) (grant 26249023) from the Japan Society for the Promotion of Science.	Chin G, 2007, SPACE SCI REV, V129, P391, DOI 10.1007/s11214-007-9153-y; [Anonymous], 1969, NASA, P1; Cadogan D, 2002, ACTA ASTRONAUT, V50, P633, DOI 10.1016/S0094-5765(01)00215-6; Hara S, 2011, J GUID CONTROL DYNAM, V34, P1828, DOI 10.2514/1.53786; Hara S., 2012, T JPN SOC MECH ENG-C, V78, P2781, DOI DOI 10.1299/KIKAIC.78.2781; Hashimoto T, 2011, ACTA ASTRONAUT, V68, P1386, DOI 10.1016/j.actaastro.2010.08.027; Ivanov M. C., 2011, TM2011216988 NASA, P8; Kushida Y., 2013, T JAPAN SOC AERONAUT, V10, pPd_67, DOI [10.2322/tastj.10.Pd_67, DOI 10.2322/TASTJ.10.PD_67]; Kushida Y, 2013, J GUID CONTROL DYNAM, V36, P776, DOI 10.2514/1.58373; McDivitt J. A., 1970, NASATMX74200 JOHNS S; Rogers W. F., 1972, TND6850 NASA, P6; Saeki N., 2014, T JAPAN SOC AERONAUT, V12, pPd_91, DOI [10.2322/tastj.12.Pd_91, DOI 10.2322/TASTJ.12.PD_91]; Son L, 2010, J VIB CONTROL, V16, P49, DOI 10.1177/1077546309102675; Son L., 2007, J SYSTEM DESIGN DYNA, V1, P14, DOI DOI 10.1299/JSDD.1.14; Son L., 2008, J SYSTEM DESIGN DYNA, V2, P425, DOI [10.1299/jsdd.2.425, DOI 10.1299/JSDD.2.425]; Tanaka S., 2010, PLANETARY PEOPLE, V19, P214; Yokoyama T., 2008, THESIS GRADUATE U AD, P100	17	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0022-4650	1533-6794		J SPACECRAFT ROCKETS	J. Spacecr. Rockets	MAY	2015	52	3					896	916		10.2514/1.A32956		21	Engineering, Aerospace	Engineering	CI8DC	WOS:000354997900023		
J	van der Ha, J; Mimasu, Y; Tsuda, Y; Mori, O				van der Ha, Jozef; Mimasu, Yuya; Tsuda, Yuichi; Mori, Osamu			Solar and Thermal Radiation Models and Flight Evaluation for IKAROS Solar Sail	JOURNAL OF SPACECRAFT AND ROCKETS			English	Article							SPACECRAFT; PRESSURE; DEMONSTRATOR	This paper gives a detailed evaluation of the solar and thermal radiation accelerations acting on the IKAROS spacecraft consisting of a solar sail and a central body during its operational mission from June to December2010. In particular, the predicted temperatures are compared with actual in-flight measurements on the sail membrane and on the body. The results show good correspondences in most cases, but a few appreciable deviations have been observed as well. The simulation results indicate that the magnitude of the thermal radiation perturbations on the solar sail trajectory is below 1% of those induced by the solar radiation. The accelerations caused by the thermal radiation turn out to be insignificant because their magnitudes are within the range of uncertainty of the accelerations induced by the solar radiation forces.	[Mimasu, Yuya; Tsuda, Yuichi; Mori, Osamu] Japan Aerosp Explorat Agcy, Sagamihara, Kanagawa 2298510, Japan	van der Ha, J (reprint author), 5808 Bell Creek Rd, Deming, WA 98244 USA.	jvdha@aol.com; mimasu.yuya@jaxa.jp; tsuda.yuichi@jaxa.jp; mori.osamu@jaxa.jp					Tsuda Y, 2011, ACTA ASTRONAUT, V69, P833, DOI 10.1016/j.actaastro.2011.06.005; Funase R, 2011, ADV SPACE RES, V48, P1740, DOI 10.1016/j.asr.2011.02.022; Mimasu Y, 2011, ADV SPACE RES, V48, P1810, DOI 10.1016/j.asr.2011.08.030; Kato T, 2012, ADV ASTRONAUT SCI, V143, P1579; Kato T., 2012, ACTA ASTRONAUT, V72, P165, DOI [10.1016/j.actaastro.2011.09.009AASTCF0094-5765, DOI 10.1016/J.ACTAASTRO.2011.09.009AASTCF0094-5765]; Mimasu Y, 2010, ADV ASTRONAUT SCI, V136, P1915; Pisacane V. L., 2008, AIAA ED SERIES, P70; Rievers B, 2012, ADV ASTRONAUT SCI, V143, P1123; Shoemaker MA, 2012, J SPACECRAFT ROCKETS, V49, P212, DOI 10.2514/1.A32063; Tsuda Y, 2013, J GUID CONTROL DYNAM, V36, P967, DOI 10.2514/1.59516; van der Ha J. C., 2014, ADV ASTRONAUTICAL SC, V152, P2727; van der Ha JC, 2010, ADV ASTRONAUT SCI, V136, P1861; Yamaguchi T, 2014, J SPACECRAFT ROCKETS, V51, P381, DOI 10.2514/1.A32387	13	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0022-4650	1533-6794		J SPACECRAFT ROCKETS	J. Spacecr. Rockets	MAY	2015	52	3					958	967		10.2514/1.A33158		10	Engineering, Aerospace	Engineering	CI8DC	WOS:000354997900027		
J	Saka, M; Yamauchi, H; Yoshioka, T; Hamada, H; Gamada, K				Saka, Masayuki; Yamauchi, Hiroki; Yoshioka, Toru; Hamada, Hidetoshi; Gamada, Kazuyoshi			Scapular Kinematics During Late Cocking of a Simulated Throwing Activity in Baseball Players With Shoulder Injury: A Cross-Sectional Study Using a 3D-to-2D Registration Technique	JOURNAL OF SPORT REHABILITATION			English	Article						scapular dyskinesis; glenohumeral rotation; arm-cocking phase; shoulder disorder	PATHOLOGICAL INTERNAL IMPINGEMENT; VIVO GLENOHUMERAL KINEMATICS; HIGH-SCHOOL BASEBALL; MUSCLE-ACTIVITY; POSITION; MOTION; INSTABILITY; RANGE; ORIENTATION; ROTATION	Context: Abnormal scapular kinematics during throwing motion in baseball players with shoulder disorders has not yet been clarified, although altered scapular position has been suggested to be associated with shoulder disorder. Objective: To determine if the shoulders of baseball players with throwing disorders demonstrate abnormal scapular kinematics during the simulated arm-cocking phase of throwing activity. Design: Cross-sectional study. Setting: Laboratory. Participants: Eleven baseball players (age 21.1 +/- 1.2 y) with a unilateral shoulder disorder volunteered to participate, including 9 players at the college level and 2 at the adult level. The mean playing experience was 12.1 +/- 2.7 y. Main Outcome Measures: Scapular upward/downward rotation, anteroposterior tilting, and external/internal rotation during simulated arm-cocking motion were analyzed using a 3-to-2-dimensional registration technique. Results: Scapular external rotation in the throwing shoulder was significantly smaller by 2.0-6.0 degrees than that of the contralateral shoulder. There were no detectable differences in scapular upward/downward rotation or anteroposterior tilting between the throwing and contralateral shoulders. Conclusions: Compared with that in the contralateral shoulder, scapular external rotation was smaller in the throwing shoulder, which would increase glenohumeral horizontal abduction during the arm-cocking phase and be related to the throwing-shoulder disorder.	[Saka, Masayuki; Gamada, Kazuyoshi] Hiroshima Int Univ, Grad Sch Med Technol & Hlth Welf Sci, Hiroshima, Japan; [Yamauchi, Hiroki] Kameda Med Ctr, Dept Rehabil, Chiba, Japan; [Yoshioka, Toru] Saka Midorii Hosp, Dept Orthoped Surg, Hiroshima, Japan; [Hamada, Hidetoshi] Hamawaki Orthoped Hosp, Dept Orthoped Surg, Hiroshima, Japan	Gamada, K (reprint author), Hiroshima Int Univ, Grad Sch Med Technol & Hlth Welf Sci, Hiroshima, Japan.	kazgamada@ortho-pt.com					Andriacchi TP, 2005, BASIC ORTHOPAEDIC BI, P91; Fleisig GS, 1999, J BIOMECH, V32, P1371, DOI 10.1016/S0021-9290(99)00127-X; Ludewig PM, 2000, PHYS THER, V80, P276; Mihata T, 2012, J BONE JOINT SURG AM, V94A, P1576, DOI 10.2106/JBJS.J.01972; Borstad JD, 2006, PHYS THER, V86, P549; Borstad JD, 2005, J ORTHOP SPORT PHYS, V35, P227; Giphart JE, 2012, AM J SPORT MED, V40, P202, DOI 10.1177/0363546511423629; Meyer KE, 2008, J APPL BIOMECH, V24, P24; Shanley E, 2011, AM J SPORT MED, V39, P1997, DOI 10.1177/0363546511408876; Matsuki K, 2012, J ORTHOP SPORT PHYS, V42, P96, DOI 10.2519/jospt.2012.3584; Matsuki K, 2011, J SHOULDER ELB SURG, V20, P659, DOI 10.1016/j.jse.2010.09.012; Andriacchi TP, 1998, J BIOMECH ENG-T ASME, V120, P743, DOI 10.1115/1.2834888; Wilk KE, 2012, CLIN ORTHOP RELAT R, V470, P1586, DOI 10.1007/s11999-012-2265-z; Thomas SJ, 2010, CLIN ORTHOP RELAT R, V468, P1551, DOI 10.1007/s11999-009-1124-z; Borich MR, 2006, J ORTHOP SPORT PHYS, V36, P926, DOI 10.2519/jospt.2006.2241; Nishinaka N, 2008, J SHOULDER ELB SURG, V17, P319, DOI 10.1016/j.jse.2007.05.018; Myers JB, 2005, AM J SPORT MED, V33, P263, DOI 10.1177/0363546504268138; Myers JB, 2006, AM J SPORT MED, V34, P385, DOI 10.1177/0363546505281804; Ogston JB, 2007, AM J SPORT MED, V35, P1361, DOI 10.1177/0363546507300820; Laudner KG, 2010, AM J SPORT MED, V38, P2106, DOI 10.1177/0363546510370291; Escamilla RF, 2009, SPORTS MED, V39, P569, DOI 10.2165/00007256-200939070-00004; Yamamoto N, 2010, J SHOULDER ELB SURG, V19, P681, DOI 10.1016/j.jse.2009.12.006; Thomas SJ, 2010, J ATHL TRAINING, V45, P44, DOI 10.4085/1062-6050-45.1.44; Lukasiewicz AC, 1999, J ORTHOP SPORT PHYS, V29, P574; Thomas SJ, 2010, J SPORT REHABIL, V19, P125; Laudner KG, 2006, J ORTHOP SPORT PHYS, V36, P485; Matsumura N, 2010, AM J SPORT MED, V38, P1000, DOI 10.1177/0363546509355143; Paletta GA, 1997, J SHOULDER ELB SURG, V6, P516, DOI 10.1016/S1058-2746(97)90084-7; JOBE CM, 1995, ARTHROSCOPY, V11, P530, DOI 10.1016/0749-8063(95)90128-0; Forthomme B, 2008, SPORTS MED, V38, P369; Burkhart SS, 2003, ARTHROSCOPY, V19, P641, DOI 10.1016/S0749-8063(03)00389-X; Endo K, 2001, J Orthop Sci, V6, P3, DOI 10.1007/s007760170017; Illyes A, 2006, KNEE SURG SPORT TR A, V14, P673, DOI 10.1007/s00167-005-0012-7; Lin JJ, 2011, J ORTHOP RES, V29, P653, DOI 10.1002/jor.21300; Miyashita K, 2010, AM J SPORT MED, V38, P363, DOI 10.1177/0363546509347542; Roddey TS, 2002, J MAN MANIPULATIVE T, V10, P124, DOI DOI 10.1179/106698102790819247; Saka M, 2012, MED ENG, V6, P19; Seitz AL, 2012, J SPORT REHABIL, V21, P186; Struyf F, 2011, SCAND J MED SCI SPOR, V21, P809, DOI 10.1111/j.1600-0838.2010.01115.x; Takagi Y, 2014, J SHOULDER ELB SURG, V23, P1757, DOI 10.1016/j.jse.2014.03.005; von Eisenhart-Rothe R, 2005, CLIN ORTHOP RELAT R, P82, DOI 10.1097/01.blo.0000150338.27113.14	41	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	MAY	2015	24	2					91	98		10.1123/jsr.2013-0056		8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CJ1UE	WOS:000355269200003		
J	Kawada, T				Kawada, Tomoyuki			Regarding "Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension"	JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION			English	Letter									Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 113, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, 1-1-5 Sendagi, Tokyo 113, Japan.						Lonn E, 2006, NEW ENGL J MED, V354, P1567; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015; Cat ena C, 2014, AM J HYPERTENS; Catena C, 2015, J AM SOC HYPERTENS, V9, P167, DOI 10.1016/j.jash.2014.12.020; Hadj-Taieb S, 2014, CLIN LAB, V60, P897, DOI 10.7754/Clin.Lab.2013.130723	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1933-1711	1878-7436		J AM SOC HYPERTENS	J. Am. Soc. Hypertens.	MAY	2015	9	5					410	411		10.1016/j.jash.2015.03.001		2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CI9DJ	WOS:000355070300016		
J	Abe, H; Kawahara, A; Azuma, K; Taira, T; Takase, Y; Fukumitsu, C; Murata, K; Yamaguchi, T; Akiba, J; Ishii, H; Okamoto, I; Hoshino, T; Takamori, S; Kage, M				Abe, Hideyuki; Kawahara, Akihiko; Azuma, Koichi; Taira, Tomoki; Takase, Yorihiko; Fukumitsu, Chihiro; Murata, Kazuya; Yamaguchi, Tomohiko; Akiba, Jun; Ishii, Hidenobu; Okamoto, Isamu; Hoshino, Tomoaki; Takamori, Shinzou; Kage, Masayoshi			Heterogeneity of Anaplastic Lymphoma Kinase Gene Rearrangement in Non-Small-Cell Lung Carcinomas A Comparative Study Between Small Biopsy and Excision Samples	JOURNAL OF THORACIC ONCOLOGY			English	Article						Anaplastic lymphoma kinase; In situ hybridization; Immunohistochemistry; Crizotinib; Biopsy sample	IN-SITU HYBRIDIZATION; ALK REARRANGEMENT; ROUTINE PRACTICE; CANCER PATIENTS; IMMUNOHISTOCHEMISTRY; ADENOCARCINOMA; FISH; GUIDELINE; FEATURES	Introduction: The standard diagnostic method for echinoderm microtubule-associated protein-like 4-anaplastic lymphoma receptor tyrosine kinase translocation is fluorescence in situ hybridization (FISH). Recently, immunohistochemistry (IHC) has been reported as a potential method in screening for anaplastic lymphoma kinase (ALK)-positive non-small-cell lung carcinomas (NSCLC), whereas several authors have reported a discordance between FISH and IHC results. We investigated the heterogeneity of ALK gene rearrangement in excision specimens by FISH and also examined whether the FISH score of ALK gene rearrangement corresponded in excision and biopsy samples from the same patient. Methods: Twenty ALK IHC-positive patients including six patients treated with crizotinib therapy were evaluated for the presence of ALK FISH. For evaluation of heterogeneity of ALK gene rearrangement in excision specimens, we defined six to 10 observation areas in each case, and the number of ALK FISH positive observation areas (>= 15% rearrangement detected) was investigated. ALK FISH score in small biopsy samples was classified as positive (>= 15% rearrangement detected), equivocal (5-14% rearrangement detected), or negative (< 4% rearrangement detected). Results: Of a total of 64 tumor observation areas from nine excision specimens, 50 areas were positive for ALK gene rearrangement (81.8%). In the comparison of excision and small biopsy samples, all excision specimens were ALK FISH-positive (100%; 6 of 6), whereas only three of the small biopsy samples in these patients were positive (50%; 3 of 6), two were equivocal (33%; 2 of 6), and one was negative (17%; 1 of 6). The two equivocal patients received crizotinib and showed a response. Conclusion: ALK gene rearrangement heterogeneity was observed in NSCLC specimens by FISH. Our findings suggested that IHCpositive/FISH-equivocal cases should not be considered true "false-negatives" when a small biopsy sample was used for ALK analysis.	[Abe, Hideyuki; Kawahara, Akihiko; Taira, Tomoki; Takase, Yorihiko; Fukumitsu, Chihiro; Murata, Kazuya; Yamaguchi, Tomohiko; Kage, Masayoshi] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka, Japan; [Azuma, Koichi; Ishii, Hidenobu; Hoshino, Tomoaki] Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Internal Med, Kurume, Fukuoka 830, Japan; [Akiba, Jun] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan; [Okamoto, Isamu] Kurume Univ Hosp, Ctr Clin & Translat Res, Kurume, Fukuoka, Japan; [Takamori, Shinzou] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 830, Japan	Abe, H (reprint author), Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka, Japan.	abe_hideyuki@kurume-u.ac.jp					Akiba J, 2014, ONCOL LETT, V8, P2155, DOI 10.3892/ol.2014.2511; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; To KF, 2013, J THORAC ONCOL, V8, P883, DOI 10.1097/JTO.0b013e3182904e22; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Proietti A, 2014, CANCER CYTOPATHOL, V122, P445, DOI 10.1002/cncy.21418; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Solomon B, 2009, J THORAC ONCOL, V4, P1450, DOI 10.1097/JTO.0b013e3181c4dedb; Rakha EA, 2014, HISTOPATHOLOGY, V64, P609, DOI 10.1111/his.12357; McLeer-Florin A, 2012, J THORAC ONCOL, V7, P348, DOI 10.1097/JTO.0b013e3182381535; Nishino M, 2012, MODERN PATHOL, V25, P1462, DOI 10.1038/modpathol.2012.109; Yi ES, 2011, J THORAC ONCOL, V6, P459, DOI 10.1097/JTO.0b013e318209edb9; Selinger CI, 2013, MODERN PATHOL, V26, P1545, DOI 10.1038/modpathol.2013.87; Camidge DR, 2012, CANCER-AM CANCER SOC, V118, P4486, DOI 10.1002/cncr.27411; Cabillic F, 2014, J THORAC ONCOL, V9, P295, DOI 10.1097/JTO.0000000000000072; Kawahara A, 2014, DIAGN CYTOPATHOL, V42, P460, DOI 10.1002/dc.22936; Le Quesne J, 2014, J THORAC ONCOL, V9, P769, DOI 10.1097/JTO.0000000000000157; Peters S, 2013, LUNG CANCER, V81, P145, DOI 10.1016/j.lungcan.2013.03.017; Yamashita-Kashima Y, 2014, GASTRIC CANCER, V17, P638, DOI 10.1007/s10120-013-0329-8; Zhou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092828	21	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	MAY	2015	10	5					800	805		10.1097/JTO.0000000000000507		6	Oncology; Respiratory System	Oncology; Respiratory System	CI8AP	WOS:000354990100021		
J	Kadota, K; Nitadori, J; Sima, CS; Ujiie, H; Rizk, NP; Jones, DR; Adusumilli, PS; Travis, WD				Kadota, Kyuichi; Nitadori, Jun-ichi; Sima, Camelia S.; Ujiie, Hideki; Rizk, Nabil P.; Jones, David R.; Adusumilli, Prasad S.; Travis, William D.			Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas	JOURNAL OF THORACIC ONCOLOGY			English	Article						Lung; Adenocarcinoma; Invasion; Spread through air spaces; Recurrence	SIGNIFICANTLY POOR-PROGNOSIS; DISTINCT PATHOLOGICAL MARKER; INTERSTITIAL PNEUMONIA DIP; MICROPAPILLARY PATTERN; HISTOLOGIC SUBTYPE; COMPETING RISK; CANCER; METASTASES; GROWTH; BRONCHIOLOALVEOLAR	Introduction: Tumor invasion in lung adenocarcinoma is defined as infiltration of stroma, blood vessels, or pleura. Based on observation of tumor spread through air spaces (STAS), we considered whether this could represent new patterns of invasion and investigated whether it correlated with locoregional versus distant recurrence according to limited resection versus lobectomy. Methods: We reviewed resected small (less than or equal to 2 cm) stage I lung adenocarcinomas (n = 411; 1995-2006). Tumor STAS was defined as tumor cells-micropapillary structures, solid nests, or single cells-spreading within air spaces in the lung parenchyma beyond the edge of the main tumor. Competing risks methods were used to estimate risk of disease recurrence and its associations with clinicopathological risk factors. Results: STAS was observed in 155 cases (38%). In the limited resection group (n = 120), the risk of any recurrence was significantly higher in patients with STAS-positive tumors than that of patients with STAS-negative tumors (5-year cumulative incidence of recurrence, 42.6% versus 10.9%; P < 0.001); the presence of STAS correlated with higher risk of distant (P = 0.035) and locoregional recurrence (P = 0.001). However, in the lobectomy group (n = 291), the presence of STAS was not associated with either any (P = 0.50) or distant recurrence (P = 0.76). In a multivariate analysis, the presence of tumor STAS remained independently associated with the risk of developing recurrence (hazard ratio, 3.08; P = 0.014). Conclusion: The presence of STAS is a significant risk factor of recurrence in small lung adenocarcinomas treated with limited resection. These findings support our proposal that STAS should formally be recognized as a pattern of invasion in lung adenocarcinoma.	[Kadota, Kyuichi; Nitadori, Jun-ichi; Ujiie, Hideki; Rizk, Nabil P.; Jones, David R.; Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Thorac Serv, Dept Surg, New York, NY 10065 USA; [Sima, Camelia S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA; [Kadota, Kyuichi] Kagawa Univ, Fac Med, Dept Diagnost Pathol, Kagawa, Japan; [Nitadori, Jun-ichi] Univ Tokyo, Grad Sch Med, Dept Thorac Surg, Tokyo, Japan	Travis, WD (reprint author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10065 USA.	adusumip@mskcc.org; travisw@mskcc.org			National Institutes of Health [R21 CA164568-01A1, R21 CA164585-01A1, R01 CA136705-06, U54 CA137788, P30 CA008748, P50 CA086438-13]; US Department of Defense [PR101053, LC110202]; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center	This study was supported by grants from the National Institutes of Health (R21 CA164568-01A1, R21 CA164585-01A1, R01 CA136705-06, U54 CA137788, P30 CA008748, and P50 CA086438-13), the US Department of Defense (PR101053 and LC110202), and Mr. William H. Goodwin and Mrs. Alice Goodwin, the Commonwealth Foundation for Cancer Research, and the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center. The authors thank Joe Dycoco of the Thoracic Surgery Service for assisting with the Thoracic Service of the Department of Surgery's lung cancer database and Alex Torres of the Thoracic Surgery Service for his editorial assistance.	Suzuki K, 2013, J CLIN ONCOL, V31, P490, DOI 10.1200/JCO.2012.45.2052; Dignam JJ, 2012, CLIN CANCER RES, V18, P2301, DOI 10.1158/1078-0432.CCR-11-2097; Kadota K, 2012, MODERN PATHOL, V25, P1117, DOI 10.1038/modpathol.2012.58; Kadota K, 2013, CANCER-AM CANCER SOC, V119, P931, DOI 10.1002/cncr.27863; Okada M, 2005, J THORAC CARDIOV SUR, V129, P87, DOI 10.1016/j.jtcvs.2004.04.030; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Wisnivesky JP, 2010, ANN SURG, V251, P550, DOI 10.1097/SLA.0b013e3181c0e5f3; Kates M, 2011, CHEST, V139, P491, DOI 10.1378/chest.09-2547; Kamiya K, 2008, MODERN PATHOL, V21, P992, DOI 10.1038/modpathol.2008.79; Donington J, 2012, CHEST, V142, P1620, DOI 10.1378/chest.12-0790; Shiono S, 2005, ANN THORAC SURG, V79, P278, DOI 10.1016/j.athoracsur.2004.06.096; Pezzella F, 1997, AM J PATHOL, V151, P1417; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; Giraud P, 2000, INT J RADIAT ONCOL, V48, P1015, DOI 10.1016/S0360-3016(00)00750-1; Kadota K, 2014, MODERN PATHOL, V27, P690, DOI 10.1038/modpathol.2013.188; Kadota K, 2014, AM J SURG PATHOL, V38, P1118, DOI 10.1097/PAS.0000000000000246; Welter S, 2007, ANN THORAC SURG, V84, P203, DOI 10.1016/j.athoracsur.2007.03.028; Nitadori J, 2013, JNCI-J NATL CANCER I, V105, P1212, DOI 10.1093/jnci/djt166; berle DR, 2011, RADIOLOGY, V258, P243, DOI DOI 10.1148/RADI0L.10091808; Chappell R, 2012, CLIN CANCER RES, V18, P2127, DOI 10.1158/1078-0432.CCR-12-0455; CLAYTON F, 1986, CANCER, V57, P1555, DOI 10.1002/1097-0142(19860415)57:8<1555::AID-CNCR2820570820>3.0.CO;2-N; Edge SB, 2009, AJCC CANC STAGING MA, P253; Grills IS, 2007, INT J RADIAT ONCOL, V69, P334, DOI 10.1016/j.ijrobp.2007.03.023; Kadota K, 2014, AM J SURG PATHOL, V38, P448, DOI 10.1097/PAS.0000000000000134; Makimoto Y, 2005, HISTOPATHOLOGY, V46, P677, DOI 10.1111/j.1365-2559.2005.02.126.x; Meng X, 2012, INT J RADIAT ONCOL, V82, P960, DOI 10.1016/j.ijrobp.2010.10.064; Miyoshi T, 2003, AM J SURG PATHOL, V27, P101, DOI 10.1097/00000478-200301000-00011; Mutton AE, 1998, HISTOPATHOLOGY, V33, P129, DOI 10.1046/j.1365-2559.1998.00463.x; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Nia PS, 2008, ANN THORAC SURG, V85, P395, DOI 10.1016/j.athoracsur.2007.08.054; Onozato ML, 2013, AM J SURG PATHOL, V37, P287, DOI 10.1097/PAS.0b013e31826885fb; Onozato Maristela L, 2012, Stud Health Technol Inform, V179, P250; Raparia K, 2014, AM J SURG PATHOL, V38, P921, DOI 10.1097/PAS.0000000000000227; Shiono S, 2005, ANN THORAC SURG, V80, P1040, DOI 10.1016/j.athoracsur.2004.12.033; Tsutsumida H, 2007, MODERN PATHOL, V20, P638, DOI 10.1038/modpathol.3800780; van Loon J, 2012, INT J RADIAT ONCOL, V82, P448, DOI 10.1016/j.ijrobp.2010.09.001	37	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	MAY	2015	10	5					806	814		10.1097/JTO.0000000000000486		9	Oncology; Respiratory System	Oncology; Respiratory System	CI8AP	WOS:000354990100022		
J	Miyanaga, A; Masuda, M; Tsuta, K; Kawasaki, K; Nakamura, Y; Sakuma, T; Asamura, H; Gemma, A; Yamada, T				Miyanaga, Akihiko; Masuda, Mari; Tsuta, Koji; Kawasaki, Kumiko; Nakamura, Yuka; Sakuma, Tomohiro; Asamura, Hisao; Gemma, Akihiko; Yamada, Tesshi			Hippo Pathway Gene Mutations in Malignant Mesothelioma Revealed by RNA and Targeted Exon Sequencing	JOURNAL OF THORACIC ONCOLOGY			English	Article						Malignant mesothelioma; Next-generation sequencer; Hippo pathway; LATS1; Fusion gene	HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; CANCER; LATS1; GROWTH; NF2	Introduction: Malignant mesothelioma (MM) is an aggressive neoplasm causatively associated with exposure to asbestos. MM is rarely responsive to conventional cytotoxic drugs, and the outcome remains dismal. It is, therefore, necessary to identify the signaling pathways that drive MM and to develop new therapeutics specifically targeting the molecules involved. Methods: We performed comprehensive RNA sequencing of 12 MM cell lines and four clinical samples using so-called next-generation sequencers. Results: We found 15 novel fusion transcripts including one derived from chromosomal translocation between the large tumor suppressor 1 (LATS1) and presenilin-1 (PSEN1) genes. LATS1 is one of the central players of the emerging Hippo signaling pathway. The LATS1-PSEN1 fusion gene product lacked the ability to phosphorylate yes-associated protein and to suppress the growth of a MM cell line. The wild-type LATS1 allele was undetectable in this cell line, indicating two-hit genetic inactivation of its tumor suppressor function. Using pathway-targeted exon sequencing, we further identified a total of 11 somatic mutations in four Hippo pathway genes (neurofibromatosis type 2 [NF2], LATS2, RASSF1, and SAV1) in 35% (8 of 23) of clinical samples. Nuclear staining of yes-associated protein was detected in 55% (24 of 44) of the clinical samples. Expression and/or phosphorylation of the Hippo signaling proteins, RASSF1, Merlin (NF2), LATS1, and LATS2, was frequently absent. Conclusions: The frequent alterations of Hippo pathway molecules found in this study indicate the therapeutic feasibility of targeting this pathway in patients with MM.	[Miyanaga, Akihiko; Masuda, Mari; Nakamura, Yuka; Yamada, Tesshi] Natl Canc Ctr, Div Chemotherapy & Clin Res, Tokyo 1040045, Japan; [Miyanaga, Akihiko; Gemma, Akihiko] Nippon Med Sch, Dept Pulm Med & Oncol, Grad Sch Med, Tokyo 113, Japan; [Tsuta, Koji] Natl Canc Ctr, Div Pathol, Tokyo, Japan; [Tsuta, Koji] Natl Canc Ctr, Clin Labs, Tokyo, Japan; [Asamura, Hisao] Natl Canc Ctr, Div Thorac Surg, Tokyo, Japan; [Kawasaki, Kumiko; Sakuma, Tomohiro] Mitsui Knowledge Ind, BioBusiness Grp, Tokyo, Japan	Yamada, T (reprint author), Natl Canc Ctr, Div Chemotherapy & Clin Res, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tya-mada@ncc.go.jp			Program for Promotion of Fundamental Studies in Health Sciences; National Cancer Center Research and Development Fund	This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences conducted by the National Institute of Biomedical Innovation of Japan and the National Cancer Center Research and Development Fund.	Murakami H, 2011, CANCER RES, V71, P873, DOI 10.1158/0008-5472.CAN-10-2164; Visser S, 2010, CELL CYCLE, V9, P3892, DOI 10.4161/cc.9.19.13386; Yang XL, 2001, ONCOGENE, V20, P6516, DOI 10.1038/sj.onc.1204817; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Yokoyama T, 2008, CARCINOGENESIS, V29, P2139, DOI 10.1093/carcin/bgn200; SEKIDO Y, 1995, CANCER RES, V55, P1227; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Xu MZ, 2009, CANCER, V115, P4576, DOI 10.1002/cncr.24495; Masuda M, 2014, MOL CELL PROTEOMICS, V13, P1429, DOI 10.1074/mcp.M113.033845; St John MAR, 1999, NAT GENET, V21, P182; Shitashige M, 2010, CANCER RES, V70, P5024, DOI 10.1158/0008-5472.CAN-10-0306; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; BIANCHI AB, 1995, P NATL ACAD SCI USA, V92, P10854, DOI 10.1073/pnas.92.24.10854; Guo G, 2015, CANCER RES, V72, P264; Ismail-Khan Roohi, 2006, Cancer Control, V13, P255; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Stanger BZ, 2012, GENE DEV, V26, P1263, DOI 10.1101/gad.196501.112; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539	25	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	MAY	2015	10	5					844	851		10.1097/JTO.0000000000000493		8	Oncology; Respiratory System	Oncology; Respiratory System	CI8AP	WOS:000354990100028		
J	Kim, YH; Mishima, M				Kim, Young Hak; Mishima, Michiaki			Relevance of Platinum Sensitivity in Patients with Relapsed or Refractory Small-Cell Lung Cancer	JOURNAL OF THORACIC ONCOLOGY			English	Letter							CHEMOTHERAPY		[Kim, Young Hak; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto 6068507, Japan	Kim, YH (reprint author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Sakyo Ku, 54 Shogoin Kawaracho, Kyoto 6068507, Japan.	ekim@kuhp.kyoto-u.ac.jp					POSTMUS PE, 1987, EUR J CANCER CLIN ON, V23, P1409, DOI 10.1016/0277-5379(87)90128-3; GIACCONE G, 1987, EUR J CANCER CLIN ON, V23, P1697, DOI 10.1016/0277-5379(87)90452-4; Johson DH, 1990, J CLIN ONCOL, V8, P1613; Kim YH, 2010, ONCOL LETT, V1, P569, DOI 10.3892/ol_00000101; Kim YH, 2008, CANCER, V113, P2518, DOI 10.1002/cncr.23871; Lara PN, 2015, J THORAC ONCOL, V10, P110, DOI 10.1097/JTO.0000000000000385	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	MAY	2015	10	5					E35	E35		10.1097/JTO.0000000000000513		1	Oncology; Respiratory System	Oncology; Respiratory System	CI8AP	WOS:000354990100008		
J	Murakami, Y; Saka, H; Oki, M				Murakami, Yasushi; Saka, Hideo; Oki, Masahide			Response to Crizotinib and Clinical Outcome in ALK-Rearranged Pulmonary Pleomorphic Carcinoma	JOURNAL OF THORACIC ONCOLOGY			English	Letter							CHEMOTHERAPY		[Murakami, Yasushi; Saka, Hideo; Oki, Masahide] Nagoya Med Ctr, Dept Resp Med, Nagoya, Aichi 4600001, Japan	Murakami, Y (reprint author), Nagoya Med Ctr, Dept Resp Med, Naka Ku, 4-1-1 Sannomaru, Nagoya, Aichi 4600001, Japan.	konyasu222@gmail.com					Bae HM, 2007, LUNG CANCER, V58, P112, DOI 10.1016/j.lungcan.2007.05.006; Rossi G, 2003, AM J SURG PATHOL, V27, P311, DOI 10.1097/00000478-200303000-00004; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Kaira K, 2010, J THORAC ONCOL, V5, P460, DOI 10.1097/JTO.0b013e3181ce3e3c; Kobayashi Y, 2013, J THORAC ONCOL, V8, pE75, DOI 10.1097/JTO.0b013e318293d96f	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	MAY	2015	10	5					E28	E29		10.1097/JTO.0000000000000450		2	Oncology; Respiratory System	Oncology; Respiratory System	CI8AP	WOS:000354990100003		
J	Duenas, S; Castan, H; Garcia, H; Fuentes, LM; Bailon, L; Campabadal, F; Rafi, JM; Gonzalez, MB; Takakura, K; Tsunoda, I; Yoneoka, M				Duenas, Salvador; Castan, Helena; Garcia, Hector; Maria Fuentes, Lisa; Bailon, Luis; Campabadal, Francesca; Marc Rafi, Joan; Bargallo Gonzalez, Mireia; Takakura, Kenitirou; Tsunoda, Isao; Yoneoka, Masashi			Hole trap distribution on 2MeV electron irradiated high-k dielectrics	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							RADIATION RESPONSE; GATE DIELECTRICS; CAPACITORS; SILICON; CHARGE; AL2O3	The effects of 2MeV electron irradiation on the electrical properties of high-k dielectric based metal-insulator-semiconductor capacitors have been studied. Samples consist of 5.9 nm-thick films of aluminum oxide and hafnium oxide deposited by atomic layer deposition on silicon substrates. Deep-level transient spectroscopy (DLTS) and admittance measurements reveal that electron irradiation modifies the defect density of both surface states at the dielectric-semiconductor interface and border traps existing inside the dielectric. The experimental results indicate that irradiation has a double effect. The incident electrons transfer their energy and generate additional surface states, leading to a degradation of the interface. On the other hand, irradiation generates electron-hole pairs inside the dielectric. Some of the holes are trapped by border traps located inside the dielectric at locations close to the interface. As a result, border traps capturing holes are neutralized and become inactive after irradiation. Moreover, interface state profiles, as measured by DLTS, are affected by the presence of border traps and yield overestimated interface state densities. Admittance spectroscopy is used to distinguish among border traps and interface traps. A detailed study of the conductance signal as a function of voltage, temperature and frequency for samples with different irradiation doses (nonirradiated, 2.5, 25, and 250 Mrad) is presented here. The influence of the irradiation dose has been analyzed in order to compare the defect distribution before and after irradiation. (C) 2015 American Vacuum Society.	[Duenas, Salvador; Castan, Helena; Garcia, Hector; Maria Fuentes, Lisa; Bailon, Luis] Univ Valladolid, Dept Elect, ETSI Telecomunicac, E-47011 Valladolid, Spain; [Campabadal, Francesca; Marc Rafi, Joan; Bargallo Gonzalez, Mireia] CSIC, IMB, CNM, Bellaterra 08193, Spain; [Takakura, Kenitirou; Tsunoda, Isao; Yoneoka, Masashi] Kumamoto Natl Coll Technol, Kumamoto 8611102, Japan	Duenas, S (reprint author), Univ Valladolid, Dept Elect, ETSI Telecomunicac, E-47011 Valladolid, Spain.	sduenas@ele.uva.es	Rafi, Joan Marc/D-5500-2012	Rafi, Joan Marc/0000-0003-4581-9477	Spanish TEC [27292-C02-01, 27292-C02-2]	The study has been supported by the Spanish TEC2011 under Grants Nos. 27292-C02-01 and 27292-C02-2.	Felix JA, 2002, IEEE T NUCL SCI, V49, P3191, DOI 10.1109/TNS.2002.805392; HEIMAN FP, 1965, IEEE T ELECTRON DEV, VED12, P167, DOI 10.1109/T-ED.1965.15475; BARBOLLA J, 1992, SOLID STATE ELECTRON, V35, P285, DOI 10.1016/0038-1101(92)90232-2; Duenas S, 1997, APPL PHYS LETT, V71, P826, DOI 10.1063/1.119658; Felix JA, 2004, MICROELECTRON RELIAB, V44, P563, DOI 10.1016/j.microrel.2003.12.005; Garcia H, 2013, THIN SOLID FILMS, V534, P482, DOI 10.1016/j.tsf.2013.02.004; Hall S, 2007, IEEE T ELECTRON DEV, V54, P272, DOI 10.1109/TED.2006.888673; Kang AY, 2002, IEEE T NUCL SCI, V49, P2636, DOI 10.1109/TNS.2002.805334; NICOLLIA.EH, 1967, BELL SYST TECH J, V46, P1055; PREIER H, 1967, APPL PHYS LETT, V10, P361, DOI 10.1063/1.1728213; Rafi JM, 2013, MICROELECTRON RELIAB, V53, P1333, DOI [10.1016/j.microrel.2013.07.023, 10.1016/j.microre1.2013.07.023]; Rafi JM, 2013, SOLID STATE ELECTRON, V79, P65, DOI 10.1016/j.sse.2012.06.011	12	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	MAY	2015	33	3							032201	10.1116/1.4915617		7	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	CI8HJ	WOS:000355011700043		
J	Higuchi, T; Sasaki, M; Horie, S; Yamada, Y; Matsumoto, S; Fukuda, S				Higuchi, Toshiharu; Sasaki, Masahiro; Horie, Shota; Yamada, Yoichi; Matsumoto, Shuji; Fukuda, Shigeki			On the mechanism of improvement of field emission properties of carbon-coated field emitters	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							ELECTRON-EMISSION; STATES; FILMS	To clarify the origin of the superior field emission characteristics of carbon-coated emitters, the authors investigated the field enhancement and the work function of model systems calculated by numerical simulations. They propose that the field enhancement is due to the triple junctions, which are distributed on the surface of the carbon film consisting of sp(3) (diamond-like) insulating and sp(2) (graphite-like) conducting nanometer-sized grains. The electric field around the triple junction is one order of magnitude higher than at other places. Based on ab initio density functional theory calculations, the authors found that (1) the work functions of diamond and graphite dramatically decrease down to 3-3.6 eV upon hydrogen termination, and (2) the effective work functions of these models decrease to 2-2.5 eV by applying an external electric field of 2.57 x 10(7) V/cm. They also estimated the field emission current from the potential distribution and the local density of states under the external electric field applied. As a result, the authors found that hydrogen termination significantly increases the field emission current. The results suggest that the triple junction and hydrogen termination are promising candidates as the mechanism of improving the emission of the carbon-coated emitters. (C) 2014 American Vacuum Society.	[Higuchi, Toshiharu; Sasaki, Masahiro; Horie, Shota; Yamada, Yoichi] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Matsumoto, Shuji; Fukuda, Shigeki] High Energy Accelerator Res Org, Accelerator Lab, Tsukuba, Ibaraki 3050801, Japan	Higuchi, T (reprint author), Univ Tsukuba, Inst Appl Phys, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058573, Japan.	toshihigu@r7.dion.ne.jp					Miyamoto Y, 1999, PHYS REV B, V59, P9858, DOI 10.1103/PhysRevB.59.9858; O'Donnell KM, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115303; Forbes RG, 2001, SOLID STATE ELECTRON, V45, P779, DOI 10.1016/S0038-1101(00)00208-2; Chung MS, 2006, J VAC SCI TECHNOL B, V24, P909, DOI 10.1116/1.2185650; Forbes RG, 2007, SURF INTERFACE ANAL, V39, P139, DOI 10.1002/sia.2477; Horie S., 2013, P 20 INT DISPL WORKS, P839; Khazaei M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.177602; MAGIC Tool Suite, FDTD PIC SOFTW EM DE; Nagashima S, 2010, J VAC SCI TECHNOL B, V28, pC2A13, DOI 10.1116/1.3333437; PENN DR, 1974, PHYS REV B, V9, P1216, DOI 10.1103/PhysRevB.9.1216; Seah M. P., 1979, Surface and Interface Analysis, V1, DOI 10.1002/sia.740010103; Wang W., 2012, IVNC 25 INT VAC NAN	12	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	MAY	2015	33	3							03C102	10.1116/1.4903229		5	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	CI8HJ	WOS:000355011700002		
J	Matsumura, H; Higashimine, K; Koyama, K; Ohdaira, K				Matsumura, Hideki; Higashimine, Koichi; Koyama, Koichi; Ohdaira, Keisuke			Comparison of crystalline-silicon/amorphous-silicon interface prepared by plasma enhanced chemical vapor deposition and catalytic chemical vapor deposition	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article								The properties of the interface between crystalline silicon (c-Si) and amorphous silicon (a-Si) were studied for two deposition methods of a-Si. One is the conventional plasma enhanced chemical vapor deposition (PECVD) and the other is catalytic chemical vapor deposition (Cat-CVD), often called hot-wire CVD. Surface recombination velocity (SRV) and atomic scale fine structure at the a-Si/c-Si interface were particularly studied. It is found that the a-Si/c-Si interface is very sharp for Cat-CVD a-Si and the width of transition-layer from c-Si to a-Si is less than 0.6 nm, which is three times smaller than for PECVD a-Si. It is also found that the SRV for Cat-CVD a-Si is about 1/3 of that for PECVD, and that the SRV appears to depend on the effective area of the interface which increases due to increase of surface roughness caused by plasma damage. (C) 2015 American Vacuum Society.	[Matsumura, Hideki; Higashimine, Koichi; Koyama, Koichi; Ohdaira, Keisuke] Japan Adv Inst Sci & Technol, Nomi, Ishikawa 9231292, Japan	Matsumura, H (reprint author), Japan Adv Inst Sci & Technol, Nomi, Ishikawa 9231292, Japan.	h-matsu@jaist.ac.jp			CREST Research Program of Japan Science and Technology Agency of Government (JST)	This work was supported by CREST Research Program of Japan Science and Technology Agency of Government (JST). The authors are grateful to H. Rutt, at University of Southampton, UK, for his valuable discussions and suggestion to English writing. The authors are also grateful to students of Japan Advanced Institute of Science and Technology (JAIST) for their various experimental supports.	Masuko K, 2014, IEEE J PHOTOVOLT, V4, P1433, DOI 10.1109/JPHOTOV.2014.2352151; Asari S, 2008, THIN SOLID FILMS, V516, P541, DOI 10.1016/j.tsf.2007.06.209; Koyama K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3483853; Higashimine K, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.4706894; Chapman B., 1980, GLOW DISCHARGE PROCE; Hattori R., 1997, IEEE GAAS IC S OCT, P78; Higashiwaki M, 2006, IEEE ELECTR DEVICE L, V27, P16, DOI 10.1109/LED.2005.860884; Koyama K., 2014, P 40 IEEE PHOT SPEC, P3304; Schroder D. K., 2005, SEMICONDUCTOR MAT DE, V3rd	9	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	MAY	2015	33	3							031201	10.1116/1.4915494		4	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	CI8HJ	WOS:000355011700020		
J	Nakamoto, M; Moon, J				Nakamoto, Masayuki; Moon, Jonghyun			Stable, ruggedized, and nanometer-order size transfer mold field emitter array in harsh oxygen radical environment	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							CARBON NANOTUBES; EMISSION; FABRICATION; CONES	Extremely sharp, uniform, stable, rugged, low operating voltage, and nanometer size molybdenum field emitter arrays (Mo FEAs) were developed by transfer mold fabrication. These can be used in stable and reliable vacuum nanoelectronic devices such as those used in electric propulsion engines and in environmentally demanding applications. Nanometer size transfer mold Mo FEAs were fabricated with base lengths of 36-370 nm. The 36 nm base length transfer mold Mo FEAs are the smallest FEA's ever reported. The tip radii were as sharp as 2.8-3.5 nm. The turn-on fields of the transfer mold Mo FEAs with a base length of 36-370 nm were found to be as low as 9.0-23.6 V/mu m for the short anode-to-apex distance of less than 10 mu m. These are lower than those of conventional FEA's such as carbon nanotube FEAs, Spindt-type FEAs, and Gray-type FEAs with approximate turn-on fields of 50-600 V/mu m. They can thus be used in reliable vacuum nanoelectronic devices. The emission fluctuation of the 36 nm base length transfer mold Mo FEAs without a resistive layer were found to be as low as 61.6% and this value is the lowest ever reported. Conventional FEAs with and without resistive layers have values of 5%-100% and higher than 100%, respectively. The field emission characteristics of the FEAs have been evaluated by in-situ oxygen radical treatment with a flux of 10(15) atoms cm(-2) s(-1). This value is 10(7)-10(8) times higher than that of typical low earth orbit fluxes. The environmental characteristics of the transfer mold Mo FEAs were compared with those of transfer mold Ni FEAs. The turn-on fields of the transfer mold Mo FEAs changed slightly from 10.8 to 22.5 V/mu m at 1 min from the initiation time. It was almost saturated at 29.4 V/mu m upon 5min of in-situ oxygen radical treatment. A rapid increase in the turn-on field from 14.9 to 59.4V/mu m upon in-situ radical treatment for 3 min was observed for the Ni FEAs. The experimental work functions measured by ultraviolet photoelectron spectroscopy and the work functions calculated by the slope of Fowler-Nordheim plots for the transfer mold Mo FEAs changed slightly from 4.3 to 5.2 eV and from 4.3 to 5.3 eV, respectively, after oxygen radical treatment for 5min. The calculated work functions are similar to the experimental work functions because the transfer mold Mo FEAs have extremely uniform geometric factors and stable emission characteristics. The emission fluctuation rates determined without the radical treatment of the transfer mold Mo FEAs without a resistive layer were found to be as low as +/-1.7%. Even with in-situ radical treatment for 30 min the transfer mold Mo FEAs exhibited remarkably stable emission without spike noise and with fluctuations as low as +/-4.5%. Therefore, the extremely stable and nanometer size transfer mold Mo FEAs are expected to be useful in the production of vacuum nanoelectronic devices. (C) 2014 American Vacuum Society.	[Nakamoto, Masayuki; Moon, Jonghyun] Shizuoka Univ, Grad Sch Engn, Elect Res Inst, Naka Ku, Hamamatsu, Shizuoka 4328011, Japan	Nakamoto, M (reprint author), Shizuoka Univ, Grad Sch Engn, Elect Res Inst, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328011, Japan.	m-nakamoto@rie.shizuoka.ac.jp					Han IT, 2002, APPL PHYS LETT, V81, P2070, DOI 10.1063/1.1506408; Nakamoto M, 2002, APPL SURF SCI, V202, P289, DOI 10.1016/S0169-4332(02)00996-0; SPINDT CA, 1976, J APPL PHYS, V47, P5248, DOI 10.1063/1.322600; Lee NS, 2001, DIAM RELAT MATER, V10, P265, DOI 10.1016/S0925-9635(00)00478-7; Li C, 2012, ACS NANO, V6, P3236, DOI 10.1021/nn300111t; BOZLER CO, 1994, J VAC SCI TECHNOL B, V12, P629, DOI 10.1116/1.587401; Gotoh Y, 1996, JPN J APPL PHYS 2, V35, pL1297; ITOH J, 1995, J VAC SCI TECHNOL B, V13, P1968, DOI 10.1116/1.588116; Martin E. E., 1960, 5 WRIGHT AIR DEV DIV, P9; Moulder J. F., 1995, HDB XRAY PHOTOELECTR, P72; Nakamoto M., 2010, VAC SCI TECHNOL B, V28, pC2B1; Nakamoto M., 1996, 42 IEEE INT EL UNPUB, P297; Nakamoto M, 2013, APPL SURF SCI, V275, P178, DOI 10.1016/j.apsusc.2012.12.170; Nakamoto M, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3559006; Pflug D. G., 2001, 47 IEEE INT EL UNPUB, P179; Spindt CA, 1996, J VAC SCI TECHNOL B, V14, P1986, DOI 10.1116/1.588970	16	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	MAY	2015	33	3							03C107	10.1116/1.4905046		8	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	CI8HJ	WOS:000355011700007		
J	Sekiya, T; Sasaki, T; Hane, K				Sekiya, Takuji; Sasaki, Takashi; Hane, Kazuhiro			Design, fabrication, and optical characteristics of freestanding GaN waveguides on silicon substrate	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							MOLECULAR-BEAM EPITAXY; QUANTUM-WELLS; 2ND-HARMONIC GENERATION; CIRCUITS; FIELD	Freestanding GaN waveguides were fabricated on a silicon substrate by a combination of Cl-2 plasma reactive ion etching and XeF2 gas selective etching. The freestanding GaN waveguides ranged from 0.23 to 8 mu m in width and were supported in air by bridge structures. The bridge structures were designed via rigorous electromagnetic simulations using the finite-difference time-domain method. The GaN layer was grown epitaxially on a silicon (111) substrate using a buffer layer to compensate for the crystal lattice constant mismatch. Using two types of masks, the GaN layer was etched using a Cl-2 inductively coupled plasma. The 625-nm-thick GaN layer was etched by the Cl-2 plasma at a substrate temperature of -17 degrees C to form the GaN waveguide patterns, at the expense of a 92-nm-thick HfO2 mask layer. The etching rate of the GaN layer was 170 nm/min and the etching ratio between the GaN and HfO2 layers was 6.8: 1. The silicon substrate was then isotropically etched using XeF2 gas to generate air gaps underneath the GaN waveguides. The transmittance of the fabricated freestanding GaN waveguides was measured using a visible (406 nm) laser and an infrared (1550 nm) laser. The waveguide losses for a 730-nm-wide and 625-nm-thick waveguide were 2.6 dB/mm at 406 nm and 2.2 dB/mm at 1550 nm. These results indicate that the structures are likely to be useful for several visible waveguide devices combined with blue GaN light emitting diodes and for optical telecommunication waveguide devices using the wide transmission window of the GaN crystal. (C) 2015 American Vacuum Society.	[Sekiya, Takuji; Sasaki, Takashi; Hane, Kazuhiro] Tohoku Univ, Dept Nanomech, Sendai, Miyagi 9808579, Japan	Sekiya, T (reprint author), Tohoku Univ, Dept Nanomech, Sendai, Miyagi 9808579, Japan.	hane2@hane.mech.tohoku.ac.jp			JSPS [24246019]; muSIC	This work was partially supported by JSPS (Grant No. 24246019) and mu SIC. The device fabrication was carried out in NMC at Tohoku University.	BURNS WK, 1977, APPL PHYS LETT, V30, P28, DOI 10.1063/1.89199; Saito W, 2004, SOLID STATE ELECTRON, V48, P1555, DOI 10.1016/j.sse.2003.10.003; Li Y, 2007, OPT EXPRESS, V15, P5860, DOI 10.1364/OE.15.005860; Xiong C, 2011, OPT EXPRESS, V19, P10462, DOI 10.1364/OE.19.010462; Hui RQ, 2005, IEEE J QUANTUM ELECT, V41, P100, DOI 10.1109/JQE.2004.838169; NODA S, 1993, IEEE J QUANTUM ELECT, V29, P1640, DOI 10.1109/3.234416; Chowdhury A, 2003, APPL PHYS LETT, V83, P1077, DOI 10.1063/1.1599044; Sameshima H, 2011, IEEE PHOTONIC TECH L, V23, P281, DOI 10.1109/LPT.2010.2102346; Skorka O, 2004, APPL PHYS LETT, V84, P3801, DOI 10.1063/1.1741025; Stolz A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3582055; Iizuka N, 2006, IEEE J QUANTUM ELECT, V42, P765, DOI 10.1109/JQE.2006.878189; Nakazato H, 2012, LAB CHIP, V12, P3419, DOI 10.1039/c2lc40178a; Hui R, 2003, APPL PHYS LETT, V82, P1326, DOI 10.1063/1.1557790; Nikishin SA, 1999, APPL PHYS LETT, V75, P2073, DOI 10.1063/1.124920; Egawa T, 2002, JPN J APPL PHYS 2, V41, pL663, DOI 10.1143/JJAP.41.L663; Fasol G., 1997, BLUE LASER DIODE; Fukazawa T, 2004, JPN J APPL PHYS 1, V43, P646, DOI 10.1143/JJAP.43.646; Waki I, 2006, JPN J APPL PHYS 1, V45, P720, DOI 10.1143/JJAP.45.720; Iizaka N., 2006, J APPL PHYS, V99; Iwakami S, 2007, JPN J APPL PHYS 2, V46, pL721, DOI 10.1143/JJAP.46.L721; Jiang HT, 1999, APPL PHYS LETT, V75, P1932, DOI 10.1063/1.124875; Kokkoris G, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/2/024004; Iizuka N, 2002, APPL PHYS LETT, V81, P1803, DOI 10.1063/1.1505116; LONG XC, 1995, APPL PHYS LETT, V67, P1349, DOI 10.1063/1.115547; Lupu A, 2008, IEEE PHOTONIC TECH L, V20, P102, DOI 10.1109/LPT.2007.912551; Okamoto K., 2011, FUNDAMENTAL OPTICAL, P37; Takeuchi T, 2000, JPN J APPL PHYS 1, V39, P413, DOI 10.1143/JJAP.39.413; Wakui M., 2010, MICROSYST TECHNOL, V17, P109	28	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	MAY	2015	33	3							031207	10.1116/1.4917487		8	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	CI8HJ	WOS:000355011700026		
J	Kozasa, T; Abe, Y; Mitsuhashi, K; Tamura, T; Aoki, H; Ishimaru, M; Nakamura, S; Okamatsu, M; Kida, H; Sakoda, Y				Kozasa, Takashi; Abe, Yuri; Mitsuhashi, Kazuya; Tamura, Tomokazu; Aoki, Hiroshi; Ishimaru, Masatoshi; Nakamura, Shigeyuki; Okamatsu, Masatoshi; Kida, Hiroshi; Sakoda, Yoshihiro			Analysis of a pair of END+ and END- viruses derived from the same bovine viral diarrhea virus stock reveals the amino acid determinants in N-pro responsible for inhibition of type I interferon production	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						bovine viral diarrhea virus; END phenomenon; interferon regulatory factor-3; N-pro; type I interferon	SWINE-FEVER VIRUS; HOG-CHOLERA VIRUS; REVERSE PLAQUE-FORMATION; NEWCASTLE DISEASE VIRUS; REGULATORY FACTOR-3; PROTEASOMAL DEGRADATION; CELL-LINE; PESTIVIRUSES; IDENTIFICATION; PATHOGENICITY	The Exaltation of Newcastle disease virus (END) phenomenon is induced by the inhibition of type I interferon in pestivirus-infected cells in vitro, via proteasomal degradation of cellular interferon regulatory factor (IRF)-3 with the property of the viral autoprotease protein N-pro. Reportedly, the amino acid residues in the zinc-binding TRASH motif of N-pro determine the difference in characteristics between END-phenomenon-positive (END) and END-phenomenon-negative (END-) classical swine fever viruses (CSFVs). However, the basic mechanism underlying this function in bovine viral diarrhea virus (BVDV) has not been elucidated from the genomic differences between END+ and END- viruses using reverse genetics till date. In the present study, comparison of complete genome sequences of a pair of END+ and END- viruses isolated from the same virus stock revealed that there were only four amino acid substitutions (D136G, I2623V, D3148G and D3502Y) between two viruses. Based on these differences, viruses with and without mutations at these positions were generated using reverse genetics. The END assay, measurements of induced type I interferon and IRF-3 detection in cells infected with these viruses revealed that the aspartic acid at position 136 in the zinc-binding TRASH motif of N-pro was required to inhibit the production of type I interferon via the degradation of cellular IRF-3, consistently with CSFV.	[Kozasa, Takashi] Minist Agr Forestry & Fisheries, Food Safety & Consumer Affairs Bur, Chiyoda Ku, Tokyo 1008950, Japan; [Kozasa, Takashi; Ishimaru, Masatoshi; Nakamura, Shigeyuki] Minist Agr Forestry & Fisheries, Natl Vet Assay Lab, Kokubunji, Tokyo 1858511, Japan; [Abe, Yuri; Mitsuhashi, Kazuya; Tamura, Tomokazu; Okamatsu, Masatoshi; Kida, Hiroshi; Sakoda, Yoshihiro] Hokkaido Univ, Microbiol Lab, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan; [Aoki, Hiroshi] Nippon Vet & Life Sci Univ, Dept Basic Sci, Sch Vet Nursing & Technol, Fac Vet Sci, Musashino, Tokyo 1808602, Japan; [Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido 0010020, Japan; [Kida, Hiroshi; Sakoda, Yoshihiro] Hokkaido Univ, Global Stn Zoonosis Control, Global Inst Collaborat Res & Educ GI CoRE, Sapporo, Hokkaido 0010020, Japan	Sakoda, Y (reprint author), Hokkaido Univ, Microbiol Lab, Dept Dis Control, Grad Sch Vet Med,Kita Ku, Kita 18 Nishi 9, Sapporo, Hokkaido 0600818, Japan.	sakoda@vetmed.hokudai.ac.jp					RUMENAPF T, 1993, J VIROL, V67, P3288; Rumenapf T, 1998, J VIROL, V72, P2544; Meyers G, 1996, ADV VIRUS RES, V47, P53, DOI 10.1016/S0065-3527(08)60734-4; STARK R, 1993, J VIROL, V67, P7088; Tautz N, 1997, J VIROL, V71, P5415; Ruggli N, 1996, J VIROL, V70, P3478; Kozasa T, 2011, BIOLOGICALS, V39, P242, DOI 10.1016/j.biologicals.2011.06.001; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Ruggli N, 2009, J VIROL, V83, P817, DOI 10.1128/JVI.01509-08; Fiebach AR, 2011, J VIROL, V85, P8002, DOI 10.1128/JVI.00330-11; Bauhofer O, 2007, J VIROL, V81, P3087, DOI 10.1128/JVI.02032-06; Kameyama K, 2006, J VIROL METHODS, V138, P140, DOI 10.1016/j.jviromet.2006.08.005; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Rasmussen TB, 2010, VET MICROBIOL, V142, P13, DOI 10.1016/j.vetmic.2009.09.037; Tamura T, 2012, J VIROL, V86, P8602, DOI 10.1128/JVI.00551-12; Kameyama K, 2006, VIRUS RES, V116, P78, DOI 10.1016/j.virusres.2005.008.016; COLLETT MS, 1988, VIROLOGY, V165, P200, DOI 10.1016/0042-6822(88)90673-3; FUKUSHO A, 1976, INFECT IMMUN, V14, P332; Gil LHVG, 2006, J VIROL, V80, P900, DOI 10.1128/JVI.80.2.900-911.2006; Gottipati K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003704; HIRANO N, 1987, VET MICROBIOL, V13, P383, DOI 10.1016/0378-1135(87)90069-1; INABA Y, 1968, JPN J MICROBIOL, V12, P35; Jenckel M, 2014, J VIROL, V88, P6983, DOI 10.1128/JVI.00620-14; KUMAGAI T, 1958, SCIENCE, V128, P366, DOI 10.1126/science.128.3320.366; Muhsen M, 2013, ARCH VIROL, V158, P753, DOI 10.1007/s00705-012-1538-x; Nagai M, 2008, VIRUS GENES, V36, P135, DOI 10.1007/s11262-007-0190-0; NAKAMURA S, 1993, VET MICROBIOL, V38, P173, DOI 10.1016/0378-1135(93)90084-K; NAKAMURA S, 1995, J VET MED SCI, V57, P677; Nishine K, 2014, J VET MED SCI, V76, P1635, DOI 10.1292/jvms.14-0220; Sakoda Y, 1998, IN VITRO CELL DEV-AN, V34, P53; Seago J, 2007, J GEN VIROL, V88, P3002, DOI 10.1099/vir.0.82934-0; SHIMIZU Y, 1970, AM J VET RES, V31, P1787; Simmonds P., 2012, VIRUS TAXONOMY, P1003; Szymanski MR, 2009, J MOL BIOL, V391, P438, DOI 10.1016/j.jmb.2009.06.040; Tamura T, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-47	35	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					511	518		10.1292/jvms.14-0420		8	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800001		
J	Ogihara, K; Naya, Y; Sato, R; Onda, K; Ochiai, H				Ogihara, Kikumi; Naya, Yuko; Sato, Reiichiro; Onda, Ken; Ochiai, Hideharu			Analysis of L-type amino acid transporter in canine hepatocellular carcinoma	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						canine; hepatoma; LAT; transporter	1 LAT1 EXPRESSION; CELL LUNG-CANCER; SYSTEM-L; MEMBRANE-PROTEIN; HEAVY-CHAIN; IDENTIFICATION; SEQUENCE; DISTINCT; TARGET; TUMORS	Analysis of L-type amino acid transport expression of hepatocellular carcinoma cells (HCCs) of the dog was performed. The leucine transport activity of canine HCCs was 0.628 +/- 0.018 nmol/mg protein/min. The inhibitor of LAT 2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (BCH) reduced 90% of the activity at I mM. The deduced amino acid sequences of canine LAT2, LAT3 and LAT4 were well conserved in mammalians, exhibiting 89, 88 and 77% homology, respectively. RT-PCR revealed distinct LAT1 expression compared with normal hepatocytes. Western blotting analysis confirmed the potent LAT1 expression in canine HCCs but not hepatocytes, and real-time RT-PCR analysis indicated that canine HCCs possessed 28 times higher LAT I expression than hepatocytes. These results indicated that the leucine transport activity of canine HCCs was due to LAT1.	[Ogihara, Kikumi; Naya, Yuko] Azabu Univ, Lab Pathol, Sch Vet Med, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Sato, Reiichiro; Onda, Ken] Azabu Univ, Lab Internal Med 3, Sch Vet Med, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Ochiai, Hideharu] Azabu Univ, Res Inst Biosci, Sch Vet Med, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan	Ochiai, H (reprint author), Azabu Univ, Res Inst Biosci, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	ochiaih@azabu-u.ac.jp			Azabu University Research Services Division	This study was in part supported by a research project grant awarded by the Azabu University Research Services Division.	Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kaira K, 2011, AM J TRANSL RES, V3, P468; Ichinoe M, 2011, PATHOL INT, V61, P281, DOI 10.1111/j.1440-1827.2011.02650.x; Janpipatkul K, 2014, CELL SIGNAL, V26, P1668, DOI 10.1016/j.cellsig.2014.04.002; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Kobayashi H, 2005, J SURG ONCOL, V90, P233, DOI 10.1002/jso.20257; Babu E, 2003, J BIOL CHEM, V278, P43838, DOI 10.1074/jbc.M305221200; OXENDER DL, 1963, NATURE, V197, P765, DOI 10.1038/197765a0; Bodoy S, 2005, J BIOL CHEM, V280, P12002, DOI 10.1074/jbc.M408638200; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Mastroberardino L, 1998, NATURE, V395, P288; Sakata T, 2009, PATHOL INT, V59, P7, DOI 10.1111/j.1440-1827.2008.02319.x; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43; Uchino H, 2002, MOL PHARMACOL, V61, P729, DOI 10.1124/mol.61.4.729; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; Nakanishi K, 2007, VIRCHOWS ARCH, V451, P681, DOI 10.1007/s00428-007-0457-9; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Fukumoto S, 2013, J VET MED SCI, V75, P431, DOI 10.1292/jvms.12-0356; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Bartlett D. L., 2011, CANC PRINCIPLES PRAC, V9th, P997; Betsunoh H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-509; CHRISTEN.HN, 1969, J BIOL CHEM, V244, P1510; Fukumoto S, 2013, VET J, V198, P164, DOI 10.1016/j.tvjl.2013.06.016; Fukumoto S, 2013, BIOCHEM BIOPH RES CO, V439, P103, DOI 10.1016/j.bbrc.2013.08.020; Kaira K, 2011, ANTICANCER RES, V31, P4075; Li J, 2013, TUMOR BIOL, V34, P2977, DOI 10.1007/s13277-013-0861-5; Maruo T, 2014, J VET MED SCI, V76, P523, DOI 10.1292/jvms.13-0170; Namikawa M., HEPATOL RES IN PRESS; NOVAK DA, 1994, BIOCHEM J, V301, P671; Ochiai H, 2009, J VET MED SCI, V71, P1233, DOI 10.1292/jvms.71.1233; Ochiai H, 2012, J VET MED SCI, V74, P917, DOI 10.1292/jvms.11-0353; OXENDER DL, 1963, J BIOL CHEM, V238, P3686; Rossier G, 1999, J BIOL CHEM, V274, P34948, DOI 10.1074/jbc.274.49.34948; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; WEISSBACH L, 1982, J BIOL CHEM, V257, P2006	38	1	1	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					527	534		10.1292/jvms.14-0392		8	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800003		
J	Zahid, MSH; Awasthi, SP; Hinenoya, A; Yamasaki, S				Zahid, M. Shamim Hasan; Awasthi, Sharda Prasad; Hinenoya, Atsushi; Yamasaki, Shinji			Anethole inhibits growth of recently emerged multidrug resistant toxigenic Vibrio cholerae O1 El Tor variant strains in vitro	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						anethole; El Tor variant; multidrug resistant; natural compounds; Vibrio cholerae	ANTIMICROBIAL ACTIVITY; TOXIN PRODUCTION; SPICES; INDIA	To search natural compounds having inhibitory effect on bacterial growth is important, particularly in view of growing multidrug resistant (MDR) strains of bacterial pathogens. Like other bacterial pathogens, MDR Vibrio cholerae, the causative agent of diarrheal disease cholera, is becoming a great concern. As an approach of searching new antimicrobial agents, here, we show that anethole, a well-studied natural component of sweet fennel and star anise seeds, could potentially inhibit the growth of MDR O1 El Tor biotype, the ongoing 7th cholera pandemic variant strains of toxigenic V cholerae. The minimum inhibitory concentration (MIC) of anethole against diverse O1 El Tor biotype strains is evaluated as 200 mu g/ml. Moreover, the effect of anethole is bactericidal and exerts rapid-killing action on V cholerae cells. This study is the first report which demonstrates that anethole, purified from natural compound, is a potent inhibitor of growth of toxigenic V cholerae. Our data suggest that anethole could be a potential antimicrobial drug candidate, particularly against MDR V cholerae mediated infections.	[Zahid, M. Shamim Hasan; Awasthi, Sharda Prasad; Hinenoya, Atsushi; Yamasaki, Shinji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Vet Sci, Izumisano, Osaka 5988531, Japan	Yamasaki, S (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, 1-58 Rinku Orai Kita, Izumisano, Osaka 5988531, Japan.	shinji@vet.osakafu-u.ac.jp			Ministry of Science, Culture and Sports of Japan	We thank Rupak K. Bhadra (Indian Institute of Chemical Biology), for critical reading the manuscript. This study was performed in partial fulfillment of the requirements of a PhD thesis for M.S.H.Z. from Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Osaka, Japan. M.S.H.Z. and S.P.A. were recipients of the Monbusho Scholarship for a PhD program from the Ministry of Science, Culture and Sports of Japan.	Ramamurthy T, 2003, MICROBES INFECT, V5, P329, DOI 10.1016/S1286-4579(03)00035-2; Sanchez J, 2011, INDIAN J MED RES, V133, P153; Son MS, 2011, J CLIN MICROBIOL, V49, P3739, DOI 10.1128/JCM.01286-11; Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Chatterjee S, 2009, J CLIN MICROBIOL, V47, P1087, DOI 10.1128/JCM.02026-08; Sjölund-Karlsson Maria, 2011, Emerg Infect Dis, V17, P2151, DOI 10.3201/eid1711.110720; Kitaoka M, 2011, J MED MICROBIOL, V60, P397, DOI 10.1099/jmm.0.023051-0; BEUCHAT LR, 1976, J FOOD SCI, V41, P899, DOI 10.1111/j.1365-2621.1976.tb00748.x; Faruque SM, 2007, P NATL ACAD SCI USA, V104, P5151, DOI 10.1073/pnas.0700365104; Bax R, 2000, INT J ANTIMICROB AG, V16, P51, DOI 10.1016/S0924-8579(00)00189-8; Morita M, 2008, MICROBIOL IMMUNOL, V52, P314, DOI 10.1111/j.1348-0421.2008.00041.x; Siddique AK, 2010, EPIDEMIOL INFECT, V138, P347, DOI 10.1017/S0950268809990550; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301; TODA M, 1992, MICROBIOL IMMUNOL, V36, P999; Thakurta P, 2007, J ETHNOPHARMACOL, V111, P607, DOI 10.1016/j.jep.2007.01.022; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; CLSI-Clinical and Laboratory Standards Institute, 2011, PERF STAND ANT SUSC; Corrigan D, 2001, NATURAL REMEDIES THE, V1st, P124; De M, 2002, PHYTOTHER RES, V16, P94, DOI 10.1002/ptr.989; Ghosh-Banerjee J, 2010, J CLIN MICROBIOL, V48, P4283, DOI 10.1128/JCM.00799-10; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075; Kamruzzaman M, 2013, ASIAN PAC J TROP MED, V6, P352, DOI 10.1016/S1995-7645(13)60038-3; Kubo I, 2008, J SCI FOOD AGR, V88, P242, DOI 10.1002/jsfa.3079; Dog TL, 2006, EXPLORE-NY, V2, P446; Nihei K, 2004, J AGR FOOD CHEM, V52, P5011, DOI 10.1021/jf049687n; Quilici ML, 2010, EMERG INFECT DIS, V16, P1804, DOI 10.3201/eid1611.100568; Rattanachaikunsopon P, 2009, BIOSCI BIOTECH BIOCH, V73, P1623, DOI 10.1271/bbb.90128; Tran HD, 2012, J MED MICROBIOL, V61, P431, DOI 10.1099/jmm.0.034744-0	28	1	1	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					535	540		10.1292/jvms.14-0664		6	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800004		
J	Igase, M; Hwang, CC; Coffey, M; Okuda, M; Noguchi, S; Mizuno, T				Igase, Masaya; Hwang, Chung Chew; Coffey, Matt; Okuda, Masaru; Noguchi, Shunsuke; Mizuno, Takuya			The oncolytic effects of reovirus in canine solid tumor cell lines	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						cancer; canine; oncolytic virotherapy; reovirus; solid tumor	PET DOGS; CANCER; APOPTOSIS; SENSITIVITY; ANTIBODIES; INFECTION; MELANOMA; RELEASE; PATHWAY	Oncolytic virotherapy is a new strategy for cancer treatment for humans and dogs. Reovirus has been proven to be a potent oncolytic virus in human medicine. Our laboratory has previously reported that canine mast cell tumor and canine lymphoma were susceptible to reovirus. In this study, canine solid tumor cell lines (mammary gland tumor, osteosarcoma and malignant melanoma) were tested to determine their susceptibility towards reovirus. We demonstrated that reovirus induces more than 50% cell death in three canine mammary gland tumors and one canine malignant melanoma cell line. The reovirus-induced cell death occurred via the activation of caspase 3. Ras activation has been shown to be one of the important mechanisms of reovirus-susceptibility in human cancers. However, Ras activation was not related to the reovinis-susceptibility in canine solid tumor cell lines, which was similar to reports in canine mast cell tumor and canine lymphoma. The results of this study highly suggest that canine mammary gland tumor and canine malignant melanoma are also potential candidates for reovirus therapy in veterinary oncology.	[Igase, Masaya; Noguchi, Shunsuke; Mizuno, Takuya] Yamaguchi Univ, Lab Mol Diagnost & Therapeut, Joint Fac Vet Med, Yamaguchi 7538515, Japan; [Hwang, Chung Chew; Noguchi, Shunsuke; Mizuno, Takuya] Yamaguchi Univ, Lab Mol Diagnost & Therapeut, United Grad Sch Vet Sci, Yamaguchi 7538515, Japan; [Coffey, Matt] Oncolyt Biotech Inc, Calgary, AB, Canada; [Okuda, Masaru] Yamaguchi Univ, Lab Vet Internal Med, Joint Fac Vet Med, Yamaguchi 7538515, Japan; [Okuda, Masaru; Noguchi, Shunsuke; Mizuno, Takuya] Yamaguchi Univ, Biomed Sci Ctr Translat Res, United Grad Sch Vet Sci, Yamaguchi 7538515, Japan	Mizuno, T (reprint author), Yamaguchi Univ, Lab Mol Diagnost & Therapeut, Joint Fac Vet Med, 1677-1 Yoshida, Yamaguchi 7538515, Japan.	mizutaku@yamaguchi-u.ac.jp					Errington F, 2008, GENE THER, V15, P1257, DOI 10.1038/gt.2008.58; Shmulevitz M, 2010, CANCER RES, V70, P4912, DOI 10.1158/0008-5472.CAN-09-4676; ROSEN L, 1963, AM J HYG, V77, P29; Connolly JL, 2000, J VIROL, V74, P2981, DOI 10.1128/JVI.74.7.2981-2989.2000; HASHIRO G, 1977, ARCH VIROL, V54, P307, DOI 10.1007/BF01314776; Alain T, 2007, MOL THER, V15, P1512, DOI 10.1038/sj.mt.6300207; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; Gobar GM, 1998, J AM VET MED ASSOC, V213, P251; Tai JH, 2005, J INFECT DIS, V191, P1221, DOI 10.1086/428911; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Marcato P, 2007, MOL THER, V15, P1522, DOI 10.1038/sj.mt.6300179; Clarke P, 2004, J VIROL, V78, P13132, DOI 10.1128/JVI.78.23.13132-13138.2004; DUNCAN MR, 1978, J VIROL, V28, P444; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Nakagawa T, 2006, RES VET SCI, V80, P317, DOI 10.1016/j.rvsc.2005.07.011; Yang WQ, 2003, CANCER RES, V63, P3162; Bianco SR, 2003, CANCER GENE THER, V10, P726, DOI 10.1038/sj.cgt.7700625; Hwang C. C., 2014, VET COMP ONCOL; Hwang CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073555; Inoue K, 2004, J VET MED SCI, V66, P1437, DOI 10.1292/jvms.66.1437; Kelsey JL, 1998, EPIDEMIOL REV, V20, P204; MacNeill AL, 2012, RES VET SCI, V93, P1036, DOI 10.1016/j.rvsc.2011.10.016; Maeda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043355; REED L. J., 1938, AMER JOUR HYG, V27, P493; Norman KL, 2002, HUM GENE THER, V13, P641, DOI 10.1089/10430340252837233; Sei S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-47; SELB B, 1994, J VIROL METHODS, V47, P15, DOI 10.1016/0166-0934(94)90062-0; Shmulevitz M, 2005, ONCOGENE, V24, P7720, DOI 10.1038/sj.onc.1209041; Thirukkumaran CM, 2003, BLOOD, V102, P377, DOI 10.1182/blood-2002-08-2508; Twigger K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-368; Urbasic AS, 2012, AM J VET RES, V73, P1252, DOI 10.2460/ajvr.73.8.1252; Vacchelli E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24612; van Houdt WJ, 2008, CANCER GENE THER, V15, P284, DOI 10.1038/cgt.2008.2	33	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					541	548		10.1292/jvms.14-0570		8	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800005		
J	Samir, H; Sasaki, K; Ahmed, E; Karen, A; Nagaoka, K; El Sayed, M; Taya, K; Watanabe, G				Samir, Haney; Sasaki, Kazuaki; Ahmed, Eman; Karen, Aly; Nagaoka, Kentaro; El Sayed, Mohamed; Taya, Kazuyoshi; Watanabe, Gen			Effect of a single injection of gonadotropin-releasing hormone (GnRH) and human chorionic gonadotropin (hCG) on testicular blood flow measured by color doppler ultrasonography in male Shiba goats	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						blood supply; goat; testis	LUTEINIZING-HORMONE; TESTOSTERONE; STALLIONS; PLASMA; TESTIS; SPERMATOGENESIS; ARTERY; REPRODUCTION; ULTRASOUND; SONOGRAPHY	Although color Doppler ultrasonography has been used to evaluate testicular blood flow in many species, very little has been done in goat. Eight male Shiba goats were exposed to a single intramuscular injection of either gonadotropin-releasing hormone (GnRH group; 1 mu g/kg BW) or human chorionic gonadotropin (hCG group; 25 IU/kg BW). Plasma testosterone (T), estradiol (E2) and inhibin (INH) were measured just before (0 hr) and at different intervals post injection by radioimmunoassay. Testis volume (TV) and Doppler indices, such as resistive index (RI) and pulsatility index (PI) of the supratesticular artery, were measured by B-mode and color Doppler ultrasonography, respectively. The results indicated an increase in testicular blood flow in both groups, as RI and PI decreased significantly (P<0.05), but this increase was significant higher and earlier in hCG group (1 hr) than in the GnRH group (2 hr). A high correlation was found for RI and PI with both T (RI, r= -0.862; PI, r= -0.707) and INH in the GnRH group (RI, r=0.661; PI, r=0.701). However, a significant (P<0.05) correlation was found between E2 and both RI (r= -0.610) and PI (r= -0.763) in hCG group. In addition, TV significantly increased and was highly correlated with RI in both groups (GnRH, r= -0.718; hCG, r= -0.779). In conclusion, hCG and GnRH may improve testicular blood flow and TV in Shiba goats.	[Samir, Haney; Ahmed, Eman; Nagaoka, Kentaro; Taya, Kazuyoshi; Watanabe, Gen] Tokyo Univ Agr & Technol, Vet Physiol Lab, Fuchu, Tokyo 1838509, Japan; [Samir, Haney; El Sayed, Mohamed] Cairo Univ, Dept Theriogenol, Fac Vet Med, Giza 12211, Egypt; [Sasaki, Kazuaki] Tokyo Univ Agr & Technol, Lab Vet Pharmacol, Fuchu, Tokyo 1838509, Japan; [Ahmed, Eman] Suez Canal Univ, Dept Pharmacol, Fac Vet Med, Ismailia 41522, Egypt; [Karen, Aly] Kafrelsheikh Univ, Dept Theriogenol, Fac Vet Med, Kafrelsheikh 13561, Egypt	Watanabe, G (reprint author), Tokyo Univ Agr & Technol, Vet Physiol Lab, Cooperat Dept Vet Med, Fac Agr, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	gen@cc.tuat.ac.jp	Nagaoka, Kentaro/C-2019-2013	Nagaoka, Kentaro/0000-0003-1038-1380			Meachem SJ, 2001, EUR J ENDOCRINOL, V145, P561, DOI 10.1530/eje.0.1450561; MIDDLETON WD, 1989, AM J ROENTGENOL, V152, P293; Gunzel-Apel AR, 2001, REPROD DOMEST ANIM, V36, P236, DOI 10.1046/j.1439-0531.2001.00288.x; YEN SSC, 1968, J CLIN ENDOCR METAB, V28, P1763; Zelli R, 2013, RES VET SCI, V95, P632, DOI 10.1016/j.rvsc.2013.04.023; Herwig R, 2004, J ASSIST REPROD GEN, V21, P175, DOI 10.1023/B:JARG.0000031251.57848.04; Pozor MA, 2004, THERIOGENOLOGY, V61, P799, DOI 10.1016/S0093-691X(03)00227-9; Sakamoto H, 2008, ASIAN J ANDROL, V10, P319, DOI 10.1111/j.1745-7262.2008.00340.x; Rosenfeld CR, 2002, VASC PHARMACOL, V38, P115, DOI 10.1016/S0306-3623(02)00135-0; TAKIHARA H, 1983, FERTIL STERIL, V39, P836; Saito H, 2012, ANIM SCI J, V83, P487, DOI 10.1111/j.1740-0929.2011.00978.x; Paltiel HJ, 2002, RADIOLOGY, V222, P114; Biagiotti G, 2002, BJU INT, V90, P903, DOI 10.1046/j.1464-4096.2002.03033.x; Bollwein H, 2008, J REPROD DEVELOP, V54, P335, DOI 10.1262/jrd.20014; DUFAU ML, 1978, VITAM HORM, V36, P461; Gabor G, 1998, THERIOGENOLOGY, V50, P177, DOI 10.1016/S0093-691X(98)00124-1; Ginther O.J., 2007, ULTRASONIC IMAGING A; Gonzalvo Victor Perez, 1993, Archivos Espanoles de Urologia, V46, P669; Gumbsch P, 2002, VET REC, V151, P140; HAMADA T, 1989, J ENDOCRINOL, V122, P697, DOI 10.1677/joe.0.1220697; HSU HS, 1994, EUR UROL, V25, P71; KANO Y, 1977, Experimental Animals (Tokyo), V26, P239; KAY GW, 1992, J REPROD FERTIL, V96, P549; Kim Sun-Ouck, 2011, Chonnam Med J, V47, P39, DOI 10.4068/cmj.2011.47.1.39; Kutzler M., 2011, VET MED INT, V2011; LIN YC, 1985, LIFE SCI, V37, P481, DOI 10.1016/0024-3205(85)90411-4; McKinnon A. O., 1993, EQUINE REPROD; PADRON RS, 1980, J CLIN ENDOCR METAB, V50, P1100; Panarace M, 2008, THERIOGENOLOGY, V70, P648, DOI 10.1016/j.theriogenology.2008.04.027; Papparella A., 2013, OPEN J PEDIAT, V3, P85; Parlevliet JM, 2001, VET QUART, V23, P84; Pozor M. A., 2007, Clinical Techniques in Equine Practice, V6, P271, DOI 10.1053/j.ctep.2007.09.007; Pozor MA, 2006, ANIM REPROD SCI, V94, P146, DOI 10.1016/j.anireprosci.2006.03.092; Roser J. F., 1995, BIOL REPROD MONOGR, V1, P661; Saleh M, 2012, REPRODUCTION, V144, P77, DOI 10.1530/REP-12-0093; SEAMANS MC, 1991, J REPROD FERTIL, P57; SEGUIN BE, 1977, AM J VET RES, V38, P1153; Serin G, 2010, THERIOGENOLOGY, V74, P1082, DOI 10.1016/j.theriogenology.2010.05.005; SETCHELL BP, 1990, REPROD FERT DEVELOP, V2, P291, DOI 10.1071/RD9900291; Taya K, 1985, JAPANESE J ANIMAL RE, V31, P186; Trinchard-Lugan I, 2002, Reprod Biomed Online, V4, P106; Ungerfeld R, 2011, REPROD DOMEST ANIM, V46, P720, DOI 10.1111/j.1439-0531.2010.01735.x; VELDHUIS JD, 1986, J CLIN INVEST, V77, P1122, DOI 10.1172/JCI112411; WIDMARK A, 1989, ACTA ENDOCRINOL-COP, V121, P621; ZWAIN I, 1989, BIOL REPROD, V40, P503, DOI 10.1095/biolreprod40.3.503	45	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					549	556		10.1292/jvms.14-0633		8	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800006		
J	Koide, R; Sakaguchi, S; Miyazawa, T				Koide, Rie; Sakaguchi, Shoichi; Miyazawa, Takayuki			Basic biological characterization of feline morbillivirus	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						feline; feline morbillivirus; quantification; replication kinetics; stability	CANINE-DISTEMPER VIRUS; MEASLES-VIRUS; INFECTION; ESTABLISHMENT; DISEASE; CATS	Feline morbillivirus (FmoPV) is an emerging virus that was recently discovered in domestic cats with chronic nephritis. Despite the potential role of FmoPV in chronic nephritis, little is known about its biological characteristics. In this study, we established a quantitative assay of FmoPV by using an indirect immunofluorescence technique. Viral titers of FmoPV were determined in one week. Treatment with polybrene (R) or trypsin which was previously used in virus isolation did not augment the virus titers. FmoPV was notably stable at 4 degrees C, retaining high titers for at least 12 days. Heat-treatment at 60 degrees C and 70 degrees C effectively inactivated FmoPV in 10 and 2 min, respectively. The biological characteristics of FmoPV reported here will be beneficial for establishing an efficient virus isolation method and will provide important information to take a measure to reduce the risk of FmoPV infection.	[Koide, Rie; Sakaguchi, Shoichi; Miyazawa, Takayuki] Kyoto Univ, Lab Signal Transduct, Dept Cell Biol, Inst Virus Res,Sakyo Ku, Kyoto 6068507, Japan	Miyazawa, T (reprint author), Kyoto Univ, Lab Signal Transduct, Dept Cell Biol, Inst Virus Res,Sakyo Ku, 53 Shogoin Kawaharacho, Kyoto 6068507, Japan.	takavet@gmail.com			Japan Society for the Promotion of Science	Shoichi Sakaguchi was supported by a fellowship of the Japan Society for the Promotion of Science.	Burnouf T, 2000, BLOOD REV, V14, P94, DOI 10.1054/blre.2000.0129; BLACK FL, 1959, VIROLOGY, V7, P184, DOI 10.1016/0042-6822(59)90186-2; Furuya T, 2014, ARCH VIROL, V159, P371, DOI 10.1007/s00705-013-1813-5; Welch BD, 2012, P NATL ACAD SCI USA, V109, P16672, DOI 10.1073/pnas.1213802109; Sakaguchi S, 2014, J GEN VIROL, V95, P1464, DOI 10.1099/vir.0.065029-0; DIBARTOLA SP, 1987, J AM VET MED ASSOC, V190, P1196; Sakaguchi S, 2008, J VET MED SCI, V70, P785, DOI 10.1292/jvms.70.785; Woo PCY, 2012, P NATL ACAD SCI USA, V109, P5435, DOI 10.1073/pnas.1119972109; Enders G., 1996, MED MICROBIOLOGY; Lamb RA, 2013, FIELDS VIROLOGY, V1, P957; LULICH JP, 1992, COMP CONT EDUC PRACT, V14, P127; MENNA JH, 1975, INFECT IMMUN, V11, P152; Nakaya Y, 2010, J VET MED SCI, V72, P67, DOI 10.1292/jvms.09-0184; Pawar RM, 2011, TROP ANIM HEALTH PRO, V43, P1617, DOI 10.1007/s11250-011-9880-7; Schlegel A, 2001, TRANSFUSION, V41, P382, DOI 10.1046/j.1537-2995.2001.41030382.x; SUMMERS BA, 1984, J COMP PATHOL, V94, P65, DOI 10.1016/0021-9975(84)90009-4; von Messling V, 2004, J VIROL, V78, P7894, DOI 10.1128/JVI.78.15.7894-7903.2004; YOUNGNER JS, 1966, J BACTERIOL, V92, P862	18	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					565	569		10.1292/jvms.14-0623		5	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800008		
J	Mori, K; Suzuki, S; Koyabu, D; Kimura, J; Han, SY; Endo, H				Mori, Kent; Suzuki, Satoshi; Koyabu, Daisuke; Kimura, Junpei; Han, Sung-Yong; Endo, Hideki			Comparative functional anatomy of hindlimb muscles and bones with reference to aquatic adaptation of the sea otter	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						hindlimb; muscle; mustelidae; sea otter; swimming locomotion	MINK MUSTELA-VISON; AMERICAN MINK; FOOD-HABITS; DIET; MORPHOLOGY; BEHAVIOR; EVOLUTIONARY; CARNIVORANS; LOCOMOTION; ENERGETICS	Although the sea otter (Enhydra lutris) is a complete aquatic species, spending its entire life in the ocean, it has been considered morphologically to be a semi-aquatic animal. This study aimed to clarify the unique hindlimb morphology and functional adaptations of E. lutris in comparison to other Mustelidae species. We compared muscle mass and bone measurements of five Mustelidae species: the sea otter, Eurasian river otter (Lutra lutra), American mink (Neovison vison), Japanese weasel (Mustela itatsi) and Siberian weasel (M sibirica). In comparison with the other 4 species, E. harts possessed significantly larger gluteus, popliteus and peroneus muscles, but smaller adductor and ischiopubic muscles. The popliteus muscle may act as a medial rotator of the crus, and the peroneus muscle may act as an abductor of the fifth toe and/or the pronator of the foot. The bundles of the gluteus superficialis muscle of E. lutris were fused with those of the tensor fasciae latae muscle and gluteofemoralis muscles, and they may play a role in femur abduction. These results suggest that E. lutris uses the abducted femur, medially rotated crus, eversion of the ankle and abducted fifth digit or extended interdigital web as a powerful propulsion generator. Therefore, we conclude that E. lutris is a complete aquatic animal, possessing differences in the proportions of the hindlimb muscles compared with those in other semi-aquatic and terrestrial mustelids.	[Mori, Kent] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Mori, Kent; Koyabu, Daisuke; Endo, Hideki] Univ Tokyo, Univ Museum, Tokyo 1130033, Japan; [Suzuki, Satoshi] Fukui City Museum Nat Hist, Fukui 9188006, Japan; [Kimura, Junpei] Seoul Natl Univ, Coll Vet Med, Dept Anat & Cell Biol, Seoul 151742, South Korea; [Han, Sung-Yong] Korean Otter Res Ctr, Hwacheon Gun 209821, Gangwon Do, South Korea	Mori, K (reprint author), Univ Tokyo, Univ Museum, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mori@um.u-tokyo.ac.jp					Sato JJ, 2012, MOL PHYLOGENET EVOL, V63, P745, DOI 10.1016/j.ympev.2012.02.025; KVITEK RG, 1993, MAR MAMMAL SCI, V9, P168, DOI 10.1111/j.1748-7692.1993.tb00441.x; Bartoszewicz M, 2003, FOLIA ZOOL, V52, P225; Fish FE, 1996, AM ZOOL, V36, P628; BRAND PW, 1981, J HAND SURG-AM, V6, P209; TARASOFF FJ, 1972, CAN J ZOOLOG, V50, P915, DOI 10.1139/z72-124; FISH FE, 1994, J MAMMAL, V75, P989, DOI 10.2307/1382481; Samuels JX, 2008, J MORPHOL, V269, P1387, DOI 10.1002/jmor.10662; Brzezinski M, 2008, MAMM BIOL, V73, P177, DOI 10.1016/j.mambio.2007.04.005; BERTA A, 1985, J PALEONTOL, V59, P809; BIRKS JDS, 1985, HOLARCTIC ECOL, V8, P245; Blanco-Garrido F, 2008, BIOL INVASIONS, V10, P641, DOI 10.1007/s10530-007-9158-1; DAY MG, 1972, J ZOOL, V167, P463; DUNSTONE N, 1980, CARNIVORE, V2-3, P56; Evans H. E., 1993, MILLERS ANATOMY DOG; FISH FE, 1991, ZOOMORPHOLOGY, V110, P339, DOI 10.1007/BF01668024; Fish FE, 2008, COMP BIOCHEM PHYS A, V150, P136, DOI 10.1016/j.cbpa.2006.06.019; Fisher E. M., 1942, OSTEOLOGY MYOLOGY CA; Gambarjan P. P., 1961, Zoologische Jahrbuecher (Anatomie), V79, P123; HOWARD L D, 1975, Proceedings of the California Academy of Sciences, V40, P335; Howell AB, 1930, AQUATIC MAMMALS THEI; Kaneko Y, 2009, MAMM STUDY, V34, P97, DOI 10.3106/041.034.0205; Kawada S., 2001, NAGOYA SOC MAMMAL, V3, P39; Kenyon K. W., 1969, SEA OTTER E PACIFIC, P68; Klingener D., 1979, LAB ANATOMY MINK; Legendre P., 1998, NUMERICAL ECOLOGY; Love J. A., 1990, SEA OTTERS; Marmi J, 2004, ZOOL SCR, V33, P481, DOI 10.1111/j.0300-3256.2004.00165.x; Nowak R. M., 1999, WALKERS MAMMALS WORL; R Core Team, 2013, R LANG ENV STAT COMP; Samuels JX, 2013, J MORPHOL, V274, P121, DOI 10.1002/jmor.20077; Sasaki Hiroshi, 1994, Journal of the Mammalogical Society of Japan, V19, P21; Smith J. M., 1956, Journal of the Linnean Society Zoology, V42, P603; STEIN BR, 1989, J MAMMAL, V70, P467, DOI 10.2307/1381418; STEIN BR, 1988, J MAMMAL, V69, P500, DOI 10.2307/1381341; Tarasoff F. J., 1972, FUNCTIONAL ANATOMY M, P333; TATARA M, 1994, ECOL RES, V9, P99, DOI 10.1007/BF02347247; Taylor WP, 1914, U CALIF PUBL GEOL, V7, P465; WILLIAMS TM, 1989, J COMP PHYSIOL A, V164, P815, DOI 10.1007/BF00616753; WILLIAMS TM, 1983, J EXP BIOL, V103, P155	40	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					571	578		10.1292/jvms.14-0534		8	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800009		
J	Yamane, I; Ishizeki, S; Yamazaki, H				Yamane, Itsuro; Ishizeki, Sayoko; Yamazaki, Hisanori			Aujeszky's disease and the effects of infection on Japanese swine herd productivity: a cross-sectional study	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						Aujeszky's disease; PigINFO; postweaning mortality; pseudorabies virus; swine	PSEUDORABIES VIRUS; RISK-FACTORS; ERADICATION; VACCINATION; PIGS; PLEUROPNEUMONIAE; GERMANY	Pseudorabies virus (PRV) is endemic in some regions of Japan. We investigated the effects of PRV infection status on herd productivity. Serum samples were obtained from 48 swine herds in Japan. Within each herd, three serum samples were obtained from growing pigs at four different ages, as well as from sows in low and high parity groups. Sera were tested for antibodies against wild-type PRY via competitive ELISA. Herds were classified into PRV positive and negative groups based on serological results. Herds infected with PRY exhibited postweaning mortalities (6.84%) that were significantly (P=0.0018) higher than those in unaffected herds (4.73%). Because of the reduced productivity in PRY positive herds, the current PRY eradication program must be strengthened.	[Yamane, Itsuro; Yamazaki, Hisanori] Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki 3050856, Japan; [Ishizeki, Sayoko] Summit Vet Serv, Maebashi, Gunma 3710232, Japan	Yamane, I (reprint author), Natl Inst Anim Hlth, 3-1-5 Kannnonndai, Tsukuba, Ibaraki 3050856, Japan.	iyamane@affrc.go.jp			NIAH; JASV	This study was supported by collaborative research grants from the NIAH and JASV. We thank the veterinarians and farmers who participated in this study.	Pensaert M, 2000, VET RES, V31, P141, DOI 10.1051/vetres:2000112; Muller T, 2003, J VET MED B, V50, P207, DOI 10.1046/j.1439-0450.2003.00666.x; BECHNIELSEN S, 1992, J AM VET MED ASSOC, V200, P1817; Boelaert F, 1999, PREV VET MED, V41, P239, DOI 10.1016/S0167-5877(99)00058-6; ELBERS ARW, 1990, VET QUART, V12, P221; Inch C, 1998, CAN VET J, V39, P23; ITAKURA C, 1981, JPN J VET SCI, V43, P923; LEONTIDES L, 1995, PREV VET MED, V23, P73, DOI 10.1016/0167-5877(94)00431-H; Ogikubo T., 2009, ALL SWINE, V34, P3; Rodriguez-Buenfil JC, 2002, PREV VET MED, V53, P205, DOI 10.1016/S0167-5877(01)00267-7; SAKANO T, 1993, J VET MED SCI, V55, P575; Shibata I, 1998, J VET MED SCI, V60, P295, DOI 10.1292/jvms.60.295; STEGEMAN A, 1995, VET QUART, V17, P150; Tamba M, 2002, PREV VET MED, V54, P203, DOI 10.1016/S0167-5877(02)00028-4; Yamada S., 2008, P JPN PIG VET SOC, V52, P22; Yamane I., 2013, Journal of Veterinary Epidemiology, V17, P44	16	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					579	582		10.1292/jvms.14-0385		4	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800010		
J	Ito, H				Ito, Hiroya			The genetic organization of the capsular polysaccharide biosynthesis region of Actinobacillus pleuropneumoniae serotype 14	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						Actinobacillus pleuropneumoniae serotype 14; Actinobacillus suis; capsular polysaccharide biosynthesis; genetic organization	LIPOPOLYSACCHARIDE-O-CHAIN; MULTIPLEX PCR; TOXIN GENOTYPES; STRAINS; IDENTIFICATION; PIGS; SEQUENCE; SEROVARS	The genetic organization of the gene involved in the capsular polysaccharide (CPS) biosynthesis of Actinobacillus pleuropneumoniae serotype 14 has been determined. The DNA region for the CPS biosynthesis of serotype 14 (cps14) comprised 9 open reading frames, designated as cps14AB(1)B(2)B(3)CDEFG genes, encoding Cps14A to Cps14G protein, respectively. Cps14A was similar to CpsA of A. pleuropneumoniae serotypes 1, 4 and 12; the Cps14B(1) and Cps14B(2) were similar to CpsB of A. pleuropneumoniae serotypes 1, 4 and 12, suggesting that CPS structure of A. pleuropneumoniae serotype 14 would belong to Group I including A. pleuropneumoniae serotypes 1, 4, 12 and 15. Surprisingly, the overall nucleotide sequence, deduced amino acid sequence, and the genetic organization of the cps14 were nearly identical to those of Actinobacillus suis. This study will provide the molecular basic knowledge for development of diagnostics and vaccine of A. pleuropneumoniae serotype 14.	Natl Agr & Food Res Org, Natl Inst Anim Hlth, Tsukuba, Ibaraki, Japan	Ito, H (reprint author), Natl Agr & Food Res Org, Natl Inst Anim Hlth, 3-1-5 Kannondai, Tsukuba, Ibaraki, Japan.	itohiroy@affrc.go.jp					Nielsen R, 1997, VET MICROBIOL, V54, P35, DOI 10.1016/S0378-1135(96)01267-9; MacLean LL, 2004, INFECT IMMUN, V72, P5925, DOI 10.1128/IAI.72.10.5925-5930.2004; Maldonado J, 2009, J VET DIAGN INVEST, V21, P854; Ito H, 2010, J VET MED SCI, V72, P653; Jessing SG, 2008, VET MICROBIOL, V129, P350, DOI 10.1016/j.vetmic.2007.12.003; Angen O, 2008, VET MICROBIOL, V132, P312, DOI 10.1016/j.vetmic.2008.05.010; Xu ZF, 2010, J BACTERIOL, V192, P5625, DOI 10.1128/JB.00535-10; Schuchert JA, 2004, J CLIN MICROBIOL, V42, P4344, DOI 10.1128/JCM.42.9.4344-4388.2004; Blackall PJ, 2002, VET MICROBIOL, V84, P47, DOI 10.1016/S0378-1135(01)00428-X; Lo TM, 1998, J CLIN MICROBIOL, V36, P1704; Bosse JT, 2014, J CLIN MICROBIOL, V52, P2380, DOI 10.1128/JCM.00685-14; Zhou L, 2008, J CLIN MICROBIOL, V46, P800, DOI 10.1128/JCM.01787-07; Bandara AB, 2003, INFECT IMMUN, V71, P3320, DOI 10.1128/IAI.71.6.3320-3328.2003; Jessing SG, 2003, J CLIN MICROBIOL, V41, P4095, DOI 10.1128/JCM.41.9.4095-4100.2003; Perry MB, 2012, VET MICROBIOL, V156, P403, DOI 10.1016/j.vetmic.2011.11.024; Perry MB, 2005, BIOCHEM CELL BIOL, V83, P61, DOI 10.1139/O04-112; BECK M, 1994, J CLIN MICROBIOL, V32, P2749; DOM P, 1994, VET QUART, V16, P10; Fussing V, 1998, VET MICROBIOL, V62, P145, DOI 10.1016/S0378-1135(98)00205-3; Gottschalk M., 2012, DIS SWINE, P653; Inzana TJ, 2004, VET MICROBIOL, V104, P63, DOI 10.1016/j.vetmic.2004.08.004; Ito H, 2004, PLASMID, V51, P41, DOI 10.1016/j.plasmid.2003.10.001; ITO H, 1995, MICROB PATHOGENESIS, V18, P29; MacInnes JI, 2012, J BACTERIOL, V194, P6686, DOI 10.1128/JB.01633-12; Maldonado J., 2006, P 19 IPVS C, V238; PERRY MB, 1990, SERODIAG IMMUN INF D, V4, P299, DOI 10.1016/0888-0786(90)90018-J; POHL S, 1983, INT J SYST BACTERIOL, V33, P510	27	1	1	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					583	586		10.1292/jvms.14-0174		4	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800011		
J	Uemura, M; Igarashi, H; Ozawa, A; Tsunekawa, N; Kurohmaru, M; Kanai-Azuma, M; Kanai, Y				Uemura, Mami; Igarashi, Hitomi; Ozawa, Aisa; Tsunekawa, Naoki; Kurohmaru, Masamichi; Kanai-Azuma, Masami; Kanai, Yoshiakira			Fate mapping of gallbladder progenitors in posteroventral foregut endoderm of mouse early somite-stage embryos	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						fate mapping; foregut; gallbladder; mouse	REDUNDANT ROLES; GUT ENDODERM; SOX17; CELLS; DIFFERENTIATION; MICE; MOVEMENT; LIVER; FETAL	In early embryogenesis, the posteroventral foregut endoderm gives rise to the budding endodermal organs including the liver, ventral pancreas and gallbladder during early somitogenesis. Despite the detailed fate maps of the liver and pancreatic progenitors in the mouse foregut endoderm, the exact location of the gallbladder progenitors remains unclear. In this study, we performed a DiI fate-mapping analysis using whole-embryo cultures of mouse early somite-stage embryos. Here, we show that the majority of gallbladder progenitors in 9-11-somite-stage embryos are located in the lateral-most domain of the foregut endoderm at the first intersomite junction level along the anteroposterior axis. This definition of their location highlights a novel entry point to understanding of the molecular mechanisms of initial specification of the gallbladder.	[Uemura, Mami; Igarashi, Hitomi; Ozawa, Aisa; Tsunekawa, Naoki; Kurohmaru, Masamichi; Kanai, Yoshiakira] Univ Tokyo, Dept Vet Anat, Bunkyo Ku, Tokyo 1138657, Japan; [Kanai-Azuma, Masami] Tokyo Med & Dent Univ, Ctr Expt Anim, Bunkyo Ku, Tokyo 1138510, Japan	Kanai, Y (reprint author), Univ Tokyo, Dept Vet Anat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aykanai@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Science, Sports and Culture of Japan	The authors wish to deeply thank Prof. Yukio Saijoh (Department of Neurobiology and Anatomy, The University of Utah, U.S.A.) for his kind and valuable suggestions on the DiI fate-mapping analyses. The authors also wish to thank Dr. Miyuri Kawasumi, Dr. Yoshiko Kuroda, Dr. Hiroki Higashiyama, Dr. Hiroyuki Sumitomo and Ms. Yuki Uchiyama for their helpful support, and Ms. Itsuko Yagihashi for her secretarial assistance. This work was supported by financial grants from the Ministry of Education, Science, Sports and Culture of Japan.	Angelo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040707; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Hara K, 2009, DEV BIOL, V330, P427, DOI 10.1016/j.ydbio.2009.04.012; Engert S, 2009, GENESIS, V47, P603, DOI 10.1002/dvg.20540; Tremblay KD, 2005, DEV BIOL, V280, P87, DOI 10.1016/j.ydbio.2005.01.003; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344; Pfister S, 2011, INT J DEV BIOL, V55, P45, DOI 10.1387/ijdb.103158sp; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Matsuura K, 2009, MECH DEVELOP, V126, P817, DOI 10.1016/j.mod.2009.07.009; Shimoda M, 2007, J CELL SCI, V120, P3859, DOI 10.1242/jcs.007856; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Kanai Y, 1996, J CELL BIOL, V133, P667, DOI 10.1083/jcb.133.3.667; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Arterbery AS, 2014, PEDIATR RES, V75, P120, DOI 10.1038/pr.2013.201; Franklin V, 2008, MECH DEVELOP, V125, P587, DOI 10.1016/j.mod.2008.04.001; Kinder SJ, 2000, METH MOL B, V135, P425; LAWSON KA, 1987, DEVELOPMENT, V101, P627; Miki R, 2012, MECH DEVELOP, V128, P597, DOI 10.1016/j.mod.2011.12.004; Nobuhisa I, 2014, MOL CELL BIOL, V34, P1976, DOI 10.1128/MCB.01485-13; Saito Y, 2013, BIOL OPEN, V2, P779, DOI 10.1242/bio.20135348; Saund RS, 2012, DEVELOPMENT, V139, P2426, DOI 10.1242/dev.079921; STURM K, 1993, METHOD ENZYMOL, V225, P164; Tam PPL, 2007, DEVELOPMENT, V134, P251, DOI 10.1242/dev.02724; Uemura M, 2013, DEVELOPMENT, V140, P639, DOI 10.1242/dev.086702; Uemura M, 2010, BIOCHEM BIOPH RES CO, V391, P357, DOI 10.1016/j.bbrc.2009.11.063	28	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					587	591		10.1292/jvms.14-0635		5	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800012		
J	Nakanishi, A; Mashita, T; Akiyama, K; Nakanishi, W; Mori, T; Yano, M; Asai, T; Kano, R; Shimamura, S; Yasuda, J				Nakanishi, Ataru; Mashita, Tadahisa; Akiyama, Kyoko; Nakanishi, Wakana; Mori, Takashi; Yano, Masaki; Asai, Tetsuo; Kano, Rui; Shimamura, Syunsuke; Yasuda, Jun			Suppurative granulomatous sinorhinitis associated with Nocardia spp. infection in a cat	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						intranasal mass; nocardiosis; radiation therapy; suppurative granulomatous inflammation	AFRICANA	A 9-year-old spayed female cat was examined for cheek skin drainage. The skin lesion did not respond to medical therapy; thereafter, facial deformity developed. A computed tomography revealed an intranasal mass and maxillary osteolysis. The mass was histopathologically diagnosed as suppurative granulomatous inflammation caused by filamentous bacteria. The lesion responded well to radiation therapy. Although actinomycosis was suspected histopathologically, no actinomycetes were detected in the nasal lesion by a bacterial culture conducted at a commercial laboratory. The submandibular lymph node and subcutaneous tissue exhibited swelling. Microbiological examination and genetic analysis based on 16S rDNA gene sequence revealed that Nocardia spp. were isolated from both lesions.	[Nakanishi, Ataru; Mashita, Tadahisa; Akiyama, Kyoko; Nakanishi, Wakana] Maizuru Anim Med Ctr, Maizuru 6250037, Japan; [Mashita, Tadahisa; Asai, Tetsuo; Shimamura, Syunsuke; Yasuda, Jun] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan; [Mori, Takashi] Gifu Univ, Lab Vet Clin Oncol, Dept Vet Med, Gifu 5011193, Japan; [Mori, Takashi; Yano, Masaki] Gifu Univ, Anim Med Ctr, Gifu 5011193, Japan; [Kano, Rui] Nihon Univ, Sch Vet Med, Dept Pathobiol, Fujisawa, Kanagawa 2528510, Japan	Nakanishi, A (reprint author), Maizuru Anim Med Ctr, Maizuru 6250037, Japan.	ataruatare@gmail.com					Angeles RM, 2008, DIAGN CYTOPATHOL, V36, P266, DOI 10.1002/dc.20804; Malik R, 2006, AUST VET J, V84, P235, DOI 10.1111/j.1751-0813.2006.00004.x; Harada H, 2009, J VET MED SCI, V71, P785, DOI 10.1292/jvms.71.785; CHUN JS, 1995, INT J SYST BACTERIOL, V45, P240; Chun J, 1998, INT J SYST BACTERIOL, V48, P901; de Farias MR, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-239; Edwards DF, 2006, INFECT DIS DOG CAT, P451; Hattori Y, 2003, J CLIN MICROBIOL, V41, P908, DOI 10.1128/JCM.41.2.908-910.2003; Linda M., SMALL ANIMAL DERMATO, V2nd, P52; MCNEILL MM, 1994, CLIN MICROBIOL REV, V7, P357	10	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					597	599		10.1292/jvms.14-0319		3	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800014		
J	Okabe, F; Nakagiri, Y; Yamada, T; Kose, H				Okabe, Fumio; Nakagiri, Yoko; Yamada, Takahisa; Kose, Hiroyuki			Laser induced injury caused hyperglycemia-like effect in Drosophila larva: a possible insect model for posttraumatic diabetes	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						animal model; Drosophila; metabolism; posttraumatic diabetes	INDUCED INSULIN-RESISTANCE; CARBOHYDRATE-METABOLISM; MELANOGASTER; STRESS; FLIES; PHOSPHORYLATION; HOMEOSTASIS; ABLATION; HORMONE; MUSCLE	Diabetic patients need particular care in case of infection, digestive disorder or external injury, because external stress often exasperates the glucose metabolism, which is known as "sick day management". In addition, severe trauma can be a cause of hyperglycemia with insulin resistance. In spite of critical component of the treatment, the precise mechanisms of how trauma develops posttraumatic diabetes remain unknown. Here, we ablated body wall muscles in Drosophila larvae by laser beam and found that the level of trehalose, the principal sugar circulating in the hemolymph or in the tissues of most insects, was increased. The model may provide a helpful tool to understand the relationship between trauma and sugar metabolism.	[Okabe, Fumio; Nakagiri, Yoko; Kose, Hiroyuki] Int Christian Univ, Dept Life Sci, Div Nat Sci, Mitaka, Tokyo 1818585, Japan; [Yamada, Takahisa] Niigata Univ, Grad Sch Sci & Technol, Lab Anim Genet, Niigata 9502181, Japan	Kose, H (reprint author), Int Christian Univ, Dept Life Sci, Div Nat Sci, Mitaka, Tokyo 1818585, Japan.	kose@icu.ac.jp					CRYER PE, 1994, DIABETES, V43, P1378, DOI 10.2337/diabetes.43.11.1378; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Spindler KD, 2009, CELL MOL LIFE SCI, V66, P3837, DOI 10.1007/s00018-009-0112-5; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Yamamoto S, 2014, EXP ANIM TOKYO, V63, P107; Marik PE, 2013, CRIT CARE MED, V41, pE93, DOI 10.1097/CCM.0b013e318283d124; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Bate Michael, 1993, P1013; Campbell Lesley V, 2006, Aust Fam Physician, V35, P405; Eakins James, 2009, J Diabetes Sci Technol, V3, P1373; Folk DG, 2004, J EXP BIOL, V207, P2671, DOI 10.1242/jeb.01048; Haselton A. T., 2011, J VIS EXP; Ishimoto H, 2011, FLY, V5, P215, DOI 10.4161/fly.5.3.15477; Lasko P, 2002, CLIN GENET, V62, P358, DOI 10.1034/j.1399-0004.2002.620502.x; Lu XM, 2009, INT J MOL MED, V24, P531, DOI 10.3892/ijmm_00000262; Mecott GA, 2010, SHOCK, V33, P5, DOI 10.1097/SHK.0b013e3181af0494; MESTER M, 1994, SURGERY, V115, P588; Morris LX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046109; Mortimer NT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003314; Tobler A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010723; Rajan A, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-38; RAYFIELD EJ, 1973, NEW ENGL J MED, V289, P618, DOI 10.1056/NEJM197309202891207; Ritzenthaler S, 2000, NAT NEUROSCI, V3, P1012; Taylor FHL, 1944, NEW ENGL J MED, V231, P437, DOI 10.1056/NEJM194409282311301; Thomsen V, 1938, ACTA MED SCAND, V96, P1; Xiu F, 2014, INT J ENDOCRINOL, DOI 10.1155/2014/486403; Zhang Q, 2005, LIFE SCI, V77, P3068, DOI 10.1016/j.lfs.2005.02.034	32	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					601	604		10.1292/jvms.14-0631		4	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800015		
J	Kojima, Y; Chiba, S; Horiuchi, N; Kobayashi, Y; Inokuma, H				Kojima, Yuka; Chiba, Shiori; Horiuchi, Noriyuki; Kobayashi, Yoshiyasu; Inokuma, Hisashi			Evaluation of S100B in cerebrospinal fluid as a potential biomarker for neurological diseases in calves	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						calf; cerebrospinal fluid; S100B	S-100B; ASTROCYTES; CATTLE	S100B in cerebrospinal fluid (CSF-S100B) was measured in calves with 20 neurologic and 21 non-neurologic diseases to clarify its utility as a biomarker for neurologic diseases. The median CSF-S100B value in the neurologic disease group (43.0 ng/m/) was significantly higher than that in the non-neurologic disease group (10.2 ng/m/). As CSF-S100B levels in calves with neurologic diseases widely differed, the utility of CSF-S100B as a diagnostic marker for neurologic diseases in cattle remains inconclusive.	[Kojima, Yuka; Inokuma, Hisashi] Obihiro Univ Agr & Vet Med, Dept Vet Clin Sci, Obihiro, Hokkaido 0808555, Japan; [Chiba, Shiori; Horiuchi, Noriyuki; Kobayashi, Yoshiyasu] Obihiro Univ Agr & Vet Med, Dept Basic Vet Sci, Obihiro, Hokkaido 0808555, Japan	Inokuma, H (reprint author), Obihiro Univ Agr & Vet Med, Dept Vet Clin Sci, Obihiro, Hokkaido 0808555, Japan.	inokuma@obihiro.ac.jp			Kuribayashi Zaidan; Obihoro University of Agriculture and Veterinary Science	We thank Ms Akiko Tomikawa for her excellent technical support. This study was supported by grants from Kuribayashi Zaidan and Obihoro University of Agriculture and Veterinary Science. We also thank the veterinarians of the Tokachi Agricultural Mutation Aid Association for introducing the clinical cases.	Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Sakatani S, 2008, J NEUROSCI, V28, P10928, DOI 10.1523/JNEUROSCI.3693-08.2008; De Lahunta A., 2008, DIS DAIRY CATTLE, P504; Gomide VC, 1999, BRAIN RES, V835, P162, DOI 10.1016/S0006-8993(99)01557-7; Green AJE, 1997, J IMMUNOL METHODS, V205, P35, DOI 10.1016/S0022-1759(97)00050-1; Green AJE, 1999, VET REC, V145, P107; Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1; Shimada N, 2005, J VET MED SCI, V67, P621, DOI 10.1292/jvms.67.621; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Wolf H, 2014, SPINE J, V14, P2918, DOI 10.1016/j.spinee.2014.04.027	11	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					605	607		10.1292/jvms.14-0578		3	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800016		
J	Ido, N; Iwabuchi, K; Sato'o, Y; Sato, Y; Sugawara, M; Yaegashi, G; Konno, M; Akiba, M; Tanaka, K; Omoe, K; Uchida, I				Ido, Noriko; Iwabuchi, Kaori; Sato'o, Yusuke; Sato, Yasuo; Sugawara, Masaru; Yaegashi, Gakuji; Konno, Masaru; Akiba, Masato; Tanaka, Kiyoshi; Omoe, Katsuhiko; Uchida, Ikuo			Molecular typing of Salmonella enterica serovar 4,[5],12:i:- isolates from humans, animals and river water in Japan by multilocus variable-number tandem repeat analysis and pulsed-field gel electrophoresis	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						MLVA; monophasic variant; PFGE; Salmonella 4,[5],12:i:- (S. 4,[5],12:i:-); S. Typhimurium	MONOPHASIC SALMONELLA; SEROTYPE TYPHIMURIUM; STRAIN; EMERGENCE; POULTRY; 4,5,12I	Fifty-one Salmonella enterica serovar 4,[5],12:i:- (S. 4, [5],12:i:-) isolates (14 human strains, 34 animal strains and 3 river water strains) which are assumed to be monophasic variants of S. Typhimurium were analyzed using pulsed-field gel electrophoresis (PFGE) and multiple-locus variable-number tandem repeat analysis (MLVA) in order to investigate their genetic diversities and relationships. PFGE, MLVA and combination of them identified 28, 27 and 34 profiles (Simpson's diversity indices [DI]=0.94, 0.96 and 0.97), respectively. No correlations were detected between MLVA clustering and PFGE clustering or phage typing. These results suggested that S. 4,[5],12:i:- originated from multiple S. Typhimurium ancestors. Two cattle and one pig isolates showing identical phage types as well as PFGE and MLVA profiles to human isolates S. 4,[5],12:i:- suggested the existence of the links between human infections and animal reservoirs.	[Ido, Noriko; Sato, Yasuo; Yaegashi, Gakuji] Iwate Prefecture Cent Livestock Hyg Serv Ctr, Takizawa City, Iwate 0200605, Japan; [Iwabuchi, Kaori] Res Inst Environm Sci & Publ Hlth Iwate Prefectur, Morioka, Iwate, Japan; [Sato'o, Yusuke; Omoe, Katsuhiko] Iwate Univ, Fac Agr, Dept Vet Med, Morioka, Iwate 020, Japan; [Sato'o, Yusuke; Omoe, Katsuhiko; Uchida, Ikuo] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Sugawara, Masaru] Iwate Prefecture North Livestock Hyg Serv Ctr, Karumai, Japan; [Konno, Masaru] Iwate Agr Res Ctr, Taneyama Livestock Lab, Oshu, Japan; [Akiba, Masato] Natl Inst Anim Hlth, Tsukuba, Ibaraki 305, Japan; [Tanaka, Kiyoshi; Uchida, Ikuo] Natl Inst Anim Hlth, Hokkaido Res Stn, Sapporo, Hokkaido, Japan	Ido, N (reprint author), Iwate Prefecture Cent Livestock Hyg Serv Ctr, 390-5 Sunakomi, Takizawa City, Iwate 0200605, Japan.	n-ido@pref.iwate.jp			Ministry of Health, Labour and Welfare of Japan [H24-Shokuhin-Ippan-008]	We gratefully acknowledge the members of the prefectural livestock hygiene service centers and prefectural institutes of public health for kindly providing the Salmonella isolates used in this study. This work was partly supported by the Ministry of Health, Labour and Welfare of Japan (H24-Shokuhin-Ippan-008).	POWELL NG, 1994, FEMS MICROBIOL LETT, V119, P193, DOI 10.1016/0378-1097(94)90413-8; Garaizar J, 2002, J CLIN MICROBIOL, V40, P2074, DOI 10.1128/JCM.40.6.2074-2078.2002; de la Torre E, 2003, J CLIN MICROBIOL, V41, P2395, DOI 10.1128/JCM.41.6.2395-2400.2003; Hauser E, 2010, APPL ENVIRON MICROB, V76, P4601, DOI 10.1128/AEM.02991-09; Switt AIM, 2009, FOODBORNE PATHOG DIS, V6, P407, DOI 10.1089/fpd.2008.0213; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233; Echeita MA, 2001, J CLIN MICROBIOL, V39, P2981, DOI 10.1128/JCM.39.8.2981-2983.2001; Amavisit P, 2005, J CLIN MICROBIOL, V43, P2736, DOI 10.1128/JCM.43.6.2736-2740.2005; Lindstedt BA, 2004, J MICROBIOL METH, V59, P163, DOI 10.1016/j.mimet.2004.06.014; Kurosawa A, 2012, VET MICROBIOL, V160, P264, DOI 10.1016/j.vetmic.2012.05.023; Zamperini K, 2007, AVIAN DIS, V51, P958, DOI 10.1637/7944-021507-REGR.1; Best EL, 2007, J APPL MICROBIOL, V103, P565, DOI 10.1111/j.1365-2672.2007.03278.x; Echeita MA, 1999, J CLIN MICROBIOL, V37, P3425; Hopkins KL, 2007, J CLIN MICROBIOL, V45, P3058, DOI 10.1128/JCM.00715-07; Ido N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104380; Laorden L, 2010, J CLIN MICROBIOL, V48, P4563, DOI 10.1128/JCM.00337-10; Mossong J, 2007, Euro Surveill, V12, pE11; Murphy TM, 2001, EPIDEMIOL INFECT, V126, P3; Ngoi ST, 2013, JPN J INFECT DIS, V66, P180; Tamamura Y, 2011, APPL ENVIRON MICROB, V77, P1739, DOI 10.1128/AEM.01910-10; Yatsuyanagi J., 2008, IASR, V29, P164	21	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					609	613		10.1292/jvms.14-0465		5	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800017		
J	Iizuka, T; Nishimura, R				Iizuka, Tomoya; Nishimura, Ryohei			Context-sensitive half-time of fentanyl in dogs	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						canine; fentanyl; half-time; infusion; pharmacokinetics	INTRAVENOUS ANESTHESIA; PHARMACOKINETICS; MANAGEMENT; CATS; PAIN	Context-sensitive half-times (CSHTs) of fentanyl in dogs were determined using pharmacokinetic models reported by Murphy et al. and Sano et al., and compared with a human model. The CSHT was defined as the time required for a 50% decrease in drug concentration in the central compartment after the termination of infusion. Although CSHTs increased gradually as the infusion time increased, the CSHTs in dogs were shorter than those in humans. The CSHTs at steady-state were 31.3 and 69.2 min in dogs, and 306.5 min in humans. The CSHTs of fentanyl in dogs are apparently shorter than those in humans; therefore, a continuous infusion of fentanyl may be a rational regimen in dogs, even if duration of infusion is extended.	[Iizuka, Tomoya; Nishimura, Ryohei] Univ Tokyo, Lab Vet Surg, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Nishimura, R (reprint author), Univ Tokyo, Lab Vet Surg, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	arn@mail.ecc.u-tokyo.ac.jp					Beers R, 2004, CNS DRUGS, V18, P1085, DOI 10.2165/00023210-200418150-00004; SHAFER SL, 1991, ANESTHESIOLOGY, V74, P53, DOI 10.1097/00000542-199101000-00010; SCOTT JC, 1987, J PHARMACOL EXP THER, V240, P159; MURPHY MR, 1983, ANESTHESIOLOGY, V59, P537, DOI 10.1097/00000542-198312000-00009; Ilkiw JE, 1999, CLIN TECH SMALL AN P, V14, P27, DOI 10.1016/S1096-2867(99)80024-3; HUGHES MA, 1992, ANESTHESIOLOGY, V76, P334, DOI 10.1097/00000542-199203000-00003; SCHWILDEN H, 1983, ANAESTHESIA, V38, P51; Peng PWH, 1999, ANESTHESIOLOGY, V90, P576, DOI 10.1097/00000542-199902000-00034; BELL J, 1994, BRIT J ANAESTH, V73, P162, DOI 10.1093/bja/73.2.162; Duke T, 2013, CAN VET J, V54, P276; Dyson DH, 2008, VET CLIN N AM-SMALL, V38, P1309, DOI 10.1016/j.cvsm.2008.06.006; MCQUAY HJ, 1979, BRIT J ANAESTH, V51, P543, DOI 10.1093/bja/51.6.543; Sano T, 2006, VET ANAESTH ANALG, V33, P266, DOI 10.1111/j.1467-2995.2005.00266.x; STOECKEL H, 1982, BRIT J ANAESTH, V54, P1087, DOI 10.1093/bja/54.10.1087	14	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					615	617		10.1292/jvms.14-0549		3	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800018		
J	Mbehang Nguema, PP; Okubo, T; Tsuchida, S; Fujita, S; Yamagiwa, J; Tamura, Y; Ushida, K				Mbehang Nguema, Pierre Philippe; Okubo, Torahiko; Tsuchida, Sayaka; Fujita, Shiho; Yamagiwa, Juichi; Tamura, Yutaka; Ushida, Kazunari			Isolation of multiple drug-resistant enteric bacteria from feces of wild Western Lowland Gorilla (Gorilla gorilla gorilla) in Gabon	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						intestinal bacteria; multiple drug-resistance; wild gorilla	ESCHERICHIA-COLI STRAINS; MULTIDRUG EFFLUX PUMP; ACHROMOBACTER-XYLOSOXIDANS; ANTIMICROBIAL RESISTANCE; BETA-LACTAMASES; NATIONAL-PARK; GENES; PCR; EPIDEMIOLOGY; PATTERNS	Prevalence of drug-resistant bacteria in wildlife can reveal the actual level of anthropological burden on the wildlife. In this study, we isolated two multiple drug-resistant strains, GG6-2 and GG6-1-1, from 27 fresh feces of wild western lowland gorillas in Moukalaba-Doudou National Park, Gabon. Isolates were identified as Achromobacter xylosoxidans and Providencia sp., respectively. Minimum inhibitory concentrations of the following 12 drugs-ampicillin (ABPC), cefazolin (CEZ), cefotaxime (CTX), streptomycin (SM), gentamicin (GM), kanamycin (KM), tetracycline (TC), nalidixic acid (NA), ciprofloxacin (CPFX), colistin (CL), chloramphenicol (CP) and trimethoprim (TMP)-were determined. Isolate GG6-2 was resistant to all antimicrobials tested and highly resistant to CTX, SM, TC, NA and TMP. Isolate GG6-1-1 was resistant to ABPC, CEZ, TC, CL, CP and TMP.	[Mbehang Nguema, Pierre Philippe] Res Inst Trop Ecol, Libreville, Gabon; [Okubo, Torahiko; Tamura, Yutaka] Rakuno Galaten Univ, Lab Food Microbiol & Food Safety, Dept Hlth & Environm Sci, Sch Vet Med, Ebetsu, Hokkaido 0690836, Japan; [Tsuchida, Sayaka; Ushida, Kazunari] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan; [Fujita, Shiho] Kagoshima Univ, United Grad Sch Vet Sci, Kagoshima 8900065, Japan; [Yamagiwa, Juichi] Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan	Ushida, K (reprint author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan.	k_ushida@kpu.ac.jp			SATREPS program (Japan Science and Technology Agency); SATREPS program (Japan International Cooperation Agency)	This study was conducted as part of the PROCOBHA (Prof. Juichi Yamagiwa) supported by SATREPS program (Japan Science and Technology Agency and Japan International Cooperation Agency). The authors thank Jean Manfoumbi Nzahou, Christian Nzoutsy Kelly, Jonas Ndoudi, Guy Roger Doukaga, Stephanie Matsanga and Jean Constant Obague Mbeang for their help with collecting fresh feces in MDNP.	Kojima A, 2005, ANTIMICROB AGENTS CH, V49, P3533, DOI 10.1128/AAC.49.8.3533-3537.2005; Cole D, 2005, EMERG INFECT DIS, V11, P935; Lambiase A, 2011, EUR J CLIN MICROBIOL, V30, P973, DOI 10.1007/s10096-011-1182-5; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Amoureux L, 2013, J CYST FIBROS, V12, P170, DOI 10.1016/j.jcf.2012.08.005; Almuzara M, 2010, INT J ANTIMICROB AG, V35, P68, DOI 10.1016/j.ijantimicag.2009.08.015; Jun LJ, 2004, AQUACULTURE, V240, P89, DOI 10.1016/j.aquaculture.2004.07.025; Bador J, 2013, ANTIMICROB AGENTS CH, V57, P603, DOI 10.1128/AAC.01243-12; Thibault M, 2003, CONSERV BIOL, V17, P1807, DOI 10.1111/j.1523-1739.2003.00159.x; Poeta P, 2008, APPL ENVIRON MICROB, V74, P7439, DOI 10.1128/AEM.00949-08; Bador J, 2011, ANTIMICROB AGENTS CH, V55, P4912, DOI 10.1128/AAC.00341-11; Aisenberg G, 2004, CANCER, V101, P2134, DOI 10.1002/cncr.20604; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Segawa T, 2013, ENV MICROBIOL REP, V5, P127, DOI 10.1111/1758-2229.12011; Benavides JA, 2012, APPL ENVIRON MICROB, V78, P4281, DOI 10.1128/AEM.07593-11; Blom A., 2003, AIRES PROTEGEES PARC; Clinical and Laboratory Standards Institute, 2011, M31A3 CLSI, V3rd; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; Homsy J., 1999, TOURISME GRANDS SING; Jakobsen T.H., 2013, PLOS ONE; Makouloutou P, 2014, HELMINTHOLOGIA, V51, P83, DOI 10.2478/s11687-014-0214-y; Matsuura N., 2014, REV PRIMATOL, P5; Mbehang Nguma P. P., 2015, TROPICS, V23, P165; Neuwirth C, 2006, EMERG INFECT DIS, V12, P1737; Poeta P, 2009, J BASIC MICROB, V49, P584, DOI 10.1002/jobm.200900066; Presterl E, 2003, AM J TROP MED HYG, V69, P406; Radhouani H, 2012, J MED MICROBIOL, V61, P837, DOI 10.1099/jmm.0.038364-0; Scherbaum M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-124; Stock I, 1998, J MED MICROBIOL, V47, P629; Su HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099826; Takenoshita Yuji, 2008, African Study Monographs Supplementary Issue, V39, P41; Tsuchida S, 2014, INT J SYST EVOL MICR, V64, P449, DOI 10.1099/ijs.0.055186-0; Tsukahara T, 2002, J GEN APPL MICROBIOL, V48, P143, DOI 10.2323/jgam.48.143; Amoureux L, 2013, APPL ENVIRON MICROB, V79, P7142, DOI 10.1128/AEM.02293-13; Xu L, 2005, J MED MICROBIOL, V54, P1183, DOI 10.1099/jmm.0.46160-0	37	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					619	623		10.1292/jvms.14-0604		5	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800019		
J	Hori, T; Atago, T; Kobayashi, M; Kawakami, E				Hori, Tatsuya; Atago, Tetsuya; Kobayashi, Masanori; Kawakami, Eiichi			Influence of different methods of collection from the canine epididymides on post-thaw caudal epididymal sperm quality	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						canine; collection method; epididymal sperm; frozen semen	IN-VITRO SURVIVAL; EQUEX STM PASTE; INTRAUTERINE INSEMINATION; PROSTATIC FLUID; DOG SPERMATOZOA; BEAGLE DOGS; FROZEN; CRYOPRESERVATION; STORAGE; TIME	Canine epididymal sperm was collected from the cauda epididymis using 2 different methods (flushing and mincing) to compare the qualities (the percentage of progressively motile, viable, morphologically abnormal, immature and intact acrosomes) before and after freezing and thawing. No significant difference was noted in the quality of the cauda epididymal sperm immediately after collection and after freezing-thawing between the collection methods, although the mean levels of sperm quality with the flushing method were slightly better than that of the mincing method. The flushing method is simple and free of blood contamination, although the vas deferens was too small to be perfused in only 1 dog, and our results suggest that the flushing method is preferable to the mincing method for collecting sperm from the canine cauda epididymis.	[Hori, Tatsuya; Atago, Tetsuya; Kobayashi, Masanori; Kawakami, Eiichi] Nippon Vet & Life Sci Univ, Lab Reprod, Musashino, Tokyo 1808602, Japan	Hori, T (reprint author), Nippon Vet & Life Sci Univ, Lab Reprod, 1-7-1 Kyonan Cho, Musashino, Tokyo 1808602, Japan.	t-hori@nvlu.ac.jp					Farstad W, 2000, THERIOGENOLOGY, V53, P175, DOI 10.1016/S0093-691X(99)00250-2; Hewitt DA, 2001, ANIM REPROD SCI, V67, P101, DOI 10.1016/S0378-4320(01)00090-2; Bainbridge DRJ, 1998, VET REC, V143, P159; Hori T, 2011, J VET MED SCI, V73, P1685, DOI 10.1292/jvms.11-0241; Hori T, 2004, J VET MED SCI, V66, P37, DOI 10.1292/jvms.66.37; Hori T, 2006, J VET MED SCI, V68, P1055, DOI 10.1292/jvms.68.1055; Hori T, 2005, THERIOGENOLOGY, V63, P1573, DOI 10.1016/j.theriogenology.2004.05.027; Hori T, 2009, J VET MED SCI, V71, P811, DOI 10.1292/jvms.71.811; Martins MIM, 2009, REPROD DOMEST ANIM, V44, P342, DOI 10.1111/j.1439-0531.2009.01431.x; Martins MIM, 2012, REPROD DOMEST ANIM, V47, P293, DOI 10.1111/rda.12042; McLachlan RI, 1998, J REPROD FERTIL, P277; Nothling JO, 2007, THERIOGENOLOGY, V67, P264, DOI 10.1016/j.theriogenology.2006.07.018; Ponglowhapan S, 2008, THERIOGENOLOGY, V69, P666, DOI [10.1016/j.theriogenology.2007.11.005, 10.1016/j.thefiogenology.2007.11.005]; Ponglowhapan S, 2006, THERIOGENOLOGY, V66, P1633, DOI 10.1016/j.theriogenology.2006.01.032; Rijsselaere T, 2002, THERIOGENOLOGY, V57, P1669, DOI 10.1016/S0093-691X(02)00663-5; Rijsselaere T, 2004, THERIOGENOLOGY, V61, P1589, DOI 10.1016/j.theriogenology.2003.09.008; Sirivaidyapong S., 2002, P 3 EVSSAR C LIEG, P170; Tittarelli C, 2006, THERIOGENOLOGY, V66, P1637, DOI 10.1016/j.theriogenology.2006.01.021; Yu I, 2002, CRYOBIOLOGY, V44, P62, DOI 10.1016/S0011-2240(02)00005-6	19	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					625	630		10.1292/jvms.14-0421		6	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800020		
J	Kaneko, Y; Torisu, S; Kitahara, G; Hidaka, Y; Satoh, H; Asanuma, T; Mizutani, S; Osawa, T; Naganobu, K				Kaneko, Yasuyuki; Torisu, Shidow; Kitahara, Go; Hidaka, Yuichi; Satoh, Hiroyuki; Asanuma, Taketoshi; Mizutani, Shinya; Osawa, Takeshi; Naganobu, Kiyokazu			Laparoscopic cryptorchidectomy in standing bulls	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						bull; cryptorchidism; gasless; laparoscopy; standing	HORSES; CATTLE; OVARY	Laparoscopic cryptorchidectomy without insufflation was applied in 10 standing bulls aged 3 to 15 months. Nine bulls were preoperatively pointed out intra-abdominal testes by computed tomography. Preoperative fasting for a minimum of 24 hr provided laparoscopic visualization of intra-abdominal area from the kidney to the inguinal region. Surgical procedure was interrupted by intra-abdominal fat and testis size. It took 0.6 to 1.5 hr in 4 animals weighing 98 to 139 kg, 0.8 to 2.8 hr in 4 animals weighing 170 to 187 kg, and 3 and 4 hr in 2 animals weighing 244 and 300 kg to complete the cryptorchidectomy. In conclusion, standing gasless laparoscopic cryptorchidectomy seems to be most suitable for bulls weighing from 100 to 180 kg.	[Kaneko, Yasuyuki; Torisu, Shidow; Mizutani, Shinya; Naganobu, Kiyokazu] Miyazaki Univ, Vet Teaching Hosp, Fac Agr, Miyazaki, Miyazaki 8892192, Japan; [Kitahara, Go; Osawa, Takeshi] Miyazaki Univ, Lab Theriogenol, Fac Agr, Miyazaki, Miyazaki 8892192, Japan; [Hidaka, Yuichi] Miyazaki Univ, Lab Vet Surg, Fac Agr, Miyazaki, Miyazaki 8892192, Japan; [Satoh, Hiroyuki; Asanuma, Taketoshi] Miyazaki Univ, Lab Vet Radiol, Fac Agr, Miyazaki, Miyazaki 8892192, Japan	Torisu, S (reprint author), Miyazaki Univ, Vet Teaching Hosp, Fac Agr, 1-1 Gakuen Kibanadai Nishi, Miyazaki, Miyazaki 8892192, Japan.	torisu@cc.miyazaki-u.ac.jp					Latimer FG, 2003, EQUINE VET J, V35, P283, DOI 10.2746/042516403776148273; Bleul U, 2005, ANIM REPROD SCI, V90, P193, DOI 10.1016/j.anireprosci.2005.01.022; Dunay MP, 2012, ACTA VET HUNG, V60, P41, DOI 10.1556/AVet.2012.004; Barisani C., 2004, SUMMA, V5, P35; Boure L, 2005, VET CLIN N AM-FOOD A, V21, P227, DOI 10.1016/j.cvfa.2004.12.002; Chiesa OA, 2009, CAN J VET RES, V73, P42; Christiansen K, 2004, TIERARZTL PRAX G N, V32, P118; Davis EW, 1997, VET SURG, V26, P326, DOI 10.1111/j.1532-950X.1997.tb01505.x; Fischer A.T., 2002, EQUINE DIAGNOSTIC SU; Freeman LJ., 1999, VET ENDOSURGERY, pxv; Hanrath M, 2002, VET SURG, V31, P117, DOI 10.1053/jvet.31049; KELLAWAY RC, 1971, AUST VET J, V47, P547, DOI 10.1111/j.1751-0813.1971.tb02052.x; Kitahara G., 2010, JPN J ULTRASONIC TEC, V2, P24; Kobayashi T., 2002, J LIVESTOCK MED, V49, P323; Maxwell D., 1980, ANIMAL LAPAROSCOPY, P133; Osawa T, 2011, J VET MED SCI, V73, P1253, DOI 10.1292/jvms.11-0122; PEARSON H, 1972, VET REC, V91, P498; SEEGER K, 1977, VET MED SM ANIM CLIN, V72, P1037; Shimada Y., 2010, J LIVESTOCK MED, V57, P543; St Jean G., 1992, THERIOGENOLOGY, V38, P951; Tanaka S., 2011, J LIVESTOCK MED, V58, P151; Traub-Dargatz J, 1992, VETERINARY GASTROENT, P61; WISHART DF, 1973, VET REC, V92, P139	23	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAY	2015	77	5					631	635		10.1292/jvms.14-0587		5	Veterinary Sciences	Veterinary Sciences	CJ3FM	WOS:000355368800021		
J	Hai, VH; Hung, NQ; Khai, BT				Vo Hong Hai; Nguyen Quoc Hung; Bui Tuan Khai			Development of gamma spectroscopy employing NaI(Tl) detector 3 inch x 3 inch and readout electronic of flash-ADC/FPGA-based technology	KERNTECHNIK			English	Article								In this article the development of a gamma spectroscopy system is described using a scintillation detector NaI(Tl) of 3 inch x 3 inch. The readout electronic for the spectroscopy is built from the fast analog-digital conversion of Flash Analog-Digital Converter (Flash-ADC) 250 MHz - 8 bits resolution, and the embedded Field-Programmable Gate Array (FPGA) technology. The embedded VHSIC Hardware Description Language (VHDL) code for FPGA is built in such a way that it works as a multi channel analyser (MCA) with 4096 Digital Charge Integration (DCI) channels. A pulse generator with frequency varying from Hz up to 12 kHz is used to evaluate the time response of the system. Two standard radioisotope sources of Ba-133 and Eu-152 with multi gamma energies ranging from several tens keV to MeV are used to evaluate the linearity and energy resolution of the system.	[Vo Hong Hai; Nguyen Quoc Hung] Univ Sci HCMC Natl Univ, Fac Phys & Engn Phys, Nucl Engn Lab, Inst Nucl Phys, Hochiminh City, Vietnam; [Vo Hong Hai] Ton Duc Thang Univ, Fac Sci Appl, Div Nucl Phys, Ho Chi Minh City, Vietnam; [Bui Tuan Khai] Osaka Univ, Grad Sch Sci, Dept Phys, Suita, Osaka 5650871, Japan	Hai, VH (reprint author), Univ Sci HCMC Natl Univ, Fac Phys & Engn Phys, Nucl Engn Lab, Inst Nucl Phys, 227 Nguyen Van Cu,Ward 4,Dist 5, Hochiminh City, Vietnam.	nqhung@hcmus.edu.vn					[Anonymous], NI LABVIEW SOFTW; [Anonymous], CHARG INT AN VS DIG; Buzzetti S, 2005, IEEE T NUCL SCI, V52, P854, DOI 10.1109/TNS.2005.852699; Hai VH, 2012, KERNTECHNIK, V77, P462; Hai Vo Hong, 2011, NUCL SCI TECHNOLOGY, V4, P53; Nomachi M., 2009, 250 MHZ 8BITS FADC T; Peachousek J., 2011, VIRTUAL INSTRUMENTAT; Vo Hong Hai, 2011, P IAU VIETN WORKSH A, P105	8	0	0	CARL HANSER VERLAG	MUNICH	KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY	0932-3902			KERNTECHNIK	Kerntechnik	MAY	2015	80	2			1		180	183		10.3139/124.110491		4	Nuclear Science & Technology	Nuclear Science & Technology	CI7AB	WOS:000354914200012		
J	Daly, M; Sergides, M; Chormaic, SN				Daly, Mark; Sergides, Marios; Chormaic, Sile Nic			Optical trapping and manipulation of micrometer and submicrometer particles	LASER & PHOTONICS REVIEWS			English	Review						Optical trapping; optical tweezers; integrated optics; plasmonics	CHANNELED WAVE-GUIDE; PHOTONIC-CRYSTAL; NEAR-FIELD; GOLD NANOPARTICLES; RADIATION PRESSURE; RAMAN-SPECTROSCOPY; FEMTOSECOND LASER; PLANE WALL; TWEEZERS; LIGHT	Subwavelength features in conjunction with light-guiding structures have gained significant interest in recent decades due to their wide range of applications to particle and atom trapping. Lately, the focus of particle trapping has shifted from the microscale to the nanoscale. This few orders of magnitude change is driven, in part, by the needs of life scientists who wish to better manipulate smaller biological samples. Devices with subwavelength features are excellent platforms for shaping local electric fields for this purpose. A major factor that inhibits the manipulation of submicrometer particles is the diffraction-limited spot size of free-space laser beams. As a result, technologies that can circumvent this limit are highly desirable. This review covers some of the more significant advances in the field, from the earliest attempts at trapping using focused Gaussian beams, to more sophisticated hybrid plasmonic/metamaterial structures. In particular, examples of emerging optical trapping configurations are presented.	[Daly, Mark; Sergides, Marios; Chormaic, Sile Nic] OIST Grad Univ, Light Matter Interact Unit, Onna, Okinawa 9040495, Japan	Chormaic, SN (reprint author), OIST Grad Univ, Light Matter Interact Unit, Onna, Okinawa 9040495, Japan.	sile.nicchormaic@oist.jp	Sergides, Marios/B-1611-2015		Okinawa Institute of Science and Technology Graduate University; JSPS through the Postdoctoral Fellowship for Overseas Researchers scheme	This work was supported in part by funding from the Okinawa Institute of Science and Technology Graduate University. MS acknowledges the support of JSPS through the Postdoctoral Fellowship for Overseas Researchers scheme.	Agate B, 2004, OPT EXPRESS, V12, P3011, DOI 10.1364/OPEX.12.003011; Amato I, 2005, CELL, V123, P967, DOI 10.1016/j.cell.2005.12.001; Carmon G, 2011, OPT LETT, V36, P40, DOI 10.1364/OL.36.000040; Lin SY, 2010, NANO LETT, V10, P2408, DOI 10.1021/nl100501d; Albaladejo S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.113602; Ploschner M, 2012, NANO LETT, V12, P1923, DOI 10.1021/nl204378r; Jaquay E, 2013, NANO LETT, V13, P2290, DOI 10.1021/nl400918x; Lee S, 2013, J AM CHEM SOC, V135, P18260, DOI 10.1021/ja408767p; Anderson PA, 2006, OPT EXPRESS, V14, P9197, DOI 10.1364/OE.14.009197; Mejia CA, 2012, OPT LETT, V37, P3690, DOI 10.1364/OL.37.003690; Zamecnik CR, 2013, J PHYS CHEM C, V117, P1879, DOI 10.1021/jp3117352; Brambilla G, 2007, OPT LETT, V32, P3041, DOI 10.1364/OL.32.003041; ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Righini M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.186804; Quidant R, 2012, MRS BULL, V37, P739, DOI 10.1557/mrs.2012.172; KRISHNAN GP, 1995, PHYS FLUIDS, V7, P2538, DOI 10.1063/1.868755; Bowman RW, 2014, COMPUT PHYS COMMUN, V185, P268, DOI 10.1016/j.cpc.2013.08.008; Lin SY, 2009, OPT LETT, V34, P3451, DOI 10.1364/OL.34.003451; Morrissey MJ, 2013, SENSORS-BASEL, V13, P10449, DOI 10.3390/s130810449; ASHKIN A, 1978, PHYS REV LETT, V40, P729, DOI 10.1103/PhysRevLett.40.729; Mirsadeghi SH, 2014, NANO LETT, V14, P5004, DOI 10.1021/nl501424d; Wong HMK, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3625936; Heller I, 2013, NAT METHODS, V10, P910, DOI [10.1038/nmeth.2599, 10.1038/NMETH.2599]; Weiner J, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/6/064401; Schmidt BS, 2007, OPT EXPRESS, V15, P14322, DOI 10.1364/OE.15.014322; Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Waleed M, 2013, BIOMED OPT EXPRESS, V4, P1533, DOI 10.1364/BOE.4.001533; Dasgupta R, 2011, OPT EXPRESS, V19, P7680, DOI 10.1364/OE.19.007680; Robinson JT, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.143901; Ng LN, 2002, OPT COMMUN, V208, P117, DOI 10.1016/S0030-4018(02)01590-0; Palima D, 2013, LASER PHOTONICS REV, V7, P478, DOI 10.1002/lpor.201200030; BIRKS TA, 1992, J LIGHTWAVE TECHNOL, V10, P432, DOI 10.1109/50.134196; Righini M, 2009, NANO LETT, V9, P3387, DOI 10.1021/nl803677x; Fazal FM, 2011, NAT PHOTONICS, V5, P318; Yong JL, 2013, ACS APPL MATER INTER, V5, P9382, DOI 10.1021/am402923t; Ashok PC, 2012, CURR OPIN BIOTECH, V23, P16, DOI 10.1016/j.copbio.2011.11.011; Barth M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2420771; Padgett M, 2011, LAB CHIP, V11, P1196, DOI [10.1039/c0lc00526f, 10.1039/c0l00526f]; Stilgoe AB, 2008, OPT EXPRESS, V16, P15039, DOI 10.1364/OE.16.015039; Liu YJ, 2012, ADV MATER, V24, pOP131, DOI 10.1002/adma.201104440; Tatarkova SA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.038101; Kotnala A, 2014, NANO LETT, V14, P853, DOI 10.1021/nl404233z; Berthelot J, 2014, NAT NANOTECHNOL, V9, P295, DOI [10.1038/nnano.2014.24, 10.1038/NNANO.2014.24]; Ward JM, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4901098; Tanaka Y, 2011, OPT EXPRESS, V19, P17462, DOI 10.1364/OE.19.017462; Donner JS, 2011, ACS NANO, V5, P5457, DOI 10.1021/nn200590u; Ploschner M, 2010, J NANOPHOTONICS, V4, DOI 10.1117/1.3332850; Song BS, 2005, NAT MATER, V4, P207, DOI 10.1038/nmat1320; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; Yang AHJ, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/04/045704; Kawata S, 1996, OPT LETT, V21, P1768, DOI 10.1364/OL.21.001768; Yang AHJ, 2009, NATURE, V457, P71, DOI 10.1038/nature07593; Seidler P, 2013, OPT EXPRESS, V21, P32468, DOI 10.1364/OE.21.032468; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Petcu-Colan A, 2011, J NONLINEAR OPT PHYS, V20, P293, DOI 10.1142/S0218863511006170; Zhang WH, 2010, NANO LETT, V10, P1006, DOI 10.1021/nl904168f; Juan ML, 2011, NAT PHOTONICS, V5, P349, DOI [10.1038/nphoton.2011.56, 10.1038/NPHOTON.2011.56]; Chen KY, 2013, NANO LETT, V13, P4118, DOI 10.1021/nl4016254; Saleh AAE, 2012, NANO LETT, V12, P5581, DOI 10.1021/nl302627c; Sahoo H, 2011, J PHOTOCH PHOTOBIO C, V12, P20, DOI 10.1016/j.jphotochemrev.2011.05.001; Seol Y, 2006, OPT LETT, V31, P2429, DOI 10.1364/OL.31.002429; de Waele R, 2009, NANO LETT, V9, P2832, DOI 10.1021/nl900597z; Padgett M, 2011, NAT PHOTONICS, V5, P343, DOI [10.1038/nphoton.2011.81, 10.1038/NPHOTON.2011.81]; Juan ML, 2009, NAT PHYS, V5, P915, DOI 10.1038/NPHYS1422; Tsai WY, 2014, NANO LETT, V14, P547, DOI 10.1021/nl403608a; Lin SY, 2012, OPT EXPRESS, V20, P3367, DOI 10.1364/OE.20.003367; Yang AHJ, 2009, NANO LETT, V9, P1182, DOI 10.1021/nl803832q; Erickson D, 2011, LAB CHIP, V11, P995, DOI [10.1039/c0lc00482k, 10.1039/c01c00482k]; Borghese F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.163903; Grujic K, 2007, OPT EXPRESS, V15, P6470, DOI 10.1364/OE.15.006470; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P637, DOI 10.1016/0009-2509(67)80047-2; MAIMAN TH, 1960, NATURE, V187, P493, DOI 10.1038/187493a0; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Galloway CM, 2013, NANO LETT, V13, P4299, DOI 10.1021/nl402071p; Demergis V, 2012, NANO LETT, V12, P5756, DOI 10.1021/nl303035p; La Porta A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.190801; Woerdemann M, 2013, LASER PHOTONICS REV, V7, P839, DOI 10.1002/lpor.201200058; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; Frawley MC, 2012, OPT COMMUN, V285, P4648, DOI 10.1016/j.optcom.2012.05.016; Pastrana E, 2011, NAT METHODS, V8, P24, DOI 10.1038/NMETH.F.323; Grujic K, 2005, OPT EXPRESS, V13, P1, DOI 10.1364/OPEX.13.000001; van Leest T, 2013, LAB CHIP, V13, P4358, DOI 10.1039/c3lc50879j; Asavei T, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063016; Baida FI, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.155314; Balijepalli A, 2012, NANO LETT, V12, P2347, DOI 10.1021/nl300301x; Cizmar T, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1915543; Cizmar T., 2004, P SPIE UNPUB, V5514; Deng Y, 2007, J OPT A-PURE APPL OP, V9, pS256, DOI 10.1088/1464-4258/9/8/S20; Fu J, 2008, CHIN OPT LETT, V6, P112; Genevet P, 2013, OPT EXPRESS, V21, P10295, DOI 10.1364/OE.21.010295; Goban A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.033603; Gordon R, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.053806; Jelley EE, 1937, NATURE, V139, P631, DOI 10.1038/139631b0; Kepler J., 1619, ASTRONOMICVS OREMATA; Kepler J., 1619, PHYS CONTINENS PHYS; Kepler J., 1619, ASTROLOGICVS SIGNIFI; Kumar R, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/1/013026; Lee MP, 2012, J MICROSC-OXFORD, V248, P219, DOI 10.1111/j.1365-2818.2012.03639.x; Lei HX, 2012, NANOSCALE, V4, P6707, DOI 10.1039/c2nr31993d; Lekner J, 2005, J PHYS B-AT MOL OPT, V38, P3849, DOI 10.1088/0953-4075/38/21/007; Lin PT, 2011, OPT LETT, V36, P424, DOI 10.1364/OL.36.000424; Liou K.-N., 1977, APPL MATH COMPUT, V3, P331, DOI 10.1016/0096-3003(77)90018-2; Lukic B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.160601; Maimaiti A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09077; Marchington RF, 2008, OPT EXPRESS, V16, P3712, DOI 10.1364/OE.16.003712; Maruyama H., 2010, 10 IEEE C NAN UNPUB; Mejia CA, 2011, OPT EXPRESS, V19, P11422, DOI 10.1364/OE.19.011422; Mellor CD, 2006, CHEMPHYSCHEM, V7, P329, DOI 10.1002/cphc.200500348; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Mortezaei N, 2013, SCI REP-UK, V3, DOI 10.1038/srep03393; Nayak KP, 2014, OPT LETT, V39, P232, DOI 10.1364/OL.39.000232; Neumann L., 2010, NANO LETT, V11, P355; Petrov DV, 2007, J OPT A-PURE APPL OP, V9, pS139, DOI 10.1088/1464-4258/9/8/S06; Poynting J. H., 1906, NATURE, V75, P90, DOI DOI 10.1038/075090A0; Quidant R, 2008, LASER PHOTONICS REV, V2, P47, DOI 10.1002/lpor.200710038; Rodriguez-Fortuno FJ, 2009, OPT LETT, V34, P3325, DOI 10.1364/OL.34.003325; Roxworthy BJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00660; Roxworthy B. J., 2014, NATURE COMMUN, V5, P1713; Scheibe G, 1937, NATURWISSENSCHAFTEN, V25, P75; Sheu FW, 2013, SENSORS-BASEL, V13, P2884, DOI 10.3390/s130302884; Simpson SH, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.043408; Skelton SE, 2012, J QUANT SPECTROSC RA, V113, P242, DOI 10.1016/j.jqsrt.2012.06.005; Snyder A. W., 1983, OPTICAL WAVEGUIDE TH; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Tanaka T, 2000, APPL PHYS LETT, V77, P3131, DOI 10.1063/1.1325397; van de Hulst H. C., 1958, Q J ROY METEOROLOG S, V84, P198; VISSCHER K, 1993, CYTOMETRY, V14, P105, DOI 10.1002/cyto.990140202; Wang K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1480; Xin HB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00818; Xu C, 2012, OPT EXPRESS, V20, P1930, DOI 10.1364/OE.20.001930; Yalla R, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.143601; Zehtabi-Oskuie A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00966; Zhang Y, 2013, LASER PHOTONICS REV, V7, P289, DOI 10.1002/lpor.201200087; Zhao X, 2011, APPL OPTICS, V50, P318, DOI 10.1364/AO.50.000318	136	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1863-8880	1863-8899		LASER PHOTONICS REV	Laser Photon. Rev.	MAY	2015	9	3					309	329		10.1002/lpor.201500006		21	Optics; Physics, Applied; Physics, Condensed Matter	Optics; Physics	CJ2SJ	WOS:000355334500005		
J	Ohno, Y; Koyama, H; Yoshikawa, T; Matsumoto, S; Sugimura, K				Ohno, Yoshiharu; Koyama, Hisanobu; Yoshikawa, Takeshi; Matsumoto, Sumiaki; Sugimura, Kazuro			Lung Cancer Assessment Using MR Imaging An Update	MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA			English	Article						Lung cancer; MR imaging; Nodules; Staging; Therapeutic effect	SOLITARY PULMONARY NODULES; CLINICAL-PRACTICE GUIDELINES; TURBO SPIN-ECHO; MEDIASTINAL LYMPH-NODES; MALIGNANT PLEURAL MESOTHELIOMA; POSITRON-EMISSION-TOMOGRAPHY; DIFFUSION-WEIGHTED MRI; CONTRAST-ENHANCED MRI; WHOLE-BODY MRI; QUALITATIVE ASSESSMENT	MR imaging has emerged as a major new research and diagnostic tool for various pulmonary diseases, especially lung cancer. State-of-the art thoracic MR imaging now has the potential to be used as a substitute for traditional imaging techniques and/or to play a complementary role in patient management. This article focuses on these recent advances in MR imaging for lung cancer imaging, especially for pulmonary nodule assessment, lung cancer staging, postoperative lung function prediction, and prediction and evaluation of therapeutic response and recurrence. The potential and limitations of routine clinical application of these advances are discussed and compared with those of other modalities.	[Ohno, Yoshiharu; Yoshikawa, Takeshi; Matsumoto, Sumiaki] Kobe Univ, Grad Sch Med, Dept Radiol, Div Funct & Diagnost Imaging Res,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Ohno, Yoshiharu; Yoshikawa, Takeshi; Matsumoto, Sumiaki] Kobe Univ, Grad Sch Med, Adv Biomed Imaging Res Ctr, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Koyama, Hisanobu; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Dept Radiol, Div Diagnost Radiol,Chuo Ku, Kobe, Hyogo 6500017, Japan	Ohno, Y (reprint author), Kobe Univ, Grad Sch Med, Dept Radiol, Div Funct & Diagnost Imaging Res,Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yosirad@kobe-u.ac.jp			Toshiba Medical Systems Corporation; Philips Electronics Japan; Bayer Pharma; Daiichi-Sankyo, Co. Ltd; Eizai, Co., Ltd.	Drs Ohno, Yoshikawa, Matsumoto and Sugimura have research grants from Toshiba Medical Systems Corporation, Philips Electronics Japan, Bayer Pharma, Daiichi-Sankyo, Co. Ltd, and/ or Eizai, Co., Ltd.	Ohno Y, 2008, J MAGN RESON IMAGING, V27, P1284, DOI 10.1002/jmri.21348; Fujimoto K, 2003, RADIOLOGY, V227, P786, DOI 10.1148/; Ohno Y, 2005, J MAGN RESON IMAGING, V21, P775, DOI 10.1002/jmri.20297; Ohno Y, 2014, AM J ROENTGENOL, V202, P515, DOI 10.2214/AJR.13.11888; Schaefer JF, 2004, RADIOLOGY, V232, P544, DOI 10.1148/radiol.2322030515; Ohno Y, 2004, RADIOLOGY, V231, P872, DOI 10.1148/radiol.2313030103; Kohan AA, 2013, EUR RADIOL, V23, P3161, DOI 10.1007/s00330-013-2914-y; Takenaka D, 2009, J MAGN RESON IMAGING, V30, P298, DOI 10.1002/jmri.21858; Sakai S, 1997, J COMPUT ASSIST TOMO, V21, P595, DOI 10.1097/00004728-199707000-00013; Ohno Y, 2011, RADIOLOGY, V261, P605, DOI 10.1148/radiol.11110281; Giesel FL, 2008, ACAD RADIOL, V15, P563, DOI 10.1016/j.acra.2007.12.014; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Ohno Y, 2011, EUR J RADIOL, V77, P97, DOI 10.1016/j.ejrad.2009.07.024; Takenaka D, 2002, EUR J RADIOL, V44, P216, DOI 10.1016/S0720-048X(02)00271-1; Spiro SG, 2005, AM J RESP CRIT CARE, V172, P523, DOI 10.1164/rccm.200504-531OE; Sommer G, 2014, EUR J RADIOL, V83, P600, DOI 10.1016/j.ejrad.2013.11.012; Silvestri GA, 2013, CHEST, V143, pE211, DOI 10.1378/chest.12-2355; Heusch P, 2014, J NUCL MED, V55, P373, DOI 10.2967/jnumed.113.129825; Mori T, 2008, J THORAC ONCOL, V3, P358, DOI 10.1097/JTO.0b013e318168d9ed; Ohno Y, 2008, RADIOLOGY, V248, P643, DOI 10.1148/radiol.2482072039; Satoh S, 2008, AM J ROENTGENOL, V191, P464, DOI 10.2214/AJR.07.3133; Giesel FL, 2006, CHEST, V129, P1570, DOI 10.1378/chest.129.6.1570; Cronin P, 2008, RADIOLOGY, V246, P772, DOI 10.1148/radiol.2463062148; Frericks BB, 2008, J MAGN RESON IMAGING, V27, P538, DOI 10.1002/jmri.21218; Yabuuchi H, 2011, RADIOLOGY, V261, P598, DOI 10.1148/radiol.11101503; MURATA K, 1994, RADIOLOGY, V191, P251; Nomori H, 2008, J THORAC CARDIOV SUR, V135, P816, DOI 10.1016/j.jtcvs.2007.10.035; Yi CA, 2008, RADIOLOGY, V248, P632, DOI 10.1148/radiol.2482071822; Allen MS, 2006, ANN THORAC SURG, V81, P1013, DOI 10.1016/j.athoracsur.2005.06.066; Guckel C, 1996, RADIOLOGY, V200, P681; Ohno Y, 2002, RADIOLOGY, V224, P503, DOI 10.1148/radiol.2242010992; Kelly RJ, 2011, CLIN CANCER RES, V17, P1190, DOI 10.1158/1078-0432.CCR-10-2331; Ohno Y, 2012, AM J ROENTGENOL, V198, P75, DOI 10.2214/AJR.11.6525; Sommer G, 2012, EUR RADIOL, V22, P2859, DOI 10.1007/s00330-012-2542-y; Sieren JC, 2010, J MAGN RESON IMAGING, V32, P1353, DOI 10.1002/jmri.22383; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ohno Y, 2001, J MAGN RESON IMAGING, V13, P215, DOI 10.1002/1522-2586(200102)13:2<215::AID-JMRI1032>3.0.CO;2-2; Kono R, 2007, AM J ROENTGENOL, V188, P26, DOI 10.2214/AJR.05.1446; Schwenzer NF, 2012, RADIOLOGY, V264, P551, DOI 10.1148/radiol.12111942; Ohno Y, 2007, J MAGN RESON IMAGING, V26, P1071, DOI 10.1002/jmri.21106; de Langen AJ, 2011, J NUCL MED, V52, P48, DOI 10.2967/jnumed.110.078261; Ohno Y, 2007, J MAGN RESON IMAGING, V26, P498, DOI 10.1002/jmri.21031; Uto T, 2009, RADIOLOGY, V252, P247, DOI 10.1148/radiol.2521081195; WEBB WR, 1991, RADIOLOGY, V178, P705; BLUM U, 1994, CHEST, V106, P1156, DOI 10.1378/chest.106.4.1156; Boiselle PM, 1998, RADIOGRAPHICS, V18, P1061; BOLLIGER CT, 1995, AM J RESP CRIT CARE, V151, P1472; Both M, 2005, EUR J RADIOL, V53, P478, DOI 10.1016/j.ejrad.2004.05.007; Bruegel M, 2007, J MAGN RESON IMAGING, V25, P73, DOI 10.1002/jmri.20824; Chung MH, 2000, J MAGN RESON IMAGING, V11, P629, DOI 10.1002/1522-2586(200006)11:6<629::AID-JMRI9>3.0.CO;2-R; Colice GL, 2007, CHEST, V132, p161S, DOI 10.1378/chest.07-1359; FEUERSTEIN IM, 1992, RADIOLOGY, V182, P123; FUJIMOTO K, 1994, AM J ROENTGENOL, V163, P565; Gaeta M, 2002, EUR RADIOL, V12, P181, DOI 10.1007/s003300100934; Gaeta M, 2001, J COMPUT ASSIST TOMO, V25, P890, DOI 10.1097/00004728-200111000-00011; Gamez C, 2006, J THORAC ONCOL, V1, P74; GEDDES DM, 1979, BRIT J DIS CHEST, V73, P1, DOI 10.1016/0007-0971(79)90002-0; Hasegawa I, 2008, J THORAC IMAG, V23, P157, DOI 10.1097/RTI.0b013e318166d2f5; HIRAOKA M, 1987, RADIOLOGY, V164, P259; Iwasawa T, 2002, J MAGN RESON IMAGING, V15, P685, DOI 10.1002/jmri.10121; Kersjes W, 1997, EUR RADIOL, V7, P1190, DOI 10.1007/s003300050272; KONO M, 1993, J THORAC IMAG, V8, P18, DOI 10.1097/00005382-199324000-00004; Koyama H, 2013, J THORAC IMAG, V28, P138, DOI 10.1097/RTI.0b013e31828d4234; Koyama H, 2008, EUR RADIOL, V18, P2120, DOI 10.1007/s00330-008-1001-2; KUSUMOTO M, 1994, INVEST RADIOL, V29, pS255, DOI 10.1097/00004424-199406001-00087; Mazzone PJ, 2005, AM J MED, V118, P578, DOI 10.1016/j.amjmed.2004.12.024; MELAMED MR, 1987, SURG CLIN N AM, V67, P909; Morikawa M, 2009, J NUCL MED, V50, P81, DOI 10.2967/jnumed.108.056408; Nahmias C, 2007, J NUCL MED, V48, P744, DOI 10.2967/jnumed.106.038513; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Nishino M, 2014, RADIOLOGY, V271, P6, DOI 10.1148/radiol.14122524; Ohno Y, 2005, RADIOLOGY, V236, P704, DOI 10.1148/radiol.2361040005; Ohno Y, 2007, AM J ROENTGENOL, V189, P400, DOI 10.2214/AJR.07.2084; Ohno Y, 2000, EUR RADIOL, V10, P1770, DOI 10.1007/s003300000542; Ohno Y, 2013, EUR J RADIOL, V82, P2018, DOI 10.1016/j.ejrad.2013.07.016; Ohno Y, 2004, EUR J RADIOL, V52, P144, DOI 10.1016/j.ejrad.2004.01.015; Ohno Y, 2004, AM J ROENTGENOL, V182, P73; Ohno Y, 2002, EUR J RADIOL, V44, P172, DOI 10.1016/S0720-048X(02)00267-X; Ohno Y, 2014, SEMIN RESP CRIT CARE, V35, P27, DOI 10.1055/s-0033-1363449; Pauls S, 2012, EUR J RADIOL, V81, P178; PIERCE RJ, 1994, AM J RESP CRIT CARE, V150, P947; Regier M, 2007, EUR RADIOL, V17, P1341, DOI 10.1007/s00330-006-0422-z; Sakai F, 1994, J Thorac Imaging, V9, P51, DOI 10.1097/00005382-199424000-00009; SAKAI F, 1992, J THORAC IMAG, V7, P64, DOI 10.1097/00005382-199206000-00007; Samson DJ, 2007, CHEST, V132, p314S, DOI 10.1378/chest.07-1384; Schroeder T, 2005, AM J ROENTGENOL, V185, P979, DOI 10.2214/AJR.04.0814; Silvestri GA, 2007, CHEST, V132, p178S, DOI 10.1378/chest.07-1360; Takahashi K, 2000, J COMPUT ASSIST TOMO, V24, P557, DOI 10.1097/00004728-200007000-00008; Wyser C, 1999, AM J RESP CRIT CARE, V159, P1450; Yi CA, 2007, AM J ROENTGENOL, V189, P386, DOI 10.2214/AJR.07.2082	90	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1064-9689	1557-9786		MAGN RESON IMAGING C	Magn. Reson. Imaging Clin. N. Am.	MAY	2015	23	2					231	+		10.1016/j.mric.2015.01.012		15	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CJ3BG	WOS:000355357800009		
J	Shirane, T				Shirane, T.			Hysteresis modelling at temperatures near Curie point based on mean-field theory	MATERIALS RESEARCH INNOVATIONS			English	Article						Mean-field theory; Hysteresis; ac susceptibility; Curie temperature; Jiles-Atherton model; Hopkinson effect	SUSCEPTIBILITY	A model is presented to explain the temperature dependence and the field dependence of magnetisation curve and the Hopkinson effect of ac susceptibility of a hard and soft magnet near the Curie temperature T-C based on a mean-field theory. The main idea is to introduce a domain structure that can incorporate the frictional domain-wall movement based on the Jiles-Atherton (JA) hysteresis model. In very low field region, the model generates hysteresis loops on both sides of T-C. From Fourier analysis of the loops, the ac susceptibility is obtained at various temperatures. The temperature dependence of the susceptibility of the soft magnet at various fields shows qualitatively agreement with that of several experimental results of the Hopkinson effect.	Sendai Natl Coll Technol, Sendai, Miyagi, Japan	Shirane, T (reprint author), Sendai Natl Coll Technol, Sendai, Miyagi, Japan.	shirane@sendai-nct.ac.jp					FUJIKI S, 1981, PROG THEOR PHYS, V65, P1130, DOI 10.1143/PTP.65.1130; WADA K, 1980, PROG THEOR PHYS, V64, P327, DOI 10.1143/PTP.64.327; Bertotti G., 1998, HYSTERESIS MAGNETISM, P130; Canepa F, 2007, J ALLOY COMPD, V442, P142, DOI 10.1016/j.jallcom.2006.07.137; Chikazumi S., 1997, PHYSICS FERROMAGNETI, P486; JILES DC, 1986, J MAGN MAGN MATER, V61, P48, DOI 10.1016/0304-8853(86)90066-1; Nair S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.094408; Sato T., 1981, J PHYS SOC JPN, V51, P1394; Shirane T, 2007, STATISTICAL AND CONDENSED MATTER PHYSICS: OVER THE HORIZON, P189; Shirane T., 2005, J KOREAN PHYS SOC, P694	10	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1432-8917	1433-075X		MATER RES INNOV	Mater. Res. Innov.	MAY	2015	19			3			S31	S33		10.1179/1432891715Z.0000000001415		3	Materials Science, Multidisciplinary	Materials Science	CJ1QW	WOS:000355260100001		
J	Yoshioka, T; Tsuchiura, H; Novak, P				Yoshioka, T.; Tsuchiura, H.; Novak, P.			Crystal field parameters with Wannier functions: application to Nd2Fe14B systems	MATERIALS RESEARCH INNOVATIONS			English	Article						crystal field parameters; Nd-Fe-B permanent magnet	MAGNETIC-PROPERTIES; IONS	A new method to calculate the crystal field parameters (CFPs) is first applied to crystalline Nd2Fe14B as the representative of rare-earth iron boron permanent magnets. The CFPs are extracted from the one electron Hamiltonian expressed in the basis of Wannier functions. The low energy properties of 4f orbitals and influence of hybridization with Fe(3d) orbitals are investigated by solving the eigenvalue problems. Authors have found the fundamental property; the more the 4f electron cloud is expanded to the a-b plane, the more the single-ion anisotropy along the c-axis increases. The magnetic anisotropy constant K-1 increases as taking into account the hybridization with Fe(3d) states. The results for CFPs are compared with previous theoretical and experimental studies.	[Yoshioka, T.; Tsuchiura, H.] Tohoku Univ, Dept Appl Phys, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Novak, P.] ASCR, Inst Phys, Prague 16200 6, Czech Republic	Yoshioka, T (reprint author), Tohoku Univ, Dept Appl Phys, Aoba Ku, Aoba 6-6-05, Sendai, Miyagi 9808579, Japan.	yoshioka@solid.apph.tohoku.ac.jp			elements strategy initiative center for magnetic materials (ECICMM)	Authors wish to acknowledge the support of the elements strategy initiative center for magnetic materials (ECICMM). A part of numerical computations in this work was carried out at the Yukawa Institute Computer Facility, and also at Cyberscience Center, Tohoku University.	FREEMAN AJ, 1962, PHYS REV, V127, P2058, DOI 10.1103/PhysRev.127.2058; HUTCHINGS MT, 1964, SOLID STATE PHYS, V16, P227; Mostofi AA, 2008, COMPUT PHYS COMMUN, V178, P685, DOI 10.1016/j.cpc.2007.11.016; RICHTER M, 1992, PHYS REV B, V46, P13919, DOI 10.1103/PhysRevB.46.13919; HERBST JF, 1984, PHYS REV B, V29, P4176, DOI 10.1103/PhysRevB.29.4176; Kunes J, 2010, COMPUT PHYS COMMUN, V181, P1888, DOI 10.1016/j.cpc.2010.08.005; Marzari N, 1997, PHYS REV B, V56, P12847, DOI 10.1103/PhysRevB.56.12847; Blaha P, 2001, WIEN2K AUGMENTED PLA; Henry N., 1952, INT TABLES XRAY CRYS, VI; Hummler K, 1996, PHYS REV B, V53, P3290, DOI 10.1103/PhysRevB.53.3290; Novak P., 2013, PHYS REV B, V87, P1; STEVENS KWH, 1952, P PHYS SOC LOND A, V65, P209, DOI 10.1088/0370-1298/65/3/308	12	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1432-8917	1433-075X		MATER RES INNOV	Mater. Res. Innov.	MAY	2015	19			3			S34	S38		10.1179/1432891715Z.0000000001416		5	Materials Science, Multidisciplinary	Materials Science	CJ1QW	WOS:000355260100002		
J	Zhou, HJ; Li, JH; Cao, X; Bao, SH; Jin, P				Zhou, H. J.; Li, J. H.; Cao, X.; Bao, S. H.; Jin, P.			Optical and electrical properties of thermochromic VO2 thin films on Pt layers	MATERIALS RESEARCH INNOVATIONS			English	Article						Vanadium dioxide; Thermochromic; Semiconductor-metal transition; Platinum		VO2 thin films have been successfully deposited on Pt(111)/Ti/SiO2/Si substrate by means of reactive magnetron sputtering technique. The IR reflectance of the as-prepared films exhibited a big contrast (similar to 50%) between the room temperature (25 degrees C) and high temperature (100 degrees C) owing to the fancy semiconductor-metal transition of VO2 thin film. Nevertheless, the initial resistance was very low and the transition cannot be triggered by the electrical field. Authors believe that the rather poor electrical switching behaviour was connected to the leakage current from the large grain boundaries and pores in the surface of the VO2 thin film. This study may provide insights for VO2 films grown on Pt(111)/Ti/SiO2/Si substrates and suggest that Pt layers can serve as a suitable substrate of VO2 films for optical switching devices but not for electrical switching ones.	[Zhou, H. J.; Li, J. H.; Cao, X.; Bao, S. H.; Jin, P.] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China; [Jin, P.] Natl Inst Adv Ind Sci & Technol, Mat Res Inst Sustainable Dev, Nagoya, Aichi 4638560, Japan	Jin, P (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.	p-jin@mail.sic.ac.cn			high-tech project of MOST [2014AA032802]; National Natural Science Foundation of China (NSFC) [51032008, 51272273, 51102270, 51272271]	This study was financially supported by the high-tech project of MOST (2014AA032802) and the National Natural Science Foundation of China (NSFC, No.: 51032008, 51272273, 51102270 and 51272271).	Whittaker L, 2011, J MATER CHEM, V21, P5580, DOI 10.1039/c0jm03833d	1	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1432-8917	1433-075X		MATER RES INNOV	Mater. Res. Innov.	MAY	2015	19			4			S246	S250		10.1179/1432891715Z.0000000001562		5	Materials Science, Multidisciplinary	Materials Science	CJ1RW	WOS:000355263000049		
J	Zhang, D; Shibayanagi, T				Zhang, D.; Shibayanagi, T.			Material flow during friction stir spot welding of dissimilar Al2024/Al materials	MATERIALS SCIENCE AND TECHNOLOGY			English	Article						Friction stir spot welding; Aluminium alloys; Material flow; Intermixing	ALUMINUM; JOINTS; STEEL	In the present paper, the material flow and intermixing during friction stir spot welding of dissimilar Al2024/Al materials were investigated. The dissimilar materials had quite different strength. The microstructural evolutions taking place during a series of lap and butt welds were observed. The effect of penetration depths, dwell time, rotational speed and tool geometry were systematically investigated. The material flow and formation of the intermixed region were explained by a modified model.	[Zhang, D.] Univ Sci & Technol Beijing, State Key Lab Adv Met & Mat, Beijing 100083, Peoples R China; [Shibayanagi, T.] Toyama Univ, Fac Engn, Dept Mat Sci & Engn, Toyama, Toyama 9308555, Japan	Zhang, D (reprint author), Univ Sci & Technol Beijing, State Key Lab Adv Met & Mat, 30 Xueyuan Rd, Beijing 100083, Peoples R China.	zhangdi@skl.ustb.edu.cn					Ipekoglu G, 2014, METALL MATER TRANS A, V45A, P3074, DOI 10.1007/s11661-014-2248-7; Nandan R, 2007, ACTA MATER, V55, P883, DOI 10.1016/j.actamat.2006.09.009; Su P, 2006, SCI TECHNOL WELD JOI, V11, P61, DOI 10.1179/174329306X77056; Nandan R, 2008, PROG MATER SCI, V53, P980, DOI 10.1016/j.pmatsci.2008.05.001; Bozkurt Y, 2013, SCI TECHNOL WELD JOI, V18, P337, DOI 10.1179/1362171813Y.0000000111; Cam G, 2014, J MATER ENG PERFORM, V23, P1936, DOI 10.1007/s11665-014-0968-x; Mishra RS, 2005, MAT SCI ENG R, V50, P1, DOI 10.1016/j.mser.2005.07.001; Fratini L, 2006, SCI TECHNOL WELD JOI, V11, P412, DOI 10.1179/174329306X113271; Su P, 2007, METALL MATER TRANS A, V38A, P584, DOI 10.1007/s11661-006-9067-4; Firouzdor V, 2010, METALL MATER TRANS A, V41A, P2914, DOI 10.1007/s11661-010-0340-1; Xue P, 2011, MAT SCI ENG A-STRUCT, V528, P4683, DOI 10.1016/j.msea.2011.02.067; Cam G, 2011, INT MATER REV, V56, P1, DOI 10.1179/095066010X12777205875750; Coelho RS, 2008, ADV ENG MATER, V10, P1127, DOI 10.1002/adem.200800227; Colligan K, 1999, WELD J, V78, p229S; Gerlich A, 2008, SCI TECHNOL WELD JOI, V13, P254, DOI 10.1179/174329308X283910; Gerlich A, 2005, SCI TECHNOL WELD JOI, V10, P647, DOI 10.1179/174329305X48383; Higashiyama M., 2006, Journal of Japan Institute of Light Metals, V56, DOI 10.2464/jilm.56.533; Hirasawa S, 2010, J MATER PROCESS TECH, V210, P1455, DOI 10.1016/j.jmatprotec.2010.04.003; Horie S, 2010, SCI TECHNOL WELD JOI, V15, P666, DOI 10.1179/136217110X12785889550145; Kaufman J.G., 2006, PROPERTIES ALUMINUM; Shibayanagi T, 2009, METALL MATER TRANS A, V40A, P920, DOI 10.1007/s11661-008-9766-0; Su P, 2006, SCI TECHNOL WELD JOI, V11, P163, DOI 10.1179/174329306X84373; Ueno S., 2011, THESIS OSAKA U OSAKA	23	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0267-0836	1743-2847		MATER SCI TECH-LOND	Mater. Sci. Technol.	MAY	2015	31	9					1077	1087		10.1179/1743284714Y.0000000674		11	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CJ2SV	WOS:000355335700008		
J	Lin, SX; Chu, XR; Bao, WK; Gao, J; Ruan, LQ				Lin, S. X.; Chu, X. R.; Bao, W. K.; Gao, J.; Ruan, L. Q.			Experimental investigation of pulse current on mechanical behaviour of AZ31 alloy	MATERIALS SCIENCE AND TECHNOLOGY			English	Article						Pulse current; Electroplastic effect; Dynamic recrystallisation; AZ31 alloy	SHAPE-MEMORY ALLOY; AL-ZN ALLOY; ELECTRIC-CURRENT; DYNAMIC RECRYSTALLIZATION; ELECTROPULSING TREATMENT; MAGNESIUM ALLOY; DEFORMATION; METALS; ELECTROPLASTICITY; CONDUCTIVITY	The effect of pulse current on the mechanical properties of AZ31 alloy is investigated through uniaxial tensile test at different temperatures. The electroplastic effect is evaluated by the change of ultimate strength. During tensile test, both microstructure evolution and fracture behaviour are sensitive to the applied deformation conditions. In this work, the influence of pulse current is discussed from the point of view of microstructure evolution and fracture characteristics. The experimental results show that the dynamic recrystallisation temperature of AZ31 is reduced by the pulse current and continuous dynamic recrystallisation is found at 100 degrees C for tensile test with current. The data also indicate that the pulse current accelerates the precipitation and dissolved of the second phase particles in AZ31 alloy.	[Lin, S. X.; Chu, X. R.; Bao, W. K.; Gao, J.] Shandong Univ, Sch Mech Elect & Informat Engn, Weihai 264209, Peoples R China; [Ruan, L. Q.] Kumamoto Univ, Magnesium Res Ctr, Kumamoto 8608555, Japan	Gao, J (reprint author), Shandong Univ, Sch Mech Elect & Informat Engn, Weihai 264209, Peoples R China.	shdgj@sdu.edu.cn			National Natural Science Foundation of China [51405266]	This project is supported by the National Natural Science Foundation of China (Grant No. 51405266).	Andrawes JS, 2007, MATER MANUF PROCESS, V22, P91, DOI 10.1080/10426910601016004; Guyot P, 1996, ACTA MATER, V44, P4161, DOI 10.1016/S1359-6454(96)00033-X; Li C, 2012, MATER DESIGN, V34, P170, DOI 10.1016/j.matdes.2011.08.007; Li XB, 2013, MATER SCI TECH-LOND, V29, P226, DOI 10.1179/1743284712Y.0000000118; Kim W, 2014, CIRP ANN-MANUF TECHN, V63, P273, DOI 10.1016/j.cirp.2014.03.064; Kim MJ, 2014, SCRIPTA MATER, V75, P58, DOI 10.1016/j.scriptamat.2013.11.019; Tan JC, 2003, MAT SCI ENG A-STRUCT, V339, P124, DOI 10.1016/S0921-5093(02)00096-5; Galiyev A, 2001, ACTA MATER, V49, P1199, DOI 10.1016/S1359-6454(01)00020-9; Jiang YB, 2009, ACTA MATER, V57, P4797, DOI 10.1016/j.actamat.2009.06.044; Delville R, 2010, ACTA MATER, V58, P4503, DOI 10.1016/j.actamat.2010.04.046; Jiang YB, 2009, APPL PHYS A-MATER, V97, P607, DOI 10.1007/s00339-009-5260-9; Conrad H, 2002, MAT SCI ENG A-STRUCT, V322, P100, DOI 10.1016/S0921-5093(01)01122-4; Molotskii M, 1995, PHYS REV B, V52, P15829, DOI 10.1103/PhysRevB.52.15829; Dariavach NG, 2000, JOM-J MIN MET MAT S, V52, P40, DOI 10.1007/s11837-000-0033-0; Guan L, 2009, J ALLOY COMPD, V487, P309, DOI 10.1016/j.jallcom.2009.07.114; Pan H, 2014, MATER SCI TECH-LOND, V30, P988, DOI 10.1179/1743284713Y.0000000401; Sitdikov O, 2001, MATER TRANS, V42, P1928, DOI 10.2320/matertrans.42.1928; Al-Samman T, 2008, MAT SCI ENG A-STRUCT, V490, P411, DOI 10.1016/j.msea.2008.02.004; Cao WH, 2013, MATER SCI TECH-LOND, V29, P1135, DOI 10.1179/1743284713Y.0000000264; Xu Q, 2010, MATER LETT, V64, P1085, DOI 10.1016/j.matlet.2010.02.017; Zhu RF, 2013, MATER DESIGN, V44, P606, DOI 10.1016/j.matdes.2012.08.045; Zhang XF, 2013, SCRIPTA MATER, V69, P453, DOI 10.1016/j.scriptamat.2013.05.033; Qin RS, 2014, MATER SCI TECH-LOND, V30, P1040, DOI 10.1179/1743284714Y.0000000533; Stolyarov VV, 2009, MAT SCI ENG A-STRUCT, V503, P18, DOI 10.1016/j.msea.2008.01.094; Zhu RF, 2013, J ALLOY COMPD, V581, P160, DOI 10.1016/j.jallcom.2013.07.017; Myshlyaev MM, 2002, MAT SCI ENG A-STRUCT, V337, P121, DOI 10.1016/S0921-5093(02)00007-2; Xu ZH, 2007, J MATER PROCESS TECH, V182, P128, DOI 10.1016/j.jmatprotec.2006.07.019; Dzialo CM, 2010, CIRP ANN-MANUF TECHN, V59, P299, DOI 10.1016/j.cirp.2010.03.014; Conrad H, 2000, MAT SCI ENG A-STRUCT, V287, P227, DOI 10.1016/S0921-5093(00)00780-2; Jiang Y., 2011, J MATER RES, V24, P1810; Liu J., 2014, MAT SCI TECHNOL; Qin R. S., 2014, MAT SCI TECHNOL; Song H, 2012, T NONFERR METAL SOC, V22, P1599, DOI 10.1016/S1003-6326(11)61362-9; TROITSKII OA, 1963, DOKL AKAD NAUK SSSR+, V148, P332	34	1	1	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0267-0836	1743-2847		MATER SCI TECH-LOND	Mater. Sci. Technol.	MAY	2015	31	9					1131	1138		10.1179/1743284714Y.0000000680		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CJ2SV	WOS:000355335700014		
J	Fujiwara, M; Kohlenbach, U				Fujiwara, Makoto; Kohlenbach, Ulrich			Classical provability of uniform versions and intuitionistic provability	MATHEMATICAL LOGIC QUARTERLY			English	Article							FUNCTIONAL INTERPRETATION; EXCLUDED MIDDLE; BAR INDUCTION; PRINCIPLES; PROOFS	Along the line of Hirst-Mummert and Dorais , we analyze the relationship between the classical provability of uniform versions Uni(S) of (2)-statements S with respect to higher order reverse mathematics and the intuitionistic provability of S. Our main theorem states that (in particular) for every (2)-statement S of some syntactical form, if its uniform version derives the uniform variant of ACA over a classical system of arithmetic in all finite types with weak extensionality, then S is not provable in strong semi-intuitionistic systems including bar induction BI in all finite types but also nonconstructive principles such as Knig's lemma KL and uniform weak Knig's lemma UWKL. Our result is applicable to many mathematical principles whose sequential versions imply ACA.	[Fujiwara, Makoto] Tohoku Univ, Math Inst, Aoba Ku, Sendai, Miyagi 980, Japan; [Kohlenbach, Ulrich] Tech Univ Darmstadt, Fachbereich Math, D-64289 Darmstadt, Germany	Fujiwara, M (reprint author), Tohoku Univ, Math Inst, Aoba Ku, 6-3 Aramaki Aoba, Sendai, Miyagi 980, Japan.	sb0m29@math.tohoku.ac.jp; kohlenbach@mathematik.tu-darmstadt.de			Shigakukai; Deutsche Forschungsgemeinschaft [KO 1737/5-2]	The first author has been supported by Shigakukai. The second author has been supported by the Deutsche Forschungsgemeinschaft (KO 1737/5-2). The first author is grateful to Takeshi Yamazaki for helpful discussion.	Avigad J, 1998, STUD LOGIC, V137, P337; Kohlenbach U, 2002, LECT NOTES LOGIC, V15, P92; Akama Y, 2004, IEEE S LOG, P192; Dorais FG, 2014, NOTRE DAME J FORM L, V55, P25, DOI 10.1215/00294527-2377860; Hirst JL, 2011, NOTRE DAME J FORM L, V52, P149, DOI 10.1215/00294527-1306163; BEZEM M, 1985, J SYMBOLIC LOGIC, V50, P652, DOI 10.2307/2274319; Dorais F. G., 2012, J LOG ANAL, V4, P1; Feferman Solomon, 1977, STUDIES LOGIC FDN MA, V90, P913; Ferreira F., 2010, LECT NOTES LOGIC, V35, P32; Fujiwara M., 2013, LECT NOTES COMPUTER, V7921, P171; HOWARD WA, 1968, COMPOS MATH, V20, P107; HOWARD WA, 1966, J SYMBOLIC LOGIC, V31, P325, DOI 10.2307/2270450; Kohlenbach U, 1996, ARCH MATH LOGIC, V36, P31, DOI 10.1007/s001530050055; Kohlenbach U, 2001, ARCH MATH LOGIC, V40, P89, DOI 10.1007/s001530000048; Kohlenbach U, 2002, ANN PURE APPL LOGIC, V114, P103, DOI 10.1016/S0168-0072(01)00077-X; KOHLENBACH U, 1992, J SYMBOLIC LOGIC, V57, P1239, DOI 10.2307/2275367; Kohlenbach U, 2008, SPRINGER MONOGR MATH, P1; Kohlenbach U., 1992, ARCH MATH LOGIC, V31, P227, DOI 10.1007/BF01794980; Kohlenbach Ulrich, 2005, LECT NOTES LOGIC, V21, P281; Luckhardt H., 1973, SPRINGER LECT NOTES, V306; Sakamoto N, 2004, MATH LOGIC QUART, V50, P587, DOI 10.1002/malq.200310122; Simpson SG, 2009, PERSPECT LOGIC, P1, DOI 10.1017/CBO9780511581007; Spector C., 1962, RECURSIVE FUNCTION T, VV, P1; Troelstra A.S., 1973, LECT NOTES MATH, V344	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0942-5616	1521-3870		MATH LOGIC QUART	Math. Log. Q.	MAY	2015	61	3					132	150		10.1002/malq.201300056		19	Mathematics; Logic	Mathematics; Science & Technology - Other Topics	CJ0AG	WOS:000355132800003		
J	Tanaka, Y; Tsuboi, A				Tanaka, Yu-ichi; Tsuboi, Akito			A construction of real closed fields	MATHEMATICAL LOGIC QUARTERLY			English	Article							MODELS	We introduce a new construction of real closed fields by using an elementary extension of an ordered field with an integer part satisfying PA. This method can be extend to a finite extension of an ordered field with an integer part satisfying PA. In general, a field obtained from our construction is either real closed or algebraically closed, so an analogy of Ostrowski's dichotomy holds. Moreover we investigate recursive saturation of an o-minimal extension of a real closed field by finitely many function symbols.	[Tanaka, Yu-ichi] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Tsuboi, Akito] Univ Tsukuba, Inst Math, Tsukuba, Ibaraki 3058571, Japan	Tanaka, Y (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan.	tyuichi@math.tsukuba.ac.jp			Kakenhi grant [25400190]	The second author was partially supported by Kakenhi grant 25400190.	Wilkie AJ, 1996, J AM MATH SOC, V9, P1051, DOI 10.1090/S0894-0347-96-00216-0; D'Aquino P, 2010, J SYMBOLIC LOGIC, V75, P1, DOI 10.2178/jsl/1264433906; Davis M., 1977, PURE APPL MATH; Kaye R., 1991, OXFORD LOGIC GUIDES, V15; MACINTYRE A, 1984, T AM MATH SOC, V282, P539, DOI 10.2307/1999251; Macintyre A., 1996, KREISELIANA G KREISE, P441; Robinson J., 1949, J SYMBOLIC LOGIC, V14, P98, DOI 10.2307/2266510; RUMELY RS, 1980, T AM MATH SOC, V262, P195, DOI 10.2307/1999979; Tarski A., 1998, QUANTIFIER ELIMINATI, P24	9	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0942-5616	1521-3870		MATH LOGIC QUART	Math. Log. Q.	MAY	2015	61	3					159	168		10.1002/malq.201300052		10	Mathematics; Logic	Mathematics; Science & Technology - Other Topics	CJ0AG	WOS:000355132800005		
J	Yorioka, T				Yorioka, Teruyuki			A note on a forcing related to the S-space problem in the extension with a coherent Suslin tree	MATHEMATICAL LOGIC QUARTERLY			English	Article								One of the main problems about error(S) is that whether a coherent Suslin tree forces that there are no S-spaces under error(S). We analyze a forcing notion related to this problem, and show that under error(S), S forces that every topology on (1) generated by a basis in the ground model is not an S-topology. This supplements the previous work due to Stevo Todorevi [25].	Shizuoka Univ, Dept Math, Shizuoka 4228529, Japan	Yorioka, T (reprint author), Shizuoka Univ, Dept Math, Ohya 836, Shizuoka 4228529, Japan.	styorio@ipc.shizuoka.ac.jp			JSPS; NSERC; Japan Society for the Promotion of Science [22540124]	The author was supported by FY2010 Researcher Exchange Program between JSPS and NSERC, Grant-in-Aid for Scientific Research (C) 22540124 Japan Society for the Promotion of Science, and Leading Young Researchers of Shizuoka University 2011.	Yorioka T, 2010, P AM MATH SOC, V138, P2961; Moore JT, 2006, J AM MATH SOC, V19, P717, DOI 10.1090/S0894-0347-05-00517-5; Tall FD, 2012, CAN J MATH, V64, P1182, DOI 10.4153/CJM-2012-010-0; MIYAMOTO T, 1993, FUND MATH, V142, P257; Todorcevic S, 2000, FUND MATH, V166, P251; Todorcevic S, 2011, B SYMB LOG, V17, P1, DOI 10.2178/bsl/1294186662; Moore JT, 2004, T AM MATH SOC, V356, P2281, DOI 10.1090/S0002-9947-03-03446-9; Larson P, 2002, T AM MATH SOC, V354, P1783, DOI 10.1090/S0002-9947-01-02936-1; Juhasz I., 1980, C MATH SOC J BOLYAI, VII, P675; Konig B., 2002, THESIS LUDWIG MAXIMI; Koszmider P., 1998, SET THEORY TECHNIQUE, P99; Kunen K., 2011, STUDIES LOGIC, V34; Kunen K., 1980, STUDIES LOGIC FDN MA, V102; Larson P, 2001, FUND MATH, V168, P77, DOI 10.4064/fm168-1-3; Larson P. B., 2010, PREPRINT; Moore JT, 2008, TOPOL APPL, V155, P304, DOI 10.1016/j.topol.2007.07.006; Roitman J., 1984, HDB SET THEORETIC TO, P295; Rudin M. E., 1980, SURVEYS GEN TOPOLOGY, P431; RUDIN ME, 1972, ILLINOIS J MATH, V16, P621; RUDIN ME, 1974, ILLINOIS J MATH, V18, P481; Szentmiklossy Z., 1978, COLL MATH SOC J BOLY, V23, P1139; TODORCEVIC S, 1987, ACTA MATH-DJURSHOLM, V159, P261, DOI 10.1007/BF02392561; Todorcevic S., 1984, HDB SET THEORETIC TO, P235; Todoreevie Stevo, 1984, CONT MATH, V31, P209, DOI 10.1090/conm/031/763902; Todorevi S., 1989, CONT MATH, V84; Todorevi S., 2011, PREPRINT	26	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0942-5616	1521-3870		MATH LOGIC QUART	Math. Log. Q.	MAY	2015	61	3					169	178		10.1002/malq.201300066		10	Mathematics; Logic	Mathematics; Science & Technology - Other Topics	CJ0AG	WOS:000355132800006		
J	Takeuchi, K; Tanaka, Y; Tsuboi, A				Takeuchi, kota; Tanaka, Yu-ichi; Tsuboi, Akito			Model companions of theories of graphs	MATHEMATICAL LOGIC QUARTERLY			English	Article							GENERIC AUTOMORPHISMS; FIELDS	We study model companions of theories extending the graph axioms. First we prove general results concerning the existence of the model companion. Then, by applying these results to the case of graphs, we give a series of companionable and non-companionable examples.	[Takeuchi, kota; Tanaka, Yu-ichi; Tsuboi, Akito] Univ Tsukuba, Div Math, Tsukuba, Ibaraki 3058571, Japan	Takeuchi, K (reprint author), Univ Tsukuba, Div Math, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058571, Japan.	kota@math.tsukuba.ac.jp			JSPS KAKENHI [26800077, 25400190]	The first author was partially supported by JSPS KAKENHI (26800077); the third author was partially supported by JSPS KAKENHI (25400190).	Macintyre A, 1997, ANN PURE APPL LOGIC, V88, P165, DOI 10.1016/S0168-0072(97)00020-1; Baldwin J. T., 1987, PERSPECTIVES MATH LO, V12; Chatzidakis Z, 2001, ILLINOIS J MATH, V45, P693; Hodges W., 1993, ENCY MATH ITS APPL, V42; Kikyo H, 2002, J SYMBOLIC LOGIC, V67, P214, DOI 10.2178/jsl/1190150038; Kikyo H, 2000, J SYMBOLIC LOGIC, V65, P1215, DOI 10.2307/2586697; Moosa R., PREPRINT; Shelah S., 1990, STUDIES LOGIC FDN MA, V92; Wilson R. J., 2012, INTRO GRAPH THEORY	9	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0942-5616	1521-3870		MATH LOGIC QUART	Math. Log. Q.	MAY	2015	61	3					236	246		10.1002/malq.201400019		11	Mathematics; Logic	Mathematics; Science & Technology - Other Topics	CJ0AG	WOS:000355132800014		
J	Sugihara, H; Ishimoto, T; Yasuda, T; Izumi, D; Eto, K; Sawayama, H; Miyake, K; Kurashige, J; Imamura, Y; Hiyoshi, Y; Iwatsuki, M; Iwagami, S; Baba, Y; Sakamoto, Y; Miyamoto, Y; Yoshida, N; Watanabe, M; Takamori, H; Baba, H				Sugihara, Hidetaka; Ishimoto, Takatsugu; Yasuda, Tadahito; Izumi, Daisuke; Eto, Kojiro; Sawayama, Hiroshi; Miyake, Keisuke; Kurashige, Junji; Imamura, Yu; Hiyoshi, Yukiharu; Iwatsuki, Masaaki; Iwagami, Shiro; Baba, Yoshifumi; Sakamoto, Yasuo; Miyamoto, Yuji; Yoshida, Naoya; Watanabe, Masayuki; Takamori, Hiroshi; Baba, Hideo			Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junction	MEDICAL ONCOLOGY			English	Article						CXCL12; Cancer-associated fibroblasts; Adenocarcinoma of the esophagogastric junction, invasion	SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASIS; ESOPHAGEAL ADENOCARCINOMA; BREAST-CANCER; IN-VITRO; EXPRESSION; AXIS; MICROENVIRONMENT; PROLIFERATION; INVOLVEMENT	Although cancer-associated fibroblasts (CAFs) mainly produce CXCL12 and stimulate CXCL12/CXCR4 signaling in cancer cells, the significance of this interaction in adenocarcinoma of the esophagogastric junction (AEG) was unclear. This study investigated the functional characteristics of CAF-derived CXCL12 in AEG. Immunohistochemical staining for CXCL12 was performed on sections from 123 AEG patients and analyzed against clinicopathological data. Newly isolated CAFs and normal fibroblasts were examined for phenotype. An invasion assay was performed with AEG cells co-cultured with CAFs isolated from AEG. CXCL12 expression was significantly associated with age, depth of invasion, lymphatic invasion, and lymph node metastases. High CXCL12 expression significantly correlated with poor prognosis. Isolated CAFs had abundant a-smooth muscle actin expression and showed various CXCL12 expression patterns. Notably, AEG cells co-cultured with CXCLhigh-expressing CAFs invaded more than when co-cultured with CXCLlow-expressing CAFs; these invasive properties were impeded by CXCR4 antagonist AMD3100. We demonstrated that AEG cells co-cultured with CXCL12(high) CAFs were significantly more invasive than those co-cultured with CXCL12(low) CAFs and that high CXCL12 expression correlates with poor prognosis in AEG patients. CXCL12 derived from CAFs in tumor microenvironment stimulates CXCL12/CXCR4 signaling in AEG cells and promotes their invasive ability, resulting in tumor progression.	[Sugihara, Hidetaka; Ishimoto, Takatsugu; Yasuda, Tadahito; Izumi, Daisuke; Eto, Kojiro; Sawayama, Hiroshi; Miyake, Keisuke; Kurashige, Junji; Imamura, Yu; Hiyoshi, Yukiharu; Iwatsuki, Masaaki; Iwagami, Shiro; Baba, Yoshifumi; Sakamoto, Yasuo; Miyamoto, Yuji; Yoshida, Naoya; Watanabe, Masayuki; Baba, Hideo] Kumamoto Univ, Dept Surg Gastroenterol, Grad Sch Med Sci, Chuo Ku, Kumamoto 8608556, Japan; [Ishimoto, Takatsugu] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Iwatsuki, Masaaki] Saiseikai Kumamoto Hosp, Dept Surg, Kumamoto, Japan; [Watanabe, Masayuki] Canc Inst Hosp JFCR, Dept Surg Gastroenterol, Tokyo, Japan	Baba, H (reprint author), Kumamoto Univ, Dept Surg Gastroenterol, Grad Sch Med Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Dai XF, 2013, ONCOL LETT, V5, P277, DOI 10.3892/ol.2012.960; Kusano C, 2008, J GASTROEN HEPATOL, V23, P1662, DOI 10.1111/j.1440-1746.2008.05572.x; Nakazawa K, 2003, CANCER RES, V63, P8848; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Herrera M, 2013, CLIN CANCER RES, V19, P5914, DOI 10.1158/1078-0432.CCR-13-0694; Hur C, 2013, CANCER-AM CANCER SOC, V119, P1149, DOI 10.1002/cncr.27834; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Wald O, 2011, J THORAC CARDIOV SUR, V141, P1503, DOI 10.1016/j.jtcvs.2010.11.056; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Cen P, 2012, ANN SURG ONCOL, V19, P1685, DOI 10.1245/s10434-011-2141-1; Costea DE, 2013, CANCER RES, V73, P3888, DOI 10.1158/0008-5472.CAN-12-4150; Ishigami S, 2007, ANN SURG ONCOL, V14, P3154, DOI 10.1245/s10434-007-9521-6; Kang H, 2005, BREAST CANCER RES, V7, pR402, DOI 10.1186/bcr1022; Lee HJ, 2012, CLIN CANCER RES, V18, P3270, DOI 10.1158/1078-0432.CCR-11-2417; Pelchen-Matthews A, 1999, IMMUNOL REV, V168, P33, DOI 10.1111/j.1600-065X.1999.tb01281.x; Sasaki K, 2008, J SURG ONCOL, V97, P433, DOI 10.1002/jso.20976; Uchida D, 2007, MOL CANCER RES, V5, P685, DOI 10.1158/1541-7786.MCR-06-0368; Yoshitake N, 2008, BRIT J CANCER, V98, P1682, DOI 10.1038/sj.bjc.6604363	26	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1357-0560	1559-131X		MED ONCOL	Med. Oncol.	MAY	2015	32	6							168	10.1007/s12032-015-0618-7		7	Oncology	Oncology	CJ1ID	WOS:000355236400001		
J	Fukui, S; Sekiya, N; Takizawa, Y; Morioka, H; Kato, H; Aono, A; Chikamatsu, K; Mitarai, S; Kobayashi, S; Kamei, S; Setoguchi, K				Fukui, Shoichi; Sekiya, Noritaka; Takizawa, Yasunobu; Morioka, Hiroshi; Kato, Hirofumi; Aono, Akio; Chikamatsu, Kinuyo; Mitarai, Satoshi; Kobayashi, Satomi; Kamei, Satoshi; Setoguchi, Keigo			Disseminated Mycobacterium abscessus Infection Following Septic Arthritis A Case Report and Review of the Literature	MEDICINE			English	Review							RAPIDLY GROWING MYCOBACTERIA; TRANSPLANT RECIPIENTS; PULMONARY INFECTION; CLINICAL-FEATURES; CYSTIC-FIBROSIS; BACTEREMIA; PATIENT; LYMPHADENOPATHY; CHELONAE; DISEASE	Mycobacterium abscessus is a rapidly growing mycobacterium found mainly in patients with respiratory or cutaneous infections, but it rarely causes disseminated infections. Little is known about the clinical characteristics, treatment, and prognosis of disseminated M abscessus infection. A 75-year-old Japanese woman who had been treated for 17 years with a corticosteroid for antisynthetase syndrome with antithreonyltRNA synthetase antibody developed swelling of her right elbow. X-ray of her right elbow joint showed osteolysis, and magnetic resonance imaging revealed fluid in her right elbow joint. M abscessus grew in joint fluid and blood cultures. She was diagnosed with a disseminated M abscessus infection following septic arthritis. Antimicrobial treatment by clarithromycin, amikacin, and imipenem/cilastatin combined with surgical debridement was administered. Although blood and joint fluid cultures became negative 1 week later, the patient died at 6 weeks from starting antimicrobial treatment. We reviewed 34 cases of disseminated M abscessus infections from the literature. Most of the patients had immunosuppressive backgrounds such as transplantation, use of immunosuppressive agents, hematological malignancy, and end stage renal disease. The duration from onset of symptoms to diagnosis was over 3 months in half of the cases. All fatal cases had positive blood cultures or use of immunosuppressive agents. Clinicians should bear in mind that mycobacterial infections including M abscessus are one of the differential diagnoses in patients with subacute arthritis and soft tissue infections.	[Fukui, Shoichi; Takizawa, Yasunobu; Kobayashi, Satomi; Kamei, Satoshi; Setoguchi, Keigo] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Rheumatol, Tokyo 1138677, Japan; [Sekiya, Noritaka; Morioka, Hiroshi; Kato, Hirofumi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Clin Lab, Tokyo 1138677, Japan; [Aono, Akio; Chikamatsu, Kinuyo; Mitarai, Satoshi] Japan AntiTB Assoc, Res Inst TB, Dept Mycobacterium Reference & Res, Kiyose, Japan	Fukui, S (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Rheumatol, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	fukui-ngs@umin.ac.jp					Huang YC, 2010, J MICROBIOL IMMUNOL, V43, P401, DOI 10.1016/S1684-1182(10)60063-1; BROWN BA, 1992, ANTIMICROB AGENTS CH, V36, P180; Liu R, 2013, CLIN INFECT DIS, V57, P981, DOI 10.1093/cid/cit443; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Bax HI, 2013, J CLIN IMMUNOL, V33, P1062, DOI 10.1007/s10875-013-9907-0; Sanguinetti M, 2001, J CLIN MICROBIOL, V39, P816, DOI 10.1128/JCM.39.2.816-819.2001; Chetchotisakd P, 2007, CLIN INFECT DIS, V45, P421, DOI 10.1086/520030; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; MOORE M, 1953, J INVEST DERMATOL, V20, P133; GRIFFITH DE, 1993, AM REV RESPIR DIS, V147, P1271; Morales P, 2010, TRANSPL P, V42, P3058, DOI 10.1016/j.transproceed.2010.08.004; Lee MR, 2012, J ANTIMICROB CHEMOTH, V67, P222, DOI 10.1093/jac/dkr420; Bastian S, 2011, ANTIMICROB AGENTS CH, V55, P775, DOI 10.1128/AAC.00861-10; Furuya EY, 2008, CLIN INFECT DIS, V46, P1181, DOI 10.1086/529191; Su SH, 2013, KAOHSIUNG J MED SCI, V29, P50, DOI 10.1016/j.kjms.2012.08.008; Asai Yukari, 2009, Nihon Kokyuki Gakkai Zasshi, V47, P1120; Miller L, 1996, JAMA-J AM MED ASSOC, V276, P1130; Chetchotisakd P, 2000, CLIN INFECT DIS, V30, P29, DOI 10.1086/313589; Clinical and Laboratory Standards Institute, 2011, M24A2 CLSI; Garrison AP, 2009, TRANSPL INFECT DIS, V11, P541, DOI 10.1111/j.1399-3062.2009.00434.x; Knoll BM, 2012, TRANSPL INFECT DIS, V14, P452, DOI 10.1111/j.1399-3062.2012.00753.x; Kuo YM, 2011, EMERG INFECT DIS, V17, P2077, DOI 10.3201/eid1711.110050; Lai CC, 2013, J MICROBIOL IMMUNOL, V46, P482, DOI 10.1016/j.jmii.2013.05.008; Liebeskind DS, 2001, NEUROLOGY, V56, P810; Phowthongkum Prasit, 2005, Journal of the Medical Association of Thailand, V88, P1153; Rosenzweig SD, 2004, J IMMUNOL, V173, P4000; Spellberg B, 2004, J ANTIMICROB CHEMOTH, V54, P832, DOI 10.1093/jac/dkh405; Sungkanuparph Somnuek, 2003, International Journal of Infectious Diseases, V7, P198, DOI 10.1016/S1201-9712(03)90052-X; Taylor JL, 2006, J HEART LUNG TRANSPL, V25, P985, DOI 10.1016/j.healun.2006.04.003; Torrado E, 2013, ADV EXP MED BIOL, V783, P121, DOI 10.1007/978-1-4614-6111-1_7; van Ingen J, 2009, J INFECTION, V59, P324, DOI 10.1016/j.jinf.2009.08.016; WALLACE RJ, 1983, REV INFECT DIS, V5, P657; Yakrus MA, 2001, J CLIN MICROBIOL, V39, P4103, DOI 10.1128/JCM.39.11.4103-4110.2001	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAY	2015	94	21							e861	10.1097/MD.0000000000000861		6	Medicine, General & Internal	General & Internal Medicine	CJ1ZQ	WOS:000355284100018		
J	Hu, M; Yang, YL; Ng, CF; Lee, CP; Lee, VWY; Hanada, H; Masuda, D; Yamashita, S; Tomlinson, B				Hu, Miao; Yang, Ya-Ling; Ng, Chi-Fai; Lee, Chui-Ping; Lee, Vivian W. Y.; Hanada, Hiroyuki; Masuda, Daisaku; Yamashita, Shizuya; Tomlinson, Brian			Effects of Phenotypic and Genotypic Factors on the Lipid Responses to Niacin in Chinese Patients With Dyslipidemia	MEDICINE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-A-I; DIACYLGLYCEROL ACYLTRANSFERASE; NICOTINIC-ACID; GENETIC-DETERMINANTS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; APO-B; DGAT2; LIVER	The acyl-CoA: diacylglycerol acyltransferase (DGAT) enzymes DGAT1 and DGAT2 catalyze the final step in triglycerides biosynthesis. This study examined the relationships of baseline phenotypes and the common polymorphisms in DGAT1 and DGAT2 with the lipid responses to niacin. Lipid responses in Chinese patients with dyslipidemia treated with the extended release (ER) niacin/laropiprant combination 1000/20mg for 4 weeks and then 2000/40mg for 8 weeks (n = 121, the primary study) or with ER niacin 1500mg for at least 4 weeks (n = 68, the replication study) were analyzed according to genotypes of DGAT1 rs7003945 T>C and DGAT2 rs3060 T>C polymorphisms. Treatment with ER niacin improved all lipid parameters in both studies. Absolute and percentage changes in lipids were related to their baseline levels, particularly for low-density lipoprotein cholesterol (LDL-C). The DGAT2 rs3060 T>C polymorphism was associated with lower baseline LDL-C, apoB, high-density lipoprotein cholesterol (HDL-C), and apoAI in patients on statin therapy in the primary study. Subjects with the DGAT2 rs3060 T>C variant had less reduction in LDL-C in the primary study and smaller changes in triglyceride and HDL-C in the replication study but these associations became nonsignificant after adjusting for baseline lipid values. The DGAT1 rs7003945 T>C polymorphism was not related to lipid baseline values or changes in either study. Concomitant statin therapy and lower body weight were also associated with greater reduction in LDL-C. Baseline lipid levels were the main determinants of lipid responses especially for LDL-C. TheDGAT2 rs3060 polymorphism might influence the lipid responses depending on baseline phenotype, but this association did not persist after adjustment for the baseline lipid levels.	[Hu, Miao; Yang, Ya-Ling; Tomlinson, Brian] Chinese Univ Hong Kong, Sch Pharm, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Ng, Chi-Fai] Chinese Univ Hong Kong, Sch Pharm, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Lee, Chui-Ping; Lee, Vivian W. Y.] Chinese Univ Hong Kong, Sch Pharm, Hong Kong, Hong Kong, Peoples R China; [Hanada, Hiroyuki] Osaka Univ, Grad Sch Med, Osaka Univ Hosp, Dept Med Technol, Osaka, Japan; [Masuda, Daisaku; Yamashita, Shizuya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka, Japan; [Yang, Ya-Ling] Cent S Univ, Inst Metab & Endocrinol, Key Lab Diabet Immunol, Ctr Diabet,Minist Educ,Xiangya Hosp 2, Changsha, Hunan, Peoples R China	Tomlinson, B (reprint author), Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	btomlinson@cuhk.edu.hk	Hu, Miao/K-4817-2014; Lee, Vivian/B-9389-2008; Tomlinson, Brian/P-5365-2015	Hu, Miao/0000-0001-5403-4095; 	Merck Sharp Dohme Corp.; Abbott Laboratories Ltd.; Merck Sharp & Dohme (MSD) Corp.	The clinical study with ER niacin/laropiprant (Tredaptive) was an investigator-initiated study supported by a grant from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ. The funding source has no role in the conduct of the study or interpretation of the data. The clinical study with ER niacin (Niaspan) was supported in part by an unrestricted grant from Abbott Laboratories Ltd. This funding source had no role in the conduct of the study or interpretation of the data.; SY received research funding and lecturer fees from Merck Sharp & Dohme (MSD) Corp.	Al-Hijji M, 2013, AM J CARDIOL, V112, P1697, DOI 10.1016/j.amjcard.2013.07.030; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Link E, 2008, NEW ENGL J MED, V359, P789; Deshmukh HA, 2012, J LIPID RES, V53, P1000, DOI 10.1194/jlr.P021113; Hu MA, 2010, PHARMACOGENET GENOM, V20, P634, DOI 10.1097/FPC.0b013e32833de489; Chasman DI, 2012, CIRC-CARDIOVASC GENE, V5, P257, DOI 10.1161/CIRCGENETICS.111.961144; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Moore RE, 2005, CIRC RES, V97, P763, DOI 10.1161/01.RES.0000185320.82962.F7; Ng CF, 2011, J SEX MED, V8, P2883, DOI 10.1111/j.1743-6109.2011.02414.x; Chapman MJ, 2010, EUR HEART J, V31, P149, DOI 10.1093/eurheartj/ehp399; Kosoglou T, 2011, EUR J CLIN PHARMACOL, V67, P483, DOI 10.1007/s00228-010-0955-6; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Hu M, 2012, J LIPID RES, V53, P802, DOI 10.1194/jlr.P023614; Ganji SH, 2004, J LIPID RES, V45, P1835, DOI 10.1194/jlr.M300403-JLR200; Bays HE, 2012, AM J CARDIOVASC DRUG, V12, P197, DOI 10.2165/11631530-000000000-00000; Sakurabayashi I, 2001, CLIN CHIM ACTA, V312, P87, DOI 10.1016/S0009-8981(01)00591-5; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Ludwig EH, 2002, CLIN GENET, V62, P68, DOI 10.1034/j.1399-0004.2002.620109.x; Albers JJ, 2013, J AM COLL CARDIOL, V62, P1575, DOI 10.1016/j.jacc.2013.06.051; Tomlinson B, 2010, CLIN PHARMACOL THER, V87, P558, DOI 10.1038/clpt.2009.232; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Yang YL, 2013, J CLIN PHARM THER, V38, P528, DOI 10.1111/jcpt.12096; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Pang J, 2014, ARTERIOSCL THROM VAS, V34, P427, DOI 10.1161/ATVBAHA.113.302019; Barter PJ, 2010, J LIPID RES, V51, P1546, DOI 10.1194/jlr.P002816; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; Coronary Drug Project Research Group, 1975, JAMA-J AM MED ASSOC, V231, P360; Coudreau SK, 2003, OBES RES, V11, P1163, DOI 10.1038/oby.2003.160; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Hopewell JC, 2012, EUR HEART J, V24; Hu M, 2014, NEW ENGL J MED, V371, P1941; Hu M, 2013, PHARMACOGENOMICS, V14, P981, DOI [10.2217/pgs.13.71, 10.2217/PGS.13.71]; Kang I, 2011, J CLIN ENDOCR METAB, V96, P3048, DOI 10.1210/jc.2011-1104; Kantartzis K, 2009, CLIN SCI, V116, P531, DOI 10.1042/CS20080306; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Lauring B, 2014, AM J THER, V14; Lauring B., 2012, SCI TRANSL MED, V4, P148, DOI DOI 10.1126/SCITRANSLMED.3003877.PMID:22914621; Le Bloc'h J, 2010, J PHARMACOL EXP THER, V334, P583, DOI 10.1124/jpet.110.167478; Liu M, 2013, DRUG RES STUTTG, V23; Millar JS, 2006, J LIPID RES, V47, P2297, DOI 10.1194/jlr.M600213-JLR200; Piepho RW, 2000, AM J CARDIOL, V86, p35L; Yamazaki T, 2005, J BIOL CHEM, V280, P21506, DOI 10.1047/jbc.M412989200	47	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAY	2015	94	20								10.1097/MD.0000000000000881		9	Medicine, General & Internal	General & Internal Medicine	CI7ZA	WOS:000354984600036		
J	Song, PP; Inagaki, Y; Wang, ZG; Hasegawa, K; Sakamoto, Y; Arita, J; Tang, W; Kokudo, N				Song, Peipei; Inagaki, Yoshinori; Wang, Zhigang; Hasegawa, Kiyoshi; Sakamoto, Yoshihiro; Arita, Junichi; Tang, Wei; Kokudo, Norihiro			High Levels of Gamma-Glutamyl Transferase and Indocyanine Green Retention Rate at 15 min as Preoperative Predictors of Tumor Recurrence in Patients With Hepatocellular Carcinoma	MEDICINE			English	Article							LONG-TERM OUTCOMES; TRANSPEPTIDASE MESSENGER-RNA; SINGLE-CENTER EXPERIENCE; NONCIRRHOTIC LIVER; PROGNOSTIC-FACTORS; MICROVASCULAR INVASION; HEPATOBILIARY DISEASE; CURATIVE RESECTION; HEPATIC RESECTION; MILAN CRITERIA	This study investigated the preoperative independent risk factors associated with survival and recurrence for patients with hepatocellular carcinoma (HCC) who underwent hepatic resection. In total, 384 consecutive patients who underwent curative hepatic resection for single primary HCC were studied. Predictive factors associated with 1-, 3-, and 5-year survival and recurrence-free survival (RFS) were assessed using a univariate log-rank test and multivariate Cox proportional hazards regression model. Gamma-glutamyl transferase (GGT) > 100 U/L was identified as a preoperative independent risk factor affecting 1-, 3-, and 5-year survival whereas GGT > 50 U/L and indocyanine green retention 15 min (ICG-R15) > 10% were identified as preoperative independent risk factors affecting 1-, 3-, and 5-year RFS. The 384 patients studied had a 1-, 3-, and 5-year RFS rate of 72.8%, 43.3%, and 27%, respectively. Patients with GGT > 50U/L had a 1-, 3-, and 5-year RFS rate of 64.5%, 36.0%, and 21.7%. These patients had lower survival rates than did patients with GGT <= 50U/L (P < 0.05). Patients with GGT > 50 U/L and ICG-R15 > 10% had a 1-, 3-, and 5-year RFS rate of 62.4%, 29.5%, and 14.1%, respectively. These patients had lower survival rates than did patients in the other 2 groups with different levels of GGT and ICG (P < 0.05, respectively). The same was also true for patients with a tumor < 5cm in size. Combined information in the form of high levels of GGT and ICGR-15 is a preoperative predictor that warrants full attention when evaluating tumor recurrence post-operatively.	[Song, Peipei; Inagaki, Yoshinori; Wang, Zhigang; Hasegawa, Kiyoshi; Sakamoto, Yoshihiro; Arita, Junichi; Tang, Wei; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Tokyo 1138655, Japan	Tang, W (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg,Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	TANG-SUR@h.u-tokyo.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan	This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports, and Culture of Japan. The authors have no conflicts of interest to disclose.	Akamatsu Nobuhisa, 2013, Intractable Rare Dis Res, V2, P77, DOI 10.5582/irdr.2013.v2.3.77; Akita H, 2008, WORLD J SURG, V32, P2668, DOI 10.1007/s00268-008-9752-0; Naito S, 2014, LIVER INT, V34, P802, DOI 10.1111/liv.12447; Smoot RL, 2011, BRIT J SURG, V98, P697, DOI 10.1002/bjs.7401; Zeng QA, 2012, EUR J GASTROEN HEPAT, V24, P575, DOI 10.1097/MEG.0b013e328351046a; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Zhu WJ, 2013, ASIAN PAC J CANCER P, V14, P7101, DOI 10.7314/APJCP.2013.14.12.7101; Muscari F, 2011, WORLD J SURG, V35, P1055, DOI 10.1007/s00268-011-1000-3; Guiu B, 2012, CARDIOVASC INTER RAD, V35, P1102, DOI 10.1007/s00270-011-0293-9; Nagasue N, 2001, BRIT J SURG, V88, P515, DOI 10.1046/j.1365-2168.2001.01732.x; Shindoh J, 2013, HPB, V15, P31, DOI 10.1111/j.1477-2574.2012.00552.x; Laurent C, 2005, J AM COLL SURGEONS, V201, P656, DOI 10.1016/j.jamcollsurg.2005.05.027; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Lim KC, 2011, ANN SURG, V254, P108, DOI 10.1097/SLA.0b013e31821ad884; Esnaola NF, 2003, ANN SURG, V238, P711, DOI 10.1097/01.sla.0000094436.34556.ac; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; Tsutsumi M, 1996, HEPATOLOGY, V23, P1093; Ikai I, 2004, CANCER, V101, P796, DOI 10.1002/cncr.20426; Zhang JB, 2011, EUR J GASTROEN HEPAT, V23, P787, DOI 10.1097/MEG.0b013e32834902dd; Poon RTP, 2002, ANN SURG, V235, P373, DOI 10.1097/00000658-200203000-00009; Weinberg ED, 1996, EUR J CANCER PREV, V5, P19; Lisotti A, 2014, HEPATOLOGY, V59, P643, DOI 10.1002/hep.26700; Zipprich A, 2010, GUT, V59, P963, DOI 10.1136/gut.2010.208595; Faber W, 2013, SURGERY, V153, P510, DOI 10.1016/j.surg.2012.09.015; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263; Sheen IS, 2003, WORLD J GASTROENTERO, V9, P468; Ju MJ, 2009, J GASTROENTEROL, V44, P635, DOI 10.1007/s00535-009-0050-x; Ardiles V, 2010, CIR ESPAN, V87, P148, DOI 10.1016/j.ciresp.2009.11.015; Brouillet A, 1998, AM J PATHOL, V152, P1039; Carr BI, 2010, J GASTROEN HEPATOL, V25, P1543, DOI 10.1111/j.1440-1746.2010.06303.x; Corti A, 2009, MUTAT RES-FUND MOL M, V669, P112, DOI 10.1016/j.mrfmmm.2009.05.010; ELLIS G, 1979, CLIN BIOCHEM, V12, P142, DOI 10.1016/S0009-9120(79)80142-3; Fung J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072306; Gao J J, 2012, Drug Discov Ther, V6, P108; GOLDBERG DM, 1975, DIGESTION, V12, P232; Guo R, 2015, BIOSCI TRENDS, V9, P65, DOI 10.5582/bst.2014.01142; HANIGAN MH, 1994, CANCER RES, V54, P286; Hudson EA, 1997, MOL CARCINOGEN, V20, P376, DOI 10.1002/(SICI)1098-2744(199712)20:4<376::AID-MC7>3.0.CO;2-H; Hung HH, 2013, J GASTROINTEST SURG, V17, P702, DOI 10.1007/s11605-012-2087-z; Javed S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073160; Kim HJ, 2015, HPB, V17, P159, DOI 10.1111/hpb.12295; Liver Cancer Study Group of Japan, 2008, GEN RUL CLIN PATH ST; Moon DO, 2012, TOXICOL IN VITRO, V26, P429, DOI 10.1016/j.tiv.2012.01.013; Nishikawa H, 2013, ONCOL LETT, V6, P1213, DOI 10.3892/ol.2013.1578; Okabe H, 2009, HEPATOL RES, V39, P107; Okabe H, 2014, NUCL MED COMMUN, V35, P478, DOI 10.1097/MNM.0000000000000075; Paolicchi A, 2003, EUR J CANCER, V39, P996, DOI 10.1016/S0959-8049(03)00067-4; Park SK, 2013, KOREAN J INTERN MED, V28, P428, DOI 10.3904/kjim.2013.28.4.428; RUPPIN DC, 1982, MED J AUSTRALIA, V1, P421; Sharfi ARA, 1997, BRIT J UROL, V80, P933, DOI 10.1046/j.1464-410X.1997.00487.x; Shindoh J, 2013, J CLIN ONCOL, V31, P766, DOI 10.1200/JCO.2012.44.3234; Song Peipei, 2013, Hepatobiliary Surg Nutr, V2, P227, DOI 10.3978/j.issn.2304-3881.2013.08.11; Song PP, 2014, BIOSCI TRENDS, V8, P266, DOI 10.5582/bst.2014.01116; STARK AA, 1994, CARCINOGENESIS, V15, P343, DOI 10.1093/carcin/15.2.343; Verhoef C, 2004, DIGEST SURG, V21, P380, DOI 10.1159/000081882; Wang Zhigang, 2014, Drug Discov Ther, V8, P134; WETMORE LA, 1993, P NATL ACAD SCI USA, V90, P7461, DOI 10.1073/pnas.90.16.7461; Zhang W, 2014, BIOSCI TRENDS, V8, P333, DOI 10.5582/bst.2014.01120; Zhao WC, 2012, WORLD J GASTROENTERO, V18, P3272, DOI 10.3748/wjg.v18.i25.3272; Zhao WC, 2013, EJSO-EUR J SURG ONC, V39, P858, DOI 10.1016/j.ejso.2013.04.003; Zhou L, 2007, J SURG ONCOL, V95, P298, DOI 10.1002/jso.20678	61	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAY	2015	94	21							e810	10.1097/MD.0000000000000810		9	Medicine, General & Internal	General & Internal Medicine	CJ1ZQ	WOS:000355284100009		
J	Ireland, DJ; Kemp, MW; Miura, Y; Saito, M; Newnham, JP; Keelan, JA				Ireland, D. J.; Kemp, M. W.; Miura, Y.; Saito, M.; Newnham, J. P.; Keelan, J. A.			Intra-amniotic pharmacological blockade of inflammatory signalling pathways in an ovine chorioamnionitis model	MOLECULAR HUMAN REPRODUCTION			English	Article						cytokine-suppressive anti-inflammatory drugs; intrauterine infection; preterm birth; TPCA-1; 5z-7-oxozeaenol	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BROAD-SPECTRUM ANTIBIOTICS; SPONTANEOUS PRETERM LABOR; AMNIOTIC-FLUID VOLUME; 7-YEAR FOLLOW-UP; FETAL MEMBRANES; INTRAUTERINE INFLAMMATION; PROPHYLACTIC ANTIBIOTICS; CHILDHOOD OUTCOMES; MICROBIAL INVASION	Intrauterine inflammation (IUI) associated with infection is the major cause of preterm birth (PTB) at < 32 weeks' gestation and accounts for 40% of all spontaneous PTBs. Pharmacological strategies to prevent PTB and improve fetal outcomes will likely require both antimicrobial and anti-inflammatory therapies. Here we investigated the effects of two cytokine-suppressive anti-inflammatory drugs (CSAIDs), compounds that specifically target inflammatory signalling pathways, in an ovine model of lipopolysaccharide (LPS)-induced chorioamnionitis. Chronically catheterized ewes at 116 days gestation (n = 7/group) received an intra-amniotic (IA) bolus of LPS (10 mg) plus vehicle or CSAIDS: TPCA-1 (1.2 mg/kg fetal weight) or 5z-7-oxozeaenol (OxZnl; 0.4 mg/kg fetal weight); controls received vehicle (dimethylsulphoxide). Amniotic fluid (AF), fetal and maternal blood samples were taken 0, 2, 6, 12, 24 and 48 h later; tissues were taken at autopsy (48 h). Administration of TPCA-1 or OxZnl abrogated the stimulatory effects of LPS (P < 0.01 versus vehicle control) on production of PGE(2) in AF, with lesser (non-significant) effects on IL-6 production. Fetal membrane polymorphonuclear cell infiltration score was significantly higher in LPS versus vehicle control animals (P < 0.01), and this difference was absent with TPCA-1 and OxZnl treatment. LPS-induced systemic fetal inflammation was highly variable, with no significant effects of CSAIDs observed. Lung inflammation was evident with LPS exposure, but unaffected by CSAID treatment. We have shown in a large animal model that IA administration of a single dose of CSAIDs can suppress LPS-induced IA inflammatory responses, while fetal effects were minimal. Further development and investigation of these compounds in infectious models is warranted.	[Ireland, D. J.; Kemp, M. W.; Miura, Y.; Saito, M.; Newnham, J. P.; Keelan, J. A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Saito, M.] Tohoku Univ Hosp, Div Perinatal Med, Sendai, Miyagi, Japan	Ireland, DJ (reprint author), Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia.	demelza.ireland@uwa.edu.au	Keelan, Jeffrey/G-2170-2011	Ireland, Demelza/0000-0002-8763-3542; Keelan, Jeffrey/0000-0002-5403-6266	Australian National Health and Medical Research Council [APP1024467]	This work was supported by an Australian National Health and Medical Research Council project grant [APP1024467 to J.A.K., M.W.K. and J.P.N.].	Keelan JA, 2011, J REPROD IMMUNOL, V88, P176, DOI 10.1016/j.jri.2010.11.003; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Simcox R, 2007, AUST NZ J OBSTET GYN, V47, P368, DOI 10.1111/j.1479-828X.2007.00759.x; Nakhai-Pour HR, 2011, CAN MED ASSOC J, V183, P1713, DOI 10.1503/cmaj.110454; Shatrov JG, 2010, OBSTET GYNECOL, V116, P387, DOI 10.1097/AOG.0b013e3181e90046; Fawke J, 2007, SEMIN FETAL NEONAT M, V12, P374, DOI 10.1016/j.siny.2007.06.002; Wu JQ, 2013, ACS CHEM BIOL, V8, P643, DOI 10.1021/cb3005897; Moss TJM, 2005, AM J OBSTET GYNECOL, V192, P1179, DOI 10.1016/j.agog.2004.11.063; Kallapur SG, 2007, J IMMUNOL, V179, P8491; Kenyon S, 2008, LANCET, V372, P1310, DOI 10.1016/S0140-6736(08)61202-7; Petrou S, 2005, BJOG-INT J OBSTET GY, V112, P10, DOI 10.1111/j.1471-0528.2005.00577.x; Stinson LF, 2014, REPRODUCTION, V147, P313, DOI 10.1530/REP-13-0576; Viscardi RM, 2004, PEDIATR RES, V55, P1009, DOI 10.1203/01.pdr.0000127015.60185.8a; Kenyon SL, 2001, LANCET, V357, P989, DOI 10.1016/S0140-6736(00)04234-3; Kenyon S, 2008, LANCET, V372, P1319, DOI 10.1016/S0140-6736(08)61203-9; Lahra MM, 2009, PEDIATRICS, V123, P1314, DOI 10.1542/peds.2008-0656; De Silva D, 2010, BRIT J PHARMACOL, V160, P1808, DOI 10.1111/j.1476-5381.2010.00839.x; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527; DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001; Romero R, 2014, J MATERN-FETAL NEO M, V27, P757, DOI 10.3109/14767058.2013.844123; Kenyon SL, 2001, LANCET, V357, P979, DOI 10.1016/S0140-6736(00)04233-1; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Romero R, 2001, PAEDIATR PERINAT EP, V15, P41, DOI 10.1046/j.1365-3016.2001.00007.x; Agrawal V, 2012, SEMIN FETAL NEONAT M, V17, P12, DOI 10.1016/j.siny.2011.09.001; Jobe AH, 2012, CLIN PERINATOL, V39, P441, DOI 10.1016/j.clp.2012.06.010; Barone FC, 2001, J PHARMACOL EXP THER, V296, P312; Lappas M, 2007, PLACENTA, V28, P936, DOI 10.1016/j.placenta.2007.02.009; Arsenescu R, 2011, AM J GASTROENTEROL, V106, P559, DOI 10.1038/ajg.2011.5; Rinaldi SF, 2011, EXPERT REV CLIN IMMU, V7, P675, DOI [10.1586/eci.11.58, 10.1586/ECI.11.58]; Kim MJ, 2009, LAB INVEST, V89, P924, DOI 10.1038/labinvest.2009.49; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Behrman RE, 2007, PRETERM BIRTH CAUSES; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Chaemsaithong P, 2014, J MATERN-FETAL NEO M, V2014, P1, DOI 10.3109/14767058.2014.961417; GRISWOLD DE, 1993, DRUG EXP CLIN RES, V19, P243; Joergensen JS, 2014, EXPERT OPIN PHARMACO, V15, P2173, DOI 10.1517/14656566.2014.950225; Joergensen JS, 2014, EXPERT OPIN PHARMACO, P1; Jones HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008205; KAPLAN BS, 1994, PEDIATR NEPHROL, V8, P700; Kaplan S, 2013, J MATERN-FETAL NEO M, V26, P1860, DOI 10.3109/14767058.2013.811227; Kemp MW, 2010, REPROD SCI, V17, P619, DOI 10.1177/1933719110373148; Kemp MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063355; Kemp MW, 2014, AM J OBSTET GYNECOL, V211; Menon R, 2008, AM J OBSTET GYNECOL, V198, p77e1; Polglase GR, 2010, J APPL PHYSIOL, V108, P1757, DOI 10.1152/japplphysiol.01336.2009; Saito M, 2014, REPROD SCI, V21, P623, DOI 10.1177/1933719113508820; Sandlin AT, 2014, ARCH GYNECOL OBSTET, V289, P967, DOI 10.1007/s00404-013-3087-2; Shahin AY, 2009, INT J GYNECOL OBSTET, V104, P44, DOI 10.1016/j.ijgo.2008.08.026; Sullivan MHF, 2002, MOL HUM REPROD, V8, P281, DOI 10.1093/molehr/8.3.281; TOMODA S, 1985, AM J PHYSIOL, V249, pR133; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290	53	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1360-9947	1460-2407		MOL HUM REPROD	Mol. Hum. Reprod.	MAY	2015	21	5					479	489		10.1093/molehr/gav005		11	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CJ2MF	WOS:000355318200008		
J	Iacopi, F; Van Hove, M; Charles, M; Endo, K				Iacopi, Francesca; Van Hove, Marleen; Charles, Matthew; Endo, Kazuhiro			Power electronics with wide bandgap materials: Toward greener, more efficient technologies	MRS BULLETIN			English	Article							GAN; HFETS; MOVPE	Greener technologies for more efficient power generation, distribution, and delivery in sectors ranging from transportation and generic energy supply to telecommunications are quickly expanding in response to the challenge of climate change. Power electronics is at the center of this fast development. As the efficiency and resiliency requirements for such technologies can no longer be met by silicon, the research, development, and industrial implementation of wide bandgap semiconductors such as gallium nitride (GaN) and silicon carbide (SiC) are progressing at an unprecedented pace. This issue of MRS Bulletin, although certainly not exhaustive, provides an overview of the pace and quality of research revolving around GaN and SiC power electronics, from the choice of substrates, film growth, devices, and circuits to examples of applications.	[Iacopi, Francesca] Griffith Univ, Queensland Micro & Nanotechnol Ctr, Nathan, Qld 4111, Australia; [Van Hove, Marleen] Interuniv Microelect Ctr, Heverlee, Belgium; [Charles, Matthew] Commissariat Energie Atom & Energies Alternat, Paris, France; [Endo, Kazuhiro] Kanazawa Inst Technol, Kanazawa, Ishikawa, Japan	Iacopi, F (reprint author), Griffith Univ, Queensland Micro & Nanotechnol Ctr, Nathan, Qld 4111, Australia.	f.iacopi@griffith.edu.au; marleen.vanhove@imec.be; matthew.charles@cea.fr; kendo@neptune.kanazawa-it.ac.jp	Griffith University, QMNC/I-5498-2013; Iacopi, Francesca/D-8934-2013	Iacopi, Francesca/0000-0002-3196-0990	Australian Research Council [FT120100445]	Kurt Gaskill (NRL), Tomas Palacios and Bin Lu (MIT), and Petre Badica (NIMP, Romania) are acknowledged for advice and helpful discussions. FI acknowledges the Australian Research Council support through the grant FT120100445 (Future Fellowship).	Abuishmais Ibrahim, 2012, Advances in Power Electronics, DOI 10.1155/2012/765619; Agarwal A., 2004, MRS P, V815, pJ11, DOI 10.1557/PROC-815-J1.1; Agarwal A. K., 2010, INT C POW CONTR EMB, P1; Aggerstam T, 2006, PHYS STATUS SOLIDI C, V3, P2373, DOI 10.1002/pssc.200565152; Amano H, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.050001; [Anonymous], 2004, SCIENCE, V303, P1731; Dai Q, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3100773; Friedli T, 2009, IEEE T IND APPL, V45, P1868, DOI 10.1109/TIA.2009.2027538; Srivastava P, 2010, IEEE ELECTR DEVICE L, V31, P851, DOI 10.1109/LED.2010.2050673; Vetury R, 2001, IEEE T ELECTRON DEV, V48, P560, DOI 10.1109/16.906451; Hamada K, 2015, IEEE T ELECTRON DEV, V62, P278, DOI 10.1109/TED.2014.2359240; Selvaraj J, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.121002; Boyd AR, 2009, PHYS STATUS SOLIDI C, V6, pS1045, DOI 10.1002/pssc.200880925; Okumura H, 2006, JPN J APPL PHYS 1, V45, P7565, DOI 10.1143/JJAP.45.7565; Bose B. K., 2012, IEEE T IND ELECTRON, V60, P2638; Hart D. W., 2010, POWER ELECT; Intergovernmental Panel for Climate Change, 2014, CLIM CHANG 2014 SYNT; Jatal W., 2014, IEEE ELECTR DEVICE L, V36, P123; Jiang QM, 2013, IEEE ELECTR DEVICE L, V34, P357, DOI 10.1109/LED.2012.2236637; Kato S, 2007, J CRYST GROWTH, V298, P831, DOI 10.1016/j.jcrysgro.2006.10.192; Kimoto T., 2014, INT EL DEV M IEDM 20, P36; Kusumori T, 2004, APPL PHYS LETT, V84, P1272, DOI 10.1063/1.1649797; Lu B., 2013, THESIS MIT; McNutt M. T., 2014, J ELECT MAT, V43, P4552; Mueller S. G., 2012, J CRYST GROWTH, V352, P39; New York State Governor's Press Office, 2014, GOV CUOM ANN 100 BUS; Pachauri R.K., 2007, CLIMATE CHANGE 2007; Pearton S., 2012, GAN ZNO BASED MAT DE; Rupp R., 2014, INT EL DEV M IEDM 20, P28; Samago H., 2014, IEEE T POWER ELECTR, V29, P2539; Stringfellow G. B., 1999, ORGANOMETALLIC VAPOU; Sugimoto M., 2007, P IEEE POW CONV C, V368; Tolbert L. M., 2003, IASTED INT C POW EN, P317; Yole Developpement, 2012, STAT POW EL IND; Yole Developpement, 2014, POW GAN GAN TECHN PO; Yole Technologies PowerDev, 2012, IND REV	36	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0883-7694	1938-1425		MRS BULL	MRS Bull.	MAY	2015	40	5					390	398		10.1557/mrs.2015.71		9	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CJ1VO	WOS:000355272900009		
J	Kitabatake, M; Ohoka, A				Kitabatake, Makoto; Ohoka, Atsushi			SiC DioMOS with precisely controlled epitaxial channel	MRS BULLETIN			English	Article							GROWTH; 6H-SIC(0001)	Silicon carbide (SiC) is the next-generation power semiconductor material, enabling an energy-efficient future society by drastically reducing energy loss in existing power electronics systems. SiC metal oxide semiconductor field-effect transistors (MOSFETs) are promising low-loss power-electronics devices. We have developed precisely controlled doping techniques for ultrathin and highly doped SiC epitaxial films and applied this to form the channels of SiC-MOSFETs. This has resulted in the successful formation of diode-integrated MOSFETs (DioMOSs), a structure enabled using SiC semiconductor material. The MOSFET current together with the diode current of the DioMOS is designed to maintain low conduction loss and good temperature stability. The high threshold voltage of MOSFETs and the perfect unipolar conduction with fast switching contribute to safety and low-loss operation. DioMOS offers a single-chip solution for next-generation power electronics compared to the parallel connection using a diode and a transistor in a conventional semiconductor device. DioMOS achieves a small and light direct current converter with high voltage, current, efficiency, and power density applicable to electric and hybrid vehicles.	[Kitabatake, Makoto; Ohoka, Atsushi] Panasonic Corp, Osaka, Japan	Kitabatake, M (reprint author), Panasonic Corp, Osaka, Japan.	mak-k@ktd.biglobe.ne.jp; ohoka.atsushi@jp.panasonic.com					Skowronski M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2159578; Matsunami H, 1997, MAT SCI ENG R, V20, P125, DOI 10.1016/S0927-796X(97)00005-3; Kamata I, 2000, JPN J APPL PHYS 1, V39, P6496, DOI 10.1143/JJAP.39.6496; LARKIN DJ, 1994, APPL PHYS LETT, V65, P1659, DOI 10.1063/1.112947; Chang KC, 2004, J APPL PHYS, V95, P8252, DOI 10.1063/1.1737801; Baliga B. J., 2008, FUNDAMENTALS POWER S; Choyke W. J., 1997, SILICON CARBIDE REV, V1; Choyke W.J., 1997, SILICON CARBIDE REV, V2; Kitabatake M, 1996, JPN J APPL PHYS 1, V35, P5261, DOI 10.1143/JJAP.35.5261; Kitabatake M, 1998, MATER SCI FORUM, V264-2, P327; Kitabatake M, 2014, MATER SCI FORUM, V778-780, P979, DOI 10.4028/www.scientific.net/MSF.778-780.979; Kitabatake M, 2009, MATER SCI FORUM, V600-603, P913, DOI 10.4028/www.scientific.net/MSF.600-603.913; Kreutzer O., 2014, P EUR C SIL IN PRESS; Ohoka A, 2014, MATER SCI FORUM, V778-780, P911, DOI 10.4028/www.scientific.net/MSF.778-780.911; Soloviev SI, 2002, MATER SCI FORUM, V389-3, P557; Takahashi K, 2000, MATER SCI FORUM, V338-3, P357; Takahashi K, 2002, MATER SCI FORUM, V389-3, P247; Uchida M., 2011, IEEE INT EL DEV M 20, P602	18	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0883-7694	1938-1425		MRS BULL	MRS Bull.	MAY	2015	40	5					425	430		10.1557/mrs.2015.91		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CJ1VO	WOS:000355272900014		
J	Okumura, H				Okumura, Hajime			A roadmap for future wide bandgap semiconductor power electronics	MRS BULLETIN			English	Article							PIN DIODES; GROWTH; DISLOCATIONS	Energy savings and efficient usage of electric power are some of the most urgent issues for future sustainable development of human society. Power electronics is recognized as a key technology in this regard, and the innovation of power electronics is increasingly required. The important role of power electronics innovations in the future human society and a technology roadmap of power electronics utilizing wide bandgap semiconductors, which are typically represented by silicon carbide, are presented. This roadmap consists of several different domains in technology, from the materials side to the applications side. On this roadmap, three generations are defined as technological streams. Based on this roadmap, recent progress in silicon carbide power electronics is reviewed, and future prospects are discussed.	Natl Inst Adv Ind Sci & Technol, Adv Power Elect Res Ctr, Osaka, Japan	Okumura, H (reprint author), Natl Inst Adv Ind Sci & Technol, Adv Power Elect Res Ctr, Osaka, Japan.	h-okumura@aist.go.jp					Miyake H, 2012, IEEE ELECTR DEVICE L, V33, P1598, DOI 10.1109/LED.2012.2215004; Senzaki J, 2012, MATER SCI FORUM, V717-720, P703, DOI 10.4028/www.scientific.net/MSF.717-720.703; Danno K, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2740580; Miyazawa T, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3517487; Tanaka Y, 2006, IEEE ELECTR DEVICE L, V27, P908, DOI 10.1109/LED.2006.884724; Jacobson H, 2004, J APPL PHYS, V95, P1485, DOI 10.1063/1.1635996; Ryu SH, 2012, MATER SCI FORUM, V717-720, P1135, DOI 10.4028/www.scientific.net/MSF.717-720.1135; Ito M, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.015001; Tsuji T, 2010, MATER SCI FORUM, V645-648, P913, DOI 10.4028/www.scientific.net/MSF.645-648.913; Daikoku H, 2012, MATER SCI FORUM, V717-720, P61, DOI 10.4028/www.scientific.net/MSF.717-720.61; Fujiwara H, 2012, MATER SCI FORUM, V717-720, P911, DOI 10.4028/www.scientific.net/MSF.717-720.911; Hamada K., 2012, 2012 INT C SOL STAT, P897; Harada S., 2014, 10 EUR C SIL CARB RE, pTU; Harada S., 2006, IEDM, V903; Ishida Y, 2004, MATER SCI FORUM, V457-460, P213; Kimoto T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.121201; Kimoto T., 2014, FUNDAMENTALS SILICON; Kondo H, 2014, MATER SCI FORUM, V778-780, P17, DOI 10.4028/www.scientific.net/MSF.778-780.17; Kono H., 2012, 2012 INT C SOL STAT, P468; Kosugi R, 2014, PROC INT SYMP POWER, P346, DOI 10.1109/ISPSD.2014.6856047; La Via F, 2013, MATER SCI FORUM, V740-742, P167, DOI 10.4028/www.scientific.net/MSF.740-742.167; Matsumoto Y., 2012, P 1 IEEE C POW ENG R; Nakamura T., 2011, IEDM, P599; Nakano Y, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.04C100; Okamoto D, 2013, MATER SCI FORUM, V740-742, P907, DOI 10.4028/www.scientific.net/MSF.740-742.907; Okumura H., 2012, J I ELECT INFORM COM, V95, P1003; Okumura Hajime, 2010, Journal of the Institute of Electronics, Information and Communication Engineers, V93; Palmour J. W., 2010, 8 EUR C SIL CARB REL, P17; Peters D., 2003, P EUR C POW EL APPL, P935; Sato S, 2011, MATER SCI FORUM, V679-680, P738, DOI 10.4028/www.scientific.net/MSF.679-680.738; Simanjorang R., 2011, P 26 ANN IEEE APPL P, P600; SPEED, PROJ ABSTR; Stum Z, 2011, MATER SCI FORUM, V679-680, P637, DOI 10.4028/www.scientific.net/MSF.679-680.637; Takao K., 2010, P IEEE 2010 EN CONV, P4558; Tanaka Y., 2010, I EL ENG JAP M, V4, P222; Yonezawa Y., 2013, IEDM, V661; Zacharias P., 2009, USE ELECT BASED POWE	37	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0883-7694	1938-1425		MRS BULL	MRS Bull.	MAY	2015	40	5					439	444		10.1557/mrs.2015.97		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CJ1VO	WOS:000355272900016		
J	Liu, Q; Zou, RJ; Wu, JH; Xu, KB; Lu, AJ; Bando, Y; Golberg, D; Hu, JQ				Liu, Qian; Zou, Rujia; Wu, Jianghong; Xu, Kaibing; Lu, Aijiang; Bando, Yoshio; Golberg, Dmitri; Hu, Junqing			Molten Au/Ge Alloy Migration in Ge Nanowires	NANO LETTERS			English	Article						Ge nanowires; Au/Ge alloy melting in situ manipulation; solid-liquid system; dynamics	TRANSMISSION ELECTRON-MICROSCOPY; LIQUID-SOLID GROWTH; GERMANIUM NANOWIRES; CARBON NANOTUBES; SEMICONDUCTOR NANOWIRES; PHASE-DIAGRAM; TEMPERATURE; SILICON; DROPLETS; THERMOMIGRATION	Herein, We report time-resolved in situ transmission electron microscopy observation of Au particle melting at a Ge nanowire tip, subsequent forming, of Au/Ge alloy liquid, and its migrating within the Ge nanowire. The migration direction and position of the Au/Ge liquid can be controlled by the applied voltage and the migration speed shows, a linear deceleration. in the nanowire. In a migration model proposed, the relevant dynamic mechanisms (electromigration, thermodiffusion, and viscous force, etc.) are discussed in detail. This work associated with the liquid mass transport in the solid nanowires should provide new insights into the crystal growth, interface engineering, and fabrication of the heterogeneous nanostructure based devices.	[Liu, Qian; Zou, Rujia; Wu, Jianghong; Xu, Kaibing; Hu, Junqing] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 201620, Peoples R China; [Zou, Rujia] City Univ Hong Kong, Dept Phys & Mat Sci, Ctr Super Diamond & Adv Films COSDAF, Hong Kong, Hong Kong, Peoples R China; [Lu, Aijiang] Donghua Univ, Dept Phys, Shanghai 201620, Peoples R China; [Bando, Yoshio; Golberg, Dmitri] Natl Inst Mat Sci NIMS, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan	Lu, AJ (reprint author), Donghua Univ, Dept Phys, Shanghai 201620, Peoples R China.	ajlu@dhu.edu.cn; hu.junqing@dhu.edu.cn	Zou, Rujia/C-8999-2014; Golberg, Dmitri/H-2776-2011	Golberg, Dmitri/0000-0003-2298-6539	National Natural Science Foundation of China [21171035, 51302035, 51472049, 11204030]; Ph.D. Programs Foundation of the Ministry of Education of China [20110075110008, 20130075120001]; National 863 Program of China [2013AA031903]; Fundamental Research Funds for the Central Universities; Chinese Ministry of Education [313015]; Science and Technology Commission of Shanghai Municipality [13ZR1451200]; Program Innovative Research Team in University [IRT1221]; Hong Kong Scholars Program; Shanghai Leading Academic Discipline Project [B603]; Program of Introducing Talents of Discipline to Universities [111-2-04]	This work was financially supported by the National Natural Science Foundation of China (Grants 21171035, 51302035, 51472049, and 11204030), the Ph.D. Programs Foundation of the Ministry of Education of China (Grants 20110075110008 and 20130075120001), the National 863 Program of China (Grant 2013AA031903), and the Fundamental Research Funds for the Central Universities. The Key Grant Project of Chinese Ministry of Education (Grant 313015), the Science and Technology Commission of Shanghai Municipality (Grant 13ZR1451200), the Program Innovative Research Team in University (Grant IRT1221), the Hong Kong Scholars Program, the Shanghai Leading Academic Discipline Project (Grant B603), and the Program of Introducing Talents of Discipline to Universities (Grant 111-2-04).	Sutter E, 2008, NANO LETT, V8, P411, DOI 10.1021/nl0719630; Chiu CH, 2013, NANOSCALE, V5, P5086, DOI 10.1039/c3nr33302g; Barreiro A, 2008, SCIENCE, V320, P775, DOI 10.1126/science.1155559; Jin CH, 2008, NAT NANOTECHNOL, V3, P17, DOI 10.1038/nnano.2007.406; Gamalski AD, 2010, NANO LETT, V10, P2972, DOI 10.1021/nl101349e; TILLER WA, 1963, J APPL PHYS, V34, P2757, DOI 10.1063/1.1729806; Chockla AM, 2009, J MATER CHEM, V19, P996, DOI 10.1039/b816954c; Dai S, 2012, NANO LETT, V12, P2379, DOI 10.1021/nl3003528; Sutter EA, 2010, ACS NANO, V4, P4943, DOI 10.1021/nn101366w; Holmberg VC, 2009, SCIENCE, V326, P405, DOI 10.1126/science.1178179; Jose-Yacaman M, 2005, J PHYS CHEM B, V109, P9703, DOI 10.1021/jp0509459; Zhang YF, 2000, PHYS REV B, V61, P4518, DOI 10.1103/PhysRevB.61.4518; Mirsaidov UM, 2012, P NATL ACAD SCI USA, V109, P7187, DOI 10.1073/pnas.1200457109; Jensen K, 2008, NAT NANOTECHNOL, V3, P533, DOI 10.1038/nnano.2008.200; ANTHONY TR, 1971, J APPL PHYS, V42, P3380, DOI 10.1063/1.1660741; Kim BJ, 2012, NANO LETT, V12, P5867, DOI 10.1021/nl303225a; van Huis MA, 2008, NANO LETT, V8, P3959, DOI 10.1021/nl8024467; Gu G, 2001, J APPL PHYS, V90, P5747, DOI 10.1063/1.1413495; Begtrup GE, 2009, NANO LETT, V9, P1835, DOI 10.1021/nl803800c; Lu XM, 2005, J AM CHEM SOC, V127, P15718, DOI 10.1021/ja055850z; Sutter PW, 2007, NAT MATER, V6, P363, DOI 10.1038/nmat1894; Wang YB, 2011, NANO LETT, V11, P1546, DOI 10.1021/nl104330h; Kodambaka S, 2007, SCIENCE, V316, P729, DOI 10.1126/science.1139105; Chen B, 2013, NANO LETT, V13, P3169, DOI 10.1021/nl401175t; Sutter E, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295605; Huang JY, 2013, NAT NANOTECHNOL, V8, P277, DOI [10.1038/nnano.2013.41, 10.1038/NNANO.2013.41]; Regan BC, 2004, NATURE, V428, P924, DOI 10.1038/nature02496; Lu Y, 2010, NAT NANOTECHNOL, V5, P218, DOI [10.1038/nnano.2010.4, 10.1038/NNANO.2010.4]; Hu JQ, 2003, ADV MATER, V15, P70, DOI 10.1002/adma.200390014; Xu SY, 2005, SMALL, V1, P1221, DOI 10.1002/smll.200500240; Zhao JO, 2010, NANO LETT, V10, P4309, DOI 10.1021/nl1008713; ANTHONY TR, 1972, J APPL PHYS, V43, P2473, DOI 10.1063/1.1661534; Araujo LS, 2012, PHYSCS PROC, V28, P62, DOI 10.1016/j.phpro.2012.03.672; Baloch KH, 2012, NAT NANOTECHNOL, V7, P315, DOI [10.1038/nnano.2012.39, 10.1038/NNANO.2012.39]; Bennett PA, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.125410; Chueh YL, 2010, NANO LETT, V10, P393, DOI 10.1021/nl902597m; CLINE HE, 1972, J APPL PHYS, V43, P4391, DOI 10.1063/1.1660932; CLINE HE, 1972, J APPL PHYS, V43, P10, DOI 10.1063/1.1660792; Costa PMFJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1429; Holmberg VC, 2011, NANO LETT, V11, P3803, DOI 10.1021/nl201879u; Hu JQ, 2010, CRYSTENGCOMM, V12, P89, DOI 10.1039/b910489p; Hu JQ, 2008, ACS NANO, V2, P107, DOI 10.1021/nn700285d; Huang XY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3243992; Liu CH, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2189907; MIZRAH T, 1980, J APPL PHYS, V51, P1207, DOI 10.1063/1.327689; PETEVES SD, 1991, METALL TRANS A, V22, P1259, DOI 10.1007/BF02660658; REZ P, 1991, ULTRAMICROSCOPY, V35, P65, DOI 10.1016/0304-3991(91)90046-9; Sutter P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.125504; Tang W, 2013, NANO LETT, V13, P6009, DOI 10.1021/nl4032023; WERNICK JH, 1956, J CHEM PHYS, V25, P47, DOI 10.1063/1.1742846; Yang WC, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.045421; Yuan CW, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3027066; Zhao J, 2010, J APPL PHYS, V107, DOI 10.1063/1.3373381; Zhao JO, 2011, NANO LETT, V11, P4647, DOI 10.1021/nl202160c; Zou RJ, 2013, ADV MATER, V25, P2693, DOI 10.1002/adma.201300257	55	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	MAY	2015	15	5					2809	2816		10.1021/acs.nanolett.5b01144		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CI6WX	WOS:000354906000007		
J	Ishikawa, Y; Tsukimoto, S; Nakayama, KS; Asao, N				Ishikawa, Yoshifumi; Tsukimoto, Susumu; Nakayama, Koji S.; Asao, Naoki			Ultrafine Sodium Titanate Nanowires with Extraordinary Sr Ion-Exchange Properties	NANO LETTERS			English	Article						Sodium titanate; nanowire; ion-exchanger; strontium; intermetallic compound	RADIOACTIVE IONS; NANOTUBES; WATER; NANOSTRUCTURES; ENTRAPMENT; FUKUSHIMA; NA2TI3O7; BARIUM	Ultrafine sodium titanate nanowires are produced from TiAl alloy precursors via a nonthermal-process where Al leaching and Ti oxidation occur simultaneously in an alkaline medium. The obtained nanowires demonstrate a layered crystal structure with a diameter of a few nanometers and exhibit remarkable Sr ion-exchange properties.	[Ishikawa, Yoshifumi; Tsukimoto, Susumu; Nakayama, Koji S.; Asao, Naoki] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Nakayama, KS (reprint author), Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.	kojisn@wpi-aimr.tohoku.ac.jp; asao@m.tohoku.ac.jp	Nakayama, Koji/E-5053-2012; Asao, Naoki/F-3057-2010		JSPS [25-10331, 25630291, 25286019, 25286012]; JST A-STEP [H25 Sendai 11-463]	Y. I. thanks the JSPS for Young Scientists for Research Fellowship #25-10331. S.T. thanks the support of JSPS Grant-in-Aid for Challenging Exploratory Research #25630291. K.S.N. thanks the support of JSPS Grant-in-Aid for Scientific Research B #25286019 and the support of JST A-STEP #H25 Sendai 11-463. N.A. thanks the support of JSPS Grant-in-Aid for Scientific Research B #25286012. We thank the "Nanotechnology Platform" of MEXT, Japan, at the Center for Integrated Nanotechnology Support, Tohoku University.	Allen S, 2002, PHYS CHEM CHEM PHYS, V4, P2409, DOI 10.1039/b111490p; Bavykin DV, 2006, ADV MATER, V18, P2807, DOI 10.1002/adma.200502696; Ma RZ, 2003, CHEM PHYS LETT, V380, P577, DOI 10.1016/j.cplett.2003.09.069; GREY IE, 1987, J SOLID STATE CHEM, V66, P7, DOI 10.1016/0022-4596(87)90215-5; Kasuga T, 1998, LANGMUIR, V14, P3160, DOI 10.1021/la9713816; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Joo J, 2005, J PHYS CHEM B, V109, P15297, DOI 10.1021/jp052458z; ANDERSSON S, 1961, ACTA CRYSTALLOGR, V14, P1245, DOI 10.1107/S0365110X61003636; Yang DJ, 2013, NANOSCALE, V5, P2232, DOI 10.1039/c3nr33622k; Burns PC, 2012, SCIENCE, V335, P1184, DOI 10.1126/science.1211285; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; Li N, 2012, ADV FUNCT MATER, V22, P835, DOI 10.1002/adfm.201102272; ANDERSSON S, 1962, ACTA CRYSTALLOGR, V15, P201, DOI 10.1107/S0365110X62000523; Sun XM, 2003, CHEM-EUR J, V9, P2229, DOI 10.1002/chem.200204394; Wang XD, 2014, CHEM REV, V114, P9346, DOI 10.1021/cr400633s; Raney M, 1940, IND ENG CHEM, V32, P1199, DOI 10.1021/ie50369a030; Buesseler KO, 2012, SCIENCE, V338, P480, DOI 10.1126/science.1228250; Xu CK, 2003, SOLID STATE COMMUN, V126, P545, DOI 10.1016/S0038-1098(03)00318-1; Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529; SRINIVASAN S, 1991, SCRIPTA METALL MATER, V25, P2513, DOI 10.1016/0956-716X(91)90059-A; SASAKI T, 1995, CHEM MATER, V7, P1001, DOI 10.1021/cm00053a029; Yang DJ, 2008, ADV MATER, V20, P2777, DOI 10.1002/adma.200702055; Yoshida N, 2012, SCIENCE, V336, P1115, DOI 10.1126/science.1219493; Chang M, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/14/145105; Chen CA, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075611; JuradoVargas M, 1997, J RADIOANAL NUCL CH, V218, P153, DOI 10.1007/BF02039327; Kim JI, 2009, CURR APPL PHYS, V9, pE252, DOI 10.1016/j.cap.2009.06.055; Komatsu Y, 1991, ANAL SCI, V7, P153, DOI 10.2116/analsci.7.Supple_153; Mao Y., 2006, AM CHEM SOC, V128, P8217; Murray J.L., 1990, BINARY ALLOY PHASE D, V1; Noh JH, 2012, J PHYS CHEM C, V116, P8102, DOI 10.1021/jp211233s; PAULUS WJ, 1992, NATURE, V357, P571, DOI 10.1038/357571a0; REID AF, 1968, ACTA CRYSTALL B-STRU, VB 24, P1228, DOI 10.1107/S0567740868004024; Sauvet AL, 2004, J SOLID STATE CHEM, V177, P4508, DOI [10.1016/j.jssc.2004.09.008, 10.1016/j.\jssc.2004.09.008]; Sun J, 2014, SCI REP-UK, V4, DOI 10.1038/srep07313; Wang H, 2014, THIN SOLID FILMS, V558, P1, DOI 10.1016/j.tsf.2014.01.056; Yada M, 2007, LANGMUIR, V23, P2815, DOI 10.1021/la062654c	37	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	MAY	2015	15	5					2980	2984		10.1021/nl504820c		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CI6WX	WOS:000354906000032		
J	Zheng, CX; Xu, ZQ; Zhang, QH; Edmonds, MT; Watanabe, K; Taniguchi, T; Bao, QL; Fuhrer, MS				Zheng, Changxi; Xu, Zai-Quan; Zhang, Qianhui; Edmonds, Mark T.; Watanabe, Kenji; Taniguchi, Takashi; Bao, Qiaoliang; Fuhrer, Michael S.			Profound Effect of Substrate Hydroxylation and Hydration on Electronic and Optical Properties of Monolayer MoS2	NANO LETTERS			English	Article						Molybdenum disulfide; transition metal dichalcogenides; substrate; doping photolumineseence; boron nitride	CRYSTAL ALPHA-AL2O3(0001) SURFACE; CHEMICAL-VAPOR-DEPOSITION; FIELD-EFFECT TRANSISTORS; WATER; GROWTH; MICA; H2O	Atomic force microscopy, Kelvin probe force microscopy, and scanning photoluminescence spectroscopy image the progressive postgrowth hydroxylation and hydration of atomically flat Al2O3(0001) under monolayer MoS2, manifested in large work function shifts (100 mV) due to charge transfer (>10(13) cm(-2)) from the substrate and changes in PL intensity, energy, and peak width. In contrast, trapped water between exfoliated graphene and Al2O3(0001) causes surface potential and doping changes one and two orders of magnitude smaller, respectively, and MoS2 grown on hydrophobic hexagonal boron nitride is unaffected by water exposure.	[Zheng, Changxi; Edmonds, Mark T.; Fuhrer, Michael S.] Monash Univ, Sch Phys, Clayton, Vic 3800, Australia; [Zheng, Changxi; Zhang, Qianhui] Monash Univ, Dept Civil Engn, Clayton, Vic 3800, Australia; [Xu, Zai-Quan; Bao, Qiaoliang] Monash Univ, Dept Mat Sci & Engn, Clayton, Vic 3800, Australia; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Bao, Qiaoliang] Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Jiangsu Key Lab Carbon Based Funct Mat & Devices, Suzhou 215123, Peoples R China; [Bao, Qiaoliang] Soochow Univ, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Suzhou 215123, Peoples R China	Fuhrer, MS (reprint author), Monash Univ, Sch Phys, Clayton, Vic 3800, Australia.	michael.fuhrer@monash.edu	Bao, Qiaoliang/A-6383-2009; WATANABE, Kenji/H-2825-2011	WATANABE, Kenji/0000-0003-3701-8119	ARC [DP150103837, FL120100038]; ARC DECRA [DE140101555, DE120101569]; 863 Program [2013AA031903]; youth 973 program [2015CB932700]; NSFC [51222208, 51290273, 91433107]; DP [DP140101501]; Engineering Seed Funding Scheme at Monash University; Elemental Strategy Initiative; JSPS [262480621, 25106006]	M.S.F, M.T.E., and C.Z. acknowledge support from ARC (DP150103837 and FL120100038). C.Z. acknowledges support from ARC DECRA (DE140101555). Q.B. acknowledges support from the 863 Program (Grant 2013AA031903), the youth 973 program (2015CB932700), the NSFC grants (Grants 51222208, 51290273, 91433107), ARC DECRA (DE120101569), DP (DP140101501), and Engineering Seed Funding Scheme (2014) at Monash University. This work was performed in part at the Melbourne Centre for Nanofabrication (MCN) in the Victorian Node of the Australian National Fabrication Facility (ANFF). K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by the MEXT, Japan. T.T. acknowledges support from a Grant-in-Aid for Scientific Research on Grant 262480621 and on Innovative Areas "Nano Informatics" (Grant 25106006) from JSPS.	Ling X, 2014, NANO LETT, V14, P464, DOI 10.1021/nl4033704; Ma L, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893143; Zhang Y, 2013, ACS NANO, V7, P8963, DOI 10.1021/nn403454e; Komurasaki H, 2012, J PHYS CHEM C, V116, P10084, DOI 10.1021/jp301402u; Nelson CE, 1998, SURF SCI, V416, P341, DOI 10.1016/S0039-6028(98)00439-7; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Bao WZ, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4789365; Lee C, 2010, ACS NANO, V4, P2695, DOI 10.1021/nn1003937; Eng PJ, 2000, SCIENCE, V288, P1029, DOI 10.1126/science.288.5468.1029; Hass KC, 1998, SCIENCE, V282, P265, DOI 10.1126/science.282.5387.265; Elam JW, 1998, J PHYS CHEM B, V102, P7008, DOI 10.1021/jp981070j; Tongay S, 2013, NANO LETT, V13, P2831, DOI 10.1021/nl4011172; Late DJ, 2012, ACS NANO, V6, P5635, DOI 10.1021/nn301572c; Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; van der Zande AM, 2013, NAT MATER, V12, P554, DOI [10.1038/nmat3633, 10.1038/NMAT3633]; Xu K, 2010, SCIENCE, V329, P1188, DOI 10.1126/science.1192907; Sutter P, 2010, J AM CHEM SOC, V132, P8175, DOI 10.1021/ja102398n; Shi YM, 2015, CHEM SOC REV, V44, P2744, DOI 10.1039/c4cs00256c; Wang XL, 2014, ACS NANO, V8, P5125, DOI 10.1021/nn501175k; Jariwala D, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803920; Chan MY, 2013, NANOSCALE, V5, P9572, DOI 10.1039/c3nr03220e; Yan J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.166802; Franks GV, 2007, J AM CERAM SOC, V90, P3373, DOI 10.1111/j.1551-2916.2007.02013.x; Taniguchi T, 2007, J CRYST GROWTH, V303, P525, DOI 10.1016/j.jcrysgro.2006.12.061; Severin N, 2012, NANO LETT, V12, P774, DOI 10.1021/nl2037358; Lee GH, 2013, ACS NANO, V7, P7931, DOI 10.1021/nn402954e; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Mak KF, 2013, NAT MATER, V12, P207, DOI [10.1038/nmat3505, 10.1038/NMAT3505]; Felice R. D., 1999, PHYS REV, V60; Peelaers H, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.241401	31	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	MAY	2015	15	5					3096	3102		10.1021/acs.nanolett.5b00098		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CI6WX	WOS:000354906000048		
J	Kawai, H; Giorgi, G; Marini, A; Yamashita, K				Kawai, Hiroki; Giorgi, Giacomo; Marini, Andrea; Yamashita, Koichi			The Mechanism of Slow Hot-Hole Cooling in Lead-Iodide Perovskite: First-Principles Calculation on Carrier Lifetime from Electron-Phonon Interaction	NANO LETTERS			English	Article						Solar cells; density functional theory; many-body perturbation theory; mixed organic-inorganic halide perovskites; carrier lifetime	ORGANOMETAL HALIDE PEROVSKITES; SOLAR-CELLS; CH3NH3PBI3; MOBILITIES; DEPOSITION; TRANSPORT; LENGTHS; POINTS	We report on an analysis of hot-carrier lifetimes from electron-phonon interaction in lead iodide perovskites using first principles calculations. Our calculations show that the holes. in CsPbI3 have very tong lifetimes in the valence band region situated 0.6 eV below the top of the valence band. On the other hand; no long lifetime is predicted in PbI3-. These different results reflect the different electronic density of states (DOSs) in the valence bands, that is, a small DOS for the former structure While a sharp DOS peak for the latter structure. We propose a reduction of the relaxation paths in the small valence DOS as' being the origin of the slow hot-hole cooling. Analyzing the generalized Eliashberg functions, we predict that different perovskite A-site cations do not have an impact on the cattier decay mechanism. The similarity between the DOS structures of CsPbI3 and CH3NH3PbI3 enables us to extend the description of the decay mechanism of fully inorganic CsPbI3 to its organic-inorganic counterpart, CH3NH3PbI3.	[Kawai, Hiroki; Giorgi, Giacomo; Yamashita, Koichi] Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Kawai, Hiroki; Giorgi, Giacomo; Yamashita, Koichi] CREST JST, Chiyoda Ku, Tokyo 1020076, Japan; [Marini, Andrea] CNR, Ist Struttura Mat, I-00016 Monterotondo, Italy; [Marini, Andrea] ETSF, I-00016 Monterotondo, Italy	Kawai, H (reprint author), Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	kawai@tcl.t.u-tokyo.ac.jp; yamasita@chemsys.t.u-tokyo.ac.jp	Giorgi, Giacomo/G-4390-2015; Marini, Andrea/D-1813-2009; Yambo, MBPT Code/O-4564-2015	Marini, Andrea/0000-0001-9289-5750; 	JSPS [24-7666]	H.K. is supported by JSPS Research Fellowships for Young Scientists (24-7666).	Yamada Y, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.032302; Giorgi G, 2014, J PHYS CHEM C, V118, P12176, DOI 10.1021/jp504479c; Bernardi M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.257402; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Etgar L, 2012, J AM CHEM SOC, V134, P17396, DOI 10.1021/ja307789s; Quarti C, 2014, J PHYS CHEM LETT, V5, P279, DOI 10.1021/jz402589q; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Giorgi G, 2015, J MATER CHEM A, V3, P8981, DOI 10.1039/c4ta05046k; Cannuccia E, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.255501; Restrepo OD, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3147189; Even J, 2014, J PHYS CHEM C, V118, P11566, DOI 10.1021/jp503337a; Gonzalez-Pedro V, 2014, NANO LETT, V14, P888, DOI 10.1021/nl404252e; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/nmat4014, 10.1038/NMAT4014]; Kawamura Y, 2002, J PHYS SOC JPN, V71, P1694, DOI 10.1143/JPSJ.71.1694; Stoumpos CC, 2013, INORG CHEM, V52, P9019, DOI 10.1021/ic401215x; Giorgi G, 2013, J PHYS CHEM LETT, V4, P4213, DOI 10.1021/jz4023865; Ponseca CS, 2014, J AM CHEM SOC, V136, P5189, DOI 10.1021/ja412583t; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Marini A, 2009, COMPUT PHYS COMMUN, V180, P1392, DOI 10.1016/j.cpc.2009.02.003; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; POGLITSCH A, 1987, J CHEM PHYS, V87, P6373, DOI 10.1063/1.453467; LAUTENSCHLAGER P, 1986, PHYS REV B, V33, P5501, DOI 10.1103/PhysRevB.33.5501; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Marini A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.106405; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Even J, 2013, J PHYS CHEM LETT, V4, P2999, DOI 10.1021/jz401532q; Brivio F, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.155204; Cannuccia E, ARXIV13040072CONDMAT; Huang LY, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.165203; Im JH, 2014, NAT NANOTECHNOL, V9, P927, DOI [10.1038/nnano.2014.181, 10.1038/NNANO.2014.181]; Kawai H, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.085202; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Xing GC, 2013, SCIENCE, V342, P344, DOI 10.1126/science.1243167	34	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	MAY	2015	15	5					3103	3108		10.1021/acs.nanolett.5b00109		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CI6WX	WOS:000354906000049		
J	Arayachukiat, S; Seemork, J; Pan-In, P; Amornwachirabodee, K; Sangphech, N; Sansureerungsikul, T; Sathornsantikun, K; Vilaivan, C; Shigyou, K; Pienpinijtham, P; Vilaivan, T; Palaga, T; Banlunara, W; Hamada, T; Wanichwecharungruang, S				Arayachukiat, Sunatda; Seemork, Jiraporn; Pan-In, Porntip; Amornwachirabodee, Kittima; Sangphech, Naunpun; Sansureerungsikul, Titiporn; Sathornsantikun, Kamonluck; Vilaivan, Chotima; Shigyou, Kazuki; Pienpinijtham, Prompong; Vilaivan, Tirayut; Palaga, Tanapat; Banlunara, Wijit; Hamada, Tsutomu; Wanichwecharungruang, Supason			Bringing Macromolecules into Cells and Evading Endosomes by Oxidized Carbon Nanoparticles	NANO LETTERS			English	Article						cellular penetration; lipid bilayer membrane; transient pore; nanoparticle; antigene; PNA; oxidized carbon particle	PEPTIDE NUCLEIC-ACIDS; RNAI THERAPEUTICS; NANOTUBES; DELIVERY; GENE; ACTIVATION; RAMAN; DNA; TRANSCRIPTION; INHIBITION	A great challenge exists in finding safe, simple, and effective delivery strategies to bring matters across cell membrane. Popular methods such as viral vectors, positively charged particles and cell penetrating peptides possess some of the following drawbacks: safety issues, lysosome trapping, limited loading capacity, and toxicity, whereas electroporation produces severe damages on both cargoes and cells. Here, we show that a serendipitously discovered, relatively nontoxic, water dispersible, stable, negatively charged, oxidized carbon nanoparticle, prepared from graphite, could deliver macromolecules into cells, without getting trapped in a lysosome. The ability of the particles to induce transient pores on lipid bilayer membranes of cell-sized liposomes was demonstrated. Delivering 12-base-long pyrrolidinyl peptide nucleic acids with d-prolyl-(1S,2S)-2-aminocyclopentanecarboxylic acid backbone (acpcPNA) complementary to the antisense strand of the NF-kappa B binding site in the promoter region of the Il6 gene into the macrophage cell line, RAW 264.7, by our particles resulted in an obvious accumulation of the acpcPNAs in the nucleus and decreased Il6 mRNA and IL-6 protein levels upon stimulation. We anticipate this work to be a starting point in a new drug delivery strategy, which involves the nanoparticle that can induce a transient pore on the lipid bilayer membrane.	[Arayachukiat, Sunatda] CU, Fac Sci, Macromol Sci Program, Bangkok 10330, Thailand; [Seemork, Jiraporn] CU, Fac Sci, Program Petrochem, Bangkok 10330, Thailand; [Pan-In, Porntip; Amornwachirabodee, Kittima; Sansureerungsikul, Titiporn; Sathornsantikun, Kamonluck; Vilaivan, Chotima; Pienpinijtham, Prompong; Vilaivan, Tirayut] CU, Fac Sci, Dept Chem, Bangkok 10330, Thailand; [Sangphech, Naunpun; Palaga, Tanapat] CU, Fac Sci, Dept Microbiol, Bangkok 10330, Thailand; [Sangphech, Naunpun; Palaga, Tanapat] CU, Interdisciplinary Program Med Microbiol, Bangkok 10330, Thailand; [Shigyou, Kazuki; Hamada, Tsutomu] JAIST, Sch Mat Sci, Nomi, Ishikawa, Japan; [Banlunara, Wijit] CU, Fac Vet Sci, Dept Pathol, Bangkok 10330, Thailand; [Wanichwecharungruang, Supason] CU, Nanotec CU Ctr Excellence Food & Agr, Bangkok 10330, Thailand	Wanichwecharungruang, S (reprint author), CU, Fac Sci, Dept Chem, Bangkok 10330, Thailand.	psupason@chula.ac.th			Ratchadapiseksompot Fund from Chulalongkom University (CU); CU 90th anniversary fund, Advance material cluster [RES 560530097]; Nanotec-CU Center of Excellence on Food and Agriculture; Thailand Research Fund, Thailand [DPG5780002]; MEXT KAKENHI [25104510, 26103516]; Kao Foundation for Arts and Sciences, Japan; CU Dutsadiphiphat Scholarship; CU	We thank Dr. Tatsuya Murakami at Japan Advanced Institute of Science and Technology for XPS analysis, and the Olympus Bioimaging Center at Mahidol University for fluorescence recording of live-cells. This work was financially supported by the Grant for Chula Research Scholar from the Ratchadapiseksompot Fund from Chulalongkom University (CU), the CU 90th anniversary fund, Advance material cluster (RES 560530097), Nanotec-CU Center of Excellence on Food and Agriculture, and the Thailand Research Fund (DPG5780002), Thailand; MEXT KAKENHI (Nos. 25104510 and 26103516) and the Kao Foundation for Arts and Sciences, Japan. J.S. is funded by CU Dutsadiphiphat Scholarship, and P.P.-I. is funded by postdoctoral fellowship from CU.	Chakravarty P, 2010, NAT NANOTECHNOL, V5, P607, DOI [10.1038/nnano.2010.126, 10.1038/NNANO.2010.126]; Copolovici DM, 2014, ACS NANO, V8, P1972, DOI 10.1021/nn4057269; De Rosa G, 2009, MOLECULES, V14, P2801, DOI 10.3390/molecules14082801; BETHUNE DS, 1991, CHEM PHYS LETT, V179, P181, DOI 10.1016/0009-2614(91)90312-W; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; Janowski BA, 2005, NAT CHEM BIOL, V1, P210, DOI 10.1038/nchembio724; Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Bandow S, 2001, CHEM PHYS LETT, V337, P48, DOI 10.1016/S0009-2614(01)00192-0; Jones AT, 2012, J CONTROL RELEASE, V161, P582, DOI 10.1016/j.jconrel.2012.04.003; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327; Shiraishi T, 2006, NAT PROTOC, V1, P633, DOI 10.1038/nprot.2006.92; Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931; Lakshmanan S, 2014, ADV DRUG DELIVER REV, V71, P98, DOI 10.1016/j.addr.2013.05.010; Somia N, 2000, NAT REV GENET, V1, P91, DOI 10.1038/35038533; Geng J, 2014, NATURE, V514, P612, DOI 10.1038/nature13817; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Corredor C, 2013, CARBON, V60, P67, DOI 10.1016/j.carbon.2013.03.057; Falsini S, 2014, J MED CHEM, V57, P1138, DOI 10.1021/jm400791q; GRIGORIEV M, 1992, J BIOL CHEM, V267, P3389; Islam MA, 2014, J CONTROL RELEASE, V193, P74, DOI 10.1016/j.jconrel.2014.05.055; Kim HJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05176; Liu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3989; Merkel OM, 2011, BIOMATERIALS, V32, P2388, DOI 10.1016/j.biomaterials.2010.11.081; RAY A, 1988, P NATL ACAD SCI USA, V85, P6701, DOI 10.1073/pnas.85.18.6701; VICKERS TA, 1995, NUCLEIC ACIDS RES, V23, P3003; Vilaivan T, 2006, ORG LETT, V8, P1897, DOI 10.1021/ol060448q	26	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	MAY	2015	15	5					3370	3376		10.1021/acs.nanolett.5b00696		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CI6WX	WOS:000354906000089		
J	Yasui, T; Kaji, N; Ogawa, R; Hashioka, S; Tokeshi, M; Horiike, Y; Baba, Y				Yasui, Takao; Kaji, Noritada; Ogawa, Ryo; Hashioka, Shingi; Tokeshi, Manabu; Horiike, Yasuhiro; Baba, Yoshinobu			Arrangement of a Nanostructure Array To Control Equilibrium and Nonequilibrium Transports of Macromolecules	NANO LETTERS			English	Article						Nonequilibrium transport; macromolecules; nanostructure array; nanopillar	DNA SEPARATION CHIPS; MOLECULES; ELECTROPHORESIS; CHANNELS; CHROMATOGRAPHY; DYNAMICS; FRACTIONATION; MATRICES; FIELD; FLOW	Exploiting the nonequilibrium transport of macromolecules makes it possible to increase the separation speed without any loss of separation resolution. Here we report the arrangement of a nanostructure array in micro-channels to control equilibrium and nonequilibrium transports of macromolecules. The direct observation and separation of macromolecules in the nanopillar array reported here are the first to reveal the nonequilibrium transport, which has a potential to overcome the intrinsic trade-off between the separation Speed and resolution.	[Yasui, Takao; Kaji, Noritada; Baba, Yoshinobu] Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yasui, Takao; Kaji, Noritada; Tokeshi, Manabu; Baba, Yoshinobu] Nagoya Univ, ImPACT Res Ctr Adv Nanobiodevices, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ogawa, Ryo; Hashioka, Shingi; Horiike, Yasuhiro] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Tokeshi, Manabu] Hokkaido Univ, Div Biotechnol & Macromol Chem, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Baba, Yoshinobu] Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Baba, Yoshinobu] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan; [Kaji, Noritada] Nagoya Univ, Grad Sch Sci, ERATO Higashiyama Live Holon Project, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Yasui, T (reprint author), Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	yasui@apchem.nagoya-u.ac.jp; kaji@apchem.nagoya-u.ac.jp; babaymtt@apchem.nagoya-u.ac.jp			Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS) through Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; JSPS [24241050, 25790028]	This research was supported by the Cabinet Office, Government of Japan and the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, the JSPS Grant-in-Aid for JSPS Fellows, the JSPS Grant-in-Aid for Scientific Research (A) 24241050, and the JSPS Grant-in-Aid for Young Scientists (B) 25790028.	Huang LR, 2002, NAT BIOTECHNOL, V20, P1048, DOI 10.1038/nbt733; Li WL, 2003, NANOTECHNOLOGY, V14, P578, DOI 10.1088/0957-4484/14/6/302; VOLKMUTH WD, 1992, NATURE, V358, P600, DOI 10.1038/358600a0; Yasui T, 2013, MICROFLUID NANOFLUID, V14, P961, DOI 10.1007/s10404-012-1103-7; Kaji N, 2004, ANAL CHEM, V76, P15, DOI 10.1021/ac030303m; GIDDINGS JC, 1968, J PHYS CHEM-US, V72, P4397, DOI 10.1021/j100859a008; Zeng Y, 2007, ANAL CHEM, V79, P2289, DOI 10.1021/ac061931h; PORATH J, 1959, NATURE, V183, P1657, DOI 10.1038/1831657a0; Han J, 2000, SCIENCE, V288, P1026, DOI 10.1126/science.288.5468.1026; Fu JP, 2007, NAT NANOTECHNOL, V2, P121, DOI 10.1038/nnano.2006.206; Tegenfeldt JO, 2004, P NATL ACAD SCI USA, V101, P10979, DOI 10.1073/pnas.0403849101; Doyle PS, 2002, SCIENCE, V295, P2237, DOI 10.1126/science.1068420; Yasui T, 2013, ACS NANO, V7, P3029, DOI 10.1021/nn4002424; Fu JP, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.018103; Reisner W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196101; Yasui T, 2011, ANAL CHEM, V83, P6635, DOI 10.1021/ac201184t; Buchholz BA, 2002, ELECTROPHORESIS, V23, P1398, DOI 10.1002/1522-2683(200205)23:10<1398::AID-ELPS1398>3.0.CO;2-8; Cross JD, 2007, J APPL PHYS, V102, DOI 10.1063/1.2757202; de Gennes P. G., 1979, SCALING CONCEPTS POL; HIRABAYASHI J, 1989, ANAL BIOCHEM, V178, P336, DOI 10.1016/0003-2697(89)90649-0; HIRABAYASHI J, 1990, BIOCHEMISTRY-US, V29, P9515, DOI 10.1021/bi00493a004; KATO Y, 1984, J BIOCHEM-TOKYO, V95, P83; Laachi N, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.098106; Mao P, 2009, LAB CHIP, V9, P586, DOI 10.1039/b809370a; Nazemifard N, 2010, ANGEW CHEM INT EDIT, V49, P3326, DOI 10.1002/anie.200906343; Park SG, 2012, LAB CHIP, V12, P1463, DOI 10.1039/c2lc00016d; Pennathur S, 2007, ANAL CHEM, V79, P8316, DOI 10.1021/ac0710580; Rahong S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05252; Reccius CH, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.268101; Strychalski EA, 2009, J APPL PHYS, V106, DOI 10.1063/1.3183953; Tabuchi M, 2004, NAT BIOTECHNOL, V22, P337, DOI 10.1038/nbt939; Turner SWP, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.128103; Ueda M, 2004, J APPL PHYS, V96, P2937, DOI 10.1063/1.1776625; Viovy JL, 2000, REV MOD PHYS, V72, P813, DOI 10.1103/RevModPhys.72.813; Wu C.-S., 2004, HDB SIZE EXCLUSION C, V2nd, p[xiv, 694]; Yasui T, 2012, ANAL CHEM, V84, P9282, DOI 10.1021/ac3020565; Yasui T, 2011, ACS NANO, V5, P7775, DOI 10.1021/nn2030379; Zeng Y, 2008, ANGEW CHEM INT EDIT, V47, P6388, DOI 10.1002/anie.200800816	38	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	MAY	2015	15	5					3445	3451		10.1021/acs.nanolett.5b00783		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CI6WX	WOS:000354906000100		
J	Fukuda, M; Takeda, H; Kato, HE; Doki, S; Ito, K; Maturana, AD; Ishitani, R; Nureki, O				Fukuda, Masahiro; Takeda, Hironori; Kato, Hideaki E.; Doki, Shintaro; Ito, Koichi; Maturana, Andres D.; Ishitani, Ryuichiro; Nureki, Osamu			Structural basis for dynamic mechanism of nitrate/nitrite antiport by NarK	NATURE COMMUNICATIONS			English	Article							ESCHERICHIA-COLI K-12; AFFINITY NITRATE TRANSPORTER; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; RESPIRATION; SYSTEM; EXCHANGER; REDUCTASE; SOFTWARE; PLANTS	NarK belongs to the nitrate/nitrite porter (NNP) family in the major facilitator superfamily (MFS) and plays a central role in nitrate uptake across the membrane in diverse organisms, including archaea, bacteria, fungi and plants. Although previous studies provided insight into the overall structure and the substrate recognition of NarK, its molecular mechanism, including the driving force for nitrate transport, remained elusive. Here we demonstrate that NarK is a nitrate/nitrite antiporter, using an in vitro reconstituted system. Furthermore, we present the high-resolution crystal structures of NarK from Escherichia coli in the nitrate-bound occluded, nitrate-bound inward-open and apo inward-open states. The integrated structural, functional and computational analyses reveal the nitrate/nitrite antiport mechanism of NarK, in which substrate recognition is coupled to the transport cycle by the concomitant movement of the transmembrane helices and the key tyrosine and arginine residues in the substrate-binding site.	[Fukuda, Masahiro; Takeda, Hironori; Kato, Hideaki E.; Doki, Shintaro; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Fukuda, Masahiro; Takeda, Hironori; Kato, Hideaki E.; Doki, Shintaro; Ishitani, Ryuichiro; Nureki, Osamu] RIKEN, Global Res Cluster, Saitama 3510198, Japan; [Ito, Koichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan; [Maturana, Andres D.] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Ishitani, R (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ishitani@bs.s.u-tokyo.ac.jp; nureki@bs.s.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) through 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)'; Core Research for Evolutional Science and Technology (CREST) Program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of Japan Science and Technology Agency (JST); HPCI STRATEGIC PROGRAM Computational Life Science and Application in Drug Discovery and Medical Development by MEXT; MEXT [22687007, 24227004]	We thank M. Hattori (University of Tokyo, Japan), T. Nishizawa (University of Tokyo), H. Kojima (University of Tokyo) and S. Newstead (University of Oxford, UK) for useful discussions and critical comments on the manuscript; T. Tsukazaki (University of Tokyo) for sharing beamtime; A. Kurabayashi (University of Tokyo) for technical assistance; K. Hirata, the beam-line staff at BL32XU of SPring-8 (Hyogo, Japan) for assistance in data collection; and the RIKEN BioResource Center (Ibaraki, Japan) for providing the E. coli str. K-12 substr. MG1655 genomic DNA. The diffraction experiments were performed at SPring-8 BL32XU (proposals 2012A1093, 2012B1146, 2012B1162 and 2013A1168) and with the approval of RIKEN. The computations were performed using mini-K super computer system at the SACLA facility. This work was supported by the Japan Society for the Promotion of Science (JSPS) through its 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)' to O.N., by the Core Research for Evolutional Science and Technology (CREST) Program 'The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation' of Japan Science and Technology Agency (JST) to O.N., by a grant for HPCI STRATEGIC PROGRAM Computational Life Science and Application in Drug Discovery and Medical Development by MEXT to R.I. and by a Grant-in-Aid for Scientific Research (S) (24227004) and a Grant-in-Aid for Young Scientists (A) (22687007) from the MEXT to O.N. and R.I., respectively.	Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nishizawa T, 2013, SCIENCE, V341, P168, DOI 10.1126/science.1239002; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Moir JWB, 2001, CELL MOL LIFE SCI, V58, P215, DOI 10.1007/PL00000849; Sun J, 2014, NATURE, V507, P73, DOI 10.1038/nature13074; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Yan HC, 2013, CELL REP, V3, P716, DOI 10.1016/j.celrep.2013.03.007; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; STEWART V, 1988, MICROBIOL REV, V52, P190; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Nacry P, 2013, PLANT SOIL, V370, P1, DOI 10.1007/s11104-013-1645-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer K, 2005, PLANT CELL, V17, P1167, DOI 10.1105/tpc.104.029694; Zheng HJ, 2013, NATURE, V497, P647, DOI 10.1038/nature12139; Parker JL, 2014, NATURE, V507, P68, DOI 10.1038/nature13116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Jia WJ, 2009, BIOCHEM J, V417, P297, DOI 10.1042/BJ20080746; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; MacGregor BJ, 2013, MAR GENOM, V11, P53, DOI [10.1016/j.margen.2013.08.001, 10.1016/j.margen2013.08.001]; Clegg SJ, 2006, MICROBIOL-SGM, V152, P2091, DOI 10.1099/mic.0.28688-0; Baba Tomoya, 2006, Mol Syst Biol, V2; Clegg S, 2002, MOL MICROBIOL, V44, P143, DOI 10.1046/j.1365-2958.2002.02858.x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DEMOSS JA, 1991, J BACTERIOL, V173, P3303; Forde BG, 2000, BBA-BIOMEMBRANES, V1465, P219, DOI 10.1016/S0005-2736(00)00140-1; Hirata K, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/1/012002; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Martinez-Espinosa RM, 2011, BIOCHEM SOC T, V39, P175, DOI 10.1042/BST0390175; NOJI S, 1989, FEBS LETT, V252, P139, DOI 10.1016/0014-5793(89)80906-8; OMATA T, 1995, PLANT CELL PHYSIOL, V36, P207; ROWE JJ, 1994, MOL MICROBIOL, V12, P579, DOI 10.1111/j.1365-2958.1994.tb01044.x; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; STEWART V, 1982, J BACTERIOL, V151, P788; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Trueman LJ, 1996, GENE, V175, P223, DOI 10.1016/0378-1119(96)00154-0; Unkles SE, 2004, P NATL ACAD SCI USA, V101, P17549, DOI 10.1073/pnas.0405054101	50	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7097	10.1038/ncomms8097		12	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5ML	WOS:000355531600005		
J	Hampton, HR; Bailey, J; Tomura, M; Brink, R; Chtanova, T				Hampton, Henry R.; Bailey, Jacqueline; Tomura, Michio; Brink, Robert; Chtanova, Tatyana			Microbe-dependent lymphatic migration of neutrophils modulates lymphocyte proliferation in lymph nodes	NATURE COMMUNICATIONS			English	Article							IN-VIVO; TRANSENDOTHELIAL MIGRATION; IMMUNE-RESPONSE; DENDRITIC CELLS; AFFERENT LYMPH; BONE-MARROW; ANTIGEN; MICE; INFLAMMATION; DIFFERENTIATION	Neutrophil recruitment to the site of injury is an essential first step of an anti-bacterial response. However, little is known about the basis for and relevance of neutrophil migration from inflamed tissue into lymphoid organs. We established a photoconversion-based system to monitor the fate of neutrophils recruited to inflamed skin. While neutrophils are efficiently recruited to sites of both microbial and sterile lesions, subsequent re-localization to draining lymph nodes happens only when bacteria are present in the primary lesion. Skin egress of neutrophils occurs via lymphatic vessels and is dependent on CD11b and CXCR4 but not CCR7. Neutrophils are the predominant immune cell to migrate from inflamed skin into lymph nodes where they augment lymphocyte proliferation. Furthermore, inhibition of neutrophil migration from skin reduces T-cell proliferation in draining lymph nodes. Thus neutrophils mediate rapid cellular communication between the initial injury site and secondary lymphoid organs and modulate immune responsiveness.	[Hampton, Henry R.; Bailey, Jacqueline; Brink, Robert; Chtanova, Tatyana] Garvan Inst Med Res, Div Immunol, Darlinghurst, NSW 2010, Australia; [Hampton, Henry R.; Brink, Robert; Chtanova, Tatyana] UNSW Australia, Fac Med, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia; [Tomura, Michio] Osaka Ohtani Univ, Immunol Lab, Fac Pharm, Osaka 5848540, Japan	Chtanova, T (reprint author), Garvan Inst Med Res, Div Immunol, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	t.chtanova@garvan.org.au			Human Frontier Science Program, National Health and Medical Research Council (NHMRC) [1012858, GNT1062328]; Australian Postgraduate Award	We thank Dr Tri Phan and Professors Ellen Robey, Anthony Basten, Michael Hickey and Charles Mackay for scientific discussion and critical reading of the manuscript. We thank Professor Karlheinz Peter for providing CD11b-deficient mice. This research was funded by Human Frontier Science Program, National Health and Medical Research Council (NHMRC) Career Development Fellowship 1012858 and project grant GNT1062328 (T.C.) and an Australian Postgraduate Award (H.R.H.) and supported by Peter and Val Duncan.	Ahr B, 2005, J BIOL CHEM, V280, P6692, DOI 10.1074/jbc.M408481200; ALTIERI DC, 1988, P NATL ACAD SCI USA, V85, P7462, DOI 10.1073/pnas.85.20.7462; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Gresham HD, 2000, J IMMUNOL, V164, P3713; Aurrand-Lions M, 2001, BLOOD, V98, P3699, DOI 10.1182/blood.V98.13.3699; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Gorlino CV, 2014, J IMMUNOL, V193, P1966, DOI 10.4049/jimmunol.1301791; Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Buckley CD, 2006, J LEUKOCYTE BIOL, V79, P303, DOI 10.1189/jlb.0905496; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Coombes JL, 2013, P NATL ACAD SCI USA, V110, pE1913, DOI 10.1073/pnas.1220272110; Abdallah DSA, 2011, INT IMMUNOL, V23, P317, DOI 10.1093/intimm/dxr007; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Yang CW, 2010, J IMMUNOL, V185, P2927, DOI 10.4049/jimmunol.1001289; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Sanz MJ, 2012, EUR J IMMUNOL, V42, P278, DOI 10.1002/eji.201142231; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Abtin A, 2014, NAT IMMUNOL, V15, P45, DOI 10.1038/ni.2769; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; WRIGHT SD, 1988, P NATL ACAD SCI USA, V85, P7734, DOI 10.1073/pnas.85.20.7734; Beauvillain C, 2007, BLOOD, V110, P2965, DOI 10.1182/blood-2006-12-063826; Kim MH, 2011, BLOOD, V117, P3343, DOI 10.1182/blood-2010-07-296970; Chavakis T, 2004, J BIOL CHEM, V279, P55602, DOI 10.1074/jbc.M404676200; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Soriano SF, 2002, J EXP MED, V196, P311, DOI 10.1084/jem.20012041; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Chtanova T, 2014, J BIOPHOTONICS, V7, P425, DOI 10.1002/jbio.201200175; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Yang CW, 2013, J EXP MED, V210, P375, DOI 10.1084/jem.20122183; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Geng S, 2013, BLOOD, V121, P1690, DOI 10.1182/blood-2012-07-445197; Culshaw S, 2008, IMMUNOL LETT, V118, P49, DOI 10.1016/j.imlet.2008.02.008; Matsushima H, 2013, BLOOD, V121, P1677, DOI 10.1182/blood-2012-07-445189; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; de Veer M, 2012, IMMUNOL CELL BIOL, V90, P404, DOI 10.1038/icb.2011.53; de Veer M, 2010, VACCINE, V28, P6597, DOI 10.1016/j.vaccine.2010.07.056; Devi S, 2013, J EXP MED, V210, P2321, DOI 10.1084/jem.20130056; HYNES RO, 1992, COLD SPRING HARB SYM, V57, P249; Ng LG, 2011, J INVEST DERMATOL, V131, P2058, DOI 10.1038/jid.2011.179	45	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7139	10.1038/ncomms8139		11	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5NB	WOS:000355533500001		
J	Udagawa, T; Fujioka, Y; Tanaka, M; Honda, D; Yokoi, S; Riku, Y; Ibi, D; Nagai, T; Yamada, K; Watanabe, H; Katsuno, M; Inada, T; Ohno, K; Sokabe, M; Okado, H; Ishigaki, S; Sobue, G				Udagawa, Tsuyoshi; Fujioka, Yusuke; Tanaka, Motoki; Honda, Daiyu; Yokoi, Satoshi; Riku, Yuichi; Ibi, Daisuke; Nagai, Taku; Yamada, Kiyofumi; Watanabe, Hirohisa; Katsuno, Masahisa; Inada, Toshifumi; Ohno, Kinji; Sokabe, Masahiro; Okado, Haruo; Ishigaki, Shinsuke; Sobue, Gen			FUS regulates AMPA receptor function and FTLD/ALS-associated behaviour via GluA1 mRNA stabilization	NATURE COMMUNICATIONS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; BINDING PROTEIN; FRONTOTEMPORAL DEMENTIA; SYNAPTIC PLASTICITY; POLY(A) TAIL; DNA-DAMAGE; TRANSLATION; ALS; COMPLEX; IDENTIFICATION	FUS is an RNA/DNA-binding protein involved in multiple steps of gene expression and is associated with amyotrophic lateral sclerosis (ALS) and fronto-temporal lobar degeneration (FTLD). However, the specific disease-causing and/or modifying mechanism mediated by FUS is largely unknown. Here we evaluate intrinsic roles of FUS on synaptic functions and animal behaviours. We find that FUS depletion downregulates GluA1, a subunit of AMPA receptor. FUS binds GluA1 mRNA in the vicinity of the 3' terminus and controls poly (A) tail maintenance, thus regulating stability. GluA1 reduction upon FUS knockdown reduces miniature EPSC amplitude both in cultured neurons and in vivo. FUS knockdown in hippocampus attenuates dendritic spine maturation and causes behavioural aberrations including hyperactivity, disinhibition and social interaction defects, which are partly ameliorated by GluA1 reintroduction. These results highlight the pivotal role of FUS in regulating GluA1 mRNA stability, post-synaptic function and FTLD-like animal behaviours.	[Udagawa, Tsuyoshi; Fujioka, Yusuke; Honda, Daiyu; Yokoi, Satoshi; Riku, Yuichi; Watanabe, Hirohisa; Katsuno, Masahisa; Ishigaki, Shinsuke; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan; [Udagawa, Tsuyoshi; Inada, Toshifumi] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Tanaka, Motoki; Sokabe, Masahiro] Nagoya Univ, Grad Sch Med, Mechanobiol Lab, Nagoya, Aichi 4668550, Japan; [Ibi, Daisuke; Nagai, Taku; Yamada, Kiyofumi] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi 4668550, Japan; [Ohno, Kinji] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4668550, Japan; [Okado, Haruo] Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Tokyo 1568506, Japan	Sobue, G (reprint author), Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan.	ishigaki-ns@umin.net; sobueg@med.nagoya-u.ac.jp	清文, 山田/I-7487-2014; Nagai, Taku/I-7507-2014	清文, 山田/0000-0002-5280-5180; 	KAKENHI from JSPS [25860708]; CREST, JST	We thank Natalie G. Farny for the kind gift of materials and critical reading of the manuscript, Akiko Miwa and Sayaka Hirai for technical support of AAV production. This work was supported by KAKENHI grant number 25860708 from JSPS and CREST, JST. A part of this study is the result of Integrated Research on neuropsychiatric disorders carried out under the Strategic Research Program for Brain Sciences, Scientific Research on Innovative Areas ('Comprehensive Brain Science Network' and 'Brain Protein Aging and Dementia Control') and Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) by MEXT, Japan.	Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Qiu HY, 2014, J CLIN INVEST, V124, P981, DOI 10.1172/JCI72723; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Vance C, 2013, HUM MOL GENET, V22, P2676, DOI 10.1093/hmg/ddt117; Yasuda K, 2013, J CELL BIOL, V203, P737, DOI 10.1083/jcb.201306058; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Wang WY, 2013, NAT NEUROSCI, V16, P1383, DOI 10.1038/nn.3514; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Miyazaki Y, 2012, NAT MED, V18, P1136, DOI 10.1038/nm.2791; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Fujii R, 2005, J CELL SCI, V118, P5755, DOI 10.1242/jcs.02692; Hornberger M, 2012, BRAIN, V135, P3015, DOI 10.1093/brain/aws239; Munoz DG, 2009, ACTA NEUROPATHOL, V118, P617, DOI 10.1007/s00401-009-0598-9; Ibi D, 2009, NEUROSCI RES, V64, P297, DOI 10.1016/j.neures.2009.03.015; Udagawa T, 2012, MOL CELL, V47, P253, DOI 10.1016/j.molcel.2012.05.016; Udagawa T, 2013, NAT MED, V19, P1473, DOI 10.1038/nm.3353; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Kim JH, 2007, GENE DEV, V21, P2571, DOI 10.1101/gad.1593007; Ruepp MD, 2009, MOL BIOL CELL, V20, P5211, DOI 10.1091/mbc.E09-05-0389; Lu W, 2012, CURR OPIN NEUROBIOL, V22, P470, DOI 10.1016/j.conb.2011.09.008; Kuroda K, 2011, HUM MOL GENET, V20, P4666, DOI 10.1093/hmg/ddr400; Uchida N, 2004, J BIOL CHEM, V279, P1383, DOI 10.1074/jbc.M309125200; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; Bembich S, 2014, NUCLEIC ACIDS RES, V42, P3362, DOI 10.1093/nar/gkt1343; Vekovischeva OY, 2004, GENES BRAIN BEHAV, V3, P253, DOI 10.1111/j.1601-183X.2004.00075.x; Arguelles S, 2013, FREE RADICAL BIO MED, V61, P61, DOI 10.1016/j.freeradbiomed.2013.03.016; Bannerman DM, 2001, BEHAV BRAIN RES, V120, P1, DOI 10.1016/S0166-4328(00)00354-5; Darnell JC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012344; Feyder M., 2007, FRONT BEHAV NEUROSCI, VI, P1; Fujioka Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02388; Ishigaki S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00529; La Via L, 2013, NUCLEIC ACIDS RES, V41, P617, DOI 10.1093/nar/gks1223; Lin CH, 2012, J NEUROSCI, V32, P1826, DOI 10.1523/JNEUROSCI.3380-11.2012; Meijer HA, 2011, METHODS MOL BIOL, V703, P123, DOI 10.1007/978-1-59745-248-9_9; Noro T, 2004, CANCER RES, V64, P7486, DOI 10.1158/0008-5472.CAN-03-1296; Okada T, 2009, HUM GENE THER, V20, P1013, DOI 10.1089/hum.2009.006; Rogelj B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00603; Sanderson DJ, 2011, LEARN MEMORY, V18, P181, DOI 10.1101/lm.2083411	44	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	MAY	2015	6								7098	10.1038/ncomms8098		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ5ML	WOS:000355531600006		
J	Imamura, H; Konomoto, T; Tanaka, E; Hisano, S; Yoshida, Y; Fujimura, Y; Miyata, T; Nunoi, H				Imamura, Hideaki; Konomoto, Takao; Tanaka, Etsuko; Hisano, Satoshi; Yoshida, Yoko; Fujimura, Yoshihiro; Miyata, Toshiyuki; Nunoi, Hiroyuki			Familial C3 glomerulonephritis associated with mutations in the gene for complement factor B	NEPHROLOGY DIALYSIS TRANSPLANTATION			English	Article						C3 glomerulonephritis; complement alternative pathway; complement factor B; genetic mutation	GLOMERULOPATHY	We report the first case of familial C3 glomerulonephritis (C3GN) associated with mutations in the gene for complement factor B (CFB). A 12-year-old girl was diagnosed with biopsy-proven C3GN. Her mother had a history of treatment for membranoproliferative glomerulonephritis, and her brother had hypocomplementemia without urinary abnormalities. DNA analysis revealed heterozygosity for CFB p.S367R in the patient, mother and brother. Evaluation of the structure-function relationship supports that this mutation has gain-of-function effects in CFB. The present case suggests that CFB has an important role in the etiology of C3GN and provides a new insight into anticomplement therapy approaches.	[Imamura, Hideaki; Konomoto, Takao; Tanaka, Etsuko; Nunoi, Hiroyuki] Miyazaki Univ, Div Pediat, Dept Reprod & Dev Med, Fac Med, Miyazaki, Japan; [Imamura, Hideaki; Konomoto, Takao; Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Osaka, Japan; [Hisano, Satoshi] Fukuoka Univ, Fac Med, Dept Pathol, Fukuoka 81401, Japan; [Yoshida, Yoko; Fujimura, Yoshihiro] Nara Med Univ, Dept Blood Transfus Med, Nara, Japan	Imamura, H (reprint author), Miyazaki Univ, Div Pediat, Dept Reprod & Dev Med, Fac Med, Miyazaki, Japan.	hideaki_imamura@med.miyazaki-u.ac.jp			JSPS KAKENHI [25860873]; Takeda Science Foundation	We are grateful to Xinping Fan for performing genetic tests on our cases. We are also grateful to Masashi Akiyama for his valuable suggestions and support in our interpretation of protein structure. This work was in part supported by JSPS KAKENHI, grant number 25860873, and Takeda Science Foundation.	Pickering MC, 2013, KIDNEY INT, V84, P1079, DOI 10.1038/ki.2013.377; Sethi S, 2011, CLIN J AM SOC NEPHRO, V6, P1009, DOI [10.2215/CJN.07110810, 10.2215/CIN.07110810]; Fan XP, 2013, MOL IMMUNOL, V54, P238, DOI 10.1016/j.molimm.2012.12.006; Hourcade DE, 1999, J IMMUNOL, V162, P2906; Sethi S, 2012, KIDNEY INT, V81, P434, DOI 10.1038/ki.2011.399; Fakhouri F, 2010, NAT REV NEPHROL, V6, P494, DOI 10.1038/nrneph.2010.85; Marinozzi MC, 2014, J AM SOC NEPHROL, V25, P2053, DOI 10.1681/ASN.2013070796; Barbour TD, 2013, NEPHROL DIAL TRANSPL, V28, P1685, DOI 10.1093/ndt/gfs430; Bomback AS, 2012, NAT REV NEPHROL, V8, P634, DOI 10.1038/nrneph.2012.213; Yuasa I, 2008, J HUM GENET, V53, P1016, DOI 10.1007/s10038-008-0337-4	10	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0931-0509	1460-2385		NEPHROL DIAL TRANSPL	Nephrol. Dial. Transplant.	MAY	2015	30	5					862	864		10.1093/ndt/gfv054		3	Transplantation; Urology & Nephrology	Transplantation; Urology & Nephrology	CJ2LE	WOS:000355315300024		
J	Nishioka, K; Oyama, G; Yoshino, H; Li, YZ; Matsushima, T; Takeuchi, C; Mochizuki, Y; Mori-Yoshimura, M; Murata, M; Yamasita, C; Nakamura, N; Konishi, Y; Ohi, K; Ichikawa, K; Terada, T; Obi, T; Funayama, M; Saiki, S; Hattori, N				Nishioka, Kenya; Oyama, Genko; Yoshino, Hiroyo; Li, Yuanzhe; Matsushima, Takashi; Takeuchi, Chisen; Mochizuki, Yoko; Mori-Yoshimura, Madoka; Murata, Miho; Yamasita, Chikara; Nakamura, Norimichi; Konishi, Yohei; Ohi, Kazuki; Ichikawa, Keiji; Terada, Tatsuhiro; Obi, Tomokazu; Funayama, Manabu; Saiki, Shinji; Hattori, Nobutaka			High frequency of beta-propeller protein-associated neurodegeneration (BPAN) among patients with intellectual disability and young-onset parkinsonism	NEUROBIOLOGY OF AGING			English	Article						Neurodegeneration with brain iron accumulation; Beta-propeller protein-associated neurodegeneration; Parkinsonism; Intellectual disability; WDR45	BRAIN IRON ACCUMULATION; OXIDATIVE STRESS; MUTATIONS; NBIA; AUTOPHAGY; DISEASE; DISTINCT; SUBTYPE; FORM	Neurodegeneration with brain iron accumulation (NBIA) is a genetically heterogeneous disorder, characterized by the accumulation of iron in regions such as the basal ganglia. We enrolled 28 patients with childhood intellectual disability and young-onset parkinsonism (<= 40 years at onset) and 4 patients with infantile neuroaxonal dystrophy. All had been clinically diagnosed, and the prevalence of genetic mutations linked to NBIA (PANK2 [exons 1-7], PLA2G6 [exons 2-17], C19orf12 [exons 1-3], WDR45 [exons 2-11], COASY [exons 1-9], FA2H [exons 1-7], and RAB39B [exons 1, 2]) was evaluated. We detected 7 female patients (25.0%, 7 of 28) with de novo heterozygote WDR45 mutations, which are known to be pathogenic for beta-propeller protein-associated neurodegeneration. All 7 patients had common clinical features. Pathogenic mutations in other NBIA genes were not found. We also screened 98 patients with early-onset parkinsonism without intellectual disability and 110 normal controls of Japanese origin for WDR45 mutations. None had WDR45 mutations. Our data suggest a high frequency of beta-propeller protein-associated neurodegeneration mutations in the Japanese population. (C) 2015 Elsevier Inc. All rights reserved.	[Nishioka, Kenya; Oyama, Genko; Li, Yuanzhe; Matsushima, Takashi; Funayama, Manabu; Saiki, Shinji; Hattori, Nobutaka] Juntendo Univ, Dept Neurol, Sch Med, Tokyo 1138421, Japan; [Yoshino, Hiroyo; Funayama, Manabu; Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Res Inst Dis Old Age, Tokyo 1138421, Japan; [Takeuchi, Chisen; Mochizuki, Yoko] Tokyo Metropolitan Kita Med & Rehabil Ctr Disable, Dept Neurol, Tokyo, Japan; [Mori-Yoshimura, Madoka; Murata, Miho] Natl Ctr Hosp, Dept Neurol, Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Yamasita, Chikara; Nakamura, Norimichi] Kyushu Univ Hosp, Dept Neurol, Fukuoka 812, Japan; [Konishi, Yohei] Yotsukaidou Tokushukai Med Ctr, Dept Neurol, Chiba, Japan; [Ohi, Kazuki; Ichikawa, Keiji] Hyogo Kenritsu Amagasaki Hosp, Dept Neurol, Amagasaki, Hyogo, Japan; [Terada, Tatsuhiro; Obi, Tomokazu] Shizuoka Inst Epilepsy & Neurol Disorders, Dept Neurol, Shizuoka, Japan	Hattori, N (reprint author), Juntendo Univ, Dept Neurol, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	nhattori@juntendo.ac.jp	Funayama, Manabu/E-6485-2013		JSPS KAKNEHI [2586076]; Japan Society for the Promotion of Science [25129707, 25111007, 23111003, 25860725, 23689046, 24659435, 25461291, 24390224]; Japanese Ministry of Education, Culture, Sports, Science and Technology; Research Committee of CNS Degenerative Diseases [H26-Nanchitou-Nan-Ippan-085]; Ministry of Health, Labour and Welfare [H26-Nanchitou-Nan-Ippan-085]; Life Science Foundation; Takeda Scientific Foundation; Cell Science Research Foundation; Nakajima Foundation	The authors obtained insightful comments from Dr. Carles Vilarino-Guell at the University of British Columbia, Vancouver, Canada. Dr. Nishioka was supported by JSPS KAKNEHI grant number 2586076. The authors are grateful for the Grant-in-Aid for Scientific Research on Innovative Areas (25129707 to Drs. Funayama, 25111007 to Saiki, and 23111003 to Hattori), the Grant-in-Aid for Young Scientists (25860725 to Drs. Li, and 23689046 to Saiki), the Grant-in-Aid for Challenging Exploratory Research (24659435 to Dr. Saiki), Grant-in-Aid for Scientific Research (25461291 to Drs. Funayama and 24390224 to Hattori) from Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research on Priority Areas (Drs. Saiki and Hattori) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and the Grants-in-Aid from the Research Committee of CNS Degenerative Diseases (H26-Nanchitou-Nan-Ippan-085 to Dr. Hattori), the Grant-in-Aid for Health Labour Sciences Research Grant (H26-Nanchitou-Nan-Ippan-085 to Dr. Hattori) from Ministry of Health, Labour and Welfare, and grants from the Life Science Foundation, the Takeda Scientific Foundation, the Cell Science Research Foundation, and the Nakajima Foundation (Dr. Saiki).	Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007; Hayflick SJ, 2013, BRAIN, V136, P1708, DOI 10.1093/brain/awt095; Schneider SA, 2013, CURR NEUROPHARMACOL, V11, P59, DOI 10.2174/157015913804999469; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415; Eaton JW, 2002, FREE RADICAL BIO MED, V32, P833, DOI 10.1016/S0891-5849(02)00772-4; Dusi S, 2014, AM J HUM GENET, V94, P11, DOI 10.1016/j.ajhg.2013.11.008; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Hogarth P, 2013, NEUROLOGY, V80, P268, DOI 10.1212/WNL.0b013e31827e07be; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Ichinose Y, 2014, NEUROL CLIN PRACT, V4, P175; Rathore GS, 2014, MOVEMENT DISORD, V29, P574, DOI 10.1002/mds.25868; Verhoeven WMA, 2014, PARKINSONISM RELAT D, V20, P332, DOI 10.1016/j.parkreldis.2013.11.019; Wilson GR, 2014, AM J HUM GENET, V95, P729, DOI 10.1016/j.ajhg.2014.10.015	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	MAY	2015	36	5								10.1016/j.neurobiolaging.2015.01.020		7	Geriatrics & Gerontology; Neurosciences	Geriatrics & Gerontology; Neurosciences & Neurology	CI9PA	WOS:000355100900022		
J	Kuboyama, T; Lee, YA; Nishiko, H; Tohda, C				Kuboyama, Tomoharu; Lee, Young-A; Nishiko, Hiroaki; Tohda, Chihiro			Inhibition of clathrin-mediated endocytosis prevents amyloid beta-induced axonal damage	NEUROBIOLOGY OF AGING			English	Article						Amyloid beta (A beta); Growth cone collapse; Clathrin-mediated endocytosis; Axonal degeneration; Memory impairment	GROWTH CONE COLLAPSE; ALZHEIMERS-DISEASE; IN-VITRO; HIPPOCAMPAL-NEURONS; RECOGNITION MEMORY; CALCIUM-CHANNELS; NERVE-TERMINALS; CELL-ADHESION; MOUSE MODEL; PROTEIN	Amyloid beta (A beta) - induced axonal degeneration is a major cause of Alzheimer's disease (AD) pathology. However, the critical target to prevent Ab-induced axonal degeneration remains unknown. Here, we analyzed growth cone collapse elicited by A beta, a putative early A beta-induced event in axons. Although no study has yet shown influence of A beta on the growth cone, we first visualized A beta-initiated growth cone collapse in cultured neurons. Furthermore, we determined that the collapse was triggered by clathrinmediated endocytosis probably via A beta-Ca2+ signaling. The inhibition of clathrin-mediated endocytosis prevented A beta-induced axonal loss both in vitro and in vivo and prevented memory impairment in an AD mouse model. Our results clarified the important role of clathrin-mediated endocytosis in Ab-induced collapse of growth cone that leads to axonal degeneration and memory impairment. (C) 2015 Elsevier Inc. All rights reserved.	[Kuboyama, Tomoharu; Lee, Young-A; Nishiko, Hiroaki; Tohda, Chihiro] Toyama Univ, Div Neuromed Sci, Inst Nat Med, Toyama 9300194, Japan; [Lee, Young-A] Catholic Univ Daegu, Dept Food Sci & Nutr, Gyongsan, South Korea	Kuboyama, T (reprint author), Toyama Univ, Div Neuromed Sci, Inst Nat Med, 2630 Sugitani, Toyama 9300194, Japan.	kuboyama@inm.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23700376]; Natural Medicine and Biotechnology Research from Toyama prefecture, Japan; Takeda Science Foundation, Japan; Uehara Memorial Foundation, Japan	The authors thank H.T. McMahon (MRC Laboratory of Molecular Biology, UK) and H. Kamiguchi (RIKEN Brain Science Institute, Japan) for giving us the plasmid encoding AP180 C-terminus. This work was partially funded by the Grants-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (23700376) (T.K.), the Natural Medicine and Biotechnology Research from Toyama prefecture, Japan (T.K.) and research grants from the Takeda Science Foundation, Japan (T.K.) and the Uehara Memorial Foundation, Japan (T.K.).	Akiyama H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000196; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Mousavi M, 2009, NEUROCHEM INT, V54, P237, DOI 10.1016/j.neuint.2008.12.001; Unoki T, 2012, NEURON, V73, P135, DOI 10.1016/j.neuron.2011.09.034; Hermes M, 2010, J CELL MOL MED, V14, P30, DOI 10.1111/j.1582-4934.2009.00976.x; Tohda C, 2011, INT J NEUROSCI, V121, P641, DOI 10.3109/00207454.2011.602809; Dutta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045799; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Lamb CA, 2013, BIOESSAYS, V35, P34, DOI 10.1002/bies.201200130; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Niederost B, 2002, J NEUROSCI, V22, P10368; Jantas D, 2011, NEUROTOXICOLOGY, V32, P845, DOI 10.1016/j.neuro.2011.05.013; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Wirths O, 2007, NEUROBIOL AGING, V28, P1689, DOI 10.1016/j.neurobiolaging.2006.07.021; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Haettig J, 2013, LEARN MEMORY, V20, P139, DOI 10.1101/lm.027847.112; Petratos S, 2008, BRAIN, V131, P90, DOI 10.1093/brain/awm260; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Yamamoto S, 2007, BBA-MOL BASIS DIS, V1772, P958, DOI 10.1016/j.bbadis.2007.03.006; Tojima T, 2010, NEURON, V66, P370, DOI 10.1016/j.neuron.2010.04.007; Vilberg KL, 2013, NEURON, V79, P1232, DOI 10.1016/j.neuron.2013.07.013; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Sosa-Ortiz AL, 2012, ARCH MED RES, V43, P600, DOI 10.1016/j.arcmed.2012.11.003; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Teshigawara K, 2013, BRIT J PHARMACOL, V168, P903, DOI 10.1111/j.1476-5381.2012.02211.x; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; Dere E, 2005, NEUROBIOL LEARN MEM, V84, P214, DOI 10.1016/j.nlm.2005.07.002; Ma QL, 2006, J NEUROSCI RES, V83, P374, DOI 10.1002/jnr.20734; Texido L, 2011, CELL CALCIUM, V49, P184, DOI 10.1016/j.ceca.2011.02.001; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Liu F, 2005, J BIOL CHEM, V280, P37755, DOI 10.1074/jbc.M507475200; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Dickson TC, 2001, NEUROSCIENCE, V105, P99, DOI 10.1016/S0306-4522(01)00169-5; Kesner RP, 2013, BEHAV BRAIN RES, V254, P1, DOI 10.1016/j.bbr.2013.01.012; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; Postuma RB, 2000, J NEUROCHEM, V74, P1122; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Sanchez-Varo R, 2012, ACTA NEUROPATHOL, V123, P53, DOI 10.1007/s00401-011-0896-x; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882; Jurney WM, 2002, J NEUROSCI, V22, P6019; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Ahmed G, 2011, J NEUROSCI, V31, P14018, DOI 10.1523/JNEUROSCI.0943-11.2011; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Barbosa FF, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00112; BENES FM, 1991, NEUROSCIENCE, V42, P651, DOI 10.1016/0306-4522(91)90034-L; Brennaman LH, 2014, J NEUROCHEM, V128, P267, DOI 10.1111/jnc.12468; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Johanson Conrad E, 2008, Cerebrospinal Fluid Res, V5, P10, DOI 10.1186/1743-8454-5-10; Joyashiki E, 2011, INT J NEUROSCI, V121, P181, DOI 10.3109/00207454.2010.541571; Kanaan Nicholas M, 2013, Exp Neurol, V246, P44, DOI 10.1016/j.expneurol.2012.06.003; MASLIAH E, 1993, AM J PATHOL, V142, P871; Nakamura NH, 2013, J NEUROSCI, V33, P11506, DOI 10.1523/JNEUROSCI.4480-12.2013; Nicol X, 2006, J NEUROSCI, V26, P862, DOI 10.1523/JNEUROSCI.3385-05.2006; Oshio Kotaro, 2005, FASEB J, V19, P76; Pardo B, 1999, DEV BRAIN RES, V115, P9, DOI 10.1016/S0165-3806(99)00040-1; SATO K, 1995, EUR J BIOCHEM, V230, P25, DOI 10.1111/j.1432-1033.1995.tb20529.x; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Tohda C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00535; Tohda C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03395; Yue X, 2008, DEV NEUROBIOL, V68, P1269, DOI 10.1002/dneu.20657; Yukawa K, 2005, INT J MOL MED, V16, P115	74	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	MAY	2015	36	5					1808	1819		10.1016/j.neurobiolaging.2015.02.005		12	Geriatrics & Gerontology; Neurosciences	Geriatrics & Gerontology; Neurosciences & Neurology	CI9PA	WOS:000355100900004		
J	Yokota, H; Yamada, K				Yokota, Hajime; Yamada, Kei			Viral Infection of the Spinal Cord and Roots	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Spinal cord; Myelopathy; Radiculopathy; MR imaging	GUILLAIN-BARRE-SYNDROME; ACUTE DISSEMINATED ENCEPHALOMYELITIS; I-ASSOCIATED MYELOPATHY; HERPES-ZOSTER MYELITIS; MR-IMAGING FINDINGS; TRANSVERSE MYELITIS; FOLLOW-UP; POSTPOLIO SYNDROME; YOUNG-CHILDREN; POLIOMYELITIS	This article summarizes myelopathy and radiculopathy caused by different viruses. The cases described are divided into three categories: acute myelitis and radiculitis, postinfectious myelopathy and radiculopathy, and chronic myelopathy. Some diseases present with characteristic imaging findings. For example, varicella zoster virus tends to injure the dorsal column, whereas poliovirus tends to injure the frontal horns. Magnetic resonance imaging is an essential tool in diagnosis. However, because imaging findings are often nonspecific, consideration of a combination of diagnostic procedures, including the clinical course, symptoms, and laboratory data, is necessary for making a correct diagnosis.	[Yokota, Hajime; Yamada, Kei] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Radiol, Kyoto 6028566, Japan; [Yokota, Hajime] Chiba Univ, Grad Sch Med, Dept Diagnost Radiol & Radiat Oncol, Chiba, Japan	Yokota, H (reprint author), Kyoto Prefectural Univ Med, Dept Radiol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	hjmykt@koto.kpu-m.ac.jp					An JY, 2008, INTERNAL MED, V47, P1539, DOI 10.2169/internalmedicine.47.1224; Anneken Kerstin, 2006, J Infect, V52, pe181, DOI 10.1016/j.jinf.2005.08.023; Chen CY, 2001, AM J NEURORADIOL, V22, P200; Sorenson EJ, 2005, NEUROLOGY, V64, P1070; GILDEN DH, 1994, NEUROLOGY, V44, P1818; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0; Araujo AQC, 2006, LANCET NEUROL, V5, P1068, DOI 10.1016/S1474-4422(06)70628-7; Scott TF, 2011, NEUROLOGY, V77, P2128, DOI 10.1212/WNL.0b013e31823dc535; Banwell B, 2009, NEUROLOGY, V72, P232, DOI 10.1212/01.wnl.0000339482.84392.bd; Leake JAD, 2004, PEDIATR INFECT DIS J, V23, P756, DOI 10.1097/01.inf.0000133048.75452.dd; Irani DN, 2008, NEUROL CLIN, V26, P635, DOI [10.1016/j.ncl.2008.03.003, 10.1016/j.nc1.2008.03.003]; DEVINSKY O, 1991, BRAIN, V114, P1181, DOI 10.1093/brain/114.3.1181; Alshekhlee A, 2008, NEUROLOGY, V70, P1608, DOI 10.1212/01.wnl.0000310983.38724.d4; Bhargava P, 2014, NEUROLOGY, V82, pE46, DOI 10.1212/WNL.0000000000000104; Bourre B, 2012, ARCH NEUROL-CHICAGO, V69, P357, DOI 10.1001/archneurol.2011.949; Chen CY, 2008, NEUROIMAG CLIN N AM, V18, pviii; Lo CP, 2008, NEUROIMAG CLIN N AM, V18, P119, DOI 10.1016/j.nic.2007.12.002; DALAKAS M, 1991, ADV NEUROL, V56, P495; FRIEDMAN DP, 1992, AM J NEURORADIOL, V13, P1404; Georgy BA, 1996, AM J ROENTGENOL, V166, P173; GEORGY BA, 1994, AM J NEURORADIOL, V15, P300; Goh C, 2014, J MAGN RESON IMAGING, V40, P1267, DOI 10.1002/jmri.24563; GRAFMAN J, 1995, ANN NY ACAD SCI, V753, P103, DOI 10.1111/j.1749-6632.1995.tb27536.x; Grayev AM, 2014, RADIOL CLIN N AM, V52, P427, DOI 10.1016/j.rcl.2013.11.002; Honkaniemi J, 2001, AM J NEURORADIOL, V22, P1117; Jang S, 2012, NEURORADIOLOGY, V54, P239, DOI 10.1007/s00234-011-0921-8; Kamei S, 2000, INTERNAL MED, V39, P894, DOI 10.2169/internalmedicine.39.894; Kinoshita A, 1996, J NEUROL NEUROSUR PS, V60, P87, DOI 10.1136/jnnp.60.1.87; KIRA J, 1991, J NEUROL SCI, V106, P41, DOI 10.1016/0022-510X(91)90192-A; Kornreich L, 1996, NEURORADIOLOGY, V38, P371; Leite Claudia, 2005, Top Magn Reson Imaging, V16, P189, DOI 10.1097/01.rmr.0000189108.55275.12; MALZBERG MS, 1993, AM J ROENTGENOL, V161, P863; Melo A, 1993, Arq Neuropsiquiatr, V51, P329; Mihai C, 2012, CURR NEUROL NEUROSCI, V12, P633, DOI 10.1007/s11910-012-0306-3; Murthy SN, 2002, PEDIATRICS, V110, P21; PERRY JR, 1994, NEURORADIOLOGY, V36, P139; SANTOSH CG, 1995, NEURORADIOLOGY, V37, P134; Sartoretti-Schefer S, 1997, NEURORADIOLOGY, V39, P865; Shakudo M, 1999, AM J NEURORADIOL, V20, P1417; Shen WC, 1999, AM J NEURORADIOL, V20, P1889; Zijdewind JM, 2014, NEUROL SCI, V35, P961, DOI 10.1007/s10072-014-1692-x	42	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	MAY	2015	25	2					247	+		10.1016/j.nic.2015.01.005		13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CJ3HF	WOS:000355373300009		
J	Sorimachi, T; Osada, T; Aoki, R; Nishiyama, J; Hirayama, A; Srivatanakul, K; Matsumae, M				Sorimachi, Takatoshi; Osada, Takahiro; Aoki, Rie; Nishiyama, Jun; Hirayama, Akihiro; Srivatanakul, Kittipong; Matsumae, Mitsunori			Density of the cerebral cortex in computed tomography angiography source images and clinical outcomes in Grade V subarachnoid hemorrhage	NEUROLOGICAL RESEARCH			English	Article						Cerebral aneurysm; Computed tomography angiography; Outcome; Subarachnoid hemorrhage; Surgery	ACUTE ISCHEMIC-STROKE; CT ANGIOGRAPHY; PERFUSION; DIFFUSION; INFARCT; BRAIN; PREDICTORS	Objective: Among patients diagnosed with Grade V subarachnoid hemorrhage (SAH) according to the World Federation of Neurosurgical Societies (WFNS), the identification of those with the possibility of recovery is not feasible, although approximately one-fifth of these patients have favorable outcomes according to a recently published series of surgical papers. We hypothesized that computed tomography angiography (CTA) source images (SIs), which have applied to the detection of acute ischemia, might be useful for selecting Grade V patients with possibilities for favorable outcomes. Methods: We retrospectively assessed 170 SAH patients who underwent surgery between January 2009 and February 2012 and quantitatively measured their mean cerebral cortical densities from the initial CTA-SIs. Results: The cortical densities of 123 patients of Grades I-IV were strongly affected by the following two CTA-SI findings that were revealed by multivariate analysis: the density of the internal carotid artery (ICA) just proximal to the petrous portion and the ratio of the subarachnoid (SA) space to intracranial volume (P < 0.05). Favorable outcomes were obtained in 9 of the 47 Grade V patients (19.1%), and the predictors of the favorable outcomes according to multivariate analysis were increased cortical densities on the CTA-SIs and female patients (P < 0.05). Conclusion: The outcomes of Grade V patients could be partly predicted based on the estimates of cortical density from the CTA-SIs, and this measure might be useful for the selection of Grade V patients for surgery, provided that both ICA density and SA space ratio are confirmed before the evaluation of cortical density.	[Sorimachi, Takatoshi; Osada, Takahiro; Aoki, Rie; Nishiyama, Jun; Hirayama, Akihiro; Srivatanakul, Kittipong; Matsumae, Mitsunori] Tokai Univ, Dept Neurosurg, Isehara, Kanagawa 2591194, Japan	Sorimachi, T (reprint author), Tokai Univ, Dept Neurosurg, 143 Simokasuya, Isehara, Kanagawa 2591194, Japan.	sorimachi@tokai-u.jp					WALDEMAR G, 1991, J CEREBR BLOOD F MET, V11, P508; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; Huang APH, 2010, NEUROSURGERY, V67, P964, DOI 10.1227/NEU.0b013e3181ee359c; Lagares A, 2012, ACTA NEUROCHIR, V154, P405, DOI 10.1007/s00701-011-1267-z; Tsuang FY, 2012, WORLD NEUROSURG, V78, P455, DOI 10.1016/j.wneu.2011.12.004; Konstas AA, 2009, AM J NEURORADIOL, V30, P885, DOI 10.3174/ajnr.A1492; Camargo ECS, 2007, RADIOLOGY, V244, P541, DOI 10.1148/radiol.2442061028; Sehba FA, 2005, J NEUROSURG, V102, P1094, DOI 10.3171/jns.2005.102.6.1094; Pulli B, 2012, RADIOLOGY, V262, P593, DOI 10.1148/radiol.11110896; Coutts SB, 2004, STROKE, V35, P2472, DOI 10.1161/01.STR.0000145330.14928.2a; Eastwood JD, 2003, AM J NEURORADIOL, V24, P1869; Schramm P, 2004, STROKE, V35, P1652, DOI 10.1161/01.STR.0000131271.54098.22; Schramm P, 2002, STROKE, V33, P2426, DOI 10.1161/01.STR.0000032244.03134.37; Germanson TP, 1998, SURG NEUROL, V49, P155, DOI 10.1016/S0090-3019(97)00337-6; Westerlaan HE, 2011, RADIOLOGY, V258, P134, DOI 10.1148/radiol.10092373; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Hadeishi H, 2002, NEUROSURGERY, V50, P741, DOI 10.1097/00006123-200204000-00010; Mortimer AM, 2013, STROKE, V44, P1480, DOI 10.1161/STROKEAHA.111.679522; Naidech AM, 2005, ARCH NEUROL-CHICAGO, V62, P410, DOI 10.1001/archneur.62.3.410; Shimoda M, 2010, ACTA NEUROCHIR, V152, P1197, DOI 10.1007/s00701-010-0640-7; van den Berg R, 2011, CRIT CARE MED, V39, P2722, DOI 10.1097/CCM.0b013e3182282a70	21	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAY	2015	37	6					484	490		10.1179/1743132815Y.0000000001		7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CJ1QI	WOS:000355258500004		
J	Liu, WT; Yamashita, T; Kurata, T; Kono, S; Hishikawa, N; Deguchi, K; Zhai, Y; Abe, K				Liu, Wentao; Yamashita, Toru; Kurata, Tomoko; Kono, Syoichiro; Hishikawa, Nozomi; Deguchi, Kentaro; Zhai, Yun; Abe, Koji			Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats	NEUROLOGICAL RESEARCH			English	Article						AD; Hypertension; Neurovascular unit; SHR-SR; Inflammasome; Telmisartan	FOCAL CEREBRAL-ISCHEMIA; ALZHEIMERS-DISEASE; AMYLOID-BETA; NEURONAL INJURY; PPAR-GAMMA; BRAIN; MODEL; MICE; ATHEROGENESIS; DISTURBANCES	Objectives: Hypertension is a crucial risk factor for both stroke and dementia, including Alzheimer's disease (AD). We inspected the effect of telmisartan on the neurovascular unit (NVU) and related inflammatory responses in spontaneously hypertensive rat stroke resistant (SHR-SR) by observing the components of NVU such as N-acetyl glucosamine oligomer (NAGO), collagen IV, astrocytes, and matrix metalloproteinase-9 (MMP-9), as well as inflammasome NOD-like receptors family protein 3 (NLRP3). Methods: In the present study, we examined the effect of a highly selective angiotensin type 1 (AT-1) antagonist of angiotensin 2 receptor with high lipid solubility, telmisartan, on NVU and related inflammatory responses in SHR-SR with a low dose (0.3 mg/kg/day) only for improving metabolic syndrome, and a high dose (3 mg/kg/day) for improving both metabolic syndrome and SHR-SR hypertension. Results: Compared to normotensive Wistar rats, long-lasting hypertension in SHR-SR disrupted NVU by changing immunohistological components such as NAGO, collagen IV, astrocytes, and MMP-9. SHR-SR also strongly induced AD-related inflammasome NLRP3 in neuronal cells with age. However, such NVU disruption and inflammasome activation were greatly improved with dose-dependent telmisartan treatments. Discussion: These results suggest that telmisartan comprehensively protected the NVU components by reducing inflammatory reactions relative to AD in hypertensive rats, which could also preclude the risk of AD under hypertension.	[Liu, Wentao; Yamashita, Toru; Kurata, Tomoko; Kono, Syoichiro; Hishikawa, Nozomi; Deguchi, Kentaro; Zhai, Yun; Abe, Koji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Okayama 7008558, Japan	Abe, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, 2-5-1 Shikatacho, Okayama 7008558, Japan.	gmd422020@s.okayama-u.ac.jp			Ministry of Health, Labour and Welfare of Japan [21390267, 24591263, 24659651]	Funding Grant-in-Aid for Scientific Research (B 21390267, (C) 24591263 and Challenging Research 24659651, and by Grantsin-Aid from the Research Committees (H. Mizusawa, I. Nakano, M. Nishizawa, H. Sasaki, and M. Aoki) from the Ministry of Health, Labour and Welfare of Japan.	Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Lou M, 2004, J CEREBR BLOOD F MET, V24, P536; Miyazaki K, 2011, J NEUROSCI RES, V89, P718, DOI 10.1002/jnr.22594; Hao LY, 2013, CURR OPIN GASTROEN, V29, P363, DOI 10.1097/MOG.0b013e32836157a4; Backstrom JR, 1996, J NEUROSCI, V16, P7910; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Mogi M, 2011, CIRC J, V75, P1042, DOI 10.1253/circj.CJ-11-0121; Tsukuda K, 2009, HYPERTENSION, V54, P782, DOI 10.1161/HYPERTENSIONAHA.109.136879; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/hh0302.105345; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Fukui Y, 2014, J STROKE CEREBROVASC, V23, P1545, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.052; Araujo AA, 2013, J CLIN PERIODONTOL, V40, P1104, DOI 10.1111/jcpe.12160; Faraci FM, 1998, PHYSIOL REV, V78, P53; Li J, 2005, FASEB J, V19, P617, DOI 10.1096/fj.04-2960fje; Luchtefeld M, 2005, BIOCHEM BIOPH RES CO, V328, P183, DOI 10.1016/j.bbrc.2004.12.152; Rosen ED, 2001, J BIOL CHEM, V276, P37731; Pravenec M, 2003, PHYSIOL RES, V52, P681; Maillard MP, 2002, J PHARMACOL EXP THER, V302, P1089, DOI 10.1124/jpet.102.036772; Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164; Kuller LH, 2005, NEUROLOGY, V64, P1548, DOI 10.1212/01.WNL.0000160115.55756.DE; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; AUGUSTIN HG, 1995, AM J PATHOL, V147, P339; Groth W, 2003, J HYPERTENS, V21, P2175, DOI 10.1097/01.hjh.0000098126.00558.9b; Chen JW, 2004, J CARDIOVASC PHARM, V44, P446, DOI 10.1097/01.fjc.0000140205.74180.3c; Dickinson CJ, 2001, J HYPERTENS, V19, P1515, DOI 10.1097/00004872-200109000-00001; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Korenov M, 2009, J NEUROSCI METH, V177, P108, DOI 10.1016/j.jneumeth.2008.09.027; Kumai Y, 2008, EXP NEUROL, V210, P441, DOI 10.1016/j.expneurol.2007.11.028; Kurata T, 2014, J STROKE CEREBROVASC, V23, P2580, DOI 10.1016/j.jstrokecerebrovasdis.2014.05.023; Kurata T, 2011, NEUROSCIENCE, V197, P358, DOI 10.1016/j.neuroscience.2011.09.030; Sanz-Rosa D, 2005, AM J PHYSIOL-HEART C, V288, P111; TURNER DC, 1987, DEV BIOL, V121, P510, DOI 10.1016/0012-1606(87)90187-4	35	1	1	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAY	2015	37	6					491	501		10.1179/1743132815Y.0000000002		11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CJ1QI	WOS:000355258500005		
J	Inaba, T; Katayama, Y; Ueda, M; Nito, C				Inaba, Toshiki; Katayama, Yasuo; Ueda, Masayuki; Nito, Chikako			Neuroprotective effects of pretreatment with macrolide antibiotics on cerebral ischemia reperfusion injury	NEUROLOGICAL RESEARCH			English	Article						Macrolide antibiotics; Focal cerebral ischemia; Neuroprotection; Ischemic tolerance	BRAIN-DAMAGE; LUNG INJURY; ERYTHROMYCIN; RAT; INDUCTION; TOLERANCE; CELLS; FK506; INFLAMMATION; STROKE	Objective: This study aims to determine if macrolide antibiotics have neuroprotective effects against transient cerebral ischemia. Methods: Sprague-Dawley rats were subjected to cerebral ischemia for 90 minutes followed by 24 or 72 hours of reperfusion. An oral suspension of roxithromycin (RXM), clarithromycin (CAM), erythromycin (EM), azithromycin (AZM), or kitasamycin (INN) was given at 10 or 100 mg/kg for 7 days before ischemia. The infarct volume, edema volume, and neurological performance were evaluated after 24 and 72 hours of reperfusion. The cerebral blood flow (CBF) was measured with a magnetic resonance imaging (MRI) system after 90 minutes of ischemia. Another experiment was conducted to investigate how the ischemic injury was affected by the interval from the antibiotic pretreatment to the ischemia in rats pretreated with CAM. Results: Roxithromycin, CAM, AZM, and INN significantly reduced the infarct volume in the high-dose group after 24 and 72 hours of reperfusion. All of the agents significantly decreased the edema in the high-dose groups at 24 and 72 hours, while only CAM and AZM significantly reduced the edema volume in the low-dose groups at 24 hours. All of the macrolide antibiotics at the high dose significantly improved neurological deficit scores at 24 and 72 hours. There were no differences in the CBF between the vehicle and respective antibiotic groups. In the experiment examining the interval, the 24-hour interval group exhibited the strongest neuroprotective effect. Discussion: These results demonstrate that the macrolide antibiotics RXM, CAM, EM, AZM, and INN may confer neuroprotective effects against ischemic damage following cerebral ischemia without affecting the CBF.	[Inaba, Toshiki; Katayama, Yasuo; Ueda, Masayuki; Nito, Chikako] Nippon Med Sch, Grad Sch Med, Dept Neurol Sci, Bunkyo Ku, Tokyo 113, Japan; [Katayama, Yasuo] Tokyo Gen Hosp, Dept Neurol, Nakano Ku, Tokyo 1658906, Japan; [Katayama, Yasuo] Tokyo Gen Hosp, Stroke Ctr, Nakano Ku, Tokyo 1658906, Japan	Katayama, Y (reprint author), Tokyo Gen Hosp, Dept Neurol, Nakano Ku, 3-15-2 Ekoda, Tokyo 1658906, Japan.	yasuo.katayama@mt.strins.or.jp			Department of Neurological Science, Graduate School of Medicine, Nippon Medical School	Funding We obtained the fund for the study from Department of Neurological Science, Graduate School of Medicine, Nippon Medical School.	Boutin H, 2001, J NEUROSCI, V21, P5528; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; Yonemori F, 1998, J CEREBR BLOOD F MET, V18, P1099, DOI 10.1097/00004647-199810000-00006; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127; Arii T, 2001, NEUROL RES, V23, P755, DOI 10.1179/016164101101199135; Iadecola C, 2001, CURR OPIN NEUROL, V14, P89, DOI 10.1097/00019052-200102000-00014; Barone FC, 1997, STROKE, V28, P1233; Nito C, 2011, NEUROL RES, V33, P881, DOI 10.1179/1743132811Y.0000000019; CHAO CC, 1992, J IMMUNOL, V149, P2736; Huber R, 1999, NEUROREPORT, V10, P1543, DOI 10.1097/00001756-199905140-00027; Azuma A, 1998, THORAX, V53, P186; Brambrink AM, 2006, ANESTHESIOLOGY, V104, P1208, DOI 10.1097/00000542-200606000-00016; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Ewing JR, 2003, J CEREBR BLOOD F MET, V23, P198, DOI 10.1097/01.WCB.0000046147.31247.E8; IBRAHIM NG, 1973, FEBS LETT, V36, P102, DOI 10.1016/0014-5793(73)80347-3; Karbowski M, 1997, BBA-LIPID LIPID MET, V1349, P242, DOI 10.1016/S0005-2760(97)00140-9; Katayama Y, 2014, BRAIN RES, V1588, P159, DOI 10.1016/j.brainres.2014.09.016; KITAGAWA K, 1990, NEUROSCIENCE, V35, P551, DOI 10.1016/0306-4522(90)90328-2; Koerner IP, 2007, ANESTHESIOLOGY, V106, P538, DOI 10.1097/00000542-200703000-00019; Labro MT, 2001, J CHEMOTHERAPY, V13, P3; Li YJ, 2002, CHEST, V122, P2137, DOI 10.1378/chest.122.6.2137; Morikawa K, 2002, INT J ANTIMICROB AG, V19, P53, DOI 10.1016/S0924-8579(01)00457-5; PIOUS DA, 1972, PEDIATR RES, V6, P687, DOI 10.1203/00006450-197208000-00007; Suda S, 2011, LIFE SCI, V89, P50, DOI 10.1016/j.lfs.2011.05.001; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Yoshino H, 1997, BRAIN RES, V767, P81, DOI 10.1016/S0006-8993(97)00616-1	27	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAY	2015	37	6					514	524		10.1179/1743132815Y.0000000005		11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CJ1QI	WOS:000355258500008		
J	Murai, N; Takeshita, N; Nishigaki, F; Irie, M; Tamura, S; Aoki, T; Matsuoka, N				Murai, Nobuhito; Takeshita, Nobuaki; Nishigaki, Fusako; Irie, Megumi; Tamura, Seiji; Aoki, Toshiaki; Matsuoka, Nobuya			AS1069562, the (+)-isomer of indeloxazine, exerts analgesic effects in rat models of nociceptive pain	NEUROLOGICAL RESEARCH			English	Article						Nociceptive pain; Arthritis; Serotonin and norepinephrine reuptake inhibitor; AS1069562; Duloxetine	KNEE OSTEOARTHRITIS; EFFICACY; DULOXETINE; ASSOCIATION; INHIBITOR; ARTHRITIS	Objectives: The (+)-isomer of indeloxazine AS1069562 has multiple pharmacological actions, such as serotonin (5-HIT) and norepinephrine (NE) reuptake inhibition and analgesic effects in animal models of neuropathic pain. Here, we investigated the analgesic effects of AS1069562 in rat models of inflammatory and noninflammatory nociceptive pain. Methods: Adjuvant-induced arthritis (AIA) and bradykinin-induced knee joint pain were used as rat models of inflammatory pain. The chronic phase of monoiodoacetate-induced arthritis (MIA) was used as a rat model of noninflammatory pain. Analgesic effects were evaluated by weight-bearing deficit in the AIA and MIA models and by pain response in the bradykinin-induced knee joint pain model. Results: In the AIA model and the bradykinin-induced knee joint pain model, AS1069562 significantly ameliorated the pain-related behavior of weight-bearing deficit and the pain response, respectively. AS1069562 also significantly improved the pain-related behavior of weight-bearing deficit in the chronic phase of the MIA model. Further, following monoiodoacetate injection, repeated administration of AS1069562 or duloxetine significantly improved weight-bearing deficit in the MIA model. Interestingly, the analgesic effect of AS1069562 was sustained for 24 hours after the last administration, although the plasma concentration of AS1069562 was reduced to undetectable levels. In contrast, the analgesic effect of duloxetine did not continue after treatment discontinuation. Discussion: AS1069562 exerts analgesic effects on inflammatory and noninflammatory nociceptive pain in rat models of arthritis pain, and repeated administration of AS1069562 exerts a more persistent analgesic effect on arthritis pain than duloxetine. These findings suggest that AS1069562 has an attractive analgesic profile for the treatment of nociceptive pain.	[Murai, Nobuhito; Takeshita, Nobuaki; Nishigaki, Fusako; Tamura, Seiji; Aoki, Toshiaki; Matsuoka, Nobuya] Astellas Pharma Inc, Pharmacol Res Labs, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan; [Irie, Megumi] Astellas Pharma Inc, Anal & Pharmacokinet Res Labs, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan	Murai, N (reprint author), Astellas Pharma Inc, Pharmacol Res Labs, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	nobuhito.murai@astellas.com			Astellas Pharma Inc.	Funding Astellas Pharma Inc.	Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)0163-8; Jones CK, 2005, J PHARMACOL EXP THER, V312, P726, DOI 10.1124/jpet.104.075960; Hill CL, 2001, J RHEUMATOL, V28, P1330; Bjordal JM, 2004, BRIT MED J, V329, P1317, DOI 10.1136/bmj.38273.626655.63; Briggs A, 1999, ANN PHARMACOTHER, V33, P1154, DOI 10.1345/aph.18411; Neugebauer V, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-8; Thor KB, 2007, INT J CLIN PRACT, V61, P1349, DOI 10.1111/j.1742-1241.2007.01433.x; Felson DT, 2001, ANN INTERN MED, V134, P541; Murai N, 2014, J PHARMACOL EXP THER, V348, P372, DOI 10.1124/jpet.113.208686; Colpaert FC, 2004, EUR J PHARMACOL, V497, P29, DOI 10.1016/j.ejphar.2004.06.026; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; Haywood L, 2003, ARTHRITIS RHEUM, V48, P2173, DOI 10.1002/art.11094; Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116; Chappell AS, 2010, PAIN PRACT, V11, P33; GOTOH S, 1988, FOLIA PHARMACOL JPN, V92, P17, DOI 10.1254/fpj.92.17; Meini S, 2008, INFLAMM RES, V57, P351, DOI 10.1007/s00011-007-7204-1; Murai N, 2014, NEUROPHARMACOLOGY, V79, P10, DOI 10.1016/j.neuropharm.2013.10.030; Murai N, 2014, EUR J PHARMACOL, V733, P54, DOI 10.1016/j.ejphar.2014.03.038; Poole A R, 1993, Agents Actions Suppl, V39, P3; Rosenzweig-Lipson S, 2007, PHARMACOL THERAPEUT, V113, P134, DOI 10.1016/j.pharmthera.2006.07.002; SHIMIZUSASAMATA M, 1993, PHARMACOL BIOCHEM BE, V45, P335, DOI 10.1016/0091-3057(93)90248-R; YAMAMOTO M, 1990, Brain Dysfunction, V3, P130; Yoshimi E, 2010, J PHARMACOL EXP THER, V334, P955, DOI 10.1124/jpet.110.167924	23	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAY	2015	37	6					525	530		10.1179/1743132815Y.0000000007		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CJ1QI	WOS:000355258500009		
J	Ou, CL; Hou, JG; Wei, TR; Jiang, B; Jiao, SQ; Li, JF; Zhu, HM				Ou, Chunlin; Hou, Jungang; Wei, Tian-Ran; Jiang, Bo; Jiao, Shuqiang; Li, Jing-Feng; Zhu, Hongmin			High thermoelectric performance of all-oxide heterostructures with carrier double-barrier filtering effect	NPG ASIA MATERIALS			English	Article							NONSTOICHIOMETRIC TITANIUM-OXIDES; FIGURE-OF-MERIT; THERMAL-CONDUCTIVITY; NANOSTRUCTURED THERMOELECTRICS; ELECTRON-GAS; WASTE HEAT; ENHANCEMENT; TIO2; NANOPARTICLES; BICUSEO	Thermoelectric materials can realize significant energy savings by generating electricity from untapped waste heat; however, the coupling of the thermoelectric parameters unfortunately limits their efficiency and practical applications. Herein, rational all-oxide TiC1-xOx@TiOy-TiO2 (x<1, 1<y<2) heterostructures with significantly enhanced thermoelectric properties have been designed, and a high dimensionless figure of merit (ZT) value of up to 0.84 at 973 K was achieved in the all-oxide TiC0.1O0.9@TiOy-TiO2 heterostructures, which is one of the highest values in n-type oxide bulk thermoelectric materials to date. The TiC1-xOx@TiOy heterostructures, which include a thin film of approximately 5-10 nm on the surface of TiC1-xOx compounds prepared by a facile anodization process, exhibit an obvious improvement of the thermoelectric power factor. Furthermore, an excellent dimensionless figure of merit value was obtained in the TiC1-xOx@TiOy-TiO2 heterostructures prepared by the anodization process assisted by the sol-gel chemical route, which can be attributed to the decrease in the carrier concentration via the carrier double-barrier filtering effect. This work develops a facile strategy for synthesizing core-shell heterostructures and demonstrates their superior ability to optimize thermoelectric energy harvesting.	[Ou, Chunlin; Hou, Jungang; Jiang, Bo; Jiao, Shuqiang; Zhu, Hongmin] Univ Sci & Technol Beijing, Sch Met & Ecol Engn, Beijing 100083, Peoples R China; [Hou, Jungang; Zhu, Hongmin] Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Wei, Tian-Ran; Li, Jing-Feng] Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China	Zhu, HM (reprint author), Tohoku Univ, Aoba Ku, 6-6-02 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	hzhu@ustb.edu.cn	Li, Jing-Feng/D-2770-2014	Li, Jing-Feng/0000-0002-0185-0512	National Science Foundation of China [51472027]; Beijing High School Youth Talent Plan [YETP0351]; National Basic Research Program of China (973 Program) [2013CB632404]; National High Technology Research and Development Program of China (863 Program) [2012AA062302]	We gratefully acknowledge the financial support provided by the National Science Foundation of China (no. 51472027), Beijing High School Youth Talent Plan (YETP0351), National Basic Research Program of China (973 Program, no. 2013CB632404) and National High Technology Research and Development Program of China (863 Program, no. 2012AA062302).	Sootsman JR, 2009, ANGEW CHEM INT EDIT, V48, P8616, DOI 10.1002/anie.200900598; CUTLER M, 1969, PHYS REV, V181, P1336, DOI 10.1103/PhysRev.181.1336; Li JH, 2013, ADV FUNCT MATER, V23, P4317, DOI 10.1002/adfm.201300146; Kim W, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.045901; Zhang LJ, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.075117; Zhao LD, 2014, ENERG ENVIRON SCI, V7, P2900, DOI 10.1039/c4ee00997e; Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; Scheele M, 2009, ADV FUNCT MATER, V19, P3476, DOI 10.1002/adfm.200901261; Jeng MS, 2008, J HEAT TRANS-T ASME, V130, DOI 10.1115/1.2818765; Okuda T, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.113104; Mehta RJ, 2012, NAT MATER, V11, P233, DOI [10.1038/nmat3213, 10.1038/NMAT3213]; Majumdar A, 2004, SCIENCE, V303, P777, DOI 10.1126/science.1093164; He M, 2012, ENERG ENVIRON SCI, V5, P8351, DOI 10.1039/c2ee21803h; Zeier WG, 2012, J AM CHEM SOC, V134, P7147, DOI 10.1021/ja301452j; He QY, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2767775; Scheele M, 2011, ACS NANO, V5, P8541, DOI 10.1021/nn2017183; Heremans JP, 2008, SCIENCE, V321, P554, DOI 10.1126/science.1159725; Joshi G, 2008, NANO LETT, V8, P4670, DOI 10.1021/nl8026795; Huxtable ST, 2002, APPL PHYS LETT, V80, P1737, DOI 10.1063/1.1455693; Jiao SQ, 2007, J ALLOY COMPD, V438, P243, DOI 10.1016/j.jallcom.2006.08.016; Li F, 2012, ENERG ENVIRON SCI, V5, P7188, DOI 10.1039/c2ee21274a; Pei YZ, 2011, ENERG ENVIRON SCI, V4, P3640, DOI 10.1039/c1ee01928g; Tritt TM, 1999, SCIENCE, V283, P804, DOI 10.1126/science.283.5403.804; Andersson DA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.144101; HICKS LD, 1993, PHYS REV B, V47, P12727, DOI 10.1103/PhysRevB.47.12727; Rhyee JS, 2009, NATURE, V459, P965, DOI 10.1038/nature08088; Vineis CJ, 2010, ADV MATER, V22, P3970, DOI 10.1002/adma.201000839; Hao L, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165445; Li JF, 2010, NPG ASIA MATER, V2, P152, DOI 10.1038/asiamat.2010.138; Sumithra S, 2011, ADV ENERGY MATER, V1, P1141, DOI 10.1002/aenm.201100338; Chiritescu C, 2007, SCIENCE, V315, P351, DOI 10.1126/science.1136494; Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; Kanatzidis MG, 2010, CHEM MATER, V22, P648, DOI 10.1021/cm902195j; Liu CY, 2012, J MATER CHEM, V22, P14180, DOI 10.1039/c2jm31469j; Liu YF, 2013, J AM CHEM SOC, V135, P7486, DOI 10.1021/ja311059m; Zhou M, 2008, J AM CHEM SOC, V130, P4527, DOI 10.1021/ja7110652; Sui JH, 2013, ENERG ENVIRON SCI, V6, P2916, DOI 10.1039/c3ee41859f; NISHIDA I, 1973, PHYS REV B, V7, P2710, DOI 10.1103/PhysRevB.7.2710; Ohta H, 2007, NAT MATER, V6, P129, DOI 10.1038/nmat1821; Zebarjadi M, 2012, ENERG ENVIRON SCI, V5, P5147, DOI 10.1039/c1ee02497c; Jiang B, 2013, J SOLID STATE CHEM, V204, P1, DOI 10.1016/j.jssc.2013.05.009; Liu Y, 2011, J AM CHEM SOC, V133, P20112, DOI 10.1021/ja2091195; Bahk J. H., 2011, MAT RES SOC S P, V1329; Bahk JH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.235209; Bahk JH, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3673615; Bak T, 2004, IONICS, V10, P166, DOI 10.1007/BF02382813; Enyashin AN, 2009, CHEM PHYS, V362, P58, DOI 10.1016/j.chemphys.2009.06.004; HOULIHAN JF, 1975, J SOLID STATE CHEM, V12, P265, DOI 10.1016/0022-4596(75)90317-5; Koga T, 1999, APPL PHYS LETT, V75, P2438, DOI 10.1063/1.125040; Li Pei Y., 2013, NPG ASIA MATER, V5, P1; Liu FS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05774; Liu Y, 2012, J AM CERAM SOC, V95, P2568, DOI 10.1111/j.1551-2916.2012.05206.x; Liu Y, 2012, J ALLOY COMPD, V531, P5, DOI 10.1016/j.jallcom.2012.02.176; Mikami M, 2012, J PHYS CONF SER, V379, DOI 10.1088/1742-6596/379/1/012006; Mun J, 2007, THERMOCHIM ACTA, V455, P55, DOI 10.1016/j.tca.2006.11.018; NAKAHARA JF, 1988, J APPL PHYS, V63, P2331, DOI 10.1063/1.341049; Okinaka N, 2010, ISIJ INT, V50, P1296, DOI 10.2355/isijinternational.50.1296; Okinaka N, 2006, JPN J APPL PHYS 1, V45, P7009, DOI 10.1143/JJAP.45.7009; Qu XR, 2011, MATER CHEM PHYS, V129, P331, DOI 10.1016/j.matchemphys.2011.04.022; Tritt TM, 2006, MRS BULL, V31, P188, DOI 10.1557/mrs2006.44; Venkatasubramanian R, 2000, PHYS REV B, V61, P3091, DOI 10.1103/PhysRevB.61.3091; Venkatasubramanian V. R., 2001, NATURE, V413, P597; Zebarjadi M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195331; Zhang GQ, 2008, ADV MATER, V20, P3654, DOI 10.1002/adma.200800162; Zhang YC, 2012, NANO LETT, V12, P1075, DOI 10.1021/nl204346g; Zhao LD, 2008, J SOLID STATE CHEM, V181, P3278, DOI 10.1016/j.jssc.2008.08.022; Zide M. O., 2010, J APPL PHYS, V108; Zide M.O., 2006, PHYS REV B, V74	68	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1884-4049	1884-4057		NPG ASIA MATER	NPG Asia Mater.	MAY	2015	7								e182	10.1038/am.2015.36		10	Materials Science, Multidisciplinary	Materials Science	CJ2SB	WOS:000355333700004		
J	Kaneko, K; Kawamoto, Y; Nishiyama, H; Kato, N; Toyoshima, M				Kaneko, Kazuma; Kawamoto, Yuichi; Nishiyama, Hiroki; Kato, Nei; Toyoshima, Mario			An efficient utilization of intermittent surface-satellite optical links by using mass storage device embedded in satellites	PERFORMANCE EVALUATION			English	Article						Satellite networks; Optical communication; Mass storage device; Traffic control		Recently, earth observation system by using satellite network has attracted much attention due to its wide coverage and disaster resistance. Although the system is useful for collecting various data, which have an effect on a natural disaster, ecology and so forth, earth observation satellite hardly send the collected observation data to the ground station. This is because that the earth observation satellite needs to orbit near surface of the earth to get high-precision data, and it limited the time that can be used to send the observed data traffic to the ground station. Additionally, the amount of the observed data drastically increase in these days. Thus, we focus on the data relay satellite using optical communication in this network. By relaying observed data to traffic to the relay satellite, which has geostationary orbit, it is possible to increase the chance of sending data for the observation satellite due to the wide coverage of the relay satellite. In addition, laser light that is used in optical communication in satellite network has high frequency and it can deliver large data compared with radio wave. However, laser light is greatly influenced by atmosphere, and optical link capacity between satellite and ground station drastically changes according to weather condition. Therefore, we propose a new data traffic control method to use the network constructed by satellites which has mass storage device effectively according to the condition of optical downlink between satellite and optical ground station. The effectiveness of the proposed method is evaluated with numerical result. (C) 2015 Elsevier B.V. All rights reserved.	[Kaneko, Kazuma; Kawamoto, Yuichi; Nishiyama, Hiroki; Kato, Nei] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan; [Toyoshima, Mario] Natl Inst Informat & Commun Technol NICT, Wireless Network Res Inst, Tokyo, Japan	Kaneko, K (reprint author), Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan.	kaneko@it.ecei.tohoku.ac.jp; youpsan@it.ecei.tohoku.ac.jp; bigtree@it.ecei.tohoku.ac.jp; kato@it.ecei.tohoku.ac.jp; morio@nict.go.jp					Shimada M, 2010, P IEEE, V98, P780, DOI 10.1109/JPROC.2009.2033724; Chambon P, 2013, IEEE GEOSCI REMOTE S, V10, P996, DOI 10.1109/LGRS.2012.2227668; Evans JV, 1997, IEEE ANTENNAS PROPAG, V39, P7, DOI 10.1109/74.598556; Friedrichs B, 2012, ADV SAT MULTMED SYS, P101, DOI 10.1109/ASMS-SPSC.2012.6333060; Furukawa K, 2013, INT GEOSCI REMOTE SE, P1143, DOI 10.1109/IGARSS.2013.6721367; Heine F, 2010, IEEE MILIT COMMUN C, P1583; JONGEJANS AW, 1993, IEEE AP-S, P1838, DOI 10.1109/APS.1993.385561; Leitgeb E., 2009, 2009 ICTON 09 11 INT, P1, DOI 10.1109/ICTON.2009.5184993; Taini G, 2012, INT GEOSCI REMOTE SE, P1722, DOI 10.1109/IGARSS.2012.6351190; Toyoshima M, 2006, IEEE LEOS ANN MTG, P80, DOI 10.1109/LEOS.2006.278846; Yamamoto S., 1997, IEEE 47TH VEHICULAR, V1, P31; Yamashita Y., 2010, 2010 INTERNATIONAL S, P1	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-5316	1872-745X		PERFORM EVALUATION	Perform. Eval.	MAY	2015	87				SI		37	46		10.1016/j.peva.2015.01.004		10	Computer Science, Hardware & Architecture; Computer Science, Theory & Methods	Computer Science	CJ2YW	WOS:000355351600004		
J	Yamaguchi, H; Hiromori, A; Higashino, T; Umehara, S; Urayama, H; Yamada, M; Maeno, T; Kaneda, S; Takai, M				Yamaguchi, Hirozumi; Hiromori, Akihito; Higashino, Teruo; Umehara, Shigeki; Urayama, Hirofumi; Yamada, Masaya; Maeno, Taka; Kaneda, Shigeru; Takai, Mineo			Scalable and robust channel allocation for densely-deployed urban wireless stations	PERFORMANCE EVALUATION			English	Article						Resource allocation; Wireless communication; Scheduling	PHYSICAL INTERFERENCE MODEL; SENSOR NETWORKS	This paper presents a scalable and robust scheduling algorithm for a set of wireless stations. Recently, road-side access points for vehicular networks and outdoor WiFi stations are deployed in wide urban areas and compete with each other for limited wireless resources. We focus on pursuing the best balance among (i) optimality of resource utilization, (ii) robustness to new station installation and traffic demand, and (iii) scalability to the population of stations and area size. The algorithm is designed based on a vector space theory with correctness proof. Compared with our previous work that presents the basic algorithm and theory, we extend the algorithm to a multi-layer (i.e. hierarchical) version to handle more realistic situations. Additionally, we have conducted extensive simulations with a variety of scenarios. Finally, the applicability of approach has been testified by a case study on a scheduling problem for roadside access points of vehicular networks in cooperation with a manufacturing corporation. (C) 2015 Elsevier B.V. All rights reserved.	[Yamaguchi, Hirozumi; Hiromori, Akihito; Higashino, Teruo; Takai, Mineo] Osaka Univ, Grad Sch IST, Suita, Osaka 5650871, Japan; [Umehara, Shigeki; Urayama, Hirofumi; Yamada, Masaya] Sumitomo Elect Ind LTD, Osaka, Japan; [Maeno, Taka] Space Time Engn Japan Inc, Tokyo, Japan; [Kaneda, Shigeru; Takai, Mineo] Space Time Engn LLC, Los Angeles, CA USA; [Takai, Mineo] Univ Calif Los Angeles, Los Angeles, CA USA	Yamaguchi, H (reprint author), Osaka Univ, Grad Sch IST, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	h-yamagu@ist.osaka-u.ac.jp			Strategic Information and Communications R&D Promotion Programme (SCOPE) of the Ministry of Internal Affairs and Communications, Japan [145007002]	This project is supported by the Strategic Information and Communications R&D Promotion Programme (SCOPE) No. 145007002 of the Ministry of Internal Affairs and Communications, Japan.	Amdouni I., 2011, TECH REP; Cruz RL, 2003, IEEE INFOCOM SER, P702; Ergen SC, 2010, WIREL NETW, V16, P985, DOI 10.1007/s11276-009-0183-0; Giuliano R, 2008, IEEE WIREL COMMUN, V15, P60, DOI 10.1109/MWC.2008.4547524; Yang JC, 2005, IEEE T COMPUT, V54, P616; Wan PJ, 2011, IEEE INFOCOM SER, P838; JOHNSON DS, 1991, OPER RES, V39, P378, DOI 10.1287/opre.39.3.378; HAJEK B, 1988, IEEE T INFORM THEORY, V34, P910, DOI 10.1109/18.21215; [Anonymous], 2009, MHZ GHZ OCTOBER; HERTZ A, 1987, COMPUTING, V39, P345, DOI 10.1007/BF02239976; Galinier P, 2006, COMPUT OPER RES, V33, P2547, DOI 10.1016/j.cor.2005.07.028; MISRA J, 1992, INFORM PROCESS LETT, V41, P131, DOI 10.1016/0020-0190(92)90041-S; Karakayali MK, 2006, IEEE WIREL COMMUN, V13, P56, DOI 10.1109/MWC.2006.1678166; Pathak PH, 2011, IEEE COMMUN SURV TUT, V13, P396, DOI 10.1109/SURV.2011.060710.00062; Xu XH, 2011, IEEE T PARALL DISTR, V22, P163, DOI 10.1109/TPDS.2010.80; Wang WZ, 2006, MOBICOM 2006, P262; Jindal N, 2008, IEEE T WIREL COMMUN, V7, P5408, DOI 10.1109/T-WC.2008.071220; Association of Radio Industries and Businesses (ARIB), 2012, 700 MHZ BAND INTTELI; Bollobas B, 1985, N HOLLAND MATH STUD, V118, P47, DOI DOI 10.1016/S0304-0208(08)73612-0; BRAR G, 2006, P ACM MOBICOM, P2, DOI 10.1145/1161089.1161092; Brelaz D., 1979, COMMUN ACM, V22; Culberson J.C., 1995, DIMACS SERIES DISCRE, P245; Gandham S, 2008, J PARALLEL DISTR COM, V68, P1122, DOI 10.1016/j.jpdc.2007.12.006; Gronkvist J., 2001, P 2 ACM INT S MOB AD, P255; Jing S, 2008, EURASIP J WIREL COMM, DOI 10.1155/2008/586878; Kang H, 2013, WIRELESS PERS COMMUN, V72, P1005, DOI 10.1007/s11277-013-1052-9; Kanj IA, 2011, THEOR COMPUT SCI, V412, P4704, DOI 10.1016/j.tcs.2011.05.005; Kumar V.S.A., 2005, P 2005 ACM SIGMETRIC, V33, P133; Leighton F., 1979, J RES NATL BUR STAND, V84; Sajith G, 2003, J PARALLEL DISTR COM, V63, P775, DOI 10.1016/S0743-7315(03)00115-1; Veronesi R, 2004, IEEE WCNC, P2515, DOI 10.1109/WCNC.2004.1311484; Yamaguchi H., 2013, PROCEEDINGS OF THE 1, P317; Zhou YQ, 2014, IEEE T PARALL DISTR, V25, P2708, DOI 10.1109/TPDS.2013.210	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-5316	1872-745X		PERFORM EVALUATION	Perform. Eval.	MAY	2015	87				SI		74	91		10.1016/j.peva.2015.02.001		18	Computer Science, Hardware & Architecture; Computer Science, Theory & Methods	Computer Science	CJ2YW	WOS:000355351600007		
J	Io, K; Nishino, T; Obata, Y; Kitamura, M; Koji, T; Kohno, S				Io, Kumiko; Nishino, Tomoya; Obata, Yoko; Kitamura, Mineaki; Koji, Takehiko; Kohno, Shigeru			SAHA SUPPRESSES PERITONEAL FIBROSIS IN MICE	PERITONEAL DIALYSIS INTERNATIONAL			English	Article						Suberoylanilide hydroxamic acid; SAHA; histone deacetylase inhibitor; peritoneal fibrosis; chlorhexidine gluconate	BONE MORPHOGENETIC PROTEIN-7; HISTONE DEACETYLASE; MESENCHYMAL TRANSITION; GROWTH-FACTOR; EPITHELIAL-CELLS; RENAL INJURY; MOUSE MODEL; INHIBITOR; PROGRESSION; EXPRESSION	Objective: Long-term peritoneal dialysis causes peritoneal fibrosis in submesothelial areas. However, the mechanism of peritoneal fibrosis is unclear. Epigenetics is the mechanism to induce heritable changes without any changes in DNA sequences. Among epigenetic modifications, histone acetylation leads to the transcriptional activation of genes. Recent studies indicate that histone acetylation is involved in the progression of fibrosis. Therefore, we examined the effect of suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, on the progression of peritoneal fibrosis in mice. Methods: Peritoneal fibrosis was induced by the injection of chlorhexidine gluconate (CG) into the peritoneal cavity of mice every other day for 3 weeks. SAHA, or a dimethylsulfoxide and saline vehicle, was administered subcutaneously every day from the start of the CG injections for 3 weeks. Morphologic peritoneal changes were assessed by Masson's trichrome staining, and fibrosis-associated factors were assessed by immunohistochemistry. Results: In CG-injected mice, a marked thickening of the submesothelial compact zone was observed. In contrast, the administration of SAHA suppressed the progression of submesothelial thickening and type III collagen accumulation in CG-injected mice. The numbers of fibroblastspecific protein-1-positive cells and alpha-smooth muscle actin alpha-positive cells were significantly decreased in the CG + SAHA group compared to that of the CG group. The level of histone acetylation was reduced in the peritoneum of the CG group, whereas it was increased in the CG + SAHA group. Conclusions: Our results indicate that SAHA can suppress peritoneal thickening and fibrosis in mice through up-regulation of histone acetylation. These results suggest that SAHA may have therapeutic potential for treating peritoneal fibrosis.	[Io, Kumiko; Nishino, Tomoya; Obata, Yoko; Kitamura, Mineaki; Kohno, Shigeru] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 8528102, Japan; [Koji, Takehiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Histol & Cell Biol, Nagasaki 8528102, Japan	Nishino, T (reprint author), Nagasaki Univ, Sch Med, Dept Internal Med 2, 1-7-1 Sakamoto, Nagasaki 8528102, Japan.	tnishino@nagasaki-u.ac.jp			JSPS [23790947]; Japanese Association of Dialysis Physicians	This work was supported by JSPS KAKENHI Grant-in-Aid for Young Scientists (B) Number 23790947 and grants from the Japanese Association of Dialysis Physicians. We would like to thank Ms. Ryoko Yamamoto and Ms. Shiho Kondo for excellent experimental assistance.	Afthentopoulos I E, 1998, Adv Ren Replace Ther, V5, P157; Iyer A, 2010, BRIT J PHARMACOL, V159, P1408, DOI 10.1111/j.1476-5381.2010.00637.x; Yoshio Y, 2004, KIDNEY INT, V66, P1677, DOI 10.1111/j.1523-1755.2004.00935.x; Dwivedi RS, 2011, KIDNEY INT, V79, P23, DOI 10.1038/ki.2010.335; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; De Petris L, 2007, NEPHROL DIAL TRANSPL, V22, P3442, DOI 10.1093/ndt/gfm503; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; Zhang XL, 2005, J AM SOC NEPHROL, V16, P79, DOI 10.1681/ASN.2004050395; Song N, 2011, ACTA HISTOCHEM CYTOC, V44, P183, DOI 10.1267/ahc.11027; Mishima Y, 2003, PERITON DIALYSIS INT, V23, P14; Advani A, 2011, AM J PATHOL, V178, P2205, DOI 10.1016/j.ajpath.2011.01.044; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Sekiguchi Y, 2012, J ARTIF ORGANS, V15, P272, DOI 10.1007/s10047-012-0648-2; GANDHI VC, 1980, ARCH INTERN MED, V140, P1201, DOI 10.1001/archinte.140.9.1201; Marumo T, 2008, J AM SOC NEPHROL, V19, P1311, DOI 10.1681/ASN.2007091040; Nishino T, 2003, KIDNEY INT, V64, P887, DOI 10.1046/j.1523-1755.2003.00169.x; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Noh H, 2009, AM J PHYSIOL-RENAL, V297, pF729, DOI 10.1152/ajprenal.00086.2009; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Arai H, 2011, ACTA HISTOCHEM CYTOC, V44, P51, DOI 10.1267/ahc.10030; Deroanne CF, 2002, ONCOGENE, V21, P427, DOI 10.1038/sj.onc.1205108; Yu MA, 2009, J AM SOC NEPHROL, V20, P567, DOI 10.1681/ASN.2008040424; Hirose M, 2013, PERITON DIALYSIS INT, V33, P132, DOI 10.3747/pdi.2011.00234; Park SH, 2008, PERITON DIALYSIS INT, V28, pS21; Williams JD, 2002, J AM SOC NEPHROL, V13, P470; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Boon MR, 2011, CYTOKINE GROWTH F R, V22, P221, DOI 10.1016/j.cytogfr.2011.08.001; Hruska KA, 2000, AM J PHYSIOL-RENAL, V279, pF130; Manson SR, 2013, J UROL; Marumo T, 2010, AM J PHYSIOL-RENAL, V298, pF133, DOI 10.1152/ajprenal.00400.2009; Oyamada N, 2008, ENDOCRINOLOGY, V149, P3764, DOI 10.1210/en.2007-1770; Pagel CN, 2009, BONE, V44, P813, DOI 10.1016/j.bone.2008.12.031; SCHINDLER R, 1990, J BIOL CHEM, V265, P10232; Ververis Katherine, 2013, Biologics, V7, P47, DOI 10.2147/BTT.S29965; Wiech NL, 2009, CURR TOP MED CHEM, V9, P257	38	1	1	MULTIMED INC	TORONTO	66 MARTIN ST, TORONTO, ON L9T 2R2, CANADA	0896-8608			PERITON DIALYSIS INT	Perit. Dial. Int.	MAY-JUN	2015	35	3					246	258		10.3747/pdi.2013.00089		13	Urology & Nephrology	Urology & Nephrology	CJ0ZB	WOS:000355209000005		
J	Sakurada, T; Kaneshiro, N; Otowa, T; Oishi, D; Koitabashi, K; Matsui, K; Konno, Y; Sato, Y; Shibagaki, Y; Kimura, K				Sakurada, Tsutomu; Kaneshiro, Nagayuki; Otowa, Takanori; Oishi, Daisuke; Koitabashi, Kenichiro; Matsui, Katsuomi; Konno, Yusuke; Sato, Yuichi; Shibagaki, Yugo; Kimura, Kenjiro			Re-Embedding Catheter Technique at the Discontinuation of Peritoneal Dialysis	PERITONEAL DIALYSIS INTERNATIONAL			English	Article						Peritoneal dialysis; re-embedding catheter technique; catheter removal	TENCKHOFF CATHETER; REMOVAL; COMPLICATIONS		[Sakurada, Tsutomu; Otowa, Takanori; Oishi, Daisuke; Koitabashi, Kenichiro; Matsui, Katsuomi; Shibagaki, Yugo; Kimura, Kenjiro] St Marianna Univ, Sch Med, Integrated Care Ctr Kidney Dis, Dept Internal Med,Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan; [Sato, Yuichi] St Marianna Univ, Sch Med, Integrated Care Ctr Kidney Dis, Dept Urol, Kawasaki, Kanagawa, Japan; [Sato, Yuichi] Kawasaki Municipal Tama Hosp, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan	Sakurada, T (reprint author), St Marianna Univ, Sch Med, Integrated Care Ctr Kidney Dis, Dept Internal Med,Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan.	sakurada@marianna-u.ac.jp					Alvarez AC, 2009, ADV CHRONIC KIDNEY D, V16, P378, DOI 10.1053/j.ackd.2009.06.004; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Ash SR, 2002, SEMIN NEPHROL, V22, P221, DOI 10.1053/snep.2002.31710; Elkabir JJ, 1999, NEPHROL DIAL TRANSPL, V14, P1550, DOI 10.1093/ndt/14.6.1550; Harvey R, 2007, PERITON DIALYSIS INT, V27, P217; Korzets Z, 2000, PERITON DIALYSIS INT, V20, P789; Pollock CA, 2001, PERITON DIALYSIS INT, V21, pS61; Quiroga I, 2003, NEPHROL DIAL TRANSPL, V18, P1682, DOI 10.1093/ndt/fgf173; Sampathkumar K, 2008, Indian J Nephrol, V18, P5, DOI 10.4103/0971-4065.41280; Yip T, 2013, INT J NEPHROL	10	0	0	MULTIMED INC	TORONTO	66 MARTIN ST, TORONTO, ON L9T 2R2, CANADA	0896-8608			PERITON DIALYSIS INT	Perit. Dial. Int.	MAY-JUN	2015	35	3					360	361		10.3747/pdi.2013.00313		2	Urology & Nephrology	Urology & Nephrology	CJ0ZB	WOS:000355209000016		
J	Okubo, K; Ishibashi, Y; Kume, H; Hirahashi, J; Nangaku, M				Okubo, K.; Ishibashi, Y.; Kume, H.; Hirahashi, J.; Nangaku, M.			Successful Management of a Chest Exit Site in a Psoriasis Patient	PERITONEAL DIALYSIS INTERNATIONAL			English	Letter							PERITONEAL ACCESS; CATHETERS		[Okubo, K.; Hirahashi, J.; Nangaku, M.] Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Tokyo, Japan; [Ishibashi, Y.] Japanese Red Cross Med Ctr, Dept Nephrol, Tokyo, Japan; [Kume, H.] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan	Okubo, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Tokyo, Japan.	okposi@hotmail.co.jp					Figueiredo A, 2010, PERITON DIALYSIS INT, V30, P424, DOI 10.3747/pdi.2010.00087; Crabtree JH, 2010, PERITON DIALYSIS INT, V30, P46, DOI 10.3747/pdi.2009.00004; Flanigan M, 2005, PERITON DIALYSIS INT, V25, P132; Twardowski ZJ, 1996, AM J KIDNEY DIS, V27, P99, DOI 10.1016/S0272-6386(96)90036-0	4	0	0	MULTIMED INC	TORONTO	66 MARTIN ST, TORONTO, ON L9T 2R2, CANADA	0896-8608			PERITON DIALYSIS INT	Perit. Dial. Int.	MAY-JUN	2015	35	3					372	373		10.3747/pdi.2014.00072		2	Urology & Nephrology	Urology & Nephrology	CJ0ZB	WOS:000355209000022		
J	Luo, H; Liu, S; Ryuu, Y				Luo, Hong; Liu, St; Ryuu, Yi			Gymnema sylvestre extract improving liver function in genetic metabolic syndrome model animal.	PHARMACOTHERAPY			English	Meeting Abstract									[Luo, Hong] GSCP, Global Culture Educ Ctr, Global Sci Inst, Tokyo, Japan; [Luo, Hong] CAMS PUMC, Beijing, Peoples R China; [Liu, St] Okayama Univ, Fac Pharmaceut Sci, Okayama 7008530, Japan; [Ryuu, Yi] GSCP, Kyoto, Japan; [Ryuu, Yi] USTB, Beijing, Peoples R China								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-0008	1875-9114		PHARMACOTHERAPY	Pharmacotherapy	MAY	2015	35	5				20	E71	E71				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CJ1IC	WOS:000355236300022		
J	Lukin, PA; Anisenkov, AV; Aulchenko, VM; Akhmetshin, RR; Banzarov, VS; Bashtovoy, NS; Berkaev, DE; Bragin, AV; Vorobiov, AI; Gayazov, SE; Grebenuk, AA; Grigoriev, DN; Gromov, EM; Epifanov, DA; Erofeev, AL; Zharinov, YM; Ignatov, FV; Karpov, SV; Kazanin, VF; Kirpotin, AN; Koop, IA; Kovalenko, OA; Kozyrev, AN; Kozyrev, EA; Krokovny, PP; Kuzmenko, AE; Kuzmin, AS; Logashenko, IB; Lysenko, AP; Mikhailov, KY; Okhapkin, VS; Pestov, YN; Perevedentsev, EA; Popov, AS; Popov, YS; Razuvaev, GP; Rogovsky, YA; Romanov, AL; Ruban, AA; Ryskulov, NM; Ryzhenenkov, AE; Sibidanov, AL; Solodov, EP; Titov, VM; Talyshev, AA; Fedotovich, GV; Khazin, BI; Shatunov, PY; Shatunov, YM; Shwartz, BA; Shwartz, DB; Shebalin, VE; Shemyakin, DN; Eidelman, SI; Epshteyn, LB; Yudin, YV				Lukin, P. A.; Anisenkov, A. V.; Aulchenko, V. M.; Akhmetshin, R. R.; Banzarov, V. Sh.; Bashtovoy, N. S.; Berkaev, D. E.; Bragin, A. V.; Vorobiov, A. I.; Gayazov, S. E.; Grebenuk, A. A.; Grigoriev, D. N.; Gromov, E. M.; Epifanov, D. A.; Erofeev, A. L.; Zharinov, Yu. M.; Ignatov, F. V.; Karpov, S. V.; Kazanin, V. F.; Kirpotin, A. N.; Koop, I. A.; Kovalenko, O. A.; Kozyrev, A. N.; Kozyrev, E. A.; Krokovny, P. P.; Kuzmenko, A. E.; Kuzmin, A. S.; Logashenko, I. B.; Lysenko, A. P.; Mikhailov, K. Yu.; Okhapkin, V. S.; Pestov, Yu. N.; Perevedentsev, E. A.; Popov, A. S.; Popov, Yu. S.; Razuvaev, G. P.; Rogovsky, Yu. A.; Romanov, A. L.; Ruban, A. A.; Ryskulov, N. M.; Ryzhenenkov, A. E.; Sibidanov, A. L.; Solodov, E. P.; Titov, V. M.; Talyshev, A. A.; Fedotovich, G. V.; Khazin, B. I.; Shatunov, P. Yu.; Shatunov, Yu. M.; Shwartz, B. A.; Shwartz, D. B.; Shebalin, V. E.; Shemyakin, D. N.; Eidelman, S. I.; Epshteyn, L. B.; Yudin, Yu. V.			Investigation of the processes e (+) e (-) -> 2 (pi(+)pi(-)pi(0)) and e (+) e (-) -> 3 (pi(+)pi(-)) with the aid of the CMD-3 detector	PHYSICS OF ATOMIC NUCLEI			English	Article							CROSS-SECTION; ANNIHILATION; VEPP-2000; COLLIDER	The cross sections for the processes e (+) e (-) -> 2(pi(+)pi(-)pi(0)) and e (+) e (-) -> 3(pi(+)pi(-)) at c.m. energies in the range of 1.5-2 GeV were measured with the aid of the CMD-3 detector at the VEPP-2000 collider of the Budker Institute of Nuclear Physics (Novosibirsk, Siberian Branch, Russian Academy of Sciences). The integrated luminosity in the respective experiment was 22 pb(-1).	[Lukin, P. A.; Anisenkov, A. V.; Aulchenko, V. M.; Akhmetshin, R. R.; Banzarov, V. Sh.; Bashtovoy, N. S.; Berkaev, D. E.; Bragin, A. V.; Vorobiov, A. I.; Gayazov, S. E.; Grebenuk, A. A.; Grigoriev, D. N.; Gromov, E. M.; Epifanov, D. A.; Erofeev, A. L.; Zharinov, Yu. M.; Ignatov, F. V.; Karpov, S. V.; Kazanin, V. F.; Kirpotin, A. N.; Koop, I. A.; Kovalenko, O. A.; Kozyrev, A. N.; Kozyrev, E. A.; Krokovny, P. P.; Kuzmenko, A. E.; Kuzmin, A. S.; Logashenko, I. B.; Lysenko, A. P.; Mikhailov, K. Yu.; Okhapkin, V. S.; Pestov, Yu. N.; Perevedentsev, E. A.; Popov, A. S.; Popov, Yu. S.; Razuvaev, G. P.; Rogovsky, Yu. A.; Romanov, A. L.; Ruban, A. A.; Ryskulov, N. M.; Ryzhenenkov, A. E.; Sibidanov, A. L.; Solodov, E. P.; Titov, V. M.; Talyshev, A. A.; Fedotovich, G. V.; Khazin, B. I.; Shatunov, P. Yu.; Shatunov, Yu. M.; Shwartz, B. A.; Shwartz, D. B.; Shebalin, V. E.; Shemyakin, D. N.; Eidelman, S. I.; Epshteyn, L. B.; Yudin, Yu. V.] Russian Acad Sci, Siberian Branch, Budker Inst Nucl Phys, Novosibirsk 630090, Russia; [Lukin, P. A.; Aulchenko, V. M.; Berkaev, D. E.; Gayazov, S. E.; Grebenuk, A. A.; Gromov, E. M.; Kazanin, V. F.; Koop, I. A.; Kovalenko, O. A.; Kozyrev, E. A.; Krokovny, P. P.; Logashenko, I. B.; Mikhailov, K. Yu.; Perevedentsev, E. A.; Popov, A. S.; Razuvaev, G. P.; Ryzhenenkov, A. E.; Solodov, E. P.; Talyshev, A. A.; Fedotovich, G. V.; Khazin, B. I.; Shwartz, B. A.; Shwartz, D. B.; Shemyakin, D. N.; Eidelman, S. I.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Grigoriev, D. N.; Kuzmenko, A. E.; Epshteyn, L. B.] Novosibirsk State Tech Univ, Novosibirsk 630073, Russia; [Epifanov, D. A.] Univ Tokyo, Dept Phys, Tokyo 1138654, Japan; [Sibidanov, A. L.] Univ Sydney, Sch Phys A28, Particle Phys Grp, Sydney, NSW 2006, Australia	Lukin, PA (reprint author), Russian Acad Sci, Siberian Branch, Budker Inst Nucl Phys, Pr Akad Lavrentieva 11, Novosibirsk 630090, Russia.	P.A.Lukin@inp.nsk.su			Ministry of Education and Science of Russian Federation; Federal Target-Oriented Program Scientific and Pedagogical Personnel of Innovating Russia [14.B37.21.07777]; Russian Foundation for Basic Research [10-02-00695-a, 10-02-00253-a, 11-02-00328-a, 11-02-00112-a, 12-02-31501-a, 12-02-31499-a, 13-02-00215-a, 12-02-31498-a, 12-02-01032-a]	This work was supported by the Ministry of Education and Science of Russian Federation, the Federal Target-Oriented Program Scientific and Pedagogical Personnel of Innovating Russia for the period of 2009-2013 (contract no. 14.B37.21.07777), and the Russian Foundation for Basic Research (project nos. 10-02-00695-a, 10-02-00253-a, 11-02-00328-a, 11-02-00112-a, 12-02-31501-a, 12-02-31499-a, 13-02-00215-a, 12-02-31498-a and 12-02-01032-a).	Abakumova E. V., ARXIV12110103V1PHYSI; Akhmetshin R. R., 2012, Nuclear Physics B, Proceedings Supplements, V225-227, DOI 10.1016/j.nuclphysbps.2012.02.016; Anisyonkov AV, 2009, NUCL INSTRUM METH A, V598, P266, DOI 10.1016/j.nima.2008.08.091; CLEGG AB, 1990, Z PHYS C PART FIELDS, V45, P677, DOI 10.1007/BF01556281; KURAEV EA, 1985, SOV J NUCL PHYS+, V41, P466; Davier M, 2003, EUR PHYS J C, V31, P503, DOI 10.1140/cpjc/s2003-01362-6; Antonelli A, 1996, PHYS LETT B, V365, P427, DOI 10.1016/0370-2693(95)01457-8; Aubert B, 2006, PHYS REV D, V73, DOI [10.1103/PhysRevD.73.012006, 10.1103/PhysRevD.73.012005, 10.1103/PhysRevD.73.112004, 10.1103/PhysRevD.73.052003]; Baldini R., 1988, FENICE WORKSH FRASC; Danilov V. V., 1996, P EPAC96 BARC, P1593; Epifanov D, 2011, J PHYS CONF SER, V293, DOI 10.1088/1742-6596/293/1/012009; Grancagnolo F, 2010, NUCL INSTRUM METH A, V623, P114, DOI 10.1016/j.nima.2010.02.166; Khazin B, 2008, NUCL PHYS B-PROC SUP, V181-82, P376, DOI 10.1016/j.nuclphysbps.2008.09.068; Koop IA, 2008, NUCL PHYS B-PROC SUP, V181-82, P371, DOI [10.1016/j.nuclphysbps.2008.09.067, 10.1016/j.nuc1physbps.2008.09.067]; Whalley MR, 2003, J PHYS G NUCL PARTIC, V29, pA1, DOI 10.1088/0954-3899/29/12A/R01	15	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1063-7788	1562-692X		PHYS ATOM NUCL+	Phys. Atom. Nuclei	MAY	2015	78	3					353	357		10.1134/S1063778815020209		5	Physics, Nuclear; Physics, Particles & Fields	Physics	CJ1EI	WOS:000355224600002		
J	Kozyrev, EA; Akhmetshin, RR; Anisenkov, AV; Aulchenko, VM; Banzarov, VS; Bashtovoy, NS; Berkaev, DE; Bragin, AV; Vorobiov, AI; Gayazov, SE; Grebenyuk, AA; Grigoriev, DN; Gromov, EM; Epifanov, DA; Erofeev, AL; Zharinov, YM; Ignatov, FV; Karpov, SV; Kazanin, VF; Kirpotin, AN; Koop, IA; Kovalenko, OA; Kozyrev, AN; Krokovny, PP; Kuzmenko, AE; Kuzmin, AS; Logashenko, IB; Lukin, PA; Lysenko, AP; Mikhailov, KY; Okhapkin, VS; Pestov, YN; Perevedentsev, EA; Popov, AS; Razuvaev, GP; Rogovsky, YA; Romanov, AL; Ruban, AA; Ryzhenenkov, AE; Ryskulov, NM; Sibidanov, AL; Solodov, EP; Titov, VM; Talyshev, AA; Fedotovich, GV; Khazin, BI; Shebalin, VE; Shemyakin, DN; Shwartz, BA; Shwartz, DB; Shatunov, PY; Shatunov, YM; Eidelman, SI; Epshteyn, LB; Yudin, YV				Kozyrev, E. A.; Akhmetshin, R. R.; Anisenkov, A. V.; Aulchenko, V. M.; Banzarov, V. Sh.; Bashtovoy, N. S.; Berkaev, D. E.; Bragin, A. V.; Vorobiov, A. I.; Gayazov, S. E.; Grebenyuk, A. A.; Grigoriev, D. N.; Gromov, E. M.; Epifanov, D. A.; Erofeev, A. L.; Zharinov, Yu. M.; Ignatov, F. V.; Karpov, S. V.; Kazanin, V. F.; Kirpotin, A. N.; Koop, I. A.; Kovalenko, O. A.; Kozyrev, A. N.; Krokovny, P. P.; Kuzmenko, A. E.; Kuzmin, A. S.; Logashenko, I. B.; Lukin, P. A.; Lysenko, A. P.; Mikhailov, K. Yu.; Okhapkin, V. S.; Pestov, Yu. N.; Perevedentsev, E. A.; Popov, A. S.; Razuvaev, G. P.; Rogovsky, Yu. A.; Romanov, A. L.; Ruban, A. A.; Ryzhenenkov, A. E.; Ryskulov, N. M.; Sibidanov, A. L.; Solodov, E. P.; Titov, V. M.; Talyshev, A. A.; Fedotovich, G. V.; Khazin, B. I.; Shebalin, V. E.; Shemyakin, D. N.; Shwartz, B. A.; Shwartz, D. B.; Shatunov, P. Yu.; Shatunov, Yu. M.; Eidelman, S. I.; Epshteyn, L. B.; Yudin, Yu. V.			Investigation of the process e (+) e (-) -> K (+) K (-) with the aid of the CMD-3 detector at the VEPP-2000 electron-positron collider	PHYSICS OF ATOMIC NUCLEI			English	Article								Preliminary results of an experiment that is aimed at measuring the cross section for the process e (+) e (-) -> K (+) K (-) at c.m. energies in the range between 1.01 and 2.0 GeV with the aid of the CMD-3 detector and which is being performed at the VEPP-2000 collider of the Budker Institute of Nuclear Physics (Novosibirsk, Siberian Branch, Russian Academy of Sciences) are presented.	[Kozyrev, E. A.; Akhmetshin, R. R.; Anisenkov, A. V.; Aulchenko, V. M.; Banzarov, V. Sh.; Bashtovoy, N. S.; Berkaev, D. E.; Bragin, A. V.; Vorobiov, A. I.; Gayazov, S. E.; Grebenyuk, A. A.; Grigoriev, D. N.; Gromov, E. M.; Erofeev, A. L.; Zharinov, Yu. M.; Ignatov, F. V.; Karpov, S. V.; Kazanin, V. F.; Kirpotin, A. N.; Koop, I. A.; Kovalenko, O. A.; Kozyrev, A. N.; Krokovny, P. P.; Kuzmenko, A. E.; Kuzmin, A. S.; Logashenko, I. B.; Lukin, P. A.; Lysenko, A. P.; Mikhailov, K. Yu.; Okhapkin, V. S.; Pestov, Yu. N.; Perevedentsev, E. A.; Popov, A. S.; Razuvaev, G. P.; Rogovsky, Yu. A.; Romanov, A. L.; Ruban, A. A.; Ryzhenenkov, A. E.; Ryskulov, N. M.; Solodov, E. P.; Titov, V. M.; Talyshev, A. A.; Fedotovich, G. V.; Khazin, B. I.; Shebalin, V. E.; Shemyakin, D. N.; Shwartz, B. A.; Shwartz, D. B.; Shatunov, P. Yu.; Shatunov, Yu. M.; Eidelman, S. I.; Epshteyn, L. B.; Yudin, Yu. V.] Russian Acad Sci, Siberian Branch, Budker Inst Nucl Phys, Novosibirsk 630090, Russia; [Kozyrev, E. A.; Aulchenko, V. M.; Berkaev, D. E.; Gayazov, S. E.; Grebenyuk, A. A.; Kazanin, V. F.; Koop, I. A.; Kovalenko, O. A.; Krokovny, P. P.; Logashenko, I. B.; Lukin, P. A.; Mikhailov, K. Yu.; Perevedentsev, E. A.; Popov, A. S.; Razuvaev, G. P.; Ryzhenenkov, A. E.; Solodov, E. P.; Talyshev, A. A.; Fedotovich, G. V.; Khazin, B. I.; Shemyakin, D. N.; Shwartz, B. A.; Shwartz, D. B.; Eidelman, S. I.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Grigoriev, D. N.; Kuzmenko, A. E.; Epshteyn, L. B.] Novosibirsk State Tech Univ, Novosibirsk 630073, Russia; [Epifanov, D. A.] Univ Tokyo, Dept Phys, Tokyo 1138654, Japan; [Sibidanov, A. L.] Univ Sydney, Sch Phys A28, Particle Phys Grp, Sydney, NSW 2006, Australia	Kozyrev, EA (reprint author), Russian Acad Sci, Siberian Branch, Budker Inst Nucl Phys, Pr Akad Lavrentieva 11, Novosibirsk 630090, Russia.	eakozyrev09@gmail.com			Ministry of Education and Science of Russian Federation; Russian Foundation for Basic Research [12-02-31501-a, 12-02-31499-a, 12-02-31498-a, 12-02-01032-a, 13-02-00215-a, 14-02-00047-a]; Deutsche Forschungsgemeinschaft [DFG HA 1457.9-1]	This work was supported by the Ministry of Education and Science of Russian Federation, the Russian Foundation for Basic Research (project nos. 12-02-31501-a, 12-02-31499-a, 12-02-31498-a, 12-02-01032-a, 13-02-00215-a, and 14-02-00047-a), and Deutsche Forschungsgemeinschaft (grant no. DFG HA 1457.9-1).	Akhmetshin RR, 2008, PHYS LETT B, V669, P217, DOI 10.1016/j.physletb.2008.09.053; Bruch C, 2005, EUR PHYS J C, V39, P41, DOI 10.1140/epjc/s2004-02064-3; Bramon A, 2000, PHYS LETT B, V486, P406, DOI 10.1016/S0370-2693(00)00770-X; Abakumova EV, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.140402; Achasov MN, 2001, PHYS REV D, V63; Arbuzov A. B., 2004, 200470 INP; BISELLO D, 1988, Z PHYS C PART FIELDS, V39, P13; Davier M, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-010-1515-z; Khazin B, 2008, NUCL PHYS B-PROC SUP, V181-82, P376, DOI 10.1016/j.nuclphysbps.2008.09.068; Lees JP, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.032013	10	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1063-7788	1562-692X		PHYS ATOM NUCL+	Phys. Atom. Nuclei	MAY	2015	78	3					358	362		10.1134/S1063778815020192		5	Physics, Nuclear; Physics, Particles & Fields	Physics	CJ1EI	WOS:000355224600003		
J	Li, DH; Ono, N; Sato, T; Sugiura, T; Altaf-Ul-Amin, M; Ohta, D; Suzuki, H; Arita, M; Tanaka, K; Ma, ZQ; Kanaya, S				Li, Donghan; Ono, Naoaki; Sato, Tetsuo; Sugiura, Tadao; Altaf-Ul-Amin, Md; Ohta, Daisaku; Suzuki, Hideyuki; Arita, Masanori; Tanaka, Ken; Ma, Zhiqiang; Kanaya, Shigehiko			Targeted Integration of RNA-Seq and Metabolite Data to Elucidate Curcuminoid Biosynthesis in Four Curcuma Species	PLANT AND CELL PHYSIOLOGY			English	Article						Curcumin; Gene expression analysis; Genus Curcuma; Metabolite analysis; RNA-Seq	BIOLOGICAL-ACTIVITIES; COEXPRESSION ANALYSIS; ARABIDOPSIS-THALIANA; REFERENCE GENOME; SEQUENCES; GENES; LONGA; IDENTIFICATION; INFORMATION; ALIGNMENT	Curcuminoids, namely curcumin and its analogs, are secondary metabolites that act as the primary active constituents of turmeric (Curcuma longa). The contents of these curcuminoids vary among species in the genus Curcuma. For this reason, we compared two wild strains and two cultivars to understand the differences in the synthesis of curcuminoids. Because the fluxes of metabolic reactions depend on the amounts of their substrate and the activity of the catalysts, we analyzed the metabolite concentrations and gene expression of related enzymes. We developed a method based on RNA sequencing (RNA-Seq) analysis that focuses on a specific set of genes to detect expression differences between species in detail. We developed a 'selection-first' method for RNA-Seq analysis in which short reads are mapped to selected enzymes in the target biosynthetic pathways in order to reduce the effect of mapping errors. Using this method, we found that the difference in the contents of curcuminoids among the species, as measured by gas chromatography-mass spectrometry, could be explained by the changes in the expression of genes encoding diketide-CoA synthase, and curcumin synthase at the branching point of the curcuminoid biosynthesis pathway.	[Li, Donghan; Ono, Naoaki; Sato, Tetsuo; Sugiura, Tadao; Altaf-Ul-Amin, Md; Kanaya, Shigehiko] Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma 6300192, Japan; [Ohta, Daisaku] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 5998531, Japan; [Suzuki, Hideyuki] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan; [Arita, Masanori] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan; [Arita, Masanori] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Tanaka, Ken] Ritsumeikan Univ, Div Pharmacognosy, Coll Pharmaceut Sci, Kusatsu 5258577, Japan; [Ma, Zhiqiang] NE Normal Univ, Sch Comp Sci & Informat Technol, Changchun 130117, Peoples R China	Ono, N (reprint author), Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma 6300192, Japan.	donghan-l@is.naist.jp; nono@is.naist.jp			National Bioscience Database Center, The Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; US National Science Foundation; Japan Science and Technology Agency; Joint Usage/Research Center (Joint Usage/Research Center for Science-Based Natural Medicine) Institute of Natural Medicine, University of Toyama	This work was supported by National Bioscience Database Center, The Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid for Scientific Research on Innovation Areas 'Biosynthetic Machinery']; the US National Science Foundation and Japan Science and Technology Agency [Strategic International Collaborative Research Program 'Metabolomics for a Low Carbon Society']; Joint Usage/Research Center (Joint Usage/Research Center for Science-Based Natural Medicine) Institute of Natural Medicine, University of Toyama in 2013 [Grant-in-Aid for the Cooperative Research Project].	Afendi FM, 2012, PLANT CELL PHYSIOL, V53, DOI 10.1093/pcp/pcr165; Albinsky D, 2010, AMINO ACIDS, V39, P1067, DOI 10.1007/s00726-010-0681-5; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Gachon CMM, 2005, PLANT MOL BIOL, V58, P229, DOI 10.1007/s11103-005-5346-5; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Katsuyama Y, 2009, J BIOL CHEM, V284, P11160, DOI 10.1074/jbc.M900070200; Katsuyama Y, 2009, FEBS LETT, V583, P2799, DOI 10.1016/j.febslet.2009.07.029; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Zaveska E, 2012, TAXON, V61, P747; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Mewis I, 2006, PHYTOCHEMISTRY, V67, P2450, DOI 10.1016/j.phytochem.2006.09.004; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; Jayaprakasha GK, 2005, TRENDS FOOD SCI TECH, V16, P533, DOI 10.1016/j.tifs.2005.08.006; Lobo R, 2009, J PHARM PHARMACOL, V61, P13, DOI 10.1211/jpp/61.01.0003; Guenin S., 2008, J EXP BOT, V60, P487; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Ikeda S, 2013, PLANT CELL PHYSIOL, V54, P711, DOI 10.1093/pcp/pct041; Kita T, 2008, BIOSCI BIOTECH BIOCH, V72, P1789, DOI 10.1271/bbb.80075; Koo HJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-27; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Morita H, 2010, P NATL ACAD SCI USA, V107, P19778, DOI 10.1073/pnas.1011499107; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Ravindran P. N., 2007, TURMERIC GENUS CURCU; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Yonekura-Sakakibara K, 2013, CURR OPIN BIOTECH, V24, P285, DOI 10.1016/j.copbio.2012.10.018; Sasikumar B., 2005, Plant Genetic Resources Characterization and Utilization, V3, P230, DOI 10.1079/PGR200574; Schaefer RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099193; Suzuki Y, 2004, BIOTECHNIQUES, V37, P542; Wada M, 2012, GENE, V503, P56, DOI 10.1016/j.gene.2012.04.043; Yonekura-Sakakibara K, 2007, J BIOL CHEM, V282, P14932, DOI 10.1074/jbc.M611498200; Yonekura-Sakakibara K, 2009, PLANT BIOTECHNOL, V26, P267, DOI 10.5511/plantbiotechnology.26.267	37	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	MAY	2015	56	5					843	851		10.1093/pcp/pcv008		9	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CJ2KS	WOS:000355313900003		
J	Wakuta, S; Mineta, K; Amano, T; Toyoda, A; Fujiwara, T; Naito, S; Takano, J				Wakuta, Shinji; Mineta, Katsuhiko; Amano, Taro; Toyoda, Atsushi; Fujiwara, Toru; Naito, Satoshi; Takano, Junpei			Evolutionary Divergence of Plant Borate Exporters and Critical Amino Acid Residues for the Polar Localization and Boron-Dependent Vacuolar Sorting of AtBOR1	PLANT AND CELL PHYSIOLOGY			English	Article						Boron; Evolution; Exporter; Membrane trafficking	RHAMNOGALACTURONAN-II; TRANSPORTER INVENTORY; CROSS-LINKING; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; EFFLUX TRANSPORTER; SELAGINELLA GENOME; VASCULAR PLANTS; CELL-WALLS; ROLES	Boron (B) is an essential micronutrient for plants but is toxic when accumulated in excess. The plant BOR family encodes plasma membrane-localized borate exporters (BORs) that control translocation and homeostasis of B under a wide range of conditions. In this study, we examined the evolutionary divergence of BORs among terrestrial plants and showed that the lycophyte Selaginella moellendorffii and angiosperms have evolved two types of BOR (clades I and II). Clade I includes AtBOR1 and homologs previously shown to be involved in efficient transport of B under conditions of limited B availability. AtBOR1 shows polar localization in the plasma membrane and high-B-induced vacuolar sorting, important features for efficient B transport under low-B conditions, and rapid down-regulation to avoid B toxicity. Clade II includes AtBOR4 and barley Bot1 involved in B exclusion for high-B tolerance. We showed, using yeast complementation and B transport assays, that three genes in S. moellendorffii, SmBOR1 in clade I and SmBOR3 and SmBOR4 in clade II, encode functional BORs. Furthermore, amino acid sequence alignments identified an acidic di-leucine motif unique in clade I BORs. Mutational analysis of AtBOR1 revealed that the acidic di-leucine motif is required for the polarity and high-B-induced vacuolar sorting of AtBOR1. Our data clearly indicated that the common ancestor of vascular plants had already acquired two types of BOR for low- and high-B tolerance, and that the BOR family evolved to establish B tolerance in each lineage by adapting to their environments.	[Wakuta, Shinji; Amano, Taro; Naito, Satoshi; Takano, Junpei] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan; [Mineta, Katsuhiko] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal 239556900, Saudi Arabia; [Toyoda, Atsushi; Fujiwara, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Naito, Satoshi] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0608589, Japan	Takano, J (reprint author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan.	jtakano@abs.agr.hokudai.ac.jp	Mineta, Katsuhiko/A-5455-2012	Mineta, Katsuhiko/0000-0002-4727-045X	Japan Society for the Promotion of Science (JSPS) [Funding Program for Next Generation World-Leading Researchers (NEXT) program]; Japan Society for the Promotion of Science (JSPS) [26712007]; Human Frontier Science Program (HFSP)	This work was supported by the the Japan Society for the Promotion of Science (JSPS) [Funding Program for Next Generation World-Leading Researchers (NEXT) program and Grants-in-Aid for Scientific Research (26712007) to J.T.]; the Human Frontier Science Program (HFSP) [Young Investigators Grant to J.T.].	Al-Hasani H, 2002, J CELL SCI, V115, P131; Kasai K, 2011, J BIOL CHEM, V286, P6175, DOI 10.1074/jbc.M110.184929; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Voxeur A, 2014, PLANT J, V79, P139, DOI 10.1111/tpj.12547; Miwa K, 2007, SCIENCE, V318, P1417, DOI 10.1126/science.1146634; Takano J, 2007, FEMS MICROBIOL LETT, V267, P230, DOI 10.1111/j.1574-6968.2006.00556.x; Perez-Castro R, 2012, PLANT CELL PHYSIOL, V53, P485, DOI 10.1093/pcp/pcs001; Viotti C, 2010, PLANT CELL, V22, P1344, DOI 10.1105/tpc.109.072637; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Reid RJ, 2004, PLANT CELL ENVIRON, V27, P1405, DOI 10.1111/j.1365-3040.2004.01243.x; Talavera G, 2007, SYSTEMATIC BIOL, V56, P564, DOI 10.1080/10635150701472164; Ishii T, 1996, CARBOHYD RES, V284, P1, DOI 10.1016/0008-6215(96)00010-9; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017; Kobayashi M, 2011, PLANT CELL PHYSIOL, V52, P1832, DOI 10.1093/pcp/pcr120; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Wimmer MA, 2009, PLANT CELL PHYSIOL, V50, P1292, DOI 10.1093/pcp/pcp073; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Canon P, 2013, PHYSIOL PLANTARUM, V149, P329, DOI 10.1111/ppl.12037; Robinson DG, 2008, PLANT PHYSIOL, V147, P1482, DOI 10.1104/pp.108.120105; Miwa K, 2013, PLANT PHYSIOL, V163, P1699, DOI 10.1104/pp.113.225995; Tanaka N, 2013, PLANT CELL PHYSIOL, V54, P2011, DOI 10.1093/pcp/pct136; Takano J, 2008, TRENDS PLANT SCI, V13, P451, DOI 10.1016/j.tplants.2008.05.007; Bock KW, 2006, PLANT PHYSIOL, V140, P1151, DOI 10.1104/pp.105.074708; Nozawa A, 2006, FEMS MICROBIOL LETT, V262, P216, DOI 10.1111/j.1574-6968.2006.00395.x; Hayes JE, 2004, PLANT PHYSIOL, V136, P3376, DOI 10.1104/pp.103.037028; Bassil E, 2004, PLANT PHYSIOL, V136, P3383, DOI 10.1104/pp.104.040527; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Brown PH, 2002, PLANT BIOLOGY, V4, P205, DOI 10.1055/s-2002-25740; Parker MD, 2013, PHYSIOL REV, V93, P803, DOI 10.1152/physrev.00023.2012; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Dell B, 1997, PLANT SOIL, V193, P103, DOI 10.1023/A:1004264009230; Ishii T, 2001, PLANT PHYSIOL, V126, P1698, DOI 10.1104/pp.126.4.1698; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Iwai H, 2006, P NATL ACAD SCI USA, V103, P16592, DOI 10.1073/pnas.0605141103; Dordas C, 2000, PLANT PHYSIOL, V124, P1349, DOI 10.1104/pp.124.3.1349; Nakagawa Y, 2007, PLANT CELL, V19, P2624, DOI 10.1105/tpc.106.049015; ONeill MA, 1996, J BIOL CHEM, V271, P22923; Park M, 2004, MOL CELL, V16, P331, DOI 10.1016/j.molcel.2004.09.030; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Schmidt U, 2006, J CELL SCI, V119, P2321, DOI 10.1242/jcs.02943; Langowski L, 2010, CURR BIOL, V20, P904, DOI 10.1016/j.cub.2010.03.059; Bowen E. B., 1965, AM FERN J, V55, P67; De Michele R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00062; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Gomez-Porras JL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00167; HOFFMAN G. R., 1966, BRYOLOGIST, V69, P182; Lalonde S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00024; Leaungthitikanchana S, 2013, PLANT CELL PHYSIOL, V54, P1056, DOI 10.1093/pcp/pct059; Matsunaga T, 2004, PLANT PHYSIOL, V134, P339, DOI 10.1104/pp.103.030072; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; [Anonymous], 1991, METHOD ENZYMOL; Takano Junpei, 2010, Proc Natl Acad Sci U S A, V107, P5220, DOI 10.1073/pnas.0910744107; Wipf D, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00036; ZUCKERKANDL EMILE, 1965, P97	57	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	MAY	2015	56	5					852	862		10.1093/pcp/pcv011		11	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CJ2KS	WOS:000355313900004		
J	Suzuki, Y; Arae, T; Green, PJ; Yamaguchi, J; Chiba, Y				Suzuki, Yuya; Arae, Toshihiro; Green, Pamela J.; Yamaguchi, Junji; Chiba, Yukako			AtCCR4a and AtCCR4b are Involved in Determining the Poly(A) Length of Granule-bound starch synthase 1 Transcript and Modulating Sucrose and Starch Metabolism in Arabidopsis thaliana	PLANT AND CELL PHYSIOLOGY			English	Article						Arabidopsis thaliana; Carbon catabolite repressor 4; Granule-bound starch synthase 1; Poly(A) length; Sucrose and starch metabolism	MESSENGER-RNA DEADENYLATION; GENE-EXPRESSION; POSTEMBRYONIC DEVELOPMENT; SACCHAROMYCES-CEREVISIAE; PROCESSING BODIES; CCR4-NOT COMPLEX; STRESS GRANULES; TAIL LENGTH; PLANT; MECHANISMS	Removing the poly(A) tail is the first and rate-limiting step of mRNA degradation and apparently an effective step not only for modulating mRNA stability but also for translation of many eukaryotic transcripts. Carbon catabolite repressor 4 (CCR4) has been identified as a major cytoplasmic deadenylase in Saccharomyces cerevisiae. The Arabidopsis thaliana homologs of the yeast CCR4, AtCCR4a and AtCCR4b, were identified by sequence-based analysis; however, their role and physiological significance in plants remain to be elucidated. In this study, we revealed that AtCCR4a and AtCCR4b are localized to cytoplasmic mRNA processing bodies, which are specific granules consisting of many enzymes involved in mRNA turnover. Double mutants of AtCCR4a and AtCCR4b exhibited tolerance to sucrose application but not to glucose. The levels of sucrose in the seedlings of the atccr4a/4b double mutants were reduced, whereas no difference was observed in glucose levels. Further, amylose levels were slightly but significantly increased in the atccr4a/4b double mutants. Consistent with this observation, we found that the transcript encoding granule-bound starch synthase 1 (GBSS1), which is responsible for amylose synthesis, is accumulated to a higher level in the atccr4a/4b double mutant plants than in the control plants. Moreover, we revealed that GBSS1 has a longer poly(A) tail in the double mutant than in the control plant, suggesting that AtCCR4a and AtCCR4b can influence the poly(A) length of transcripts related to starch metabolism. Our results collectively suggested that AtCCR4a and AtCCR4b are involved in sucrose and starch metabolism in A. thaliana.	[Suzuki, Yuya; Arae, Toshihiro; Yamaguchi, Junji; Chiba, Yukako] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Green, Pamela J.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA; [Yamaguchi, Junji; Chiba, Yukako] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan; [Chiba, Yukako] JST PRESTO, Kawaguchi, Saitama 3320012, Japan	Chiba, Y (reprint author), Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan.	yukako@mail.sci.hokudai.ac.jp			Japan Science and Technology Agency; Japan Society for the Promotion of Science [13J00043]; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [25119702]; National Science Foundation [MCB-0445638, MCB-1021636]	This work was supported by the the Japan Science and Technology Agency [Precursory Research for Embryonic Science and Technology to Y.C.]; the Japan Society for the Promotion of Science [a Grant-in-Aid for JSPS Fellows (No. 13J00043 to Y.S.)]; the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [Grants-in-Aid for Scientific Research on Innovative Areas; 'Power to Overcome the Environment' (No. 25119702 to Y.C.)]; the National Science Foundation [MCB-0445638, MCB-1021636 to P.J.G.].	Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Ho SL, 2001, PLANT PHYSIOL, V125, P877, DOI 10.1104/pp.125.2.877; Weber C, 2008, PLANT J, V56, P517, DOI 10.1111/j.1365-313X.2008.03623.x; Hostettler C, 2011, METHODS MOL BIOL, V775, P387, DOI 10.1007/978-1-61779-237-3_21; Chiba Y, 2009, J PLANT BIOL, V52, P114, DOI 10.1007/s12374-009-9021-2; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Araya T, 2006, PLANT CELL PHYSIOL, V47, P644, DOI 10.1093/pep/pcj033; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Cevher MA, 2010, EMBO J, V29, P1674, DOI 10.1038/emboj.2010.59; Kedersha N, 2005, J CELL BIOL, V169, P871; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Wagner E, 2007, MOL CELL BIOL, V27, P1686, DOI 10.1128/MCB.01483-06; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Iwasaki S, 2007, FEBS LETT, V581, P2455, DOI 10.1016/j.febslet.2007.04.051; Kojima S, 2012, GENE DEV, V26, P2724, DOI 10.1101/gad.208306.112; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Morris JZ, 2005, DEVELOPMENT, V132, P1165, DOI 10.1242/dev.01672; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Li N, 2011, PLANTA, V233, P241, DOI 10.1007/s00425-010-1296-5; Chiba Y, 2013, PLANT CELL PHYSIOL, V54, P180, DOI 10.1093/pcp/pcs164; Perez-Ortin JE, 2007, TRENDS GENET, V23, P250, DOI 10.1016/j.tig.2007.03.006; Wang H, 2010, EMBO J, V29, P2566, DOI 10.1038/emboj.2010.152; Smith AM, 2012, STARCH-STARKE, V64, P421, DOI 10.1002/star.201100163; Assenholt J, 2011, RNA, V17, P1788, DOI 10.1261/rna.2919911; Banks W. D., 1980, BIOCH PLANTS, V3, P321; Bogamuwa SP, 2014, PLANT CELL PHYSIOL, V55, P1367, DOI 10.1093/pcp/pcu074; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Cheng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030088; Chiba Y, 2004, GENE, V328, P95, DOI 10.1016/j.gene.2003.11.028; Cho YH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001263; Clarke BR, 1999, PLANTA, V209, P324, DOI 10.1007/s004250050639; Dupressoir A, 2001, BMC Genomics, V2, P9, DOI 10.1186/1471-2164-2-9; Hirayama T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3247; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Liang WX, 2009, CELL RES, V19, P307, DOI 10.1038/cr.2008.317; Morita-Yamamuro C, 2005, PLANT CELL PHYSIOL, V46, P902, DOI 10.1093/pcp/pci095; Nagarajan VK, 2013, BBA-GENE REGUL MECH, V1829, P590, DOI 10.1016/j.bbagrm.2013.03.005; Reverdatto SV, 2004, RNA, V10, P1200, DOI 10.1261/rna.7540204; Rook F, 2003, J EXP BOT, V54, P495, DOI 10.1093/jxb/erg054; SHEU JJ, 1994, PLANT J, V5, P655, DOI 10.1111/j.1365-313X.1994.00655.x; Viswanathan P, 2003, J BIOL CHEM, V278, P14949, DOI 10.1074/jbc.M211794200; von Arnim A. G., 2013, ARABIDOPSIS BOOK, pe0165; Walley JW, 2010, PLANT PHYSIOL, V152, P866, DOI 10.1104/pp.109.149005; Xu Kun, 2014, Frontiers in Genetics, V5, DOI 10.3389/fgene.2014.00137	54	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	MAY	2015	56	5					863	874		10.1093/pcp/pcv012		12	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CJ2KS	WOS:000355313900005		
J	Kaneko, T; Horie, T; Nakahara, Y; Tsuji, N; Shibasaka, M; Katsuhara, M				Kaneko, Toshiyuki; Horie, Tomoaki; Nakahara, Yoshiki; Tsuji, Nobuya; Shibasaka, Mineo; Katsuhara, Maki			Dynamic Regulation of the Root Hydraulic Conductivity of Barley Plants in Response to Salinity/Osmotic Stress	PLANT AND CELL PHYSIOLOGY			English	Article						Aquaporin; Barley; Osmotic stress; Root hydraulic conductivity; Salinity stress; Water transport	PLASMA-MEMBRANE AQUAPORINS; WATER CHANNEL ACTIVITY; SALT TOLERANCE; ARABIDOPSIS ROOTS; TRANSPORT; CELLS; PHOSPHORYLATION; PERMEABILITY; MECHANISMS; PHYSIOLOGY	Salinity stress significantly reduces the root hydraulic conductivity (Lp(r)) of several plant species including barley (Hordeum vulgare). Here we characterized changes in the Lp(r) of barley plants in response to salinity/osmotic stress in detail using a pressure chamber. Salt-tolerant and intermediate barley cultivars, K305 and Haruna-nijyo, but not a salt-sensitive cultivar, I743, exhibited characteristic time-dependent Lp(r) changes induced by 100 mM NaCl. An identical response was evoked by isotonic sorbitol, indicating that this phenomenon was triggered by osmotic imbalances. Further examination of this mechanism using barley cv. Haruna-nijyo plants in combination with the use of various inhibitors suggested that various cellular processes such as protein phosphorylation/dephosphorylation and membrane internalization appear to be involved. Interestingly, the three above-mentioned barley cultivars did not exhibit a remarkable difference in root cell sap osmolality under hypertonic conditions, in contrast to the case of Lp(r). The possible biological significance of the regulation of Lp(r) in barley plants upon salinity/osmotic stress is discussed.	[Kaneko, Toshiyuki; Horie, Tomoaki; Nakahara, Yoshiki; Tsuji, Nobuya; Shibasaka, Mineo; Katsuhara, Maki] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan; [Kaneko, Toshiyuki] Asahikawa Med Univ, Dept Physiol, Asahikawa, Hokkaido 0788510, Japan; [Horie, Tomoaki] Shinshu Univ, Fac Text Sci & Technol, Div Appl Biol, Ueda, Nagano 3868567, Japan	Katsuhara, M (reprint author), Okayama Univ, Inst Plant Sci & Resources, 20-1,Chuo 2 Chome, Kurashiki, Okayama 7100046, Japan.	kmaki@rib.okayama-u.ac.jp			Program for Promotion of Basic Research Activities for Innovative Biosciences; Ministry of Education, Culture, Sports, Science and Technology, Japan [25119709]	This work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences [to M.K]; the Ministry of Education, Culture, Sports, Science and Technology, Japan [grant No. 25119709 to T.H.].	Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Horie T, 2011, PLANT CELL PHYSIOL, V52, P663, DOI 10.1093/pcp/pcr027; Van Wilder V, 2008, PLANT CELL PHYSIOL, V49, P1364, DOI 10.1093/pcp/pcn112; Hauser F, 2010, PLANT CELL ENVIRON, V33, P552, DOI 10.1111/j.1365-3040.2009.02056.x; Peyrano G, 1997, PLANT PHYSIOL BIOCH, V35, P387; Li XJ, 2011, PLANT CELL, V23, P3780, DOI 10.1105/tpc.111.091454; Prak S, 2008, MOL CELL PROTEOMICS, V7, P1019, DOI 10.1074/mcp.M700566-MCP200; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Maurel C, 2001, PLANT PHYSIOL, V125, P135, DOI 10.1104/pp.125.1.135; ZHANG WH, 1991, AUST J PLANT PHYSIOL, V18, P603; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Lee HK, 2009, PLANT CELL, V21, P622, DOI 10.1105/tpc.108.061994; Emans N, 2002, PLANT CELL, V14, P71, DOI 10.1105/tpc.010339; Katsuhara M, 2011, SOIL SCI PLANT NUTR, V57, P50, DOI 10.1080/00380768.2010.541870; Leshem Y, 2007, PLANT J, V51, P185, DOI 10.1111/j.1365-313X.2007.03134.x; STEUDLE E, 1983, PLANTA, V158, P237, DOI 10.1007/BF01075260; Lee SH, 2012, PLANT PHYSIOL, V159, P479, DOI 10.1104/pp.112.194506; Boursiac Y, 2008, PLANT J, V56, P207, DOI 10.1111/j.1365-313X.2008.03594.x; Carvajal M, 1999, PHYSIOL PLANTARUM, V105, P95, DOI 10.1034/j.1399-3054.1999.105115.x; Luu DT, 2012, PLANT J, V69, P894, DOI 10.1111/j.1365-313X.2011.04841.x; AZAIZEH H, 1991, PLANT PHYSIOL, V97, P1136, DOI 10.1104/pp.97.3.1136; NAGAO T, 1987, PLANT CELL PHYSIOL, V28, P1181; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Vera-Estrella R, 2004, PLANT PHYSIOL, V135, P2318, DOI 10.1104/pp.104.044891; Aroca R, 2012, J EXP BOT, V63, P43, DOI 10.1093/jxb/err266; Hachez C, 2014, PLANT CELL, V26, P3132, DOI 10.1105/tpc.114.127159; Johansson I, 1998, PLANT CELL, V10, P451; Horie T, 2009, TRENDS PLANT SCI, V14, P660, DOI 10.1016/j.tplants.2009.08.009; Zelazny E, 2007, P NATL ACAD SCI USA, V104, P12359, DOI 10.1073/pnas.0701180104; Besserer A, 2012, PLANT CELL, V24, P3463, DOI 10.1105/tpc.112.101758; Li GW, 2014, BBA-GEN SUBJECTS, V1840, P1574, DOI 10.1016/j.bbagen.2013.11.004; Tyerman SD, 1999, J EXP BOT, V50, P1055, DOI 10.1093/jexbot/50.suppl_1.1055; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; Kjellbom P, 1999, TRENDS PLANT SCI, V4, P308, DOI 10.1016/S1360-1385(99)01438-7; Hachez C, 2006, BBA-BIOMEMBRANES, V1758, P1142, DOI 10.1016/j.bbamem.2006.02.017; BERNSTEIN L, 1958, ANNU REV PLANT PHYS, V9, P25, DOI 10.1146/annurev.pp.09.060158.000325; Horie T, 2012, RICE, V5, DOI 10.1186/1939-8433-5-11; Ito M., 2012, PLANT J, V69, P204; Kaneko T, 2009, J MEMBRANE BIOL, V228, P33, DOI 10.1007/s00232-009-9156-6; Katsuhara M, 2002, PLANT CELL PHYSIOL, V43, P885, DOI 10.1093/pcp/pcf102; Ligaba A, 2010, J PLANT RES, V123, P105, DOI 10.1007/s10265-009-0272-2; Mano Y., 1996, STUDIES BREEDING EVA, V2, P1; Martinez-Ballesta MC, 2003, J PLANT PHYSIOL, V160, P689; Martinez-Ballesta MD, 2000, AUST J PLANT PHYSIOL, V27, P685, DOI 10.1071/PP99203; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Ohshima Y, 2001, PLANT CELL PHYSIOL, V42, P1119, DOI 10.1093/pcp/pce141; Robinson G. R., 2008, PLANT PHYSIOL, V147, P1482; Shibasaka M., 2012, PLANT SIGNAL BEHAV, V7, P1; Tazawa M, 1996, BOT ACTA, V109, P388; Verdoucq L, 2014, CURR OPIN PLANT BIOL, V22, P101, DOI 10.1016/j.pbi.2014.09.011	55	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	MAY	2015	56	5					875	882		10.1093/pcp/pcv013		8	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CJ2KS	WOS:000355313900006		
J	Kusama, Y; Inoue, S; Jimbo, H; Takaichi, S; Sonoike, K; Hihara, Y; Nishiyama, Y				Kusama, Yuri; Inoue, Shuhei; Jimbo, Haruhiko; Takaichi, Shinichi; Sonoike, Kintake; Hihara, Yukako; Nishiyama, Yoshitaka			Zeaxanthin and Echinenone Protect the Repair of Photosystem II from Inhibition by Singlet Oxygen in Synechocystis sp PCC 6803	PLANT AND CELL PHYSIOLOGY			English	Article						Echinenone; Orange carotenoid protein; Photoinhibition; Photosystem II; Singlet oxygen; Zeaxanthin	ELONGATION-FACTOR-G; LOW-TEMPERATURE PHOTOINHIBITION; SP PCC-6803; PHOTOSYNTHETIC MACHINERY; CAROTENOID PROTEIN; OXIDATIVE STRESS; MEMBRANE-LIPIDS; ENVIRONMENTAL-STRESS; ESCHERICHIA-COLI; ALPHA-TOCOPHEROL	Carotenoids are important components of antioxidative systems in photosynthetic organisms. We investigated the roles of zeaxanthin and echinenone in the protection of PSII from photoinhibition in Synechocystis sp. PCC 6803, using mutants of the cyanobacterium that lack these carotenoids. The activity of PSII in mutant cells deficient in either zeaxanthin or echinenone was more sensitive to strong light than the activity in wild-type cells, and the activity in mutant cells deficient in both carotenoids was hypersensitive to strong light, indicating that the absence of these carotenoids increased the extent of photoinhibition. Nonetheless, the rate of photodamage to PSII, as measured in the presence of chloramphenicol, which blocks the repair of PSII, was unaffected by the absence of either carotenoid, suggesting that these carotenoids might act by protecting the repair of PSII. Knockout of the gene for the so-called orange carotenoid protein (OCP), in which the 3'-hydroxyechinenone cofactor, a derivative of echinenone, is responsible for the thermal dissipation of excitation energy, increased the extent of photoinhibition but did not affect photodamage, suggesting that thermal dissipation also protects the repair of PSII. In mutant cells lacking OCP, as well as those lacking zeaxanthin and echinenone, the production of singlet oxygen was stimulated and the synthesis de novo of various proteins, including the D1 protein, was markedly suppressed under strong light. These observations suggest that the carotenoids and thermal dissipation might protect the repair of photodamaged PSII by depressing the levels of singlet oxygen that inhibits protein synthesis.	[Kusama, Yuri; Inoue, Shuhei; Jimbo, Haruhiko; Hihara, Yukako; Nishiyama, Yoshitaka] Saitama Univ, Dept Biochem & Mol Biol, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; [Takaichi, Shinichi] Nippon Med Sch, Dept Biol, Musashino, Tokyo 1800023, Japan; [Sonoike, Kintake] Waseda Univ, Fac Educ & Integrated Arts & Sci, Shinjuku Ku, Tokyo 1628480, Japan; [Hihara, Yukako; Nishiyama, Yoshitaka] Saitama Univ, Inst Environm Sci & Technol, Sakura Ku, Saitama 3388570, Japan	Nishiyama, Y (reprint author), Saitama Univ, Dept Biochem & Mol Biol, Grad Sch Sci & Engn, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	nishiyama@molbiol.saitama-u.ac.jp	Hihara, Yukako/E-3461-2010; Sonoike, Kintake/E-3699-2010	Sonoike, Kintake/0000-0002-5327-473X	Japan Society for the Promotion of Science [24570039, 25119704]	This work was supported by the Japan Society for the Promotion of Science [Grants-in-Aid for Scientific Research (Nos. 24570039 and 25119704 to Y.N.)].	Vass I, 2012, BBA-BIOENERGETICS, V1817, P209, DOI 10.1016/j.bbabio.2011.04.014; Tyystjarvi E, 1996, P NATL ACAD SCI USA, V93, P2213, DOI 10.1073/pnas.93.5.2213; Sarvikas P, 2006, PLANT CELL PHYSIOL, V47, P391, DOI 10.1093/pcp/pcj006; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; El Bissati K, 2000, BBA-BIOENERGETICS, V1457, P229, DOI 10.1016/S0005-2728(00)00104-3; Nishiyama Y, 2004, BIOCHEMISTRY-US, V43, P11321, DOI 10.1021/bi036178q; Schafer L, 2005, J PHOTOCH PHOTOBIO B, V78, P195, DOI 10.1016/j.jphotobiol.2004.11.007; MOON BY, 1995, P NATL ACAD SCI USA, V92, P6219, DOI 10.1073/pnas.92.14.6219; Kojima K, 2009, J BIOL CHEM, V284, P18685, DOI 10.1074/jbc.M109.015131; Zhu YH, 2010, ARCH BIOCHEM BIOPHYS, V504, P86, DOI 10.1016/j.abb.2010.07.007; Wilson A, 2008, P NATL ACAD SCI USA, V105, P12075, DOI 10.1073/pnas.0804636105; Nishiyama Y, 2014, APPL MICROBIOL BIOT, V98, P8777, DOI 10.1007/s00253-014-6020-0; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Takaichi S, 2007, CELL MOL LIFE SCI, V64, P2607, DOI 10.1007/s00018-007-7190-z; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; GOMBOS Z, 1994, P NATL ACAD SCI USA, V91, P8787, DOI 10.1073/pnas.91.19.8787; WADA H, 1994, P NATL ACAD SCI USA, V91, P4273, DOI 10.1073/pnas.91.10.4273; Bersanini L, 2014, PLANT PHYSIOL, V164, P805, DOI 10.1104/pp.113.231969; Hakala M, 2005, BBA-BIOENERGETICS, V1706, P68, DOI 10.1016/j.bbabio.2004.09.001; Takahashi S, 2009, PLANT PHYSIOL, V149, P1560, DOI 10.1104/pp.108.134122; Anderson JM, 2002, PHILOS T ROY SOC B, V357, P1421, DOI 10.1098/rstb.2002.1138; Inoue S, 2011, BBA-BIOENERGETICS, V1807, P236, DOI 10.1016/j.bbabio.2010.11.003; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Hideg E, 2007, PHYSIOL PLANTARUM, V131, P33, DOI 10.1111/j.1399-3054.2007.00913.x; Punginelli C, 2009, BBA-BIOENERGETICS, V1787, P280, DOI 10.1016/j.bbabio.2009.01.011; Ogawa T, 2013, PLANT CELL PHYSIOL, V54, P1164, DOI 10.1093/pcp/pct068; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Tyystjarvi E, 2013, INT REV CEL MOL BIO, V300, P243, DOI 10.1016/B978-0-12-405210-9.00007-2; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Murata N, 2012, BBA-BIOENERGETICS, V1817, P1127, DOI 10.1016/j.bbabio.2012.02.020; Young AJ, 1996, J PHOTOCH PHOTOBIO B, V36, P3, DOI 10.1016/S1011-1344(96)07397-6; Ohnishi N, 2005, BIOCHEMISTRY-US, V44, P8494, DOI 10.1021/bi047518q; Rehman AU, 2013, BBA-BIOENERGETICS, V1827, P689, DOI 10.1016/j.bbabio.2013.02.016; Sonoike K, 2001, PLANT CELL PHYSIOL, V42, P379, DOI 10.1093/pcp/pce046; Sedoud A, 2014, PLANT CELL, V26, P1781, DOI 10.1105/tpc.114.123802; Keren N, 1997, P NATL ACAD SCI USA, V94, P1579, DOI 10.1073/pnas.94.4.1579; Kerfeld CA, 2003, STRUCTURE, V11, P55, DOI 10.1016/S0969-2126(02)00936-X; Takaichi S, 2001, PLANT CELL PHYSIOL, V42, P756, DOI 10.1093/pcp/pce098; Bugos RC, 1996, P NATL ACAD SCI USA, V93, P6320, DOI 10.1073/pnas.93.13.6320; Allakhverdiev SI, 2004, BBA-BIOENERGETICS, V1657, P23, DOI 10.1016/j.bbabio.2004.03.003; Graham JE, 2008, J NAT PROD, V71, P1647, DOI 10.1021/np800310b; Hakkila K, 2014, BBA-BIOENERGETICS, V1837, P217, DOI 10.1016/j.bbabio.2013.11.011; Kojima K, 2007, MOL MICROBIOL, V65, P936, DOI 10.1111/j.1365-2958.2007.05836.x; LIDHOLM J, 1987, PLANT CELL PHYSIOL, V28, P1133; Mochimaru M, 2008, J BACTERIOL, V190, P6726, DOI 10.1128/JB.01881-07; Nagano T, 2012, J BIOL CHEM, V287, P28697, DOI 10.1074/jbc.M112.378067; Sozer O, 2010, PLANT CELL PHYSIOL, V51, P823, DOI 10.1093/pcp/pcq031	54	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	MAY	2015	56	5					906	916		10.1093/pcp/pcv018		11	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CJ2KS	WOS:000355313900009		
J	Fujimaki, S; Maruyama, T; Suzui, N; Kawachi, N; Miwa, E; Higuchi, K				Fujimaki, Shu; Maruyama, Teppei; Suzui, Nobuo; Kawachi, Naoki; Miwa, Eitaro; Higuchi, Kyoko			Base to Tip and Long-Distance Transport of Sodium in the Root of Common Reed [Phragmites australis (Cav.) Trin. ex Steud.] at Steady State Under Constant High-Salt Conditions	PLANT AND CELL PHYSIOLOGY			English	Article						Common reed; Na; PETIS; Phloem; Salt tolerance; Xylem	NA+ EXCLUSION; SALINITY TOLERANCE; KEY DETERMINANTS; SHOOT BASE; PLANTS; RICE; ARABIDOPSIS; GENES; WHEAT; PHLOEM	We analyzed the directions and rates of translocation of sodium ions (Na+) within tissues of a salt-tolerant plant, common reed [Phragmites australis (Cav.) Trin. ex Steud.], and a salt-sensitive plant, rice (Oryza sativa L.), under constant high-salt conditions using radioactive Na-22 tracer and a positron-emitting tracer imaging system (PETIS). First, the test plants were incubated in a nutrient solution containing 50 mM NaCl and a trace level of Na-22 for 24 h (feeding step). Then the original solution was replaced with a fresh solution containing 50 mM NaCl but no Na-22, in which the test plants remained for > 48 h (chase step). Non-invasive dynamic visualization of Na-22 distribution in the test plants was conducted during feeding and chase steps with PETIS. Our results revealed that Na-22 was absorbed in the roots of common reed, but not transported to the upper shoot beyond the shoot base. During the chase step, a basal to distal movement of Na-22 was detected within the root tissue over > 5 cm with a velocity of approximately 0.5 cm h(-1). On the other hand, Na-22 that was absorbed in the roots of rice was continuously translocated to and accumulated in the whole shoot. We concluded that the basal roots and the shoot base of common reed have constitutive functions of Na+ exclusion only in the direction of root tips, even under constant high-salt conditions. This function apparently may contribute to the low Na+ concentration in the upper shoot and high salt tolerance of common reed.	[Fujimaki, Shu; Suzui, Nobuo; Kawachi, Naoki] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Takasaki, Gumma 3701292, Japan; [Maruyama, Teppei; Miwa, Eitaro; Higuchi, Kyoko] Tokyo Univ Agr, Dept Appl Biol & Chem, Lab Plant Prod Chem, Setagaya Ku, Tokyo 1568502, Japan	Higuchi, K (reprint author), Tokyo Univ Agr, Dept Appl Biol & Chem, Lab Plant Prod Chem, Setagaya Ku, 1-1-1 Sakuragaoka, Tokyo 1568502, Japan.	khiguchi@nodai.ac.jp	Suzui, Nobuo/C-5855-2013	Suzui, Nobuo/0000-0003-1081-7578	Ministry of Education, Culture, Sports, Science, and Technology, Japan [18658028, 21380049]	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology, Japan [Grant-in-Aid for Scientific Research grant Nos. 18658028 and 21380049 to K.H.].	Kanai M, 2007, NEW PHYTOL, V176, P572, DOI 10.1111/j.1469-8137.2007.02188.x; Huang S, 2008, J EXP BOT, V59, P927, DOI 10.1093/jxb/ern033; Davenport RJ, 2007, PLANT CELL ENVIRON, V30, P497, DOI 10.1111/j.1365-3040.2007.01637.x; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Fujimaki S, 2010, PLANT PHYSIOL, V152, P1796, DOI 10.1104/pp.109.151035; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; James RA, 2006, PLANT PHYSIOL, V142, P1537, DOI 10.1104/pp.106.086538; Horie T, 2009, TRENDS PLANT SCI, V14, P660, DOI 10.1016/j.tplants.2009.08.009; Platten JD, 2006, TRENDS PLANT SCI, V11, P372, DOI 10.1016/j.tplants.2006.06.001; Kong XQ, 2012, J EXP BOT, V63, P2105, DOI 10.1093/jxb/err420; Moller IS, 2007, TRENDS PLANT SCI, V12, P534, DOI 10.1016/j.tplants.2007.09.009; MATSUSHITA N, 1991, PHYSIOL PLANTARUM, V83, P170, DOI 10.1034/j.1399-3054.1991.830126.x; Uchida H, 2004, NUCL INSTRUM METH A, V516, P564, DOI 10.1016/j.nima.2003.08.165; Lohaus G, 2000, J EXP BOT, V51, P1721, DOI 10.1093/jexbot/51.351.1721; Takahashi R, 2009, J PLANT PHYSIOL, V166, P301, DOI 10.1016/j.jplph.2008.04.002; Olias R, 2009, PLANT CELL ENVIRON, V32, P904, DOI 10.1111/j.1365-3040.2009.01971.x; Blom-Zandstra M, 1998, J EXP BOT, V49, P1863, DOI 10.1093/jexbot/49.328.1863; Fritz M, 2013, PLANT CELL ENVIRON, V36, P1860, DOI 10.1111/pce.12095; Fujikake H, 2003, J EXP BOT, V54, P1379, DOI 10.1093/jxb/erg147; MARSCHNER H., 1995, MINERAL NUTR HIGHER; MATSUSHITA N, 1992, SOIL SCI PLANT NUTR, V38, P565; Sunarpi H. T., 2005, PLANT J, V44, P928, DOI DOI 10.1111/J.1365-313X.2005.02595.X; Takahashi R, 2007, J EXP BOT, V58, P4387, DOI 10.1093/jxb/erm306; WOLF O, 1990, J EXP BOT, V41, P1133, DOI 10.1093/jxb/41.9.1133	25	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	MAY	2015	56	5					943	950		10.1093/pcp/pcv021		8	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CJ2KS	WOS:000355313900012		
J	Kamau, PK; Sano, S; Takami, T; Matsushima, R; Maekawa, M; Sakamoto, W				Kamau, Peter K.; Sano, Shingo; Takami, Tsuneaki; Matsushima, Ryo; Maekawa, Masahiko; Sakamoto, Wataru			A Mutation in GIANT CHLOROPLAST Encoding a PARC6 Homolog Affects Spikelet Fertility in Rice	PLANT AND CELL PHYSIOLOGY			English	Article						Chloroplast; Division ring; GIANT CHLOROPLAST; Monocots; Oryza sativa; PARC6	DIVISION PROTEIN FTSZ; ORYZA-SATIVA L.; PLASTID-DIVISION; CELL-DIVISION; HIGHER-PLANTS; ESCHERICHIA-COLI; Z-RING; PHYSCOMITRELLA-PATENS; ARABIDOPSIS-THALIANA; GENE FAMILIES	Chloroplasts are not generated de novo but proliferate from a pre-existing population of plastids present in meristematic cells. Chloroplast division is executed by the co-ordinated action of at least two molecular machineries: internal machinery located on the stromal side of the inner envelope membrane and external machinery located on the cytosolic side of the outer envelope membrane. To date, molecular studies of chloroplast division in higher plants have been limited to several species such as Arabidopsis. To elucidate chloroplast division in rice, we performed forward genetics and isolated a mutant displaying large chloroplasts among an ethyl methanesulfonate (EMS)-mutagenized Oryza sativa spp japonica Nipponbare population. Using a map-based approach, this mutation, termed giant chloroplast (gic), was allocated in a gene that encodes a protein that is homologous to Paralog of ARC6 (PARC6), which is known to play a role in chloroplast division. GIC is unique in that it has a long C-terminal extension that is not present in other PARC6 homologs. Characterization of gic phenotypes in a rice field showed that gic exhibited defective growth in seed setting, suggesting that the gic mutant negatively affects the reproductive stage. This report is the first describing a chloroplast division mutant in monocotyledons and its effect on plant development.	[Kamau, Peter K.; Sano, Shingo; Takami, Tsuneaki; Matsushima, Ryo; Maekawa, Masahiko; Sakamoto, Wataru] Okayama Univ, IPSR, Kurashiki, Okayama 7100046, Japan	Sakamoto, W (reprint author), Okayama Univ, IPSR, Kurashiki, Okayama 7100046, Japan.	saka@okayama-u.ac.jp	Sakamoto, Wataru/J-5588-2015		Japan Society for the Promotion of Science [22380007]; Ministry of Education, Culture, Sports, Science and Technology [NC-CARP]; Oohara Foundation	This work was supported by the Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research (No. 22380007 to W.S.)]; the Ministry of Education, Culture, Sports, Science and Technology [Grant-in-Aid from the NC-CARP project (to W.S.)]; the Oohara Foundation [to W.S.].	Aldridge C, 2005, J EXP BOT, V56, P1061, DOI 10.1093/jxb/eri118; Schmitz AJ, 2009, MOL PLANT, V2, P1211, DOI 10.1093/mp/ssp077; Sakamoto W, 2014, J EXP BOT, V65, P3835, DOI 10.1093/jxb/eru091; Glynn JM, 2009, PLANT J, V59, P700, DOI 10.1111/j.1365-313X.2009.03905.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038//nrm1745; Olson BJSC, 2010, J BIOL CHEM, V285, P20634, DOI 10.1074/jbc.M110.122614; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Glynn JM, 2007, TRAFFIC, V8, P451, DOI 10.1111/j.1600-0854.2007.00545.x; Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; Jeong WJ, 2002, PLANT PHYSIOL, V129, P112, DOI 10.1104/pp.000588; Maple J, 2002, PLANT J, V31, P269, DOI 10.1046/j.1365-313X.2002.01358.x; Wilson ME, 2011, PLANT CELL, V23, P2939, DOI 10.1105/tpc.111.088112; PYKE KA, 1994, PLANT PHYSIOL, V104, P201; Himmelbach A, 2007, PLANT PHYSIOL, V145, P1192, DOI 10.1104/pp.107.111575; Yoshida Y, 2006, SCIENCE, V313, P1435, DOI 10.1126/science.1129689; Matsushima R, 2010, PLANT CELL PHYSIOL, V51, P728, DOI 10.1093/pcp/pcq040; Glynn JM, 2008, PLANT CELL, V20, P2460, DOI 10.1105/tpc.108.061440; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; Koniger M, 2008, J EXP BOT, V59, P2285, DOI 10.1093/jxb/ern099; Miyagishima S, 2011, PLANT PHYSIOL, V155, P1533, DOI 10.1104/pp.110.170688; Osteryoung KW, 2014, ANNU REV PLANT BIOL, V65, P443, DOI 10.1146/annurev-arplant-050213-035748; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; PYKE KA, 1994, PLANT PHYSIOL, V106, P1169; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Zhang M, 2013, PLANT CELL, V25, P1787, DOI 10.1105/tpc.113.111047; Emanuelsson O, 1999, PROTEIN SCI, V8, P978; Pyke KA, 1999, PLANT CELL, V11, P549, DOI 10.1105/tpc.11.4.549; Stokes KD, 2003, GENE, V320, P97, DOI 10.1016/S0378-1119(03)00814-X; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Yang Y, 2008, CURR OPIN PLANT BIOL, V11, P577, DOI 10.1016/j.pbi.2008.10.001; Matsushima R, 2014, PLANT PHYSIOL, V164, P623, DOI 10.1104/pp.113.229591; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; TerBush AD, 2012, J CELL BIOL, V199, P623, DOI 10.1083/jcb.201205114; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754; Colletti KS, 2000, CURR BIOL, V10, P507, DOI 10.1016/S0960-9822(00)00466-8; Vitha S, 2003, PLANT CELL, V15, P1918, DOI 10.1105/tpc.013292; Okazaki K, 2009, PLANT CELL, V21, P1769, DOI 10.1105/tpc.109.067785; Miyagishima SY, 2006, PLANT CELL, V18, P2517, DOI 10.1105/tpc.106.045484; Kasahara M, 2002, NATURE, V420, P829, DOI 10.1038/nature01213; Maple J, 2007, EMBO REP, V8, P293, DOI 10.1038/sj.embor.7400902; Vitha S, 2001, J CELL BIOL, V153, P111, DOI 10.1083/jcb.153.1.111; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Osteryoung KW, 1998, PLANT CELL, V10, P1991, DOI 10.1105/tpc.10.12.1991; Austin I.I.J., 2005, PHOTOSYNTH RES, V85, P373; Bart R., 2006, PLANT METHODS, V2, P1; BI E, 1991, RES MICROBIOL, V142, P249, DOI 10.1016/0923-2508(91)90037-B; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Hayashida A, 2005, PLANT BIOLOGY, V7, P300, DOI 10.1055/s-2005-837691; LEECH RM, 1981, NEW PHYTOL, V87, P1, DOI 10.1111/j.1469-8137.1981.tb01686.x; Machida M, 2006, P NATL ACAD SCI USA, V103, P6753, DOI 10.1073/pnas.0510693103; Maple J, 2007, ANN BOT-LONDON, V99, P565, DOI 10.1093/aob/mcl249; Maple J, 2010, BIOCHEM SOC T, V38, P783, DOI 10.1042/BST0380783; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, P192, DOI DOI 10.1093/NAR/KG2; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; PLATTALOIA KA, 1977, NEW PHYTOL, V78, P599, DOI 10.1111/j.1469-8137.1977.tb02163.x; Pyke KA, 2013, PLANTA, V237, P381, DOI 10.1007/s00425-012-1739-2; Sakamoto Wataru, 2008, Arabidopsis Book, V6, pe0110, DOI 10.1199/tab.0110; Sugita C, 2012, PLANT CELL PHYSIOL, V53, P1124, DOI 10.1093/pcp/pcs058; Yun MS, 2009, PLANT CELL PHYSIOL, V50, P1617, DOI 10.1093/pcp/pcp104; Zhang M, 2009, CELL RES, V19, P877, DOI 10.1038/cr.2009.78	66	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	MAY	2015	56	5					977	991		10.1093/pcp/pcv024		15	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CJ2KS	WOS:000355313900015		
J	Yamada, Y; Motomura, Y; Sato, F				Yamada, Yasuyuki; Motomura, Yukiya; Sato, Fumihiko			CjbHLH1 homologs regulate sanguinarine biosynthesis in Eschscholzia californica cells	PLANT AND CELL PHYSIOLOGY			English	Article						Basic helix-loop-helix; Eschscholzia californica (California poppy); Isoquinoline alkaloids; Transcriptional regulation	BENZYLISOQUINOLINE ALKALOID BIOSYNTHESIS; COPTIS-JAPONICA CELLS; MOLECULAR-CLONING; TRANSCRIPTION FACTORS; NORCOCLAURINE 6-O-METHYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; NICOTINE BIOSYNTHESIS; CULTURED-CELLS; OPIUM POPPY; ENZYME	Isoquinoline alkaloids (IQAs), terpenoid indole alkaloid and nicotine are some of the most studied alkaloids. Recently, several groups have reported that the biosynthesis of these alkaloids is regulated by basic helix-loop-helix (bHLH) transcription factors. Whereas the biosyntheses of nicotine and terpenoid indole alkaloid in Nicotiana plants and Catharanthus roseus are directly or indirectly regulated by Arabidopsis thaliana MYC2 homologs, a non-MYC2-type bHLH transcription factor, CjbHLH1, comprehensively regulates berberine biosynthesis in Coptis japonica. Interestingly, CjbHLH1 homologous genes were found in many IQA-producing plant species, which suggests that non-MYC2-type CjbHLH homologs are specifically associated with IQA biosynthesis. To test whether CjbHLH1 homologs are involved in the biosynthesis of IQA in a plant other than C. japonica, we isolated two genes homologous to CjbHLH1, i.e. EcbHLH1-1 and EcbHLH1-2, from Eschscholzia californica (California poppy). Stable transformants in which the expression levels of EcbHLH1 genes were constitutively suppressed by RNA interference (RNAi) showed a reduced expression of some IQA biosynthetic enzyme genes. A metabolite analysis confirmed that the suppression of EcbHLH1, particularly EcbHLH1-2, caused a decrease in sanguinarine accumulation in transgenic cultured cells. These results indicate that non-MYC2-type EcbHLH1s regulate IQA biosynthesis in California poppy like CjbHLH1 in C. japonica.	[Yamada, Yasuyuki; Motomura, Yukiya; Sato, Fumihiko] Kyoto Univ, Grad Sch Biostudies, Dept Plant Gene & Totipotency, Sakyo Ku, Kyoto 6068502, Japan	Sato, F (reprint author), Kyoto Univ, Grad Sch Biostudies, Dept Plant Gene & Totipotency, Sakyo Ku, Kyoto 6068502, Japan.	fsato@lif.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [21248013, 25108713, 26252012, 26221201]	This research was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [Grant-in-Aid Nos. 21248013, 25108713, 26252012 and 26221201 to F.S.].	Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Inui T, 2007, PLANT CELL PHYSIOL, V48, P252, DOI 10.1093/pcp/pcl062; Hagel JM, 2012, J BIOL CHEM, V287, P42972, DOI 10.1074/jbc.M112.420414; Shoji T, 2011, PLANT CELL PHYSIOL, V52, P1117, DOI 10.1093/pcp/pcr063; SATO F, 1994, EUR J BIOCHEM, V225, P125, DOI 10.1111/j.1432-1033.1994.00125.x; Takemura T, 2013, PHYTOCHEMISTRY, V91, P100, DOI 10.1016/j.phytochem.2012.02.013; Todd AT, 2010, PLANT J, V62, P589, DOI 10.1111/j.1365-313X.2010.04186.x; Zhang HT, 2011, PLANT J, V67, P61, DOI 10.1111/j.1365-313X.2011.04575.x; Yamada Y, 2011, PLANT CELL PHYSIOL, V52, P1131, DOI 10.1093/pcp/pcr062; Beaudoin GAW, 2013, BIOCHEM BIOPH RES CO, V431, P597, DOI 10.1016/j.bbrc.2012.12.129; Ikezawa N, 2003, J BIOL CHEM, V278, P38557, DOI 10.1074/jbc.M302470200; Ifuku K, 2005, PLANT PHYSIOL, V139, P1175, DOI 10.1104/pp.105.068643; Sato F, 2013, BIOSCI BIOTECH BIOCH, V77, P1, DOI 10.1271/bbb.120759; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Sato F, 2001, P NATL ACAD SCI USA, V98, P367, DOI 10.1073/pnas.011526398; Samanani N, 2004, PLANT J, V40, P302, DOI 10.1111/j.1365-313X.2004.02210.x; Facchini PJ, 2001, ANNU REV PLANT PHYS, V52, P29, DOI 10.1146/annurev.arplant.52.1.29; Zhang HB, 2012, MOL PLANT, V5, P73, DOI 10.1093/mp/ssr056; Ikezawa N, 2009, PLANT CELL REP, V28, P123, DOI 10.1007/s00299-008-0624-8; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Gesell A, 2011, PLANTA, V233, P1185, DOI 10.1007/s00425-011-1357-4; TAKESHITA N, 1995, PLANT CELL PHYSIOL, V36, P29; Choi KB, 2002, J BIOL CHEM, V277, P830, DOI [10.1074/jbc.M106405200, 10.1074/jbc.M200528200]; DITTRICH H, 1991, P NATL ACAD SCI USA, V88, P9969, DOI 10.1073/pnas.88.22.9969; De Geyter N, 2012, TRENDS PLANT SCI, V17, P349, DOI 10.1016/j.tplants.2012.03.001; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; Morishige T, 2000, J BIOL CHEM, V275, P23398, DOI 10.1074/jbc.M002439200; Fossati E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4283; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; Kato N, 2007, PLANT CELL PHYSIOL, V48, P8, DOI 10.1093/pcp/pcl041; Matsushima Y, 2012, PLANT BIOTECHNOL-NAR, V29, P473, DOI 10.5511/plantbiotechnology.12.1101a; Minami H, 2007, J BIOL CHEM, V282, P6274, DOI 10.1074/jbc.M608933200; Mishra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052784; Nakagawa A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1327; Pauli HH, 1998, PLANT J, V13, P793, DOI 10.1046/j.1365-313X.1998.00085.x; Samanani N, 2002, J BIOL CHEM, V277, P33878, DOI 10.1074/jbc.M203051200; Takemura T, 2010, PLANT CELL PHYSIOL, V51, P949, DOI 10.1093/pcp/pcq063; Yamada Y, 2013, INT REV CEL MOL BIO, V305, P339, DOI 10.1016/B978-0-12-407695-2.00008-1; Yamada Yasuyuki, 2011, Plant Signal Behav, V6, P1627, DOI 10.4161/psb.6.11.17599	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	MAY	2015	56	5					1019	1030		10.1093/pcp/pcv027		12	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CJ2KS	WOS:000355313900018		
J	Susaki, D; Takeuchi, H; Tsutsui, H; Kurihara, D; Higashiyama, T				Susaki, Daichi; Takeuchi, Hidenori; Tsutsui, Hiroki; Kurihara, Daisuke; Higashiyama, Tetsuya			Live Imaging and Laser Disruption Reveal the Dynamics and Cell-Cell Communication During Torenia fournieri Female Gametophyte Development	PLANT AND CELL PHYSIOLOGY			English	Article						Female gametophyte; Live-cell imaging; Megagametogenesis; Torenia fournieri	POLLEN-TUBE GUIDANCE; NAKED EMBRYO SAC; EGG-CELL; SYNERGID CELL; PLANT TRANSFORMATION; DOUBLE FERTILIZATION; BINARY VECTORS; IN-VITRO; ARABIDOPSIS; ATTRACTANT	The female gametophytes of many flowering plants contain one egg cell, one central cell, two synergid cells and three antipodal cells with respective morphological characteristics and functions. These cells are formed by cellularization of a multinuclear female gametophyte. However, the dynamics and mechanisms of female gametophyte development remain largely unknown due to the lack of a system to visualize directly and manipulate female gametophytes in living material. Here, we established an in vitro ovule culture system to examine female gametophyte development in Torenia fournieri, a unique plant species with a protruding female gametophyte. The four-nucleate female gametophyte became eight nucleate by the final (third) mitosis and successively cellularized and matured to attract a pollen tube. The duration of final mitosis was 28 +/- 6.5 min, and cellularization was completed in 54 +/- 20 min after the end of the third mitosis. Fusion of polar nuclei in the central cell occurred in 13.1 +/- 1.1 h, and onset of expression of LURE2, a pollen tube attractant gene, was visualized by a green fluorescent protein reporter 10.7 +/- 2.3 h after cellularization. Laser disruption analysis demonstrated that the egg and central cells were required for synergid cells to acquire the pollen tube attraction function. Moreover, aberrant nuclear positioning and down-regulation of LURE2 were observed in one of the two synergid cells after disrupting an immature egg cell, suggesting that cell specification was affected. Our system provides insights into the precise dynamics and mechanisms of female gametophyte development in T. fournieri.	[Susaki, Daichi; Takeuchi, Hidenori; Tsutsui, Hiroki; Kurihara, Daisuke; Higashiyama, Tetsuya] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Takeuchi, Hidenori; Kurihara, Daisuke; Higashiyama, Tetsuya] Nagoya Univ, JST ERATO Higashiyama Live Holon Project, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Higashiyama, Tetsuya] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Higashiyama, T (reprint author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	higashi@bio.nagoya-u.ac.jp	kurihara, daisuke/I-7206-2014	kurihara, daisuke/0000-0003-2703-0405	Japan Science and Technology Agency [ERATO]; Japan Society for the Promotion of Science [7811, 5834, 6264]; Japan Advanced Plant Science Network	This study was supported the Japan Science and Technology Agency [ERATO project to T.H.]; the Japan Society for the Promotion of Science for Young Scientists [grants from research fellowships (No. 7811 to D.S., No. 5834 to H. Takeuchi and No. 6264 to H. Tsutsui]. The microscopy was conducted at the Institute of Transformative Bio-Molecules (WPI-ITbM) of Nagoya University and supported by the Japan Advanced Plant Science Network.	AIDA R, 1995, BREEDING SCI, V45, P71; Kessler SA, 2011, CURR OPIN PLANT BIOL, V14, P622, DOI 10.1016/j.pbi.2011.07.012; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Kanaoka MM, 2011, ANN BOT-LONDON, V108, P739, DOI 10.1093/aob/mcr111; Gross-Hardt R, 2007, PLOS BIOL, V5, P494, DOI 10.1371/journal.pbio.0050047; Marton ML, 2012, CURR BIOL, V22, P1194, DOI 10.1016/j.cub.2012.04.061; Imre K, 1999, SEX PLANT REPROD, V12, P152, DOI 10.1007/s004970050186; Capron A, 2008, PLANT CELL, V20, P3038, DOI 10.1105/tpc.108.061713; Ngo QA, 2014, DEV CELL, V29, P491, DOI 10.1016/j.devcel.2014.04.008; Alandete-Saez M, 2008, MOL PLANT, V1, P586, DOI 10.1093/mp/ssn015; Higashiyama T, 1997, PLANTA, V203, P101, DOI 10.1007/s004250050170; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Maruyama D, 2013, DEV CELL, V25, P317, DOI 10.1016/j.devcel.2013.03.013; Martin MV, 2013, PLANT CELL, V25, P1573, DOI 10.1105/tpc.113.109306; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Kessler SA, 2010, SCIENCE, V330, P968, DOI 10.1126/science.1195211; Palovaara J, 2013, TRENDS PLANT SCI, V18, P514, DOI 10.1016/j.tplants.2013.04.011; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Kubo T, 2013, PLANT CELL PHYSIOL, V54, P750, DOI 10.1093/pcp/pct029; Van Norman JM, 2011, PLANT CELL, V23, P855, DOI 10.1105/tpc.111.082982; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Higashiyama T, 1998, PLANT CELL, V10, P2019; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Sprunck S, 2011, SEX PLANT REPROD, V24, P123, DOI 10.1007/s00497-011-0161-4; Higashiyama T, 2006, PLANT PHYSIOL, V142, P481, DOI 10.1104/pp.106.083832; Higashiyama T, 2010, PLANT CELL PHYSIOL, V51, P177, DOI 10.1093/pcp/pcq008; Marton ML, 2005, SCIENCE, V307, P573, DOI 10.1126/science.1104954; Moll C, 2008, PLANT J, V56, P913, DOI 10.1111/j.1365-313X.2008.03650.x; Wolf S, 2014, PLANT CELL, V26, P1848, DOI 10.1105/tpc.114.125518; Krohn NG, 2012, DEV CELL, V23, P219, DOI 10.1016/j.devcel.2012.05.018; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Chen YH, 2007, PLANT CELL, V19, P3563, DOI 10.1105/tpc.107.053967; Drews Gary N, 2011, Arabidopsis Book, V9, pe0155, DOI 10.1199/tab.0155; Goto H, 2011, PLANT CELL PHYSIOL, V52, P49, DOI 10.1093/pcp/pcq191; Grossniklaus U, 2011, SEX PLANT REPROD, V24, P91, DOI 10.1007/s00497-011-0170-3; Hamamura Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5722; Huang R. Q., 1992, SEX PLANT REPROD, V5, P151; Kawano N, 2011, CYTOLOGIA, V76, P177, DOI 10.1508/cytologia.76.177; Lawit SJ, 2013, PLANT REPROD, V26, P125, DOI 10.1007/s00497-013-0215-x; Massart D. L., 1988, CHEMOMETRICS TXB, P339; Osaka M, 2013, PLANT CELL PHYSIOL, V54, P1894, DOI 10.1093/pcp/pct133; Suzuki G, 2009, PLANT CELL PHYSIOL, V50, P1857, DOI 10.1093/pcp/pcp142; Takeuchi H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001449; Volz R, 2012, DEVELOPMENT, V139, P498, DOI 10.1242/dev.075234; Yamaguchi H, 2011, PLANT BIOTECHNOL-NAR, V28, P263, DOI 10.5511/plantbiotechnology.11.0124c	48	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-0781	1471-9053		PLANT CELL PHYSIOL	Plant Cell Physiol.	MAY	2015	56	5					1031	1041		10.1093/pcp/pcv031		11	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	CJ2KS	WOS:000355313900019		
J	Karp, NA; Meehan, TF; Morgan, H; Mason, JC; Blake, A; Kurbatova, N; Smedley, D; Jacobsen, J; Mott, RF; Iyer, V; Matthews, P; Melvin, DG; Wells, S; Flenniken, AM; Masuya, H; Wakana, S; White, JK; Lloyd, KCK; Reynolds, CL; Paylor, R; West, DB; Svenson, KL; Chesler, EJ; de Angelis, MH; Tocchini-Valentini, GP; Sorg, T; Herault, Y; Parkinson, H; Mallon, AM; Brown, SDM				Karp, Natasha A.; Meehan, Terry F.; Morgan, Hugh; Mason, Jeremy C.; Blake, Andrew; Kurbatova, Natalja; Smedley, Damian; Jacobsen, Julius; Mott, Richard F.; Iyer, Vivek; Matthews, Peter; Melvin, David G.; Wells, Sara; Flenniken, Ann M.; Masuya, Hiroshi; Wakana, Shigeharu; White, Jacqueline K.; Lloyd, K. C. Kent; Reynolds, Corey L.; Paylor, Richard; West, David B.; Svenson, Karen L.; Chesler, Elissa J.; de Angelis, Martin Hrabe; Tocchini-Valentini, Glauco P.; Sorg, Tania; Herault, Yann; Parkinson, Helen; Mallon, Ann-Marie; Brown, Steve D. M.			Applying the ARRIVE Guidelines to an In Vivo Database	PLOS BIOLOGY			English	Editorial Material							EXPERIMENTAL-DESIGN; SEX; QUALITY; CALL	The Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines were developed to address the lack of reproducibility in biomedical animal studies and improve the communication of research findings. While intended to guide the preparation of peer-reviewed manuscripts, the principles of transparent reporting are also fundamental for in vivo databases. Here, we describe the benefits and challenges of applying the guidelines for the International Mouse Phenotyping Consortium (IMPC), whose goal is to produce and phenotype 20,000 knockout mouse strains in a reproducible manner across ten research centres. In addition to ensuring the transparency and reproducibility of the IMPC, the solutions to the challenges of applying the ARRIVE guidelines in the context of IMPC will provide a resource to help guide similar initiatives in the future.	[Karp, Natasha A.; Smedley, Damian; Jacobsen, Julius; Melvin, David G.] Wellcome Trust Sanger Inst, Mouse Informat Grp, Cambridge, England; [Meehan, Terry F.; Mason, Jeremy C.; Kurbatova, Natalja; Parkinson, Helen] European Bioinformat Inst, Samples Phenotypes & Ontol, European Mol Biol Lab, Cambridge, England; [Morgan, Hugh; Blake, Andrew; Wells, Sara; Mallon, Ann-Marie; Brown, Steve D. M.] MRC, Mammalian Genet Unit, Harwell, Berks, England; [Mott, Richard F.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Iyer, Vivek; Matthews, Peter] Wellcome Trust Sanger Inst, Cellular Genet, Cambridge, England; [Flenniken, Ann M.] Mt Sinai Hosp, Toronto Ctr Phenogen, Toronto, ON M5G 1X5, Canada; [Masuya, Hiroshi; Wakana, Shigeharu] RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan; [White, Jacqueline K.] Wellcome Trust Sanger Inst, Mouse Genet Project, Cambridge, England; [Lloyd, K. C. Kent] Univ Calif Davis, Mouse Biol Program, Davis, CA 95616 USA; [Reynolds, Corey L.] Baylor Coll Med, Mol Physiol & Biophys, Houston, TX 77030 USA; [Paylor, Richard] Baylor Coll Med, Mol & Human Genet, Houston, TX 77030 USA; [West, David B.] Childrens Hosp Oakland, Res Inst, Genet, Oakland, CA 94609 USA; [Svenson, Karen L.; Chesler, Elissa J.] Jackson Lab, Genet, Bar Habour, ME USA; [de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Mouse Clin, Inst Expt Genet, Neuherberg, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Expt Genet Ctr Life & Food, Freising Weihenstephan, Germany; [Tocchini-Valentini, Glauco P.] CNR Inst Cell Biol & Neurobiol, Monterotondo Mouse Clin, Monterotondo, Scalo, Italy; [Sorg, Tania; Herault, Yann] CNRS, PHENOMIN, Illkirch Graffenstaden, France; [Sorg, Tania; Herault, Yann] Univ Strasbourg, Inst Clin Souris, Illkirch Graffenstaden, France; [Sorg, Tania; Herault, Yann] INSERM, U964, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France	Karp, NA (reprint author), Wellcome Trust Sanger Inst, Mouse Informat Grp, Cambridge, England.	nk3@sanger.ac.uk	Hrabe de Angelis, Martin/F-5531-2012; 	Karp, Natasha/0000-0002-8404-2907; Parkinson, Helen/0000-0003-3035-4195			Blair DR, 2013, CELL, V155, P70, DOI 10.1016/j.cell.2013.08.030; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Brown SDM, 2012, DIS MODEL MECH, V5, P289, DOI 10.1242/dmm.009878; Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167; Kim AM, 2010, NATURE, V465, P688, DOI 10.1038/465688a; Clayton JA, 2014, NATURE, V509, P282; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Bebarta V, 2003, ACAD EMERG MED, V10, P684, DOI 10.1111/j.1553-2712.2003.tb00056.x; Flanagan KL, 2014, T ROY SOC TROP MED H, V108, P385, DOI 10.1093/trstmh/tru079; Baker D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001756; group Rw, 2010, GA PASSP KEY CONS AN; Karp NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052410; Karp NA, 2010, MAMM GENOME, V21, P467, DOI 10.1007/s00335-010-9279-1; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Smedley D, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat025; Woodruff TK, 2014, P NATL ACAD SCI USA, V111, P5063, DOI 10.1073/pnas.1404203111	17	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1545-7885			PLOS BIOL	PLoS. Biol.	MAY	2015	13	5							e1002151	10.1371/journal.pbio.1002151		11	Biochemistry & Molecular Biology; Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	CJ2HU	WOS:000355305600010		
J	Kato, H; Ishizaki, K; Kouno, M; Shirakawa, M; Bowman, JL; Nishihama, R; Kohchi, T				Kato, Hirotaka; Ishizaki, Kimitsune; Kouno, Masaru; Shirakawa, Makoto; Bowman, John L.; Nishihama, Ryuichi; Kohchi, Takayuki			Auxin-Mediated Transcriptional System with a Minimal Set of Components Is Critical for Morphogenesis through the Life Cycle in Marchantia polymorpha	PLOS GENETICS			English	Article							INDUCIBLE GENE-EXPRESSION; RESPONSE FACTOR; LAND PLANTS; ARABIDOPSIS EMBRYOGENESIS; DIFFERENTIAL GROWTH; BINDING PROTEIN-1; APICAL DOMINANCE; AUX/IAA PROTEINS; STRUCTURAL BASIS; DNA-BINDING	The plant hormone auxin regulates many aspects of plant growth and development. Recent progress in Arabidopsis provided a scheme that auxin receptors, TIR1/AFBs, target transcriptional co-repressors, AUX/IAAs, for degradation, allowing ARFs to regulate transcription of auxin responsive genes. The mechanism of auxin-mediated transcriptional regulation is considered to have evolved around the time plants adapted to land. However, little is known about the role of auxin-mediated transcription in basal land plant lineages. We focused on the liverwort Marchantia polymorpha, which belongs to the earliest diverging lineage of land plants. M. polymorpha has only a single TIR1/AFB (MpTIR1), a single AUX/IAA (MpIAA), and three ARFs (MpARF1, MpARF2, and MpARF3) in the genome. Expression of a dominant allele of MpIAA with mutations in its putative degron sequence conferred an auxin resistant phenotype and repressed auxin-dependent expression of the auxin response reporter proGH3:GUS. We next established a system for DEX-inducible auxin-response repression by expressing the putatively stabilized MpIAA protein fused with the glucocorticoid receptor domain (MpIAAmDII-GR). Repression of auxin responses in proMpIAA: MpIAAmDII-GR plants caused severe defects in various developmental processes, including gemmaling development, dorsiventrality, organogenesis, and tropic responses. Transient transactivation assays showed that the three MpARFs had different transcriptional activities, each corresponding to their phylogenetic classifications. Moreover, MpIAA and MpARF proteins interacted with each other with different affinities. This study provides evidence that pleiotropic auxin responses can be achieved by a minimal set of auxin signaling factors and suggests that the transcriptional regulation mediated by TIR1/AFB, AUX/IAA, and three types of ARFs might have been a key invention to establish body plans of land plants. We propose that M. polymorpha is a good model to investigate the principles and the evolution of auxin-mediated transcriptional regulation and its roles in land plant morphogenesis.	[Kato, Hirotaka; Ishizaki, Kimitsune; Kouno, Masaru; Shirakawa, Makoto; Nishihama, Ryuichi; Kohchi, Takayuki] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Ishizaki, Kimitsune] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 657, Japan; [Bowman, John L.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Bowman, John L.] Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA	Kato, H (reprint author), Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan.	tkohchi@lif.kyoto-u.ac.jp	Shirakawa, Makoto/N-8817-2015; 	Shirakawa, Makoto/0000-0003-3719-7081; Ishizaki, Kimitsune/0000-0003-0504-8196	Japan Society for the Promotion of Science [25113009, 25119711, 26281059, 24-7037]; Australian Research Council [FF0561326, DP110100070]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (25113009 to TK; 25119711 to KI), a Grant-in-Aid for Scientific Research (B) (26281059 to TK), Joint Research Project (to TK), JSPS Fellows (24-7037 to HK) from the Japan Society for the Promotion of Science, and the Australian Research Council (FF0561326 and DP110100070 to JLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff F, 2014, TRANSGENIC RES, V23, P235, DOI 10.1007/s11248-013-9746-z; Kubota A, 2013, BIOSCI BIOTECH BIOCH, V77, P167, DOI 10.1271/bbb.120700; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Korasick DA, 2014, P NATL ACAD SCI USA, V111, P5427, DOI 10.1073/pnas.1400074111; Cooke TJ, 2002, PLANT MOL BIOL, V49, P319, DOI 10.1023/A:1015242627321; Ishizaki K, 2013, PLANT CELL, V25, P4075, DOI 10.1105/tpc.113.117051; Villalobos LIAC, 2012, NAT CHEM BIOL, V8, P477, DOI 10.1038/NCHEMBIO.926; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; Park JY, 2002, PLANT J, V32, P669, DOI 10.1046/j.1365-313X.2002.01459.x; BINNS AN, 1972, AM J BOT, V59, P691, DOI 10.2307/2441140; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Prigge MJ, 2010, CURR BIOL, V20, P1907, DOI 10.1016/j.cub.2010.08.050; Bennett TA, 2014, CURR BIOL, V24, P2776, DOI 10.1016/j.cub.2014.09.054; Chen JG, 2001, PLANT J, V28, P607, DOI 10.1046/j.1365-313x.2001.01152.x; Boer DR, 2014, CELL, V156, P577, DOI 10.1016/j.cell.2013.12.027; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Fujita T, 2008, EVOL DEV, V10, P176, DOI 10.1111/j.1525-142X.2008.00225.x; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.108630; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Moore I, 2006, PLANT J, V45, P651, DOI 10.1111/j.1365-313X.2006.02660.x; Yasui Y, 2012, PLANT CELL, V24, P3248, DOI 10.1105/tpc.112.101915; Qiao M, 2012, PLANT J, V71, P14, DOI 10.1111/j.1365-313X.2012.04944.x; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Bowman JL, 2007, CELL, V129, P229, DOI 10.1016/j.cell.2007.04.004; Steffens B, 2001, PLANT J, V27, P591, DOI 10.1046/j.1365-313X.2001.01103.x; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Schenck D, 2010, PLANT PHYSIOL, V152, P1183, DOI 10.1104/pp.109.149591; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Tromas A, 2010, TRENDS PLANT SCI, V15, P436, DOI 10.1016/j.tplants.2010.05.001; RUCK A, 1993, PLANT J, V4, P41, DOI 10.1046/j.1365-313X.1993.04010041.x; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Chiyoda S, 2008, PLANT CELL REP, V27, P1467, DOI 10.1007/s00299-008-0570-5; Hamann T, 1999, DEVELOPMENT, V126, P1387; Xu TD, 2014, SCIENCE, V343, P1025, DOI 10.1126/science.1245125; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Ishizaki K, 2012, J PLANT RES, V125, P643, DOI 10.1007/s10265-012-0477-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; LLOYD AM, 1994, SCIENCE, V266, P436, DOI 10.1126/science.7939683; Liu XD, 2010, PLANT J, V62, P416, DOI 10.1111/j.1365-313X.2010.04164.x; Finet C, 2013, MOL BIOL EVOL, V30, P45, DOI 10.1093/molbev/mss220; Barnes CR, 1907, BOT GAZ, V44, P0197, DOI 10.1086/329317; Barnes CR, 1908, BOT GAZ, V46, P401, DOI 10.1086/329782; Bennett T., 2014, AUXIN AND ITS ROLE I, P3; Bowman JL, 2013, CURR OPIN PLANT BIOL, V16, P70, DOI 10.1016/j.pbi.2012.10.001; Chen X, 2014, NATURE; DAVIDONI.GH, 1972, BOT GAZ, V133, P177, DOI 10.1086/336631; Durand EJ, 1908, B TORREY BOT CLUB, V35, P321, DOI 10.2307/2485335; Escher D, 2000, MOL CELL BIOL, V20, P2774, DOI 10.1128/MCB.20.8.2774-2782.2000; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; Ishizaki K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01532; KAUL KM, 1962, ANN BOT-LONDON, V26, P447; Kubota A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4668; La RUE CARL D., 1957, NEW PHYTOL, V56, P61, DOI 10.1111/j.1469-8137.1957.tb07449.x; Liscum E, 2002, PLANT MOL BIOL; MARAVOLO NC, 1966, BOT GAZ, V127, P79, DOI 10.1086/336346; MARAVOLO NC, 1980, B TORREY BOT CLUB, V107, P308, DOI 10.2307/2484154; McConaha M, 1941, AM J BOT, V28, P301, DOI 10.2307/2436787; Mirbel M, 1835, MEM ACAD SCI I FR, V13, P337; Möller Benjamin, 2010, Plant Signal Behav, V5, P601, DOI 10.4161/psb.11501; Nanao MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4617; Otto KR, 1975, Z PFLANZENPHYSIOL, V80, P197; Perez-Perez JM, 2010, PLANT CELL PHYSIOL, V51, P1661, DOI 10.1093/pcp/pcq123; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Piya S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00744; Rousseau J., 1953, B SOC BOT FRANCE, V100, P179; ROUSSEAU J, 1950, CR HEBD ACAD SCI, V230, P675; ROUSSEAU J, 1951, CR HEBD ACAD SCI, V232, P107; SCHENA M, 1991, P NATL ACAD SCI USA, V88, P10421, DOI 10.1073/pnas.88.23.10421; Schiffner V, 1909, ANN JARDIN BOTANIQ S, V3, P473; SCHNEIDE.MJ, 1967, BOT GAZ, V128, P174, DOI 10.1086/336395; Shikata M, 2003, BIOSCI BIOTECH BIOCH, V67, P2495, DOI 10.1271/bbb.67.2495; Shimizu-Mitao Y, 2014, PLANT CELL PHYSIOL, V55, P1450, DOI 10.1093/pcp/pcu077; Taren N, 1958, THE BRYOLOGIST, V61, P191; Timme RE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-96; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C	90	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7390	1553-7404		PLOS GENET	PLoS Genet.	MAY	2015	11	5							UNSP e1005084	10.1371/journal.pgen.1005084		26	Genetics & Heredity	Genetics & Heredity	CJ2HQ	WOS:000355305200004		
J	Pennell, MW; Kirkpatrick, M; Otto, SP; Vamosi, JC; Peichel, CL; Valenzuela, N; Kitano, J				Pennell, Matthew W.; Kirkpatrick, Mark; Otto, Sarah P.; Vamosi, Jana C.; Peichel, Catherine L.; Valenzuela, Nicole; Kitano, Jun			Y Fuse? Sex Chromosome Fusions in Fishes and Reptiles	PLOS GENETICS			English	Article							PARENTAL ORIGIN; SOREX-ARANEUS; MEIOTIC DRIVE; EVOLUTION; REARRANGEMENTS; TRANSITIONS; AUTOSOMES; KARYOTYPE; SELECTION; DYNAMICS	Chromosomal fusion plays a recurring role in the evolution of adaptations and reproductive isolation among species, yet little is known of the evolutionary drivers of chromosomal fusions. Because sex chromosomes (X and Y in male heterogametic systems, Z and W in female heterogametic systems) differ in their selective, mutational, and demographic environments, those differences provide a unique opportunity to dissect the evolutionary forces that drive chromosomal fusions. We estimate the rate at which fusions between sex chromosomes and autosomes become established across the phylogenies of both fishes and squamate reptiles. Both the incidence among extant species and the establishment rate of Y-autosome fusions is much higher than for X-autosome, Z-autosome, or W-autosome fusions. Using population genetic models, we show that this pattern cannot be reconciled with many standard explanations for the spread of fusions. In particular, direct selection acting on fusions or sexually antagonistic selection cannot, on their own, account for the predominance of Y-autosome fusions. The most plausible explanation for the observed data seems to be (a) that fusions are slightly deleterious, and (b) that the mutation rate is male-biased or the reproductive sex ratio is female-biased. We identify other combinations of evolutionary forces that might in principle account for the data although they appear less likely. Our results shed light on the processes that drive structural changes throughout the genome.	[Pennell, Matthew W.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Kirkpatrick, Mark] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Otto, Sarah P.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Vamosi, Jana C.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci & Human Biol, Seattle, WA 98104 USA; [Valenzuela, Nicole] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Kitano, Jun] Natl Inst Genet, Ecol Genet Lab, Mishima, Shizuoka 411, Japan	Pennell, MW (reprint author), Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA.	jkitano@lab.nig.ac.jp			National Evolutionary Synthesis Center (The Tree of Sex; NSF) [EF-0905606]; National Science Foundation [DEB-0819901, MCB 1244355]; Ministry of Education, Culture, Sports, Science and Technology [23113007, 23113001]; Natural Sciences and Engineering Research Council of Canada	This research was supported by the National Evolutionary Synthesis Center (The Tree of Sex; NSF#EF-0905606; http://www.nescent.org/). Funding was also provided by National Science Foundation grant DEB-0819901 to MK (http://www.nsf.gov/), National Science Foundation grant MCB 1244355 to NV (http://www.nsf.gov/), and the Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research on Innovative Areas (23113007 and 23113001) and to JK (http://www.mext.go.jp). MWP was supported by a Natural Sciences and Engineering Research Council of Canada postgraduate fellowship (http://www.nserc-crsng.gc.ca/index_eng.asp). SPO and JCV were supported by grants from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertollo LAC, 2004, HEREDITY, V93, P228, DOI 10.1038/sj.hdy.6800511; Wyrobek AJ, 2006, P NATL ACAD SCI USA, V103, P9601, DOI 10.1073/pnas.0506468103; Guerrero RF, 2014, EVOLUTION, V68, P2747, DOI 10.1111/evo.12481; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; van Doorn GS, 2007, NATURE, V449, P909, DOI 10.1038/nature06178; Perez-Ortin JE, 2002, GENOME RES, V12, P1533, DOI 10.1101/gr.436602; Maddison WP, 2013, EVOLUTION, V67, P2258, DOI 10.1111/evo.12109; Mank JE, 2012, CHROMOSOME RES, V20, P21, DOI 10.1007/s10577-011-9251-2; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Kitano J, 2012, ENVIRON BIOL FISH, V94, P549, DOI 10.1007/s10641-011-9853-8; Hou J, 2014, CURR BIOL, V24, P1153, DOI 10.1016/j.cub.2014.03.063; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; van Doorn GS, 2010, GENETICS, V186, P629, DOI 10.1534/genetics.110.118596; de Villena FPM, 2001, MAMM GENOME, V12, P331, DOI 10.1007/s003350040003; Bachtrog D, 2011, TRENDS GENET, V27, P350, DOI 10.1016/j.tig.2011.05.005; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; FitzJohn RG, 2012, METHODS ECOL EVOL, V3, P1084, DOI 10.1111/j.2041-210X.2012.00234.x; Sartorelli EMP, 2001, FERTIL STERIL, V76, P1119, DOI 10.1016/S0015-0282(01)02894-1; CHARLESWORTH D, 1980, GENET RES, V35, P205; Bachtrog D, 2008, GENETICS, V179, P1513, DOI 10.1534/genetics.107.084012; Pyron RA, 2014, ECOL LETT, V17, P13, DOI 10.1111/ele.12168; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Bandyopadhyay R, 2002, AM J HUM GENET, V71, P1456, DOI 10.1086/344662; BATISTA DAS, 1993, HUM GENET, V92, P117; Beukeboom LW, 2014, EVOLUTION OF SEX DETERMINATION, P1, DOI 10.1093/acprof:oso/9780199657148.001.0001; Bull J. J., 1983, EVOLUTION SEX DETERM; CHAMBERLIN J, 1980, HUM GENET, V53, P343; Chang SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003232; Charlesworth B, 1999, P ROY SOC B-BIOL SCI, V266, P51; CLARK AG, 1988, GENETICS, V119, P711; Dobigny G, 2004, CHROMOSOMA, V113, P34, DOI 10.1007/s00412-004-0292-6; Ellegren H, 2011, NAT REV GENET, V12, P257; Ezaz T, 2009, CYTOGENET GENOME RES, V127, P249, DOI 10.1159/000300507; Ezaz T, 2006, CURR BIOL, V16, pR736, DOI 10.1016/j.cub.2006.08.021; Gardner R, 2012, CHROMOSOME ABNORMALI; Grossmann V, 2010, CLIN GENET, V78, P548, DOI 10.1111/j.1399-0004.2010.01419.x; King M, 1993, SPECIES EVOLUTION RO; NACHMAN MW, 1995, TRENDS ECOL EVOL, V10, P397, DOI 10.1016/S0169-5347(00)89155-7; Ohno S., 1967, SEX CHROMOSOMES SEX; de Villena FPM, 2001, GENETICS, V159, P1179; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Rabosky DL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2958; SEARLE JB, 1986, GENET RES, V47, P147; The Tree of Sex Consortium, 2014, SCI DATA, V1; Thomas NS, 2010, J MED GENET, V47, P112, DOI 10.1136/jmg.2009.069716; White M. J. D., 1973, ANIMAL CYTOLOGY EVOL; Wyttenbach A, 1998, CYTOGENET CELL GENET, V83, P199, DOI 10.1159/000015178; Yoshida K, 2012, EVOLUTION, V66, P3198, DOI 10.1111/j.1558-5646.2012.01681.x	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7390	1553-7404		PLOS GENET	PLoS Genet.	MAY	2015	11	5							e1005237	10.1371/journal.pgen.1005237		17	Genetics & Heredity	Genetics & Heredity	CJ2HQ	WOS:000355305200047		
J	Sano, H; Nakamura, A; Texada, MJ; Truman, JW; Ishimoto, H; Kamikouchi, A; Nibu, Y; Kume, K; Ida, T; Kojima, M				Sano, Hiroko; Nakamura, Akira; Texada, Michael J.; Truman, James W.; Ishimoto, Hiroshi; Kamikouchi, Azusa; Nibu, Yutaka; Kume, Kazuhiko; Ida, Takanori; Kojima, Masayasu			The Nutrient-Responsive Hormone CCHamide-2 Controls Growth by Regulating Insulin-like Peptides in the Brain of Drosophila melanogaster	PLOS GENETICS			English	Article							ORPHAN RECEPTOR BRS-3; SEPTATE JUNCTION; LEPTIN RECEPTOR; SIGNAL-TRANSDUCTION; EXPRESSION; BARRIER; CELLS; GENE; SECRETION; PROTEIN	The coordination of growth with nutritional status is essential for proper development and physiology. Nutritional information is mostly perceived by peripheral organs before being relayed to the brain, which modulates physiological responses. Hormonal signaling ensures this organ-to-organ communication, and the failure of endocrine regulation in humans can cause diseases including obesity and diabetes. In Drosophila melanogaster, the fat body (adipose tissue) has been suggested to play an important role in coupling growth with nutritional status. Here, we show that the peripheral tissue-derived peptide hormone CCHamide-2 (CCHa2) acts as a nutrient-dependent regulator of Drosophila insulin-like peptides (Dilps). A BAC-based transgenic reporter revealed strong expression of CCHa2 receptor (CCHa2-R) in insulin-producing cells (IPCs) in the brain. Calcium imaging of brain explants and IPC-specific CCHa2-R knockdown demonstrated that peripheral-tissue derived CCHa2 directly activates IPCs. Interestingly, genetic disruption of either CCHa2 or CCHa2-R caused almost identical defects in larval growth and developmental timing. Consistent with these phenotypes, the expression of dilp5, and the release of both Dilp2 and Dilp5, were severely reduced. Furthermore, transcription of CCHa2 is altered in response to nutritional levels, particularly of glucose. These findings demonstrate that CCHa2 and CCHa2-R form a direct link between peripheral tissues and the brain, and that this pathway is essential for the coordination of systemic growth with nutritional availability. A mammalian homologue of CCHa2-R, Bombesin receptor subtype-3 (Brs3), is an orphan receptor that is expressed in the islet beta-cells; however, the role of Brs3 in insulin regulation remains elusive. Our genetic approach in Drosophila melanogaster provides the first evidence, to our knowledge, that bombesin receptor signaling with its endogenous ligand promotes insulin production.	[Sano, Hiroko; Kojima, Masayasu] Kurume Univ, Inst Life Sci, Dept Mol Genet, Kurume, Fukuoka 830, Japan; [Nakamura, Akira] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Germline Dev, Kumamoto, Japan; [Texada, Michael J.; Truman, James W.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA; [Ishimoto, Hiroshi; Kamikouchi, Azusa] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648601, Japan; [Kamikouchi, Azusa] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Tokyo, Japan; [Nibu, Yutaka] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA; [Kume, Kazuhiko] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Ida, Takanori] Miyazaki Univ, Frontier Sci Res Ctr, Dept Bioact Peptides, Div Searching & Identificat Bioact Peptides, Miyazaki, Miyazaki, Japan	Sano, H (reprint author), Kurume Univ, Inst Life Sci, Dept Mol Genet, Kurume, Fukuoka 830, Japan.	sano_hiroko@kurume-u.ac.jp		Sano, Hiroko/0000-0001-9834-647X	Japan Society for the Promotion of Science (JSPS) [24770203]; Tomizawa Jun-ichi & Keiko Fund of the Molecular Biology Society of Japan for Young Scientist; Ishibashi Foundation; Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University; JSPS [25650088, 25115007, 22126003]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported by a Grant-in-Aid for Young Scientists (B) 24770203 from the Japan Society for the Promotion of Science (JSPS), the Tomizawa Jun-ichi & Keiko Fund of the Molecular Biology Society of Japan for Young Scientist, a Research Grant from the Ishibashi Foundation, and the program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University to HS along with supplemental funding by a Grant-in-Aid for Challenging Exploratory Research 25650088 from JSPS to AN, a Grant-in-Aid for Scientific Research on Innovative Areas 25115007 from JSPS and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to AK, a Grant-in-Aid for Scientific Research on Innovative Areas 22126003 from JSPS and MEXT to MK, and Howard Hughes Medical Institute to JWT, hosting MJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; OhkiHamazaki H, 1997, NATURE, V390, P165, DOI 10.1038/36568; FREDERICH RC, 1995, J CLIN INVEST, V96, P1658, DOI 10.1172/JCI118206; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; BENYA RV, 1992, MOL PHARMACOL, V42, P1058; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Asha H, 2003, GENETICS, V163, P203; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/nmeth.1331, 10.1038/NMETH.1331]; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Fridell YWC, 2009, AGING-US, V1, P699; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Wright VM, 2011, CELL SIGNAL, V23, P920, DOI 10.1016/j.cellsig.2011.01.020; Okamoto N, 2012, P NATL ACAD SCI USA, V109, P2406, DOI 10.1073/pnas.1116050109; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Faivre-Sarrailh C, 2004, DEVELOPMENT, V131, P4931, DOI 10.1242/dev.01372; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ryan RR, 1998, J PHARMACOL EXP THER, V287, P366; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/nmeth.1592, 10.1038/NMETH.1592]; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Feng Y, 2011, ENDOCRINOLOGY, V152, P4106, DOI 10.1210/en.2011-1440; Ryan RR, 1998, J BIOL CHEM, V273, P13613, DOI 10.1074/jbc.273.22.13613; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Wang SW, 2009, MOL BIOTECHNOL, V42, P110, DOI 10.1007/s12033-009-9142-3; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Desalvo MK, 2011, GLIA, V59, P1322, DOI 10.1002/glia.21147; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Ida Takanori, 2012, Front Endocrinol (Lausanne), V3, P177, DOI 10.3389/fendo.2012.00177; Li C, 1998, J BIOL CHEM, V273, P10078, DOI 10.1074/jbc.273.16.10078; Moore LA, 1998, DEVELOPMENT, V125, P837; Nishino H, 1998, AM J PHYSIOL-GASTR L, V274, pG525; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Qin XQ, 2012, J MOL NEUROSCI, V46, P88, DOI 10.1007/s12031-011-9675-3; Rewitz KF, 2010, DEV CELL, V19, P895, DOI 10.1016/j.devcel.2010.10.021; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Veenstra JA, 2014, CELL TISSUE RES; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Zhou WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031997	66	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7390	1553-7404		PLOS GENET	PLoS Genet.	MAY	2015	11	5							e1005209	10.1371/journal.pgen.1005209		26	Genetics & Heredity	Genetics & Heredity	CJ2HQ	WOS:000355305200028		
J	Hyodo, K; Taniguchi, T; Manabe, Y; Kaido, M; Mise, K; Sugawara, T; Taniguchi, H; Okuno, T				Hyodo, Kiwamu; Taniguchi, Takako; Manabe, Yuki; Kaido, Masanori; Mise, Kazuyuki; Sugawara, Tatsuya; Taniguchi, Hisaaki; Okuno, Tetsuro			Phosphatidic Acid Produced by Phospholipase D Promotes RNA Replication of a Plant RNA Virus	PLOS PATHOGENS			English	Article							NECROTIC-MOSAIC-VIRUS; CAP-INDEPENDENT TRANSLATION; 3' UNTRANSLATED REGION; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; DEFENSE RESPONSES; VIRAL-RNA; NICOTIANA-BENTHAMIANA; ENDOPLASMIC-RETICULUM; IN-VITRO	Eukaryotic positive-strand RNA [(+) RNA] viruses are intracellular obligate parasites replicate using the membrane-bound replicase complexes that contain multiple viral and host components. To replicate, (+) RNA viruses exploit host resources and modify host metabolism and membrane organization. Phospholipase D (PLD) is a phosphatidylcholine-and phosphatidylethanolamine-hydrolyzing enzyme that catalyzes the production of phosphatidic acid (PA), a lipid second messenger that modulates diverse intracellular signaling in various organisms. PA is normally present in small amounts (less than 1% of total phospholipids), but rapidly and transiently accumulates in lipid bilayers in response to different environmental cues such as biotic and abiotic stresses in plants. However, the precise functions of PLD and PA remain unknown. Here, we report the roles of PLD and PA in genomic RNA replication of a plant (+) RNA virus, Red clover necrotic mosaic virus (RCNMV). We found that RCNMV RNA replication complexes formed in Nicotiana benthamiana contained PLD alpha and PLD beta. Gene-silencing and pharmacological inhibition approaches showed that PLDs and PLDs-derived PA are required for viral RNA replication. Consistent with this, exogenous application of PA enhanced viral RNA replication in plant cells and plant-derived cell-free extracts. We also found that a viral auxiliary replication protein bound to PA in vitro, and that the amount of PA increased in RCNMV-infected plant leaves. Together, our findings suggest that RCNMV hijacks host PA-producing enzymes to replicate.	[Hyodo, Kiwamu; Kaido, Masanori; Mise, Kazuyuki; Okuno, Tetsuro] Kyoto Univ, Grad Sch Agr, Plant Pathol Lab, Kyoto, Japan; [Taniguchi, Takako; Taniguchi, Hisaaki] Univ Tokushima, Inst Enzyme Res, Tokushima 770, Japan; [Manabe, Yuki; Sugawara, Tatsuya] Kyoto Univ, Lab Marine Bioprod Technol, Grad Sch Agr, Kyoto, Japan	Okuno, T (reprint author), Kyoto Univ, Grad Sch Agr, Plant Pathol Lab, Kyoto, Japan.	okuno@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science [22248002, 25115509]	This study was supported by a Grant-in Aid for Science Research (A) (22248002) and by a Grant-in Aid for Science Research on Innovative Areas (25115509) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MN, 2010, VIROLOGY, V405, P100, DOI 10.1016/j.virol.2010.05.022; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; McLoughlin F, 2013, BIOCHEM J, V450, P573, DOI 10.1042/BJ20121639; Zhao J, 2013, NEW PHYTOL, V199, P228, DOI 10.1111/nph.12256; Weng LY, 2010, J VIROL, V84, P11761, DOI 10.1128/JVI.00638-10; Nchoutmboube JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003401; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Park J, 2004, PLANT PHYSIOL, V134, P129, DOI 10.1104/pp.103.031393; Testerink C, 2011, J EXP BOT, V62, P2349, DOI 10.1093/jxb/err079; Huang PY, 2014, PLANT J, V79, P243, DOI 10.1111/tpj.12557; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Belov GA, 2014, CURR OPIN VIROL, V9, P19, DOI 10.1016/j.coviro.2014.08.007; Mandadi KK, 2013, PLANT CELL, V25, P1489, DOI 10.1105/tpc.113.111658; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; de Jong CF, 2004, PLANT J, V39, P1, DOI 10.1111/j.1365-313X.2004.02110.x; Zhu F, 2014, MOL PLANT MICROBE IN, V27, P567, DOI 10.1094/MPMI-11-13-0349-R; Pogany J, 2015, J VIROL, V89, P5714, DOI 10.1128/JVI.03711-14; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Munnik T, 1995, PLANT CELL, V7, P2197, DOI 10.1105/tpc.7.12.2197; Kirik A, 2009, P NATL ACAD SCI USA, V106, P20532, DOI 10.1073/pnas.0903859106; Pinosa F, 2013, PLANT PHYSIOL, V163, P896, DOI 10.1104/pp.113.223503; Yamaguchi T, 2005, PLANT CELL PHYSIOL, V46, P579, DOI 10.1093/pcp/pci065; Zhao J, 2015, J EXP BOT, V66, P1721, DOI 10.1093/jxb/eru540; Zhang YY, 2009, PLANT CELL, V21, P2357, DOI 10.1105/tpc.108.062992; den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012; Hong YY, 2010, PLANT CELL ENVIRON, V33, P627, DOI 10.1111/j.1365-3040.2009.02087.x; Andersson MX, 2006, PLANT J, V47, P947, DOI 10.1111/j.1365-313X.2006.02844.x; Li MY, 2009, BBA-MOL CELL BIOL L, V1791, P927, DOI 10.1016/j.bbalip.2009.02.017; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Laliberte JF, 2014, ANN REV VIROL, V1, P237, DOI 10.1146/annurev-virology-031413-085532; Mine A, 2012, CURR OPIN VIROL, V2, P669, DOI 10.1016/j.coviro.2012.09.014; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; Konan KV, 2014, CURR OPIN VIROL, V9, P45, DOI 10.1016/j.coviro.2014.09.005; Bargmann BOR, 2006, PLANT J, V45, P358, DOI 10.1111/j.1365-313X.2005.02631.x; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Canonne Joanne, 2011, Plant Signal Behav, V6, P13; Chuang CK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003944; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Duijsings D, 2007, J GEN VIROL, V88, P3027, DOI 10.1099/vir.0.83169-0; Guo L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00051; Hirata Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002860; Hyodo K, 2011, VIROLOGY, V413, P300, DOI 10.1016/j.virol.2011.02.017; Hyodo K, 2014, PLANT SCI, V5; Hyodo K, 2014, PLANT SIGNAL BEHAV, V9; Hyodo K, 2014, J GEN PLANT PATHOL, V80, P123, DOI 10.1007/s10327-014-0505-7; Hyodo K, 2013, J VIROL, V87, P163, DOI 10.1128/JVI.02383-12; Iwakawa H, 2011, J VIROL, V85, P497, DOI 10.1128/JVI.01754-10; Iwakawa HO, 2012, J VIROL, V86, P7836, DOI 10.1128/JVI.00538-12; Iwakawa HO, 2007, VIROLOGY, V369, P168, DOI 10.1016/j.virol.2007.07.016; Janda M, 2015, PLANT SCI, V6; JANDA M, 1987, VIROLOGY, V158, P259, DOI 10.1016/0042-6822(87)90265-0; Johansson ON, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00639; Kaido M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004505; Kaido M, 2009, VIROLOGY, V395, P232, DOI 10.1016/j.virol.2009.09.022; Kim SC, 2013, J BIOL CHEM, V288, P11834, DOI 10.1074/jbc.M112.427229; Komoda K, 2004, P NATL ACAD SCI USA, V101, P1863, DOI 10.1073/pnas.0307131101; Kusumanegara K, 2012, VIROLOGY, V433, P131, DOI 10.1016/j.virol.2012.07.017; Iwakawa HO, 2008, J VIROL, V82, P10162, DOI 10.1128/JVI.01027-08; Mine A, 2012, J VIROL, V86, P12091, DOI 10.1128/JVI.01659-12; Mine A, 2010, J VIROL, V84, P6070, DOI 10.1128/JVI.00054-10; Mine A, 2010, VIROLOGY, V407, P213, DOI 10.1016/j.virol.2010.07.038; Mizumoto H, 2003, J VIROL, V77, P12113, DOI 10.1128/JVI.77.22.12113-12121.2003; Mizumoto H, 2006, J VIROL, V80, P3781, DOI 10.1128/JVI.80.8.3781-3791.2006; Nakano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075124; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Okuno T, 2013, ADV VIRUS RES, V87, P36; Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584; Takeda A, 2005, EMBO J, V24, P3147, DOI 10.1038/sj.emboj.7600776; Turner KA, 2004, VIROLOGY, V320, P276, DOI 10.1016/j.virol.2003.12.006; van der Luit AH, 2000, PLANT PHYSIOL, V123, P1507, DOI 10.1104/pp.123.4.1507; Verheije MH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000088; Wang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093577; XIONG ZG, 1991, VIROLOGY, V182, P388, DOI 10.1016/0042-6822(91)90687-7; Yamaguchi T, 2009, PLANT PHYSIOL, V150, P308, DOI 10.1104/pp.108.131979; Zhang WD, 2008, MOL CELLS, V26, P258	77	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7366	1553-7374		PLOS PATHOG	PLoS Pathog.	MAY	2015	11	5							UNSP e1004909	10.1371/journal.ppat.1004909		28	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	CJ1UF	WOS:000355269300048		
J	Kaneko, I; Iwanaga, S; Kato, T; Kobayashi, I; Yuda, M				Kaneko, Izumi; Iwanaga, Shiroh; Kato, Tomomi; Kobayashi, Issei; Yuda, Masao			Genome-Wide Identification of the Target Genes of AP2-O, a Plasmodium AP2-Family Transcription Factor	PLOS PATHOGENS			English	Article							MOSQUITO MIDGUT INVASION; MALARIA PARASITES; DNA-BINDING; SEXUAL DEVELOPMENT; TOXOPLASMA-GONDII; PROTEIN FAMILY; MEMBRANE; SPOROZOITES; TRANSMISSION; NETWORKS	Stage-specific transcription is a fundamental biological process in the life cycle of the Plasmodium parasite. Proteins containing the AP2 DNA-binding domain are responsible for stage-specific transcriptional regulation and belong to the only known family of transcription factors in Plasmodium parasites. Comprehensive identification of their target genes will advance our understanding of the molecular basis of stage-specific transcriptional regulation and stage-specific parasite development. AP2-O is an AP2 family transcription factor that is expressed in the mosquito midgut-invading stage, called the ookinete, and is essential for normal morphogenesis of this stage. In this study, we identified the genome-wide target genes of AP2-O by chromatin immunoprecipitation-sequencing and elucidate how this AP2 family transcription factor contributes to the formation of this motile stage. The analysis revealed that AP2-O binds specifically to the upstream genomic regions of more than 500 genes, suggesting that approximately 10% of the parasite genome is directly regulated by AP2-O. These genes are involved in distinct biological processes such as morphogenesis, locomotion, midgut penetration, protection against mosquito immunity and preparation for subsequent oocyst development. This direct and global regulation by AP2-O provides a model for gene regulation in Plasmodium parasites and may explain how these parasites manage to control their complex life cycle using a small number of sequence-specific AP2 transcription factors.	[Kaneko, Izumi; Iwanaga, Shiroh; Kato, Tomomi; Yuda, Masao] Mie Univ, Dept Med Zool, Grad Sch Med, Tsu, Mie 514, Japan; [Kobayashi, Issei] Mie Univ, Core Lab, Grad Sch Reg Innovat Studies, Tsu, Mie 514, Japan	Yuda, M (reprint author), Mie Univ, Dept Med Zool, Grad Sch Med, Tsu, Mie 514, Japan.	m-yuda@doc.medic.mie-u.ac.jp			JSPS KAKENHI [90293779]	This work was supported by JSPS KAKENHI Grant Number 90293779. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Kafsack BFC, 2014, NATURE, V507, P248, DOI 10.1038/nature12920; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Hughes TR, 2013, GENETICS, V195, P9, DOI 10.1534/genetics.113.153262; Tran JQ, 2012, EUKARYOT CELL, V11, P206, DOI 10.1128/EC.05161-11; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deligianni E, 2013, CELL MICROBIOL, V15, P1438, DOI 10.1111/cmi.12131; Kariu T, 2006, MOL MICROBIOL, V59, P1369, DOI 10.1111/j.1365-2958.2958.2005.05024.x; Patra KP, 2008, PROTEOMICS, V8, P2492, DOI 10.1002/pmic.200700727; Lal K, 2009, PROTEOMICS, V9, P1142, DOI 10.1002/pmic.200800404; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Kondos SC, 2010, TISSUE ANTIGENS, V76, P341, DOI 10.1111/j.1399-0039.2010.01566.x; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Cheng C, 2011, BIOINFORMATICS, V27, P3221, DOI 10.1093/bioinformatics/btr552; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Adryan B, 2006, BIOINFORMATICS, V22, P1532, DOI 10.1093/bioinformatics/btl143; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Orosz F, 2009, INFECT GENET EVOL, V9, P1275, DOI 10.1016/j.meegid.2009.09.001; Gilk SD, 2006, EUKARYOT CELL, V5, P1622, DOI 10.1128/EC.00114-06; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; Sinha A, 2014, NATURE, V507, P253, DOI 10.1038/nature12970; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Kaiser K, 2004, MOL BIOCHEM PARASIT, V133, P15, DOI 10.1016/j.molbiopara.2003.08.009; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Kadota K, 2004, P NATL ACAD SCI USA, V101, P16310, DOI 10.1073/pnas.0406187101; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Ecker A, 2007, EXP PARASITOL, V116, P504, DOI 10.1016/j.exppara.2007.01.015; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; HUBER M, 1991, P NATL ACAD SCI USA, V88, P2807, DOI 10.1073/pnas.88.7.2807; Sebastian S, 2012, CELL HOST MICROBE, V12, P9, DOI 10.1016/j.chom.2012.05.014; Wu S, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-18; Jortzik E, 2012, INT J MED MICROBIOL, V302, P187, DOI 10.1016/j.ijmm.2012.07.007; Yuda M, 2001, MOL BIOCHEM PARASIT, V116, P65, DOI 10.1016/S0166-6851(01)00304-8; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Barkhuff WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023977; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Bushell ESC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000539; Ecker A, 2008, MOL MICROBIOL, V70, P209, DOI 10.1111/j.1365-2958.2008.06407.x; Hall N, 2005, CURR OPIN GENET DEV, V15, P609, DOI 10.1016/j.gde.2005.09.001; Hinds L, 2009, EUKARYOT CELL, V8, P1869, DOI 10.1128/EC.00218-09; Iwanaga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047557; Khater EI, 2004, J CELL BIOL, V167, P425, DOI 10.1083/jcb.200406068; Marois E, 2011, CURR OPIN MICROBIOL, V14, P429, DOI 10.1016/j.mib.2011.07.016; Montagna GN, 2012, J BIOL CHEM, V287, P2410, DOI 10.1074/jbc.M111.302109; Ning J, 2013, GENE DEV, V27, P1198, DOI 10.1101/gad.212746.112; Pastrana-Mena R, 2010, J BIOL CHEM, V285, P27045, DOI 10.1074/jbc.M110.122275; Poulin B, 2013, BIOL OPEN, V2, P1160, DOI 10.1242/bio.20136163; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Srinivasan P, 2008, CELL MICROBIOL, V10, P1304, DOI 10.1111/j.1462-5822.2008.01127.x; Tremp AZ, 2008, J BIOL CHEM, V283, P27604, DOI 10.1074/jbc.M801302200; Tremp AZ, 2011, J BIOL CHEM, V286, P5383, DOI 10.1074/jbc.M110.187195; Vega-Rodriguez J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000302; Yuda M, 1999, J EXP MED, V189, P1947, DOI 10.1084/jem.189.12.1947; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	61	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7366	1553-7374		PLOS PATHOG	PLoS Pathog.	MAY	2015	11	5							e1004905	10.1371/journal.ppat.1004905		27	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	CJ1UF	WOS:000355269300045		
J	Terao, K; Kanenaga, R; Yoshida, T; Mizuno, K; Bachinger, HP				Terao, Ken; Kanenaga, Ryoko; Yoshida, Tasuku; Mizuno, Kazunori; Baechinger, Hans Peter			Temperature induced complex formation-deformation behavior of collagen model peptides and polyelectrolytes in aqueous solution	POLYMER			English	Article						Intermolecular interactions; Small-angle X-ray scattering; Sodium carboxymethyl amylose	TRIPLE-HELICAL STRUCTURE; LIQUID-CHROMATOGRAPHY; MOLECULAR-STRUCTURE; SCATTERING FUNCTION; WORMLIKE CHAINS; STABILIZATION; AMYLOSE; SYSTEM	Since the triple-helical collagen model peptides with a free N-terminus have three cationic groups at one end, it may have strong interactions with polyelectrolytes. In this study, complex formation behavior was investigated for sodium carboxymethyl amylose (NaCMA) + H-(Pro-Pro-Gly)(10)-OH (PPG10), a collagen model peptide, in aqueous NaCl with ionic strength of 10 mM and 100 mM by means of small-angle X-ray scattering (SAXS) and circular dichroism at different temperatures. The previously reported [Macromolecules 2012, 45, 392-400] sodium polyacrylate (NaPAA) and H-(Gly-Pro-4-(R)-Hyp)(9)-OH (GPO9) system was also investigated to elucidate complex formation nearby the transition temperature region between triple helix and single coil of the peptide. The complex formed near the melting temperature of the triple helices, confirmed that the triple helical structure is directly related to the complex formation. (C) 2015 Elsevier Ltd. All rights reserved.	[Terao, Ken; Kanenaga, Ryoko; Yoshida, Tasuku] Osaka Univ, Dept Macromol Sci, Toyonaka, Osaka 5600043, Japan; [Mizuno, Kazunori; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Terao, K (reprint author), Osaka Univ, Dept Macromol Sci, 1-1 Machikaneyama Cho, Toyonaka, Osaka 5600043, Japan.	kterao@chem.sci.osaka-u.ac.jp; hpb@shcc.org	Terao, Ken/B-9143-2008	Terao, Ken/0000-0001-7363-4491	JSPS KAKENHI [25410130, 23350055]; Photon Factory Program Advisory Committee [2011G557]	We are grateful to Professor Takahiro Sato in Osaka University for fruitful discussion and to Dr. Nobutaka Shimizu and Dr. Noriyuki Igarashi in KEK and Dr. Noboru Ohta in SPring-8 for SAXS measurements. The synchrotron radiation experiments were performed at the BL-10C in KEK-PF wider the approval of the Photon Factory Program Advisory Committee (No. 2011G557) and at the BL40B2 in SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2013A1046). This work was partially supported by JSPS KAKENHI Grant Nos. 25410130 and 23350055.	BERRY GC, 1966, J CHEM PHYS, V44, P4550, DOI 10.1063/1.1726673; Gummel J, 2008, MACROMOLECULES, V41, P2898, DOI 10.1021/ma702242d; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; KITAMURA S, 1982, POLYM J, V14, P93, DOI 10.1295/polymj.14.93; Fallas JA, 2010, CHEM SOC REV, V39, P3510, DOI 10.1039/b919455j; Fields GB, 2010, ORG BIOMOL CHEM, V8, P1237, DOI 10.1039/b920670a; Di Palma S, 2012, J PROTEOMICS, V75, P3791, DOI 10.1016/j.jprot.2012.04.033; REGNIER FE, 1983, SCIENCE, V222, P245, DOI 10.1126/science.6353575; Morfin I, 2011, BIOMACROMOLECULES, V12, P859, DOI 10.1021/bm100861g; HUBER K, 1989, MACROMOLECULES, V22, P3332, DOI 10.1021/ma00198a024; NAGASAKA K, 1991, MACROMOLECULES, V24, P924, DOI 10.1021/ma00004a018; Okuyama K, 2008, CONNECT TISSUE RES, V49, P299, DOI 10.1080/03008200802325110; Berisio R, 2009, J PEPT SCI, V15, P131, DOI 10.1002/psc.1082; BURCHARD W, 1970, PROC R SOC LON SER-A, V316, P185, DOI 10.1098/rspa.1970.0074; Glatter O., 1982, SMALL ANGLE XRAY SCA; HOLTZER A, 1955, J POLYM SCI, V17, P432, DOI 10.1002/pol.1955.120178515; Kita Y, 2010, KOBUNSHI RONBUNSHU, V67, P686, DOI 10.1295/koron.67.686; Nakamura Y., 2008, SOFT MATTER CHARACTE, P235, DOI 10.1007/978-1-4020-4465-6_5; Nakamura Y, 2004, J POLYM SCI POL PHYS, V42, P1398, DOI 10.1002/polb.20026; OKUYAMA K, 1981, J MOL BIOL, V152, P427, DOI 10.1016/0022-2836(81)90252-7; Okuyama K, 2010, KOBUNSHI RONBUNSHU, V67, P229; Shikata T, 2009, J PHYS CHEM B, V113, P14504, DOI 10.1021/jp906719f; Terao K, 2008, MACROMOLECULES, V41, P7203, DOI 10.1021/ma800790w; Terao K, 2012, MACROMOLECULES, V45, P392, DOI 10.1021/ma202176w; Tsuboi A, 1996, LANGMUIR, V12, P6295, DOI 10.1021/la960653m; WALDMANN H, 1986, CARBOHYD RES, V157, pC4, DOI 10.1016/0008-6215(86)85078-9	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0032-3861	1873-2291		POLYMER	Polymer	MAY 1	2015	64						8	13		10.1016/j.polymer.2015.03.013		6	Polymer Science	Polymer Science	CJ1KB	WOS:000355241400002		
J	Sato, E; Yamanishi, K; Inui, T; Horibe, H; Matsumoto, A				Sato, Eriko; Yamanishi, Keisuke; Inui, Tadashi; Horibe, Hideo; Matsumoto, Akikazu			Acetal-protected acrylic copolymers for dismantlable adhesives with spontaneous and complete removability	POLYMER			English	Article						Deprotection; Reactive polymer; Pressure-sensitive adhesive	PRESSURE-SENSITIVE ADHESIVES; BLOCK-COPOLYMERS; PHOTOIRRADIATION; POSTBAKING; PERFORMANCE; BEHAVIOR; SYSTEM	Acetal-protected acrylic copolymers consisting of 1-isobutoxyethyl aciylate (iBEA), 2-ethylhexyl acrylate (2EHA), and 2-hydroxyethyl acrylate (HEA) repeating units were applied to the pressure-sensitive adhesive (PSA) types of dismantlable adhesives. The random and block copolymers with a relatively high HEA content showed good PSA properties before dismantling treatment. The deprotection of the acetal-protected group of the iBEA unit took place in response to individual external stimuli, soaking in boiling water and UV irradiation in the presence of a photoacid generator. The random copolymers containing an HEA unit of more than 10 mol% and an iBEA unit of more than 70 mol% achieved spontaneous debonding with interfacial failures at both the stainless steel and polyethylene terephthalate support film sides by soaking in boiling water within 10 min, whereas the corresponding block copolymer did not achieve interfacial failure even after a 20-min soaking. Photoirradiation of the random copolymers containing N-hydroxynaphthalimide triflate as a photoacid generator resulted in interfacial failures at both sides with a sufficiently reduced peel strength, where cross-linking arose due to the transacetalization and trans-esterification of a hydroxy group in the HEA unit along with deprotection. (C) 2015 Elsevier Ltd. All rights reserved.	[Sato, Eriko; Yamanishi, Keisuke; Inui, Tadashi; Horibe, Hideo] Osaka City Univ, Grad Sch Engn, Dept Appl Chem & Bioengn, Sumiyoshi Ku, Osaka 5588585, Japan; [Matsumoto, Akikazu] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, Sakai, Osaka 5998531, Japan	Sato, E (reprint author), Osaka City Univ, Grad Sch Engn, Dept Appl Chem & Bioengn, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	sato@a-chem.eng.osaka-cu.ac.jp; matsumoto@chem.osakafu-u.ac.jp					Mcelhanon JR, 2002, J APPL POLYM SCI, V85, P1496, DOI 10.1002/app.10753; Inui T, 2014, RSC ADV, V4, P24719, DOI 10.1039/c4ra03745f; Yamago S, 2009, CHEM REV, V109, P5051, DOI 10.1021/cr9001269; Sato E, 2010, ACS APPL MATER INTER, V2, P2594, DOI 10.1021/am1004392; Inui T, 2012, ACS APPL MATER INTER, V4, P2124, DOI 10.1021/am300103c; Trenor SR, 2005, J ADHESION, V81, P213, DOI 10.1080/00218460590922011; Harris JJ, 2000, LANGMUIR, V16, P2006, DOI 10.1021/la990620h; Wang LJ, 2000, J POLYM SCI POL CHEM, V38, P3771, DOI 10.1002/1099-0518(20001015)38:20<3771::AID-POLA80>3.0.CO;2-4; Wang RM, 2010, LANGMUIR, V26, P2999, DOI 10.1021/la9046403; Kobayashi M, 2013, POLYM CHEM-UK, V4, P4987, DOI 10.1039/c3py00146f; Lee JT, 2009, J AM CHEM SOC, V131, P11294, DOI 10.1021/ja904554m; Yamago S, 2002, J AM CHEM SOC, V124, P2874, DOI 10.1021/ja025554b; Inui T, 2013, MACROMOLECULES, V46, P8111, DOI 10.1021/ma401595w; Sato E, 2012, ACS APPL MATER INTER, V4, P2057, DOI 10.1021/am300028f; Boyne JM, 2001, INT J ADHES ADHES, V21, P49, DOI 10.1016/S0143-7496(00)00027-0; Ebe K, 2003, J APPL POLYM SCI, V90, P436, DOI 10.1002/app.12673; Freitas JCR, 2012, MAGN RESON CHEM, V50, P481, DOI 10.1002/mrc.3826; Gilbert MD, 2007, Patent No. [US 2007/0269659 A1, 20070269659]; HERTLER WR, 1992, MAKROMOL CHEM-M SYMP, V64, P137, DOI 10.1002/masy.19920640114; Kobayashi M, 2011, SOFT MATTER, V7, P5717, DOI 10.1039/c1sm05132f; Leijonmarck S, 2011, J ELECTROCHEM SOC, V158, P109; Leijonmarck S, 2012, INT J ADHES ADHES, V32, P39, DOI 10.1016/j.ijadhadh.2011.09.003; Malik S., 1999, Journal of Photopolymer Science and Technology, V12, DOI 10.2494/photopolymer.12.591; Nishiyama Y, 2003, INT J ADHES ADHES, V23, P377, DOI 10.1016/S0143-7496(03)00067-8; Ogino K, 1998, CHEM MATER, V10, P3833, DOI 10.1021/cm9801183; Sato E, 2014, J PHOTOPOLYM SCI TEC, V27, P531; Simmons III HE, 1994, APPL POLYM SCI, V52, P727; Yamanishi K, 2013, J PHOTOPOLYM SCI TEC, V26, P239	28	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0032-3861	1873-2291		POLYMER	Polymer	MAY 1	2015	64						260	267		10.1016/j.polymer.2015.01.057		8	Polymer Science	Polymer Science	CJ1KB	WOS:000355241400033		
J	Fujiwara, T				Fujiwara, T.			Effectiveness of public health practices against shaken baby syndrome/abusive head trauma in Japan	PUBLIC HEALTH			English	Article						Abusive head trauma; Shaken baby syndrome; Crying; Intervention; Japan; Public health	RANDOMIZED CONTROLLED-TRIAL; AGE-RELATED INCIDENCE; CHANGE KNOWLEDGE; YOUNG-CHILDREN; COMPUTED-TOMOGRAPHY; IMPACT SYNDROME; BEHAVIOR; SHAKING; INJURY; ABUSE	Objectives: Previous studies have demonstrated the effectiveness of educational materials on infant crying to change caregivers' knowledge and behaviours related to shaken baby syndrome or abusive head trauma (SBS/AHT) using selected samples in randomized controlled trials. This study investigated the impact of public health practices to prevent SBS/AHT in Japan through the use of educational materials. Study design: Cross-sectional study. Methods: The intervention was comprised of two parts: (1) the screening of an educational DVD at a prenatal class; and (2) the distribution of a public health pamphlet at a postnatal home visit. Expectant parents watched a DVD (The Period of PURPLE Crying) about the features of infant crying and recommended behaviours (walking away if frustrated in the event of unsoothable crying, sharing information on crying with other caregivers) at a preterm parenting class held at eightmonths' gestation. A postnatal home-visit service was implemented in which a maternity nurse distributed a pamphlet to explain information about infant crying. Before the four-month health check-up, a self-administered questionnaire was distributed to assess exposure to these public health practices and outcome variables (i.e. infant crying knowledge, walk-away and information-sharing behaviours), and responses were collected at the four-month health check-up (n = 1316). The impacts of these interventions on outcome variables were analysed by comparing those exposed to both interventions, either intervention and neither intervention after adjusting for covariates. Results: Crying and shaking knowledge were significantly higher among women exposed to the public health practices, with a dose-response relationship (both P < 0.001). Further, walk-away behaviour during periods of unsoothable crying was higher among the intervention group. However, sharing information about infant crying with other caregivers was less likely among the intervention group. Conclusions: The impact of educational materials in public health practice on knowledge of crying and shaking, and walk-away behaviour in Japan had a dose-response relationship; however, an increase in sharing information with other caregivers was not observed. (C) 2015 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.	Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, Tokyo, Japan	Fujiwara, T (reprint author), Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, Tokyo, Japan.	fujiwara-tk@ncchd.go.jp			Ministry of Education, Culture, Sports, Science and Technology [KAKENHI 21790593]; Ministry of Health, Labour, and Welfare [H23-Seisaku-Ippan-005]	This study was partially supported by grants from Grant-in-Aid for Young Scientists (B) Scientific Research, Ministry of Education, Culture, Sports, Science and Technology (KAKENHI 21790593) and Ministry of Health, Labour, and Welfare (H23-Seisaku-Ippan-005).	Altman RL, 2011, PEDIATRICS, V128, pE1164, DOI 10.1542/peds.2010-3260; Kairys SW, 2001, PEDIATRICS, V108, P206; Bechtel K, 2011, ACAD PEDIATR, V11, P481, DOI 10.1016/j.acap.2011.08.001; Fujiwara T, 2012, CHILD ABUSE NEGLECT, V36, P613, DOI 10.1016/j.chiabu.2012.07.003; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Barr RG, 2009, PEDIATRICS, V123, P972, DOI 10.1542/peds.2008-0908; SINAL SH, 1987, SOUTHERN MED J, V80, P1505; HADLEY MN, 1989, NEUROSURGERY, V24, P536; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; Barr RG, 2009, CAN MED ASSOC J, V180, P727, DOI 10.1503/cmaj.081419; Lee C, 2007, J DEV BEHAV PEDIATR, V28, P288, DOI 10.1097/DBP.0b013e3180327b55; Fujiwara T, 2008, PEDIATRICS, V122, pE841, DOI 10.1542/peds.2008-0387; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Stewart TC, 2011, J TRAUMA, V71, P1801, DOI 10.1097/TA.0b013e31823c484a; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; Kesler H, 2008, J NEUROS-PEDIATR, V1, P351, DOI 10.3171/PED/2008/1/5/351; ZIMMERMAN RA, 1979, RADIOLOGY, V130, P687; Barr RG, 2004, PERIOD PURPLE CRYING; Dias Mark S, 2005, Pediatrics, V115, pe470, DOI 10.1542/peds.2004-1896; Fujiwara T, 2010, PSYCHOLOGIA, V53, P211; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Ministry of Health Labour and Welfare, 2010, ANN REPORT; Schleiss MR, 2011, RUDOLPHS PEDIAT, V22nd; Showers J, 1998, P 2 NAT C SHAK BAB S; Simonnet H, 2014, CHILD ABUSE NEGLECT, V38, P1914, DOI 10.1016/j.chiabu.2014.06.002; Talvik I, 2008, ACTA PAEDIATR, V97, P782, DOI 10.1111/j.1651-2227.2008.00778.x; Tolliday F, 2010, COMMUNITIES CHILDREN, V5, P31; Yamada F, 2014, INT J ENV RES PUB HE, V11, P6485, DOI 10.3390/ijerph110606485	30	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0033-3506	1476-5616		PUBLIC HEALTH	Public Health	MAY	2015	129	5					475	482		10.1016/j.puhe.2015.01.018		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CJ0EF	WOS:000355146400009		
J	Osaki, K; Kosen, S; Indriasih, E; Pritasari, K; Hattori, T				Osaki, K.; Kosen, S.; Indriasih, E.; Pritasari, K.; Hattori, T.			Factors affecting the utilisation of maternal, newborn, and child health services in Indonesia: the role of the Maternal and Child Health Handbook	PUBLIC HEALTH			English	Article							MORTALITY		[Osaki, K.] Japan Int Cooperat Agcy, Tokyo 1028012, Japan; [Kosen, S.; Indriasih, E.; Pritasari, K.] Republ Indonesia, Minist Hlth, Jakarta, Indonesia; [Hattori, T.] Hlth & Dev Serv, Tokyo, Japan	Osaki, K (reprint author), Japan Int Cooperat Agcy, Chiyoda Ku, 5-25 Niban Cho, Tokyo 1028012, Japan.	Osaki.Keiko@jica.go.jp; soewarta.kosen7@gmail.com; e_indriasih@yahoo.com; kirana72012@gmail.com; ryoma.intl@gmail.com					Achadi EI, 2014, 91325 WORLD BANK GRO; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Ronsmans C, 2009, B WORLD HEALTH ORGAN, V87, P416, DOI 10.2471/BLT.08.051581; Badan Penelitian dan Pengembangan Kesehatan (Institute for Research and Health Development), 2010, MIN HLTH MOH; Kusmayati A, 2007, J INT HLTH, V22, P143; Osaki K., 2013, Global Health Action, V6, P20429; Trisnantoro L, 2010, B WORLD HEALTH ORGAN, V88, P642, DOI 10.2471/BLT.10.082073; WHO UNICEF, 2012, COUNTD 2015 BUILD FU	9	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0033-3506	1476-5616		PUBLIC HEALTH	Public Health	MAY	2015	129	5					582	586		10.1016/j.puhe.2015.01.001		5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CJ0EF	WOS:000355146400025		
J	Tsuji, T; Itoh, Y; Nakamura, T; Toyozumi, Y; Arima, N; Tsuda, H				Tsuji, T.; Itoh, Y.; Nakamura, T.; Toyozumi, Y.; Arima, N.; Tsuda, H.			Crystalglobulinemia syndrome due to monoclonal gammopathy of renal significance	QJM-AN INTERNATIONAL JOURNAL OF MEDICINE			English	Editorial Material							MULTIPLE-MYELOMA; PATIENT		[Tsuji, T.; Tsuda, H.] Kumamoto City Hosp, Div Hematol Oncol, Kumamoto 8628505, Japan; [Itoh, Y.] Kumamoto City Hosp, Div Neurol, Kumamoto 8628505, Japan; [Nakamura, T.] Kumamoto City Hosp, Div Nephrol, Kumamoto 8628505, Japan; [Toyozumi, Y.; Arima, N.] Kumamoto City Hosp, Div Clin Pathol, Kumamoto 8628505, Japan	Tsuji, T (reprint author), Kumamoto City Hosp, Div Hematol Oncol, Kumamoto 8628505, Japan.	tsuji.takahiro@city.kumamoto.lg.jp					Leung N, 2012, BLOOD, V120, P4292, DOI 10.1182/blood-2012-07-445304; MATSUYAMA N, 1994, AM J KIDNEY DIS, V23, P859; Merlini G, 2012, HEMATOL-AM SOC HEMAT, P595, DOI 10.1182/asheducation-2012.1.595; BALL NJ, 1993, CANCER, V71, P1231, DOI 10.1002/1097-0142(19930215)71:4<1231::AID-CNCR2820710410>3.0.CO;2-J; Hashimoto R, 2007, INT J HEMATOL, V85, P203, DOI 10.1532/IJH97.06074; Kanno Y, 2001, CLIN NEPHROL, V56, P398	6	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1460-2725	1460-2393		QJM-INT J MED	QJM-An Int. J. Med.	MAY 1	2015	108	5					417	418		10.1093/qjmed/hcu114		2	Medicine, General & Internal	General & Internal Medicine	CJ2KG	WOS:000355312600011		
J	Ohtani, K; Shimizu, T				Ohtani, Kaori; Shimizu, Tohru			Regulation of toxin gene expression in Clostridium perfringens	RESEARCH IN MICROBIOLOGY			English	Article						Substance A; Two-component system; Cell-cell signaling; Regulatory RNA; Cell-pathogen signaling	ENTEROPATHOGENIC ESCHERICHIA-COLI; VIRULENCE GENES; PERFRINGOLYSIN-O; VIRR/VIRS SYSTEM; RNA MOLECULE; BACTERIA; CONTACT; MUTANTS; LOCUS; COMPLEMENTATION	The Gram-positive, anaerobic, spore-forming, rod-shaped Clostridium perfringens is widely distributed in nature, especially in soil and the gastrointestinal tract of humans and animals. C. perfringens causes clostridial myonecrosis (or gas gangrene), enteritis and enterotoxemia in humans and livestock by producing numerous extracellular toxins and enzymes. The toxin gene expression is regulated by a two-component regulatory system and regulatory RNA VirR/VirS-VR-RNA cascade. The VirR/VirS system was originally found in a type A strain, but a recent report showed that it is also important for the toxin gene regulation in other types of strains. Two types of cell cell signaling, i.e., agr-system and AI-2 signaling, are also important for the regulation of toxin genes. Several regulatory systems independent from the VirR/VirS system, including virX, the orphan histidine kinase ReeS and orphan response regulator RevR, are also involved in the regulation of toxin genes. In addition, the expression of toxin genes is upregulated after contact with Caco-2 cells. C. perfringens has a complex regulatory network for toxin gene expression and thus the coordination of toxin gene expression is important for the process of infection. (C) 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.	[Ohtani, Kaori; Shimizu, Tohru] Kanazawa Univ, Grad Sch Med Sci, Dept Bacteriol, Kanazawa, Ishikawa 9208640, Japan	Ohtani, K (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Bacteriol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	ohtanik@med.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Health and Labor Sciences Research Grants (Research on Food Safety)	The work carried out in my laboratory was supported by KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas "Applied Genomics" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by Health and Labor Sciences Research Grants (Research on Food Safety).	Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Ohtani K, 2009, J BACTERIOL, V191, P3919, DOI 10.1128/JB.01455-08; Shimizu T, 2002, MOL MICROBIOL, V43, P257, DOI 10.1046/j.1365-2958.2002.02743.x; Vidal JE, 2009, CELL MICROBIOL, V11, P1306, DOI 10.1111/j.1462-5822.2009.01332.x; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Okumura K, 2008, J BACTERIOL, V190, P7719, DOI 10.1128/JB.01573-07; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; Parker CT, 2009, CELL MICROBIOL, V11, P363, DOI 10.1111/j.1462-5822.2008.01272.x; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; NOVICK RP, 1993, EMBO J, V12, P3967; Leverton LQ, 2005, INFECT IMMUN, V73, P1034, DOI 10.1128/IAI.73.2.1034-1043.2005; FUQUA WC, 1994, J BACTERIOL, V176, P269; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; SHIMIZU T, 1994, J BACTERIOL, V176, P1616; Ohtani K, 2002, MOL MICROBIOL, V44, P171, DOI 10.1046/j.1365-2958.2002.02863.x; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Banu S, 2000, MOL MICROBIOL, V35, P854, DOI 10.1046/j.1365-2958.2000.01760.x; BaThein W, 1996, J BACTERIOL, V178, P2514; Chen J, 2014, GUT MICROBES, V5, P1; Chen J, INFECT IMMUN, V80, P3008; Chen J, MBIO, V2; Cheung JK, 2004, J BACTERIOL, V186, P3321, DOI 10.1128/JB.186.11.3321-3330.2004; Cheung JK, INFECT IMMUN, V78, P3064; Cheung JK, 2000, J BACTERIOL, V182, P57; Dineen SS, J BACTERIOL, V192, P5350; GINOCCHIO CC, 1994, CELL, V76, P717, DOI 10.1016/0092-8674(94)90510-X; HIGASHI Y, 1973, BIKEN J, V16, P1; Hiscox TJ, PLOS ONE, V8; Hiscox TJ, INFECT IMMUN, V79, P2145; IMAGAWA T, 1992, MICROBIOL IMMUNOL, V36, P523; IMAGAWA T, 1981, BIKEN J, V24, P13; Johansson J, 2003, TRENDS MICROBIOL, V11, P280, DOI 10.1016/S0966-842X(03)00118-5; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Keyburn AL, TOXINS BASEL, V2, P1913; Li J, MBIO, V4; Li JH, 2011, INFECT IMMUN, V79, P2451, DOI 10.1128/IAI.00169-11; Lindback T, ENV MICROBIOL, V14, P2233; LYRISTIS M, 1994, MOL MICROBIOL, V12, P761, DOI 10.1111/j.1365-2958.1994.tb01063.x; Ma M., MBIO, V2; Masse E, 2003, CURR OPIN MICROBIOL, V6, P120, DOI 10.1016/S1369-5274(03)00027-4; Novick RP, 1999, CURR OPIN MICROBIOL, V2, P40, DOI 10.1016/S1369-5274(99)80007-1; Ohtani K, 2003, FEMS MICROBIOL LETT, V222, P137, DOI 10.1016/S0378-1097(03)00255-6; Ohtani K, J BACTERIOL, V195, P2931; Ohtani K, 2010, ANAEROBE, V16, P258, DOI 10.1016/j.anaerobe.2009.10.003; Ohtani K, 2000, MICROBIOL IMMUNOL, V44, P525; Ohtani K, 2002, FEMS MICROBIOL LETT, V209, P109, DOI 10.1016/S0378-1097(02)00493-7; SLOAN J, 1992, PLASMID, V27, P207, DOI 10.1016/0147-619X(92)90023-4; Stenz L, FEMS IMMUNOL MED MIC, V62, P123; Thoendel M, CHEM REV, V111, P117; van Schaik W, 2009, INFECT IMMUN, V77, P4437, DOI 10.1128/IAI.00716-09; Vidal JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006232; Vidal JE, MOL MICROBIOL, V83, P179; Vidal JE, 2006, INFECT IMMUN, V74, P2293, DOI 10.1128/IAI.74.4.2293-2303.2006	57	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0923-2508	1769-7123		RES MICROBIOL	Res. Microbiol.	MAY	2015	166	4			SI		280	289		10.1016/j.resmic.2014.09.010		10	Microbiology	Microbiology	CI8QZ	WOS:000355038100007		
J	Sakaguchi, Y; Suzuki, T; Yamamoto, Y; Nishikawa, A; Oguma, K				Sakaguchi, Yoshihiko; Suzuki, Tomonori; Yamamoto, Yumiko; Nishikawa, Atsushi; Oguma, Keiji			Genomics of Clostridium botulinum group III strains	RESEARCH IN MICROBIOLOGY			English	Article						Clostridium botulinum group III; Neurotoxin; Progenitor toxin; C2 toxin; C3 exoenzyme; Phage conversion	COMPLETE NUCLEOTIDE-SEQUENCE; C PROGENITOR TOXIN; PHAGE-CONVERSION; BACILLUS-THURINGIENSIS; MONOCLONAL-ANTIBODIES; HEMAGGLUTININ HA1; SUBUNIT STRUCTURE; ONE SUBCOMPONENT; TYPE-C1 TOXIN; SEROTYPE-D	In Clostridium botulinum, the characteristics of type C and D strains are quite different from other types, and they are classified as group III. They produce C2 binary toxin and C3 exoenzyme in addition to type C and D neurotoxins. Two different phages and many plasmids are identified in the organisms. The genes of neurotoxin and C3 exoenzyme are converted from toxigenic strains to non-toxigenic strains by the specific bacteriophages (phages), whereas, the C2 toxin gene is carried by large or small plasmids. Classification of type C and D strains has been in confusion because 1) antigenicity of type C and D neurotoxins is complex, 2) the cells produce two types of toxins, neurotoxin and C2 toxin, and 3) some non-toxigenic strains can be converted to produce C or D neurotoxin by the infection with phages. Until now, entire nucleotide sequences of cell chromosomes, phages, and plasmids have been determined. Since both genetic and protein-chemical analyses have been clarifying the above confusions, these data are reviewed historically. (C) 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.	[Sakaguchi, Yoshihiko] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki 8892192, Japan; [Suzuki, Tomonori] Tokyo Univ Agr, Dept Nutr Sci & Food Safety, Fac Appl Biosci, Setagaya Ku, Tokyo 1568502, Japan; [Yamamoto, Yumiko; Oguma, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Bacteriol, Kita Ku, Okayama 7008558, Japan; [Nishikawa, Atsushi] Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan; [Oguma, Keiji] Hakodate Internal Med Hosp, Hakodate, Hokkaido 0410843, Japan	Oguma, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Bacteriol, Kita Ku, 2-3-5 Shikata Cyo, Okayama 7008558, Japan.	ysakaguc@med.miyazaki-u.ac.jp; ts200588@nodai.ac.jp; yumiya@md.okayama-u.ac.jp; nishikaw@cc.tuat.ac.jp; kuma@md.okayama-u.ac.jp					AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; OGUMA K, 1976, INFECT IMMUN, V14, P597; Inoue K, 2001, MICROBIOL-UK, V147, P811; AKTORIES K, 1987, BIOCHEM J, V247, P363; Oguma K, 1999, J TOXICOL-TOXIN REV, V18, P17; Fujinaga Y, 2004, MICROBIOL-SGM, V150, P1529, DOI [10.1099/mic.0.26805-0, 10.1099/mic.0.026805-0]; Sakaguchi Y, 2009, J BACTERIOL, V191, P3282, DOI 10.1128/JB.01797-08; Hasegawa K, 2007, J BIOL CHEM, V282, P24777, DOI 10.1074/jbc.M703446200; Yamashita S, 2012, FEBS LETT, V586, P2404, DOI 10.1016/j.febslet.2012.05.055; Sakaguchi Y, 2005, P NATL ACAD SCI USA, V102, P17472, DOI 10.1073/pnas.0505503102; Kouguchi H, 2002, J BIOL CHEM, V277, P2650, DOI 10.1074/jbc.M106762200; Inoue K, 1999, MICROBIOL-UK, V145, P2533; OGUMA K, 1995, MICROBIOL IMMUNOL, V39, P161; FUJINAGA Y, 1994, BIOCHEM BIOPH RES CO, V205, P1291, DOI 10.1006/bbrc.1994.2805; JOHNSON JL, 1975, J GEN MICROBIOL, V88, P229; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; INOUE K, 1971, JPN J MED SCI BIOL, V24, P53; Inoue K, 1996, INFECT IMMUN, V64, P1589; TSUZUKI K, 1992, BIOCHEM BIOPH RES CO, V183, P1273, DOI 10.1016/S0006-291X(05)80328-6; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; EKLUND MW, 1972, NATURE-NEW BIOL, V235, P16; EKLUND MW, 1971, SCIENCE, V172, P480, DOI 10.1126/science.172.3982.480; EKLUND MW, 1974, APPL MICROBIOL, V27, P251; EKLUND MW, 1972, APPL MICROBIOL, V24, P108; Fujii N, 1996, BIOCHEM BIOPH RES CO, V220, P353, DOI 10.1006/bbrc.1996.0409; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; INOUE K, 1970, JPN J MICROBIOL, V14, P87; JANSEN B C, 1971, Onderstepoort Journal of Veterinary Research, V38, P93; Kimura K, 1998, VET MICROBIOL, V62, P27, DOI 10.1016/S0378-1135(98)00195-3; KIMURA K, 1990, BIOCHEM BIOPH RES CO, V171, P1304, DOI 10.1016/0006-291X(90)90828-B; Matsuka Y, 2012, J TOXICOL, V2012; Moriishi K, 1996, BBA-GENE STRUCT EXPR, V1307, P123, DOI 10.1016/0167-4781(96)00006-1; MORIISHI K, 1991, J BACTERIOL, V173, P6025; Mutoh S, 2003, BIOCHEMISTRY-US, V42, P10991, DOI 10.1021/bi034996c; OGUMA K, 1982, INFECT IMMUN, V38, P14; OGUMA K, 1976, J GEN MICROBIOL, V92, P67; OGUMA K, 1986, APPL ENVIRON MICROB, V51, P256; OGUMA K, 1984, INFECT IMMUN, V43, P584; OGUMA K, 1973, JPN J MICROBIOL, V17, P425; OGUMA K, 1981, INFECT IMMUN, V34, P382; OGUMA K, 1976, INFECT IMMUN, V13, P855; OGUMA K, 1980, INFECT IMMUN, V30, P656; OHISHI I, 1983, INFECT IMMUN, V40, P336; Oliva MA, 2012, P NATL ACAD SCI USA, V109, P7711, DOI 10.1073/pnas.1121546109; Sakaguchi G, 1984, BACTERIAL PROTEIN TO, P435; Skarin H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-185; Smith L. D., 1977, BOTULISM ORGANISM IT; Suzuki T, 2005, MICROBIOL-SGM, V151, P1475, DOI 10.1099/mic.0.27801-0; Tang MJ, 2006, APPL ENVIRON MICROB, V72, P6948, DOI 10.1128/AEM.00976-06; Tinsley E, 2006, J BACTERIOL, V188, P2829, DOI 10.1128/JB.188.8.2829-2835.2006; TSUZUKI K, 1990, INFECT IMMUN, V58, P3173; Uotsu N, 2006, BBA-MOL CELL RES, V1763, P120, DOI 10.1016/j.bbamcr.2005.11.014	52	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0923-2508	1769-7123		RES MICROBIOL	Res. Microbiol.	MAY	2015	166	4			SI		318	325		10.1016/j.resmic.2014.07.016		8	Microbiology	Microbiology	CI8QZ	WOS:000355038100010		
J	Kobayashi, N; Takezaki, S; Kobayashi, I; Iwata, N; Mori, M; Nagai, K; Nakano, N; Miyoshi, M; Kinjo, N; Murata, T; Masunaga, K; Umebayashi, H; Imagawa, T; Agematsu, K; Sato, S; Kuwana, M; Yamada, M; Takei, S; Yokota, S; Koike, K; Ariga, T				Kobayashi, Norimoto; Takezaki, Shunichiro; Kobayashi, Ichiro; Iwata, Naomi; Mori, Masaaki; Nagai, Kazushige; Nakano, Naoko; Miyoshi, Mari; Kinjo, Noriko; Murata, Takuji; Masunaga, Kenji; Umebayashi, Hiroaki; Imagawa, Tomoyuki; Agematsu, Kazunaga; Sato, Shinji; Kuwana, Masataka; Yamada, Masafumi; Takei, Shuji; Yokota, Shumpei; Koike, Kenichi; Ariga, Tadashi			Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis	RHEUMATOLOGY			English	Article						juvenile dermatomyositis; interstitial lung disease; interleukin-18; anti-melanoma differentiation-associated gene 5; KL-6; ferritin	IDIOPATHIC INFLAMMATORY MYOPATHIES; AMYOPATHIC DERMATOMYOSITIS; ANTI-CADM-140 ANTIBODY; MACROPHAGE ACTIVATION; ANTI-MDA5 ANTIBODY; CYCLOSPORINE-A; INTERLEUKIN-18; KL-6; FERRITIN; PREDICTS	Objective. Rapidly progressive interstitial lung disease (RP-ILD) is a rare but potentially fatal complication of JDM. The aim of this study was to establish markers for the prediction and early diagnosis of RP-ILD associated with JDM. Methods. The clinical records of 54 patients with JDM were retrospectively reviewed: 10 had RP-ILD (7 died, 3 survived), 19 had chronic ILD and 24 were without ILD. Routine tests included a high-resolution CT (HRCT) scan of the chest and measurement of serum levels of creatine phosphokinase, ferritin and Krebs von den Lungen-6 (KL-6). Anti-melanoma differentiation-associated gene 5 (MDA5) antibodies and IL-18 levels were measured by ELISA. Results. No differences were found in the ratio of juvenile clinically amyopathic DM between the three groups. Initial chest HRCT scan findings were variable and could not distinguish between RP-ILD and chronic ILD. Anti-MDA5 antibodies were positive in all 8 patients with RP-ILD and 10 of 14 with chronic ILD, but none of the patients without ILD. Serum levels of anti-MDA5 antibody, ferritin, KL-6 and IL-18 were significantly higher in the RP-ILD group than in the chronic ILD and non-ILD groups. Serum levels of IL-18 positively correlated with serum KL-6 (R = 0.66, P < 0.001). Conclusion. High serum levels of IL-18, KL-6, ferritin and anti-MDA5 antibodies (e.g. > 200 units by ELISA) are associated with RP-ILD. These can be used as an indication for early intensive treatment. Both alveolar macrophages and autoimmunity to MDA5 are possibly involved in the development of RP-ILD associated with JDM.	[Kobayashi, Norimoto; Koike, Kenichi] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 390, Japan; [Takezaki, Shunichiro; Kobayashi, Ichiro; Yamada, Masafumi; Ariga, Tadashi] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido 0608638, Japan; [Iwata, Naomi] Aichi Childrens Hlth & Med Ctr, Dept Immunol & Infect Dis, Obu, Japan; [Mori, Masaaki; Yokota, Shumpei] Yokohama City Univ, Dept Pediat, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Nagai, Kazushige] Sapporo Med Univ, Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan; [Nakano, Naoko] Ehime Univ, Dept Pediat, Grad Sch Med, Matsuyama, Ehime, Japan; [Miyoshi, Mari] Hyogo Prefectural Kobe Childrens Hosp, Dept Allergy & Immunol, Kobe, Hyogo, Japan; [Kinjo, Noriko] Univ Ryukyus, Dept Pediat, Naha, Japan; [Murata, Takuji] Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 569, Japan; [Masunaga, Kenji] Kurume Univ, Sch Med, Dept Pediat, Kurume, Fukuoka 830, Japan; [Umebayashi, Hiroaki] Miyagi Childrens Hosp, Dept Gen Pediat, Sendai, Miyagi, Japan; [Imagawa, Tomoyuki] Kanagawa Childrens Med Ctr, Div Infect Immunol & Rheumatol, Yokohama, Kanagawa, Japan; [Agematsu, Kazunaga] Shinshu Univ, Dept Infect & Host Def, Grad Sch Med, Matsumoto, Nagano 390, Japan; [Sato, Shinji] Tokai Univ, Sch Med, Dept Rheumatol, Isehara, Kanagawa 25911, Japan; [Kuwana, Masataka] Keio Univ, Sch Med, Dept Rheumatol, Tokyo, Japan; [Takei, Shuji] Kagoshima Univ, Fac Med, Sch Hlth Sci, Kagoshima 890, Japan	Kobayashi, I (reprint author), Hokkaido Univ, Grad Sch Med, Dept Pediat, Kita Ku, North 15 West 7, Sapporo, Hokkaido 0608638, Japan.	ichikobaya@med.hokudai.ac.jp			Ministry of Health, Labour and Welfare of Japan	This work was supported by a Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan.	Nakashima R, 2010, RHEUMATOLOGY, V49, P433, DOI 10.1093/rheumatology/kep375; Kameda H, 2005, J RHEUMATOL, V32, P1719; Gono T, 2012, RHEUMATOLOGY, V51, P1336, DOI 10.1093/rheumatology/kes012; Ravelli A, 2010, ARTHRIT CARE RES, V62, P63, DOI 10.1002/acr.20015; Satoh H, 2006, J INTERN MED, V260, P429, DOI 10.1111/j.1365-2796.2006.01704.x; Shimizu M, 2010, RHEUMATOLOGY, V49, P1645, DOI 10.1093/rheumatology/keq133; Gono T, 2010, RHEUMATOLOGY, V49, P1878, DOI 10.1093/rheumatology/keq196; Sanner H, 2011, ANN RHEUM DIS, V70, P86, DOI 10.1136/ard.2010.131433; Kobayashi I, 2001, J PEDIATR-US, V138, P274, DOI 10.1067/mpd.2001.110324; McCann LJ, 2006, RHEUMATOLOGY, V45, P1255, DOI 10.1093/rheumatology/kel099; Sato S, 2013, MOD RHEUMATOL, V23, P496, DOI 10.1007/s10165-012-0663-4; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Mukae H, 2009, CHEST, V136, P1341, DOI 10.1378/chest.08-2740; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Sakurai N, 2011, J RHEUMATOL, V38, P963, DOI 10.3899/jrheum.101220; Sato S, 2005, ARTHRITIS RHEUM, V52, P1571, DOI 10.1002/art.21023; Kobayashi I, 2011, J PEDIATR-US, V158, P675, DOI 10.1016/j.jpeds.2010.11.033; Feldman BM, 2008, LANCET, V371, P2201, DOI 10.1016/S0140-6736(08)60955-1; Kobayashi I, 2000, ACTA PAEDIATR, V89, P617, DOI 10.1080/080352500750027989; Gono T, 2010, RHEUMATOLOGY, V49, P1354, DOI 10.1093/rheumatology/keq073; Yokoyama A, 1998, AM J RESP CRIT CARE, V158, P1680; BITNUM S, 1964, J PEDIATR-US, V64, P101, DOI 10.1016/S0022-3476(64)80325-5; KOHNO N, 1989, CHEST, V96, P68, DOI 10.1378/chest.96.1.68; Englund P, 2007, ARTHRITIS RHEUM, V56, P372, DOI 10.1002/art.22293; Gerami P, 2007, BRIT J DERMATOL, V157, P637, DOI 10.1111/j.1365-2133.2007.08055.x; Gono T, 2011, MOD RHEUMATOL, V21, P223, DOI 10.1007/s10165-010-0371-x; Gono T, 2012, RHEUMATOLOGY, V51, P1563, DOI 10.1093/rheumatology/kes102; Hall JC, 2013, ARTHRIT CARE RES, V65, P1307, DOI 10.1002/acr.21992; Huber AM, 2014, ARTHRIT CARE RES, V66, P732, DOI [10.1002/acr.22212, 10.1002/acr.22200]; Ishikawa J, 2011, J JPN PEDIAT SOC, V115, P793; Kang EH, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-223; Kaser A, 2004, BLOOD, V103, P648, DOI 10.1182/blood-2002-07-2322; Kobayashi I, 2003, RHEUMATOLOGY, V42, P371, DOI 10.1093/rheumatology/keg040; Kobayashi S, 1997, ACTA PAEDIATR JAPON, V39, P257; Kono H, 2000, ANN RHEUM DIS, V59, P372, DOI 10.1136/ard.59.5.372; Kourakata H, 1999, Respirology, V4, P223, DOI 10.1046/j.1440-1843.1999.00179.x; Kumanovics G, 2003, RHEUMATOL INT, V23, P6, DOI 10.1007/s00296-002-0243-6; Mendez EP, 2003, ARTHRIT RHEUM-ARTHR, V49, P300, DOI 10.1002/art.11122; MILLER LC, 1987, CLIN PEDIATR, V26, P561, DOI 10.1177/000992288702601101; Monneaux F, 2002, ARTHRITIS RHEUM, V46, P1430, DOI 10.1002/art.10263; Nagai Y, 2010, EUR J DERMATOL, V20, P208, DOI 10.1684/ejd.2010.0846; Nonaka Y, 2008, J JPN PEDIAT SOC, V112, P719; SYMMONS DPM, 1995, BRIT J RHEUMATOL, V34, P732; Tucci M, 2006, CLIN EXP IMMUNOL, V146, P21, DOI 10.1111/j.1365-2249.2006.03180.x; Yokota S, 2010, MINISTRY HLTH LABOUR	45	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-0324	1462-0332		RHEUMATOLOGY	RHEUMATOLOGY	MAY	2015	54	5					784	791		10.1093/rheumatology/keu385		8	Rheumatology	Rheumatology	CI8IY	WOS:000355017200006		
J	Sugihara, T; Ishizaki, T; Hosoya, T; Iga, S; Yokoyama, W; Hirano, F; Miyasaka, N; Harigai, M				Sugihara, Takahiko; Ishizaki, Tatsuro; Hosoya, Tadashi; Iga, Shoko; Yokoyama, Waka; Hirano, Fumio; Miyasaka, Nobuyuki; Harigai, Masayoshi			Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE)	RHEUMATOLOGY			English	Article						elderly-onset RA; treat to target; structural remission; functional remission; clinical practice	ANTITUMOR-NECROSIS-FACTOR; MODIFYING ANTIRHEUMATIC DRUGS; POSTMARKETING SURVEILLANCE; SERIOUS INFECTION; JOINT DAMAGE; RADIOGRAPHIC PROGRESSION; ETANERCEPT TREATMENT; PLUS METHOTREXATE; JAPANESE PATIENTS; DOUBLE-BLIND	Objective. The aim of this study was to evaluate structural damage and physical disability in patients with elderly-onset RA (EORA) who were treated in clinical practice with a therapeutic strategy targeting low disease activity (LDA). Methods. Data from 151 MTX-naive patients (mean age 74.9 years) with EORA from a prospective, monocentric registry were analysed. Treatment was adjusted every 3 months targeting LDA [28-joint DAS using ESR (DAS28-ESR) < 3.2]. Treatment was initiated with non-biologic DMARDs (nbDMARDs), followed by TNF inhibitors (TNFis) or tocilizumab. The primary outcome was change from week 0 to week 52 in the modified total Sharp score (Delta mTSS). Secondary outcomes were derived from the HAQ Disability Index (HAQ-DI) and DAS28 at week 52. Predictors of clinically relevant radiographic progression [CRRP; Delta mTSS/year more than the smallest detectable change (2.1 points)] were examined using multivariate logistic regression models. Results. Adherence to the treat-to-target strategy was observed in 83.4% of the 151 patients at week 24 and in 75.5% at week 52. At week 52, 67.6% of the patients were receiving a nbDMARD alone, 31.0% a TNFi with or without MTX and 1.4% tocilizumab. At week 52, structural remission (Delta mTSS/yr a parts per thousand currency sign0.5) was achieved in 49.7% of the patients, functional remission (HAQ-DI a parts per thousand currency sign0.5) in 63.4% and LDA in 51.0%. Clinical responses at weeks 12 and 24 were significant independent predictors of CRRP. Cumulative disease activity during the first 12 weeks predicted CRRP with a C-statistic of 0.888. Conclusion. Achieving structural remission, functional remission and LDA in clinical practice in EORA patients are realistic goals. Our results indicate significant benefits for a therapeutic strategy targeting LDA for EORA patients in clinical practice.	[Sugihara, Takahiko; Hosoya, Tadashi; Iga, Shoko; Yokoyama, Waka; Hirano, Fumio] Tokyo Metropolitan Geriatr Hosp, Dept Med & Rheumatol, Itabashi Ku, Tokyo 1730015, Japan; [Ishizaki, Tatsuro] Tokyo Metropolitan Inst Gerontol, Human Care Res Team, Tokyo, Japan; [Hosoya, Tadashi; Yokoyama, Waka; Hirano, Fumio; Miyasaka, Nobuyuki; Harigai, Masayoshi] Tokyo Med & Dent Univ, Dept Med & Rheumatol, Tokyo, Japan; [Yokoyama, Waka; Hirano, Fumio; Harigai, Masayoshi] Tokyo Med & Dent Univ, Dept Pharmacovigilance, Tokyo, Japan	Sugihara, T (reprint author), Tokyo Metropolitan Geriatr Hosp, Dept Med & Rheumatol, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan.	takahiko_sugihara@tmghig.jp			Tokyo Metropolitan Geriatric Hospital	This study was supported by a grant from the Tokyo Metropolitan Geriatric Hospital.	Bakker MF, 2012, ANN INTERN MED, V156, P329, DOI 10.7326/0003-4819-156-5-201203060-00004; Dixon WG, 2012, ANN RHEUM DIS, V71, P1128, DOI 10.1136/annrheumdis-2011-200702; Takeuchi T, 2008, ANN RHEUM DIS, V67, P189, DOI 10.1136/ard.2007.072967; Kroot EJJA, 2000, ARTHRITIS RHEUM, V43, P1831, DOI 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6; Kavanaugh A, 2013, ANN RHEUM DIS, V72, P64, DOI 10.1136/annrheumdis-2011-201247; Tanaka M, 2012, MOD RHEUMATOL, V22, P849, DOI 10.1007/s10165-012-0615-z; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2896, DOI 10.1002/art.22808; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242; Koller MD, 2009, RHEUMATOLOGY, V48, P1575, DOI 10.1093/rheumatology/kep291; Tutuncu Z, 2006, ANN RHEUM DIS, V65, P1226, DOI 10.1136/ard.2005.051144; Wolfe F, 2006, ARTHRITIS RHEUM, V54, P628, DOI 10.1002/art.21568; Sakai R, 2012, ARTHRIT CARE RES, V64, P1125, DOI 10.1002/acr.21666; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Landewe R, 2006, ARTHRITIS RHEUM, V54, P3119, DOI 10.1002/art.22143; Bruynesteyn K, 2005, ANN RHEUM DIS, V64, P179, DOI 10.1136/ard.2003.018457; Schmajuk G, 2007, ARTHRIT RHEUM-ARTHR, V57, P928, DOI 10.1002/art.22890; Koike T, 2012, MOD RHEUMATOL, V22, P498, DOI 10.1007/s10165-011-0541-5; Leirisalo-Repo M, 2013, ANN RHEUM DIS, V72, P851, DOI 10.1136/annrheumdis-2012-201365; Aletaha D, 2006, ARTHRITIS RHEUM, V54, P2784, DOI 10.1002/art.22052; Schneeweiss S, 2007, ARTHRITIS RHEUM, V56, P1754, DOI 10.1002/art.22600; Visser K, 2010, ANN RHEUM DIS, V69, P1333, DOI 10.1136/ard.2009.121160; Smolen JS, 2006, ARTHRITIS RHEUM, V54, P702, DOI 10.1002/art.21678; Verstappen SMM, 2007, ANN RHEUM DIS, V66, P1443, DOI 10.1136/ard.2007.071092; Takeuchi T, 2014, ANN RHEUM DIS, V73, P536, DOI 10.1136/annrheumdis-2012-202433; Komano Y, 2011, J RHEUMATOL, V38, P1258, DOI 10.3899/jrheum.101009; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Koike T, 2011, MOD RHEUMATOL, V21, P343, DOI 10.1007/s10165-010-0406-3; Bathon JM, 2006, J RHEUMATOL, V33, P234; Koike T, 2009, J RHEUMATOL, V36, P898, DOI 10.3899/jrheum.080791; Radner H, 2011, RHEUMATOLOGY, V50, P381, DOI 10.1093/rheumatology/keq334; DEAL CL, 1985, ARTHRITIS RHEUM, V28, P987, DOI 10.1002/art.1780280905; Emery P, 2010, ARTHRITIS RHEUM-US, V62, P674, DOI 10.1002/art.27268; Genevay S, 2007, ARTHRIT RHEUM-ARTHR, V57, P679, DOI 10.1002/art.22688; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM, V52, P3381, DOI 10.1002/art.21405; Harigai M, 2007, NEW ENGL J MED, V357, P1874, DOI 10.1056/NEJMc070728; Harris JA, 2013, J RHEUMATOL, V40, P1823, DOI 10.3899/jrheum.121316; Ishizaki T, 2008, J EVAL CLIN PRACT, V14, P416, DOI 10.1111/j.1365-2753.2007.00882.x; Koike R, 2007, MOD RHEUMATOL, V17, P451, DOI 10.3109/s10165-007-0626-3; Koike T, 2011, ANN RHEUM DIS, V70, P2148, DOI 10.1136/ard.2011.151092; Komano Y, 2009, ARTHRIT RHEUM-ARTHR, V61, P305, DOI 10.1002/art.24283; Mueller RB, 2014, RHEUMATOLOGY, V53, P671, DOI 10.1093/rheumatology/ket399; Pease CT, 1999, RHEUMATOLOGY, V38, P228, DOI 10.1093/rheumatology/38.3.228; Radovits BJ, 2009, ANN RHEUM DIS, V68, P1470, DOI 10.1136/ard.2008.094730; Rasch EK, 2003, ARTHRITIS RHEUM, V48, P917, DOI 10.1002/art.10897; VANDERHEIJDE DMFM, 1991, J RHEUMATOL, V18, P1285; Vermeer M, 2011, ARTHRITIS RHEUM-US, V63, P2865, DOI 10.1002/art.30494; Welsing PMJ, 2004, ARTHRITIS RHEUM, V50, P2082, DOI 10.1002/art.20350; Widdifield J, 2013, ARTHRITIS CARE RES H, V65, P353; Yamanaka H, 2006, MOD RHEUMATOL, V16, P75	50	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-0324	1462-0332		RHEUMATOLOGY	RHEUMATOLOGY	MAY	2015	54	5					798	807		10.1093/rheumatology/keu395		10	Rheumatology	Rheumatology	CI8IY	WOS:000355017200008		
J	Takahashi, N; Kojima, T; Kaneko, A; Kida, D; Hirano, Y; Fujibayashi, T; Yabe, Y; Takagi, H; Oguchi, T; Miyake, H; Kato, T; Fukaya, N; Hayashi, M; Tsuboi, S; Kanayama, Y; Funahashi, K; Hanabayashi, M; Hirabara, S; Asai, S; Yoshioka, Y; Ishiguro, N				Takahashi, Nobunori; Kojima, Toshihisa; Kaneko, Atsushi; Kida, Daihei; Hirano, Yuji; Fujibayashi, Takayoshi; Yabe, Yuichiro; Takagi, Hideki; Oguchi, Takeshi; Miyake, Hiroyuki; Kato, Takefumi; Fukaya, Naoki; Hayashi, Masatoshi; Tsuboi, Seiji; Kanayama, Yasuhide; Funahashi, Koji; Hanabayashi, Masahiro; Hirabara, Shinya; Asai, Shuji; Yoshioka, Yutaka; Ishiguro, Naoki			Use of a 12-week observational period for predicting low disease activity at 52 weeks in RA patients treated with abatacept: a retrospective observational study based on data from a Japanese multicentre registry study	RHEUMATOLOGY			English	Article						predictors; adequate observational period; long-term efficacy; abatacept; RA; Japanese; multicentre registry system	RHEUMATOID-ARTHRITIS PATIENTS; SEDIMENTATION-RATE; CLINICAL-EFFICACY; TOCILIZUMAB; METHOTREXATE; ADALIMUMAB; TRIAL; REMISSION; THERAPY; VALUES	Objective. Only a few studies have assessed predictive factors for the long-term efficacy of abatacept. This study aimed to provide clinical evidence of an adequate observational period for predicting low disease activity (LDA) achievement at 52 weeks in RA patients treated with abatacept. Methods. Participants were all patients registered in a Japanese multicentre registry who were treated with abatacept and had at least 52 weeks of follow-up (n = 254). Results. Areas under the receiver operating characteristic curves for the 28-joint count with CRP (DAS28-CRP) at each time point for LDA achievement at 52 weeks were: 0.686 (cut-off score: 4.6) at baseline, 0.780 (3.8) at 4 weeks, 0.875 (3.3) at 12 weeks, and 0.900 (3.0) at 24 weeks. Although patients with a DAS28-CRP score < 3.0 at 24 weeks had the highest proportion of LDA achievement at 52 weeks (79.3%), the proportion for those with a score < 3.3 at 12 weeks was comparable (77.2%, P = 0.697). Proportions were significantly lower in patients with a score < 3.8 at 4 weeks or < 4.6 at baseline. Multivariate logistic regression demonstrated that a DAS28 score of < 3.3 at 12 weeks was an independent strong predictor for LDA at 52 weeks (adjusted odds ratio: 15.2, P < 0.001). Conclusion. Twelve weeks is an adequate observational period to judge the long-term clinical efficacy of abatacept, and is about as early as the period for assessing TNF blockade therapy.	[Takahashi, Nobunori; Kojima, Toshihisa; Funahashi, Koji; Hanabayashi, Masahiro; Hirabara, Shinya; Asai, Shuji; Yoshioka, Yutaka; Ishiguro, Naoki] Nagoya Univ, Grad Sch Med, Dept Orthoped Surg & Rheumatol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kaneko, Atsushi; Kida, Daihei] Nagoya Med Ctr, Dept Orthoped Surg & Rheumatol, Naka Ku, Nagoya, Aichi, Japan; [Hirano, Yuji] Toyohashi Municipal Hosp, Dept Rheumatol, Toyohashi, Aichi, Japan; [Fujibayashi, Takayoshi] Konan Kosei Hosp, Dept Orthoped Surg, Konan, Aichi, Japan; [Yabe, Yuichiro] Tokyo Koseinenkin Hosp, Dept Rheumatol, Shinjuku Ku, Tokyo, Japan; [Takagi, Hideki] Nagoya Cent Hosp, Dept Orthoped Surg, Nakamura Ku, Nagoya, Aichi, Japan; [Oguchi, Takeshi] Anjo Kosei Hosp, Dept Orthoped Surg, Anjo, Aichi, Japan; [Miyake, Hiroyuki] Ichinomiya Municipal Hosp, Dept Orthoped Surg, Bunkyo Ku, Ichinomiya, Aichi, Japan; [Kato, Takefumi] Kato Orthoped Clin, Okazaki, Aichi, Japan; [Fukaya, Naoki] Kariya Toyota Gen Hosp, Dept Orthoped Surg, Kariya, Aichi, Japan; [Hayashi, Masatoshi] Nagano Red Cross Hosp, Dept Rheumatol, Nagano, Japan; [Tsuboi, Seiji] Shizuoka Kosei Hosp, Dept Orthoped Surg, Aoi Ku, Shizuoka, Japan; [Kanayama, Yasuhide] Toyota Kosei Hosp, Dept Orthoped Surg, Toyota, Aichi, Japan	Takahashi, N (reprint author), Nagoya Univ, Nagoya Univ Hosp, Grad Sch Med, Dept Orthoped Surg & Rheumatol,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	nobunori@med.nagoya-u.ac.jp			Mitsubishi Tanabe Pharma Corporation; Takeda Pharma Corporation; Eisai Pharma Corporation; Abbvie; Bristol-Myers Squibb; Pfizer; Chugai Pharma Corporation; Janssen Pharmaceutical; Astellas Pharma Corporation; Abbott Japan Co. Ltd; Eisai Co. Ltd; Pfizer Co. Ltd; Chugai Pharmaceutical Co. Ltd; Bristol-Myers Squibb Co. Ltd.; AbbVie Japan Co. Ltd; Astellas Pharma; Takeda Pharmaceutical Co. Ltd; Mitsubishi-Tanabe Pharmaceutical Co. Ltd; Astellas Pharmaceutical Inc.; Abbott Japan; Daiichi Sankyo Company Ltd; Janssen; Kaken Pharmaceutical Co. Ltd; Pfizer Japan Inc.; Hisamitsu Pharmaceutical Co. Inc.; Otsuka Pharmaceutical Co. Ltd; Taisho Toyama Pharmaceutical Co. Ltd; Janssen Pharmaceutical KK; Mitsubishi Tanabe Pharmaceutical; UCB Japan; Astellas Pharma Inc.; Chugai Pharmaceutical Co. Ltd.	T.Ko. has received lecture fees from Mitsubishi Tanabe Pharma Corporation, Takeda Pharma Corporation, Eisai Pharma Corporation, Abbvie, Bristol-Myers Squibb, Pfizer and Chugai Pharma Corporation; and research grants from Takeda Pharma Corporation, Janssen Pharmaceutical and Astellas Pharma Corporation. N.T. has received speaking fees (<$5000) from Abbott Japan Co. Ltd, Eisai Co. Ltd, Mitsubishi Tanabe Pharma Corporation, Pfizer Co. Ltd, Chugai Pharmaceutical Co. Ltd and Bristol-Myers Squibb Co. Ltd. Y.H. has received speaking fees from AbbVie Japan Co. Ltd, Eisai Co. Ltd, Mitsubishi Tanabe Pharma Corporation, Pfizer Co. Ltd, Chugai Pharmaceutical Co. Ltd, Astellas Pharma and Bristol-Myers Squibb Co. Ltd. N.I. has received research funding from Takeda Pharmaceutical Co. Ltd, Mitsubishi-Tanabe Pharmaceutical Co. Ltd, Astellas Pharmaceutical Inc., Chugai Pharmaceutical Co. Ltd, Abbott Japan, Bristol-Myers Squibb, Eisai Co. Ltd, Daiichi Sankyo Company Ltd, Janssen, Kaken Pharmaceutical Co. Ltd and Pfizer Japan Inc.; and lecture fees including service on speaker bureaus from Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Co. Ltd, Hisamitsu Pharmaceutical Co. Inc., Otsuka Pharmaceutical Co. Ltd, Taisho Toyama Pharmaceutical Co. Ltd, Kaken Pharmaceutical Co. Ltd, Eisai Co. Ltd, Janssen Pharmaceutical KK, Bristol-Myers Squibb, Abbott Japan, Chugai Pharmaceutical Co. Ltd, Mitsubishi Tanabe Pharmaceutical, UCB Japan, Astellas Pharma Inc. and Pfizer Japan Inc. K.F. has received speaking fees (<$5000) from Abbvie Japan Co. Ltd, Eisai Co. Ltd, Mitsubishi Tanabe Pharma Corporation, Pfizer Co. Ltd and Chugai Pharmaceutical Co. Ltd. A.K. has received speaking fees (<$5000) from Abbott Japan Co. Ltd, Eisai Co. Ltd, Mitsubishi Tanabe Pharma Corporation, Pfizer Co. Ltd, Chugai Pharmaceutical Co. Ltd and Bristol-Myers Squibb Co. Ltd. All other authors have declared no conflicts of interest.	Kremer JM, 2006, ANN INTERN MED, V144, P865; Leffers HC, 2011, ANN RHEUM DIS, V70, P1216, DOI 10.1136/ard.2010.140129; Kremer JM, 2011, ANN RHEUM DIS, V70, P1826, DOI 10.1136/ard.2010.139345; Weinblatt ME, 2013, ARTHRITIS RHEUM-US, V65, P28, DOI 10.1002/art.37711; Akobeng AK, 2007, ACTA PAEDIATR, V96, P338, DOI 10.1111/j.1651-2227.2006.00180.x; Katchamart W, 2010, ARTHRIT CARE RES, V62, P1128, DOI 10.1002/acr.20188; van der Heijde D, 2012, J RHEUMATOL, V39, P1326, DOI 10.3899/jrheum.111171; Takeuchi T, 2011, RHEUMATOLOGY, V50, P1908, DOI 10.1093/rheumatology/ker221; Kojima T, 2012, MOD RHEUMATOL, V22, P339, DOI 10.1007/s10165-011-0518-4; Matsui T, 2007, ANN RHEUM DIS, V66, P1221, DOI 10.1136/ard.2006.063834; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Takahashi N, 2013, MOD RHEUMATOL, V23, P904, DOI 10.1007/s10165-012-0760-4; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659; Kaneko A, 2013, MOD RHEUMATOL, V23, P466, DOI 10.1007/s10165-012-0705-y; Pers YM, 2014, RHEUMATOLOGY, V53, P76, DOI 10.1093/rheumatology/ket301; Takahashi N, 2014, CLIN RHEUMATOL, V33, P39, DOI 10.1007/s10067-013-2392-2; Vander Cruyssen Bert, 2006, Arthritis Res Ther, V8, pR112; Westhovens R, 2009, ANN RHEUM DIS, V68, P1870, DOI 10.1136/ard.2008.101121; Zintzaras E, 2008, CLIN THER, V30, P1939, DOI 10.1016/j.clinthera.2008.11.007	20	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-0324	1462-0332		RHEUMATOLOGY	RHEUMATOLOGY	MAY	2015	54	5					854	859		10.1093/rheumatology/keu418		6	Rheumatology	Rheumatology	CI8IY	WOS:000355017200015		
J	Nishida, A; Funaki, H; Kobayashi, M; Tanaka, Y; Akasaka, Y; Kubo, T; Ikegaya, H				Nishida, Atsushi; Funaki, Hironao; Kobayashi, Masaki; Tanaka, Yuka; Akasaka, Yoshihisa; Kubo, Toshikazu; Ikegaya, Hiroshi			Blood creatinine level in postmortem cases	SCIENCE & JUSTICE			English	Article						Creatinine; HPLC; Postmortem; Blood	PERFORMANCE LIQUID-CHROMATOGRAPHY; SERUM CREATININE; INTERVAL ESTIMATION; URIC-ACID; MICE; MUSCLE; DEATH	Blood chemical analysis for the diagnosis of diseases in forensic cases should be conducted in the same way as for clinical cases. However, it is sometimes difficult to obtain serum samples in forensic cases because of postmortem changes such as hemolysis and putrefaction. This study aimed to evaluate renal function in postmortem cases by blood creatinine analysis. The blood creatinine level was measured by high performance liquid chromatography (HPLC) using whole blood samples taken from 77 postmortem cases, and the relationships between blood creatinine level, postmortem interval, and cause of death were examined. The median blood creatinine level was found to be 1.15 mg/dL, with no significant differences between blood samples taken from different parts of the body. The blood creatinine level was stable for 3 days after death and gradually increased after that period, in line with a previous study using enzymatic analysis that found the serum creatinine level was stable in the early postmortem period. The blood creatinine level was high in the cases of blunt injury, intoxication, and in deaths caused by fire. This was considered to reflect acute renal dysfunction. However, the postmortem blood creatinine level remained higher than the clinical normal value despite omitting cases with renal dysfunction from the analysis. Therefore, we next investigated the change in postmortem creatinine levels in mice and found that the blood creatinine level increased with the emergence of rigor mortis. Our findings indicate that HPLC is useful in the postmortem evaluation of renal function even in the cases where serum cannot be obtained. However, the presence of rigor mortis should be considered in the evaluation of blood creatinine values. (C) 2014 The Chartered Society of Forensic Sciences. Published by Elsevier Ireland Ltd. All rights reserved.	[Nishida, Atsushi; Funaki, Hironao; Kobayashi, Masaki; Tanaka, Yuka; Akasaka, Yoshihisa; Ikegaya, Hiroshi] Kyoto Prefectural Univ Med, Dept Forens Med, Grad Sch Med Sci, Kyoto 6028566, Japan; [Nishida, Atsushi; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Dept Orthoped Surg, Grad Sch Med Sci, Kyoto 6028566, Japan	Ikegaya, H (reprint author), Kyoto Prefectural Univ Med, Dept Forens Med, Grad Sch Med Sci, 465 Kajiicho, Kyoto 6028566, Japan.						WEBER JA, 1991, CLIN CHEM, V37, P695; Stevens LA, 2005, MED CLIN N AM, V89, P457, DOI 10.1016/j.mcna.2004.11.009; Zhu BL, 2002, FORENSIC SCI INT, V125, P59, DOI 10.1016/S0379-0738(01)00617-X; BRION F, 1991, FORENSIC SCI INT, V52, P113, DOI 10.1016/0379-0738(91)90103-P; Dunn SR, 2004, KIDNEY INT, V65, P1959, DOI 10.1111/j.1523-1755.2004.00600.x; BOWERS LD, 1980, CLIN CHEM, V26, P555; Keppler A, 2007, KIDNEY INT, V71, P74, DOI 10.1038/sj.ki.5001988; Zhu Bao-Li, 2007, Legal Medicine, V9, P115, DOI 10.1016/j.legalmed.2006.10.002; Yuen PST, 2004, AM J PHYSIOL-RENAL, V286, pF1116, DOI 10.1152/ajprenal.00366.2003; Coe J I, 1974, J Forensic Sci, V19, P13; COE JI, 1993, AM J FOREN MED PATH, V14, P91, DOI 10.1097/00000433-199306000-00001; DAFONSECAWOLLHEIM F, 1988, J CLIN CHEM CLIN BIO, V26, P523; GALLOISMONTBRUN FG, 1988, FORENSIC SCI INT, V37, P189, DOI 10.1016/0379-0738(88)90183-1; Johns BA, 2001, J CHROMATOGR B, V759, P343, DOI 10.1016/S0378-4347(01)00229-8; Lolekha PH, 2001, J CLIN LAB ANAL, V15, P116, DOI 10.1002/jcla.1013; MEYER MH, 1985, ANAL BIOCHEM, V144, P285, DOI 10.1016/0003-2697(85)90118-6; Palmiere C., 2014, INT J LEGAL MED; Uemura Koichi, 2008, J Forensic Leg Med, V15, P312, DOI 10.1016/j.jflm.2007.12.003	18	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1355-0306	1876-4452		SCI JUSTICE	Sci. Justice	MAY	2015	55	3					195	199		10.1016/j.scijus.2014.12.005		5	Medicine, Legal; Pathology	Legal Medicine; Pathology	CJ3BP	WOS:000355358700007		
J	Iagallo, A; Tanabe, S; Roddaro, S; Takamura, M; Sekine, Y; Hibino, H; Miseikis, V; Coletti, C; Piazza, V; Beltram, F; Heun, S				Iagallo, Andrea; Tanabe, Shinichi; Roddaro, Stefano; Takamura, Makoto; Sekine, Yoshiaki; Hibino, Hiroki; Miseikis, Vaidotas; Coletti, Camilla; Piazza, Vincenzo; Beltram, Fabio; Heun, Stefan			Bilayer-induced asymmetric quantum Hall effect in epitaxial graphene	SEMICONDUCTOR SCIENCE AND TECHNOLOGY			English	Article						Epitaxial graphene on SiC; quantum Hall effect; resistance standard; monolayer graphene; bilayer graphene; metrology	RESISTANCE; TRANSPORT; SIC(0001); SILICON; LAYERS	The transport properties of epitaxial graphene on SiC(0001) at quantizing magnetic fields are investigated. Devices patterned perpendicularly to SiC terraces clearly exhibit bilayer inclusions distributed along the substrate step edges. We show that the transport properties in the quantum Hall regime are heavily affected by the presence of bilayer inclusions, and observe a significant departure from the conventional quantum Hall characteristics. In particular, we observe anomalous values of the quantized resistance and a peculiar asymmetry with magnetic field which was not observed before for graphene on SiC. A quantitative model involving enhanced inter-channel scattering mediated by the presence of bilayer inclusions is presented that successfully explains the observed symmetry properties.	[Iagallo, Andrea; Roddaro, Stefano; Beltram, Fabio; Heun, Stefan] CNR, Ist Nanosci, NEST, I-56127 Pisa, Italy; [Tanabe, Shinichi; Takamura, Makoto; Sekine, Yoshiaki; Hibino, Hiroki] Scuola Normale Super Pisa, I-56127 Pisa, Italy; [Miseikis, Vaidotas; Coletti, Camilla; Piazza, Vincenzo; Beltram, Fabio] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; [Tanabe, Shinichi] Ist Italiano Tecnol, Ctr Nanotechnol Innovat NEST, I-56127 Pisa, Italy	Iagallo, A (reprint author), CNR, Ist Nanosci, NEST, Piazza San Silvestro 12, I-56127 Pisa, Italy.	stefan.heun@nano.cnr.it	Takamura, Makoto/C-4352-2013; Heun, Stefan/B-4406-2011; 	Takamura, Makoto/0000-0002-9454-6754; Heun, Stefan/0000-0003-1989-5679; Miseikis, Vaidotas/0000-0001-6263-4250	Italian Ministry of Research (MIUR-FIRB) [RBID08B3FM]; Italian Ministry of Foreign Affairs; CNR; JSPS (Japan); European Union [604391]	The authors acknowledge financial support from the Italian Ministry of Research (MIUR-FIRB project RBID08B3FM), from the Italian Ministry of Foreign Affairs (Ministero degli Affari Esteri, Direzione Generale per la Promozione del Sistema Paese, progetto: Nanoelettronica quantistica per le tecnologie delle informazioni), and from the CNR in the framework of the agreement on scientific collaboration between CNR and JSPS (Japan), joint project title 'High-mobility graphene monolayers for novel quantum devices'. We also acknowledge funding from the European Union Seventh Framework Programme under grant agreement no. 604391 Graphene Flagship.	BUTTIKER M, 1988, PHYS REV B, V38, P9375, DOI 10.1103/PhysRevB.38.9375; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Graf D, 2007, NANO LETT, V7, P238, DOI 10.1021/nl061702a; VONKLITZING K, 1980, PHYS REV LETT, V45, P494; Forti S, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/9/094013; Delahaye F, 2003, METROLOGIA, V40, P217, DOI 10.1088/0026-1394/40/5/302; Norimatsu W, 2014, PHYS CHEM CHEM PHYS, V16, P3501, DOI 10.1039/c3cp54523g; Janssen TJBM, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/093026; Ki DK, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.033301; Lee DS, 2008, NANO LETT, V8, P4320, DOI 10.1021/nl802156w; Emtsev KV, 2009, NAT MATER, V8, P203, DOI [10.1038/nmat2382, 10.1038/NMAT2382]; Hibino H, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/15/154008; Seyller T, 2008, PHYS STATUS SOLIDI B, V245, P1436, DOI 10.1002/pssb.200844143; Giesbers AJM, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3043426; Jobst J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195434; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; HARTLAND A, 1991, PHYS REV LETT, V66, P969, DOI 10.1103/PhysRevLett.66.969; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Yager T, 2013, NANO LETT, V13, P4217, DOI 10.1021/nl402347g; Schumann T, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.235402; Novoselov KS, 2007, SCIENCE, V315, P1379, DOI 10.1126/science.1137201; Varchon F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.126805; Tanabe S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.115458; Yakes MK, 2010, NANO LETT, V10, P1559, DOI 10.1021/nl9035302; Schopfer F, 2007, J APPL PHYS, V102, DOI 10.1063/1.2776371; Tzalenchuk A, 2010, NAT NANOTECHNOL, V5, P186, DOI [10.1038/nnano.2009.474, 10.1038/NNANO.2009.474]; Chua C, 2014, NANO LETT, V14, P3369, DOI 10.1021/nl5008757; DELAHAYE F, 1986, METROLOGIA, V22, P103, DOI 10.1088/0026-1394/22/2/005; Girvin S. M., 2000, TOPOLOGICAL ASPECTS; Guignard J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.165420; Iagallo A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.235406; Janssen TJBM, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/10/104501; JECKELMANN B, 1995, IEEE T INSTRUM MEAS, V44, P269, DOI 10.1109/19.377828; Jobst J, 2011, SOLID STATE COMMUN, V151, P1061, DOI 10.1016/j.ssc.2011.05.015; Ki DK, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195327; Lofwander T, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.205429; Pallecchi E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04558; Rohrl J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2929746; Seyller T, 2006, SURF SCI, V600, P3906, DOI 10.1016/j.susc.2006.01.102; Tanabe S, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.075102; Tanabe S, 2011, MRS P, V1283; Tanaka S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041406; Tian JF, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.125410; Tsukuda A, 2011, J PHYS CONF SER, V334, DOI 10.1088/1742-6596/334/1/012038	45	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0268-1242	1361-6641		SEMICOND SCI TECH	Semicond. Sci. Technol.	MAY	2015	30	5							055007	10.1088/0268-1242/30/5/055007		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Condensed Matter	Engineering; Materials Science; Physics	CJ1AE	WOS:000355212600011		
J	Lindberg, F; Jonsson, P; Honjo, T; Wastberg, D				Lindberg, Fredrik; Jonsson, Per; Honjo, Tsuyoshi; Waestberg, Dag			Solar energy on building envelopes-3D modelling in a 2D environment	SOLAR ENERGY			English	Article						GIS; Raster modelling; Vegetation; Sweden	URBAN; RADIATION	A new model, Solar Energy on Building Envelopes (SEBE) for estimating shortwave irradiance on ground, roofs and building walls is presented. SEBE adopts a 2D raster modelling approach to derive 3D irradiance information, which makes it possible to compute extensive areas up to city scale. High resolution digital surface models (DSMs) are used to describe the urban geometry and additional DSMs including 3D vegetation structures can also be incorporated. Inclusion of vegetation is shown to be essential when modelling irradiances for wall surfaces within the urban environment. To obtain a detailed description of input forcing conditions, the model utilizes observed hourly data of shortwave radiation as meteorological input information. The model is evaluated for a tilted roof as well as for a wall location in Goteborg, Sweden. The overall performance of the model is high, both for the roof and wall evaluation point. Application of the model is exemplified by 3D visualisation and city scale model output presentation. (C) 2015 Elsevier Ltd. All rights reserved.	[Lindberg, Fredrik] Univ Gothenburg, Goteborg Urban Climate Grp, Ctr Earth Sci, SE-40530 Gothenburg, Sweden; [Jonsson, Per; Waestberg, Dag] Tyrens AB, Gothenburg, Sweden; [Honjo, Tsuyoshi] Chiba Univ, Grad Sch Hort, Matsudo, Chiba 2718510, Japan	Lindberg, F (reprint author), Univ Gothenburg, Goteborg Urban Climate Grp, Ctr Earth Sci, Box 460, SE-40530 Gothenburg, Sweden.	fredrikl@gvc.gu.se					Fu PD, 2002, COMPUT ELECTRON AGR, V37, P25, DOI 10.1016/S0168-1699(02)00115-1; Norton B, 2011, SOL ENERGY, V85, P1629, DOI 10.1016/j.solener.2009.10.004; REINDL DT, 1990, SOL ENERGY, V45, P1, DOI 10.1016/0038-092X(90)90060-P; Lindberg F, 2010, CLIM RES, V42, P177, DOI 10.3354/cr00882; Robinson D, 2004, SOL ENERGY, V77, P295, DOI 10.1016/j.solener.2004.05.010; Redweik P, 2013, SOL ENERGY, V97, P332, DOI 10.1016/j.solener.2013.08.036; Montero G, 2009, SOL ENERGY, V83, P998, DOI 10.1016/j.solener.2009.01.004; Lindberg F, 2011, URBAN ECOSYST, V14, P617, DOI 10.1007/s11252-011-0184-5; Lindberg F, 2008, INT J BIOMETEOROL, V52, P697, DOI 10.1007/s00484-008-0162-7; Lindberg F, 2011, THEOR APPL CLIMATOL, V105, P311, DOI 10.1007/s00704-010-0382-8; Yu BL, 2009, INT J REMOTE SENS, V30, P4359, DOI 10.1080/01431160802555846; PEREZ R, 1993, SOL ENERGY, V50, P235, DOI 10.1016/0038-092X(93)90017-I; Thorsson S, 2011, INT J CLIMATOL, V31, P324, DOI 10.1002/joc.2231; Wiginton LK, 2010, COMPUT ENVIRON URBAN, V34, P345, DOI 10.1016/j.compenvurbsys.2010.01.001; Suri M, 2007, SOL ENERGY, V81, P1295, DOI 10.1016/j.solener.2006.12.007; Holmgren J, 2004, REMOTE SENS ENVIRON, V90, P415, DOI 10.1016/S0034-4257(03)00140-8; Lindberg F, 2007, METEOROL APPL, V14, P263, DOI 10.1002/met.29; Goodwin NR, 2009, CAN J REMOTE SENS, V35, P297; Konarska J., 2013, THEORET APPL CLIMATO, P1; Lindberg F., 2011, SEES MODEL; Lindberg F, 2005, MAPPING IMAGE SCI, V2, P32; Ratti C.F., 1999, P CAADFUTURES99 AT G; RCoreTeam, 2014, R LANG ENV STAT COMP; Ratti C, 2004, ENVIRON PLANN B, V31, P297, DOI 10.1068/b2665; Teller J, 2001, SOL ENERGY, V70, P187, DOI 10.1016/S0038-092X(00)00097-9; Tregenza P., 1993, ALGORITHMS, P1350; Tyrens, 2013, SOL EN MAP STOCKH PR; Wood J., 2007, USER MANUAL SUNSHINE	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-092X			SOL ENERGY	Sol. Energy	MAY	2015	115						369	378		10.1016/j.solener.2015.03.001		10	Energy & Fuels	Energy & Fuels	CI8TC	WOS:000355043600033		
J	Tanaka, H; El-Maghlany, WM; Teamah, MA				Tanaka, Hiroshi; El-Maghlany, Wael M.; Teamah, Mohamed A.			Analytical study on solar energy absorbed on elliptic curved collector	SOLAR ENERGY			English	Article						Solar thermal; Collector; Elliptic; Curved	BUILDING INTEGRATION; OPTICAL-PERFORMANCE; SYSTEMS; DESIGN	A new type of solar thermal collector which can be integrated with facades and roofs to provide pleasant shapes is introduced. The solar collector has an elliptic curved shape, and ellipse aspect ratio was varied to cover all geometric shapes. The mathematical equations were developed to calculate the beam and diffuse radiation absorbed on the elliptic curved collector. Theoretical analysis was done to determine the effects of the ellipse aspect ratio and the azimuth angle of the collector on the performance of the collector, and the results were compared with a conventional tilted fiat plate collector for four typical clear-sky days (spring and fall equinoxes and summer and winter solstices). The total energy received throughout the year is also compared. The elliptic curved collector is able to absorb a sufficient amount of solar radiation to be competitive with a conventional flat plate collector. One of the advantages of this study is in the mathematical expression that enables the designers to simulate not only all possible configurations but also all possible orientations of the elliptic curved collectors covering all days. (C) 2015 Elsevier Ltd. All rights reserved.	[Tanaka, Hiroshi] Kurume Natl Coll Technol, Dept Mech Engn, Kurume, Fukuoka 8308555, Japan; [El-Maghlany, Wael M.] Univ Alexandria, Fac Engn, Dept Mech Engn, Alexandria, Egypt; [Teamah, Mohamed A.] Arab Acad Sci Technol & Maritime Transport, Coll Engn & Technol, Dept Mech Engn, Alexandria, Egypt	Tanaka, H (reprint author), Kurume Natl Coll Technol, Dept Mech Engn, Kurume, Fukuoka 8308555, Japan.	tanakad@kurume-nct.ac.jp					Probst MM, 2007, SOL ENERGY, V81, P1104, DOI 10.1016/j.solener.2007.02.009; Fischer S, 2004, SOL ENERGY, V76, P117, DOI 10.1016/j.solener.2003.07.021; Motte F, 2013, APPL ENERG, V102, P631, DOI 10.1016/j.apenergy.2012.08.012; Bonhote P, 2009, SOL ENERGY, V83, P799, DOI 10.1016/j.solener.2008.11.014; Tagliafico LA, 2014, RENEW SUST ENERG REV, V30, P526, DOI 10.1016/j.rser.2013.10.023; Gonzalez-Pardo A, 2013, SOL ENERGY, V97, P447, DOI 10.1016/j.solener.2013.09.009; HOTTEL HC, 1976, SOL ENERGY, V18, P129, DOI 10.1016/0038-092X(76)90045-1; Kalogirou SA, 2004, PROG ENERG COMBUST, V30, P231, DOI 10.1016/j.pecs.2004.02.001; Chemisana D, 2011, ENERG CONVERS MANAGE, V52, P3241, DOI 10.1016/j.enconman.2011.05.006; Ibrahim A, 2014, ENERG CONVERS MANAGE, V77, P527, DOI 10.1016/j.enconman.2013.10.033; BOPSHETTY SV, 1992, ENERG CONVERS MANAGE, V33, P1007, DOI 10.1016/0196-8904(92)90135-J; Hestnes AG, 1999, SOL ENERGY, V67, P181, DOI 10.1016/S0038-092X(00)00065-7; Japan Solar Energy Soc, 1985, SOL EN UT HDB, P1; Maurer C, 2014, ENERGY P, V48, P1385; Maurer C, 2012, ENRGY PROCED, V30, P1035, DOI 10.1016/j.egypro.2012.11.116; Rodriguez-Sanchez D, 2014, APPL ENERG, V116, P66, DOI 10.1016/j.apenergy.2013.10.059; Tripanagnostopoulos Y, 2000, SOL ENERGY, V68, P343, DOI 10.1016/S0038-092X(00)00031-1; Visa I., 2014, ENERGY P, V48, P1429	18	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-092X			SOL ENERGY	Sol. Energy	MAY	2015	115						667	679		10.1016/j.solener.2015.03.025		13	Energy & Fuels	Energy & Fuels	CI8TC	WOS:000355043600061		
J	Eastwood, JP; Hietala, H; Toth, G; Phan, TD; Fujimoto, M				Eastwood, J. P.; Hietala, H.; Toth, G.; Phan, T. D.; Fujimoto, M.			What Controls the Structure and Dynamics of Earth's Magnetosphere?	SPACE SCIENCE REVIEWS			English	Review						Magnetosphere; Bow shock; Magnetopause; Magnetotail; Computer simulation	INTERPLANETARY MAGNETIC-FIELD; LATITUDE BOUNDARY-LAYER; KELVIN-HELMHOLTZ INSTABILITY; GLOBAL MHD SIMULATION; FLUX-TRANSFER EVENTS; MAGNETOTAIL GEOTAIL OBSERVATIONS; DIAMAGNETIC CAVITIES UPSTREAM; CORONAL MASS EJECTIONS; QUASI-PARALLEL SHOCKS; HIGH-SPEED JETS	Unlike most cosmic plasma structures, planetary magnetospheres can be extensively studied in situ. In particular, studies of the Earth's magnetosphere over the past few decades have resulted in a relatively good experimental understanding of both its basic structural properties and its response to changes in the impinging solar wind. In this article we provide a broad overview, designed for researchers unfamiliar with magnetospheric physics, of the main processes and parameters that control the structure and dynamics of planetary magnetospheres, especially the Earth's. In particular, we concentrate on the structure and dynamics of three important regions: the bow shock, the magnetopause and the magnetotail. In the final part of this review we describe the current status of global magnetospheric modelling, which is crucial to placing in situ observations in the proper context and providing a better understanding of magnetospheric structure and dynamics under all possible input conditions. Although the parameter regime experienced in the solar system is limited, the plasma physics that is learned by studying planetary magnetospheres can, in principle, be translated to more general studies of cosmic plasma structures. Conversely, studies of cosmic plasma under a wide range of conditions should be used to understand Earth's magnetosphere under extreme conditions. We conclude the review by discussing this and summarizing some general properties and principles that may be applied to studies of other cosmic plasma structures.	[Eastwood, J. P.; Hietala, H.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2AZ, England; [Toth, G.] Univ Michigan, Dept AOSS, Ctr Space Environm Modeling, Ann Arbor, MI 48109 USA; [Phan, T. D.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Fujimoto, M.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Fujimoto, M.] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528551, Japan	Eastwood, JP (reprint author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Prince Consort Rd, London SW7 2AZ, England.	jonathan.eastwood@imperial.ac.uk	Toth, Gabor/B-7977-2013; 	Toth, Gabor/0000-0002-5654-9823; Hietala, Heli/0000-0002-3039-1255	STFC Advanced Fellowship; STFC [ST/K001051/1, ST/G00725X/1]; Alfred Kordelin foundation	JPE is supported by an STFC Advanced Fellowship, and research at Imperial is supported by STFC grants ST/K001051/1 and ST/G00725X/1. HH also thanks the Alfred Kordelin foundation for financial support.	FUSELIER SA, 1987, J GEOPHYS RES, V92, P3187, DOI 10.1029/JA092iA04p03187; COWLEY SWH, 1976, J GEOPHYS RES-SPACE, V81, P3455, DOI 10.1029/JA081i019p03455; JORDANOVA VK, 1994, GEOPHYS RES LETT, V21, P2785, DOI 10.1029/94GL02695; DiBraccio GA, 2013, J GEOPHYS RES-SPACE, V118, P997, DOI 10.1002/jgra.50123; LEE LC, 1985, GEOPHYS RES LETT, V12, P105, DOI 10.1029/GL012i002p00105; Sibeck DG, 1999, J GEOPHYS RES-SPACE, V104, P4577, DOI 10.1029/1998JA900021; BAUMJOHANN W, 1989, J GEOPHYS RES, V94, P6597, DOI 10.1029/JA094iA06p06597; GOSLING JT, 1990, GEOPHYS RES LETT, V17, P1833, DOI 10.1029/GL017i011p01833; Johnson JR, 1997, GEOPHYS RES LETT, V24, P1423, DOI 10.1029/97GL01333; Gustafsson G, 2001, ANN GEOPHYS-GERMANY, V19, P1219; Toth G, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011126; Peroomian V, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016253; Kallio E, 2010, ICARUS, V206, P152, DOI 10.1016/j.icarus.2009.05.015; MITCHELL DG, 1987, J GEOPHYS RES, V92, P7394, DOI 10.1029/JA092iA07p07394; Burgess D, 2005, SPACE SCI REV, V118, P205, DOI 10.1007/s11214-005-3832-3; Blanco-Cano X, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013406; Dunlop MW, 2011, ANN GEOPHYS-GERMANY, V29, P1683, DOI 10.5194/angeo-29-1683-2011; Daldorff LKS, 2014, J COMPUT PHYS, V268, P236, DOI 10.1016/j.jcp.2014.03.009; Hietala H, 2013, J GEOPHYS RES-SPACE, V118, P7237, DOI 10.1002/2013JA019172; Toth G, 2012, J COMPUT PHYS, V231, P870, DOI 10.1016/j.jcp.2011.02.006; Haaland S, 2010, ANN GEOPHYS-GERMANY, V28, P1483, DOI 10.5194/angeo-28-1483-2010; Bunce EJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022888; Shue JH, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039842; BOROVSKY JE, 1993, J GEOPHYS RES, V98, P3807, DOI 10.1029/92JA02556; Burgess D, 2013, SPACE SCI REV, V178, P513, DOI 10.1007/s11214-013-9969-6; Angelopoulos V, 2013, SCIENCE, V341, P1478, DOI 10.1126/science.1236992; GONZALEZ WD, 1974, J GEOPHYS RES, V79, P4186, DOI 10.1029/JA079i028p04186; Wing S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013950; Frey HU, 2003, NATURE, V426, P533, DOI 10.1038/nature02084; Gosling JT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029033; Johnson CL, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004217; Raeder J, 2001, J GEOPHYS RES-SPACE, V106, P381, DOI 10.1029/2000JA000605; Glocer A, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014418; Bale SD, 2005, SPACE SCI REV, V118, P161, DOI 10.1007/s11214-005-3827-0; Dmitriev AV, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA016861; Lucek E. A., 2004, Journal of Geophysical Research, V109, DOI 10.1029/2003JA010016; Anderson BJ, 2011, SCIENCE, V333, P1859, DOI 10.1126/science.1211001; Trattner KJ, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA016959; THOMAS VA, 1991, J GEOPHYS RES, V96, P11625, DOI 10.1029/91JA01092; Brecht SH, 2012, EARTH PLANETS SPACE, V64, P165, DOI 10.5047/eps.2011.05.037; Paschmann G, 2013, SPACE SCI REV, V178, P385, DOI 10.1007/s11214-012-9957-2; Archer MO, 2013, ANN GEOPHYS-GERMANY, V31, P319, DOI 10.5194/angeo-31-319-2013; Omidi N, 2006, ADV SPACE RES, V38, P632, DOI 10.1016/j.asr.2005.11.019; Sitnov MI, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013980; Cowley SWH, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010796; Nagai T, 1998, J GEOPHYS RES-SPACE, V103, P4419, DOI 10.1029/97JA02190; Eastwood JP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033475; Sugiyama T, 2001, J GEOPHYS RES-SPACE, V106, P21657, DOI 10.1029/2001JA900063; Zhang JC, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011846; Slavin JA, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017926; Palmroth M, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009446; Eastwood JP, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010617; Phan TD, 2013, GEOPHYS RES LETT, V40, P4475, DOI 10.1002/grl.50917; Fok MC, 2001, J GEOPHYS RES-SPACE, V106, P8417, DOI 10.1029/2000JA000235; Sergeev VA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050859; Jackman CM, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016682; THOMSEN MF, 1986, J GEOPHYS RES, V91, P2961, DOI 10.1029/JA091iA03p02961; Fok MC, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012558; Omidi N, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011169; ACUNA MH, 1995, SPACE SCI REV, V71, P5, DOI 10.1007/BF00751323; Toffoletto F, 2003, SPACE SCI REV, V107, P175, DOI 10.1023/A:1025532008047; SONG P, 1992, J GEOPHYS RES, V97, P1411, DOI 10.1029/91JA02377; Karimabadi H, 2013, SPACE SCI REV, V178, P307, DOI 10.1007/s11214-013-0021-7; Savin S, 2008, JETP LETT+, V87, P593, DOI 10.1134/S0021364008110015; Jacobsen KS, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013873; Terasawa T, 1997, GEOPHYS RES LETT, V24, P935, DOI 10.1029/96GL04018; Lavraud B, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011566; Fujimoto M, 1998, J GEOPHYS RES-SPACE, V103, P4391, DOI 10.1029/97JA03340; GONZALEZ WD, 1994, J GEOPHYS RES, V99, P5771, DOI 10.1029/93JA02867; Cassak PA, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2795630; Runov A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038980; Phan TD, 2010, ASTROPHYS J LETT, V719, pL199, DOI 10.1088/2041-8205/719/2/L199; Hasegawa H, 2004, NATURE, V430, P755, DOI 10.1038/nature02799; Powell KG, 1999, J COMPUT PHYS, V154, P284, DOI 10.1006/jcph.1999.6299; Kivelson MG, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011176; Jia XZ, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017575; De Zeeuw DL, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010366; PASCHMANN G, 1979, NATURE, V282, P243, DOI 10.1038/282243a0; Dunlop MW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.025004; Raeder J, 1997, GEOPHYS RES LETT, V24, P951, DOI 10.1029/97GL00218; Trattner KJ, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012270; Glocer A, 2013, J GEOPHYS RES-SPACE, V118, P1635, DOI 10.1002/jgra.50221; Fuselier SA, 1995, ADV SPACE RES, V15, P43, DOI 10.1016/0273-1177(94)00083-D; Gonzalez WD, 1999, SPACE SCI REV, V88, P529, DOI 10.1023/A:1005160129098; Plaschke F, 2013, ANN GEOPHYS-GERMANY, V31, P1877, DOI 10.5194/angeo-31-1877-2013; COWLEY SWH, 1989, PLANET SPACE SCI, V37, P1461, DOI 10.1016/0032-0633(89)90116-5; Swisdak M, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009726; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Meng X, 2013, J GEOPHYS RES-SPACE, V118, P5639, DOI 10.1002/jgra.50539; Toth G, 2008, J COMPUT PHYS, V227, P6967, DOI 10.1016/j.jcp.2008.04.010; Hellinger P, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015915; Hietala H, 2012, ANN GEOPHYS-GERMANY, V30, P33, DOI 10.5194/angeo-30-33-2012; Janhunen P, 2012, J ATMOS SOL-TERR PHY, V80, P48, DOI 10.1016/j.jastp.2012.03.006; Haaland SE, 2007, ANN GEOPHYS-GERMANY, V25, P239; Oieroset M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021523; Angelopoulos V, 2008, SCIENCE, V321, P931, DOI 10.1126/science.1160495; Trattner KJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028397; Lavraud B, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010808; Oka M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028156; Palmroth M, 2013, J ATMOS SOL-TERR PHY, V99, P41, DOI 10.1016/j.jastp.2012.09.013; Phan TD, 2013, GEOPHYS RES LETT, V40, P11, DOI 10.1029/2012GL054528; Baker DN, 1996, J GEOPHYS RES-SPACE, V101, P12975, DOI 10.1029/95JA03753; Burgess D, 2012, SPACE SCI REV, V173, P5, DOI 10.1007/s11214-012-9901-5; Pokhotelov D, 2013, ANN GEOPHYS-GERMANY, V31, P2207, DOI 10.5194/angeo-31-2207-2013; Fear RC, 2008, ANN GEOPHYS-GERMANY, V26, P2353; RAEDER J, 1995, GEOPHYS RES LETT, V22, P349, DOI 10.1029/94GL03380; ROSTOKER G, 1980, J GEOPHYS RES-SPACE, V85, P1663, DOI 10.1029/JA085iA04p01663; GOSLING JT, 1986, J GEOPHYS RES, V91, P3029, DOI 10.1029/JA091iA03p03029; SONNERUP BU, 1974, J GEOPHYS RES, V79, P1546, DOI 10.1029/JA079i010p01546; Phan TD, 2000, NATURE, V404, P848, DOI 10.1038/35009050; Pulkkinen A, 2013, SPACE WEATHER, V11, P369, DOI 10.1002/swe.20056; Lyon JG, 2004, J ATMOS SOL-TERR PHY, V66, P1333, DOI 10.1016/j.jastp.2004.03.020; Hasegawa H, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044219; Phan TD, 2004, ANN GEOPHYS-GERMANY, V22, P2355; Richardson IG, 2001, GEOPHYS RES LETT, V28, P2569, DOI 10.1029/2001GL013052; Slavin JA, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA016900; Amata E, 2011, PLANET SPACE SCI, V59, P482, DOI 10.1016/j.pss.2010.07.021; Miyashita Y, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013225; RUSSELL CT, 1978, SPACE SCI REV, V22, P681; AKASOFU SI, 1964, PLANET SPACE SCI, V12, P273, DOI 10.1016/0032-0633(64)90151-5; Owen CJ, 2004, ANN GEOPHYS-GERMANY, V22, P971; Petrinec SM, 1996, J GEOPHYS RES, V101, P137, DOI 10.1029/95JA02834; SIBECK DG, 1985, J GEOPHYS RES-SPACE, V90, P4011, DOI 10.1029/JA090iA05p04011; Shay MA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.065001; NESS NF, 1965, J GEOPHYS RES, V70, P2989, DOI 10.1029/JZ070i013p02989; Karimabadi H, 2011, ASTR SOC P, V444, P281; Angelopoulos V, 2008, SPACE SCI REV, V141, P5, DOI 10.1007/s11214-008-9336-1; Raeder J, 2006, ANN GEOPHYS-GERMANY, V24, P381; Sitnov MI, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016920; Phan TD, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023355; Glocer A, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014053; SCHWARTZ SJ, 1985, NATURE, V318, P269, DOI 10.1038/318269a0; Omidi N, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011663; Eastwood JP, 2005, SPACE SCI REV, V118, P41, DOI 10.1007/s11214-005-3824-3; Nishimura Y, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015166; Nykyri K, 2001, GEOPHYS RES LETT, V28, P3565, DOI 10.1029/2001GL013239; Li WH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021524; Archer MO, 2013, J GEOPHYS RES-SPACE, V118, P5454, DOI 10.1002/jgra.50519; AXFORD WI, 1961, CAN J PHYS, V39, P1433; Bagenal F., 2007, JUPITER PLANET SATEL; Baumjohann W., 1996, BASIC SPACE PLASMA P; BEHANNON KW, 1968, J GEOPHYS RES, V73, P7257, DOI 10.1029/JA073i023p07257; Borovsky JE, 1998, J GEOPHYS RES-SPACE, V103, P17617, DOI 10.1029/97JA02986; Branduardi-Raymont G, 2012, EXP ASTRON, V33, P403, DOI 10.1007/s10686-011-9239-0; BURGESS D, 1989, J GEOPHYS RES, V94, P472, DOI 10.1029/JA094iA01p00472; Burgess D, 1995, ADV SPACE RES, V15, P159, DOI 10.1016/0273-1177(94)00098-L; Chaston C, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033601; Christon SP, 1998, J GEOPHYS RES-SPACE, V103, P23521, DOI 10.1029/98JA01914; COWLEY SWH, 1993, PLANET SPACE SCI, V41, P987, DOI 10.1016/0032-0633(93)90103-9; COWLEY SWH, 1981, PLANET SPACE SCI, V29, P79, DOI 10.1016/0032-0633(81)90141-0; Cowley SWH, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2001GL016030; Cravens T, 1997, PHYS SOLAR SYSTEM PL; CROOKER NU, 1979, J GEOPHYS RES-SPACE, V84, P951, DOI 10.1029/JA084iA03p00951; De Keyser J, 2005, SPACE SCI REV, V118, P231, DOI 10.1007/s11214-005-3834-1; Delamere PA, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015347; Dougherty MK, 2009, SATURN FROM CASSINI-HUYGENS, P1, DOI 10.1007/978-1-4020-9217-6; Dungey J.W., 1963, GEOPHYS EXTERIEURE, P504; EASTMAN TE, 1985, J GEOPHYS RES-SPACE, V90, P9519, DOI 10.1029/JA090iA10p09519; Eastwood JP, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017722; Eastwood J.P., 2014, MAGNETOTAILS SOLAR S; Eastwood JP, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016467; Eastwood JP, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.225001; Eastwood JP, 2008, PHILOS T R SOC A, V366, P4489, DOI 10.1098/rsta.2008.0161; Eastwood JP, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/12/124001; Fairfield DH, 2000, J GEOPHYS RES-SPACE, V105, P21159, DOI 10.1029/1999JA000316; FAIRFIELD DH, 1992, J GEOPHYS RES, V97, P1403, DOI 10.1029/91JA02388; Farrugia CJ, 2001, SPACE SCI REV, V95, P443, DOI 10.1023/A:1005288703357; Fear RC, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017831; Fermi E., 1949, Physical Review, V75, DOI 10.1103/PhysRev.75.1169; Fillingim MO, 2011, J ATMOS SOL-TERR PHY, V73, P137, DOI 10.1016/j.jastp.2010.03.001; Forbes TG, 2000, J GEOPHYS RES-SPACE, V105, P23153, DOI 10.1029/2000JA000005; Fujimoto M., 2005, STRUCTURE PLASMA SHE, P19; Fujimoto M, 1996, J GEOMAGN GEOELECTR, V48, P711; FUSELIER SA, 1994, GEOPH MONOG SERIES, V81, P107; Glocer A, 2009, J ATMOS SOL-TERR PHY, V71, P1653, DOI 10.1016/j.jastp.2009.01.003; Gombosi TI, 2002, J COMPUT PHYS, V177, P176, DOI 10.1006/jcph.2002.7009; GOSLING JT, 1991, J GEOPHYS RES, V96, P7831, DOI 10.1029/91JA00316; Hasegawa A., 1975, SERIES PHYS CHEM SPA, V8; Hasegawa H., 2012, MONOGR ENV EARTH PLA, V1, P71, DOI [10.5047/meep.2012.00102.0071, DOI 10.5047/MEEP.2012.00102.0071]; Hietala H, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016669; Hietala H, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.245001; Hietala H, 2012, ASTROPHYS J LETT, V751, DOI 10.1088/2041-8205/751/1/L14; HONES EW, 1977, J GEOPHYS RES-SPACE, V82, P5633, DOI 10.1029/JA082i035p05633; Hwang KJ, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016596; INTRILIGATOR DS, 1979, GEOPHYS RES LETT, V6, P585, DOI 10.1029/GL006i007p00585; Jackman CM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029764; Jarvinen R, 2009, ANN GEOPHYS-GERMANY, V27, P4333; Kamide Y, 1998, J GEOPHYS RES-SPACE, V103, P17705, DOI 10.1029/98JA01426; Karimabadi H, 2006, ASTR SOC P, V359, P257; Keiling A., 2014, MAGNETOTAILS SOLAR S; Khotyaintsev YV, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.165001; Kivelson M. G., 1995, INTRO SPACE PHYS; KRIMIGIS SM, 1992, SPACE SCI REV, V59, P167, DOI 10.1007/BF01262539; Lavraud B, 2011, IAGA SPEC SOPRON, V3, P3, DOI 10.1007/978-94-007-0501-2_1; LE G, 1994, GEOPH MONOG SERIES, V81, P87; Liemohn MW, 2001, J GEOPHYS RES-SPACE, V106, P29531, DOI 10.1029/2001JA000045; Liu J, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA015886; Lotko W., 1995, GEOPHYS MONOGRAPH SE, V90; LUNDIN R, 1988, SPACE SCI REV, V48, P263; Ma YJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031627; Maezawa K, 1997, ADV SPACE RES-SERIES, V20, P949, DOI 10.1016/S0273-1177(97)00503-6; Masters A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051372; Masters A, 2013, NAT PHYS, V9, P164, DOI 10.1038/nphys2541; Meng X, 2012, J COMPUT PHYS, V231, P3610, DOI 10.1016/j.jcp.2011.12.042; Meng X, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017791; Merka J, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010944; Milan SE, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039997; Milan S.E., 2014, FESTSCHRIFT J DUNGEY; MIURA A, 1995, GEOPHYS RES LETT, V22, P2993, DOI 10.1029/95GL02793; Moore TE, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000194; Nemecek Z, 1998, GEOPHYS RES LETT, V25, P1273, DOI 10.1029/98GL50873; Nishida A, 2000, SPACE SCI REV, V91, P507, DOI 10.1023/A:1005223124330; Oieroset M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.165007; Oieroset M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033661; Omidi N, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028698; Palmroth M, 2006, ANN GEOPHYS-GERMANY, V24, P3467; Paschmann G, 1997, SPACE SCI REV, V80, P217, DOI 10.1023/A:1004926004806; PASCHMANN G, 1988, J GEOPHYS RES, V93, P11279, DOI 10.1029/JA093iA10p11279; Phan TD, 1997, J GEOPHYS RES-SPACE, V102, P19883, DOI 10.1029/97JA01596; Phan T, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016885; Phan TD, 2005, SPACE SCI REV, V118, P367, DOI 10.1007/s11214-005-3836-z; Plaschke F, 2009, ANN GEOPHYS-GERMANY, V27, P4521; Reme H, 2001, ANN GEOPHYS-GERMANY, V19, P1303; Ridley AJ, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000253; Russell CT, 2001, PLANET SPACE SCI, V49, P1005, DOI 10.1016/S0032-0633(01)00017-4; SCHOLER M, 1988, GEOPHYS RES LETT, V15, P291, DOI 10.1029/GL015i004p00291; SCHWARTZ SJ, 1988, J GEOPHYS RES, V93, P11295, DOI 10.1029/JA093iA10p11295; Sibeck DG, 1999, SPACE SCI REV, V88, P207, DOI 10.1023/A:1005255801425; Sibeck DG, 1998, GEOPHYS RES LETT, V25, P453, DOI 10.1029/98GL00134; Slavin JA, 1999, GEOPHYS RES LETT, V26, P2897, DOI 10.1029/1999GL003606; Slavin JA, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2000JA003501; Song P., 1995, PHYS MAGNETOPAUSE; SONNERUP BUO, 1980, J GEOPHYS RES-SPACE, V85, P2017, DOI 10.1029/JA085iA05p02017; SONNERUP BUO, 1981, J GEOPHYS RES-SPACE, V86, P49, DOI 10.1029/JA086iA12p10049; SOUTHWOO.DJ, 1968, PLANET SPACE SCI, V16, P587, DOI 10.1016/0032-0633(68)90100-1; SOUTHWOOD DJ, 1988, PLANET SPACE SCI, V36, P503, DOI 10.1016/0032-0633(88)90109-2; Strangeway RJ, 2000, J GEOPHYS RES-SPACE, V105, P21129, DOI 10.1029/2000JA900032; Sugiyama T, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3552026; Suvorova AV, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015404; Swisdak M, 2010, ASTROPHYS J, V710, P1769, DOI 10.1088/0004-637X/710/2/1769; THOMAS VA, 1993, J GEOPHYS RES, V98, P11425, DOI 10.1029/93JA00604; THOMSEN MF, 1988, J GEOPHYS RES, V93, P11311, DOI 10.1029/JA093iA10p11311; THOMSEN MF, 1993, J GEOPHYS RES, V98, P15319, DOI 10.1029/93JA00792; Treumann R. A., 1995, GEOPHYS MONOGR SER, V90, P331; Tsurutani B.T., 2006, J GEOPHYS RES SPACE, V1978-2012, P1, DOI DOI 10.1029/2005JA011273; Tsurutani B.T., 1985, COLLISIONLESS SHOCKS; Vasyliunas V., 1983, PHYS JOVIAN MAGNETOS, V1, P395, DOI DOI 10.1029/CB09780511564574.005; Walker R, 1999, SPACE SCI REV, V88, P285, DOI 10.1023/A:1005207918263; Wang YL, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011342; Welling DT, 2010, SPACE WEATHER, V8, DOI 10.1029/2009SW000494; WOLF RA, 1982, J GEOPHYS RES-SPACE, V87, P5949, DOI 10.1029/JA087iA08p05949; Zaharia S, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011619; Zhong J, 2013, J GEOPHYS RES-SPACE, V118, P1904, DOI 10.1002/jgra.50281	253	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-6308	1572-9672		SPACE SCI REV	Space Sci. Rev.	MAY	2015	188	1-4					251	286		10.1007/s11214-014-0050-x		36	Astronomy & Astrophysics	Astronomy & Astrophysics	CJ0FO	WOS:000355151400008		
J	Tashiro, K; Hirata, N; Okada, A; Yamaguchi, T; Takayama, K; Mizuguchi, H; Kawabata, K				Tashiro, Katsuhisa; Hirata, Nobue; Okada, Atsumasa; Yamaguchi, Tomoko; Takayama, Kazuo; Mizuguchi, Hiroyuki; Kawabata, Kenji			Expression of Coxsackievirus and Adenovirus Receptor Separates Hematopoietic and Cardiac Progenitor Cells in Fetal Liver Kinase 1-Expressing Mesoderm	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						Mesoderm; Differentiation; Coxsackievirus and adenovirus receptor; Hematopoietic cells; Cardiomyocytes; Fetal liver kinase 1	PLURIPOTENT STEM-CELLS; SMOOTH-MUSCLE; MOUSE; DIFFERENTIATION; CARDIOMYOCYTE; TRANSDUCTION; LINEAGE; GENERATION; INDUCTION; DELETION	In developing embryos or in vitro differentiation cultures using pluripotent stem cells (PSCs), such as embryonic stem cells and induced pluripotent stem cells, fetal liver kinase 1 (Flk1)-expressing mesodermal cells are thought to be a heterogeneous population that includes hematopoietic progenitors, endothelial progenitors, and cardiac progenitors. However, information on cell surface markers for separating these progenitors in Flk1(+) cells is currently limited. In the present study, we show that distinct types of progenitor cells in Flk1(+) cells could be separated according to the expression of coxsackievirus and adenovirus receptor (CAR, also known as CXADR), a tight junction component molecule. We found that mouse and human PSC- and mouse embryo-derived Flk1(+) cells could be subdivided into Flk1(+)CAR(+) cells and Flk1(+)CAR(-) cells. The progenitor cells with cardiac potential were almost entirely restricted to Flkl(+)CAR(+) cells, and Flk1(+)CAR(-) cells efficiently differentiated into hematopoietic cells. Endothelial differentiation potential was observed in both populations. Furthermore, from the expression of CAR, Flk1, and platelet-derived growth factor receptor-alpha (PDGFR alpha), Flk1(+) cells could be separated into three populations (Flk1(+)PDGFR alpha(-)CAR(-) cells, Flk1(+)PDGFR alpha(-)CAR(+) cells, and Flk1(+)PDGFR alpha(+)CAR(+) cells). Flk1(+)PDGFR alpha(+) cells and Flk1(+)PDGFR alpha(-) cells have been reported as cardiac and hematopoietic progenitor cells, respectively. We identified a novel population (Flk1(+)PDGFR alpha(-)CAR(+) cells) with the potential to differentiate into not only hematopoietic cells and endothelial cells but also cardiomyocytes. Our findings indicate that CAR would be a novel and prominent marker for separating PSC- and embryo-derived Flk1(+) mesodermal cells with distinct differentiation potentials.	[Tashiro, Katsuhisa; Hirata, Nobue; Okada, Atsumasa; Yamaguchi, Tomoko; Kawabata, Kenji] Natl Inst Biomed Innovat, Lab Stem Cell Regulat, Osaka 5670085, Japan; [Takayama, Kazuo; Mizuguchi, Hiroyuki] Natl Inst Biomed Innovat, Lab Hepatocyte Regulat, Osaka 5670085, Japan; [Takayama, Kazuo; Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Osaka, Japan; [Takayama, Kazuo; Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, IPS Cell Based Res Project Hepat Toxic & Metab, Osaka, Japan; [Kawabata, Kenji] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biomed Innovat, Osaka, Japan; [Mizuguchi, Hiroyuki] Osaka Univ, Ctr Adv Med Engn & Informat, Osaka, Japan	Kawabata, K (reprint author), Natl Inst Biomed Innovat, Lab Stem Cell Regulat, 7-6-8 Saito Asagi, Osaka 5670085, Japan.	kawabata@nibio.go.jp			Ministry of Health, Labour, and Welfare of Japan; Hokuto Foundation for Bioscience; Japan Society for the Promotion of Science	We thank R. Hirabayashi and M. Nishijima (National Institute of Biomedical Innovation) for their help. We thank Dr. T. Imai (KAN Research Institute) for providing the anti-mouse CAR monoclonal antibody. We also thank Dr. S. Yamanaka for kindly providing the mouse iPS cell line 38C2 and human iPS cell line 201B7, and Dr. N. Nakatsuji for kindly providing the human ES cell line KhES-3. This work was supported by grants from the Ministry of Health, Labour, and Welfare of Japan and by the Award for Encouragement of Research from Hokuto Foundation for Bioscience. K. Takayama is supported by a grant-in-aid from the Japan Society for the Promotion of Science Fellows.	Tashiro K, 2010, CELL REPROGRAM, V12, P501, DOI 10.1089/cell.2010.0023; Dorner AA, 2005, J CELL SCI, V118, P3509, DOI 10.1242/jcs.02476; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Lugus JJ, 2009, BLOOD, V113, P563, DOI 10.1182/blood-2008-06-162750; Yamashita JK, 2005, FASEB J, V19, P1534, DOI 10.1096/fj.04-3540fje; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Chen JW, 2006, CIRC RES, V98, P923, DOI 10.1161/01.RES.0000218041.41932.e3; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Asher DR, 2005, GENESIS, V42, P77, DOI 10.1002/gene.20127; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Tashiro K, 2009, STEM CELLS, V27, P1802, DOI 10.1002/stem.108; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Liu F, 2012, BLOOD, V119, P3295, DOI 10.1182/blood-2012-01-403766; Van Handel B, 2012, CELL, V150, P590, DOI 10.1016/j.cell.2012.06.026; Choi KD, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.184; Honda T, 2000, Brain Res Mol Brain Res, V77, P19; Kawabata K, 2005, MOL THER, V12, P547, DOI 10.1016/j.ymthe.2005.04.015; Neering SJ, 1996, BLOOD, V88, P1147; Rebel VI, 2000, STEM CELLS, V18, P176, DOI 10.1634/stemcells.18-3-176; Tashiro K, 2012, STEM CELLS DEV, V21, P3381, DOI 10.1089/scd.2012.0100; Tashiro K, 2012, STEM CELL RES, V8, P300, DOI 10.1016/j.scr.2011.09.001; Zhang HL, 2014, STEM CELLS, V32, P191, DOI 10.1002/stem.1536	32	0	0	ALPHAMED PRESS	DURHAM	318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	MAY	2015	4	5					424	436		10.5966/sctm.2014-0173		13	Cell & Tissue Engineering	Cell Biology	CI9DD	WOS:000355069700012		
J	Nakamura, H; Suzuki, S; Sakata, I; Kajikawa, Y				Nakamura, Hiroko; Suzuki, Shinji; Sakata, Ichiro; Kajikawa, Yuya			Knowledge combination modeling: The measurement of knowledge similarity between different technological domains	TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE			English	Article						Patent analysis; Citation analysis; Bibliometrics; Breadth search; Knowledge recombination	CITATION ANALYSIS; PATENT STATISTICS; SEARCH; INDICATORS; INNOVATION; SCIENCE; BIBLIOMETRICS; BREADTH; SYSTEM; ENERGY	This paper proposes the DB-Combination model that considers three different knowledge combinations in depth (D) and breadth (B) based on similarities of two technological knowledge domains. We also investigate three methodologies A1, A2 and A3 to highlight the three knowledge combinations. To identify technological knowledge domains, citation analysis on patent information was used for A1 and A2 and pre-existing patent classification analysis was used for A3. And to measure the similarity between identified technological knowledge domains, text similarity measurements, existing intra-industrial citation tracing and IPC share similarity comparison were used for A1, A2 and A3 respectively. The usability of the model and methodologies were demonstrated through a case study on technological knowledge of the automobile industry and the aircraft industry. While these methodologies still need to be improved, it was demonstrated that the three measurements can highlight candidates of the three knowledge combination proposed in DB-Combination model. This research contributes to accelerate breadth knowledge recombination in a complex technology industry. (C) 2014 Elsevier Inc. All rights reserved.	[Nakamura, Hiroko; Suzuki, Shinji] Univ Tokyo, CAIR, Bunkyo Ku, Tokyo 1138654, Japan; [Sakata, Ichiro] Univ Tokyo, Innovat Policy Res Ctr, Tokyo 1138654, Japan; [Kajikawa, Yuya] Tokyo Inst Technol, Grad Sch Innovat Management, Tokyo 152, Japan	Nakamura, H (reprint author), Univ Tokyo, CAIR, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan.	techhn@mail.ecc.u-tokyo.ac.jp			Research Institute of Science and Technology for Society (RISTEX) of Japan Science and Technology Agency (JST)	A part of this research is financially supported by theResearch Institute of Science and Technology for Society (RISTEX) of Japan Science and Technology Agency (JST).	NARIN F, 1994, SCIENTOMETRICS, V30, P147, DOI 10.1007/BF02017219; Schilling MA, 2011, RES POLICY, V40, P1321, DOI 10.1016/j.respol.2011.06.009; NELSON RR, 1977, RES POLICY, V6, P36, DOI 10.1016/0048-7333(77)90029-4; Smalheiser NR, 2012, J AM SOC INF SCI TEC, V63, P218, DOI 10.1002/asi.21599; Meyer M, 2000, SCIENTOMETRICS, V49, P93, DOI 10.1023/A:1005613325648; Martin BR, 2012, RES POLICY, V41, P1219, DOI 10.1016/j.respol.2012.03.012; Nicolaisen J, 2007, ANNU REV INFORM SCI, V41, P609, DOI 10.1002/aris.2007.1440410120; Kostoff RN, 1998, SCIENTOMETRICS, V43, P27, DOI 10.1007/BF02458392; Leiponen A, 2010, STRATEG MANAGE J, V31, P224, DOI 10.1002/smj.807; Adai AT, 2004, J MOL BIOL, V340, P179, DOI 10.1016/j.jmb.2004.04.047; Michel J, 2001, SCIENTOMETRICS, V51, P185, DOI 10.1023/A:1010577030871; Cronin B, 2001, J INFORM SCI, V27, P1; Katila R, 2002, ACAD MANAGE J, V45, P1183, DOI 10.2307/3069433; Fleming L, 2001, RES POLICY, V30, P1019, DOI 10.1016/S0048-7333(00)00135-9; Schoenmakers W, 2010, RES POLICY, V39, P1051, DOI 10.1016/j.respol.2010.05.013; PAVITT K, 1985, SCIENTOMETRICS, V7, P77, DOI 10.1007/BF02020142; Nerur SP, 2008, STRATEG MANAGE J, V29, P319, DOI 10.1002/smj.659; Kajikawa Y, 2008, TECHNOL FORECAST SOC, V75, P771, DOI 10.1016/j.techfore.2007.05.005; TIJSSEN RJW, 1992, RES POLICY, V21, P27, DOI 10.1016/0048-7333(92)90025-Y; Cantu FJ, 2010, EXPERT SYST APPL, V37, P5272, DOI 10.1016/j.eswa.2010.01.012; Criscuolo P, 2006, SCIENTOMETRICS, V66, P23, DOI 10.1007/s11192-006-0003-6; DOSI G, 1982, RES POLICY, V11, P147, DOI 10.1016/0048-7333(82)90016-6; Eriksson S, 2000, TECHNOVATION, V20, P653, DOI 10.1016/S0166-4972(00)00009-2; EVERETT JE, 1993, J APPL SOC PSYCHOL, V23, P750, DOI 10.1111/j.1559-1816.1993.tb01113.x; Garfield I., 1979, SCIENTOMETRICS, V1, P359; Gordon M. D., 2002, ACM T INTERNET TECHN, V2, P261, DOI 10.1145/604596.604597; GRILICHES Z, 1990, J ECON LIT, V28, P1661; Herrero A, 2010, COMPUT INTELL, V26, P26, DOI 10.1111/j.1467-8640.2009.00351.x; JAFFE AB, 1986, AM ECON REV, V76, P984; Jones B, 2007, ROUTL ADV MANAG BUS, V31, P1; Kajikawa Y, 2006, J INF SCI, V32, P511, DOI 10.1177/0165551506067125; Kostoff RN, 2008, TECHNOL FORECAST SOC, V75, P165, DOI 10.1016/j.techfore.2007.11.004; Leydesdorff L, 2008, J AM SOC INF SCI TEC, V59, P1582, DOI 10.1002/asi.20814; Leydesdorff L, 2012, SCIENTOMETRICS; M Alavi, 2001, MIS Q, V25, P107; Moorthy S, 2010, J KNOWL MANAG, V14, P359, DOI 10.1108/13673271011050102; Nakamura H., 2011, TECHNOLOGICAL MANAGE; Nakamura H, 2011, SCIENTOMETRICS, V87, P221, DOI 10.1007/s11192-011-0341-x; Nakamura H., 2012, SUSTAIN SCI; NESTA L, 2005, PHARM IND, V53, P123; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026113; NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14; NONAKA I, 1991, HARVARD BUS REV, V69, P96; OECD, 1994, MEAS SCI TECHN ACT U; Schoen A., 2012, 17 INT C SCI TECHN I; Schumpeter J. A., 1934, THEORY EC DEV; Smalheiser NR, 1998, COMPUT METH PROG BIO, V57, P149, DOI 10.1016/S0169-2607(98)00033-9; SOETE LG, 1983, SCIENTOMETRICS, V5, P31, DOI 10.1007/BF02097176; Zeschky M., 2008, CREATIVITY INNOVATIO, V17, P97, DOI 10.1111/j.1467-8691.2008.00475.x	49	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0040-1625	1873-5509		TECHNOL FORECAST SOC	Technol. Forecast. Soc. Chang.	MAY	2015	94						187	201		10.1016/j.techfore.2014.09.009		15	Business; Planning & Development	Business & Economics; Public Administration	CI8SP	WOS:000355042300011		
J	Gi, M; Fujioka, M; Yamano, S; Shimomura, E; Ishii, N; Kakehashi, A; Takeshita, M; Wanibuchi, H				Gi, Min; Fujioka, Masaki; Yamano, Shotaro; Shimomura, Eri; Ishii, Naomi; Kakehashi, Anna; Takeshita, Masanori; Wanibuchi, Hideki			Determination of Hepatotoxicity and Its Underlying Metabolic Basis of 1,2-Dichloropropane in Male Syrian Hamsters and B6C3F1 Mice	TOXICOLOGICAL SCIENCES			English	Article						1; 2-DCP; hepatotoxicity; CYP2E1; GST-T1; hamster; mouse	2-YEAR DRINKING-WATER; DICHLOROMETHANE; RATS; CHOLANGIOCARCINOMA; INHALATION; CARCINOGENICITY; WORKERS; CANCER; MECHANISMS; TOXICITY	1,2-Dichloropropane (1,2-DCP) has recently been reclassified from not classifiable as to its carcinogenicity to humans (Group 3) to carcinogenic to humans (Group 1) by the International Agency for Research on Cancer. This was based on the findings of epidemiological studies in Japan that occupational exposure to paint stripers containing 1,2-DCP was associated with increased cholangiocarcinomas. It is known that 1,2-DCP is negative for cholangiocarcinogenicity in rats and mice. However, its toxicity and carcinogenicity has not been examined in hamsters and little is known about the regulation of its metabolism in hamsters. The purpose of this study was to determine the hepatobiliary toxicity of 1,2-DCP in hamsters and to characterize and compare the altered patterns of hepatic xenometabolic enzymes in hamsters and mice. Male Syrian hamsters and male B6C3F1 mice were treated with various doses of 1,2-DCP for 4 h or 3 days or 4 weeks. These experiments demonstrated that a high dose of 1,2-DCP induced centrilobular hepatocellular necrosis in hamsters. CYP2E1 is possibly the key enzyme responsible for bioactivation and the consequent hepatocytotoxicity of 1,2-DCP, and GSH conjugation catalyzed by GST-T1 may exert a cytoprotective role in hamsters and mice. Notably, the expression pattern of GST-T1 in bile duct epithelial cells differed between hamsters and mice: GST-T1 was expressed in bile duct epithelial cells of mice but not hamsters. This indicates that responses to 1,2-DCP in the bile duct of hamsters might differ from that of mice, and suggests that long-term studies are necessary to clarify the chalangiocarcinogenicity of 1,2-DCP in hamsters, though no biliary toxicity was observed in the present short-term experiments.	[Gi, Min; Fujioka, Masaki; Yamano, Shotaro; Shimomura, Eri; Ishii, Naomi; Kakehashi, Anna; Takeshita, Masanori; Wanibuchi, Hideki] Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Osaka 558, Japan	Wanibuchi, H (reprint author), Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Osaka 558, Japan.	wani@med.osaka-cu.ac.jp			Ministry of Health, Labor and Welfare of Japan [H23-KAGAKU-SHITEI-007, H26-KAGAKU-SHITEI-001]; Japan Society for the Promotion of Science [26340042]	Health Labour Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan (grant numbers H23-KAGAKU-SHITEI-007, H26-KAGAKU-SHITEI-001), and a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (grant number 26340042).	GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; IMRAY CHE, 1992, EUR J SURG ONCOL, V18, P373; Bruning T, 1997, ARCH TOXICOL, V71, P596, DOI 10.1007/s002040050432; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Sanz N, 2002, BBA-MOL BASIS DIS, V1587, P12, DOI 10.1016/S0925-4439(02)00048-0; Takahashi M, 2008, CARCINOGENESIS, V29, P1608, DOI 10.1093/carcin/bgn152; Benbrahim-Tallaa L, 2014, LANCET ONCOL, V15, P924, DOI 10.1016/S1470-2045(14)70316-X; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; THAMAVIT W, 1993, CARCINOGENESIS, V14, P2415, DOI 10.1093/carcin/14.11.2415; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Franco R, 2012, ANTIOXID REDOX SIGN, V17, P1694, DOI 10.1089/ars.2012.4553; Guengerich FP, 2003, J BIOCHEM MOL BIOL, V36, P20; SEROTA DG, 1986, FOOD CHEM TOXICOL, V24, P959, DOI 10.1016/0278-6915(86)90324-8; Kubo S, 2014, J HEPATO-BIL-PAN SCI, V21, P479, DOI 10.1002/jhbp.86; Umeda Y, 2010, INHAL TOXICOL, V22, P1116, DOI 10.3109/08958378.2010.526973; SEROTA DG, 1986, FOOD CHEM TOXICOL, V24, P951, DOI 10.1016/0278-6915(86)90323-6; BUREK JD, 1984, FUND APPL TOXICOL, V4, P30, DOI 10.1016/0272-0590(84)90217-3; Sherratt PJ, 2002, TOXICOL APPL PHARM, V179, P89, DOI 10.1006/taap.2002.9348; Kumagai S, 2013, OCCUP ENVIRON MED, V70, P508, DOI 10.1136/oemed-2012-101246; Landi S, 2000, MUTAT RES-REV MUTAT, V463, P247, DOI 10.1016/S1383-5742(00)00050-8; IARC, 1986, IARC MON EV CARC RIS, V41, P43; IARC, 2014, IARC MONOGR IN PRESS; IARC, 1999, IARC MON, V71, P1393; Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286; NTP, 1986, NATL TOX PROGR TECH, V263, P1; NTP, 1986, NATL TOXICOL PROGRAM, V306, P1; Suzuki T, 2014, J OCCUP HEALTH, V56, P205; TIMCHALK C, 1991, TOXICOLOGY, V68, P291, DOI 10.1016/0300-483X(91)90076-D; Tornero-Velez R, 2004, DRUG METAB DISPOS, V32, P123, DOI 10.1124/dmd.32.1.123; Wei M, 2009, TOXICOL PATHOL, V37, P983, DOI 10.1177/0192623309351720; WOODRUFF RC, 1985, ENVIRON MUTAGEN, V7, P677, DOI 10.1002/em.2860070507	33	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	MAY	2015	145	1					196	208		10.1093/toxsci/kfv045		13	Toxicology	Toxicology	CJ1YL	WOS:000355280900020		
J	Aranishi, T; Ikeda, S				Aranishi, T.; Ikeda, S.			SUGGESTION OF NEW METHODS TO CALCULATE CONFIDENCE INTERVAL FOR INCREMENTAL COST-EFFECTIVENESS RATIO WHICH SOLVE THE ISSUES WITH CONVENTIONAL METHOD	VALUE IN HEALTH			English	Meeting Abstract									[Aranishi, T.; Ikeda, S.] Int Univ Hlth & Welf, Ohtawara City, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PRM32	A15	A16				4	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498500076		
J	Asami, Y; Kuribayashi, K; Hoshino, Y; Yamamoto, Y; Nagayasu, S; Yamazaki, T; Fujimoto, Y				Asami, Y.; Kuribayashi, K.; Hoshino, Y.; Yamamoto, Y.; Nagayasu, S.; Yamazaki, T.; Fujimoto, Y.			A RETROSPECTIVE COHORT STUDY USING CLAIMS DATABASE TO INVESTIGATE THE ACTUAL SITUATION IN TREATMENT OF PANIC DISORDER IN JAPAN	VALUE IN HEALTH			English	Meeting Abstract									[Asami, Y.; Kuribayashi, K.; Hoshino, Y.; Fujimoto, Y.] Pfizer Japan Inc, Tokyo, Japan; [Yamamoto, Y.; Nagayasu, S.; Yamazaki, T.] MinaCare Co Ltd, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PMH5	A115	A115				1	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498502020		
J	Dasa, V; DeKoven, M; Lim, S; Long, K; Heeckt, P				Dasa, V; DeKoven, M.; Lim, S.; Long, K.; Heeckt, P.			CLINICAL AND COST OUTCOMES FROM DIFFERENT HYALURONIC ACID TREATMENTS IN PATIENTS WITH KNEE OSTEOARTHRITIS	VALUE IN HEALTH			English	Meeting Abstract									[Dasa, V] Louisiana State Univ, New Orleans, LA USA; [DeKoven, M.] IMS Hlth, Fairfax, VA USA; [Lim, S.] Seikagaku Corp, Tokyo, Japan; [Long, K.; Heeckt, P.] Bioventus LLC, Durham, NC USA								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PMD26	A42	A42				1	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498500222		
J	Gai, R				Gai, R.			COST-EFFECTIVENESS ANALYSIS OF FEMALE HUMAN PAPILLOMAVIRUS VACCINATION IN MAINLAND CHINA	VALUE IN HEALTH			English	Meeting Abstract									[Gai, R.] Natl Ctr Child Hlth & Dev, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PCN75	A202	A203				4	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498503193		
J	Hamashima, C; Kim, Y; Choi, KS				Hamashima, C.; Kim, Y.; Choi, K. S.			COMPARISON OF GUIDELINES AND MANAGEMENT FOR GASTRIC CANCER SCREENING BETWEEN KOREA AND JAPAN	VALUE IN HEALTH			English	Meeting Abstract									[Hamashima, C.] Natl Canc Ctr, Tokyo 104, Japan; [Kim, Y.; Choi, K. S.] Natl Canc Control Inst, Gyeonggi Do, South Korea								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PHS150	A272	A272				1	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498504263		
J	Igarashi, A; Goto, R; Yoshikawa, R; Suwa, K; Ward, AJ; Moller, J				Igarashi, A.; Goto, R.; Yoshikawa, R.; Suwa, K.; Ward, A. J.; Moller, J.			COST-EFFECTIVENESS ANALYSIS OF SMOKING CESSATION INTERVENTIONS IN JAPAN USING THE DISCRETE EVENT SIMULATION MODEL	VALUE IN HEALTH			English	Meeting Abstract									[Igarashi, A.] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Goto, R.] Kyoto Univ, Kyoto, Japan; [Yoshikawa, R.; Suwa, K.] Pfizer Japan Inc, Tokyo, Japan; [Ward, A. J.] Evidera Inc, Lexington, MD USA; [Moller, J.] Evidera, London, England								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PRS27	A174	A174				1	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498503035		
J	Ikeda, S; Inoue, S; Kobayashi, M				Ikeda, S.; Inoue, S.; Kobayashi, M.			COST-EFFECTIVENESS ANALYSIS OF CONDOLIASE IN PATIENTS WITH LUMBAR DISC HERNIATION IN JAPAN	VALUE IN HEALTH			English	Meeting Abstract									[Ikeda, S.; Inoue, S.] Int Univ Hlth & Welf, Otawara City, Tochigi, Japan; [Kobayashi, M.] CRECON Med Assessment Inc, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PMS49	A161	A161				1	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498502270		
J	Ito, C; Nishikino, R; Onishi, Y				Ito, C.; Nishikino, R.; Onishi, Y.			ASSESSING A PHYSICIAN VISIT FOR HEPATIC DYSFUNCTION BASED ON DATABASE MERGING CLAIMS AND ANNUAL HEALTH CHECKUP DATA IN JAPAN	VALUE IN HEALTH			English	Meeting Abstract									[Ito, C.; Nishikino, R.] JMDC Co Ltd, Tokyo, Japan; [Onishi, Y.] Creativ Ceut KK, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PHS95	A263	A263				1	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498504215		
J	Jamotte, A; Onishi, Y; Clay, E; Aballea, S				Jamotte, A.; Onishi, Y.; Clay, E.; Aballea, S.			PRESCRIPTION PATTERNS FOLLOWING FIRST-LINE SECOND-GENERATION ANTIPSYCHOTICS FOR PATIENTS WITH SCHIZOPHRENIA IN JAPAN: AN INSURANCE CLAIMS DATABASE ANALYSIS	VALUE IN HEALTH			English	Meeting Abstract									[Jamotte, A.; Clay, E.; Aballea, S.] Creativ Ceut, Paris, France; [Onishi, Y.] Creat Ceut KK, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PMH80	A129	A129				1	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498502095		
J	Kamae, I; Sugimoto, T; Yamabe, K				Kamae, I; Sugimoto, T.; Yamabe, K.			AN ANALYTICAL CRITERION FOR JUDGING THE EXTENDED DOMINANCY OF A NEW TECHNOLOGY COMPARED TO THE STANDARD OF CARE AND PLACEBO CONTROL	VALUE IN HEALTH			English	Meeting Abstract									[Kamae, I; Sugimoto, T.] Univ Tokyo, Grad Sch Publ Policy, Tokyo, Japan; [Yamabe, K.] Takeda Pharmaceut Co Ltd, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PRM141	A34	A35				4	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498500181		
J	Kawabata, I; Ii, Y; Yamamoto, Y; Yamazaki, T; Fujimoto, Y				Kawabata, I; Ii, Y.; Yamamoto, Y.; Yamazaki, T.; Fujimoto, Y.			THE ACTUAL CLINICAL USE OF ANTIFUNGAL DRUGS IN PATIENTS WHO RECEIVED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN JAPAN: A RETROSPECTIVE DATABASE STUDY	VALUE IN HEALTH			English	Meeting Abstract									[Kawabata, I; Ii, Y.; Fujimoto, Y.] Pfizer Japan Inc, Tokyo, Japan; [Yamamoto, Y.; Yamazaki, T.] MinaCare Co Ltd, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PSY11	A293	A293				1	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498505063		
J	Miller, D; Rivas, DG; Meyer, K; Clark, RS; Kohno, T				Miller, D.; Gonzalez Rivas, D.; Meyer, K.; Clark, R. S.; Kohno, T.			PCN139 THE IMPACT OF ENDOSCOPIC LINEAR STAPLING DEVICE STABILITY IN THORACIC SURGERY: A DELPHI PANEL APROACH	VALUE IN HEALTH			English	Meeting Abstract									[Miller, D.] WellStar Med Grp, Austell, GA USA; [Gonzalez Rivas, D.] Coruna Univ Hosp, Coruna, Spain; [Meyer, K.] Xcenda Corp, Tampa, FL USA; [Clark, R. S.] Xcenda, Palm Harbor, FL USA; [Kohno, T.] Toranomon Gen Hosp, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PCN139	A213	A213				1	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498503251		
J	Narimatsu, A; Ishii, K; Adachi, K				Narimatsu, A.; Ishii, K.; Adachi, K.			REVIEW OF CAREGIVER BURDEN SCALES FOR PATIENTS WITH VISUAL IMPAIREMENT IN JAPAN	VALUE IN HEALTH			English	Meeting Abstract									[Narimatsu, A.; Ishii, K.; Adachi, K.] Bayer Yakuhin Ltd, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PRM116	A30	A30				1	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498500156		
J	Sawachi, S				Sawachi, S.			A RETROSPECTIVE DATABASE STUDY TO INVESTIGATE THE MORBIDITY AND PHARMACEUTICAL INTERVENTION OF PULMONARY ARTERIAL HYPERTENSION IN JAPAN	VALUE IN HEALTH			English	Meeting Abstract									[Sawachi, S.] Pfizer Japan Inc, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PCV37	A136	A136				1	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498502131		
J	Sugimoto, N; Kawai, N; Yoshiyama, T; Yamamoto, Y; Yamazaki, T; Shirai, C; Fujimoto, Y				Sugimoto, N.; Kawai, N.; Yoshiyama, T.; Yamamoto, Y.; Yamazaki, T.; Shirai, C.; Fujimoto, Y.			A RETROSPECTIVE COHORT STUDY TO INVESTIGATE ACTUAL TREATMENT FOR GLAUCOMA USING A JAPANESE HEALTHCARE DATABASE	VALUE IN HEALTH			English	Meeting Abstract									[Sugimoto, N.; Kawai, N.; Yoshiyama, T.; Shirai, C.; Fujimoto, Y.] Pfizer Japan Inc, Tokyo, Japan; [Yamamoto, Y.; Yamazaki, T.] MinaCare Co Ltd, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PSS38	A185	A185				1	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498503098		
J	Sugimoto, T; Kamae, I; Yamabe, K				Sugimoto, T.; Kamae, I; Yamabe, K.			ASSESSING THE QUALITY OF HEALTH ECONOMIC EVALUATIONS PUBLISHED IN JAPANESE SETTIGNS: A SYSTEMATIC REVIEW OF 1991-2012 LITERATURE	VALUE IN HEALTH			English	Meeting Abstract									[Sugimoto, T.; Kamae, I] Univ Tokyo, Grad Sch Publ Policy, Tokyo, Japan; [Yamabe, K.] Takeda Pharmaceut Co Ltd, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PHP140	A94	A94				1	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498501218		
J	Takahashi, O; Ohde, S; Deshpande, G				Takahashi, O.; Ohde, S.; Deshpande, G.			SOCIOECONOMIC STATUS AND DEPRESSION IN JAPAN	VALUE IN HEALTH			English	Meeting Abstract									[Takahashi, O.; Ohde, S.; Deshpande, G.] St Lukes Life Sci Inst, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1098-3015	1524-4733		VALUE HEALTH	Value Health	MAY	2015	18	3				PMH18	A117	A117				1	Economics; Health Care Sciences & Services; Health Policy & Services	Business & Economics; Health Care Sciences & Services	CI1IZ	WOS:000354498502033		
J	Scherr, D; Ebner, J; Manninger, M; Ohnewein, B; Brussee, H; Klein, A; Betaglia, E; Deisenhofer, I; Grebmer, C; Shinsuke, M; Yoshido, I; Calkins, H; Marine, J				Scherr, D.; Ebner, J.; Manninger, M.; Ohnewein, B.; Brussee, H.; Klein, A.; Betaglia, E.; Deisenhofer, I.; Grebmer, C.; Shinsuke, M.; Yoshido, I.; Calkins, H.; Marine, J.			Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation: a multicenter study	WIENER KLINISCHE WOCHENSCHRIFT			English	Meeting Abstract									Med Univ Graz, Klin Abt Kardiol, Graz, Austria; Cleveland Clin, Cleveland, OH 44106 USA; Osped Civile, Mirano, Italy; Deutsch Herzzentrum Munich, Munich, Germany; Kinki Univ, Sch Med Yokosuka, Yokosuka, Kanagawa, Japan; Johns Hopkins Univ, Baltimore, MD USA								0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0043-5325	1613-7671		WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	MAY	2015	127			1		BA I - 1	S1	S1				1	Medicine, General & Internal	General & Internal Medicine	CJ1EA	WOS:000355223700002		
J	El Osta, R; Demont, A; Audebrand, N; Molard, Y; Nguyen, TT; Gautier, R; Brylev, KA; Mironov, YV; Naumov, NG; Kitamura, N; Cordier, S				El Osta, Racha; Demont, Antoine; Audebrand, Nathalie; Molard, Yann; Thi Thuong Nguyen; Gautier, Regis; Brylev, Konstantin A.; Mironov, Youri V.; Naumov, Nikolay G.; Kitamura, Noboru; Cordier, Stephane			Supramolecular Frameworks Built up from Red-Phosphorescent trans-Re-6 Cluster Building Blocks: One Pot Synthesis, Crystal Structures, and DFT Investigations	ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE			English	Article						Cluster compounds; Rhenium; Supramolecular frameworks; Luminescence; Density functional calculations	RHENIUM(III) CHALCOGENIDE CLUSTERS; TRANSITION-METAL CLUSTERS; PRUSSIAN BLUE ANALOGS; BRIDGED RE(6)Q(8) Q; COORDINATION POLYMERS; SILICA NANOPARTICLES; HEXANUCLEAR MOLYBDENUM; SELENIDE CLUSTERS; ZNO NANOCRYSTALS; HYDROGEN-BONDS	The reaction of a K-4[{Re6S8i}(OH)(6)(a)]center dot 8H(2)O rhenium cluster salt with 4,4'-bipyridine (bpy) or 4-aminopyridine (apy) in an aqueous solution at mild temperature and pressure conditions lead to cluster functionalization and to the formation of two new compounds [{Re6S8i}(OH)(2)(a)(bpy)(4)(a)]center dot bpy center dot 4H(2)O (1) and [{Re6S8i}(OH)(2)(a)(apy)(4)(a)]center dot 2apy center dot 2H(2)O (2). Their crystal structures are built up from trans-[{Re6S8i}(OH)(2)(a)(L)(4)(a)] neutral units and the cohesions of both supramolecular frameworks are based on p-p stacking as well as hydrogen bonds, involving the cluster units trans[{Re6S8i}(OH)(2)(a)(L)(4)(a)], interstitial L ligands and water molecules. 1 and 2 present 2D and 3D cluster frameworks, respectively. Both compounds show red-NIR luminescence in the solid states. DFT calculations demonstrate that association of face capped Re-6 clusters with bpy and apy ligands enabled to form supramolecular frameworks that retain luminescent properties of the cluster units.	[El Osta, Racha; Audebrand, Nathalie; Molard, Yann; Thi Thuong Nguyen; Gautier, Regis] Univ Rennes 1, ENSCR, CNRS, Inst Sci Chim Rennes,UMR 6226, Rennes, France; [Brylev, Konstantin A.; Mironov, Youri V.; Naumov, Nikolay G.; Cordier, Stephane] Novosibirsk State Univ, Nikolaev Inst Inorgan Chem, Novosibirsk 630090, Russia; [Demont, Antoine] CNRS, PROMES, F-66120 Font Romeu, France; [Brylev, Konstantin A.; Kitamura, Noboru] Hokkaido Univ, Dept Chem, Fac Sci, Sapporo, Hokkaido 0600810, Japan	Audebrand, N (reprint author), Univ Rennes 1, ENSCR, CNRS, Inst Sci Chim Rennes,UMR 6226, Rennes, France.	Nathalie.audebrand@univ-rennes1.fr; stephane.cordier@univ-rennes1.fr			France-Russia programs PICS [5822]; Japan Society for the Promotion of Science (JSPS)	We thank the France-Russia programs PICS (2011-2013 No5822) and International Associate Laboratory CLUSPOM (2014-2017) as well as the IDEMAT chemistry project in the frame of the Franco-Siberian Center of Training and Research. K. A. Brylev thanks the Japan Society for the Promotion of Science (JSPS) for a Post-Doctoral Fellowship for Foreign Researchers.	Amela-Cortes M, 2014, J MATER CHEM C, V2, P9813, DOI 10.1039/c4tc02098g; Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U; Beauvais LG, 1998, CHEM MATER, V10, P3783, DOI 10.1021/cm980564q; vanLenthe E, 1996, J CHEM PHYS, V105, P6505, DOI 10.1063/1.472460; Naumov NG, 1998, ANGEW CHEM INT EDIT, V37, P1943, DOI 10.1002/(SICI)1521-3773(19980803)37:13/14<1943::AID-ANIE1943>3.0.CO;2-Q; Naumov NG, 2003, SOLID STATE SCI, V5, P1359, DOI 10.1016/S1293-2558(03)00193-6; Naumov NG, 2005, SOLID STATE SCI, V7, P1517, DOI 10.1016/j.solidstatesciences.2005.08.022; Bennett MV, 2001, J AM CHEM SOC, V123, P8022, DOI 10.1021/ja0110473; Ledneva AY, 2014, POLYHEDRON, V67, P351, DOI 10.1016/j.poly.2013.09.015; Steiner T, 1998, J PHYS CHEM A, V102, P7041, DOI 10.1021/jp981604g; Aubert T, 2013, PART PART SYST CHAR, V30, P90, DOI 10.1002/ppsc.201200047; Bennett MV, 2000, J AM CHEM SOC, V122, P6664, DOI 10.1021/ja000593d; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Molard Y, 2011, CHEM MATER, V23, P5122, DOI 10.1021/cm201589d; vanLenthe E, 1996, INT J QUANTUM CHEM, V57, P281, DOI 10.1002/(SICI)1097-461X(1996)57:3<281::AID-QUA2>3.0.CO;2-U; te Velde G, 2001, J COMPUT CHEM, V22, P931, DOI 10.1002/jcc.1056; Aubert T, 2013, J PHYS CHEM C, V117, P20154, DOI 10.1021/jp405836q; Gray TG, 2003, J AM CHEM SOC, V125, P4755, DOI 10.1021/ja0286371; Garreau A, 2013, ACS NANO, V7, P2977, DOI 10.1021/nn400763r; Kim Y, 2009, J MATER CHEM, V19, P7178, DOI 10.1039/b903929p; Ariga K, 2011, J NANOSCI NANOTECHNO, V11, P1, DOI 10.1166/jnn.2011.3839; Aubert T, 2010, LANGMUIR, V26, P18512, DOI 10.1021/la103784v; Shores MP, 1999, J AM CHEM SOC, V121, P775, DOI 10.1021/ja983530s; Efremova OA, 2014, DALTON T, V43, P6021, DOI 10.1039/c3dt53126k; Molard Y, 2013, ADV FUNCT MATER, V23, P4821, DOI 10.1002/adfm.201300417; Majumder A, 2006, CRYST GROWTH DES, V6, P2355, DOI 10.1021/cg060337y; Shestopalov MA, 2014, INORG CHEM, V53, P9006, DOI 10.1021/ic500553v; Nishio M, 2004, CRYSTENGCOMM, V6, P130, DOI 10.1039/b313104a; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Grasset F, 2008, ADV MATER, V20, P143, DOI 10.1002/adma.200701686; Zhou HJ, 2007, EUR J INORG CHEM, P1053, DOI 10.1002/ejic.200600900; Beauvais LG, 2000, J AM CHEM SOC, V122, P2763, DOI 10.1021/ja994186h; Ariga K, 2014, NEW J CHEM, V38, P5149, DOI 10.1039/c4nj00864b; Tarasenko MS, 2009, CHEM COMMUN, P2655, DOI 10.1039/b820722d; VANLENTHE E, 1994, J CHEM PHYS, V101, P9783, DOI 10.1063/1.467943; Grasset F, 2008, ADV MATER, V20, P1710, DOI 10.1002/adma.200701845; Brylev KA, 2009, J CLUST SCI, V20, P165, DOI 10.1007/s10876-008-0215-4; Altomare A, 1999, J APPL CRYSTALLOGR, V32, P115, DOI 10.1107/S0021889898007717; Brylev KA, 2007, INORG CHEM, V46, P7414, DOI 10.1021/ic7005265; Deng Q, 2013, J SOLID STATE CHEM, V200, P60, DOI 10.1016/j.jssc.2013.01.003; Shestopalov MA, 2009, INORG CHEM, V48, P1482, DOI 10.1021/ic8018277; Amela-Cortes M, 2014, J MATER CHEM C, V2, P1545, DOI 10.1039/c3tc31309c; Ariga K, 2014, CHEM LETT, V43, P36, DOI 10.1246/cl.130987; Dybtsev D, 2010, LANGMUIR, V26, P11283, DOI 10.1021/la100601a; [Anonymous], 2012, AMST DENS FUNCT ADF; Selby HD, 2003, ACCOUNTS CHEM RES, V36, P933, DOI 10.1021/ar020134c; Barras A, 2012, APPL CATAL B-ENVIRON, V123, P1, DOI 10.1016/j.apcatb.2012.04.006; Mocanu AS, 2011, CHEM COMMUN, V47, P2056, DOI 10.1039/c0cc05012a; Kumar P, 2014, RSC ADV, V4, P10420, DOI 10.1039/c3ra47255h; Cordier S, 2004, INORG CHEM, V43, P219, DOI 10.1021/ic034443q; Nerambourg N, 2014, J COLLOID INTERF SCI, V424, P132, DOI 10.1016/j.jcis.2014.03.008; Fedorov VE, 2002, J STRUCT CHEM+, V43, P669, DOI 10.1023/A:1022060806724; Zhang JJ, 2007, J AM CHEM SOC, V129, P250, DOI 10.1021/ja066104c; Barras A, 2013, APPL CATAL B-ENVIRON, V130, P270, DOI 10.1016/j.apcatb.2012.11.017; Zhao Y, 2013, ADV ENERGY MATER, V3, P1143, DOI 10.1002/aenm.201300173; Molard Y, 2010, CHEM-EUR J, V16, P5613, DOI 10.1002/chem.200902131; Shores MP, 1999, INORG CHEM, V38, P1648, DOI 10.1021/ic9900408; Molard Y, 2010, ANGEW CHEM INT EDIT, V49, P3351, DOI 10.1002/anie.201000325; Backer J, 2011, EUR J INORG CHEM, P4089, DOI 10.1002/ejic.201100365; BINO A, 1982, J AM CHEM SOC, V104, P4383, DOI 10.1021/ja00380a012; Brylev KA, 2005, EUR J INORG CHEM, P461, DOI 10.1002/ejic.200400391; Brylev KA, 2004, INORG CHEM, V43, P4833, DOI 10.1021/ic040046j; Cordier S, 2015, J CLUST SCI, V26, P53, DOI 10.1007/s10876-014-0734-0; Cordier S, 2015, J INORG ORGANOMET P, V25, P189, DOI 10.1007/s10904-014-0112-2; Desiraju G. R., 1999, IUCR MONOGRAPHS CRYS, V9; Dorson F, 2009, DALTON T, P1297, DOI 10.1039/b822105g; D'Vries RF, 2013, J AM CHEM SOC, V135, P5782, DOI 10.1021/ja4005046; Efremova OA, 2014, J MATER CHEM C, V2, P8630, DOI 10.1039/c4tc01643b; Farrugia L. J., 1999, J APPL CRYSTALLOGR, V32, P837, DOI DOI 10.1107/S0021889899006020; Gao EJ, 2010, Z ANORG ALLG CHEM, V636, P1565, DOI 10.1002/zaac.200900554; Gao EJ, 2010, RUSS J COORD CHEM+, V36, P674, DOI 10.1134/S107032841009006X; Gao L, 2010, CHEM MATER, V22, P6240, DOI 10.1021/cm101609p; Gautier R., 2009, COMPUTATIONAL INORGA; Grasset F, 2008, CHEM COMMUN, P4729, DOI 10.1039/b806919k; Janiak C, 2000, J CHEM SOC DALTON, P3885, DOI 10.1039/b003010o; Lenthe E. V., 1993, J CHEM PHYS, V99, DOI 10.1063/1.466059; Magliocchi C, 2004, INORG CHEM, V43, P1902, DOI 10.1021/ic035050u; Mironov YV, 2004, ANGEW CHEM INT EDIT, V43, P1297, DOI 10.1002/anie.200351595; Nagashima S, 2014, J CLUST SCI, V25, P1203, DOI 10.1007/s10876-014-0700-x; Naumov NG, 2001, CHEM COMMUN, P571, DOI 10.1039/b008040n; Prasad T. K., 2005, CRYST GROWTH DES, V5, P488; Refson K., 2005, Z KRISTALLOGR, V220, P567; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Yarovoi SS, 2005, EUR J INORG CHEM, P3945, DOI 10.1002/ejic.200500284; Yoshida Y, 2014, EUR J INORG CHEM, P3871, DOI 10.1002/ejic.201400119; Yoshimura T, 2011, INORG CHEM, V50, P9918, DOI 10.1021/ic2010858; Yoshimura T, 2010, INORG CHEM, V49, P531, DOI 10.1021/ic9015788; Yoshimura T, 2000, INORG CHEM, V39, P1765, DOI 10.1021/ic991282a; Zhang JJ, 2009, J CHEM CRYSTALLOGR, V39, P1, DOI 10.1007/s10870-008-9423-x; Zhou HJ, 2007, CHEM MATER, V19, P2238, DOI 10.1021/cm063005p	90	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0044-2313	1521-3749		Z ANORG ALLG CHEM	Z. Anorg. Allg. Chem.	MAY	2015	641	6			SI		1156	1163		10.1002/zaac.201500074		8	Chemistry, Inorganic & Nuclear	Chemistry	CJ1LL	WOS:000355245000026		
J	Sakai, S; Yamaguchi, AA				Sakai, Shigeta; Yamaguchi, Atsushi A.			Theoretical analysis of optical polarization properties in semipolar and nonpolar InGaN quantum wells for precise determination of valence-band parameters in InGaN alloy material	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						InGaN; optical gain; optical polarization; quantum wells; valence band	SEMICONDUCTORS	In order to make a precise determination of InGaN material parameters (valence-band A parameters and deformation potentials), reported experimental data on polarization properties have been analyzed by the k center dot p perturbation theory, in which we utilized fact that the polarization properties are sensitive to the material parameters. It is found that the polarization properties are largely affected by the deformation potentials while the valence-band A parameters have small effects. In addition, it is found that two deformation potentials' sets roughly fit with the reported experimental data. From the calculation using these two parameters' sets, it is predicted that low-angle semipolar substrate orientation (theta=30 degrees-40 degrees) are promising for low-cost and high-performance green laser diodes with cleaved facet cavity mirrors. These results support our previous prediction based on analytical calculations.	[Sakai, Shigeta; Yamaguchi, Atsushi A.] Kanazawa Inst Technol, Optoelect Device Syst R&D Ctr, Nonoichi, Ishikawa 9218501, Japan	Sakai, S (reprint author), Kanazawa Inst Technol, Optoelect Device Syst R&D Ctr, Nonoichi, Ishikawa 9218501, Japan.	b6300467@planet.kanazawa-it.ac.jp			Grant-in-Aid for Scientific Research on Priority Areas [21016006]	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (no. 21016006).	Rinke P, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075202; Vurgaftman I, 2003, J APPL PHYS, V94, P3675, DOI 10.1063/1.1600519; Yan QM, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3236533; Scheibenzuber WG, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.115320; Masui H, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.071002; You S, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.102103; Chuang SL, 1996, PHYS REV B, V54, P2491, DOI 10.1103/PhysRevB.54.2491; CHUNG RB, JPN J APPL PHYS, V49, P2023; Feneberg M, 2007, J APPL PHYS, V101, DOI 10.1063/1.2710306; Kojima K, 2008, PHYS STATUS SOLIDI C, V5, P3038, DOI 10.1002/pssc.200779277; KUBOTA M, 2008, APPL PHYS LETT, V92; Kyono T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.011003; Masui H, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2890050; Nakagawa S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2800817; SCHEIBENZUBER WG, 2010, PHYS STATUS SOLIDI B, V3, P647; Takeuchi T, 2000, JPN J APPL PHYS 1, V39, P413, DOI 10.1143/JJAP.39.413; Tamaki H, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3624462; Ueda M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.233303; Vurgaftman I., 2007, NITRIDE SEMICONDUCTO; Yamada H, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1041101; Yamaguchi AA, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3561761; Yamaguchi AA, 2007, JPN J APPL PHYS 2, V46, pL789, DOI 10.1143/JJAP.46.L789; Yan QM, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3507289	23	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		885	889		10.1002/pssb.201451594		5	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300056		
J	Miyahara, S; Kano, H; Okada, K; Okita, Y				Miyahara, Shunsuke; Kano, Hiroya; Okada, Kenji; Okita, Yutaka			Aortic arch aneurysm in a patient with cold agglutinin disease	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Editorial Material						Total arch replacement; Mild hypothermia; Cold agglutinin disease			[Miyahara, Shunsuke; Kano, Hiroya; Okada, Kenji; Okita, Yutaka] Kobe Univ, Grad Sch Med, Div Cardiovasc Surg, Dept Surg, Kobe, Hyogo 6500017, Japan	Okita, Y (reprint author), Kobe Univ, Sch Med, Div Cardiovasc Surg, Dept Surg,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yokita@med.kobe-u.ac.jp					Barbara DW, 2013, J THORAC CARDIOV SUR, V146, P668, DOI 10.1016/j.jtcvs.2013.03.009	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	MAY	2015	20	5					687	687				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI5LO	WOS:000354798000033		
J	Miyahara, S; Kano, H; Okada, K; Okita, Y				Miyahara, Shunsuke; Kano, Hiroya; Okada, Kenji; Okita, Yutaka			Aortic arch aneurysm in a patient with cold agglutinin disease	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Editorial Material						Total arch replacement; Mild hypothermia; Cold agglutinin disease	CIRCULATORY ARREST; REPLACEMENT		[Miyahara, Shunsuke; Kano, Hiroya; Okada, Kenji; Okita, Yutaka] Kobe Univ, Grad Sch Med, Div Cardiovasc Surg, Dept Surg, Kobe, Hyogo 657, Japan	Miyahara, S (reprint author), Kobe Univ, Grad Sch Med, Div Cardiovasc Surg, Dept Surg, Kobe, Hyogo 657, Japan.						Kanemitsu S, 2010, J THORAC CARDIOV SUR, V140, pE73, DOI 10.1016/j.jtcvs.2010.06.030; Ishida N, 2011, INTERACT CARDIOV TH, V13, P432, DOI 10.1510/icvts.2011.275602; Miyahara S, 2015, INTERACT CARDIOVASC, V20, P687; Touati GD, 2003, ANN THORAC SURG, V76, P2115, DOI 10.1016/S0003-4975(03)00739-2; Wilson ML, 2007, SOUTH MED J, V100, P215	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	MAY	2015	20	5					687	688		10.1093/icvts/ivu424		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI5LO	WOS:000354798000034		
J	Lee, J; Nishiyama, M; Kono, S; Sakashita, M				Lee, Jaeman; Nishiyama, Minehiro; Kono, Susumu; Sakashita, Masanobu			Diagonal Tension Failure of Reinforced and Prestressed Concrete Member	ACI STRUCTURAL JOURNAL			English	Article						critical shear crack width; debonded length; diagonal shear crack; diagonal tension failure; fracture energy; fracture mechanics	SHEAR FAILURE; BEAMS; STRENGTH; STIRRUPS	The mechanism of the diagonal tension failure of the reinforced and prestressed concrete beams with the shear reinforcement was investigated. In the experimental program, static-reversed cyclic loading tests on half-scale post-tensioned precast concrete beams were conducted. Two experimental parameters-the shear span ratio and the shear reinforcement ratio-were selected. In the analytical program, the width of the primary shear crack and the failure mode using the fracture energy of concrete released at the shear cracking were predicted. The analytical crack angle, crack width, and failure mode were verified by the comparison with experimental results. The proposed analytical model proved effective to evaluate the primary shear crack width of the reinforced and prestressed concrete beams.	[Lee, Jaeman] Sungkyunkwan Univ, Construct & Environm Res Inst, Suwon, South Korea; [Nishiyama, Minehiro; Sakashita, Masanobu] Kyoto Univ, Dept Architectural Engn, Kyoto 6068501, Japan; [Kono, Susumu] Tokyo Inst Technol, Struct Engn Res Ctr, Yokohama, Kanagawa 227, Japan	Lee, J (reprint author), Sungkyunkwan Univ, Construct & Environm Res Inst, Suwon, South Korea.						Yang KH, 2003, ENG STRUCT, V25, P1343, DOI 10.1016/S0141-0296(03)00110-X; Bentz EC, 2006, ACI STRUCT J, V103, P614; Ismail M, 2004, CEMENT CONCRETE RES, V34, P711, DOI 10.1016/j.cemconres.2003.10.025; BAZANT ZP, 1991, ACI STRUCT J, V88, P268; Raynor DJ, 2002, ACI STRUCT J, V99, P568; Bazant ZP, 1997, J ENG MECH-ASCE, V123, P162; Architectural Institute of Japan, 1998, STAND STRUCT DES CON; Architectural Institute of Japan, 1999, DES GUID EARTHQ RES; Collins M. P., 1991, PRESTRESSED CONCRETE, P309; Comite Euro-International du Beton, 1990, CEB FIP MOD COD 1990, P82; Comite Euro-International du Beton, 1990, CEB FIP MOD COD 1990, P34; Fukui T., 1998, THESIS NIHON U TOKYO, P11; Gastebled OJ, 2001, ACI STRUCT J, V98, P184; Gopalaratanam V. S., 1985, ACI J P, V82, P345; Griffith A.A., 1920, Philosophical Transactions of the Royal Society of London, V221; Hordijk A. D., 1991, THESIS DELFT U TECHN; Kitada Y., 1988, ANN M JAP OCT, P697; Kiuchi Y., 2000, ANN M JAP SEPT, P1013; Kokusho S., 1987, ANN M JAP MAR, P83; Lee J., 2013, THESIS KYOTO U TOKYO, P78; Lee J., 2013, P 22 S DEV PRESTR CO, P103; Li B., 1991, INT WORKSH CONCR SHE, P226; Matsumoto T., 2004, P JCI, V26, P823; Ogawa T., 1999, ANN M JAP SEPT, P1077; Ohtaga K., 2002, ANN M JAP OCT, P991; Ookuma A., 1996, ANN M JAP SEPT, P877; Ookuma A., 1997, ANN M JAP SEPT, P847; OUYANG CS, 1994, ACI STRUCT J, V91, P69; Park R., 1975, REINFORCED CONCRETE; Takagi H., 1989, P JCI, V11, P75; Yuasa N., 2000, ANN M JAP SEPT, P969	31	0	0	AMER CONCRETE INST	FARMINGTON HILLS	38800 COUNTRY CLUB DR, FARMINGTON HILLS, MI 48331 USA	0889-3241	1944-7361		ACI STRUCT J	ACI Struct. J.	MAY-JUN	2015	112	3					311	321				11	Construction & Building Technology; Engineering, Civil; Materials Science, Multidisciplinary	Construction & Building Technology; Engineering; Materials Science	CI5VS	WOS:000354828500005		
J	Acharyya, SS; Ghosh, S; Tiwari, R; Pendem, C; Sasaki, T; Bal, R				Acharyya, Shankha Shubhra; Ghosh, Shilpi; Tiwari, Ritesh; Pendem, Chandrashekar; Sasaki, Takehiko; Bal, Rajaram			Synergistic Effect between Ultrasmall Cu(II) Oxide and CuCr2O4 Spinel Nanoparticles in Selective Hydroxylation of Benzene to Phenol with Air as Oxidant	ACS CATALYSIS			English	Article						ultrasmall Cu(II) oxide; CuCr2O4 spinel nanoparticles; benzene; phenol; air	PHASE CATALYTIC-OXIDATION; ONE-STEP OXIDATION; MOLECULAR-OXYGEN; ACTIVATION; ZEOLITES; EFFICIENT; BONDS; ACID	Phenol is an important commodity chemical, and the catalytic conversion of benzene to phenol by molecular oxygen with minimum waste production is of high significance from an academic as well as industrial point of view. We have developed a facile synthesis method for the preparation of 2-8 nm Cu(II) oxide nanoparticles supported on CuCr2O4 spinel nanoparticles (with size similar to 55 nm). Detailed characterization of the material was carried out by XRD, SEM, TEM, XPS, FTIR, TGA, TPR, BET surface area, XANES, and ICP-AES methods. XRD and XPS analyses revealed that the main phase is CuCr2O4 spinel, where a small amount of CuO is dispersed on it. The catalyst was highly active for selective oxidation of benzene to phenol with air as oxidant. The influence of reaction parameters was investigated in detail. The high catalytic performance of the catalyst is due to the ultrasmall size of Cu(II) oxide nanoparticles and the strong synergy between ultrasmall Cu(II) oxide and CuCr2O4 spinel nanoparticles that plays a pivotal role in activating air to generate active oxygen species which accomplishes benzene to phenol conversion (36%) with very high selectivity (78%) in a continuous process.	[Acharyya, Shankha Shubhra; Ghosh, Shilpi; Tiwari, Ritesh; Pendem, Chandrashekar; Bal, Rajaram] Indian Inst Petr, CSIR, Catalyt Convers & Proc Div, Dehra Dun 248005, Uttar Pradesh, India; [Sasaki, Takehiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan	Bal, R (reprint author), Indian Inst Petr, CSIR, Catalyt Convers & Proc Div, Dehra Dun 248005, Uttar Pradesh, India.	raja@iip.res.in	Sasaki, Takehiko/E-8160-2014	Sasaki, Takehiko/0000-0001-6190-4087	CSIR; UGC of India; CSIR, New Delhi, India [CSC-0125, CSC- 0117]; Photon Factory Advisory Committee [2013G210]	S.S.A. thanks the CSIR and S.G. thanks the UGC of India for a fellowship. The Director of the CSIR-IIP is acknowledged for his help and encouragement. The authors thank the Analytical Science Division, CSIR-Indian Institute of Petroleum, for analytical services. R.B. thanks the CSIR, New Delhi, India, for financial support in the form of the 12 FYP Project (CSC-0125, CSC- 0117). The XAFS measurements were performed at KEK-IMSS-PF with the approval of the Photon Factory Advisory Committee (project 2013G210).	Acharyya SS, 2014, CHEM COMMUN, V50, P13311, DOI 10.1039/c4cc02937b; Acharyya SS, 2014, CATAL SCI TECHNOL, V4, P4232, DOI 10.1039/c4cy00615a; Liu P, 2013, J AM CHEM SOC, V135, P14032, DOI 10.1021/ja406820f; Cornils B, 2003, J CATAL, V216, P23, DOI 10.1016/S0021-9517(02)00128-8; Bigi MA, 2012, J AM CHEM SOC, V134, P9721, DOI 10.1021/ja301685r; Tada M, 2007, J PHYS CHEM C, V111, P10095, DOI 10.1021/jp072928k; Balcells D, 2010, CHEM REV, V110, P749, DOI 10.1021/cr900315k; Ghosh S, 2014, ACS CATAL, V4, P2169, DOI 10.1021/cs5004454; Kamata K, 2010, NAT CHEM, V2, P478, DOI [10.1038/nchem.648, 10.1038/NCHEM.648]; Tani M, 2005, ANGEW CHEM INT EDIT, V44, P2586, DOI 10.1002/anie.200462769; Chary KVR, 2005, J PHYS CHEM B, V109, P9437, DOI 10.1021/jp0500135; Archipov T, 2009, J PHYS CHEM C, V113, P4107, DOI 10.1021/jp805976a; Yan YP, 2013, ANGEW CHEM INT EDIT, V52, P5827, DOI 10.1002/anie.201300957; Hamada R, 2003, PHYS CHEM CHEM PHYS, V5, P956, DOI 10.1039/b209706k; Cai SF, 2013, ACS CATAL, V3, P478, DOI 10.1021/cs300707y; Borah P, 2012, ANGEW CHEM INT EDIT, V51, P7756, DOI 10.1002/anie.201203275; Gunay A, 2010, CHEM REV, V110, P1060, DOI 10.1021/cr900269x; Roduner E, 2013, CHEMCATCHEM, V5, P82, DOI 10.1002/cctc.201200266; Ene AB, 2011, J PHYS CHEM C, V115, P3688, DOI 10.1021/jp1104664; Ackermann L, 2009, ANGEW CHEM INT EDIT, V48, P9792, DOI 10.1002/anie.200902996; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Bal R, 2006, ANGEW CHEM INT EDIT, V45, P448, DOI 10.1002/anie.200502940; Wang LS, 2013, CHEMCATCHEM, V5, P2203, DOI 10.1002/cctc.201300166; Lucke B, 2004, ADV SYNTH CATAL, V346, P1407, DOI 10.1002/adsc.200404027; Acharyya SS, 2014, ACS APPL MATER INTER, V6, P14451, DOI 10.1021/am503722t; Severino F, 1998, J CATAL, V177, P82, DOI 10.1006/jcat.1998.2094; Edwards MA, 2002, PHYS CHEM CHEM PHYS, V4, P3902, DOI 10.1039/b202347b; Fiege H, 2000, ULLMANNS ENCY IND CH, DOI [10.1002/14356007.a19_313, DOI 10.1002/14356007.A19_313]; Goldman A. S., 2004, ACS SYM SER, V885, P1, DOI American Chemical Society; Huo C, 2014, SCI REP, V4, P1; Kawamoto AM, 2004, AEROSP SCI TECHNOL, V8, P591, DOI 10.1016/j.ast.2004.06.010; Kitamura T, 2004, CAN J CHEM, V82, P1597, DOI 10.1139/V04-123; Kromer A, 2013, CHEMPLUSCHEM, V78, P268, DOI 10.1002/cplu.201200285; Long Z., 2014, SCI REP, V4, P1; KHARITONOV AS, 1993, APPL CATAL A-GEN, V98, P33, DOI 10.1016/0926-860X(93)85023-I; Pantaleo G, 2009, MATER CHEM PHYS, V114, P604, DOI 10.1016/j.matchemphys.2008.10.006; Shang SS, 2014, CHEMPLUSCHEM, V79, P680, DOI 10.1002/cplu.201400007; Sheldon R. A., 1981, METAL CATALYZED OXID, P329; Shibata Y, 2005, IND ENG CHEM RES, V44, P8765, DOI 10.1021/ie050821i; Tabler A, 2013, J MOL CATAL A-CHEM, V379, P139, DOI 10.1016/j.molcata.2013.08.012; TANEV PT, 1994, NATURE, V368, P321, DOI 10.1038/368321a0; Xin HC, 2009, CHEM COMMUN, P7590, DOI 10.1039/b917038c	42	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	MAY	2015	5	5					2850	2858		10.1021/cs5020699		9	Chemistry, Physical	Chemistry	CH4OG	WOS:000354012200021		
J	Watanabe, H; Asano, S; Fujita, S; Yoshida, H; Arai, M				Watanabe, Hiroyuki; Asano, Sayaka; Fujita, Shin-ichiro; Yoshida, Hiroshi; Arai, Masahiko			Nitrogen-Doped, Metal-Free Activated Carbon Catalysts for Aerobic Oxidation of Alcohols	ACS CATALYSIS			English	Article						activated carbon; nitrogen doping; metal-free carbon catalyst; oxidation; alcohol	OXYGEN REDUCTION REACTION; KNOEVENAGEL CONDENSATION; NITRIDE MATERIALS; NANOTUBES; SYSTEM	Various nitrogen-doped carbon materials were prepared via treatments of an activated carbon (AC) with ammonia and hydrogen peroxide, and their catalytic performance was tested for aerobic oxidation of several alcohols in ethanol. The amount and nature of doped nitrogen-species were examined by X-ray photoelectron spectroscopy to discuss the genesis of active species by nitrogen doping. The nitrogen-doped AC catalysts are active for the oxidation of such alcohols as benzyl alcohol, cinnamyl alcohol, and 5-(hydroxymethyl)-2-furaldehyde, and in some cases, they are even more selective to the oxidation of the hydroxyl group compared with conventional Pt/C and Ru/C catalysts, for which coupling products with the ethanol solvent are formed at low conversion levels. Graphite-type doped nitrogen species are significant for the formation of active sites on the surface of AC. The present results demonstrate the potential of nitrogen-doped AC materials as metal-free, carbon-based catalysts useable for organic synthetic reactions.	[Watanabe, Hiroyuki; Asano, Sayaka; Fujita, Shin-ichiro; Yoshida, Hiroshi; Arai, Masahiko] Hokkaido Univ, Fac Engn, Div Chem Proc Engn, Sapporo, Hokkaido 0608628, Japan	Arai, M (reprint author), Hokkaido Univ, Fac Engn, Div Chem Proc Engn, Sapporo, Hokkaido 0608628, Japan.	marai@eng.hokudai.ac.jp					Cao YH, 2014, ACS CATAL, V4, P1617, DOI 10.1021/cs500187q; Goettmann F, 2007, ANGEW CHEM INT EDIT, V46, P2717, DOI 10.1002/anie.200603478; Ikeda T, 2008, J PHYS CHEM C, V112, P14706, DOI 10.1021/jp806084d; Xu J, 2013, CATAL LETT, V143, P600, DOI 10.1007/s10562-013-0994-6; Yu DS, 2010, J PHYS CHEM LETT, V1, P2165, DOI 10.1021/jz100533t; Raymundo-Pinero E, 2002, CARBON, V40, P597, DOI 10.1016/S0008-6223(01)00155-5; Yu H, 2011, ANGEW CHEM INT EDIT, V50, P3978, DOI 10.1002/anie.201007932; Thomas A, 2008, J MATER CHEM, V18, P4893, DOI 10.1039/b800274f; Ozaki J, 2007, CARBON, V45, P1847, DOI 10.1016/j.carbon.2007.04.031; Gao YJ, 2013, ANGEW CHEM INT EDIT, V52, P2109, DOI 10.1002/anie.201207918; Maldonado S, 2006, CARBON, V44, P1429, DOI 10.1016/j.carbon.2005.11.027; Li WJ, 2014, ACS CATAL, V4, P1261, DOI 10.1021/cs500062s; Yang JH, 2013, ENERG ENVIRON SCI, V6, P793, DOI 10.1039/c3ee23623d; Ozaki J, 2006, CARBON, V44, P3358, DOI 10.1016/j.carbon.2006.08.022; Su DS, 2010, CHEMSUSCHEM, V3, P169, DOI 10.1002/cssc.200900180; Liao SX, 2014, APPL CATAL A-GEN, V478, P1, DOI 10.1016/j.apcata.2014.03.024; Yamaguchi K, 2003, CHEM-EUR J, V9, P4353, DOI 10.1002/chem.200304916; Long JL, 2012, ACS CATAL, V2, P622, DOI 10.1021/cs3000396; Fujita S, 2014, J MOL CATAL A-CHEM, V393, P257, DOI 10.1016/j.molcata.2014.06.021; Fujita SI, 2014, APPL CATAL A-GEN, V488, P171, DOI 10.1016/j.apcata.2014.09.049; Goettmann F., 2006, ANGEW CHEM INT EDIT, V45, P44657; Jin X., 2008, ANGEW CHEM INT EDIT, V48, P7884; Kan-Nari N, 2010, ADV SYNTH CATAL, V352, P1476, DOI 10.1002/adsc.201000029; Kawashita Y, 2009, B CHEM SOC JPN, V82, P482, DOI 10.1246/bcsj.82.482; Kondo T, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035436; Liao SX, 2014, CHEMCATCHEM, V6, P555, DOI 10.1002/cctc.201300909; Mabena L. F., 2011, APPL NANOSCI, V1, P67, DOI DOI 10.1007/S13204-011-0013-4; Sano Y, 2007, CHEM LETT, V36, P1414, DOI 10.1246/cl.2007.1414; Sheldon R. A., 2001, FINE CHEM HETEROGENE, p[309, 491]; van Dommele S., 2006, CHEM COMMUN, V64, P4858; Wang LL, 2011, CATAL COMMUN, V15, P78, DOI 10.1016/j.catcom.2011.08.013; Woods MP, 2010, CATAL LETT, V136, P1, DOI 10.1007/s10562-010-0304-5; Yoshida H., 2014, 7 TOK C ADV CAT SCI	33	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	MAY	2015	5	5					2886	2894		10.1021/acscatal.5b00375		9	Chemistry, Physical	Chemistry	CH4OG	WOS:000354012200026		
J	Gridnev, ID; Imamoto, T				Gridnev, Ilya D.; Imamoto, Tsuneo			Challenging the Major/Minor Concept in Rh-Catalyzed Asymmetric Hydrogenation	ACS CATALYSIS			English	Article						asymmetric hydrogenation; Rh complexes; origin of enantioselectivity; DFT calculations; reaction mechanism	DEHYDROAMINO ACIDS; PROCHIRAL ENAMIDES; MINIPHOS CATALYSTS; RHODIUM COMPLEXES; REACTION PATHWAYS; BISP-ASTERISK; MECHANISM; ORIGIN; ENANTIOSELECTION; SCOPE	Herein, we provide evidence showing that the long-held major-minor concept for catalytic asymmetric reactions needs to be readdressed. The asymmetric hydrogenation of enamide 1 catalyzed by the chiral Rh(I) complex of (R,R)-BenzP* quantitatively yields the corresponding hydrogenated R-product 2 with 89.6% ee. The most abundant catalyst-substrate species in the reaction pool was found to be [Rh((R,R)-BenzP*)(Ph(MeCONH)C=CH2)]+SbF6- (5). This species is also the most reactive to hydrogen among the various Rh complexes. Low-temperature hydrogenation experiments showed direct transformation of 5 to 2 with over 98% ee (R). However, the oxidative addition of H-2 to 5 would yield the S-product. Computation has now revealed a low-energy R-enantioselective route, whereby H-2 addition to 5 is followed by pi-bond dissociation, isomerization of nonchelating Rh species, and recoordination of the double bond before C-H bond formation occurs.	[Gridnev, Ilya D.] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan; [Imamoto, Tsuneo] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan; [Imamoto, Tsuneo] Nippon Chem Ind Co Ltd, Div Res & Dev, Tokyo 1368515, Japan	Gridnev, ID (reprint author), Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan.	igridnev@m.tohoku.ac.jp; imamoto@faculty.chiba-u.jp					Gridnev ID, 2000, J AM CHEM SOC, V122, P10486, DOI 10.1021/ja005554g; Yasutake M, 2001, ORG LETT, V3, P1701, DOI 10.1021/ol0158967; Imamoto T, 2012, J AM CHEM SOC, V134, P1754, DOI 10.1021/ja209700j; Feldgus S, 2001, ORGANOMETALLICS, V20, P2374, DOI 10.1021/om010060t; Armstrong A, 2014, CHEM SCI, V5, P2057, DOI 10.1039/c3sc53416b; HALPERN J, 1982, SCIENCE, V217, P401, DOI 10.1126/science.217.4558.401; Evans DA, 2003, J AM CHEM SOC, V125, P3534, DOI 10.1021/ja012639o; Gridnev ID, 2008, J AM CHEM SOC, V130, P2560, DOI 10.1021/ja076542z; Gridnev ID, 2004, P NATL ACAD SCI USA, V101, P5385, DOI 10.1073/pnas.0306993101; Gridnev ID, 2000, J AM CHEM SOC, V122, P7183, DOI 10.1021/ja000813n; LANDIS CR, 1987, J AM CHEM SOC, V109, P1746, DOI 10.1021/ja00240a025; Feldgus S, 2000, J AM CHEM SOC, V122, P12714, DOI 10.1021/ja0019373; Giernoth R, 2000, J AM CHEM SOC, V122, P12381, DOI 10.1021/ja002516o; Drexler HJ, 2005, ANGEW CHEM INT EDIT, V44, P1184, DOI 10.1002/anie.200461716; Brown J. M, 1999, COMPREHENSIVE ASYMME, V1, P119; BROWN JM, 1993, CHEM SOC REV, V22, P25, DOI 10.1039/cs9932200025; Gridnev ID, 2009, CHEM COMMUN, P7447, DOI 10.1039/b912440c; Gridnev ID, 2007, CHEM COMMUN, P1319, DOI 10.1039/b617705k; Gridnev ID, 2014, DALTON T, V43, P1785, DOI 10.1039/c3dt52383g; Gridnev ID, 2014, ACS CATAL, V4, P203, DOI 10.1021/cs400767e; Gridnev ID, 2001, J AM CHEM SOC, V123, P4631, DOI 10.1021/ja015611l; Gridnev ID, 2001, J AM CHEM SOC, V123, P5268, DOI 10.1021/ja010161i; Gridnev ID, 2012, CHEM COMMUN, V48, P2186, DOI 10.1039/c2cc17335b; Gridnev ID, 2004, ACCOUNTS CHEM RES, V37, P633, DOI 10.1021/ar030156e; Halpern J., 1985, ASYMMETRIC SYNTHESIS, V5, P41; Heinrich H, 2001, CHEM COMMUN, P1296, DOI 10.1039/b102316k; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, V1-3; Landis CR, 2000, ANGEW CHEM INT EDIT, V39, P2863, DOI 10.1002/1521-3773(20000818)39:16<2863::AID-ANIE2863>3.0.CO;2-K; Landis CR, 1999, J AM CHEM SOC, V121, P8741, DOI 10.1021/ja991606u; Mikami K., 2007, NEW FRONTIERS ASYMME; Ojima I., 2010, CATALYTIC ASYMMETRIC; Walsh P. J., 2009, FUNDAMENTALS ASYMMET	32	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	MAY	2015	5	5					2911	2915		10.1021/acscatal.5b00424		5	Chemistry, Physical	Chemistry	CH4OG	WOS:000354012200030		
J	Yamamoto, A; Mizuno, Y; Teramura, K; Hosokawa, S; Tanaka, T				Yamamoto, Akira; Mizuno, Yuto; Teramura, Kentaro; Hosokawa, Saburo; Tanaka, Tsunehiro			Noble-Metal-Free NOx Storage over Ba-Modified TiO2 Photocatalysts under UV-Light Irradiation at Low Temperatures	ACS CATALYSIS			English	Article						photocatalyst; nitrogen oxides; NOx; titanium dioxide; barium; NOx storage; lean NOx trap	SELECTIVE CATALYTIC-REDUCTION; NITROGEN MONOXIDE; OXIDATION; OXIDE; AMMONIA; SURFACE; SCR; PERFORMANCE; REMOVAL; ATMOSPHERE	Photoassisted nitrogen oxide (NOx) storage was investigated over the barium-modified titanium dioxide (Ba/TiO2) photocatalysts under UV-light irradiation at a high concentration of nitrogen monoxide (NO) of 200 ppm and a high gas hourly space velocity (GHSV) of 50 000 h(-1). The NO removal efficiency was kept >99% during the 1020 s interval from the start of the reaction over the Ba/TiO2 photocatalyst. The temperature-programed desorption (TPD) measurement and X-ray diffraction (XRD) technique revealed that barium oxide (BaO) species functioned as a NOx storage material even at low temperatures, which result in improvement of the performance of the photoassisted NOx storage.	[Yamamoto, Akira; Mizuno, Yuto; Teramura, Kentaro; Hosokawa, Saburo; Tanaka, Tsunehiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Teramura, Kentaro; Hosokawa, Saburo; Tanaka, Tsunehiro] Kyoto Univ, ESICB, Nishikyo Ku, Kyoto 6158520, Japan; [Teramura, Kentaro; Tanaka, Tsunehiro] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Teramura, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan.	teramura@moleng.kyoto-u.ac.jp; tanakat@moleng.kyoto-u.ac.jp			Program for Element Strategy Initiative for Catalysts and Batteries (ESICB); Japan Science and Technology Agency (JST); JSPS	This study was partially supported by the Program for Element Strategy Initiative for Catalysts and Batteries (ESICB), commissioned by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and the Precursory Research for Embryonic Science and Technology (PRESTO), supported by the Japan Science and Technology Agency (JST). A.Y. thanks the JSPS Research Fellowships for Young Scientists.	Lasek J, 2013, J PHOTOCH PHOTOBIO C, V14, P29, DOI 10.1016/j.jphotochemrev.2012.08.002; Takahashi N, 2007, APPL CATAL B-ENVIRON, V70, P198, DOI 10.1016/j.apcatb.2005.10.029; Epling WS, 2004, CATAL REV, V46, P163, DOI 10.1081/CR-200031932; Yin S, 2005, SOLID STATE SCI, V7, P1479, DOI 10.1016/j.solidstatesciences.2005.07.004; Kaspar J, 2003, CATAL TODAY, V77, P419, DOI 10.1016/S0920-5861(02)00384-X; Li JH, 2011, CATAL TODAY, V175, P147, DOI 10.1016/j.cattod.2011.03.034; Hadjiivanov K, 2000, PHYS CHEM CHEM PHYS, V2, P2803, DOI 10.1039/b002065f; Long RQ, 2002, J CATAL, V207, P274, DOI 10.1006/jcat.2002.3521; Liu G, 2011, CATAL SCI TECHNOL, V1, P552, DOI 10.1039/c1cy00007a; Ishibai Y, 2007, J PHOTOCH PHOTOBIO A, V188, P106, DOI 10.1016/j.jphotochem.2006.11.026; Sullivan JA, 1995, APPL CATAL B-ENVIRON, V7, P137, DOI 10.1016/0926-3373(95)00031-3; IBUSUKI T, 1994, J MOL CATAL, V88, P93, DOI 10.1016/0304-5102(93)E0247-E; Dalton JS, 2002, ENVIRON POLLUT, V120, P415, DOI 10.1016/S0269-7491(02)00107-0; Shelimov BN, 2008, J PHOTOCH PHOTOBIO A, V195, P81, DOI 10.1016/j.jphotochem.2007.09.009; Ballari MM, 2010, APPL CATAL B-ENVIRON, V95, P245, DOI 10.1016/j.apcatb.2010.01.002; Soylu AM, 2014, APPL SURF SCI, V318, P142, DOI 10.1016/j.apsusc.2014.02.065; Dillert R, 2013, PHYS CHEM CHEM PHYS, V15, P20876, DOI 10.1039/c3cp54469a; Koebel M, 2000, CATAL TODAY, V59, P335, DOI 10.1016/S0920-5861(00)00299-6; Fu XZ, 1996, ENVIRON SCI TECHNOL, V30, P647, DOI 10.1021/es950391v; Wang XY, 2010, APPL CATAL B-ENVIRON, V100, P19, DOI 10.1016/j.apcatb.2010.07.001; Centi G, 2003, J CATAL, V216, P443, DOI 10.1016/S0021-9517(02)00072-6; Takahashi N, 1996, CATAL TODAY, V27, P63, DOI 10.1016/0920-5861(95)00173-5; Ohko Y, 2009, J PHOTOCH PHOTOBIO A, V205, P28, DOI 10.1016/j.jphotochem.2009.04.005; Fridell E, 1999, J CATAL, V183, P196, DOI 10.1006/jcat.1999.2415; Baik JH, 2004, TOP CATAL, V30-1, P37, DOI 10.1023/B:TOCA.0000029725.88068.97; Lietti L, 2001, J CATAL, V204, P175, DOI 10.1006/jcat.2001.3370; Long RQ, 1999, J AM CHEM SOC, V121, P5595, DOI 10.1021/ja9842262; Hashimoto K, 2000, J PHOTOCH PHOTOBIO A, V136, P103, DOI 10.1016/S1010-6030(00)00329-4; Wu QP, 2012, J AM CHEM SOC, V134, P9369, DOI 10.1021/ja302246b; Folli A, 2011, J PHOTOCH PHOTOBIO A, V220, P85, DOI 10.1016/j.jphotochem.2011.03.017; Hadjiivanov KI, 2000, CATAL REV, V42, P71, DOI 10.1081/CR-100100260; Hashimoto K, 2009, CATAL TODAY, V144, P37, DOI 10.1016/j.cattod.2008.12.025; Busca G, 1998, APPL CATAL B-ENVIRON, V18, P1, DOI 10.1016/S0926-3373(98)00040-X; Corbos EC, 2009, APPL CATAL A-GEN, V365, P187, DOI 10.1016/j.apcata.2009.06.008; Dana L., 2012, URBAN OFF CYCLE NOX; Hashimoto K, 2001, APPL CATAL B-ENVIRON, V30, P429, DOI 10.1016/S0926-3373(00)00258-7; Linstrom P. J., 2011, NIST CHEM WEBBOOK; Liqiang J., 2004, J SOLID STATE CHEM, V177, P3375, DOI 10.1016/j.jssc.2004.05.064; Ma AZ, 1999, CHEM COMMUN, P71, DOI 10.1039/a807490i; Zhou G, 2006, APPL CATAL B-ENVIRON, V64, P88, DOI 10.1016/j.apcatb.2005.10.027	40	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	MAY	2015	5	5					2939	2943		10.1021/acscatal.5b00151		5	Chemistry, Physical	Chemistry	CH4OG	WOS:000354012200035		
J	Paul, CE; Tischler, D; Riedel, A; Heine, T; Itoh, N; Hollmann, F				Paul, Caroline E.; Tischler, Dirk; Riedel, Anika; Heine, Thomas; Itoh, Nobuya; Hollmann, Frank			Nonenzymatic Regeneration of Styrene Monooxygenase for Catalysis	ACS CATALYSIS			English	Article						asymmetric epoxidation; electron transfer; mNADHs; styrene monooxygenases; two-component flavin monooxygenases	BIOCATALYTIC ASYMMETRIC EPOXIDATION; TRYPTOPHAN 7-HALOGENASE PRNA; RHODOCOCCUS-OPACUS 1CP; HALOGENATING ENZYMES; PHENOL HYDROXYLASE; COFACTORS; NICOTINAMIDE; CHLORINATION; CHEMISTRY; MECHANISM	Styrene monooxygenase (SMO) is a two-component flavoprotein catalyzing the selective epoxidation of various C=C double bonds. For cell-free catalysis, traditionally a cascade of NAD(P)H:flavin oxidoreductase, nicotinamide cofactor (NADH), and NADH regeneration enzyme is required to supply StyA with the reduced flavin adenine dinucleotide cofactor (FADH(2)) required for catalysis. Herein, we present a more direct and efficient FADH(2) regeneration system using the nicotinamide cofactor mimic 1-benzyl-1,4-dihydronicotinamide (BNAH) as the sole reductant. Thus, BNAH replaces two enzymes and the nicotinamide cofactor, resulting in a significantly simplified reaction system.	[Paul, Caroline E.; Hollmann, Frank] Delft Univ Technol, Dept Biotechnol, NL-2628 BL Delft, Netherlands; [Tischler, Dirk; Riedel, Anika; Heine, Thomas] TU Bergakad Freiberg, Interdisciplinary Ecol Ctr, D-09599 Freiberg, Germany; [Itoh, Nobuya] Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan; [Itoh, Nobuya] Toyama Prefectural Univ, Dept Biotechnol, Toyama 9390398, Japan	Hollmann, F (reprint author), Delft Univ Technol, Dept Biotechnol, Julianalaan 136, NL-2628 BL Delft, Netherlands.	f.hollmann@tudelft.nl			Marie Curie IEF "Biomimic" - European Union [327647]	This work is supported by the Marie Curie IEF "Biomimic" financed by the European Union through the seventh Framework People Programme (grant agreement number 327647).	Schmid A, 2001, ADV SYNTH CATAL, V343, P732, DOI 10.1002/1615-4169(200108)343:6/7<732::AID-ADSC732>3.3.CO;2-H; Panke S, 2002, BIOTECHNOL BIOENG, V80, P33, DOI 10.1002/bit.10346; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Poizat M, 2010, J MOL CATAL B-ENZYM, V63, P149, DOI 10.1016/j.molcatb.2010.01.006; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Montersino S, 2011, ADV SYNTH CATAL, V353, P2301, DOI 10.1002/adsc.201100384; Tischler D, 2009, J BACTERIOL, V191, P4996, DOI 10.1128/JB.00307-09; Julsing MK, 2012, BIOTECHNOL BIOENG, V109, P1109, DOI 10.1002/bit.24404; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; Paul CE, 2014, ACS CATAL, V4, P788, DOI 10.1021/cs4011056; Ryan JD, 2008, CHEMBIOCHEM, V9, P2579, DOI 10.1002/cbic.200800246; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Hofstetter K, 2004, ANGEW CHEM INT EDIT, V43, P2163, DOI 10.1002/anie.200353338; Tischler D, 2012, APPL BIOCHEM BIOTECH, V167, P931, DOI 10.1007/s12010-012-9659-y; Flecks S, 2008, ANGEW CHEM INT EDIT, V47, P9533, DOI 10.1002/anie.200802466; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004; Lutz J, 2004, J ORGANOMET CHEM, V689, P4783, DOI 10.1016/j.jorganchem.2004.09.044; Tischler D, 2010, J BACTERIOL, V192, P5220, DOI 10.1128/JB.00723-10; Paul CE, 2013, ORG LETT, V15, P180, DOI 10.1021/ol303240a; Chen XP, 2008, ACTA BIOCH BIOPH SIN, V40, P183, DOI 10.1111/j.1745-7270.2008.00390.x; Duffner FM, 1998, FEMS MICROBIOL LETT, V161, P37, DOI 10.1111/j.1574-6968.1998.tb12926.x; Hollmann F, 2003, J AM CHEM SOC, V125, P8209, DOI 10.1021/ja034119u; Hollmann F, 2005, J AM CHEM SOC, V127, P6540, DOI 10.1021/ja050997b; Hollmann F, 2006, TRENDS BIOTECHNOL, V24, P163, DOI 10.1016/j.tibtech.2006.02.003; Holtmann D, 2014, CHEM COMMUN, V50, P13180, DOI 10.1039/c3cc49747j; Keller S, 2000, ANGEW CHEM INT EDIT, V39, P2300, DOI 10.1002/1521-3773(20000703)39:13<2300::AID-ANIE2300>3.0.CO;2-I; Lin H, 2011, TETRAHEDRON-ASYMMETR, V22, P134, DOI 10.1016/j.tetasy.2010.12.022; Paul CE, 2014, BIOORGAN MED CHEM, V22, P5692, DOI 10.1016/j.bmc.2014.05.074; Ruinatscha R, 2011, MOLECULES, V16, P5975, DOI 10.3390/molecules16075975; Ruinatscha R, 2009, ADV SYNTH CATAL, V351, P2505, DOI 10.1002/adsc.200900291; Toda H, 2012, APPL MICROBIOL BIOT, V96, P407, DOI 10.1007/s00253-011-3849-3; Toda H, 2012, TETRAHEDRON-ASYMMETR, V23, P1542, DOI 10.1016/j.tetasy.2012.09.017; Unversucht S, 2005, ADV SYNTH CATAL, V347, P1163, DOI 10.1002/adsc.200505029; van Pee KH, 2012, CURR ORG CHEM, V16, P2583; Wu S., 2013, ACS CATAL, V4, P409	36	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	MAY	2015	5	5					2961	2965		10.1021/acscatal.5b00041		5	Chemistry, Physical	Chemistry	CH4OG	WOS:000354012200038		
J	Shiraishi, Y; Kofuji, Y; Sakamoto, H; Tanaka, S; Ichikawa, S; Hirai, T				Shiraishi, Yasuhiro; Kofuji, Yusuke; Sakamoto, Hirokatsu; Tanaka, Shunsuke; Ichikawa, Satoshi; Hirai, Takayuki			Effects of Surface Defects on Photocatalytic H2O2 Production by Mesoporous Graphitic Carbon Nitride under Visible Light Irradiation	ACS CATALYSIS			English	Article						photocatalysis; hydrogen peroxide; graphitic carbon nitride; visible light; oxygen reduction	METAL-FREE ELECTROCATALYSTS; EFFICIENT OXYGEN REDUCTION; HYDROGEN-PEROXIDE; SELECTIVE PRODUCTION; AEROBIC OXIDATION; TITANIUM-DIOXIDE; MOLECULAR-OXYGEN; SUPEROXIDE IONS; TIO2 PARTICLES; NANOPARTICLES	Photocatalytic production of hydrogen peroxide (H2O2) from ethanol (EtOH) and molecular oxygen (O-2) was carried out by visible light irradiation (lambda > 420 nm) of mesoporous graphitic carbon nitride (GCN) catalysts with different surface areas prepared by silica-templated thermal polymerization of cyanamide. On these catalysts, the photoformed positive hole oxidize EtOH and the conduction band electrons localized at the 1,4-positions of the melem unit promote two-electron reduction of O-2 (H2O2 formation). The GCN catalysts with 56 and 160 m(2) g(-1) surface areas exhibit higher activity for H2O2 production than the catalyst prepared without silica template (surface area: 10 m(2) g(-1)), but a further increase in the surface area (228 m(2) g(-1)) decreases the activity. In addition, the selectivity for H2O2 formation significantly decreases The mesoporous GCN with larger surface areas inherently contain a larger number of primary amine moieties at the surface mesopores. These defects behave as the active sites for four-electron reduction of O-2, thus decreasing the H2O2 selectivity. Furthermore, these defects also behave as the active sites for photocatalytic decomposition of the formed H2O2. Consequently, the GCN catalysts with relatively large surface area but with a small number of surface defects promote relatively efficient H2O2 formation.	[Shiraishi, Yasuhiro; Kofuji, Yusuke; Sakamoto, Hirokatsu; Hirai, Takayuki] Osaka Univ, Res Ctr Solar Energy Chem, Toyonaka, Osaka 5608531, Japan; [Shiraishi, Yasuhiro; Kofuji, Yusuke; Sakamoto, Hirokatsu; Hirai, Takayuki] Osaka Univ, Div Chem Engn, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Shiraishi, Yasuhiro] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Tanaka, Shunsuke] Kansai Univ, Dept Chem Energy & Environm Engn, Suita, Osaka 5648680, Japan; [Ichikawa, Satoshi] Osaka Univ, Inst NanoSci Design, Toyonaka, Osaka 5608531, Japan	Shiraishi, Y (reprint author), Osaka Univ, Res Ctr Solar Energy Chem, Toyonaka, Osaka 5608531, Japan.	shiraish@cheng.es.osaka-u.ac.jp	Tanaka, Shunsuke/O-3288-2014		Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [26289296]; Precursory Research for Embryonic Science and Technology (PRESTO) from Japan Science and Technology Agency (JST)	This work was supported by a Grant-in-Aid for Scientific Research (No. 26289296) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), and by the Precursory Research for Embryonic Science and Technology (PRESTO) from Japan Science and Technology Agency (JST).	Niu P, 2012, ADV FUNCT MATER, V22, P4763, DOI 10.1002/adfm.201200922; Tahir M, 2013, J MATER CHEM A, V1, P13949, DOI 10.1039/c3ta13291a; Tahir M, 2014, CRYSTENGCOMM, V16, P1825, DOI 10.1039/c3ce42135j; Teranishi M, 2010, J AM CHEM SOC, V132, P7850, DOI 10.1021/ja102651g; Wang XC, 2009, NAT MATER, V8, P76, DOI [10.1038/nmat2317, 10.1038/NMAT2317]; Sano T, 2013, J MATER CHEM A, V1, P6489, DOI 10.1039/c3ta10472a; Shi L, 2014, CATAL SCI TECHNOL, V4, P3235, DOI 10.1039/c4cy00411f; Gao J, 2012, NANOSCALE, V4, P3687, DOI 10.1039/c2nr30777d; Wang XC, 2009, J AM CHEM SOC, V131, P1680, DOI 10.1021/ja809307s; Tsukamoto D, 2012, ACS CATAL, V2, P599, DOI 10.1021/cs2006873; Shiraishi Y, 2005, J AM CHEM SOC, V127, P12820, DOI 10.1021/ja053265s; Guo ZY, 2014, SMALL, V10, P2087, DOI 10.1002/smll.201303642; Sheng JY, 2014, ACS CATAL, V4, P732, DOI 10.1021/cs400927w; Martin DJ, 2014, ANGEW CHEM INT EDIT, V53, P9240, DOI 10.1002/anie.201403375; Thomas A, 2008, J MATER CHEM, V18, P4893, DOI 10.1039/b800274f; Liu Y, 2013, ENVIRON SCI TECHNOL, V47, P13889, DOI 10.1021/es4032216; Guo CC, 2014, J PHYS CHEM C, V118, P25792, DOI 10.1021/jp508627h; Wang J, 2014, CHEM COMMUN, V50, P14237, DOI 10.1039/c4cc06869f; Shiraishi Y, 2012, CATAL SCI TECHNOL, V2, P400, DOI 10.1039/c1cy00331c; Di Y, 2010, CHEMCATCHEM, V2, P834, DOI 10.1002/cctc.201000057; HARBOUR JR, 1978, J PHYS CHEM-US, V82, P1397, DOI 10.1021/j100501a015; Maurino V, 2005, CHEM COMMUN, P2627, DOI 10.1039/b418789j; Shiraishi Y, 2014, ANGEW CHEM INT EDIT, V53, P13454, DOI 10.1002/anie.201407938; Shiraishi Y, 2010, ANGEW CHEM INT EDIT, V49, P1656, DOI 10.1002/anie.200906573; Li L, 2010, CHEM COMMUN, V46, P7620, DOI 10.1039/c0cc01237h; Edwards JK, 2009, SCIENCE, V323, P1037, DOI 10.1126/science.1168980; Zhang XD, 2013, J AM CHEM SOC, V135, P18, DOI 10.1021/ja308249k; Li GS, 2008, CHEM MATER, V20, P3983, DOI 10.1021/cm800236z; Ding ZX, 2011, CHEMSUSCHEM, V4, P274, DOI 10.1002/cssc.201000149; Maeda K, 2014, J MATER CHEM A, V2, P15146, DOI 10.1039/c4ta03128h; Su FZ, 2010, J AM CHEM SOC, V132, P16299, DOI 10.1021/ja102866p; Cai RX, 2003, J CATAL, V219, P214, DOI 10.1016/S0021-9517(03)00197-0; Liu QS, 2008, ANGEW CHEM INT EDIT, V47, P6221, DOI 10.1002/anie.200801517; Lin L, 2014, J AM CHEM SOC, V136, P11027, DOI 10.1021/ja504696r; Zheng Y, 2011, J AM CHEM SOC, V133, P20116, DOI 10.1021/ja209206c; Zhang GG, 2012, J MATER CHEM, V22, P8083, DOI 10.1039/c2jm00097k; Tsukamoto D, 2012, J AM CHEM SOC, V134, P6309, DOI 10.1021/ja2120647; Kiskan B, 2012, ACS MACRO LETT, V1, P546, DOI 10.1021/mz300116w; Zhao L, 2010, CHEMSUSCHEM, V3, P840, DOI 10.1002/cssc.201000044; Shaegh SAM, 2012, ENERG ENVIRON SCI, V5, P8225, DOI 10.1039/c2ee21806b; Sheng H, 2013, ANGEW CHEM INT EDIT, V52, P9686, DOI 10.1002/anie.201304481; Shiraishi Y, 2014, ACS CATAL, V4, P774, DOI 10.1021/cs401208c; Jiang HL, 2014, CHEM-EUR J, V20, P3106, DOI 10.1002/chem.201304561; Chen XF, 2009, CHEM MATER, V21, P4093, DOI 10.1021/cm902130z; Lee SC, 2012, CHEM-ASIAN J, V7, P2139, DOI 10.1002/asia.201200383; Schwinghammer K, 2014, J AM CHEM SOC, V136, P1730, DOI 10.1021/ja411321s; Xu J, 2013, PHYS CHEM CHEM PHYS, V15, P4510, DOI 10.1039/c3cp44402c; Sugano Y, 2013, ANGEW CHEM INT EDIT, V52, P5295, DOI 10.1002/anie.201301669; Dong F, 2013, J COLLOID INTERF SCI, V401, P70, DOI 10.1016/j.jcis.2013.03.034; Zhu JJ, 2014, ACS APPL MATER INTER, V6, P16449, DOI 10.1021/am502925j; Hirakawa T, 2008, J PHYS CHEM C, V112, P15818, DOI 10.1021/jp8055015; Goto H, 2004, J CATAL, V225, P223, DOI 10.1016/j.jcat.2004.04.001; Campos-Martin JM, 2006, ANGEW CHEM INT EDIT, V45, P6962, DOI 10.1002/anie.200503779; Sun B, 2014, INORG CHEM, V53, P8600, DOI 10.1021/ic501210t; Li S, 2014, CHEMSUSCHEM, V7, P3002, DOI 10.1002/cssc.201402680; Sandelin F, 2006, IND ENG CHEM RES, V45, P986, DOI 10.1021/ie050593s; Shiraishi Y, 2013, ANGEW CHEM INT EDIT, V52, P8304, DOI 10.1002/anie.201302430	57	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	MAY	2015	5	5					3058	3066		10.1021/acscatal.5b00408		9	Chemistry, Physical	Chemistry	CH4OG	WOS:000354012200048		
J	Ohmura, T; Taniguchi, H; Suginome, M				Ohmura, Toshimichi; Taniguchi, Hiroki; Suginome, Michinori			Site- and Regioselective Silaborative C-C Cleavage of 1-Alkyl-2-Methylenecyclopropanes Using a Platinum Catalyst with a Sterically Demanding Silylboronic Ester	ACS CATALYSIS			English	Article						homogeneous catalysis; platinum catalyst; C-C bond cleavage; silaboration; methylenecyclopropane; organoboron compound; organosilicon compound; selectivity	RING-OPENING ISOMERIZATION; BOND-CLEAVAGE; ALKYLIDENECYCLOPROPANE DERIVATIVES; INTERMOLECULAR HYDROAMINATION; MESO-METHYLENECYCLOPROPANES; ADDITION POLYMERIZATION; 3+2 CYCLOADDITIONS; METAL-COMPLEXES; PALLADIUM; 2-ARYL-1-METHYLENECYCLOPROPANES	1-Alkyl-2-methylenecyclopropanes react with silylboronic esters under mild conditions in the presence of a phosphine-free platinum catalyst, giving 3-substituted 2-boryl-4silyl-1-butenes through selective cleavage of the less hindered proximal C-C bond of the cyclopropane ring. The steric bulk of the silyl group of the silylboronic esters was critical for efficient formation of the silaboration products, and i-PrPh2Si-B(pin) was developed as a silylboronic ester of choice.	[Ohmura, Toshimichi; Taniguchi, Hiroki; Suginome, Michinori] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan	Ohmura, T (reprint author), Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.	ohmura@sbchem.kyoto-u.ac.jp; suginome@sbchem.kyoto-u.ac.jp			JSPS	H.T. acknowledges JSPS for fellowship support.	Ackermann L, 2012, CHEM-EUR J, V18, P12068, DOI 10.1002/chem.201200406; Nakamura I, 1998, J ORG CHEM, V63, P6458, DOI 10.1021/jo981468b; Terao J, 2010, ANGEW CHEM INT EDIT, V49, P144, DOI 10.1002/anie.200904721; Oestreich M, 2013, CHEM REV, V113, P402, DOI 10.1021/cr3003517; Beletskaya I, 2006, CHEM REV, V106, P2320, DOI 10.1021/cr050530j; Brandi A, 1998, CHEM REV, V98, P589, DOI 10.1021/cr940341t; Schinkel M, 2013, ORG LETT, V15, P4482, DOI 10.1021/ol402037f; Suginome M, 2000, ORGANOMETALLICS, V19, P4647, DOI 10.1021/om000254t; Kim S, 2002, J AM CHEM SOC, V124, P762, DOI 10.1021/ja017460s; Shirakura M, 2009, J AM CHEM SOC, V131, P5060, DOI 10.1021/ja900876w; Akai Y, 2012, J AM CHEM SOC, V134, P11092, DOI 10.1021/ja303506k; Suginome M, 1997, ANGEW CHEM INT EDIT, V36, P2516, DOI 10.1002/anie.199725161; Yu L, 2011, ORG PREP PROCED INT, V43, P209, DOI 10.1080/00304948.2011.564551; Pellissier H, 2010, TETRAHEDRON, V66, P8341, DOI 10.1016/j.tet.2010.08.031; Sakae R, 2014, ORG LETT, V16, P1228, DOI 10.1021/ol5001507; Rubin M, 2007, CHEM REV, V107, P3117, DOI 10.1021/cr050988l; Nakamura I, 2002, ADV SYNTH CATAL, V344, P111, DOI 10.1002/1615-4169(200202)344:2<111::AID-ADSC111>3.0.CO;2-0; Ogata K, 2013, ORG LETT, V15, P1182, DOI 10.1021/ol303548x; Brandi A, 2003, CHEM REV, V103, P1213, DOI 10.1021/cr010005u; Ohmura T, 2009, B CHEM SOC JPN, V82, P29, DOI 10.1246/bcsj.82.29; Itazaki M, 2005, J MOL CATAL A-CHEM, V241, P65, DOI 10.1016/j.molcata.2005.06.045; Ogata K, 2010, ORG LETT, V12, P4536, DOI 10.1021/ol101838q; BAPUJI SA, 1989, TETRAHEDRON LETT, V30, P7107; Burks HE, 2007, CHEM COMMUN, P4717, DOI 10.1039/b707779c; Camacho DH, 2001, J ORG CHEM, V66, P270, DOI 10.1021/jo001428j; Durieux G, 2008, EUR J INORG CHEM, P4236, DOI 10.1002/ejic.200800285; Inami T, 2011, CHEM COMMUN, V47, P9711, DOI 10.1039/c1cc13540f; Inami T, 2011, ORG LETT, V13, P3837, DOI 10.1021/ol201540b; Ishiyama T, 1999, SYNLETT, P1790; Itazaki M, 2002, J ORG CHEM, V67, P6889, DOI 10.1021/jo020293+; Kim S, 2003, MACROMOL CHEM PHYSIC, V204, P666, DOI 10.1002/macp.200390035; KITATANI K, 1977, B CHEM SOC JPN, V50, P3288, DOI 10.1246/bcsj.50.3288; Kozhushkov SI, 2008, ORG LETT, V10, P3409, DOI 10.1021/ol8011875; LAUTENS M, 1994, J AM CHEM SOC, V116, P8821, DOI 10.1021/ja00098a057; Lautens M, 1996, J AM CHEM SOC, V118, P10676, DOI 10.1021/ja962582j; Lautens M, 1996, J AM CHEM SOC, V118, P9597, DOI 10.1021/ja9611809; LEWIS LN, 1992, INORG CHEM, V31, P3555, DOI 10.1021/ic00043a014; Nishihara Y, 2001, ORGANOMETALLICS, V20, P2124, DOI 10.1021/om010081n; Nishihara Y, 2002, TETRAHEDRON LETT, V43, P2059, DOI 10.1016/S0040-4039(02)00165-X; Ohmura T, 2009, ORG LETT, V11, P2880, DOI 10.1021/ol900829c; Ohmura T, 2007, J AM CHEM SOC, V129, P3518, DOI 10.1021/ja0703170; Osakada K, 1998, ORGANOMETALLICS, V17, P4532, DOI 10.1021/om980142q; Pohlmann T, 2000, ORG LETT, V2, P3877, DOI 10.1021/01006618v; Sagawa T, 2002, ORGANOMETALLICS, V21, P5879, DOI 10.1021/om020686z; Shao LX, 2010, EUR J ORG CHEM, P6448, DOI 10.1002/ejoc.201001082; Shi M, 2005, J ORG CHEM, V70, P5606, DOI 10.1021/jo050560m; Smolensky E, 2007, ORGANOMETALLICS, V26, P4510, DOI 10.1021/om700455e; Smolensky E, 2005, ORGANOMETALLICS, V24, P5495, DOI 10.1021/om050518h; Suginome M, 2000, J AM CHEM SOC, V122, P11015, DOI 10.1021/ja002885k; Suginome M., 2011, BORONIC ACIDS, V1, P171, DOI DOI 10.1002/9783527639328.CH3; Takeuchi D, 2004, ANGEW CHEM INT EDIT, V43, P1233, DOI 10.1002/anie.200352837; Takeuchi D, 2002, CHEM COMMUN, P646, DOI 10.1039/b111697e; Takeuchi D, 2002, MACROMOLECULES, V35, P9628, DOI 10.1021/ma020988c; Taniguchi H, 2009, J AM CHEM SOC, V131, P11298, DOI 10.1021/ja9046894; Tsukada N, 1997, J AM CHEM SOC, V119, P8123, DOI 10.1021/ja970261h	55	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	MAY	2015	5	5					3074	3077		10.1021/acscatal.5b00513		4	Chemistry, Physical	Chemistry	CH4OG	WOS:000354012200050		
J	Bernard, SM; Akey, DL; Tripathi, A; Park, SR; Konwerski, JR; Anzai, Y; Li, SY; Kato, F; Sherman, DH; Smith, JL				Bernard, Steffen M.; Akey, David L.; Tripathi, Ashootosh; Park, Sung Ryeol; Konwerski, Jamie R.; Anzai, Yojiro; Li, Shengying; Kato, Fumio; Sherman, David H.; Smith, Janet L.			Structural Basis of Substrate Specificity and Regiochemistry in the MycF/TyIF Family of Sugar O-Methyltransferases.	ACS CHEMICAL BIOLOGY			English	Article							BIOSYNTHETIC GENE-CLUSTER; MYCINAMICIN MACROLIDE ANTIBIOTICS; STREPTOMYCES-FRADIAE; MICROMONOSPORA-GRISEORUBIDA; SACCHAROPOLYSPORA-SPINOSA; FUNCTIONAL-ANALYSIS; KINETIC MECHANISM; CRYSTAL-STRUCTURE; MYCG; GLYCODIVERSIFICATION	Sugar moieties in natural products are frequently modified by O-methylation. In the biosynthesis of the macrolide antibiotic mycinamicin, methylation of a 6'-deoxyallose substituent occurs in a stepwise manner first at the 2'- and then the 3'-hydroxyl groups to produce the mycinose moiety in the final product. The timing and placement of the O-methylations impact final stage C-H functionalization reactions mediated by the P450 monooxygenase MycG. The structural basis of pathway ordering and substrate specificity is unknown. A series of crystal structures of MycF, the 3'-O-methyltransferase, including the free enzyme and complexes with S-adenosyl homocysteine (SAH), substrate, product, and unnatural substrates, show that SAM binding induces substantial ordering that creates the binding site for the natural substrate, and a bound metal ion positions the substrate for catalysis. A single amino acid substitution relaxed the 2'-methoxy specificity but retained regiospecificity. The engineered variant produced a new mycinamicin analog, demonstrating the utility of structural information to facilitate bioengineering approaches for the chemoenzymatic synthesis of complex small molecules containing modified sugars. Using the MycF substrate complex and the modeled substrate complex of a 4'-specific homologue, active site residues were identified that correlate with the 3' or 4' specificity of MycF family members and define the protein and substrate features that direct the regiochemistry of methyltransfer. This classification scheme will be useful in the annotation of new secondary metabolite pathways that utilize this family of enzymes.	[Bernard, Steffen M.] Univ Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA; [Bernard, Steffen M.; Akey, David L.; Tripathi, Ashootosh; Park, Sung Ryeol; Konwerski, Jamie R.; Li, Shengying; Sherman, David H.; Smith, Janet L.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Anzai, Yojiro; Kato, Fumio] Toho Univ, Fac Pharmaceut Sci, Funabashi, Chiba 2748510, Japan; [Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Smith, JL (reprint author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	janetsmith@umich.edu			NIH [DK042303]; National Institutes of Health [GM078553]; Hans W. Vahlteich Professorship; University of Michigan Chemistry-Biology Interface (CBI) (NIH) [5T32GM008597]; National Cancer Institute [Y1-CO- 1020]; National Institute of General Medical Sciences [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]	This work was supported by NIH grant DK042303 to J.L.S. and National Institutes of Health grant GM078553 and the Hans W. Vahlteich Professorship to D.H.S. S.M.B. acknowledges training grant support from the University of Michigan Chemistry-Biology Interface (CBI) training program (NIH rant 5T32GM008597). GM/CA has been funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO- 1020) and the National Institute of General Medical Sciences (Y1-GM-1104). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract No. DE-AC02-06CH11357.	Akey DL, 2011, J MOL BIOL, V413, P438, DOI 10.1016/j.jmb.2011.08.040; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Singh S, 2012, NAT PROD REP, V29, P1201, DOI 10.1039/c2np20039b; Ward SL, 2004, ANTIMICROB AGENTS CH, V48, P4703, DOI 10.1128/AAC.78.12.4703-4712.2004; Pojer F, 2002, MICROBIOL-SGM, V148, P3901; Anzai Y, 2008, CHEM BIOL, V15, P950, DOI 10.1016/j.chembiol.2008.07.014; Park SR, 2010, APPL MICROBIOL BIOT, V85, P1227, DOI 10.1007/s00253-009-2326-8; Anzai Y, 2012, ANTIMICROB AGENTS CH, V56, P3648, DOI 10.1128/AAC.06063-11; Wang ZX, 2000, ANTIMICROB AGENTS CH, V44, P3040, DOI 10.1128/AAC.44.11.3040-3048.2000; Hansen DA, 2013, J AM CHEM SOC, V135, P11232, DOI 10.1021/ja404134f; Ferrer JL, 2005, PLANT PHYSIOL, V137, P1009, DOI 10.1104/pp.104.048751; Liscombe DK, 2012, NAT PROD REP, V29, P1238, DOI 10.1039/c2np20029e; [Anonymous], 1994, KOUSHU LISHI, P141; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Anzai Y, 2003, FEMS MICROBIOL LETT, V218, P135, DOI 10.1016/S0378-1097(02)01123-0; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Mortison JD, 2010, J ORG CHEM, V75, P7041, DOI 10.1021/jo101124n; Cundliffe E, 2001, ANTON LEEUW INT J G, V79, P229, DOI 10.1023/A:1012065300116; Li SY, 2009, CHEMBIOCHEM, V10, P1297, DOI 10.1002/cbic.200900088; SATOI S, 1980, J ANTIBIOT, V33, P364; Zhang C, 2006, CHEMBIOCHEM, V7, P795, DOI 10.1002/cbic.200500504; Torkkell S, 2001, MOL GENET GENOMICS, V266, P276; BAUER NJ, 1988, J BIOL CHEM, V263, P15619; Bruender NA, 2012, PROTEIN SCI, V21, P876, DOI 10.1002/pro.2074; Garcia IG, 2010, J MOL BIOL, V395, P390, DOI 10.1016/j.jmb.2009.10.045; Hahn DR, 2006, J IND MICROBIOL BIOT, V33, P94, DOI 10.1007/s10295-005-0016-9; Kim HJ, 2010, J AM CHEM SOC, V132, P2901, DOI 10.1021/ja910223x; KREUZMAN AJ, 1988, J BIOL CHEM, V263, P15626; Li SY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.410340; Meyers CLF, 2004, ANGEW CHEM INT EDIT, V43, P67, DOI 10.1002/anie.200352626; Patallo EP, 2001, J BIOL CHEM, V276, P18765, DOI 10.1074/jbc.M101225200; Singh S, 2008, J BIOL CHEM, V283, P22628, DOI 10.1074/jbc.M800503200; Singh S, 2013, ACS CHEM BIOL, V8, P1632, DOI 10.1021/cb400068k; Waldron C, 2001, CHEM BIOL, V8, P487, DOI 10.1016/S1074-5521(01)00029-1	35	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1554-8929	1554-8937		ACS CHEM BIOL	ACS Chem. Biol.	MAY	2015	10	5					1340	1351		10.1021/cb5009348		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI6XL	WOS:000354907400021		
J	Nishimura, K; Tsuru, S; Suzuki, H; Yomo, T				Nishimura, Kazuya; Tsuru, Saburo; Suzuki, Hiroaki; Yomo, Tetsuya			Stochasticity in Gene Expression in a Cell-Sized Compartment	ACS SYNTHETIC BIOLOGY			English	Article						artificial cell; fluctuation; gene expression	PROTEIN-SYNTHESIS; GIANT LIPOSOMES; SELF-REPRODUCTION; LIPID VESICLES; FLOW-CYTOMETRY; NOISE; MOLECULE; MICROREACTORS; INFORMATION; SENSITIVITY	The gene expression in a clonal cell population fluctuates significantly, and its relevance to various cellular functions is under intensive debate. A fundamental question is whether the fluctuation is a consequence of the complexity and redundancy in living cells or an inevitable attribute of the minute microreactor nature of cells. To answer this question, we constructed an artificial cell, which consists of only necessary components for the gene expression (in vitro transcription and translation system) and its boundary as a microreactor (cell sized lipid vesicle), and investigated the gene expression noise. The variation in the expression of two fluorescent proteins was decomposed into the components that were correlated and uncorrelated between the two proteins using a method similar to the one used by Elowitz and co-workers to analyze the expression noise in E. coli. The observed fluctuation was compared with a theoretical model that expresses the amplitude of noise as a function of the average number of intermediate molecules and products. With the assumption that the transcripts are partly active, the theoretical model was able to well describe the noise in the artificial system. Furthermore, the same measurement for E. coli cells harboring an identical plasmid revealed that the E. coli exhibited a similar level of expression noise. Our results demonstrated that the level of fluctuation found in bacterial cells is mostly an intrinsic property that arises even in a primitive form of the cell.	[Nishimura, Kazuya; Tsuru, Saburo; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka 5650871, Japan; [Nishimura, Kazuya] RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka 5650874, Japan; [Suzuki, Hiroaki] Chuo Univ, Fac Sci & Engn, Bunkyo Ku, Tokyo 1128551, Japan; [Yomo, Tetsuya] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Suita, Osaka 5650871, Japan; [Yomo, Tetsuya] Osaka Univ, Dept Frontier Biosci, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Yomo, T (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Yamadaoka 1-5, Suita, Osaka 5650871, Japan.	Yomo@ist.osaka-u.ac.jp			"Global Centers of Excellence Program" of the Ministry of Education, Culture, Sports, Science, and Technology, Japan	We thank Dr. Yasuaki Kazuta, Ms. Hitomi Komai, and Ms. Tomomi Sakamoto for producing the PURE system. This research was supported in part by the "Global Centers of Excellence Program" of the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Kazuta Y, 2008, MOL CELL PROTEOMICS, V7, P1530, DOI 10.1074/mcp.M800051-MCP200; Yu W, 2001, J BIOSCI BIOENG, V92, P590, DOI 10.1263/jbb.92.590; Nishimura K, 2009, LANGMUIR, V25, P10439, DOI 10.1021/la902237y; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Kurihara K, 2011, NAT CHEM, V3, P775, DOI [10.1038/nchem.1127, 10.1038/NCHEM.1127]; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Karig DK, 2013, ACS SYNTH BIOL, V2, P497, DOI 10.1021/sb400028c; Saito H, 2009, CHEMBIOCHEM, V10, P1640, DOI 10.1002/cbic.200900205; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Hase M, 2007, LANGMUIR, V23, P348, DOI 10.1021/la0618521; Luisi PL, 2007, CHEM BIODIVERS, V4, P603, DOI 10.1002/cbdv.200790053; de Souza TP, 2009, CHEMBIOCHEM, V10, P1056, DOI 10.1002/cbic.200800810; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Stano P, 2010, CHEM COMMUN, V46, P3639, DOI 10.1039/b913997d; Pautot S, 2003, LANGMUIR, V19, P2870, DOI 10.1021/la026100v; Fujii S, 2013, P NATL ACAD SCI USA, V110, P16796, DOI 10.1073/pnas.1314585110; Paleos CM, 2011, CHEMBIOCHEM, V12, P510, DOI 10.1002/cbic.201000614; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; OBERHOLZER T, 1995, CHEM BIOL, V2, P677, DOI 10.1016/1074-5521(95)90031-4; Zhu TF, 2009, J AM CHEM SOC, V131, P5705, DOI 10.1021/ja900919c; Walde P, 2010, CHEMBIOCHEM, V11, P848, DOI 10.1002/cbic.201000010; Kita H, 2008, CHEMBIOCHEM, V9, P2403, DOI 10.1002/cbic.200800360; LASIC DD, 1988, BIOCHEM J, V256, P1; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Fischer A, 2002, CHEMBIOCHEM, V3, P409, DOI 10.1002/1439-7633(20020503)3:5<409::AID-CBIC409>3.0.CO;2-P; de Souza TP, 2011, CHEMBIOCHEM, V12, P2325, DOI 10.1002/cbic.201100306; Oberholzer T, 1999, BIOCHEM BIOPH RES CO, V261, P238, DOI 10.1006/bbrc.1999.0404; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Nomura S, 2003, CHEMBIOCHEM, V4, P1172, DOI 10.1002/cbic.200300630; Mercier R, 2013, CELL, V152, P997, DOI 10.1016/j.cell.2013.01.043; Tsuru S, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036015; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Briers Y, 2012, BIOESSAYS, V34, P1078, DOI 10.1002/bies.201200080; Calviello L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S7; Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090; Hosoda K, 2008, LANGMUIR, V24, P13540, DOI 10.1021/la802432f; Jewett MC, 2010, CURR OPIN BIOTECH, V21, P697, DOI 10.1016/j.copbio.2010.06.008; Matsuura T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.50; Nishikawa T., 2012, J NUCL ACIDS, V2012; Nishimura K, 2012, LANGMUIR, V28, P8426, DOI 10.1021/la3001703; Pantazis Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-311; Schrum JP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002212; Segre D, 2000, EMBO REP, V1, P217, DOI 10.1093/embo-reports/kvd063; Terasawa H, 2012, P NATL ACAD SCI USA, V109, P5942, DOI 10.1073/pnas.1120327109; Zhu TF, 2012, P NATL ACAD SCI USA, V109, P9828, DOI 10.1073/pnas.1203212109	53	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	MAY	2015	4	5					566	576		10.1021/sb500249g		11	Biochemical Research Methods	Biochemistry & Molecular Biology	CI6ZP	WOS:000354913000009		
J	Akter, F; Yokobayashi, Y				Akter, Farhima; Yokobayashi, Yohei			RNA Signal Amplifier Circuit with Integrated Fluorescence Output	ACS SYNTHETIC BIOLOGY			English	Article						RNA engineering; RNA circuit; Spinach aptamer; signal amplification	DI-GMP; PROTEIN; MIMICS	We designed an in vitro signal amplification circuit that takes a short RNA input that catalytically activates the Spinach RNA aptamer to produce a fluorescent output The circuit consists of three RNA strands: an internally blocked Spinach aptamer, a fuel strand, and an input strand (catalyst), as well as the Spinach aptamer ligand 3,5-difluoro-4-hydroxylbenzylidene imidazolinone (DFHBI). The input strand initially displaces the internal inhibitory strand to activate the fluorescent aptamer while exposing a toehold to which the fuel strand can bind to further displace and recycle the input strand. Under a favorable condition, one input strand was able to activate up to five molecules of the internally blocked Spinach aptamer in 185 min at 30 degrees C. The simple RNA circuit reported here serves as a model for catalytic activation of arbitrary RNA effectors by chemical triggers.	[Akter, Farhima; Yokobayashi, Yohei] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Yokobayashi, Yohei] Okinawa Inst Sci & Technol Grad Univ, Nucle Acid Chem & Engn Unit, Onna Son, Okinawa 9040495, Japan	Yokobayashi, Y (reprint author), Univ Calif Davis, Dept Biomed Engn, 451 Hlth Sci Dr, Davis, CA 95616 USA.	yoko@ucdavis.edu	Yokobayashi, Yohei/B-5898-2009	Yokobayashi, Yohei/0000-0002-2417-1934	National Institutes of Health [GM099748]	National Institutes of Health (GM099748)	Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Bhadra S, 2014, RNA, V20, P1183, DOI 10.1261/rna.045047.114; Hochrein LM, 2013, J AM CHEM SOC, V135, P17322, DOI 10.1021/ja404676x; Nakayama S, 2012, CHEM COMMUN, V48, P9059, DOI 10.1039/c2cc34379g; Song WJ, 2013, NAT METHODS, V10, P873, DOI [10.1038/nmeth.2568, 10.1038/NMETH.2568]; Paige JS, 2012, SCIENCE, V335, P1194, DOI 10.1126/science.1218298; Bhadra S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku074; Huang H, 2014, NAT CHEM BIOL, V10, P686, DOI [10.1038/nchembio.1561, 10.1038/NCHEMBIO.1561]; Kellenberger CA, 2013, J AM CHEM SOC, V135, P4906, DOI 10.1021/ja311960g; Warner KD, 2014, NAT STRUCT MOL BIOL, V21, P658, DOI 10.1038/nsmb.2865; Li BL, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr504	11	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	MAY	2015	4	5					655	658		10.1021/sb500314r		4	Biochemical Research Methods	Biochemistry & Molecular Biology	CI6ZP	WOS:000354913000018		
J	Escobar, MS; Kaneko, H; Funatsu, K				Escobar, Matheus S.; Kaneko, Hiromasa; Funatsu, Kimito			Combined generative topographic mapping and graph theory unsupervised approach for nonlinear fault identification	AICHE JOURNAL			English	Article						generative topographic mapping; graph theory; fault identification; process monitoring; nonlinear systems	PRINCIPAL COMPONENT ANALYSIS; STATISTICAL PROCESS-CONTROL; APPLICABILITY DOMAIN; INDUSTRIAL-PROCESS; SOFT SENSORS; PCA; MACHINE; MIXTURE; MODELS	Identifying anomalies in chemical processes is highly desirable. Usually, one relies on previous knowledge of normal and faulty samples, excluding anomalies from model training and associating deviations to faults. How reliable is such knowledge, however, is questionable, especially during atypical scenarios. Unsupervised approaches, using no labels, provide an unbiased analysis. A generative topographic mapping (GTM) and graph theory combined approach, then, is proposed for unsupervised fault identification. GTM, given its probabilistic nature, highlights system features, reducing variable dimensionality. With this information, correlation between samples is calculated. Graph theory, then, generates a network, clustering similar samples. Two anomaly cases are analyzed: an artificial dataset and Tennessee Eastman Process. Principal component analysis (PCA) and Dynamic PCA indexes Q and T-2 along GTM and graph theory-independent monitoring methodologies are used for comparison, considering supervised and unsupervised approaches. The proposed method performed similarly to all supervised methodologies, motivating its application and developments. (c) 2015 American Institute of Chemical Engineers AIChE J, 61: 1559-1571, 2015	[Escobar, Matheus S.; Kaneko, Hiromasa; Funatsu, Kimito] Univ Tokyo, Chem Syst Engn Dept, Bunkyo Ku, Tokyo 1138656, Japan	Funatsu, K (reprint author), Univ Tokyo, Chem Syst Engn Dept, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138656, Japan.	funatsu@chemsys.t.u-tokyo.ac.jp			Core Research for Evolutionary Science and Technology (CREST) project 'Development of a knowledge-generating platform driven by big data in drug discovery through production processes' of the Japan Science and Technology Agency (JST)	The author acknowledges the support of the Core Research for Evolutionary Science and Technology (CREST) project 'Development of a knowledge-generating platform driven by big data in drug discovery through production processes' of the Japan Science and Technology Agency (JST).	Kaneko H, 2013, AICHE J, V59, P2046, DOI 10.1002/aic.14010; Russell EL, 2000, CHEMOMETR INTELL LAB, V51, P81, DOI 10.1016/S0169-7439(00)00058-7; Lee JM, 2004, CHEM ENG SCI, V59, P223, DOI 10.1016/j.ces.2003.09.012; Kourti T, 2005, INT J ADAPT CONTROL, V19, P213, DOI 10.1002/acs.859; Ge ZQ, 2013, IND ENG CHEM RES, V52, P1947, DOI 10.1021/ie301945s; Bersimis S, 2007, QUAL RELIAB ENG INT, V23, P517, DOI 10.1002/qre.829; Chiang LH, 2000, CHEMOMETR INTELL LAB, V50, P243, DOI 10.1016/S0169-7439(99)00061-1; Li WH, 2000, J PROCESS CONTR, V10, P471, DOI 10.1016/S0959-1524(00)00022-6; Kittiwachana S, 2010, J CHEMOMETR, V24, P96, DOI 10.1002/cem.1281; Yu JB, 2013, MECH SYST SIGNAL PR, V37, P293, DOI 10.1016/j.ymssp.2013.01.010; Ku WF, 1995, CHEMOMETR INTELL LAB, V30, P179, DOI 10.1016/0169-7439(95)00076-3; Yu J, 2008, AICHE J, V54, P1811, DOI 10.1002/aic.11515; Bishop CM, 1998, NEURAL COMPUT, V10, P215, DOI 10.1162/089976698300017953; Arakawa M, 2008, J COMPUT AIDED CHEM, V9, P70, DOI 10.2751/jcac.9.70; Bastian M., 2009, INT AAAI C WEBL SOC; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Chen Q, 2004, CONTROL ENG PRACT, V12, P745, DOI 10.1016/J.conegprac.2003.08.004; Choi SW, 2005, IND ENG CHEM RES, V44, P2316, DOI 10.1021/ie049081o; DOWNS JJ, 1993, COMPUT CHEM ENG, V17, P245, DOI 10.1016/0098-1354(93)80018-I; Escobar MS, 2014, CHEMOMETR INTELL LAB, V137, P33, DOI 10.1016/j.chemolab.2014.06.005; Harary F., 1994, GRAPH THEORY; Jolliffe I., 2002, PRINCIPAL COMPONENT; Kaneko H, 2011, AICHE J, V57, P1506, DOI 10.1002/aic.12351; Kaneko H, 2014, AICHE J, V60, P160, DOI 10.1002/aic.14260; Masuda Y, 2014, IND ENG CHEM RES, V53, P8553, DOI 10.1021/ie501024w; Newman M, 2003, PHYS REV E, V69, P1, DOI DOI 10.1103/PHYSREVE.69.026113; Shen Hua-Wei, 2013, COMMUNITY STRUCTURE; Svensen JFM, 1998, GTM GENERATIVE TOPOG; Wasserman S., 1994, SOCIAL NETWORK ANAL; Wieling M, 2011, COMPUT SPEECH LANG, V25, P700, DOI 10.1016/j.csl.2010.05.004	30	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-1541	1547-5905		AICHE J	AICHE J.	MAY	2015	61	5					1559	1571		10.1002/aic.14748		13	Engineering, Chemical	Engineering	CI4DF	WOS:000354696200009		
J	Meng, L; Yu, X; Niimi, T; Nagasawa, H; Kanezashi, M; Yoshioka, T; Tsuru, T				Meng, Lie; Yu, Xin; Niimi, Takuya; Nagasawa, Hiroki; Kanezashi, Masakoto; Yoshioka, Tomohisa; Tsuru, Toshinori			Methylcyclohexane dehydrogenation for hydrogen production via a bimodal catalytic membrane reactor	AICHE JOURNAL			English	Article						membrane reactor; organosilica membrane; methylcyclohexane dehydrogenation; hydrogen production	AMORPHOUS SILICA MEMBRANES; PARTIAL OXIDATION; HYDROTHERMAL STABILITY; AMMONIA DECOMPOSITION; METHANE; SEPARATION; STORAGE; SYNGAS; CYCLOHEXANE; PERFORMANCE	The dehydrogenation of methylcyclohexane (MCH) to toluene (TOL) for hydrogen production was theoretically and experimentally investigated in a bimodal catalytic membrane reactor (CMR), that combined Pt/Al2O3 catalysts with a hydrogen-selective organosilica membrane prepared via sol-gel processing using bis(triethoxysilyl) ethane (BTESE). Effects of operating conditions on the membrane reactor performance were systematically investigated, and the experimental results were in good agreement with those calculated by a simulation model with a fitted catalyst loading. With H-2 extraction from the reaction stream to the permeate stream, MCH conversion at 250 degrees C was significantly increased beyond the equilibrium conversion of 0.44-0.86. Because of the high H-2 selectivity and permeance of BTESE-derived membranes, a H-2 flow with purity higher than 99.8% was obtained in the permeate stream, and the H-2 recovery ratio reached 0.99 in a pressurized reactor. A system that combined the CMR with a fixed-bed prereactor was proposed for MCH dehydrogenation. (c) 2015 American Institute of Chemical Engineers AIChE J, 61: 1628-1638, 2015	[Meng, Lie; Yu, Xin; Niimi, Takuya; Nagasawa, Hiroki; Kanezashi, Masakoto; Yoshioka, Tomohisa; Tsuru, Toshinori] Hiroshima Univ, Grad Sch Engn, Dept Chem Engn, Higashihiroshima 7398527, Japan	Tsuru, T (reprint author), Hiroshima Univ, Grad Sch Engn, Dept Chem Engn, 1-4-1 Kagami Yama, Higashihiroshima 7398527, Japan.	tsuru@hiroshima-u.ac.jp	Nagasawa, Hiroki/D-7613-2012; Meng, Lie/F-3280-2013; Kanezashi, Masakoto/G-3938-2010	Nagasawa, Hiroki/0000-0001-7972-2425; Meng, Lie/0000-0003-4770-9589; 			Akamatsu K, 2008, IND ENG CHEM RES, V47, P9842, DOI 10.1021/ie800786h; ALI JK, 1994, CHEM ENG SCI, V49, P2129, DOI 10.1016/0009-2509(94)E0035-O; Amirabadi S, 2013, IND ENG CHEM RES, V52, P1508, DOI 10.1021/ie301583w; Paturzo L, 2002, REV CHEM ENG, V18, P511; McLeary EE, 2006, MICROPOR MESOPOR MAT, V90, P198, DOI 10.1016/j.micromeso.2005.10.050; Lee HR, 2011, AICHE J, V57, P2755, DOI 10.1002/aic.12501; Teichmann D, 2011, ENERG ENVIRON SCI, V4, P2767, DOI 10.1039/c1ee01454d; Grochala W, 2004, CHEM REV, V104, P1283, DOI 10.1021/cr030691s; Kanezashi M, 2009, J AM CHEM SOC, V131, P414, DOI 10.1021/ja806762q; Funke HH, 1997, IND ENG CHEM RES, V36, P137, DOI 10.1021/ie960472f; Ali JK, 1997, APPL CATAL A-GEN, V155, P41, DOI 10.1016/S0926-860X(96)00343-2; Anderson M, 2013, AICHE J, V59, P2207, DOI 10.1002/aic.14103; Tsuru T, 2004, AICHE J, V50, P2794, DOI 10.1002/aic.10215; Li G, 2013, AICHE J, V59, P168, DOI 10.1002/aic.13794; Tsuru T, 2006, APPL CATAL A-GEN, V302, P78, DOI 10.1016/j.apcata.2005.12.029; Akamatsu K, 2009, J MEMBRANE SCI, V330, P1, DOI 10.1016/j.memsci.2008.12.044; Criscuoli A, 2001, J MEMBRANE SCI, V181, P21, DOI 10.1016/S0376-7388(00)00374-4; Julbe A, 2001, J MEMBRANE SCI, V181, P3, DOI 10.1016/S0376-7388(00)00375-6; Usman M, 2012, IND ENG CHEM RES, V51, P158, DOI 10.1021/ie201539v; Tsai CY, 1997, AICHE J, V43, P2741, DOI 10.1002/aic.690431320; Kanezashi M, 2010, J MEMBRANE SCI, V348, P310, DOI 10.1016/j.memsci.2009.11.014; Oda K, 2010, IND ENG CHEM RES, V49, P11287, DOI 10.1021/ie101210x; Palo DR, 2007, CHEM REV, V107, P3992, DOI 10.1021/cr050198b; Alhumaidan F, 2011, ENERG FUEL, V25, P4217, DOI 10.1021/ef200829x; Armor JN, 1998, J MEMBRANE SCI, V147, P217, DOI 10.1016/S0376-7388(98)00124-0; Tsuru T, 2008, J MEMBRANE SCI, V316, P53, DOI 10.1016/j.memsci.2007.10.057; Niimi T, 2014, J MEMBRANE SCI, V455, P375, DOI 10.1016/j.memsci.2014.01.003; Turner JA, 2004, SCIENCE, V305, P972, DOI 10.1126/science.1103197; Wei YY, 2013, CHEM ENG J, V220, P185, DOI 10.1016/j.cej.2013.01.048; Gallucci F, 2004, INT J HYDROGEN ENERG, V29, P611, DOI 10.1016/j.ijhydene.2003.08.003; Jiang H, 2011, IND ENG CHEM RES, V50, P10458, DOI 10.1021/ie200398g; Crabtree RH, 2008, ENERG ENVIRON SCI, V1, P134, DOI 10.1039/b805644g; Augustine AS, 2011, INT J HYDROGEN ENERG, V36, P5350, DOI 10.1016/j.ijhydene.2011.01.172; Jeong BH, 2003, J MEMBRANE SCI, V224, P151, DOI 10.1016/j.memsci.2003.08.004; Li G, 2012, INT J HYDROGEN ENERG, V37, P12105, DOI 10.1016/j.ijhydene.2012.05.132; Baker R., 2004, MEMBRANE TECHNOLOGY; Coronas J, 2004, TOP CATAL, V29, P29, DOI 10.1023/B:TOCA.0000024926.42080.a7; Ferreira-Aparicio P, 2002, J CATAL, V212, P182, DOI 10.1006/jcat.2002.3786; ITOH N, 1987, AICHE J, V33, P1576, DOI 10.1002/aic.690330921; Jin WQ, 2000, J MEMBRANE SCI, V166, P13, DOI 10.1016/S0376-7388(99)00245-8; Kniep J, 2011, IND ENG CHEM RES, V50, P7941, DOI 10.1021/ie2001346; Li G, 2013, INT J HYDROGEN ENERG, V38, P15302, DOI 10.1016/j.ijhydene.2013.09.104; Li G, 2013, IND ENG CHEM RES, V52, P13325, DOI 10.1021/ie401306q; Li K., 2007, CERAMIC MEMBRANES SE; Li N. N., 2008, ADV MEMBRANE TECHNOL; OKUBO T, 1991, IND ENG CHEM RES, V30, P614, DOI 10.1021/ie00052a002; Tsuru T, 2011, J JPN PETROL INST, V54, P277, DOI 10.1627/jpi.54.277	47	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-1541	1547-5905		AICHE J	AICHE J.	MAY	2015	61	5					1628	1638		10.1002/aic.14764		11	Engineering, Chemical	Engineering	CI4DF	WOS:000354696200015		
J	Kinoshita, M; Tanaka, H; Arita, H; Goto, Y; Oshino, S; Watanabe, Y; Yoshimine, T; Saitoh, Y				Kinoshita, M.; Tanaka, H.; Arita, H.; Goto, Y.; Oshino, S.; Watanabe, Y.; Yoshimine, T.; Saitoh, Y.			Pituitary-Targeted Dynamic Contrast-Enhanced Multisection CT for Detecting MR Imaging-Occult Functional Pituitary Microadenoma	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							CUSHINGS-DISEASE; LOCALIZATION; PETROSAL	BACKGROUND AND PURPOSE: Although resection of a tumor by trans-sphenoidal surgery is considered the criterion standard for successful surgical treatment of functional pituitary microadenoma, MR imaging occasionally fails to visualize and identify the tumor and supplementary imaging modalities are necessary. We tested the possibility of dynamic contrast-enhanced multisection CT of the pituitary gland accompanying image reconstruction of contrast agent dynamics to identify the localizations of microadenomas and compared the diagnostic performance with conventional pituitary-targeted MR imaging. MATERIALS AND METHODS: Twenty-eight patients with surgically confirmed functional pituitary microadenomas (including growth hormone, adrenocorticotropic hormone, and prolactin-secreting adenomas) who underwent pituitary-targeted dynamic contrast-enhanced multisection CT were retrospectively investigated. We undertook image reconstruction of the dynamics of the contrast agent around the pituitary gland in a voxelwise manner, visualizing any abnormality and enabling qualification of contrast dynamics within the tumor. RESULTS: Fifteen cases were correctly diagnosed by MR imaging, while dynamic contrast-enhanced multisection CT correctly diagnosed 26 cases. The accuracy of localization was markedly better for adrenocorticotropic hormone secreting microadenomas, increasing from 32% on MR imaging to 85% by dynamic contrast-enhanced multisection CT. Compared with the normal pituitary gland, adrenocorticotropic hormone secreting adenoma showed the least difference in contrast enhancement of the different functional microadenomas. Images acquired at 45-60 seconds after contrast agent injection showed the largest difference in contrast enhancement between an adenoma and the normal pituitary gland. CONCLUSIONS: Dynamic contrast-enhanced multisection CT combined with image reconstruction of the contrast-enhanced dynamic's holds promise in detecting MR imaging occult pituitary microadenomas.	[Kinoshita, M.; Arita, H.; Goto, Y.; Oshino, S.; Yoshimine, T.; Saitoh, Y.] Osaka Univ, Grad Sch Med, Dept Neurosurg, Osaka, Japan; [Tanaka, H.; Watanabe, Y.] Osaka Univ, Grad Sch Med, Dept Radiol, Osaka, Japan; [Kinoshita, M.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Neurosurg, Osaka, Japan; [Saitoh, Y.] Osaka Univ, Grad Sch Med, Dept Neuromodulat & Neurosurg, Ctr Med Innovat & Translat Res, Suita, Osaka 5650871, Japan	Saitoh, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Neuromodulat & Neurosurg, Ctr Med Innovat & Translat Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	neurosaitoh@mbk.nifty.com			Aichi Cancer Research Foundation; SENSHIN Medical Research Foundation; Life Science Foundation of Japan; Japan Society for the Promotion of Science KAKENHI [25462256]	This work was supported by the Aichi Cancer Research Foundation, the SENSHIN Medical Research Foundation, the Life Science Foundation of Japan, and the Japan Society for the Promotion of Science KAKENHI (25462256).	Abe T, 2002, ACTA RADIOL, V43, P556, DOI 10.1034/j.1600-0455.2002.430602.x; Batista D, 2006, J CLIN ENDOCR METAB, V91, P221, DOI 10.1210/jc.2005-1096; Ikeda H, 2010, J NEUROSURG, V112, P750, DOI 10.3171/2009.7.JNS09285; Starke RM, 2013, J CLIN ENDOCR METAB, V98, P3190, DOI 10.1210/jc.2013-1036; Lefournier V, 2003, J CLIN ENDOCR METAB, V88, P196, DOI 10.1210/jc.2002-020374; BONNEVILLE JF, 1993, RADIOLOGY, V187, P857; Colao A, 2014, ENDOCRINE, V47, P9, DOI 10.1007/s12020-013-0129-2; Kasaliwal R, 2013, CLIN ENDOCRINOL, V78, P825, DOI 10.1111/cen.12069; Lee HB, 2012, EUR RADIOL, V22, P514, DOI 10.1007/s00330-011-2291-3; Portocarrero-Ortiz L, 2010, PITUITARY, V13, P230, DOI 10.1007/s11102-010-0222-y; Suda K, 2013, ENDOCR J, V60, P507; Teramoto A, 1998, J NEUROSURG, V89, P762, DOI 10.3171/jns.1998.89.5.0762	12	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAY	2015	36	5					904	908		10.3174/ajnr.A4220		5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CI5VU	WOS:000354828700018		
